PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Reichhardt, T				Reichhardt, T			Curb on foreign computers puts damper on US climate modelling	NATURE			English	News Item																		1997, NATURE, V389, P432	1	1	1	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					373	373		10.1038/16961	http://dx.doi.org/10.1038/16961			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667987	Bronze			2022-12-28	WOS:000078461700003
J	Reichhardt, T				Reichhardt, T			Geophysicists call for action on global warming	NATURE			English	News Item																			0	1	1	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					373	373		10.1038/16961	http://dx.doi.org/10.1038/16961			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667987	Bronze			2022-12-28	WOS:000078461700004
J	Armstrong, K				Armstrong, Katrina			If You Can't Beat It, Join It: Uncertainty and Trust in Medicine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							EXPRESSIONS; EXCHANGE		[Armstrong, Katrina] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Armstrong, K (corresponding author), Massachusetts Gen Hosp, Dept Med, Grey Bigelow 7th Floor,55 Fruit St, Boston, MA 02114 USA.	karmstrong6@mgh.harvard.edu						BIANCO W, 1998, TRUST GOVERNANCE, V1, P245; Epstein RM, 2007, J GEN INTERN MED, V22, P1731, DOI 10.1007/s11606-007-0416-9; Gordon GH, 2000, PATIENT EDUC COUNS, V40, P59, DOI 10.1016/S0738-3991(99)00069-5; Hardin R., 2001, TRUST SOC, P3; Hunter DJ, 2016, NEW ENGL J MED, V375, P711, DOI 10.1056/NEJMp1608282; KOLLOCK P, 1994, AM J SOCIOL, V100, P313, DOI 10.1086/230539; Molm LD, 2000, AM J SOCIOL, V105, P1396, DOI 10.1086/210434; Nelson W, 2008, ANN BEHAV MED, V35, P261, DOI 10.1007/s12160-008-9037-8; Ransohoff DF, 1997, ANN INTERN MED, V127, P1029, DOI 10.7326/0003-4819-127-11-199712010-00016; Shea JA, 2008, J GEN INTERN MED, V23, P727, DOI 10.1007/s11606-008-0575-3	10	19	19	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2018	168	11					818	+		10.7326/M18-0445	http://dx.doi.org/10.7326/M18-0445			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI3EK	29710210				2022-12-28	WOS:000434254100010
J	Buenrostro, JD; Corces, MR; Lareau, CA; Wu, BJ; Schep, AN; Aryee, MJ; Majeti, R; Chang, HY; Greenleaf, WJ				Buenrostro, Jason D.; Corces, M. Ryan; Lareau, Caleb A.; Wu, Beijing; Schep, Alicia N.; Aryee, Martin J.; Majeti, Ravindra; Chang, Howard Y.; Greenleaf, William J.			Integrated Single-Cell Analysis Maps the Continuous Regulatory Landscape of Human Hematopoietic Differentiation	CELL			English	Article							STEM-CELLS; RNA-SEQ; MYELOID PROGENITORS; LINEAGE COMMITMENT; SELF-RENEWAL; ACCESSIBILITY; CHROMATIN; REVEALS; HETEROGENEITY; ENHANCERS	Human hematopoiesis involves cellular differentiation of multipotent cells into progressively more lineage-restricted states. While the chromatin accessibility landscape of this process has been explored in defined populations, single-cell regulatory variation has been hidden by ensemble averaging. We collected single-cell chromatin accessibility profiles across 10 populations of immunophenotypically defined human hematopoietic cell types and constructed a chromatin accessibility landscape of human hematopoiesis to characterize differentiation trajectories. We find variation consistent with lineage bias toward different developmental branches in multipotent cell types. We observe heterogeneity within common myeloid progenitors (CMPs) and granulocyte-macrophage progenitors (GMPs) and develop a strategy to partition GMPs along their differentiation trajectory. Furthermore, we integrated single-cell RNA sequencing (scRNA-seq) data to associate transcription factors to chromatin accessibility changes and regulatory elements to target genes through correlations of expression and regulatory element accessibility. Overall, this work provides a framework for integrative exploration of complex regulatory dynamics in a primary human tissue at single-cell resolution.	[Buenrostro, Jason D.; Lareau, Caleb A.; Aryee, Martin J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Buenrostro, Jason D.] Harvard Univ, Harvard Soc Fellows, Cambridge, MA 02138 USA; [Corces, M. Ryan; Chang, Howard Y.; Greenleaf, William J.] Stanford Univ, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Wu, Beijing; Schep, Alicia N.; Chang, Howard Y.; Greenleaf, William J.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Majeti, Ravindra] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Majeti, Ravindra] Stanford Univ, Dept Med, Div Hematol, Sch Med, Stanford, CA 94305 USA; [Chang, Howard Y.] Stanford Univ, Program Epithelial Biol, Sch Med, Stanford, CA 94305 USA; [Greenleaf, William J.] Stanford Univ, Dept Appl Phys, Stanford, CA 94025 USA; [Greenleaf, William J.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Aryee, Martin J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA; [Aryee, Martin J.] Harvard Med Sch, Boston, MA 02115 USA; [Lareau, Caleb A.; Aryee, Martin J.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Buenrostro, JD (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Buenrostro, JD (corresponding author), Harvard Univ, Harvard Soc Fellows, Cambridge, MA 02138 USA.; Greenleaf, WJ (corresponding author), Stanford Univ, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA.; Greenleaf, WJ (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.; Greenleaf, WJ (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.	jbuen@broadinstitute.org; wjg@stanford.edu	Aryee, Martin/AAC-8113-2020; Lareau, Caleb/ABF-9490-2020; Corces, M. Ryan/ABG-6947-2020	Lareau, Caleb/0000-0003-4179-4807; Corces, M. Ryan/0000-0001-7465-7652; Majeti, Ravindra/0000-0002-5814-0984	NIH [P50HG007735, UM1HG009442, U19AI057266]; Stinehart- Reed Foundation; Rita Allen Foundation; Baxter Foundation Faculty Scholar Grant; Human Frontiers Science Program grant [RGY006S]; Chan Zuckerberg Initiative [2017-174468, 2018-182817]; Harvard Society; Broad Institute Fellowship; Allen Distinguished Investigator Program, through The Paul G. Allen Fronteirs Group; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007735, T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stinehart- Reed Foundation; Rita Allen Foundation; Baxter Foundation Faculty Scholar Grant; Human Frontiers Science Program grant; Chan Zuckerberg Initiative; Harvard Society; Broad Institute Fellowship; Allen Distinguished Investigator Program, through The Paul G. Allen Fronteirs Group; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of Greenleaf, Chang, Majeti, and Buenrostro labs for valuable discussions. We acknowledge the C. Bustamante lab for help with sequencing. This work was supported by NIH (P50HG007735 and UM1HG009442 to H.Y.C. and W.J.G. and U19AI057266 to W.J.G.), Stinehart- Reed Foundation (to R.M. and H.Y.C.), the Rita Allen Foundation (to W.J.G.), the Baxter Foundation Faculty Scholar Grant, and the Human Frontiers Science Program grant RGY006S (to W.J.G). W.J.G is a Chan Zuckerberg Biohub investigator and acknowledges grants 2017-174468 and 2018-182817 from the Chan Zuckerberg Initiative. J.D.B. acknowledges support from the Harvard Society of Fellows and Broad Institute Fellowship. J.D.B. also acknowledges the Allen Distinguished Investigator Program, through The Paul G. Allen Fronteirs Group, for funding. R.M. is a Leukemia and Lymphoma Society Scholar. M.R.C is a Fellow of The Leukemia & Lymphoma Society.	Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Chen L, 2014, SCIENCE, V345, P1580, DOI 10.1126/science.1251033; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Crane GM, 2017, NAT REV IMMUNOL, V17, P573, DOI 10.1038/nri.2017.53; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Espin-Palazon R, 2014, CELL, V159, P1070, DOI 10.1016/j.cell.2014.10.031; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Farlik M, 2016, CELL STEM CELL, V19, P808, DOI 10.1016/j.stem.2016.10.019; Frelin C, 2013, NAT IMMUNOL, V14, P1037, DOI 10.1038/ni.2692; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Grun D, 2016, CELL STEM CELL, V19, P266, DOI 10.1016/j.stem.2016.05.010; Guo MH, 2017, P NATL ACAD SCI USA, V114, pE327, DOI 10.1073/pnas.1619052114; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Javierre BM, 2016, CELL, V167, P1369, DOI 10.1016/j.cell.2016.09.037; Karamitros D, 2018, NAT IMMUNOL, V19, P85, DOI 10.1038/s41590-017-0001-2; Kelsey G, 2017, SCIENCE, V358, P69, DOI 10.1126/science.aan6826; Laurenti E, 2018, NATURE, V553, P418, DOI 10.1038/nature25022; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; Li HP, 2017, NAT GENET, V49, P708, DOI 10.1038/ng.3818; Long HK, 2016, CELL, V167, P1170, DOI 10.1016/j.cell.2016.09.018; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Matsuoka Y, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.22; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pei WK, 2017, NATURE, V548, P456, DOI 10.1038/nature23653; Perie L, 2015, CELL, V163, P1655, DOI 10.1016/j.cell.2015.11.059; Regev A, 2017, ELIFE, V6, DOI 10.7554/eLife.27041; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Sawamiphak S, 2014, DEV CELL, V31, P640, DOI 10.1016/j.devcel.2014.11.007; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Waddington C H, 1957, STRATEGY GENES DISCU; Woodworth MB, 2017, NAT REV GENET, V18, P230, DOI 10.1038/nrg.2016.159; Yu VWC, 2016, CELL, V167, P1310, DOI 10.1016/j.cell.2016.10.045; Zhao C, 2012, STEM CELLS, V30, P709, DOI 10.1002/stem.1050; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	49	270	275	6	94	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2018	173	6					1535	+		10.1016/j.cell.2018.03.074	http://dx.doi.org/10.1016/j.cell.2018.03.074			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GH9KU	29706549	Bronze, Green Accepted			2022-12-28	WOS:000433989100023
J	Coquel, F; Silva, MJ; Techer, H; Zadorozhny, K; Sharma, S; Nieminuszczy, J; Mettling, C; Dardillac, E; Barthe, A; Schmitz, AL; Promonet, A; Cribier, A; Sarrazin, A; Niedzwiedz, W; Lopez, B; Costanzo, V; Krejci, L; Chabes, A; Benkirane, M; Lin, YL; Pasero, P				Coquel, Flavie; Silva, Maria-Joao; Techer, Herve; Zadorozhny, Karina; Sharma, Sushma; Nieminuszczy, Jadwiga; Mettling, Clement; Dardillac, Elodie; Barthe, Antoine; Schmitz, Anne-Lyne; Promonet, Alexy; Cribier, Alexandra; Sarrazin, Amelie; Niedzwiedz, Wojciech; Lopez, Bernard; Costanzo, Vincenzo; Krejci, Lumir; Chabes, Andrei; Benkirane, Monsef; Lin, Yea-Lih; Pasero, Philippe			SAMHD1 acts at stalled replication forks to prevent interferon induction	NATURE			English	Article							AICARDI-GOUTIERES SYNDROME; RESTRICTION FACTOR SAMHD1; CYTOSOLIC DNA SENSOR; HIV-1 RESTRICTION; NUCLEASE ACTIVITY; MAMMALIAN-CELLS; END RESECTION; PROTEIN; STABILITY; REPAIR	SAMHD1 was previously characterized as a dNTPase that protects cells from viral infections. Mutations in SAMHD1 are implicated in cancer development and in a severe congenital inflammatory disease known as Aicardi-Goutieres syndrome. The mechanism by which SAMHD1 protects against cancer and chronic inflammation is unknown. Here we show that SAMHD1 promotes degradation of nascent DNA at stalled replication forks in human cell lines by stimulating the exonuclease activity of MRE11. This function activates the ATR-CHK1 checkpoint and allows the forks to restart replication. In SAMHD1-depleted cells, single-stranded DNA fragments are released from stalled forks and accumulate in the cytosol, where they activate the cGAS-STING pathway to induce expression of pro-inflammatory type I interferons. SAMHD1 is thus an important player in the replication stress response, which prevents chronic inflammation by limiting the release of single-stranded DNA from stalled replication forks.	[Coquel, Flavie; Silva, Maria-Joao; Barthe, Antoine; Schmitz, Anne-Lyne; Promonet, Alexy; Costanzo, Vincenzo; Lin, Yea-Lih; Pasero, Philippe] Univ Montpellier, Lab Maintien Integr Genome Cours Repl, Inst Genet Humaine, CNRS,Ligue Canc, Montpellier, France; [Techer, Herve] IFOM, Milan, Italy; [Zadorozhny, Karina; Krejci, Lumir] Masaryk Univ, Dept Biol, Brno, Czech Republic; [Zadorozhny, Karina; Krejci, Lumir] Masaryk Univ, Natl Ctr Biomol Res, Brno, Czech Republic; [Sharma, Sushma; Chabes, Andrei] Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden; [Sharma, Sushma; Chabes, Andrei] Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden; [Nieminuszczy, Jadwiga; Niedzwiedz, Wojciech] Inst Canc Res, London, England; [Mettling, Clement] Univ Montpellier, Inst Genet Humaine, CNRS, Domiciliat Activat Immunitaire & Infect, Montpellier, France; [Dardillac, Elodie; Lopez, Bernard] Univ Paris Sud, CNRS, UMR 8200, Villejuif, France; [Dardillac, Elodie; Lopez, Bernard] Univ Paris Sud, Inst Cancerol Gustave Roussy, Ligue Canc, Villejuif, France; [Cribier, Alexandra; Benkirane, Monsef] Univ Montpellier, CNRS, Inst Genet Humaine, Lab Virol Mol, Montpellier, France; [Sarrazin, Amelie] Univ Montpellier, CNRS, BioCampus Montpellier, Montpellier, France; [Krejci, Lumir] St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic; [Silva, Maria-Joao] Peter MacCallum Canc Ctr, East Melbourne, Vic, Australia	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; IFOM - FIRC Institute of Molecular Oncology; Masaryk University Brno; Masaryk University Brno; Umea University; Umea University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; St Anne's University Hospital Brno (FNUSA-ICRC); Peter Maccallum Cancer Center	Lin, YL; Pasero, P (corresponding author), Univ Montpellier, Lab Maintien Integr Genome Cours Repl, Inst Genet Humaine, CNRS,Ligue Canc, Montpellier, France.	ylin@igh.cnrs.fr; ppasero@igh.cnrs.fr	Lopez, Bernard S/O-7308-2017; Técher, Hervé/ABG-3769-2020; Pasero, Philippe/O-2340-2018; Krejci, Lumir/B-7842-2009	Lopez, Bernard S/0000-0001-5088-0155; Técher, Hervé/0000-0002-4161-0791; Pasero, Philippe/0000-0001-5891-0822; Krejci, Lumir/0000-0002-4732-1405; COQUEL, Flavie/0000-0002-6953-3409; Costanzo, Vincenzo/0000-0002-2920-9508; Chabes, Andrei/0000-0003-1708-8259; Sharma, Sushma/0000-0003-2713-5813; Silva, Maria Joao/0000-0003-0803-6561; Mettling, Clement/0000-0002-4963-2928; niedzwiedz, wojciech/0000-0002-8518-6304	Agence Nationale pour la Recherche (ANR); Institut National du Cancer (INCa); Ligue Contre le Cancer (equipe labellisee); Canceropole Grand Sud-ouest; SIRIC Montpellier Cancer; MSDAvenir fund; Medical Research Council; Institute of Cancer Research; Swedish Cancer Society; Swedish Research Council; Czech Science Foundation [GACR 17-17720S, 13-26629S]; National Program of Sustainability II (MEYS CR) [LQ1605]; CNRS, Region LR; Fondation ARC; French MRES; Fondation Recherche Medicale; Associazione Italiana per Ricerca sul Cancro (AIRC); European Research Council (ERC) Consolidator Grant [614541]; Armenise-Harvard Foundation career development award; AICR Worldwide Cancer Research award [13-0026]	Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Ligue Contre le Cancer (equipe labellisee); Canceropole Grand Sud-ouest; SIRIC Montpellier Cancer; MSDAvenir fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institute of Cancer Research; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Czech Science Foundation(Grant Agency of the Czech Republic); National Program of Sustainability II (MEYS CR); CNRS, Region LR; Fondation ARC; French MRES; Fondation Recherche Medicale; Associazione Italiana per Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); European Research Council (ERC) Consolidator Grant(European Research Council (ERC)); Armenise-Harvard Foundation career development award; AICR Worldwide Cancer Research award	We thank N. Laguette, G. Uze, F. van Kuppeveld and S. Paludan for reagents and cell lines. We also thank J. Cau and the MRI Imaging facility for help with image analysis and the DNA combing facility of Montpellier for silanized coverslips. We thank A. Constantinou, D. Maiorano, B. Pardo, M. Moriel-Carretero and H. Tourriere for discussions and C. Featherstone for professional editing. This work was supported by grants from the Agence Nationale pour la Recherche (ANR) and Institut National du Cancer (INCa) to P.P. and B.L., the Ligue Contre le Cancer (equipe labellisee), Canceropole Grand Sud-ouest and SIRIC Montpellier Cancer to P.P. and the MSDAvenir fund to P.P. and M. B. Work in W.N.'s laboratory is supported by funding from the Medical Research Council and the Institute of Cancer Research. Work in A.C.'s laboratory is supported by the Swedish Cancer Society and the Swedish Research Council. Work in L.K.'s laboratory is supported by the Czech Science Foundation grants (GACR 17-17720S and 13-26629S) and project no. LQ1605 from the National Program of Sustainability II (MEYS CR). M. J. S. was supported by fellowships from CNRS, Region LR and Fondation ARC. F. C. is supported by a fellowship from the French MRES and from Fondation Recherche Medicale. This work was also funded by the Associazione Italiana per Ricerca sul Cancro (AIRC), the European Research Council (ERC) Consolidator Grant 614541, an Armenise-Harvard Foundation career development award and an AICR Worldwide Cancer Research award (13-0026) to V.C.	Bartsch K, 2017, HUM MOL GENET, V26, P3960, DOI 10.1093/hmg/ddx283; Beloglazova N, 2013, J BIOL CHEM, V288, P8101, DOI 10.1074/jbc.M112.431148; Betous R, 2012, GENE DEV, V26, P151, DOI 10.1101/gad.178459.111; Chaudhuri AR, 2016, NATURE, V535, P382, DOI 10.1038/nature18325; Clifford R, 2014, BLOOD, V123, P1021, DOI 10.1182/blood-2013-04-490847; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Cruz-Garcia A, 2014, CELL REP, V9, P451, DOI 10.1016/j.celrep.2014.08.076; Daddacha W, 2017, CELL REP, V20, P1921, DOI 10.1016/j.celrep.2017.08.008; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Garcin G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4016; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gunn A, 2011, J BIOL CHEM, V286, P42470, DOI 10.1074/jbc.M111.309252; Hansen EC, 2014, P NATL ACAD SCI USA, V111, pE1843, DOI 10.1073/pnas.1401706111; Hartlova A, 2015, IMMUNITY, V42, P332, DOI 10.1016/j.immuni.2015.01.012; Hashimoto Y, 2011, METHODS MOL BIOL, V745, P437, DOI 10.1007/978-1-61779-129-1_25; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; Ho SSW, 2016, IMMUNITY, V44, P1177, DOI 10.1016/j.immuni.2016.04.010; Holm CK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10680; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Jazayeri A, 2008, EMBO J, V27, P1953, DOI 10.1038/emboj.2008.128; Jia Shaodong, 2015, Methods Mol Biol, V1300, P113, DOI 10.1007/978-1-4939-2596-4_8; Kolinjivadi AM, 2017, MOL CELL, V67, P867, DOI 10.1016/j.molcel.2017.07.001; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Langereis MA, 2015, J VIROL, V89, P11169, DOI 10.1128/JVI.01781-15; Lee J, 2013, MOL BIOL CELL, V24, P1343, DOI 10.1091/mbc.E13-01-0025; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Lim YW, 2015, ELIFE, V4, DOI 10.7554/eLife.08007; Lin YL, 2004, HUM GENE THER, V15, P588, DOI 10.1089/104303404323142033; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Maelfait J, 2016, CELL REP, V16, P1492, DOI 10.1016/j.celrep.2016.07.002; Marini V, 2012, DNA REPAIR, V11, P789, DOI 10.1016/j.dnarep.2012.05.007; Matulova P, 2009, J BIOL CHEM, V284, P7733, DOI 10.1074/jbc.M806192200; Pasero P, 2017, ANNU REV GENET, V51, P477, DOI 10.1146/annurev-genet-120116-024745; Pinto C, 2016, ELIFE, V5, DOI 10.7554/eLife.18574; Rentoft M, 2016, P NATL ACAD SCI USA, V113, P4723, DOI 10.1073/pnas.1519128113; Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626; Sannino V, 2017, METHOD ENZYMOL, V591, P211, DOI 10.1016/bs.mie.2017.03.018; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Seamon KJ, 2015, NUCLEIC ACIDS RES, V43, P6486, DOI 10.1093/nar/gkv633; Shen YJ, 2015, CELL REP, V11, P460, DOI 10.1016/j.celrep.2015.03.041; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; Wolf C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11752; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Zadorozhny K, 2017, CELL REP, V21, P333, DOI 10.1016/j.celrep.2017.09.062; Zellweger R, 2015, J CELL BIOL, V208, P563, DOI 10.1083/jcb.201406099; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhao K, 2013, CELL REP, V4, P1108, DOI 10.1016/j.celrep.2013.08.019	51	202	214	2	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2018	557	7703					57	+		10.1038/s41586-018-0050-1	http://dx.doi.org/10.1038/s41586-018-0050-1			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5BW	29670289	Green Submitted			2022-12-28	WOS:000431234500029
J							Dry Eye Assessment Management Stud	n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; MEIBOMIAN GLAND DYSFUNCTION; CLINICAL-TRIAL; OMEGA-3-FATTY-ACIDS; OMEGA-3; INFLAMMATION; DIFFERENCE	BACKGROUND Dry eye disease is a common chronic condition that is characterized by ocular discomfort and visual disturbances that decrease quality of life. Many clinicians recommend the use of supplements of n-3 fatty acids (often called omega-3 fatty acids) to relieve symptoms. METHODS In a multicenter, double-blind clinical trial, we randomly assigned patients with moderateto-severe dry eye disease to receive a daily oral dose of 3000 mg of fish-derived n-3 eicosapentaenoic and docosahexaenoic acids (active supplement group) or an olive oil placebo (placebo group). The primary outcome was the mean change from baseline in the score on the Ocular Surface Disease Index (OSDI; scores range from 0 to 100, with higher scores indicating greater symptom severity), which was based on the mean of scores obtained at 6 and 12 months. Secondary outcomes included mean changes per eye in the conjunctival staining score (ranging from 0 to 6) and the corneal staining score (ranging from 0 to 15), with higher scores indicating more severe damage to the ocular surface, as well as mean changes in the tear break-up time (seconds between a blink and gaps in the tear film) and the result on Schirmer's test (length of wetting of paper strips placed on the lower eyelid), with lower values indicating more severe signs. RESULTS A total of 349 patients were assigned to the active supplement group and 186 to the placebo group; the primary analysis included 329 and 170 patients, respectively. The mean change in the OSDI score was not significantly different between the active supplement group and the placebo group (-13.9 points and - 12.5 points, respectively; mean difference in change after imputation of missing data, - 1.9 points; 95% confidence interval [CI], -5.0 to 1.1; P = 0.21). This result was consistent across prespecified subgroups. There were no significant differences between the active supplement group and the placebo group in mean changes from baseline in the conjunctival staining score (mean difference in change, 0.0 points; 95% CI, - 0.2 to 0.1), corneal staining score (0.1 point; 95% CI, - 0.2 to 0.4), tear break-up time (0.2 seconds; 95% CI, - 0.1 to 0.5), and result on Schirmer's test (0.0 mm; 95% CI, - 0.8 to 0.9). At 12 months, the rate of adherence to treatment in the active supplement group was 85.2%, according to the level of n-3 fatty acids in red cells. Rates of adverse events were similar in the two trial groups. CONCLUSIONS Among patients with dry eye disease, those who were randomly assigned to receive supplements containing 3000 mg of n-3 fatty acids for 12 months did not have significantly better outcomes than those who were assigned to receive placebo.					massaro, marika/AAQ-1204-2020	massaro, marika/0000-0001-6124-5077; Kuklinski, Eric/0000-0003-0264-2763; Saunders, Bryan/0000-0003-0995-9077; Chapkin, Robert/0000-0002-6515-3898; Shtein, Roni/0000-0001-8202-3270	National Eye Institute, National Institutes of Health (NIH) [U10EY022879, U10EY022881]; NIH; NATIONAL CANCER INSTITUTE [R35CA197707] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [U10EY022879, U10EY022881] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by cooperative agreements (U10EY022879 and U10EY022881) from the National Eye Institute, National Institutes of Health (NIH), and by grant supplements from the NIH.	12-Item Ocular Surface Disease Index (OSDI), 2004, 12 IT OC SURF DIS IN; American Academy of Ophthalmology Cornea/External Disease Panel, 2013, PREF PRACT PATT GUID; Bhargava R, 2016, CURR EYE RES, V41, P1274, DOI 10.3109/02713683.2015.1122810; Bhargava R, 2015, CONTACT LENS ANTERIO, V38, P206, DOI 10.1016/j.clae.2015.01.007; Bhargava R, 2015, CORNEA, V34, P413, DOI 10.1097/ICO.0000000000000386; Bhargava R, 2013, INT J OPHTHALMOL-CHI, V6, P811, DOI 10.3980/j.issn.2222-3959.2013.06.13; Craig JP, 2017, OCUL SURF, V15, P276, DOI 10.1016/j.jtos.2017.05.008; Deinema LA, 2017, OPHTHALMOLOGY, V124, P43, DOI 10.1016/j.ophtha.2016.09.023; Epitropoulos AT, 2016, CORNEA, V35, P1185, DOI 10.1097/ICO.0000000000000940; Foulks Gary N, 2003, Ocul Surf, V1, P20; Holland EJ, 2017, OPHTHALMOLOGY, V124, P53, DOI 10.1016/j.ophtha.2016.09.025; Kangari H, 2013, OPHTHALMOLOGY, V120, P2191, DOI 10.1016/j.ophtha.2013.04.006; Kawakita T, 2013, BIOMED RES-TOKYO, V34, P215, DOI 10.2220/biomedres.34.215; LIANG KY, 1993, ANNU REV PUBL HEALTH, V14, P43, DOI 10.1146/annurev.pu.14.050193.000355; Macsai Marian S, 2008, Trans Am Ophthalmol Soc, V106, P336; Malhotra C, 2015, CORNEA, V34, P637, DOI 10.1097/ICO.0000000000000446; Miller KL, 2010, ARCH OPHTHALMOL-CHIC, V128, P94, DOI 10.1001/archophthalmol.2009.356; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Olenik A, 2013, CLIN INTERV AGING, V8, P1133, DOI 10.2147/CIA.S48955; Paulsen AJ, 2014, AM J OPHTHALMOL, V157, P799, DOI 10.1016/j.ajo.2013.12.023; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Sheppard JD, 2013, CORNEA, V32, P1297, DOI 10.1097/ICO.0b013e318299549c; Stapleton F, 2017, OCUL SURF, V15, P334, DOI 10.1016/j.jtos.2017.05.003; Wei Y, 2014, EYE CONTACT LENS, V40, P248, DOI 10.1097/ICL.0000000000000042; Wojtowicz JC, 2011, CORNEA, V30, P308, DOI 10.1097/ICO.0b013e3181f22e03; Yu JH, 2011, CORNEA, V30, P379, DOI 10.1097/ICO.0b013e3181f7f363	27	114	118	3	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2018	378	18					1681	1690		10.1056/NEJMoa1709691	http://dx.doi.org/10.1056/NEJMoa1709691			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GE4WO	29652551	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000431218600006
J	Seah, HM; Mautone, M				Seah, Huey Ming; Mautone, Marcela			Aspiration of a Chicken Bone	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Seah, Huey Ming; Mautone, Marcela] Monash Hlth, Clayton, Vic, Australia		Seah, HM (corresponding author), Monash Hlth, Clayton, Vic, Australia.	hmcseah@gmail.com							0	0	0	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2018	378	18							e25	10.1056/NEJMicm1713423	http://dx.doi.org/10.1056/NEJMicm1713423			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GE4WO	29719185				2022-12-28	WOS:000431218600011
J	Wade, L				Wade, Lizzie			Cleaning up the killing fields	SCIENCE			English	Editorial Material																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					371	371		10.1126/science.360.6387.371	http://dx.doi.org/10.1126/science.360.6387.371			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1AR	29700248				2022-12-28	WOS:000430949600017
J	Callaway, E				Callaway, Ewen			Flu virus finally sequenced in its native form Technique could help to unpick role of enigmatic chemical modifications in genetic material	NATURE			English	News Item																		Courtney DG, 2017, CELL HOST MICROBE, V22, P377, DOI 10.1016/j.chom.2017.08.004; Garalde DR, 2018, NAT METHODS, V15, P201, DOI [10.1038/NMETH.4577, 10.1038/nmeth.4577]; Keller M. W., 2018, PREPRINT AT BIORXIV, DOI [10.1101/300384, DOI 10.1101/300384]; PEATTIE DA, 1979, P NATL ACAD SCI USA, V76, P1760, DOI 10.1073/pnas.76.4.1760	4	6	9	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					420	420		10.1038/d41586-018-04908-5	http://dx.doi.org/10.1038/d41586-018-04908-5			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8VX	29691505	Bronze			2022-12-28	WOS:000430793000019
J	Morris, NP				Morris, Nathaniel P.			When Mind Deforms Body	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Morris, Nathaniel P.] Stanford Univ, Sch Med, Dept Psychiat, 401 Quarry Rd, Stanford, CA 94304 USA	Stanford University	Morris, NP (corresponding author), Stanford Univ, Sch Med, Dept Psychiat, 401 Quarry Rd, Stanford, CA 94304 USA.	npm@stanford.edu						Murphy S, 2017, DEATHS FINAL DATA 20; Rui, NATL HOSP AMBULATORY	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2018	319	16					1659	1660		10.1001/jama.2018.4102	http://dx.doi.org/10.1001/jama.2018.4102			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD7RF	29710169				2022-12-28	WOS:000430709300018
J	Rubin, R				Rubin, Rita			Scientists Affirm Survey's Value for Impaired Driving Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2018	319	16					1648	1648		10.1001/jama.2018.4286	http://dx.doi.org/10.1001/jama.2018.4286			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD7RF	29710148				2022-12-28	WOS:000430709300004
J	Arkinson, C; Walden, H				Arkinson, Connor; Walden, Helen			Parkin function in Parkinson's disease	SCIENCE			English	Editorial Material							LIGASE PARKIN; ACTIVATION; REVEALS; MECHANISM; BINDING; DOMAIN; PRIMES		[Arkinson, Connor; Walden, Helen] Univ Glasgow, Inst Mol Cell & Syst Biol, Univ Ave, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Walden, H (corresponding author), Univ Glasgow, Inst Mol Cell & Syst Biol, Univ Ave, Glasgow G12 8QQ, Lanark, Scotland.	helen.walden@glasgow.ac.uk	MUI, HOI LING/I-3220-2018	Arkinson, Connor/0000-0003-3665-2484	Medical Research Council [MC_UU_12016/12] Funding Source: Medline; MRC [MC_UU_12016/12] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aguirre JD, 2017, P NATL ACAD SCI USA, V114, P298, DOI 10.1073/pnas.1613040114; Caulfield TR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003935; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Dove KK, 2017, J MOL BIOL, V429, P3363, DOI 10.1016/j.jmb.2017.08.008; Kazlauskaite A, 2015, EMBO REP, V16, P939, DOI 10.15252/embr.201540352; Kumar A, 2017, NAT STRUCT MOL BIOL, V24, P475, DOI 10.1038/nsmb.3400; Kumar A, 2015, EMBO J, V34, P2506, DOI 10.15252/embj.201592337; Lazarou M, 2013, J CELL BIOL, V200, P163, DOI 10.1083/jcb.201210111; Lechtenberg BC, 2016, NATURE, V529, P546, DOI 10.1038/nature16511; Panicker N, 2017, BIOCHEM J, V474, P3075, DOI 10.1042/BCJ20170476; Sauve V, 2015, EMBO J, V34, P2492, DOI 10.15252/embj.201592237; Tang MY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14697; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Wauer T, 2015, NATURE, V524, P370, DOI 10.1038/nature14879; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966	15	38	38	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2018	360	6386					267	268		10.1126/science.aar6606	http://dx.doi.org/10.1126/science.aar6606			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD3IC	29674580	Green Accepted			2022-12-28	WOS:000430396600025
J	Lee, HE; Ahn, HY; Mun, J; Lee, YY; Kim, M; Cho, NH; Chang, K; Kim, WS; Rho, J; Nam, KT				Lee, Hye-Eun; Ahn, Hyo-Yong; Mun, Jungho; Lee, Yoon Young; Kim, Minkyung; Cho, Nam Heon; Chang, Kiseok; Kim, Wook Sung; Rho, Junsuk; Nam, Ki Tae			Amino-acid- and peptide-directed synthesis of chiral plasmonic gold nanoparticles	NATURE			English	Article							SITU ATR-IR; RHOMBIC DODECAHEDRA; STRUCTURAL-CHANGES; METAL-SURFACES; L-GLUTATHIONE; NANOSTRUCTURES; ADSORPTION; CYSTEINE; RECOGNITION	Understanding chirality, or handedness, in molecules is important because of the enantioselectivity that is observed in many biochemical reactions(1), and because of the recent development of chiral metamaterials with exceptional light-manipulating capabilities, such as polarization control(2-4), a negative refractive index(5) and chiral sensing(6). Chiral nanostructures have been produced using nanofabrication techniques such as lithography(7) and molecular self-assembly(8-11), but large-scale and simple fabrication methods for three-dimensional chiral structures remain a challenge. In this regard, chirality transfer represents a simpler and more efficient method for controlling chiral morphology(12-18). Although a few studies(18,19) have described the transfer of molecular chirality into micrometre-sized helical ceramic crystals, this technique has yet to be implemented for metal nanoparticles with sizes of hundreds of nanometres. Here we develop a strategy for synthesizing chiral gold nanoparticles that involves using amino acids and peptides to control the optical activity, handedness and chiral plasmonic resonance of the nanoparticles. The key requirement for achieving such chiral structures is the formation of high-Miller-index surfaces ({hkl}, h not equal k not equal l not equal 0) that are intrinsically chiral, owing to the presence of 'kink' sites(20-22) in the nanoparticles during growth. The presence of chiral components at the inorganic surface of the nanoparticles and in the amino acids and peptides results in enantioselective interactions at the interface between these elements; these interactions lead to asymmetric evolution of the nanoparticles and the formation of helicoid morphologies that consist of highly twisted chiral elements. The gold nanoparticles that we grow display strong chiral plasmonic optical activity (a dissymmetry factor of 0.2), even when dispersed randomly in solution; this observation is supported by theoretical calculations and direct visualizations of macroscopic colour transformations. We anticipate that our strategy will aid in the rational design and fabrication of three-dimensional chiral nanostructures for use in plasmonic metamaterial applications.	[Lee, Hye-Eun; Ahn, Hyo-Yong; Lee, Yoon Young; Cho, Nam Heon; Nam, Ki Tae] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul, South Korea; [Mun, Jungho; Rho, Junsuk] Pohang Univ Sci & Technol POSTECH, Dept Chem Engn, Pohang, South Korea; [Kim, Minkyung; Rho, Junsuk] POSTECH, Dept Mech Engn, Pohang, South Korea; [Chang, Kiseok; Kim, Wook Sung] LG Display, R&D Ctr, LG Sci Pk, Seoul, South Korea; [Kim, Wook Sung] POSTECH, Dept Elect Engn, Pohang, South Korea	Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); LG Display; Pohang University of Science & Technology (POSTECH)	Nam, KT (corresponding author), Seoul Natl Univ, Dept Mat Sci & Engn, Seoul, South Korea.; Rho, J (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Chem Engn, Pohang, South Korea.; Rho, J (corresponding author), POSTECH, Dept Mech Engn, Pohang, South Korea.	jsrho@postech.ac.kr; nkitae@snu.ac.kr	Mun, Jungho/GYQ-7080-2022; Cho, Nam Heon/ABF-9534-2020; Rho, Junsuk/AAN-7917-2020; Nam, Ki Tae/A-1866-2011; Chang, Kiseok/ABA-5033-2020; Ahn, Hyo-Yong/N-5750-2018	Rho, Junsuk/0000-0002-2179-2890; Nam, Ki Tae/0000-0001-6353-8877; Ahn, Hyo-Yong/0000-0003-4330-1375; Kim, Minkyung/0000-0001-5229-4520; Mun, Jungho/0000-0002-7290-6253; Lee, Hye-Eun/0000-0002-8994-7537	Seoul National University; LG Display under LGD-SNU Incubation Program; Creative Materials Discovery Program - National Research Foundation (NRF) under the Ministry of Science, ICT and Future Planning (MSIP), South Korea [2017M3D1A1039377]; KIST-SNU [0543-20180021]; Global Frontier R&D Program of the Center for Multiscale Energy System - NRF-MSIP, South Korea [2012M3A6A7054855]; Engineering Research Center Program of the Center for Optically-assisted Mechanical Systems - NRF-MSIP, South Korea [2015R1A5A1037668]; Global Frontier R&D Program of the Center for Advanced Meta-Materials - NRF-MSIP, South Korea [2014M3A6B3063708]; Global PhD Fellowship Program - NRF-MSIP, South Korea [2014H1A2A1020809, 2017H1A2A1043204]	Seoul National University; LG Display under LGD-SNU Incubation Program; Creative Materials Discovery Program - National Research Foundation (NRF) under the Ministry of Science, ICT and Future Planning (MSIP), South Korea; KIST-SNU; Global Frontier R&D Program of the Center for Multiscale Energy System - NRF-MSIP, South Korea; Engineering Research Center Program of the Center for Optically-assisted Mechanical Systems - NRF-MSIP, South Korea; Global Frontier R&D Program of the Center for Advanced Meta-Materials - NRF-MSIP, South Korea; Global PhD Fellowship Program - NRF-MSIP, South Korea	This research was supported by a Seoul National University research grant in 2015, the LG Display under LGD-SNU Incubation Program, the Creative Materials Discovery Program (2017M3D1A1039377), which is funded by the National Research Foundation (NRF) under the Ministry of Science, ICT and Future Planning (MSIP), South Korea, and the KIST-SNU Joint Research Program (0543-20180021). K.T.N. acknowledges financial supports from the Global Frontier R&D Program of the Center for Multiscale Energy System (2012M3A6A7054855), which is funded by the NRF-MSIP, South Korea. J.R. acknowledges financial support from the Engineering Research Center Program of the Center for Optically-assisted Mechanical Systems (2015R1A5A1037668) and the Global Frontier R&D Program of the Center for Advanced Meta-Materials (2014M3A6B3063708), which is funded by the NRF-MSIP, South Korea. H.-Y.A. and M.K. are grateful to the Global PhD Fellowship Program (2014H1A2A1020809 and 2017H1A2A1043204, respectively), which is funded by the NRF-MSIP, South Korea. J.R. thanks T. Liedl (Ludwig Maximilian University of Munich) and N. Liu (University of Heidelberg) for discussions.	Ahmadi A, 1999, LANGMUIR, V15, P2420, DOI 10.1021/la9810915; Ahn HY, 2013, J MATER CHEM C, V1, P6861, DOI 10.1039/c3tc31135j; Ansar SM, 2013, NANO LETT, V13, P1226, DOI 10.1021/nl304703w; Arrigan DWM, 1999, ANALYST, V124, P1645, DOI 10.1039/a905370k; Barron LD, 2007, NATURE, V446, P505, DOI 10.1038/446505a; Bieri M, 2006, PHYS CHEM CHEM PHYS, V8, P513, DOI 10.1039/b511146c; Bieri M, 2005, LANGMUIR, V21, P1354, DOI 10.1021/la047735s; Che S, 2004, NATURE, V429, P281, DOI 10.1038/nature02529; Coppage R, 2012, ACS NANO, V6, P1625, DOI 10.1021/nn204600d; Dickerson MB, 2008, CHEM REV, V108, P4935, DOI 10.1021/cr8002328; Gansel JK, 2009, SCIENCE, V325, P1513, DOI 10.1126/science.1177031; Grahn P, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/9/093033; Greber T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.056103; Hao CL, 2015, ADV FUNCT MATER, V25, P5816, DOI 10.1002/adfm.201502429; Hazen RM, 2003, NAT MATER, V2, P367, DOI 10.1038/nmat879; Hendry E, 2010, NAT NANOTECHNOL, V5, P783, DOI [10.1038/nnano.2010.209, 10.1038/NNANO.2010.209]; Horvath JD, 2004, J AM CHEM SOC, V126, P14988, DOI 10.1021/ja045537h; JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Kuhnle A, 2002, NATURE, V415, P891, DOI 10.1038/415891a; Kuhnle A, 2006, J AM CHEM SOC, V128, P1076, DOI 10.1021/ja0568751; Kuzyk A, 2014, NAT MATER, V13, P862, DOI [10.1038/NMAT4031, 10.1038/nmat4031]; Kuzyk A, 2012, NATURE, V483, P311, DOI 10.1038/nature10889; Lan X, 2015, J AM CHEM SOC, V137, P457, DOI 10.1021/ja511333q; Lee HE, 2017, CHEMNANOMAT, V3, P685, DOI 10.1002/cnma.201700208; Lee HE, 2015, ACS NANO, V9, P8384, DOI 10.1021/acsnano.5b03065; Liu H, 2014, SCI REP-UK, V4, DOI 10.1038/srep03969; Ma W, 2017, CHEM REV, V117, P8041, DOI 10.1021/acs.chemrev.6b00755; Maoz BM, 2012, J AM CHEM SOC, V134, P17807, DOI 10.1021/ja309016k; McFadden CF, 1996, LANGMUIR, V12, P2483, DOI 10.1021/la950348l; McPhie P, 2001, ANAL BIOCHEM, V293, P109, DOI 10.1006/abio.2001.5113; Meinzer N, 2014, NAT PHOTONICS, V8, P889, DOI [10.1038/nphoton.2014.247, 10.1038/nphoton.2010.247]; Orme CA, 2001, NATURE, V411, P775, DOI 10.1038/35081034; Pendry JB, 2004, SCIENCE, V306, P1353, DOI 10.1126/science.1104467; Prodan E, 2003, SCIENCE, V302, P419, DOI 10.1126/science.1089171; Sanchez C, 2005, NAT MATER, V4, P277, DOI 10.1038/nmat1339; Sau TK, 2004, J AM CHEM SOC, V126, P8648, DOI 10.1021/ja047846d; Schillinger R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.136102; Sholl DS, 2001, J PHYS CHEM B, V105, P4771, DOI 10.1021/jp004524x; Slocik JM, 2011, NANO LETT, V11, P701, DOI 10.1021/nl1038242; Soukoulis CM, 2011, NAT PHOTONICS, V5, P523, DOI [10.1038/NPHOTON.2011.154, 10.1038/nphoton.2011.154]; Switzer JA, 2003, NATURE, V425, P490, DOI 10.1038/nature01990; Weiner RG, 2015, ANGEW CHEM INT EDIT, V54, P1181, DOI 10.1002/anie.201409966; WEISSBUCH I, 1991, SCIENCE, V253, P637, DOI 10.1126/science.253.5020.637; Wu HL, 2011, INORG CHEM, V50, P8106, DOI 10.1021/ic200504n; Wu XL, 2013, J AM CHEM SOC, V135, P18629, DOI 10.1021/ja4095445; Xiao WD, 2016, NAT CHEM, V8, P326, DOI [10.1038/nchem.2449, 10.1038/NCHEM.2449]; Yan J, 2016, NANOSCALE, V8, P10030, DOI 10.1039/c6nr00767h; Yan WJ, 2012, J AM CHEM SOC, V134, P15114, DOI 10.1021/ja3066336; Yuan MQ, 2008, LANGMUIR, V24, P8707, DOI 10.1021/la800287e; Zhang S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1908	50	497	502	134	1300	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2018	556	7701					360	+		10.1038/s41586-018-0034-1	http://dx.doi.org/10.1038/s41586-018-0034-1			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1TW	29670265				2022-12-28	WOS:000430285200048
J	Turajlic, S; Xu, H; Litchfield, K; Rowan, A; Chambers, T; Lopez, JI; Nicol, D; O'Brien, T; Larkin, J; Horswell, S; Stares, M; Au, L; Jamal-Hanjani, M; Challacombe, B; Chandra, A; Hazell, S; Eichler-Jonsson, C; Soultati, A; Chowdhury, S; Rudman, S; Lynch, J; Fernando, A; Stamp, G; Nye, E; Jabbar, F; Spain, L; Lall, S; Guarch, R; Falzon, M; Proctor, I; Pickering, L; Gore, M; Watkins, TBK; Ward, S; Stewart, A; DiNatale, R; Becerra, MF; Reznik, E; Hsieh, JJ; Richmond, TA; Mayhew, GF; Hill, SM; McNally, CD; Jones, C; Rosenbaum, H; Stanislaw, S; Burgess, DL; Alexander, NR; Swanton, C				Turajlic, Samra; Xu, Hang; Litchfield, Kevin; Rowan, Andrew; Chambers, Tim; Lopez, Jose I.; Nicol, David; O'Brien, Tim; Larkin, James; Horswell, Stuart; Stares, Mark; Au, Lewis; Jamal-Hanjani, Mariam; Challacombe, Ben; Chandra, Ashish; Hazell, Steve; Eichler-Jonsson, Claudia; Soultati, Aspasia; Chowdhury, Simon; Rudman, Sarah; Lynch, Joanna; Fernando, Archana; Stamp, Gordon; Nye, Emma; Jabbar, Faiz; Spain, Lavinia; Lall, Sharanpreet; Guarch, Rosa; Falzon, Mary; Proctor, Ian; Pickering, Lisa; Gore, Martin; Watkins, Thomas B. K.; Ward, Sophia; Stewart, Aengus; DiNatale, Renzo; Becerra, Maria F.; Reznik, Ed; Hsieh, James J.; Richmond, Todd A.; Mayhew, George F.; Hill, Samantha M.; McNally, Catherine D.; Jones, Carol; Rosenbaum, Heidi; Stanislaw, Stacey; Burgess, Daniel L.; Alexander, Nelson R.; Swanton, Charles		PEACE TRACERx Renal Consortium	Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal	CELL			English	Article							CELL CARCINOMA; BRANCHED EVOLUTION; NATURAL-HISTORY; TUMOR THROMBUS; MANAGEMENT; EXPRESSION; PATTERNS	Clear-cell renal cell carcinoma (ccRCC) exhibits a broad range of metastatic phenotypes that have not been systematically studied to date. Here, we analyzed 575 primary and 335 metastatic biopsies across 100 patients with metastatic ccRCC, including two cases sampledat post-mortem. Metastatic competence was afforded by chromosome complexity, and we identify 9p loss as a highly selected event driving metastasis and ccRCC-related mortality (p = 0.0014). Distinct patterns of metastatic dissemination were observed, including rapid progression to multiple tissue sites seeded by primary tumors of monoclonal structure. By contrast, we observed attenuated progression in cases characterized by high primary tumor heterogeneity, with metastatic competence acquired gradually and initial progression to solitary metastasis. Finally, we observed early divergence of primitive ancestral clones and protracted latency of up to two decades as a feature of pancreatic metastases.	[Turajlic, Samra; Xu, Hang; Litchfield, Kevin; Rowan, Andrew; Chambers, Tim; Stares, Mark; Eichler-Jonsson, Claudia; Jabbar, Faiz; Watkins, Thomas B. K.; Ward, Sophia; Swanton, Charles] Francis Crick Inst, Translat Canc Therapeut Lab, London NW1 1AT, England; [Turajlic, Samra; Larkin, James; Stares, Mark; Au, Lewis; Lynch, Joanna; Spain, Lavinia; Pickering, Lisa; Gore, Martin] Royal Marsden Hosp NHS Fdn Trust, Renal Unit, London SW3 6JJ, England; [Turajlic, Samra; Larkin, James; Stares, Mark; Au, Lewis; Lynch, Joanna; Spain, Lavinia; Pickering, Lisa; Gore, Martin] Royal Marsden Hosp NHS Fdn Trust, Skin Unit, London SW3 6JJ, England; [Lopez, Jose I.; Stewart, Aengus] Univ Basque Country, Cruces Univ Hosp, Biocruces Inst, Dept Pathol, Baracaldo, Spain; [Nicol, David] Royal Marsden NHS Fdn Trust, Dept Urol, London SW3 6JJ, England; [O'Brien, Tim; Challacombe, Ben; Fernando, Archana] Guys & St Thomas NHS Fdn Trust, Urol Ctr, London, England; [Horswell, Stuart] Francis Crick Inst, Dept Bioinformat & Biostat, London NW1 1AT, England; [Jamal-Hanjani, Mariam; Ward, Sophia; Swanton, Charles] UCL, Canc Res UK Lung Canc Ctr Excellence London, Canc Inst, London WC1E 6DD, England; [Chandra, Ashish] Guys & St Thomas NHS Fdn Trust, Dept Cellular Pathol, London SE1 7EH, England; [Hazell, Steve] Royal Marsden NHS Fdn Trust, Dept Pathol, London SW3 6JJ, England; [Soultati, Aspasia; Chowdhury, Simon; Rudman, Sarah; Lall, Sharanpreet] Guys & St Thomas NHS Fdn Trust, Dept Oncol, London, England; [Stamp, Gordon; Nye, Emma] Francis Crick Inst, Expt Histopathol Lab, London NW1 1AT, England; [Guarch, Rosa] Complejo Hosp Navarra, Dept Pathol, Pamplona 31008, Spain; [Falzon, Mary; Proctor, Ian] Univ Coll London Hosp, Dept Pathol, London WC1E 6DE, England; [DiNatale, Renzo; Becerra, Maria F.] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, 1275 York Ave, New York, NY 10021 USA; [Reznik, Ed] Mem Sloan Kettering Canc Ctr, Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA; [Hsieh, James J.] Washington Univ, Dept Med, Siteman Canc Ctr, Mol Oncol, St Louis, MO USA; [Richmond, Todd A.; Mayhew, George F.; Rosenbaum, Heidi; Burgess, Daniel L.] Roche Sequencing Solut, Res & Dev, Madison, WI 53719 USA; [Hill, Samantha M.; McNally, Catherine D.; Jones, Carol; Alexander, Nelson R.] Ventana Med Syst, Tucson, AZ 85755 USA; [Swanton, Charles] Univ Coll London Hosp, Dept Med Oncol, London NW1 2BU, England	Francis Crick Institute; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Hospital Universitario Cruces; University of Basque Country; Royal Marsden NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Francis Crick Institute; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Francis Crick Institute; Servicio Navarro de Salud - Osasunbidea; University College London Hospitals NHS Foundation Trust; University of London; University College London; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Siteman Cancer Center; Washington University (WUSTL); Roche Holding; Ventana Medical Systems, Inc.; University College London Hospitals NHS Foundation Trust; University of London; University College London	Swanton, C (corresponding author), Francis Crick Inst, Translat Canc Therapeut Lab, London NW1 1AT, England.; Swanton, C (corresponding author), UCL, Canc Res UK Lung Canc Ctr Excellence London, Canc Inst, London WC1E 6DD, England.; Swanton, C (corresponding author), Univ Coll London Hosp, Dept Med Oncol, London NW1 2BU, England.	charles.swanton@crick.ac.uk	Challacombe, Ben/AAM-9505-2020; Lopez, Jose Ignacio/L-3884-2019; Nicol, David L/M-6809-2016	Challacombe, Ben/0000-0001-8631-0314; Lopez, Jose Ignacio/0000-0003-0842-5348; Nicol, David L/0000-0002-5623-7467; Spain, Lavinia/0000-0002-9356-8812; Di Natale, Renzo G/0000-0002-7867-2881; Nicol, David/0000-0003-0107-6990; Litchfield, Kevin/0000-0002-3725-0914; Larkin, James/0000-0001-5569-9523; turajlic, samra/0000-0001-8846-136X; Horswell, Stuart/0000-0003-2787-1933; Xu, Hang/0000-0002-5847-655X; Stewart, Aengus/0000-0001-5182-653X; Mayhew, George/0000-0003-0609-6018; Swanton, Charles/0000-0002-4299-3018	Cancer Research UK (CRUK) [C50947/A18176]; NIH Research (NIHR) Biomedical Research Centre (BRC) at the Royal Marsden Hospital [A109]; NIH Research (NIHR) Biomedical Research Centre (BRC) at the Institute of Cancer Research [A109]; Ministerio de Economia y Competitividad (MINECO) [SAF2016-79847-R]; Royal Marsden Cancer Charity; UK Medical Research Council [MR/P014712/1, FC001202]; CRUK; Rosetrees; NIHR BRC at University College London Hospitals; Cancer Research UK (TRACERx); Cancer Research UK (CRUK Cancer Immunotherapy Catalyst Network); CRUK Lung Cancer Centre of Excellence; Stand Up 2 Cancer (SU2C); Rosetrees Trust; Stoneygate Trust; NovoNordisk Foundation [16584]; Breast Cancer Research Foundation (BCRF); European Research Council (THESEUS); Marie Curie Network PloidyNet; CRUK University College London Experimental Cancer Medicine Centre; Cancer Research UK [C50947/A18176, FC001202]; Ventana Medical Systems [10467, 10530]; Kidney Cancer Fund of The Royal Marsden Cancer Charity; NIHR BRC at the Royal Marsden Hospital [A109]; NIHR BRC at the Institute of Cancer Research [A109]; Francis Crick Institute; Wellcome Trust [FC001202]; Advanced Sequencing Facility at the Francis Crick Institute; High-Performance Computing at the Francis Crick Institute; Medical Research Council [MR/L016311/1]; MRC [MR/P014712/1, MR/L016311/1] Funding Source: UKRI	Cancer Research UK (CRUK)(Cancer Research UK); NIH Research (NIHR) Biomedical Research Centre (BRC) at the Royal Marsden Hospital; NIH Research (NIHR) Biomedical Research Centre (BRC) at the Institute of Cancer Research; Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Royal Marsden Cancer Charity(Royal Society of New ZealandMarsden Fund (NZ)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK(Cancer Research UK); Rosetrees(Rosetrees Trust); NIHR BRC at University College London Hospitals; Cancer Research UK (TRACERx); Cancer Research UK (CRUK Cancer Immunotherapy Catalyst Network); CRUK Lung Cancer Centre of Excellence; Stand Up 2 Cancer (SU2C); Rosetrees Trust(Rosetrees Trust); Stoneygate Trust; NovoNordisk Foundation(Novo Nordisk FoundationNovocure Limited); Breast Cancer Research Foundation (BCRF); European Research Council (THESEUS)(European Research Council (ERC)); Marie Curie Network PloidyNet; CRUK University College London Experimental Cancer Medicine Centre; Cancer Research UK(Cancer Research UK); Ventana Medical Systems; Kidney Cancer Fund of The Royal Marsden Cancer Charity; NIHR BRC at the Royal Marsden Hospital; NIHR BRC at the Institute of Cancer Research; Francis Crick Institute; Wellcome Trust(Wellcome Trust); Advanced Sequencing Facility at the Francis Crick Institute; High-Performance Computing at the Francis Crick Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	S.T. and H.X. are funded by Cancer Research UK (CRUK) (C50947/A18176). S.T., T.C., J.L., and M.G. are funded by the NIH Research (NIHR) Biomedical Research Centre (BRC) at the Royal Marsden Hospital and Institute of Cancer Research (A109). J.I.L. is funded by the Ministerio de Economia y Competitividad (MINECO, SAF2016-79847-R). M.S., A.S., J.L., R.F., L.A., and L.S. are funded by the Royal Marsden Cancer Charity. K.L. is funded by UK Medical Research Council (MR/P014712/1). N.M. receives funding from CRUK, Rosetrees, and the NIHR BRC at University College London Hospitals. C.S is Royal Society Napier Research Professor. C.S. is funded by Cancer Research UK (TRACERx and CRUK Cancer Immunotherapy Catalyst Network), the CRUK Lung Cancer Centre of Excellence, Stand Up 2 Cancer (SU2C), the Rosetrees and Stoneygate Trusts, NovoNordisk Foundation (ID 16584), the Breast Cancer Research Foundation (BCRF), the European Research Council (THESEUS), Marie Curie Network PloidyNet, the NIHR BRC at University College London Hospitals, and the CRUK University College London Experimental Cancer Medicine Centre. The work presented in this manuscript was funded by Cancer Research UK (grant reference number C50947/A18176), Ventana Medical Systems (grant reference numbers 10467 and 10530), the Kidney Cancer Fund of The Royal Marsden Cancer Charity, NIHR BRC at the Royal Marsden Hospital and Institute of Cancer Research (grant reference number A109), and the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001202), the UK Medical Research Council (FC001202), and the Wellcome Trust (FC001202). In particular, we acknowledge the support of the Advanced Sequencing Facility and the High-Performance Computing at the Francis Crick Institute. This project was enabled through access to the MRC eMedLab Medical Bioinformatics infrastructure, supported by the Medical Research Council (grant number MR/L016311/1).	Adey N, 2013, BMC CLIN PATHOL, V13, DOI 10.1186/1472-6890-13-29; Arai E, 2014, INT J CANCER, V135, P1330, DOI 10.1002/ijc.28768; Bashashati A, 2013, J PATHOL, V231, P21, DOI 10.1002/path.4230; Becerra M. F., 2017, EUR UROL FOCUS; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Bex A, 2017, ANN ONCOL, V28, pv605, DOI [10.1093/annonc/mdx440.030, DOI 10.1093/ANNONC/MDX440.030]; Bex A, 2016, EUR UROL, V70, P901, DOI 10.1016/j.eururo.2016.07.005; Bhindi B, 2018, BJU INT, V121, P684, DOI 10.1111/bju.14127; Bianchi M, 2012, ANN ONCOL, V23, P973, DOI 10.1093/annonc/mdr362; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Casuscelli J, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92688; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Dabestani S, 2014, LANCET ONCOL, V15, pE549, DOI 10.1016/S1470-2045(14)70235-9; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; De Sano L, 2016, BIOINFORMATICS, V32, P1911, DOI 10.1093/bioinformatics/btw035; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Eldredge N, 1997, SCIENCE, V276, P338; Fang H, 2016, NAT PROTOC, V11, P2529, DOI 10.1038/nprot.2016.150; Field MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02428-w; Gao RL, 2016, NAT GENET, V48, P1119, DOI 10.1038/ng.3641; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gershman B, 2017, EUR UROL, V72, P300, DOI 10.1016/j.eururo.2016.12.027; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Haffner MC, 2013, J CLIN INVEST, V123, P4918, DOI 10.1172/JCI70354; Joseph RW, 2016, J UROLOGY, V195, P180, DOI 10.1016/j.juro.2015.07.113; Klatte T, 2009, J CLIN ONCOL, V27, P746, DOI 10.1200/JCO.2007.15.8345; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kutikov A, 2010, BJU INT, V106, P218, DOI 10.1111/j.1464-410X.2009.09079.x; La Rochelle J, 2010, CANCER-AM CANCER SOC, V116, P4696, DOI 10.1002/cncr.25279; Lee SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090459; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McGranahan N, 2017, CELL, V170, P825, DOI 10.1016/j.cell.2017.08.012; Mckay RR, 2014, EUR UROL, V65, P577, DOI 10.1016/j.eururo.2013.08.012; McPherson A, 2016, NAT GENET, V48, P758, DOI 10.1038/ng.3573; Mitchell TJ, 2018, CELL, V173, P611, DOI 10.1016/j.cell.2018.02.020; NIKZAINAL S, 2012, CELL, V149; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; Notta F, 2016, NATURE, V538, P378, DOI 10.1038/nature19823; Psutka SP, 2015, THER ADV UROL, V7, P216, DOI 10.1177/1756287215576443; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reese AC, 2013, UROL ONCOL-SEMIN ORI, V31, P1305, DOI 10.1016/j.urolonc.2011.12.006; Robinson DR, 2017, NATURE, V548, P297, DOI 10.1038/nature23306; Santaguida S, 2015, NAT REV MOL CELL BIO, V16, P473, DOI 10.1038/nrm4025; Schwarz RF, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001789; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Talevich E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004873; Turajlic S, 2018, CELL, V173, P595, DOI 10.1016/j.cell.2018.03.043; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weichselbaum RR, 2011, NAT REV CLIN ONCOL, V8, P378, DOI 10.1038/nrclinonc.2011.44; Woodruff DY, 2013, UROL ONCOL-SEMIN ORI, V31, P517, DOI 10.1016/j.urolonc.2011.03.006; Wszolek MF, 2008, NAT CLIN PRACT UROL, V5, P35, DOI 10.1038/ncpuro0963; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yates LR, 2017, CANCER CELL, V32, P169, DOI 10.1016/j.ccell.2017.07.005; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333; Zhang J, 2010, CANCER INVEST, V28, P588, DOI 10.3109/07357900903286941; Zhao ZM, 2016, P NATL ACAD SCI USA, V113, P2140, DOI 10.1073/pnas.1525677113	60	378	385	4	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2018	173	3					581	+		10.1016/j.cell.2018.03.057	http://dx.doi.org/10.1016/j.cell.2018.03.057			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7GB	29656895	Green Published, hybrid			2022-12-28	WOS:000430677400010
J	Voelker, R				Voelker, Rebecca			Duodenoscope Warning	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2018	319	15					1540	1540		10.1001/jama.2018.3986	http://dx.doi.org/10.1001/jama.2018.3986			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD0UT	29677288				2022-12-28	WOS:000430217100009
J	Watts, G				Watts, Geoff			Guo-Qiang Chen: haematologist who risked all for research success	LANCET			English	Biographical-Item																		CHEN GQ, PUBLICATION LIST	1	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2018	391	10129					1473	1473		10.1016/S0140-6736(18)30733-5	http://dx.doi.org/10.1016/S0140-6736(18)30733-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GC6TS	29676271				2022-12-28	WOS:000429926000014
J	Rutlin, M; Ho, CY; Abraira, VE; Cassidy, C; Bai, L; Woodbury, CJ; Ginty, DD				Rutlin, Michael; Ho, Cheng-Ying; Abraira, Victoria E.; Cassidy, Colleen; Bai, Ling; Woodbury, C. Jeffery; Ginty, David D.			The Cellular and Molecular Basis of Direction Selectivity of A delta-LTMRs (vol 159, pg 1640, 2014)	CELL			English	Correction												woodbury@uwyo.edu; david_ginty@hms.harvard.edu						Rutlin M, 2014, CELL, V159, P1640, DOI 10.1016/j.cell.2014.11.038	1	8	8	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 26	2015	160	5					1027	1027		10.1016/j.cell.2015.02.013	http://dx.doi.org/10.1016/j.cell.2015.02.013			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CD5GN	29698636	Bronze			2022-12-28	WOS:000351116100023
J	Rattenborg, NC; Lima, SL; Amlaner, CJ				Rattenborg, NC; Lima, SL; Amlaner, CJ			Half-awake to the risk of predation	NATURE			English	Letter							SLEEP-DEPRIVATION		Indiana State Univ, Dept Life Sci, Terre Haute, IN 47809 USA	Indiana State University	Rattenborg, NC (corresponding author), Indiana State Univ, Dept Life Sci, Terre Haute, IN 47809 USA.			Amlaner, Charles/0000-0002-0325-9275				[Anonymous], 1994, PRINCIPLES PRACTICE; Ball NJ, 1988, SLEEP 86, P151; BREDENKOTTER M, 1990, VISUAL NEUROSCI, V5, P155, DOI 10.1017/S0952523800000201; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; Hoffmann R F, 1979, Waking Sleeping, V3, P1; Lima SL, 1998, ADV STUD BEHAV, V27, P215; Oleksenko A.I., 1992, Journal of Sleep Research, V1, P40; RECHTSCHAFFEN A, 1983, SCIENCE, V221, P182, DOI 10.1126/science.6857280; SCHAEFFEL F, 1986, VISION RES, V26, P1977, DOI 10.1016/0042-6989(86)90123-9	9	124	128	1	43	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					397	398		10.1038/17037	http://dx.doi.org/10.1038/17037			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667967				2022-12-28	WOS:000078461700031
J	Egan, MF; Kost, J; Tariot, PN; Aisen, PS; Cummings, JL; Vellas, B; Sur, C; Mukai, Y; Voss, T; Furtek, C; Mahoney, E; Mozley, LH; Vandenberghe, R; Mo, Y; Michelson, D				Egan, Michael F.; Kost, James; Tariot, Pierre N.; Aisen, Paul S.; Cummings, Jeffrey L.; Vellas, Bruno; Sur, Cyrille; Mukai, Yuki; Voss, Tiffini; Furtek, Christine; Mahoney, Erin; Mozley, Lyn Harper; Vandenberghe, Rik; Mo, Yi; Michelson, David			Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BETA IMMUNIZATION AN1792; CLINICAL-TRIALS; RATING-SCALE; BAPINEUZUMAB; SOLANEZUMAB; INVENTORY; DEMENTIA; OUTCOMES; VOLUME	BACKGROUND Alzheimer's disease is characterized by the deposition of amyloid-beta (A beta) plaques in the brain. A beta is produced from the sequential cleavage of amyloid precursor protein by beta-site amyloid precursor protein-cleaving enzyme 1 (BACE-1) followed by gamma-secretase. Verubecestat is an oral BACE-1 inhibitor that reduces the A beta level in the cerebrospinal fluid of patients with Alzheimer's disease. METHODS We conducted a randomized, double-blind, placebo-controlled, 78-week trial to evaluate verubecestat at doses of 12 mg and 40 mg per day, as compared with placebo, in patients who had a clinical diagnosis of mild-to-moderate Alzheimer's disease. The coprimary outcomes were the change from baseline to week 78 in the score on the cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog; scores range from 0 to 70, with higher scores indicating worse dementia) and in the score on the Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory scale (ADCS-ADL; scores range from 0 to 78, with lower scores indicating worse function). RESULTS A total of 1958 patients underwent randomization; 653 were randomly assigned to receive verubecestat at a dose of 12 mg per day (the 12-mg group), 652 to receive verubecestat at a dose of 40 mg per day (the 40-mg group), and 653 to receive matching placebo. The trial was terminated early for futility 50 months after onset, which was within 5 months before its scheduled completion, and after enrollment of the planned 1958 patients was complete. The estimated mean change from baseline to week 78 in the ADAS-cog score was 7.9 in the 12-mg group, 8.0 in the 40-mg group, and 7.7 in the placebo group (P = 0.63 for the comparison between the 12-mg group and the placebo group and P = 0.46 for the comparison between the 40-mg group and the placebo group). The estimated mean change from baseline to week 78 in the ADCS-ADL score was-8.4 in the 12-mg group,-8.2 in the 40-mg group, and-8.9 in the placebo group (P = 0.49 for the comparison between the 12-mg group and the placebo group and P = 0.32 for the comparison between the 40-mg group and the placebo group). Adverse events, including rash, falls and injuries, sleep disturbance, suicidal ideation, weight loss, and hair-color change, were more common in the verubecestat groups than in the placebo group. CONCLUSIONS Verubecestat did not reduce cognitive or functional decline in patients with mild-to-moderate Alzheimer's disease and was associated with treatment-related adverse events.	[Egan, Michael F.; Kost, James; Sur, Cyrille; Mukai, Yuki; Voss, Tiffini; Furtek, Christine; Mahoney, Erin; Mozley, Lyn Harper; Mo, Yi; Michelson, David] Merck, Merck Res Labs, Kenilworth, NJ USA; [Tariot, Pierre N.] Banner Alzheimers Inst, Phoenix, AZ USA; [Aisen, Paul S.] Univ Southern Calif, San Diego, CA USA; [Cummings, Jeffrey L.] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Las Vegas, NV USA; [Vellas, Bruno] Toulouse Univ Hosp, Alzheimers Dis Res & Clin Ctr, INSERM Unite 1027, Gerontopole, Toulouse, France; [Vandenberghe, Rik] Katholieke Univ Leuven, Alzheimer Res Ctr, Leuven Inst Neurosci & Dis, Leuven, Belgium; [Vandenberghe, Rik] Katholieke Univ Leuven, Dept Neurosci, Lab Cognit Neurol, Leuven, Belgium; [Vandenberghe, Rik] Univ Hosp, Neurol, Leuven, Belgium	Merck & Company; Banner Research; Banner Health; Banner Alzheimer's Institute; University of Southern California; Cleveland Clinic Foundation; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); KU Leuven; KU Leuven	Egan, MF (corresponding author), Merck & Co Inc, UG 4C-06,351 N Sumneytown Pike, N Wales, PA 19454 USA.	michael.egan@merck.com	Cummings, Jeffrey/AAC-5947-2019; Vandenberghe, Rik/K-2145-2014; Sur, Cyrille/G-1154-2010; Vandenberghe, Rik/AAR-7485-2020	Cummings, Jeffrey/0000-0001-8944-4158; Vandenberghe, Rik/0000-0001-6237-2502; Vandenberghe, Rik/0000-0001-6237-2502	Merck; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109025] Funding Source: NIH RePORTER	Merck(Merck & Company); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by Merck.	[Anonymous], 2000, DIAGN STAT MAN MENT, V4th; Ba MW, 2016, TRANSL NEURODEGENER, V5, DOI 10.1186/s40035-016-0067-z; Coric V, 2012, ARCH NEUROL-CHICAGO, V69, P1430, DOI 10.1001/archneurol.2012.2194; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox NC, 2005, NEUROLOGY, V64, P1563, DOI 10.1212/01.WNL.0000159743.08996.99; Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Kennedy ME, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9704; Landau SM, 2015, J NUCL MED, V56, P567, DOI 10.2967/jnumed.114.148981; Masters CL, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.56; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mo Yi, 2017, Alzheimers Dement (Amst), V6, P201, DOI 10.1016/j.dadm.2017.02.004; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Novak G, 2016, J ALZHEIMERS DIS, V49, P1123, DOI 10.3233/JAD-150448; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Schneider LS, 2009, ALZHEIMERS DEMENT, V5, P388, DOI 10.1016/j.jalz.2009.07.038; Scott JD, 2016, J MED CHEM, V59, P10435, DOI 10.1021/acs.jmedchem.6b00307; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Siemers ER, 2016, ALZHEIMERS DEMENT, V12, P110, DOI [10.1016/j.jalz.2015.06.1893, 10.1016/j.dadm.2016.02.006]; Sperling R, 2014, NEURON, V84, P608, DOI 10.1016/j.neuron.2014.10.038; Yan RQ, 2014, LANCET NEUROL, V13, P319, DOI 10.1016/S1474-4422(13)70276-X	28	357	365	0	75	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2018	378	18					1691	1703		10.1056/NEJMoa1706441	http://dx.doi.org/10.1056/NEJMoa1706441			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GE4WO	29719179	Bronze, Green Accepted			2022-12-28	WOS:000431218600007
J	Oquendo, MA; Volkow, ND				Oquendo, Maria A.; Volkow, Nora D.			Suicide: A Silent Contributor to Opioid-Overdose Deaths	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Oquendo, Maria A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Volkow, Nora D.] NIDA, Bethesda, MD 20892 USA	University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Oquendo, MA (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.		Oquendo, Maria/AAC-6237-2019		NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		[Anonymous], 2017, AM J PUBLIC HEALTH, V107, P421; Bohnert KM, 2017, ADDICTION, V112, P1193, DOI 10.1111/add.13774; Johnson EM, 2013, J GEN INTERN MED, V28, P522, DOI 10.1007/s11606-012-2225-z; Mack Karin A, 2017, MMWR Surveill Summ, V66, P1, DOI 10.15585/mmwr.ss6619a1; Stone DM, 2017, AM J PUBLIC HEALTH, V107, P1233, DOI [10.2105/AJPH.2017.303863, 10.2105/ajph.2017.303863]	5	127	127	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2018	378	17					1567	1569		10.1056/NEJMp1801417	http://dx.doi.org/10.1056/NEJMp1801417			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GD8XP	29694805				2022-12-28	WOS:000430797900002
J	Song, XQ; Jensen, MO; Jogini, V; Stein, RA; Lee, CH; Mchaourab, HS; Shaw, DE; Gouaux, E				Song, Xianqiang; Jensen, Morten O.; Jogini, Vishwanath; Stein, Richard A.; Lee, Chia-Hsueh; Mchaourab, Hassane S.; Shaw, David E.; Gouaux, Eric			Mechanism of NMDA receptor channel block by MK-801 and memantine	NATURE			English	Article							HIGH-LEVEL EXPRESSION; D-ASPARTATE RECEPTORS; GENERAL FORCE-FIELD; ION-CHANNEL; SUBUNIT ARRANGEMENT; SYNAPTIC PLASTICITY; CRYSTAL-STRUCTURE; CELL-LINE; IN-VIVO; NEURONS	The NMDA (N-methyl-d-aspartate) receptor transduces the binding of glutamate and glycine, coupling it to the opening of a calcium-permeable ion channel(1). Owing to the lack of high-resolution structural studies of the NMDA receptor, the mechanism by which ion-channel blockers occlude ion permeation is not well understood. Here we show that removal of the amino-terminal domains from the GluN1-GluN2B NMDA receptor yields a functional receptor and crystals with good diffraction properties, allowing us to map the binding site of the NMDA receptor blocker, MK-801. This crystal structure, together with long-timescale molecular dynamics simulations, shows how MK-801 and memantine (a drug approved for the treatment of Alzheimer's disease) bind within the vestibule of the ion channel, promote closure of the ion channel gate and lodge between the M3-helix-bundle crossing and the M2-pore loops, physically blocking ion permeation.	[Song, Xianqiang; Lee, Chia-Hsueh; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA; [Jensen, Morten O.; Jogini, Vishwanath; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Stein, Richard A.; Mchaourab, Hassane S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Shaw, David E.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA; [Lee, Chia-Hsueh] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA	Oregon Health & Science University; D. E. Shaw Research; Vanderbilt University; Columbia University; Howard Hughes Medical Institute; Oregon Health & Science University; Rockefeller University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.; Shaw, DE (corresponding author), DE Shaw Res, New York, NY 10036 USA.; Shaw, DE (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA.; Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA.	David.Shaw@DEShawResearch.com; gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019; Song, Xianqiang/B-9768-2017	Gouaux, Eric/0000-0002-8549-2360; Song, Xianqiang/0000-0002-5637-3119	National Institutes of Health [R01 NS038631]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Vaskalis and H. Owen for manuscript preparation, Gouaux laboratory members, S. Piana and M. Eastwood for discussions, and the Berkeley Center for Structural Biology (5.0.2) and the Advanced Photon Source (24ID-C and 24ID-E) for assistance with data collection. This work was supported by the National Institutes of Health (R01 NS038631). E.G. is an investigator of the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chang HR, 2008, J NEUROSCI, V28, P1546, DOI 10.1523/JNEUROSCI.3485-07.2008; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hackos DH, 2016, NEURON, V89, P983, DOI 10.1016/j.neuron.2016.01.016; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; HART HE, 1979, MOL IMMUNOL, V16, P265, DOI 10.1016/0161-5890(79)90065-8; Hu NW, 2009, P NATL ACAD SCI USA, V106, P20504, DOI 10.1073/pnas.0908083106; INOUYE H, 1982, J BACTERIOL, V149, P434, DOI 10.1128/JB.149.2.434-439.1982; Jensen MO, 2013, J GEN PHYSIOL, V141, P619, DOI 10.1085/jgp.201210820; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Jeschke G, 2002, J MAGN RESON, V155, P72, DOI 10.1006/jmre.2001.2498; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Kashiwagi K, 2002, MOL PHARMACOL, V61, P533, DOI 10.1124/mol.61.3.533; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; Kovacic P, 2010, OXID MED CELL LONGEV, V3, P13, DOI 10.4161/oxim.3.1.10028; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mishra S, 2014, ELIFE, V3, DOI 10.7554/eLife.02740; Murthy SE, 2012, J GEN PHYSIOL, V140, P267, DOI 10.1085/jgp.201210786; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Paoletti P, 2011, EUR J NEUROSCI, V33, P1351, DOI 10.1111/j.1460-9568.2011.07628.x; PARSONS CG, 1995, NEUROPHARMACOLOGY, V34, P1239, DOI 10.1016/0028-3908(95)00092-K; Parsons MP, 2014, NEURON, V82, P279, DOI 10.1016/j.neuron.2014.03.030; Pierson TM, 2014, ANN CLIN TRANSL NEUR, V1, P190, DOI 10.1002/acn3.39; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Roux B, 2008, BIOPHYS J, V95, P4205, DOI 10.1529/biophysj.108.136499; Shaw DE, 2014, INT CONF HIGH PERFOR, P41, DOI 10.1109/SC.2014.9; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; Sobolevsky AI, 1998, J PHYSIOL-LONDON, V512, P47, DOI 10.1111/j.1469-7793.1998.047bf.x; Stein RA, 2015, METHOD ENZYMOL, V563, P531, DOI 10.1016/bs.mie.2015.07.031; STERN P, 1994, J PHYSIOL-LONDON, V476, P391, DOI 10.1113/jphysiol.1994.sp020140; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vilar S, 2008, CURR TOP MED CHEM, V8, P1555, DOI 10.2174/156802608786786624; Wollmuth LP, 1998, J PHYSIOL-LONDON, V506, P33, DOI 10.1111/j.1469-7793.1998.00033.x; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005; Wollmuth LP, 1996, J PHYSIOL-LONDON, V491, P779, DOI 10.1113/jphysiol.1996.sp021257; Yu WB, 2012, J COMPUT CHEM, V33, P2451, DOI 10.1002/jcc.23067; Yuan HJ, 2015, NEURON, V85, P1305, DOI 10.1016/j.neuron.2015.02.008; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009	57	122	124	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					515	+		10.1038/s41586-018-0039-9	http://dx.doi.org/10.1038/s41586-018-0039-9			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8VX	29670280	Green Submitted, Green Accepted			2022-12-28	WOS:000430793000050
J	Pitman, A; Suleman, S; Hyde, N; Hodgkiss, A				Pitman, Alexandra; Suleman, Sahil; Hyde, Nicholas; Hodgkiss, Andrew			Exploring low mood in a person with cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SUICIDE; DEPRESSION; TRIAL; RISK		[Pitman, Alexandra; Suleman, Sahil; Hyde, Nicholas] St Georges Univ Hosp NHS Fdn Trust, London, England; [Pitman, Alexandra; Suleman, Sahil] UCL, Div Psychiat, London, England; [Hodgkiss, Andrew] Cent & North West London NHS Fdn Trust, London, England; [Hodgkiss, Andrew] Royal Marsden NHS Fdn Trust, London, England; [Hodgkiss, Andrew] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England	University of London; University College London; Royal Marsden NHS Foundation Trust; University of London; King's College London	Pitman, A (corresponding author), St Georges Univ Hosp NHS Fdn Trust, London, England.; Pitman, A (corresponding author), UCL, Div Psychiat, London, England.	a.pitman@ucl.ac.uk		Suleman, Sahil/0000-0001-5910-6756; Pitman, Alexandra/0000-0002-9742-1359				Breitbart W, 2000, JAMA-J AM MED ASSOC, V284, P2907, DOI 10.1001/jama.284.22.2907; Crawford MJ, 2011, BRIT J PSYCHIAT, V198, P379, DOI 10.1192/bjp.bp.110.083592; Gross Anne F, 2007, Prim Care Companion J Clin Psychiatry, V9, P382; Johnson TV, 2012, PSYCHO-ONCOLOGY, V21, P351, DOI 10.1002/pon.1905; Kendal WS, 2007, ANN ONCOL, V18, P381, DOI 10.1093/annonc/mdl385; National Institute for Health and Care Excellence, 2004, IMPR SUPP PALL CAR A; Robson A, 2010, PSYCHO-ONCOLOGY, V19, P1250, DOI 10.1002/pon.1717; Sharpe M, 2014, LANCET, V384, P1099, DOI 10.1016/S0140-6736(14)61231-9; Smith HR, 2015, ONCOL LETT, V9, P1509, DOI 10.3892/ol.2015.2944; Stark DPH, 2000, BRIT J CANCER, V83, P1261, DOI 10.1054/bjoc.2000.1405	10	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2018	361								k1488	10.1136/bmj.k1488	http://dx.doi.org/10.1136/bmj.k1488			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF4WC	29695482	Green Submitted			2022-12-28	WOS:000431963600005
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: AI in medicine must be rigorously tested	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Care Quality Commission, 2017, BAB HEALTHC SERV LTD; McCartney M, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3980	2	5	5	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2018	361								k1752	10.1136/bmj.k1752	http://dx.doi.org/10.1136/bmj.k1752			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF4VZ	29691220	Bronze, Green Published			2022-12-28	WOS:000431963200009
J	Protopopoff, N; Mosha, JF; Lukole, E; Charlwood, JD; Wright, A; Mwalimu, CD; Manjurano, A; Mosha, FW; Kisinza, W; Kleinschmidt, I; Rowland, M				Protopopoff, Natacha; Mosha, Jacklin F.; Lukole, Eliud; Charlwood, Jacques D.; Wright, Alexandra; Mwalimu, Charles D.; Manjurano, Alphaxard; Mosha, Franklin W.; Kisinza, William; Kleinschmidt, Immo; Rowland, Mark			Effectiveness of a long-lasting piperonyl butoxide-treated insecticidal net and indoor residual spray interventions, separately and together, against malaria transmitted by pyrethroid-resistant mosquitoes: a cluster, randomised controlled, two-by-two factorial design trial	LANCET			English	Article							ANOPHELES-GAMBIAE; WESTERN KENYA; BED NETS; AREA; TRANSMISSION; PROTECTION; MORTALITY; SELECTION; TANZANIA; EFFICACY	Background Progress in malaria control is under threat by wide-scale insecticide resistance in malaria vectors. Two recent vector control products have been developed: a long-lasting insecticidal net that incorporates a synergist piperonyl butoxide (PBO) and a long-lasting indoor residual spraying formulation of the insecticide pirimiphosmethyl. We evaluated the effectiveness of PBO long-lasting insecticidal nets versus standard long-lasting insecticidal nets as single interventions and in combination with the indoor residual spraying of pirimiphos-methyl. Methods We did a four-group cluster randomised controlled trial using a two-by-two factorial design of 48 clusters derived from 40 villages in Muleba (Kagera, Tanzania). We randomly assigned these clusters using restricted randomisation to four groups: standard long-lasting insecticidal nets, PBO long-lasting insecticidal nets, standard long-lasting insecticidal nets plus indoor residual spraying, or PBO long-lasting insecticidal nets plus indoor residual spraying. Both standard and PBO nets were distributed in 2015. Indoor residual spraying was applied only once in 2015. We masked the inhabitants of each cluster to the type of nets received, as well as field staff who took blood samples. Neither the investigators nor the participants were masked to indoor residual spraying. The primary outcome was the prevalence of malaria infection in children aged 6 months to 14 years assessed by cross-sectional surveys at 4, 9, 16, and 21 months after intervention. The endpoint for assessment of indoor residual spraying was 9 months and PBO long-lasting insecticidal nets was 21 months. This trial is registered with ClinicalTrials.gov, number NCT02288637. Findings 7184 (68.0%) of 10 560 households were selected for post-intervention survey, and 15 469 (89.0%) of 17 377 eligible children from the four surveys were included in the intention-to-treat analysis. Of the 878 households visited in the two indoor residual spraying groups, 827 (94%) had been sprayed. Reported use of long-lasting insecticidal nets, across all groups, was 15 341 (77.3%) of 19 852 residents after 1 year, decreasing to 12 503 (59.2%) of 21 105 in the second year. Malaria infection prevalence after 9 months was lower in the two groups that received PBO long-lasting insecticidal nets than in the two groups that received standard long-lasting insecticidal nets (531 [29%] of 1852 children vs 767 [42%] of 1809; odds ratio [OR] 0.37, 95% CI 0.21-0.65; p=0.0011). At the same timepoint, malaria prevalence in the two groups that received indoor residual spraying was lower than in groups that did not receive indoor residual spraying (508 [28%] of 1846 children vs 790 [44%] of 1815; OR 0.33, 95% CI 0.19-0.55; p<0.0001) and there was evidence of an interaction between PBO long-lasting insecticidal nets and indoor residual spraying (OR 2.43, 95% CI 1.19-4.97; p=0.0158), indicating redundancy when combined. The PBO long-lasting insecticidal net effect was sustained after 21 months with a lower malaria prevalence than the standard long-lasting insecticidal net (865 [45%] of 1930 children vs 1255 [62%] of 2034; OR 0.40, 0.20-0.81; p=0.0122). Interpretation The PBO long-lasting insecticidal net and non-pyrethroid indoor residual spraying interventions showed improved control of malaria transmission compared with standard long-lasting insecticidal nets where pyrethroid resistance is prevalent and either intervention could be deployed to good effect. As a result, WHO has since recommended to increase coverage of PBO long-lasting insecticidal nets. Combining indoor residual spraying with pirimiphos-methyl and PBO long-lasting insecticidal nets provided no additional benefit compared with PBO long-lasting insecticidal nets alone or standard long-lasting insecticidal nets plus indoor residual spraying. Copyright (C) The Author(s). Published by Elsevier Ltd.	[Protopopoff, Natacha; Charlwood, Jacques D.; Wright, Alexandra; Rowland, Mark] London Sch Hyg & Trop Med, Dept Dis Control, London WC1E 7HT, England; [Kleinschmidt, Immo] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London, England; [Mosha, Jacklin F.; Manjurano, Alphaxard] Mwanza Med Res Ctr, Natl Inst Med Res, Mwanza, Tanzania; [Lukole, Eliud; Mosha, Franklin W.] Kilimanjaro Christian Med Univ Coll, Pan African Malaria Vector Res Consortium, Moshi, Tanzania; [Mwalimu, Charles D.] Minist Hlth Community Dev Gender Elderly & Childr, Natl Malaria Control Program, Dar Es Salaam, Tanzania; [Kisinza, William] Amani Med Res Ctr, Natl Inst Med Res, Muheza, Tanzania; [Kleinschmidt, Immo] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; National Institute of Medical Research; University of Witwatersrand	Protopopoff, N (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1E 7HT, England.	natacha.protopopoff@lshtm.ac.uk		Protopopoff, Natacha/0000-0001-6698-4936; Mosha, Jacklin/0000-0001-7940-8903	UK Department for International Development; Medical Research Council; Wellcome Trust; Medical Research Council [MR/L004437/1, MR/K012126/1] Funding Source: researchfish; MRC [MR/L004437/1] Funding Source: UKRI	UK Department for International Development; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	UK Department for International Development, Medical Research Council, and Wellcome Trust.	[Anonymous], 1987, SUPPLEMENT ANOPHELIN; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Bass C, 2008, ACTA TROP, V107, P50, DOI 10.1016/j.actatropica.2008.04.009; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; Corbel V, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-22; Corbel V, 2012, LANCET INFECT DIS, V12, P617, DOI 10.1016/S1473-3099(12)70081-6; Corbel V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-113; Drakeley C, 2003, TROP MED INT HEALTH, V8, P767, DOI 10.1046/j.1365-3156.2003.01100.x; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Hayes RJ, 2009, INTERD STAT, P3; Katureebe A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002167; Kleinschmidt I, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0782-4; Lindblade KA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0554-1; Matowo J, 2015, MED VET ENTOMOL, V29, P51, DOI 10.1111/mve.12090; Ochomo E, 2017, EMERG INFECT DIS, V23, P758, DOI 10.3201/eid2305.161315; Ochomo EO, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-368; Oxborough RM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1201-1; Pennetier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075134; Pinder M, 2015, LANCET, V385, P1436, DOI 10.1016/S0140-6736(14)61007-2; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Rowland M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069516; Viana M, 2016, P NATL ACAD SCI USA, V113, P8975, DOI 10.1073/pnas.1603431113; West PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115661; West PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001630; WHO, 2016, WORLD MAL REP 2016; WHO, 2015, COND US LONG LAST IN; WHO, 2009, 12 WHOPES WORK GROUP; WIRTZ RA, 1987, B WORLD HEALTH ORGAN, V65, P39; World Health Organization, 2012, 15 WHOPES WORK GROUP; World Health Organization, 2017, COND DEPL MOSQ NETS	32	171	171	5	32	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2018	391	10130					1577	1588		10.1016/S0140-6736(18)30427-6	http://dx.doi.org/10.1016/S0140-6736(18)30427-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD5JG	29655496	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000430542700027
J	Iranzo, DA; Nanot, S; Dias, EJC; Epstein, I; Peng, C; Efetov, DK; Lundeberg, MB; Parret, R; Osmond, J; Hong, JY; Kong, J; Englund, DR; Peres, NMR; Koppens, FHL				Alcaraz Iranzo, David; Nanot, Sebastien; Dias, Eduardo J. C.; Epstein, Itai; Peng, Cheng; Efetov, Dmitri K.; Lundeberg, Mark B.; Parret, Romain; Osmond, Johann; Hong, Jin-Yong; Kong, Jing; Englund, Dirk R.; Peres, Nuno M. R.; Koppens, Frank H. L.			Probing the ultimate plasmon confinement limits with a van der Waals heterostructure	SCIENCE			English	Article							HEXAGONAL BORON-NITRIDE; GRAPHENE; ENHANCEMENT; DENSITY; FOIL	The ability to confine light into tiny spatial dimensions is important for applications such as microscopy, sensing, and nanoscale lasers. Although plasmons offer an appealing avenue to confine light, Landau damping in metals imposes a trade-off between optical field confinement and losses. We show that a graphene-insulator-metal heterostructure can overcome that trade-off, and demonstrate plasmon confinement down to the ultimate limit of the length scale of one atom. This is achieved through far-field excitation of plasmon modes squeezed into an atomically thin hexagonal boron nitride dielectric spacer between graphene and metal rods. A theoretical model that takes into account the nonlocal optical response of both graphene and metal is used to describe the results. These ultraconfined plasmonic modes, addressed with far-field light excitation, enable a route to new regimes of ultrastrong light-matter interactions.	[Alcaraz Iranzo, David; Nanot, Sebastien; Epstein, Itai; Efetov, Dmitri K.; Lundeberg, Mark B.; Parret, Romain; Osmond, Johann; Koppens, Frank H. L.] Barcelona Inst Sci & Technol, Inst Photon Sci, Inst Ciencies Foton ICFO, Castelldefels 08860, Barcelona, Spain; [Nanot, Sebastien] niv Montpellier, CNRS, Lab Charles Coulomb L2C, F-34095 Montpellier, France; [Dias, Eduardo J. C.; Peres, Nuno M. R.] Univ Minho, Ctr Fis, P-4710057 Braga, Portugal; [Dias, Eduardo J. C.; Peres, Nuno M. R.] Univ Minho, Dept Fis, P-4710057 Braga, Portugal; [Dias, Eduardo J. C.; Peres, Nuno M. R.] Univ Minho, QuantaLab, P-4710057 Braga, Portugal; [Peng, Cheng; Efetov, Dmitri K.; Hong, Jin-Yong; Kong, Jing; Englund, Dirk R.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Koppens, Frank H. L.] ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universidade do Minho; Universidade do Minho; Universidade do Minho; Massachusetts Institute of Technology (MIT); ICREA	Koppens, FHL (corresponding author), Barcelona Inst Sci & Technol, Inst Photon Sci, Inst Ciencies Foton ICFO, Castelldefels 08860, Barcelona, Spain.; Koppens, FHL (corresponding author), ICREA, Barcelona, Spain.	frank.koppens@icfo.eu	Englund, Dirk Robert/GNH-1681-2022; Dias, Eduardo J. C./E-4804-2017; Efetov, Dmitri/P-5697-2018; parret, romain/F-7583-2019	Englund, Dirk Robert/0000-0002-1043-3489; Dias, Eduardo J. C./0000-0002-6347-5631; Efetov, Dmitri/0000-0001-5862-0462; parret, romain/0000-0003-0662-6373; Alcaraz Iranzo, David/0000-0002-2141-569X; Nanot, Sebastien/0000-0002-3185-1583; Epstein, Itai/0000-0002-6174-4025; Hong, Jin-Yong/0000-0003-4044-4063	Spanish Ministry of Economy and Competitiveness, through the Severo Ochoa Programme for Centres of Excellence in RD [SEV-2015-0522]; Fundacio Cellex Barcelona; Mineco grants Ramon y Cajal [RYC-2012-12281]; government of Catalonia through the SGR grant [2014-SGR-1535]; European Union [604391]; European Research Council starting grant [307806]; project GRASP [FP7-ICT-2013-613024-GRASP]; FPI [BES-2014-068504]; Portuguese Foundation for Science and Technology (FCT) [UID/FIS/04650/2013]; Center for Excitonics, an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001088]; Army Research Office [16112776]; U.S. Air Force Office of Scientific Research Foldable and Adaptive 2D Electronics Multidisciplinary University Research Initiative [FA9550-15-1-0514];  [FIS2013-47161-P];  [FIS2014-59639-JIN]	Spanish Ministry of Economy and Competitiveness, through the Severo Ochoa Programme for Centres of Excellence in RD; Fundacio Cellex Barcelona(Foundation CELLEXEuropean Commission); Mineco grants Ramon y Cajal; government of Catalonia through the SGR grant; European Union(European Commission); European Research Council starting grant(European Research Council (ERC)); project GRASP; FPI(Spanish Government); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Center for Excitonics, an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Army Research Office; U.S. Air Force Office of Scientific Research Foldable and Adaptive 2D Electronics Multidisciplinary University Research Initiative; ; 	We acknowledge financial support from the Spanish Ministry of Economy and Competitiveness, through the Severo Ochoa Programme for Centres of Excellence in R&D (grant SEV-2015-0522), and support by Fundacio Cellex Barcelona, the Mineco grants Ramon y Cajal (grant RYC-2012-12281), Plan Nacional (grants FIS2013-47161-P and FIS2014-59639-JIN), and the government of Catalonia through the SGR grant (2014-SGR-1535). Furthermore, the research leading to these results has received funding from the European Union H2020 Programme under grant agreement 604391 Graphene Flagship, the European Research Council starting grant (307806, CarbonLight), and project GRASP (FP7-ICT-2013-613024-GRASP). D.A.I. acknowledges the FPI grant BES-2014-068504. N.M.R.P. and E.J.C.D acknowledge support from the Portuguese Foundation for Science and Technology (FCT) in the framework of the Strategic Financing UID/FIS/04650/2013. This work was supported in part by the Center for Excitonics, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under award DE-SC0001088, and the Army Research Office (grant 16112776). J.-Y.H. and J.K. acknowledge support from the U.S. Air Force Office of Scientific Research Foldable and Adaptive 2D Electronics Multidisciplinary University Research Initiative, grant FA9550-15-1-0514.	Alonso-Gonzalez P, 2017, NAT NANOTECHNOL, V12, P31, DOI [10.1038/nnano.2016.185, 10.1038/NNANO.2016.185]; Basov DN, 2016, SCIENCE, V354, DOI 10.1126/science.aag1992; Benz F, 2016, SCIENCE, V354, P726, DOI 10.1126/science.aah5243; Bozhevolnyi SI, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.046802; Brar VW, 2014, NANO LETT, V14, P3876, DOI 10.1021/nl501096s; Brar VW, 2013, NANO LETT, V13, P2541, DOI 10.1021/nl400601c; Christensen T, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.157402; Ciraci C, 2012, SCIENCE, V337, P1072, DOI 10.1126/science.1224823; David C, 2014, ACS NANO, V8, P9558, DOI 10.1021/nn5038527; Dionne JA, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.035407; Fang ZY, 2013, ACS NANO, V7, P2388, DOI 10.1021/nn3055835; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Khurgin J. B., 2016, QUANTUM PLASMONICS, P303; Kim KK, 2012, NANO LETT, V12, P161, DOI 10.1021/nl203249a; Lin IT, 2017, IEEE J SEL TOP QUANT, V23, DOI 10.1109/JSTQE.2016.2596262; Low T, 2017, NAT MATER, V16, P182, DOI [10.1038/NMAT4792, 10.1038/nmat4792]; Lundeberg MB, 2017, SCIENCE, V357, P187, DOI 10.1126/science.aan2735; Maier SA, 2006, OPT EXPRESS, V14, P1957, DOI 10.1364/OE.14.001957; Miyazaki HT, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.097401; Novoselov KS, 2016, SCIENCE, V353, DOI 10.1126/science.aac9439; Oulton RF, 2008, NAT PHOTONICS, V2, P496, DOI 10.1038/nphoton.2008.131; Park JH, 2014, ACS NANO, V8, P8520, DOI 10.1021/nn503140y; Popov VV, 2011, J INFRARED MILLIM TE, V32, P1178, DOI 10.1007/s10762-011-9813-6; Principi A, 2011, SOLID STATE COMMUN, V151, P1627, DOI 10.1016/j.ssc.2011.07.015; Ruppin R, 2002, PHYS LETT A, V299, P309, DOI 10.1016/S0375-9601(01)00838-6; Stauber T, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/11/113050; Stockman MI, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.137404; Teperik TV, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.263901; Woessner A, 2015, NAT MATER, V14, P421, DOI [10.1038/NMAT4169, 10.1038/nmat4169]; Yan HG, 2013, NAT PHOTONICS, V7, P394, DOI [10.1038/NPHOTON.2013.57, 10.1038/nphoton.2013.57]; Zhao RK, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.033602	31	205	206	21	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2018	360	6386					291	295		10.1126/science.aar8438	http://dx.doi.org/10.1126/science.aar8438			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD3IC	29674587	Green Submitted			2022-12-28	WOS:000430396600037
J	Mervis, J				Mervis, Jeffrey			DEMOGRAPHY Plan for 2020 U.S. census is fatally flawed, critics say	SCIENCE			English	News Item																			0	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2018	360	6386					250	252		10.1126/science.360.6386.250	http://dx.doi.org/10.1126/science.360.6386.250			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD3IC	29674572				2022-12-28	WOS:000430396600017
J	Schwartz, MA; Vestweber, D; Simons, M				Schwartz, Martin A.; Vestweber, Dietmar; Simons, Michael			A unifying concept in vascular health and disease	SCIENCE			English	Editorial Material							ATHEROSCLEROSIS; ANGIOGENESIS		[Schwartz, Martin A.; Simons, Michael] Yale Cardiovasc Res Ctr, 300 George St, New Haven, CT 06511 USA; [Schwartz, Martin A.; Simons, Michael] Yale Sch Med, Dept Med Cardiol, New Haven, CT 06510 USA; [Schwartz, Martin A.; Simons, Michael] Yale Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Schwartz, Martin A.] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA; [Vestweber, Dietmar] Max Planck Inst Mol Biomed, Munster, Germany	Yale University; Yale University; Yale University; Max Planck Society	Schwartz, MA (corresponding author), Yale Cardiovasc Res Ctr, 300 George St, New Haven, CT 06511 USA.; Schwartz, MA (corresponding author), Yale Sch Med, Dept Med Cardiol, New Haven, CT 06510 USA.; Schwartz, MA (corresponding author), Yale Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.; Schwartz, MA (corresponding author), Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.	martin.schwartz@yale.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL135582] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL135582] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Chen PY, 2015, J CLIN INVEST, V125, P4514, DOI 10.1172/JCI82719; Dejana E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14361; Lampugnani MG, 2017, CURR OPIN HEMATOL, V24, P256, DOI 10.1097/MOH.0000000000000338; Mitchell RN, 2004, CARDIOVASC PATHOL, V13, P33, DOI 10.1016/S1054-8807(03)00108-X; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Parikh SM, 2017, CURR OPIN HEMATOL, V24, P432, DOI 10.1097/MOH.0000000000000361; Santilli F, 2015, VASC PHARMACOL, V74, P23, DOI 10.1016/j.vph.2015.09.003; Simons M, 2015, CIRC RES, V116, P1712, DOI 10.1161/CIRCRESAHA.116.302953; Tabas I, 2015, J CELL BIOL, V209, P13, DOI 10.1083/jcb.201412052; Tual-Chalot S, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00025; Yurdagul A, 2016, BIOCHEM J, V473, P1281, DOI 10.1042/BJ20150844	12	49	51	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2018	360	6386					270	271		10.1126/science.aat3470	http://dx.doi.org/10.1126/science.aat3470			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD3IC	29674582	Green Accepted			2022-12-28	WOS:000430396600027
J	Babbitt, SE; Kiss, A; Deffenbaugh, AE; Chang, YH; Bailly, E; Erdjument-Bromage, H; Tempst, P; Buranda, T; Sklar, LA; Baumler, J; Gogol, E; Skowyra, D				Babbitt, Shalon E.; Kiss, Alexi; Deffenbaugh, Andrew E.; Chang, Yie-Hwa; Bailly, Eric; Erdjument-Bromage, Hediye; Tempst, Paul; Buranda, Tione; Sklar, Larry A.; Baumler, Jennifer; Gogol, Edward; Skowyra, Dorota			RETRACTION: ATP Hydrolysis-Dependent Disassembly of the 26S Proteasome Is Part of the Catalytic Cycle (Retraction of Vol 121, Pg 553, 2005)	CELL			English	Retraction									[Babbitt, Shalon E.; Kiss, Alexi; Deffenbaugh, Andrew E.; Chang, Yie-Hwa; Bailly, Eric; Erdjument-Bromage, Hediye; Tempst, Paul; Buranda, Tione; Sklar, Larry A.; Baumler, Jennifer; Gogol, Edward; Skowyra, Dorota] St Louis Univ, St Louis, MO 63103 USA	Saint Louis University	Babbitt, SE (corresponding author), St Louis Univ, St Louis, MO 63103 USA.		Kiss, Alexi/AAH-6830-2021					Babbitt SE, 2005, CELL, V121, P553, DOI 10.1016/j.cell.2005.03.028	1	0	0	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2018	173	3					804	804		10.1016/j.cell.2018.04.009	http://dx.doi.org/10.1016/j.cell.2018.04.009			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7GB	29677518	Bronze			2022-12-28	WOS:000430677400026
J	Banegas, JR; Ruilope, LM; de la Sierra, A; Vinyoles, E; Gorostidi, M; de la Cruz, JJ; Ruiz-Hurtado, G; Segura, J; Rodriguez-Artalejo, F; Williams, B				Banegas, J. R.; Ruilope, L. M.; de la Sierra, A.; Vinyoles, E.; Gorostidi, M.; de la Cruz, J. J.; Ruiz-Hurtado, G.; Segura, J.; Rodriguez-Artalejo, F.; Williams, B.			RETRACTED: Relationship between Clinic and Ambulatory Blood-Pressure Measurements and Mortality (Retracted article. See vol. 382, pg. 786, 2020)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Retracted Publication							WHITE-COAT HYPERTENSION; MASKED HYPERTENSION; CARDIOVASCULAR EVENTS; EUROPEAN-SOCIETY; PROGNOSTIC VALUE; INTERNATIONAL DATABASE; OLDER PATIENTS; FOLLOW-UP; RISK; HOME	BACKGROUND Evidence for the influence of ambulatory blood pressure on prognosis derives mainly from population-based studies and a few relatively small clinical investigations. This study examined the associations of blood pressure measured in the clinic (clinic blood pressure) and 24-hour ambulatory blood pressure with all-cause and cardiovascular mortality in a large cohort of patients in primary care. METHODS We analyzed data from a registry-based, multicenter, national cohort that included 63,910 adults recruited from 2004 through 2014 in Spain. Clinic and 24-hour ambulatory blood-pressure data were examined in the following categories: sustained hypertension (elevated clinic and elevated 24-hour ambulatory blood pressure), "white-coat" hypertension (elevated clinic and normal 24-hour ambulatory blood pressure), masked hypertension (normal clinic and elevated 24-hour ambulatory blood pressure), and normotension (normal clinic and normal 24-hour ambulatory blood pressure). Analyses were conducted with Cox regression models, adjusted for clinic and 24-hour ambulatory blood pressures and for confounders. RESULTS During a median follow-up of 4.7 years, 3808 patients died from any cause, and 1295 of these patients died from cardiovascular causes. In a model that included both 24-hour and clinic measurements, 24-hour systolic pressure was more strongly associated with all-cause mortality (hazard ratio, 1.58 per 1-SD increase in pressure; 95% confidence interval [CI], 1.56 to 1.60, after adjustment for clinic blood pressure) than the clinic systolic pressure (hazard ratio, 1.02; 95% CI, 1.00 to 1.04, after adjustment for 24-hour blood pressure). Corresponding hazard ratios per 1-SD increase in pressure were 1.55 (95% CI, 1.53 to 1.57, after adjustment for clinic and daytime blood pressures) for nighttime ambulatory systolic pressure and 1.54 (95% CI, 1.52 to 1.56, after adjustment for clinic and nighttime blood pressures) for daytime ambulatory systolic pressure. These relationships were consistent across subgroups of age, sex, and status with respect to obesity, diabetes, cardiovascular disease, and antihypertensive treatment. Masked hypertension was more strongly associated with all-cause mortality (hazard ratio, 2.83; 95% CI, 2.12 to 3.79) than sustained hypertension (hazard ratio, 1.80; 95% CI, 1.41 to 2.31) or white-coat hypertension (hazard ratio, 1.79; 95% CI, 1.38 to 2.32). Results for cardiovascular mortality were similar to those for all-cause mortality. CONCLUSIONS Ambulatory blood-pressure measurements were a stronger predictor of all-cause and cardiovascular mortality than clinic blood-pressure measurements. White-coat hypertension was not benign, and masked hypertension was associated with a greater risk of death than sustained hypertension. (Funded by the Spanish Society of Hypertension and others.)	[Banegas, J. R.; Ruilope, L. M.; de la Cruz, J. J.; Rodriguez-Artalejo, F.] Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth, Inst Invest Hosp Univ La Paz IdiPAZ, Madrid, Spain; [Banegas, J. R.; Ruilope, L. M.; de la Cruz, J. J.; Rodriguez-Artalejo, F.] Ctr Invest Biomed Red CIBER Epidemiol & Publ Hlth, Madrid, Spain; [Ruilope, L. M.; Ruiz-Hurtado, G.; Segura, J.] Hosp Univ 12 Octubre, Inst Res, Hypertens Unit, Dept Nephrol, Madrid, Spain; [Ruilope, L. M.; Ruiz-Hurtado, G.; Segura, J.] Hosp Univ 12 Octubre, Inst Res, Cardiorenal Translat Res Lab, Madrid, Spain; [Ruilope, L. M.; Ruiz-Hurtado, G.; Segura, J.] CIBER Cardiovasc Dis, Madrid, Spain; [Ruilope, L. M.] Univ Europea Madrid, Sch Doctoral Studies & Res, Madrid, Spain; [Rodriguez-Artalejo, F.] Campus Excelencia Int Univ Autonoma Madrid, Madrid Inst Adv Studies, Food Inst, Madrid, Spain; [Rodriguez-Artalejo, F.] CSIC, Madrid, Spain; [de la Sierra, A.] Univ Barcelona, Dept Internal Med, Hosp Mutua Terrassa, Barcelona, Spain; [Vinyoles, E.] Univ Barcelona, La Mina Primary Care Ctr, Barcelona, Spain; [Gorostidi, M.] Hosp Univ Cent Asturias, Nephrol Serv, Red Invest Renal, Oviedo, Spain; [Williams, B.] UCL, Inst Cardiovasc Sci, London, England; [Williams, B.] UCL, Natl Inst Hlth Res UCL Hosp, Biomed Res Ctr, London, England	Autonomous University of Madrid; Hospital Universitario La Paz; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; European University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Hospital Universitario Mutua Terrassa; University of Barcelona; University of Barcelona; Central University Hospital Asturias; University of London; University College London; University of London; University College London	Banegas, JR (corresponding author), Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth, IdiPAZ CIBER Epidemiol & Publ Hlth, Avda Arzobispo Morcillo 2, Madrid 28029, Spain.	joseramon.banegas@uam.es	Vinyoles, Ernest/GRX-4615-2022; Ruiz-Hurtado, Gema/C-8254-2011	Ruiz-Hurtado, Gema/0000-0003-3482-0915; Segura, Julian/0000-0003-4677-9526; Williams, Bryan/0000-0002-8094-1841; Vinyoles, Ernest/0000-0002-8725-9431; Ruilope, Luis M/0000-0001-6278-7951	Spanish Society of Hypertension; Lacer Laboratories, Spain; Fondo de Investigaciones Sanitarias of Instituto de Salud Carlos III (Fondo Europeo de Desarrollo Regional and Fondo Social Europeo) [PI16/01460]; Centro de Investigacion Biomedica en Red of Epidemiology and Public Health, Spain; University College London Hospitals Biomedical Research Centre; Abbott; Daiichi Sankyo; Menarini; Lacer; Pfizer; AstraZeneca; Chiesi; Medtronic; Esteve; Servier; Vascular Dynamics; Relypsa; Novartis; MRC [MC_PC_13090] Funding Source: UKRI	Spanish Society of Hypertension; Lacer Laboratories, Spain; Fondo de Investigaciones Sanitarias of Instituto de Salud Carlos III (Fondo Europeo de Desarrollo Regional and Fondo Social Europeo); Centro de Investigacion Biomedica en Red of Epidemiology and Public Health, Spain; University College London Hospitals Biomedical Research Centre(General Electric); Abbott(Abbott Laboratories); Daiichi Sankyo(Daiichi Sankyo Company Limited); Menarini(Menarini Group); Lacer; Pfizer(Pfizer); AstraZeneca(AstraZeneca); Chiesi(Chiesi Pharmaceuticals Inc); Medtronic(Medtronic); Esteve; Servier(Servier); Vascular Dynamics; Relypsa; Novartis(Novartis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by the Spanish Society of Hypertension and by an unrestricted grant from Lacer Laboratories, Spain. Specific funding for this analysis was obtained from a grant (PI16/01460) from Fondo de Investigaciones Sanitarias of Instituto de Salud Carlos III (cofunded by Fondo Europeo de Desarrollo Regional and Fondo Social Europeo) and from Centro de Investigacion Biomedica en Red of Epidemiology and Public Health, Spain. Dr. Williams is a Senior Investigator for the National Institute for Health Research, and his research is supported by the University College London Hospitals Biomedical Research Centre.; Dr. de la Sierra reports receiving lecture fees from Abbott, Daiichi Sankyo, Menarini, and Lacer, and receiving advisory board fees and lecture fees from Pfizer; Dr. Segura, receiving lecture fees from AstraZeneca, Chiesi, Daiichi Sankyo, Medtronic, Pfizer, Menarini, Esteve, and Servier; and Dr. Williams, receiving consulting fees from Vascular Dynamics, Relypsa, and Novartis, honoraria from Daiichi Sankyo, Boehringer Ingelheim, Servier, and Pfizer, and serving as an advisor to HealthStats PTE, Singapore. No other potential conflict of interest relevant to this article was reported.	Asayama K, 2014, HYPERTENSION, V64, P935, DOI 10.1161/HYPERTENSIONAHA.114.03614; Banegas JR, 2014, EUR HEART J, V35, P3304, DOI 10.1093/eurheartj/ehu016; Ben-Dov IZ, 2008, J HYPERTENS, V26, P699, DOI 10.1097/HJH.0b013e3282f4b3bf; Boggia J, 2007, LANCET, V370, P1219, DOI 10.1016/S0140-6736(07)61538-4; BRENNER H, 1993, EPIDEMIOLOGY, V4, P229, DOI 10.1097/00001648-199305000-00006; Briasoulis A, 2016, J HYPERTENS, V34, P593, DOI 10.1097/HJH.0000000000000832; Clement DL, 2003, NEW ENGL J MED, V348, P2407, DOI 10.1056/NEJMoa022273; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Dolan E, 2005, HYPERTENSION, V46, P156, DOI 10.1161/01.HYP.0000170138.56903.7a; Fagard RH, 2005, J HUM HYPERTENS, V19, P801, DOI 10.1038/sj.jhh.1001903; Fagard RH, 2008, HYPERTENSION, V51, P55, DOI 10.1161/HYPERTENSIONAHA.107.100727; Fagard RH, 2007, J HYPERTENS, V25, P2193, DOI 10.1097/HJH.0b013e3282ef6185; Franklin SS, 2017, EUR HEART J, V38, P1112, DOI 10.1093/eurheartj/ehw502; Franklin SS, 2016, J AM COLL CARDIOL, V68, P2033, DOI 10.1016/j.jacc.2016.08.035; Franklin SS, 2013, HYPERTENSION, V62, P982, DOI 10.1161/HYPERTENSIONAHA.113.01275; Franklin SS, 2012, HYPERTENSION, V59, P564, DOI 10.1161/HYPERTENSIONAHA.111.180653; Gorostidi M, 2016, EUR J CLIN INVEST, V46, P92, DOI 10.1111/eci.12565; Hansen TW, 2011, HYPERTENSION, V57, P3, DOI 10.1161/HYPERTENSIONAHA.109.133900; Hansen TW, 2005, HYPERTENSION, V45, P499, DOI 10.1161/01.HYP.0000160402.39597.3b; Huang YL, 2017, J HYPERTENS, V35, P677, DOI 10.1097/HJH.0000000000001226; Instituto Nacional de Estadistica, 2018, EST DEF SEG CAUS MUE; Kikuya M, 2005, HYPERTENSION, V45, P240, DOI 10.1161/01.HYP.0000152079.04553.2c; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; Caro JLL, 2012, MED CLIN-BARCELONA, V139, P653, DOI 10.1016/j.medcli.2011.10.023; Mancia G, 2006, HYPERTENSION, V47, P846, DOI 10.1161/01.HYP.0000215363.69793.bb; Mancia G, 2016, J AM COLL CARDIOL, V68, P2044, DOI 10.1016/j.jacc.2016.08.043; Mancia G, 2015, CIRC RES, V116, P1034, DOI 10.1161/CIRCRESAHA.116.303755; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; O'Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/00004872-200305000-00001; O'Brien E, 2013, J HYPERTENS, V31, P1731, DOI 10.1097/HJH.0b013e328363e964; Ohkubo T, 2005, J AM COLL CARDIOL, V46, P508, DOI 10.1016/j.jacc.2005.03.070; Parati G, 2014, J HYPERTENS, V32, P1359, DOI 10.1097/HJH.0000000000000221; Pickering TG, 2006, NEW ENGL J MED, V354, P2368, DOI 10.1056/NEJMra060433; Pierdomenico SD, 2011, AM J HYPERTENS, V24, P52, DOI 10.1038/ajh.2010.203; Sega R, 2005, CIRCULATION, V111, P1777, DOI 10.1161/01.CIR.0000160923.04524.5B; Staessen JA, 1999, JAMA-J AM MED ASSOC, V282, P539, DOI 10.1001/jama.282.6.539; Staessen JA, 2017, AM J HYPERTENS, V30, P453, DOI 10.1093/ajh/hpw148; Stergiou GS, 2014, HYPERTENSION, V63, P675, DOI 10.1161/HYPERTENSIONAHA.113.02741; Verdecchia P, 2005, HYPERTENSION, V45, P203, DOI 10.1161/01.HYP.0000151623.49780.89; Verdecchia P, 2007, BLOOD PRESS MONIT, V12, P387, DOI 10.1097/MBP.0b013e32824958e5	40	340	357	2	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2018	378	16					1509	1520		10.1056/NEJMoa1712231	http://dx.doi.org/10.1056/NEJMoa1712231			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD2EI	29669232	Bronze, Green Published			2022-12-28	WOS:000430312500006
J	Christiansen, EM; Yang, SJ; Ando, DM; Javaherian, A; Skibinski, G; Lipnick, S; Mount, E; O'Neil, A; Shah, K; Lee, AK; Goyal, P; Fedus, W; Poplin, R; Esteva, A; Berndl, M; Rubin, LL; Nelson, P; Finkbeiner, S				Christiansen, Eric M.; Yang, Samuel J.; Ando, D. Michael; Javaherian, Ashkan; Skibinski, Gaia; Lipnick, Scott; Mount, Elliot; O'Neil, Alison; Shah, Kevan; Lee, Alicia K.; Goyal, Piyush; Fedus, William; Poplin, Ryan; Esteva, Andre; Berndl, Marc; Rubin, Lee L.; Nelson, Philip; Finkbeiner, Steven			In Silico Labeling: Predicting Fluorescent Labels in Unlabeled Images	CELL			English	Article							CELL DETECTION; GENERATION	Microscopy is a central method in life sciences. Many popular methods, such as antibody labeling, are used to add physical fluorescent labels to specific cellular constituents. However, these approaches have significant drawbacks, including inconsistency; limitations in the number of simultaneous labels because of spectral overlap; and necessary perturbations of the experiment, such as fixing the cells, to generate the measurement. Here, we show that a computational machine- learning approach, which we call "in silico labeling'' (ISL), reliably predicts some fluorescent labels from transmitted- light images of unlabeled fixed or live biological samples. ISL predicts a range of labels, such as those for nuclei, cell type (e.g., neural), and cell state (e.g., cell death). Because prediction happens in silico, the method is consistent, is not limited by spectral overlap, and does not disturb the experiment. ISL generates biological measurements that would otherwise be problematic or impossible to acquire.	[Christiansen, Eric M.; Yang, Samuel J.; Ando, D. Michael; Fedus, William; Poplin, Ryan; Esteva, Andre; Berndl, Marc; Nelson, Philip] Google Inc, Mountain View, CA 94043 USA; [Javaherian, Ashkan; Skibinski, Gaia; Mount, Elliot; Shah, Kevan; Lee, Alicia K.; Goyal, Piyush; Finkbeiner, Steven] Gladstone Inst, Taube Koret Ctr Neurodegenerat Dis Res & Daedalus, San Francisco, CA 94158 USA; [Lipnick, Scott; O'Neil, Alison; Rubin, Lee L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Lipnick, Scott] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Fedus, William] Univ Montreal, Montreal Inst Learning Algorithms, Montreal, PQ, Canada; [Esteva, Andre] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Lipnick, Scott] Massachusetts Gen Hosp, Ctr Assessment Technol & Continuous Hlth, Boston, MA 02114 USA	Google Incorporated; University of California System; University of California San Francisco; The J David Gladstone Institutes; Harvard University; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universite de Montreal; Stanford University; Harvard University; Massachusetts General Hospital	Christiansen, EM; Nelson, P (corresponding author), Google Inc, Mountain View, CA 94043 USA.; Finkbeiner, S (corresponding author), Gladstone Inst, Taube Koret Ctr Neurodegenerat Dis Res & Daedalus, San Francisco, CA 94158 USA.; Finkbeiner, S (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.; Finkbeiner, S (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.	ericmc@google.com; pqnelson@google.com; sfinkbeiner@gladstone.ucsf.edu		ONeil, Alison/0000-0002-0759-4740; Shah, Kevan/0000-0002-6284-2030; Ando, Michael/0000-0001-9022-8444; Rubin, Lee/0000-0002-8658-841X; Yang, Samuel/0000-0003-2460-6456	NCRR NIH HHS [C06 RR018928] Funding Source: Medline; NIA NIH HHS [RF1 AG056151, RF1 AG058476] Funding Source: Medline; NIGMS NIH HHS [T32 GM008568] Funding Source: Medline; NINDS NIH HHS [U54 NS091046, R01 NS083390, R37 NS101996] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS091046, R37NS101996, R01NS083390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG058476, RF1AG056151] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abadi M, 2015, TENSORFLOW LARGE SCA, V1; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Buggenthin F, 2017, NAT METHODS, V14, P403, DOI 10.1038/nmeth.4182; Burkhardt MF, 2013, MOL CELL NEUROSCI, V56, P355, DOI 10.1016/j.mcn.2013.07.007; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen L. - C., 2015, ARXIV14127062V4; Chen T, 2014, LECT NOTES COMPUT SC, V8679, P17, DOI 10.1007/978-3-319-10581-9_3; Coelho LP, 2009, I S BIOMED IMAGING, P518, DOI 10.1109/ISBI.2009.5193098; Dong B, 2015, I S BIOMED IMAGING, P772, DOI 10.1109/ISBI.2015.7163986; Du ZW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7626; Dumoulin V., 2016, ARXIV160307285V2; Farabet C, 2013, IEEE T PATTERN ANAL, V35, P1915, DOI 10.1109/TPAMI.2012.231; Finkbeiner S, 2015, NEURON, V86, P160, DOI 10.1016/j.neuron.2015.02.023; Golovin D, 2017, KDD'17: PROCEEDINGS OF THE 23RD ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1487, DOI 10.1145/3097983.3098043; Goodfellow I., 2016, ARXIV160305027V3; Goodfellow I.J., 2014, PROC NEURAL INFORM P, DOI DOI 10.1002/RCS.128; Held M, 2010, NAT METHODS, V7, P747, DOI 10.1038/nmeth.1486; Jones E., 2001, SCIPY OPEN SOURCE SC; King DB, 2015, ACS SYM SER, V1214, P1; Long X, 2010, COMPUT BIOL MED, V40, P168, DOI 10.1016/j.compbiomed.2009.11.013; Mao YX, 2015, I S BIOMED IMAGING, P190, DOI 10.1109/ISBI.2015.7163847; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Ramsundar B., 2015, ARXIV150202072V1; Rigamonti A, 2016, STEM CELL REP, V6, P993, DOI 10.1016/j.stemcr.2016.05.010; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Sadanandan SK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07599-6; Schroff F., 2015, ARXIV150303832V3; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Snoek J., 2012, ADV NEURAL INFORM PR, V2, P2951, DOI DOI 10.48550/ARXIV.1206.2944; Szegedy C., 2016, ARXIV160207261V2; Szegedy C., 2015, ARXIV14094842V1; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; van den Oord A., 2016, COMPUT SCI ENG; Van Valen DA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005177; Waskom M., 2016, SEABORN V0 7 0; Xu Y., 2016, ARXIV160703222V2; Zhong Q, 2012, NAT METHODS, V9, P711, DOI [10.1038/NMETH.2046, 10.1038/nmeth.2046]	38	271	279	22	109	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2018	173	3					792	+		10.1016/j.cell.2018.03.040	http://dx.doi.org/10.1016/j.cell.2018.03.040			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7GB	29656897	Green Accepted, Bronze			2022-12-28	WOS:000430677400025
J	Iacobucci, G				Iacobucci, Gareth			Poorly performing general practices are more likely to prescribe homeopathy	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Walker AJ, 2018, J ROY SOC MED, V111, P167, DOI 10.1177/0141076818765779	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2018	361								k1754	10.1136/bmj.k1754	http://dx.doi.org/10.1136/bmj.k1754			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8WQ	29674393				2022-12-28	WOS:000430795300011
J	Dyer, C				Dyer, Clare			NHS failed to communicate feeding advice to refugee mother, court rules	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2018	361								k1711	10.1136/bmj.k1711	http://dx.doi.org/10.1136/bmj.k1711			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8WP	29669724				2022-12-28	WOS:000430795200009
J	Daniel, H; Bornstein, SS; Kane, GC				Daniel, Hilary; Bornstein, Sue S.; Kane, Gregory C.		Hlth Public Policy Comm Amer Coll	Addressing Social Determinants to Improve Patient Care and Promote Health Equity: An American College of Physicians Position Paper	ANNALS OF INTERNAL MEDICINE			English	Review							SOCIOECONOMIC-STATUS; AIR-POLLUTION; BREAST-CANCER; PUBLIC-HEALTH; PREMATURE MORTALITY; LIFE EXPECTANCY; UNITED-STATES; RISK-FACTORS; DISPARITIES; CHILDREN	Social determinants of health are nonmedical factors that can affect a person's overall health and health outcomes. Where a person is born and the social conditions they are born into can affect their risk factors for premature death and their life expectancy. In this position paper, the American College of Physicians acknowledges the role of social determinants in health, examines the complexities associated with them, and offers recommendations on better integration of social determinants into the health care system while highlighting the need to address systemic issues hindering health equity. Annals.org	[Daniel, Hilary] Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA; [Bornstein, Sue S.] Texas Med Home Initiat, Austin, TX USA; [Kane, Gregory C.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Med, 1025 Walnut St, Philadelphia, PA 19107 USA; [Bornstein, Sue S.] 3111 Beverly Dr, Dallas, TX 75205 USA	American College of Physicians; Jefferson University	Daniel, H (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.	hdaniel@acponline.org			ACP operating budget	ACP operating budget	Financial support for the development of this position paper comes exclusively from the ACP operating budget.	ACGME, 2014, CLER PATHW EXC EXP O; Adler NE, 2015, NEW ENGL J MED, V372, P698, DOI 10.1056/NEJMp1413945; Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; American Cancer Society Cancer Action Network, 2017, CERV CANC INC RAT RE; American College of Physicians, 2010, RAC ETHN DISP HLTH C; American Psychological Association (APA), 2018, MEAS SOC STAT SUBJ S; Anderson LM, 2003, AM J PREV MED, V24, P21, DOI 10.1016/S0749-3797(02)00653-0; Anderson MP, 2016, 13 AM DONT USE INTER; [Anonymous], 2014, AM COMMUNITY SURVEY; APA, 2018, ED SOC STAT; Avendano M, 2014, ANNU REV PUBL HEALTH, V35, P307, DOI 10.1146/annurev-publhealth-032013-182411; Baer TE, 2015, J ADOLESCENT HEALTH, V57, P601, DOI 10.1016/j.jadohealth.2015.08.013; Bauman AE, 2014, HEALTH PROMOT INT, V29, P143, DOI 10.1093/heapro/dau049; Betancourt JR, 2015, GUIDE PREVENTING REA; Bishaw A., 2014, AM COMMUNITY SURVEY; Bloom DA, 2017, FY 2018 PRESIDENTS B; Boyce CA, 2011, AM J PREV MED, V40, pS86, DOI 10.1016/j.amepre.2010.10.006; Bradley EH, 2016, HEALTH AFFAIR, V35, P760, DOI 10.1377/hlthaff.2015.0814; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; Brunekreef B, 1997, EPIDEMIOLOGY, V8, P298, DOI 10.1097/00001648-199705000-00012; California Department of Public Health, HLTH ALL POL HIAP; California Health in All Policies Task Force, CAL HLTH ALL POL TAS; Calvillo-King L, 2013, J GEN INTERN MED, V28, P269, DOI 10.1007/s11606-012-2235-x; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; CDC, 2004, PREV LEAD EXP YOUNG; Center for Disease Control and Prevention, 2022, SOCIAL DETERMINANTS; Center for Outcomes Research & Education, INT HOUS HLTH HLTH F; Centers for Disease Control and Prevention, 2016, ICD 10 CM OFF GUID C; Centers for Disease Control and Prevention, PHYS ACT EV BEN PHYS; Centers for Medicare & Medicaid Services (CMS), ACC HLTH COMM MOD; Cheng JK, 2012, NEW ENGL J MED, V367, P1976, DOI 10.1056/NEJMp1209420; Chetty R, 2016, 22910 NAT BUR EC RES, DOI [10.3386/w22910, DOI 10.3386/W22910]; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Committee on Educating Health Professionals to Address the Social Determinants of Health; Board on Global Health; Institute of Medicine National Academies of Sciences Engineering and Medicine, 2016, FRAMEWORK ED HLTH PR, DOI [DOI 10.17226/21923, 10.17226/21923]; Community of Hope, 2016, PERM SUPP HOUS; Cotter EW, 2017, PUBLIC HEALTH NUTR, V20, P1452, DOI 10.1017/S1368980017000088; Crowley RA, 2016, ANN INTERN MED, V164, P608, DOI 10.7326/M15-2766; Cummins S, 2014, HEALTH AFFAIR, V33, P283, DOI 10.1377/hlthaff.2013.0512; Department of Vermont Health Access, VERM CHRON CAR IN; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P31, DOI 10.3322/caac.21320; Doherty RB, 2013, ANN INTERN MED, V159, P620, DOI 10.7326/0003-4819-159-9-201311050-00710; Estacio EV, 2019, J HEALTH PSYCHOL, V24, P1668, DOI 10.1177/1359105317695429; Federal Communications Commission, 2016, 2016 BROADB PROGR RE; Federal Interagency Forum on Aging Statistics, 2016, OLD AM 2016 KEY IND; Fleegler EW, 2007, PEDIATRICS, V119, pE1332, DOI 10.1542/peds.2006-1505; Focus on Hospitals, RISK ADJ METH READM; Food access and its relationship to diet and health outcomes, 2009, ACC AFF NUTR FOOD ME, P51; Galea S, 2011, AM J PUBLIC HEALTH, V101, P1456, DOI 10.2105/AJPH.2010.300086; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P527, DOI 10.1136/jech.2005.044727; Garg A, 2016, JAMA-J AM MED ASSOC, V316, P813, DOI 10.1001/jama.2016.9282; Garg A, 2013, JAMA-J AM MED ASSOC, V309, P2001, DOI 10.1001/jama.2013.1471; Garshick E, 2003, EPIDEMIOLOGY, V14, P728, DOI 10.1097/01.ede.0000082045.50073.66; Gawande A. A., 2011, PERSONAL BEST; Gerend MA, 2008, CANCER EPIDEM BIOMAR, V17, P2913, DOI 10.1158/1055-9965.EPI-07-0633; Gortmaker SL, BRIEF COST EFFECTIVE; Gottlieb L, 2016, HEALTH AFFAIR, V35, P2116, DOI 10.1377/hlthaff.2016.0723; Govindarajan A, 2003, ANN EMERG MED, V41, P481, DOI 10.1067/mem.2003.108; Gupta S, OUR MOUTHS WERE AJAR; Hankin CS, 2013, J ALLERGY CLIN IMMUN, V131, P1084, DOI 10.1016/j.jaci.2012.12.662; Healthy People 2020, SDOH 4 1 2 PROP HOUS; Heiman H. J., 2015, HLTH CARE ROLE SOCIA; Hood E, 2005, ENVIRON HEALTH PERSP, V113, pA310, DOI 10.1289/ehp.113-a310; Horrigan J., 2015, FACT TANK; Houston D, 2004, J URBAN AFF, V26, P565, DOI 10.1111/j.0735-2166.2004.00215.x; Institute of Medicine, 2014, CAPT SOC BEH DOM MEA; Institute of Medicine, 2012, PRIM CAR PUBL HLTH E; Internal Displacement Monitoring Centre, 2015, GLOBAL ESTIMATES 201; Kennedy Chinaro, 2016, MMWR Morb Mortal Wkly Rep, V65, P650, DOI 10.15585/mmwr.mm6525e1; Kershaw KN, 2017, JAMA INTERN MED, V177, P996, DOI 10.1001/jamainternmed.2017.1226; Mann L, 2015, J CANCER EDUC, V30, P374, DOI 10.1007/s13187-014-0716-9; Mayo Clinic, 2016, LEAD POIS; Miller G, 2011, PREVENTION VS TREATM, P37; Nagasako EM, 2014, HEALTH AFFAIR, V33, P786, DOI 10.1377/hlthaff.2013.1148; National Alliance to End Homelessness, 2012, CHANG HUD DEF HOM; National Cancer Institute, CANC HLTH DISP; National Center for Education Statistics, EMPL UN RAT ED ATT; National Center for Medical-Legal Partnership, 2017, HELP FAM KEEP THIER; National Prevention Council, 2014, NAT PREV HLTH PROM P; National Quality Forum, 2014, TECHNICAL REPORT; Noh S, 2003, AM J PUBLIC HEALTH, V93, P232, DOI 10.2105/AJPH.93.2.232; Nuckols TK, 2017, ANN INTERN MED, V166, P368, DOI 10.7326/M16-2947; O'Brien MJ, 2014, ADV MED EDUC PRACT, V5, P307, DOI 10.2147/AMEP.S67480; O'Connor GT, 2008, J ALLERGY CLIN IMMUN, V121, P1133, DOI 10.1016/j.jaci.2008.02.020; Paradies Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138511; Pratt Rebekah, 2015, J Comorb, V5, P110, DOI 10.15256/joc.2015.5.35; Reich D., 2017, BLOCK GRANTING LOW I; Reuben A, 2017, JAMA-J AM MED ASSOC, V317, P1244, DOI 10.1001/jama.2017.1712; Rimal RN, 2009, B WORLD HEALTH ORGAN, V87, P247, DOI 10.2471/BLT.08.056713; Robert Wood Johnson Foundation, 2011, HLTH CAR BLIND SID; Robert Wood Johnson Foundation, 2012, DOES TRANSP IMP HLTH; Robert Wood Johnson Foundation, 2016, US SOC DET HLTH DAT; Robert Wood Johnson Foundation, 2008, OV OBST HLTH REP RW; Ross T., 2013, DISASTER MAKING ADDR, P33; Ross T, 2016, LESSONS FLINT CASE I; Rudolph L, 2013, HLTH ALL POLICIES GU; Safe Routes to School National Partnership, 2015, FIGHT EQ TRANSP WHY; Seligman HK, FOOD INSECURITY DIAB; Shi L, 2002, HEALTH SERV RES, V37, P529, DOI 10.1111/1475-6773.t01-1-00036; Shi L. Y., 2009, Journal of Medical Sciences, V29, P43; Stringhini S, 2017, LANCET, V389, P1229, DOI 10.1016/S0140-6736(16)32380-7; Syed ST, 2013, J COMMUN HEALTH, V38, P976, DOI 10.1007/s10900-013-9681-1; Syme S Leonard, 2004, Prev Chronic Dis, V1, pA02; Taylor LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160217; The Commonwealth Fund, 2014, FOC US HOUS IMPR HLT; The Pew Charitable Trusts, HLTH IMP PROJ HLTH I; Transportation for America, 2016, PRIOR PUBL HLTH BEN; Tsao TY, 2016, AM J PUBLIC HEALTH, V106, P1036, DOI 10.2105/AJPH.2016.303188; U.S. Census Bureau, CENS BUR MEAS POV; U.S. Department of Agriculture, DEF FOOD DES; U. S. Department of Health and Human Services, 2014, HLTH PEOPL 2020 LEAD; U. S. Department of Health and Human Services, NAT PREV COUNC; U. S. Department of Health and Human Services; National Institutes of Health, 2009, NIH HLTH DISP STRAT; U. S. Department of Housing and Urban Development, 2017, AFF HOUS; U. S. Department of Housing and Urban Development, HLTH HOM LEAD HAZ CO; U. S. Environmental Protection Agency, LEARN LEAD LOW YOUR; Ubri P, 2016, DISPARITIES HLTH HLT; UC Davis Center for Poverty Research, WHAT IS CURR POV RAT; United States Government Accountability Office, 2017, GAO17317; Viswanath K, 2007, J NUTR EDUC BEHAV, V39, pS20, DOI 10.1016/j.jneb.2006.07.008; Wernham A, 2015, J PUBLIC HEALTH MAN, V21, pS56, DOI 10.1097/PHH.0000000000000130; Westfall JM, 2013, J AM BOARD FAM MED, V26, P239, DOI 10.3122/jabfm.2013.03.130094; Williams DR, 2008, J PUBLIC HEALTH MAN, pS8, DOI 10.1097/01.PHH.0000338382.36695.42; Wise Lifestyle, 2017, SHUFU TEIGI WA; Woolhandler S, 2017, ANN INTERN MED, V167, P424, DOI 10.7326/M17-1403; Zhang Y, 2008, CIRCULATION, V118, P1577, DOI 10.1161/CIRCULATIONAHA.108.772285	129	236	239	4	56	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2018	168	8					577	+		10.7326/M17-2441	http://dx.doi.org/10.7326/M17-2441			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GC8XZ	29677265				2022-12-28	WOS:000430083100018
J	[Anonymous]				[Anonymous]			Yaws Eradication Requires Improved Approach	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2018	319	15					1539	1539		10.1001/jama.2018.4126	http://dx.doi.org/10.1001/jama.2018.4126			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD0UT	29677311				2022-12-28	WOS:000430217100005
J	Sanganyado, E				Sanganyado, Edmond			My path to contentment	SCIENCE			English	Editorial Material									[Sanganyado, Edmond] Shantou Univ, Shantou, Guangdong, Peoples R China	Shantou University	Sanganyado, E (corresponding author), Shantou Univ, Shantou, Guangdong, Peoples R China.	SciCareerEditor@aaas.org	Sanganyado, Edmond/B-8542-2013	Sanganyado, Edmond/0000-0001-6244-3059					0	0	0	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2018	360	6385					234	234		10.1126/science.360.6385.234	http://dx.doi.org/10.1126/science.360.6385.234			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC5DK	29650675				2022-12-28	WOS:000429805400052
J	Harvey, PH				Harvey, PH			Biological exuberance: Animal homosexuality and natural diversity	NATURE			English	Book Review									Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Harvey, PH (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.							BAGEMIHL B, 1998, BIOL EXUBERANCE ANIM	1	0	0	2	80	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					402	403		10.1038/17058	http://dx.doi.org/10.1038/17058			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667975	Bronze			2022-12-28	WOS:000078461700036
J	Emmons, KM; Doubeni, CA; Fernandez, ME; Miglioretti, DL; Samet, JM				Emmons, Karen M.; Doubeni, Chyke A.; Fernandez, Maria E.; Miglioretti, Diana L.; Samet, Jonathan M.			National Institutes of Health Pathways to Prevention Workshop: Methods for Evaluating Natural Experiments in Obesity	ANNALS OF INTERNAL MEDICINE			English	Review							RECENT METHODOLOGICAL DEVELOPMENTS	On 5 and 6 December 2017, the National Institutes of Health (NIH) convened the Pathways to Prevention Workshop: Methods for Evaluating Natural Experiments in Obesity to identify the status of methods for assessing natural experiments to reduce obesity, areas in which these methods could be improved, and research needs for advancing the field. This article considers findings from a systematic evidence review on methods for evaluating natural experiments in obesity, workshop presentations by experts and stakeholders, and public comment. Research gaps are identified, and recommendations related to 4 key issues are provided. Recommendations on population-based data sources and data integration include maximizing use and sharing of existing surveillance and research databases and ensuring significant effort to integrate and link databases. Recommendations on measurement include use of standardized and validated measures of obesity-related outcomes and exposures, systematic measurement of co-benefits and unintended consequences, and expanded use of validated technologies for measurement. Study design recommendations include improving guidance, documentation, and communication about methods used; increasing use of designs that minimize bias in natural experiments; and more carefully selecting control groups. Cross-cutting recommendations target activities that the NIH and other funders might undertake to improve the rigor of natural experiments in obesity, including training and collaboration on modeling and causal inference, promoting the importance of community engagement in the conduct of natural experiments, ensuring maintenance of relevant surveillance systems, and supporting extended followup assessments for exemplar natural experiments. To combat the significant public health threat posed by obesity, researchers should continue to take advantage of natural experiments. The recommendations in this report aim to strengthen evidence from such studies.	[Emmons, Karen M.] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, 677 Huntington Ave,Kresge 601, Boston, MA 02115 USA; [Doubeni, Chyke A.] Univ Penn, Perelman Sch Med, Dept Family Med & Community Hlth, PPMC Andrew Mutch Bldg 720,51 North 39th St, Philadelphia, PA 19104 USA; [Fernandez, Maria E.] Univ Texas Hlth Sci Ctr Houston, Ctr Hlth Promot & Prevent Res, Sch Publ Hlth, 7000 Fannin St,Suite 2080, Houston, TX 77030 USA; [Miglioretti, Diana L.] Univ Calif Davis, Davis, CA 95616 USA; [Samet, Jonathan M.] Colorado Sch Publ Hlth, Aurora, CO USA; [Miglioretti, Diana L.] UC Davis Sch Med, Med Sci 1C,One Shields Ave,Suite 145, Davis, CA 95616 USA; [Samet, Jonathan M.] USC Inst Global Hlth, 2001 North Soto St,SSB 330A, Los Angeles, CA 90033 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of California System; University of California Davis; Colorado School of Public Health; University of California System; University of California Davis	Emmons, KM (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, 677 Huntington Ave,Kresge 601, Boston, MA 02115 USA.	kemmons@hsph.harvard.edu						Bennett WL, 2017, AHRQ PUBLICATION, V18-EHC006-EF; Institute of Medicine, 2012, ACCELERATING PROGR O, DOI [10.17226/13275, DOI 10.17226/13275]; Medical Research Council, 2009, US NAT EXP EV POP HL; Turner EL, 2017, AM J PUBLIC HEALTH, V107, P1078, DOI 10.2105/AJPH.2017.303707; Turner EL, 2017, AM J PUBLIC HEALTH, V107, P907, DOI 10.2105/AJPH.2017.303706; Varnell SP, 2001, EVALUATION REV, V25, P440, DOI 10.1177/0193841X0102500402	6	10	10	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2018	168	11					809	+		10.7326/M18-0501	http://dx.doi.org/10.7326/M18-0501			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI3EK	29710235				2022-12-28	WOS:000434254100008
J	Dieleman, JL; Sadat, N; Chang, AY; Fullman, N; Abbafati, C; Acharya, P; Adou, AK; Kiadaliri, AA; Alam, K; Alizadeh-Navaei, R; Alkerwi, A; Ammar, W; Antonio, CAT; Arernu, O; Asgedom, SW; Atey, TM; Avila-Burgos, L; Awasthi, A; Ayer, R; Badali, H; Banach, M; Banstola, A; Barac, A; Belachew, AB; Birungi, C; Bragazzi, NL; Breitborde, NJK; Cahuana-Hurtado, L; Car, J; Catala-Lopez, F; Chapin, A; Chen, CS; Dandona, L; Dandona, R; Daryani, A; Dharmaratne, SD; Dubey, M; Edessa, D; Eldrenkamp, E; Eshrati, B; Faro, A; Feigl, AB; Fenny, AP; Fischer, F; Foigt, N; Foreman, KJ; Furst, T; Ghimire, M; Goli, S; Hailu, AD; Hamidi, S; Harb, HL; Hay, SI; Hendrie, D; Ikilezi, G; Javanbakht, M; John, D; Jonas, JB; Kaldjian, A; Kasaeian, A; Kasahun, YC; Khalil, IA; Khang, YH; Khubchandani, J; Kim, YJ; Kinge, JM; Kosen, S; Krohn, KJ; Kumar, GA; Lafranconi, A; Lam, H; Listl, S; Abd El Razek, HM; Abd El Razek, MM; Majeed, A; Malekzadeh, R; Malta, DC; Martinez, G; Mensah, GA; Meretoja, A; Micah, A; Miller, TR; Mirrakhimov, EM; Mlashu, FW; Mohammed, E; Mohammed, S; Mokdad, AH; Moses, M; Mousavi, SM; Naghavi, M; Nangia, V; Ngalesoni, FN; Nguyen, CT; Nguyen, TH; Niriayo, Y; Noroozi, M; Owolabi, MO; Patel, T; Pereira, DM; Polinder, S; Qorbani, M; Rafay, A; Rafiei, A; Rahimi-Movaghar, V; Rai, RK; Ram, U; Ranabhat, CL; Ray, SE; Reiner, RC; Sajadi, HS; Santoro, R; Santos, JV; Sarker, AR; Sartorius, B; Satpathy, M; Sepanlou, SG; Shaikh, MA; Sharif, M; She, J; Sheikh, A; Shrime, MG; Sisay, M; Soneji, S; Soofi, M; Sorensen, RJD; Tao, T; Templin, T; Tesema, AG; Thapa, S; Tobe-Gai, R; Topor-Madry, R; Tran, BX; Tran, KB; Tran, TT; Undurraga, EA; Vasankari, T; Violante, FS; Werdecker, A; Wijeratne, T; Xu, GL; Yonemoto, N; Younis, MZ; Yu, CH; Zaki, ME; Zlavog, B; Murray, CJL				Dieleman, Joseph L.; Sadat, Nafis; Chang, Angela Y.; Fullman, Nancy; Abbafati, Cristiana; Acharya, Pawan; Adou, Arsene Kouablan; Kiadaliri, Aliasghar Ahmad; Alam, Khurshid; Alizadeh-Navaei, Reza; Alkerwi, Ala'a; Ammar, Walid; Antonio, Carl Abelardo T.; Arernu, Olatunde; Asgedom, Solomon Weldegebreal; Atey, Tesfay Mehari; Avila-Burgos, Leticia; Awasthi, A.; Ayer, Rakesh; Badali, Hamid; Banach, Maciej; Banstola, Amrit; Barac, Aleksandra; Belachew, Abate Bekele; Birungi, Charles; Bragazzi, Nicola L.; Breitborde, Nicholas J. K.; Cahuana-Hurtado, Lucero; Car, Josip; Catala-Lopez, Ferran; Chapin, Abigail; Chen, Catherine S.; Dandona, Lalit; Dandona, Rakhi; Daryani, Ahmad; Dharmaratne, Samath D.; Dubey, Manisha; Edessa, Dumessa; Eldrenkamp, Erika; Eshrati, Babak; Faro, Andre; Feigl, Andrea B.; Fenny, Ama P.; Fischer, Florian; Foigt, Nataliya; Foreman, Kyle J.; Furst, Thomas; Ghimire, Mamata; Goli, Srinivas; Hailu, Alemayehu Desalegne; Hamidi, Samer; Harb, Hilda L.; Hay, Simon I.; Hendrie, Delia; Ikilezi, Gloria; Javanbakht, Mehdi; John, Denny; Jonas, Jost B.; Kaldjian, Alexander; Kasaeian, Amir; Kasahun, Yawukal Chane; Khalil, Ibrahim A.; Khang, Young-Ho; Khubchandani, Jagdish; Kim, Yun Jin; Kinge, Jonas M.; Kosen, Soewarta; Krohn, Kristopher J.; Kumar, G. Anil; Lafranconi, Alessandra; Lam, Hilton; Listl, Stefan; Abd El Razek, Hassan Magdy; Abd El Razek, Mohammed Magdy; Majeed, Azeem; Malekzadeh, Reza; Malta, Deborah Carvalho; Martinez, Gabriel; Mensah, George A.; Meretoja, Atte; Micah, Angela; Miller, Ted R.; Mirrakhimov, Erkin M.; Mlashu, Fitsum Weldegebreal; Mohammed, Ebrahim; Mohammed, Shafiu; Mokdad, Ali H.; Moses, Mark; Mousavi, Seyyed Meysam; Naghavi, Mohsen; Nangia, Vinay; Ngalesoni, Frida Namnyak; Cuong Tat Nguyen; Trang Huyen Nguyen; Niriayo, Yirga; Noroozi, Mehdi; Owolabi, Mayowa O.; Patel, Tejas; Pereira, David M.; Polinder, Suzanne; Qorbani, Mostafa; Rafay, Anwar; Rafiei, Alireza; Rahimi-Movaghar, Vafa; Rai, Rajesh Kumar; Ram, Usha; Ranabhat, Chhabi Lal; Ray, Sarah E.; Reiner, Robert C.; Sajadi, Haniye Sadat; Santoro, Rocco; Santos, Joao Vasco; Sarker, Abdur Razzaque; Sartorius, Benn; Satpathy, Maheswar; Sepanlou, Sadaf G.; Shaikh, Masood Ali; Sharif, Mehdi; She, Jun; Sheikh, Aziz; Shrime, Mark G.; Sisay, Mekonnen; Soneji, Samir; Soofi, Moslem; Sorensen, Reed J. D.; Tao, Tianchan; Templin, Tara; Tesema, Azeb Gebresilassie; Thapa, Subash; Tobe-Gai, Ruoyan; Topor-Madry, Roman; Bach Xuan Tran; Khanh Bao Tran; Tung Thanh Tran; Undurraga, Eduardo A.; Vasankari, Tommi; Violante, Francesco S.; Werdecker, Andrea; Wijeratne, Tissa; Xu, Gelin; Yonemoto, Naohiro; Younis, Mustafa Z.; Yu, Chuanhua; Zaki, Maysaa El Sayed; Zlavog, Bianca; Murray, Christopher J. L.		Global Burden Dis Hlth Financing	Trends in future health financing and coverage: future health spending and universal health coverage in 188 countries, 2016-40	LANCET			English	Article							GOVERNMENT; TRANSITION; MORTALITY	Background Achieving universal health coverage (UHC) requires health financing systems that provide prepaid pooled resources for key health services without placing undue financial stress on households. Understanding current and future trajectories of health financing is vital for progress towards UHC. We used historical health financing data for 188 countries from 1995 to 2015 to estimate future scenarios of health spending and pooled health spending through to 2040. Methods We extracted historical data on gross domestic product (GDP) and health spending for 188 countries from 1995 to 2015, and projected annual GDP, development assistance for health, and government, out-of-pocket, and prepaid private health spending from 2015 through to 2040 as a reference scenario. These estimates were generated using an ensemble of models that varied key demographic and socioeconomic determinants. We generated better and worse alternative future scenarios based on the global distribution of historic health spending growth rates. Last, we used stochastic frontier analysis to investigate the association between pooled health resources and UHC index, a measure of a country's UHC service coverage. Finally, we estimated future UHC performance and the number of people covered under the three future scenarios. Findings In the reference scenario, global health spending was projected to increase from US$10 trillion (95% uncertainty interval 10 trillion to 10 trillion) in 2015 to $20 trillion (18 trillion to 22 trillion) in 2040. Per capita health spending was projected to increase fastest in upper-middle-income countries, at 4.2% (3.4-5.1) per year, followed by lower-middle-income countries (4.0%, 3.6-4.5) and low-income countries (2.2%, 1.7-2.8). Despite global growth, per capita health spending was projected to range from only $40 (24-65) to $413 (263-668) in 2040 in low-income countries, and from $140 (90-200) to $1699 (711-3423) in lower-middle-income countries. Globally, the share of health spending covered by pooled resources would range widely, from 19.8% (10.3-38.6) in Nigeria to 97.9% (96.4-98.5) in Seychelles. Historical performance on the UHC index was significantly associated with pooled resources per capita. Across the alternative scenarios, we estimate UHC reaching between 5.1 billion (4.9 billion to 5.3 billion) and 5.6 billion (5.3 billion to 5.8 billion) lives in 2030. Interpretation We chart future scenarios for health spending and its relationship with UHC. Ensuring that all countries have sustainable pooled health resources is crucial to the achievement of UHC. Copyright (c) 2018 The Author(s). Published by Elsevier Ltd.	[Dieleman, Joseph L.; Sadat, Nafis; Chang, Angela Y.; Fullman, Nancy; Chapin, Abigail; Chen, Catherine S.; Dandona, Lalit; Dandona, Rakhi; Eldrenkamp, Erika; Foreman, Kyle J.; Hay, Simon I.; Ikilezi, Gloria; Kaldjian, Alexander; Khalil, Ibrahim A.; Krohn, Kristopher J.; Micah, Angela; Moses, Mark; Naghavi, Mohsen; Ray, Sarah E.; Reiner, Robert C.; Sorensen, Reed J. D.; Tao, Tianchan; Zlavog, Bianca; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Abbafati, Cristiana] Univ Roma La Sapienza, Rome, Italy; [Acharya, Pawan] Nepal Dev Soc, Chitwan, Nepal; Univ Southern Denmark, Unit Hlth Promot Res, Fac Hlth Sci, Esbjerg, Denmark; [Adou, Arsene Kouablan] Assoc Ivoirienne Bien Etre Familial, Abidjan, Cote Ivoire; [Kiadaliri, Aliasghar Ahmad] Lund Univ, Dept Clin Sci Lund, Clin Epidemiol Unit, Orthoped, Lund, Sweden; [Alam, Khurshid] Univ Western Australia, Sch Populat & Global Hlth, Perth, WA, Australia; [Alizadeh-Navaei, Reza] Mazandaran Univ Med Sci, Gastrointestinal Canc Res Ctr, Sari, Iran; [Badali, Hamid] Mazandaran Univ Med Sci, Invas Fungi Res Ctr, Sari, Iran; [Daryani, Ahmad; Sharif, Mehdi] Mazandaran Univ Med Sci, Toxoplasmosis Res Ctr, Sari, Iran; [Rafiei, Alireza] Mazandaran Univ Med Sci, Mol & Cell Biol Res Ctr, Sch Med, Sari, Iran; [Alkerwi, Ala'a] Luxembourg Inst Hlth, Strassen, Strassen, Luxembourg; [Ammar, Walid; Harb, Hilda L.] Minist Publ Hlth, Beirut, Lebanon; [Antonio, Carl Abelardo T.] Univ Philippines Manila, Dept Hlth Policy & Adm, Coll Publ Hlth, Manila, Philippines; [Arernu, Olatunde] Univ Dept Publ Hlth & Therapies, Birmingham, W Midlands, England; [Belachew, Abate Bekele] Sch Publ Hlth, Mekelle, Ethiopia; [Asgedom, Solomon Weldegebreal; Atey, Tesfay Mehari; Mohammed, Ebrahim; Niriayo, Yirga; Tesema, Azeb Gebresilassie] Mekelle Univ, Mekelle, Ethiopia; [Avila-Burgos, Leticia; Cahuana-Hurtado, Lucero] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Awasthi, A.] Indian Inst Publ Hlth, Gandhinagar, India; [Ayer, Rakesh] Univ Tokyo, Tokyo, Japan; [Banach, Maciej] Med Univ Lodz, Dept Hypertens, Lodz, Poland; [Banstola, Amrit] Publ Hlth Perspect Nepal, Pokhara, Nepal; [Barac, Aleksandra] Univ Belgrade, Fac Med, Belgrade, Serbia; [Birungi, Charles] UCL, London, England; [Bragazzi, Nicola L.] Univ Genoa, Genoa, Italy; [Breitborde, Nicholas J. K.] Ohio State Univ, Columbus, OH 43210 USA; [Car, Josip] Nanyang Technol Univ, LKCMed, Singapore, Singapore; [Majeed, Azeem] Imperial Coll London, Dept Primary Care & Publ Hlth, London, England; [Car, Josip; Foreman, Kyle J.; Furst, Thomas] Imperial Coll London, London, England; [Catala-Lopez, Ferran] Univ Valencia, Dept Med, INCLIVA Hlth Res Inst, Valencia, Spain; [Catala-Lopez, Ferran] Univ Valencia, CIBERSAM, Valencia, Spain; [Catala-Lopez, Ferran] Ottawa Hosp, Clin Epidemiol Program, Res Inst, Ottawa, ON, Canada; [Dandona, Lalit; Dandona, Rakhi; Kumar, G. Anil] Publ Hlth Fdn India, Gurugram, India; [Dharmaratne, Samath D.] Univ Peradeniya, Dept Community Med, Fac Med, Peradeniya, Sri Lanka; [Dubey, Manisha; Ram, Usha] Int Inst Populat Sci, Bombay, Maharashtra, India; [Edessa, Dumessa; Mlashu, Fitsum Weldegebreal; Sisay, Mekonnen] Haramaya Univ, Harar, Ethiopia; [Eshrati, Babak] Minist Hlth & Med Educ, Tehran, Iran; [Eshrati, Babak] Arak Univ Med Sci, Arak, Iran; [Faro, Andre] Univ Fed Sergipe, Aracaju, Brazil; [Feigl, Andrea B.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Fenny, Ama P.] Univ Ghana, Legon, Ghana; [Fischer, Florian] Bielefeld Univ, Sch Publ Hlth, Bielefeld, Germany; [Foigt, Nataliya] Acad Med Sci, Inst Gerontol, Kiev, Ukraine; [Ghimire, Mamata] Univ Tsukuba, Tsukuba, Ibaraki, Japan; [Goli, Srinivas] Jawaharlal Nehru Univ, New Delhi, India; [Hailu, Alemayehu Desalegne] Addis Ababa Univ, Addis Ababa, Ethiopia; [Hailu, Alemayehu Desalegne] Univ Bergen, Bergen, Norway; [Hamidi, Samer] Hamdan Bin Mohammed Smart Univ, Dubai, U Arab Emirates; [Hay, Simon I.] Univ Oxford, Oxford Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England; [Hendrie, Delia; Miller, Ted R.] Curtin Univ, Sch Publ Hlth, Perth, WA, Australia; [Javanbakht, Mehdi] Univ Aberdeen, Aberdeen, Scotland; [John, Denny] Campbell Collaborat, New Delhi, India; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany; [Kasaeian, Amir] Univ Tehran Med Sci, Hematol Oncol & Stem Cell Transplantat Res Ctr, Tehran, Iran; [Kasaeian, Amir] Univ Tehran Med Sci, Hematol Malignancies Res Ctr, Tehran, Iran; [Malekzadeh, Reza; Sepanlou, Sadaf G.] Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran; [Mousavi, Seyyed Meysam] Univ Tehran Med Sci, Dept Hlth Management & Econ, Sch Publ Hlth, Tehran, Iran; [Rahimi-Movaghar, Vafa] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran; [Sajadi, Haniye Sadat] Univ Tehran Med Sci, Natl Inst Hlth Res, Tehran, Iran; [Kasahun, Yawukal Chane] Hawassa Univ, Hawassa, Ethiopia; [Khang, Young-Ho] Seoul Natl Univ, Dept Hlth Policy & Management, Coll Med, Seoul, South Korea; [Khang, Young-Ho] Seoul Natl Univ, Inst Hlth Policy & Management, Med Ctr, Seoul, South Korea; [Khubchandani, Jagdish] Ball State Univ, Dept Nutr & Hlth Sci, Muncie, IN 47306 USA; [Kim, Yun Jin] Xiamen Univ, Sch Med, Malaysia Campus, Xiamen, Malaysia; [Kinge, Jonas M.] Norwegian Inst Publ Hlth, Oslo, Norway; [Lafranconi, Alessandra] Univ Milano Bicocca, Monza, Italy; [Lam, Hilton] Inst Hlth Policy & Dev Studies, Natl Inst Hlth, Manila, Philippines; [Listl, Stefan] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands; [Mohammed, Shafiu] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany; [Listl, Stefan] Heidelberg Univ, Heidelberg, Germany; [Abd El Razek, Hassan Magdy; Zaki, Maysaa El Sayed] Mansoura Univ, Fac Med, Mansoura, Egypt; [Abd El Razek, Mohammed Magdy] Aswan Univ Hosp, Aswan Fac Med, Aswan, Egypt; [Malta, Deborah Carvalho] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Martinez, Gabriel] Inst Tecnol Autonomo Mexico, Mexico City, DF, Mexico; [Mensah, George A.] NHLBI, NIH, Ctr Translat Res & Implementat Sci, Bldg 10, Bethesda, MD 20892 USA; [Meretoja, Atte] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Wijeratne, Tissa] Univ Melbourne, Melbourne, Vic, Australia; [Meretoja, Atte] Helsinki Univ Hosp, Dept Neurol, Helsinki, Finland; [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA; [Mirrakhimov, Erkin M.] Kyrgyz State Med Acad, Bishkek, Kyrgyzstan; [Mirrakhimov, Erkin M.] Natl Ctr Cardiol & Internal Dis, Bishkek, Kyrgyzstan; [Mohammed, Shafiu] Ahmadu Bello Univ, Hlth Syst & Policy Res Unit, Zaria, Nigeria; [Nangia, Vinay] Suraj Eye Inst, Nagpur, Maharashtra, India; [Ngalesoni, Frida Namnyak] Minist Hlth & Social Welf, Dar Es Salaam, Tanzania; [Cuong Tat Nguyen; Trang Huyen Nguyen; Tung Thanh Tran] Duy Tan Univ, Inst Global Hlth Innovat, Da Nang, Vietnam; [Noroozi, Mehdi] Univ Social Welf & Rehabil Sci, Substance Abuse & Dependence Res Ctr, Tehran, Iran; [Owolabi, Mayowa O.] Univ Ibadan, Dept Med, Ibadan, Nigeria; [Owolabi, Mayowa O.] Blossom Specialist Med Ctr, Ibadan, Nigeria; [Patel, Tejas] White Plains Hosp, White Plains, NY USA; [Pereira, David M.] Univ Med Ctr Rotterdam, REQUIMTE LAQV, Lab Farmacognosia, Dept Quim,Fac Farm, Rotterdam, Netherlands; [Polinder, Suzanne] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands; [Santos, Joao Vasco] Univ Porto, Fac Med, Porto, Portugal; [Qorbani, Mostafa] Alborz Univ Med Sci, Noncommunicable Dis Res Ctr, Karaj, Iran; [Rafay, Anwar] Contech Int Hlth Consultants, Lahore, Pakistan; [Rafay, Anwar] Contech Sch Publ Hlth, Lahore, Pakistan; [Rai, Rajesh Kumar] Soc Hlth & Demog Surveillance, Suri, India; [Murray, Christopher J. L.] Yonsei Univ, Wonju Coll Med, Dept Prevent Med, Wonju, South Korea; [Ranabhat, Chhabi Lal] Hlth Sci Fdn & Study Ctr, Kathmandu, Nepal; [Santos, Joao Vasco] Ctr Hlth Technol & Serv Res CINTESIS, Dept Community Med Informat & Hlth Decis Sci, Porto, Portugal; [Sarker, Abdur Razzaque] Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh; [Sartorius, Benn] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Publ Hlth Med, Durban, South Africa; [Sartorius, Benn] South African Med Res Council, UKZN Gastrointestinal Canc Res Ctr, Durban, South Africa; [Satpathy, Maheswar] Utkal Univ, Ctr Adv Study Psychol, Bhubaneswar, India; [She, Jun] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai, Peoples R China; [Sheikh, Aziz] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Sheikh, Aziz; Shrime, Mark G.] Harvard Med Sch, Boston, MA USA; [Soneji, Samir] Dartmouth Coll, Hanover, NH 03755 USA; [Soofi, Moslem] Kermanshah Univ Med Sci, Kermanshah, Iran; [Templin, Tara] Stanford Univ, Palo Alto, CA 94304 USA; [Thapa, Subash] Katholieke Univ Leuven, Leuven, Belgium; [Tobe-Gai, Ruoyan] Natl Ctr Child Hlth & Dev, Tokyo, Japan; [Topor-Madry, Roman] Jagellonian Univ, Inst Publ Hlth, Fac Hlth Sci, Med Coll, Krakow, Poland; Wroclaw Med Univ, Fac Hlth Sci, Wroclaw, Poland; [Topor-Madry, Roman] Wroclaw Med Univ, Fac Hlth Sci, Wroclaw, Poland; [Bach Xuan Tran] Johns Hopkins Univ, Baltimore, MD USA; [Bach Xuan Tran] Hanoi Med Univ, Hanoi, Vietnam; [Khanh Bao Tran] Univ Auckland, Auckland Canc Soc Res Ctr, Auckland, New Zealand; [Undurraga, Eduardo A.] Pontificia Univ Catolica Chile, Sch Govt, Santiago, Chile; [Vasankari, Tommi] UKK Inst Hlth Promot Res, Tampere, Finland; [Violante, Francesco S.] Univ Bologna, Bologna, Italy; [Werdecker, Andrea] Fed Inst Populat Res, Competence Ctr Mortal Follow Up, German Natl Cohort, Wiesbaden, Germany; [Wijeratne, Tissa] Western Hlth, Footscray, Vic, Australia; [Xu, Gelin] Nanjing Univ, Jinling Hosp, Dept Neurol, Sch Med, Nanjing, Jiangsu, Peoples R China; [Yonemoto, Naohiro] Kyoto Univ, Sch Publ Hlth, Dept Biostat, Kyoto, Japan; [Younis, Mustafa Z.] Jackson State Univ, Jackson, MS USA; [Yu, Chuanhua] Wuhan Univ, Sch Publ Hlth & Global Hlth Inst, Dept Epidemiol & Biostat, Wuhan, Hubei, Peoples R China	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Sapienza University Rome; University of Southern Denmark; Lund University; University of Western Australia; Mazandaran University Medical Sciences; Mazandaran University Medical Sciences; Mazandaran University Medical Sciences; Mazandaran University Medical Sciences; Luxembourg Institute of Health; University of the Philippines System; University of the Philippines Manila; Mekelle University; Instituto Nacional de Salud Publica; University of Tokyo; Medical University Lodz; University of Belgrade; University of London; University College London; University of Genoa; University System of Ohio; Ohio State University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Imperial College London; Imperial College London; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Valencia; University of Ottawa; Ottawa Hospital Research Institute; Public Health Foundation of India; University of Peradeniya; International Institute for Population Sciences; Haramaya University; Ministry of Health & Medical Education (MOHME); Universidade Federal de Sergipe; Harvard University; Harvard T.H. Chan School of Public Health; University of Ghana; University of Bielefeld; National Academy of Medical Sciences of Ukraine; D. F. Chebotarev Institute of Gerontology of the National Academy of Medical Sciences of Ukraine; University of Tsukuba; Jawaharlal Nehru University, New Delhi; Addis Ababa University; University of Bergen; University of Oxford; Curtin University; University of Aberdeen; Ruprecht Karls University Heidelberg; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Hawassa University; Seoul National University (SNU); Seoul National University (SNU); Ball State University; Xiamen University Malaysia Campus; Norwegian Institute of Public Health (NIPH); University of Milano-Bicocca; Radboud University Nijmegen; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Aswan University; Universidade Federal de Minas Gerais; Instituto Tecnologico Autonomo de Mexico; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Melbourne; University of Melbourne; University of Helsinki; Helsinki University Central Hospital; Pacific Institute for Research & Evaluation (PIRE); Kyrgyz State Medical Academy; Ministry of Health - Kyrgyzstan; Ahmadu Bello University; Suraj Eye Institute; Duy Tan University; University of Ibadan; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Universidade do Porto; Yonsei University; International Centre for Diarrhoeal Disease Research (ICDDR); University of Kwazulu Natal; South African Medical Research Council; Utkal University; Fudan University; University of Edinburgh; Harvard University; Harvard Medical School; Dartmouth College; Kermanshah University of Medical Sciences; Stanford University; KU Leuven; National Center for Child Health & Development - Japan; Jagiellonian University; Collegium Medicum Jagiellonian University; Wroclaw Medical University; Wroclaw Medical University; Johns Hopkins University; Hanoi Medical University; University of Auckland; Pontificia Universidad Catolica de Chile; UKK Institute; University of Bologna; Nanjing University; Kyoto University; Jackson State University; Wuhan University	Dieleman, JL (corresponding author), Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.	dieleman@uw.edu	Yimer, Ebrahim M./N-4597-2018; Zaki, Maysaa El Sayed/H-3049-2019; Alizadeh-Navaei, Reza/B-2207-2017; Rubino, Salvatore/AAC-5848-2022; Satpathy, Maheswar/J-3135-2017; KUMAR, ANIL/ACD-8340-2022; Santos, João V/F-4602-2018; Khubchandani, Jagdish/D-1831-2014; Kasaeian, Amir/C-8290-2017; Boothapati, Anil Kumar/HHS-1813-2022; Meretoja, Atte/H-6531-2019; abbafati, cristiana/AAD-7511-2022; Santoro, Rocco/HCI-4466-2022; Belachew, Abate Bekele/I-1758-2019; Avila-Burgos, Leticia/AAR-1815-2021; Banstola, Amrit/T-4242-2019; Naohiro, Yonemoto/Y-3761-2019; Rafiei, Alireza/A-2314-2009; Antonio, Carl Abelardo/AAP-4280-2020; Kim, Yun Jin/AAE-8281-2019; Hay, Simon Iain/F-8967-2015; Hailu, Alemayehu/AAZ-5206-2020; Fenny, Ama/I-1828-2019; Santos, João/HHZ-5595-2022; Rahimi-Movaghar, Vafa/L-6339-2019; Ram, Usha/AAS-4140-2020; rahim, fakher/AAC-3905-2019; Catalá-López, Ferrán/N-6018-2018; Zaki, Maysaa El Sayed/C-1522-2013; Banach, Maciej/A-1271-2009; Awasthi, Ashish/Y-5915-2019; Barac, Aleksandra/W-9785-2019; Qorbani, Mostafa/M-8171-2017; Mohammed, Shafiu/P-2016-2014; Pereira, David/M-9286-2013; Edessa, Dumessa/K-2892-2019; Topor-Madry, Roman/ABF-5449-2020; Mousavi, Seyyed Meysam/P-7797-2015; Bragazzi, Nicola Luigi/G-1672-2011; Malta, Deborah Carvalho/L-2491-2019; FRACP, Tissa Wijeratne MD PhD/I-2086-2019; Sisay, Mekonnen/AAD-3257-2020; Violante, Francesco S/A-6934-2009; Edessa, Dumessa/K-3885-2019; Faro, Andre/J-1696-2014; Daryani, Ahmad/E-2186-2017; Goli, Srinivas/J-7238-2012; Car, Josip/H-6755-2015; Tran, Khanh/A-2437-2019; Sepanlou, Sadaf G/H-9343-2016; Undurraga, Eduardo/I-3739-2014; Foigt, Nataliya/AAU-5229-2020; Mokdad, Ali H./AAD-1232-2022; Listl, Stefan/S-7600-2017; John, Denny/J-7815-2017; Badali, Hamid/J-8036-2016; Mirrakhimov, Erkin/E-6900-2017; Rahimi-Movaghar, Vafa/T-7816-2017; Soofi, Moslem/E-7665-2019	Yimer, Ebrahim M./0000-0003-3140-4967; Zaki, Maysaa El Sayed/0000-0001-5431-0248; Alizadeh-Navaei, Reza/0000-0003-0580-000X; Satpathy, Maheswar/0000-0003-3521-4781; Santos, João V/0000-0003-4696-1002; Khubchandani, Jagdish/0000-0002-9058-4278; Kasaeian, Amir/0000-0003-2018-9368; Meretoja, Atte/0000-0001-6433-1931; Santoro, Rocco/0000-0002-6001-2666; Belachew, Abate Bekele/0000-0003-2583-9913; Banstola, Amrit/0000-0003-3185-9638; Rafiei, Alireza/0000-0002-1766-6605; Antonio, Carl Abelardo/0000-0001-7476-0553; Kim, Yun Jin/0000-0001-8853-6587; Hay, Simon Iain/0000-0002-0611-7272; Hailu, Alemayehu/0000-0003-4872-8036; Fenny, Ama/0000-0001-9367-1265; Ram, Usha/0000-0001-6722-7347; rahim, fakher/0000-0002-2857-4562; Catalá-López, Ferrán/0000-0002-3833-9312; Zaki, Maysaa El Sayed/0000-0001-5431-0248; Banach, Maciej/0000-0001-6690-6874; Awasthi, Ashish/0000-0002-9308-9782; Mohammed, Shafiu/0000-0001-5715-966X; Pereira, David/0000-0003-0384-7592; Mousavi, Seyyed Meysam/0000-0002-6795-7224; Bragazzi, Nicola Luigi/0000-0001-8409-868X; Malta, Deborah Carvalho/0000-0002-8214-5734; FRACP, Tissa Wijeratne MD PhD/0000-0002-1701-7111; Sisay, Mekonnen/0000-0001-6611-1174; Violante, Francesco S/0000-0003-4084-2782; Edessa, Dumessa/0000-0001-6558-5829; Faro, Andre/0000-0002-7348-6297; Daryani, Ahmad/0000-0001-8571-5803; Goli, Srinivas/0000-0002-8481-484X; Car, Josip/0000-0001-8969-371X; Tran, Khanh/0000-0002-8730-3340; Sepanlou, Sadaf G/0000-0002-3669-5129; Undurraga, Eduardo/0000-0002-4425-1253; Foigt, Nataliya/0000-0002-3613-5965; Mokdad, Ali H./0000-0002-4994-3339; Listl, Stefan/0000-0002-8176-3397; John, Denny/0000-0002-4486-632X; Badali, Hamid/0000-0002-6010-8414; Mirrakhimov, Erkin/0000-0003-2982-6108; Sheikh, Aziz/0000-0001-7022-3056; Cahuana-Hurtado, Lucero/0000-0002-9438-1443; Alam, Khurshid/0000-0002-7402-7519; Hamidi, Samer/0000-0002-6766-3728; Owolabi, Mayowa/0000-0003-1146-3070; Rai, Rajesh Kumar/0000-0002-5249-9937; , bennsartorius/0000-0001-6761-2325; Rahimi-Movaghar, Vafa/0000-0001-7347-8767; Miller, Ted/0000-0002-0958-2639; Soofi, Moslem/0000-0003-4922-8412; Barac, Aleksandra/0000-0002-0132-2277; Hendrie, Delia/0000-0001-5022-5281; Aremu, Olatunde/0000-0002-5832-2403; Magdy Abd El Razek, Hassan/0000-0002-8857-0408; kasahun, yawukal/0000-0002-4758-7780; Dandona, Rakhi/0000-0003-0926-788X; Ray, Sarah/0000-0002-5775-8344; Kiadaliri, Ali/0000-0002-4254-9099	Bill AMP; Melinda Gates Foundation	Bill AMP; Melinda Gates Foundation(CGIAR)	The Bill & Melinda Gates Foundation.	[Anonymous], 1978, INT C PRIM HLTH CAR; Barber RM, 2017, LANCET, V390, P231, DOI [10.1016/S0140-6736(17)30818-8, 10.1016/s0140-6736(17)30818-8]; Bitran R., EXPLICIT HLTH GUARAN; Bivand RS, 2015, J STAT SOFTW, V63, P1; Bokhari FAS, 2007, HEALTH ECON, V16, P257, DOI 10.1002/hec.1157; Campbell J, 2013, B WORLD HEALTH ORGAN, V91, P853, DOI 10.2471/BLT.13.118729; Cylus J., 2016, SPENDING TARGETS HLT; Dieleman JL, 2018, LANCET, V391, P1799, DOI 10.1016/S0140-6736(18)30698-6; Dieleman JL, 2017, LANCET, V389, P2005, DOI 10.1016/S0140-6736(17)30873-5; Dieleman JL, 2016, LANCET, V387, P2521, DOI 10.1016/S0140-6736(16)30167-2; Fan VY, 2014, SOC SCI MED, V105, P112, DOI 10.1016/j.socscimed.2014.01.014; Farahani M, 2010, HEALTH ECON, V19, P1361, DOI 10.1002/hec.1557; Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1; Fullman N, 2018, LANCET GLOB HEALTH, V6, pE122, DOI 10.1016/S2214-109X(17)30487-4; Fullman N, 2017, LANCET, V390, P1423, DOI 10.1016/S0140-6736(17)32336-X; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Glassman A, WHATS WHATS OUT DESI; Gupta PD, 1993, STANDARDIZATION DECO; Hanvoravongchai P., HLTH FINANCING REFOR; Ikegami N., 2014, UNIVERSAL HLTH COVER; Institute for Health Metrics and Evaluation, FIN GLOB HLTH; James SL, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-12; Lagomarsino G, 2012, LANCET, V380, P933, DOI 10.1016/S0140-6736(12)61147-7; Lindgren F, 2011, J R STAT SOC B, V73, P423, DOI 10.1111/j.1467-9868.2011.00777.x; R Development Core Team, 2009, R LANG ENV STAT COMP; Reeves A, 2015, LANCET, V386, P274, DOI 10.1016/S0140-6736(15)60574-8; Reich MR, 2016, LANCET, V387, P811, DOI 10.1016/S0140-6736(15)60002-2; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Savedoff W, TRANSITIONS HLTH FIN; Savedoff WD, 2012, LANCET, V380, P924, DOI 10.1016/S0140-6736(12)61083-6; Solimano G, 2010, UNIVERSAL HLTH COVER; Tangcharoensathien V, 2018, LANCET, V391, P1205, DOI 10.1016/S0140-6736(18)30198-3; The World Bank, WORLD BANK COUNTR LE; UN, 2015, UN TRANSF OUR WORLD, DOI [10.1201/b20466-7, DOI 10.1201/B20466-7]; Wagstaff A, 2018, LANCET GLOB HEALTH, V6, pE169, DOI [10.1016/S2214-109X(17)30486-2, 10.1016/s2214-109x(17)30486-2, 10.1016/S2214-109X(17)30429-1]; WHO, 2010, WOR HEALT REP, P1; WHO, POOL; WHO, 2017, 13 GEN PROG IN PRESS; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; World Bank, UN HLTH COV STUD SER; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K, 2011, DETERMINANTS HLTH EX	42	80	80	5	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2018	391	10132					1783	1798		10.1016/S0140-6736(18)30697-4	http://dx.doi.org/10.1016/S0140-6736(18)30697-4			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GE7NY	29678341	Green Published, hybrid			2022-12-28	WOS:000431421300026
J	Larsen, KP; Mathiharan, YK; Kappel, K; Coey, AT; Chen, DH; Barrero, D; Madigan, L; Puglisi, JD; Skiniotis, G; Puglisi, EV				Larsen, Kevin P.; Mathiharan, Yamuna Kalyani; Kappel, Kalli; Coey, Aaron T.; Chen, Dong-Hua; Barrero, Daniel; Madigan, Lauren; Puglisi, Joseph D.; Skiniotis, Georgios; Puglisi, Elisabetta Viani			Architecture of an HIV-1 reverse transcriptase initiation complex	NATURE			English	Article							PRIMER ACTIVATION SIGNAL; DEPENDENT DNA-POLYMERASE; SECONDARY STRUCTURE; RNA SEQUENCES; VIRUS; ELONGATION; DYNAMICS; TRNA(3)(LYS); RESOLUTION; RIBOSOME	Reverse transcription of the HIV-1 RNA genome into doublestranded DNA is a central step in viral infection1 and a common target of antiretroviral drugs(2). The reaction is catalysed by viral reverse transcriptase (RT)(3,4) that is packaged in an infectious virion with two copies of viral genomic RNA(5) each bound to host lysine 3 transfer RNA (tRNA(3)(Lys)), which acts as a primer for initiation of reverse transcription(6,7). Upon viral entry into cells, initiation is slow and non-processive compared to elongation(8,9). Despite extensive efforts, the structural basis of RT function during initiation has remained a mystery. Here we use cryo-electron microscopy to determine a three-dimensional structure of an HIV-1 RT initiation complex. In our structure, RT is in an inactive polymerase conformation with open fingers and thumb and with the nucleic acid primer-template complex shifted away from the active site. The primer binding site (PBS) helix formed between tRNA(3)(Lys) and HIV-1 RNA lies in the cleft of RT and is extended by additional pairing interactions. The 5' end of the tRNA refolds and stacks on the PBS to create a long helical structure, while the remaining viral RNA forms two helical stems positioned above the RT active site, with a linker that connects these helices to the RNase H region of the PBS. Our results illustrate how RNA structure in the initiation complex alters RT conformation to decrease activity, highlighting a potential target for drug action.	[Larsen, Kevin P.; Kappel, Kalli; Coey, Aaron T.] Stanford Univ, Program Biophys, Stanford, CA 94305 USA; [Larsen, Kevin P.; Coey, Aaron T.; Chen, Dong-Hua; Barrero, Daniel; Madigan, Lauren; Puglisi, Joseph D.; Skiniotis, Georgios; Puglisi, Elisabetta Viani] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Mathiharan, Yamuna Kalyani; Skiniotis, Georgios] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA USA	Stanford University; Stanford University; Stanford University	Puglisi, EV (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	epuglisi@stanford.edu		Mathiharan, Yamuna Kalyani/0000-0003-4042-6199; Skiniotis, Georgios/0000-0003-0238-7846; Larsen, Kevin/0000-0002-3464-2023; Kappel, Kalli/0000-0002-2129-199X	National Institutes of Health [GM082545, T32-GM008294]; National Science Foundation Graduate Research Fellowship Program [DGE-114747]; Gabilan Stanford Graduate Fellowship; NIH Shared Instrumentation Grant [1S10RR02664701]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008294, P50GM082545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Gabilan Stanford Graduate Fellowship; NIH Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Frost and L. Stryer for suggesting beta-octyl glucoside as an additive for cryo-EM, R. Kornberg, M. Levitt, P. Geiduschek and W. Sundquist for reading the manuscript, M. Levitt for discussion of alternative tRNA folds and general support, D. Herschlag for discussions, and N.R. Latorraca for discussions and assistance with the Sherlock cluster. Supported by National Institutes of Health grant GM082545 to E.V.P., T32-GM008294 (Molecular Biophysics Training Program) to K.P.L., A.T.C. and K.K., National Science Foundation Graduate Research Fellowship Program (DGE-114747) to A.T.C and K. K., and Gabilan Stanford Graduate Fellowship to K. K. We thank Stanford University and the Stanford Research Computing Center for providing the Sherlock cluster resources. Additional calculations were performed on the Stanford BioX3 cluster, supported by NIH Shared Instrumentation Grant 1S10RR02664701.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Aitken CE, 2010, NAT STRUCT MOL BIOL, V17, P793, DOI 10.1038/nsmb.1828; BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; Beerens N, 2002, J VIROL, V76, P2329, DOI 10.1128/JVI.76.5.2329-2339.2002; Beerens N, 2001, J BIOL CHEM, V276, P31247, DOI 10.1074/jbc.M102441200; Beerens N, 2013, RNA, V19, P517, DOI 10.1261/rna.035733.112; Chen J, 2012, J AM CHEM SOC, V134, P5734, DOI 10.1021/ja2119964; Coey A, 2016, RNA, V22, P1689, DOI 10.1261/rna.056804.116; Das K, 2012, NAT STRUCT MOL BIOL, V19, P253, DOI 10.1038/nsmb.2223; Das R, 2010, NAT METHODS, V7, P291, DOI [10.1038/nmeth.1433, 10.1038/NMETH.1433]; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foley B., 2013, HIV SEQUENCE COMPEND; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; Goldschmidt V, 2004, J BIOL CHEM, V279, P35923, DOI 10.1074/jbc.M404473200; Goldschmidt V, 2003, NUCLEIC ACIDS RES, V31, P850, DOI 10.1093/nar/gkg187; Goldschmidt V, 2002, J BIOL CHEM, V277, P43233, DOI 10.1074/jbc.M205295200; GOTTE M, 1995, EMBO J, V14, P833, DOI 10.1002/j.1460-2075.1995.tb07061.x; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; HUANG Y, 1994, J VIROL, V68, P7676, DOI 10.1128/JVI.68.12.7676-7683.1994; Isel C, 1999, EMBO J, V18, P1038, DOI 10.1093/emboj/18.4.1038; ISEL C, 1995, J MOL BIOL, V247, P236, DOI 10.1006/jmbi.1994.0136; Isel C, 1996, EMBO J, V15, P917, DOI 10.1002/j.1460-2075.1996.tb00426.x; Isel C, 2010, VIRUSES-BASEL, V2, P213, DOI 10.3390/v2010213; Iwatani Y, 2003, J BIOL CHEM, V278, P14185, DOI 10.1074/jbc.M211618200; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Johansson M, 2014, CELL REP, V7, P1534, DOI 10.1016/j.celrep.2014.04.034; Lanchy JM, 1998, J BIOL CHEM, V273, P24425, DOI 10.1074/jbc.273.38.24425; Lanchy JM, 1996, EMBO J, V15, P7178, DOI 10.1002/j.1460-2075.1996.tb01109.x; Lavender CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004230; Li A, 2016, J BIOL CHEM, V291, P26554, DOI 10.1074/jbc.M116.753152; Liang C, 1997, J VIROL, V71, P5750, DOI 10.1128/JVI.71.8.5750-5757.1997; Liu SX, 2010, NAT STRUCT MOL BIOL, V17, P1453, DOI 10.1038/nsmb.1937; Marshall RA, 2008, P NATL ACAD SCI USA, V105, P15364, DOI 10.1073/pnas.0805299105; O'Leary SE, 2013, STRUCTURE, V21, P2197, DOI 10.1016/j.str.2013.09.016; Paillart JC, 2004, NAT REV MICROBIOL, V2, P461, DOI 10.1038/nrmicro903; Peisley Alys, 2015, Methods Mol Biol, V1335, P29, DOI 10.1007/978-1-4939-2914-6_3; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Puglisi EV, 2011, J MOL BIOL, V410, P863, DOI 10.1016/j.jmb.2011.04.024; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Scheres SHW, 2016, METHOD ENZYMOL, V579, P125, DOI 10.1016/bs.mie.2016.04.012; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Wriggers W, 2012, ACTA CRYSTALLOGR D, V68, P344, DOI 10.1107/S0907444911049791; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	54	35	35	2	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2018	557	7703					118	+		10.1038/s41586-018-0055-9	http://dx.doi.org/10.1038/s41586-018-0055-9			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5BW	29695867	Green Accepted			2022-12-28	WOS:000431234500041
J	Koh, HK; McCarthy, GA				Koh, Howard K.; McCarthy, Gina A.			Private and Public Sector Responses to Climate Change	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Koh, Howard K.] Harvard TH Chan Sch Publ Hlth, Practice Publ Hlth Leadership, Boston, MA 02115 USA; [Koh, Howard K.] Harvard Kennedy Sch, Cambridge, MA 02138 USA; [McCarthy, Gina A.] Harvard Chans Ctr Hlth & Global Environm, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Koh, HK (corresponding author), Harvard TH Chan Sch Publ Hlth, Practice Publ Hlth Leadership, Boston, MA 02115 USA.; Koh, HK (corresponding author), Harvard Kennedy Sch, Cambridge, MA 02138 USA.	hkoh@hsph.harvard.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2018	319	17					1756	1757		10.1001/jama.2018.4804	http://dx.doi.org/10.1001/jama.2018.4804			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GE3UQ	29715345	Bronze			2022-12-28	WOS:000431138800004
J	Abate-Shen, C				Abate-Shen, Cory			Prostate Cancer Metastasis - Fueled by Fat?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							OBESITY		[Abate-Shen, Cory] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Urol, New York, NY 10027 USA; [Abate-Shen, Cory] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Med, New York, NY 10027 USA; [Abate-Shen, Cory] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Abate-Shen, Cory] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Syst Biol, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Columbia University	Abate-Shen, C (corresponding author), Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Urol, New York, NY 10027 USA.; Abate-Shen, C (corresponding author), Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Med, New York, NY 10027 USA.; Abate-Shen, C (corresponding author), Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Pathol & Cell Biol, New York, NY 10027 USA.; Abate-Shen, C (corresponding author), Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Syst Biol, New York, NY 10027 USA.				NATIONAL CANCER INSTITUTE [R01CA173481, R01CA183929] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA183929, R01 CA173481] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chen M, 2018, NAT GENET, V50, P206, DOI 10.1038/s41588-017-0027-2; Deng T, 2016, ANNU REV PATHOL-MECH, V11, P421, DOI 10.1146/annurev-pathol-012615-044359; Hopkins BD, 2016, J CLIN ONCOL, V34, P4277, DOI 10.1200/JCO.2016.67.9712; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Vidal AC, 2017, EUR UROL, V72, P78, DOI 10.1016/j.eururo.2016.10.011	5	9	10	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2018	378	17					1643	1645		10.1056/NEJMcibr1800808	http://dx.doi.org/10.1056/NEJMcibr1800808			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GD8XP	29694822	Green Accepted			2022-12-28	WOS:000430797900015
J	Pitman, A; Suleman, S; Hyde, N; Hodgkiss, A				Pitman, Alexandra; Suleman, Sahil; Hyde, Nicholas; Hodgkiss, Andrew			Depression and anxiety in patients with cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MAJOR DEPRESSION; PROSTATE-CANCER; BREAST-CANCER; PREVALENCE; METAANALYSIS; SURVIVORS; RISK; CARE		[Pitman, Alexandra; Suleman, Sahil; Hyde, Nicholas] St Georges Univ Hosp NHS Fdn Trust, London, England; [Pitman, Alexandra; Suleman, Sahil] UCL, Div Psychiat, London, England; [Hodgkiss, Andrew] Cent & Nortg West London NHS Fdn Trust, London, England; [Hodgkiss, Andrew] Royal Marsden NHS Fdn Trust, London, England; [Hodgkiss, Andrew] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England	University of London; University College London; Royal Marsden NHS Foundation Trust; University of London; King's College London	Pitman, A (corresponding author), St Georges Univ Hosp NHS Fdn Trust, London, England.; Pitman, A (corresponding author), UCL, Div Psychiat, London, England.	a.pitman@ucl.ac.uk		Suleman, Sahil/0000-0001-5910-6756; Pitman, Alexandra/0000-0002-9742-1359				Ashbury FD, 2003, SUPPORT CARE CANCER, V11, P278, DOI 10.1007/s00520-003-0446-8; Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Benros ME, 2009, INT J CANCER, V124, P2917, DOI 10.1002/ijc.24274; Breitbart W, 2014, PSYCHO-ONCOLOGY, V23, P339, DOI 10.1002/pon.3422; Burgess C, 2005, BRIT MED J, V330, P702, DOI 10.1136/bmj.38343.670868.D3; Cancer Research UK, CANC INC STAT; Chang CK, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004295; Cherner MM, 2009, PSYCHO-ONCOLOGY, V18, P237, DOI 10.1002/pon.1401; Darnell RB, 2011, CONT NEUROLOGY SERIE, V79; Die Trill Maria, 2013, EJC Suppl, V11, P216, DOI 10.1016/j.ejcsup.2013.07.009; DiMatteo MR, 2011, DEPRESSION CANC, P101; Else-Quest NM, 2009, PSYCHOL HEALTH, V24, P949, DOI 10.1080/08870440802074664; Glynne-Jones R, 1997, Clin Oncol (R Coll Radiol), V9, P25, DOI 10.1016/S0936-6555(97)80055-6; Gross Anne F, 2007, Prim Care Companion J Clin Psychiatry, V9, P382; Hage MP, 2012, J THROID RES, V2012, DOI 10.1155/2012/590648; Hoffman KE, 2009, ARCH INTERN MED, V169, P1274, DOI 10.1001/archinternmed.2009.179; HOLLAND JC, 1986, AM J PSYCHIAT, V143, P982; Jick S, 2015, CANCER EPIDEMIOL, V39, P901, DOI 10.1016/j.canep.2015.10.012; Koch L, 2014, PSYCHO-ONCOLOGY, V23, P547, DOI 10.1002/pon.3452; Krebber AMH, 2014, PSYCHO-ONCOLOGY, V23, P121, DOI 10.1002/pon.3409; Kreitler S, 1999, CANCER INVEST, V17, P514, DOI 10.3109/07357909909032861; Linden W, 2012, J AFFECT DISORDERS, V141, P343, DOI 10.1016/j.jad.2012.03.025; Mitchell Alex J, 2013, Lancet Oncol, V14, P721, DOI 10.1016/S1470-2045(13)70244-4; Mitchell AJ, 2011, LANCET ONCOL, V12, P160, DOI 10.1016/S1470-2045(11)70002-X; Mulick A, 2018, LANCET PSYCHIAT, V5, P321, DOI 10.1016/S2215-0366(18)30061-0; Robson A, 2010, PSYCHO-ONCOLOGY, V19, P1250, DOI 10.1002/pon.1717; Rocca WA, 2008, MENOPAUSE, V15, P1050, DOI [10.1097/gme.0b013e318174f155, 10.1097/GME.0000000000001229]; Sharpe M, 2014, LANCET, V384, P1099, DOI 10.1016/S0140-6736(14)61231-9; Smith HR, 2015, ONCOL LETT, V9, P1509, DOI 10.3892/ol.2015.2944; Snijders-Keilholz A, 1993, ANTICANCER RES, V13; Stark DPH, 2000, BRIT J CANCER, V83, P1261, DOI 10.1054/bjoc.2000.1405; Steel Z, 2014, INT J EPIDEMIOL, V43, P476, DOI 10.1093/ije/dyu038; Thornton LM, 2008, CANCER-AM CANCER SOC, V113, P638, DOI 10.1002/cncr.23589; Vodermaier A, 2011, BRIT J CANCER, V105, P1814, DOI 10.1038/bjc.2011.503; Walker J, 2014, LANCET PSYCHIAT, V1, P343, DOI 10.1016/S2215-0366(14)70313-X; Wick W, 2016, LANCET ONCOL, V17, pE529, DOI 10.1016/S1470-2045(16)30571-X	36	182	193	7	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2018	361								k1415	10.1136/bmj.k1415	http://dx.doi.org/10.1136/bmj.k1415			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF4WC	29695476	Green Submitted			2022-12-28	WOS:000431963600004
J	Richardson, K; Fox, C; Maidment, I; Steel, N; Loke, YK; Arthur, A; Myint, PK; Grossi, CM; Mattishent, K; Bennett, K; Campbell, NL; Boustani, M; Robinson, L; Brayne, C; Matthews, FE; Savva, GM				Richardson, Kathryn; Fox, Chris; Maidment, Ian; Steel, Nicholas; Loke, Yoon K.; Arthur, Antony; Myint, Phyo K.; Grossi, Carlota M.; Mattishent, Katharina; Bennett, Kathleen; Campbell, Noll L.; Boustani, Malaz; Robinson, Louise; Brayne, Carol; Matthews, Fiona E.; Savva, George M.			Anticholinergic drugs and risk of dementia: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICATION USE; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; PARKINSONS-DISEASE; OVERACTIVE BLADDER; BEERS CRITERIA; OLDER-PEOPLE; POPULATION; BURDEN; BRAIN	OBJECTIVES To estimate the association between the duration and level of exposure to different classes of anticholinergic drugs and subsequent incident dementia. DESIGN Case-control study. SETTING General practices in the UK contributing to the Clinical Practice Research Datalink. PARTICIPANTS 40 770 patients aged 65-99 with a diagnosis of dementia between April 2006 and July 2015, and 283 933 controls without dementia. INTERVENTIONS Daily defined doses of anticholinergic drugs coded using the Anticholinergic Cognitive Burden (ACB) scale, in total and grouped by subclass, prescribed 4-20 years before a diagnosis of dementia. MAIN OUTCOME MEASURES Odds ratios for incident dementia, adjusted for a range of demographic and health related covariates. RESULTS 14 453 (35%) cases and 86 403 (30%) controls were prescribed at least one anticholinergic drug with an ACB score of 3 (definite anticholinergic activity) during the exposure period. The adjusted odds ratio for any anticholinergic drug with an ACB score of 3 was 1.11 (95% confidence interval 1.08 to 1.14). Dementia was associated with an increasing average ACB score. When considered by drug class, gastrointestinal drugs with an ACB score of 3 were not distinctively linked to dementia. The risk of dementia increased with greater exposure for antidepressant, urological, and antiparkinson drugs with an ACB score of 3. This result was also observed for exposure 15-20 years before a diagnosis. CONCLUSIONS A robust association between some classes of anticholinergic drugs and future dementia incidence was observed. This could be caused by a class specific effect, or by drugs being used for very early symptoms of dementia. Future research should examine anticholinergic drug classes as opposed to anticholinergic effects intrinsically or summing scales for anticholinergic exposure.	[Richardson, Kathryn; Arthur, Antony; Grossi, Carlota M.; Savva, George M.] Univ East Anglia, Sch Hlth Sci, Norwich NR4 7TJ, Norfolk, England; [Fox, Chris; Steel, Nicholas; Loke, Yoon K.; Mattishent, Katharina] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England; [Maidment, Ian] Aston Univ, Sch Life & Hlth Sci, Birmingham, W Midlands, England; [Myint, Phyo K.] Univ Aberdeen, Sch Med Med Sci & Nutr, Aberdeen, Scotland; [Bennett, Kathleen] Royal Coll Surgeons Ireland, Div Populat Hlth Sci, Dublin, Ireland; [Campbell, Noll L.] Purdue Univ, Coll Pharm, Dept Pharm Practice, W Lafayette, IN 47907 USA; [Boustani, Malaz] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Robinson, Louise] Newcastle Univ, Inst Ageing, Newcastle Upon Tyne, Tyne & Wear, England; [Brayne, Carol] Univ Cambridge, Cambridge Inst Publ Hlth, Cambridge, England; [Matthews, Fiona E.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England	University of East Anglia; University of East Anglia; Aston University; University of Aberdeen; Royal College of Surgeons - Ireland; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University Bloomington; Newcastle University - UK; University of Cambridge; Newcastle University - UK	Richardson, K (corresponding author), Univ East Anglia, Sch Hlth Sci, Norwich NR4 7TJ, Norfolk, England.	k.richardson@uea.ac.uk	Savva, George M/E-9670-2011; Steel, Nicholas/K-1592-2014; Matthews, Fiona/O-6932-2015; Boustani, Malaz/Q-3850-2019; Brayne, Carol/AAA-4285-2020	Savva, George M/0000-0001-9190-124X; Steel, Nicholas/0000-0003-1528-140X; Matthews, Fiona/0000-0002-1728-2388; Boustani, Malaz/0000-0003-0330-677X; Brayne, Carol/0000-0001-5307-663X; Mattishent, Katharina/0000-0002-7577-0689; Maidment, Ian/0000-0003-4152-9704; Bennett, Kathleen/0000-0002-2861-7665; Grossi, carlota/0000-0003-3722-5425; Arthur, Antony/0000-0001-8617-5714; Fox, Chris/0000-0001-9480-5704	Alzheimer's Society [AS-PG-2013-017]; MRC [G9901400, G0601022] Funding Source: UKRI	Alzheimer's Society; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by the Alzheimer's Society (AS-PG-2013-017). The funders had no role is the design of the study or the interpretation of the findings.	Aarsland D, 2001, NEUROLOGY, V56, P730, DOI 10.1212/WNL.56.6.730; Boustani M., 2008, AGING HLTH, V4, P311, DOI [10.2217/1745509x.4.3.311, DOI 10.2217/1745509X.4.3.311, 10.2217/1745509XA3.311, 10.2217/1745509X.4.3.311]; Brown A, 2016, EMERG THEMES EPIDEMI, V13, P1, DOI 10.1186/s12982-016-0053-z; Cai XY, 2013, ALZHEIMERS DEMENT, V9, P377, DOI 10.1016/j.jalz.2012.02.005; Campbell NL, 2013, J AM GERIATR SOC, V61, pS142; Carnahan RM, 2006, J CLIN PHARMACOL, V46, P1481, DOI 10.1177/0091270006292126; Carriere I, 2009, ARCH INTERN MED, V169, P1317, DOI 10.1001/archinternmed.2009.229; Chatterjee S, 2016, AM J GERIAT PSYCHIAT, V24, P485, DOI 10.1016/j.jagp.2015.12.011; Chiang CH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/187819; Ehrt U, 2010, J NEUROL NEUROSUR PS, V81, P160, DOI 10.1136/jnnp.2009.186239; Exalto LG, 2014, ALZHEIMERS DEMENT, V10, P562, DOI 10.1016/j.jalz.2013.05.1772; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Fox C, 2011, J AM GERIATR SOC, V59, P1477, DOI 10.1111/j.1532-5415.2011.03491.x; Gallagher P, 2008, AGE AGEING, V37, P673, DOI 10.1093/ageing/afn197; Gao L, 2018, AGE AGEING, V47, P220, DOI 10.1093/ageing/afx158; Gray SL, 2015, JAMA INTERN MED, V175, P401, DOI 10.1001/jamainternmed.2014.7663; Health and Social Care Information Centre, 2013, NHS OUTC FRAM; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; HORWITZ RI, 1980, AM J MED, V68, P255, DOI 10.1016/0002-9343(80)90363-0; Imfeld P, 2013, J ALZHEIMERS DIS, V35, P565, DOI 10.3233/JAD-121819; Kaup AR, 2016, JAMA PSYCHIAT, V73, P525, DOI 10.1001/jamapsychiatry.2016.0004; Kay GG, 2008, INT J CLIN PRACT, V62, P1792, DOI 10.1111/j.1742-1241.2008.01849.x; Kersten H, 2013, J GERONTOL A-BIOL, V68, P271, DOI 10.1093/gerona/gls176; Langholz B, 2009, EPIDEMIOLOGY, V20, P321, DOI 10.1097/EDE.0b013e31819e370b; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Mirza SS, 2016, LANCET PSYCHIAT, V3, P628, DOI 10.1016/S2215-0366(16)00097-3; National Institute for Health and Care Excellence, 2015, CG171 NICE NAT I HLT; Ott A, 1998, AM J EPIDEMIOL, V147, P574; Perry EK, 2003, ANN NEUROL, V54, P235, DOI 10.1002/ana.10639; Prescribing and Medicines Team, 2017, PRESCR DISP COMM STA; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Risacher SL, 2016, JAMA NEUROL, V73, P721, DOI 10.1001/jamaneurol.2016.0580; Rose S, 2014, AM J EPIDEMIOL, V179, P663, DOI 10.1093/aje/kwt318; Sakakibara R, 2014, INT J UROL, V21, P33, DOI 10.1111/iju.12288; Salahudeen MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151084; Salahudeen MS, 2015, J AM GERIATR SOC, V63, P85, DOI 10.1111/jgs.13206; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; Schneeweiss S, 2010, PHARMACOEPIDEM DR S, V19, P858, DOI 10.1002/pds.1926; Singh-Manoux A, 2017, JAMA PSYCHIAT, V74, P712, DOI 10.1001/jamapsychiatry.2017.0660; Tannenbaum C, 2012, DRUG AGING, V29, P639, DOI 10.2165/11633250-000000000-00000; Vandenbroucke JP, 2012, INT J EPIDEMIOL, V41, P1480, DOI 10.1093/ije/dys147; White LR, 2016, NEUROLOGY, V86, P1000, DOI 10.1212/WNL.0000000000002480; Winblad B, 2016, LANCET NEUROL, V15, P455, DOI 10.1016/S1474-4422(16)00062-4; Yoshiyama Y, 2015, NEURODEGENER DIS, V15, P140, DOI 10.1159/000381484	45	217	220	8	38	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2018	361								k1315	10.1136/bmj.k1315	http://dx.doi.org/10.1136/bmj.k1315			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GF4WC	29695481	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-28	WOS:000431963600002
J	Zhao, Q; Zhu, YP; Xu, ZY; Cheng, ZY; Mei, J; Chen, X; Wang, XW				Zhao, Qiang; Zhu, Yunpeng; Xu, Zhiyun; Cheng, Zhaoyun; Mei, Ju; Chen, Xin; Wang, Xiaowei			Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLOPIDOGREL; PREVENTION; EVENTS; DEFINITIONS; SURGERY	IMPORTANCE The effect of ticagrelor with or without aspirin on saphenous vein graft patency in patients undergoing coronary artery bypass grafting (CABG) is unknown.& para;& para;OBJECTIVE To compare the effect of ticagrelor + aspirin or ticagrelor alone vs aspirin alone on saphenous vein graft patency 1 year after CABG.& para;& para;DESIGN, SETTING, AND PARTICIPANTS Randomized. multicenter, open-label. clinical trial among 6 tertiary hospitals in China. Eligible patients were aged 18 to 80 years with indications for elective CABG. Patients requiring urgent revascularization, concomitant cardiac surgery, dual antiplatelet or vitamin K antagonist therapy post-CABG, and who were at risk of serious bleeding were excluded. From July 2014 until November 2015, 1256 patients were identified and 500 were enrolled. Follow-up was completed in January 2017.& para;& para;INTERVENTIONS Patients were randomized (1:1:1) to start ticagrelor (90 mg twice daily) + aspirin (100 mg once daily) (n = 168), ticagrelor (90 mg twice daily) (n = 166), or aspirin (100 mg once daily) (n = 166) within 24 hours post-CABG. Neither patients nor treating physicians were blinded to allocation.& para;& para;MAIN OUTCOMES AND MEASURES Primary outcome was saphenous vein graft patency 1 year after CABG (FitzGibbon grade A) adjudicated independently by a committee blinded to allocation. Saphenous vein graft patency was assessed by multislice computed tomographic angiography or coronary angiography.& para;& para;RESULTS Among 500 randomized patients (mean age, 63.6 years; women, 91 [18.2%]), 461 (92.2%) completed the trial. Saphenous vein graft patency rates 1year post-CABG were 88.7% (432 of 487 vein grafts) with ticagrelor + aspirin; 82.8% (404 of 488 vein grafts) with ticagrelor alone; and 76.5% (371 of 485 vein grafts) with aspirin alone. The difference between ticagrelor + aspirin vs aspirin alone was statistically significant (12.2% [95% CI, 5.2% to 19.2%]; P < .001), whereas the difference between ticagrelor alone vs aspirin alone was not statistically significant (6.3% [95% Cl, -1.1% to 13.7%]; P = .10). Five major bleeding episodes occurred during 1year of follow-up (3 with ticagrelor + aspirin; 2 with ticagrelor alone).& para;& para;CONCLUSIONS AND RELEVANCE Among patients undergoing elective CABG with saphenous vein grafting, ticagrelor + aspirin significantly increased graft patency after 1 year vs aspirin alone; there was no significant difference between ticagrelor alone and aspirin alone. Further research with more patients is needed to assess comparative bleeding risks.	[Zhao, Qiang; Zhu, Yunpeng] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai, Peoples R China; [Xu, Zhiyun] Changhai Hosp Shanghai, Shanghai, Peoples R China; [Cheng, Zhaoyun] Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China; [Mei, Ju] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai, Peoples R China; [Chen, Xin] Nanjing First Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Xiaowei] Jiangsu Prov Hosp, Nanjing, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Naval Medical University; Zhengzhou University; Shanghai Jiao Tong University; Nanjing Medical University	Zhao, Q (corresponding author), Shanghai Jiao Tong Univ, Sch Medicine, Ruijin Hosp, Dept Cardiovasc Surg, Shanghai 200025, Peoples R China.	zq11607@rjh.com.cn		Zhu, Yunpeng/0000-0001-9245-7857	AstraZeneca	AstraZeneca(AstraZeneca)	The study was funded by AstraZeneca. AstraZeneca provided the study medication free of charge.	Aldea GS, 2016, ANN THORAC SURG, V101, P801, DOI 10.1016/j.athoracsur.2015.09.100; Alexander JH, 2016, NEW ENGL J MED, V374, P1954, DOI 10.1056/NEJMra1406944; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Fox KAA, 2004, CIRCULATION, V110, P1202, DOI 10.1161/01.CIR.0000140675.85342.1B; Gao CQ, 2009, ANN THORAC SURG, V88, P59, DOI 10.1016/j.athoracsur.2009.04.024; Gao G, 2010, J AM COLL CARDIOL, V56, P1639, DOI 10.1016/j.jacc.2010.03.104; Gaudino M, 2017, CIRCULATION, V136, P1749, DOI 10.1161/CIRCULATIONAHA.117.027597; Halabi AR, 2005, AM J CARDIOL, V96, P1254, DOI 10.1016/j.amjcard.2005.06.067; Held C, 2011, J AM COLL CARDIOL, V57, P672, DOI 10.1016/j.jacc.2010.10.029; Hicks KA, 2015, J AM COLL CARDIOL, V66, P403, DOI 10.1016/j.jacc.2014.12.018; Lopes RD, 2009, NEW ENGL J MED, V361, P235, DOI 10.1056/NEJMoa0900708; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Saw J, 2016, HEART, V102, P763, DOI 10.1136/heartjnl-2015-308691; Sianos Georgios, 2005, EuroIntervention, V1, P219; Sun JCJ, 2010, AM HEART J, V160, P1178, DOI 10.1016/j.ahj.2010.07.035; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Yusuf S, 2001, NEW ENGL J MED, V345, P494	20	121	132	3	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2018	319	16					1677	1686		10.1001/jama.2018.3197	http://dx.doi.org/10.1001/jama.2018.3197			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD7RF	29710164	Bronze, Green Published			2022-12-28	WOS:000430709300022
J	Schaal, A				Schaal, Aaron			Science must rise up to support people like me	NATURE			English	Editorial Material									[Schaal, Aaron] Ludwig Maximilians Univ Munchen, Math Phys, Munich, Germany	University of Munich	Schaal, A (corresponding author), Ludwig Maximilians Univ Munchen, Math Phys, Munich, Germany.	schaal@math.lmu.de							0	3	3	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2018	556	7701					275	275		10.1038/d41586-018-04598-z	http://dx.doi.org/10.1038/d41586-018-04598-z			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1TW	29670268	Bronze			2022-12-28	WOS:000430285200013
J	Tate, JE; Mwenda, JM; Armah, G; Jani, B; Omore, R; Ademe, A; Mujuru, H; Mpabalwani, E; Ngwira, B; Cortese, MM; Mihigo, R; Glover-Addy, H; Mbaga, M; Osawa, F; Tadesse, A; Mbuwayesango, B; Simwaka, J; Cunliffe, N; Lopman, BA; Weldegebriel, G; Ansong, D; Msuya, D; Ogwel, B; Karengera, T; Manangazira, P; Bvulani, B; Yen, C; Zawaira, FR; Narh, CT; Mboma, L; Saula, P; Teshager, F; Getachew, H; Moeti, RM; Eweronu-Laryea, C; Parashar, UD				Tate, J. E.; Mwenda, J. M.; Armah, G.; Jani, B.; Omore, R.; Ademe, A.; Mujuru, H.; Mpabalwani, E.; Ngwira, B.; Cortese, M. M.; Mihigo, R.; Glover-Addy, H.; Mbaga, M.; Osawa, F.; Tadesse, A.; Mbuwayesango, B.; Simwaka, J.; Cunliffe, N.; Lopman, B. A.; Weldegebriel, G.; Ansong, D.; Msuya, D.; Ogwel, B.; Karengera, T.; Manangazira, P.; Bvulani, B.; Yen, C.; Zawaira, F. R.; Narh, C. T.; Mboma, L.; Saula, P.; Teshager, F.; Getachew, H.; Moeti, R. M.; Eweronu-Laryea, C.; Parashar, U. D.		African Intussusception Surveil	Evaluation of Intussusception after Monovalent Rotavirus Vaccination in Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONTROLLED CASE-SERIES; US INFANTS; RISK; IMMUNIZATION; VACCINES; CHILDREN; PROGRAM; SAFETY; HOSPITALIZATIONS; GASTROENTERITIS	BACKGROUND Postlicensure evaluations have identified an association between rotavirus vaccination and intussusception in several high-and middle-income countries. We assessed the association between monovalent human rotavirus vaccine and intussusception in lower-income sub-Saharan African countries. METHODS Using active surveillance, we enrolled patients from seven countries (Ethiopia, Ghana, Kenya, Malawi, Tanzania, Zambia, and Zimbabwe) who had intussusception that met international (Brighton Collaboration level 1) criteria. Rotavirus vaccination status was confirmed by review of the vaccine card or clinic records. The risk of intussusception within 1 to 7 days and 8 to 21 days after vaccination among infants 28 to 245 days of age was assessed by means of the self-controlled case-series method. RESULTS Data on 717 infants who had intussusception and confirmed vaccination status were analyzed. One case occurred in the 1 to 7 days after dose 1, and 6 cases occurred in the 8 to 21 days after dose 1. Five cases and 16 cases occurred in the 1 to 7 days and 8 to 21 days, respectively, after dose 2. The risk of intussusception in the 1 to 7 days after dose 1 was not higher than the background risk of intussusception (relative incidence [i.e., the incidence during the risk window vs. all other times], 0.25; 95% confidence interval [CI], <0.001 to 1.16); findings were similar for the 1 to 7 days after dose 2 (relative incidence, 0.76; 95% CI, 0.16 to 1.87). In addition, the risk of intussusception in the 8 to 21 days or 1 to 21 days after either dose was not found to be higher than the background risk. CONCLUSIONS The risk of intussusception after administration of monovalent human rotavirus vaccine was not higher than the background risk of intussusception in seven lower-income sub-Saharan African countries. (Funded by the GAVI Alliance through the CDC Foundation.)	[Tate, J. E.; Cortese, M. M.; Lopman, B. A.; Yen, C.; Getachew, H.; Parashar, U. D.] Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS-A34, Atlanta, GA 30333 USA; [Mwenda, J. M.; Mihigo, R.; Zawaira, F. R.; Moeti, R. M.] WHO, Reg Off Africa, Brazzaville, Rep Congo; [Armah, G.] Noguchi Mem Inst Med Res, Accra, Ghana; [Eweronu-Laryea, C.] Coll Hlth Sci, Sch Med & Dent, Accra, Ghana; [Glover-Addy, H.] Univ Ghana, Accra, Ghana; [Glover-Addy, H.] Korle Bu Teaching Hosp, Accra, Ghana; [Ansong, D.] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Narh, C. T.] Univ Hlth & Allied Sci, Sch Publ Hlth, Hohoe, Ghana; [Jani, B.] WHO, Country Off, Moshi, Tanzania; [Mbaga, M.] Muhimbili Natl Hosp, Dar Es Salaam, Tanzania; [Msuya, D.] Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Mboma, L.] Mbeya Zonal Referral Hosp, Mbeya, Tanzania; [Omore, R.; Ogwel, B.] Ctr Global Hlth Res, Kenya Med Res Inst, Kisumu, Kenya; [Osawa, F.] Univ Nairobi, Sch Med, Dept Surg, Nairobi, Kenya; [Saula, P.] Moi Univ, Sch Med, Eldoret, Kenya; [Ademe, A.; Karengera, T.; Teshager, F.] WHO, Country Off, Addis Ababa, Ethiopia; [Tadesse, A.] Addis Ababa Univ, Sch Med, Addis Ababa, Ethiopia; [Mujuru, H.; Mbuwayesango, B.] Harare Cent Hosp, Harare, Zimbabwe; [Mujuru, H.] Univ Zimbabwe, Dept Pediat & Child Hlth, Harare, Zimbabwe; [Weldegebriel, G.] WHO, Intercountry Support Team, Harare, Zimbabwe; [Manangazira, P.] Minist Hlth & Child Care, Epidemiol & Dis Control, Harare, Zimbabwe; [Mpabalwani, E.] Childrens Hosp, Lusaka, Zambia; [Simwaka, J.] Adult Hosp, Virol Lab, Lusaka, Zambia; [Bvulani, B.] Adult Hosp, Dept Surg, Pediat Surg Unit, Lusaka, Zambia; Univ Teaching Hosp, Lusaka, Zambia; [Ngwira, B.] Univ Malawi, Coll Med, Blantyre, Malawi; [Cunliffe, N.] Univ Liverpool, Inst Infect & Global Hlth, Ctr Global Vaccine Res, Liverpool, Merseyside, England	Centers for Disease Control & Prevention - USA; World Health Organization; University of Ghana; University of Ghana; Kwame Nkrumah University Science & Technology; World Health Organization; Kilimanjaro Christian Medical Centre; Kenya Medical Research Institute; University of Nairobi; Moi University; World Health Organization; Addis Ababa University; University of Zimbabwe; World Health Organization; University of Zambia; University of Malawi; University of Liverpool	Tate, JE (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS-A34, Atlanta, GA 30333 USA.	jqt8@cdc.gov	Narh, Clement/AAP-3097-2021; Mujuru, Hilda Angela/AAF-2511-2020	Mujuru, Hilda Angela/0000-0003-1615-3856; Ogwel, Billy/0000-0002-9097-2713; Narh, Clement/0000-0002-4025-5433; Mpabalwani, Evans/0000-0002-3193-8750; Cunliffe, Nigel/0000-0002-5449-4988	Gavi Alliance through the CDC Foundation	Gavi Alliance through the CDC Foundation	Supported by the Gavi Alliance through the CDC Foundation.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P533; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Bines JE, 2004, VACCINE, V22, P569, DOI 10.1016/j.vaccine.2003.09.016; Carlin JB, 2013, CLIN INFECT DIS, V57, P1427, DOI 10.1093/cid/cit520; Cortese Margaret M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Farrington CP, 2009, BIOSTATISTICS, V10, P3, DOI 10.1093/biostatistics/kxn013; Global Advisory Committee on Vaccine Safety, 2014, WKLY EPIDEMIOL REC, V89, P53; Jiang JQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055729, 10.1371/journal.pone.0068482]; Jonesteller CL, 2017, CLIN INFECT DIS, V65, P840, DOI 10.1093/cid/cix369; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Mpabalwani EM, 2017, J TROP PEDIATRICS, V63, P221, DOI 10.1093/tropej/fmw069; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Patel MM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001330; Patel MM, 2011, NEW ENGL J MED, V364, P2283, DOI 10.1056/NEJMoa1012952; Peter G, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.6.e67; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Shah MP, 2017, EXPERT REV VACCINES, V16, P987, DOI 10.1080/14760584.2017.1371595; Steele AD, 2010, VACCINE, V28, P6542, DOI 10.1016/j.vaccine.2008.08.034; Stowe J, 2016, VACCINE, V34, P3684, DOI 10.1016/j.vaccine.2016.04.050; Tate JE, 2008, PEDIATRICS, V121, pE1125, DOI 10.1542/peds.2007-1590; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; VIEW-hub, VACC INTR CURR VACC; Weintraub ES, 2014, NEW ENGL J MED, V370, P513, DOI 10.1056/NEJMoa1311738; Whitaker HJ, 2009, STAT METHODS MED RES, V18, P7, DOI 10.1177/0962280208092342; Yih WK, 2014, NEW ENGL J MED, V370, P503, DOI 10.1056/NEJMoa1303164; Yung CF, 2015, J PEDIATR-US, V167, P163, DOI 10.1016/j.jpeds.2015.03.038	27	63	66	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2018	378	16					1521	1528		10.1056/NEJMoa1713909	http://dx.doi.org/10.1056/NEJMoa1713909			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD2EI	29669224	Bronze			2022-12-28	WOS:000430312500007
J	Chan, AC; Burke, CA; Coffey, EM; Hilden, DR; Coira, DL; Warner-Cohen, J; Grady, M; Muskin, PR; Shinozaki, G				Chan, Aubrey C.; Burke, Christopher A.; Coffey, Ellen M.; Hilden, David R.; Coira, Diego L.; Warner-Cohen, Jessy; Grady, Margaret; Muskin, Philip R.; Shinozaki, Gen			Integrated Inpatient Medical and Psychiatric Care: Experiences of 5 Institutions	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DISORDERS		[Chan, Aubrey C.] Univ Iowa Hosp & Clin, Dept Psychiat & Internal Med, 200 Hawkins Dr, Iowa City, IA 52242 USA; [Shinozaki, Gen] Univ Iowa Hosp & Clin, Dept Psychiat, Med Labs B002F,25 South Grand Ave, Iowa City, IA 52242 USA; [Burke, Christopher A.] Long Isl Jewish Med Ctr, 270-05 76th Ave,Staff House Room 306, New Hyde Pk, NY 11040 USA; [Warner-Cohen, Jessy] Long Isl Jewish Med Ctr, Dept Psychiat, 270-05 76th Ave, New Hyde Pk, NY 11040 USA; [Coffey, Ellen M.] Hennepin Cty Med Ctr, Dept Internal Med, 701 Pk Ave, Minneapolis, MN 55415 USA; [Hilden, David R.] Hennepin Cty Med Ctr, Dept Med G5, 701 Pk Ave, Minneapolis, MN 55415 USA; [Coira, Diego L.; Grady, Margaret] Coira Inst, 851 Franklin Lake Rd,Suite 105, Franklin Lakes, NJ 07417 USA; [Muskin, Philip R.] Columbia Univ, Med Ctr, Dept Psychiat, 622 West 168th St,Mailbox 427, New York, NY 10032 USA	University of Iowa; University of Iowa; Northwell Health; Northwell Health; Hennepin County Medical Center; Hennepin County Medical Center; Columbia University	Shinozaki, G (corresponding author), Univ Iowa Hosp & Clin, Dept Psychiat, Med Labs B002F,25 South Grand Ave, Iowa City, IA 52242 USA.	gen-shinozaki@uiowa.edu	Shinozaki, Gen/O-1281-2017	Shinozaki, Gen/0000-0001-6129-2789; Chan, Aubrey/0000-0002-9191-2173; Levin, Jessy/0000-0003-0928-8947				Baumeister H, 2015, BIOPSYCHOSOC MED, V9, DOI 10.1186/s13030-015-0039-z; Briskman I, 2012, INT J PSYCHIAT MED, V43, P339, DOI 10.2190/PM.43.4.d; Hussain M, 2014, PSYCHOSOMATICS, V55, P315, DOI 10.1016/j.psym.2013.08.003; Kathol RG, 2009, PSYCHOSOMATICS, V50, P93, DOI 10.1176/appi.psy.50.2.93; Mather B, 2014, ARCH PSYCHIAT NURS, V28, P80, DOI 10.1016/j.apnu.2013.10.009; Owens P, 2007, CARE ADULTS MENTAL H, V10	6	8	8	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2018	168	11					815	+		10.7326/M17-3186	http://dx.doi.org/10.7326/M17-3186			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI3EK	29710091				2022-12-28	WOS:000434254100009
J	Yang, J; Siri, JG; Remais, JV; Cheng, Q; Zhang, H; Chan, KKY; Sun, Z; Zhao, YY; Cong, N; Li, XY; Zhang, W; Bai, YQ; Bi, J; Cai, WJ; Chan, EYY; Chen, WQ; Fan, WC; Fu, H; He, JQ; Huang, H; Ji, JS; Jia, P; Jiang, XP; Kwan, MP; Li, TH; Li, XG; Liang, S; Liang, XF; Liang, L; Liu, QY; Lu, YM; Luo, Y; Ma, XL; Schwartlander, B; Shen, ZY; Shi, PJ; Su, J; Wu, TG; Yang, CH; Yin, YY; Zhang, Q; Zhang, YP; Zhang, Y; Xu, B; Gong, P				Yang, Jun; Siri, Jose G.; Remais, Justin V.; Cheng, Qu; Zhang, Han; Chan, Karen K. Y.; Sun, Zhe; Zhao, Yuanyuan; Cong, Na; Li, Xueyan; Zhang, Wei; Bai, Yuqi; Bi, Jun; Cai, Wenjia; Chan, Emily Y. Y.; Chen, Wanqing; Fan, Weicheng; Fu, Hua; He, Jianqing; Huang, Hong; Ji, John S.; Jia, Peng; Jiang, Xiaopeng; Kwan, Mei-Po; Li, Tianhong; Li, Xiguang; Liang, Song; Liang, Xiaofeng; Liang, Lu; Liu, Qiyong; Lu, Yongmei; Luo, Yong; Ma, Xiulian; Schwartlander, Bernhard; Shen, Zhiyong; Shi, Peijun; Su, Jing; Wu, Tinghai; Yang, Changhong; Yin, Yongyuan; Zhang, Qiang; Zhang, Yinping; Zhang, Yong; Xu, Bing; Gong, Peng			The Tsinghua-Lancet Commission on Healthy Cities in China: unlocking the power of cities for a healthy China	LANCET			English	Review							PARTICULATE MATTER POLLUTION; CAUSE-SPECIFIC MORTALITY; PHYSICAL-ACTIVITY; URBAN CHINA; AIR-QUALITY; CARDIOVASCULAR-DISEASE; POPULATION HEALTH; GLOBAL BURDEN; PUBLIC-HEALTH; MENTAL-HEALTH		Tsinghua Univ, Dept Earth Syst Sci, Key Lab Earth Syst Modeling, Minist Educ, Beijing, Peoples R China; Joint Ctr Global Change Studies JCGCS, Beijing, Peoples R China; Tsinghua Univ, Ctr Hlth Cities, Inst China Sustainable Urbanizat, Beijing, Peoples R China; [Siri, Jose G.] United Nations Univ Int, Inst Global Hlth, Kuala Lumpur, Malaysia; [Remais, Justin V.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing, Jiangsu, Peoples R China; Chinese Univ Hong Kong, Fac Med, JC Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; Chinese Acad Med Sci, Canc Hosp, Natl Cent Canc Registry Canc Inst Hosp, Natl Canc Ctr,Natl Off Canc Prevent & Control, Beijing, Peoples R China; [Chen, Wanqing] Peking Union Med Coll, Natl Canc Ctr, Beijing, Peoples R China; Tsinghua Univ, Inst Publ Safety Res, Dept Engn Phys, Beijing, Peoples R China; Fudan Univ, Sch Publ Hlth, Fudan Hlth Commun Inst, Shanghai, Peoples R China; China Natl Engn Res Ctr Human Settlements, Beijing, Peoples R China; Duke Kunshan Univ, Environm Res Ctr, Kunshan, Peoples R China; [Ji, John S.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; Harvard Sch Business, Harvard Ctr Shanghai, Asia Pacific Res Ctr, Boston, MA USA; Univ Twente, Fac Geoinformat Sci & Earth Observat ITC, Dept Earth Observat Sci, Enschede, Netherlands; [Jiang, Xiaopeng] WHO China Country Off, Beijing, Peoples R China; WHO, Geneva, Switzerland; [Kwan, Mei-Po] Univ Illinois, Dept Geog & Geog Informat Sci, Urbana, IL USA; [Kwan, Mei-Po] Univ Utrecht, Dept Human Geog & Spatial Planning, Utrecht, Netherlands; [Li, Tianhong] Univ Calif Davis, Sch Med, UC Davis Comprehens Canc Ctr, Dept Internal Med,Div Hematol & Oncol, Sacramento, CA 95817 USA; [Li, Xiguang] Tsinghua Univ, Sch Journalism & Commun, Beijing, Peoples R China; [Liang, Song] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA; [Liang, Xiaofeng] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Liang, Lu] Univ Arkansas Monticello, Univ Arkansas Div Agr, Arkansas Forest Resources Ctr, Sch Forestry & Nat Resources, Monticello, AR USA; [Liu, Qiyong] Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Lu, Yongmei] Texas State Univ San Marcos, Dept Geog, San Marcos, TX USA; [Ma, Xiulian] Chinese Acad Governance, Beijing, Peoples R China; [Shen, Zhiyong] Baidu Inc, Beijing, Peoples R China; [Shi, Peijun] Beijing Normal Univ, Acad Disaster Reduct & Emergency Management, State Key Lab Earth Surface Proc & Resource Ecol, Beijing, Peoples R China; Tsinghua Univ, Sch Med, Beijing, Peoples R China; Tsinghua Univ, Sch Architecture, Beijing, Peoples R China; [Yang, Changhong] Sichuan Ctr Dis Control & Prevent, Inst Publ Hlth Informat, Chengdu, Sichuan, Peoples R China; [Zhang, Yinping] Tsinghua Univ, Dept Bldg Sci, Beijing Key Lab Indoor Air Qual Evaluat & Control, Beijing, Peoples R China; Natl Hlth & Family Planning Commiss, Bur Dis Prevent & Control, Beijing, Peoples R China	Tsinghua University; Tsinghua University; University of California System; University of California Berkeley; Nanjing University; Chinese University of Hong Kong; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University; Fudan University; Duke Kunshan University; Duke University; Harvard University; University of Twente; World Health Organization; University of Illinois System; University of Illinois Urbana-Champaign; Utrecht University; University of California System; University of California Davis; Tsinghua University; State University System of Florida; University of Florida; Chinese Center for Disease Control & Prevention; University of Arkansas System; University Arkansas Monticello; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Texas State University System; Texas State University San Marcos; Baidu; Beijing Normal University; Tsinghua University; Tsinghua University; Tsinghua University	Xu, B; Gong, P (corresponding author), Tsinghua Univ, Dept Earth Syst Sci, Key Lab Earth Syst Modeling, Minist Educ, Beijing 100084, Peoples R China.	bingxu@tsinghua.edu.cn; penggong@tsinghua.edu.cn	Cheng, Qu/R-1186-2019; Chan, Emily Ying Yang/H-6849-2017; Zhang, Yinping/B-5187-2012; Lu, Yongmei/GXV-4278-2022; Jia, Peng/K-1446-2017; Remais, Justin/V-3207-2019; Yang, Jun/E-2519-2011; Zhang, Qiang/D-9034-2012; Cai, Wenjia/HDL-7837-2022; Ji, John/AAT-4219-2021; Gong, Peng/AAM-1516-2021; Kwan, Mei-Po/S-4162-2016; Yang, Jun/AAH-4967-2021	Cheng, Qu/0000-0003-3074-9218; Zhang, Yinping/0000-0001-9175-7890; Lu, Yongmei/0000-0003-1994-3458; Jia, Peng/0000-0003-0110-3637; Remais, Justin/0000-0002-0223-4615; Yang, Jun/0000-0003-0824-749X; Ji, John/0000-0002-5002-118X; Gong, Peng/0000-0003-1513-3765; Kwan, Mei-Po/0000-0001-8602-9258; Yang, Jun/0000-0003-0824-749X; , Jiansong/0000-0001-6975-620X; Siri, Jose/0000-0001-7041-0310; Shi, Peijun/0000-0002-2968-7331; Su, Jing/0000-0002-5363-0677; Cai, Wenjia/0000-0002-4436-512X	Cyrus Tang Foundation; Cross-strait Tsinghua Research Institute; Ministry of Science and Technology of China [2016YFA0600104, 2014FY121100]; Chinese Scholar Council [201706215005]; China National Engineering Research Center for Human Settlements; National Natural Science Foundation of China [41529101]; University of Illinois Research Board; Hong Kong Polytechnic University [1-ZE24]; National Key Research and Development Program [2016YFA0602404]; Natural Science Foundation of China [51420105010, 51521005]	Cyrus Tang Foundation; Cross-strait Tsinghua Research Institute; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Scholar Council; China National Engineering Research Center for Human Settlements; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Illinois Research Board; Hong Kong Polytechnic University(Hong Kong Polytechnic University); National Key Research and Development Program; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank WHO Beijing Office for arranging and providing meeting spaces. We thank staff from the Department of Earth System Sciences, Tsinghua University for providing logistical support for the first and third commission meetings in Tsinghua University. PG was supported by grants from the Cyrus Tang Foundation and the Cross-strait Tsinghua Research Institute. BX was supported by a grant from the Ministry of Science and Technology of China (2016YFA0600104). JY was supported by a grant from the Chinese Scholar Council (201706215005). JH was supported by research and development funds from the China National Engineering Research Center for Human Settlements. WCh was supported by a grant from the Ministry of Science and Technology of China (2014FY121100). M-PK was supported by a grant from the National Natural Science Foundation of China (41529101), a grant from the University of Illinois Research Board, and Grant 1-ZE24 (Project of Strategic Importance) from the Hong Kong Polytechnic University. PS was supported by the National Key Research and Development Program (2016YFA0602404). KKYC was supported by a grant from the Ministry of Science and Technology of China (2016YFA0600104). NC was supported by Cyrus Tang Foundation. YiZhang was supported by the Natural Science Foundation of China (51420105010 and 51521005). Finally, we thank the Office of National Patriotic Health Campaign Committee of China for their help in organising the survey and the 36 cities for participation.	Alfonzo M, 2014, PREV MED, V69, pS79, DOI 10.1016/j.ypmed.2014.10.002; Anderson G, 2016, J ECONOMETRICS, V191, P348, DOI 10.1016/j.jeconom.2015.12.006; [Anonymous], 2015, CHIN AIDS RESP PROGR; [Anonymous], 1989, GAZETTE ST COUNCIL C, V3; [Anonymous], 2009, EMERGING THEORIES HL; [Anonymous], 2019, CHIN DRUG REP 2018; Bao CZ, 2015, INT J ENV RES PUB HE, V12, P7172, DOI 10.3390/ijerph120707172; Bellos I., 2017, SUSTAINABLE SUPPLY C, P355; Bezold C, 2014, NATL CIV REV, V103, P66; Bi J, 2017, EARTHSCAN RISK SOC, P112; Bircher J, 2014, J PUBLIC HEALTH POL, V35, P363, DOI 10.1057/jphp.2014.19; Bloom DE, 2014, J ECON AGEING, V4, P100, DOI 10.1016/j.jeoa.2014.08.003; Blumenthal D, 2015, NEW ENGL J MED, V372, P1281, DOI 10.1056/NEJMp1410425; Bode AM, 2016, NATL SCI REV, V3, P117, DOI 10.1093/nsr/nwv054; Brixi H, 2013, HEALTH POLICY PLANN, V28, P809, DOI 10.1093/heapol/czs120; Building Healthy Cities (BHC) project, 2019, MAK LEV WORKSH BUILD; Cai BF, 2016, GLOBAL ENVIRON CHANG, V39, P275, DOI 10.1016/j.gloenvcha.2016.05.013; Cai Y, 2010, POPUL DEV REV, V36, P419, DOI 10.1111/j.1728-4457.2010.00341.x; Cao H, 2011, PREV MED, V53, P316, DOI 10.1016/j.ypmed.2011.09.002; Center for Health Statistics and Information, 2016, AN REP NAT HLTH SERV; Center for Opportunity and Equality, 2016, OECD IN UPD 2016 INC; Central Committee of Chinese Communist Party. State Council, 2016, PLAN HLTH CHIN 2030; Central Committee of Chinese Communist Party. State Council, 1997, DEC REF DEV HLTH; Chaskin RJ, 2001, URBAN AFF REV, V36, P291, DOI 10.1177/10780870122184876; Chen G., 2013, INF CHINA CONSTR, V17, P10; Chen J, 2015, INT J ENV RES PUB HE, V12, P9012, DOI 10.3390/ijerph120809012; Chen PJ, 2013, RES Q EXERCISE SPORT, V84, pS1, DOI 10.1080/02701367.2013.851162; Chen QR, 2017, ASIAN POPUL STUD, V13, P172, DOI 10.1080/17441730.2017.1286071; Chen RJ, 2017, AM J RESP CRIT CARE, V196, P73, DOI [10.1164/rccm.201609-1862OC, 10.1164/rccm.201609-1862oc, 10.1164/rccm.201612-2427OC]; Chen TT, 2016, HABITAT INT, V58, P12, DOI 10.1016/j.habitatint.2016.09.001; Chen Wan-qing, 2012, Zhonghua Zhong Liu Za Zhi, V34, P517, DOI 10.3760/cma.j.issn.0253-3766.2012.07.010; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chen WQ, 2015, THORAC CANCER, V6, P209, DOI 10.1111/1759-7714.12169; Chen WY, 2010, ENERG POLICY, V38, P2123, DOI 10.1016/j.enpol.2009.06.003; Chen XY, 2017, J CLEAN PROD, V142, P915, DOI 10.1016/j.jclepro.2016.02.119; Chen Y, 2011, CHIN HLTH RESOUR, V14, P201; Cheng Q, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005701; Cheng Y, 2014, J ADOLESCENT HEALTH, V55, pS31, DOI 10.1016/j.jadohealth.2014.08.020; Cheng Z, 2013, ATMOS ENVIRON, V65, P186, DOI 10.1016/j.atmosenv.2012.10.022; China Internet Network Information Center, 2017, CHIN STAT REP INT DE; Chinese Center for Disease Prevention and Control, 2016, CHIN AD TOB SURV REP; Corburn J., 2017, HLTH CITIES, P31; Dataway, 2016, MARK RES, V3, P10; Day Kristen, 2016, Prev Med Rep, V3, P303, DOI 10.1016/j.pmedr.2016.03.007; de Leeuw E, 2015, HEALTH PROMOT INT, V30, pi18, DOI 10.1093/heapro/dav035; de Leeuw E, 2012, J URBAN HEALTH, V89, P217, DOI 10.1007/s11524-011-9617-y; Deng Y, 2015, J GEOGR SCI, V25, P1507, DOI 10.1007/s11442-015-1248-x; Department for Disease Prevention and Control National Health and Family Planning Commission, 2016, INSTR PROC NAT IMM P; Department of Energy Statistics National Bureau of Statistics, 2015, CHIN EN STAT YB 2014; Department of Health Government of the Hong Kong Special Administrative Region, 2016, HLTH FACTS HONG KONG; Department of Migrant Population National Health and Family Planning Commission of the People's Republic of China, 2017, DEV REP CHIN MIGR PO; Department of Planning and Information National Health and Family Planning Commission, STAT COMM DEV HLTH F; Department of Policy Studies, 2016, ADV HUM RES SOC SEC; Department of Publicity National Health and Family Planning Committee, 2016, CONSTR NAT CHRON DIS; Development Research Center of the State Council & The World Bank, 2014, URB CHIN EFF INCL SU; Ding Bo, 2016, Int J Chron Obstruct Pulmon Dis, V11, P1139, DOI 10.2147/COPD.S103873; Dong GH, 2015, EPIDEMIOLOGY, V26, P740, DOI 10.1097/EDE.0000000000000336; Dong GH, 2014, MATERN CHILD HLTH J, V18, P129, DOI 10.1007/s10995-013-1245-6; Du ZJ, 2014, ENVIRON INT, V73, P33, DOI 10.1016/j.envint.2014.06.014; Duan WL, 2016, NAT HAZARDS, V82, P401, DOI 10.1007/s11069-016-2207-2; Economics Department. OECD, 2013, WHAT FUT HLTH SPEND; Fan JG, 2013, J GASTROEN HEPATOL, V28, P11, DOI 10.1111/jgh.12036; Fang CL, 2017, J GEOGR SCI, V27, P1431, DOI 10.1007/s11442-017-1445-x; Fang CL, 2017, LANDSCAPE URBAN PLAN, V162, P126, DOI 10.1016/j.landurbplan.2017.02.014; Fang LQ, 2009, TROP MED INT HEALTH, V14, P14, DOI 10.1111/j.1365-3156.2008.02189.x; Fang XM, 2014, SOC SCI MED, V102, P33, DOI 10.1016/j.socscimed.2013.11.022; Feng J, 2015, J SOC SIC CHINA, V3, P85; Feng XY, 2014, ADV PARASIT, V86, P81, DOI 10.1016/B978-0-12-800869-0.00004-4; Feng Y, 2014, AMBIO, V43, P687, DOI 10.1007/s13280-013-0436-0; Freudenberg N., 2006, CITIES HLTH PUBLIC, P294; Fu DB, 2003, B WORLD HEALTH ORGAN, V81, P174; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Gan WH, 2013, SCI TOTAL ENVIRON, V447, P108, DOI 10.1016/j.scitotenv.2012.12.091; Gandhi S, 2017, CAN J CARDIOL, V33, P219, DOI 10.1016/j.cjca.2016.08.017; Gao C, 2014, SOC SCI MED, V111, P10, DOI 10.1016/j.socscimed.2014.03.035; Gao X., 2016, GERONTECHNOLOGY, V14, P210, DOI DOI 10.4017/GT.2016.14.4.008.00; Gatzweiler FW, 2017, URB HEALTH WELLBEING, P1, DOI 10.1007/978-981-10-3364-3_1; Gaudreau M, 2015, J ENVIRON DEV, V24, P418, DOI 10.1177/1070496515602044; Giles-Corti B, 2016, LANCET, V388, P2912, DOI 10.1016/S0140-6736(16)30066-6; Goggins WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038551; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; Grant M, 2015, HEALTH PROMOT INT, V30, pi54, DOI 10.1093/heapro/dav033; Gu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065356; Guo K, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0051-3; Guo P, 2012, ANN ONCOL, V23, P2755, DOI 10.1093/annonc/mds069; Gupta S, 2016, EXPERT REV PHARM OUT, V16, P393, DOI 10.1586/14737167.2016.1102062; Han LJ, 2016, ENVIRON POLLUT, V208, P96, DOI 10.1016/j.envpol.2015.08.039; Hancock Trevor, 1993, Journal of Public Health Policy, V14, P5, DOI 10.2307/3342823; He AJ, 2016, APPL HEALTH ECON HEA, V15, P1; He GZ, 2017, SUSTAIN SCI, V12, P187, DOI 10.1007/s11625-016-0403-3; Herd R, 2013, ECON CHANG RESTRUCT, V46, P109, DOI 10.1007/s10644-012-9138-z; Hill S, 2011, KNOWLEDGEABLE PATIEN, P184; Hodgson K., 2011, COMPREHENSIVE PLANNI; Hsu J, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5955; Hu XUJ, 2008, LANCET, V372, P1717, DOI 10.1016/S0140-6736(08)61360-4; Hu Z, 2006, PUBLIC HEALTH, V120, P339, DOI 10.1016/j.puhe.2005.10.016; Huang C, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1426-2; Huang J, 2008, CHIN J HLTH ED, V24, P389; Huang YQ, 2015, URBAN STUD, V52, P2948, DOI 10.1177/0042098014564535; International Energy Agency, 2016, WORLD EN OUTL 2016 E; International Health Conference, 2002, Bull World Health Organ, V80, P983; IPE. NRDC, 2016, ASS POLL INF TRANSP; Ji CY, 2013, BIOMED ENVIRON SCI, V26, P1, DOI 10.3967/0895-3988.2013.01.001; Jia JP, 2014, ALZHEIMERS DEMENT, V10, P1, DOI 10.1016/j.jalz.2013.01.012; Jia P, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040369; Jia ZW, 2013, LANCET, V382, P1195, DOI 10.1016/S0140-6736(12)61898-4; Jiang BG, 2017, LANCET, V390, P1781, DOI 10.1016/S0140-6736(17)31958-X; Jiang QB, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2778-0; Jiang Y, 2015, ENVIRON SCI POLICY, V54, P106, DOI 10.1016/j.envsci.2015.06.006; Kent JL, 2014, J PLAN LIT, V29, P239, DOI 10.1177/0885412214520712; Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559; Kong XY, 2015, J CHIN MED ASSOC, V78, P569, DOI 10.1016/j.jcma.2015.02.006; Kwan MP, 2014, ASIAN GEOGR, V31, P167, DOI 10.1080/10225706.2014.950484; Li BQ, 2016, ENVIRON URBAN, V28, P515, DOI 10.1177/0956247816647345; Li BQ, 2015, ENVIRON URBAN, V27, P285, DOI 10.1177/0956247814565567; Li H, 2014, SPORTS SCI RES, V18, P21; Li JP, 2012, J FOOD AGRIC ENVIRON, V10, P201; Li Juan, 2013, BMC Public Health, V13, P986, DOI 10.1186/1471-2458-13-986; Li L, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2024-9; Li L, 2017, INT J HEALTH PLAN M, V32, P240, DOI 10.1002/hpm.2424; Li Q, 2017, SCI TOTAL ENVIRON, V576, P347, DOI 10.1016/j.scitotenv.2016.10.080; Li SB, 2006, QUAL CIVIL ENG CONST, V7, P29; Li SM, 2014, EURASIAN GEOGR ECON, V55, P307, DOI 10.1080/15387216.2015.1019906; Li TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28161; Li W, 2014, TOP CURR CHEM, V343, P103, DOI 10.1007/128_2013_483; Li XH, 2012, CURR OPIN ENV SUST, V4, P436, DOI 10.1016/j.cosust.2012.09.007; Li YH, 2015, BIOMED ENVIRON SCI, V28, P127, DOI 10.3967/bes2015.015; Li Y, 2012, PROG PLANN, V78, P55, DOI 10.1016/j.progress.2012.03.001; Li YC, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0894-5; [李越 Li Yue], 2016, [中国公共卫生, China Journal of Public Health], V32, P398; Li Yushi, 2010, World Health Popul, V12, P23; Li Z, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0343-7; Lin GZ, 2016, INJURY PREV, V22, P68, DOI 10.1136/injuryprev-2014-041270; Lin V, 2012, CURR SOCIOL, V60, P427, DOI 10.1177/0011392112438329; Liu F, 2015, ATMOS CHEM PHYS, V15, P13299, DOI 10.5194/acp-15-13299-2015; Liu Ming, 2014, Beijing Da Xue Xue Bao Yi Xue Ban, V46, P782; Liu SW, 2016, B WORLD HEALTH ORGAN, V94, P46, DOI 10.2471/BLT.15.153148; Liu XJ, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090845; Liu YZ, 2010, AUSTRALAS MED J, V3, P375, DOI 10.4066/AMJ.2010.310; Liu Y, 2013, SEX HEALTH, V10, P282, DOI 10.1071/SH12181; Liu YT, 2008, J URBAN AFF, V30, P21, DOI 10.1111/j.1467-9906.2007.00372.x; Liu YT, 2010, HABITAT INT, V34, P135, DOI 10.1016/j.habitatint.2009.08.003; Luo X., 2009, HUANGDI NEIJING; Mackintosh M, 2016, LANCET, V388, P596, DOI 10.1016/S0140-6736(16)00342-1; Mangili A, 2005, LANCET, V365, P989, DOI 10.1016/S0140-6736(05)71089-8; McCollum R, 2014, INT J HEALTH PLAN M, V29, pE107, DOI 10.1002/hpm.2165; Meng Q., 2014, REPORT COMPREHENSIVE; Meng QY, 2015, LANCET, V386, P1484, DOI 10.1016/S0140-6736(15)00342-6; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Ministry of Civil Affairs, 2015, CHIN CIV AFF STAT YB; Ministry of Environmental Protection, 2015, ACT PLAN WAT POLL CO; Ministry of Environmental Protection, 2017, 2016 REP STAT ENV CH; Ministry of Health, 2003, CHIN HLTH STAT YB 20; Ministry of Housing and Urban Rural Development of China, 2016, 2015 REP STAT URB RU; Ministry of Housing and Urban- Rural Development, 2016, CHIN URB CONSTR STAT; Ministry of Human Resources and Social Security, 2006, ANN STAT B HUM RES S; Ministry of Human Resources and Social Security, 2017, ANN STAT B HUM RES S; Mover.io, 2017, MOV CLOUD FILE MIGR; Muldavin J, 2015, DEV CHANGE, V46, P993, DOI 10.1111/dech.12178; Muntner P, 2005, AM J PUBLIC HEALTH, V95, P1631, DOI 10.2105/AJPH.2004.044743; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; National Bureau of Statistics, 2016, CENS DAT; National Bureau of Statistics, 2015, CHIN STAT YB 2015; National Bureau of Statistics, 2016, STAT DAT; National Bureau of Statistics, 2008, STAT METH DEFINING U; National Bureau of Statistics, 2016, STAT CONV MIGR WORK; National Bureau of Statistics, 2003, CHIN STAT YB ENV 200; National Bureau of Statistics, 2015, CHIN SOC STAT YB 201; National Center for Cardiovascular Diseases, 2015, REP CARD DIS CHIN 20; National Commission for Population Aging of China, 2015, 4 SURV REP LIV STAT; National Development and Reform Commission; the Ministry of Housing and Urban- Rural Development, 2017, NOT PIL PROJ BUILD C; National Development and Reform Commission; the Ministry of Housing and Urban- Rural Development, 2016, ACT PLAN URB AD CLIM; National Health and Family Planning Commission, 2016, CHIN STAT YB HLTH FA; National Health and Family Planning Commission, 2014, CHIN STAT YB HLTH FA; National Health and Family Planning Commission of China, 2015, CHIN STAT YB HLTH FA; National Health and Family Planning Commission of the People's Republic of China, 2015, CAPITAL J PUBLIC HLT, V9, P97; National Healthy and Family Planning Commission, 2011, CHIN STAT YB HLTH FA; National Patriotic Health Campaign Committee, 2016, GUID REG DEV HLTH CI; Nie Xueqiong, 2014, Zhonghua Yu Fang Yi Xue Za Zhi, V48, P566; Nutbeam D, 2015, HEALTH PROMOT INT, V30, P270, DOI 10.1093/heapro/dat037; Office of China National Narcotics Control Commission, 1999, ANN REP DRUG CONTR C; Pal A, 2014, ENVIRON INT, V71, P46, DOI 10.1016/j.envint.2014.05.025; Pan CY, 2010, INT J GEN MED, V3, P173; Peng HJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-83; Peng ZQ, 2012, INT J INFECT DIS, V16, pE99, DOI 10.1016/j.ijid.2011.09.023; Peters M, 2015, J GEOCHEM EXPLOR, V157, P36, DOI 10.1016/j.gexplo.2015.05.013; Plochg T, 2013, EUR J PUBLIC HEALTH, V23, P939, DOI 10.1093/eurpub/ckt038; Policy and Economics Research Institute China Academy of Information and Communications Technology, 2018, REP SOC IMP BIK SHAR; Qian DF, 2010, HEALTH POLICY, V98, P227, DOI 10.1016/j.healthpol.2010.06.014; Qin B, 2014, CHINA ECON REV, V30, P495, DOI 10.1016/j.chieco.2014.07.008; Qin D.H., 2015, CHINA NATL ASSESSMEN; Quelch JA, 2016, NEW IMPERATIVE BUSIN, P1; Raeburn J, 2006, HEALTH PROMOT INT, V21, P84, DOI 10.1093/heapro/dal055; Ramaswami A, 2016, SCIENCE, V352, P940, DOI 10.1126/science.aaf7160; Ramesh M, 2014, HEALTH POLICY PLANN, V29, P663, DOI 10.1093/heapol/czs109; Ronald JV, 2017, ATMOS CHEM PHYS, V17, P1775, DOI 10.5194/acp-17-1775-2017; Rosenberg P., 2016, GLOBAL REPORT URBAN; Rydin Y, 2012, LANCET, V379, P2079, DOI 10.1016/S0140-6736(12)60435-8; Salat S, 2011, CITIES FORMS SUSTAIN; Sallis JF, 2016, LANCET, V388, P2936, DOI 10.1016/S0140-6736(16)30068-X; Satterthwaite D, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7979; Schroeder PM, 2014, SUSTAIN CITIES SOC, V11, P31, DOI 10.1016/j.scs.2013.11.007; SCPRC (State Council of the People's Republic of China), 2014, GUOJIA XINXING CHENG; Sha Li, 2015, Zhonghua Jie He He Hu Xi Za Zhi, V38, P664; Shi P, 2015, WORLD ATLAS NATURAL; Shi SS, 2017, ENVIRON POLLUT, V220, P337, DOI 10.1016/j.envpol.2016.09.069; Shi Y, 2015, OPEN CYBERNETICS SYS, V9, P2847; Shum MHY, 2015, J AM MED DIR ASSOC, V16, P784, DOI 10.1016/j.jamda.2015.04.010; Song QB, 2015, DIABETES VASC DIS RE, V12, P189, DOI 10.1177/1479164114562410; Song XQ, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060535; State Council, 2015, MAD IN CHIN 2025; State Council, 2013, AIR POLL PREV CONTR; State Council, 2015, OP STAT COUNC FURTH; Stevenson M, 2016, LANCET, V388, P2925, DOI 10.1016/S0140-6736(16)30067-8; Suk JE, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25287; Sun LL, 2016, LAND USE POLICY, V58, P208, DOI 10.1016/j.landusepol.2016.07.025; [孙霞 SUN Xia], 2009, [中国心理卫生杂志, Chinese Mental Health Journal], V23, P729; Szreter S, 1997, POPUL DEV REV, V23, P693, DOI 10.2307/2137377; Szreter S, 2003, AM J PUBLIC HEALTH, V93, P421, DOI 10.2105/AJPH.93.3.421; Tang DL, 2014, ENVIRON INT, V73, P235, DOI 10.1016/j.envint.2014.07.016; Tang Q, 2016, SHANGHAI J PREV MED, V28, P7; Tang YL, 2013, B WORLD HEALTH ORGAN, V91, P270, DOI 10.2471/BLT.12.107318; Teng HY, 2015, ASIA-PAC J PUBLIC HE, V27, p61S, DOI 10.1177/1010539515571579; ThinkTank Research Center for Health Development, 2017, TOB CONTR CHIN 2017; Thresia CU, 2013, INT J HEALTH SERV, V43, P31, DOI 10.2190/HS.43.1.c; Tobe RG, 2011, BIOSCI TRENDS, V5, P226, DOI 10.5582/bst.2011.v5.6.226; Tong YD, 2016, ENVIRON RES, V149, P57, DOI 10.1016/j.envres.2016.05.009; Tozan Y, 2015, J URBAN HEALTH, V92, P490, DOI 10.1007/s11524-015-9963-2; Tsouros AD, 2017, HLTH CITIES THEORY P, P489; Tu W, 2006, ENVIRON MANAGE, V37, P307, DOI 10.1007/s00267-003-0155-6; United Nations, 2015, TRANSF OUR WORLD 203; Urban Data Lab, 2017, 2017 WHIT PAP BIK SH; van der Kamp D, 2017, WORLD DEV, V95, P164, DOI 10.1016/j.worlddev.2017.02.021; Verstraeten WW, 2015, NAT GEOSCI, V8, P690, DOI 10.1038/NGEO2493; Vlahov D, 2004, ACAD MED, V79, P1133, DOI 10.1097/00001888-200412000-00003; Wan LY, 2007, B WORLD HEALTH ORGAN, V85, P401, DOI 10.2471/BLT.06.036376; Wang BH, 2015, ONCOLOGIST, V20, P627, DOI 10.1634/theoncologist.2014-0303; Wang Chun-Chuan, 2010, Hu Li Za Zhi, V57, P10; Wang G., 2016, POPUL EC, V5, P1, DOI DOI 10.3969/J.ISSN.1000-4149.2016.05.001; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wang HHX, 2015, BRIT MED BULL, V116, P139, DOI 10.1093/bmb/ldv043; Wang HL, 2016, J ECON INEQUAL, V14, P41, DOI 10.1007/s10888-015-9315-1; Wang HF, 2011, HEALTH POLICY, V99, P37, DOI 10.1016/j.healthpol.2010.07.003; Wang JD, 2017, SCI TOTAL ENVIRON, V584, P426, DOI 10.1016/j.scitotenv.2017.01.027; Wang J, 2012, CLIMATIC CHANGE, V115, P537, DOI 10.1007/s10584-012-0468-7; Wang L, 2016, REPORT CHRONIC DIS R; Wang L, 2012, CHINESE SCI BULL, V57, P2802, DOI 10.1007/s11434-012-5235-7; Wang LM, 2017, JAMA-J AM MED ASSOC, V317, P2515, DOI 10.1001/jama.2017.7596; Wang LX, 2010, CHINESE SCI BULL, V55, P1469, DOI 10.1007/s11434-010-3094-7; Wang Q, 2016, RENEW SUST ENERG REV, V58, P341, DOI 10.1016/j.rser.2015.12.104; Wang SX, 2014, J ENVIRON SCI, V26, P13, DOI 10.1016/S1001-0742(13)60381-2; Wang T, 2012, REPORT CHRONIC DIS R; Wang Y., 2012, HLTH ED CONTEXT INT, P253; Wang Y, 2016, NATL DIS SURVEILANCE; Wang Y, 2016, ANN REPORT HLTH CITY; Watson B, 1996, BASIC WRITINGS; Watts N, 2015, LANCET, V386, P1861, DOI 10.1016/S0140-6736(15)60854-6; Weng WG, 2015, SIMUL-T SOC MOD SIM, V91, P407, DOI 10.1177/0037549715581637; Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1; Wong Tai-Chee, 2015, POPULATION MOBILITY; World Bank, 2013, CHINA 2030: BUILDING A MODERN, HARMONIOUS, AND CREATIVE SOCIETY, P1, DOI 10.1596/978-0-8213-9545-5; World Bank, 2016, OUT OF POCK HLTH EXP; World Bank, 2017, HLTH EXP; World Health Organization, 2016, AMBIENT AIR POLLUTIO, DOI 10.17159/2410-972X/2016/v26n2a4; World Health Organization, 2011, GUID DRINK WAT QUAL, V1, DOI DOI 10.1016/S1462-0758(00)00006-6; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, 1998, HLTH PROM GLOSS; Worldwatch Institute, 2006, STAT WORLD 2007 OUR; Wu F, 2016, INT J URBAN REGIONAL, V40, P1134, DOI 10.1111/1468-2427.12437; Wu M., 2008, CHIN J HLTH POL, V1, P54; Wu XM, 2016, ENVIRON POLLUT, V214, P556, DOI 10.1016/j.envpol.2016.04.042; Wu YF, 2016, CIRCULATION, V133, P2545, DOI 10.1161/CIRCULATIONAHA.115.008728; Xia Y, 2016, ATMOS ENVIRON, V139, P147, DOI 10.1016/j.atmosenv.2016.05.036; Xiao HJ, 2013, NAT HAZARDS, V67, P611, DOI 10.1007/s11069-013-0592-3; Xie B, 2016, J MAPS, V12, P181, DOI 10.1080/17445647.2014.1000984; Xie E, 2011, FRONT ECON CHINA, V6, P131, DOI 10.1007/s11459-011-0125-5; Xie Y, 2015, CHINA ECON J, V8, P235, DOI 10.1080/17538963.2015.1108118; Xin XX, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0454-7; Xiong WY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-704; Xu JF, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0839-0; [徐伟 Xu Wei], 2004, [自然灾害学报, Journal of Natural Disasters], V13, P9; Xu YH, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-016-0964-4; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yan CH, 2013, ENVIRON HEALTH PERSP, V121, pA294, DOI 10.1289/ehp.1307558; Yan F, 2016, CHIN J CONT NEUROL N, V16, P235; Yang G, 2015, STAT RES, V32, P95; YANG JF, 2016, NAT ENVIRON POLLUT T, V15, P51; Yang TZ, 2016, EUR J PUBLIC HEALTH, V26, P513, DOI 10.1093/eurpub/ckv193; Yang ZS, 2017, J TRANSP GEOGR, V58, P127, DOI 10.1016/j.jtrangeo.2016.11.015; Yi LX, 2012, NAT HAZARDS, V60, P295, DOI 10.1007/s11069-011-0011-6; Yu H, 2012, CHIN J HLTH POLICY, V5, P30; Yu WH, 2016, SOC INDIC RES, V129, P1349, DOI 10.1007/s11205-015-1166-4; Yue DH, 2017, J URBAN HEALTH, V94, P149, DOI 10.1007/s11524-016-0106-1; Zang JJ, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0364-z; Zeng Y, 2016, LANCET, V388, P1930, DOI 10.1016/S0140-6736(16)31405-2; Zhai FY, 2014, OBES REV, V15, P16, DOI 10.1111/obr.12124; Zhang HB, 2016, SOC SCI CHINA, V37, P77, DOI 10.1080/02529203.2016.1162010; Zhang J, 2016, POPUL RES, V40, P38; Zhang L, 2016, CHIN J PUBLIC HLTH M, V32, P150; Zhang L, 2016, CURR OPIN ENV SUST, V18, P17, DOI 10.1016/j.cosust.2015.03.009; Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7; Zhang LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085319; Zhang N, 2016, CHINA HLTH IND, V21, P58; Zhang Q, 2009, ATMOS CHEM PHYS, V9, P5131, DOI 10.5194/acp-9-5131-2009; Zhang TX, 2016, PSYCHOL REP, V118, P737, DOI 10.1177/0033294116646160; Zhang X, 2013, J GEOGR SCI, V24, P46; Zhang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124995; Zhang Y, 2015, OPEN HOUSE INT, V40, P12; Zhang YP, 2013, ENVIRON HEALTH PERSP, V121, P751, DOI 10.1289/ehp.1205983; Zhang YM, 2011, ENVIRON URBAN, V23, P41, DOI 10.1177/0956247810396987; Zhao JY, 2012, B WORLD HEALTH ORGAN, V90, P461, DOI 10.2471/BLT.11.093849; Zhao PJ, 2010, INT DEV PLANN REV, V32, P363, DOI 10.3828/idpr.2010.13; Zheng B, 2015, APPL ENERG, V156, P230, DOI 10.1016/j.apenergy.2015.07.018; Zheng SQ, 2014, REG SCI URBAN ECON, V47, P61, DOI 10.1016/j.regsciurbeco.2013.09.003; Zhong BL, 2017, EPIDEMIOL PSYCHIAT S, P1; Zhongdan C, 2008, EVAL PROGRAM PLANN, V31, P10, DOI 10.1016/j.evalprogplan.2007.09.001; Zhou M, 2000, J ENV HLTH, V17, P377; Zhou MG, 2016, LANCET, V387, P251, DOI 10.1016/S0140-6736(15)00551-6; Zhou NQ, 2013, NAT HAZARDS, V67, P797, DOI 10.1007/s11069-013-0606-1; Zhou Q., 2017, J GUANGZHOU CITY POL, V11, P27; Zhou Q, 2017, SOC INDIC RES, V132, P1307, DOI 10.1007/s11205-016-1330-5; Zhou SH, 2015, HABITAT INT, V49, P177, DOI 10.1016/j.habitatint.2015.05.022; Zhou SH, 2015, CITIES, V45, P81, DOI 10.1016/j.cities.2015.03.002; Zhou ZL, 2017, SOC INDIC RES, V132, P241, DOI 10.1007/s11205-015-1221-1; Zhou ZL, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-23; [朱党生 Zhu Dangsheng], 2010, [水利学报, Journal of Hydraulic Engineering], V41, P914; Zhu YG, 2011, ENVIRON SCI TECHNOL, V45, P5099, DOI 10.1021/es2004254; Zipser D., 2016, MODERNIZATION CHINES; 阮师漫, 2014, [环境与健康杂志, Journal of Environment and Health], V31, P829; 罗勇, 2011, [中国公共卫生, China Public Health], V27, P1229	330	102	107	31	245	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2018	391	10135					2140	2184		10.1016/S0140-6736(18)30486-0	http://dx.doi.org/10.1016/S0140-6736(18)30486-0			45	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GH2UJ	29678340	Bronze, Green Published			2022-12-28	WOS:000433257200029
J	Gupta, R; Somyajit, K; Narita, T; Maskey, E; Stanlie, A; Kremer, M; Typas, D; Lammers, M; Mailand, N; Nussenzweig, A; Lukas, J; Choudhary, C				Gupta, Rajat; Somyajit, Kumar; Narita, Takeo; Maskey, Elina; Stanlie, Andre; Kremer, Magdalena; Typas, Dimitris; Lammers, Michael; Mailand, Niels; Nussenzweig, Andre; Lukas, Jiri; Choudhary, Chunaram			DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity	CELL			English	Article							DAMAGE-RESPONSE; 53BP1; BRCA1; CELLS; RESECTION; SWITCH; REPLICATION; ANNOTATION; TELOMERES; PATHWAYS	Repair of damaged DNA is essential for maintaining genome integrity and for preventing genome-instability-associated diseases, such as cancer. By combining proximity labeling with quantitative mass spectrometry, we generated high-resolution interaction neighborhood maps of the endogenously expressed DNA repair factors 53BP1, BRCA1, and MDC1. Our spatially resolved interaction maps reveal rich network intricacies, identify shared and bait-specific interaction modules, and implicate previously concealed regulators in this process. We identified a novel vertebrate-specific protein complex, shieldin, comprising REV7 plus three previously uncharacterized proteins, RINN1 (CTC-534A2.2), RINN2 (FAM35A), and RINN3 (C20ORF196). Recruitment of shieldin to DSBs, via the ATM-RNF8-RNF168-53BP1-RIF1 axis, promotes NHEJ-dependent repair of intrachromosomal breaks, immunoglobulin class-switch recombination (CSR), and fusion of unprotected telomeres. Shieldin functions as a downstream effector of 53BP1-RIF1 in restraining DNA end resection and in sensitizing BRCA1-deficient cells to PARP inhibitors. These findings have implications for understanding cancer-associated PARPi resistance and the evolution of antibody CSR in higher vertebrates.	[Gupta, Rajat; Narita, Takeo; Maskey, Elina; Choudhary, Chunaram] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, Prote Program, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark; [Somyajit, Kumar; Typas, Dimitris; Mailand, Niels; Lukas, Jiri] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, Prot Signaling Program, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark; [Stanlie, Andre; Nussenzweig, Andre] NIH, Lab Genome Integr, Bethesda, MD 20892 USA; [Kremer, Magdalena; Lammers, Michael] Univ Cologne, Inst Genet & Cologne Excellence Cluster Cellular, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Lammers, Michael] Ernst Moritz Arndt Univ Greifswald, Inst Biochem Synthet & Struct Biochem, Felix Hausdorff Str 4, D-17487 Greifswald, Germany; [Choudhary, Chunaram] Univ Copenhagen, Fac Hlth & Med Sci, CCS, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; National Institutes of Health (NIH) - USA; University of Cologne; Ernst Moritz Arndt Universitat Greifswald; University of Copenhagen	Choudhary, C (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, Prote Program, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.; Choudhary, C (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, CCS, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	chuna.choudhary@cpr.ku.dk	Lammers, Michael/AAX-1164-2020; choudhary, chunaram/ABE-6634-2020	choudhary, chunaram/0000-0002-9863-433X; Lammers, Michael/0000-0003-4168-4640; Somyajit, Kumar/0000-0003-2496-7155; gupta, rajat/0000-0002-9743-1995; Typas, Dimitris/0000-0002-8737-1319; Narita, Takeo/0000-0002-2705-7838	EMBO long-term postdoctoral fellowship [ALTF271-2014]; Human Frontier Science Foundation long-term fellowship [LT000129/2015]; Hallas Moller Investigator Fellowship from the Novo Nordisk Foundation [NNF14OC0008541]; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [648039]; Heisenberg Fellowship of the German Research Foundation (Deutsche Forschungsgemeinschaft [DFG]) [LA 2984/3-1]; Cologne Graduate School of Ageing Research (CGA); Intramural Research Program of the NIH; Ellison Medical Foundation Senior Scholar in Aging Award; Department of Defense Idea Expansion and Breakthrough Awards; Alex Lemonade Stand Foundation Award; Danish National Research Foundation [DNRF 115]; Novo Nordisk Foundation [NNF14CC0001]; NATIONAL CANCER INSTITUTE [ZIABC010959] Funding Source: NIH RePORTER	EMBO long-term postdoctoral fellowship(European Molecular Biology Organization (EMBO)); Human Frontier Science Foundation long-term fellowship; Hallas Moller Investigator Fellowship from the Novo Nordisk Foundation; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC)); Heisenberg Fellowship of the German Research Foundation (Deutsche Forschungsgemeinschaft [DFG])(German Research Foundation (DFG)); Cologne Graduate School of Ageing Research (CGA); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation Senior Scholar in Aging Award(Lawrence Ellison Foundation); Department of Defense Idea Expansion and Breakthrough Awards; Alex Lemonade Stand Foundation Award; Danish National Research Foundation(Danmarks Grundforskningsfond); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the members of our laboratories for their help and useful discussions. We thank Rebeca Soria Romero for her excellent technical assistance. R.G. is supported by the EMBO long-term postdoctoral fellowship (ALTF271-2014). A.S. is supported by Human Frontier Science Foundation long-term fellowship (LT000129/2015). C.C. is supported by the Hallas Moller Investigator Fellowship from the Novo Nordisk Foundation (NNF14OC0008541). This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement 648039). M.L. is supported by Heisenberg Fellowship of the German Research Foundation (Deutsche Forschungsgemeinschaft [DFG; LA 2984/3-1]). M.K. is funded by the Cologne Graduate School of Ageing Research (CGA). The A.N. laboratory is supported by the Intramural Research Program of the NIH, an Ellison Medical Foundation Senior Scholar in Aging Award, the Department of Defense Idea Expansion and Breakthrough Awards, and the Alex Lemonade Stand Foundation Award. We thank Jacqueline Jacobs and Titia de Lange for providing the TRF2ts MEF cell line and Ozgun Ozer from the Ian D. Hickson laboratory for her helpful discussions on the telomere FISH analysis. We thank the CPR Mass Spectrometry Platform and the CPR Protein Imaging Platform for their technical assistance. The Center for Chromosome Stability is supported by the Danish National Research Foundation (DNRF 115). The Novo Nordisk Foundation Center for Protein Research is supported financially by the Novo Nordisk Foundation (NNF14CC0001).	Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Boersma V, 2015, NATURE, V521, P537, DOI 10.1038/nature14216; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Chatr-aryamontri A, 2017, NUCLEIC ACIDS RES, V45, pD369, DOI 10.1093/nar/gkw1102; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Chen LY, 2012, NATURE, V488, P540, DOI 10.1038/nature11269; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Conomos D, 2014, NAT STRUCT MOL BIOL, V21, P760, DOI 10.1038/nsmb.2877; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Di Paolo A, 2014, FASEB J, V28, P5250, DOI 10.1096/fj.14-250266; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Flynn RL, 2011, NATURE, V471, P532, DOI 10.1038/nature09772; Gaillard H, 2016, ANNU REV BIOCHEM, V85, P291, DOI 10.1146/annurev-biochem-060815-014908; Hara K, 2009, ACTA CRYSTALLOGR F, V65, P1302, DOI 10.1107/S1744309109046181; Hothorn T, 2008, J STAT SOFTW, V28, P1; Hustedt N, 2017, NAT CELL BIOL, V19, P1, DOI 10.1038/ncb3452; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kappei D, 2013, EMBO J, V32, P1681, DOI 10.1038/emboj.2013.105; Konishi A, 2008, GENE DEV, V22, P1221, DOI 10.1101/gad.1634008; Kumar S, 2017, MOL BIOL EVOL, V34, P1812, DOI 10.1093/molbev/msx116; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li JSZ, 2017, SCIENCE, V355, P638, DOI 10.1126/science.aah6752; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lord CJ, 2017, SCIENCE, V355, P1152, DOI 10.1126/science.aam7344; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; Ochs F, 2016, NAT STRUCT MOL BIOL, V23, P714, DOI 10.1038/nsmb.3251; Pageau GJ, 2006, J CELL BIOL, V175, P693, DOI 10.1083/jcb.200602055; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Raschle M, 2015, SCIENCE, V348, DOI 10.1126/science.1253671; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Savage KI, 2015, FEBS J, V282, P630, DOI 10.1111/febs.13150; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sonnhammer ELL, 2015, NUCLEIC ACIDS RES, V43, pD234, DOI 10.1093/nar/gku1203; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; The UniProt Consortium, 2017, NUCLEIC ACIDS RES, V46, P2699; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, P11033, DOI 10.1093/nar/gkw880; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu P, 2012, CELL, V150, P39, DOI 10.1016/j.cell.2012.05.026; Wyatt HDM, 2017, MOL CELL, V65, P848, DOI 10.1016/j.molcel.2017.01.031; Xu GT, 2015, NATURE, V521, P541, DOI 10.1038/nature14328; Zhu C, 2012, CURR BIOL, V22, P872, DOI 10.1016/j.cub.2012.03.060	54	220	229	3	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 3	2018	173	4					972	+		10.1016/j.cell.2018.03.050	http://dx.doi.org/10.1016/j.cell.2018.03.050			40	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GG1TU	29656893	Bronze, Green Accepted			2022-12-28	WOS:000432471100018
J	Rosenberg, M				Rosenberg, Martha			FDA discounted potential risks when approving continuous glucose monitoring device, expert claims	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Kaufman F, PATIENTS COVERED MED; Shapiro AR, 2017, JAMA-J AM MED ASSOC, V318, P1541, DOI 10.1001/jama.2017.12075; Shapiro Alan R, 2017, J Diabetes Sci Technol, V11, P833, DOI 10.1177/1932296816688303; Tucker M., 2017, MEDICARE SPELLS OUT; US Food and Drug Administration, 2016, FDA EXP IND CONT GLU; US Food and Drug Administration, CTR DEV RAD HLTH MED	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2018	361								k1775	10.1136/bmj.k1775	http://dx.doi.org/10.1136/bmj.k1775			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF4VW	29685896				2022-12-28	WOS:000431962900007
J	Silver, RM; Branch, DW				Silver, Robert M.; Branch, D. Ware			Placenta Accreta Spectrum	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MORBIDLY ADHERENT PLACENTA; CONSERVATIVE TREATMENT; BALLOON CATHETERS; RISK-FACTORS; WOMEN; DIAGNOSIS; HYSTERECTOMY; SONOGRAPHY; PERCRETA; OUTCOMES	A 36-year-old woman with three previous cesarean deliveries is referred at 28 weeks of gestation because of placenta previa detected on ultrasonography. Other ultrasonographic findings include multiple intraplacental lacunae and loss of the normal retroplacental hypoechoic zone in the area underlying the dome of the maternal bladder. Placenta accreta is suspected. The course of the patient's pregnancy otherwise has been normal. How should she be counseled and her care be managed?	[Silver, Robert M.; Branch, D. Ware] Univ Utah, Hlth Sci Ctr, Dept Obstet & Gynecol, 30 N 1900 East,Rm 2B200 SOM, Salt Lake City, UT 84132 USA; [Branch, D. Ware] Intermt Healthcare, Women & Newborns Clin Program, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center	Silver, RM (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Obstet & Gynecol, 30 N 1900 East,Rm 2B200 SOM, Salt Lake City, UT 84132 USA.	bob.silver@hsc.utah.edu			Gestavision	Gestavision	Dr. Silver reports receiving consulting fees from Gestavision. No other potential conflict of interest relevant to this article was reported.	American College of Obstetricians and Gynecologists, 2006, Obstet Gynecol, V108, P1039; Bailit JL, 2015, OBSTET GYNECOL, V125, P683, DOI 10.1097/AOG.0000000000000680; Balcacer P, 2016, J ULTRAS MED, V35, P1445, DOI 10.7863/ultra.15.07040; Baldwin HJ, 2018, OBSTET GYNECOL, V131, P227, DOI 10.1097/AOG.0000000000002434; Ballas J, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.007; Belfort MA, 2010, AM J OBSTET GYNECOL, V203, P430, DOI 10.1016/j.ajog.2010.09.013; Berkley EM, 2013, J ULTRAS MED, V32, P1345, DOI 10.7863/ultra.32.8.1345; Bishop S, 2011, INT J OBSTET ANESTH, V20, P70, DOI 10.1016/j.ijoa.2010.09.012; Blanchette H, 2011, OBSTET GYNECOL, V118, P687, DOI 10.1097/AOG.0b013e318227b8d9; Bodner LJ, 2006, CARDIOVASC INTER RAD, V29, P354, DOI 10.1007/s00270-005-0023-2; Bowman ZS, 2014, J ULTRAS MED, V33, P2153, DOI 10.7863/ultra.33.12.2153; Bowman ZS, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.029; Bowman ZS, 2014, AM J PERINAT, V31, P799, DOI 10.1055/s-0033-1361833; Burke WM, 2017, PLACENTA ACCRETA SYN, P71; Cali G, 2014, EUR J OBSTET GYN R B, V179, P36, DOI 10.1016/j.ejogrb.2014.05.007; Chandraharan E, 2012, INT J GYNECOL OBSTET, V117, P191, DOI 10.1016/j.ijgo.2011.12.005; Chen LM, 2017, J MINIM INVAS GYN, V24, P299, DOI 10.1016/j.jmig.2016.10.018; Comstock CH, 2014, BJOG-INT J OBSTET GY, V121, P171, DOI 10.1111/1471-0528.12557; D'Antonio F, 2014, ULTRASOUND OBST GYN, V44, P8, DOI 10.1002/uog.13327; Eller AG, 2009, BJOG-INT J OBSTET GY, V116, P648, DOI 10.1111/j.1471-0528.2008.02037.x; Eller AG, 2011, OBSTET GYNECOL, V117, P331, DOI 10.1097/AOG.0b013e3182051db2; Ersoy AO, 2016, J MATERN-FETAL NEO M, V29, P4020, DOI 10.3109/14767058.2016.1152576; Fitzpatrick KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052893; Gyamfi-Bannerman C, 2016, NEW ENGL J MED, V374, P1311, DOI 10.1056/NEJMoa1516783; Hare A A, 2005, J Obstet Gynaecol, V25, P108; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Jaraquemada JMP, 2004, ACTA OBSTET GYN SCAN, V83, P738, DOI 10.1080/j.0001-6349.2004.00517.x; Kuczkowski KM, 2011, CURR OPIN OBSTET GYN, V23, P401, DOI 10.1097/GCO.0b013e32834cb779; Lee PS, 2008, OBSTET GYNECOL, V112, P421, DOI 10.1097/AOG.0b013e31817e7966; Lee Paula S, 2017, Gynecol Oncol Res Pract, V4, P11, DOI 10.1186/s40661-017-0049-6; Lyell DJ, 2015, J PERINATOL, V35, P570, DOI 10.1038/jp.2015.40; Main EK, 2015, OBSTET GYNECOL, V126, P155, DOI 10.1097/AOG.0000000000000869; Miller DA, 1997, AM J OBSTET GYNECOL, V177, P210, DOI 10.1016/S0002-9378(97)70463-0; Pather S, 2014, AUST NZ J OBSTET GYN, V54, P84, DOI 10.1111/ajo.12149; READ JA, 1980, OBSTET GYNECOL, V56, P31; Riteau AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094866; Robinson BK, 2010, OBSTET GYNECOL, V116, P835, DOI 10.1097/AOG.0b013e3181f3588d; Salim R, 2015, OBSTET GYNECOL, V126, P1022, DOI 10.1097/AOG.0000000000001113; Sentilhes L, 2010, OBSTET GYNECOL, V115, P526, DOI 10.1097/AOG.0b013e3181d066d4; Sentilhes L, 2010, HUM REPROD, V25, P2803, DOI 10.1093/humrep/deq239; Shakur H, 2017, LANCET, V389, P2105, DOI 10.1016/S0140-6736(17)30638-4; Shamshirsaz AA, 2018, OBSTET GYNECOL, V131, P234, DOI 10.1097/AOG.0000000000002442; Shamshirsaz AA, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.08.019; Shellhaas CS, 2009, OBSTET GYNECOL, V114, P224, DOI 10.1097/AOG.0b013e3181ad9442; Shrivastava V, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.08.001; Silver RM, 2006, OBSTET GYNECOL, V107, P1226, DOI 10.1097/01.AOG.0000219750.79480.84; Silver RM, 2015, AM J OBSTET GYNECOL, V212, P561, DOI 10.1016/j.ajog.2014.11.018; Warshak CR, 2010, OBSTET GYNECOL, V115, P65, DOI 10.1097/AOG.0b013e3181c4f12a; Wright JD, 2010, OBSTET GYNECOL, V115, P1194, DOI 10.1097/AOG.0b013e3181df94e8; Wu S, 2005, AM J OBSTET GYNECOL, V192, P1458, DOI 10.1016/j.ajog.2004.12.074	50	164	175	11	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2018	378	16					1529	1536		10.1056/NEJMcp1709324	http://dx.doi.org/10.1056/NEJMcp1709324			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD2EI	29669225				2022-12-28	WOS:000430312500008
J	Hemingway, JD; Hilton, RG; Hovius, N; Eglinton, TI; Haghipour, N; Wacker, L; Chen, MC; Galy, VV				Hemingway, Jordon D.; Hilton, Robert G.; Hovius, Niels; Eglinton, Timothy I.; Haghipour, Negar; Wacker, Lukas; Chen, Meng-Chiang; Galy, Valier V.			Microbial oxidation of lithospheric organic carbon in rapidly eroding tropical mountain soils	SCIENCE			English	Article							CYCLE; TAIWAN; RIVERS; TRANSPORT; EROSION; BIOMASS; BELT; CO2	Lithospheric organic carbon ("petrogenic"; OCpetro) is oxidized during exhumation and subsequent erosion of mountain ranges. This process is a considerable source of carbon dioxide (CO2) to the atmosphere over geologic time scales, but the mechanisms that govern oxidation rates in mountain landscapes are poorly constrained. We demonstrate that, on average, 67 +/- 11% of the OCpetro initially present in bedrock exhumed from the tropical, rapidly eroding Central Range of Taiwan is oxidized in soils, leading to CO2 emissions of 6.1 to 18.6 metric tons of carbon per square kilometer per year. The molecular and isotopic evolution of bulk OC and lipid biomarkers during soil formation reveals that OCpetro remineralization is microbially mediated. Rapid oxidation in mountain soils drives CO2 emission fluxes that increase with erosion rate, thereby counteracting CO2 drawdown by silicate weathering and biospheric OC burial.	[Hemingway, Jordon D.; Galy, Valier V.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, 266 Woods Hole Rd, Woods Hole, MA 02543 USA; [Hemingway, Jordon D.] MIT WHOI Joint Program Oceanog & Appl Ocean Sci &, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Hilton, Robert G.] Univ Durham, Dept Geog, South Rd, Durham DH1 3LE, England; [Hovius, Niels] GFZ German Res Ctr Geosci Telegrafenberg, D-14473 Potsdam, Germany; [Hovius, Niels] Univ Potsdam, Dept Earth & Environm Sci, Karl Liebknechtstr 24, D-14476 Golm, Germany; [Eglinton, Timothy I.; Haghipour, Negar] ETH, Geol Inst, Dept Earth Sci, Sonneggstr 5, CH-8092 Zurich, Switzerland; [Wacker, Lukas] ETH, Dept Phys, Lab Ion Beam Phys, Otto Stern Weg 5, CH-8092 Zurich, Switzerland; [Chen, Meng-Chiang] Taroko Natl Pk Headquarters, Hualien 972, Taiwan; [Hemingway, Jordon D.] Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA	Woods Hole Oceanographic Institution; Durham University; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; University of Potsdam; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Harvard University	Hemingway, JD (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, 266 Woods Hole Rd, Woods Hole, MA 02543 USA.; Hemingway, JD (corresponding author), MIT WHOI Joint Program Oceanog & Appl Ocean Sci &, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Hemingway, JD (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	jordon_hemingway@fas.harvard.edu	galy, valier/I-6185-2012; Galy, valier/AAD-2248-2021	galy, valier/0000-0003-0385-8443; Galy, valier/0000-0003-0385-8443; Eglinton, Timothy/0000-0001-5060-2155; Wacker, Lukas/0000-0002-8215-2678	NSF Graduate Research Fellowship [2012126152]; WHOI Ocean Ventures Fund; European Research Council [678779 ROC-CO2]; NSF [OCE-0851015, OCE-0928582]; WHOI Independent Study Award [27005306]	NSF Graduate Research Fellowship(National Science Foundation (NSF)); WHOI Ocean Ventures Fund; European Research Council(European Research Council (ERC)European Commission); NSF(National Science Foundation (NSF)); WHOI Independent Study Award	This research was supported by NSF Graduate Research Fellowship number 2012126152 and the WHOI Ocean Ventures Fund (J.D.H.); European Research Council Starting Grant 678779 ROC-CO2 (R.G.H.); and NSF grants OCE-0851015 and OCE-0928582 and WHOI Independent Study Award 27005306 (V.V.G.).	Bergman NM, 2004, AM J SCI, V304, P397, DOI 10.2475/ajs.304.5.397; Berner RA, 1997, GEOLOGY, V25, P955, DOI 10.1130/0091-7613(1997)025<0955:TNFMBA>2.3.CO;2; Beyssac O, 2007, TECTONICS, V26, DOI 10.1029/2006TC002064; BLAIR N, 1985, APPL ENVIRON MICROB, V50, P996, DOI 10.1128/AEM.50.4.996-1001.1985; Bolton EW, 2006, AM J SCI, V306, P575, DOI 10.2475/08.2006.01; Calmels D, 2011, EARTH PLANET SC LETT, V303, P48, DOI 10.1016/j.epsl.2010.12.032; Chang SB, 1999, GEOCHIM COSMOCHIM AC, V63, P3301, DOI 10.1016/S0016-7037(99)00252-5; Dadson SJ, 2003, NATURE, V426, P648, DOI 10.1038/nature02150; Emberson R, 2016, EARTH SURF DYNAM, V4, P727, DOI 10.5194/esurf-4-727-2016; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Galy V, 2015, NATURE, V521, P204, DOI 10.1038/nature14400; Hemingway JD, 2017, BIOGEOSCIENCES, V14, P5099, DOI 10.5194/bg-14-5099-2017; Hilton RG, 2014, EARTH PLANET SC LETT, V403, P27, DOI 10.1016/j.epsl.2014.06.021; Hilton RG, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2012GB004314; Hilton RG, 2011, GEOLOGY, V39, P71, DOI 10.1130/G31352.1; Hilton RG, 2010, GEOCHIM COSMOCHIM AC, V74, P3164, DOI 10.1016/j.gca.2010.03.004; Hopkins FM, 2014, SOIL BIOL BIOCHEM, V76, P57, DOI 10.1016/j.soilbio.2014.04.028; Hovius N, 2000, J GEOL, V108, P73, DOI 10.1086/314387; Hovius N, 2011, EARTH PLANET SC LETT, V304, P347, DOI 10.1016/j.epsl.2011.02.005; Keil R. G., 2014, TREATISE GEOCHEMISTR, V12; Larsen IJ, 2014, SCIENCE, V343, P637, DOI 10.1126/science.1244908; Li G, 2017, EARTH PLANET SC LETT, V472, P253, DOI 10.1016/j.epsl.2017.04.040; Marc O, 2016, J GEOPHYS RES-EARTH, V121, P640, DOI 10.1002/2015JF003732; MOLNAR P, 1990, NATURE, V346, P29, DOI 10.1038/346029a0; Petsch ST, 2001, SCIENCE, V292, P1127, DOI 10.1126/science.1058332; Schillawski S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002980; Torres MA, 2016, EARTH PLANET SC LETT, V450, P381, DOI 10.1016/j.epsl.2016.06.012; Torres MA, 2014, NATURE, V507, P346, DOI 10.1038/nature13030; Tsai Chen-Chi, 2001, Proceedings of the National Science Council Republic of China Part B Life Sciences, V25, P34; West AJ, 2012, GEOLOGY, V40, P811, DOI 10.1130/G33041.1; Zheng LW, 2017, EARTH PLANET SC LETT, V465, P103, DOI 10.1016/j.epsl.2017.02.037	33	65	66	6	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2018	360	6385					209	+		10.1126/science.aao6463	http://dx.doi.org/10.1126/science.aao6463			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC5DK	29650673	Green Submitted, Green Accepted			2022-12-28	WOS:000429805400047
J	Visscher, PK; Camazine, S				Visscher, PK; Camazine, S			Collective decisions and cognition in bees	NATURE			English	Letter									Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; Penn State Univ, Dept Entomol, State Coll, PA 16802 USA	University of California System; University of California Riverside; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Visscher, PK (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.							CAMAZINE S, IN PRESS BIOL SYSTEM; CAMAZINE S, IN PRESS INSECTES SO; DENEUBOURG JL, 1990, J INSECT BEHAV, V3, P159, DOI 10.1007/BF01417909; GAMAZINE S, 1991, J THEOR BIOL, V149, P547; Gould J. L., 1994, ANIMAL MIND; Griffin D.R., 1992, ANIMAL MINDS; LINDAUER M, 1955, Z VERGL PHYSIOL, V37, P263, DOI 10.1007/BF00303153; LINDAUER M, 1957, NATURE, V179, P63, DOI 10.1038/179063a0; LINDAUER M, 1951, NATURWISSENSCHAFTEN, V40, P379; Seeley T., 1995, WISDOM HIVE SOCIAL P	10	75	77	1	26	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					400	400		10.1038/17047	http://dx.doi.org/10.1038/17047			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667972				2022-12-28	WOS:000078461700034
J	Levinson, W; Born, K; Wolfson, D				Levinson, Wendy; Born, Karen; Wolfson, Daniel			Choosing Wisely Campaigns A Work in Progress	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PATIENT SAFETY		[Levinson, Wendy] Univ Toronto, Dept Med, Toronto, ON, Canada; [Born, Karen] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Wolfson, Daniel] Amer Board Internal Med Fdn, Philadelphia, PA USA	University of Toronto; University of Toronto; American Board of Internal Medicine	Levinson, W (corresponding author), Dept Med, 190 Elizabeth St,R Fraser Elliott Bldg 3-805, Toronto, ON M5G 2C4, Canada.	wendy.levinson@utoronto.ca						Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; Ghanouni A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010723; Kerr EA, 2017, HEALTH AFFAIR, V36, P2012, DOI 10.1377/hlthaff.2017.0953; Mafi JN, 2018, BMJ QUAL SAF, V27, P333, DOI 10.1136/bmjqs-2017-007477; Robert G., 2005, DIFFUSION INNOVATION; Shekelle PG, 2011, ANN INTERN MED, V154, P693, DOI 10.7326/0003-4819-154-10-201105170-00011; Wachter RM, 2010, HEALTH AFFAIR, V29, P165, DOI 10.1377/hlthaff.2009.0785	7	80	80	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2018	319	19					1975	1976		10.1001/jama.2018.2202	http://dx.doi.org/10.1001/jama.2018.2202			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF8QV	29710232				2022-12-28	WOS:000432238300009
J	Searle, SD; Rockwood, K				Searle, Samuel D.; Rockwood, Kenneth			What proportion of older adults in hospital are frail?	LANCET			English	Editorial Material									[Searle, Samuel D.; Rockwood, Kenneth] Dalhousie Univ, Div Geriatr Med, Halifax, NS B3H 2E1, Canada	Dalhousie University	Rockwood, K (corresponding author), Dalhousie Univ, Div Geriatr Med, Halifax, NS B3H 2E1, Canada.	kenneth.rockwood@dal.ca	Rockwood, Kenneth/AAD-8951-2019					Cesari M, 2016, EUR J INTERN MED, V31, P11, DOI 10.1016/j.ejim.2016.03.005; Ellis G, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006211.pub3; Gilbert T, 2018, LANCET, V391, P1775, DOI 10.1016/S0140-6736(18)30668-8; Kumeliauskas L, 2013, CAN GERIATR J, V16, P49, DOI 10.5770/cgj.16.64; Papoutsi C, 2018, AGE AGEING, V47, P311, DOI 10.1093/ageing/afx194; Rockwood K, 2005, CAN MED ASSOC J, V173, P1500, DOI 10.1503/cmaj.051045; Rutenberg AD, 2018, EXP GERONTOL, V107, P126, DOI 10.1016/j.exger.2017.08.027; Stow D, 2018, AGE AGEING, V47, P564, DOI 10.1093/ageing/afy022	8	14	18	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2018	391	10132					1751	1752		10.1016/S0140-6736(18)30907-3	http://dx.doi.org/10.1016/S0140-6736(18)30907-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GE7NY	29706363	hybrid			2022-12-28	WOS:000431421300004
J	Haffner, C; Chelladurai, D; Fedoryshyn, Y; Josten, A; Baeuerle, B; Heni, W; Watanabe, T; Cui, T; Cheng, BJ; Saha, S; Elder, DL; Dalton, LR; Boltasseva, A; Shalaev, VM; Kinsey, N; Leuthold, J				Haffner, Christian; Chelladurai, Daniel; Fedoryshyn, Yuriy; Josten, Arne; Baeuerle, Benedikt; Heni, Wolfgang; Watanabe, Tatsuhiko; Cui, Tong; Cheng, Bojun; Saha, Soham; Elder, Delwin L.; Dalton, Larry. R.; Boltasseva, Alexandra; Shalaev, Vladimir M.; Kinsey, Nathaniel; Leuthold, Juerg			Low-loss plasmon-assisted electro-optic modulator	NATURE			English	Article							LONG-RANGE; WAVE-GUIDE; PHASE; NONLINEARITIES; TRANSPORT	For nearly two decades, researchers in the field of plasmonics(1)-which studies the coupling of electromagnetic waves to the motion of free electrons near the surface of a metal(2)-have sought to realize subwavelength optical devices for information technology(3-6), sensing(7,8), nonlinear optics(9,10), optical nanotweezers(11) and biomedical applications(12). However, the electron motion generates heat through ohmic losses. Although this heat is desirable for some applications such as photo-thermal therapy, it is a disadvantage in plasmonic devices for sensing and information technology(13) and has led to a widespread view that plasmonics is too lossy to be practical. Here we demonstrate that the ohmic losses can be bypassed by using 'resonant switching'. In the proposed approach, light is coupled to the lossy surface plasmon polaritons only in the device's off state (in resonance) in which attenuation is desired, to ensure large extinction ratios between the on and off states and allow subpicosecond switching. In the on state (out of resonance), destructive interference prevents the light from coupling to the lossy plasmonic section of a device. To validate the approach, we fabricated a plasmonic electro-optic ring modulator. The experiments confirm that low on-chip optical losses, operation at over 100 gigahertz, good energy efficiency, low thermal drift and a compact footprint can be combined in a single device. Our result illustrates that plasmonics has the potential to enable fast, compact on-chip sensing and communications technologies.	[Haffner, Christian; Chelladurai, Daniel; Fedoryshyn, Yuriy; Josten, Arne; Baeuerle, Benedikt; Heni, Wolfgang; Watanabe, Tatsuhiko; Cui, Tong; Cheng, Bojun; Leuthold, Juerg] ETH, IEF, Zurich, Switzerland; [Elder, Delwin L.; Dalton, Larry. R.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Saha, Soham; Boltasseva, Alexandra; Shalaev, Vladimir M.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Saha, Soham; Boltasseva, Alexandra; Shalaev, Vladimir M.] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA; [Kinsey, Nathaniel] Virginia Commonwealth Univ, Dept Elect & Comp Engn, Richmond, VA USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Washington; University of Washington Seattle; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Virginia Commonwealth University	Haffner, C; Leuthold, J (corresponding author), ETH, IEF, Zurich, Switzerland.	haffnerc@ethz.ch; leuthold@ethz.ch	Haffner, Christian/AAK-3274-2021; Fedoryshyn, Yuriy/F-3401-2019; Leuthold, Juerg/I-6667-2012; Kinsey, Nathaniel/GRS-0277-2022; Haffner, Christian/AAV-9454-2021; Shalaev, Vladimir M./B-9331-2019; Boltasseva, Alexandra/C-1674-2019	Fedoryshyn, Yuriy/0000-0002-6482-7870; Leuthold, Juerg/0000-0003-0111-8169; Shalaev, Vladimir M./0000-0001-8976-1102; Boltasseva, Alexandra/0000-0001-8905-2605; Josten, Arne/0000-0002-8900-3237; Chelladurai, Daniel/0000-0003-3877-600X; Cheng, Bojun/0000-0001-5551-4242; Haffner, Christian/0000-0002-8947-5293; Saha, Soham/0000-0002-1022-8047	EU Project PLASMOFAB [688166]; ERC grant PLASILOR [640478]; National Science Foundation (NSF) [DMR-1303080]; Air Force Office of Scientific Research grants [FA9550-15-1-0319, FA9550-17-1-0243]; Virginia Microelectronics Consortium; Virginia Commonwealth University Presidential Research Quest Fund; Direct For Mathematical & Physical Scien [1303080] Funding Source: National Science Foundation	EU Project PLASMOFAB; ERC grant PLASILOR; National Science Foundation (NSF)(National Science Foundation (NSF)); Air Force Office of Scientific Research grants; Virginia Microelectronics Consortium; Virginia Commonwealth University Presidential Research Quest Fund; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank U. Drechsler and H.-R. Benedickter for their technical assistance. We acknowledge partial funding of this project by the EU Project PLASMOFAB (688166), by ERC grant PLASILOR (640478), by the National Science Foundation (NSF) (DMR-1303080) and by the Air Force Office of Scientific Research grants (FA9550-15-1-0319 and FA9550-17-1-0243). N.K. acknowledges support from the Virginia Microelectronics Consortium and the Virginia Commonwealth University Presidential Research Quest Fund. This work was carried out at the BRNC Zurich and ETH Zurich.	Alloatti L, 2016, APPL PHYS LETT, V108, DOI 10.1063/1.4944999; Becker J, 2010, PLASMONICS, V5, P161, DOI 10.1007/s11468-010-9130-2; Bogaerts W, 2012, LASER PHOTONICS REV, V6, P47, DOI 10.1002/lpor.201100017; Bozhevolnyi SI, 2006, NATURE, V440, P508, DOI 10.1038/nature04594; Brolo AG, 2012, NAT PHOTONICS, V6, P709, DOI 10.1038/nphoton.2012.266; Cai WS, 2011, SCIENCE, V333, P1720, DOI 10.1126/science.1207858; Chang F, 2010, IEEE COMMUN MAG, V48, pS48, DOI 10.1109/MCOM.2010.5434378; Delacour C, 2010, NANO LETT, V10, P2922, DOI 10.1021/nl101065q; Dionne JA, 2009, NANO LETT, V9, P897, DOI 10.1021/nl803868k; Elder DL, 2017, CHEM MATER, V29, P6457, DOI 10.1021/acs.chemmater.7b02020; Emboras A, 2016, NANO LETT, V16, P709, DOI 10.1021/acs.nanolett.5b04537; Gheorma IL, 2002, IEEE PHOTONIC TECH L, V14, P795, DOI 10.1109/LPT.2002.1003096; Girouard P, 2017, IEEE J QUANTUM ELECT, V53, DOI 10.1109/JQE.2017.2718222; Gramotnev DK, 2010, NAT PHOTONICS, V4, P83, DOI 10.1038/nphoton.2009.282; Haffner C, 2015, NAT PHOTONICS, V9, P525, DOI [10.1038/nphoton.2015.127, 10.1038/NPHOTON.2015.127]; Haffner C, 2017, OPT MATER EXPRESS, V7, P2168, DOI 10.1364/OME.7.002168; Haffner C, 2016, P IEEE, V104, P2362, DOI 10.1109/JPROC.2016.2547990; Heni W, 2017, OPT EXPRESS, V25, P2627, DOI 10.1364/OE.25.002627; Hill MT, 2007, NAT PHOTONICS, V1, P589, DOI 10.1038/nphoton.2007.171; Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100; Hoessbacher C, 2017, OPT EXPRESS, V25, P1762, DOI 10.1364/OE.25.001762; Jin WW, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4884829; Josten A, 2017, APPL SCI-BASEL, V7, DOI 10.3390/app7070655; Kauranen M, 2012, NAT PHOTONICS, V6, P737, DOI [10.1038/NPHOTON.2012.244, 10.1038/nphoton.2012.244]; Keeler G. A., 2017, OPTICAL FIBER COMMUN; Khurgin JB, 2015, NAT NANOTECHNOL, V10, P2, DOI 10.1038/nnano.2014.310; Kieninger C., 2017, C LAS EL STU3N 2 OPT; Kress SJP, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700688; Kretz J, 2005, MICROELECTRON ENG, V78-79, P479, DOI 10.1016/j.mee.2004.12.061; Maier S.A., 2007, PLASMONICS FUNDAMENT, DOI DOI 10.1007/0-387-37825-1; Maier SA, 2001, ADV MATER, V13, P1501, DOI 10.1002/1521-4095(200110)13:19<1501::AID-ADMA1501>3.0.CO;2-Z; Melikyan A, 2014, NAT PHOTONICS, V8, P229, DOI [10.1038/NPHOTON.2014.9, 10.1038/nphoton.2014.9]; Messner A, 2017, 2017 OPTICAL FIBER COMMUNICATIONS CONFERENCE AND EXHIBITION (OFC); Miller DAB, 2017, J LIGHTWAVE TECHNOL, V35, P346, DOI 10.1109/JLT.2017.2647779; Min BK, 2009, NATURE, V457, P455, DOI 10.1038/nature07627; Ndukaife JC, 2016, NAT NANOTECHNOL, V11, P53, DOI [10.1038/nnano.2015.248, 10.1038/NNANO.2015.248]; Oulton RF, 2008, NAT PHOTONICS, V2, P496, DOI 10.1038/nphoton.2008.131; Phare CT, 2015, NAT PHOTONICS, V9, P511, DOI [10.1038/nphoton.2015.122, 10.1038/NPHOTON.2015.122]; Reed GT, 2010, NAT PHOTONICS, V4, P518, DOI [10.1038/nphoton.2010.179, 10.1038/NPHOTON.2010.179]; Sorger VJ, 2012, NANOPHOTONICS-BERLIN, V1, P17, DOI 10.1515/nanoph-2012-0009; Srinivasan A., 2016, OPT FIB COMM C TU3D; Sun S. S., 2008, INTRO ORGANIC ELECT, P28; Timurdogan E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5008; Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939; Wang C., 2017, PREPRINT; Watanabe T, 2017, J LIGHTWAVE TECHNOL, V35, P4663, DOI 10.1109/JLT.2017.2755673; Xu QF, 2005, NATURE, V435, P325, DOI 10.1038/nature03569; Zanotto S, 2015, LASER PHOTONICS REV, V9, P666, DOI 10.1002/lpor.201500101; Zhu SY, 2013, OPT EXPRESS, V21, P8320, DOI 10.1364/OE.21.008320; Zhu WQ, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700909	51	232	250	30	441	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					483	+		10.1038/s41586-018-0031-4	http://dx.doi.org/10.1038/s41586-018-0031-4			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8VX	29695845	Green Submitted, Green Accepted			2022-12-28	WOS:000430793000043
J	Korones, DN				Korones, David N.			The Long Ride Home	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Korones, David N.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA	University of Rochester	Korones, DN (corresponding author), Univ Rochester, Med Ctr, Rochester, NY 14642 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2018	378	17					1569	1571		10.1056/NEJMp1801166	http://dx.doi.org/10.1056/NEJMp1801166			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GD8XP	29694810				2022-12-28	WOS:000430797900003
J	Pastushenko, I; Brisebarre, A; Sifrim, A; Fioramonti, M; Revenco, T; Boumahdi, S; Van Keymeulen, A; Brown, D; Moers, V; Lemaire, S; De Clercq, S; Minguijon, E; Balsat, C; Sokolow, Y; Dubois, C; De Cock, F; Scozzaro, S; Sopena, F; Lanas, A; D'Haene, N; Salmon, I; Marine, JC; Voet, T; Sotiropoulou, PA; Blanpain, C				Pastushenko, Ievgenia; Brisebarre, Audrey; Sifrim, Alejandro; Fioramonti, Marco; Revenco, Tatiana; Boumahdi, Soufiane; Van Keymeulen, Alexandra; Brown, Daniel; Moers, Virginie; Lemaire, Sophie; De Clercq, Sarah; Minguijon, Esmeralda; Balsat, Cedric; Sokolow, Youri; Dubois, Christine; De Cock, Florian; Scozzaro, Samuel; Sopena, Federico; Lanas, Angel; D'Haene, Nicky; Salmon, Isabelle; Marine, Jean-Christophe; Voet, Thierry; Sotiropoulou, Panagiota A.; Blanpain, Cedric			Identification of the tumour transition states occurring during EMT	NATURE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; BREAST-CANCER; METASTATIC COLONIZATION; TRANSCRIPTION FACTORS; PANCREATIC-CANCER; INITIATING CELLS; TGF-BETA; CHEMORESISTANCE; HETEROGENEITY	In cancer, the epithelial-to-mesenchymal transition (EMT) is associated with tumour stemness, metastasis and resistance to therapy. It has recently been proposed that, rather than being a binary process, EMT occurs through distinct intermediate states. However, there is no direct in vivo evidence for this idea. Here we screen a large panel of cell surface markers in skin and mammary primary tumours, and identify the existence of multiple tumour subpopulations associated with different EMT stages: from epithelial to completely mesenchymal states, passing through intermediate hybrid states. Although all EMT subpopulations presented similar tumour-propagating cell capacity, they displayed differences in cellular plasticity, invasiveness and metastatic potential. Their transcriptional and epigenetic landscapes identify the underlying gene regulatory networks, transcription factors and signalling pathways that control these different EMT transition states. Finally, these tumour subpopulations are localized in different niches that differentially regulate EMT transition states.	[Pastushenko, Ievgenia; Brisebarre, Audrey; Fioramonti, Marco; Revenco, Tatiana; Boumahdi, Soufiane; Van Keymeulen, Alexandra; Moers, Virginie; Lemaire, Sophie; Dubois, Christine; De Cock, Florian; Scozzaro, Samuel; Sotiropoulou, Panagiota A.; Blanpain, Cedric] Univ Libre Buxelles, Lab Stem Cells & Canc, Brussels, Belgium; [Sifrim, Alejandro; Brown, Daniel; Voet, Thierry] Univ Leuven, Dept Human Genet, Leuven, Belgium; [Sifrim, Alejandro; Voet, Thierry] Wellcome Trust Sanger Inst, Sanger Inst, EBI Single Cell Genom Ctr, Hinxton, England; [Brown, Daniel; Marine, Jean-Christophe] VIB Ctr Canc Biol, Lab Mol Canc Biol, Leuven, Belgium; [De Clercq, Sarah; Minguijon, Esmeralda; D'Haene, Nicky; Salmon, Isabelle] Univ Libre Bruxelles, Erasme Univ Hosp, Pathol Dept, Brussels, Belgium; [Balsat, Cedric; Salmon, Isabelle] Univ Libre Bruxelles, Ctr Microscopy & Mol Imaging, DIAPath, Gosselies, Belgium; [Sokolow, Youri] Univ Libre Bruxelles, Erasme Univ Hosp, Thorac Surg, Brussels, Belgium; [Sopena, Federico] Hosp Clin Univ Lozano Blesa, IIS Aragon, Gastroenterol Dept, Zaragoza, Spain; [Lanas, Angel] Univ Zaragoza, IIS Aragon, CIBERehd, Zaragoza, Spain; [Marine, Jean-Christophe] Katholieke Univ Leuven, Dept Oncol, Lab Mol Canc Biol, Leuven, Belgium; [Blanpain, Cedric] Univ Libre Bruxelles, WELBIO, Brussels, Belgium	Universite Libre de Bruxelles; KU Leuven; Wellcome Trust Sanger Institute; Flanders Institute for Biotechnology (VIB); Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Lozano Blesa University Clinical Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; KU Leuven; Universite Libre de Bruxelles; WELBIO	Blanpain, C (corresponding author), Univ Libre Buxelles, Lab Stem Cells & Canc, Brussels, Belgium.; Blanpain, C (corresponding author), Univ Libre Bruxelles, WELBIO, Brussels, Belgium.	cedric.blanpain@ulb.ac.be	Voet, Thierry/E-8877-2017; Brisebarre, Audrey/ABE-4955-2020; Marine, Jean-Christophe/K-3292-2016; Sifrim, Alejandro/AAY-2019-2021; Blanpain, Cedric/ABD-8392-2021	Voet, Thierry/0000-0003-1204-9963; Marine, Jean-Christophe/0000-0003-2433-9837; Sifrim, Alejandro/0000-0001-8247-4020; Brown, Daniel/0000-0002-3594-5851; brisebarre, Audrey/0000-0003-0162-5195; Minguijon, Esmeralda/0000-0002-7801-7625	TELEVIE; FNRS; KULeuven SymBioSys; Stiching Tegen Kanker; FWO postdoctoral fellowship [12W7318N]; Marie Sklodowska-Curie fellowship [1205617N]; Fonds Erasme; WELBIO; Fondation Contre le Cancer; ULB Foundation; European Research Council; Worldwide Cancer Research; Foundation Baillet Latour	TELEVIE; FNRS(Fonds de la Recherche Scientifique - FNRS); KULeuven SymBioSys; Stiching Tegen Kanker; FWO postdoctoral fellowship(FWO); Marie Sklodowska-Curie fellowship; Fonds Erasme; WELBIO(WELBIO); Fondation Contre le Cancer; ULB Foundation; European Research Council(European Research Council (ERC)European Commission); Worldwide Cancer Research; Foundation Baillet Latour	We thank the ULB animal facility, the ULB genomic core facility (F. Libert and A. Lefort), G. Berx (Ghent University) and M. Mazzone (VIB-KUL) for MMTV-PyMT mice. I.P TEL. is supported by TELEVIE. P.A.S. is supported by FNRS. A.S., D.B. and T.V. are supported by KULeuven SymBioSys, Stiching Tegen Kanker, FWO postdoctoral fellowship #12W7318N and Marie Sklodowska-Curie fellowship #1205617N. The Department of Pathology acknowledges Fonds Yvonne Boel. The PDX platform is supported by Fonds Erasme. C.Bla. is supported by WELBIO, FNRS, Fondation Contre le Cancer, ULB Foundation, European Research Council, Worldwide Cancer Research and the Foundation Baillet Latour.	Aiello NM, 2017, NATURE, V547, pE7, DOI 10.1038/nature22963; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bierie B, 2017, P NATL ACAD SCI USA, V114, pE2337, DOI 10.1073/pnas.1618298114; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Diepenbruck M, 2016, CURR OPIN CELL BIOL, V43, P7, DOI 10.1016/j.ceb.2016.06.002; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Hong T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004569; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huang RYJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.442; Jolly MK, 2016, ONCOTARGET, V7, P27067, DOI 10.18632/oncotarget.8166; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kiselev VY, 2017, NAT METHODS, V14, P483, DOI [10.1038/NMETH.4236, 10.1038/nmeth.4236]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lapouge G, 2012, EMBO J, V31, P4563, DOI 10.1038/emboj.2012.312; Latil M, 2017, CELL STEM CELL, V20, P191, DOI 10.1016/j.stem.2016.10.018; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin YD, 2015, CELL REP, V13, P2456, DOI 10.1016/j.celrep.2015.11.025; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Medina-Rivera A, 2015, NUCLEIC ACIDS RES, V43, pW50, DOI 10.1093/nar/gkv362; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Seguin L, 2014, NAT CELL BIOL, V16, P457, DOI 10.1038/ncb2953; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Slack-Davis JK, 2009, CANCER RES, V69, P1469, DOI 10.1158/0008-5472.CAN-08-2678; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Van Keymeulen A, 2015, NATURE, V525, P119, DOI 10.1038/nature14665; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Wang J, 2017, ONCOGENE, V36, P1351, DOI 10.1038/onc.2016.299; Ye X, 2017, NATURE, V547, pE1, DOI 10.1038/nature22816; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Zhang JY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005304; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	45	696	711	13	234	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					463	+		10.1038/s41586-018-0040-3	http://dx.doi.org/10.1038/s41586-018-0040-3			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8VX	29670281				2022-12-28	WOS:000430793000039
J	Turnbull, C; Scott, RH; Thomas, E; Jones, L; Murugaesu, N; Pretty, FB; Halai, D; Baple, E; Craig, C; Hamblin, A; Henderson, S; Patch, C; O'Neill, A; Devereau, A; Smith, K; Martin, AR; Sosinsky, A; McDonagh, EM; Sultana, R; Mueller, M; Smedley, D; Toms, A; Dinh, L; Fowler, T; Bale, M; Hubbard, T; Rendon, A; Hill, S; Caulfield, MJ				Turnbull, Clare; Scott, Richard H.; Thomas, Ellen; Jones, Louise; Murugaesu, Nirupa; Pretty, Freya Boardman; Halai, Dina; Baple, Emma; Craig, Clare; Hamblin, Angela; Henderson, Shirley; Patch, Christine; O'Neill, Amanda; Devereau, Andrew; Smith, Katherine; Martin, Antonio Rueda; Sosinsky, Alona; McDonagh, Ellen M.; Sultana, Razvan; Mueller, Michael; Smedley, Damian; Toms, Adam; Dinh, Lisa; Fowler, Tom; Bale, Mark; Hubbard, Tim; Rendon, Augusto; Hill, Sue; Caulfield, Mark J.		100 000 Genomes Project	The 100 000 Genomes Project: bringing whole genome sequencing to the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CANCER GENOME; MUTATIONAL SIGNATURES; DNA		[Turnbull, Clare; Scott, Richard H.; Thomas, Ellen; Jones, Louise; Murugaesu, Nirupa; Pretty, Freya Boardman; Halai, Dina; Baple, Emma; Craig, Clare; Hamblin, Angela; Henderson, Shirley; Patch, Christine; O'Neill, Amanda; Devereau, Andrew; Smith, Katherine; Martin, Antonio Rueda; Sosinsky, Alona; McDonagh, Ellen M.; Sultana, Razvan; Mueller, Michael; Smedley, Damian; Toms, Adam; Dinh, Lisa; Fowler, Tom; Bale, Mark; Hubbard, Tim; Rendon, Augusto; Caulfield, Mark J.] Genom England, London, England; [Thomas, Ellen; Patch, Christine] Guys & St Thomas NHS Fdn, London, England; [Smedley, Damian; Caulfield, Mark J.] Queen Mary Univ London, William Harvey Res Inst, London, England; [Turnbull, Clare; Craig, Clare] Inst Canc Res, London, England; [Scott, Richard H.] Great Ormond St Hosp NHS Trust, London, England; [Jones, Louise] Queen Mary Univ London, Barts Canc Inst, London, England; [Murugaesu, Nirupa] St Georges Univ Hosp NHS Fdn Trust, London, England; Univ Exeter, Exeter, Devon, England; [Hamblin, Angela] Oxford Univ NHS Fdn Trust, Oxford BRC Haematol Theme, Oxford, England; [Henderson, Shirley; Hill, Sue] NHS England, London, England; [Patch, Christine] Kings Coll London, Florence Nightingale Fac Nursing & Midwifery, London, England; [O'Neill, Amanda; Rendon, Augusto] Univ Cambridge, Cambridge, England; [Bale, Mark] Sci Res & Evidence Directorate, Dept Hlth & Social Care, London, England; [Hubbard, Tim] Kings Coll London, Med & Mol Genet, London, England	University of London; Queen Mary University London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; Queen Mary University London; University of Exeter; Oxford University Hospitals NHS Foundation Trust; University of London; King's College London; University of Cambridge; University of London; King's College London	Turnbull, C (corresponding author), Genom England, London, England.; Turnbull, C (corresponding author), Inst Canc Res, London, England.	clare.turnbull@genomicsengland.co.uk	Hubbard, Tim J.P./AAT-4571-2020; Hubbard, Tim J/C-2567-2008; Turnbull, Clare/AAA-6596-2019; Smedley, Damian/AAL-8172-2021; Fowler, Tom/AGT-1933-2022	Hubbard, Tim J.P./0000-0002-1767-9318; Hubbard, Tim J/0000-0002-1767-9318; Fowler, Tom/0000-0002-7258-2279; Rendon, Augusto/0000-0001-8994-0039; Bale, Mark/0000-0003-3603-2461; McDonagh, Ellen M/0000-0001-5806-6174; Turnbull, Clare/0000-0002-1734-5772; Patch, Christine/0000-0002-4191-0663	MRC [G0700491] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2010, HOUSE COMMONS SCI TE; [Anonymous], 2013, INT RARE DIS RES CON; Chief Medical Officer, 2017, ANN REP CHIEF MED OF; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Dancey JE, 2012, CELL, V148, P409, DOI 10.1016/j.cell.2012.01.014; Davies H, 2017, NAT MED, V23, P517, DOI 10.1038/nm.4292; Department of Health, 2013, UK STRAT RAR DIS; Ellard S, 2017, ACGS BEST PRACTICE G; Firth HV, 2011, DEV MED CHILD NEUROL, V53, P702, DOI 10.1111/j.1469-8749.2011.04032.x; Gagan J, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0203-x; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Genomics England, 2015, 100 000 GENOMES PROJ; Hayden EC, 2014, NATURE, V507, P294, DOI 10.1038/507294a; Heather JM, 2016, GENOMICS, V107, P1, DOI 10.1016/j.ygeno.2015.11.003; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jones S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7161; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lionel AC, 2018, GENET MED, V20, P435, DOI 10.1038/gim.2017.119; Lomas DA, 2013, STRATEGIC PRIORITIES; NHS Digital, 2018, NHS DIGITAL HOSP EPI; NHS England, 2017, CREAT GEN MED SERV L; NHS England, 2016, IMPR OUTC PERS MED W; O'Leary B, 2016, CLIN ONCOL-UK, V28, P735, DOI 10.1016/j.clon.2016.08.007; Petljak M, 2016, CARCINOGENESIS, V37, P531, DOI 10.1093/carcin/bgw055; Rare Diseases Translational Research Collaboration, 2014, RARE DIS TRANSLATION; Schmidt KT, 2016, J CLIN PHARMACOL, V56, P1484, DOI 10.1002/jcph.765; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; The Human Genomics Strategy Group, 2012, BUILD OUR INH GEN TE; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wright Caroline F, 2018, Nat Rev Genet, V19, P325, DOI 10.1038/nrg.2018.12; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0	32	211	215	2	35	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2018	361								k1687	10.1136/bmj.k1687	http://dx.doi.org/10.1136/bmj.k1687			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF4VZ	29691228	Green Published			2022-12-28	WOS:000431963200004
J	[Anonymous]				[Anonymous]			Retrogression in New York City (Reprinted from JAMA, vol 70, pg 1231-1232, 1918)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		REILING J, 1918, JAMA-J AM MED ASSOC, V70, P1231	1	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2018	319	16					1730	1730		10.1001/jama.2017.12347	http://dx.doi.org/10.1001/jama.2017.12347			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD7RF	29710153				2022-12-28	WOS:000430709300035
J	Kuzmin, E; VanderSluis, B; Wang, W; Tan, GH; Deshpande, R; Chen, YQ; Usaj, M; Balint, A; Usaj, MM; van Leeuwen, J; Koch, EN; Pons, C; Dagilis, AJ; Pryszlak, M; YangWang, JZ; Hanchard, J; Riggi, M; Xu, KC; Heydari, H; Luis, BJS; Shuteriqi, E; Zhu, HW; Van Dyk, N; Sharifpoor, S; Costanzo, M; Loewith, R; Caudy, A; Bolnick, D; Brown, GW; Andrews, BJ; Boone, C; Myers, CL				Kuzmin, Elena; VanderSluis, Benjamin; Wang, Wen; Tan, Guihong; Deshpande, Raamesh; Chen, Yiqun; Usaj, Matej; Balint, Attila; Usaj, Mojca Mattiazzi; van Leeuwen, Jolanda; Koch, Elizabeth N.; Pons, Carles; Dagilis, Andrius J.; Pryszlak, Michael; YangWang, Jason Zi; Hanchard, Julia; Riggi, Margot; Xu, Kaicong; Heydari, Hamed; Luis, Bryan-Joseph San; Shuteriqi, Ermira; Zhu, Hongwei; Van Dyk, Nydia; Sharifpoor, Sara; Costanzo, Michael; Loewith, Robbie; Caudy, Amy; Bolnick, Daniel; Brown, Grant W.; Andrews, Brenda J.; Boone, Charles; Myers, Chad L.			Systematic analysis of complex genetic interactions	SCIENCE			English	Article							MISSING HERITABILITY; PROTEIN COMPLEXES; YEAST; LANDSCAPE; EVOLUTION; EPISTASIS; DELETION; GENOME; MODELS; FORM	To systematically explore complex genetic interactions, we constructed similar to 200,000 yeast triple mutants and scored negative trigenic interactions. We selected double-mutant query genes across a broad spectrum of biological processes, spanning a range of quantitative features of the global digenic interaction network and tested for a genetic interaction with a third mutation. Trigenic interactions often occurred among functionally related genes, and essential genes were hubs on the trigenic network. Despite their functional enrichment, trigenic interactions tended to link genes in distant bioprocesses and displayed a weaker magnitude than digenic interactions. We estimate that the global trigenic interaction network is similar to 100 times as large as the global digenic network, highlighting the potential for complex genetic interactions to affect the biology of inheritance, including the genotype-to-phenotype relationship.	[Kuzmin, Elena; Tan, Guihong; Chen, Yiqun; Usaj, Matej; Balint, Attila; Usaj, Mojca Mattiazzi; van Leeuwen, Jolanda; Pryszlak, Michael; YangWang, Jason Zi; Hanchard, Julia; Heydari, Hamed; Luis, Bryan-Joseph San; Shuteriqi, Ermira; Zhu, Hongwei; Van Dyk, Nydia; Sharifpoor, Sara; Costanzo, Michael; Caudy, Amy; Brown, Grant W.; Andrews, Brenda J.; Boone, Charles] Univ Toronto, Donnelly Ctr, 160 Coll St, Toronto, ON M5S 3E1, Canada; [Kuzmin, Elena; YangWang, Jason Zi; Hanchard, Julia; Heydari, Hamed; Caudy, Amy; Andrews, Brenda J.; Boone, Charles] Univ Toronto, Dept Mol Genet, 160 Coll St, Toronto, ON M5S 3E1, Canada; [VanderSluis, Benjamin; Wang, Wen; Deshpande, Raamesh; Koch, Elizabeth N.; Pons, Carles; Xu, Kaicong; Myers, Chad L.] Univ Minnesota Twin Cities, Dept Comp Sci & Engn, 200 Union St, Minneapolis, MN 55455 USA; [Balint, Attila; Brown, Grant W.] Univ Toronto, Dept Biochem, 160 Coll St, Toronto, ON M5S 3E1, Canada; [Dagilis, Andrius J.; Bolnick, Daniel] Univ Texas Austin, Dept Integrat Biol, 1 Univ Stn C0990, Austin, TX 78712 USA; [Riggi, Margot; Loewith, Robbie] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Riggi, Margot] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Riggi, Margot; Loewith, Robbie] IGE3 Inst Genet & Genom Geneva, CH-1211 Geneva, Switzerland; [Riggi, Margot; Loewith, Robbie] Swiss Natl Ctr Competence Res Programme Chem Biol, CH-1211 Geneva, Switzerland; [Boone, Charles] RIKEN, Ctr Sustainable Resource Sci, Wako, Saitama, Japan; [Kuzmin, Elena] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, 1160 Ave Pins Ouest, Montreal, PQ H3A 1A3, Canada; [Balint, Attila] Univ Copenhagen, Ctr Chromosome Stabil, Dept Cellular & Mol Med, Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark	University of Toronto; University of Toronto; University of Minnesota System; University of Minnesota Twin Cities; University of Toronto; University of Texas System; University of Texas Austin; University of Geneva; University of Geneva; RIKEN; McGill University; University of Copenhagen	Andrews, BJ; Boone, C (corresponding author), Univ Toronto, Donnelly Ctr, 160 Coll St, Toronto, ON M5S 3E1, Canada.; Andrews, BJ; Boone, C (corresponding author), Univ Toronto, Dept Mol Genet, 160 Coll St, Toronto, ON M5S 3E1, Canada.; Myers, CL (corresponding author), Univ Minnesota Twin Cities, Dept Comp Sci & Engn, 200 Union St, Minneapolis, MN 55455 USA.; Boone, C (corresponding author), RIKEN, Ctr Sustainable Resource Sci, Wako, Saitama, Japan.	brenda.andrews@utoronto.ca; charlie.boone@utoronto.ca; chadm@umn.edu	Dagilis, Andrius Jonas/AAV-1706-2020; Pons, Carles/B-6841-2016; Wang, Wen/E-6320-2012; Usaj, Matej/J-5454-2015	Dagilis, Andrius Jonas/0000-0003-2013-0825; Pons, Carles/0000-0002-9131-9089; Wang, Wen/0000-0002-5812-6744; Balint, Attila/0000-0002-6481-1772; Mattiazzi Usaj, Mojca/0000-0002-7389-8478; Usaj, Matej/0000-0003-0675-2847; van Leeuwen, Jolanda/0000-0003-3991-518X; Brown, Grant/0000-0002-9002-5003	NIH [R01HG005853, R01HG005084, R01GM104975]; Canadian Institutes of Health Research (CIHR) [FDN-143264, FDN-143265]; NSF [DBI\0953881, DEB-1456462]; CIHR [MOP-79368]; Swiss National Science Foundation; Canton of Geneva; European Research Council Consolidator Grant program; Natural Science and Engineering Research Council of Canada Postgraduate Scholarship-Doctoral PGS D2; University of Toronto Open Fellowship; University of Minnesota Doctoral Dissertation Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005853, R01HG005084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104975] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NSF(National Science Foundation (NSF)); CIHR(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canton of Geneva; European Research Council Consolidator Grant program; Natural Science and Engineering Research Council of Canada Postgraduate Scholarship-Doctoral PGS D2(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Toronto Open Fellowship(University of Toronto); University of Minnesota Doctoral Dissertation Fellowship(University of Minnesota System); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was primarily supported by the NIH (grant R01HG005853 to C.B., B.J.A., and C.L.M. and grants R01HG005084 and R01GM104975 to C.L.M.), the Canadian Institutes of Health Research (CIHR) (grants FDN-143264 and FDN-143265 to C.B. and B.J.A.), and the NSF (grant DBI\0953881 to C.L.M.). Computing resources and data storage services were partially provided by the Minnesota Supercomputing Institute and the University of Minnesota Office of Information Technology, respectively. Additional support was provided by the CIHR (grant MOP-79368 to G.W.B.), the NSF (DEB-1456462 to D.B.), the Swiss National Science Foundation (R.L.), the Canton of Geneva and the European Research Council Consolidator Grant program (R.L.), Natural Science and Engineering Research Council of Canada Postgraduate Scholarship-Doctoral PGS D2 (E.K.), a University of Toronto Open Fellowship (E.K.), and a University of Minnesota Doctoral Dissertation Fellowship (B.V). C.L.M, B.J.A., and C.B. are fellows of the Canadian Institute for Advanced Research.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Argmann CA, 2016, CELL METAB, V23, P13, DOI 10.1016/j.cmet.2015.11.012; Babu M, 2012, NATURE, V489, P585, DOI 10.1038/nature11354; Baryshnikova A, 2016, CELL SYST, V2, P412, DOI 10.1016/j.cels.2016.04.014; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Bloom JS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9712; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Bustard DE, 2012, J BIOL CHEM, V287, P11374, DOI 10.1074/jbc.M111.336263; Chi RJ, 2014, J CELL BIOL, V204, P793, DOI 10.1083/jcb.201309084; Chong YT, 2015, CELL, V161, P1413, DOI 10.1016/j.cell.2015.04.051; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Deshpande R., 2017, BIORXIV, DOI [10.1101/159632, DOI 10.1101/159632]; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Eugster A, 2004, MOL BIOL CELL, V15, P1011, DOI 10.1091/mbc.E03-10-0724; Foley BR, 2013, HEREDITY, V111, P391, DOI 10.1038/hdy.2013.61; Forsberg SKG, 2017, NAT GENET, V49, P497, DOI 10.1038/ng.3800; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavrilets S., 2004, MONOGRAPHS IN POPULA, P149; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Gillingham AK, 2004, J CELL BIOL, V167, P281, DOI 10.1083/jcb.200407088; Gonzalez A, 2017, EMBO J, V36, P397, DOI 10.15252/embj.201696010; Haber JE, 2013, CELL REP, V3, P2168, DOI 10.1016/j.celrep.2013.05.007; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hettema EH, 2014, CURR OPIN CELL BIOL, V29, P25, DOI 10.1016/j.ceb.2014.02.002; Hutchison CA, 2016, SCIENCE, V351, DOI 10.1126/science.aad6253; Huttenhower C, 2006, BIOINFORMATICS, V22, P2890, DOI 10.1093/bioinformatics/btl492; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Karpichev IV, 1998, MOL CELL BIOL, V18, P6560, DOI 10.1128/MCB.18.11.6560; Kira S, 2016, MOL BIOL CELL, V27, P382, DOI 10.1091/mbc.E15-07-0470; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Moyle LC, 2010, SCIENCE, V329, P1521, DOI 10.1126/science.1193063; Noda Y, 2007, J CELL BIOCHEM, V101, P686, DOI 10.1002/jcb.21225; NOVICK P, 1985, CELL, V40, P405, DOI 10.1016/0092-8674(85)90154-0; ORR HA, 1995, GENETICS, V139, P1805; Peli-Gulli MP, 2015, CELL REP, V13, P1, DOI 10.1016/j.celrep.2015.08.059; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Richardson SM, 2017, SCIENCE, V355, P1040, DOI 10.1126/science.aaf4557; Sackton TB, 2016, CELL, V166, P279, DOI 10.1016/j.cell.2016.06.047; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sun YD, 2015, MOL BIOL CELL, V26, P3841, DOI 10.1091/mbc.E15-04-0252; Tang SW, 2009, SCIENCE, V323, P779, DOI 10.1126/science.1169123; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Taylor MB, 2015, TRENDS GENET, V31, P34, DOI 10.1016/j.tig.2014.09.001; Taylor MB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004324; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Usaj M, 2017, G3-GENES GENOM GENET, V7, P1539, DOI 10.1534/g3.117.040220; van der Zand A, 2012, CELL, V149, P397, DOI 10.1016/j.cell.2012.01.054; van Leeuwen J, 2016, SCIENCE, V354, DOI 10.1126/science.aag0839; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Welch JJ, 2004, EVOLUTION, V58, P1145; Whyte JRC, 2001, CURR BIOL, V11, P1074, DOI 10.1016/S0960-9822(01)00273-1; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zou J, 2009, MOL BIOL CELL, V20, P3239, DOI 10.1091/mbc.E08-12-1255; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	62	136	136	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2018	360	6386							eaao1729	10.1126/science.aao1729	http://dx.doi.org/10.1126/science.aao1729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD3IC	29674565	Green Accepted			2022-12-28	WOS:000430396600034
J	Mikhaleva, S; Lemke, EA				Mikhaleva, Sofya; Lemke, Edward A.			Beyond the Transport Function of Import Receptors: What's All the FUS about?	CELL			English	Review							PHASE-TRANSITION; FG-NUCLEOPORINS; PROTEIN; SEPARATION; COMPLEXITY; GRANULES; DOMAINS; DISEASE	Nuclear import receptors are central players in transporting protein cargoes into the nucleus. Moving beyond this role, four newly published articles describe a function in regulating supramolecular assemblies by fine-tuning the phase separating properties of RNA-binding proteins, which has implications for a variety of devastating neurodegenerative disorders.	[Lemke, Edward A.] Johannes Gutenberg Univ Mainz, Dept Biol & Chem, Johann Joachim Becher Weg 7, D-55128 Mainz, Germany; [Lemke, Edward A.] Johannes Gutenberg Univ Mainz, Dept Pharm, Johann Joachim Becher Weg 7, D-55128 Mainz, Germany; [Lemke, Edward A.] Johannes Gutenberg Univ Mainz, Dept Geosci, Johann Joachim Becher Weg 7, D-55128 Mainz, Germany; [Lemke, Edward A.] Inst Mol Biol, Ackermannweg 4, D-55128 Mainz, Germany; [Mikhaleva, Sofya; Lemke, Edward A.] European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Institute of Molecular Biology (IMB); European Molecular Biology Laboratory (EMBL)	Lemke, EA (corresponding author), Johannes Gutenberg Univ Mainz, Dept Biol & Chem, Johann Joachim Becher Weg 7, D-55128 Mainz, Germany.; Lemke, EA (corresponding author), Johannes Gutenberg Univ Mainz, Dept Pharm, Johann Joachim Becher Weg 7, D-55128 Mainz, Germany.; Lemke, EA (corresponding author), Johannes Gutenberg Univ Mainz, Dept Geosci, Johann Joachim Becher Weg 7, D-55128 Mainz, Germany.; Lemke, EA (corresponding author), Inst Mol Biol, Ackermannweg 4, D-55128 Mainz, Germany.; Lemke, EA (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	edlemke@uni-mainz.de	; Lemke, Edward/J-3337-2015	Mikhaleva, Sofya/0000-0001-8427-2211; Lemke, Edward/0000-0002-0634-0503	DFG [SFB1129]; ERC [SMPFv2.0]	DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission)	The Lemke lab thanks its members for helpful discussions and funding from the DFG (SFB1129) and ERC (SMPFv2.0).	Babu MM, 2016, BIOCHEM SOC T, V44, P1185, DOI 10.1042/BST20160172; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Chang WL, 2009, NUCLEIC ACIDS RES, V37, P6600, DOI 10.1093/nar/gkp717; Forbes DJ, 2015, CURR OPIN CELL BIOL, V35, P78, DOI 10.1016/j.ceb.2015.04.012; Guo L, 2018, CELL, V173, P677, DOI 10.1016/j.cell.2018.03.002; Hofweber M, 2018, CELL, V173, P706, DOI 10.1016/j.cell.2018.03.004; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Milles S, 2013, EMBO REP, V14, P178, DOI 10.1038/embor.2012.204; Murray DT, 2017, CELL, V171, P615, DOI 10.1016/j.cell.2017.08.048; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Qamar S, 2018, CELL, V173, P720, DOI 10.1016/j.cell.2018.03.056; Tan PS, 2018, CELL REP, V22, P3660, DOI 10.1016/j.celrep.2018.03.022; Walport LJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11974; Yoshizawa T, 2018, CELL, V173, P693, DOI 10.1016/j.cell.2018.03.003	17	13	13	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2018	173	3					549	553		10.1016/j.cell.2018.04.002	http://dx.doi.org/10.1016/j.cell.2018.04.002			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7GB	29677508	Bronze, Green Accepted			2022-12-28	WOS:000430677400007
J	Qamar, S; Wang, GZ; Randle, SJ; Ruggeri, FS; Varela, JA; Lin, JQ; Phillips, EC; Miyashita, A; Williams, D; Strohl, F; Meadows, W; Ferry, R; Dardov, VJ; Tartaglia, GG; Farrer, LA; Schierle, GSK; Kaminski, CF; Holt, CE; Fraser, PE; Schmitt-Ulms, G; Klenerman, D; Knowles, T; Vendruscolo, M; St George-Hyslop, P				Qamar, Seema; Wang, GuoZhen; Randle, Suzanne J.; Ruggeri, Francesco Simone; Varela, Juan A.; Lin, Julie Qiaojin; Phillips, Emma C.; Miyashita, Akinori; Williams, Declan; Strohl, Florian; Meadows, William; Ferry, Rodylyn; Dardov, Victoria J.; Tartaglia, Gian G.; Farrer, Lindsay A.; Schierle, Gabriele S. Kaminski; Kaminski, Clemens F.; Holt, Christine E.; Fraser, Paul E.; Schmitt-Ulms, Gerold; Klenerman, David; Knowles, Tuomas; Vendruscolo, Michele; St George-Hyslop, Peter			FUS Phase Separation Is Modulated by a Molecular Chaperone and Methylation of Arginine Cation-pi Interactions	CELL			English	Article							CELL-FREE FORMATION; STRUCTURAL BASIS; LOCAL TRANSLATION; NUCLEAR IMPORT; PROTEIN; RNA; RECOGNITION; TRANSITION; HYDROGELS; MUTATION	Reversible phase separation underpins the role of FUS in ribonucleoprotein granules and other membrane-free organelles and is, in part, driven by the intrinsically disordered low-complexity (LC) domain of FUS. Here, we report that cooperative cation-pi interactions between tyrosines in the LC domain and arginines in structured C-terminal domains also contribute to phase separation. These interactions are modulated by post-translational arginine methylation, wherein arginine hypomethylation strongly promotes phase separation and gelation. Indeed, significant hypomethylation, which occurs in FUSassociated frontotemporal lobar degeneration (FTLD), induces FUS condensation into stable intermolecular beta-sheet-rich hydrogels that disrupt RNP granule function and impair new protein synthesis in neuron terminals. We show that transportin acts as a physiological molecular chaperone of FUS in neuron terminals, reducing phase separation and gelation of methylated and hypomethylated FUS and rescuing protein synthesis. These results demonstrate how FUS condensation is physiologically regulated and how perturbations in these mechanisms can lead to disease.	[Qamar, Seema; Wang, GuoZhen; Randle, Suzanne J.; Phillips, Emma C.; Meadows, William; St George-Hyslop, Peter] Univ Cambridge, Cambridge Inst Med Res, Dept Clin Neurosci, Cambridge CB2 0XY, England; [Ruggeri, Francesco Simone; Varela, Juan A.; Klenerman, David; Knowles, Tuomas; Vendruscolo, Michele] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Lin, Julie Qiaojin; Holt, Christine E.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; [Miyashita, Akinori; Williams, Declan; Ferry, Rodylyn; Fraser, Paul E.; Schmitt-Ulms, Gerold; St George-Hyslop, Peter] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; [Miyashita, Akinori; Williams, Declan; Ferry, Rodylyn; Fraser, Paul E.; Schmitt-Ulms, Gerold; St George-Hyslop, Peter] Univ Toronto, Dept Med, Toronto, ON M5S 3H2, Canada; [Miyashita, Akinori; Williams, Declan; Ferry, Rodylyn; Schmitt-Ulms, Gerold; St George-Hyslop, Peter] Univ Toronto, Dept Med Biophys & Lab Med, Toronto, ON M5S 3H2, Canada; [Miyashita, Akinori; Williams, Declan; Ferry, Rodylyn; Fraser, Paul E.; Schmitt-Ulms, Gerold; St George-Hyslop, Peter] Univ Toronto, Dept Pathobiol, Toronto, ON M5S 3H2, Canada; [Strohl, Florian; Schierle, Gabriele S. Kaminski; Kaminski, Clemens F.] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB3 0AS, England; [Dardov, Victoria J.] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Tartaglia, Gian G.] Barcelona Inst Sci & Technol, Ctr Genom Regulat, Barcelona 08003, Spain; [Tartaglia, Gian G.] Univ Pompeu Fabra, Barcelona 08003, Spain; [Tartaglia, Gian G.] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain; [Farrer, Lindsay A.] Boston Univ, Dept Med, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Dept Neurol, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Dept Ophthalmol, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Dept Epidemiol, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Dept Biostat, Boston, MA 02118 USA; [Knowles, Tuomas] Univ Cambridge, Dept Phys, Cavendish Lab, Cambridge CB3 0HE, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Cambridge; Cedars Sinai Medical Center; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA; Boston University; Boston University; Boston University; Boston University; Boston University; University of Cambridge	St George-Hyslop, P (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Clin Neurosci, Cambridge CB2 0XY, England.; St George-Hyslop, P (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada.; St George-Hyslop, P (corresponding author), Univ Toronto, Dept Med, Toronto, ON M5S 3H2, Canada.; St George-Hyslop, P (corresponding author), Univ Toronto, Dept Med Biophys & Lab Med, Toronto, ON M5S 3H2, Canada.; St George-Hyslop, P (corresponding author), Univ Toronto, Dept Pathobiol, Toronto, ON M5S 3H2, Canada.	p.hyslop@utoronto.ca	Ruggeri, Francesco Simone/C-8004-2012; Lin, Qiaojin/ABA-3382-2020; Vendruscolo, Michele/F-5901-2012; Lin, Julie Qiaojin/AAY-5309-2020; Knowles, Tuomas/C-6663-2009; Kaminski, Clemens/G-7488-2016; Farrer, Lindsay/AAS-1035-2020; FAPESP, CDMF/J-3591-2015; Tartaglia, Gian Gaetano/K-1229-2014	Ruggeri, Francesco Simone/0000-0002-1232-1907; Lin, Qiaojin/0000-0002-2669-6478; Vendruscolo, Michele/0000-0002-3616-1610; Lin, Julie Qiaojin/0000-0002-2669-6478; Knowles, Tuomas/0000-0002-7879-0140; Kaminski, Clemens/0000-0002-5194-0962; FAPESP, CDMF/0000-0002-4464-0937; Tartaglia, Gian Gaetano/0000-0001-7524-6310; St George-Hyslop, Peter/0000-0003-0796-7209; Holt, Christine Elizabeth/0000-0003-2829-121X; Varela, Juan Alberto/0000-0003-1901-1378; Klenerman, David/0000-0001-7116-6954; Williams, Declan/0000-0002-6754-1624	Canadian Consortium on Neurodegeneration and Aging of the Canadian Institutes of Health Research; Wellcome Trust; European Research Council starting grant [RIBOMYLOME_ 309545]; European Research Council [322817]; Swiss National Foundation for Science; ALS Society of Canada/Brain Canada; BBSRC [BB/H023917/1] Funding Source: UKRI; EPSRC [EP/H018301/1] Funding Source: UKRI; MRC [G0902243, MR/K02292X/1] Funding Source: UKRI	Canadian Consortium on Neurodegeneration and Aging of the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council starting grant(European Research Council (ERC)); European Research Council(European Research Council (ERC)European Commission); Swiss National Foundation for Science(Swiss National Science Foundation (SNSF)); ALS Society of Canada/Brain Canada; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Canadian Consortium on Neurodegeneration and Aging of the Canadian Institutes of Health Research (to P.S.H.), Wellcome Trust (to P.S.H., M.V., D.K., T.K., C.F.K., and G.S.K.S.), a European Research Council starting grant (RIBOMYLOME_ 309545) (to G.G.T.), a European Research Council grant (322817) (to C.E.H.), the Swiss National Foundation for Science (to F.S.R.), and the ALS Society of Canada/Brain Canada (to P.S.H.).	Blanc RS, 2017, MOL CELL, V65, P8, DOI 10.1016/j.molcel.2016.11.003; Dazzi A, 2012, APPL SPECTROSC, V66, P1365, DOI 10.1366/12-06804; Dormann D, 2012, EMBO J, V31, P4258, DOI 10.1038/emboj.2012.261; Galante D, 2016, INT J BIOCHEM CELL B, V79, P261, DOI 10.1016/j.biocel.2016.08.037; Gotzl JK, 2016, AGEING RES REV, V32, P122, DOI 10.1016/j.arr.2016.04.008; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Harmon TS, 2017, ELIFE, V6, DOI 10.7554/eLife.30294; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Klingstedt T, 2013, CHEM-EUR J, V19, P10179, DOI 10.1002/chem.201301463; Leung KM, 2008, NAT PROTOC, V3, P1318, DOI 10.1038/nprot.2008.113; Lin AC, 2007, EMBO J, V26, P3729, DOI 10.1038/sj.emboj.7601808; Muller T, 2014, LAB CHIP, V14, P1315, DOI 10.1039/c3lc51219c; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Neumann M, 2012, ACTA NEUROPATHOL, V124, P705, DOI 10.1007/s00401-012-1020-6; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Rappsilber J, 2003, ANAL CHEM, V75, P3107, DOI 10.1021/ac026283q; Ruggeri FS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8831; Ruggeri FS, 2015, ANGEW CHEM INT EDIT, V54, P2462, DOI 10.1002/anie.201409050; Scaramuzzino C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061576; Sephton CF, 2015, CELL MOL LIFE SCI, V72, P3621, DOI 10.1007/s00018-015-1943-x; Tripsianes K, 2011, NAT STRUCT MOL BIOL, V18, P1414, DOI 10.1038/nsmb.2185; Twyffels L, 2014, FEBS LETT, V588, P1857, DOI 10.1016/j.febslet.2014.04.023; Urwin H, 2010, ACTA NEUROPATHOL, V120, P33, DOI 10.1007/s00401-010-0698-6; Volpatti LR, 2016, J MATER CHEM B, V4, P7989, DOI 10.1039/c6tb02683d; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Zhang H, 2017, P NATL ACAD SCI USA, V114, P12483, DOI 10.1073/pnas.1711486114	28	410	413	20	115	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2018	173	3					720	+		10.1016/j.cell.2018.03.056	http://dx.doi.org/10.1016/j.cell.2018.03.056			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7GB	29677515	Green Published, hybrid			2022-12-28	WOS:000430677400020
J	Bekiari, E; Kitsios, K; Thabit, H; Tauschmann, M; Athanasiadou, E; Karagiannis, T; Haidich, AB; Hovorka, R; Tsapas, A				Bekiari, Eleni; Kitsios, Konstantinos; Thabit, Hood; Tauschmann, Martin; Athanasiadou, Eleni; Karagiannis, Thomas; Haidich, Anna-Bettina; Hovorka, Roman; Tsapas, Apostolos			Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LOOP INSULIN DELIVERY; OVERNIGHT GLUCOSE CONTROL; SENSOR-AUGMENTED PUMP; UNIFIED SAFETY SYSTEM; HOME-USE; GLYCEMIC CONTROL; PUBLICATION BIAS; OUTCOME MEASURES; BIONIC PANCREAS; OPEN-LABEL	OBJECTIVE To evaluate the efficacy and safety of artificial pancreas treatment in non-pregnant outpatients with type 1 diabetes. DESIGN Systematic review and meta-analysis of randomised controlled trials. DATA SOURCES Medline, Embase, Cochrane Library, and grey literature up to 2 February 2018. ELIGIBILITY CRITERIA FOR SELECTING STUDIES Randomised controlled trials in non-pregnant outpatients with type 1 diabetes that compared the use of any artificial pancreas system with any type of insulin based treatment. Primary outcome was proportion (%) of time that sensor glucose level was within the near normoglycaemic range (3.9-10 mmol/L). Secondary outcomes included proportion (%) of time that sensor glucose level was above 10 mmol/L or below 3.9 mmol/L, low blood glucose index overnight, mean sensor glucose level, total daily insulin needs, and glycated haemoglobin. The Cochrane Collaboration risk of bias tool was used to assess study quality. RESULTS 40 studies (1027 participants with data for 44 comparisons) were included in the meta-analysis. 35 comparisons assessed a single hormone artificial pancreas system, whereas nine comparisons assessed a dual hormone system. Only nine studies were at low risk of bias. Proportion of time in the near normoglycaemic range (3.9-10.0 mmol/L) was significantly higher with artificial pancreas use, both overnight (weighted mean difference 15.15%, 95% confidence interval 12.21% to 18.09%) and over a 24 hour period (9.62%, 7.54% to 11.7%). Artificial pancreas systems had a favourable effect on the proportion of time with sensor glucose level above 10 mmol/L (-8.52%, -11.14% to -5.9%) or below 3.9 mmol/L (-1.49%, -1.86% to -1.11%) over 24 hours, compared with control treatment. Robustness of findings for the primary outcome was verified in sensitivity analyses, by including only trials at low risk of bias (11.64%, 9.1% to 14.18%) or trials under unsupervised, normal living conditions (10.42%, 8.63% to 12.2%). Results were consistent in a subgroup analysis both for single hormone and dual hormone artificial pancreas systems. CONCLUSIONS Artificial pancreas systems are an efficacious and safe approach for treating outpatients with type 1 diabetes. The main limitations of current research evidence on artificial pancreas systems are related to inconsistency in outcome reporting, small sample size, and short follow-up duration of individual trials.	[Bekiari, Eleni; Athanasiadou, Eleni; Karagiannis, Thomas; Tsapas, Apostolos] Aristotle Univ Thessaloniki, Clin Res & Evidence Based Med Unit, Thessaloniki 54642, Greece; [Kitsios, Konstantinos] Aristotle Univ Thessaloniki, Med Dept 2, Ctr Diabet, Thessaloniki, Greece; [Thabit, Hood; Tauschmann, Martin; Hovorka, Roman] Univ Cambridge, Wellcome Trust, MRC, Inst Metab Sci, Cambridge, England; [Haidich, Anna-Bettina] Aristotle Univ Thessaloniki, Sch Med, Dept Hyg & Epidemiol, Thessaloniki, Greece; [Tsapas, Apostolos] Univ Oxford, Harris Manchester Coll, Oxford, England	Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; University of Cambridge; Wellcome Trust Sanger Institute; Aristotle University of Thessaloniki; University of Oxford	Tsapas, A (corresponding author), Aristotle Univ Thessaloniki, Clin Res & Evidence Based Med Unit, Thessaloniki 54642, Greece.; Tsapas, A (corresponding author), Univ Oxford, Harris Manchester Coll, Oxford, England.	atsapas@auth.gr	Haidich, Anna Bettina/L-9426-2019; Tsapas, Apostolos/P-5593-2019; Hovorka, Roman/O-1116-2019; Tauschmann, Martin/GLN-8103-2022; Hovorka, Roman/J-4123-2016; Karagiannis, Thomas/H-9476-2019	Haidich, Anna Bettina/0000-0001-5100-8799; Tsapas, Apostolos/0000-0003-0221-4072; Hovorka, Roman/0000-0003-2901-461X; Hovorka, Roman/0000-0003-2901-461X; Karagiannis, Thomas/0000-0001-5242-0574; Bekiari, Eleni/0000-0001-9975-3835	Aristotle University Research Committee (ELKE AUTh); National Institute for Health Research Cambridge Biomedical Research Centre; Wellcome Strategic Award [100574/Z/12/Z]	Aristotle University Research Committee (ELKE AUTh); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Strategic Award	The study was partly funded by the Aristotle University Research Committee (ELKE AUTh), and supported by the National Institute for Health Research Cambridge Biomedical Research Centre and Wellcome Strategic Award (100574/Z/12/Z). The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Agiostratidou G, 2017, DIABETES CARE, V40, P1622, DOI 10.2337/dc17-1624; Agrawal Pratik, 2011, J Diabetes Sci Technol, V5, P1137; [Anonymous], 2009, SYSTEMATIC REV CRDS; Bally L, 2017, LANCET DIABETES ENDO, V5, P261, DOI 10.1016/S2213-8587(17)30001-3; Barnard KD, 2015, DIABETES TECHNOL THE, V17, P311, DOI 10.1089/dia.2014.0316; Barnard KD, 2015, DIABETES TECHNOL THE, V17, P295, DOI 10.1089/dia.2014.0305; Battelino T, 2015, BEST PRACT RES CL EN, V29, P315, DOI 10.1016/j.beem.2015.03.001; Bekiari E, 2017, LANCET DIABETES ENDO, V5, P685, DOI 10.1016/S2213-8587(17)30261-9; Bergenstal RM, 2016, JAMA-J AM MED ASSOC, V316, P1407, DOI 10.1001/jama.2016.11708; Bergenstal RM, 2010, NEW ENGL J MED, V363, P311, DOI 10.1056/NEJMoa1002853; Biester T, 2016, PEDIAT DIABETES, V17, P146; Blauw H, 2016, DIABETES OBES METAB, V18, P671, DOI 10.1111/dom.12663; Bode BW, 2017, DIABETES TECHNOL THE, V19, P25, DOI 10.1089/dia.2016.0350; Breton MD, 2017, DIABETES CARE, V40, P1644, DOI 10.2337/dc17-0883; Brown SA, 2017, J CLIN ENDOCR METAB, V102, P3674, DOI 10.1210/jc.2017-00556; Chernavvsky DR, 2016, PEDIATR DIABETES, V17, P28, DOI 10.1111/pedi.12230; Danne T, 2017, DIABETES CARE, V40, P1631, DOI 10.2337/dc17-1600; de Bock MI, 2015, DIABETES CARE, V38, pE186, DOI 10.2337/dc15-1047; DeBoer MD, 2017, DIABETES TECHNOL THE, V19, P293, DOI 10.1089/dia.2016.0424; Del Favero S, 2016, DIABETES CARE, V39, P1180, DOI 10.2337/dc15-2815; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ding H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120519; Drazen JM, 2016, NEW ENGL J MED, V375, P1182, DOI 10.1056/NEJMe1611027; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ekhlaspour L, 2016, DIABETES, V65, pA21; El-Khatib FH, 2016, LANCET; Elbourne DR, 2002, INT J EPIDEMIOL, V31, P140, DOI 10.1093/ije/31.1.140; Elleri D, 2010, DIABETES TECHNOL THE, V12, P35, DOI 10.1089/dia.2009.0084; Forlenza GP, 2018, PEDIATR DIABETES, V19, P420, DOI 10.1111/pedi.12603; Forlenza GP, 2017, DIABETES CARE, V40, P1096, DOI 10.2337/dc17-0500; Garg SK, 2017, DIABETES TECHNOL THE, V19, P155, DOI 10.1089/dia.2016.0421; Haidar A, 2017, DIABETES OBES METAB, V19, P713, DOI 10.1111/dom.12880; Haidar A, 2016, J CLIN ENDOCR METAB, V101, P213, DOI 10.1210/jc.2015-3003; Haidar A, 2015, LANCET DIABETES ENDO, V3, P595, DOI 10.1016/S2213-8587(15)00141-2; Heller S, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1285; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hovorka R, 2014, DIABETES CARE, V37, P1204, DOI 10.2337/dc13-2644; Huyett L, 2016, LANCET DIABETES ENDO, V4, P880, DOI 10.1016/S2213-8587(16)30144-9; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Kingman RS, 2017, DIABETES, V66, pA94; Kovatchev BP, 2014, DIABETES CARE, V37, P1789, DOI 10.2337/dc13-2076; Kovatchev BP, 1998, DIABETES CARE, V21, P1870, DOI 10.2337/diacare.21.11.1870; Kropff J, 2015, LANCET DIABETES ENDO, V3, P939, DOI 10.1016/S2213-8587(15)00335-6; Kumareswaran Kavita, 2011, J Diabetes Sci Technol, V5, P1352; Leelarathna L, 2014, DIABETES CARE, V37, P1931, DOI 10.2337/dc13-2911; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Ly T, 2015, DIABETES TECHNOL THE, V17, pA97; Ly TT, 2016, DIABETES CARE, V39, pE106, DOI 10.2337/dc16-0817; Ly TT, 2016, DIABETES TECHNOL THE, V18, P377, DOI 10.1089/dia.2015.0431; Ly TT, 2015, DIABETES CARE, V38, P1205, DOI 10.2337/dc14-3073; Ly TT, 2014, DIABETES CARE, V37, P2310, DOI 10.2337/dc14-0147; Maahs DM, 2016, DIABETES CARE, V39, P1175, DOI 10.2337/dc15-2716; National Institute for Health and Care Excellence, 2008, CONT SUBC INS INF TR; Nimri R, 2017, DIABETES OBES METAB, V19, P553, DOI 10.1111/dom.12852; Nimri R, 2014, DIABETES CARE, V37, P3025, DOI 10.2337/dc14-0835; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Peters JL, 2007, STAT MED, V26, P4544, DOI 10.1002/sim.2889; Phillip M, 2013, NEW ENGL J MED, V368, P824, DOI 10.1056/NEJMoa1206881; Renard E, 2017, DIABETES, V66, pA79; Riemsma R, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20170; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Roze S, 2016, J MED ECON, V19, P236, DOI 10.3111/13696998.2015.1113979; Russell SJ, 2016, LANCET DIABETES ENDO, V4, P233, DOI 10.1016/S2213-8587(15)00489-1; Russell SJ, 2014, NEW ENGL J MED, V371, P313, DOI 10.1056/NEJMoa1314474; Schierloh U, 2015, DIABETES TECHNOL THE, V17, pA99; Selph SS, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-107; Sharifi A, 2016, DIABETES TECHNOL THE, V18, P772, DOI 10.1089/dia.2016.0288; Spaic T, 2017, DIABETES CARE, V40, P359, DOI 10.2337/dc16-1794; Taichman DB, 2016, JAMA-J AM MED ASSOC, V315, P467, DOI 10.1001/jama.2015.18164; Tauschmann M, 2016, DIABETES CARE, V39, P2019, DOI 10.2337/dc16-1094; Tauschmann M, 2016, DIABETES CARE, V39, P1168, DOI 10.2337/dc15-2078; Thabit H, 2015, NEW ENGL J MED, V373, P2129, DOI 10.1056/NEJMoa1509351; Thabit H, 2017, LANCET DIABETES ENDO, V5, P117, DOI 10.1016/S2213-8587(16)30280-7; Thabit H, 2014, LANCET DIABETES ENDO, V2, P701, DOI 10.1016/S2213-8587(14)70114-7; US Food and Drug Administration, 2012, CONT INV DEV EX IDE; van Bon AC, 2011, DIABETES TECHNOL THE, V13, P731, DOI 10.1089/dia.2011.0013; Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135; Weisman A, 2017, LANCET DIABETES ENDO, V5, P501, DOI 10.1016/S2213-8587(17)30167-5; Yeh Hsin-Chieh, 2012, Ann Intern Med, V157, P336	79	204	205	11	63	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2018	361								k1310	10.1136/bmj.k1310	http://dx.doi.org/10.1136/bmj.k1310			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8WP	29669716	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000430795200001
J	[Anonymous]				[Anonymous]			A Comeback for European Shellfish	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2018	319	15					1540	1540		10.1001/jama.2018.3977	http://dx.doi.org/10.1001/jama.2018.3977			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD0UT	29677287				2022-12-28	WOS:000430217100008
J	Butler, D				Butler, D			Leaked CNRS report raises fears and hopes on job security	NATURE			English	News Item																		1998, NATURE, V396, P607	1	0	0	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					378	378		10.1038/16986	http://dx.doi.org/10.1038/16986			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667955	Bronze			2022-12-28	WOS:000078461700013
J	Macilwain, C; Reichhardt, T				Macilwain, C; Reichhardt, T			US budget 'freezes' spending on research	NATURE			English	News Item																		COLWELL R, 1999, NATURE, V397, P285	1	2	2	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					377	377		10.1038/16983	http://dx.doi.org/10.1038/16983			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667960	Bronze			2022-12-28	WOS:000078461700012
J	Braithwaite, RS				Braithwaite, R. Scott			Risk Adjustment for Quality Measures Is Neither Binary nor Mandatory	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Braithwaite, R. Scott] NYU, Sch Med, 227 E 30th St,Room 615, New York, NY 10016 USA	New York University	Braithwaite, RS (corresponding author), NYU, Sch Med, 227 E 30th St,Room 615, New York, NY 10016 USA.	scott.braithwaite@nyumc.org		Braithwaite, Ronald Scott/0000-0001-7067-3655				Baker DW, 2017, ANN INTERN MED, V167, P418, DOI 10.7326/M17-0691; Berry JG, 2016, JAMA PEDIATR, V170, P319, DOI 10.1001/jamapediatrics.2015.4527; Braithwaite RS, 2014, SAGE OPEN MED, V2, DOI 10.1177/2050312114523425; National Committee for Quality Assurance, HEDIS 2018 RISK ADJ; National Quality Forum, RISK ADJ SOC STAT OT; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Pauly MV, 2010, NEW ENGL J MED, V362, P671, DOI 10.1056/NEJMp0912181	7	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2018	319	20					2077	2078		10.1001/jama.2018.3368	http://dx.doi.org/10.1001/jama.2018.3368			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4PT	29710277				2022-12-28	WOS:000432679400016
J	Eggermont, AMM; Blank, CU; Mandala, M; Long, GV; Atkinson, V; Dalle, S; Haydon, A; Lichinitser, M; Khattak, A; Carlino, MS; Sandhu, S; Larkin, J; Puig, S; Ascierto, PA; Rutkowski, P; Schadendorf, D; Koornstra, R; Hernandez-Aya, L; Maio, M; van den Eertwegh, AJM; Grob, JJ; Gutzmer, R; Jamal, R; Lorigan, P; Ibrahim, N; Marreaud, S; van Akkooi, ACJ; Suciu, S; Robert, C				Eggermont, Alexander M. M.; Blank, Christian U.; Mandala, Mario; Long, Georgina, V; Atkinson, Victoria; Dalle, Stephane; Haydon, Andrew; Lichinitser, Mikhail; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Maio, Michele; van den Eertwegh, Alfonsus J. M.; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; Lorigan, Paul; Ibrahim, Nageatte; Marreaud, Sandrine; van Akkooi, Alexander C. J.; Suciu, Stefan; Robert, Caroline			Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NODE-POSITIVE MELANOMA; HIGH-RISK MELANOMA; PEGYLATED INTERFERON-ALPHA-2B; CUTANEOUS MELANOMA; ANTI-PD-1 THERAPY; PHASE-3 TRIAL; TUMOR BURDEN; EORTC 18952; IPILIMUMAB; SURVIVAL	BACKGROUND The programmed death 1 (PD-1) inhibitor pembrolizumab has been found to prolong progression-free and overall survival among patients with advanced melanoma. We conducted a phase 3 double-blind trial to evaluate pembrolizumab as adjuvant therapy in patients with resected, high-risk stage III melanoma. METHODS Patients with completely resected stage III melanoma were randomly assigned (with stratification according to cancer stage and geographic region) to receive 200 mg of pembrolizumab (514 patients) or placebo (505 patients) intravenously every 3 weeks for a total of 18 doses (approximately 1 year) or until disease recurrence or unacceptable toxic effects occurred. Recurrence-free survival in the overall intention-to-treat population and in the subgroup of patients with cancer that was positive for the PD-1 ligand (PD-L1) were the primary end points. Safety was also evaluated. RESULTS At a median follow-up of 15 months, pembrolizumab was associated with significantly longer recurrence-free survival than placebo in the overall intention-to-treat population (1-year rate of recurrence-free survival, 75.4% [95% confidence interval {CI}, 71.3 to 78.9] vs. 61.0% [95% CI, 56.5 to 65.1]; hazard ratio for recurrence or death, 0.57; 98.4% CI, 0.43 to 0.74; P < 0.001) and in the subgroup of 853 patients with PD-L1-positive tumors (1-year rate of recurrence-free survival, 77.1% [95% CI, 72.7 to 80.9] in the pembrolizumab group and 62.6% [95% CI, 57.7 to 67.0] in the placebo group; hazard ratio, 0.54; 95% CI, 0.42 to 0.69; P < 0.001). Adverse events of grades 3 to 5 that were related to the trial regimen were reported in 14.7% of the patients in the pembrolizumab group and in 3.4% of patients in the placebo group. There was one treatment-related death due to myositis in the pembrolizumab group. CONCLUSIONS As adjuvant therapy for high-risk stage III melanoma, 200 mg of pembrolizumab administered every 3 weeks for up to 1 year resulted in significantly longer recurrence-free survival than placebo, with no new toxic effects identified.	[Eggermont, Alexander M. M.; Robert, Caroline] Gustave Roussy, Canc Campus Grand Paris, F-94805 Villejuif, France; [Eggermont, Alexander M. M.; Robert, Caroline] Univ Paris Saclay, F-94805 Villejuif, France; [Dalle, Stephane] Lyon Univ, Canc Res Ctr Lyon, Canc Inst, Hosp Civils Lyon, Lyon, France; [Grob, Jean-Jacques] Aix Marseille Univ, Hop la Timone, AP HM, Marseille, France; [Blank, Christian U.; van Akkooi, Alexander C. J.] Netherlands Canc Inst Antoni van Leeuwenhoek, Amsterdam, Netherlands; [van den Eertwegh, Alfonsus J. M.] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Koornstra, Rutger] Radboud Univ Nijmegen, Med Ctr Nijmegen, Nijmegen, Netherlands; [Mandala, Mario] Azienda Osped Papa Giovanni XXIII, Bergamo, Italy; [Ascierto, Paolo A.] Ist Ricovero & Cura Carattere Sci Fdn G Pascale, Ist Nazl Tumori, Naples, Italy; [Maio, Michele] Univ Siena, Policlin Scotte, Siena, Italy; [Long, Georgina, V; Carlino, Matteo S.] Univ Sydney, Sydney, NSW, Australia; [Long, Georgina, V] Mater Hosp, Sydney, NSW, Australia; [Long, Georgina, V] Royal North Shore Hosp, Sydney, NSW, Australia; [Carlino, Matteo S.] Westmead Hosp, Sydney, NSW, Australia; [Carlino, Matteo S.] Blacktown Hosp, Melanoma Inst Australia, Sydney, NSW, Australia; [Atkinson, Victoria] Univ Queensland, Princess Alexandra Hosp, Brisbane, Qld, Australia; [Haydon, Andrew] Alfred Hosp, Melbourne, Vic, Australia; [Sandhu, Shahneen] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Khattak, Adnan] Edith Cowan Univ Perth, Univ Western Australia, Fiona Stanley Hosp, Perth, WA, Australia; [Lichinitser, Mikhail] Canc Res Ctr, Moscow, Russia; [Larkin, James] Royal Marsden Hosp, London, England; [Puig, Susana] Univ Barcelona, Hosp Clin Barcelona, Barcelona, Spain; [Rutkowski, Piotr] Maria Sklodowska Curie Inst, Oncol Ctr, Warsaw, Poland; [Schadendorf, Dirk] Univ Hosp Essen, Essen, Germany; [Schadendorf, Dirk] German Canc Consortium, Heidelberg, Germany; [Gutzmer, Ralf] Hannover Med Sch, Skin Canc Ctr, Dept Dermatol, Hannover, Germany; [Hernandez-Aya, Leonel] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Jamal, Rahima] CHUM, Ctr Rech, Montreal, PQ, Canada; [Lorigan, Paul] Christie NHS Fdn Trust, Manchester, Lancs, England; [Ibrahim, Nageatte] Merck, Kenilworth, NJ USA; [Marreaud, Sandrine; Suciu, Stefan] European Org Res & Treatment Canc Headquarters, Brussels, Belgium	UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; CHU Lyon; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Netherlands Cancer Institute; Vrije Universiteit Amsterdam; Radboud University Nijmegen; ASST Papa Giovanni XXIII; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Siena; University of Sydney; Royal North Shore Hospital; University of Sydney; Blacktown & Mount Druitt Hospital; Melanoma Institute Australia; University of Queensland; Florey Institute of Neuroscience & Mental Health; Peter Maccallum Cancer Center; Edith Cowan University; University of Western Australia; Royal Marsden NHS Foundation Trust; University of Barcelona; Hospital Clinic de Barcelona; Maria Sklodowska-Curie National Research Institute of Oncology; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); Hannover Medical School; Washington University (WUSTL); Universite de Montreal; Christie NHS Foundation Trust; Merck & Company; European Organisation for Research & Treatment of Cancer	Eggermont, AMM (corresponding author), Gustave Roussy, Canc Campus Grand Paris, F-94805 Villejuif, France.; Eggermont, AMM (corresponding author), Univ Paris Saclay, F-94805 Villejuif, France.	alexander.eggermont@gustaveroussy.fr	Long, Georgina V/C-1771-2013; Ascierto, Paolo A/J-9106-2016; Atkinson, Victoria G/G-2507-2015; Puig, Susana/AAB-2091-2020; Mandala', Mario/AAA-4258-2019; mandala, mario/AAB-8637-2022; Dalle, Stephane/E-4552-2018; Robert, Caroline/G-6157-2018; Schadendorf, Dirk/AAE-8206-2019; Rutkowski, Piotr/B-3907-2013; Carlino, Matteo/GRS-7198-2022; Lorigan, Paul/J-6898-2015	Long, Georgina V/0000-0001-8894-3545; Ascierto, Paolo A/0000-0002-8322-475X; Puig, Susana/0000-0003-1337-9745; Dalle, Stephane/0000-0002-3423-4548; Robert, Caroline/0000-0002-9493-0238; Rutkowski, Piotr/0000-0002-8920-5429; Lorigan, Paul/0000-0002-8875-2164; Melucci, Maria Teresa/0000-0002-1677-3345; Schadendorf, Dirk/0000-0003-3524-7858; Larkin, James/0000-0001-5569-9523; van Akkooi, Alexander Christopher Jonathan/0000-0002-3262-6935; Sandhu, Shahneen/0000-0002-8660-4475; Carlino, Matteo/0000-0002-7861-4104	Merck; Actelion; Agenus; Bayer; Bristol-Myers Squibb (BMS); GlaxoSmithKline (GSK); ISA Pharmaceuticals; HalioDX; MedImmune; Merck Serono; Merck Sharpe and Dohme (MSD); Nektar; Sanofi; BMS; Novartis; GSK; Lilly; MSD; Pfizer; Roche; Array; Amgen; Pierre Fabre; Incyte; Pierre-Fabre; Eisai; Kymab; Roche-Genentech; Larkin; Secarna; EUSA Pharma; Isdin; Genmab; NewLink Genetics; Syndax; AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; MerckEMD; Medicament; Merck-Pfizer; Sun Pharma; Johnson Johnson; Philiogen	Merck(Merck & Company); Actelion; Agenus; Bayer(Bayer AG); Bristol-Myers Squibb (BMS)(Bristol-Myers Squibb); GlaxoSmithKline (GSK)(GlaxoSmithKline); ISA Pharmaceuticals; HalioDX; MedImmune(AstraZenecaMedimmune); Merck Serono(Merck & Company); Merck Sharpe and Dohme (MSD); Nektar; Sanofi; BMS(Bristol-Myers Squibb); Novartis(Novartis); GSK(GlaxoSmithKline); Lilly(Eli Lilly); MSD; Pfizer(Pfizer); Roche(Roche Holding); Array; Amgen(Amgen); Pierre Fabre; Incyte; Pierre-Fabre; Eisai(Eisai Co Ltd); Kymab; Roche-Genentech(Roche HoldingGenentech); Larkin; Secarna; EUSA Pharma; Isdin; Genmab(Genmab); NewLink Genetics; Syndax; AstraZeneca(AstraZeneca); Blueprint Medicines; Boehringer Ingelheim(Boehringer Ingelheim); MerckEMD(Merck & Company); Medicament; Merck-Pfizer; Sun Pharma; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Philiogen	Supported by Merck.; Dr. Eggermont reports receiving advisory board fees from Actelion, Agenus, Bayer, Bristol-Myers Squibb (BMS), GlaxoSmithKline (GSK), Incyte, ISA Pharmaceuticals, HalioDX, MedImmune, Merck Serono, Merck Sharpe and Dohme (MSD), Nektar, and Sanofi, and advisory board fees and fees for data and safety monitoring board membership from Novartis and Pfizer; Dr. Blank, receiving grant support and fees for advising, paid to his institution, from BMS and Novartis, and fees for advising, paid to his institution, from GSK, Lilly, MSD, Pfizer, and Roche; Dr. Mandala, receiving consulting fees, lecture fees, and fees for serving on speakers' bureaus from MSD and BMS; Dr. Long, receiving consulting fees from Array, BMS, Novartis, Roche, Amgen, Pierre Fabre, MSD, and Incyte; Dr. Atkinson, receiving advisory board fees, lecture fees, and travel support from BMS, advisory board fees from Merck Serono, Pierre Fabre, and Roche, and advisory board fees and lecture fees from MSD and Novartis; Dr. Dalle, receiving grant support and travel support from BMS and travel support from MSD; Dr. Haydon, receiving advisory board fees from Novartis and Pierre-Fabre; Dr. Khattak, receiving lecture fees and travel support from MSD; Dr. Carlino, receiving advisory board fees from MSD, BMS, and Novartis; Dr. Sandhu, receiving advisory board fees from Merck and BMS; Dr. Larkin, receiving consulting fees from Eisai, GSK, Kymab, Roche-Genentech, Secarna, Pierre Fabre, and EUSA Pharma, and grant support and consulting fees from BMS, MSD, Pfizer, and Novartis; Dr. Puig, receiving patients' fees, paid to her institution, from Amgen, Biofrontera, Regeneron Pharmaceuticals, and Philiogen, advisory board fees from Isdin, course fees paid on her behalf by Lilly, lecture fees and training fees paid of her behalf by LaRoche Posay, grant support, advisory board fees, and patients' fees, paid to her institution, from Leo Pharma and Almirall, grant support, honoraria, and fees to attend a seminar paid on her behalf by Novartis, grant support and lecture fees from Roche, lecture fees from Pierre Fabre, and lecture fees and patients' fees, paid to her institution, from BMS; Dr. Ascierto, receiving grant support, consulting fees, and advisory fees from BMS, Roche-Genentech, and Array, and consulting fees and advisory fees from MSD, Novartis, Amgen, Merck Serono, Pierre Fabre, Incyte, Genmab, NewLink Genetics, MedImmune, Syndax, and AstraZeneca; Dr. Rutkowski, receiving lecture fees and advisory board fees from MSD, Roche, and Amgen, grant support, lecture fee, and advisory board fees from BMS and Novartis, advisory board fees from Blueprint Medicines, and lecture fees from Pfizer; Dr. Schadendorf, receiving advisory board fees from Amgen, Leo Pharma, AstraZeneca, Pfizer, and Array, lecture fees from Boehringer Ingelheim, advisory board fees, lecture fees and patients' fees from Roche, Novartis, BMS, and MerckEMD, advisory board fees and lecture fees from Incyte and Pierre Fabre, advisory board fees and patients' fees from Regeneron and Philiogen, and honoraria from 4SC; Dr. Koornstra, receiving advisory board fees and lecture fees from Novartis and BMS, advisory board fees from Roche and Pierre Fabre Medicament, and lecture fees from MSD; Dr. Hernandez-Aya, receiving fees to conduct clinical trials, paid to his institution, from BMS, Merck, Amgen, Roche, Regeneron, Novartis, Immunocore, Merck-EMD, Corvus, Polynoma, and Genentech; Dr. Maio, receiving advisory board fees from BMS, Roche, MSD, AstraZeneca, GSK, and Incyte; Dr.; van den Eertwegh, receiving advisory board fees from BMS, MSD, Amgen, Novartis, and Roche; Dr. Grob, receiving advisory board fees from MSD, BMS, Novartis, Amgen, Merck-Pfizer, and Pierre-Fabre, grant support and advisory board fees from Roche, and grant support from Sun Pharma; Dr. Gutzmer, lecture fees, honoraria, and patients' fees from Amgen, lecture fees from Boehringer Ingelheim and AstraZeneca, honoraria from Leo Pharma and Incyte, lecture fees, honoraria, support for meeting participation, and patients' fees from Roche and BMS, grant support, lecture fees, honoraria, and patients' fees from Novartis, honoraria and patients' fees from Regeneron and 4SC, lecture fees, honoraria, and support for meeting participation from Pierre Fabre, lecture fees and honoraria from Merck-EMD and Almirall-Hermal, grant support from Pfizer and Johnson & Johnson, and patients' fees from Philiogen and Array; Dr. Jamal, receiving grant support and patients' fees, paid to her institution, from BMS and Merck, and patients' fees, paid to her institution, from Pfizer, Roche-Genentech, AstraZeneca, Novartis, MedImmune, and GSK; Dr. Lorigan, receiving grant support, advisory board fees, fees for serving on a speakers' bureau, and travel support from Bristol-Myers Squibb, advisory board fees, fees for serving on a speakers' bureau, and travel support from MSD, advisory board fees and fees for serving on a speakers bureau from Novartis and Roche, and advisory board fees from Amgen, Nektar, Pierre Fabre, and Nera Care; Dr. Ibrahim, being employed by and owning stock in Merck, and owning stock in GSK; Dr. van Akkooi, receiving grant support, consulting fees, and honoraria from Amgen and Novartis, and consulting fees and honoraria from MSD, Merck-Pfizer, and BMS; and Dr. Robert, receiving consulting fees and advisory board fees from BMS, GSK, Novartis, Amgen, Merck, and Roche. No other potential conflict of interest relevant to this article was reported.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Daud AI, 2016, J CLIN ONCOL, V34, P4102, DOI 10.1200/JCO.2016.67.2477; Eggermont AMM, 2016, NEW ENGL J MED, V375, P1845, DOI 10.1056/NEJMoa1611299; Eggermont AMM, 2008, LANCET, V372, P117, DOI 10.1016/S0140-6736(08)61033-8; Eggermont AMM, 2017, EUR J CANCER, V86, P101, DOI 10.1016/j.ejca.2017.09.014; Eggermont AMM, 2016, EUR J CANCER, V55, P111, DOI 10.1016/j.ejca.2015.11.014; Eggermont AMM, 2015, LANCET ONCOL, V16, P522, DOI 10.1016/S1470-2045(15)70122-1; Eggermont AMM, 2014, LANCET, V383, P816, DOI 10.1016/S0140-6736(13)60802-8; Eggermont AMM, 2012, J CLIN ONCOL, V30, P3810, DOI 10.1200/JCO.2011.41.3799; Eggermont AMM, 2012, EUR J CANCER, V48, P218, DOI 10.1016/j.ejca.2011.09.028; Eggermont AMM, 2005, LANCET, V366, P1189, DOI 10.1016/S0140-6736(05)67482-X; Faries MB, 2017, NEW ENGL J MED, V376, P2211, DOI 10.1056/NEJMoa1613210; Garbe C, 2016, EUR J CANCER, V63, P201, DOI 10.1016/j.ejca.2016.05.005; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hofmann L, 2016, EUR J CANCER, V60, P190, DOI 10.1016/j.ejca.2016.02.025; Ives NJ, 2017, EUR J CANCER, V82, P171, DOI 10.1016/j.ejca.2017.06.006; Leiter U, 2016, LANCET ONCOL, V17, P757, DOI 10.1016/S1470-2045(16)00141-8; Long GV, 2017, NEW ENGL J MED, V377, P1813, DOI 10.1056/NEJMoa1708539; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Spiessens B, 2010, CONTEMP CLIN TRIALS, V31, P647, DOI 10.1016/j.cct.2010.08.011; Suciu S, 2018, JNCI-J NATL CANCER I, V110, P87; Ugurel S, 2017, EUR J CANCER, V83, P247, DOI 10.1016/j.ejca.2017.06.028; van Akkooi ACJ, 2008, ANN SURG, V248, P949, DOI 10.1097/SLA.0b013e31818fefe0; van der Ploeg APT, 2014, EUR J CANCER, V50, P111, DOI 10.1016/j.ejca.2013.08.023; van der Ploeg APT, 2011, J CLIN ONCOL, V29, P2206, DOI 10.1200/JCO.2010.31.6760; Weber J, 2017, NEW ENGL J MED, V377, P1824, DOI 10.1056/NEJMoa1709030; Zimmer L, 2016, EUR J CANCER, V60, P210, DOI 10.1016/j.ejca.2016.02.024	30	965	992	4	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2018	378	19					1789	1801		10.1056/NEJMoa1802357	http://dx.doi.org/10.1056/NEJMoa1802357			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF2MO	29658430	Bronze, Green Published			2022-12-28	WOS:000431774400006
J	Kim, C; Gao, RL; Sei, E; Brandt, R; Hartman, J; Hatschek, T; Crosetto, N; Foukakis, T; Navin, NE				Kim, Charissa; Gao, Ruli; Sei, Emi; Brandt, Rachel; Hartman, Johan; Hatschek, Thomas; Crosetto, Nicola; Foukakis, Theodoros; Navin, Nicholas E.			Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing	CELL			English	Article							WHOLE-GENOME; TUMOR EVOLUTION; OVARIAN-CANCER; RNA-SEQ; MESENCHYMAL TRANSITION; EXTRACELLULAR-MATRIX; GENETIC-VARIATION; CLONAL EVOLUTION; REVEALS; HETEROGENEITY	Triple-negative breast cancer (TNBC) is an aggressive subtype that frequently develops resistance to chemotherapy. An unresolved question is whether resistance is caused by the selection of rare preexisting clones or alternatively through the acquisition of new genomic aberrations. To investigate this question, we applied single-cell DNA and RNA sequencing in addition to bulk exome sequencing to profile longitudinal samples from 20 TNBC patients during neoadjuvant chemotherapy (NAC). Deep-exome sequencing identified 10 patients in which NAC led to clonal extinction and 10 patients in which clones persisted after treatment. In 8 patients, we performed a more detailed study using single-cell DNA sequencing to analyze 900 cells and single-cell RNA sequencing to analyze 6,862 cells. Our data showed that resistant genotypes were pre-existing and adaptively selected by NAC, while transcriptional profiles were acquired by reprogramming in response to chemotherapy in TNBC patients.	[Kim, Charissa; Gao, Ruli; Sei, Emi; Brandt, Rachel; Navin, Nicholas E.] UT MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Kim, Charissa; Navin, Nicholas E.] UT MD Anderson Canc Ctr, Grad Sch Biol Sci, Houston, TX 77030 USA; [Hartman, Johan; Hatschek, Thomas; Foukakis, Theodoros] Karolinska Inst, Dept Oncol Pathol, SE-17176 Stockholm, Sweden; [Crosetto, Nicola] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Navin, Nicholas E.] UT MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Karolinska Institutet; Karolinska Institutet; University of Texas System; UTMD Anderson Cancer Center	Navin, NE (corresponding author), UT MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.; Navin, NE (corresponding author), UT MD Anderson Canc Ctr, Grad Sch Biol Sci, Houston, TX 77030 USA.; Foukakis, T (corresponding author), Karolinska Inst, Dept Oncol Pathol, SE-17176 Stockholm, Sweden.; Navin, NE (corresponding author), UT MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA.	theodoros.foukakis@ki.se; nnavin@mdanderson.org	Kim, Charissa/AAO-5993-2020	Kim, Charissa/0000-0003-4899-5898; Gao, Ruli/0000-0002-1137-4564; Foukakis, Theodoros/0000-0001-8952-9987	Lefkofsky Family Foundation; NCI [1RO1CA169244-01]; American Cancer Society [129098-RSG-16-092-01-TBG]; MD Anderson Sequencing Core Facility Grant [CA016672]; Flow Cytometry Facility grant from the NIH [CA016672]; Breast Cancer Research Foundation [N013869]; Swedish Cancer Society [CAN 2015/713]; Cancer Society in Stockholm [154132, 081141]; KI-MDACC grant from the Sister Network Institution Fund and GAP program at MD Anderson [40033]; StratCan at the Karolinska Institute; ALA Fellowship; Susan Komen Postdoctoral Fellowship [PDF17487910]; AACR Basic Cancer Research Fellowship [17-40-42-GAO]; Roche; Swedish Breast Cancer Association; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA169244] Funding Source: NIH RePORTER	Lefkofsky Family Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); MD Anderson Sequencing Core Facility Grant; Flow Cytometry Facility grant from the NIH; Breast Cancer Research Foundation; Swedish Cancer Society(Swedish Cancer Society); Cancer Society in Stockholm; KI-MDACC grant from the Sister Network Institution Fund and GAP program at MD Anderson; StratCan at the Karolinska Institute; ALA Fellowship; Susan Komen Postdoctoral Fellowship(Susan G. Komen Breast Cancer Foundation); AACR Basic Cancer Research Fellowship; Roche(Roche Holding); Swedish Breast Cancer Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants to N.E.N. from the Lefkofsky Family Foundation, NCI (1RO1CA169244-01), and the American Cancer Society (129098-RSG-16-092-01-TBG). N.E.N. is a T.C. Hsu Endowed Scholar, AAAS Wachtel Scholar, Andrew Sabin Family Fellow, and Randall Innovator. This study was supported by the MD Anderson Sequencing Core Facility Grant (CA016672) and the Flow Cytometry Facility grant from the NIH (CA016672). The study was also supported by grants from the Breast Cancer Research Foundation (N013869), the Swedish Cancer Society (CAN 2015/713), and the Cancer Society in Stockholm (154132) to T.F. The study was also supported by a KI-MDACC grant from the Sister Network Institution Fund and GAP program (40033) at MD Anderson to N.E.N. and the StratCan at the Karolinska Institute to N.C., T.F., and J.H. Additional funding support includes the ALA Fellowship to C.K., Susan Komen Postdoctoral Fellowship (PDF17487910) to R.G., and AACR Basic Cancer Research Fellowship (17-40-42-GAO) to R.G. The PROMIX clinical trial was supported by grants from Roche, the Cancer Society in Stockholm (154132, 081141), and the Swedish Breast Cancer Association to T.H. We thank Helen Piwnica-Worms, Gloria Echeverria, Funda Meric-Bernstam, Debu Tripathy, Ken Chen, and Russell Broaddus for useful discussions and Sohrab Shah for assistance with software.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; [Anonymous], 2017, BIORXIV; [Anonymous], 2002, MANUAL SETTING USING; Balko JM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3001; Balko JM, 2014, CANCER DISCOV, V4, P232, DOI 10.1158/2159-8290.CD-13-0286; Balko JM, 2012, NAT MED, V18, P1052, DOI 10.1038/nm.2795; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cosse JP, 2008, ANTI-CANCER AGENT ME, V8, P790, DOI 10.2174/187152008785914798; Creighton CJ, 2007, ONCOGENE, V26, P4648, DOI 10.1038/sj.onc.1210245; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; do Valle IF, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1190-7; Doktorova H, 2015, BIOMED PAP, V159, P166, DOI 10.5507/bp.2015.025; Donaldson J, 2016, T DISTRIBUTED STOCHA; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gao RL, 2016, NAT GENET, V48, P1119, DOI 10.1038/ng.3641; Gendoo DMA, 2016, BIOINFORMATICS, V32, P1097, DOI 10.1093/bioinformatics/btv693; Gerstung M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1814; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Habib N, 2016, SCIENCE, V353, P925, DOI 10.1126/science.aad7038; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hennig C., 2015, FPC FLEXIBLE PROCEDU; Hu YZ, 2013, J CELL BIOCHEM, V114, P498, DOI 10.1002/jcb.24390; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/nmeth.2772, 10.1038/NMETH.2772]; Jaakkola MK, 2017, BRIEF BIOINFORM, V18, P735, DOI 10.1093/bib/bbw057; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Kim H, 2015, GENOME RES, V25, P316, DOI 10.1101/gr.180612.114; Kim SH, 2007, ANN NY ACAD SCI, V1095, P82, DOI 10.1196/annals.1397.012; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kolodziejczyk AA, 2015, MOL CELL, V58, P610, DOI 10.1016/j.molcel.2015.04.005; Kurtova AV, 2015, NATURE, V517, P209, DOI 10.1038/nature14034; Lake BB, 2016, SCIENCE, V352, P1586, DOI 10.1126/science.aaf1204; Langdon WB, 2015, BIODATA MIN, V8, DOI 10.1186/s13040-014-0034-0; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Luria SE, 1943, GENETICS, V28, P491; Malikic S, 2015, BIOINFORMATICS, V31, P1349, DOI 10.1093/bioinformatics/btv003; Marcucci F, 2016, NAT REV DRUG DISCOV, V15, P311, DOI 10.1038/nrd.2015.13; Martelotto LG, 2017, NAT MED, V23, P376, DOI 10.1038/nm.4279; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McPherson A, 2016, NAT GENET, V48, P758, DOI 10.1038/ng.3573; Meyer M, 2015, P NATL ACAD SCI USA, V112, P851, DOI 10.1073/pnas.1320611111; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin NE, 2014, CELL REP, V6, P417, DOI 10.1016/j.celrep.2014.01.035; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nilsen G., 2013, COPYNUMBER SEGMENTAT; Oesper L, 2014, BIOINFORMATICS, V30, P3532, DOI 10.1093/bioinformatics/btu651; Oesper L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r80; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Oskarsson T, 2013, BREAST, V22, pS66, DOI 10.1016/j.breast.2013.07.012; Owonikoko TK, 2013, AM SOC CLIN ONCOL ED; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Petit C, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2776-1; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/nmeth.2883, 10.1038/NMETH.2883]; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shah SP, 2006, BIOINFORMATICS, V22, pE431, DOI 10.1093/bioinformatics/btl238; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smith M., 2017, TIMESCAPE PATIENT CL; Smith M. A., 2016, BIORXIV, DOI [10.1101/080622, DOI 10.1101/080622]; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Tung PY, 2017, SCI REP-UK, V7, DOI 10.1038/srep39921; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang Y, 2015, MOL CELL, V58, P598, DOI 10.1016/j.molcel.2015.05.005; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886; Yuan JZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33883; Zahn H, 2017, NAT METHODS, V14, P167, DOI [10.1038/NMETH.4140, 10.1038/nmeth.4140]; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	88	437	454	29	187	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 3	2018	173	4					879	+		10.1016/j.cell.2018.03.041	http://dx.doi.org/10.1016/j.cell.2018.03.041			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GG1TU	29681456	Green Accepted, Bronze			2022-12-28	WOS:000432471100011
J	Cavalcanti, D				Cavalcanti, Daniel			Split, but still attached Entanglement survives between spatially separated atoms of an atomic cloud after it expands	SCIENCE			English	Editorial Material							CONTINUOUS VARIABLE SYSTEMS; CRITERION		[Cavalcanti, Daniel] Barcelona Inst Sci & Technol, Inst Ciencies Foton ICFO, Barcelona 08860, Spain	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO)	Cavalcanti, D (corresponding author), Barcelona Inst Sci & Technol, Inst Ciencies Foton ICFO, Barcelona 08860, Spain.	daniel.cavalcanti@icfo.eu						Cavalcanti D, 2017, REP PROG PHYS, V80, DOI 10.1088/1361-6633/80/2/024001; Duan LM, 2000, PHYS REV LETT, V84, P2722, DOI 10.1103/PhysRevLett.84.2722; Fadel M, 2018, SCIENCE, V360, P409, DOI 10.1126/science.aao1850; Friis N., 2017, ARXIV171111092QUANTP; Kunkel P, 2018, SCIENCE, V360, P413, DOI 10.1126/science.aao2254; Lange K, 2018, SCIENCE, V360, P416, DOI 10.1126/science.aao2035; Pezze L., 2017, ARXIV160901609V2QUAN; Schrodinger E, 1935, P CAMB PHILOS SOC, V31, P555, DOI 10.1017/S0305004100013554; Simon R, 2000, PHYS REV LETT, V84, P2726, DOI 10.1103/PhysRevLett.84.2726; Wang XL, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.210502; Wiseman HM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.140402	11	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					376	377		10.1126/science.aat4590	http://dx.doi.org/10.1126/science.aat4590			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1AR	29700250				2022-12-28	WOS:000430949600019
J	Phillips, C				Phillips, Carly			My second coming out	SCIENCE			English	Editorial Material									[Phillips, Carly] Univ Georgia, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Phillips, C (corresponding author), Univ Georgia, Athens, GA 30602 USA.	SciCareerEditor@aaas.org							0	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					458	458		10.1126/science.360.6387.458	http://dx.doi.org/10.1126/science.360.6387.458			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1AR	29700267	Bronze			2022-12-28	WOS:000430949600046
J	Smith, FA; Smith, REE; Lyons, SK; Payne, JL				Smith, Felisa A.; Smith, Rosemary E. Elliott; Lyons, S. Kathleen; Payne, Jonathan L.			Body size downgrading of mammals over the late Quaternary	SCIENCE			English	Article							MASS EXTINCTION; MEGAFAUNA; OVERKILL; EUROPE; WORLD; EARTH	Since the late Pleistocene, large-bodied mammals have been extirpated from much of Earth. Although all habitable continents once harbored giant mammals, the few remaining species are largely confined to Africa. This decline is coincident with the global expansion of hominins over the late Quaternary. Here, we quantify mammalian extinction selectivity, continental body size distributions, and taxonomic diversity over five time periods spanning the past 125,000 years and stretching approximately 200 years into the future. We demonstrate that size-selective extinction was already under way in the oldest interval and occurred on all continents, within all trophic modes, and across all time intervals. Moreover, the degree of selectivity was unprecedented in 65 million years of mammalian evolution. The distinctive selectivity signature implicates hominin activity as a primary driver of taxonomic losses and ecosystem homogenization. Because megafauna have a disproportionate influence on ecosystem structure and function, past and present body size downgrading is reshaping Earth's biosphere.	[Smith, Felisa A.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Smith, Rosemary E. Elliott] Univ Calif San Diego, Dept Math, La Jolla, CA 92093 USA; [Lyons, S. Kathleen] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Payne, Jonathan L.] Stanford Univ, Dept Geol Sci, Stanford, CA 94305 USA	University of New Mexico; University of California System; University of California San Diego; University of Nebraska System; University of Nebraska Lincoln; Stanford University	Smith, FA (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	fasmith@unm.edu	Payne, Jonathan L/A-1240-2007; Smith, Felisa/ABE-6160-2021	Payne, Jonathan L/0000-0002-9601-3310; Smith, Felisa/0000-0001-6262-436X; Lyons, S. Kathleen/0000-0001-5112-2508	NSF [DEB-1555525, DEB-1257625, EAR-1151022]; Direct For Biological Sciences [1555525] Funding Source: National Science Foundation; Division Of Environmental Biology [1744223] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by NSF grants DEB-1555525, DEB-1257625, and EAR-1151022.	Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Burney DA, 2005, TRENDS ECOL EVOL, V20, P395, DOI 10.1016/j.tree.2005.04.022; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Carto SL, 2009, J HUM EVOL, V56, P139, DOI 10.1016/j.jhevol.2008.09.004; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Doughty CE, 2016, P NATL ACAD SCI USA, V113, P868, DOI 10.1073/pnas.1502549112; Ernest SKM, 2001, ECOLOGY, V82, P2118, DOI 10.2307/2680220; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Johnson CN, 2009, P ROY SOC B-BIOL SCI, V276, P2509, DOI 10.1098/rspb.2008.1921; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Lyons SK, 2004, EVOL ECOL RES, V6, P339; Mellars P, 2011, SCIENCE, V333, P623, DOI 10.1126/science.1206930; Nielsen R, 2017, NATURE, V541, P302, DOI 10.1038/nature21347; Oppenheimer S, 2012, PHILOS T R SOC B, V367, P770, DOI 10.1098/rstb.2011.0306; Payne JL, 2016, SCIENCE, V353, P1284, DOI 10.1126/science.aaf2416; Plotnick RE, 2016, ECOL LETT, V19, P546, DOI 10.1111/ele.12589; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Roebroeks W, 2011, P NATL ACAD SCI USA, V108, P5209, DOI 10.1073/pnas.1018116108; Smith FA, 2016, ECOGRAPHY, V39, P99, DOI 10.1111/ecog.02156; Smith FA, 2016, P NATL ACAD SCI USA, V113, P874, DOI 10.1073/pnas.1502547112; Smith FA, 2010, SCIENCE, V330, P1216, DOI 10.1126/science.1194830; Surovell T, 2005, P NATL ACAD SCI USA, V102, P6231, DOI 10.1073/pnas.0501947102; Surovell Todd A., 2009, P77, DOI 10.1007/978-1-4020-8793-6_5; Timmermann A, 2016, NATURE, V538, P92, DOI 10.1038/nature19365; Turvey ST, 2009, HOLOCENE EXTINCTIONS; World Wildlife Fund, 2016, LIV PLAN REP 2016 RI; Zuo WY, 2013, AM NAT, V182, P524, DOI 10.1086/671995	30	121	124	6	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2018	360	6386					310	+		10.1126/science.aao5987	http://dx.doi.org/10.1126/science.aao5987			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD3IC	29674591	Green Published			2022-12-28	WOS:000430396600042
J	Sydnes, LK				Sydnes, Leiv K.			How to curb production of chemical weapons	NATURE			English	Editorial Material									[Sydnes, Leiv K.] Univ Bergen, Chem, Bergen, Norway	University of Bergen	Sydnes, LK (corresponding author), Univ Bergen, Chem, Bergen, Norway.	leiv.sydnes@uib.no						[Anonymous], 2005, CONV PROH DEV PROD S; [Anonymous], 2007, COMPENDIUM CHEM WARF; KRUGLYAK YL, 1972, ZH OBSHCH KHIM+, V42, P811; Malygin VV, 2003, J TOXICOL ENV HEAL A, V66, P611, DOI 10.1080/15287390390156326; OPCW Technical Secretariat, 2017, STAT LAB DES AN AUTH; Pearson GS, 2005, GLOB ISS SER, P1, DOI 10.1057/9780230512580; RAEVSKII OA, 1987, ZH OBSHCH KHIM+, V57, P2073	7	3	3	8	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2018	556	7701					293	295		10.1038/d41586-018-04579-2	http://dx.doi.org/10.1038/d41586-018-04579-2			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1TW	29654293	Bronze			2022-12-28	WOS:000430285200022
J	Bekiari, E; Karagiannis, T; Tsapas, A				Bekiari, Eleni; Karagiannis, Thomas; Tsapas, Apostolos			In type 2 diabetes, weekly semaglutide reduced HbA(1c) and increased weight loss more than weekly ER exenatide	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARDIOVASCULAR OUTCOMES; LIRAGLUTIDE		[Bekiari, Eleni; Karagiannis, Thomas; Tsapas, Apostolos] Aristotle Univ Thessaloniki, Thessaloniki, Greece	Aristotle University of Thessaloniki	Bekiari, E (corresponding author), Aristotle Univ Thessaloniki, Thessaloniki, Greece.		Tsapas, Apostolos/P-5593-2019; Karagiannis, Thomas/H-9476-2019	Tsapas, Apostolos/0000-0003-0221-4072; Bekiari, Eleni/0000-0001-9975-3835; Karagiannis, Thomas/0000-0001-5242-0574				Buse JB, 2013, LANCET, V381, P117, DOI 10.1016/S0140-6736(12)61267-7; Holman RR, 2017, NEW ENGL J MED, V377, P1228, DOI 10.1056/NEJMoa1612917; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Marso SP, 2016, NEW ENGL J MED, V375, P1834, DOI 10.1056/NEJMoa1607141; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827	5	0	0	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2018	168	8					JC46	JC46		10.7326/ACPJC-2018-168-8-046	http://dx.doi.org/10.7326/ACPJC-2018-168-8-046			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GC8XZ	29677253				2022-12-28	WOS:000430083100011
J	Saegusa, A				Saegusa, A			Japanese labs balk at bid to boost external evaluation	NATURE			English	News Item																		ARIMA, 1993, NATURE, V362, P387; 1998, NATURE, V395, P730	2	1	1	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					378	378		10.1038/16989	http://dx.doi.org/10.1038/16989			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667981	Bronze			2022-12-28	WOS:000078461700014
J	Bekelman, JE; Joffe, S				Bekelman, Justin E.; Joffe, Steven			Three Steps Toward a More Sustainable Path for Targeted Cancer Drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bekelman, Justin E.] Univ Penn, Leonard Davis Inst Hlth Econ, Perelman Sch Med, Abramson Canc Ctr,Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Joffe, Steven] Univ Penn, Leonard Davis Inst Hlth Econ, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Bekelman, JE (corresponding author), Univ Penn, Perelman Sch Med, 3400 Civ Ctr Blvd,4W, Philadelphia, PA 19104 USA.	bekelman@upenn.edu	Joffe, Steven/H-3941-2019	Joffe, Steven/0000-0002-0667-7384	NATIONAL CANCER INSTITUTE [K07CA163616] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Hochhaus A, 2017, NEW ENGL J MED, V376, P917, DOI 10.1056/NEJMoa1609324; INIS Institute for Healthcare Informatics, 2016, GLOB ONC TREND REP; MS Institute for Healthcare Informatics, 2017, MED US SPEND US; US Department of Health and Human Services, 2017, HIGH PRIC DRUGS AR I; *US FDA, CANC DRUG APPR ENDP; US Food and Drug Administration, 2017, FDA APPR NER EXT ADJ	6	8	8	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2018	319	21					2167	2168		10.1001/jama.2018.3414	http://dx.doi.org/10.1001/jama.2018.3414			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI1MA	29710240				2022-12-28	WOS:000434133400010
J	Farrell, JA; Wang, YQ; Riesenfeld, SJ; Shekhar, K; Regev, A; Schier, AF				Farrell, Jeffrey A.; Wang, Yiqun; Riesenfeld, Samantha J.; Shekhar, Karthik; Regev, Aviv; Schier, Alexander F.			Single-cell reconstruction of developmental trajectories during zebrafish embryogenesis	SCIENCE			English	Article							ENDODERM FORMATION; EXPRESSION; FATE; GENE; GASTRULATION; FIBROBLASTS; MYOBLASTS; DYNAMICS; CASANOVA; PROTEIN		[Farrell, Jeffrey A.; Wang, Yiqun; Schier, Alexander F.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Riesenfeld, Samantha J.; Shekhar, Karthik; Regev, Aviv; Schier, Alexander F.] Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Koch Inst Integrat Canc Res, Dept Biol, Cambridge, MA 02140 USA; [Schier, Alexander F.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Schier, Alexander F.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Schier, Alexander F.] Univ Basel, Biozentrum, Basel, Switzerland; [Schier, Alexander F.] Univ Washington, Allen Discovery Ctr Cell Lineage Tracing, Seattle, WA 98195 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; University of Basel; University of Washington; University of Washington Seattle	Schier, AF (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.; Regev, A; Schier, AF (corresponding author), Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA.; Regev, A (corresponding author), MIT, Howard Hughes Med Inst, Koch Inst Integrat Canc Res, Dept Biol, Cambridge, MA 02140 USA.; Schier, AF (corresponding author), Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA.; Schier, AF (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.; Schier, AF (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.; Schier, AF (corresponding author), Univ Washington, Allen Discovery Ctr Cell Lineage Tracing, Seattle, WA 98195 USA.	aregev@broadinstitute.org; schier@fas.harvard.edu	Horwitz, Marshall/AAE-8376-2021	Regev, Aviv/0000-0003-3293-3158; Riesenfeld, Samantha/0000-0001-9144-021X; Wang, Yiqun/0000-0001-6861-8761; Schier, Alexander Franz/0000-0001-7645-5325; Farrell, Jeffrey/0000-0003-4774-1562	NIH; Allen Discovery Center for Cell Lineage Tracing; Jane Coffin Childs Memorial Fund; Charles A. King Trust; Howard Hughes Medical Institute; Klarman Cell Observatory; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K99HD091291, R01HD085905, DP1HD094764] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K99EY028625] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RM1HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH105960] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allen Discovery Center for Cell Lineage Tracing; Jane Coffin Childs Memorial Fund; Charles A. King Trust; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Klarman Cell Observatory; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the NIH (A.F.S., J.A.F., and A.R.), Allen Discovery Center for Cell Lineage Tracing (A.F.S.), Jane Coffin Childs Memorial Fund (J.A.F.), Charles A. King Trust (J.A.F.), Howard Hughes Medical Institute (A.R.), and Klarman Cell Observatory (A.R.).	Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Cannoodt R, 2016, EUR J IMMUNOL, V46, P2496, DOI 10.1002/eji.201646347; Carmany-Rampey A, 2001, CURR BIOL, V11, P1261, DOI 10.1016/S0960-9822(01)00353-0; Chechik G, 2008, NAT BIOTECHNOL, V26, P1251, DOI 10.1038/nbt.1499; Cusanovich DA, 2018, NATURE, V555, P538, DOI 10.1038/nature25981; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dickmeis T, 2001, GENE DEV, V15, P1487, DOI 10.1101/gad.196901; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Gardiner MR, 2007, MECH DEVELOP, V124, P762, DOI 10.1016/j.mod.2007.06.005; Gritsman K, 2000, DEVELOPMENT, V127, P921; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Haghverdi L, 2015, BIOINFORMATICS, V31, P2989, DOI 10.1093/bioinformatics/btv325; Halpern ME, 1995, DEVELOPMENT, V121, P4257; Jang SM, 2017, ELIFE, V6, DOI 10.7554/eLife.20487; Kikuchi Y, 2001, GENE DEV, V15, P1493, DOI 10.1101/gad.892301; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Moens CB, 2002, DEV DYNAM, V224, P1, DOI 10.1002/dvdy.10086; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Raj B., 2018, NAT BIOTECHNOL, V40, P181; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Seiliez I, 2006, DEV BIOL, V290, P152, DOI 10.1016/j.ydbio.2005.11.021; Setty M, 2016, NAT BIOTECHNOL, V34, P637, DOI 10.1038/nbt.3569; Swindell EC, 2008, GENESIS, V46, P177, DOI 10.1002/dvg.20380; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TALBOT WS, 1995, NATURE, V378, P150, DOI 10.1038/378150a0; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; THISSE C, 1994, DEV BIOL, V164, P420, DOI 10.1006/dbio.1994.1212; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wagner A, 2016, NAT BIOTECHNOL, V34, P1145, DOI 10.1038/nbt.3711; WOO K, 1995, CURR OPIN GENET DEV, V5, P439, DOI 10.1016/0959-437X(95)90046-J; Zhang L, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.45	37	333	335	17	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2018	360	6392					979	+	eaar3131	10.1126/science.aar3131	http://dx.doi.org/10.1126/science.aar3131			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6SL	29700225	Green Published, Green Accepted			2022-12-28	WOS:000433574200032
J	Liu, LR; Hood, JD; Yu, Y; Zhang, JT; Hutzler, NR; Rosenband, T; Ni, KK				Liu, L. R.; Hood, J. D.; Yu, Y.; Zhang, J. T.; Hutzler, N. R.; Rosenband, T.; Ni, K. -K.			Building one molecule from a reservoir of two atoms	SCIENCE			English	Article							CHEMICAL-REACTIONS; POLAR-MOLECULES; BIMOLECULAR REACTIONS; OPTICAL TWEEZERS; NOBEL LECTURE; SINGLE ATOMS; QUANTUM; COLLISIONS; SCATTERING; DYNAMICS	Chemical reactions typically proceed via stochastic encounters between reactants. Going beyond this paradigm, we combined exactly two atoms in a single, controlled reaction. The experimental apparatus traps two individual laser-cooled atoms [one sodium (Na) and one cesium (Cs)] in separate optical tweezers and then merges them into one optical dipole trap. Subsequently, photoassociation forms an excited-state NaCs molecule. The discovery of previously unseen resonances near the molecular dissociation threshold and measurement of collision rates are enabled by the tightly trapped ultracold sample of atoms. As laser-cooling and trapping capabilities are extended to more elements, the technique will enable the study of more diverse, and eventually more complex, molecules in an isolated environment, as well as synthesis of designer molecules for qubits.	[Liu, L. R.; Hood, J. D.; Yu, Y.; Zhang, J. T.; Hutzler, N. R.; Ni, K. -K.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Liu, L. R.; Yu, Y.; Zhang, J. T.; Hutzler, N. R.; Rosenband, T.; Ni, K. -K.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Liu, L. R.; Hood, J. D.; Yu, Y.; Zhang, J. T.; Hutzler, N. R.; Ni, K. -K.] Harvard MIT Ctr Ultracold Atoms, Cambridge, MA 02138 USA; [Hutzler, N. R.] CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA	Harvard University; Harvard University; Harvard University; California Institute of Technology	Hutzler, NR (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Hutzler, NR (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.; Hutzler, NR (corresponding author), Harvard MIT Ctr Ultracold Atoms, Cambridge, MA 02138 USA.	ni@chemistry.harvard.edu	LIU, LEE/AAE-2624-2021	Hutzler, Nicholas/0000-0002-5203-3635	Arnold and Mabel Beckman Foundation; AFOSR Young Investigator Program; NSF through the Harvard-MIT CUA; Alfred P. Sloan Foundation	Arnold and Mabel Beckman Foundation; AFOSR Young Investigator Program; NSF through the Harvard-MIT CUA; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This work is supported by the Arnold and Mabel Beckman Foundation as well as the AFOSR Young Investigator Program, the NSF through the Harvard-MIT CUA, and the Alfred P. Sloan Foundation.	Barredo D, 2016, SCIENCE, V354, P1021, DOI 10.1126/science.aah3778; Bergmann K, 1998, REV MOD PHYS, V70, P1003, DOI 10.1103/RevModPhys.70.1003; Beugnon J, 2007, NAT PHYS, V3, P696, DOI 10.1038/nphys698; CLINE RA, 1994, OPT LETT, V19, P207, DOI 10.1364/OL.19.000207; DAGDIGAI.PJ, 1972, J CHEM PHYS, V57, P1487, DOI 10.1063/1.1678429; de Miranda MHG, 2011, NAT PHYS, V7, P502, DOI [10.1038/NPHYS1939, 10.1038/nphys1939]; DeMille D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.067901; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Endres M, 2016, SCIENCE, V354, P1024, DOI 10.1126/science.aah3752; Fuhrmanek A, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.062708; Grochola A, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.012507; Grochola A, 2010, CHEM PHYS LETT, V497, P22, DOI 10.1016/j.cplett.2010.07.093; Henson AB, 2012, SCIENCE, V338, P234, DOI 10.1126/science.1229141; HERSCHBACH DR, 1987, ANGEW CHEM INT EDIT, V26, P1221, DOI 10.1002/anie.198712211; Hutzler NR, 2017, NEW J PHYS, V19, DOI 10.1088/1367-2630/aa5a3b; Jones KM, 2006, REV MOD PHYS, V78, P483, DOI 10.1103/RevModPhys.78.483; Kaufman AM, 2014, SCIENCE, V345, P306, DOI 10.1126/science.1250057; Kaufman AM, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.041014; Klein A, 2017, NAT PHYS, V13, P35, DOI [10.1038/nphys3904, 10.1038/NPHYS3904]; Korek M, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2710257; LEE YT, 1987, ANGEW CHEM INT EDIT, V26, P939, DOI 10.1002/anie.198709393; LEROY RJ, 1970, J CHEM PHYS, V52, P3869, DOI 10.1063/1.1673585; Li X, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.103001; Liu KP, 2001, ANNU REV PHYS CHEM, V52, P139, DOI 10.1146/annurev.physchem.52.1.139; Liu L. R., 2017, ARXIV170103121PHYSIC; Marinescu M, 1999, PHYS REV A, V59, P390, DOI 10.1103/PhysRevA.59.390; MONROE C, 1995, PHYS REV LETT, V75, P4011, DOI 10.1103/PhysRevLett.75.4011; Moses SA, 2015, SCIENCE, V350, P659, DOI 10.1126/science.aac6400; Ni KK, 2010, NATURE, V464, P1324, DOI 10.1038/nature08953; Ospelkaus S, 2010, SCIENCE, V327, P853, DOI 10.1126/science.1184121; Ratschbacher L, 2012, NAT PHYS, V8, P649, DOI [10.1038/nphys2373, 10.1038/NPHYS2373]; Safronova MS, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.022505; Schlosser N, 2001, NATURE, V411, P1024, DOI 10.1038/35082512; Sompet P, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.051401; Sundar B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21699-x; Ueberholz B, 2000, J PHYS B-AT MOL OPT, V33, pL135, DOI 10.1088/0953-4075/33/4/105; Yao NY, 2018, NAT PHYS, V14, P405, DOI 10.1038/s41567-017-0030-7; Yu Y., 2017, ARXIV170803296PHYSIC	41	129	129	9	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391					900	904		10.1126/science.aar7797	http://dx.doi.org/10.1126/science.aar7797			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG9RW	29650700	Green Submitted, Green Accepted			2022-12-28	WOS:000433039800046
J	Landier, J; Parker, DM; Thu, AM; Lwin, KM; Delmas, G; Nosten, FH				Landier, Jordi; Parker, Daniel M.; Thu, Aung Myint; Lwin, Khin Maung; Delmas, Gilles; Nosten, Francois H.		Malaria Elimination Task Force Grp	Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme	LANCET			English	Article							SPREAD; EPIDEMIOLOGY; RESISTANCE; AREA	Background Potentially untreatable Plasmodium falciparum malaria threatens the Greater Mekong subregion. A previous series of pilot projects in Myanmar, Laos, Cambodia, and Vietnam suggested that mass drug administration was safe, and when added to provision of early diagnosis and treatment, could reduce the reservoir of P falciparum and interrupts transmission. We examined the effects of a scaled-up programme of this strategy in four townships of eastern Myanmar on the incidence of P falciparum malaria. Methods The programme was implemented in the four townships of Myawaddy, Kawkareik, Hlaingbwe, and Hpapun in Kayin state, Myanmar. Increased access to early diagnosis and treatment of malaria was provided to all villages through community-based malaria posts equipped with rapid diagnostic tests, and treatment with artemether-lumefantrine plus single low-dose primaquine. Villages were identified as malarial hotspots (operationally defined as > 40% malaria, of which 20% was P falciparum) with surveys using ultrasensitive quantitative PCR either randomly or targeted at villages where the incidence of clinical cases of P falciparum malaria remained high (ie, > 100 cases per 1000 individuals per year) despite a functioning malaria post. During each survey, a 2 mL sample of venous blood was obtained from randomly selected adults. Hotspots received targeted mass drug administration with dihydroartemisinin-piperaquine plus single-dose primaquine once per month for 3 consecutive months in addition to the malaria posts. The main outcome was the change in village incidence of clinical P falciparum malaria, quantified using a multivariate, generalised, additive multilevel model. Malaria prevalence was measured in the hotspots 12 months after mass drug administration. Findings Between May 1, 2014, and April 30, 2017, 1222 malarial posts were opened, providing early diagnosis and treatment to an estimated 365 000 individuals. Incidence of P falciparum malaria decreased by 60 to 98% in the four townships. 272 prevalence surveys were undertaken and 69 hotspot villages were identified. By April 2017, 50 hotspots were treated with mass drug administration. Hotspot villages had a three times higher incidence of P falciparum at malarial posts than neighbouring villages (adjusted incidence rate ratio [IRR] 2.7, 95% CI 1.8-4.4). Early diagnosis and treatment was associated with a significant decrease in P falciparum incidence in hotspots (IRR 0.82, 95% CI 0.76-0.88 per quarter) and in other villages (0.75, 0.73-0.78 per quarter). Mass drug administration was associated with a five-times decrease in P falciparum incidence within hotspot villages (IRR 0.19, 95% CI 0.13-0.26). By April, 2017, 965 villages (79%) of 1222 corresponding to 104 village tracts were free from P falciparum malaria for at least 6 months. The prevalence of wild-type genotype for K13 molecular markers of artemisinin resistance was stable over the three years (39%; 249/631). Interpretation Providing early diagnosis and effective treatment substantially decreased village-level incidence of artemisinin-resistant P falciparum malaria in hard-to-reach, politically sensitive regions of eastern Myanmar. Targeted mass drug administration significantly reduced malaria incidence in hotspots. If these activities could proceed in all contiguous endemic areas in addition to standard control programmes already implemented, there is a possibility of subnational elimination of P falciparum.	[Landier, Jordi; Parker, Daniel M.; Thu, Aung Myint; Lwin, Khin Maung; Delmas, Gilles; Nosten, Francois H.] Mahidol Univ, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, POB 46, Mae Sot 63110, Thailand; [Landier, Jordi] Aix Marseille Univ, Inst Rech Dev, INSERM, SESSTIM, Marseille, France; [Parker, Daniel M.] Univ Calif Irvine, Dept Populat Hlth & Dis Prevent, Irvine, CA USA; [Delmas, Gilles; Nosten, Francois H.] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of California System; University of California Irvine; University of Oxford	Landier, J (corresponding author), Mahidol Univ, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, POB 46, Mae Sot 63110, Thailand.	jordi.landier@gmail.com	Chaumeau, Victor/AAZ-5422-2021; gaudart, jean/D-9071-2013; Phyo, Aung Pyae/K-2413-2019; Parker, Daniel M./B-5471-2013; White, Lisa/AAC-9396-2020; Nosten, Francois/AAC-5509-2019	Chaumeau, Victor/0000-0003-0171-2176; gaudart, jean/0000-0001-9006-5729; Phyo, Aung Pyae/0000-0002-0383-9624; Parker, Daniel M./0000-0002-5352-7338; White, Lisa/0000-0002-6523-185X; Nosten, Francois/0000-0002-7951-0745; Bonnington, Craig A./0000-0003-3133-9384; White, Nicholas/0000-0002-1897-1978; corbel, vincent/0000-0003-0995-3257; Landier, Jordi/0000-0001-8619-9775; Tangseefa, Decha/0000-0002-0329-6471	Bill & Melinda Gates Foundation; Regional Artemisinin Initiative (Global Fund against AIDS, Tuberculosis and Malaria); Wellcome Trust	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Regional Artemisinin Initiative (Global Fund against AIDS, Tuberculosis and Malaria); Wellcome Trust(Wellcome TrustEuropean Commission)	The Bill & Melinda Gates Foundation, the Regional Artemisinin Initiative (Global Fund against AIDS, Tuberculosis and Malaria), and the Wellcome Trust.	Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Thu AM, 2017, FEBS J, V284, P2569, DOI 10.1111/febs.14127; Das S, 2017, AM J TROP MED HYG, V97, P1540, DOI 10.4269/ajtmh.17-0245; Eisele TP, 2016, J INFECT DIS, V214, P1831, DOI 10.1093/infdis/jiw416; Goncalves BP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01270-4; Imwong M, 2015, J INFECT DIS, V213; Imwong M, 2017, LANCET INFECT DIS, V17, P1022, DOI 10.1016/S1473-3099(17)30524-8; Imwong M, 2017, LANCET INFECT DIS, V17, P491, DOI [10.1016/s1473-3099(17)30048-8, 10.1016/S1473-3099(17)30048-8]; Imwong M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0906-x; Imwong M, 2014, J CLIN MICROBIOL, V52, P3303, DOI 10.1128/JCM.01057-14; Kajeechiwa Ladda, 2017, Wellcome Open Res, V2, P59, DOI 10.12688/wellcomeopenres.12051.1; Konig A., 2018, Wellcome Open Research, V3, P22, DOI 10.12688/wellcomeopenres.13965.1; Landier J, 2017, WELLCOME OPEN RES, V2, P1; Landier J, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1399-y; Luxemburger C, 1997, T ROY SOC TROP MED H, V91, P256, DOI 10.1016/S0035-9203(97)90066-3; Lwin KM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0838-5; Maude RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037166; Mu TT, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1567-0; Nguitragool W, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2407-y; Parker DM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0712-5; Parker DM, 2017, MYANMAR WELLCOME OPE, V2, P98; PAYNE D, 1987, PARASITOL TODAY, V3, P241, DOI 10.1016/0169-4758(87)90147-5; Phyo AP, 2016, CLIN INFECT DIS, V63, P784, DOI 10.1093/cid/ciw388; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Smithuis FM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-363; Stigler S M, 1997, Stat Methods Med Res, V6, P103; Tadesse FG, 2018, CLIN INFECT DIS, V66, P1883, DOI 10.1093/cid/cix1123; Tripura R, 2017, MALARIA J, V16, P1; Tun KM, 2015, LANCET INFECT DIS, V3099, P21; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; WHO, 2017, MASS DRUG ADM FALC M; World Health Organization, 2016, EL MAL GREAT MEK SUB	32	82	82	3	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2018	391	10133					1916	1926		10.1016/S0140-6736(18)30792-X	http://dx.doi.org/10.1016/S0140-6736(18)30792-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF3NC	29703425	Green Published, hybrid			2022-12-28	WOS:000431861800027
J	Espiritu, SMG; Liu, LY; Rubanova, Y; Bhandari, V; Holgersen, EM; Szyca, LM; Fox, NS; Chua, MLK; Yamaguchi, TN; Heisler, LE; Livingstone, J; Wintersinger, J; Yousif, F; Lalonde, E; Rouette, A; Salcedo, A; Houlahan, KE; Li, CH; Huang, V; Fraser, M; Van der Kwast, T; Morris, QD; Bristow, RG; Boutros, PC				Espiritu, Shadrielle Melijah G.; Liu, Lydia Y.; Rubanova, Yulia; Bhandari, Vinayak; Holgersen, Erle M.; Szyca, Lesia M.; Fox, Natalie S.; Chua, Melvin L. K.; Yamaguchi, Takafumi N.; Heisler, Lawrence E.; Livingstone, Julie; Wintersinger, Jeff; Yousif, Fouad; Lalonde, Emilie; Rouette, Alexandre; Salcedo, Adriana; Houlahan, Kathleen E.; Li, Constance H.; Huang, Vincent; Fraser, Michael; Van der Kwast, Theodorus; Morris, Quaid D.; Bristow, Robert G.; Boutros, Paul C.			The Evolutionary Landscape of Localized Prostate Cancers Drives Clinical Aggression	CELL			English	Article							SEQUENCING DATA; INTRATUMOR HETEROGENEITY; TUMORS; MUTATIONS; TRACKING; HISTORY	The majority of newly diagnosed prostate cancers are slow growing, with a long natural life history. Yet a subset can metastasize with lethal consequences. We reconstructed the phylogenies of 293 localized prostate tumors linked to clinical outcome data. Multiple subclones were detected in 59% of patients, and specific subclonal architectures associate with adverse clinicopathological features. Early tumor development is characterized by point mutations and deletions followed by later subclonal amplifications and changes in trinucleotide mutational signatures. Specific genes are selectively mutated prior to or following subclonal diversification, including MTOR, NKX3-1, and RB1. Patients with low-risk monoclonal tumors rarely relapse after primary therapy (7%), while those with high-risk polyclonal tumors frequently do (61%). The presence of multiple subclones in an index biopsy may be necessary, but not sufficient, for relapse of localized prostate cancer, suggesting that evolution-aware biomarkers should be studied in prospective studies of low-risk tumors suitable for active surveillance.	[Espiritu, Shadrielle Melijah G.; Liu, Lydia Y.; Bhandari, Vinayak; Holgersen, Erle M.; Szyca, Lesia M.; Fox, Natalie S.; Yamaguchi, Takafumi N.; Heisler, Lawrence E.; Livingstone, Julie; Yousif, Fouad; Lalonde, Emilie; Rouette, Alexandre; Salcedo, Adriana; Houlahan, Kathleen E.; Li, Constance H.; Huang, Vincent; Fraser, Michael; Boutros, Paul C.] Ontario Inst Canc Res, Informat & Biocomp Program, Toronto, ON M5G 1L7, Canada; [Rubanova, Yulia; Wintersinger, Jeff; Morris, Quaid D.] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3G4, Canada; [Rubanova, Yulia; Wintersinger, Jeff; Morris, Quaid D.] Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Bhandari, Vinayak; Fox, Natalie S.; Lalonde, Emilie; Salcedo, Adriana; Houlahan, Kathleen E.; Li, Constance H.; Bristow, Robert G.; Boutros, Paul C.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Chua, Melvin L. K.; Fraser, Michael; Morris, Quaid D.; Bristow, Robert G.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Van der Kwast, Theodorus] Toronto Gen Hosp, Univ Hlth Network, Dept Pathol & Lab Med, Toronto, ON M5S 1A1, Canada; [Boutros, Paul C.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A8, Canada; [Morris, Quaid D.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Morris, Quaid D.] Vector Inst Artificial Intelligence, Toronto, ON M5G 1M1, Canada	Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto	Boutros, PC (corresponding author), Ontario Inst Canc Res, Informat & Biocomp Program, Toronto, ON M5G 1L7, Canada.; Morris, QD (corresponding author), Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3G4, Canada.; Morris, QD (corresponding author), Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada.; Bristow, RG; Boutros, PC (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada.; Morris, QD; Bristow, RG (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada.; Boutros, PC (corresponding author), Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A8, Canada.; Morris, QD (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada.; Morris, QD (corresponding author), Vector Inst Artificial Intelligence, Toronto, ON M5G 1M1, Canada.	quaid.morris@utoronto.ca; robert.bristow@manchester.ac.uk; paul.boutros@oicr.on.ca	Morris, Quaid/ABE-8343-2020; Chua, Melvin LK/ABG-6045-2020	Chua, Melvin LK/0000-0002-1648-1473; Huang, Vincent/0000-0002-6504-179X; Morris, Quaid/0000-0002-2760-6999; Bhandari, Vinayak/0000-0003-0265-0835; Bristow, Robert/0000-0002-8553-9544; Heisler, Lawrence/0000-0002-1332-1802; Boutros, Paul/0000-0003-0553-7520; Yamaguchi, Takafumi/0000-0003-1082-3871; Lalonde, Emilie/0000-0002-8573-1966	Movember funds through Prostate Cancer Canada; Ontario Institute for Cancer Research; Government of Ontario; Canadian Institutes of Health Research; Princess Margaret Cancer Centre Foundation; Radiation Medicine Program Academic Enrichment Fund; Canadian Cancer Society Research Scientist Award; Prostate Cancer Canada; Movember Foundation [RS2014-01]; Princess Margaret Cancer Foundation Hold'em for Life Prostate Cancer Fund; Terry Fox Research Institute New Investigator Award; CIHR New Investigator Award; Genome Canada through a Large-Scale Applied Research Project; NSERC Discovery Grants [RGPIN-2016-05541]; Compute Resource Grant from Compute Canada; Canada First Research Excellence Fund (CFREF); Government of Canada through Genome Canada; Ontario Genomics Institute [OGI-125]	Movember funds through Prostate Cancer Canada; Ontario Institute for Cancer Research; Government of Ontario; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Princess Margaret Cancer Centre Foundation(University of Toronto); Radiation Medicine Program Academic Enrichment Fund; Canadian Cancer Society Research Scientist Award; Prostate Cancer Canada; Movember Foundation; Princess Margaret Cancer Foundation Hold'em for Life Prostate Cancer Fund; Terry Fox Research Institute New Investigator Award; CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); Genome Canada through a Large-Scale Applied Research Project(Genome Canada); NSERC Discovery Grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); Compute Resource Grant from Compute Canada; Canada First Research Excellence Fund (CFREF); Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute	The authors thank all members of the Boutros, Bristow, and Morris labs for helpful suggestions and technical support, especially Jennifer A. Aguiar, Jennifer J. Lin, and Kevin Thai. The authors gratefully thank Dr. Faiyaz Notta and Dr. Gavin Ha for insightful suggestions and critical commentary. This study was conducted with the support of Movember funds through Prostate Cancer Canada and with the additional support of the Ontario Institute for Cancer Research, funded by the Government of Ontario. This work has been funded by a fellowship from the Canadian Institutes of Health Research (to V.B.). The authors gratefully thank the Princess Margaret Cancer Centre Foundation and Radiation Medicine Program Academic Enrichment Fund for support (to R.G.B.). R.G.B. is a recipient of a Canadian Cancer Society Research Scientist Award. This work was supported by Prostate Cancer Canada and is proudly funded by the Movember Foundation (grant #RS2014-01 to P.C.B.). Work described in this manuscript was supported, in part, by the Princess Margaret Cancer Foundation Hold'em for Life Prostate Cancer Fund. P.C.B. was supported by a Terry Fox Research Institute New Investigator Award and a CIHR New Investigator Award. This project was supported by Genome Canada through a Large-Scale Applied Research Project contract (to P.C.B. and Drs. Ryan Morin and Sohrab P. Shah). This work was supported by NSERC Discovery Grants (RGPIN-2016-05541 to Q.D.M. and P.C.B.). PhyloWGS development was supported by a Compute Resource Grant from Compute Canada. This work has been funded by fellowships from the Canadian Institutes of Health Research (to L.Y.L., E.L., N.S.F., K.E.H., and A.S.), and the Government of Ontario (to E.L.), and Prostate Cancer Canada (to N.S.F.). TrackSig analysis was performed as part of the University of Toronto's Medicine by Design initiative, which receives funding from the Canada First Research Excellence Fund (CFREF). This work was funded by the Government of Canada through Genome Canada and the Ontario Genomics Institute (OGI-125). The results described here are in part based on data generated by the TCGA Research Network: https://cancergenome.nih.gov/.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Boutros PC, 2015, NAT GENET, V47, P736, DOI 10.1038/ng.3315; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; Cooper CS, 2015, NAT GENET, V47, P367, DOI 10.1038/ng.3221; Cuzick J, 2011, LANCET ONCOL, V12, P245, DOI 10.1016/S1470-2045(10)70295-3; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Demichelis F, 2009, GENE CHROMOSOME CANC, V48, P366, DOI 10.1002/gcc.20647; Deshwar AG, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0602-8; Ding JR, 2012, BIOINFORMATICS, V28, P167, DOI 10.1093/bioinformatics/btr629; Ding ZH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku181; Erho N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066855; Fraser M, 2017, NATURE, V541, P359, DOI 10.1038/nature20788; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Ha G, 2014, GENOME RES, V24, P1881, DOI 10.1101/gr.180281.114; Halkidi M., 2008, ACM T KNOWL DISCOV D, V1, P1; Jiang YC, 2016, P NATL ACAD SCI USA, V113, pE5528, DOI 10.1073/pnas.1522203113; Klein EA, 2014, EUR UROL, V66, P550, DOI 10.1016/j.eururo.2014.05.004; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lai D.H.G., 2016, HMMCOPY COPY NUMBER; Lalonde E, 2017, EUR UROL, V72, P22, DOI 10.1016/j.eururo.2016.10.013; Lalonde E, 2014, LANCET ONCOL, V15, P1521, DOI 10.1016/S1470-2045(14)71021-6; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McPherson A, 2016, NAT GENET, V48, P758, DOI 10.1038/ng.3573; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Notta F, 2016, NATURE, V538, P378, DOI 10.1038/nature19823; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Senbabaoglu Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06207; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Song S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045835; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Taghiyar MJ, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix042; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Taylor RA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13671; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weischenfeldt J, 2013, CANCER CELL, V23, P159, DOI 10.1016/j.ccr.2013.01.002; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930	52	121	121	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 3	2018	173	4					1003	+		10.1016/j.cell.2018.03.029	http://dx.doi.org/10.1016/j.cell.2018.03.029			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GG1TU	29681457	Bronze			2022-12-28	WOS:000432471100020
J	Zhu, JB; Watson, EM; Tang, J; Chen, EYX				Zhu, Jian-Bo; Watson, Eli M.; Tang, Jing; Chen, Eugene Y. -X.			A synthetic polymer system with repeatable chemical recyclability	SCIENCE			English	Article							RING-OPENING POLYMERIZATION; SUSTAINABLE POLYMERS; CYCLIC POLYMERS; GAMMA-BUTYROLACTONE; DEGRADABLE POLYMERS; POLY(LACTIC ACID); POLYESTER; LACTIDE; POLY(ETHYLENE-TEREPHTHALATE); STEREOCOMPLEX	The development of chemically recyclable polymers offers a solution to the end-of-use issue of polymeric materials and provides a closed-loop approach toward a circular materials economy. However, polymers that can be easily and selectively depolymerized back to monomers typically require low-temperature polymerization methods and also lack physical properties and mechanical strengths required for practical uses. We introduce a polymer system based on g-butyrolactone (GBL) with a trans-ring fusion at the alpha and beta positions. Such trans-ring fusion renders the commonly considered as nonpolymerizable GBL ring readily polymerizable at room temperature under solvent-free conditions to yield a high-molecular weight polymer. The polymer has enhanced thermostability and can be repeatedly and quantitatively recycled back to its monomer by thermolysis or chemolysis. Mixing of the two enantiomers of the polymer generates a highly crystalline supramolecular stereocomplex.	[Zhu, Jian-Bo; Watson, Eli M.; Tang, Jing; Chen, Eugene Y. -X.] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA	Colorado State University	Chen, EYX (corresponding author), Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.	eugene.chen@colostate.edu	Zhu, Jian-Bo/ABH-8585-2020	Zhu, Jian-Bo/0000-0002-7062-6733; Watson, Eli/0000-0001-9376-6993	NSF [NSF-1664915]; W. M. Keck Foundation	NSF(National Science Foundation (NSF)); W. M. Keck Foundation(W.M. Keck Foundation)	This work was supported by the NSF (grant NSF-1664915) and the W. M. Keck Foundation.	Aida T, 1996, ACCOUNTS CHEM RES, V29, P39, DOI 10.1021/ar950029l; Albertsson AC, 2017, SCIENCE, V358, P872, DOI 10.1126/science.aap8115; Amgoune A, 2006, ANGEW CHEM INT EDIT, V45, P2782, DOI 10.1002/anie.200600058; Amgoune A, 2006, CHEM-EUR J, V12, P169, DOI 10.1002/chem.200500856; Anderson SM, 2017, J AM CHEM SOC, V139, P15774, DOI 10.1021/jacs.7b07505; Bielawski CW, 2002, SCIENCE, V297, P2041, DOI 10.1126/science.1075401; Brown HA, 2013, ACCOUNTS CHEM RES, V46, P2585, DOI 10.1021/ar400072z; Carpentier JF, 2015, ORGANOMETALLICS, V34, P4175, DOI 10.1021/acs.organomet.5b00540; Cheng M, 1999, J AM CHEM SOC, V121, P11583, DOI 10.1021/ja992678o; Culkin DA, 2007, ANGEW CHEM INT EDIT, V46, P2627, DOI 10.1002/anie.200604740; Diesendruck CE, 2014, NAT CHEM, V6, P624, DOI [10.1038/nchem.1938, 10.1038/NCHEM.1938]; Duda A., 2009, HDB RING OPENING POL; Dudnik AS, 2014, NAT CHEM, V6, P1100, DOI [10.1038/NCHEM.2087, 10.1038/nchem.2087]; Eagan JM, 2017, SCIENCE, V355, P814, DOI 10.1126/science.aah5744; Endo K, 2008, ADV POLYM SCI, V217, P121, DOI 10.1007/12_2008_157; ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B; Fukushima K, 2006, POLYM INT, V55, P626, DOI 10.1002/pi.2010; Fukushima K, 2011, J POLYM SCI POL CHEM, V49, P1273, DOI 10.1002/pola.24551; Garcia JM, 2017, SCIENCE, V358, P870, DOI 10.1126/science.aaq0324; Garcia JM, 2014, SCIENCE, V344, P732, DOI 10.1126/science.1251484; Guo L, 2009, J AM CHEM SOC, V131, P18072, DOI 10.1021/ja907380d; Haba O, 2014, POLYM J, V46, P89, DOI 10.1038/pj.2013.70; Hillmyer MA, 2017, SCIENCE, V358, P868, DOI 10.1126/science.aao6711; Hong M, 2017, GREEN CHEM, V19, P3692, DOI 10.1039/c7gc01496a; Hong M, 2016, ANGEW CHEM INT EDIT, V55, P4188, DOI 10.1002/anie.201601092; Hong M, 2016, NAT CHEM, V8, P42, DOI [10.1038/NCHEM.2391, 10.1038/nchem.2391]; Houk KN, 2008, J ORG CHEM, V73, P2674, DOI 10.1021/jo702567v; Jia XQ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501591; Jones GO, 2016, P NATL ACAD SCI USA, V113, P7722, DOI 10.1073/pnas.1600924113; Kaitz JA, 2013, J AM CHEM SOC, V135, P12755, DOI 10.1021/ja405628g; KENNEWELL PD, 1982, J CHEM SOC PERK T 1, P2563, DOI 10.1039/p19820002563; Kopinke FD, 1996, POLYM DEGRAD STABIL, V53, P329, DOI 10.1016/0141-3910(96)00102-4; Kumaki J, 2007, ANGEW CHEM INT EDIT, V46, P5348, DOI 10.1002/anie.200700455; LIQUORI AM, 1965, NATURE, V206, P358, DOI 10.1038/206358a0; Liu Y, 2017, ANGEW CHEM INT EDIT, V56, P4862, DOI 10.1002/anie.201701438; Lizundia E, 2017, POLYM CHEM-UK, V8, P3530, DOI 10.1039/c7py00695k; Longo JM, 2014, J AM CHEM SOC, V136, P15897, DOI 10.1021/ja509440g; MacDonald JP, 2016, POLYM CHEM-UK, V7, P553, DOI 10.1039/c5py01606a; Nishida H, 2003, POLYM DEGRAD STABIL, V81, P515, DOI 10.1016/S0141-3910(03)00152-6; Rahimi A, 2017, NAT REV CHEM, V1, DOI 10.1038/s41570-017-0046; Sarasua JR, 2005, MACROMOLECULES, V38, P8362, DOI 10.1021/ma051266z; Schneiderman DK, 2017, MACROMOLECULES, V50, P3733, DOI 10.1021/acs.macromol.7b00293; Schneiderman DK, 2016, ACS MACRO LETT, V5, P515, DOI 10.1021/acsmacrolett.6b00193; Semlyen J. A., 2000, CYCLIC POLYM; Slager J, 2003, ADV DRUG DELIVER REV, V55, P549, DOI 10.1016/S0169-409X(03)00042-5; Tang XY, 2016, J AM CHEM SOC, V138, P14326, DOI 10.1021/jacs.6b07974; Torres N, 2000, EUR POLYM J, V36, P2075, DOI 10.1016/S0014-3057(99)00301-8; Vargas R, 2000, J AM CHEM SOC, V122, P4750, DOI 10.1021/ja993600a; Wang Y, 2012, MACROMOLECULES, V45, P6957, DOI 10.1021/ma3007625; World Economic Forum Ellen MacArthur Foundation McKinsey Company, 2016, WORLD EC FORUM; Yoshida S, 2016, SCIENCE, V351, P1196, DOI 10.1126/science.aad6359; Zhang XY, 2018, CHEM REV, V118, P839, DOI 10.1021/acs.chemrev.7b00329; Zhu YQ, 2016, NATURE, V540, P354, DOI 10.1038/nature21001	53	269	277	59	618	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					398	403		10.1126/science.aar5498	http://dx.doi.org/10.1126/science.aar5498			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1AR	29700260				2022-12-28	WOS:000430949600033
J	Leeming, J				Leeming, Jack			Behind the scenes	NATURE			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					525	527		10.1038/d41586-018-04881-z	http://dx.doi.org/10.1038/d41586-018-04881-z			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD8VX	29695856	Bronze			2022-12-28	WOS:000430793000052
J	McDermott, MM; Spring, B; Berger, JS; Treat-Jacobson, D; Conte, MS; Creager, MA; Criqui, MH; Ferrucci, L; Gornik, HL; Guralnik, JM; Hahn, EA; Henke, P; Kibbe, MR; Kohlman-Trighoff, D; Li, LY; Lloyd-Jones, D; McCarthy, W; Polonsky, TS; Skelly, C; Tian, L; Zhao, LH; Zhang, DX; Rejeski, J				McDermott, Mary M.; Spring, Bonnie; Berger, Jeffrey S.; Treat-Jacobson, Diane; Conte, Michael S.; Creager, Mark A.; Criqui, Michael H.; Ferrucci, Luigi; Gornik, Heather L.; Guralnik, Jack M.; Hahn, Elizabeth A.; Henke, Peter; Kibbe, Melina R.; Kohlman-Trighoff, Debra; Li, Lingyu; Lloyd-Jones, Donald; McCarthy, Walter; Polonsky, Tamar S.; Skelly, Christopher; Tian, Lu; Zhao, Lihui; Zhang, Dongxue; Rejeski, Jack			Effect of a Home-Based Exercise Intervention of Wearable Technology and Telephone Coaching on Walking Performance in Peripheral Artery Disease The HONOR Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERMITTENT CLAUDICATION; RHEUMATOID-ARTHRITIS; SUPERVISED EXERCISE; PRACTICE GUIDELINES; HEART-ASSOCIATION; SHORT-FORM; RESPONSIVENESS; VALIDITY; POPULATIONS; MANAGEMENT	IMPORTANCE Clinical practice guidelines support home-based exercise for patients with peripheral artery disease (PAD), but no randomized trials have tested whether an exercise intervention without periodic medical center visits improves walking performance.& para;& para;OBJECTIVE To determine whether a home-based exercise intervention consisting of a wearable activity monitor and telephone coaching improves walking ability over 9 months in patients with PAD.& para;& para;DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial conducted at 3 US medical centers. Patients with PAD were randomized between June 18, 2015, and April 4, 2017, to home-based exercise vs usual care for 9 months. Final follow-up was on December 5, 2017.& para;& para;INTERVENTIONS The exercise intervention group (n = 99) received 4 weekly medical center visits during the first month followed by 8 months of a wearable activity monitor and telephone coaching. The usual care group (n = 101) received no onsite sessions, active exercise, or coaching intervention.& para;& para;MAIN OUTCOMES AND MEASURES The primary outcome was change in 6-minute walk distance at 9-month follow-up (minimal clinically important difference [MCID], 20 m). Secondary outcomes included 9-month change in subcomponents of the Walking Impairment Questionnaire (WIQ) (0-100 score; 100, best), SF-36 physical functioning score, Patient-Reported Outcomes Measurement Information System (PROMIS) mobility questionnaire (higher = better; MCID, 2 points), PROMIS satisfaction with social roles questionnaire, PROMIS pain interference questionnaire (lower = better; MOD range, 3.5-4.5 points), and objectively measured physical activity.& para;& para;RESULTS Among 200 randomized participants (mean [SD] age, 70.2 [10.4] years; 105 [52.5%] women), 182 (91%) completed 9-month follow-up. The mean change from baseline to 9-month follow-up in the 6-minute walk distance was 5.5 m in the intervention group vs 14.4 m in the usual care group (difference, -8.9 m; 95% CI, 26.0 to 8.2 m; P = .31). The exercise intervention worsened the PROMIS pain interference score, mean change from baseline to 9 months was 0.7 in the intervention group vs -2.8 in the usual care group (difference, 3.5; 95% CI, 1.3 to 5.8; P = .002). There were no significant between-group differences in the WIQ score, the SF-36 physical functioning score, or the PROMIS mobility or satisfaction with social roles scores.& para;& para;CONCLUSIONS AND RELEVANCE Among patients with PAD, a home-based exercise intervention consisting of a wearable activity monitor and telephone coaching, compared with usual care, did not improve walking performance at 9-month follow-up. These results do not support home-based exercise interventions of wearable devices and telephone counseling without periodic onsite visits to improve walking performance in patients with PAD.	[McDermott, Mary M.; Hahn, Elizabeth A.; Li, Lingyu; Lloyd-Jones, Donald; Zhang, Dongxue] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [McDermott, Mary M.; Spring, Bonnie; Lloyd-Jones, Donald; Zhao, Lihui] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Spring, Bonnie] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Spring, Bonnie] Northwestern Univ, Weinberg Coll Arts & Sci, Evanston, IL USA; [Berger, Jeffrey S.] NYU, Sch Med, Dept Preventat Cardiol, New York, NY USA; [Treat-Jacobson, Diane] Univ Minnesota, Sch Nursing, Ctr Aging Sci & Care Innovat, Minneapolis, MN 55455 USA; [Conte, Michael S.] Univ Calif San Francisco, Dept Surg, Div Vasc & Endovasc Surg, San Francisco, CA USA; [Creager, Mark A.] Dartmouth Hitchcock Med Ctr, Dartmouth Geisel Sch Med, Dept Vasc Med, Hanover, NH USA; [Criqui, Michael H.] Univ Calif San Diego, Dept Family Med & Publ Hlth, Div Prevent Med, San Diego, CA 92103 USA; [Ferrucci, Luigi] NIA, Div Intramural Res, Baltimore, MD 21224 USA; [Gornik, Heather L.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Cardiovasc Med, Cleveland, OH 44106 USA; [Guralnik, Jack M.] Univ Maryland, Dept Epidemiol, Baltimore, MD 21201 USA; [Henke, Peter] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Kibbe, Melina R.] Univ N Carolina, Dept Surg, Sch Med, Chapel Hill, NC USA; [Kohlman-Trighoff, Debra] Duke Univ, Dept Cardiol & Cardiovasc Med, Durham, NC USA; [McCarthy, Walter] Rush Univ, Med Ctr, Dept Cardiovasc & Thorac Surg, Chicago, IL 60612 USA; [Polonsky, Tamar S.] Univ Chicago, Med Sch, Dept Med, Chicago, IL 60611 USA; [Skelly, Christopher] Univ Chicago, Med Sch, Dept Surg, Chicago, IL 60611 USA; [Tian, Lu] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Rejeski, Jack] Wake Forest Univ, Sch Med, Dept Hlth & Exercise Sci, Winston Salem, NC 27109 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; New York University; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; Dartmouth College; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Case Western Reserve University; Cleveland Clinic Foundation; University System of Maryland; University of Maryland Baltimore; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; Rush University; University of Chicago; University of Chicago; Stanford University; Wake Forest University	McDermott, MM (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Gen Internal Med & Geriatr, 750 N Lake Shore Dr, Chicago, IL 60611 USA.	mdm608@northwestern.edu	Skelly, Christopher/ABD-6187-2020	Berger, Jeffrey/0000-0001-8216-4647; Lloyd-Jones, Donald/0000-0003-0847-6110; Treat-Jacobson, Diane/0000-0003-3296-8764; tian, lu/0000-0002-5893-0169	Patient-Centered Outcomes Research Institute [CER-1306-02719]; National Institute on Aging	Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by grant CER-1306-02719 from the Patient-Centered Outcomes Research Institute and funding from the intramural program at the National Institute on Aging.	Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; Amirhamzeh MMR, 1997, EUR J VASC ENDOVASC, V13, P301, DOI 10.1016/S1078-5884(97)80102-5; Askew RL, 2016, J CLIN EPIDEMIOL, V73, P103, DOI 10.1016/j.jclinepi.2015.08.035; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; Baumeister RF, 1994, LOSING CONTROL WHY P, DOI 10.5860/choice.32-6508; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Chen CX, 2018, PAIN, V159, P775, DOI 10.1097/j.pain.0000000000001121; Conte MS, 2015, J VASC SURG, V61, p2S, DOI 10.1016/j.jvs.2014.12.009; Criqui M H, 1996, Vasc Med, V1, P65; Gardner AW, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001107; Gardner AW, 2011, CIRCULATION, V123, P491, DOI 10.1161/CIRCULATIONAHA.110.963066; Gerhard-Herman MD, 2017, CIRCULATION, V135, pE726, DOI 10.1161/CIR.0000000000000471; Hahn EA, 2016, J CLIN EPIDEMIOL, V73, P135, DOI 10.1016/j.jclinepi.2015.08.034; Hahn EA, 2014, HEALTH PSYCHOL, V33, P490, DOI 10.1037/hea0000055; Harwood AE, 2016, ANN VASC SURG, V34, P280, DOI 10.1016/j.avsg.2016.02.009; Hays RD, 2015, ANN RHEUM DIS, V74, P104, DOI 10.1136/annrheumdis-2013-204053; Heun R, 1998, INT J GERIATR PSYCH, V13, P368, DOI 10.1002/(SICI)1099-1166(199806)13:6<368::AID-GPS775>3.3.CO;2-0; Jakicic JM, 2016, JAMA-J AM MED ASSOC, V316, P1161, DOI 10.1001/jama.2016.12858; Kelly Louise A, 2013, BMC Med Phys, V13, P5, DOI 10.1186/1756-6649-13-5; Kooiman TJM, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0018-5; McDermott MM, 2008, CIRCULATION, V117, P2484, DOI 10.1161/CIRCULATIONAHA.107.736108; McDermott MM, 2014, CIRCULATION, V130, P61, DOI 10.1161/CIRCULATIONAHA.114.007002; McDermott MM, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000711; McDermott MM, 2013, JAMA-J AM MED ASSOC, V310, P57, DOI 10.1001/jama.2013.7231; McDermott MM, 2009, JAMA-J AM MED ASSOC, V301, P165, DOI 10.1001/jama.2008.962; McDermott MM, 2015, CIRC RES, V116, P1540, DOI 10.1161/CIRCRESAHA.114.303517; McDermott M, 2017, JAMA-J AM MED ASSOC, V318, P2089, DOI 10.1001/jama.2017.17437; McDermott M, 2017, JAMA-J AM MED ASSOC, V317, P689, DOI 10.1001/jama.2016.20673; McDermott MM, 2000, J VASC SURG, V32, P1164, DOI 10.1067/mva.2000.108640; McDermott MM, 2001, JAMA-J AM MED ASSOC, V286, P1599; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; Regensteiner JG, 1990, J VASC MED BIOL, V2, P142; Schalet BD, 2016, J CLIN EPIDEMIOL, V73, P112, DOI 10.1016/j.jclinepi.2015.08.039; Thosar SS, 2017, BRIT J SPORT MED, P1; Ward MM, 2014, ARTHRIT CARE RES, V66, P1783, DOI 10.1002/acr.22392; Ware JE, 1993, SF36 HLTH SURVEY MAN	37	85	86	5	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2018	319	16					1665	1676		10.1001/jama.2018.3275	http://dx.doi.org/10.1001/jama.2018.3275			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GD7RF	29710165	Green Published, Bronze			2022-12-28	WOS:000430709300021
J	Dyer, C				Dyer, Clare			Former specialist registrar wins appeal against "flawed" decision to strike him off	BMJ-BRITISH MEDICAL JOURNAL			English	News Item									[Dyer, Clare] BMJ, London, England		Dyer, C (corresponding author), BMJ, London, England.								0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2018	361								k1774	10.1136/bmj.k1774	http://dx.doi.org/10.1136/bmj.k1774			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF4VW	29686049				2022-12-28	WOS:000431962900006
J	Dyer, O				Dyer, Owen			FDA launches criminal investigation of unauthorised herpes vaccine trial	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Taylor M., 2018, KAISER HLTH NEWS	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2018	361								k1763	10.1136/bmj.k1763	http://dx.doi.org/10.1136/bmj.k1763			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF4VW	29685996				2022-12-28	WOS:000431962900003
J	Walhout, AJM				Walhout, Albertha J. M.			If two deletions don't stop growth, try three	SCIENCE			English	Editorial Material									[Walhout, Albertha J. M.] Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA; [Walhout, Albertha J. M.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Walhout, AJM (corresponding author), Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA.; Walhout, AJM (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	marian.walhout@umassmed.edu						Argmann CA, 2016, CELL METAB, V23, P13, DOI 10.1016/j.cmet.2015.11.012; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kuzmin E, 2018, SCIENCE, V360, DOI 10.1126/science.aao1729; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041	8	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2018	360	6386					269	270		10.1126/science.aat4667	http://dx.doi.org/10.1126/science.aat4667			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD3IC	29674581				2022-12-28	WOS:000430396600026
J	Muller-Sanchez, F; Nevin, R; Comerford, JM; Davies, RI; Privon, GC; Treister, E				Muller-Sanchez, F.; Nevin, R.; Comerford, J. M.; Davies, R. I.; Privon, G. C.; Treister, E.			Two separate outflows in the dual supermassive black hole system NGC 6240	NATURE			English	Article							ACTIVE GALACTIC NUCLEUS; LINE EMISSION; GALAXIES; STARBURST; GAS; NGC-6240; CLASSIFICATION; SPECTROSCOPY; COEVOLUTION; FEEDBACK	Theoretical models and numerical simulations have established a framework of galaxy evolution in which galaxies merge and create dual supermassive black holes (with separations of one to ten kiloparsecs), which eventually sink into the centre of the merger remnant, emit gravitational waves and coalesce. The merger also triggers star formation and supermassive black hole growth, and gas outflows regulate the stellar content(1-3). Although this theoretical picture is supported by recent observations of starburst-driven and supermassive black hole-driven outflows(4-6), it remains unclear how these outflows interact with the interstellar medium. Furthermore, the relative contributions of star formation and black hole activity to galactic feedback remain unknown(7-9). Here we report observations of dual outflows in the central region of the prototypical merger NGC 6240. We find a black-hole-driven outflow of [O III] to the northeast and a starburst-driven outflow of Ha to the northwest. The orientations and positions of the outflows allow us to isolate them spatially and study their properties independently. We estimate mass outflow rates of 10 and 75 solar masses per year for the Ha bubble and the [O III] cone, respectively. Their combined mass outflow is comparable to the star formation rate(10), suggesting that negative feedback on star formation is occurring.	[Muller-Sanchez, F.; Nevin, R.; Comerford, J. M.] Univ Colorado, Dept Astrophys & Planetary Sci, Boulder, CO 80309 USA; [Davies, R. I.] Max Planck Inst Extraterr Phys, Garching, Germany; [Privon, G. C.; Treister, E.] Pontificia Univ Catolica Chile, Inst Astrofis, Fac Fis, Santiago, Chile; [Privon, G. C.; Treister, E.] Pontificia Univ Catolica Chile, Ctr Astroingn, Fac Fis, Santiago, Chile; [Privon, G. C.] Univ Florida, Dept Astron, Gainesville, FL 32611 USA	University of Colorado System; University of Colorado Boulder; Max Planck Society; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; State University System of Florida; University of Florida	Muller-Sanchez, F (corresponding author), Univ Colorado, Dept Astrophys & Planetary Sci, Boulder, CO 80309 USA.	francisco.mullersanchez@colorado.edu		Davies, Richard/0000-0003-4949-7217	NASA [NAS5-26555]; NASA HST [HST-AR-13260.001]; FONDECYT [3150361, 1120061, 1160999]; University of Florida; CONICYT Anillo [ACT1101]; Basal-CATA [PFB-06/2007]	NASA(National Aeronautics & Space Administration (NASA)); NASA HST(National Aeronautics & Space Administration (NASA)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); University of Florida(University of Florida); CONICYT Anillo(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS); Basal-CATA(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL)	Some of the data presented in this paper were obtained from the Mikulski Archive for Space Telescopes (MAST). The Space Telescope Science Institute is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS5-26555. The optical spectroscopic data reported here were obtained at the Apache Point Observatory 3.5-m telescope, which is owned and operated by the Astrophysical Research Consortium. F.M.-S. acknowledges financial support from NASA HST Grant HST-AR-13260.001. G.C.P. acknowledges support from a FONDECYT Postdoctoral Fellowship (number 3150361) and the University of Florida. E.T. acknowledges support from CONICYT Anillo ACT1101, FONDECYT regular grants 1120061 and 1160999, and Basal-CATA PFB-06/2007.	BALDWIN JA, 1981, PUBL ASTRON SOC PAC, V93, P5, DOI 10.1086/130766; Belfiore F, 2016, MON NOT R ASTRON SOC, V461, P3111, DOI 10.1093/mnras/stw1234; Bonnet H., 2004, MESSENGER, V117, P17; Crenshaw DM, 2000, ASTROPHYS J, V532, pL101, DOI 10.1086/312581; Davies R, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/69; Davies RI, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/2/101; Di Matteo T, 2005, NATURE, V433, P604, DOI 10.1038/nature03335; DOPITA MA, 1995, ASTROPHYS J, V455, P468, DOI 10.1086/176596; Eisenhauer F, 2003, P SOC PHOTO-OPT INS, V4841, P1548, DOI 10.1117/12.459468; Engel H, 2010, ASTRON ASTROPHYS, V524, DOI 10.1051/0004-6361/201015338; Fernandes RC, 2010, MON NOT R ASTRON SOC, V403, P1036, DOI 10.1111/j.1365-2966.2009.16185.x; Fischer TC, 2013, ASTROPHYS J SUPPL S, V209, DOI 10.1088/0067-0049/209/1/1; Greene JE, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/1/86; Heckman TM, 2014, ANNU REV ASTRON ASTR, V52, P589, DOI 10.1146/annurev-astro-081913-035722; HECKMAN TM, 1990, ASTROPHYS J SUPPL S, V74, P833, DOI 10.1086/191522; Hickox RC, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/1/9; Hopkins PF, 2012, MON NOT R ASTRON SOC, V421, P3522, DOI 10.1111/j.1365-2966.2012.20593.x; Howell JH, 2010, ASTROPHYS J, V715, P572, DOI 10.1088/0004-637X/715/1/572; Iono D, 2004, ASTROPHYS J, V616, P199, DOI 10.1086/424797; Karouzos M, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/2/137; Kewley LJ, 2006, MON NOT R ASTRON SOC, V372, P961, DOI 10.1111/j.1365-2966.2006.10859.x; Kewley LJ, 2001, ASTROPHYS J, V556, P121, DOI 10.1086/321545; Komossa S, 2003, ASTROPHYS J, V582, pL15, DOI 10.1086/346145; Lira P, 2002, MON NOT R ASTRON SOC, V333, P709, DOI 10.1046/j.1365-8711.2002.05456.x; Max CE, 2005, ASTROPHYS J, V621, P738, DOI 10.1086/427546; Medling AM, 2015, MON NOT R ASTRON SOC, V448, P2301, DOI 10.1093/mnras/stv081; MOORWOOD AFM, 1988, ASTRON ASTROPHYS, V203, P278; Muller-Sanchez F, 2013, ASTROPHYS J LETT, V763, DOI 10.1088/2041-8205/763/1/L1; Muller-Sanchez F, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/2/69; Pogge RW, 2000, ASTROPHYS J, V532, P323, DOI 10.1086/308567; Puccetti S, 2016, ASTRON ASTROPHYS, V585, DOI 10.1051/0004-6361/201527189; PUXLEY PJ, 1990, ASTROPHYS J, V364, P77, DOI 10.1086/169386; Riffel RA, 2010, MON NOT R ASTRON SOC, V404, P166, DOI 10.1111/j.1365-2966.2010.16308.x; Rodriguez-Ardila A, 2004, ASTRON ASTROPHYS, V425, P457, DOI 10.1051/0004-6361:20034285; Roos O, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/1/19; Sanchez FM, 2009, ASTROPHYS J, V691, P749, DOI 10.1088/0004-637X/691/1/749; Schawinski K, 2015, MON NOT R ASTRON SOC, V451, P2517, DOI 10.1093/mnras/stv1136; Schmitt HR, 2003, ASTROPHYS J SUPPL S, V148, P327, DOI 10.1086/377440; Schnorr-Muller A, 2016, MON NOT R ASTRON SOC, V457, P972, DOI 10.1093/mnras/stw037; Somerville RS, 2008, MON NOT R ASTRON SOC, V391, P481, DOI 10.1111/j.1365-2966.2008.13805.x; Steffen W, 2011, IEEE T VIS COMPUT GR, V17, P454, DOI 10.1109/TVCG.2010.62; Tacconi LJ, 1999, ASTROPHYS J, V524, P732, DOI 10.1086/307839; Tecza M, 2000, ASTROPHYS J, V537, P178, DOI 10.1086/309021; VANDERWERF PP, 1993, ASTROPHYS J, V405, P522, DOI 10.1086/172384; Veilleux S, 2003, ASTRON J, V126, P2185, DOI 10.1086/379000; Veilleux S, 2005, ANNU REV ASTRON ASTR, V43, P769, DOI 10.1146/annurev.astro.43.072103.150610; Yoshida M, 2016, ASTROPHYS J, V820, DOI 10.3847/0004-637X/820/1/48	50	18	18	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2018	556	7701					345	+		10.1038/s41586-018-0033-2	http://dx.doi.org/10.1038/s41586-018-0033-2			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1TW	29670264	Green Submitted			2022-12-28	WOS:000430285200045
J	Turajlic, S; Xu, H; Litchfield, K; Rowan, A; Horswell, S; Chambers, T; O'Brien, T; Lopez, JI; Watkins, TBK; Nicol, D; Stares, M; Challacombe, B; Hazell, S; Chandra, A; Mitchell, TJ; Au, L; Eichler-Jonsson, C; Jabbar, F; Soultati, A; Chowdhury, S; Rudman, S; Lynch, J; Fernando, A; Stamp, G; Nye, E; Stewart, A; Xing, W; Smith, JC; Escudero, M; Huffman, A; Matthews, N; Elgar, G; Phillimore, B; Costa, M; Begum, S; Ward, S; Salm, M; Boeing, S; Fisher, R; Spain, L; Navas, C; Gronroos, E; Hobor, S; Sharma, S; Aurangzeb, I; Lall, S; Polson, A; Varia, M; Horsfield, C; Fotiadis, N; Pickering, L; Schwarz, RF; Silva, B; Herrero, J; Luscombe, NM; Jamal-Hanjani, M; Rosenthal, R; Birkbak, NJ; Wilson, GA; Pipek, O; Ribli, D; Krzystanek, M; Csabai, I; Szallasi, Z; Gore, M; McGranahan, N; Van Loo, P; Campbell, P; Larkin, J; Swanton, C				Turajlic, Samra; Xu, Hang; Litchfield, Kevin; Rowan, Andrew; Horswell, Stuart; Chambers, Tim; O'Brien, Tim; Lopez, Jose I.; Watkins, Thomas B. K.; Nicol, David; Stares, Mark; Challacombe, Ben; Hazell, Steve; Chandra, Ashish; Mitchell, Thomas J.; Au, Lewis; Eichler-Jonsson, Claudia; Jabbar, Faiz; Soultati, Aspasia; Chowdhury, Simon; Rudman, Sarah; Lynch, Joanna; Fernando, Archana; Stamp, Gordon; Nye, Emma; Stewart, Aengus; Xing, Wei; Smith, Jonathan C.; Escudero, Mickael; Huffman, Adam; Matthews, Nik; Elgar, Greg; Phillimore, Ben; Costa, Marta; Begum, Sharmin; Ward, Sophia; Salm, Max; Boeing, Stefan; Fisher, Rosalie; Spain, Lavinia; Navas, Carolina; Gronroos, Eva; Hobor, Sebastijan; Sharma, Sarkhara; Aurangzeb, Ismaeel; Lall, Sharanpreet; Polson, Alexander; Varia, Mary; Horsfield, Catherine; Fotiadis, Nicos; Pickering, Lisa; Schwarz, Roland F.; Silva, Bruno; Herrero, Javier; Luscombe, Nick M.; Jamal-Hanjani, Mariam; Rosenthal, Rachel; Birkbak, Nicolai J.; Wilson, Gareth A.; Pipek, Orsolya; Ribli, Dezso; Krzystanek, Marcin; Csabai, Istvan; Szallasi, Zoltan; Gore, Martin; McGranahan, Nicholas; Van Loo, Peter; Campbell, Peter; Larkin, James; Swanton, Charles		TRACERx Renal Consortium	Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal	CELL			English	Article							COPY-NUMBER ALTERATIONS; CELL CARCINOMA; INTERNATIONAL SOCIETY; ACTIVE SURVEILLANCE; DRIVER MUTATION; BAP1; PBRM1; PROGRESSION; PATTERNS; INACTIVATION	The evolutionary features of clear-cell renal cell carcinoma (ccRCC) have not been systematically studied to date. We analyzed 1,206 primary tumor regions from 101 patients recruited into the multi-center prospective study, TRACERx Renal. We observe up to 30 driver events per tumor and show that subclonal diversification is associated with known prognostic parameters. By resolving the patterns of driver event ordering, co-occurrence, and mutual exclusivity at clone level, we show the deterministic nature of clonal evolution. ccRCC can be grouped into seven evolutionary subtypes, ranging from tumors characterized by early fixation of multiple mutational and copy number drivers and rapid metastases to highly branched tumors with > 10 subclonal drivers and extensive parallel evolution associated with attenuated progression. We identify genetic diversity and chromosomal complexity as determinants of patient outcome. Our insights reconcile the variable clinical behavior of ccRCC and suggest evolutionary potential as a biomarker for both intervention and surveillance.	[Turajlic, Samra; Xu, Hang; Litchfield, Kevin; Rowan, Andrew; Chambers, Tim; Watkins, Thomas B. K.; Stares, Mark; Eichler-Jonsson, Claudia; Jabbar, Faiz; Ward, Sophia; Fisher, Rosalie; Navas, Carolina; Gronroos, Eva; Hobor, Sebastijan; Sharma, Sarkhara; Aurangzeb, Ismaeel; Birkbak, Nicolai J.; Wilson, Gareth A.; Swanton, Charles] Francis Crick Inst, Translat Canc Therapeut Lab, London NW1 1AT, England; [Turajlic, Samra; Au, Lewis; Lynch, Joanna; Spain, Lavinia; Pickering, Lisa; Gore, Martin; Larkin, James] Royal Marsden NHS Fdn Trust, Renal & Skin Units, London SW3 6JJ, England; [Horswell, Stuart; Stewart, Aengus; Escudero, Mickael; Salm, Max; Boeing, Stefan] Francis Crick Inst, Dept Bioinformat & Biostat, London NW1 1AT, England; [O'Brien, Tim; Challacombe, Ben; Fernando, Archana] Guys & St Thomas NHS Fdn Trust, Urol Ctr, London SE1 9RT, England; [Lopez, Jose I.] Univ Basque Country, Cruces Univ Hosp, Biocruces Inst, Dept Pathol, Baracaldo, Spain; [Nicol, David] Royal Marsden NHS Fdn Trust, Dept Urol, London SW3 6JJ, England; [Hazell, Steve] Royal Marsden NHS Fdn Trust, Dept Pathol, London SW3 6JJ, England; [Chandra, Ashish; Polson, Alexander; Varia, Mary; Horsfield, Catherine] Guys & St Thomas NHS Fdn Trust, Dept Pathol, London SE1 7EH, England; [Mitchell, Thomas J.; Campbell, Peter] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Watkins, Thomas B. K.] Addenbrookes Hosp NHS Fdn Trust, Dept Surg, Cambridge CB2 0QQ, England; [Soultati, Aspasia; Chowdhury, Simon; Rudman, Sarah; Lall, Sharanpreet] Guys & St Thomas NHS Fdn Trust, Dept Med Oncol, London SE1 9RT, England; [Stamp, Gordon; Nye, Emma] Francis Crick Inst, Expt Histopathol Lab, London NW1 1AT, England; [Xing, Wei; Smith, Jonathan C.; Huffman, Adam; Silva, Bruno] Francis Crick Inst, Dept Sci Comp, London NW1 1AT, England; [Matthews, Nik; Elgar, Greg; Phillimore, Ben; Costa, Marta; Begum, Sharmin; Ward, Sophia] Francis Crick Inst, Adv Sequencing Facil, London NW1 1AT, England; [Fotiadis, Nicos] Royal Marsden NHS Fdn Trust, Dept Radiol, London SW3 6JJ, England; [Schwarz, Roland F.] Berlin Inst Med Syst Biol, Max Delbrueck Ctr Mol Med, Berlin, Germany; [Herrero, Javier; Rosenthal, Rachel] UCL, UCL Canc Inst, Bill Lyons Informat Ctr, London WC1E 6DD, England; [Luscombe, Nick M.] Francis Crick Inst, Bioinformat & Computat Biol Lab, London NW1 1AT, England; [Jamal-Hanjani, Mariam; Rosenthal, Rachel; Birkbak, Nicolai J.; Wilson, Gareth A.; McGranahan, Nicholas; Swanton, Charles] UCL, Canc Res UK Lung Canc Ctr Excellence London, Canc Inst, London WC1E 6DD, England; [Pipek, Orsolya; Ribli, Dezso; Csabai, Istvan] Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary; [Krzystanek, Marcin; Szallasi, Zoltan] Tech Univ Denmark, Dept Bio & Hlth Informat, DK-2800 Lyngby, Denmark; [Szallasi, Zoltan] Harvard Med Sch, Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA USA; [Van Loo, Peter] Francis Crick Inst, Canc Genom Lab, London NW1 1AT, England; [Van Loo, Peter] Univ Leuven, Dept Human Genet, B-3000 Leuven, Belgium; [Swanton, Charles] Univ Coll London Hosp, Dept Med Oncol, London NW1 2BU, England	Francis Crick Institute; Royal Marsden NHS Foundation Trust; Francis Crick Institute; Guy's & St Thomas' NHS Foundation Trust; Hospital Universitario Cruces; University of Basque Country; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Guy's & St Thomas' NHS Foundation Trust; Francis Crick Institute; Francis Crick Institute; Francis Crick Institute; Royal Marsden NHS Foundation Trust; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of London; University College London; Francis Crick Institute; University of London; University College London; Eotvos Lorand University; Technical University of Denmark; Harvard University; Boston Children's Hospital; Harvard Medical School; Francis Crick Institute; KU Leuven; University College London Hospitals NHS Foundation Trust; University of London; University College London	Swanton, C (corresponding author), Francis Crick Inst, Translat Canc Therapeut Lab, London NW1 1AT, England.; Larkin, J (corresponding author), Royal Marsden NHS Fdn Trust, Renal & Skin Units, London SW3 6JJ, England.; Swanton, C (corresponding author), UCL, Canc Res UK Lung Canc Ctr Excellence London, Canc Inst, London WC1E 6DD, England.; Swanton, C (corresponding author), Univ Coll London Hosp, Dept Med Oncol, London NW1 2BU, England.	james.larkin@rmh.nhs.uk; charles.swanton@crick.ac.uk	Csabai, Istvan/F-6045-2011; Lopez, Jose Ignacio/L-3884-2019; Challacombe, Ben/AAM-9505-2020; Navas, Carolina/T-7623-2018; McGranahan, Nicholas/ABD-6561-2021; Nicol, David L/M-6809-2016; Pipek, Orsolya/J-3124-2018; Herrero, Javier/H-6971-2019	Csabai, Istvan/0000-0001-9232-9898; Lopez, Jose Ignacio/0000-0003-0842-5348; Challacombe, Ben/0000-0001-8631-0314; McGranahan, Nicholas/0000-0001-9537-4045; Nicol, David L/0000-0002-5623-7467; Pipek, Orsolya/0000-0001-8109-0340; Herrero, Javier/0000-0001-7313-717X; Escudero, Mickael/0000-0002-1336-815X; Gronroos, Eva/0000-0001-8303-5409; Spain, Lavinia/0000-0002-9356-8812; Elgar, Greg/0000-0001-7323-1596; Szallasi, Zoltan/0000-0001-5395-7509; Xu, Hang/0000-0002-5847-655X; Salm, Max/0000-0002-5742-3376; Litchfield, Kevin/0000-0002-3725-0914; Stewart, Aengus/0000-0001-5182-653X; Schwarz, Roland/0000-0001-9155-4268; Van Loo, Peter/0000-0003-0292-1949; Swanton, Charles/0000-0002-4299-3018; Horswell, Stuart/0000-0003-2787-1933; Birkbak, Nicolai/0000-0003-1613-9587; Mitchell, Thomas/0000-0003-0761-9503; turajlic, samra/0000-0001-8846-136X; Larkin, James/0000-0001-5569-9523; Nicol, David/0000-0003-0107-6990	Cancer Research UK (CRUK) [C50947/A18176]; National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at the Royal Marsden Hospital and Institute of Cancer Research [A109]; Ministerio de Economia y Competitividad (MINECO) [SAF2016-79847-R]; Royal Marsden Cancer Charity; UK Medical Research Council [MR/P014712/1, FC010110]; European Union Seventh Framework Programme (FP7-People-ITN); NIHR; Wellcome Trust Joint Investigator Award [103760/Z/14/Z]; MRC eMedLab Medical Bioinformatics Infrastructure Award [MR/L016311/1]; Danish Cancer Society grant [R90-A6213]; Wellcome Trust [FC010110, WT088340MA]; CRUK; Rosetrees; NIHR BRC at University College London Hospitals; Cancer Research UK (TRACERx and CRUK Cancer Immunotherapy Catalyst Network); CRUK Lung Cancer Centre of Excellence; Stand Up 2 Cancer (SU2C); Rosetrees and Stoneygate Trusts; NovoNordisk Foundation (THESEUS); Marie Curie Network PloidyNet; CRUK University College London Experimental Cancer Medicine Centre; NovoNordisk Foundation [16584]; National Research, Development and Innovation Office of Hungary [NVKP_16-1-20160004]; CRUK (Clinical Scientist Fellowship) [C50947/A18176]; Cancer Reseach UK [FC010110]; NIHR BRC at the Royal Marsden Hospital and Institute of Cancer Research [A109]; eMedLab; TCGA Research; MRC [MR/L016311/1, MR/P014712/1] Funding Source: UKRI	Cancer Research UK (CRUK)(Cancer Research UK); National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at the Royal Marsden Hospital and Institute of Cancer Research; Ministerio de Economia y Competitividad (MINECO); Royal Marsden Cancer Charity(Royal Society of New ZealandMarsden Fund (NZ)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union Seventh Framework Programme (FP7-People-ITN); NIHR(National Institute for Health Research (NIHR)); Wellcome Trust Joint Investigator Award(Wellcome Trust); MRC eMedLab Medical Bioinformatics Infrastructure Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Society grant(Danish Cancer Society); Wellcome Trust(Wellcome TrustEuropean Commission); CRUK(Cancer Research UK); Rosetrees(Rosetrees Trust); NIHR BRC at University College London Hospitals; Cancer Research UK (TRACERx and CRUK Cancer Immunotherapy Catalyst Network); CRUK Lung Cancer Centre of Excellence; Stand Up 2 Cancer (SU2C); Rosetrees and Stoneygate Trusts; NovoNordisk Foundation (THESEUS); Marie Curie Network PloidyNet; CRUK University College London Experimental Cancer Medicine Centre; NovoNordisk Foundation(Novo Nordisk Foundation); National Research, Development and Innovation Office of Hungary; CRUK (Clinical Scientist Fellowship); Cancer Reseach UK; NIHR BRC at the Royal Marsden Hospital and Institute of Cancer Research; eMedLab; TCGA Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Aida Murra, Naheed Shaikh, Justine Korteweg, Jeremy Tai, Eleanor Carlyle, Leonora Conneely, KimEdmonds, Karla Lingard, Karen O'Meara, Helen Breeze, Sarah Sarker, Lesley Cooper, Linda Shephard, Susie Slater, and Catherine Rogers for study support. We thank the patients and their families. S.T. and H.X. are funded by Cancer Research UK (CRUK) (C50947/A18176). S.T., T.C., J.L., and M.G. are funded by the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at the Royal Marsden Hospital and Institute of Cancer Research (A109). J.I.L. is funded by the Ministerio de Economia y Competitividad (MINECO, SAF2016-79847-R). M.S., A.S., J. Lynch, R.F., L.A., and L.S. are funded by the Royal Marsden Cancer Charity. K.L. is funded by UK Medical Research Council (MR/P014712/1). T.B.K.W. is funded by the European Union Seventh Framework Programme (FP7-People-2013-ITN). M.J.-H. is funded by the NIHR. N.M.L. is a Winton Group Leader in recognition of the Winton Charitable Foundation's support towards the establishment of The Francis Crick Institute. N.M.L. is additionally funded by a Wellcome Trust Joint Investigator Award (103760/Z/14/Z) and the MRC eMedLab Medical Bioinformatics Infrastructure Award (MR/L016311/1). M.K. is funded by the Danish Cancer Society grant (R90-A6213). P.C. is funded by the Wellcome Trust (WT088340MA). N.M. receives funding from CRUK, Rosetrees, and the NIHR BRC at University College London Hospitals. C.S. is a Royal Society Napier Research Professor. C.S. is funded by Cancer Research UK (TRACERx and CRUK Cancer Immunotherapy Catalyst Network), the CRUK Lung Cancer Centre of Excellence, Stand Up 2 Cancer (SU2C), the Rosetrees and Stoneygate Trusts, NovoNordisk Foundation (THESEUS), Marie Curie Network PloidyNet, the NIHR BRC at University College London Hospitals, and the CRUK University College London Experimental Cancer Medicine Centre. C.S., O.P., D.R., I.C., and Z.S. are funded by NovoNordisk Foundation (16584). O.P., D.R., and I.C. are funded by the National Research, Development and Innovation Office of Hungary (NVKP_16-1-20160004). This work was supported by CRUK (Clinical Scientist Fellowship to S.T., C50947/A18176), The Francis Crick Institute, which receives its core funding from Cancer Reseach UK (FC010110), the UK Medical Research Council (FC010110), the Wellcome Trust (FC010110), and NIHR BRC at the Royal Marsden Hospital and Institute of Cancer Research (A109). High-performance computing was supported by eMedLab. The results published here are in whole or part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/.	Arai E, 2014, INT J CANCER, V135, P1330, DOI 10.1002/ijc.28768; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Bex A, 2016, EUR UROL, V70, P901, DOI 10.1016/j.eururo.2016.07.005; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chen FJ, 2016, CELL REP, V14, P2476, DOI 10.1016/j.celrep.2016.02.024; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; da Costa WH, 2012, BJU INT, V109, P544, DOI 10.1111/j.1464-410X.2011.10366.x; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Davis CF, 2014, CANCER CELL, V26, P319, DOI 10.1016/j.ccr.2014.07.014; De Sano L, 2016, BIOINFORMATICS, V32, P1911, DOI 10.1093/bioinformatics/btw035; Delahunt B, 2013, AM J SURG PATHOL, V37, P1490, DOI 10.1097/PAS.0b013e318299f0fb; Eldredge N, 1997, SCIENCE, V276, P338; Endesfelder D, 2014, CANCER RES, V74, P4853, DOI 10.1158/0008-5472.CAN-13-2664; Fang H, 2016, NAT PROTOC, V11, P2529, DOI 10.1038/nprot.2016.150; Gabadinho A, 2011, J STAT SOFTW, V40, P1; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Goldschmidt R., 1940, MAT BASIS EVOLUTION; Griffith DM, 2016, J STAT SOFTW, V69, P1; Gu YF, 2017, CANCER DISCOV, V7, P900, DOI 10.1158/2159-8290.CD-17-0292; Hakimi AA, 2015, MODERN PATHOL, V28, P845, DOI 10.1038/modpathol.2015.6; Hakimi AA, 2013, CLIN CANCER RES, V19, P3259, DOI 10.1158/1078-0432.CCR-12-3886; Ito T, 2016, J UROLOGY, V195, P852, DOI 10.1016/j.juro.2015.10.180; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Jewett MAS, 2011, EUR UROL, V60, P39, DOI 10.1016/j.eururo.2011.03.030; Joseph RW, 2016, J UROLOGY, V195, P180, DOI 10.1016/j.juro.2015.07.113; Kane CJ, 2008, CANCER, V113, P78, DOI 10.1002/cncr.23518; Kapur P, 2013, LANCET ONCOL, V14, P159, DOI 10.1016/S1470-2045(12)70584-3; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kojima T, 2009, ONCOGENE, V28, P297, DOI 10.1038/onc.2008.391; La Rochelle J, 2010, CANCER-AM CANCER SOC, V116, P4696, DOI 10.1002/cncr.25279; Leibovich BC, 2003, CANCER-AM CANCER SOC, V97, P1663, DOI 10.1002/cncr.11234; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Malouf GG, 2016, EUR UROL, V70, P348, DOI 10.1016/j.eururo.2016.01.051; Martinez P, 2013, J PATHOL, V230, P356, DOI 10.1002/path.4214; Mitchell TJ, 2018, CELL, V173, P611, DOI 10.1016/j.cell.2018.02.020; Monzon FA, 2011, MODERN PATHOL, V24, P1470, DOI 10.1038/modpathol.2011.107; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; Noorbakhsh J, 2017, NAT GENET, V49, P1288, DOI 10.1038/ng.3876; Ortmann CA, 2015, NEW ENGL J MED, V372, P601, DOI 10.1056/NEJMoa1412098; Pena-Llopis S, 2013, CANCER RES, V73, P4173, DOI 10.1158/0008-5472.CAN-13-0360; Peng JT, 2015, CANCER LETT, V369, P167, DOI 10.1016/j.canlet.2015.08.013; Pengelly RJ, 2013, GENOME MED, V5, DOI 10.1186/gm492; Perrino CM, 2015, HUM PATHOL, V46, P9, DOI 10.1016/j.humpath.2014.09.001; Przybycin CG, 2014, AM J SURG PATHOL, V38, P1260, DOI 10.1097/PAS.0000000000000251; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reiter JG, 2013, EVOL APPL, V6, P34, DOI 10.1111/eva.12020; Rini BI, 2016, LANCET ONCOL, V17, P1317, DOI 10.1016/S1470-2045(16)30196-6; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/nmeth.2883, 10.1038/NMETH.2883]; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Scelo G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6135; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Srigley JR, 2013, AM J SURG PATHOL, V37, P1469, DOI 10.1097/PAS.0b013e318299f2d1; Talevich E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004873; Tomasetti C, 2015, P NATL ACAD SCI USA, V112, P118, DOI 10.1073/pnas.1421839112; Turajlic S, 2018, CELL, V173, P581, DOI 10.1016/j.cell.2018.03.057; Turajlic S, 2017, NAT REV UROL, V14, P575, DOI 10.1038/nrurol.2017.112; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang ZX, 2017, CLIN CANCER RES, V23, P6686, DOI 10.1158/1078-0432.CCR-17-1057; Welch HG, 2018, JAMA INTERN MED, V178, P221, DOI 10.1001/jamainternmed.2017.7508; Williamson SR, 2014, HUM PATHOL, V45, P735, DOI 10.1016/j.humpath.2013.10.033; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang BY, 2015, BJU INT, V115, P405, DOI 10.1111/bju.12781; Znaor A, 2015, EUR UROL, V67, P519, DOI 10.1016/j.eururo.2014.10.002	68	287	291	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2018	173	3					595	+		10.1016/j.cell.2018.03.043	http://dx.doi.org/10.1016/j.cell.2018.03.043			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7GB	29656894	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000430677400011
J	Britnell, M				Britnell, Mark			PROVOCATIONS The NHS can fly the flag in post-Brexit Britain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Britnell, Mark] KPMG Int, Healthcare Govt & Infrastruct, Amsterdam, Netherlands		Britnell, M (corresponding author), KPMG Int, Healthcare Govt & Infrastruct, Amsterdam, Netherlands.	Mark.Britnell@KPMG.co.uk						Iacobucci G, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k1435	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2018	361								k1685	10.1136/bmj.k1685	http://dx.doi.org/10.1136/bmj.k1685			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8WK	29666055				2022-12-28	WOS:000430794600005
J	Horton, R				Horton, Richard			Offline: "A sea of suffering"	LANCET			English	Editorial Material												richard.horton@lancet.com							0	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2018	391	10129					1465	1465		10.1016/S0140-6736(18)30889-4	http://dx.doi.org/10.1016/S0140-6736(18)30889-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GC6TS	29676266	Bronze			2022-12-28	WOS:000429926000009
J	Moreno, C; Vilas-Varela, M; Kretz, B; Garcia-Lekue, A; Costache, MV; Paradinas, M; Panighel, M; Ceballos, G; Valenzuela, SO; Pena, D; Mugarza, A				Moreno, Cesar; Vilas-Varela, Manuel; Kretz, Bernhard; Garcia-Lekue, Aran; Costache, Marius V.; Paradinas, Markos; Panighel, Mirko; Ceballos, Gustavo; Valenzuela, Sergio O.; Pena, Diego; Mugarza, Aitor			Bottom-up synthesis of multifunctional nanoporous graphene	SCIENCE			English	Article							ON-SURFACE CHEMISTRY; POROUS GRAPHENE; MOLECULAR PRECURSORS; ELECTRONIC-STRUCTURE; WATER DESALINATION; NANORIBBONS; ACTIVATION; MEMBRANE; BANDGAP; STATE	Nanosize pores can turn semimetallic graphene into a semiconductor and, from being impermeable, into the most efficient molecular-sieve membrane. However, scaling the pores down to the nanometer, while fulfilling the tight structural constraints imposed by applications, represents an enormous challenge for present top-down strategies. Here we report a bottom-up method to synthesize nanoporous graphene comprising an ordered array of pores separated by ribbons, which can be tuned down to the 1-nanometer range. The size, density, morphology, and chemical composition of the pores are defined with atomic precision by the design of the molecular precursors. Our electronic characterization further reveals a highly anisotropic electronic structure, where orthogonal one-dimensional electronic bands with an energy gap of similar to 1 electron volt coexist with confined pore states, making the nanoporous graphene a highly versatile semiconductor for simultaneous sieving and electrical sensing of molecular species.	[Moreno, Cesar; Costache, Marius V.; Paradinas, Markos; Panighel, Mirko; Ceballos, Gustavo; Valenzuela, Sergio O.; Mugarza, Aitor] CSIC, Catalan Inst Nanosci & Nanotechnol ICN2, Campus UAB, Barcelona 08193, Spain; [Moreno, Cesar; Costache, Marius V.; Paradinas, Markos; Panighel, Mirko; Ceballos, Gustavo; Valenzuela, Sergio O.; Mugarza, Aitor] Barcelona Inst Sci & Technol, Campus UAB, Barcelona 08193, Spain; [Vilas-Varela, Manuel; Pena, Diego] Univ Santiago de Compostela, Ctr Singular Invest Quim Biol & Mat Mol CIQUS, Santiago De Compostela 15782, Spain; [Vilas-Varela, Manuel; Pena, Diego] Univ Santiago de Compostela, Dept Quim Organ, Santiago De Compostela 15782, Spain; [Kretz, Bernhard; Garcia-Lekue, Aran] DIPC, San Sebastian 20018, Spain; [Garcia-Lekue, Aran] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain; [Valenzuela, Sergio O.; Mugarza, Aitor] ICREA, Barcelona 08010, Spain	Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Catalan Institute of Nanoscience & Nanotechnology (ICN2); Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Universidade de Santiago de Compostela; CiQUS; Universidade de Santiago de Compostela; Basque Foundation for Science; ICREA	Moreno, C; Mugarza, A (corresponding author), CSIC, Catalan Inst Nanosci & Nanotechnol ICN2, Campus UAB, Barcelona 08193, Spain.; Moreno, C; Mugarza, A (corresponding author), Barcelona Inst Sci & Technol, Campus UAB, Barcelona 08193, Spain.; Pena, D (corresponding author), Univ Santiago de Compostela, Ctr Singular Invest Quim Biol & Mat Mol CIQUS, Santiago De Compostela 15782, Spain.; Pena, D (corresponding author), Univ Santiago de Compostela, Dept Quim Organ, Santiago De Compostela 15782, Spain.; Mugarza, A (corresponding author), ICREA, Barcelona 08010, Spain.	cesar.moreno@icn2.cat; diego.pena@usc.es; aitor.mugarza@icn2.cat	Garcia-Lekue, Aran/B-4444-2013; Costache, Marius Vasile/AAQ-3947-2021; Valenzuela, Sergio/A-1169-2007; Paradinas, Markos/P-3532-2015; Moreno, Cesar/AAA-8199-2019; Peña, Diego/D-2051-2009; Panighel, Mirco/J-9767-2015; Manuel, Vilas-Varela/ABI-5881-2020; Ceballos, Gustavo/B-6360-2012; mugarza, aitor/B-6871-2012	Costache, Marius Vasile/0000-0001-7432-6175; Valenzuela, Sergio/0000-0002-4632-8891; Paradinas, Markos/0000-0003-1006-9506; Moreno, Cesar/0000-0003-2682-211X; Peña, Diego/0000-0003-3814-589X; Panighel, Mirco/0000-0001-8413-5196; Manuel, Vilas-Varela/0000-0002-6768-5441; Ceballos, Gustavo/0000-0002-6713-7963; mugarza, aitor/0000-0002-2698-885X; Garcia-Lekue, Aran/0000-0001-5556-0898; Kretz, Bernhard/0000-0002-6728-1025	Centres de Recerca de Catalunya Programme-Generalitat de Catalunya; Xunta de Galicia (Centro singular de investigacion de Galicia accreditation) [ED431G/09]; European Regional Development Fund; Spanish Ministry of Economy and Competitiveness [MAT2016-78293-C6-2-R, MAT2016-78293-C6-3-R, MAT2016-78293-C6-4-R, MAT2016-75952-R]; Secretariat for Universities and Research, Knowledge Department of the Generalitat de Catalunya [2014 SGR 715, 2014 SGR 56, 2017 SGR 827]; Basque Department of Education [PI-2016-1-0027]; European Union [696656]; Agency for Management of University and Research grants (AGAUR) of the Catalan government through European Commission under Marie Curie COFUND action [600385]; Spanish Ministry of Economy and Competitiveness (Severo Ochoa) [SEV-2013-0295]	Centres de Recerca de Catalunya Programme-Generalitat de Catalunya; Xunta de Galicia (Centro singular de investigacion de Galicia accreditation); European Regional Development Fund(European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); Secretariat for Universities and Research, Knowledge Department of the Generalitat de Catalunya; Basque Department of Education; European Union(European Commission); Agency for Management of University and Research grants (AGAUR) of the Catalan government through European Commission under Marie Curie COFUND action; Spanish Ministry of Economy and Competitiveness (Severo Ochoa)(Spanish Government)	This research was funded by the Centres de Recerca de Catalunya Programme-Generalitat de Catalunya, the Xunta de Galicia (Centro singular de investigacion de Galicia accreditation 2016-2019, ED431G/09), and the European Regional Development Fund. This research was supported by the Spanish Ministry of Economy and Competitiveness (under contract no. MAT2016-78293-C6-2-R, MAT2016-78293-C6-3-R, MAT2016-78293-C6-4-R, and MAT2016-75952-R and Severo Ochoa no. SEV-2013-0295); the Secretariat for Universities and Research, Knowledge Department of the Generalitat de Catalunya 2014 SGR 715, 2014 SGR 56, and 2017 SGR 827; the Basque Department of Education (contract no. PI-2016-1-0027); and the European Union's Horizon 2020 research and innovation program under grant agreement 696656. C.M. was supported by the Agency for Management of University and Research grants (AGAUR) of the Catalan government through the FP7 framework program of the European Commission under Marie Curie COFUND action 600385.	Bai JW, 2010, NAT NANOTECHNOL, V5, P190, DOI [10.1038/nnano.2010.8, 10.1038/NNANO.2010.8]; Basagni A, 2015, J AM CHEM SOC, V137, P1802, DOI 10.1021/ja510292b; Bieri M, 2009, CHEM COMMUN, P6919, DOI 10.1039/b915190g; Blankenburg S, 2010, SMALL, V6, P2266, DOI 10.1002/smll.201001126; Cai JM, 2010, NATURE, V466, P470, DOI 10.1038/nature09211; Chen YC, 2015, NAT NANOTECHNOL, V10, P156, DOI [10.1038/NNANO.2014.307, 10.1038/nnano.2014.307]; Chen YC, 2013, ACS NANO, V7, P6123, DOI 10.1021/nn401948e; Cohen-Tanugi D, 2012, NANO LETT, V12, P3602, DOI 10.1021/nl3012853; Csanyi G, 2005, NAT PHYS, V1, P42, DOI 10.1038/nphys119; Feng M, 2008, SCIENCE, V320, P359, DOI 10.1126/science.1155866; Feng M, 2011, ACCOUNTS CHEM RES, V44, P360, DOI 10.1021/ar1001445; Floris A, 2016, J AM CHEM SOC, V138, P5837, DOI 10.1021/jacs.5b11594; Franc G, 2011, PHYS CHEM CHEM PHYS, V13, P14283, DOI 10.1039/c1cp20700h; Garaj S, 2010, NATURE, V467, P190, DOI 10.1038/nature09379; Han MY, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206805; Held PA, 2017, CHEM-EUR J, V23, P5874, DOI 10.1002/chem.201604047; Huang H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00983; Jiang DE, 2009, NANO LETT, V9, P4019, DOI 10.1021/nl9021946; Kocic N, 2016, J AM CHEM SOC, V138, P5585, DOI 10.1021/jacs.5b13461; Koenig SP, 2012, NAT NANOTECHNOL, V7, P728, DOI [10.1038/NNANO.2012.162, 10.1038/nnano.2012.162]; Kou LZ, 2014, J PHYS CHEM LETT, V5, P2675, DOI 10.1021/jz501188k; Lafferentz L, 2012, NAT CHEM, V4, P215, DOI [10.1038/nchem.1242, 10.1038/NCHEM.1242]; Li Q, 2016, J AM CHEM SOC, V138, P2809, DOI 10.1021/jacs.5b13286; Liang XG, 2010, NANO LETT, V10, P2454, DOI 10.1021/nl100750v; Llinas JP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00734-x; Rollings RC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11408; Ruffieux P, 2012, ACS NANO, V6, P6930, DOI 10.1021/nn3021376; Sanchez-Sanchez C, 2016, ACS NANO, V10, P8006, DOI 10.1021/acsnano.6b04025; Sint K, 2008, J AM CHEM SOC, V130, P16448, DOI 10.1021/ja804409f; Sun Q, 2014, CHEM COMMUN, V50, P11825, DOI 10.1039/c4cc05482b; Surwade SP, 2015, NAT NANOTECHNOL, V10, P459, DOI [10.1038/nnano.2015.37, 10.1038/NNANO.2015.37]; Teeter JD, 2017, NANOSCALE, V9, P18835, DOI 10.1039/c7nr06027k; Venkatesan BM, 2011, NAT NANOTECHNOL, V6, P615, DOI [10.1038/NNANO.2011.129, 10.1038/nnano.2011.129]; Xia FN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5458; Zhang YQ, 2016, NANO LETT, V16, P4274, DOI 10.1021/acs.nanolett.6b01324	35	314	319	39	597	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2018	360	6385					199	203		10.1126/science.aar2009	http://dx.doi.org/10.1126/science.aar2009			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC5DK	29650671	Green Accepted, Green Submitted			2022-12-28	WOS:000429805400045
J	Holme, O; Loberg, M; Kalager, M; Bretthauer, M; Hernan, MA; Aas, E; Eide, TJ; Skovlund, E; Lekven, J; Schneede, J; Tveit, KM; Vatn, M; Ursin, G; Hoff, G				Holme, Oyvind; Loberg, Magnus; Kalager, Mette; Bretthauer, Michael; Hernan, Miguel A.; Aas, Eline; Eide, Tor J.; Skovlund, Eva; Lekven, Jon; Schneede, Jorn; Tveit, Kjell Magne; Vatn, Morten; Ursin, Giske; Hoff, Geir		NORCCAP Study Grp	Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							FOLLOW-UP; COLONOSCOPY; RISK; SEX; UK	Background: The long-term effects of sigmoidoscopy screening on colorectal cancer (CRC) incidence and mortality in women and men are unclear. Objective: To determine the effectiveness of flexible sigmoidoscopy screening after 15 years of follow-up in women and men. Design: Randomized controlled trial. (ClinicalTrials.gov: NCT00119912) Setting: Oslo and Telemark County, Norway. Participants: Adults aged 50 to 64 years at baseline without prior CRC. Intervention: Screening (between 1999 and 2001) with flexible sigmoidoscopy with and without additional fecal blood testing versus no screening. Participants with positive screening results were offered colonoscopy. Measurements: Age-adjusted CRC incidence and mortality stratified by sex. Results: Of 98 678 persons, 20 552 were randomly assigned to screening and 78 126 to no screening. Adherence rates were 64.7% in women and 61.4% in men. Median follow-up was 14.8 years. The absolute risks for CRC in women were 1.86% in the screening group and 2.05% in the control group (risk difference, -0.19 percentage point [95% CI, -0.49 to 0.11 percentage point]; HR, 0.92 [CI, 0.79 to 1.07]). In men, the corresponding risks were 1.72% and 2.50%, respectively (risk difference, -0.78 percentage point [CI, -1.08 to -0.48 percentage points]; hazard ratio [HR], 0.66 [CI, 0.57 to 0.78]) (P for heterogeneity = 0.004). The absolute risks for death from CRC in women were 0.60% in the screening group and 0.59% in the control group (risk difference, 0.01 percentage point [CI, -0.16 to 0.18 percentage point]; HR, 1.01 [CI, 0.77 to 1.33]). The corresponding risks for death from CRC in men were 0.49% and 0.81%, respectively (risk difference, -0.33 percentage point [CI, -0.49 to -0.16 percentage point]; HR, 0.63 [CI, 0.47 to 0.83]) (P for heterogeneity = 0.014). Limitation: Follow-up through national registries. Conclusion: Offering sigmoidoscopy screening in Norway reduced CRC incidence and mortality in men but had little or no effect in women.	[Holme, Oyvind; Loberg, Magnus; Bretthauer, Michael; Eide, Tor J.] Sorlandet Hosp Kristiansand, Kristiansand, Norway; [Holme, Oyvind; Loberg, Magnus; Kalager, Mette; Bretthauer, Michael; Hernan, Miguel A.; Aas, Eline; Eide, Tor J.] Univ Oslo, Inst Hlth & Soc, Oslo, Norway; [Holme, Oyvind; Loberg, Magnus; Kalager, Mette; Bretthauer, Michael; Hernan, Miguel A.; Eide, Tor J.; Skovlund, Eva; Tveit, Kjell Magne; Vatn, Morten] Oslo Univ Hosp, Postbox 4950 Nydalen, N-0424 Oslo, Norway; [Kalager, Mette; Hernan, Miguel A.; Aas, Eline] Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA; [Kalager, Mette; Hernan, Miguel A.; Aas, Eline] Harvard Mit Div Hlth Sci & Technol, Boston, MA USA; [Skovlund, Eva] Norwegian Univ Sci & Technol, N-7491 Trondheim, Norway; [Lekven, Jon] Univ Bergen, Surg Res Lab, Postbox 1400, N-5021 Bergen, Norway; [Schneede, Jorn] Umea Univ, Clin Pharmacol Unit, SE-90187 Umea, Sweden; [Tveit, Kjell Magne; Vatn, Morten; Ursin, Giske; Hoff, Geir] Univ Oslo, Inst Clin Med, Postbox 1089 Blindern, N-0318 Oslo, Norway; [Ursin, Giske; Hoff, Geir] Canc Registry Norway, Postbox 5313 Majorstuen, N-0304 Oslo, Norway; [Ursin, Giske] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Ursin, Giske] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Hoff, Geir] Telemark Hosp, Skien, Norway; [Holme, Oyvind; Loberg, Magnus; Kalager, Mette; Bretthauer, Michael; Aas, Eline] Univ Oslo, Inst Hlth & Soc, Dept Hlth Management & Hlth Econ, Postbox 1089 Blindern, N-0318 Oslo, Norway	University of Oslo; University of Oslo; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Norwegian University of Science & Technology (NTNU); University of Bergen; Umea University; University of Oslo; University of Oslo; University of Oslo; University of Southern California; Telemark Hospital Trust; University of Oslo	Holme, O (corresponding author), Univ Oslo, Inst Hlth & Soc, Dept Hlth Management & Hlth Econ, Postbox 1089 Blindern, N-0318 Oslo, Norway.	oyvind.holme@medisin.uio.no; magnus.loberg@medisin.uio.no; geir.hoff@kreftregisteret.no		Hernan, Miguel/0000-0003-1619-8456	Norwegian government; Norwegian Cancer Society; Research Council of Norway; South-East Regional Health Authority of Norway; Fulbright Foundation; Sorlandet Hospital Kristiansand; National Institutes of Health; NATIONAL CANCER INSTITUTE [P01CA134294] Funding Source: NIH RePORTER	Norwegian government; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); South-East Regional Health Authority of Norway; Fulbright Foundation; Sorlandet Hospital Kristiansand; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By research grants from the Norwegian government and the Norwegian Cancer Society. Work with the present manuscript was funded by research grants from the Norwegian Cancer Society, the Research Council of Norway, the South-East Regional Health Authority of Norway, the Fulbright Foundation, Sorlandet Hospital Kristiansand, and the National Institutes of Health.	Atkin W, 2017, LANCET, V389, P1299, DOI 10.1016/S0140-6736(17)30396-3; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V315, P2564, DOI 10.1001/jama.2016.5989; Brenner H, 2011, AM J EPIDEMIOL, V174, P1140, DOI 10.1093/aje/kwr188; Bretthauer N, 2002, SCAND J GASTROENTERO, V37, P568, DOI 10.1080/00365520252903125; Gondal G, 2003, SCAND J GASTROENTERO, V38, P635, DOI 10.1080/00365520310003002; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; Hoff G, 1996, SCAND J GASTROENTERO, V31, P834, DOI 10.3109/00365529609051989; Holme O, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6673; Holme O, 2014, JAMA-J AM MED ASSOC, V312, P606, DOI 10.1001/jama.2014.8266; Kim SE, 2015, WORLD J GASTROENTERO, V21, P5167, DOI 10.3748/wjg.v21.i17.5167; Larsen IK, 2002, SCAND J GASTROENTERO, V37, P850, DOI 10.1080/713786520; Robb KA, 2012, J MED SCREEN, V19, P171, DOI 10.1258/jms.2012.012129; Robertson DJ, 2015, GUT, V64, P982, DOI 10.1136/gutjnl-2014-308076; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; Segnan N, 2011, J NATL CANCER I, V103, P1310, DOI 10.1093/jnci/djr284; Senore C, 2011, J MED SCREEN, V18, P128, DOI 10.1258/jms.2011.010135; Shaukat A, 2013, NEW ENGL J MED, V369, P1106, DOI 10.1056/NEJMoa1300720; Swartz AW, 2017, ANN INTERN MED, V167, P602, DOI 10.7326/M17-0859	20	81	83	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2018	168	11					775	+		10.7326/M17-1441	http://dx.doi.org/10.7326/M17-1441			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3EK	29710125	Green Accepted			2022-12-28	WOS:000434254100004
J	Gaudino, M; Benedetto, U; Fremes, S; Biondi-Zoccai, G; Sedrakyan, A; Puskas, JD; Angelini, GD; Buxton, B; Frati, G; Hare, DL; Hayward, P; Nasso, G; Moat, N; Peric, M; Yoo, KJ; Speziale, G; Girardi, LN; Taggart, DP				Gaudino, Mario; Benedetto, Umberto; Fremes, Stephen; Biondi-Zoccai, Giuseppe; Sedrakyan, Art; Puskas, John D.; Angelini, Gianni D.; Buxton, Brian; Frati, Giacomo; Hare, David L.; Hayward, Philip; Nasso, Giuseppe; Moat, Neil; Peric, Miodrag; Yoo, Kyung J.; Speziale, Giuseppe; Girardi, Leonard N.; Taggart, David P.		RADIAL Investigators	Radial-Artery or Saphenous-Vein Grafts in Coronary-Artery Bypass Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-OUTCOMES; REVASCULARIZATION; PATENCY; CONDUITS; SURVIVAL; FAILURE; SOCIETY; DISEASE	BACKGROUND The use of radial-artery grafts for coronary-artery bypass grafting (CABG) may result in better postoperative outcomes than the use of saphenous-vein grafts. However, randomized, controlled trials comparing radial-artery grafts and saphenous-vein grafts have been individually underpowered to detect differences in clinical outcomes. We performed a patient-level combined analysis of randomized, controlled trials to compare radial-artery grafts and saphenous-vein grafts for CABG. METHODS Six trials were identified. The primary outcome was a composite of death, myocardial infarction, or repeat revascularization. The secondary outcome was graft patency on follow-up angiography. Mixed-effects Cox regression models were used to estimate the treatment effect on the outcomes. RESULTS A total of 1036 patients were included in the analysis (534 patients with radialartery grafts and 502 patients with saphenous-vein grafts). After a mean (+/- SD) follow-up time of 60 +/- 30 months, the incidence of adverse cardiac events was significantly lower in association with radial-artery grafts than with saphenousvein grafts (hazard ratio, 0.67; 95% confidence interval [CI], 0.49 to 0.90; P = 0.01). At follow-up angiography (mean follow-up, 50 +/- 30 months), the use of radial-artery grafts was also associated with a significantly lower risk of occlusion (hazard ratio, 0.44; 95% CI, 0.28 to 0.70; P<0.001). As compared with the use of saphenous-vein grafts, the use of radial-artery grafts was associated with a nominally lower incidence of myocardial infarction (hazard ratio, 0.72; 95% CI, 0.53 to 0.99; P = 0.04) and a lower incidence of repeat revascularization (hazard ratio, 0.50; 95% CI, 0.40 to 0.63; P< 0.001) but not a lower incidence of death from any cause (hazard ratio, 0.90; 95% CI, 0.59 to 1.41; P = 0.68). CONCLUSIONS As compared with the use of saphenous-vein grafts, the use of radial-artery grafts for CABG resulted in a lower rate of adverse cardiac events and a higher rate of patency at 5 years of follow-up. (Funded by Weill Cornell Medicine and others.)	[Gaudino, Mario; Girardi, Leonard N.] Weill Cornell Med, Dept Cardiothorac Surg, 525 E 68th St, New York, NY 10065 USA; [Sedrakyan, Art] Weill Cornell Med, Dept Healthcare Policy & Res, New York, NY USA; [Puskas, John D.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Benedetto, Umberto; Angelini, Gianni D.] Bristol Heart Inst, Bristol, Avon, England; [Moat, Neil] Royal Brompton & Harefield Trust, London, England; [Taggart, David P.] Univ Oxford, Oxford, England; [Fremes, Stephen] Univ Toronto, Schulich Heart Ctr, Sunnybrook Hlth Sci, Toronto, ON, Canada; [Biondi-Zoccai, Giuseppe; Frati, Giacomo] Sapienza Univ, Dept Medicosurg Sci & Biotechnol, Rome, Italy; [Biondi-Zoccai, Giuseppe; Frati, Giacomo] IRCCS Neuromed, Dept Angiocardioneurol, Pozzilli, Italy; [Nasso, Giuseppe; Speziale, Giuseppe] Anthea Hosp, Bari, Italy; [Buxton, Brian; Hare, David L.] Univ Melbourne, Melbourne, Vic, Australia; [Hayward, Philip] Austin Hosp, Melbourne, Vic, Australia; [Peric, Miodrag] Dedinje Cardiovasc Inst, Belgrade, Serbia; [Peric, Miodrag] Univ Belgrade, Sch Med, Belgrade, Serbia; [Yoo, Kyung J.] Yonsei Univ, Coll Med, Seoul, South Korea	Cornell University; Cornell University; Icahn School of Medicine at Mount Sinai; University of Bristol; Royal Brompton & Harefield NHS Foundation Trust; University of Oxford; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Sapienza University Rome; IRCCS Neuromed; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Belgrade; Yonsei University; Yonsei University Health System	Gaudino, M (corresponding author), Weill Cornell Med, Dept Cardiothorac Surg, 525 E 68th St, New York, NY 10065 USA.	mfg9004@med.cornell.edu	Frati, Giacomo/ABI-7410-2020; Biondi-Zoccai, Giuseppe/C-9670-2012; Nasso, Giuseppe/AAS-7579-2020	Biondi-Zoccai, Giuseppe/0000-0001-6103-8510; angelini, gianni/0000-0002-1753-3730; Benedetto, Umberto/0000-0002-7074-7949; Nasso, Giuseppe/0000-0002-3519-770X	Department of Cardiothoracic Surgery of Weill Cornell Medicine; National Institute for Health Research Bristol Biomedical Research Centre; Bernard S. Goldman Chair in Cardiovascular Surgery; Abbott Vascular; Bayer; Amgen; AstraZeneca; Merck; Sanofi; Novartis; Pfizer; Servier	Department of Cardiothoracic Surgery of Weill Cornell Medicine; National Institute for Health Research Bristol Biomedical Research Centre; Bernard S. Goldman Chair in Cardiovascular Surgery; Abbott Vascular(Abbott Laboratories); Bayer(Bayer AG); Amgen(Amgen); AstraZeneca(AstraZeneca); Merck(Merck & Company); Sanofi; Novartis(Novartis); Pfizer(Pfizer); Servier(Servier)	Supported by the Department of Cardiothoracic Surgery of Weill Cornell Medicine, the National Institute for Health Research Bristol Biomedical Research Centre (to Dr. Benedetto), and the Bernard S. Goldman Chair in Cardiovascular Surgery (to Dr. Fremes).; Dr. Biondi-Zoccai reports receiving consulting fees and lecture fees from Abbott Vascular and lecture fees from Bayer; and Dr. Hare, receiving advisory board fees from Amgen, AstraZeneca, Merck, and Sanofi, lecture fees from Novartis, consulting fees from Pfizer, and grant support from Servier. No other potential conflict of interest relevant to this article was reported.	Aldea GS, 2016, ANN THORAC SURG, V101, P801, DOI 10.1016/j.athoracsur.2015.09.100; Buxton BF, 2003, J THORAC CARDIOV SUR, V125, P1363, DOI 10.1016/S0022-5223(02)73241-8; Collins P, 2008, CIRCULATION, V117, P2859, DOI 10.1161/CIRCULATIONAHA.107.736215; Deb S, 2012, J AM COLL CARDIOL, V60, P28, DOI 10.1016/j.jacc.2012.03.037; ElBardissi AW, 2012, J THORAC CARDIOV SUR, V143, P273, DOI 10.1016/j.jtcvs.2011.10.029; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9; Garcia S, 2013, J AM COLL CARDIOL, V62, P1421, DOI 10.1016/j.jacc.2013.05.033; Gaudino M, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008010; Gaudino M, 2016, J AM COLL CARDIOL, V68, P603, DOI 10.1016/j.jacc.2016.05.062; Gaudino M, 2015, J AM COLL CARDIOL, V66, P1729, DOI 10.1016/j.jacc.2015.08.395; Gowda S, 2010, N AM J MED SCI, V2, P170; Hillis LD, 2011, CIRCULATION, V124, pE652, DOI 10.1161/CIR.0b013e31823c074e; Kolh P, 2014, EUR J CARDIO-THORAC, V46, P517, DOI DOI 10.1093/EJCTS/EZU366; LOOP FD, 1986, NEW ENGL J MED, V314, P1, DOI 10.1056/NEJM198601023140101; Lopes RD, 2012, CIRCULATION, V125, P749, DOI 10.1161/CIRCULATIONAHA.111.040311; Nasso G, 2009, J THORAC CARDIOV SUR, V137, P1093, DOI 10.1016/j.jtcvs.2008.10.029; Petrovic I, 2015, J CARDIOTHORAC SURG, V10, DOI 10.1186/s13019-015-0331-9; Shavadia J, 2015, AM HEART J, V169, P833, DOI 10.1016/j.ahj.2015.02.022; Song SW, 2012, KOREAN CIRC J, V42, P107, DOI 10.4070/kcj.2012.42.2.107	20	296	321	1	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2018	378	22					2069	2077		10.1056/NEJMoa1716026	http://dx.doi.org/10.1056/NEJMoa1716026			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH5AL	29708851	Green Published, Bronze			2022-12-28	WOS:000433428000005
J	Kelley, AT; Tipirneni, R				Kelley, A. Taylor; Tipirneni, Renuka			Care for Undocumented Immigrants - Rethinking State Flexibility in Medicaid Waivers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kelley, A. Taylor] Univ Michigan, Dept Internal Med, Med Sch, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; Ann Arbor Hlth Syst, Dept Vet Affairs, Ann Arbor, MI USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Kelley, AT (corresponding author), Univ Michigan, Dept Internal Med, Med Sch, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA.		Kelley, Alan Taylor/AAN-1369-2020	Kelley, Alan Taylor/0000-0003-0462-4737				Cervantes L, 2018, JAMA INTERN MED, V178, P188, DOI 10.1001/jamainternmed.2017.7039; Chokshi DA, 2016, NEW ENGL J MED, V375, P1790, DOI 10.1056/NEJMhpr1608578; Musumeci M, 2018, MED DEMONSTRATION WA; Schrag Wendy Funk, 2015, Nephrol News Issues, V29, P14; Sheikh-Hamad David, 2007, Tex Med, V103, P54	5	11	11	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2018	378	18					1661	1663		10.1056/NEJMp1801871	http://dx.doi.org/10.1056/NEJMp1801871			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GE4WO	29719186				2022-12-28	WOS:000431218600001
J	Nasralla, D; Coussios, CC; Mergental, H; Akhtar, MZ; Butler, AJ; Ceresa, CDL; Chiocchia, V; Dutton, SJ; Garcia-Valdecasas, JC; Heaton, N; Imber, C; Jassem, W; Jochmans, I; Karani, J; Knight, SR; Kocabayoglu, P; Malago, M; Mirza, D; Morris, PJ; Pallan, A; Paul, A; Pavel, M; Perera, MTPR; Pirenne, J; Ravikumar, R; Russell, L; Upponi, S; Watson, CJE; Weissenbacher, A; Ploeg, RJ; Friend, PJ				Nasralla, David; Coussios, Constantin C.; Mergental, Hynek; Akhtar, M. Zeeshan; Butler, Andrew J.; Ceresa, Carlo D. L.; Chiocchia, Virginia; Dutton, Susan J.; Carlos Garcia-Valdecasas, Juan; Heaton, Nigel; Imber, Charles; Jassem, Wayel; Jochmans, Ina; Karani, John; Knight, Simon R.; Kocabayoglu, Peri; Malago, Massimo; Mirza, Darius; Morris, Peter J.; Pallan, Arvind; Paul, Andreas; Pavel, Mihai; Perera, M. Thamara P. R.; Pirenne, Jacques; Ravikumar, Reena; Russell, Leslie; Upponi, Sara; Watson, Chris J. E.; Weissenbacher, Annemarie; Ploeg, Rutger J.; Friend, Peter J.		Consortium Organ Preservation Euro	A randomized trial of normothermic preservation in liver transplantation	NATURE			English	Article							ISCHEMIC CHOLANGIOPATHY; REPERFUSION INJURY; RISK-FACTORS; PERFUSION; DEATH; ALLOGRAFTS; DONATION	Liver transplantation is a highly successful treatment, but is severely limited by the shortage in donor organs. However, many potential donor organs cannot be used; this is because sub-optimal livers do not tolerate conventional cold storage and there is no reliable way to assess organ viability preoperatively. Normothermic machine perfusion maintains the liver in a physiological state, avoids cooling and allows recovery and functional testing. Here we show that, in a randomized trial with 220 liver transplantations, compared to conventional static cold storage, normothermic preservation is associated with a 50% lower level of graft injury, measured by hepatocellular enzyme release, despite a 50% lower rate of organ discard and a 54% longer mean preservation time. There was no significant difference in bile duct complications, graft survival or survival of the patient. If translated to clinical practice, these results would have a major impact on liver transplant outcomes and waiting list mortality.	[Nasralla, David; Akhtar, M. Zeeshan; Ceresa, Carlo D. L.; Knight, Simon R.; Morris, Peter J.; Ravikumar, Reena; Weissenbacher, Annemarie; Ploeg, Rutger J.; Friend, Peter J.] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Coussios, Constantin C.] Univ Oxford, Inst Biomed Engn, Dept Engn Sci, Oxford, England; [Mergental, Hynek; Mirza, Darius; Perera, M. Thamara P. R.] Queen Elizabeth Hosp Birmingham, Birmingham, W Midlands, England; [Akhtar, M. Zeeshan] Univ Oxford, Target Discovery Inst, Oxford, England; [Butler, Andrew J.; Watson, Chris J. E.] Univ Cambridge, Dept Surg, Addenbrookes Hosp, Cambridge, England; [Chiocchia, Virginia] Univ Oxford, Ctr Stat Med, Oxford, England; [Chiocchia, Virginia] Univ Oxford, Nuffield Dept Surg Sci, Surg Intervent Trials Unit, Oxford, England; [Dutton, Susan J.] Univ Oxford, Oxford Clin Trials Res Unit, Oxford, England; [Carlos Garcia-Valdecasas, Juan; Pavel, Mihai] Hosp Clin Barcelona, Dept Hepatobiliopancreat & Transplant Surg, Barcelona, Spain; [Heaton, Nigel; Jassem, Wayel; Karani, John] Kings Coll Hosp London, Inst Liver Studies, London, England; [Imber, Charles; Malago, Massimo] Royal Free Hosp, Dept Hepatopancreatobiliary & Liver Trans, London, England; [Jochmans, Ina; Pirenne, Jacques] Univ Hosp Leuven, Dept Surg, Abdominal Transplant Surg, Leuven, Belgium; [Jochmans, Ina; Pirenne, Jacques] Katholieke Univ Leuven, Lab Abdominal Transplantat, Dept Microbiol & Immunol, Leuven, Belgium; [Karani, John] Kings Coll Hosp London, Dept Radiol, London, England; [Knight, Simon R.; Morris, Peter J.] Royal Coll Surgeons England, Clin Effectiveness Unit, Ctr Evidence Transplantat, London, England; [Paul, Andreas] Univ Hosp Essen, Dept Gen Visceral & Transplantat Surg, Essen, Germany; [Pallan, Arvind] Queen Elizabeth Hosp Birmingham, Dept Radiol, Birmingham, W Midlands, England; [Russell, Leslie] OrganOx Ltd, Oxford, England; [Upponi, Sara] Addenbrookes Hosp, Dept Radiol, Cambridge, England; [Watson, Chris J. E.] Cambridge Biomed Res Ctr, NIHR, Cambridge, England	University of Oxford; University of Oxford; University of Birmingham; University of Oxford; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; University of Oxford; University of Oxford; University of Barcelona; Hospital Clinic de Barcelona; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; KU Leuven; University Hospital Leuven; KU Leuven; King's College Hospital NHS Foundation Trust; King's College Hospital; Royal College of Surgeons of England; University of Duisburg Essen; University of Birmingham; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Nasralla, D; Friend, PJ (corresponding author), Univ Oxford, Nuffield Dept Surg Sci, Oxford, England.; Coussios, CC (corresponding author), Univ Oxford, Inst Biomed Engn, Dept Engn Sci, Oxford, England.	nasralla@nds.ox.ac.uk; constantin.coussios@eng.ox.ac.uk; peter.friend@nds.ox.ac.uk	Jochmans, Ina/R-2471-2017; Heaton, Nigel/AAK-8363-2020; Friend, Peter/AAH-6512-2019; Mergental, Hynek/H-9485-2013; Chiocchia, Virginia/H-8885-2019; Mergental, Hynek/AAY-7122-2021; Pirenne, Jacques/I-3728-2018; Akhtar, Mohammed/AAZ-7752-2020	Jochmans, Ina/0000-0003-4592-2810; Mergental, Hynek/0000-0001-5480-9380; Chiocchia, Virginia/0000-0002-6196-3308; Mergental, Hynek/0000-0001-5480-9380; Pirenne, Jacques/0000-0002-8147-8801; Nasralla, David/0000-0001-5531-3387; Coussios, Constantin/0000-0001-8792-7818; Jassem, Wayel/0000-0003-2918-5232; Weissenbacher, Annemarie/0000-0002-0582-1815; Dutton, Susan/0000-0003-4573-5257	European Commission through the Seventh Framework Programme; European Commission Seventh Framework Programme (FP7) [305934]; MRC [MR/P001734/1] Funding Source: UKRI	European Commission through the Seventh Framework Programme; European Commission Seventh Framework Programme (FP7); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was performed by the Consortium for Organ Preservation in Europe (COPE). We thank the European Commission for their support through the Seventh Framework Programme. The following organisations, groups and individuals also made substantial contributions without which this trial could not have been completed successfully: NHS Blood and Transplant; the Surgical Intervention Trials Unit, University of Oxford; the Clinical Trials and Research Governance unit, University of Oxford; Centre for Evidence in Transplantation, Royal College of Surgeons of England; the Liver Transplant Coordinators, anaesthetists and liver unit physicians at the Queen Elizabeth Hospital, Birmingham, Addenbrooke's Hospital, Cambridge, King's College Hospital, London, the Royal Free Hospital London, Hospital Clinic, Barcelona, University Hospitals, Leuven, University Hospital, Essen; M. Soo, S. Morrish, C. Morris, L. Randle, R. Macedo Arantes, R. Morovat, A. Elsharkawy, G. Hirschfield, P. Muiesan, J. Isaac, J. Grayer, B. Buchholz, H. Vilca-Melendez, A. Zamalloa, D. Chasiotis, S. Khorsandi, B. Davidson, D. Sharma, A. Esson, D. Monbaliu, S. Mertens, S. Swoboda, J. Neuhaus, T. Benko, V. Molina, R. Kumar, A. Bradley, M. Laspeyres, B. Patel, A. Mukwamba, S. Banks, the COPE Transplant Technicians, the Specialist Nurses in Organ Donation and, of course, all of the donors and their families. This study was funded by a European Commission Seventh Framework Programme (FP7) Grant (No 305934).	Angelico R, 2016, TRANSPLANT DIRECT, V2, DOI 10.1097/TXD.0000000000000611; [Anonymous], 2017, ORG DON TRANSPL ACT; [Anonymous], 2017, 18 C EUR SOC ORG TRA, V30; [Anonymous], 2017, ANN REPORT LIVER TRA; Brockmann J, 2009, ANN SURG, V250, P1, DOI 10.1097/SLA.0b013e3181a63c10; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; CLAVIEN PA, 1992, TRANSPLANTATION, V53, P957, DOI 10.1097/00007890-199205000-00001; Eisenbach C, 2009, TRANSPL P, V41, P1727, DOI 10.1016/j.transproceed.2009.01.084; Jay CL, 2011, ANN SURG, V253, P259, DOI 10.1097/SLA.0b013e318204e658; Leithead JA, 2013, TRANSPL INT, V26, P1116, DOI 10.1111/tri.12175; Mergental H, 2016, AM J TRANSPLANT, V16, P3235, DOI 10.1111/ajt.13875; Mourad MM, 2014, WORLD J GASTROENTERO, V20, P6159, DOI 10.3748/wjg.v20.i20.6159; Olthoff KM, 2010, LIVER TRANSPLANT, V16, P943, DOI 10.1002/lt.22091; Perera MTPR, 2016, LIVER TRANSPLANT, V22, P120, DOI 10.1002/lt.24369; Ravikumar R, 2016, AM J TRANSPLANT, V16, P1779, DOI 10.1111/ajt.13708; Reddy S, 2005, LIVER TRANSPLANT, V11, P35, DOI 10.1002/lt.20287; The All-Party-Parliamentary Hepatology Group (APPHG), 2014, LIV DIS TOD COMPL TO; TODO S, 1989, JAMA-J AM MED ASSOC, V261, P711, DOI 10.1001/jama.261.5.711; Watson CJE, 2016, AM J TRANSPLANT, V16, P353, DOI 10.1111/ajt.13448; Xu HZ, 2012, J SURG RES, V173, pE83, DOI 10.1016/j.jss.2011.09.057	20	523	542	8	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2018	557	7703					50	+		10.1038/s41586-018-0047-9	http://dx.doi.org/10.1038/s41586-018-0047-9			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5BW	29670285	Green Submitted, Green Published			2022-12-28	WOS:000431234500028
J	Lange, K; Peise, J; Lucke, B; Kruse, I; Vitagliano, G; Apellaniz, I; Kleinmann, M; Toth, G; Klempt, C				Lange, Karsten; Peise, Jan; Luecke, Bernd; Kruse, Ilka; Vitagliano, Giuseppe; Apellaniz, Iagoba; Kleinmann, Matthias; Toth, Geza; Klempt, Carsten			Entanglement between two spatially separated atomic modes	SCIENCE			English	Article							CONTINUOUS VARIABLE SYSTEMS; BOSE-EINSTEIN CONDENSATE; QUANTUM; CRITERION; LIMIT; NONLOCALITY; GENERATION; STATES; BEAMS	Modern quantum technologies in the fields of quantum computing, quantum simulation, and quantum metrology require the creation and control of large ensembles of entangled particles. In ultracold ensembles of neutral atoms, nonclassical states have been generated with mutual entanglement among thousands of particles. The entanglement generation relies on the fundamental particle-exchange symmetry in ensembles of identical particles, which lacks the standard notion of entanglement between clearly definable subsystems. Here, we present the generation of entanglement between two spatially separated clouds by splitting an ensemble of ultracold identical particles prepared in a twin Fock state. Because the clouds can be addressed individually, our experiments open a path to exploit the available entangled states of indistinguishable particles for quantum information applications.	[Lange, Karsten; Peise, Jan; Luecke, Bernd; Kruse, Ilka; Klempt, Carsten] Leibniz Univ Hannover, Inst Quantenopt, Welfengarten 1, D-30167 Hannover, Germany; [Vitagliano, Giuseppe] Austrian Acad Sci, IQOQI, Boltzmanngasse 3, A-1090 Vienna, Austria; [Vitagliano, Giuseppe; Apellaniz, Iagoba; Kleinmann, Matthias; Toth, Geza] Univ Basque Country UPV EHU, Dept Theoret Phys, POB 644, E-48080 Bilbao, Spain; [Kleinmann, Matthias] Univ Siegen, Naturwissenschaftlich Tech Fak, Walter Flex Str 3, D-57068 Siegen, Germany; [Toth, Geza] Basque Fdn Sci, Ikerbasque, E-48013 Bilbao, Spain; [Toth, Geza] Hungarian Acad Sci, Wigner Res Ctr Phys, POB 49, H-1525 Budapest, Hungary	Leibniz University Hannover; Austrian Academy of Sciences; University of Basque Country; Universitat Siegen; Basque Foundation for Science; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Wigner Research Centre for Physics	Klempt, C (corresponding author), Leibniz Univ Hannover, Inst Quantenopt, Welfengarten 1, D-30167 Hannover, Germany.	klempt@iqo.uni-hannover.de	Toth, Geza/A-6693-2008; Klempt, Carsten/AAQ-9483-2021; Kleinmann, Matthias/E-9242-2017; Apellaniz, Iagoba/AAV-1395-2021	Toth, Geza/0000-0002-9602-751X; Klempt, Carsten/0000-0003-2402-3162; Kleinmann, Matthias/0000-0002-5782-804X; Apellaniz, Iagoba/0000-0002-3688-3242; Vitagliano, Giuseppe/0000-0002-5563-3222; Lange, Karsten/0000-0003-4342-6151	European Union (European Research Council Starting Grant) [258647/GEDENTQOPT, CHIST-ERA QUASAR, COST Action CA15220]; European Research Council Consolidator Grant [683107/TempoQ, QuantERA CEBBEC]; Spanish Ministry of Economy, Industry and Competitiveness; European Regional Development Fund FEDER (MINECO/FEDER) [FIS2015-67161-P]; Basque government [IT986-16]; National Research, Development, and Innovation Office (NKFIH) [K124351]; Deutsche Forschungsgemeinschaft (DFG) (Forschungsstipendium) [KL 2726/2-1, KL2421/2-1]; FQXi [FQXi-RFP-1608]; Austrian Science Fund (FWF) through the START project [Y879-N27]; DFG [RTG 1729, CRC 1227]	European Union (European Research Council Starting Grant); European Research Council Consolidator Grant(European Research Council (ERC)); Spanish Ministry of Economy, Industry and Competitiveness(Spanish Government); European Regional Development Fund FEDER (MINECO/FEDER); Basque government(Basque Government); National Research, Development, and Innovation Office (NKFIH)(National Research, Development & Innovation Office (NRDIO) - Hungary); Deutsche Forschungsgemeinschaft (DFG) (Forschungsstipendium)(German Research Foundation (DFG)); FQXi; Austrian Science Fund (FWF) through the START project(Austrian Science Fund (FWF)); DFG(German Research Foundation (DFG))	This work was supported by the European Union (European Research Council Starting Grant 258647/GEDENTQOPT, CHIST-ERA QUASAR, COST Action CA15220, European Research Council Consolidator Grant 683107/TempoQ and QuantERA CEBBEC); the Spanish Ministry of Economy, Industry and Competitiveness and the European Regional Development Fund FEDER through grant FIS2015-67161-P (MINECO/FEDER); the Basque government (project IT986-16); the National Research, Development, and Innovation Office (NKFIH) (grant K124351); the Deutsche Forschungsgemeinschaft (DFG) (Forschungsstipendium KL 2726/2-1 and project KL2421/2-1); the FQXi (grant FQXi-RFP-1608); and the Austrian Science Fund (FWF) through the START project Y879-N27. We also acknowledge support from DFG through RTG 1729 and CRC 1227 (DQ-mat), project A02.	Berrada T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3077; Bucker R, 2011, NAT PHYS, V7, P608, DOI [10.1038/NPHYS1992, 10.1038/nphys1992]; DiGuglielmo J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.012323; Duan LM, 2000, PHYS REV LETT, V85, P3991, DOI 10.1103/PhysRevLett.85.3991; Duan LM, 2000, PHYS REV LETT, V84, P2722, DOI 10.1103/PhysRevLett.84.2722; Dussarrat P, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.173202; Eberle T, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.052329; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Esteve J, 2008, NATURE, V455, P1216, DOI 10.1038/nature07332; Fadel M, 2018, SCIENCE, V360, P409, DOI 10.1126/science.aao1850; Gross C, 2010, NATURE, V464, P1165, DOI 10.1038/nature08919; Haas F, 2014, SCIENCE, V344, P180, DOI 10.1126/science.1248905; Hamley CD, 2012, NAT PHYS, V8, P305, DOI [10.1038/nphys2245, 10.1038/NPHYS2245]; Hosten O, 2016, NATURE, V529, P505, DOI 10.1038/nature16176; Islam R, 2015, NATURE, V528, P77, DOI 10.1038/nature15750; Julsgaard B, 2001, NATURE, V413, P400, DOI 10.1038/35096524; Kiesel N, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.032316; Killoran N, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.150501; Klempt C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.195302; Kunkel P, 2018, SCIENCE, V360, P413, DOI 10.1126/science.aao2254; Laloe F, 2009, EUR PHYS J B, V70, P377, DOI 10.1140/epjb/e2009-00248-6; Lopes R, 2015, NATURE, V520, P66, DOI 10.1038/nature14331; Lucke B, 2011, SCIENCE, V334, P773, DOI 10.1126/science.1208798; Lucke B, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.155304; Luo XY, 2017, SCIENCE, V355, P620, DOI 10.1126/science.aag1106; McConnell R, 2015, NATURE, V519, P439, DOI 10.1038/nature14293; Monz T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.130506; Peise J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9984; REID MD, 1989, PHYS REV A, V40, P913, DOI 10.1103/PhysRevA.40.913; Riedel MF, 2010, NATURE, V464, P1170, DOI 10.1038/nature08988; Scherer M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.135302; Schmied R, 2016, SCIENCE, V352, P441, DOI 10.1126/science.aad8665; Simon R, 2000, PHYS REV LETT, V84, P2726, DOI 10.1103/PhysRevLett.84.2726; Tura J, 2015, ANN PHYS-NEW YORK, V362, P370, DOI 10.1016/j.aop.2015.07.021; Tura J, 2014, SCIENCE, V344, P1256, DOI 10.1126/science.1247715; Wang XL, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.210502; YURKE B, 1992, PHYS REV A, V46, P2229, DOI 10.1103/PhysRevA.46.2229	38	92	94	3	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					416	418		10.1126/science.aao2035	http://dx.doi.org/10.1126/science.aao2035			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1AR	29700263	Green Submitted			2022-12-28	WOS:000430949600037
J	Myhrvold, C; Freije, CA; Gootenberg, JS; Abudayyeh, OO; Metsky, HC; Durbin, AF; Kellner, MJ; Tan, AL; Paul, LM; Parham, LA; Garcia, KF; Barnes, KG; Chak, B; Mondini, A; Nogueira, ML; Isern, S; Michael, SF; Lorenzana, I; Yozwiak, NL; MacInnis, BL; Bosch, I; Gehrke, L; Zhang, F; Sabeti, PC				Myhrvold, Cameron; Freije, Catherine A.; Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Metsky, Hayden C.; Durbin, Ann F.; Kellner, Max J.; Tan, Amanda L.; Paul, Lauren M.; Parham, Leda A.; Garcia, Kimberly F.; Barnes, Kayla G.; Chak, Bridget; Mondini, Adriano; Nogueira, Mauricio L.; Isern, Sharon; Michael, Scott F.; Lorenzana, Ivette; Yozwiak, Nathan L.; MacInnis, Bronwyn L.; Bosch, Irene; Gehrke, Lee; Zhang, Feng; Sabeti, Pardis C.			Field-deployable viral diagnostics using CRISPR-Cas13	SCIENCE			English	Article							ZIKA-VIRUS; PCR; AMPLIFICATION; INFECTION; AMERICA; ASSAY	Mitigating global infectious disease requires diagnostic tools that are sensitive, specific, and rapidly field deployable. In this study, we demonstrate that the Cas13-based SHERLOCK (specific high-sensitivity enzymatic reporter unlocking) platform can detect Zika virus (ZIKV) and dengue virus (DENV) in patient samples at concentrations as low as 1 copy per microliter. We developed HUDSON (heating unextracted diagnostic samples to obliterate nucleases), a protocol that pairs with SHERLOCK for viral detection directly from bodily fluids, enabling instrument-free DENVdetection directly from patient samples in <2 hours. We further demonstrate that SHERLOCK can distinguish the four DENV serotypes, as well as region-specific strains of ZIKV from the 2015-2016 pandemic. Finally, we report the rapid (<1 week) design and testing of instrument-free assays to detect clinically relevant viral single-nucleotide polymorphisms.	[Myhrvold, Cameron; Freije, Catherine A.; Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Metsky, Hayden C.; Kellner, Max J.; Barnes, Kayla G.; Chak, Bridget; Yozwiak, Nathan L.; MacInnis, Bronwyn L.; Zhang, Feng; Sabeti, Pardis C.] Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA 02142 USA; [Myhrvold, Cameron; Freije, Catherine A.; Barnes, Kayla G.; Chak, Bridget; Yozwiak, Nathan L.; Zhang, Feng; Sabeti, Pardis C.] Harvard Univ, Dept Organismal & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02138 USA; [Freije, Catherine A.; Durbin, Ann F.; Gehrke, Lee; Sabeti, Pardis C.] Harvard Med Sch, Div Med Sci, PhD Program Virol, Boston, MA 02115 USA; [Gootenberg, Jonathan S.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Zhang, Feng] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Zhang, Feng] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Abudayyeh, Omar O.] MIT, Dept Hlth Sci & Technol, Cambridge, MA 02139 USA; [Metsky, Hayden C.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Durbin, Ann F.; Bosch, Irene; Gehrke, Lee] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Tan, Amanda L.; Paul, Lauren M.; Isern, Sharon; Michael, Scott F.] Florida Gulf Coast Univ, Dept Biol Sci, Ft Myers, FL 33965 USA; [Parham, Leda A.; Garcia, Kimberly F.; Lorenzana, Ivette] Univ Nacl Autonoma Honduras, Inst Invest Microbiol, Ctr Invest Genet, Tegucigalpa, Honduras; [Barnes, Kayla G.; MacInnis, Bronwyn L.; Sabeti, Pardis C.] Harvard Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Mondini, Adriano] Sao Paulo State Univ, Sch Pharmaceut Sci, Araraquara Lab Publ Hlth, Sao Paulo, Brazil; [Nogueira, Mauricio L.] Fac Med Sao Jose do Rio Preto, Lab Pesquisas Virol, Sao Paulo, Brazil; [Bosch, Irene] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Gehrke, Lee] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Sabeti, Pardis C.] HHMI, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); State University System of Florida; Florida Gulf Coast University; Universidad Nacional Autonoma de Honduras; Harvard University; Harvard T.H. Chan School of Public Health; Universidade Estadual Paulista; Icahn School of Medicine at Mount Sinai; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Myhrvold, C; Freije, CA; Sabeti, PC (corresponding author), Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA 02142 USA.; Myhrvold, C; Freije, CA; Sabeti, PC (corresponding author), Harvard Univ, Dept Organismal & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02138 USA.; Freije, CA; Sabeti, PC (corresponding author), Harvard Med Sch, Div Med Sci, PhD Program Virol, Boston, MA 02115 USA.; Sabeti, PC (corresponding author), Harvard Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.; Sabeti, PC (corresponding author), HHMI, Chevy Chase, MD 20815 USA.	cmyhrvol@broadinstitute.org; cfreije@broadinstitute.org; pardis@broadinstitute.org	Sabeti, Pardis/GQH-8610-2022; Gootenberg, Jonathan/AAY-8174-2021; Macrae, Rhiannon/AAX-1536-2020; Abudayyeh, Omar/ABF-1746-2020; Nogueira, Mauricio L/B-7599-2012; Mondini, Adriano/F-7446-2012; Mondini, Adriano/AAB-4358-2020	Gootenberg, Jonathan/0000-0003-2757-2175; Abudayyeh, Omar/0000-0002-7979-3220; Nogueira, Mauricio L/0000-0003-1102-2419; Mondini, Adriano/0000-0002-5557-9721; Mondini, Adriano/0000-0002-5557-9721; Metsky, Hayden/0000-0002-8871-2349; Bosch, Irene/0000-0003-1352-5888; Lorenzana, Ivette/0000-0002-8128-8602; Paul, Lauren/0000-0001-5503-7570; Myhrvold, Cameron/0000-0002-8971-184X	HHMI; Broad Institute Chemical Biology and Therapeutics Science Shark Tank; NIH [U19AI110818, F30 NRSA 1F30-CA210382, AI 100190, 1R01-HG009761, 1R01-MH110049, 1DP1-HL141201]; Defense Advanced Research Projects Agency [D18AC00006]; Paul and Daisy Soros fellowship; NIH National Institute of Allergy and Infectious Diseases [R01AI099210]; New York Stem Cell foundation; Allen foundation; Vallee foundation; Tan-Yang Center at MIT; Sao Paulo Research Foundation (FAPESP) [13/21719-3]; NATIONAL CANCER INSTITUTE [F30CA210382] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [DP1HL141201] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI110818, R21AI100190, R01AI099210, R33AI100190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH110049] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); Broad Institute Chemical Biology and Therapeutics Science Shark Tank; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Paul and Daisy Soros fellowship; NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); New York Stem Cell foundation; Allen foundation; Vallee foundation; Tan-Yang Center at MIT; Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We acknowledge funding from HHMI, the Broad Institute Chemical Biology and Therapeutics Science Shark Tank, NIH grant U19AI110818, and Defense Advanced Research Projects Agency grant D18AC00006. The views, opinions, and/or findings expressed should not be interpreted as representing the official views or policies of the Department of Defense or the U.S. government. This study has been approved for public release; distribution is unlimited. C.M. is supported by HHMI. O.O.A. is supported by a Paul and Daisy Soros fellowship and NIH grant F30 NRSA 1F30-CA210382. S.I. and S.F.M. are supported by NIH National Institute of Allergy and Infectious Diseases grant R01AI099210. I.B. and L.G. are supported by NIH grant AI 100190. F.Z. is supported by NIH grants 1R01-HG009761, 1R01-MH110049, and 1DP1-HL141201; HHMI; the New York Stem Cell, Allen, and Vallee foundations; the Tan-Yang Center at MIT; and J. and P. Poitras and R. Metcalfe. F.Z. is a New York Stem Cell Foundation-Robertson Investigator. M.L.N. is supported by the Sao Paulo Research Foundation (FAPESP; grant 13/21719-3) and is a Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Research Fellow.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100; Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114; Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589; Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538; Du Y, 2017, ANGEW CHEM INT EDIT, V56, P992, DOI 10.1002/anie.201609108; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Eboigbodin KE, 2016, DIAGN MICR INFEC DIS, V86, P369, DOI 10.1016/j.diagmicrobio.2016.08.027; Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401; Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005; Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311; Gootenberg JS, 2018, SCIENCE, V360, P439, DOI 10.1126/science.aaq0179; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400; Kim S, 2007, ANNU REV BIOMED ENG, V9, P289, DOI 10.1146/annurev.bioeng.9.060906.152037; Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402; Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059; Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113; Requena-Castro R, 2017, MEM I OSWALDO CRUZ, V112, P520, DOI 10.1590/0074-02760160468; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Van Ness J, 2003, P NATL ACAD SCI USA, V100, P4504, DOI 10.1073/pnas.0730811100; Waggoner JJ, 2013, J CLIN MICROBIOL, V51, P3418, DOI 10.1128/JCM.01359-13; WEICKMANN JL, 1982, J BIOL CHEM, V257, P8705; Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120	26	595	635	44	369	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					444	448		10.1126/science.aas8836	http://dx.doi.org/10.1126/science.aas8836			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1AR	29700266	Green Published, Green Accepted			2022-12-28	WOS:000430949600044
J	Young, G; Hundt, N; Cole, D; Fineberg, A; Andrecka, J; Tyler, A; Olerinyova, A; Ansari, A; Marklund, EG; Collier, MP; Chandler, SA; Tkachenko, O; Allen, J; Crispin, M; Billington, N; Takagi, Y; Sellers, JR; Eichmann, C; Selenko, P; Frey, L; Riek, R; Galpin, MR; Struwe, WB; Benesch, JLP; Kukura, P				Young, Gavin; Hundt, Nikolas; Cole, Daniel; Fineberg, Adam; Andrecka, Joanna; Tyler, Andrew; Olerinyova, Anna; Ansari, Ayla; Marklund, Erik G.; Collier, Miranda P.; Chandler, Shane A.; Tkachenko, Olga; Allen, Joel; Crispin, Max; Billington, Neil; Takagi, Yasuharu; Sellers, James R.; Eichmann, Cedric; Selenko, Philipp; Frey, Lukas; Riek, Roland; Galpin, Martin R.; Struwe, Weston B.; Benesch, Justin L. P.; Kukura, Philipp			Quantitative mass imaging of single biological macromolecules	SCIENCE			English	Article							LABEL-FREE; HIGH-RESOLUTION; PROTEIN; MOLECULE; TRACKING; ACTIN; SPECTROSCOPY; AGGREGATION; MECHANISMS; MICROSCOPY	The cellular processes underpinning life are orchestrated by proteins and their interactions. The associated structural and dynamic heterogeneity, despite being key to function, poses a fundamental challenge to existing analytical and structural methodologies. We used interferometric scattering microscopy to quantify the mass of single biomolecules in solution with 2% sequence mass accuracy, up to 19-kilodalton resolution, and 1-kilodalton precision. We resolved oligomeric distributions at high dynamic range, detected small-molecule binding, and mass-imaged proteins with associated lipids and sugars. These capabilities enabled us to characterize themolecular dynamics of processes as diverse as glycoprotein cross-linking, amyloidogenic protein aggregation, and actin polymerization. Interferometric scattering mass spectrometry allows spatiotemporally resolved measurement of a broad range of biomolecular interactions, one molecule at a time.	[Young, Gavin; Hundt, Nikolas; Cole, Daniel; Fineberg, Adam; Andrecka, Joanna; Tyler, Andrew; Olerinyova, Anna; Ansari, Ayla; Collier, Miranda P.; Chandler, Shane A.; Tkachenko, Olga; Galpin, Martin R.; Struwe, Weston B.; Benesch, Justin L. P.; Kukura, Philipp] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, South Pk Rd, Oxford OX1 3QZ, England; [Marklund, Erik G.] Uppsala Univ, Biomed Ctr, Dept Chem, Box 576, S-75123 Uppsala, Sweden; [Allen, Joel; Crispin, Max] Univ Oxford, Oxford Glycobiol Inst, Dept Biochem, Oxford OX1 3QU, England; [Billington, Neil; Takagi, Yasuharu; Sellers, James R.] NHLBI, Cell Biol & Physiol Ctr, Bethesda, MD 20892 USA; [Eichmann, Cedric; Selenko, Philipp] Leibniz Inst Mol Pharmacol FMP Berlin, Dept NMR Supported Struct Biol, In Cell NMR Lab, Robert Rossle Str 10, D-13125 Berlin, Germany; [Frey, Lukas; Riek, Roland] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Lab Phys Chem, CH-8093 Zurich, Switzerland; [Riek, Roland] Scripps Res Inst, Dept Immunol & Microbiol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Allen, Joel; Crispin, Max] Univ Southampton, Ctr Biol Sci, Southampton SO17 1BJ, Hants, England; [Allen, Joel; Crispin, Max] Univ Southampton, Inst Life Sci, Southampton SO17 1BJ, Hants, England	University of Oxford; Uppsala University; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Swiss Federal Institutes of Technology Domain; ETH Zurich; Scripps Research Institute; University of Southampton; University of Southampton	Benesch, JLP; Kukura, P (corresponding author), Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, South Pk Rd, Oxford OX1 3QZ, England.	justin.benesch@chem.ox.ac.uk; philipp.kukura@chem.ox.ac.uk	Frey, Lukas/C-3073-2019; Fineberg, Adam/AAL-9334-2021; Crispin, Max/AAG-4098-2020; Eichmann, Cédric/U-1360-2018; Marklund, Erik G/G-7480-2012	Frey, Lukas/0000-0002-1052-1104; Fineberg, Adam/0000-0002-6808-1818; Crispin, Max/0000-0002-1072-2694; Eichmann, Cédric/0000-0002-8476-1936; Marklund, Erik G/0000-0002-9804-5009; Billington, Neil/0000-0003-2306-0228; Hundt, Nikolas/0000-0001-8217-671X; Tyler, Andrew/0000-0001-7013-2648; Young, Gavin/0000-0001-8835-5225; Olerinyova, Anna/0000-0002-0358-4262; Allen, Joel/0000-0003-2547-968X; Riek, Roland/0000-0002-6333-066X	Zvi and Ofra Meitar Magdalen Graduate Scholarship; DFG (German Research Foundation) research fellowship [HU 2462/1-1]; Swedish Research Council; European Commission for a Marie Sklodowska Curie International Career Grant [2015-00559]; Oxford University Press; Biotechnology and Biological Sciences Research Council; Waters Corp through the iCASE studentship [BB/L017067/1]; St John's College, University of Oxford; Engineering and Physical Sciences Research Council (EPSRC) Studentship; National Institute of Allergy and Infectious Diseases (Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery grant) [UM1AI100663]; NHLBI intramural program [HL0001786]; Swiss National Science Foundation advanced postdoctoral mobility fellowship [P300PA160979]; European Research Council (ERC) Consolidator Grant (NeuroInCellNMR) [647474]; EPSRC [EP/J01835X/1]; ERC Starting Investigator Grant (Nanoscope) [337577]; BBSRC [BB/J018082/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL001786, ZIAHL001786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663] Funding Source: NIH RePORTER	Zvi and Ofra Meitar Magdalen Graduate Scholarship; DFG (German Research Foundation) research fellowship(German Research Foundation (DFG)); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Commission for a Marie Sklodowska Curie International Career Grant; Oxford University Press; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Waters Corp through the iCASE studentship; St John's College, University of Oxford; Engineering and Physical Sciences Research Council (EPSRC) Studentship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute of Allergy and Infectious Diseases (Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery grant); NHLBI intramural program; Swiss National Science Foundation advanced postdoctoral mobility fellowship; European Research Council (ERC) Consolidator Grant (NeuroInCellNMR)(European Research Council (ERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ERC Starting Investigator Grant (Nanoscope); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	G.Y. was supported by a Zvi and Ofra Meitar Magdalen Graduate Scholarship. N.H. was supported by a DFG (German Research Foundation) research fellowship (HU 2462/1-1). E.G.M. thanks the Swedish Research Council and the European Commission for a Marie Sklodowska Curie International Career Grant (2015-00559). M.P.C. is a Clarendon Scholar supported by the Oxford University Press. S.A.C. is supported by the Biotechnology and Biological Sciences Research Council and Waters Corp through the iCASE studentship BB/L017067/1 to J.L.P.B. O.T. acknowledges a Lamb and Flag Scholarship from St John's College, University of Oxford, and an Engineering and Physical Sciences Research Council (EPSRC) Studentship. J.Al. and M.C. were supported by the National Institute of Allergy and Infectious Diseases (Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery grant UM1AI100663). J.R.S. was supported by NHLBI intramural program HL0001786. C.E. is supported by a Swiss National Science Foundation advanced postdoctoral mobility fellowship (P300PA160979). P.S. is funded by a European Research Council (ERC) Consolidator Grant (NeuroInCellNMR, 647474). J.L.P.B. thanks the EPSRC for EP/J01835X/1. P.K. was supported by an ERC Starting Investigator Grant (Nanoscope, 337577).	Ahnert SE, 2015, SCIENCE, V350, DOI 10.1126/science.aaa2245; Arroyo JO, 2014, NANO LETT, V14, P2065, DOI 10.1021/nl500234t; Bibow S, 2017, NAT STRUCT MOL BIOL, V24, P187, DOI 10.1038/nsmb.3345; Bohren C., 2008, ABSORPTION SCATTERIN; Cao LW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14954; Chakraborty M, 2012, BIOPHYS J, V103, P949, DOI 10.1016/j.bpj.2012.07.034; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; Cole D, 2017, ACS PHOTONICS, V4, P211, DOI 10.1021/acsphotonics.6b00912; Denisov IG, 2017, CHEM REV, V117, P4669, DOI 10.1021/acs.chemrev.6b00690; ERICKSON HP, 1989, J MOL BIOL, V206, P465, DOI 10.1016/0022-2836(89)90494-4; Galvagnion C, 2015, NAT CHEM BIOL, V11, P229, DOI [10.1038/NCHEMBIO.1750, 10.1038/nchembio.1750]; Greenleaf WJ, 2007, ANNU REV BIOPH BIOM, V36, P171, DOI 10.1146/annurev.biophys.36.101106.101451; Hemmat M, 2018, CURR OPIN CELL BIOL, V50, P8, DOI 10.1016/j.ceb.2017.12.013; Hopper JTS, 2017, STRUCTURE, V25, P773, DOI 10.1016/j.str.2017.03.015; Hua BY, 2014, NAT METHODS, V11, P1233, DOI [10.1038/NMETH.3143, 10.1038/nmeth.3143]; Iyer A, 2016, BIOPHYS J, V111, P2440, DOI 10.1016/j.bpj.2016.10.016; Jain A, 2011, NATURE, V473, P484, DOI 10.1038/nature10016; Kanno DM, 2014, J PHYS CHEM B, V118, P12404, DOI 10.1021/jp507741r; KASAI M, 1962, BIOCHIM BIOPHYS ACTA, V57, P22, DOI 10.1016/0006-3002(62)91073-9; Kukura P, 2009, NAT METHODS, V6, P923, DOI 10.1038/nmeth.1395; LASKY LA, 1986, SCIENCE, V233, P209, DOI 10.1126/science.3014647; Liebel M, 2017, NANO LETT, V17, P1277, DOI 10.1021/acs.nanolett.6b05040; Lusvarghi S, 2016, ACS INFECT DIS, V2, P882, DOI 10.1021/acsinfecdis.6b00139; Piliarik M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5495; Rottner K, 2017, J CELL SCI, V130, P3427, DOI 10.1242/jcs.206433; Schuler B, 2008, CURR OPIN STRUC BIOL, V18, P16, DOI 10.1016/j.sbi.2007.12.003; Struwe WB, 2017, ACS CHEM BIOL, V12, P357, DOI 10.1021/acschembio.6b00854; Swanson MD, 2010, J BIOL CHEM, V285, P8646, DOI 10.1074/jbc.M109.034926; van de Waterbeemd MV, 2017, NAT METHODS, V14, P283, DOI [10.1038/nmeth.4147, 10.1038/NMETH.4147]; Wang HW, 2017, PROTEIN SCI, V26, P32, DOI 10.1002/pro.3022	30	228	228	20	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					423	+		10.1126/science.aar5839	http://dx.doi.org/10.1126/science.aar5839			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1AR	29700264	Green Accepted, Green Submitted			2022-12-28	WOS:000430949600039
J	Chen, PY				Chen, Po-Yi			Colon Cutoff Sign	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chen, Po-Yi] Natl Taiwan Univ Hosp, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital	Chen, PY (corresponding author), Natl Taiwan Univ Hosp, Taipei, Taiwan.	c2c389@hotmail.com							0	0	0	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2018	378	17					1621	1621		10.1056/NEJMicm1714270	http://dx.doi.org/10.1056/NEJMicm1714270			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GD8XP	29694821				2022-12-28	WOS:000430797900009
J	Heald, R				Heald, Rebecca			A lab co-op helps young faculty members to thrive	NATURE			English	Editorial Material									[Heald, Rebecca] Univ Calif Berkeley, Cell & Dev Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Heald, R (corresponding author), Univ Calif Berkeley, Cell & Dev Biol, Berkeley, CA 94720 USA.	bheald@berkeley.edu		Heald, Rebecca/0000-0001-6671-6528					0	2	2	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					409	409		10.1038/d41586-018-04923-6	http://dx.doi.org/10.1038/d41586-018-04923-6			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD8VX	29686370	Bronze			2022-12-28	WOS:000430793000013
J	Staerk, L; Wang, BQ; Preis, SR; Larson, MG; Lubitz, SA; Ellinor, PT; McManus, DD; Ko, D; Weng, LC; Lunetta, KL; Frost, L; Benjamin, EJ; Trinquart, L				Staerk, Laila; Wang, Biqi; Preis, Sarah R.; Larson, Martin G.; Lubitz, Steven A.; Ellinor, Patrick T.; McManus, David D.; Ko, Darae; Weng, Lu-Chen; Lunetta, Kathryn L.; Frost, Lars; Benjamin, Emelia J.; Trinquart, Ludovic			Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREVALENCE; EPIDEMIOLOGY; POPULATION; TRENDS; HOSPITALIZATION; MULTIMORBIDITY; MORTALITY; DISEASE; DESIGN; BURDEN	OBJECTIVE To examine the association between risk factor burdens-categorized as optimal, borderline, or elevated-and the lifetime risk of atrial fibrillation. DESIGN Community based cohort study. SETTING Longitudinal data from the Framingham Heart Study. PARTICIPANTS Individuals free of atrial fibrillation at index ages 55, 65, and 75 years were assessed. Smoking, alcohol consumption, body mass index, blood pressure, diabetes, and history of heart failure or myocardial infarction were assessed as being optimal (that is, all risk factors were optimal), borderline (presence of borderline risk factors and absence of any elevated risk factor), or elevated (presence of at least one elevated risk factor) at index age. MAIN OUTCOME MEASURE Lifetime risk of atrial fibrillation at index age up to 95 years, accounting for the competing risk of death. RESULTS At index age 55 years, the study sample comprised 5338 participants (2531 (47.4%) men). In this group, 247 (4.6%) had an optimal risk profile, 1415 (26.5%) had a borderline risk profile, and 3676 (68.9%) an elevated risk profile. The prevalence of elevated risk factors increased gradually when the index ages rose. For index age of 55 years, the lifetime risk of atrial fibrillation was 37.0% (95% confidence interval 34.3% to 39.6%). The lifetime risk of atrial fibrillation was 23.4% (12.8% to 34.5%) with an optimal risk profile, 33.4% (27.9% to 38.9%) with a borderline risk profile, and 38.4% (35.5% to 41.4%) with an elevated risk profile. Overall, participants with at least one elevated risk factor were associated with at least 37.8% lifetime risk of atrial fibrillation. The gradient in lifetime risk across risk factor burden was similar at index ages 65 and 75 years. CONCLUSIONS Regardless of index ages at 55, 65, or 75 years, an optimal risk factor profile was associated with a lifetime risk of atrial fibrillation of about one in five; this risk rose to more than one in three in individuals with at least one elevated risk factor.	[Staerk, Laila; Preis, Sarah R.; Larson, Martin G.; Lunetta, Kathryn L.; Benjamin, Emelia J.] NHLBI, Framingham, MA USA; [Staerk, Laila; Preis, Sarah R.; Larson, Martin G.; Lunetta, Kathryn L.; Benjamin, Emelia J.] Boston Univ Framingham Heart Study, Framingham, MA USA; [Staerk, Laila] Univ Copenhagen, Dept Cardiol, Hosp Herlev & Gentofte, Copenhagen, Denmark; [Wang, Biqi; Preis, Sarah R.; Larson, Martin G.; Lunetta, Kathryn L.; Trinquart, Ludovic] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Lubitz, Steven A.; Ellinor, Patrick T.; Weng, Lu-Chen] Harvard & Massachusetts Inst Technol, Broad Inst, Cambridge, MA USA; [Lubitz, Steven A.; Ellinor, Patrick T.; Weng, Lu-Chen] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [McManus, David D.] Univ Massachusetts, Med Sch, Dept Med, Cardiol Div, Worcester, MA 01605 USA; [Ko, Darae; Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Med, Sect Prevent Med, Boston, MA 02118 USA; [Ko, Darae; Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Med, Sect Cardiovasc Med, Boston, MA 02118 USA; [Frost, Lars] Aarhus Univ Hosp, Dept Clin Med, Silkeborg Hosp, Aarhus, Denmark; [Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Framingham Heart Study; University of Copenhagen; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester; Boston University; Boston University; Aarhus University; Boston University	Trinquart, L (corresponding author), Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA.	ludovic@bu.edu	Frost, Lars/Q-9295-2019; Trinquart, Ludovic/H-4961-2019; Frost, Lars/V-3982-2017; Benjamin, Emelia/E-7103-2011	Frost, Lars/0000-0001-9215-9796; Trinquart, Ludovic/0000-0002-3028-4900; Frost, Lars/0000-0001-9215-9796; Benjamin, Emelia/0000-0003-4076-2336; Lunetta, Kathryn/0000-0002-9268-810X; Preis, Sarah/0000-0002-9360-4166	Boston University School of Medicine; National Heart, Lung, and Blood Institute's Framingham Heart Study [NIH/NHLBI N01-HC25195l, HHSN268201500001I, 2R01HL092577, 1R01HL128914, 1P50HL120163]; Velux Foundation; National Institutes of Health (NIH) [K23HL114724]; Doris Duke Charitable Foundation Clinical Scientist Development Award [2014105]; NIH [K24HL105780, R01HL126911, R01HL135219, R01HL136660, UH3 TR000921-04]; Established Investigator Award from the American Heart Association [13EIA14220013]; Foundation Leducq [14CVD01]; National Science Foundation [NSF-12-512]; American Heart Association [2017D000729]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000921] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL105780, R01HL135219, P50HL120163, K23HL114724, R01HL092577, R01HL136660, R01HL128914, R01HL126911] Funding Source: NIH RePORTER	Boston University School of Medicine; National Heart, Lung, and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Velux Foundation(Velux Fonden); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation Clinical Scientist Development Award(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Established Investigator Award from the American Heart Association(American Heart Association); Foundation Leducq(Leducq Foundation); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Boston University School of Medicine, and the National Heart, Lung, and Blood Institute's Framingham Heart Study (contract NIH/NHLBI N01-HC25195l; HHSN268201500001I; 2R01HL092577; 1R01HL128914; 1P50HL120163). The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of this manuscript. Additional support for this project from the Velux Foundation (LS); National Institutes of Health (NIH) grants K23HL114724 and Doris Duke Charitable Foundation Clinical Scientist Development Award 2014105 (SAL); NIH grant K24HL105780, Established Investigator Award from the American Heart Association (13EIA14220013) and the Foundation Leducq (<SUP>14</SUP>CVD01) (PTE); NIH grants R01HL126911, R01HL135219, R01HL136660, UH3 TR000921-04, and National Science Foundation grant NSF-12-512 (DDM); postdoctoral fellowship from the American Heart Association (2017D000729) (LCW); grants 2R01HL092577, 1R01HL128914, and 1P50HL120163 (EJB).	Al Mamun A, 2004, EUR HEART J, V25, P409, DOI 10.1016/j.ehj.2003.12.015; Alonso A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000102; [Anonymous], R LANG ENV STAT COMP; [Anonymous], 2017, ACCAHA; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Beiser A, 2000, STAT MED, V19, P1495, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1495::AID-SIM441>3.0.CO;2-E; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Chamberlain AM, 2017, AM HEART J, V185, P74, DOI 10.1016/j.ahj.2016.11.008; Colilla S, 2013, AM J CARDIOL, V112, P1142, DOI 10.1016/j.amjcard.2013.05.063; Dewland TA, 2013, CIRCULATION, V128, P2470, DOI 10.1161/CIRCULATIONAHA.113.002449; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Freeman JV, 2017, CIRCULATION, V135, P1227, DOI 10.1161/CIRCULATIONAHA.116.022388; Godino JG, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002185; Guo YT, 2015, CHEST, V147, P109, DOI 10.1378/chest.14-0321; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Huxley RR, 2011, CIRCULATION, V123, P1501, DOI [10.1161/circulationaha.110.009035, 10.1161/CIRCULATIONAHA.110.009035]; Li JN, 2015, LIFETIME DATA ANAL, V21, P197, DOI 10.1007/s10985-014-9313-9; Lip GYH, 2012, CHEST, V142, P1489, DOI 10.1378/chest.11-2888; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Magnussen C, 2017, CIRCULATION, V136, P1588, DOI [10.1161/CIRCULATIONAHA.117.028981, 10.1161/circulationaha.117.028981]; Mandalenakis Z, 2015, EUROPACE, V17, P1018, DOI 10.1093/europace/euv036; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Newman AB, 2013, EPIDEMIOL REV, V35, P181, DOI 10.1093/epirev/mxs013; Odutayo A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4482; Piccini JP, 2014, EUR HEART J, V35, P250, DOI 10.1093/eurheartj/eht483; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Rahman F, 2016, HYPERTENSION, V68, P597, DOI 10.1161/HYPERTENSIONAHA.116.07683; Rodriguez CJ, 2015, ANN EPIDEMIOL, V25, P71, DOI 10.1016/j.annepidem.2014.11.024; Schnabel RB, 2015, LANCET, V386, P154, DOI 10.1016/S0140-6736(14)61774-8; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Staerk L, 2017, CIRC RES, V120, P1501, DOI 10.1161/CIRCRESAHA.117.309732; Tucker NR, 2014, CIRC RES, V114, P1469, DOI 10.1161/CIRCRESAHA.114.302225; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; Weng LC, 2018, CIRCULATION, V137, P1027, DOI 10.1161/CIRCULATIONAHA.117.031431; Yi ZN, 2017, TOB INDUC DIS, V15, DOI 10.1186/s12971-017-0121-3	36	144	146	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2018	361								k1453	10.1136/bmj.k1453	http://dx.doi.org/10.1136/bmj.k1453			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF4WE	29699974	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000431963800002
J	Aveyard, P; Arnott, D; Johnson, KC				Aveyard, Paul; Arnott, Deborah; Johnson, Kenneth C.			Should we recommend e-cigarettes to help smokers quit?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SMOKING-CESSATION		[Aveyard, Paul] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Arnott, Deborah] Act Smoking & Hlth, London, England; [Johnson, Kenneth C.] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada	University of Oxford; University of Ottawa	Aveyard, P (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England.; Johnson, KC (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.	paul.aveyard@phc.ox.ac.uk; ken47johnson@gmail.com		Aveyard, Paul/0000-0002-1802-4217	British Heart Foundation; Cancer Research UK	British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK)	All authors have read and understood BMJ policy on declaration of interests and declare the following interests: PA conducts independent research on smoking cessation and harm reduction funded by public bodies. He was chief investigator of a smoking cessation trial funded by the National Institute of Health for which GlaxoSmithKline donated nicotine patches to the NHS in support of excess treatment costs. DA is chief executive of Action on Smoking and Health, which receives funding from the British Heart Foundation and Cancer Research UK. She was a member of the NICE committee that developed the 2018 guidance on smoking cessation interventions and services.	Alzahrani T, 2018, 24 ANN M BALT 21 24; Bauld L, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14090973; Beard E, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4645; Beard E, 2013, TOB CONTROL, V22, P118, DOI 10.1136/tobaccocontrol-2011-050007; British Medical Association, 2017, E CIG BAL RISKS OPP; Callard C., 2017, OMG BATS PLANS NEXT; Cancer Research UK, 2018, E CIG; Chapman S, 2018, NICOTINE TOB RES, DOI [10.1093/ntr/nty067.29660054, DOI 10.1093/NTR/NTY067.29660054]; de Andrade M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7473; Department of Health (DoH), 2017, SMOK GEN TOB CONTR P; East K, 2018, J ADOLESCENT HEALTH, V62, P539, DOI 10.1016/j.jadohealth.2017.11.301; Glantz SA, 2018, ANNU REV PUBL HEALTH, V39, P215, DOI 10.1146/annurev-publhealth-040617-013757; Hackshaw A, 2018, BMJ-BRIT MED J, V360, DOI [10.1136/bmj.j5855, 10.1136/bmj.k1611]; Hartmann-Boyce J, 2016, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD010216.pub3, 10.1002/14651858.CD010216.pub4]; HARTMANNBOYCE J, 2018, BMJ-BRIT MED J, V360, P12538, DOI DOI 10.1136/BMJ.J5543; Hitchman SC, 2015, NICOTINE TOB RES, V17, P1187, DOI 10.1093/ntr/ntv078; Kulik MC, 2018, AM J PREV MED, V54, P603, DOI 10.1016/j.amepre.2017.12.017; McNeill A, 2018, EVIDENCE REV E CIGAR; McNeill A., 2018, EVIDENCE REV ECIGARE; Moore D, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1024; National Academies of Sciences Engineering and Medicine, 2018, PUBL HLTH CONS E CIG; National Institute for Health and Clinical Excellence, STOP SMOK INT SERV N; NHS Digital, 2017, STAT NHS STOP SMOK; NHS Digital, 2017, SMOK DRINK DRUG US Y; Pasquereau A, 2017, ADDICTION, V112, P1620, DOI 10.1111/add.13869; Pokhrel S, 2016, LANCET, V388, P95; Royal College of General Practitioners, 2017, RCGP POS STAT US EL; Soneji SS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193328; Stead LF, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008286.pub3; Tobacco Advisory Group of the Royal College of Physicians, 2016, NIC SMOK TOB HARM RE; West R, 2018, TRENDS ELECT CIGARET; World Health Organization, 2012, WHO GLOB REP MORT AT; Zhu SH, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3262	33	16	16	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2018	361								k1759	10.1136/bmj.k1759	http://dx.doi.org/10.1136/bmj.k1759			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GF4WC	29695405	Green Published			2022-12-28	WOS:000431963600011
J	Chen, I; Cooney, R; Feachem, RGA; Lal, A; Mpanju-Shumbusho, W				Chen, Ingrid; Cooney, Rebecca; Feachem, Richard G. A.; Lal, Altaf; Mpanju-Shumbusho, Winnie			The Lancet Commission on malaria eradication	LANCET			English	Editorial Material									[Chen, Ingrid; Feachem, Richard G. A.] Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94158 USA; [Cooney, Rebecca] Lancet, New York, NY USA; [Lal, Altaf] Sun Pharmaceut Ind Ltd, Gurgaon, Haryana, India; [Mpanju-Shumbusho, Winnie] RBM Partnership End Malaria, Geneva, Switzerland	University of California System; University of California San Francisco	Chen, I (corresponding author), Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94158 USA.	ingrid.chen@ucsf.edu			Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	RC and WM-S declare no competing interests. IC and RGAF receive grants from the Bill & Melinda Gates Foundation, which is supporting this Commission. The Malaria Elimination Initiative (MEI) of the Global Health Group at UCSF exists to accelerate the progress of malaria elimination and eradication. The MEI collaborates in this endeavour with numerous governments and organisations around the world. Funding comes from multiple sources. AL is the Senior Advisor Global Health and Innovation at Sun Pharmaceuticals Industries Limited; Sun Pharma has developed the antimalarial drug Synriam, which has been launched for use in India, and Sun Pharma's Foundation for Disease Elimination and Control is working with the Indian Council of Medical Research and Government of Madhya Pradesh to demonstrate feasibility of eliminating malaria using case management and vector control strategies in 1233 villages of District Mandla in Madhya Pradesh.	[Anonymous], 2017, PLOS MED, V14; Bruno JM, 1997, NATURE, V386, P541, DOI 10.1038/386541a0; Commonwealth Heads of Government Meeting London, COMM FUT; Gates B, 2014, ASPIRATION ACTION WH; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Lee MCS, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0063-9; Newby G, 2016, LANCET, V387, P1775, DOI 10.1016/S0140-6736(16)00230-0; PATH Malaria Vaccine Initiative, 2017, RTS S GHAN KENY MAL; Senaratne R, 2016, LANCET, V388, P1038, DOI 10.1016/S0140-6736(16)31572-0; Tanner M, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0384-6; WHO, 2016, 90 000 CAS ZER 2 DEC; WHO, 2016, NEW WHO ADV GROUP TA; World Health Organization, 2017, DEPRESSION	13	22	22	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2018	391	10130					1556	1558		10.1016/S0140-6736(18)30911-5	http://dx.doi.org/10.1016/S0140-6736(18)30911-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GD5JG	29673872				2022-12-28	WOS:000430542700007
J	Voosen, P				Voosen, Paul			PLANETARY SCIENCE NASA lander to probe interior of Mars	SCIENCE			English	News Item																			0	1	1	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2018	360	6386					247	248		10.1126/science.360.6386.247	http://dx.doi.org/10.1126/science.360.6386.247			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD3IC	29674569				2022-12-28	WOS:000430396600014
J	Peeples, L				Peeples, Lynne			TIME TRIALS	NATURE			English	News Item							CHRONOTHERAPY; FLUOROURACIL; CHEMOTHERAPY; OXALIPLATIN; CANCER											Chan S, 2017, CLIN ONCOL-UK, V29, P231, DOI 10.1016/j.clon.2016.12.005; Chen CY, 2016, P NATL ACAD SCI USA, V113, P206, DOI 10.1073/pnas.1508249112; Fischer D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178782; Giacchetti S., 2017, CANC RES, V77; Giacchetti S, 2006, J CLIN ONCOL, V24, P3562, DOI 10.1200/JCO.2006.06.1440; Hermida RC, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12909; Kobayashi M, 2002, CHRONOBIOL INT, V19, P237, DOI 10.1081/CBI-120002600; Leder K, 2014, CELL, V156, P603, DOI 10.1016/j.cell.2013.12.029; Levi F, 1997, LANCET, V350, P681, DOI 10.1016/S0140-6736(97)03358-8; Li J, 2015, CANCER CHEMOTH PHARM, V76, P651, DOI 10.1007/s00280-015-2804-x; Montaigne D, 2018, LANCET, V391, P59, DOI 10.1016/S0140-6736(17)32132-3; Pitter KL, 2016, BRAIN, V139, P1458, DOI 10.1093/brain/aww046; Selfridge JM, 2016, DRUGS, V76, P1507, DOI 10.1007/s40265-016-0646-4; Slat EA, 2017, J BIOL RHYTHM, V32, P121, DOI 10.1177/0748730417696788	14	12	12	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2018	556	7701					290	292		10.1038/d41586-018-04600-8	http://dx.doi.org/10.1038/d41586-018-04600-8			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1TW	29666501	Bronze			2022-12-28	WOS:000430285200021
J	Taddeo, M; Floridi, L				Taddeo, Mariarosaria; Floridi, Luciano			Regulate artificial intelligence to avert cyber arms race	NATURE			English	Editorial Material									[Taddeo, Mariarosaria] Univ Oxford, Oxford Internet Inst, Digital Eth Lab, Oxford, England; [Taddeo, Mariarosaria] Alan Turing Inst, London, England; [Floridi, Luciano] Univ Oxford, Philosophy & Eth Informat, Oxford, England; [Floridi, Luciano] Oxford Internet Inst, Digital Eth Lab, Oxford, England; [Floridi, Luciano] Alan Turing Inst, Data Eth Grp, London, England	University of Oxford; University of Oxford; University of Oxford	Taddeo, M (corresponding author), Univ Oxford, Oxford Internet Inst, Digital Eth Lab, Oxford, England.; Taddeo, M (corresponding author), Alan Turing Inst, London, England.	mariarosaria.taddeo@oii.ox.ac.uk	Floridi, Luciano/G-7699-2014	Floridi, Luciano/0000-0002-5444-2280	Alan Turing Institute [TU/B/000055] Funding Source: researchfish	Alan Turing Institute		Floridi L, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2016.0112; P& S Market Research, 2017, ART INT AI CYB SEC M; Taddeo M, 2018, PHILOS TECHNOLOGY, V31, P339, DOI [10.1007/s13347-017-0290-2, DOI 10.1007/S13347-017-0290-2]; Taddeo M, 2017, MIND MACH, V27, P387, DOI 10.1007/s11023-017-9446-1; US Defense Science Board, 2016, SUMM STUD AUT; US FBI, 2017, PROT YOUR NETW RANS; Yang GZ, 2018, SCI ROBOT, V3, DOI 10.1126/scirobotics.aar7650	7	46	47	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2018	556	7701					296	298		10.1038/d41586-018-04602-6	http://dx.doi.org/10.1038/d41586-018-04602-6			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1TW	29662138	Green Submitted, Bronze			2022-12-28	WOS:000430285200023
J	Jelovsek, JE; Barber, MD; Brubaker, L; Norton, P; Gantz, M; Richter, HE; Weidner, A; Menefee, S; Schaffer, J; Pugh, N; Meilde, S				Jelovsek, J. Eric; Barber, Matthew D.; Brubaker, Linda; Norton, Peggy; Gantz, Marie; Richter, Holly E.; Weidner, Alison; Menefee, Shawn; Schaffer, Joseph; Pugh, Norma; Meilde, Susan		NICHD Pelvic Floor Disorders Net	Effect of Uterosacral Ligament Suspension vs Sacrospinous Ligament Fixation With or Without Perioperative Behavioral Therapy for Pelvic Organ Vaginal Prolapse on Surgical Outcomes and Prolapse Symptoms at 5 Years in the OPTIMAL Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; URINARY-INCONTINENCE; REPAIR; SURGERY; WOMEN; SACROCOLPOPEXY; VALIDATION; SEVERITY	IMPORTANCE Uterosacral ligament suspension (ULS) and sacrospinous ligament fixation (SSLF) are commonly performed pelvic organ prolapse procedures despite a lack of long-term efficacy data. OBJECTIVE To compare outcomes in women randomized to (1) ULS or SSLF and (2) usual care or perioperative behavioral therapy and pelvic floor muscle training (BPMT) for vaginal apical prolapse. DESIGN, SETTING, AND PARTICIPANTS This 2 x 2 factorial randomized clinical trial was conducted at 9 US medical centers. Eligible participants who completed the Operations and Pelvic Muscle Training in the Management of Apical Support Loss Trial enrolled between January 2008 and March 2011 and were followed up 5 years after their index surgery from April 2011 through June 2016. INTERVENTIONS Two randomizations: (1) BPMT (n = 186) or usual care (n = 188) and (2) surgical intervention (ULS: n = 188 or SSLF: n = 186). MAIN OUTCOMES AND MEASURES The primary surgical outcomewas time to surgical failure. Surgical failure was defined as (1) apical descent greater than one-third of total vaginal length or anterior or posterior vaginal wall beyond the hymen or retreatment for prolapse (anatomic failure), or (2) bothersome bulge symptoms. The primary behavioral outcomes were time to anatomic failure and Pelvic Organ Prolapse Distress Inventory scores (range, 0-300). RESULTS The original study randomized 374 patients, of whom 309 were eligible for this extended trial. For this study, 285 enrolled (mean age, 57.2 years), of whom 244 (86%) completed the extended trial. By year 5, the estimated surgical failure rate was 61.5% in the ULS group and 70.3% in the SSLF group (adjusted difference, -8.8% [95% CI, -24.2 to 6.6]). The estimated anatomic failure rate was 45.6% in the BPMT group and 47.2% in the usual care group (adjusted difference, -1.6%[95% CI, -21.2 to 17.9]). Improvements in Pelvic Organ Prolapse Distress Inventory scores were -59.4 in the BPMT group and -61.8 in the usual care group (adjusted mean difference, 2.4 [95% CI, -13.7 to 18.4]). CONCLUSIONS AND RELEVANCE Among women who had undergone vaginal surgery for apical pelvic organ vaginal prolapse, there was no significant difference between ULS and SSLF in rates of surgical failure and no significant difference between perioperative behavioral muscle training and usual care on rates of anatomic success and symptom scores at 5 years. Compared with outcomes at 2 years, rates of surgical failure increased during the follow-up period, although prolapse symptom scores remained improved.	[Jelovsek, J. Eric; Barber, Matthew D.] Cleveland Clin, Obstet Gynecol & Womens Hlth Inst, Cleveland, OH 44106 USA; [Brubaker, Linda] Loyola Univ Chicago, Dept Obstet & Gynecol, Stritch Sch Med, Chicago, IL USA; [Brubaker, Linda] Loyola Univ Chicago, Dept Urol, Stritch Sch Med, Chicago, IL USA; [Brubaker, Linda] JAMA, Chicago, IL USA; [Norton, Peggy] Univ Utah, Med Ctr, Dept Obstet & Gynecol, Salt Lake City, UT 84132 USA; [Gantz, Marie; Pugh, Norma] RTI Int, Res Triangle Pk, NC USA; [Richter, Holly E.] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35294 USA; [Weidner, Alison] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA; [Menefee, Shawn] Southern Calif Kaiser Permanente, Dept Obstet & Gynecol, San Diego, CA USA; [Schaffer, Joseph] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX USA; [Meilde, Susan] Northwest Phys Grp, Amarillo, TX USA	Cleveland Clinic Foundation; Loyola University Chicago; Loyola University Chicago; Utah System of Higher Education; University of Utah; Research Triangle Institute; University of Alabama System; University of Alabama Birmingham; Duke University; Kaiser Permanente; Permanente Medical Groups; University of Texas System; University of Texas Southwestern Medical Center Dallas	Jelovsek, JE (corresponding author), Duke Univ, Obstet & Gynecol, 209 Baker House,DUMC 3084, Durham, NC 27710 USA.	eric.jelovsek@duke.edu		Richter, Holly E/0000-0001-7741-5771; Gantz, Marie/0000-0001-8528-0184; Pugh, Norma/0000-0003-3052-2232	NICHD [U01 HD041249, U10 HD041250, U10 HD041261, U10 HD041267, U10 HD054136, U10 HD054214, U10 HD054215, U01 HD069031, U10 HD054241]; NIH Office of Research onWomen's Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD054136, U10HD054241, U10HD041267, U01HD069031, U10HD054215, U10HD041250, U10HD041261, U10HD054214, UG1HD054241, U24HD069031] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD041249] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH Office of Research onWomen's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by grants U01 HD041249, U10 HD041250, U10 HD041261, U10 HD041267, U10 HD054136, U10 HD054214, U10 HD054215, U01 HD069031, and U10 HD054241 from the NICHD and the NIH Office of Research onWomen's Health.	Barber MD, 2014, JAMA-J AM MED ASSOC, V311, P1023, DOI 10.1001/jama.2014.1719; Barber MD, 2009, OBSTET GYNECOL, V114, P600, DOI 10.1097/AOG.0b013e3181b2b1ae; Barber MD, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.02.007; Barber MD, 2006, AM J OBSTET GYNECOL, V194, P1492, DOI 10.1016/j.ajog.2006.01.076; Barber MD, 2001, AM J OBSTET GYNECOL, V185, P1388, DOI 10.1067/mob.2001.118659; Barbera MD, 2009, CONTEMP CLIN TRIALS, V30, P178, DOI 10.1016/j.cct.2008.12.001; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; DeLancey JO, 2001, OBG MANAGEMENT, V13, P18; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Diwadkar GB, 2009, OBSTET GYNECOL, V113, P367, DOI 10.1097/AOG.0b013e318195888d; FitzGerald MP, 2007, PHYS THER, V87, P1316, DOI 10.2522/ptj.20060073; Haylen BT, 2010, INT UROGYNECOL J, V21, P5, DOI [10.1007/s00192-009-0976-9, 10.1590/S1677-55382010000100032]; Jelovsek JE, 2007, LANCET, V369, P1027, DOI 10.1016/S0140-6736(07)60462-0; Jelovsek JE, 2014, FEMALE PELVIC MED RE, V20, P342, DOI 10.1097/SPV.0000000000000078; Lukacz ES, 2016, OBSTET GYNECOL, V127, P1071, DOI 10.1097/AOG.0000000000001442; Maher C, 2016, COCHRANE DB SYST REV, V10; Maher C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004014.pub5; MORLEY GW, 1988, AM J OBSTET GYNECOL, V158, P872, DOI 10.1016/0002-9378(88)90088-9; Nygaard I, 2013, JAMA-J AM MED ASSOC, V309, P2016, DOI 10.1001/jama.2013.4919; SANDVIK H, 1993, J EPIDEMIOL COMMUN H, V47, P497, DOI 10.1136/jech.47.6.497; Schimpf MO, 2016, OBSTET GYNECOL, V128, P81, DOI 10.1097/AOG.0000000000001451; Shull BL, 2000, AM J OBSTET GYNECOL, V183, P1365, DOI 10.1067/mob.2000.110910; Siddiqui NY, 2015, OBSTET GYNECOL, V125, P44, DOI 10.1097/AOG.0000000000000570; Tulikangas P, 2017, OBSTET GYNECOL, V130, pE234; Wu JM, 2014, OBSTET GYNECOL, V123, P1201, DOI 10.1097/AOG.0000000000000286; Wu JM, 2014, OBSTET GYNECOL, V123, P141, DOI 10.1097/AOG.0000000000000057; Yalcin I, 2003, AM J OBSTET GYNECOL, V189, P98, DOI 10.1067/mob.2003.379	27	106	116	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2018	319	15					1554	1565		10.1001/jama.2018.2827	http://dx.doi.org/10.1001/jama.2018.2827			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD0UT	29677302	Green Published, Bronze			2022-12-28	WOS:000430217100016
J	[Anonymous]				[Anonymous]			New Option for Drug-resistant HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2018	319	15					1540	1540		10.1001/jama.2018.3975	http://dx.doi.org/10.1001/jama.2018.3975			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD0UT	29677286				2022-12-28	WOS:000430217100007
J	Sperber, A				Sperber, Amanda			Mediators help migrants access health services in Italy	LANCET			English	Editorial Material																			0	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2018	391	10129					1468	1469		10.1016/S0140-6736(18)30892-4	http://dx.doi.org/10.1016/S0140-6736(18)30892-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GC6TS	29676268				2022-12-28	WOS:000429926000011
J	Neill, C; Roushan, P; Kechedzhi, K; Boixo, S; Isakov, SV; Smelyanskiy, V; Megrant, A; Chiaro, B; Dunsworth, A; Arya, K; Barends, R; Burkett, B; Chen, Y; Chen, Z; Fowler, A; Foxen, B; Giustina, M; Graff, R; Jeffrey, E; Huang, T; Kelly, J; Klimov, P; Lucero, E; Mutus, J; Neeley, M; Quintana, C; Sank, D; Vainsencher, A; Wenner, J; White, TC; Neven, H; Martinis, JM				Neill, C.; Roushan, P.; Kechedzhi, K.; Boixo, S.; Isakov, S. V.; Smelyanskiy, V.; Megrant, A.; Chiaro, B.; Dunsworth, A.; Arya, K.; Barends, R.; Burkett, B.; Chen, Y.; Chen, Z.; Fowler, A.; Foxen, B.; Giustina, M.; Graff, R.; Jeffrey, E.; Huang, T.; Kelly, J.; Klimov, P.; Lucero, E.; Mutus, J.; Neeley, M.; Quintana, C.; Sank, D.; Vainsencher, A.; Wenner, J.; White, T. C.; Neven, H.; Martinis, J. M.			A blueprint for demonstrating quantum supremacy with superconducting qubits	SCIENCE			English	Article							SYSTEMS	A key step toward demonstrating a quantum system that can address difficult problems in physics and chemistry will be performing a computation beyond the capabilities of any classical computer, thus achieving so-called quantum supremacy. In this study, we used nine superconducting qubits to demonstrate a promising path toward quantum supremacy. By individually tuning the qubit parameters, we were able to generate thousands of distinct Hamiltonian evolutions and probe the output probabilities. The measured probabilities obey a universal distribution, consistent with uniformly sampling the full Hilbert space. As the number of qubits increases, the system continues to explore the exponentially growing number of states. Extending these results to a system of 50 qubits has the potential to address scientific questions that are beyond the capabilities of any classical computer.	[Neill, C.; Chiaro, B.; Dunsworth, A.; Chen, Z.; Foxen, B.; Quintana, C.; Wenner, J.; Martinis, J. M.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Roushan, P.; Boixo, S.; Isakov, S. V.; Smelyanskiy, V.; Megrant, A.; Arya, K.; Barends, R.; Burkett, B.; Chen, Y.; Fowler, A.; Giustina, M.; Graff, R.; Jeffrey, E.; Huang, T.; Kelly, J.; Klimov, P.; Lucero, E.; Mutus, J.; Neeley, M.; Sank, D.; Vainsencher, A.; White, T. C.; Neven, H.; Martinis, J. M.] Google, Santa Barbara, CA 93117 USA; [Kechedzhi, K.] NASA, Ames Res Ctr, Quantum Artificial Intelligence Lab QuAIL, Moffett Field, CA 94035 USA; [Kechedzhi, K.] Univ Space Res Assoc, Mountain View, CA 94043 USA	University of California System; University of California Santa Barbara; Google Incorporated; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Universities Space Research Association (USRA)	Neill, C; Martinis, JM (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.; Martinis, JM (corresponding author), Google, Santa Barbara, CA 93117 USA.	cneill@google.com; martinis@physics.ucsb.edu	Kechedzhi, Kostyantyn/L-3613-2013; Wenner, James/G-3777-2014	Kechedzhi, Kostyantyn/0000-0002-0136-1428; Wenner, James/0000-0001-7107-4734	Google; NSF [DGE-1144085]; NSF; NASA Academic Mission Services [NNA16BD14C]	Google(Google Incorporated); NSF(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NASA Academic Mission Services	This work was supported by Google. C.Q. and Z.C. acknowledge support from the NSF Graduate Research Fellowship under grant DGE-1144085. Devices were made at the UCSB Nanofabrication Facility, a part of the NSF-funded National Nanotechnology Infrastructure Network. K.K. acknowledges support from NASA Academic Mission Services, under contract number NNA16BD14C. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of the U.S. government. The U.S. government is authorized to reproduce and distribute reprints for governmental purposes, notwithstanding any copyright annotation thereon.	Aaronson S., 2011, P 43 ANN ACM S THEOR, P333; Basko DM, 2006, ANN PHYS-NEW YORK, V321, P1126, DOI 10.1016/j.aop.2005.11.014; Boixo S., 2016, ARXIV160800263QUANTP; Boixo S, 2014, NAT PHYS, V10, P218, DOI [10.1038/nphys2900, 10.1038/NPHYS2900]; Buluta I, 2009, SCIENCE, V326, P108, DOI 10.1126/science.1177838; Denchev VS, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.031015; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Haner T., 2017, P INT C HIGH PERF CO; Kadowaki T, 1998, PHYS REV E, V58, P5355, DOI 10.1103/PhysRevE.58.5355; Lanyon BP, 2010, NAT CHEM, V2, P106, DOI [10.1038/NCHEM.483, 10.1038/nchem.483]; Lloyd S., 2013, ARXIV13070411QUANTPH; Mezzacapo A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13153; Pal A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.174411; Peropadre B, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.140505; Peruzzo A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5213; Polkovnikov A, 2011, REV MOD PHYS, V83, P863, DOI 10.1103/RevModPhys.83.863; PORTER CE, 1956, PHYS REV, V104, P483, DOI 10.1103/PhysRev.104.483; Preskill, 2012, ARXIV12035813QUANTPH; Rigol M, 2008, NATURE, V452, P854, DOI 10.1038/nature06838; Schreiber M, 2015, SCIENCE, V349, P842, DOI 10.1126/science.aaa7432	23	239	243	4	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2018	360	6385					195	198		10.1126/science.aao4309	http://dx.doi.org/10.1126/science.aao4309			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC5DK	29650670	Green Submitted			2022-12-28	WOS:000429805400044
J	Cao, Y; Parker, ID; Yu, G; Zhang, C; Heeger, AJ				Cao, Y; Parker, ID; Yu, G; Zhang, C; Heeger, AJ			Improved quantum efficiency for electroluminescence in semiconducting polymers	NATURE			English	Article							LIGHT-EMITTING-DIODES; CONJUGATED POLYMERS; POLY(PHENYLENE VINYLENE); TRANSPARENT ANODE; HOLE TRANSPORT; ELECTRON; PHOTOLUMINESCENCE; POLYETHYLENE; EMISSION	Some conjugated polymers have luminescence properties that are potentially useful for applications such as light-emitting diodes, whose performance is ultimately limited by the maximum quantum efficiency theoretically attainable far electroluminescence(1,2). If the lowest-energy excited states are strongly bound excitons (electron-hole pairs in singlet or triplet spin states), this theoretical upper limit is only 25% of the corresponding quantum efficiency for photoluminescence: an electron in the pi*-band and a hole (or missing electron) in the pi-band can form a triplet,vith spin multiplicity of three, or a singlet with spin multiplicity of one, but only the singlet will decay radiatively(3). But if the electron-hole binding energy is sufficiently weak, the ratio of the maximum quantum efficiencies for electroluminescence and photoluminescence can theoretically approach unity. Here we report a value of similar to 50% for the ratio of these efficiencies (electroluminescence:photoluminescence) in polymer light-emitting diodes, attained by blending electron transport materials with the conjugated polymer to improve the injection of electrons. This value significantly exceeds the theoretical limit for strongly bound singlet and triplet excitons, assuming they comprise the lowest-energy excited states. Our results imply that the exciton binding energy is weak, or that singlet bound states are formed with higher probability than triplets.	UNIAX Corp, Santa Barbara, CA 93117 USA		Heeger, AJ (corresponding author), UNIAX Corp, 6780 Cortona Dr, Santa Barbara, CA 93117 USA.							Blom PWM, 1997, PHYS REV B, V55, pR656, DOI 10.1103/PhysRevB.55.R656; Blom PWM, 1997, APPL PHYS LETT, V71, P930, DOI 10.1063/1.119692; Blom PWM, 1996, APPL PHYS LETT, V68, P3308, DOI 10.1063/1.116583; BRADLEY DDC, 1993, SYNTHETIC MET, V54, P401, DOI 10.1016/0379-6779(93)91086-H; BRAUN D, 1991, APPL PHYS LETT, V58, P1982, DOI 10.1063/1.105039; BROMS P, 1995, SYNTHETIC MET, V74, P179, DOI 10.1016/0379-6779(95)03375-0; BURROUGHES JH, 1990, NATURE, V347, P539, DOI 10.1038/347539a0; Campbell IH, 1996, PHYS REV LETT, V76, P1900, DOI 10.1103/PhysRevLett.76.1900; Cao Y, 1997, SYNTHETIC MET, V87, P171, DOI 10.1016/S0379-6779(97)03823-X; Gao J, 1996, SYNTHETIC MET, V82, P221, DOI 10.1016/S0379-6779(96)03794-0; GREENHAM NC, 1994, ADV MATER, V6, P491, DOI 10.1002/adma.19940060612; GREENHAM NC, 1995, CHEM PHYS LETT, V241, P89, DOI 10.1016/0009-2614(95)00584-Q; GREENHAM NC, 1998, B AM PHYS SOC, V43, P14; Hide F, 1996, SCIENCE, V273, P1833, DOI 10.1126/science.273.5283.1833; KERSTING R, 1994, PHYS REV LETT, V73, P1440, DOI 10.1103/PhysRevLett.73.1440; KUHN H, 1970, J CHEM PHYS, V53, P101, DOI 10.1063/1.1673749; Lemmer U, 1996, APPL PHYS LETT, V68, P3007, DOI 10.1063/1.116679; Moses D, 1996, PHYS REV B, V54, P4748, DOI 10.1103/PhysRevB.54.4748; PARKER ID, 1994, J APPL PHYS, V75, P1656, DOI 10.1063/1.356350; RICHTER MM, 1994, CHEM PHYS LETT, V226, P115, DOI 10.1016/0009-2614(94)00716-0; Sariciftci N. S., 1997, PRIMARY PHOTOEXCITAT; SCHMIDT A, 1995, J APPL PHYS, V78, P5619, DOI 10.1063/1.359685; SMILOWITZ L, 1992, SYNTHETIC MET, V48, P193, DOI 10.1016/0379-6779(92)90061-M; YANG Y, 1995, J APPL PHYS, V77, P694, DOI 10.1063/1.359056	24	826	887	9	196	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					414	417		10.1038/17087	http://dx.doi.org/10.1038/17087			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667982				2022-12-28	WOS:000078461700041
J	Matthews, D				Matthews, David			SCIENCE GOES VIRTUAL	NATURE			English	Editorial Material																			0	23	23	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2018	557	7703					127	128		10.1038/d41586-018-04997-2	http://dx.doi.org/10.1038/d41586-018-04997-2			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE5BW	29713071				2022-12-28	WOS:000431234500043
J	Peltzer, N; Darding, M; Montinaro, A; Draber, P; Draberova, H; Kupka, S; Rieser, E; Fisher, A; Hutchinson, C; Taraborrelli, L; Hartwig, T; Lafont, E; Haas, TL; Shimizu, Y; Boiers, C; Sarr, A; Rickard, J; Alvarez-Diaz, S; Ashworth, MT; Beal, A; Enver, T; Bertin, J; Kaiser, W; Strasser, A; Silke, J; Bouillet, P; Walczak, H				Peltzer, Nieves; Darding, Maurice; Montinaro, Antonella; Draber, Peter; Draberova, Helena; Kupka, Sebastian; Rieser, Eva; Fisher, Amanda; Hutchinson, Ciaran; Taraborrelli, Lucia; Hartwig, Torsten; Lafont, Elodie; Haas, Tobias L.; Shimizu, Yutaka; Boiers, Charlotta; Sarr, Aida; Rickard, James; Alvarez-Diaz, Silvia; Ashworth, Michael T.; Beal, Allison; Enver, Tariq; Bertin, John; Kaiser, William; Strasser, Andreas; Silke, John; Bouillet, Philippe; Walczak, Henning			LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis	NATURE			English	Article							LINEAR UBIQUITIN CHAINS; PSEUDOKINASE MLKL; KEY REGULATOR; INFLAMMATION; RIPK1; IMMUNODEFICIENCY; AUTOINFLAMMATION; AMYLOPECTINOSIS; COMPLEX; DOMAIN	The linear ubiquitin chain assembly complex (LUBAC) is required for optimal gene activation and prevention of cell death upon activation of immune receptors, including TNFR11. Deficiency in the LUBAC components SHARPIN or HOIP in mice results in severe inflammation in adulthood or embryonic lethality, respectively, owing to deregulation of TNFR1-mediated cell death(2-8). In humans, deficiency in the third LUBAC component HOIL-1 causes autoimmunity and inflammatory disease, similar to HOIP deficiency, whereas HOIL-1 deficiency in mice was reported to cause no overt phenotype(9-11). Here we show, by creating HOIL-1-deficient mice, that HOIL-1 is as essential for LUBAC function as HOIP, albeit for different reasons: whereas HOIP is the catalytically active component of LUBAC, HOIL-1 is required for LUBAC assembly, stability and optimal retention in the TNFR1 signalling complex, thereby preventing aberrant cell death. Both HOIL-1 and HOIP prevent embryonic lethality at mid-gestation by interfering with aberrant TNFR1-mediated endothelial cell death, which only partially depends on RIPK1 kinase activity. Co-deletion of caspase-8 with RIPK3 or MLKL prevents cell death in Hoil-1(-/-) (also known as Rbck1(-/-)) embryos, yet only the combined loss of caspase-8 with MLKL results in viable HOIL-1-deficient mice. Notably, triple-knockout Ripk3(-/-)Casp8(-/-)Hoil-1(-/-) embryos die at late gestation owing to haematopoietic defects that are rescued by co-deletion of RIPK1 but not MLKL. Collectively, these results demonstrate that both HOIP and HOIL-1 are essential LUBAC components and are required for embryogenesis by preventing aberrant cell death. Furthermore, they reveal that when LUBAC and caspase-8 are absent, RIPK3 prevents RIPK1 from inducing embryonic lethality by causing defects in fetal haematopoiesis.	[Peltzer, Nieves; Darding, Maurice; Montinaro, Antonella; Draber, Peter; Draberova, Helena; Kupka, Sebastian; Rieser, Eva; Taraborrelli, Lucia; Hartwig, Torsten; Lafont, Elodie; Shimizu, Yutaka; Boiers, Charlotta; Sarr, Aida; Enver, Tariq; Walczak, Henning] UCL, UCL Canc Inst, London, England; [Draber, Peter; Draberova, Helena] Czech Acad Sci, Inst Mol Genet, Lab Adapt Immun, Prague, Czech Republic; [Fisher, Amanda; Kaiser, William] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Hutchinson, Ciaran; Ashworth, Michael T.] UCL Great Ormond St Inst Child Hlth, London, England; [Haas, Tobias L.] Univ Cattolica Sacro Cuore, Inst Gen Pathol, Rome, Italy; [Rickard, James; Alvarez-Diaz, Silvia; Strasser, Andreas; Silke, John; Bouillet, Philippe] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Rickard, James; Alvarez-Diaz, Silvia; Strasser, Andreas; Silke, John; Bouillet, Philippe] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Beal, Allison; Bertin, John] GlaxoSmithKline, Immunoinflammat Therapeut Area, Pattern Recognit Receptor Discovery Performance U, Collegeville, PA USA	University of London; University College London; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; University of Texas System; University of Texas Health San Antonio; University of London; University College London; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Walter & Eliza Hall Institute; University of Melbourne; GlaxoSmithKline	Walczak, H (corresponding author), UCL, UCL Canc Inst, London, England.	h.walczak@ucl.ac.uk	Bouillet, Philippe/E-1241-2013; Strasser, Andreas/C-7581-2013; Lafont, Elodie/L-3288-2019; Alvarez-Diaz, Silvia/P-4948-2018; Silke, John/B-7622-2008; Draber, Peter/G-3141-2014; Lafont, Elodie/GPS-9642-2022; Walczak, Henning/AAV-2214-2020; Dráberová, Helena/T-1930-2017; Peltzer, Nieves/AAI-2831-2020	Bouillet, Philippe/0000-0002-9012-6058; Strasser, Andreas/0000-0002-5020-4891; Lafont, Elodie/0000-0003-1978-7491; Alvarez-Diaz, Silvia/0000-0002-8897-1893; Silke, John/0000-0002-7611-5774; Draber, Peter/0000-0001-8658-4614; Lafont, Elodie/0000-0003-1978-7491; Walczak, Henning/0000-0002-6312-4591; Dráberová, Helena/0000-0003-4654-1438; Peltzer, Nieves/0000-0002-4134-5852; Boiers, Charlotta/0000-0002-4876-1218; Hutchinson, John Ciaran/0000-0002-1708-2634	Cancer Research UK through the CRUK-UCL Centre [515818]; Cancer Immunotherapy Accelerator award (CITA) [525877]; Wellcome Trust Senior Investigator Award [096831/Z/11/Z]; ERC Advanced grant [294880]; Cancer Research UK programme [A17341]; NHMRC [602516, 1037321, 1043414, 1080321, 1105209, 461221, 1042629, 1057905]; Leukemia and Lymphoma Society [7015]; Swiss National Science Foundation [P300P3_158509]; MRC [MR/M009033/1, MR/N000838/1] Funding Source: UKRI	Cancer Research UK through the CRUK-UCL Centre; Cancer Immunotherapy Accelerator award (CITA); Wellcome Trust Senior Investigator Award(Wellcome Trust); ERC Advanced grant(European Research Council (ERC)); Cancer Research UK programme(Cancer Research UK); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	V. Dixit and K. Newton provided Ripk3<SUP>-/-</SUP> mice, S. Hedrick and R. Hakem provided Casp8<SUP>fl/fl</SUP> mice; H. Anderton and U. Nachbur helped with Sharpin<SUP>cpdm</SUP> analysis; P. Levy and staff and L. Lawrence provided technical and histology services. A. Leister and J. Marinis advised on GSK'457A. T. Marafioti and A. Akarsa helped with phosphorylated MLKL detection. A. Annibaldi provided scientific advice and helpful discussions. B.J. Ferguson provided reagents and advice. The flow cytometry, microscopy and imaging core facilities are supported by Cancer Research UK through the CRUK-UCL Centre (515818) and a Cancer Immunotherapy Accelerator award (CITA, 525877). This work was funded by a Wellcome Trust Senior Investigator Award (096831/Z/11/Z), an ERC Advanced grant (294880) and a Cancer Research UK programme grant (A17341) awarded to H.W., NHMRC grants awarded to P.B., A.St., J. S. and H.W. (602516, 1037321, 1043414, 1080321, 1105209, 461221, 1042629, 1057905), the Leukemia and Lymphoma Society (Specialised Center of Research grant 7015) and a postdoctoral fellowship awarded to N.P. by the Swiss National Science Foundation (P300P3_158509).	Alvarez-Diaz S, 2016, IMMUNITY, V45, P513, DOI 10.1016/j.immuni.2016.07.016; Annibaldi A, 2018, TRENDS MOL MED, V24, P49, DOI 10.1016/j.molmed.2017.11.002; Berger SB, 2014, J IMMUNOL, V192, P5476, DOI 10.4049/jimmunol.1400499; Boisson B, 2015, J EXP MED, V212, P939, DOI 10.1084/jem.20141130; Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; Clapes T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00487; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Gustafsson E, 2001, J CELL SCI, V114, P671; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Harris PA, 2017, J MED CHEM, V60, P1247, DOI 10.1021/acs.jmedchem.6b01751; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kumari Snehlata, 2014, Elife, V3, DOI 10.7554/eLife.03422; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Peltzer N, 2016, TRENDS CELL BIOL, V26, P445, DOI 10.1016/j.tcb.2016.01.006; Peltzer N, 2014, CELL REP, V9, P153, DOI 10.1016/j.celrep.2014.08.066; Pietras EM, 2017, BLOOD, V130, P1693, DOI 10.1182/blood-2017-06-780882; Rickard JA, 2014, ELIFE, V3, DOI 10.7554/eLife.03464; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; Roderick JE, 2014, P NATL ACAD SCI USA, V111, P14436, DOI 10.1073/pnas.1409389111; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Sasaki Y, 2013, EMBO J, V32, P2463, DOI 10.1038/emboj.2013.184; Sato Y, 2011, P NATL ACAD SCI USA, V108, P20520, DOI 10.1073/pnas.1109088108; Shimizu Y, 2015, IMMUNOL REV, V266, P190, DOI 10.1111/imr.12309; Stieglitz B, 2012, EMBO REP, V13, P840, DOI 10.1038/embor.2012.105; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821	30	120	120	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2018	557	7703					112	+		10.1038/s41586-018-0064-8	http://dx.doi.org/10.1038/s41586-018-0064-8			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5BW	29695863	Green Submitted, Green Accepted			2022-12-28	WOS:000431234500040
J	Hampton, T				Hampton, Tracy			Genomes of Distinctive Species Reveal Clues to Human Health and Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2018	319	17					1755	1756		10.1001/jama.2017.12860	http://dx.doi.org/10.1001/jama.2017.12860			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GE3UQ	29715335				2022-12-28	WOS:000431138800003
J	Jones, CM; Einstein, EB; Compton, WM				Jones, Christopher M.; Einstein, Emily B.; Compton, Wilson M.			Changes in Synthetic Opioid Involvement in Drug Overdose Deaths in the United States, 2010-2016	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Jones, Christopher M.] Substance Abuse & Mental Hlth Serv Adm, 5600 Fishers Ln,Ste 18E63, Rockville, MD 20857 USA; [Einstein, Emily B.; Compton, Wilson M.] Natl Inst Drug Abuse, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Jones, CM (corresponding author), Substance Abuse & Mental Hlth Serv Adm, 5600 Fishers Ln,Ste 18E63, Rockville, MD 20857 USA.	christopher.jones@samhsa.hhs.gov						Carroll JJ, 2017, INT J DRUG POLICY, V46, P136, DOI 10.1016/j.drugpo.2017.05.023; Centers for Disease Control and Prevention, 2017, NAT VIT STAT SYST 20; Drug Enforcement Administration, 2017, NAT DRUG THREAT ASS; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Tomassoni AJ, 2017, MMWR-MORBID MORTAL W, V66, P107, DOI 10.15585/mm6604a4	5	201	201	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2018	319	17					1819	1821		10.1001/jama.2018.2844	http://dx.doi.org/10.1001/jama.2018.2844			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GE3UQ	29715347	Green Published, Bronze			2022-12-28	WOS:000431138800021
J	Clery, D				Clery, Daniel			Data trove helps pin down the shape of the Milky Way Europe's Gaia satellite reveals motions for 1.3 billion stars	SCIENCE			English	News Item														Clery, Daniel/0000-0002-8742-3596					0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					363	363		10.1126/science.360.6387.363	http://dx.doi.org/10.1126/science.360.6387.363			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1AR	29700242				2022-12-28	WOS:000430949600011
J	Kuo, CJ; Curtis, C				Kuo, Calvin J.; Curtis, Christina			Organoids reveal cancer dynamics	NATURE			English	Editorial Material							BIOBANK; DISEASE	Single-cell analyses in cancer are limited by the small biomass of individual cells. In vitro production of 3D organoid structures from single tumour-derived cells generates sufficient biomass for in-depth analyses.	[Kuo, Calvin J.] Stanford Univ, Sch Med, Stanford Canc Inst, Div Hematol, Stanford, CA 94305 USA; [Curtis, Christina] Stanford Univ, Sch Med, Div Oncol, Stanford, CA 94305 USA; [Curtis, Christina] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford Cancer Institute; Stanford University; Stanford University; Stanford University	Kuo, CJ (corresponding author), Stanford Univ, Sch Med, Stanford Canc Inst, Div Hematol, Stanford, CA 94305 USA.	cjkuo@stanford.edu; cncurtis@stanford.edu		Kuo, Calvin/0000-0002-7427-5985				Bivona TG, 2016, NAT MED, V22, P472, DOI 10.1038/nm.4091; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Fujii M, 2016, CELL STEM CELL, V18, P827, DOI 10.1016/j.stem.2016.04.003; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Roerink SF, 2018, NATURE, V556, P457, DOI 10.1038/s41586-018-0024-3; Sachs N, 2018, CELL, V172, P373, DOI 10.1016/j.cell.2017.11.010; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Sun RP, 2017, NAT GENET, V49, P1015, DOI 10.1038/ng.3891; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122	13	12	12	5	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					441	442		10.1038/d41586-018-03841-x	http://dx.doi.org/10.1038/d41586-018-03841-x			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD8VX	29686366	Bronze			2022-12-28	WOS:000430793000032
J	Ponomarenko, A; Korotkova, T				Ponomarenko, Alexey; Korotkova, Tatiana			Hunger is a gatekeeper of pain	NATURE			English	Editorial Material							NEURAL CIRCUIT; NEURONS; AGRP	A neuronal population has now been found that regulates two competing needs - hunger and pain. Urgent pain overrides hunger, but appetite-inducing neuronal activity dampens long-term pain responses to enable feeding.	[Ponomarenko, Alexey] Heinrich Heine Univ, Med Fac, Inst Clin Neurosci & Med Psychol, D-40225 Dusseldorf, Germany; [Korotkova, Tatiana] Max Planck Inst Metab Res, D-50931 Cologne, Germany	Heinrich Heine University Dusseldorf	Ponomarenko, A (corresponding author), Heinrich Heine Univ, Med Fac, Inst Clin Neurosci & Med Psychol, D-40225 Dusseldorf, Germany.	alexey.ponomarenko@med.uni-duesseldorf.de; tatiana.korotkova@sf.mpg.de	Ponomarenko, Alexey/F-7783-2017	Ponomarenko, Alexey/0000-0002-5185-0107				Alhadeff AL, 2018, CELL, V173, P140, DOI 10.1016/j.cell.2018.02.057; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Campos CA, 2018, NATURE, V555, P617, DOI 10.1038/nature25511; Carter ME, 2013, NATURE, V503, P111, DOI 10.1038/nature12596; Carus-Cadavieco M, 2017, NATURE, V542, P232, DOI 10.1038/nature21066; Chen YM, 2015, CELL, V160, P829, DOI 10.1016/j.cell.2015.01.033; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Jennings JH, 2015, CELL, V160, P516, DOI 10.1016/j.cell.2014.12.026; Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Nieh EH, 2015, CELL, V160, P528, DOI 10.1016/j.cell.2015.01.003; SAPER CB, 1980, BRAIN RES, V197, P291, DOI 10.1016/0006-8993(80)91117-8; Steculorum SM, 2016, CELL, V165, P125, DOI 10.1016/j.cell.2016.02.044; Sternson SM, 2017, ANNU REV PHYSIOL, V79, P401, DOI 10.1146/annurev-physiol-021115-104948	15	3	4	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					445	446		10.1038/d41586-018-04759-0	http://dx.doi.org/10.1038/d41586-018-04759-0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD8VX	29686371				2022-12-28	WOS:000430793000035
J	DeVito, NJ; French, L; Goldacre, B				DeVito, Nicholas J.; French, Lisa; Goldacre, Ben			Noncommercial Funders Policies on Trial Registration, Access to Summary Results, and Individual Patient Data Availability	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[DeVito, Nicholas J.; French, Lisa; Goldacre, Ben] Univ Oxford, EBM Datalab, Oxford, England	University of Oxford	Goldacre, B (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Radcliffe Observ Quarter, EBM Datalab, Woodstock Rd, Oxford OX2 6GG, England.	ben.goldacre@phc.ox.ac.uk	DeVito, Nicholas J./Q-5952-2017	DeVito, Nicholas J./0000-0001-8286-1995; French, Lisa/0000-0001-7279-8582				Goldacre B, 2017, BMJ-BRIT MED J, V358, pi3334; Meerpohl JJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006666; Moher D, 2016, LANCET, V387, P1573, DOI 10.1016/S0140-6736(15)00307-4; Nasser M, 2017, LANCET, V389, P1006, DOI 10.1016/S0140-6736(17)30657-8; Viergever RF, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-015-0074-z	5	20	20	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2018	319	16					1721	1723		10.1001/jama.2018.2841	http://dx.doi.org/10.1001/jama.2018.2841			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD7RF	29710154	Bronze, Green Published			2022-12-28	WOS:000430709300027
J	Killeen, GF; Ranson, H				Killeen, Gerry F.; Ranson, Hilary			Insecticide-resistant malaria vectors must be tackled	LANCET			English	Editorial Material							PLASMODIUM-FALCIPARUM; AFRICA		[Killeen, Gerry F.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Dept, POB 53, Morogoro, Tanzania; [Killeen, Gerry F.; Ranson, Hilary] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool, Merseyside, England	Ifakara Health Institute; Liverpool School of Tropical Medicine	Killeen, GF (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci Dept, POB 53, Morogoro, Tanzania.; Killeen, GF (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool, Merseyside, England.	gkilleen@ihi.or.tz		Ranson, Hilary/0000-0003-2332-8247				Bayili K, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1846-4; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Churcher TS, 2016, ELIFE, V5, DOI 10.7554/eLife.16090; Gething PW, 2016, NEW ENGL J MED, V375, P2435, DOI 10.1056/NEJMoa1606701; Hemingway J, 2016, LANCET, V387, P1785, DOI 10.1016/S0140-6736(15)00417-1; Horton R, 2018, LANCET, V391, P643, DOI 10.1016/S0140-6736(18)30304-0; Killeen GF, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000211; Protopopoff N, 2018, LANCET; Smith GCS, 2003, BRIT MED J, V327, P1459, DOI 10.1136/bmj.327.7429.1459; WHO, 2016, WORLD MAL REP 2016; World Health Organization, 2012, WHO GLOB MAL PROGR G; World Health Organization, 2017, COND DEPL MOSQ NETS	12	31	31	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2018	391	10130					1551	1552		10.1016/S0140-6736(18)30844-4	http://dx.doi.org/10.1016/S0140-6736(18)30844-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GD5JG	29655495	Green Accepted, hybrid			2022-12-28	WOS:000430542700004
J	Dyer, C				Dyer, Clare			Court rejects parents' appeal over life support for son	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2018	361								k1737	10.1136/bmj.k1737	http://dx.doi.org/10.1136/bmj.k1737			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8WQ	29674387				2022-12-28	WOS:000430795300009
J	Goldstein, JN; Dudzinski, DM; Erickson, TB; Linder, G				Goldstein, Joshua N.; Dudzinski, David M.; Erickson, Timothy B.; Linder, Grace			Case 12-2018: A 30-Year-Old Woman with Cardiac Arrest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRAVENOUS LIPID EMULSION; TRICYCLIC ANTIDEPRESSANT INGESTION; EMERGENCY-DEPARTMENT; PREDICTING SEIZURES; OVERDOSE; TOXICITY; CARDIOTOXICITY; AMITRIPTYLINE; THERAPY; PHYSOSTIGMINE		[Goldstein, Joshua N.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Dudzinski, David M.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA USA; [Linder, Grace] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Boston, MA USA; [Erickson, Timothy B.] Harvard Med Sch, Brigham & Womens Hosp, Dept Emergency Med, Boston, MA USA; [Goldstein, Joshua N.; Erickson, Timothy B.] Harvard Med Sch, Dept Emergency Med, Boston, MA 02115 USA; [Dudzinski, David M.] Harvard Med Sch, Dept Med, Boston, MA USA; [Linder, Grace] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Goldstein, JN (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02115 USA.; Goldstein, JN (corresponding author), Harvard Med Sch, Dept Emergency Med, Boston, MA 02115 USA.		Goldstein, Joshua N/H-8953-2016; Erickson, Timothy/ABB-7761-2021					Abeyaratne Dayakshi D K, 2016, BMC Res Notes, V9, P167, DOI 10.1186/s13104-016-1963-0; Agarwala R, 2014, J MED TOXICOL, V10, P210, DOI 10.1007/s13181-013-0353-4; Am Acad Clin Toxicol, 2005, CLIN TOXICOL, V43, P61, DOI 10.1081/CLT-200051867; Amer Coll Med Toxicology, 2017, J MED TOXICOL, V13, P124, DOI 10.1007/s13181-016-0550-z; Amiri H, 2016, JRSM CARDIOVASC DIS, V5, DOI 10.1177/2048004016682178; Barrueto F, 2006, J MED TOXICOL, V2, P147, DOI 10.1007/BF03161182; Bebarta VS, 2007, AM J CARDIOL, V100, P656, DOI 10.1016/j.amjcard.2007.03.077; Blaber MS, 2012, J EMERG MED, V43, P465, DOI 10.1016/j.jemermed.2011.09.010; BOEHNERT MT, 1985, NEW ENGL J MED, V313, P474, DOI 10.1056/NEJM198508223130804; Bruccoleri RE, 2016, J MED TOXICOL, V12, P121, DOI 10.1007/s13181-015-0483-y; Burns MJ, 2000, ANN EMERG MED, V35, P374, DOI 10.1016/S0196-0644(00)70057-6; CALLAHAM M, 1985, ANN EMERG MED, V14, P1, DOI 10.1016/S0196-0644(85)80725-3; Cao DZ, 2015, J EMERG MED, V48, P387, DOI 10.1016/j.jemermed.2014.10.009; Chia MYC, 2017, RESUSCITATION, V111, P34, DOI 10.1016/j.resuscitation.2016.11.019; EREN CS, 2014, AM J EMERG MED, V32, P1103, DOI DOI 10.1016/J.AJEM.2014.05.019; Fettiplace MR, 2015, ANN EMERG MED, V66, P185, DOI 10.1016/j.annemergmed.2015.01.020; Foianini A, 2010, CLIN TOXICOL, V48, P325, DOI 10.3109/15563650.2010.487050; Garg U, 2012, THERAPEUTIC DRUG MONITORING: NEWER DRUGS AND BIOMARKERS, P269, DOI 10.1016/B978-0-12-385467-4.00013-0; GOODWIN DA, 1993, CRIT CARE MED, V21, P625, DOI 10.1097/00003246-199304000-00025; Gosselin S, 2016, CLIN TOXICOL, V54, P899, DOI 10.1080/15563650.2016.1214275; Harrigan RA, 1999, AM J EMERG MED, V17, P387, DOI 10.1016/S0735-6757(99)90094-3; Heinonen JA, 2013, BASIC CLIN PHARMACOL, V113, P193, DOI 10.1111/bcpt.12082; Khalid MM., 2017, STATPEARLS; Kontio T, 2015, THER HYPOTHERMIA TEM, V5, P104, DOI 10.1089/ther.2014.0030; LAVOIE FW, 1990, ANN EMERG MED, V19, P696, DOI 10.1016/S0196-0644(05)82482-5; Le Fevre P, 2017, BMJ CASE REP; Levine MD, 2018, ROSENS EMERGENCY MED, P1868; Levine M, 2016, CLIN TOXICOL, V54, P194, DOI 10.3109/15563650.2015.1126286; Levine M, 2014, J MED TOXICOL, V10, P10, DOI 10.1007/s13181-013-0356-1; LIEBELT EL, 1995, ANN EMERG MED, V26, P195, DOI 10.1016/S0196-0644(95)70151-6; Liebelt EL, 1997, CRIT CARE MED, V25, P1721, DOI 10.1097/00003246-199710000-00024; Melanson SEF, 2007, J ANAL TOXICOL, V31, P270, DOI 10.1093/jat/31.5.270; Milone MC, 2012, THERAPEUTIC DRUG MONITORING: NEWER DRUGS AND BIOMARKERS, P49, DOI 10.1016/B978-0-12-385467-4.00003-8; NIEMANN JT, 1986, AM J CARDIOL, V57, P1154, DOI 10.1016/0002-9149(86)90691-0; Odigwe Chibuzo Clement, 2016, Proc (Bayl Univ Med Cent), V29, P284; Olson KR, 2010, J MED TOXICOL, V6, P190, DOI 10.1007/s13181-010-0046-1; PENTEL P, 1980, ANN EMERG MED, V9, P588, DOI 10.1016/S0196-0644(80)80232-0; Phillips MA, 2014, J MED TOXICOL, V10, P205, DOI 10.1007/s13181-013-0330-y; Ramasubbu BM, 2016, TOXICOL LETT, V258, pS100, DOI 10.1016/j.toxlet.2016.06.1429; Shanon M, 1998, PEDIATR EMERG CARE, V14, P293, DOI 10.1097/00006565-199808000-00015; Varney SM, 2014, ACAD EMERG MED, V21, P1212, DOI 10.1111/acem.12513; Watkins JW, 2015, J MED TOXICOL, V11, P179, DOI 10.1007/s13181-014-0452-x	42	4	4	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2018	378	16					1538	1549		10.1056/NEJMcpc1800322	http://dx.doi.org/10.1056/NEJMcpc1800322			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD2EI	29669228				2022-12-28	WOS:000430312500011
J	Barnett, R				Barnett, Richard			Syphilis	LANCET			English	Editorial Material												richard@richardbarnettwriter.com						Davidson Roger, 2001, SEX SIN SUFFERING VE; Levine Philippa, 2003, PROSTITUTION RACE PO; Parascandola J., 2008, SEX SIN SCI HIST SYP	3	9	10	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2018	391	10129					1471	1471		10.1016/S0140-6736(18)30833-X	http://dx.doi.org/10.1016/S0140-6736(18)30833-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GC6TS	29676270				2022-12-28	WOS:000429926000013
J	Papale, P				Papale, P			Strain-induced magma fragmentation in explosive eruptions	NATURE			English	Article							EXPERIMENTAL SIMULATIONS; VOLCANIC-ERUPTIONS; SILICATE MELTS; AD 79; RHEOLOGY; FLOW; DECOMPRESSION; VESICULARITY; CONDUITS; VESUVIUS	Explosive eruptions are the most powerful and destructive type of volcanic activity. These eruptions are characterized by magma fragmentation, the process through which a bubbly or foamy magma is transformed into a gas-pyroclast dispersion(1). Although magma fragmentation has been investigated both experimentally(2-7) and theoretically(8-10), and the basic transport phenomena that occur in a volcanic conduit have been modelIed(11-17), the underlying mechanism responsible for magma fragmentation is still poorly understood. This lack of understanding seriously limits our ability to forecast volcanic hazards, preventing reliable discrimination between conditions that lead to explosive and effusive eruptions. Here I develop a model in which a fragmentation criterion, based on a rate-limited crossing of the glass transition(1,18-20), is incorporated into a multiphase fluid-dynamic description of magma ascent(17). The numerical results of this model demonstrate the feasibility of strain-induced brittle fragmentation of magma in volcanic eruptions, and reconcile experimental with theoretical studies as well as with the observed volcanic products of large explosive eruptions.	CNR, CSGSDA, I-56126 Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR)	Papale, P (corresponding author), CNR, CSGSDA, Via S Maria 53, I-56126 Pisa, Italy.			Papale, Paolo/0000-0002-5207-2124				Alidibirov M, 1996, NATURE, V380, P146, DOI 10.1038/380146a0; ALIDIBIROV MA, 1994, B VOLCANOL, V56, P459, DOI 10.1007/s004450050055; BARMIN AA, 1993, IZV ROS AKAD NAUK ME, V2, P49; Dingwell DB, 1996, SCIENCE, V273, P1054, DOI 10.1126/science.273.5278.1054; DINGWELL DB, 1989, PHYS CHEM MINER, V16, P508; Dingwell DB, 1997, J PETROL, V38, P1635, DOI 10.1093/petrology/38.12.1635; DOBRAN F, 1992, J VOLCANOL GEOTH RES, V49, P285, DOI 10.1016/0377-0273(92)90019-A; HOUGHTON BF, 1989, B VOLCANOL, V51, P451, DOI 10.1007/BF01078811; Kaminski E, 1997, J GEOPHYS RES-SOL EA, V102, P12187, DOI 10.1029/97JB00622; Klug C, 1996, B VOLCANOL, V58, P87, DOI 10.1007/s004450050128; LEJEUNE AM, 1995, J GEOPHYS RES-SOL EA, V100, P4215, DOI 10.1029/94JB02985; MADER HM, 1994, NATURE, V372, P85, DOI 10.1038/372085a0; Mader HM, 1996, J GEOPHYS RES-SOL EA, V101, P5547, DOI 10.1029/95JB02515; Mangan MT, 1996, J VOLCANOL GEOTH RES, V73, P1, DOI 10.1016/0377-0273(96)00018-2; Maxwell J. C., 1867, PHILOS T R SOC LONDO, V157, DOI DOI 10.1098/RSTL.1867.0004; PAPALE P, 1993, J VOLCANOL GEOTH RES, V58, P101, DOI 10.1016/0377-0273(93)90104-Y; PAPALE P, IN PRESS DEV VOLCANO; PAPEL P, 1994, J GEOPHYS RES, V99, P4355; PHILLIPS JC, 1995, B VOLCANOL, V57, P263, DOI 10.1007/s004450050093; RAMOS JI, 1995, INT J NUMER METH FL, V21, P253, DOI 10.1002/fld.1650210306; SPARKS RSJ, 1978, J VOLCANOL GEOTH RES, V3, P1, DOI 10.1016/0377-0273(78)90002-1; THOMAS N, 1994, J GEOPHYS RES-SOL EA, V99, P15633, DOI 10.1029/94JB00650; WEBB SL, 1990, J GEOPHYS RES-SOLID, V95, P15695, DOI 10.1029/JB095iB10p15695; Whitham A. G., 1986, Bulletin of Volcanology, V48, P209, DOI 10.1007/BF01087675; WILSON L, 1980, GEOPHYS J ROY ASTR S, V63, P117, DOI 10.1111/j.1365-246X.1980.tb02613.x; WOHLETZ KH, 1989, J GEOPHYS RES-SOLID, V94, P15703, DOI 10.1029/JB094iB11p15703; WOODS AW, 1995, EARTH PLANET SC LETT, V131, P189, DOI 10.1016/0012-821X(95)00012-2; Zhang YX, 1997, J GEOPHYS RES-SOL EA, V102, P3077, DOI 10.1029/96JB03181; ZIMANOWSKI RB, 1997, J GEOPHYS RES, V102, P803	29	305	307	0	55	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					425	428		10.1038/17109	http://dx.doi.org/10.1038/17109			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667961				2022-12-28	WOS:000078461700045
J	Rodriguez-Quinones, F				Rodriguez-Quinones, F			Spanish researchers defeated by the system	NATURE			English	Letter									Univ Birmingham, Sch Biol Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Rodriguez-Quinones, F (corresponding author), Univ Birmingham, Sch Biol Sci, POB 363, Birmingham B15 2TT, W Midlands, England.							Bosch X, 1998, NATURE, V396, P712, DOI 10.1038/25414; 1998, NATURE, V396, P709	2	0	0	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					384	384		10.1038/17002	http://dx.doi.org/10.1038/17002			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667954	Bronze			2022-12-28	WOS:000078461700019
J	Riddell, CA; Harper, S; Cerda, M; Kaufman, JS				Riddell, Corinne A.; Harper, Sam; Cerda, Magdalena; Kaufman, Jay S.			Comparison of Rates of Firearm and Nonfirearm Homicide and Suicide in Black and White Non-Hispanic Men, by US State	ANNALS OF INTERNAL MEDICINE			English	Article							CASE-FATALITY RATES; UNITED-STATES; GUN OWNERSHIP; VIOLENT CRIME; RISK; EPIDEMIOLOGY; CONNECTICUT; SEGREGATION; PREVENTION; HOME	Background: The extent to which differences in homicide and suicide rates in black versus white men vary by U.S. state is unknown. Objective: To compare the rates of firearm and nonfirearm homicide and suicide in black and white non-Hispanic men by U.S. state and to examine whether these deaths are associated with state prevalence of gun ownership. Design: Surveillance study. Setting: 50 states and the District of Columbia, 2008 to 2016. Cause-of-death data were abstracted by using the Centers for Disease Control and Prevention's WONDER (Wide-ranging Online Data for Epidemiologic Research) database. Participants: Non-Hispanic black and non-Hispanic white males, all ages. Measurements: Absolute rates of and rate differences in firearm and nonfirearm homicide and suicide in black and white men. Results: During the 9-year study period, 84 113 homicides and 251 772 suicides occurred. Black-white differences in rates of firearm homicide and suicide varied widely across states. Relative to white men, black men had between 9 and 57 additional firearm homicides per 100 000 per year, with black men in Missouri, Michigan, Illinois, Indiana, and Pennsylvania having more than 40 additional firearm homicides per 100 000 per year. White men had between 2 fewer and 16 more firearm suicides per 100 000 per year, with the largest inequalities observed in southern and western states and the smallest in the District of Columbia and densely populated northeastern states. Limitations: Some homicides and suicides may have been misclassified as deaths due to unintentional injury. Survey data on state household gun ownership were collected in 2004 and may have shifted during the past decade. Conclusion: The large state-to-state variation in firearm homicide and suicide rates, as well as the racial inequalities in these numbers, highlights states where policies may be most beneficial in reducing homicide and suicide deaths and the racial disparities in their rates.	[Riddell, Corinne A.; Harper, Sam; Kaufman, Jay S.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, 1020 Pine Ave West,Room 27, Montreal, PQ, Canada; [Cerda, Magdalena] Univ Calif Davis, Dept Emergency Med, 2315 Stockton Blvd, Davis, CA 95616 USA	McGill University; University of California System; University of California Davis	Riddell, CA (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, 1020 Pine Ave West,Room 27, Montreal, PQ, Canada.	corinne.riddell@mail.mcgill.ca	Harper, Sam/A-3406-2008	Harper, Sam/0000-0002-2767-1053; Kaufman, Jay/0000-0003-1606-401X	Department of Epidemiology, Biostatistics, and Occupational Health; Chercheur Boursier Junior 2 from Fonds de la Recherche en Sante du Quebec; National Institutes of Health [1R21 DA041154-01]; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA041154] Funding Source: NIH RePORTER	Department of Epidemiology, Biostatistics, and Occupational Health; Chercheur Boursier Junior 2 from Fonds de la Recherche en Sante du Quebec; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Dr. Riddell is a postdoctoral researcher at McGill University and received salary support from the Department of Epidemiology, Biostatistics, and Occupational Health. Dr. Harper is supported by a Chercheur Boursier Junior 2 from the Fonds de la Recherche en Sante du Quebec. Dr. Cerda is a CAMPOS Faculty Scholar, ADVANCE Program at the University of California, Davis, and supported by the National Institutes of Health (grant 1R21 DA041154-01).	[Anonymous], 2014, R LANG ENV STAT COMP; Arias E, 2008, VITAL HEALTH STAT, V2; Blumstein A, 1995, J CRIM LAW CRIM, V86, P10, DOI 10.2307/1143998; Branas CC, 2004, AM J PUBLIC HEALTH, V94, P1750, DOI 10.2105/AJPH.94.10.1750; Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada and Social Sciences and Humanities Research Council of Canada, 2014, TRIC POL STAT ETH CO; Centers for Disease Control and Prevention National Center for Health Statistics, 2017, UND CAUS DEATH 1999; Chong, 2019, DRUG POISONING MORTA; Cook PJ, 2017, AM J PUBLIC HEALTH, V107, P1324, DOI [10.2105/AJPH.2017.303837, 10.2105/ajph.2017.303837]; Crifasi CK, 2015, PREV MED, V79, P43, DOI 10.1016/j.ypmed.2015.07.013; Crosby A. E., 2009, Morbidity and Mortality Weekly Report, V58, P637; Cubbin C, 2000, AM J PUBLIC HEALTH, V90, P579, DOI 10.2105/AJPH.90.4.579; Fleegler EW, 2013, JAMA INTERN MED, V173, DOI [10.1001/jamainternmed.2013.9957, 10.1001/jamainternmed.2013.1286]; Fryer RG, 2013, ECON INQ, V51, P1651, DOI 10.1111/j.1465-7295.2012.00506.x; Gibbs JT, 1997, SUICIDE LIFE-THREAT, V27, P68; Hirsch JK, 2006, CRISIS, V27, P189, DOI 10.1027/0227-5910.27.4.189; KELLERMANN AL, 1992, NEW ENGL J MED, V327, P467, DOI 10.1056/NEJM199208133270705; KELLERMANN AL, 1993, NEW ENGL J MED, V329, P1084, DOI 10.1056/NEJM199310073291506; Kubrin CE, 2009, SOC SCI QUART, V90, P1203, DOI 10.1111/j.1540-6237.2009.00654.x; Loeber R, 2011, LONG RES SOC BEH SCI, P1, DOI 10.1007/978-1-4419-9949-8; Logan JE, 2013, MMWR-MORBID MORTAL W, V62, P164; Massey D., 2001, PROBLEM CENTURY, P314; Miller M, 2004, ANN EMERG MED, V43, P723, DOI 10.1016/j.annemergmed.2004.01.018; Miller M, 2002, AM J PUBLIC HEALTH, V92, P1988, DOI 10.2105/AJPH.92.12.1988; Miller M, 2013, REDUCING GUN VIOLENC, P14; Miller M, 2007, J TRAUMA, V62, P1029, DOI 10.1097/01.ta.0000198214.24056.40; Miller M, 2007, SOC SCI MED, V64, P656, DOI 10.1016/j.socscimed.2006.09.024; Miller M, 2013, AM J EPIDEMIOL, V178, P946, DOI 10.1093/aje/kwt197; Monuteaux MC, 2015, AM J PREV MED, V49, P207, DOI 10.1016/j.amepre.2015.02.008; Moscicki EK, 2001, CLIN NEUROSCI RES, V1, P310, DOI 10.1016/S1566-2772(01)00032-9; Moscicki EK, 1997, PSYCHIAT CLIN N AM, V20, P499, DOI 10.1016/S0193-953X(05)70327-0; Ousey GC, 2009, SOC PROBL, V56, P447, DOI 10.1525/sp.2009.56.3.447; PETERSON RD, 1993, SOC FORCES, V71, P1001, DOI 10.2307/2580128; Rudolph KE, 2015, AM J PUBLIC HEALTH, V105, pE49, DOI 10.2105/AJPH.2015.302703; Shihadeh ES, 1996, SOC FORCES, V74, P1325, DOI 10.2307/2580353; Siegel M, 2017, AM J PUBLIC HEALTH, V107, P1923, DOI 10.2105/AJPH.2017.304057; Siegel M, 2013, AM J PUBLIC HEALTH, V103, P2098, DOI 10.2105/AJPH.2013.301409; Spicer RS, 2000, AM J PUBLIC HEALTH, V90, P1885, DOI 10.2105/AJPH.90.12.1885; Williams DR, 2005, HEALTH AFFAIR, V24, P325, DOI 10.1377/hlthaff.24.2.325; Wilson R., 1987, TRULY DISADVANTAGED; Wintemute GJ, 2015, ANNU REV PUBL HEALTH, V36, P5, DOI 10.1146/annurev-publhealth-031914-122535	40	53	53	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2018	168	10					712	+		10.7326/M17-2976	http://dx.doi.org/10.7326/M17-2976			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI3DE	29710093				2022-12-28	WOS:000434250700015
J	Bauchner, H				Bauchner, Howard			Super Bowls: Serving Bowl Size and Food Consumption (Expression of Concern of Vol 293, Pg 1727, 2005)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Expression of Concern									[Bauchner, Howard] JAMA & JAMA Network, 330 N Wabash Ave, Chicago, IL 60611 USA		Bauchner, H (corresponding author), JAMA & JAMA Network, 330 N Wabash Ave, Chicago, IL 60611 USA.	howard.bauchner@jamanetvvork.org						Hanks AS, 2013, JAMA PEDIATR, V167, P673, DOI 10.1001/jamapediatrics.2013.82; Tal A, 2014, JAMA INTERN MED, V174, P1842, DOI 10.1001/jamainternmed.2014.4098; Tal A, 2013, JAMA INTERN MED, V173, P1146, DOI 10.1001/jamainternmed.2013.650; Wansink B, 2005, JAMA-J AM MED ASSOC, V293, P1727, DOI 10.1001/jama.293.14.1727; Wansink B, 2008, ARCH PEDIAT ADOL MED, V162, P994, DOI 10.1001/archpedi.162.10.994; Wansink B, 2012, ARCH INTERN MED, V172, P961, DOI 10.1001/archinternmed.2012.1278	6	1	1	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2018	319	18					1869	1869		10.1001/jama.2018.4908	http://dx.doi.org/10.1001/jama.2018.4908			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF1CB	29710107	Bronze			2022-12-28	WOS:000431668600015
J	Reilly, BM				Reilly, Brendan M.			The Best Medical Care in the World	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Reilly, Brendan M.] Geisel Sch Med Dartmouth, Hanover, NH 03755 USA	Dartmouth College	Reilly, BM (corresponding author), Geisel Sch Med Dartmouth, Hanover, NH 03755 USA.							Jamison K. R., 1993, TOUCHED FIRE MANIC D, DOI [10.4135/9781483349985.n388, DOI 10.4135/9781483349985.N388]; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Matlock DD, 2013, JAMA INTERN MED, V173, P379, DOI 10.1001/jamainternmed.2013.2130; Relman A, 1992, ATLANTIC, V269, p[98, 105]; Relman Arnold S, 1992, Atlantic, V269, P98; Rosenbaum L, 2016, NEW ENGL J MED, V375, P1585, DOI 10.1056/NEJMms1610125; Shakespeare T, 2009, LANCET, V374, P1815, DOI 10.1016/S0140-6736(09)62050-X	7	1	1	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2018	378	18					1741	1743		10.1056/NEJMms1802026	http://dx.doi.org/10.1056/NEJMms1802026			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GE4WO	29719189				2022-12-28	WOS:000431218600016
J	Voelker, R				Voelker, Rebecca			New Option for Patients With Advanced Hodgkin Lymphoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2018	319	17					1758	1758		10.1001/jama.2018.4903	http://dx.doi.org/10.1001/jama.2018.4903			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GE3UQ	29715339				2022-12-28	WOS:000431138800005
J	Lin, JF; Nicastro, D				Lin, Jianfeng; Nicastro, Daniela			Asymmetric distribution and spatial switching of dynein activity generates ciliary motility	SCIENCE			English	Article							INNER ARM DYNEIN; IN-VIVO; REGULATORY COMPLEX; RADIAL SPOKES; MECHANISM; I1; FLAGELLA; REVEALS; PROTEIN; VISUALIZATION	Motile cilia and flagella are essential, highly conserved organelles, and their motility is driven by the coordinated activities of multiple dynein isoforms. The prevailing "switch-point" hypothesis posits that dyneins are asymmetrically activated to drive flagellar bending. To test this model, we applied cryo-electron tomography to visualize activity states of individual dyneins relative to their locations along beating flagella of sea urchin sperm cells. As predicted, bending was generated by the asymmetric distribution of dynein activity on opposite sides of the flagellum. However, contrary to predictions, most dyneins were in their active state, and the smaller population of conformationally inactive dyneins switched flagellar sides relative to the bending direction. Thus, our data suggest a "switch-inhibition" mechanism in which force imbalance is generated by inhibiting, rather than activating, dyneins on alternating sides of the flagellum.	[Lin, Jianfeng; Nicastro, Daniela] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol & Biophys, Dallas, TX 75390 USA; [Lin, Jianfeng; Nicastro, Daniela] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biol, Waltham, MA 02454 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Brandeis University	Nicastro, D (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol & Biophys, Dallas, TX 75390 USA.; Nicastro, D (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biol, Waltham, MA 02454 USA.	daniela.nicastro@utsouthwestern.edu		Nicastro, Daniela/0000-0002-0122-7173; Lin, Jianfeng/0000-0001-5732-1209; Lin, Jianfeng/0000-0003-1215-0906	National Institutes of Health [GM083122]; March of Dimes Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institutes of Health (GM083122 to D.N.) and March of Dimes Foundation (to D.N.).	BOUCHARD P, 1981, P NATL ACAD SCI-BIOL, V78, P1033, DOI 10.1073/pnas.78.2.1033; Bower R, 2009, MOL BIOL CELL, V20, P3055, DOI 10.1091/mbc.E09-04-0277; BROKAW CJ, 1987, CELL MOTIL CYTOSKEL, V8, P68, DOI 10.1002/cm.970080110; Carbajal-Gonzalez BI, 2013, CYTOSKELETON, V70, P101, DOI 10.1002/cm.21094; Chen DTN, 2015, BIOPHYS J, V109, P2562, DOI 10.1016/j.bpj.2015.11.003; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; GIBBONS IR, 1965, SCIENCE, V149, P424, DOI 10.1126/science.149.3682.424; HARAUZ G, 1986, OPTIK, V73, P146; Hayashi S, 2008, J CELL SCI, V121, P2833, DOI 10.1242/jcs.031195; Heumann JM, 2011, J STRUCT BIOL, V175, P288, DOI 10.1016/j.jsb.2011.05.011; Heuser T, 2012, P NATL ACAD SCI USA, V109, pE2067, DOI 10.1073/pnas.1120690109; Hook P, 2006, J CELL SCI, V119, P4369, DOI 10.1242/jcs.03176; Kamiya R, 2014, ZOOL SCI, V31, P633, DOI 10.2108/zs140066; Kikkawa M, 2013, J CELL BIOL, V202, P15, DOI 10.1083/jcb.201304099; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Leidel C, 2012, BIOPHYS J, V103, P492, DOI 10.1016/j.bpj.2012.06.038; Lin JF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6727; Lin JF, 2014, NAT CELL BIOL, V16, P479, DOI 10.1038/ncb2939; Lin JF, 2011, J BIOL CHEM, V286, P29175, DOI 10.1074/jbc.M111.241760; Lin JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031686; LINDEMANN CB, 1994, J THEOR BIOL, V168, P175, DOI 10.1006/jtbi.1994.1097; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MITCHELL DR, 1985, J CELL BIOL, V100, P1228, DOI 10.1083/jcb.100.4.1228; Mitchison HM, 2017, J PATHOL, V241, P294, DOI 10.1002/path.4843; Mitchison TJ, 2010, NATURE, V463, P308, DOI 10.1038/463308a; Mizuno N, 2012, J MOL BIOL, V422, P163, DOI 10.1016/j.jmb.2012.05.040; Mogami T, 2007, J BIOL CHEM, V282, P21639, DOI 10.1074/jbc.M701914200; Myster SH, 1999, J CELL BIOL, V146, P801, DOI 10.1083/jcb.146.4.801; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Perrone CA, 2000, MOL BIOL CELL, V11, P2297, DOI 10.1091/mbc.11.7.2297; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reddy BJN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12259; Riedel-Kruse IH, 2007, HFSP J, V1, P192, DOI 10.2976/1.2773861; Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667; SALE WS, 1977, P NATL ACAD SCI USA, V74, P2045, DOI 10.1073/pnas.74.5.2045; SALE WS, 1986, J CELL BIOL, V102, P2042, DOI 10.1083/jcb.102.6.2042; Sartori P, 2016, ELIFE, V5, DOI 10.7554/eLife.13258; Schmidt H, 2016, BIOPOLYMERS, V105, P557, DOI 10.1002/bip.22856; Smith EF, 2004, CELL MOTIL CYTOSKEL, V57, P8, DOI 10.1002/cm.10155; SUMMERS KE, 1971, P NATL ACAD SCI USA, V68, P3092, DOI 10.1073/pnas.68.12.3092; TAMM SL, 1984, J CELL BIOL, V99, P1364, DOI 10.1083/jcb.99.4.1364; Toba S, 2011, MOL BIOL CELL, V22, P342, DOI 10.1091/mbc.E10-10-0806; Wacke M, 2001, J GEN PHYSIOL, V118, P11, DOI 10.1085/jgp.118.1.11; WAISSTEIDER J, 1979, J SUPRAMOL STR CELL, V11, P339, DOI 10.1002/jss.400110309; WEISS J, 1976, J GEN PHYSIOL, V68, P503, DOI 10.1085/jgp.68.5.503; Wirschell M, 2013, NAT GENET, V45, P262, DOI 10.1038/ng.2533; WITMAN GB, 1978, J CELL BIOL, V76, P729, DOI 10.1083/jcb.76.3.729; Zhang K, 2017, CELL, V169, P1303, DOI 10.1016/j.cell.2017.05.025	50	111	111	2	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387							eaar1968	10.1126/science.aar1968	http://dx.doi.org/10.1126/science.aar1968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1AR	29700238	Green Accepted, Green Submitted			2022-12-28	WOS:000430949600031
J	Sardon, H; Dove, AP				Sardon, Haritz; Dove, Andrew P.			Plastics recycling with a difference	SCIENCE			English	Editorial Material							SUSTAINABLE POLYMERS		[Sardon, Haritz] Univ Basque Country, UPV EHU, POLYMAT, Paseo Manuel de Lardizabal 3, Donostia San Sebastian 20018, Spain; [Dove, Andrew P.] Univ Birmingham, Sch Chem, Birmingham B15 2TT, W Midlands, England	University of Basque Country; POLYMAT; University of Birmingham	Dove, AP (corresponding author), Univ Birmingham, Sch Chem, Birmingham B15 2TT, W Midlands, England.	a.dove@bham.ac.uk	Sardon, Haritz/C-4044-2015; Dove, Andrew/F-8935-2013	Sardon, Haritz/0000-0002-6268-0916; Dove, Andrew/0000-0001-8208-9309				Albertsson AC, 2017, SCIENCE, V358, P872, DOI 10.1126/science.aap8115; Brutman JP, 2016, IND ENG CHEM RES, V55, P11097, DOI 10.1021/acs.iecr.6b02931; Ellen MacArthur Foundation, 2017, NEW PLAST EC RETH FU; Garcia JM, 2014, SCIENCE, V344, P732, DOI 10.1126/science.1251484; Gardea F, 2014, MACROMOL CHEM PHYS, V215, P2260, DOI 10.1002/macp.201400267; Hong M, 2017, GREEN CHEM, V19, P3692, DOI 10.1039/c7gc01496a; Hong M, 2016, ANGEW CHEM INT EDIT, V55, P4188, DOI 10.1002/anie.201601092; Hong M, 2016, NAT CHEM, V8, P42, DOI [10.1038/NCHEM.2391, 10.1038/nchem.2391]; Jones GO, 2016, P NATL ACAD SCI USA, V113, P7722, DOI 10.1073/pnas.1600924113; MacArthur DE, 2017, SCIENCE, V358, P843, DOI 10.1126/science.aao6749; Schneiderman DK, 2017, MACROMOLECULES, V50, P3733, DOI 10.1021/acs.macromol.7b00293; Stanford MJ, 2010, CHEM SOC REV, V39, P486, DOI 10.1039/b815104k; Zhang XY, 2018, CHEM REV, V118, P839, DOI 10.1021/acs.chemrev.7b00329; Zhu JB, 2018, SCIENCE, V360, P398, DOI 10.1126/science.aar5498	14	162	165	27	282	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					380	381		10.1126/science.aat4997	http://dx.doi.org/10.1126/science.aat4997			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1AR	29700253				2022-12-28	WOS:000430949600022
J	Flynn, PM				Flynn, Patricia M.			A broader look at paediatric HIV infection	NATURE			English	Editorial Material							EARLY ANTIRETROVIRAL THERAPY; CHILDREN	An epidemiological study of adolescents who had acquired HIV around the time of birth highlights how high-income countries benefit from the ability to begin treating all infected children in the first years of life.	[Flynn, Patricia M.] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Flynn, PM (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	pat.flynn@stjude.org	Flynn, Patricia M/N-8146-2018					Barlow-Mosha L, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21552; Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, 2018, PLOS MED, V15; Laughton B, 2012, AIDS, V26, P1685, DOI 10.1097/QAD.0b013e328355d0ce; Penazzato M, 2017, CLIN INFECT DIS, V64, P1597, DOI 10.1093/cid/cix194; SCOTT GB, 1989, NEW ENGL J MED, V321, P1791, DOI 10.1056/NEJM198912283212604; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971	6	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					439	440		10.1038/d41586-018-04476-8	http://dx.doi.org/10.1038/d41586-018-04476-8			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD8VX	29686368	Bronze			2022-12-28	WOS:000430793000030
J	Mann, C				Mann, Clifford			PROVOCATIONS Doctors need to give up professional protectionism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mann, Clifford] Taunton & Somerset NHS Fdn Trust, Taunton, Somerset, England		Mann, C (corresponding author), Taunton & Somerset NHS Fdn Trust, Taunton, Somerset, England.	clifford.mann@gmail.com	MUI, HOI LING/I-3220-2018						0	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2018	361								k1757	10.1136/bmj.k1757	http://dx.doi.org/10.1136/bmj.k1757			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF4VZ	29691227				2022-12-28	WOS:000431963200010
J	Dick, AG; Houghton, JM; Bankes, MJK				Dick, Alastair G.; Houghton, Jonathan M.; Bankes, Marcus J. K.			PRACTICE POINTER An approach to hip pain in a young adult	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OF-THE-LITERATURE; FEMOROACETABULAR IMPINGEMENT; FEMORAL-HEAD; CLINICAL PRESENTATION; PERIACETABULAR OSTEOTOMY; CONSENSUS STATEMENT; SURGICAL-TREATMENT; DYSPLASIA; OSTEOARTHRITIS; OSTEONECROSIS		[Dick, Alastair G.; Bankes, Marcus J. K.] Guys & St Thomas NHS Fdn Trust, London, England; [Houghton, Jonathan M.] Fortius Clin, London, England	Guy's & St Thomas' NHS Foundation Trust	Dick, AG (corresponding author), Guys & St Thomas NHS Fdn Trust, London, England.	alastair.dick@nhs.net	Dick, Alastair/AAP-6734-2020	Dick, Alastair/0000-0002-3968-4193				Arbab D, 2016, DTSCH ARZTEBL INT, V113, P31, DOI 10.3238/arztebl.2016.0031; Beck M, 2005, J BONE JOINT SURG BR, V87B, P1012, DOI 10.1302/0301-620X.87B7.15203; British Hip Society, 2017, NON HIP REG 2017 ANN; Byrd J, 2005, OPERATIVE HIP ARTHRO, DOI [10.1007/b138526, DOI 10.1007/B138526]; Casartelli NC, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094414; Chen YT, 2013, CURR REV MUSCULOSKE, V6, P173, DOI 10.1007/s12178-013-9167-x; Clohisy JC, 2008, J BONE JOINT SURG AM, V90A, P2267, DOI 10.2106/JBJS.G.01267; Clohisy JC, 2009, CLIN ORTHOP RELAT R, V467, P638, DOI 10.1007/s11999-008-0680-y; Diaz-Ledezma C, 2013, QUAL LIFE RES, V22, P2323, DOI 10.1007/s11136-013-0359-z; Egol KA, 1998, CLIN ORTHOP RELAT R, P72; Furia JP, 2009, AM J SPORT MED, V37, P1806, DOI 10.1177/0363546509333014; Gala L, 2016, J BONE JOINT SURG AM, V98, P63, DOI 10.2106/JBJS.O.00109; Ganz R, 2003, CLIN ORTHOP RELAT R, P112, DOI 10.1097/01.blo.0000096804.78689.c2; Griffin DR, 2016, BRIT J SPORT MED, V50, P1169, DOI 10.1136/bjsports-2016-096743; Khan W, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115601030; KLAUE K, 1991, J BONE JOINT SURG BR, V73, P423, DOI 10.1302/0301-620X.73B3.1670443; Lavernia C J, 1999, J Am Acad Orthop Surg, V7, P250; Leunig M, 2004, CLIN ORTHOP RELAT R, P74, DOI 10.1097/00003086-200401000-00013; Leunig M, 2009, CLIN ORTHOP RELAT R, V467, P616, DOI 10.1007/s11999-008-0646-0; Luo RB, 2014, MED SCI MONITOR, V20, P2439, DOI 10.12659/MSM.891123; Mountjoy M, 2014, BRIT J SPORT MED, V48, P491, DOI 10.1136/bjsports-2014-093502; Musielak B, 2015, ARCH MED SCI, V11, P1052, DOI 10.5114/aoms.2015.52734; Nakamura J, 2017, MOD RHEUMATOL, V27, P503, DOI 10.1080/14397595.2016.1209830; Nepple JJ, 2013, J AM ACAD ORTHOP SUR, V21, pS53, DOI 10.5435/JAAOS-21-07-S53; Nepple JJ, 2013, J AM ACAD ORTHOP SUR, V21, pS16, DOI 10.5435/JAAOS-21-07-S16; Nunley RM, 2011, J BONE JOINT SURG AM, V93A, P17, DOI 10.2106/JBJS.J.01735; Ochoa LM, 2010, CLIN ORTHOP RELAT R, V468, P2710, DOI 10.1007/s11999-010-1233-8; Pascual-Garrido C, 2017, J ARTHROPLASTY, V32, pS32, DOI 10.1016/j.arth.2017.02.015; Pihlajamaki HK, 2006, J BONE JOINT SURG BR, V88B, P1574, DOI 10.1302/0301-620X.88B12.17996; Potalivo G, 2017, HIP INT, V27, P111, DOI 10.5301/hipint.5000464; Reiman MP, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094302; Roling MA, 2016, J HIP PRESERV SURG, V3, P203, DOI 10.1093/jhps/hnw009; Spencer-Gardner L, 2017, J HIP PRESERV SURG, V4, P39, DOI 10.1093/jhps/hnw051; Steppacher SD, 2008, CLIN ORTHOP RELAT R, V466, P1633, DOI 10.1007/s11999-008-0242-3; Timperley A, 2017, HIP JOINT RESTORATIO, P967, DOI [10.1007/978-1-4614-0694-5_106, DOI 10.1007/978-1-4614-0694-5_106]; Wall PDH, 2013, PM&R, V5, P418, DOI 10.1016/j.pmrj.2013.02.005; Zalavras CG, 2014, J AM ACAD ORTHOP SUR, V22, P455, DOI 10.5435/JAAOS-22-07-455	37	9	10	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2018	361								k1086	10.1136/bmj.k1086	http://dx.doi.org/10.1136/bmj.k1086			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8WQ	29674488				2022-12-28	WOS:000430795300002
J	Larson, EB				Larson, Eric B.			Guideline: In patients with mild cognitive impairment, the AAN recommends regular exercise and no drugs or supplements	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Larson, Eric B.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA 98101 USA	Kaiser Permanente	Larson, EB (corresponding author), Kaiser Permanente Washington Hlth Res Inst, Seattle, WA 98101 USA.							Haymart MR, 2017, NEW ENGL J MED, V377, P203, DOI 10.1056/NEJMp1703787; KRAL VA, 1962, CAN MED ASSOC J, V86, P257	2	1	2	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2018	168	8					JC38	JC38		10.7326/ACPJC-2018-168-8-038	http://dx.doi.org/10.7326/ACPJC-2018-168-8-038			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GC8XZ	29677245				2022-12-28	WOS:000430083100004
J	Rimmer, A				Rimmer, Abi			GMC should lose right to appeal fitness to practise decisions, says BMA	BMJ-BRITISH MEDICAL JOURNAL			English	News Item							MANSLAUGHTER											Dyer C, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k1416; Dyer C, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k417; European Commission, EUR NETW CIV AV SAF; Iacobucci G, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k592	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2018	361								k1702	10.1136/bmj.k1702	http://dx.doi.org/10.1136/bmj.k1702			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8WK	29666109				2022-12-28	WOS:000430794600011
J	Shepherd, A				Shepherd, Alison			THE BIG PICTURE Freed, after 15 years in jail for a stillbirth	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2018	361								k1700	10.1136/bmj.k1700	http://dx.doi.org/10.1136/bmj.k1700			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8WK	29666110				2022-12-28	WOS:000430794600009
J	[Anonymous]				[Anonymous]			The Regular Medical Corps-An Opportunity (Reprinted from JAMA vol 70, pg 1160-1162 1918)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		REILING J, 1918, JAMA-J AM MED ASSOC, V70, P1160	1	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2018	319	15					1624	1624		10.1001/jama.2017.12336	http://dx.doi.org/10.1001/jama.2017.12336			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD0UT	29677291				2022-12-28	WOS:000430217100032
J	Crossley, MP; Cimprich, KA				Crossley, Madzia P.; Cimprich, Karlene A.			Faulty replication can sting	NATURE			English	Editorial Material							SAMHD1; TRIPHOSPHOHYDROLASE; CELLS		[Crossley, Madzia P.; Cimprich, Karlene A.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Crossley, MP (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	mpcross@stanford.edu; cimprich@stanford.edu			NIGMS NIH HHS [R01 GM119334] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119334] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bakhoum SF, 2018, NATURE, V553, P467, DOI 10.1038/nature25432; Chaudhuri AR, 2016, NATURE, V535, P382, DOI 10.1038/nature18325; Clifford R, 2014, BLOOD, V123, P1021, DOI 10.1182/blood-2013-04-490847; Coquel F, 2018, NATURE, V557, P57, DOI 10.1038/s41586-018-0050-1; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Pasero P, 2017, ANNU REV GENET, V51, P477, DOI 10.1146/annurev-genet-120116-024745; Rentoft M, 2016, P NATL ACAD SCI USA, V113, P4723, DOI 10.1073/pnas.1519128113; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897	13	1	2	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2018	557	7703					34	35		10.1038/d41586-018-02804-6	http://dx.doi.org/10.1038/d41586-018-02804-6			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE5BW	29713064				2022-12-28	WOS:000431234500021
J	Jiang, MH; Zhang, SK; Yang, ZH; Lin, HY; Zhu, J; Liu, L; Wang, WD; Liu, S; Liu, W; Ma, YW; Zhang, LF; Cao, XT				Jiang, Minghong; Zhang, Shikun; Yang, Zongheng; Lin, Hongyu; Zhu, Jun; Liu, Lun; Wang, Wendie; Liu, Shuo; Liu, Wei; Ma, Yuanwu; Zhang, Lianfeng; Cao, Xuetao			Self-Recognition of an Inducible Host IncRNA by RIG-I Feedback Restricts Innate Immune Response	CELL			English	Article							LONG NONCODING RNA; DOUBLE-STRANDED-RNA; ANTIVIRAL RESPONSES; MESSENGER-RNA; ACTIVATION; HELICASE; INFLAMMATION; DISEASE; BINDING; SEQ	The innate RNA sensor RIG-I is critical in the initiation of antiviral type I interferons (IFNs) production upon recognition of "non-self" viral RNAs. Here, we identify a host-derived, IFN-inducible long noncoding RNA, lnc-Lsm3b, that can compete with viral RNAs in the binding of RIG-I monomers and feedback inactivate the RIG-I innate function at late stage of innate response. Mechanistically, binding of lnc-Lsm3b restricts RIG-I protein's conformational shift and prevents downstream signaling, thereby terminating type I IFNs production. Multivalent structural motifs and long-stem structure are critical features of lnc-Lsm3b for RIG-I binding and inhibition. These data reveal a non-canonical self-recognition mode in the regulation of immune response and demonstrate an important role of an inducible "self" lncRNA acting as a potent molecular decoy actively saturating RIG-I binding sites to restrict the duration of "non-self" RNA-induced innate immune response and maintaining immune homeostasis, with potential utility in inflammatory disease management.	[Jiang, Minghong; Zhang, Shikun; Yang, Zongheng; Lin, Hongyu; Zhu, Jun; Liu, Lun; Wang, Wendie; Liu, Shuo; Liu, Wei; Cao, Xuetao] Chinese Acad Med Sci, Natl Key Lab Med Mol Biol, Dept Immunol, Peking Union Med Coll, Beijing 100005, Peoples R China; [Jiang, Minghong; Zhang, Shikun; Yang, Zongheng; Lin, Hongyu; Zhu, Jun; Liu, Lun; Wang, Wendie; Liu, Shuo; Liu, Wei; Cao, Xuetao] Chinese Acad Med Sci, Peking Union Med Coll, Ctr Immunotherapy, Inst Basic Med Sci, Beijing 100005, Peoples R China; [Ma, Yuanwu; Zhang, Lianfeng] Chinese Acad Med Sci, Inst Lab Anim Sci, MOH Key Lab Human Dis Comparat Med, Beijing 100021, Peoples R China; [Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Cao, Xuetao] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Naval Medical University; Naval Medical University; Nankai University	Cao, XT (corresponding author), Chinese Acad Med Sci, Natl Key Lab Med Mol Biol, Dept Immunol, Peking Union Med Coll, Beijing 100005, Peoples R China.; Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China.; Cao, XT (corresponding author), Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China.; Cao, XT (corresponding author), Nankai Univ, Sch Med, Tianjin 300071, Peoples R China.	caoxt@immunol.org		Zhang, Shikun/0000-0001-6962-9665; Ma, Yuanwu/0000-0002-1882-1777	National Natural Science Foundation of China [81788101, 31390431, 91642000]; National 135 Mega Program of China [2017ZX10202203-002, 2017ZX10203206-001]; CAMS Innovation Fund for Medical Sciences [2016-12M-1-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 135 Mega Program of China; CAMS Innovation Fund for Medical Sciences	This work is supported by grants from the National Natural Science Foundation of China (81788101, 31390431, 91642000), National 135 Mega Program of China (2017ZX10202203-002, 2017ZX10203206-001), and CAMS Innovation Fund for Medical Sciences (2016-12M-1-003).	Anchisi S, 2015, MBIO, V6, DOI 10.1128/mBio.02349-14; Atianand MK, 2016, CELL, V165, P1672, DOI 10.1016/j.cell.2016.05.075; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Cabili MN, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0586-4; Cao XT, 2016, NAT REV IMMUNOL, V16, P35, DOI 10.1038/nri.2015.8; Castellanos-Rubio A, 2016, SCIENCE, V352, P91, DOI 10.1126/science.aad0467; Chen WL, 2013, CELL, V152, P467, DOI 10.1016/j.cell.2013.01.011; Cho JA, 2013, CELL HOST MICROBE, V13, P558, DOI 10.1016/j.chom.2013.03.011; Feng M, 2013, PROTEIN CELL, V4, P142, DOI 10.1007/s13238-012-2088-4; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590; Hajishengallis G, 2011, NAT REV IMMUNOL, V11, P187, DOI 10.1038/nri2918; Hiller D, 2009, BIOINFORMATICS, V25, P3056, DOI 10.1093/bioinformatics/btp544; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Liu XF, 2012, EMBO J, V31, P4415, DOI 10.1038/emboj.2012.292; Louber J, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0166-9; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Meng J, 2016, J AUTOIMMUN, V73, P42, DOI 10.1016/j.jaut.2016.05.012; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Nallagatla SR, 2007, SCIENCE, V318, P1455, DOI 10.1126/science.1147347; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Runge S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004081; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schnell G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002839; Schuberth-Wagner C, 2015, IMMUNITY, V43, P41, DOI 10.1016/j.immuni.2015.06.015; Shah A, 2017, BIOINFORMATICS, V33, P566, DOI 10.1093/bioinformatics/btw653; Stossi F, 2014, CHEM BIOL, V21, P743, DOI 10.1016/j.chembiol.2014.03.013; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoon JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3939; Zhang HX, 2013, P NATL ACAD SCI USA, V110, P6459, DOI 10.1073/pnas.1304432110	41	146	160	3	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 3	2018	173	4					906	+		10.1016/j.cell.2018.03.064	http://dx.doi.org/10.1016/j.cell.2018.03.064			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GG1TU	29706547	Bronze			2022-12-28	WOS:000432471100013
J	McMillan, EA; Ryu, MJ; Diep, CH; Mendiratta, S; Clemenceau, JR; Vaden, RM; Kim, JH; Motoyaji, T; Covington, KR; Peyton, M; Huffman, K; Wu, XFF; Girard, L; Sung, YJ; Chen, PH; Mallipeddi, PL; Lee, JY; Hanson, J; Voruganti, S; Yu, YK; Park, S; Sudderth, J; DeSevo, C; Muzny, DM; Doddapaneni, H; Gazdar, A; Gibbs, RA; Hwang, TH; Heymach, JV; Wistuba, I; Coombes, KR; Williams, NS; Wheeler, DA; MacMillan, JB; Deberardinis, RJ; Roth, MG; Posner, BA; Minna, JD; Kim, HS; White, MA				McMillan, Elizabeth A.; Ryu, Myung-Jeom; Diep, Caroline H.; Mendiratta, Saurabh; Clemenceau, Jean R.; Vaden, Rachel M.; Kim, Ju-Hwa; Motoyaji, Takashi; Covington, Kyle R.; Peyton, Michael; Huffman, Kenneth; Wu, Xiaofeng; Girard, Luc; Sung, Yeojin; Chen, Pei-Hsaun; Mallipeddi, Prema L.; Lee, Joo Young; Hanson, Jordan; Voruganti, Sukesh; Yu, Yunku; Park, Sunho; Sudderth, Jessica; DeSevo, Christopher; Muzny, Donna M.; Doddapaneni, HarshaVardhan; Gazdar, Adi; Gibbs, Richard A.; Hwang, Tae-Hyun; Heymach, John V.; Wistuba, Ignacio; Coombes, Kevin R.; Williams, Noelle S.; Wheeler, David A.; MacMillan, John B.; Deberardinis, Ralph J.; Roth, Michael G.; Posner, Bruce A.; Minna, John D.; Kim, Hyun Seok; White, Michael A.			Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer	CELL			English	Article							SYSTEMATIC IDENTIFICATION; DRUG-SENSITIVITY; CELL-SURVIVAL; GLUT8; CONTRIBUTES; MECHANISM; TRANSPORT	Diversity in the genetic lesions that cause cancer is extreme. In consequence, a pressing challenge is the development of drugs that target patient-specific disease mechanisms. To address this challenge, we employed a chemistry-first discovery paradigm for de novo identification of druggable targets linked to robust patient selection hypotheses. In particular, a 200,000 compound diversity-oriented chemical library was profiled across a heavily annotated test-bed of >100 cellular models representative of the diverse and characteristic somatic lesions for lung cancer. This approach led to the delineation of 171 chemical-genetic associations, shedding light on the targetability of mechanistic vulnerabilities corresponding to a range of oncogenotypes present in patient populations lacking effective therapy. Chemically addressable addictions to ciliogenesis in TTC21B mutants and GLUT8-dependent serine biosynthesis in KRAS/KEAP1 double mutants are prominent examples. These observations indicate a wealth of actionable opportunities within the complex molecular etiology of cancer.	[McMillan, Elizabeth A.; Diep, Caroline H.; Mendiratta, Saurabh; Clemenceau, Jean R.; Vaden, Rachel M.; Wu, Xiaofeng; DeSevo, Christopher; White, Michael A.] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Ryu, Myung-Jeom; Kim, Ju-Hwa; Sung, Yeojin; Lee, Joo Young; Kim, Hyun Seok] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Severance Biomed Sci Inst, Seoul, South Korea; [Motoyaji, Takashi] Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, Biomol Res Labs, Fujisawa, Kanagawa, Japan; [Covington, Kyle R.; Muzny, Donna M.; Doddapaneni, HarshaVardhan; Gibbs, Richard A.; Wheeler, David A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Peyton, Michael; Huffman, Kenneth; Girard, Luc; Minna, John D.] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Therapeut Oncol, Dallas, TX 75390 USA; [Chen, Pei-Hsaun; Sudderth, Jessica; Deberardinis, Ralph J.] Univ Texas Southwestern Med Ctr Dallas, Childrens Res Inst, Dallas, TX 75390 USA; [Mallipeddi, Prema L.; Hanson, Jordan; Voruganti, Sukesh; Williams, Noelle S.; MacMillan, John B.; Roth, Michael G.; Posner, Bruce A.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Yu, Yunku; Park, Sunho; Hwang, Tae-Hyun] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Heymach, John V.] Univ Texas MD Anderson Canc Ctr, Dept Thoracic Head & Neck Med Oncol, Houston, TX 77030 USA; [Wistuba, Ignacio] Univ Texas MD Anderson Canc Ctr, Translat Mol Pathol, Houston, TX 77030 USA; [Coombes, Kevin R.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Gazdar, Adi] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Yonsei University; Yonsei University Health System; Takeda Pharmaceutical Company Ltd; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University System of Ohio; Ohio State University; University of Texas System; University of Texas Southwestern Medical Center Dallas	White, MA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.; Kim, HS (corresponding author), Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Severance Biomed Sci Inst, Seoul, South Korea.; Minna, JD (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Therapeut Oncol, Dallas, TX 75390 USA.	john.minna@utsouthwestern.edu; hsfkim@yuhs.ac; michael.white@utsouthwestern.edu	Heymach, John/AAG-2361-2019; Wheeler, David A/M-9740-2018	Heymach, John/0000-0001-9068-8942; Wheeler, David A/0000-0002-9056-6299; Kim, Hyun Seok/0000-0003-4498-8690; Roth, Michael/0000-0002-9056-332X; Clemenceau, Jean/0000-0002-6222-6457; doddapaneni, harshavardhan/0000-0002-2433-633X; Diep, Ph.D., Caroline/0000-0001-9011-6450; Yeu, Yunku/0000-0001-7544-531X	NIH [CA197717, CA176284, CA70907, CA142543]; CPRIT [RP120732, RP110708]; Robert Welch Foundation [I-1414]; Korea Health Technology R & D project through the Korea Health Industry Development Institute [HI14C1324]; National R&D Program for Cancer Control - Ministry of Health & Welfare, Republic of Korea [1420100]; NIH training grant [5T32GM8203-27, 5T32CA124334-09]; CPRIT training grant [RP140110]; NATIONAL CANCER INSTITUTE [P30CA016058, R35CA220449, U01CA176284, T32CA124334, P50CA070907, P30CA142543, R35CA197717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; Robert Welch Foundation(The Welch Foundation); Korea Health Technology R & D project through the Korea Health Industry Development Institute; National R&D Program for Cancer Control - Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH (CA197717, CA176284, CA70907, CA142543), CPRIT (RP120732, RP110708, RP110708), Robert Welch Foundation (I-1414), the Korea Health Technology R & D project through the Korea Health Industry Development Institute (HI14C1324), and the National R&D Program for Cancer Control (1420100), funded by the Ministry of Health & Welfare, Republic of Korea. E.A.M. was supported by NIH training grant 5T32GM8203-27, C.D. and R.M.V were supported by CPRIT training grant RP140110, and R.M.V was supported by NIH training grant 5T32CA124334-09. We would like to thank Hanspeter Niederstrasser, Melissa McCoy, Shuguang Wei, Hong Chen, and Anwu Zhou in the UT Southwestern High-throughput Screening Core for their support of the large-scale screening and dose-response experiments described herein.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Baumgart A, 2015, ONCOGENE, V34, P578, DOI 10.1038/onc.2013.592; Carayannopoulos MO, 2000, P NATL ACAD SCI USA, V97, P7313, DOI 10.1073/pnas.97.13.7313; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; Chu D, 2011, ANN ONCOL, V22, P2440, DOI 10.1093/annonc/mdq776; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Deng D, 2015, NATURE, V526, P391, DOI 10.1038/nature14655; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eskiocak B, 2017, CANCER DISCOV, V7, P832, DOI 10.1158/2159-8290.CD-16-0955; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Goldstein LD, 2016, CELL REP, V16, P2605, DOI 10.1016/j.celrep.2016.08.010; Hafner M, 2017, NAT BIOTECHNOL, V35, P500, DOI 10.1038/nbt.3882; Hirotsu Y, 2012, NUCLEIC ACIDS RES, V40, P10228, DOI 10.1093/nar/gks827; Inaba H, 2010, LANCET ONCOL, V11, P1096, DOI 10.1016/S1470-2045(10)70114-5; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Kapoor K, 2016, P NATL ACAD SCI USA, V113, P4711, DOI 10.1073/pnas.1603735113; Kim HS, 2013, CELL, V155, P552, DOI 10.1016/j.cell.2013.09.041; Kim J, 2016, NATURE, V538, P114, DOI 10.1038/nature19771; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Long WT, 2015, CELL HEALTH CYTOSKEL, V7, P167, DOI 10.2147/CHC.S60484; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; McBrayer SK, 2012, BLOOD, V119, P4686, DOI 10.1182/blood-2011-09-377846; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Real PJ, 2009, NAT MED, V15, P50, DOI 10.1038/nm.1900; Revollo JR, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004389; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schmidt S, 2009, AM J PHYSIOL-ENDOC M, V296, pE614, DOI 10.1152/ajpendo.91019.2008; Seashore-Ludlow B, 2015, CANCER DISCOV, V5, P1210, DOI 10.1158/2159-8290.CD-15-0235; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tabatabaie L, 2009, HUM MUTAT, V30, P749, DOI 10.1002/humu.20934; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356	36	60	60	3	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 3	2018	173	4					864	+		10.1016/j.cell.2018.03.028	http://dx.doi.org/10.1016/j.cell.2018.03.028			44	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GG1TU	29681454	Bronze, Green Accepted			2022-12-28	WOS:000432471100010
J	Chertow, DS				Chertow, Daniel S.			Next-generation diagnostics with CRISPR	SCIENCE			English	Editorial Material									[Chertow, Daniel S.] NIAID, Dept Crit Care Med, NIH, Ctr Clin, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Chertow, Daniel S.] NIAID, Immunoregulat Lab, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chertow, DS (corresponding author), NIAID, Dept Crit Care Med, NIH, Ctr Clin, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Chertow, DS (corresponding author), NIAID, Immunoregulat Lab, Bldg 10, Bethesda, MD 20892 USA.	chertowd@cc.nih.gov			Intramural Research Programs of the National Institutes of Health (Clinical Center, Critical Care Medicine Department and Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases), U.S. Department of Health and Human Services	Intramural Research Programs of the National Institutes of Health (Clinical Center, Critical Care Medicine Department and Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases), U.S. Department of Health and Human Services	The Intramural Research Programs of the National Institutes of Health (Clinical Center, Critical Care Medicine Department and Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases), U.S. Department of Health and Human Services, supported this work. The content of this publication does not necessarily reflect the views or policies of the U.S. Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government.	Broadhurst MJ, 2016, CLIN MICROBIOL REV, V29, P773, DOI 10.1128/CMR.00003-16; Chen JS, 2018, SCIENCE, V360, P436, DOI 10.1126/science.aar6245; Dorward J, 2018, LANCET HIV, V5, pE8, DOI 10.1016/S2352-3018(17)30211-4; Gootenberg JS, 2018, SCIENCE, V360, P439, DOI 10.1126/science.aaq0179; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Hille F, 2018, CELL, V172, P1239, DOI 10.1016/j.cell.2017.11.032; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Myhrvold C, 2018, SCIENCE, V360, P444, DOI 10.1126/science.aas8836; Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445; Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Wardlaw T, 2006, LANCET, V368, P1048, DOI 10.1016/S0140-6736(06)69334-3	12	155	159	9	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					381	382		10.1126/science.aat4982	http://dx.doi.org/10.1126/science.aat4982			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1AR	29700254				2022-12-28	WOS:000430949600023
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Tube feeding and deteriorating patients-guidelines can take us only so far	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ARTIFICIAL NUTRITION; GASTROSTOMY; PLACEMENT					davidoliver372@googlemail.com						BMA, 2018, CLIN ASS NUTR HYDR C; British Association for Parenteral and Enteral Nutrition, 2012, STAND GUID NUTR SUPP; Brooke J, 2015, NUTRIENTS, V7, P2456, DOI 10.3390/nu7042456; Desport J-C, 2005, COMPLICATIONS SURVIV, DOI [10.1080/14660820410021258a, DOI 10.1080/14660820410021258A]; Druml C, 2016, CLIN NUTR, V35, P545, DOI 10.1016/j.clnu.2016.02.006; Good P, 2014, COCHRANE DB SYST REV, V4; Good P, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006273.pub3; Harwood RH, 2014, J ROY COLL PHYS EDIN, V44, P232, DOI 10.4997/JRCPE.2014.310; Horne M, 2017, CAN CLINICALLY ASSIS; Johnston SD, 2008, GASTROINTEST ENDOSC, V68, P223, DOI 10.1016/j.gie.2007.10.019; Lim JH, 2016, INTEST RES, V14, P333, DOI 10.5217/ir.2016.14.4.333; Mitchell SL, 2000, J GERONTOL A-BIOL, V55, pM735, DOI 10.1093/gerona/55.12.M735; National Council for Palliative Care, 2011, ART NUTR HYDR SUMM G; Royal College of Physicians, 2010, OR FEED DIFF DIL; Ying I., 2015, CAN FAM PHYSICIAN, V61, pe125; Ying I, 2015, CAN FAM PHYSICIAN, V61, P245	16	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2018	361								k1707	10.1136/bmj.k1707	http://dx.doi.org/10.1136/bmj.k1707			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF4VZ	29691219	Green Published, Bronze			2022-12-28	WOS:000431963200005
J	Brandler, WM; Antaki, D; Gujral, M; Kleiber, ML; Whitney, J; Maile, MS; Hong, O; Chapman, TR; Tan, S; Tandon, P; Pang, T; Tang, SC; Vaux, KK; Yang, Y; Harrington, E; Juul, S; Turner, DJ; Thiruvahindrapuram, B; Kaur, G; Wang, ZZ; Kingsmore, SF; Gleeson, JG; Bisson, D; Kakaradov, B; Telenti, A; Venter, JC; Corominas, R; Toma, C; Cormand, B; Rueda, I; Guijarro, S; Messer, KS; Nievergelt, CM; Arranz, MJ; Courchesne, E; Pierce, K; Muotri, AR; Iakoucheva, LM; Hervas, A; Scherer, SW; Corsello, C; Sebat, J				Brandler, William M.; Antaki, Danny; Gujral, Madhusudan; Kleiber, Morgan L.; Whitney, Joe; Maile, Michelle S.; Hong, Oanh; Chapman, Timothy R.; Tan, Shirley; Tandon, Prateek; Pang, Timothy; Tang, Shih C.; Vaux, Keith K.; Yang, Yan; Harrington, Eoghan; Juul, Sissel; Turner, Daniel J.; Thiruvahindrapuram, Bhooma; Kaur, Gaganjot; Wang, Zhuozhi; Kingsmore, Stephen F.; Gleeson, Joseph G.; Bisson, Denis; Kakaradov, Boyko; Telenti, Amalio; Venter, J. Craig; Corominas, Roser; Toma, Claudio; Cormand, Bru; Rueda, Isabel; Guijarro, Silvina; Messer, Karen S.; Nievergelt, Caroline M.; Arranz, Maria J.; Courchesne, Eric; Pierce, Karen; Muotri, Alysson R.; Iakoucheva, Lilia M.; Hervas, Amaia; Scherer, Stephen W.; Corsello, Christina; Sebat, Jonathan			Paternally inherited cis-regulatory structural variants are associated with autism	SCIENCE			English	Article							DE-NOVO; SPECTRUM DISORDER; MUTATIONS; GENOME; ARCHITECTURE; GENES; TRANSCRIPTION; PATTERNS; RISK; RARE	The genetic basis of autism spectrum disorder (ASD) is known to consist of contributions from de novo mutations in variant-intolerant genes. We hypothesize that rare inherited structural variants in cis-regulatory elements (CRE-SVs) of these genes also contribute to ASD. We investigated this by assessing the evidence for natural selection and transmission distortion of CRE-SVs in whole genomes of 9274 subjects from 2600 families affected by ASD. In a discovery cohort of 829 families, structural variants were depleted within promoters and untranslated regions, and paternally inherited CRE-SVs were preferentially transmitted to affected offspring and not to their unaffected siblings. The association of paternal CRE-SVs was replicated in an independent sample of 1771 families. Our results suggest that rare inherited noncoding variants predispose children to ASD, with differing contributions from each parent.	[Brandler, William M.; Antaki, Danny; Gujral, Madhusudan; Kleiber, Morgan L.; Maile, Michelle S.; Hong, Oanh; Chapman, Timothy R.; Tan, Shirley; Tandon, Prateek; Pang, Timothy; Tang, Shih C.; Sebat, Jonathan] Univ Calif San Diego, Beyster Ctr Genom Psychiat Dis, La Jolla, CA 92093 USA; [Brandler, William M.; Antaki, Danny; Gujral, Madhusudan; Kleiber, Morgan L.; Maile, Michelle S.; Hong, Oanh; Chapman, Timothy R.; Tan, Shirley; Tandon, Prateek; Nievergelt, Caroline M.; Iakoucheva, Lilia M.; Corsello, Christina; Sebat, Jonathan] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Brandler, William M.; Antaki, Danny; Gujral, Madhusudan; Kleiber, Morgan L.; Maile, Michelle S.; Hong, Oanh; Chapman, Timothy R.; Tan, Shirley; Tandon, Prateek; Muotri, Alysson R.; Sebat, Jonathan] Univ Calif San Diego, Dept Cellular & Mol Med & Pediat, La Jolla, CA 92093 USA; [Brandler, William M.; Bisson, Denis; Kakaradov, Boyko; Telenti, Amalio; Venter, J. Craig] Human Longev Inc, San Diego, CA 92121 USA; [Antaki, Danny] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Whitney, Joe; Thiruvahindrapuram, Bhooma; Kaur, Gaganjot; Wang, Zhuozhi; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom Genet & Genome Biol, Toronto, ON, Canada; [Pang, Timothy; Tang, Shih C.; Corsello, Christina] Rady Childrens Hosp, San Diego, CA 92123 USA; [Vaux, Keith K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Yang, Yan; Harrington, Eoghan; Juul, Sissel] Oxford Nanopore Technol Inc, New York, NY 10013 USA; [Turner, Daniel J.] Oxford Nanopore Technol Ltd, Oxford, England; [Kingsmore, Stephen F.] Rady Childrens Hosp, Rady Childrens Inst Genom Med, San Diego, CA 92123 USA; [Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Rady Childrens Inst Genom Med, Dept Neurosci, La Jolla, CA 92093 USA; [Venter, J. Craig] J Craig Venter Inst, La Jolla, CA 92037 USA; [Corominas, Roser] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Genet Unit, Barcelona, Spain; [Corominas, Roser; Cormand, Bru] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain; [Toma, Claudio; Cormand, Bru] Univ Barcelona, Fac Biol, Dept Genet Microbiol & Estat, Catalonia, Spain; [Toma, Claudio] Neurosci Res Australia, Sydney, NSW, Australia; [Toma, Claudio] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia; [Cormand, Bru] IBUB, Catalonia, Spain; [Cormand, Bru] IR SJD, Esplugues, Catalonia, Spain; [Rueda, Isabel] Hosp St Joan Deu, Dept Psychiat, Barcelona, Spain; [Guijarro, Silvina; Hervas, Amaia] Hosp Univ Mutua Terrassa, Child & Adolescent Mental Hlth Unit, Barcelona, Spain; [Messer, Karen S.] Univ Calif San Diego, Dept Family Med & Publ Hlth, Div Biostat & Bioinformat, La Jolla, CA 92093 USA; [Arranz, Maria J.] Fdn Docencia Recerca Mutua Terrassa, Res Lab Unit, Barcelona, Spain; [Courchesne, Eric; Pierce, Karen] Univ Calif San Diego, Dept Neurosci, Autism Ctr Excellence, La Jolla, CA 92093 USA; [Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON, Canada	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Oxford Nanopore Technologies; Oxford Nanopore Technologies; Rady Childrens Hospital San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; J. Craig Venter Institute; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Neuroscience Research Australia; University of New South Wales Sydney; University of Barcelona; Hospital Universitario Mutua Terrassa; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Toronto; University of Toronto	Sebat, J (corresponding author), Univ Calif San Diego, Beyster Ctr Genom Psychiat Dis, La Jolla, CA 92093 USA.; Sebat, J (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.; Sebat, J (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med & Pediat, La Jolla, CA 92093 USA.	jsebat@ucsd.edu	Toma, Claudio/L-7853-2014; Scherer, Stephen W./B-3785-2013; Vaux, Keith/R-2716-2019; Cormand, Bru/H-5338-2015; Telenti, Amalio/AAY-1674-2021; Corominas Castineira, Roser/H-4163-2016	Toma, Claudio/0000-0003-3901-7507; Scherer, Stephen W./0000-0002-8326-1999; Vaux, Keith/0000-0001-8738-5940; Cormand, Bru/0000-0001-5318-4382; Corominas Castineira, Roser/0000-0001-8888-5402; Antaki, Danny/0000-0003-0381-7801; Kleiber, Morgan/0000-0002-9241-642X; Gujral, Madhusudan/0000-0001-5010-4826; Iakoucheva, Lilia/0000-0002-4542-5219	NIH [MH076431, MH113715, R21 MH104766, R01 MH105524, R01 MH109885, GM008666, R01MH108528, R01MH109885, HD0077693]; Simons Foundation Autism Research Initiative (SFARI) [275724]; ASD Enlight Foundation; National Institute of Mental Health (NIMH) [R01MH110558]; NIMH [R01MH110558, I-P50-MH081755]; Simons Foundation Grant; Simons Foundation [345469]; Ministerio de Economia, Industria y Competitividad [SAF2015-68341-R]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [2014-SGR-0932]; La Marato de TV3 [092020, 092010]; European Commission H2020 Programme MiND [643051]; Institute Carlos III [FIS PI11/00620]; Mutua Terrassa (FMT) [BE062]; Autism Science Foundation; Canadian Institutes of Health Research; California Institute for Regenerative Medicine [IT1-06611]; National Alliance for Research on Schizophrenia and Depression; Spanish Ministry of Health [FIS PI/15/01295 IP]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U19HD077693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH108528, R01MH105524, R21MH104766, R01MH109885, R01MH113715, P50MH081755, R01MH110558, R01MH076431] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative (SFARI); ASD Enlight Foundation; National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation Grant; Simons Foundation; Ministerio de Economia, Industria y Competitividad; Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); La Marato de TV3; European Commission H2020 Programme MiND; Institute Carlos III(Instituto de Salud Carlos III); Mutua Terrassa (FMT); Autism Science Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Alliance for Research on Schizophrenia and Depression(NARSAD); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by grants to J.S. from NIH (MH076431 and MH113715) and the Simons Foundation Autism Research Initiative (SFARI) (275724) and by a gift to J.S. from the Beyster Family Foundation. Support to J.S. and K.K.V. was also provided from the ASD Enlight Foundation. Support for the generation of nanopore sequence data was provided by Oxford Nanopore Technologies. Funding for K.P. is from the National Institute of Mental Health (NIMH) (R01MH110558). Funding for E.C. is from NIMH (R01MH110558 and I-P50-MH081755) and a Simons Foundation Grant. L.M.I. was supported by NIH (R21 MH104766, R01 MH105524, and R01 MH109885) and in part by Simons Foundation grant 345469. S.W.S. holds the GlaxoSmithKline-Canadian Institutes of Health Research Chair in Genome Sciences at the University of Toronto and the Hospital for Sick Children. Funding for B.C. is from Ministerio de Economia, Industria y Competitividad (SAF2015-68341-R), Agencia de Gestio d'Ajuts Universitaris i de Recerca (2014-SGR-0932), La Marato de TV3 (092020), and the European Commission H2020 Programme MiND (643051). A.H. and M.J.A. received grant support from the Institute Carlos III (FIS PI11/00620) and Mutua Terrassa (FMT grant BE062). Support for the generation of nanopore sequence data was provided by Oxford Nanopore Technologies. Funding for C.T. was provided by La Marato de TV3 (092010). Postdoctoral fellowships were provided to W.B. from the Autism Science Foundation and to M.L.K. from the Canadian Institutes of Health Research. A T32 training grant was provided to D.A. from NIH (GM008666). Funding for collection of fibroblast cell lines was provided by a grant (IT1-06611) to J.G.G. from the California Institute for Regenerative Medicine. A.R.M. is supported by a grant from the National Alliance for Research on Schizophrenia and Depression and NIH grants R01MH108528 and R01MH109885. S.F.K. is supported by NIH grant HD0077693. A.H. is supported by a grant from the Spanish Ministry of Health (FIS PI/15/01295 IP). We thank Genome Canada and the Centre for Applied Genomics (TCAG) for contributing the replication data set from the Autism Speaks MSSNG cohort (www.mss.ng).	Antaki D., 2018, BIOINFORMATICS, V2018; Brandler W. M., 2017, 102327 BIORXIV; Brandler WM, 2016, AM J HUM GENET, V98, P667, DOI 10.1016/j.ajhg.2016.02.018; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Doan RN, 2016, CELL, V167, P341, DOI 10.1016/j.cell.2016.08.071; Iossifov I, 2015, P NATL ACAD SCI USA, V112, pE5600, DOI 10.1073/pnas.1516376112; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Rands CM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004525; Robinson EB, 2016, NAT GENET, V48, P552, DOI 10.1038/ng.3529; Ruderfer DM, 2016, NAT GENET, V48, P1107, DOI 10.1038/ng.3638; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Turner TN, 2017, CELL, V171, P710, DOI 10.1016/j.cell.2017.08.047; Turner TN, 2016, AM J HUM GENET, V98, P58, DOI 10.1016/j.ajhg.2015.11.023; Wang BB, 2016, SCI REP-UK, V6, DOI 10.1038/srep25954; Ye K, 2017, P NATL ACAD SCI USA, V114, P7073, DOI 10.1073/pnas.1700439114; Yuen RKC, 2017, NAT NEUROSCI, V20, P602, DOI 10.1038/nn.4524; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	29	98	101	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2018	360	6386					327	330		10.1126/science.aan2261	http://dx.doi.org/10.1126/science.aan2261			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD3IC	29674594	Green Submitted, Green Accepted			2022-12-28	WOS:000430396600047
J	Li, JX; Shalev-Benami, M; Sando, R; Jiang, X; Kibrom, A; Wang, J; Leon, K; Katanski, C; Nazarko, O; Lu, YC; Sudhof, TC; Skiniotis, G; Arac, D				Li, Jingxian; Shalev-Benami, Moran; Sando, Richard; Jiang, Xian; Kibrom, Amanuel; Wang, Jie; Leon, Katherine; Katanski, Christopher; Nazarko, Olha; Lu, Yue C.; Sudhof, Thomas C.; Skiniotis, Georgios; Arac, Demet			Structural Basis for Teneurin Function in Circuit-Wiring: A Toxin Motif at the Synapse	CELL			English	Article							CORTICOTROPIN-RELEASING-FACTOR; TERMINAL ASSOCIATED PEPTIDE; PHYLOGENETIC ANALYSIS; FACTOR CRF; FAMILY; EXPRESSION; GENERATION; MUTATIONS; NEURESTIN; MECHANISM	Teneurins (TENs) are cell-surface adhesion proteins with critical roles in tissue development and axon guidance. Here, we report the 3.1-angstrom cryoelectron microscopy structure of the human TEN2 extracellular region (ECR), revealing a striking similarity to bacterial Tc-toxins. The ECR includes a large beta barrel that partially encapsulates a C-terminal domain, which emerges to the solvent through an opening in the mid-barrel region. An immunoglobulin (Ig)-like domain seals the bottom of the barrel while a beta propeller is attached in a perpendicular orientation. We further show that an alternatively spliced region within the beta propeller acts as a switch to regulate transcellular adhesion of TEN2 to latrophilin (LPHN), a transmembrane receptor known to mediate critical functions in the central nervous system. One splice variant activates trans-cellular signaling in a LPHN-dependent manner, whereas the other induces inhibitory postsynaptic differentiation. These results highlight the unusual structural organization of TENs giving rise to their multifarious functions.	[Li, Jingxian; Kibrom, Amanuel; Leon, Katherine; Katanski, Christopher; Nazarko, Olha; Lu, Yue C.; Arac, Demet] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA; [Li, Jingxian; Kibrom, Amanuel; Leon, Katherine; Katanski, Christopher; Nazarko, Olha; Lu, Yue C.; Arac, Demet] Univ Chicago, Grossman Inst Neurosci Quantitat Biol & Human Beh, Chicago, IL 60637 USA; [Shalev-Benami, Moran; Sando, Richard; Jiang, Xian; Wang, Jie; Sudhof, Thomas C.; Skiniotis, Georgios] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Shalev-Benami, Moran; Skiniotis, Georgios] Stanford Univ, Dept Struct Biol, Stanford, CA 94305 USA; [Sando, Richard; Jiang, Xian; Wang, Jie; Sudhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	University of Chicago; University of Chicago; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Arac, D (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.; Arac, D (corresponding author), Univ Chicago, Grossman Inst Neurosci Quantitat Biol & Human Beh, Chicago, IL 60637 USA.; Sudhof, TC; Skiniotis, G (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Skiniotis, G (corresponding author), Stanford Univ, Dept Struct Biol, Stanford, CA 94305 USA.; Sudhof, TC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	tcs1@stanford.edu; yiorgo@stanford.edu; arac@uchicago.edu	Li, Jingxian/ABH-3527-2021	Wang, Jie/0000-0002-3530-5029; Katanski, Christopher/0000-0002-1707-081X; Skiniotis, Georgios/0000-0003-0238-7846	NIH [R01-GM120322, R01 DK090165, R37 MH052804-22, T32GM007183]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183, R01GM120322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH052804] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Tobin R. Sosnick for generously providing DesG tag construct to improve behavior of the proteins, Liqun Luo for discussions on teneurin, Engin Ozkan for the use of flow cytometer and providing feedback on the manuscript, Chuan He lab for the use of their luminescence plate reader, Gabriel. S. Salzman for technical assistance on flow-cytometry binding assays, Adam M. Zmyslowski for discussions on the beta barrel, and Haim Rozenberg for advice on model refinement. This work was supported by NIH grants R01-GM120322 (to D.A.), R01 DK090165 (to G.S.), R37 MH052804-22 (to T.C.S.), and T32GM007183.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aldahmesh MA, 2012, GENET MED, V14, P900, DOI 10.1038/gim.2012.71; Alkelai A, 2016, CLIN GENET, V90, P211, DOI 10.1111/cge.12782; Anderson GR, 2017, J CELL BIOL, V216, P3831, DOI 10.1083/jcb.201703042; Aoto J, 2013, CELL, V154, P75, DOI 10.1016/j.cell.2013.05.060; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Ben-Zur T, 2000, DEV BIOL, V217, P107, DOI 10.1006/dbio.1999.9532; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Boucard AA, 2014, J BIOL CHEM, V289, P387, DOI 10.1074/jbc.M113.504779; Busby JN, 2013, NATURE, V501, P547, DOI 10.1038/nature12465; Chand D, 2013, MOL CELL NEUROSCI, V52, P38, DOI 10.1016/j.mcn.2012.09.006; Dharmaratne N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043083; Drabikowski K, 2005, DEV BIOL, V282, P27, DOI 10.1016/j.ydbio.2005.02.017; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erb S, 2014, BEHAV BRAIN RES, V269, P1, DOI 10.1016/j.bbr.2014.04.013; Feng K, 2002, J BIOL CHEM, V277, P26128, DOI 10.1074/jbc.M203722200; Fernandez-Leiro R, 2017, ACTA CRYSTALLOGR D, V73, P496, DOI 10.1107/S2059798316019276; Fuccillo MV, 2015, NEURON, V87, P326, DOI 10.1016/j.neuron.2015.06.028; Hamann J, 2015, PHARMACOL REV, V67, P338, DOI 10.1124/pr.114.009647; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; Hor H, 2015, HUM MOL GENET, V24, P5677, DOI 10.1093/hmg/ddv281; Irimia M, 2014, CELL, V159, P1511, DOI 10.1016/j.cell.2014.11.035; King N, 2004, DEV CELL, V7, P313, DOI 10.1016/j.devcel.2004.08.010; King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853; Landsberg MJ, 2011, P NATL ACAD SCI USA, V108, P20544, DOI 10.1073/pnas.1111155108; Langenhan T, 2009, DEV CELL, V17, P494, DOI 10.1016/j.devcel.2009.08.008; Leamey CA, 2007, PLOS BIOL, V5, P2077, DOI 10.1371/journal.pbio.0050241; Leamey CA, 2014, SEMIN CELL DEV BIOL, V35, P173, DOI 10.1016/j.semcdb.2014.08.007; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lossie AC, 2005, GENETICS, V169, P285, DOI 10.1534/genetics.104.034967; Lovejoy DA, 2006, GEN COMP ENDOCR, V148, P299, DOI 10.1016/j.ygcen.2006.01.012; Lovejoy DA, 2013, J CHEM NEUROANAT, V54, P50, DOI 10.1016/j.jchemneu.2013.09.006; Meusch D, 2014, NATURE, V508, P61, DOI 10.1038/nature13015; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Minet AD, 2000, GENE, V257, P87, DOI 10.1016/S0378-1119(00)00388-7; Moriya T, 2017, JOVE-J VIS EXP, DOI 10.3791/55448; Mosca TJ, 2012, NATURE, V484, P237, DOI 10.1038/nature10923; Mu L, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/181536; Nakamura H, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-9; O'Sullivan ML, 2014, NEURAL DEV, V9, DOI 10.1186/1749-8104-9-7; Otaki JM, 1999, DEV BIOL, V212, P165, DOI 10.1006/dbio.1999.9310; Otaki JM, 1999, NEUROREPORT, V10, P2677, DOI 10.1097/00001756-199908200-00044; Peisley Alys, 2015, Methods Mol Biol, V1335, P29, DOI 10.1007/978-1-4939-2914-6_3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Scholz N, 2017, ELIFE, V6, DOI 10.7554/eLife.28360; Scholz N, 2015, CELL REP, V11, P866, DOI 10.1016/j.celrep.2015.04.008; Silva JP, 2011, P NATL ACAD SCI USA, V108, P12113, DOI 10.1073/pnas.1019434108; Skinner JJ, 2014, P NATL ACAD SCI USA, V111, P15975, DOI 10.1073/pnas.1404213111; Sudhof TC, 2017, CELL, V171, P745, DOI 10.1016/j.cell.2017.10.024; Tan LA, 2011, PHYSIOL BEHAV, V104, P199, DOI 10.1016/j.physbeh.2011.03.015; Thalhammer A, 2017, CELL REP, V20, P333, DOI 10.1016/j.celrep.2017.06.055; Tucker RP, 2012, MOL BIOL EVOL, V29, P1019, DOI 10.1093/molbev/msr271; Tucker RP, 2006, DEV BIOL, V290, P237, DOI 10.1016/j.ydbio.2005.11.038; Tucker RP, 2001, DEV DYNAM, V220, P27, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1084>3.0.CO;2-B; Vysokov NV, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00059; Wang LQ, 2005, MOL BRAIN RES, V133, P253, DOI 10.1016/j.molbrainres.2004.10.019; Winkler Jana, 2016, Worm, V5, pe1170274, DOI 10.1080/21624054.2016.1170274; Woelfle R, 2016, TRANSL NEUROSCI, V7, P17, DOI 10.1515/tnsci-2016-0004; Young TR, 2013, J NEUROSCI, V33, P12490, DOI 10.1523/JNEUROSCI.4708-12.2013; Young TR, 2009, INT J BIOCHEM CELL B, V41, P990, DOI 10.1016/j.biocel.2008.06.014; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18; Zhou XH, 2003, GENE EXPR PATTERNS, V3, P397, DOI 10.1016/S1567-133X(03)00087-5	62	75	75	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2018	173	3					735	+		10.1016/j.cell.2018.03.036	http://dx.doi.org/10.1016/j.cell.2018.03.036			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7GB	29677516	Bronze, Green Accepted			2022-12-28	WOS:000430677400021
J	Ricketts, CJ; Linehan, WM				Ricketts, Christopher J.; Linehan, W. Marston			Multi-regional Sequencing Elucidates the Evolution of Clear Cell Renal Cell Carcinoma	CELL			English	Editorial Material								Extensive multi-regional whole-genome and -exome sequencing performed in tumors from patients with localized, as well as metastatic, clear cell renal cell carcinoma provides a comprehensive description of the tumor origin, intratumoral heterogeneity, evolution, and route to metastasis, laying the foundation for the development of precision clinical management.	[Ricketts, Christopher J.; Linehan, W. Marston] NCI, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Linehan, WM (corresponding author), NCI, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	wml@nih.gov	Ricketts, Christopher/AAV-9580-2020		NATIONAL CANCER INSTITUTE [ZIABC011038] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Fei SS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11588; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Mitchell TJ, 2018, CELL, V173, P611, DOI 10.1016/j.cell.2018.02.020; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Turajlic S, 2018, CELL, V173, P595, DOI 10.1016/j.cell.2018.03.043; Turajlic S, 2018, CELL, V173, P581, DOI 10.1016/j.cell.2018.03.057	10	29	29	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2018	173	3					538	540		10.1016/j.cell.2018.03.077	http://dx.doi.org/10.1016/j.cell.2018.03.077			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7GB	29677504	Bronze			2022-12-28	WOS:000430677400003
J	Zhang, Y; Kou, GJ; Li, Y; Li, YQ				Zhang, Yan; Kou, Guanjun; Li, Yi; Li, Yanqing			CASE REVIEW A woman with intractable nausea and vomiting	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NEUROMYELITIS-OPTICA		[Zhang, Yan; Kou, Guanjun; Li, Yanqing] Shandong Univ, Dept Gastroenterol, Qilu Hosp, Jinan, Shandong, Peoples R China; [Zhang, Yan; Kou, Guanjun; Li, Yanqing] Shandong Univ, Qilu Hosp, Lab Translat Gastroenterol, Jinan, Shandong, Peoples R China; [Li, Yi] Shandong Univ, Qilu Hosp, Dept Neurol, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Li, YQ (corresponding author), Shandong Univ, Dept Gastroenterol, Qilu Hosp, Jinan, Shandong, Peoples R China.; Li, YQ (corresponding author), Shandong Univ, Qilu Hosp, Lab Translat Gastroenterol, Jinan, Shandong, Peoples R China.	liyanqing@sdu.edu.cn		Li, Yanqing/0000-0003-0575-0399; Zhang, Yan/0000-0002-8299-2220				Asgari N, 2011, NEUROLOGY, V76, P1589, DOI 10.1212/WNL.0b013e3182190f74; Camilleri M, 2013, AM J GASTROENTEROL, V108, P18, DOI 10.1038/ajg.2012.373; Drossman DA, 2016, GASTROENTEROLOGY, V150, P1257, DOI 10.1053/j.gastro.2016.03.035; Goodwin TM, 2015, OBSTET GYNECOL, V126, pE12; Iorio R, 2013, CLIN GASTROENTEROL H, V11, P240, DOI 10.1016/j.cgh.2012.11.021; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Matthews A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007575.pub3; National Institute for Health and Care Excellence, 2014, ASS MOT GASTR TRACT; Papadopoulos MC, 2014, NAT REV NEUROL, V10, P493, DOI 10.1038/nrneurol.2014.141; Quigley EMM, 2001, GASTROENTEROLOGY, V120, P263, DOI 10.1053/gast.2001.20516; Trebst C, 2014, J NEUROL, V261, P1, DOI 10.1007/s00415-013-7169-7; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Waters PJ, 2012, NEUROLOGY, V78, P665, DOI 10.1212/WNL.0b013e318248dec1; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729	14	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2018	361								k1082	10.1136/bmj.k1082	http://dx.doi.org/10.1136/bmj.k1082			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8WQ	29674473				2022-12-28	WOS:000430795300001
J	Lader, E				Lader, Ellis			Review: Adding clopidogrel to ASA reduces CV morbidity but increases bleeding in patients at high risk for CV events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DISEASE		[Lader, Ellis] Mid Valley Cardiol, Kingston, NY 12401 USA		Lader, E (corresponding author), Mid Valley Cardiol, Kingston, NY 12401 USA.							Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Bonaca MP, 2013, CIRCULATION, V127, P1522, DOI 10.1161/CIRCULATIONAHA.112.000679; Eikelboom JW, 2017, NEW ENGL J MED, V377, P1319, DOI 10.1056/NEJMoa1709118	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2018	168	8					JC45	JC45		10.7326/ACPJC-2018-168-8-045	http://dx.doi.org/10.7326/ACPJC-2018-168-8-045			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GC8XZ	29677252				2022-12-28	WOS:000430083100010
J	Vian, L; Pekowska, A; Rao, SSP; Kieffer-Kwon, KR; Jung, S; Baranello, L; Huang, SC; El Khattabi, L; Dose, M; Pruett, N; Sanborn, AL; Canela, A; Maman, Y; Oksanen, A; Resch, W; Li, XW; Lee, B; Kovalchuk, AL; Tang, ZH; Nelson, S; Di Pierro, M; Cheng, RR; Machol, I; St Hilaire, BG; Durand, NC; Shamim, MS; Stamenova, EK; Onuchic, JN; Ruan, YJ; Nussenzweig, A; Levens, D; Aiden, EL; Casellas, R				Vian, Laura; Pekowska, Aleksandra; Rao, Suhas S. P.; Kieffer-Kwon, Kyong-Rim; Jung, Seolkyoung; Baranello, Laura; Huang, Su-Chen; El Khattabi, Laila; Dose, Marei; Pruett, Nathanael; Sanborn, Adrian L.; Canela, Andres; Maman, Yaakov; Oksanen, Anna; Resch, Wolfgang; Li, Xingwang; Lee, Byoungkoo; Kovalchuk, Alexander L.; Tang, Zhonghui; Nelson, Steevenson; Di Pierro, Michele; Cheng, Ryan R.; Machol, Ido; St Hilaire, Brian Glenn; Durand, Neva C.; Shamim, Muhammad S.; Stamenova, Elena K.; Onuchic, Jose N.; Ruan, Yijun; Nussenzweig, Andre; Levens, David; Aiden, Erez Lieberman; Casellas, Rafael			The Energetics and Physiological Impact of Cohesin Extrusion	CELL			English	Article							MAMMALIAN GENOMES; LOOP DOMAINS; 3D GENOME; DNA; ORGANIZATION; ACTIVATION; PRINCIPLES; TRANSCRIPTION; REVEALS; CTCF	Cohesin extrusion is thought to play a central role in establishing the architecture of mammalian genomes. However, extrusion has not been visualized in vivo, and thus, its functional impact and energetics are unknown. Using ultra-deep Hi-C, we show that loop domains form by a process that requires cohesin ATPases. Once formed, however, loops and compartments are maintained for hours without energy input. Strikingly, without ATP, we observe the emergence of hundreds of CTCF-independent loops that link regulatory DNA. We also identify architectural "stripes,'' where a loop anchor interacts with entire domains at high frequency. Stripes often tether super-enhancers to cognate promoters, and in B cells, they facilitate Igh transcription and recombination. Stripe anchors represent major hotspots for topoisomerase-mediated lesions, which promote chromosomal translocations and cancer. In plasmacytomas, stripes can deregulate Igh-translocated oncogenes. We propose that higher organisms have coopted cohesin extrusion to enhance transcription and recombination, with implications for tumor development.	[Vian, Laura; Pekowska, Aleksandra; Kieffer-Kwon, Kyong-Rim; Jung, Seolkyoung; El Khattabi, Laila; Dose, Marei; Pruett, Nathanael; Oksanen, Anna; Resch, Wolfgang; Nelson, Steevenson; Casellas, Rafael] NIAMS, Lymphocyte Nucl Biol, NIH, Bethesda, MD 20892 USA; [Rao, Suhas S. P.; Huang, Su-Chen; Sanborn, Adrian L.; Machol, Ido; St Hilaire, Brian Glenn; Durand, Neva C.; Shamim, Muhammad S.; Stamenova, Elena K.; Aiden, Erez Lieberman] Baylor Coll Med, Ctr Genome Architecture, Houston, TX 77030 USA; [Rao, Suhas S. P.] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA; [Baranello, Laura; Levens, David] NCI, Gene Regulat, Lab Pathol, NIH, Bethesda, MD 20892 USA; [Sanborn, Adrian L.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Canela, Andres; Maman, Yaakov; Nussenzweig, Andre] NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA; [Li, Xingwang; Lee, Byoungkoo; Tang, Zhonghui; Ruan, Yijun] Univ Connecticut, Jackson Lab Genom Med, Farmington, CT 06030 USA; [Li, Xingwang; Lee, Byoungkoo; Tang, Zhonghui; Ruan, Yijun] Univ Connecticut, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Kovalchuk, Alexander L.] NIAID, Lab Immunogenet, NIH, Rockville, MD 20852 USA; [Di Pierro, Michele; Cheng, Ryan R.; Onuchic, Jose N.; Aiden, Erez Lieberman] Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77030 USA; [Casellas, Rafael] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Aiden, Erez Lieberman] ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Baylor College of Medicine; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Jackson Laboratory; University of Connecticut; University of Connecticut; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Rice University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); ShanghaiTech University	Casellas, R (corresponding author), NIAMS, Lymphocyte Nucl Biol, NIH, Bethesda, MD 20892 USA.; Aiden, EL (corresponding author), Baylor Coll Med, Ctr Genome Architecture, Houston, TX 77030 USA.; Aiden, EL (corresponding author), Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77030 USA.; Casellas, R (corresponding author), NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.; Aiden, EL (corresponding author), ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai, Peoples R China.	erez@erez.com; rafael.casellas@nih.gov	Pekowska, Aleksandra/AAC-5143-2020; Aiden, Erez Lieberman/A-2908-2010	Pekowska, Aleksandra/0000-0002-0425-4388; Resch, Wolfgang/0000-0001-7594-5963; Tang, Zhonghui/0000-0003-2907-3986; Baranello, Laura/0000-0001-6039-1849; Shamim, Muhammad/0000-0002-2600-5147; el khattabi, laila/0000-0003-1546-5276; Kovalchuk, Alexander/0000-0003-2761-0442	NIAMS; NCI; NIAID funding; NIH Helix Systems; Paul and Daisy Soros Fellowship; Fannie and John Hertz Foundation Fellowship; Cornelia de Lange Syndrome Foundation; NIH New Innovator Award [1DP2OD008540-01]; NSF Physics Frontiers Center Award [PHY-1427654]; NHGRI Center for Excellence for Genomic Sciences [HG006193]; Welch Foundation [Q-1866, C-1792]; NVIDIA Research Center Award; IBM University Challenge Award; Google Research Award; Cancer Prevention Research Institute of Texas Scholar Award [R1304]; USDA Agriculture and Food Research Initiative Grant [2017-05741]; McNair Medical Institute Scholar Award; NIH Encyclopedia of DNA Elements Mapping Center Award [UM1HG009375]; President's Early Career Award in Science and Engineering; NSF [PHY-1427654, CHE-1614101]; Div Of Molecular and Cellular Bioscience [1614101] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA034196, ZIABC011011, R01CA186714] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG009375, RM1HG006193, R25HG007631, P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK107967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008294, T32GM008307] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008540] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID funding; NIH Helix Systems(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul and Daisy Soros Fellowship; Fannie and John Hertz Foundation Fellowship; Cornelia de Lange Syndrome Foundation; NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Physics Frontiers Center Award; NHGRI Center for Excellence for Genomic Sciences; Welch Foundation(The Welch Foundation); NVIDIA Research Center Award; IBM University Challenge Award(International Business Machines (IBM)); Google Research Award(Google Incorporated); Cancer Prevention Research Institute of Texas Scholar Award; USDA Agriculture and Food Research Initiative Grant; McNair Medical Institute Scholar Award; NIH Encyclopedia of DNA Elements Mapping Center Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); President's Early Career Award in Science and Engineering; NSF(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Kim Nasmyth, who independently noticed stripes in Hi-C data, for his valuable input on the manuscript. We thank Megan Laycock for proofreading the manuscript and Gustavo Gutierrez for technical assistance. This work was supported by NIAMS, NCI, and NIAID funding and NIH Helix Systems (https://helix.nih.gov). This work was also supported by a Paul and Daisy Soros Fellowship, a Fannie and John Hertz Foundation Fellowship, a Cornelia de Lange Syndrome Foundation grant (to S.S.P.R.), an NIH New Innovator Award (1DP2OD008540-01), an NSF Physics Frontiers Center Award (PHY-1427654), the NHGRI Center for Excellence for Genomic Sciences (HG006193), the Welch Foundation (Q-1866), an NVIDIA Research Center Award, an IBM University Challenge Award, a Google Research Award, a Cancer Prevention Research Institute of Texas Scholar Award (R1304), a USDA Agriculture and Food Research Initiative Grant (2017-05741), a McNair Medical Institute Scholar Award, an NIH Encyclopedia of DNA Elements Mapping Center Award (UM1HG009375), and the President's Early Career Award in Science and Engineering (to E.L.A.). Work at CTBP was supported by NSF (PHY-1427654, CHE-1614101) and Welch Foundation (C-1792).	Aiden EL, 2015, CELL, V162, P708, DOI 10.1016/j.cell.2015.07.034; Alipour E, 2012, NUCLEIC ACIDS RES, V40, P11202, DOI 10.1093/nar/gks925; Beckouet F, 2016, MOL CELL, V61, P563, DOI 10.1016/j.molcel.2016.01.026; Benner C, 2015, P NATL ACAD SCI USA, V112, P12776, DOI 10.1073/pnas.1512995112; Birshtein Barbara K., 2012, Frontiers in Genetics, V3, P251, DOI 10.3389/fgene.2012.00251; Busslinger GA, 2017, NATURE, V544, P503, DOI 10.1038/nature22063; Canela A, 2017, CELL, V170, P507, DOI 10.1016/j.cell.2017.06.034; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davidson IF, 2016, EMBO J, V35, P2671, DOI 10.15252/embj.201695402; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Denker A, 2016, GENE DEV, V30, P1357, DOI 10.1101/gad.281964.116; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Gostissa M, 2009, NATURE, V462, P803, DOI 10.1038/nature08633; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Hnisz D, 2017, CELL, V169, P13, DOI 10.1016/j.cell.2017.02.007; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Hu B, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv670; Hu B, 2011, CURR BIOL, V21, P12, DOI 10.1016/j.cub.2010.12.004; Hu JZ, 2015, CELL, V163, P947, DOI 10.1016/j.cell.2015.10.016; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kanke M, 2016, EMBO J, V35, P2686, DOI 10.15252/embj.201695756; Ke YW, 2017, CELL, V170, P367, DOI 10.1016/j.cell.2017.06.029; Kieffer-Kwon KR, 2017, MOL CELL, V67, P566, DOI 10.1016/j.molcel.2017.07.013; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Kovalchuk AL, 2012, P NATL ACAD SCI USA, V109, P10972, DOI 10.1073/pnas.1200106109; Ladurner R, 2014, CURR BIOL, V24, P2228, DOI 10.1016/j.cub.2014.08.011; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; MAJUMDAR A, 1984, P NATL ACAD SCI-BIOL, V81, P6100, DOI 10.1073/pnas.81.19.6100; Nakahashi H, 2013, CELL REP, V3, P1678, DOI 10.1016/j.celrep.2013.04.024; Natsume T, 2016, CELL REP, V15, P210, DOI 10.1016/j.celrep.2016.03.001; Nichols MH, 2015, CELL, V162, P702, DOI 10.1016/j.cell.2015.07.053; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Pandya-Jones A, 2009, RNA, V15, P1896, DOI 10.1261/rna.1714509; Rao SSP, 2017, CELL, V171, P305, DOI 10.1016/j.cell.2017.09.026; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Robinson JT, 2018, CELL SYST, V6, P256, DOI 10.1016/j.cels.2018.01.001; Rowley MJ, 2016, CURR OPIN CELL BIOL, V40, P8, DOI 10.1016/j.ceb.2016.01.009; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Stigler J, 2016, CELL REP, V15, P988, DOI 10.1016/j.celrep.2016.04.003; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Terakawa T, 2017, SCIENCE, V358, P672, DOI 10.1126/science.aan6516; Uuskula-Reimand L, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1043-8; van Berkum NL, 2009, METHODS MOL BIOL, V567, P189, DOI 10.1007/978-1-60327-414-2_13; Wright RHG, 2016, SCIENCE, V352, P1221, DOI 10.1126/science.aad9335; Xu ZM, 2012, NAT REV IMMUNOL, V12, P517, DOI 10.1038/nri3216	53	205	207	2	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 17	2018	173	5					1165	+		10.1016/j.cell.2018.03.072	http://dx.doi.org/10.1016/j.cell.2018.03.072			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GG1UA	29706548	Green Accepted, Bronze			2022-12-28	WOS:000432471700013
J	Stephenson, J; Heslehurst, N; Hall, J; Schoenaker, DAJM; Hutchinson, J; Cade, JE; Poston, L; Barrett, G; Crozier, SR; Barker, M; Kumaran, K; Yajnik, CS; Baird, J; Mishra, GD				Stephenson, Judith; Heslehurst, Nicola; Hall, Jennifer; Schoenaker, Danielle A. J. M.; Hutchinson, Jayne; Cade, Janet E.; Poston, Lucilla; Barrett, Geraldine; Crozier, Sarah R.; Barker, Mary; Kumaran, Kalyanaraman; Yajnik, Chittaranjan S.; Baird, Janis; Mishra, Gita D.			Before the beginning: nutrition and lifestyle in the preconception period and its importance for future health	LANCET			English	Article							GESTATIONAL DIABETES-MELLITUS; OBESE PREGNANT-WOMEN; BODY-MASS INDEX; PREPREGNANCY DIETARY PATTERNS; FOLIC-ACID SUPPLEMENTATION; LONG-TERM HEALTH; PHYSICAL-ACTIVITY; UNPLANNED PREGNANCY; MATERNAL OBESITY; LONDON MEASURE	A woman who is healthy at the time of conception is more likely to have a successful pregnancy and a healthy child. We reviewed published evidence and present new data from low-income, middle-income, and high-income countries on the timing and importance of preconception health for subsequent maternal and child health. We describe the extent to which pregnancy is planned, and whether planning is linked to preconception health behaviours. Observational studies show strong links between health before pregnancy and maternal and child health outcomes, with consequences that can extend across generations, but awareness of these links is not widespread. Poor nutrition and obesity are rife among women of reproductive age, and differences between high-income and low-income countries have become less distinct, with typical diets falling far short of nutritional recommendations in both settings and especially among adolescents. Several studies show that micronutrient supplementation starting in pregnancy can correct important maternal nutrient deficiencies, but effects on child health outcomes are disappointing. Other interventions to improve diet during pregnancy have had little effect on maternal and newborn health outcomes. Comparatively few interventions have been made for preconception diet and lifestyle. Improvements in the measurement of pregnancy planning have quantified the degree of pregnancy planning and suggest that it is more common than previously recognised. Planning for pregnancy is associated with a mixed pattern of health behaviours before conception. We propose novel definitions of the preconception period relating to embryo development and actions at individual or population level. A sharper focus on intervention before conception is needed to improve maternal and child health and reduce the growing burden of non-communicable diseases. Alongside continued efforts to reduce smoking, alcohol consumption, and obesity in the population, we call for heightened awareness of preconception health, particularly regarding diet and nutrition. Importantly, health professionals should be alerted to ways of identifying women who are planning a pregnancy.	[Stephenson, Judith; Hall, Jennifer; Barrett, Geraldine] UCL, Inst Womens Hlth, London WC1E 6AU, England; [Heslehurst, Nicola] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Schoenaker, Danielle A. J. M.; Mishra, Gita D.] Univ Queensland, Sch Publ Hlth, Herston, Qld, Australia; [Hutchinson, Jayne; Cade, Janet E.] Univ Leeds, Sch Food Sci & Nutr, Nutrit Epidemiol Grp, Leeds, W Yorkshire, England; [Poston, Lucilla] St Thomas Hosp, Kings Coll London, Dept Women & Childrens Hlth, London, England; [Crozier, Sarah R.; Barker, Mary; Kumaran, Kalyanaraman; Baird, Janis] Univ Southampton, Southampton Gen Hosp, Med Res Council, Lifecourse Epidemiol Unit, Southampton, Hants, England; [Barker, Mary; Baird, Janis] Southampton Gen Hosp, Natl Inst Hlth Res, Southampton Biomed Res Ctr, Southampton, Hants, England; [Kumaran, Kalyanaraman] CSI Holdsworth Mem Hosp, Epidemiol Res Unit, Mysore, Karnataka, India; [Yajnik, Chittaranjan S.] King Edward Mem Hosp & Res Ctr, Diabet Unit, Pune, Maharashtra, India	University of London; University College London; Newcastle University - UK; University of Queensland; University of Leeds; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Southampton; University of Southampton	Stephenson, J (corresponding author), UCL, Inst Womens Hlth, London WC1E 6AU, England.	judith.stephenson@ucl.ac.uk	Schoenaker, Danielle/H-5397-2011; Cade, Janet/G-4250-2016; Mishra, Gita/F-8052-2011	Schoenaker, Danielle/0000-0002-7652-990X; Cade, Janet/0000-0003-3421-0121; Barrett, Geraldine/0000-0002-9738-1051; Barker, Mary/0000-0003-2976-0217; Poston, Lucilla/0000-0003-1100-2821; Heslehurst, Nicola/0000-0001-8656-2319; Crozier, Sarah/0000-0002-9524-1127; Baird, Janis/0000-0002-4039-4361; Mishra, Gita/0000-0001-9610-5904	Rank Prize Funds, on Developmental Programming for Human Disease: Preconception Nutrition and Lifelong Health in Grasmere, UK; Australian Government Department of Health; Tommy's Charity, London, UK; National Institute for Health Research Biomedical Research Centre at King's College London; Guys and St Thomas' National Health Service (NHS) Foundation Trust, London, UK; Central and North West London NHS Foundation Trust, London, UK; MRC [MC_UP_A620_1016, MC_UU_12011/4, MR/N011848/1, MC_UU_12011/3, MC_UP_A620_1017, MR/M026361/1] Funding Source: UKRI	Rank Prize Funds, on Developmental Programming for Human Disease: Preconception Nutrition and Lifelong Health in Grasmere, UK; Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing); Tommy's Charity, London, UK; National Institute for Health Research Biomedical Research Centre at King's College London; Guys and St Thomas' National Health Service (NHS) Foundation Trust, London, UK; Central and North West London NHS Foundation Trust, London, UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The idea for this Series was conceived by JS and developed during a 4-day symposium, led by MB and JS and funded by The Rank Prize Funds, on Developmental Programming for Human Disease: Preconception Nutrition and Lifelong Health in Grasmere, UK, in February, 2016. We thank the Australian Government Department of Health for funding the Australian Longitudinal Study on Women's Health, Kate Best for producing the Forest plots, and Andrew Copp for advice on folate concentrations and the developing fetus. LP is supported by Tommy's Charity, London, UK, and the National Institute for Health Research Biomedical Research Centre at King's College London, and Guys and St Thomas' National Health Service (NHS) Foundation Trust, London, UK. JS is supported by Central and North West London NHS Foundation Trust, London, UK.	Almaghaslah E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185433; [Anonymous], 2013, FP2020 PARTNERSHIP A; [Anonymous], 2016, ALC PREGN PREV MAN F; Aune D, 2014, EPIDEMIOLOGY, V25, P331, DOI 10.1097/EDE.0000000000000036; Baird J, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1603-y; Baker PN, 2009, AM J CLIN NUTR, V89, P1114, DOI 10.3945/ajcn.2008.27097; Bankole A, 1998, J BIOSOC SCI, V30, P439, DOI 10.1017/S0021932098004398; Bao W, 2014, AM J CLIN NUTR, V99, P1378, DOI 10.3945/ajcn.113.082966; Barrett G, 2004, J EPIDEMIOL COMMUN H, V58, P426, DOI 10.1136/jech.2003.014787; Barrett G, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0672-3; Bates B, 2014, NATL DIET NUTR SURVE; Bath SC, 2013, LANCET, V382, P331, DOI 10.1016/S0140-6736(13)60436-5; Been JV, 2014, LANCET, V383, P1549, DOI 10.1016/S0140-6736(14)60082-9; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Boylan S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2332; Brackenridge L, CLIN OBES IN PRESS; Campbell F, 2010, SYSTEMATIC REV DIETA; Centers for Disease Control and Prevention, PREC HLTH REPR LIF P; Chiswick C, 2015, LANCET DIABETES ENDO, V3, P778, DOI 10.1016/S2213-8587(15)00219-3; Cooper C, 2016, LANCET DIABETES ENDO, V4, P393, DOI 10.1016/S2213-8587(16)00044-9; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Crozier SR, 2009, PAEDIATR PERINAT EP, V23, P446, DOI 10.1111/j.1365-3016.2009.01036.x; Cuskelly GJ, 1996, LANCET, V347, P657, DOI 10.1016/S0140-6736(96)91205-2; Davies SC, 2014, ANN REPORT CHIEF MED, P167; De-Regil Luz Maria, 2015, Cochrane Database Syst Rev, pCD007950, DOI 10.1002/14651858.CD007950.pub3; De-Regil LM, 2016, COCHRANE DB SYST REV, DOI [10.1590/1516-3180.20161343T2, 10.1002/14651858.CD008873.pub3]; Dean S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001508; Dean SV, 2014, REPROD HEALTH, V11, DOI [10.1186/1742-4755-11-S3-S1, 10.1186/1742-4755-11-S3-S3]; Devakumar D, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0633-3; Dodd JM, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0161-y; Flynn AC, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0450-2; Galazis N, 2014, EUR J OBSTET GYN R B, V181, P45, DOI 10.1016/j.ejogrb.2014.07.015; Gao YF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165626; Gardner B, 2011, OBES REV, V12, pE602, DOI 10.1111/j.1467-789X.2011.00884.x; Gnoth C, 2003, HUM REPROD, V18, P1959, DOI 10.1093/humrep/deg366; Godfrey KM, 2017, LANCET DIABETES ENDO, V5, P53, DOI 10.1016/S2213-8587(16)30107-3; Goossens J, 2016, HUM REPROD, V31, P2821, DOI 10.1093/humrep/dew266; Graham W, 2016, LANCET, V388, P2164, DOI 10.1016/S0140-6736(16)31533-1; Gresham E, 2016, PUBLIC HEALTH NUTR, V19, P2975, DOI 10.1017/S1368980016001245; Grieger JA, 2014, J NUTR, V144, P1075, DOI 10.3945/jn.114.190686; Habib MA, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1339-z; Haider BA, 2015, COCHRANE DB SYST REV; Hall J, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-200; Hall JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165621; Hanson M, 2017, LANCET DIABETES ENDO, V5, P65, DOI 10.1016/S2213-8587(16)30108-5; Hanson MA, 2015, INT J GYNECOL OBSTET, V131, pS213, DOI 10.1016/S0020-7292(15)30034-5; Harding KB, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011761.pub2; He Y, 2016, LANCET, V388, P91; Hodgetts VA, 2015, BJOG-INT J OBSTET GY, V122, P478, DOI 10.1111/1471-0528.13202; Inskip HM, 2006, INT J EPIDEMIOL, V35, P42, DOI 10.1093/ije/dyi202; International Weight Management in Pregnancy (i-WIP) Collaborative Group, 2017, BMJ, V358, pj3119, DOI 10.1136/bmj.j3119; Johansson K, 2015, NEW ENGL J MED, V372, P814, DOI 10.1056/NEJMoa1405789; Johnson KA, 2012, ACOUSTIC AUDITORY PH, P1; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Kort HI, 2006, J ANDROL, V27, P450, DOI 10.2164/jandrol.05124; Kumaran Kalyanaraman, 2017, BMC Nutr, V3, P41, DOI 10.1186/s40795-017-0143-5; Law DCG, 2007, HUM REPROD, V22, P414, DOI 10.1093/humrep/de1400; Lee C, 2005, INT J EPIDEMIOL, V34, P987, DOI 10.1093/ije/dyi098; Marchi J, 2015, OBES REV, V16, P621, DOI 10.1111/obr.12288; Mastroiacovo P, 2011, BIOFACTORS, V37, P272, DOI 10.1002/biof.172; Mitchell EW, 2012, MATERN CHILD HLTH J, V16, P31, DOI 10.1007/s10995-010-0663-y; Morof D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035381; Mosher William D, 2012, Natl Health Stat Report, P1; Muktabhant B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007145.pub3; National Center for Chronic Disease Prevention and Health Promo- tion (U.S.) Office on Smoking and Health, 2014, HLTH CONSMOK 50 YE; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Patel N, 2017, INT J OBESITY, V41, P1018, DOI 10.1038/ijo.2017.44; Pena-Rosas JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub4; Phelan S, 2017, JAMA-J AM MED ASSOC, V317, P2381, DOI 10.1001/jama.2017.7119; Poston L, 2016, LANCET DIABETES ENDO, V4, P1025, DOI 10.1016/S2213-8587(16)30217-0; Potdar RD, 2014, AM J CLIN NUTR, V100, P1257, DOI 10.3945/ajcn.114.084921; POTTER RG, 1964, POP STUD-J DEMOG, V18, P99, DOI 10.2307/2172634; Public Health England, 2016, GOV DIET REC GOV REC; Ramakrishnan U, 2012, PAEDIATR PERINAT EP, V26, P285, DOI 10.1111/j.1365-3016.2012.01281.x; Rao R, 2003, J NUTR, V133, P3215, DOI 10.1093/jn/133.10.3215; Reeves Shane, 2008, Expert Rev Obstet Gynecol, V3, P719, DOI 10.1586/17474108.3.6.719; Rocca C, 2016, CONTRACEPTION, V94, P423, DOI 10.1016/j.contraception.2016.07.148; Rocca CH, 2010, DEMOGR RES, V23, P293, DOI 10.4054/DemRes.2010.23.11; Roshanaei S, 2015, E MEDITERR HEALTH J, V21, P572, DOI 10.26719/2015.21.8.572; Sahariah SA, 2016, J NUTR, V146, p1453S, DOI 10.3945/jn.115.223461; Schoenaker DAJM, 2016, AM J CLIN NUTR, V104, P638, DOI 10.3945/ajcn.116.133884; Schoenaker DAJM, 2015, DIABETOLOGIA, V58, P2726, DOI 10.1007/s00125-015-3742-1; Schoenaker DAJM, 2015, AM J CLIN NUTR, V102, P94, DOI 10.3945/ajcn.114.102475; Schummers L, 2015, OBSTET GYNECOL, V125, P133, DOI 10.1097/AOG.0000000000000591; Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x; Stephenson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103085; Stoltzfus RJ, 2001, J NUTR, V131, p565S, DOI 10.1093/jn/131.2.565S; Syngelaki A, 2016, NEW ENGL J MED, V374, P434, DOI 10.1056/NEJMoa1509819; The Demographic and Health Surveys Programme, MOD WOM QUEST; Tian X, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113910; Tobias DK, 2012, AM J CLIN NUTR, V96, P289, DOI 10.3945/ajcn.111.028266; Tobias DK, 2011, DIABETES CARE, V34, P223, DOI 10.2337/dc10-1368; Turcksin R, 2014, MATERN CHILD NUTR, V10, P166, DOI 10.1111/j.1740-8709.2012.00439.x; US AID Strengthening Partnerships Results and Innovations in Nutrition Globally (SPRING), 2015, NUTR AD GIRLS WOM RE; Borges ALV, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1037-2; Wellings K, 2013, LANCET, V382, P1807, DOI 10.1016/S0140-6736(13)62071-1; WHO Food and Agricultural Organization of the United Nations, 2006, GUIDELINES FOOD FORT; Who Mers-Cov Research Group, 2013, PLoS Curr, V5, DOI 10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8; Yi XY, 2015, INT J GYNECOL OBSTET, V130, P3, DOI 10.1016/j.ijgo.2015.01.011; Zhang C, 2006, DIABETOLOGIA, V49, P2604, DOI 10.1007/s00125-006-0422-1; Zhang CL, 2006, ARCH INTERN MED, V166, P543, DOI 10.1001/archinte.166.5.543; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	103	452	459	22	213	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2018	391	10132					1830	1841		10.1016/S0140-6736(18)30311-8	http://dx.doi.org/10.1016/S0140-6736(18)30311-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GE7NY	29673873	Green Accepted, Green Submitted			2022-12-28	WOS:000431421300028
J	Borchard, NA; Nayak, JV				Borchard, Nicole A.; Nayak, Jayakar V.			Orbital Apex Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Borchard, Nicole A.; Nayak, Jayakar V.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Nayak, JV (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.	jnayak@stanford.edu		Salvi, Nicole Borchard/0000-0002-4383-1619					0	9	9	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2018	378	17					E23	E23		10.1056/NEJMicm1703770	http://dx.doi.org/10.1056/NEJMicm1703770			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GD8XP	29694826				2022-12-28	WOS:000430797900010
J	Houghton, IA; Koseff, JR; Monismith, SG; Dabiri, JO				Houghton, Isabel A.; Koseff, Jeffrey R.; Monismith, Stephen G.; Dabiri, John O.			Vertically migrating swimmers generate aggregation-scale eddies in a stratified column	NATURE			English	Article							TURBULENCE; ZOOPLANKTON; BEHAVIOR; KRILL; FLUX	Biologically generated turbulence has been proposed as an important contributor to nutrient transport and ocean mixing(1-3). However, to produce non-negligible transport and mixing, such turbulence must produce eddies at scales comparable to the length scales of stratification in the ocean. It has previously been argued that biologically generated turbulence is limited to the scale of the individual animals involved(4), which would make turbulence created by highly abundant centimetre-scale zooplankton such as krill irrelevant to ocean mixing. Their small size notwithstanding, zooplankton form dense aggregations tens of metres in vertical extent as they undergo diurnal vertical migration over hundreds of metres(3,5,6). This behaviour potentially introduces additional length scales-such as the scale of the aggregation-that are of relevance to animal interactions with the surrounding water column. Here we show that the collective vertical migration of centimetre-scale swimmers-as represented by the brine shrimp Artemia salina-generates aggregation-scale eddies that mix a stable density stratification, resulting in an effective turbulent diffusivity up to three orders of magnitude larger than the molecular diffusivity of salt. These observed large-scale mixing eddies are the result of flow in the wakes of the individual organisms coalescing to form a large-scale downward jet during upward swimming, even in the presence of a strong density stratification relative to typical values observed in the ocean. The results illustrate the potential for marine zooplankton to considerably alter the physical and biogeochemical structure of the water column, with potentially widespread effects owing to their high abundance in climatically important regions of the ocean(7).	[Houghton, Isabel A.; Koseff, Jeffrey R.; Monismith, Stephen G.; Dabiri, John O.] Stanford Univ, Bob & Norma St Environm Fluid Mech Lab, Civil & Environm Engn, Stanford, CA 94305 USA; [Dabiri, John O.] Stanford Univ, Mech Engn, Stanford, CA 94305 USA	Stanford University; Stanford University	Dabiri, JO (corresponding author), Stanford Univ, Bob & Norma St Environm Fluid Mech Lab, Civil & Environm Engn, Stanford, CA 94305 USA.; Dabiri, JO (corresponding author), Stanford Univ, Mech Engn, Stanford, CA 94305 USA.	jodabiri@stanford.edu		Monismith, Stephen/0000-0002-7388-3313; Koseff, Jeffrey/0000-0003-2121-4844	US National Science Foundation [1510607]	US National Science Foundation(National Science Foundation (NSF))	We gratefully acknowledge M. M. Wilhelmus for the original development of laboratory controlled migrations and for advice on development of the current facility; E. Meiburg for technical advice; and R. Strickler for assistance in development of the schlieren imaging system and use of his facilities for obtaining Fig. 4a We also gratefully acknowledge funding from the US National Science Foundation (Grant 1510607).	AREF H, 1989, PHYS FLUIDS A-FLUID, V1, P470, DOI 10.1063/1.857416; Bianchi D, 2013, NAT GEOSCI, V6, P545, DOI 10.1038/NGEO1837; Catton KB, 2011, J EXP BIOL, V214, P1845, DOI 10.1242/jeb.050997; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; Dewar WK, 2006, J MAR RES, V64, P541, DOI 10.1357/002224006778715720; Economidou M, 2009, EXP FLUIDS, V46, P453, DOI 10.1007/s00348-008-0571-8; Fuhrman JA, 2015, NAT REV MICROBIOL, V13, P133, DOI 10.1038/nrmicro3417; HAMNER WM, 1983, SCIENCE, V220, P433, DOI 10.1126/science.220.4595.433; HANAMURA Y, 1984, Mer (Tokyo), V22, P63; Huntley ME, 2004, MAR ECOL PROG SER, V273, P65, DOI 10.3354/meps273065; Jackson PR, 2014, J PHYS OCEANOGR, V44, P2661, DOI 10.1175/JPO-D-14-0027.1; Katija K, 2009, NATURE, V460, P624, DOI 10.1038/nature08207; Koch DL, 2011, ANNU REV FLUID MECH, V43, P637, DOI 10.1146/annurev-fluid-121108-145434; Kunze E, 2006, SCIENCE, V313, P1768, DOI 10.1126/science.1129378; LINDEN PF, 1980, J FLUID MECH, V100, P691, DOI 10.1017/S002211208000136X; LONGHURST AR, 1988, DEEP-SEA RES, V35, P881, DOI 10.1016/0198-0149(88)90065-9; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/NGEO1765, 10.1038/ngeo1765]; Nash JD, 2002, J PHYS OCEANOGR, V32, P2312, DOI 10.1175/1520-0485(2002)032<2312:MEOTSF>2.0.CO;2; OMORI M, 1982, MAR BIOL, V72, P193, DOI 10.1007/BF00396920; PEDLEY TJ, 1992, ANNU REV FLUID MECH, V24, P313, DOI 10.1146/annurev.fluid.24.1.313; Sato M, 2013, MAR ECOL PROG SER, V480, P39, DOI 10.3354/meps10215; Settles G.S., 2001, EXP FLUID MECH, DOI 10.1007/978-3-642-56640-0; Shih LH, 2005, J FLUID MECH, V525, P193, DOI 10.1017/S0022112004002587; Tarling GA, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.2015; TURNER JS, 1966, J FLUID MECH, V26, P779, DOI 10.1017/S0022112066001526; Whitehead JA, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2821913; Wilhelmus MM, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4895655; Zhang XS, 1997, DEEP-SEA RES PT II, V44, P2191, DOI 10.1016/S0967-0645(97)00060-X	29	48	48	3	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					497	+		10.1038/s41586-018-0044-z	http://dx.doi.org/10.1038/s41586-018-0044-z			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8VX	29670284				2022-12-28	WOS:000430793000046
J	Rough, K; Seage, GR; Williams, PL; Hernandez-Diaz, S; Huo, Y; Chadwick, EG; Currier, JS; Hoffman, RM; Barr, E; Shapiro, DE; Patel, K				Rough, Kathryn; Seage, George R., III; Williams, Paige L.; Hernandez-Diaz, Sonia; Huo, Yanling; Chadwick, Ellen G.; Currier, Judith S.; Hoffman, Risa M.; Barr, Emily; Shapiro, David E.; Patel, Kunjal		PHACS IMPAACT P1025 Study Teams	Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXPOSED UNINFECTED INFANTS; UTERO ANTIRETROVIRAL EXPOSURE; IN-UTERO; DISOPROXIL FUMARATE; INFECTED WOMEN; PRETERM BIRTH; CONGENITAL-ANOMALIES; HIV-1-INFECTED WOMEN; LOPINAVIR EXPOSURE; GROWTH OUTCOMES	BACKGROUND In a previous trial of antiretroviral therapy (ART) involving pregnant women with human immunodeficiency virus (HIV) infection, those randomly assigned to receive tenofovir, emtricitabine, and ritonavir-boosted lopinavir (TDF-FTC-LPV/r) had infants at greater risk for very premature birth and death within 14 days after delivery than those assigned to receive zidovudine, lamivudine, and ritonavir-boosted lopinavir (ZDV-3TC-LPV/r). METHODS Using data from two U. S.-based cohort studies, we compared the risk of adverse birth outcomes among infants with in utero exposure to ZDV-3TC-LPV/r, TDF-FTC-LPV/r, or TDF-FTC with ritonavir-boosted atazanavir (ATV/r). We evaluated the risk of preterm birth (<37 completed weeks of gestation), very preterm birth (<34 completed weeks), low birth weight (<2500 g), and very low birth weight (<1500 g). Risk ratios with 95% confidence intervals were estimated with the use of modified Poisson models to adjust for confounding. RESULTS There were 4646 birth outcomes. Few infants or fetuses were exposed to TDF-FTC-LPV/r (128 [2.8%]) as the initial ART regimen during gestation, in contrast with TDF-FTC-ATV/r (539 [11.6%]) and ZDV-3TC-LPV/r (954 [20.5%]). As compared with women receiving ZDV-3TC-LPV/r, women receiving TDF-FTC-LPV/r had a similar risk of preterm birth (risk ratio, 0.90; 95% confidence interval [CI], 0.60 to 1.33) and low birth weight (risk ratio, 1.13; 95% CI, 0.78 to 1.64). As compared to women receiving TDF-FTC-ATV/r, women receiving TDF-FTC-LPV/r had a similar or slightly higher risk of preterm birth (risk ratio, 1.14; 95% CI, 0.75 to 1.72) and low birth weight (risk ratio, 1.45; 95% CI, 0.96 to 2.17). There were no significant differences between regimens in the risk of very preterm birth or very low birth weight. CONCLUSIONS The risk of adverse birth outcomes was not higher with TDF-FTC-LPV/r than with ZDV-3TC-LPV/r or TDF-FTC-ATV/r among HIV-infected women and their infants in the United States, although power was limited for some comparisons. (Funded by the National Institutes of Health and others.)	[Rough, Kathryn; Seage, George R., III; Williams, Paige L.; Hernandez-Diaz, Sonia; Patel, Kunjal] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA; [Williams, Paige L.; Shapiro, David E.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Huo, Yanling; Shapiro, David E.; Patel, Kunjal] Harvard TH Chan Sch Publ Hlth, Ctr Biostat & AIDS Res, Boston, MA 02115 USA; [Rough, Kathryn] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA; [Rough, Kathryn] Harvard Med Sch, Boston, MA USA; [Chadwick, Ellen G.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Currier, Judith S.; Hoffman, Risa M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Currier, Judith S.; Hoffman, Risa M.] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Barr, Emily] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Northwestern University; Feinberg School of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Colorado System; University of Colorado Anschutz Medical Campus	Patel, K (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	ker704@mail.harvard.edu		Barr, Emily/0000-0002-8164-7345	National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD052104, U01HD052102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI106716, U01AI068616, T32AI007433, UM1AI068616, UM1AI068632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institutes of Health and others.	Best BM, 2010, JAIDS-J ACQ IMM DEF, V54, P381, DOI 10.1097/QAI.0b013e3181d6c9ed; Brogly SB, 2010, PEDIATR INFECT DIS J, V29, P721, DOI 10.1097/INF.0b013e3181e74a2f; Caniglia EC, 2016, AIDS, V30, P1267, DOI 10.1097/QAD.0000000000001052; Celen MK, 2013, WORLD J GASTROENTERO, V19, P9377, DOI 10.3748/wjg.v19.i48.9377; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Council O. of A.R.A, 2021, AIDSINFO, P12; Elens L, 2010, PHARMACOGENOMICS, V11, P1223, DOI 10.2217/PGS.10.94; Fowler MG, 2016, NEW ENGL J MED, V375, P1726, DOI 10.1056/NEJMoa1511691; Gibb DM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001217; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Greenup AJ, 2014, J HEPATOL, V61, P502, DOI 10.1016/j.jhep.2014.04.038; Kinai E, 2012, AIDS, V26, P2119, DOI 10.1097/QAD.0b013e328358ccaa; Knapp KM, 2012, PEDIATR INFECT DIS J, V31, P164, DOI 10.1097/INF.0b013e318235c7aa; Livingston EG, 2016, JAIDS-J ACQ IMM DEF, V73, P74, DOI 10.1097/QAI.0000000000001021; Aspiroz EL, 2013, CURR DRUG METAB, V14, P729; Mirochnick M, 2008, JAIDS-J ACQ IMM DEF, V49, P485, DOI 10.1097/QAI.0b013e318186edd0; Nurutdinova D, 2008, ANN PHARMACOTHER, V42, P1581, DOI 10.1345/aph.1L083; Patel K, 2010, J INFECT DIS, V201, P1035, DOI 10.1086/651232; Purswani MU, 2016, JAIDS-J ACQ IMM DEF, V73, P63, DOI 10.1097/QAI.0000000000001010; Ransom CE, 2013, JAIDS-J ACQ IMM DEF, V64, P374, DOI 10.1097/QAI.0b013e3182a7adb2; Rice ML, 2013, PEDIATR INFECT DIS J, V32, pE406, DOI 10.1097/INF.0b013e31829b80ee; Siberry GK, 2015, CLIN INFECT DIS, V61, P996, DOI 10.1093/cid/civ437; Siberry GK, 2012, AIDS, V26, P1151, DOI 10.1097/QAD.0b013e328352d135; Sibiude J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001635; Sirois PA, 2013, PEDIATR INFECT DIS J, V32, P648, DOI 10.1097/INF.0b013e318284129a; Stek AM, 2006, AIDS, V20, P1931, DOI 10.1097/01.aids.0000247114.43714.90; Tassiopoulos K, 2010, AIDS BEHAV, V14, P1269, DOI 10.1007/s10461-010-9705-0; Uthman OA, 2017, LANCET HIV, V4, pE21, DOI 10.1016/S2352-3018(16)30195-3; Vigano A, 2011, ANTIVIR THER, V16, P1259, DOI 10.3851/IMP1909; Vivanti A, 2015, AIDS, V29, P1319, DOI 10.1097/QAD.0000000000000564; Watts DH, 2013, J INFECT DIS, V207, P612, DOI 10.1093/infdis/jis728; Williams PL, 2015, JAMA PEDIATR, V169, P48, DOI 10.1001/jamapediatrics.2014.1889; Williams PL, 2012, AM J EPIDEMIOL, V175, P950, DOI 10.1093/aje/kwr401; World Health Organization, 2016, CONS GUID US ANT DRU	34	20	20	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2018	378	17					1593	1603		10.1056/NEJMoa1701666	http://dx.doi.org/10.1056/NEJMoa1701666			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8XP	29694825	Green Accepted, Bronze			2022-12-28	WOS:000430797900006
J	Slomski, A				Slomski, Anita			Disadvantaged Pain Patients Benefit From Psychological Interventions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2018	319	16					1649	1649		10.1001/jama.2018.4739	http://dx.doi.org/10.1001/jama.2018.4739			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GD7RF	29710161				2022-12-28	WOS:000430709300009
J	Kojima, K; Booth, CM; Summermatter, K; Bennett, A; Heisz, M; Blacksell, SD; McKinney, M				Kojima, Kazunobu; Booth, Catherine Makison; Summermatter, Kathrin; Bennett, Allan; Heisz, Marianne; Blacksell, Stuart D.; McKinney, Michelle			Risk-based reboot for global lab biosafety	SCIENCE			English	Editorial Material									[Kojima, Kazunobu; Booth, Catherine Makison] WHO, Geneva, Switzerland; [Booth, Catherine Makison] Hlth & Safety Lab, Buxton, England; [Summermatter, Kathrin] Inst Immunol & Virol, Mittelhausern, Switzerland; [Bennett, Allan] Publ Hlth England, Salisbury, Wilts, England; [Heisz, Marianne] Publ Hlth Agcy Canada, Ottawa, ON, Canada; [Blacksell, Stuart D.] Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Blacksell, Stuart D.] Univ Oxford, Churchill Hosp, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [McKinney, Michelle] Ctr Dis Control & Prevent, Washington, DC USA; [McKinney, Michelle] NIH, Bldg 10, Bethesda, MD 20892 USA	World Health Organization; Public Health England; Public Health Agency of Canada; Mahidol Oxford Tropical Medicine Research Unit (MORU); University of Oxford; Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA	Kojima, K (corresponding author), WHO, Geneva, Switzerland.	kojimak@who.int	Blacksell, Stuart/D-5530-2018; Summermatter, Kathrin/R-2343-2019; Summermatter, Kathrin/AAH-7495-2019	Blacksell, Stuart/0000-0001-6576-726X; Bennett, Allan/0000-0001-7448-8182	Biosecurity Engagement Program of the U.S. Department of State; Global Partnership Program of Global Affairs Canada; Wellcome Trust of the United Kingdom	Biosecurity Engagement Program of the U.S. Department of State; Global Partnership Program of Global Affairs Canada; Wellcome Trust of the United Kingdom(Wellcome Trust)	The authors thank relevant WHO staff for their support of this revision project, in particular, S. Cognat, F. Fuchs, and G. Rodier. We are grateful for financial assistance from the Biosecurity Engagement Program of the U.S. Department of State and the Global Partnership Program of Global Affairs Canada. S.D.B. is supported by the Wellcome Trust of the United Kingdom. The authors alone are responsible for the views expressed in this article, and they do not necessarily represent the views, decisions, or policies of the institutions with which they are affiliated.	European Committee for Standardization (CEN), 2011, CEN WORKSH AGR CEN B; [OIE] World Organisation for Animal Health, 2015, MANUAL DIAGNOSTIC TE; Tian DQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101163; WHO, 2006, BIOR MAN LAB BIOS GU; World Health Organization, 2016, JOINT EXT EV TOOL IN; Wurtz N, 2016, EUR J CLIN MICROBIOL, V35, P1247, DOI 10.1007/s10096-016-2657-1	6	10	11	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2018	360	6386					260	262		10.1126/science.aar2231	http://dx.doi.org/10.1126/science.aar2231			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD3IC	29674576	Green Submitted			2022-12-28	WOS:000430396600021
J	Liu, TL; Upadhyayula, S; Milkie, DE; Singh, V; Wang, K; Swinburne, IA; Mosaliganti, KR; Collins, ZM; Hiscock, TW; Shea, J; Kohrman, AQ; Medwig, TN; Dambournet, D; Forster, R; Cunniff, B; Ruan, Y; Yashiro, H; Scholpp, S; Meyerowitz, EM; Hockemeyer, D; Drubin, DG; Martin, BL; Matus, DQ; Koyama, M; Megason, SG; Kirchhausen, T; Betzig, E				Liu, Tsung-Li; Upadhyayula, Srigokul; Milkie, Daniel E.; Singh, Ved; Wang, Kai; Swinburne, Ian A.; Mosaliganti, Kishore R.; Collins, Zach M.; Hiscock, Tom W.; Shea, Jamien; Kohrman, Abraham Q.; Medwig, Taylor N.; Dambournet, Daphne; Forster, Ryan; Cunniff, Brian; Ruan, Yuan; Yashiro, Hanako; Scholpp, Steffen; Meyerowitz, Elliot M.; Hockemeyer, Dirk; Drubin, David G.; Martin, Benjamin L.; Matus, David Q.; Koyama, Minoru; Megason, Sean G.; Kirchhausen, Tom; Betzig, Eric			Observing the cell in its native state: Imaging subcellular dynamics in multicellular organisms	SCIENCE			English	Article							GROWTH CONES; RESOLUTION; CLATHRIN; FILOPODIA; ENDOCYTOSIS; MICROSCOPY; MIGRATION	True physiological imaging of subcellular dynamics requires studying cells within their parent organisms, where all the environmental cues that drive gene expression, and hence the phenotypes that we actually observe, are present. A complete understanding also requires volumetric imaging of the cell and its surroundings at high spatiotemporal resolution, without inducing undue stress on either. We combined lattice light-sheet microscopy with adaptive optics to achieve, across large multicellular volumes, noninvasive aberration-free imaging of subcellular processes, including endocytosis, organelle remodeling during mitosis, and the migration of axons, immune cells, and metastatic cancer cells in vivo. The technology reveals the phenotypic diversity within cells across different organisms and developmental stages and may offer insights into how cells harness their intrinsic variability to adapt to different physiological environments.	[Liu, Tsung-Li; Upadhyayula, Srigokul; Milkie, Daniel E.; Singh, Ved; Wang, Kai; Shea, Jamien; Koyama, Minoru; Kirchhausen, Tom; Betzig, Eric] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Upadhyayula, Srigokul; Cunniff, Brian; Kirchhausen, Tom] Harvard Med Sch, Dept Cell Biol, 200 Longwood Ave, Boston, MA 02115 USA; [Upadhyayula, Srigokul; Cunniff, Brian; Kirchhausen, Tom] Boston Childrens Hosp, Program Cellular & Mol Med, 200 Longwood Ave, Boston, MA 02115 USA; [Upadhyayula, Srigokul; Kirchhausen, Tom] Harvard Med Sch, Dept Pediat, 200 Longwood Ave, Boston, MA 02115 USA; [Swinburne, Ian A.; Mosaliganti, Kishore R.; Collins, Zach M.; Hiscock, Tom W.; Megason, Sean G.] Harvard Med Sch, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02115 USA; [Kohrman, Abraham Q.; Medwig, Taylor N.; Martin, Benjamin L.; Matus, David Q.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Dambournet, Daphne; Forster, Ryan; Hockemeyer, Dirk; Drubin, David G.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Ruan, Yuan; Yashiro, Hanako; Meyerowitz, Elliot M.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Ruan, Yuan; Yashiro, Hanako; Meyerowitz, Elliot M.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Scholpp, Steffen] Univ Exeter, Coll Life & Environm Sci, Living Syst Inst, Exeter EX4 4QD, Devon, England; [Scholpp, Steffen] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany; [Wang, Kai] Chinese Acad Sci, Inst Neurosci, 320 Yueyang Rd, Shanghai, Peoples R China; [Cunniff, Brian] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05401 USA	Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California Berkeley; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; University of Exeter; Helmholtz Association; Karlsruhe Institute of Technology; Chinese Academy of Sciences; University of Vermont	Betzig, E (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	betzige@janelia.hhmi.org	Meyerowitz, Elliot M/A-7118-2009; Matus, David/E-9972-2010; Scholpp, Steffen/E-4472-2018	Matus, David/0000-0002-1570-5025; Scholpp, Steffen/0000-0002-4903-9657; Medwig-Kinney, Taylor/0000-0001-7989-3291; Hiscock, Tom/0000-0002-0319-8679; Swinburne, Ian/0000-0003-4162-0508; Koyama, Minoru/0000-0002-9774-9223; Martin, Benjamin/0000-0001-5474-4492; Kohrman, Abraham/0000-0002-3726-1090; Collins, Zach/0000-0002-8943-7967; Upadhyayula, Srigokul/0000-0001-6727-5883; Milkie, Daniel/0000-0002-3917-6965; Wang, Kai/0000-0001-7858-944X	Howard Hughes Medical Institute (HHMI); Biogen; Ionis Pharmaceuticals; NIH [R01GM075252, R01DC015478, 5R00CA154870-05, 1R01GM121597-01, R01CA196884, R35GM118149]; Living Systems Institute start-up grant, University of Exeter; Carol M. Baldwin Foundation; Damon Runyon Cancer Research Foundation [DRR-47-17]; NSF [IOS1452928]; Pew Charitable Trusts; Human Frontier Science Program Fellowship; NATIONAL CANCER INSTITUTE [R01CA196884, R00CA154870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075252, R01GM121597, R25GM103792, R35GM118149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC015478] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Biogen(Biogen); Ionis Pharmaceuticals; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Living Systems Institute start-up grant, University of Exeter; Carol M. Baldwin Foundation; Damon Runyon Cancer Research Foundation; NSF(National Science Foundation (NSF)); Pew Charitable Trusts; Human Frontier Science Program Fellowship(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	T.-L.L., D.E.M., V.S., J.S., M.K., E.M.M., and E.B. are funded by the Howard Hughes Medical Institute (HHMI). T.K. and S.U. are funded by grants from Biogen, Ionis Pharmaceuticals, and NIH grant R01GM075252 (to T.K.). S.U. is a Fellow at the Image and Data Analysis core at Harvard Medical School. S. S. is funded by a Living Systems Institute start-up grant, University of Exeter. K.R.M., I.A.S., Z.M.C., T.W.H., and S.G.M. were supported by NIH grant R01DC015478. D.Q.M. is funded by the NIH (5R00CA154870-05 and 1R01GM121597-01). D.Q.M. and B.L.M. are funded by the Carol M. Baldwin Foundation and are Damon Runyon-Rachleff Innovators supported (in part) by the Damon Runyon Cancer Research Foundation (DRR-47-17). B.L.M. is also funded by the NSF (IOS1452928). D.H. is a Pew-Stewart Scholar for Cancer Research supported by the Pew Charitable Trusts and NIH grant R01CA196884. D.D. was supported by a Human Frontier Science Program Fellowship. D.G.D. was supported by NIH grant R35GM118149.	Aguet F, 2016, MOL BIOL CELL, V27, P3418, DOI 10.1091/mbc.E16-03-0164; Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Arbizzani F, 2015, ZEBRAFISH, V12, P202, DOI 10.1089/zeb.2015.1501; Aviles-Espinosa R, 2011, BIOMED OPT EXPRESS, V2, P3135, DOI 10.1364/BOE.2.003135; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Bourgenot C, 2012, OPT EXPRESS, V20, P13252, DOI 10.1364/OE.20.013252; Cai D, 2013, NAT METHODS, V10, P540, DOI [10.1038/NMETH.2450, 10.1038/nmeth.2450]; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Chhetri RK, 2015, NAT METHODS, V12, P1171, DOI 10.1038/nmeth.3632; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; de Oliveira S, 2016, NAT REV IMMUNOL, V16, P378, DOI 10.1038/nri.2016.49; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Icha J, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700003; Icha J, 2016, J CELL BIOL, V215, P259, DOI 10.1083/jcb.201604095; Icha J, 2016, JOVE-J VIS EXP, DOI 10.3791/53966; Ji N, 2017, NAT METHODS, V14, P374, DOI 10.1038/nmeth.4218; Kadlecova Z, 2017, J CELL BIOL, V216, P167, DOI 10.1083/jcb.201608071; Kinkhabwala A, 2011, P NATL ACAD SCI USA, V108, P1164, DOI 10.1073/pnas.1012185108; Kumar A, 2014, NAT PROTOC, V9, P2555, DOI 10.1038/nprot.2014.172; Kural C, 2012, CELL REP, V2, P1111, DOI 10.1016/j.celrep.2012.09.025; Laissue PP, 2017, NAT METHODS, V14, P657, DOI 10.1038/nmeth.4344; Li D, 2015, SCIENCE, V349, DOI 10.1126/science.aab3500; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Lu L, 2009, MOL BIOL CELL, V20, P3471, DOI 10.1091/mbc.E09-04-0327; Marki A, 2018, J LEUKOCYTE BIOL, V103, P67, DOI 10.1189/jlb.1AB0617-230R; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pittet MJ, 2011, CELL, V147, P983, DOI 10.1016/j.cell.2011.11.004; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Royer LA, 2016, NAT BIOTECHNOL, V34, P1267, DOI 10.1038/nbt.3708; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Sidhaye J, 2017, ELIFE, V6, DOI 10.7554/eLife.22689; Simmonds RD, 2013, J OPTICS-UK, V15, DOI 10.1088/2040-8978/15/9/094010; Stoletov K, 2010, J CELL SCI, V123, P2332, DOI 10.1242/jcs.069443; Strzyz PJ, 2015, DEV CELL, V32, P203, DOI 10.1016/j.devcel.2014.12.001; Swinburne IA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134005; Swoger J, 2007, OPT EXPRESS, V15, P8029, DOI 10.1364/OE.15.008029; Tomer R, 2012, NAT METHODS, V9, P755, DOI [10.1038/NMETH.2062, 10.1038/nmeth.2062]; Vassilopoulos S, 2014, J CELL BIOL, V205, P377, DOI 10.1083/jcb.201309096; Wang K, 2014, NAT METHODS, V11, P625, DOI [10.1038/NMETH.2925, 10.1038/nmeth.2925]; Weigert R, 2010, HISTOCHEM CELL BIOL, V133, P481, DOI 10.1007/s00418-010-0692-z; Wilding D, 2016, OPT EXPRESS, V24, P24896, DOI 10.1364/OE.24.024896; Zheng JQ, 1996, J NEUROSCI, V16, P1140	43	294	297	19	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2018	360	6386							eaaq1392	10.1126/science.aaq1392	http://dx.doi.org/10.1126/science.aaq1392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD3IC	29674564	Green Submitted, Green Accepted			2022-12-28	WOS:000430396600035
J	Angus-Leppan, H; Liu, RSN				Angus-Leppan, Heather; Liu, Rebecca S. N.			Weighing the risks of valproate in women who could become pregnant	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BIPOLAR DISORDER; ANTIEPILEPTIC DRUGS; SODIUM VALPROATE; EPILEPSY; LITHIUM; LAMOTRIGINE; OUTCOMES; ACID; TOPIRAMATE; MANAGEMENT		[Angus-Leppan, Heather; Liu, Rebecca S. N.] Royal Free London, Epilepsy Initiat Grp, London, England; [Angus-Leppan, Heather] UCL, London, England; [Angus-Leppan, Heather] Univ Hertfordshire, Ctr Res Publ Hlth & Community Care, Hatfield, Herts, England	University of London; University College London; Royal Free London NHS Foundation Trust; University of London; University College London; University of Hertfordshire	Angus-Leppan, H (corresponding author), Royal Free London, Epilepsy Initiat Grp, London, England.; Angus-Leppan, H (corresponding author), UCL, London, England.; Angus-Leppan, H (corresponding author), Univ Hertfordshire, Ctr Res Publ Hlth & Community Care, Hatfield, Herts, England.	heather.angus-leppan@nhs.net	Angus-Leppan, Heather/AAF-5168-2019	Angus-Leppan, Heather/0000-0001-7004-3848				AADRAC, 2009, VALPR PREGN; Al Wattar BH, 2015, EUR J OBSTET GYN R B, V195, P193, DOI 10.1016/j.ejogrb.2015.10.017; [Anonymous], 1982, LANCET, V2, P1313; [Anonymous], 2016, THE LOCAL; ANSM, 2017, VALPR DER; Aurlien D, 2012, EPILEPSIA, V53, P258, DOI 10.1111/j.1528-1167.2011.03334.x; Austin JK, 2002, EPILEPSIA, V43, P1564, DOI 10.1046/j.1528-1157.2002.26002.x; Bowden CL, 2000, ARCH GEN PSYCHIAT, V57, P481, DOI 10.1001/archpsyc.57.5.481; Bromley R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010236.pub2; Bushnell CD, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b664; Campbell E, 2014, J NEUROL NEUROSUR PS, V85, P1029, DOI 10.1136/jnnp-2013-306318; Casassus B, 2017, LANCET, V390, P217, DOI 10.1016/S0140-6736(17)31866-4; Casassus B, 2016, LANCET, V387, P1148, DOI 10.1016/S0140-6736(16)30013-7; Christensen J, 2013, JAMA-J AM MED ASSOC, V309, P1696, DOI 10.1001/jama.2013.2270; Cipriani A, 2005, AM J PSYCHIAT, V162, P1805, DOI 10.1176/appi.ajp.162.10.1805; Department of Health and Social Care, 2018, REV LAUNCH RESP PAT; Dierking C, 2018, EPILEPSY BEHAV, V79, P17, DOI 10.1016/j.yebeh.2017.11.013; Dodrill CB, 2004, EPILEPSY BEHAV, V5, pS21, DOI 10.1016/j.yebeh.2003.11.004; EMPIRE, ANT DRUG AED MAN PRE; Epilepsy Action, 2017, VALPR SURV WOM; Epilepsy Society of Australia, 2018, US SOD VALPR WOM CHI; European Medicine Agency, 2018, EMA1456002018; European Medicines Agency, 2017, EMA6457522017; Farinelli E, 2015, WORLD J HEPATOL, V7, P1251, DOI 10.4254/wjh.v7.i9.1251; FDA, 2013, DRUG SAF COMM VALPR; Friedrich L, 2018, EPILEPSY BEHAV, V80, P122, DOI 10.1016/j.yebeh.2018.01.002; Fryar C, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2217; Geddes JR, 2013, LANCET, V381, P1672, DOI 10.1016/S0140-6736(13)60857-0; General Medical Council, CONS; Gentile S, 2006, BIPOLAR DISORD, V8, P207, DOI 10.1111/j.1399-5618.2006.00295.x; Gentile S, 2010, SCHIZOPHRENIA BULL, V36, P518, DOI 10.1093/schbul/sbn107; Harden CL, 2009, NEUROLOGY, V73, P142, DOI 10.1212/WNL.0b013e3181a6b325; Hernandez-Diaz S, 2012, NEUROLOGY, V78, P1692, DOI 10.1212/WNL.0b013e3182574f39; ILAE, 2016, VALPR TREATM EP WOM; Jarvis S, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k80; Jazayeri D, 2018, SEIZURE-EUR J EPILEP, V56, P111, DOI 10.1016/j.seizure.2018.02.009; Jones SC, 2017, CNS DRUGS, V31, P737, DOI 10.1007/s40263-017-0452-x; Kapoor D, 2014, OBSTET MED, V7, P160, DOI 10.1177/1753495X14553257; Keddie S, 2016, JRSM Open, V7, p2054270416654358, DOI 10.1177/2054270416654358; Linde M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010611; MacGregor A, 2009, MANAGEMENT MIGRAINE, DOI [10.1002/pnp.137/pdf, DOI 10.1002/PNP.137/PDF]; Macritchie KA, 2001, COCHRANE DB SYST REV, V3, DOI [10.1002/14651858, 10.1002/14651858.CD003196, DOI 10.1002/14651858.CD003196]; Marson AG, 2007, LANCET, V369, P1016, DOI 10.1016/S0140-6736(07)60461-9; Marson AG, 2007, LANCET, V369, P1000, DOI 10.1016/S0140-6736(07)60460-7; MBRRACE-UK, 2017, SAV LIV IMPR MOTH CA; Meador KJ, 2013, LANCET NEUROL, V12, P244, DOI 10.1016/S1474-4422(12)70323-X; Medicines and Healthcare Products Regulatory Agency, 2018, NEW MEAS AV VALPR EX; Medicines and Healthcare products Regulatory Agency (MHRA), 2016, VALPR RISK ABN PREGN; Medsafe New Zealand, 2018, VALPR PREGN 2014; MHRA, 2013, SOD VALPR RISK NEUR; MHRA, 2015, MED REL VALPR RISK A; Miura T, 2014, LANCET PSYCHIAT, V1, P351, DOI 10.1016/S2215-0366(14)70314-1; Mole TB, 2015, SEIZURE-EUR J EPILEP, V24, P127, DOI 10.1016/j.seizure.2014.08.006; Moretti ME, 2003, THER DRUG MONIT, V25, P364, DOI 10.1097/00007691-200306000-00017; OACS, 2018, WHAT AR FET ANT SYND; Patorno E, 2017, NEW ENGL J MED, V376, P2245, DOI 10.1056/NEJMoa1612222; Pearlstein T, 2013, WOMENS HEALTH, V9, P605, DOI [10.2217/whe.13.54, 10.2217/WHE.13.54]; Pennell PB, 2016, NEUROTHERAPEUTICS, V13, P811, DOI 10.1007/s13311-016-0464-0; Perucca P, 2015, EPILEPSIA, V56, P1175, DOI 10.1111/epi.13029; Public Health England National Neurology Intelligence network and National End of life Care Intelligence Network, 2018, DEATHS ASS NEUR COND; Robins J., 2010, EPILIM CASE SHOWS FL; SANADII, 2017, PRAGM RAND CONTR TRI; Tomson T., 2017, TERATOGENIC OTHER CO; Tomson T, 2016, EPILEPSIA, V57, pE173, DOI 10.1111/epi.13437; Tomson T, 2015, EPILEPSIA, V56, P1006, DOI 10.1111/epi.13021; Tomson T, 2012, LANCET NEUROL, V11, P803, DOI 10.1016/S1474-4422(12)70103-5; Vajda FJ, 2013, NEUROLOGY, V81, P999, DOI 10.1212/WNL.0b013e3182a43e81; Van McCrary S, 2015, EPILEPSIA, V56, P1020, DOI 10.1111/epi.13043; Viguera AC, 2007, AM J PSYCHIAT, V164, P1817, DOI 10.1176/appi.ajp.2007.06101639; WHO, 2018, PAT RIGHTS	70	22	22	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2018	361								k1596	10.1136/bmj.k1596	http://dx.doi.org/10.1136/bmj.k1596			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8WP	29669717				2022-12-28	WOS:000430795200003
J	Kazanjian, P				Kazanjian, Powel			The Short-Lived Epidemic of Botulism From Commercially Canned Foods in the United States, 1919 to 1925	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							B BOTULINUS; SPORES	In 1919, three deadly outbreaks of botulism caused by consumption of canned olives packed in California captured national headlines. In all of the outbreaks, which occurred in separate locales, unsuspecting people died after consuming tainted food during a banquet or family meal. The press's sensational portrayal of canned food as hazardous aroused alarm among consumers at a time when commercial canning was becoming more common. Intent on restoring the image of their product as safe and wholesome, canning industry leaders funded a "botulism commission" of scientific experts in 1919 to investigate how to systematically eliminate the threat of botulism that had imperiled their business. The commissioners identified the scientific reasons for the outbreaks, and on the basis of their findings, the California Department of Public Health issued explicit recommendations for sterilization procedures intended to ensure safety. However, the department did not mandate inspections for all canneries. When commercially packed fruits and vegetables continued to cause botulism, industry leaders voluntarily backed a cannery inspection act to legally require all California canners to possess appropriate equipment and follow scientifically validated sterilization procedures. After the California legislature approved the act in 1925, canneries were inspected, regulations were enforced, and no further outbreaks occurred. This botulism epidemic is an example of a disease outbreak that was controlled when business interests became aligned with public health goals. The press's portrayal of afflicted persons as innocent victims and worthy citizens galvanized businessmen to implement safeguards to protect consumers from botulism intoxication. To preserve their customer base and salvage their corporations, leaders of the canning industry acknowledged the public health threat of their unregulated procedures and acted on the recommendations of scientists. Annals.org	[Kazanjian, Powel] Univ Michigan, Michigan Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Kazanjian, P (corresponding author), Univ Michigan, Michigan Med, Dept Internal Med, Div Infect Dis, 1500 East Med Ctr Dr,Univ Hosp South SPC 5226, Ann Arbor, MI 48109 USA.	pkazanji@umich.edu						Albright F., 1922, INDIANA FARMERS GUID, V34, P21; [Anonymous], 1920, MORNING OREGONI 1220, P16; [Anonymous], 1921, COMMUNICATION; [Anonymous], 1920, NY TIMES, P9; [Anonymous], 1921, MONTGOMERY ADVE 0721, P5; [Anonymous], 1920, IDAHO DAILY STA 0201, P4; [Anonymous], 1919, LEXINGTON HERAL 1026, P1; [Anonymous], 1922, ATLANTA CONSTIT 1220, pA16; [Anonymous], 1922, DALLAS MORNING NEWS, P2; [Anonymous], 1922, ABERDEEN AM     1013, P8; [Anonymous], CIGARETTE CENTURY; [Anonymous], 1920, DETROIT FREE PRESS, P18; [Anonymous], 1920, SD DAILY NEWS   0216, P8; [Anonymous], 1922, CURRENT OPINION, P78; [Anonymous], 1919, FLINT DAILY J   1025, P1; [Anonymous], 1920, ANN ARBOR TIMES 0228, P3; [Anonymous], 1919, CINCINNATI ENQUIRER, P7; [Anonymous], 1922, CHICAGO DAILY TRIBUN, P10; [Anonymous], 1919, CINCINNATI ENQUIRER, P1; Armstrong C., 1919, PUBLIC HLTH REPORTS, V34, P2898; Bentley RI, 1925, COMMUNICATION; Bentley RI, 1919, COMMUNICATION; Bentley RI, 1923, COMMUNICATION; Bentley RI, 1920, COMMUNICATION; Botulism, 1928, SCI AM, P219; Bowers J., 1974, COMMUNICATION; Brandt A., 1988, AIDS BURDENS HIST, P271; Bruce HA, 1922, STATE, P4; Colonel C. C., 1919, CINCINNATI ENQUIRER, P1; Cruess WV, 1924, COMMERCIAL FRUIT VEG, P1; Curtis OL, 1920, COMMUNICATION; Department of Agriculture, 1920, PUBLIC HLTH REPORTS, V35, P327; Diner Steven J., 1998, VERY DIFFERENT AGE A; Duckwall E., 1905, CANNING PRESERVING F, P201; Duffy M., 1961, FOOD DRUG COSMET LAW, P443; Duffy M., 1926, COMMUNICATION; Ebright G., 1925, COMMUNICATION; Ebright G, 1922, COMMUNICATION; Esty JR, 1935, AM J PUBLIC HEALTH N, V25, P165, DOI 10.2105/AJPH.25.2.165; Esty JR, 1923, COMMUNICATION; Evans WA, 1919, CHICAGO DAILY   0506, P8; Hardy A., 2014, SALMONELLA INFECTION; Hoey J., 1921, COMMUNICATION; Hollomon JA, 1920, ATLANTA CONSTIT 1220, pA14; Ibsen H, 1882, FOLKEFIENDE; Koser SA, 1920, J AGRIC RES, V20, P0375; Markowitz G, 2013, THE LEAD WARS; McKinney P., 1924, COMMUNICATION; Meyer K., 1924, COMMUNICATION; Meyer K., 1935, SCI MONTHLY, V40, P562; Meyer K., 1924, STERILIZATION OLIVES; MEYER K. F., 1931, Journal of Preventive Medicine, V5, P261; Meyer KF, 1922, J INFECT DIS, V31, P559, DOI 10.1093/infdis/31.6.559; MEYER KF, 1973, CALIF MED, V118, P63; Meyer KF, 1950, 50 YEARS BOTULISM US, P15; Morgan WM, 1982, RECOLLECTION OLIVE P; National Canners Association, 1922, WHAT EV CANN SHOULD, P1; National Canners Association, 1959, CANN IND ITS HIST IM, P1; National Center for Infectious Diseases, 1998, BOT US 1899 1996; Risse Guenter, 2012, PLAGUE FEAR POLITICS; Schoenholz P, 1923, J INFECT DIS, V33, P289, DOI 10.1093/infdis/33.4.289; Stevens IM, 1923, COMMUNICATION; Taylor J., 2000, OLIVE CALIFORNIA HIS, P168; The Canner, 1921, CONV NUMB 1921, V52, P1; Thom C, 1919, J AMER MED ASSOC, V73, P907, DOI 10.1001/jama.1919.02610380033011; Thom C, 1924, AM J PUBLIC HEALTH, V14, P1029, DOI 10.2105/AJPH.14.12.1029; Weaver K., 2017, NATL LAW REV    0110; Young J H, 1976, Bull Hist Med, V50, P372; Zavalla J., 1916, CANNING FRUITS VEGET, Vvii, P41	69	0	0	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2018	168	8					579	+		10.7326/M17-2853	http://dx.doi.org/10.7326/M17-2853			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GC8XZ	29677267				2022-12-28	WOS:000430083100019
J	Navarese, EP; Robinson, JG; Kowalewski, M; Kolodziejczak, M; Andreotti, F; Bliden, K; Tantry, U; Kubica, J; Raggi, P; Gurbel, PA				Navarese, Eliano P.; Robinson, Jennifer G.; Kowalewski, Mariusz; Kolodziejczak, Michalina; Andreotti, Felicita; Bliden, Kevin; Tantry, Udaya; Kubica, Jacek; Raggi, Paolo; Gurbel, Paul A.			Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CORONARY-HEART-DISEASE; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; AVERAGE CHOLESTEROL LEVELS; HIGH-DOSE ATORVASTATIN; MYOCARDIAL-INFARCTION; PRIMARY PREVENTION; HYPERTENSIVE PATIENTS; CARDIAC OUTCOMES; REDUCING LIPIDS	IMPORTANCE Effects on specific fatal and nonfatal end points appear to vary for low-density lipoprotein cholesterol (LDL-C)-lowering drug trials. OBJECTIVE To evaluate whether baseline LDL-C level is associated with total and cardiovascular mortality risk reductions. DATA SOURCESAND STUDY SELECTION Electronic databases (Cochrane, MEDLINE, EMBASE, TCTMD, ClinicalTrials.gov, major congress proceedings) were searched through February 2, 2018, to identify randomized clinical trials of statins, ezetimibe, and PCSK9-inhibiting monoclonal antibodies. DATA EXTRACTION AND SYNTHESIS Two investigators abstracted data and appraised risks of bias. Intervention groups were categorized as "more intensive" (more potent pharmacologic intervention) or "less intensive" (less potent, placebo, or control group). MAIN OUTCOMES AND MEASURES The coprimary end points were total mortality and cardiovascular mortality. Random-effects meta-regression and meta-analyses evaluated associations between baseline LDL-C level and reductions in mortality end points and secondary end points including major adverse cardiac events (MACE). RESULTS In 34 trials, 136 299 patients received more intensive and 133 989 received less intensive LDL-C lowering. All-cause mortality was lower for more vs less intensive therapy (7.08% vs 7.70%; rate ratio [RR], 0.92 [95% CI, 0.88 to 0.96]), but varied by baseline LDL-C level. Meta-regression showed more intensive LDL-C lowering was associated with greater reductions in all-cause mortality with higher baseline LDL-C levels (change in RRs per 40-mg/dL increase in baseline LDL-C, 0.91 [95% CI, 0.86 to 0.96]; P=.001; absolute risk difference [ARD], -1.05 incident cases per 1000 person-years [95% CI, -1.59 to -0.51]), but only when baseline LDL-C levelswere 100mg/dL or greater (P <.001 for interaction) in ameta-analysis. Cardiovascular mortalitywas lower for more vs less intensive therapy (3.48% vs 4.07%; RR, 0.84 [95% CI, 0.79 to 0.89]) but varied by baseline LDL-C level. Meta-regression showed more intensive LDL-C lowering was associated with a greater reduction in cardiovascular mortality with higher baseline LDL-C levels (change in RRs per 40-mg/dL increase in baseline LDL-C, 0.86 [95% CI, 0.80 to 0.94]; P<.001; ARD, -1.0 incident cases per 1000 person-years [95% CI, -1.51 to -0.45]), but only when baseline LDL-C levelswere 100mg/dL or greater (P <.001 for interaction) in ameta-analysis. Trials with baseline LDL-C levels of 160mg/dL or greater had the greatest reduction in all-cause mortality (RR, 0.72 [95% CI, 0.62 to 0.84]; P<.001; 4.3 fewer deaths per 1000 person-years) in ameta-analysis. More intensive LDL-C lowering was also associated with progressively greater risk reductions with higher baseline LDL-C level for myocardial infarction, revascularization, and MACE. CONCLUSIONS AND RELEVANCE In these meta-analyses and meta-regressions, more intensive compared with less intensive LDL-C lowering was associated with a greater reduction in risk of total and cardiovascular mortality in trials of patients with higher baseline LDL-C levels. This association was not present when baseline LDL-C level was less than 100mg/dL, suggesting that the greatest benefit from LDL-C-lowering therapy may occur for patients with higher baseline LDL-C levels.	[Navarese, Eliano P.; Bliden, Kevin; Tantry, Udaya; Gurbel, Paul A.] Inova Heart & Vasc Inst, Inova Ctr Thrombosis Res & Drug Dev, Intervent Cardiol & Cardiovasc Med Res, Falls Church, VA USA; [Navarese, Eliano P.; Kowalewski, Mariusz; Kolodziejczak, Michalina; Andreotti, Felicita; Gurbel, Paul A.] Systemat Invest & Res Intervent & Outcomes SIRIO, Dusseldorf, Germany; [Navarese, Eliano P.; Kolodziejczak, Michalina; Kubica, Jacek] Nicolaus Copernicus Univ, Ludwik Rydygier Coll Med, Cardiovasc Inst, Bydgoszcz, Poland; [Robinson, Jennifer G.] Univ Iowa, Dept Epidemiol, Prevent Intervent Ctr, Iowa City, IA USA; [Robinson, Jennifer G.] Univ Iowa, Dept Med, Prevent Intervent Ctr, Iowa City, IA USA; [Kowalewski, Mariusz] Dr Antoni Jurasz Mem Univ Hosp, Cardiovasc Inst, Dept Cardiac Surg, Bydgoszcz, Poland; [Andreotti, Felicita] Catholic Univ, Med Sch, Inst Cardiol, Rome, Italy; [Raggi, Paolo] Univ Alberta, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada	Inova Fairfax Hospital; Nicolaus Copernicus University; University of Iowa; University of Iowa; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Alberta	Robinson, JG (corresponding author), Prevent Intervent Ctr, Dept Epidemiol, 145 N Riverside Dr,5455 CPHB, Iowa City, IA 52242 USA.; Robinson, JG (corresponding author), Prevent Intervent Ctr, Prevent Med, 145 N Riverside Dr,5455 CPHB, Iowa City, IA 52242 USA.	jennifer-g-robinson@uima.edu	Kowalewski, Mariusz/AAA-6845-2020; Kołodziejczak, Michalina/AAL-3968-2020; Andreotti, Felicita/A-9962-2019; Kubica, Jacek/D-6906-2014; , Jennifer/AAD-8336-2019	Kołodziejczak, Michalina/0000-0001-5969-6055; Andreotti, Felicita/0000-0002-1456-6430; Kubica, Jacek/0000-0001-8250-754X; Navarese, Eliano/0000-0002-2355-4589	Amgen; Sanofi; Acasti; Amarin; AstraZeneca; Esai; Esperion; Merck; Pfizer; Regeneron; Takeda; Akcea/Ioinis; Dr Reddy Laboratories; Eli Lilly; Actelion; Bayer; Boehringer-Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Menarini International Foundation; Medicure	Amgen(Amgen); Sanofi; Acasti; Amarin; AstraZeneca(AstraZeneca); Esai; Esperion; Merck(Merck & Company); Pfizer(Pfizer); Regeneron(Regeneron); Takeda(Takeda Pharmaceutical Company Ltd); Akcea/Ioinis; Dr Reddy Laboratories; Eli Lilly(Eli Lilly); Actelion; Bayer(Bayer AG); Boehringer-Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Daiichi Sankyo(Daiichi Sankyo Company Limited); Menarini International Foundation(Menarini Group); Medicure	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Navarese reported receiving research grants from Amgen and personal fees from Amgen and Sanofi. Dr Robinson reported receiving research grants from Acasti, Amarin, Amgen, AstraZeneca, Esai, Esperion, Merck, Pfizer, Regeneron, Sanofi, and Takeda and receiving personal fees from Akcea/Ioinis, Dr Reddy Laboratories, Eli Lilly, Esperion, Pfizer, Regeneron, and Sanofi. Dr Andreotti reported receiving personal fees from Actelion, Amgen, Bayer, Boehringer-Ingelheim; Bristol-Myers Squibb, Pfizer, Daiichi Sankyo, and the Menarini International Foundation. Dr Tantry reported receiving personal fees from AstraZeneca and Medicure. Dr Raggi reported receiving grants from Amgen and Sanofi. Dr Gurbel reported receiving a grant from Amgen. No other authors reported disclosures.	Amarenco P, 2006, NEW ENGL J MED, V355, P549; [Anonymous], 2000, Ital Heart J, V1, P810; Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Athyros VG, 2002, CURR MED RES OPIN, V18, P220, DOI 10.1185/030079902125000787; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Campeau L, 1997, NEW ENGL J MED, V336, P153; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI 10.1001/jama.288.23.2998; Goodman S, 2017, AM COLL CARD 66 ANN; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Holdaas H, 2003, LANCET, V361, P2024, DOI 10.1016/S0140-6736(03)13638-0; Knopp RH, 2006, DIABETES CARE, V29, P1478, DOI 10.2337/dc05-2415; Koren MJ, 2004, J AM COLL CARDIOL, V44, P1772, DOI 10.1016/j.jacc.2004.07.053; Landmesser U, 2017, EUR HEART J, V38, P2245, DOI 10.1093/eurheartj/ehw480; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; Navarese EP, 2015, ANN INTERN MED, V163, P40, DOI 10.7326/M14-2957; PEDERSEN TR, 1994, LANCET, V344, P1383; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Ridker PM, 2017, NEW ENGL J MED, V376, P1527, DOI 10.1056/NEJMoa1701488; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Robinson JG, 2016, J AM COLL CARDIOL, V68, P2412, DOI 10.1016/j.jacc.2016.09.928; Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Sabatine MS, 2015, NEW ENGL J MED, V372, P1500, DOI 10.1056/NEJMoa1500858; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schwartz GG, 2014, AM HEART J, V168, P682, DOI 10.1016/j.ahj.2014.07.028; SEEGER P, 1968, PSYCHOL BULL, V69, P269, DOI 10.1037/h0025667; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Stijnen T, 2010, STAT MED, V29, P3046, DOI 10.1002/sim.4040; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Tice JA, 2017, EVOLOCUMAB TREATMENT; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Yusuf S, 2016, NEW ENGL J MED, V374, P2021, DOI 10.1056/NEJMoa1600176	46	228	234	5	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2018	319	15					1566	1579		10.1001/jama.2018.2525	http://dx.doi.org/10.1001/jama.2018.2525			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD0UT	29677301	Green Published, Bronze			2022-12-28	WOS:000430217100017
J	Ekeland, I				Ekeland, I			Mathematics - Counting up to four	NATURE			English	Editorial Material									Univ Paris 09, F-75775 Paris 16, France	UDICE-French Research Universities; PSL Research University Paris; Universite Paris-Dauphine	Ekeland, I (corresponding author), Univ Paris 09, F-75775 Paris 16, France.							Erd?s P., 1936, J LOND MATH SOC, V11, P261; FREIMAN GR, 1966, MATH MONOGR, V37; FURSTENBERG H, 1977, J ANAL MATH, V31, P204, DOI 10.1007/BF02813304; Gowers WT, 1998, GEOM FUNCT ANAL, V8, P529, DOI 10.1007/s000390050065; ROTH KF, 1953, J LOND MATH SOC, V28, P245; RUZSA IZ, 1994, ACTA MATH HUNG, V65, P379, DOI 10.1007/BF01876039; Szemeredi E., 1975, ACTA ARITH, V27, P199	7	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					393	394		10.1038/17026	http://dx.doi.org/10.1038/17026			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667963				2022-12-28	WOS:000078461700027
J	Hoffman, PF; Maloof, AC				Hoffman, PF; Maloof, AC			Glaciation: the snowball theory still holds water	NATURE			English	Letter							OBLIQUITY		Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Harvard University	Hoffman, PF (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.							BILLS BG, 1994, GEOPHYS RES LETT, V21, P177, DOI 10.1029/93GL02024; Bills BG, 1998, NATURE, V396, P405, DOI 10.1038/24711; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; HUNT BG, 1982, J METEOROL SOC JPN, V60, P309, DOI 10.2151/jmsj1965.60.1_309; Kirschvink J. L., 1992, PROTEROZOIC BIOSPHER, P51; Williams DM, 1998, NATURE, V396, P453, DOI 10.1038/24845; WILLIAMS GE, 1993, EARTH-SCI REV, V34, P1, DOI 10.1016/0012-8252(93)90004-Q; [No title captured]	8	10	14	0	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					384	384		10.1038/17006	http://dx.doi.org/10.1038/17006			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667989	Bronze			2022-12-28	WOS:000078461700021
J	Lehrman, S				Lehrman, S			AAAS head wants to see scientists on school boards	NATURE			English	News Item																			0	1	1	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					374	374		10.1038/16968	http://dx.doi.org/10.1038/16968			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667962	Bronze			2022-12-28	WOS:000078461700006
J	Fincher, CT; Wurtzel, O; de Hoog, T; Kravarik, KM; Reddien, PW				Fincher, Christopher T.; Wurtzel, Omri; de Hoog, Thom; Kravarik, Kellie M.; Reddien, Peter W.			Cell type transcriptome atlas for the planarian Schmidtea mediterranea	SCIENCE			English	Article							STEM-CELLS; GENE-EXPRESSION; SYSTEM REGENERATION; EXCRETORY SYSTEM; RNA-SEQ; REGULATORS; MAINTENANCE; EVOLUTION	The transcriptome of a cell dictates its unique cell type biology. We used single-cell RNA sequencing to determine the transcriptomes for essentially every cell type of a complete animal: the regenerative planarian Schmidtea mediterranea. Planarians contain a diverse array of cell types, possess lineage progenitors for differentiated cells (including pluripotent stem cells), and constitutively express positional information, making them ideal for this undertaking. We generated data for 66,783 cells, defining transcriptomes for known and many previously unknown planarian cell types and for putative transition states between stem and differentiated cells. We also uncovered regionally expressed genes in muscle, which harbors positional information. Identifying the transcriptomes for potentially all cell types for many organisms should be readily attainable and represents a powerful approach to metazoan biology.	[Fincher, Christopher T.; Wurtzel, Omri; de Hoog, Thom; Kravarik, Kellie M.; Reddien, Peter W.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Fincher, Christopher T.; Wurtzel, Omri; de Hoog, Thom; Kravarik, Kellie M.; Reddien, Peter W.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Fincher, Christopher T.; Kravarik, Kellie M.; Reddien, Peter W.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Reddien, PW (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Reddien, PW (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.; Reddien, PW (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	reddien@wi.mit.edu	Wurtzel, Omri/AAG-3985-2019	Wurtzel, Omri/0000-0002-6865-5914; Kravarik, Kellie/0000-0001-9884-4663; /0000-0002-5569-333X; Fincher, Christopher/0000-0003-0022-1260	NIH [R01GM080639]; Eleanor Schwartz Charitable Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080639] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eleanor Schwartz Charitable Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge NIH (R01GM080639) support. P.W.R. is an Investigator of the Howard Hughes Medical Institute and an associate member of the Broad Institute of Harvard and MIT. We thank the Eleanor Schwartz Charitable Foundation for support.	Anonymous, 1998, GENOME SEQUENCE OF T, V0282; BAGUNA J, 1981, HYDROBIOLOGIA, V84, P181, DOI 10.1007/BF00026179; Barberan S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28071; Cao JY, 2017, SCIENCE, V357, P661, DOI 10.1126/science.aam8940; Cebria F, 2002, DEV GROWTH DIFFER, V44, P135; Cebria F, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00008; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Forsthoefel DJ, 2012, DEV CELL, V23, P691, DOI 10.1016/j.devcel.2012.09.008; Guo TX, 2006, DEV CELL, V11, P159, DOI 10.1016/j.devcel.2006.06.004; Han XP, 2018, CELL, V172, P1091, DOI 10.1016/j.cell.2018.02.001; He XW, 2017, DEVELOPMENT, V144, P4540, DOI 10.1242/dev.156349; Hill EM, 2015, DEVELOPMENT, V142, P4217, DOI 10.1242/dev.123612; Hyman LH, 1951, THE INVERTEBRATES PL, VII; Ishii S, 1965, Fukushima J Med Sci, V12, P67; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lapan SW, 2012, CELL REP, V2, P294, DOI 10.1016/j.celrep.2012.06.018; Lapan SW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002226; Laumer CE, 2015, CURR BIOL, V25, P2000, DOI 10.1016/j.cub.2015.06.068; Liu SY, 2013, NATURE, V500, P81, DOI 10.1038/nature12414; LoCascio SA, 2017, DEV CELL, V40, P381, DOI 10.1016/j.devcel.2017.02.002; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; McDavid A, 2013, BIOINFORMATICS, V29, P461, DOI 10.1093/bioinformatics/bts714; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; Newmark PA, 2003, P NATL ACAD SCI USA, V100, P11861, DOI 10.1073/pnas.1834205100; PEDERSEN KJ, 1961, Z ZELLFORSCH MIK ANA, V53, P569, DOI 10.1007/BF00339508; PEDERSEN KJ, 1959, Z ZELLFORSCH MIK ANA, V50, P121, DOI 10.1007/BF00350411; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Petersen CP, 2011, SCIENCE, V332, P852, DOI 10.1126/science.1202143; Reddien PW, 2013, DEVELOPMENT, V140, P951, DOI 10.1242/dev.080499; Reddien PW, 2011, TRENDS GENET, V27, P277, DOI 10.1016/j.tig.2011.04.004; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Rink JC, 2011, DEVELOPMENT, V138, P3769, DOI 10.1242/dev.066852; Roberts-Galbraith RH, 2016, ELIFE, V5, DOI 10.7554/eLife.17002; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Scimone ML, 2017, NATURE, V551, P623, DOI 10.1038/nature24660; Scimone ML, 2014, STEM CELL REP, V3, P339, DOI 10.1016/j.stemcr.2014.06.001; Scimone ML, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003999; Scimone ML, 2011, DEVELOPMENT, V138, P4387, DOI 10.1242/dev.068098; Scimone ML, 2016, ELIFE, V5, DOI 10.7554/eLife.12845; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Stubenhaus BM, 2016, ELIFE, V5, DOI 10.7554/eLife.14175; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Tu KC, 2015, ELIFE, V4, DOI 10.7554/eLife.10501; van Wolfswinkel JC, 2014, CELL STEM CELL, V15, P326, DOI 10.1016/j.stem.2014.06.007; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vogg MC, 2014, DEV BIOL, V390, P136, DOI 10.1016/j.ydbio.2014.03.016; Vu HTK, 2015, ELIFE, V4, DOI 10.7554/eLife.07405; Wagner DE, 2012, CELL STEM CELL, V10, P299, DOI 10.1016/j.stem.2012.01.016; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983; Wang IE, 2016, ELIFE, V5, DOI 10.7554/eLife.16996; Wang YY, 2007, P NATL ACAD SCI USA, V104, P5901, DOI 10.1073/pnas.0609708104; Willier BH, 1925, J MORPHOL PHYSIOL, V40, P299, DOI 10.1002/jmor.1050400205; Witchley JN, 2013, CELL REP, V4, P633, DOI 10.1016/j.celrep.2013.07.022; Wurtzel O, 2017, DEV CELL, V40, P491, DOI 10.1016/j.devcel.2017.02.008; Wurtzel O, 2015, DEV CELL, V35, P632, DOI 10.1016/j.devcel.2015.11.004; Zayas RM, 2010, DEV DYNAM, V239, P2888, DOI 10.1002/dvdy.22427; Zhu SJ, 2015, ELIFE, V4, DOI 10.7554/eLife.07025	60	188	191	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391							aaq1736	10.1126/science.aaq1736	http://dx.doi.org/10.1126/science.aaq1736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG9RW	29674431	Green Accepted			2022-12-28	WOS:000433039800038
J	Peltz, G; Sudhof, TC				Peltz, Gary; Sudhof, Thomas C.			The Neurobiology of Opioid Addiction and the Potential for Prevention Strategies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DEPENDENCE		[Peltz, Gary] Stanford Univ, Sch Med, Dept Anesthesia, Stanford, CA 94305 USA; [Sudhof, Thomas C.] Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA USA	Stanford University; Howard Hughes Medical Institute	Peltz, G (corresponding author), Stanford Univ, Med Sch, 300 Pasteur Dr, Stanford, CA 94305 USA.	gpeltz@stanford.edu			National Institutes of Health/National Institute on Drug Abuse [U01 DA044399]; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA044399] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by a research award from the National Institutes of Health/National Institute on Drug Abuse (U01 DA044399).	[Anonymous], 2017, ANN SURVEILLANCE REP; Chu LF, 2009, PHARMACOGENET GENOM, V19, P193, DOI 10.1097/FPC.0b013e328322e73d; Department of Health and Human Services, RES 2006 NAT SURV DR; Koob GF, 2016, LANCET PSYCHIAT, V3, P760, DOI 10.1016/S2215-0366(16)00104-8; Manglik A, 2016, NATURE, V537, P185, DOI 10.1038/nature19112; Mendelson J, 2008, EXP CLIN PSYCHOPHARM, V16, P435, DOI 10.1037/a0013637; Shah A, 2017, MMWR-MORBID MORTAL W, V66, P265, DOI 10.15585/mmwr.mm6610a1; University of Washington, COMM CAR PLUS; Wang JC, 2012, ANNU REV GENOM HUM G, V13, P241, DOI 10.1146/annurev-genom-090711-163844	9	15	14	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2018	319	20					2071	2072		10.1001/jama.2018.3394	http://dx.doi.org/10.1001/jama.2018.3394			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4PT	29710202				2022-12-28	WOS:000432679400013
J	Schulz, A; Ajayi, T; Specchio, N; de Los Reyes, E; Gissen, P; Ballon, D; Dyke, JP; Cahan, H; Slasor, P; Jacoby, D; Kohlschutter, A				Schulz, Angela; Ajayi, Temitayo; Specchio, Nicola; de Los Reyes, Emily; Gissen, Paul; Ballon, Douglas; Dyke, Jonathan P.; Cahan, Heather; Slasor, Peter; Jacoby, David; Kohlschutter, Alfried		CLN2 Study Grp	Study of Intraventricular Cerliponase Alfa for CLN2 Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; ENZYME REPLACEMENT; LYSOSOMAL STORAGE; CANINE MODEL; PERSPECTIVES; MUTATIONS; DISORDER	BACKGROUND Recombinant human tripeptidyl peptidase 1 (cerliponase alfa) is an enzyme-replacement therapy that has been developed to treat neuronal ceroid lipofuscinosis type 2 (CLN2) disease, a rare lysosomal disorder that causes progressive dementia in children. METHODS In a multicenter, open-label study, we evaluated the effect of intraventricular infusion of cerliponase alfa every 2 weeks in children with CLN2 disease who were between the ages of 3 and 16 years. Treatment was initiated at a dose of 30 mg, 100 mg, or 300 mg; all the patients then received the 300-mg dose for at least 96 weeks. The primary outcome was the time until a 2-point decline in the score on the motor and language domains of the CLN2 Clinical Rating Scale (which ranges from 0 to 6, with 0 representing no function and 3 representing normal function in each of the two domains), which was compared with the time until a 2-point decline in 42 historical controls. We also compared the rate of decline in the motor-language score between the two groups, using data from baseline to the last assessment with a score of more than 0, divided by the length of follow-up (in units of 48 weeks). RESULTS Twenty-four patients were enrolled, 23 of whom constituted the efficacy population. The median time until a 2-point decline in the motor-language score was not reached for treated patients and was 345 days for historical controls. The mean (+/- SD) unadjusted rate of decline in the motor-language score per 48-week period was 0.27 +/- 0.35 points in treated patients and 2.12 +/- 0.98 points in 42 historical controls (mean difference, 1.85; P<0.001). Common adverse events included convulsions, pyrexia, vomiting, hypersensitivity reactions, and failure of the intraventricular device. In 2 patients, infections developed in the intraventricular device that was used to administer the infusion, which required antibiotic treatment and device replacement. CONCLUSIONS Intraventricular infusion of cerliponase alfa in patients with CLN2 disease resulted in less decline in motor and language function than that in historical controls. Serious adverse events included failure of the intraventricular device and device-related infections.	[Schulz, Angela; Kohlschutter, Alfried] Univ Med Ctr Hamburg Eppendorf, Dept Pediat, Martinistr 52, D-20246 Hamburg, Germany; [Ajayi, Temitayo; Cahan, Heather; Slasor, Peter; Jacoby, David] BioMarin Pharmaceut, Novato, CA USA; [Specchio, Nicola] Bambino Gesu Pediat Hosp, IRCCS, Dept Neurosci, Rome, Italy; [de Los Reyes, Emily] Nationwide Childrens Hosp, Columbus, OH USA; [de Los Reyes, Emily] Ohio State Univ, Columbus, OH 43210 USA; [Gissen, Paul] UCL Great Ormond St Inst Child Hlth, London, England; [Ballon, Douglas; Dyke, Jonathan P.] Weill Cornell Med Coll, Citigrp Biomed Imaging Ctr, Dept Radiol, New York, NY USA; [Ballon, Douglas; Dyke, Jonathan P.] Weill Cornell Med Coll, Citigrp Biomed Imaging Ctr, Dept Med Genet, New York, NY USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; BioMarin Pharmaceutical Inc.; IRCCS Bambino Gesu; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University of London; University College London; Cornell University; Cornell University	Schulz, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Pediat, Martinistr 52, D-20246 Hamburg, Germany.	an.schulz@uke.de	Kohlschütter, Alfried/ABH-5710-2020; Kohlschütter, Alfried/ABE-3495-2021; de los Reyes, Emily C/AAP-3836-2020; Specchio, Nicola/K-9461-2016; Dyke, Jonathan/AAX-4362-2020	Kohlschütter, Alfried/0000-0002-2700-0401; Dyke, Jonathan/0000-0001-7170-488X; SPECCHIO, NICOLA/0000-0002-8120-0287; Nickel, Miriam/0000-0002-1870-1142; Gissen, Paul/0000-0002-9712-6122	BioMarin Pharmaceutical; German Federal Ministry of Education and Research [NCL2Treat]; European Union [66691, 281234]; National Institute for Health Research; UCL Institute of Child Health Biomedical Research Centre	BioMarin Pharmaceutical(Johnson & Johnson); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); UCL Institute of Child Health Biomedical Research Centre	Supported by BioMarin Pharmaceutical, by a grant (NCL2Treat, to Dr. Schulz) from the German Federal Ministry of Education and Research, by a grant (66691, to Dr. Schulz) from the European Union's Horizon 2020 Research and Innovation Program, and by a grant from the National Institute for Health Research to Great Ormond Street Hospital and UCL Institute of Child Health Biomedical Research Centre, which provided core funding for the clinical research facility. The Dementia in Childhood consortium, which provided data for the historical cohort, is supported by a grant (281234, to Dr. Schulz) from the European Union Seventh Framework Program.	Bigger BW, 2015, BEST PRACT RES CL EN, V29, P183, DOI 10.1016/j.beem.2015.01.006; Hunt SV, 2009, INT J CLIN PHARM TH, V47, pS86; Johannsen J, 2016, NEUROPEDIATRICS, V47, P194, DOI 10.1055/s-0036-1579784; Katz ML, 2014, J NEUROSCI RES, V92, P1591, DOI 10.1002/jnr.23423; Kishnani PS, 2016, MOL GENET METAB, V117, P66, DOI 10.1016/j.ymgme.2015.11.001; Kohlschutter A, 2016, PEDIATR ENDOCR REV P, V13, P682; Mole S., 2011, NEURONAL CEROID LIPO, DOI DOI 10.1093/MED/9780199590018.003.0018; Mole SE, 2004, BRAIN PATHOL, V14, P70, DOI 10.1111/j.1750-3639.2004.tb00500.x; Schulz A, 2015, EUR J PAEDIAT NEU S1, V19, pS16; Schulz A, 2013, BBA-MOL BASIS DIS, V1832, P1801, DOI 10.1016/j.bbadis.2013.04.008; Sleat DE, 1999, AM J HUM GENET, V64, P1511, DOI 10.1086/302427; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; Steinfeld R, 2002, AM J MED GENET, V112, P347, DOI 10.1002/ajmg.10660; Vuillemenot BR, 2015, MOL GENET METAB, V114, P281, DOI 10.1016/j.ymgme.2014.09.004; Vuillemenot BR, 2011, MOL GENET METAB, V104, P325, DOI 10.1016/j.ymgme.2011.06.018; Whiting REH, 2014, EXP EYE RES, V125, P164, DOI 10.1016/j.exer.2014.06.008; Worgall S, 2007, NEUROLOGY, V69, P521, DOI 10.1212/01.wnl.0000267885.47092.40	17	231	243	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2018	378	20					1898	1907		10.1056/NEJMoa1712649	http://dx.doi.org/10.1056/NEJMoa1712649			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF9LR	29688815	Green Published, Bronze			2022-12-28	WOS:000432299600007
J	Skinner, J; Chandra, A				Skinner, Jonathan; Chandra, Amitabh			Health Care Employment Growth and the Future of US Cost Containment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Skinner, Jonathan] Dartmouth Coll, Geisel Sch Med, Dept Econ, One Med Ctr Dr, Lebanon, NH 03766 USA; [Chandra, Amitabh] Harvard Univ, Kennedy Sch Govt, Cambridge, MA 02138 USA	Dartmouth College; Harvard University	Skinner, J (corresponding author), Dartmouth Coll, Geisel Sch Med, Dept Econ, One Med Ctr Dr, Lebanon, NH 03766 USA.	jon.skinner@dartmouth.edu			National Institute on Aging	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Both authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Skinner reported receiving grant support from the National Institute on Aging; being an investor in Dorsata Inc; and serving as a consultant for Bartko, Zankel, and Bunzel. Dr Chandra reported receiving speaking fees from Leigh and Washington; serving on advisory boards for Health Engine, Maxwell Health, Kyruus, and SmithRx; and serving as a consultant to Precision Health Economics.	Auerbach DI, 2011, HEALTH AFFAIR, V30, P1630, DOI 10.1377/hlthaff.2011.0585; Chandra A, 2013, BROOKINGS PAP ECO AC, P261, DOI 10.1353/eca.2013.0014; Cooper Z, 23748 NAT BUR EC RES; Glied S, 2016, HEALTH AFFAIR, V35, P1197, DOI 10.1377/hlthaff.2015.1356; Institute of Medicine, 2012, GEOGR ADJ MED PAYM P; Terhune C., OUR COSTLY ADDICTION; US Centers for Medicare & Medicaid Services, HLTH EXP STAT PROV; Young J., US EXPERIENCES UNPRE	8	13	13	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2018	319	18					1861	1862		10.1001/jama.2018.2078	http://dx.doi.org/10.1001/jama.2018.2078			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF1CB	29710344				2022-12-28	WOS:000431668600011
J	Levy, S; Bagley, N; Rajkumar, R				Levy, Scott; Bagley, Nicholas; Rajkumar, Rahul			Reform at Risk - Mandating Participation in Alternative Payment Plans	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACCOUNTABLE CARE ORGANIZATIONS		[Levy, Scott] Yale Law Sch, New Haven, CT 06511 USA; [Bagley, Nicholas] Univ Michigan, Law Sch, Ann Arbor, MI 48109 USA; [Rajkumar, Rahul] Blue Cross Blue Shield North Carolina, Durham, NC USA	Yale University; University of Michigan System; University of Michigan	Levy, S (corresponding author), Yale Law Sch, New Haven, CT 06511 USA.							[Anonymous], 2017, INN CTR NEW DIR REQ; [Anonymous], 2016, ANS QUEST REC FOLL H; McWilliams JM, 2015, NEW ENGL J MED, V372, P1927, DOI 10.1056/NEJMsa1414929; Nyweide DJ, 2015, JAMA-J AM MED ASSOC, V313, P2152, DOI 10.1001/jama.2015.4930	4	13	13	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2018	378	18					1663	1665		10.1056/NEJMp1800483	http://dx.doi.org/10.1056/NEJMp1800483			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GE4WO	29719177	Green Published			2022-12-28	WOS:000431218600002
J	Choi, JH; Sim, SE; Kim, JI; Choi, DI; Oh, J; Ye, S; Lee, J; Kim, T; Ko, HG; Lim, CS; Kaang, BK				Choi, Jun-Hyeok; Sim, Su-Eon; Kim, Ji-il; Choi, Dong Il; Oh, Jihae; Ye, Sanghyun; Lee, Jaehyun; Kim, TaeHyun; Ko, Hyoung-Gon; Lim, Chae-Seok; Kaang, Bong-Kiun			Interregional synaptic maps among engram cells underlie memory formation	SCIENCE			English	Article							GREEN FLUORESCENT PROTEIN; FEAR MEMORY; HIPPOCAMPUS; INDUCTION; STRONTIUM; CA1	Memory resides in engram cells distributed across the brain. However, the site-specific substrate within these engram cells remains theoretical, even though it is generally accepted that synaptic plasticity encodes memories. We developed the dual-eGRASP (green fluorescent protein reconstitution across synaptic partners) technique to examine synapses between engram cells to identify the specific neuronal site for memory storage. We found an increased number and size of spines on CA1 engram cells receiving input from CA3 engram cells. In contextual fear conditioning, this enhanced connectivity between engram cells encoded memory strength. CA3 engram to CA1 engram projections strongly occluded long-term potentiation. These results indicate that enhanced structural and functional connectivity between engram cells across two directly connected brain regions forms the synaptic correlate for memory formation.	[Choi, Jun-Hyeok; Sim, Su-Eon; Kim, Ji-il; Choi, Dong Il; Oh, Jihae; Ye, Sanghyun; Lee, Jaehyun; Kim, TaeHyun; Ko, Hyoung-Gon; Lim, Chae-Seok; Kaang, Bong-Kiun] Seoul Natl Univ, Sch Biol Sci, Seoul 08826, South Korea	Seoul National University (SNU)	Kaang, BK (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 08826, South Korea.	kaang@snu.ac.kr	Kim, TaeHyun/AAS-7581-2021	Kim, TaeHyun/0000-0003-3871-5776; Sim, Su-Eon/0000-0003-3711-5322; Ko, Hyoung-Gon/0000-0002-7730-6986; Choi, Dong il/0000-0003-1167-6375; Choi, Jun Hyeok/0000-0003-2130-8605; Oh, Jihae/0000-0002-5909-6153	National Honor Scientist Program of Korea [NRF-2012R1A3A1050385]; Basic Science Research Program through the National Research Foundation (NRF) of Korea [NRF-2016R1D1A1B03931525]	National Honor Scientist Program of Korea; Basic Science Research Program through the National Research Foundation (NRF) of Korea	This work was supported by the National Honor Scientist Program (NRF-2012R1A3A1050385) of Korea. C.S.L. was supported by the Basic Science Research Program (NRF-2016R1D1A1B03931525) through the National Research Foundation (NRF) of Korea.	Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Andersen N, 2017, CURR OPIN NEUROBIOL, V45, P188, DOI 10.1016/j.conb.2017.06.001; Bindels DS, 2017, NAT METHODS, V14, P53, DOI [10.1038/NMETH.4074, 10.1038/nmeth.4074]; Bliss TVP, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-5; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Chen HX, 1999, J NEUROPHYSIOL, V82, P526, DOI 10.1152/jn.1999.82.2.526; Choi JH, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-17; Denny CA, 2014, NEURON, V83, P189, DOI 10.1016/j.neuron.2014.05.018; DODGE FA, 1969, J PHYSIOL-LONDON, V200, P267, DOI 10.1113/jphysiol.1969.sp008692; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; FINNERTY GT, 1993, NEUROSCIENCE, V56, P101, DOI 10.1016/0306-4522(93)90566-X; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Kim J, 2012, NAT METHODS, V9, P96, DOI [10.1038/NMETH.1784, 10.1038/nmeth.1784]; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Loew R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-81; Markwardt ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017896; Morrison DJ, 2016, NEUROBIOL LEARN MEM, V135, P91, DOI 10.1016/j.nlm.2016.07.007; Pisabarro MT, 1996, BIOCHEMISTRY-US, V35, P10634, DOI 10.1021/bi960203t; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Shcherbakova DM, 2013, NAT METHODS, V10, P751, DOI 10.1038/nmeth.2521; Tanaka KZ, 2014, NEURON, V84, P347, DOI 10.1016/j.neuron.2014.09.037; van Haasteren G, 2000, NEUROENDOCRINOLOGY, V72, P368, DOI 10.1159/000054606; Wachter RM, 1998, STRUCTURE, V6, P1267, DOI 10.1016/S0969-2126(98)00127-0; Xu-Friedman MA, 1999, BIOPHYS J, V76, P2029, DOI 10.1016/S0006-3495(99)77360-1; Zhou X, 2006, GENE THER, V13, P1382, DOI 10.1038/sj.gt.3302780; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	30	140	146	8	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					430	435		10.1126/science.aas9204	http://dx.doi.org/10.1126/science.aas9204			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1AR	29700265				2022-12-28	WOS:000430949600041
J	Dyer, C				Dyer, Clare			Children's hospital must be allowed to withdraw life support from Alfie Evans, court rules	BMJ-BRITISH MEDICAL JOURNAL			English	News Item									[Dyer, Clare] BMJ, London, England		Dyer, C (corresponding author), BMJ, London, England.							Supreme Court, 2018, MATT ALF EV PERM APP	1	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2018	361								k1773	10.1136/bmj.k1773	http://dx.doi.org/10.1136/bmj.k1773			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF4VW	29685901				2022-12-28	WOS:000431962900005
J	Iacobucci, G				Iacobucci, Gareth			NHS risks missing out on benefits of genomics, MPs warn	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2018	361								k1749	10.1136/bmj.k1749	http://dx.doi.org/10.1136/bmj.k1749			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8WT	29678812				2022-12-28	WOS:000430795700003
J	Mitchell, TJ; Turajlic, S; Rowan, A; Nicol, D; Farmery, JHR; O'Brien, T; Martincorena, I; Tarpey, P; Angelopoulos, N; Yates, LR; Butler, AP; Raine, K; Stewart, GD; Challacombe, B; Fernando, A; Lopez, JI; Hazell, S; Chandra, A; Chowdhury, S; Rudman, S; Soultati, A; Stamp, G; Fotiadis, N; Pickering, L; Au, L; Spain, L; Lynch, J; Stares, M; Teague, J; Maura, F; Wedge, DC; Horswell, S; Chambers, T; Litchfield, K; Xu, H; Stewart, A; Elaidi, R; Oudard, S; McGranahan, N; Csabai, I; Gore, M; Futreal, PA; Larkin, J; Lynch, AG; Szallasi, Z; Swanton, C; Campbell, PJ				Mitchell, Thomas J.; Turajlic, Samra; Rowan, Andrew; Nicol, David; Farmery, James H. R.; O'Brien, Tim; Martincorena, Inigo; Tarpey, Patrick; Angelopoulos, Nicos; Yates, Lucy R.; Butler, Adam P.; Raine, Keiran; Stewart, Grant D.; Challacombe, Ben; Fernando, Archana; Lopez, Jose I.; Hazell, Steve; Chandra, Ashish; Chowdhury, Simon; Rudman, Sarah; Soultati, Aspasia; Stamp, Gordon; Fotiadis, Nicos; Pickering, Lisa; Au, Lewis; Spain, Lavinia; Lynch, Joanna; Stares, Mark; Teague, Jon; Maura, Francesco; Wedge, David C.; Horswell, Stuart; Chambers, Tim; Litchfield, Kevin; Xu, Hang; Stewart, Aengus; Elaidi, Reza; Oudard, Stephane; McGranahan, Nicholas; Csabai, Istvan; Gore, Martin; Futreal, P. Andrew; Larkin, James; Lynch, Andy G.; Szallasi, Zoltan; Swanton, Charles; Campbell, Peter J.		TRACERx Renal Consortium	Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal	CELL			English	Article							TERT PROMOTER MUTATIONS; COPY-NUMBER; SOMATIC MUTATIONS; PATTERNS; IDENTIFICATION; CHROMOTHRIPSIS; TRANSCRIPTION; LANDSCAPE; HETEROGENEITY; ACTIVATION	Clear cell renal cell carcinoma (ccRCC) is characterized by near-universal loss of the short arm of chromosome 3, deleting several tumor suppressor genes. We analyzed whole genomes from 95 biopsies across 33 patients with clear cell renal cell carcinoma. We find hotspots of point mutations in the 50 UTR of TERT, targeting a MYC-MAX-MAD1 repressor associated with telomere lengthening. The most common structural abnormality generates simultaneous 3p loss and 5q gain (36% patients), typically through chromothripsis. This event occurs in childhood or adolescence, generally as the initiating event that precedes emergence of the tumor's most recent common ancestor by years to decades. Similar genomic changes drive inherited ccRCC. Modeling differences in age incidence between inherited and sporadic cancers suggests that the number of cells with 3p loss capable of initiating sporadic tumors is no more than a few hundred. Early development of ccRCC follows well-defined evolutionary trajectories, offering opportunity for early intervention.	[Mitchell, Thomas J.; Martincorena, Inigo; Tarpey, Patrick; Angelopoulos, Nicos; Yates, Lucy R.; Butler, Adam P.; Raine, Keiran; Teague, Jon; Maura, Francesco; Campbell, Peter J.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Mitchell, Thomas J.; Stewart, Grant D.] Univ Cambridge, Acad Urol Grp, Dept Surg, Addenbrookes Hosp NHS Fdn Trust, Hills Rd, Cambridge CB2 0QQ, England; [Turajlic, Samra; Rowan, Andrew; Hazell, Steve; Chambers, Tim; Litchfield, Kevin; Xu, Hang; McGranahan, Nicholas; Swanton, Charles] Francis Crick Inst, Translat Canc Therapeut Lab, 1 Midland Rd, London NW1 1AT, England; [Turajlic, Samra; Nicol, David; Yates, Lucy R.; Pickering, Lisa; Au, Lewis; Spain, Lavinia; Lynch, Joanna; Stares, Mark; Gore, Martin; Larkin, James] Royal Marsden Natl Hlth Serv NHS Fdn Trust, Renal & Skin Units, London SW3 6JJ, England; [Farmery, James H. R.; Lynch, Andy G.] Univ Cambridge, CRUK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England; [O'Brien, Tim; Challacombe, Ben; Fernando, Archana; Chandra, Ashish; Chowdhury, Simon; Rudman, Sarah; Soultati, Aspasia] Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, Great Maze Pond, London SE1 9RT, England; [Lopez, Jose I.] Univ Basque Country, Biocruces Inst, Cruces Univ Hosp, Dept Pathol,UPV EHU, Baracaldo, Spain; [Stamp, Gordon] Francis Crick Inst, Expt Histopathol Lab, 1 Midland Rd, London NW1 1AT, England; [Fotiadis, Nicos] Royal Marsden Natl Hlth Serv NHS Fdn Trust, Intervent Radiol Dept, London SW3 6JJ, England; [Wedge, David C.] Univ Oxford, Big Data Inst, Old Rd Campus, Oxford OX3 7FZ, England; [Horswell, Stuart; Stewart, Aengus] Francis Crick Inst, Bioinformat & Biostat STP, 1 Midland Rd, London NW1 1AT, England; [Elaidi, Reza; Oudard, Stephane] Hop Europeen Georges Pompidou 20, Rue Leblanc, F-75908 Paris, France; [McGranahan, Nicholas; Swanton, Charles] UCL, Canc Inst, Canc Res UK Lung Canc Ctr Excellence, Paul OGorman Bldg,72 Huntley St, London WC1E 6BT, England; [Csabai, Istvan] Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary; [Futreal, P. Andrew] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Lynch, Andy G.] Univ St Andrews, Sch Med, St Andrews KY16 9TF, Fife, Scotland; [Szallasi, Zoltan] Tech Univ Denmark, Ctr Biol Sequence Anal, Lyngby, Denmark; [Szallasi, Zoltan] Harvard Med Sch, Childrens Hosp Informat Program, Harvard Div Hlth Sci & Technol, CHIP HST, Boston, MA USA; [Swanton, Charles] Univ Coll London Hosp, Dept Med Oncol, 235 Euston Rd, London NW1 2BU, England; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England	Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Francis Crick Institute; Royal Marsden NHS Foundation Trust; CRUK Cambridge Institute; University of Cambridge; Hospital Universitario Cruces; University of Basque Country; Francis Crick Institute; Royal Marsden NHS Foundation Trust; University of Oxford; Francis Crick Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Cancer Research UK; University of London; University College London; Eotvos Lorand University; University of Texas System; UTMD Anderson Cancer Center; University of St Andrews; Technical University of Denmark; Harvard University; Boston Children's Hospital; Harvard Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Cambridge	Campbell, PJ (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England.; Swanton, C (corresponding author), Francis Crick Inst, Translat Canc Therapeut Lab, 1 Midland Rd, London NW1 1AT, England.; Swanton, C (corresponding author), UCL, Canc Inst, Canc Res UK Lung Canc Ctr Excellence, Paul OGorman Bldg,72 Huntley St, London WC1E 6BT, England.; Swanton, C (corresponding author), Univ Coll London Hosp, Dept Med Oncol, 235 Euston Rd, London NW1 2BU, England.; Campbell, PJ (corresponding author), Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England.	charles.swanton@crick.ac.uk; pc8@sanger.ac.uk	Wedge, David/AAC-4977-2021; Lopez, Jose Ignacio/L-3884-2019; MAURA, FRANCESCO/AAG-7416-2021; Nicol, David L/M-6809-2016; Challacombe, Ben/AAM-9505-2020; McGranahan, Nicholas/ABD-6561-2021; Csabai, Istvan/F-6045-2011	Lopez, Jose Ignacio/0000-0003-0842-5348; MAURA, FRANCESCO/0000-0002-5017-1620; Nicol, David L/0000-0002-5623-7467; Challacombe, Ben/0000-0001-8631-0314; McGranahan, Nicholas/0000-0001-9537-4045; Csabai, Istvan/0000-0001-9232-9898; Wedge, David/0000-0002-7572-3196; Horswell, Stuart/0000-0003-2787-1933; Xu, Hang/0000-0002-5847-655X; Stewart, Aengus/0000-0001-5182-653X; Nicol, David/0000-0003-0107-6990; Martincorena, Inigo/0000-0003-1122-4416; Raine, Keiran/0000-0002-5634-1539; Stewart, Grant D./0000-0003-3188-9140; Mitchell, Thomas/0000-0003-0761-9503; Spain, Lavinia/0000-0002-9356-8812; Swanton, Charles/0000-0002-4299-3018; Litchfield, Kevin/0000-0002-3725-0914; Larkin, James/0000-0001-5569-9523; OUDARD, Stephane/0000-0003-0893-285X; Angelopoulos, Nicos/0000-0002-7507-9177; Yates, Lucy/0000-0003-4519-7794; turajlic, samra/0000-0001-8846-136X; Lynch, Andy/0000-0002-7876-7338; Szallasi, Zoltan/0000-0001-5395-7509	EU FP7 (project PREDICT) [259303]; Wellcome Trust; Cancer Research UK; Cancer Research UK [C50947/A18176]; National Institute for Health Research (NIHR) Biomedical Research Centre at the Royal Marsden Hospital and Institute of Cancer Research [A109]; University of Cambridge, Cancer Research UK [C14303/A17197]; Hutchison Whampoa; UK Medical Research Council Skills Development Fellowship Award; Cancer Research UK (TRACERx); Rosetrees Trust; NovoNordisk Foundation [16584]; EU FP7 [259303]; Prostate Cancer Foundation; Breast Cancer Research Foundation; European Research Council (THESEUS); National Institute for Health Research University College London Hospitals Biomedical Research Centre; Wellcome Trust Senior Clinical Research Fellowship [WT088340MA]; MRC [MR/P014712/1] Funding Source: UKRI	EU FP7 (project PREDICT); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); National Institute for Health Research (NIHR) Biomedical Research Centre at the Royal Marsden Hospital and Institute of Cancer Research; University of Cambridge, Cancer Research UK(Cancer Research UKUniversity of Cambridge); Hutchison Whampoa; UK Medical Research Council Skills Development Fellowship Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK (TRACERx); Rosetrees Trust(Rosetrees Trust); NovoNordisk Foundation(Novo Nordisk FoundationNovocure Limited); EU FP7(European Commission); Prostate Cancer Foundation; Breast Cancer Research Foundation; European Research Council (THESEUS)(European Research Council (ERC)); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); Wellcome Trust Senior Clinical Research Fellowship(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Eleanor Carlyle, Aida Murra, Justine Korteweg, Kim Edmonds, Karla Lingard, Karen O'Meara, Helen Breeze, Lesley Cooper, Linda Shephard, Sharanpreet Lall, Sarah Sarker, and Leonora Conneely for study support. We thank members of the HeritX organization for discussions on prevention of inherited cancers. We thank the patients and their families. The work presented in this manuscript was funded by EU FP7 (project PREDICT ID number 259303) and the Wellcome Trust and Cancer Research UK. S. T. is funded by Cancer Research UK (C50947/A18176). S. T., J. L., and M. G. receive funding from the National Institute for Health Research (NIHR) Biomedical Research Centre at the Royal Marsden Hospital and Institute of Cancer Research (A109). J. H. R. F. and A. G. L. were supported by the University of Cambridge, Cancer Research UK (C14303/A17197), and Hutchison Whampoa. K. L. is supported by a UK Medical Research Council Skills Development Fellowship Award. C. S. is funded by Cancer Research UK (TRACERx), the Rosetrees Trust, NovoNordisk Foundation (16584), EU FP7 (projects PREDICT and RESPONSIFY, ID number 259303), the Prostate Cancer Foundation, the Breast Cancer Research Foundation, the European Research Council (THESEUS), and National Institute for Health Research University College London Hospitals Biomedical Research Centre. P. J. C. has a Wellcome Trust Senior Clinical Research Fellowship (WT088340MA).	Alexandrov LB, 2015, NAT GENET, V47, P1402, DOI 10.1038/ng.3441; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Ali H, 2013, GENE CHROMOSOME CANC, V52, P402, DOI 10.1002/gcc.22038; Barthel FP, 2017, NAT GENET, V49, P349, DOI 10.1038/ng.3781; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Cancer Research UK, 2017, KIDN CANC INC STAT; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Davis CF, 2014, CANCER CELL, V26, P319, DOI 10.1016/j.ccr.2014.07.014; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Dey P, 2017, NATURE, V542, P119, DOI 10.1038/nature21052; Durinck S, 2011, CANCER DISCOV, V1, P137, DOI 10.1158/2159-8290.CD-11-0028; Farmery H.J.R., 2017, BIORXIV, DOI [10.1101/139972, DOI 10.1101/139972]; Fei SS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11588; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Frew IJ, 2015, ANNU REV PATHOL-MECH, V10, P263, DOI 10.1146/annurev-pathol-012414-040306; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Greenman CD, 2012, GENOME RES, V22, P346, DOI 10.1101/gr.118414.110; Horikawa I, 2002, MOL BIOL CELL, V13, P2585, DOI 10.1091/mbc.E01-11-0107; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Jones D., 2016, CURR PROTOC BIOINFOR, V56, DOI DOI 10.1002/CPBI.20MEDLINE; Kinsella M, 2014, NUCLEIC ACIDS RES, V42, P8231, DOI 10.1093/nar/gku525; Klatte T, 2009, J CLIN ONCOL, V27, P746, DOI 10.1200/JCO.2007.15.8345; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; KOVACS G, 1987, INT J CANCER, V40, P171, DOI 10.1002/ijc.2910400208; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li LJ, 2013, CANCER CELL, V24, P738, DOI 10.1016/j.ccr.2013.10.025; Maciejowski J, 2015, CELL, V163, P1641, DOI 10.1016/j.cell.2015.11.054; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Martincorena I, 2017, CELL, V171, P1029, DOI 10.1016/j.cell.2017.09.042; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; Nielsen SM, 2016, J CLIN ONCOL, V34, P2172, DOI 10.1200/JCO.2015.65.6140; Nijhawan D, 2012, CELL, V150, P842, DOI 10.1016/j.cell.2012.07.023; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Oh S, 2000, ONCOGENE, V19, P1485, DOI 10.1038/sj.onc.1203439; Pavlovich CP, 2003, GENE CHROMOSOME CANC, V37, P252, DOI 10.1002/gcc.10209; Raine K.M., 2016, CURR PROTOC BIOINFOR, V56; Raine K.M., 2015, CURR PROTOC BIOINFOR, V52; Sabo A, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014191; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Turajlic S, 2018, CELL, V173, P595, DOI 10.1016/j.cell.2018.03.043; Turajlic S, 2018, CELL, V173, P581, DOI 10.1016/j.cell.2018.03.057; Turajlic S, 2017, NAT REV UROL, V14, P575, DOI 10.1038/nrurol.2017.112; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Yang ZQ, 2000, JPN J CANCER RES, V91, P156, DOI 10.1111/j.1349-7006.2000.tb00927.x; ZBAR B, 1987, NATURE, V327, P721, DOI 10.1038/327721a0; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493	63	238	239	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2018	173	3					611	+		10.1016/j.cell.2018.02.020	http://dx.doi.org/10.1016/j.cell.2018.02.020			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7GB	29656891	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000430677400012
J	Shukla, SA; Bachireddy, P; Schilling, B; Galonska, C; Zhan, Q; Bango, C; Langer, R; Lee, PC; Gusenleitner, D; Keskin, DB; Babadi, M; Mohammad, A; Gnirke, A; Clement, K; Cartun, ZJ; Van Allen, EM; Miao, D; Huang, Y; Snyder, A; Merghoub, T; Wolchok, JD; Garraway, LA; Meissner, A; Weber, JS; Hacohen, N; Neuberg, D; Potts, PR; Murphy, GF; Lian, CG; Schadendorf, D; Hodi, FS; Wu, CJ				Shukla, Sachet A.; Bachireddy, Pavan; Schilling, Bastian; Galonska, Christina; Zhan, Qian; Bango, Clyde; Langer, Rupert; Lee, Patrick C.; Gusenleitner, Daniel; Keskin, Derin B.; Babadi, Mehrtash; Mohammad, Arman; Gnirke, Andreas; Clement, Kendell; Cartun, Zachary J.; Van Allen, Eliezer M.; Miao, Diana; Huang, Ying; Snyder, Alexandra; Merghoub, Taha; Wolchok, Jedd D.; Garraway, Levi A.; Meissner, Alexander; Weber, Jeffrey S.; Hacohen, Nir; Neuberg, Donna; Potts, Patrick R.; Murphy, George F.; Lian, Christine G.; Schadendorf, Dirk; Hodi, F. Stephen; Wu, Catherine J.			Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade	CELL			English	Article							METASTATIC MELANOMA; UBIQUITIN LIGASES; TUMOR-ANTIGEN; MAGE FAMILY; T-CELLS; AUTOPHAGY; IPILIMUMAB; GENES; IMMUNOTHERAPY; LYMPHOCYTES	CTLA-4 immune checkpoint blockade is clinically effective in a subset of patients with metastatic melanoma. We identify a subcluster of MAGE-A cancer-germline antigens, located within a narrow 75 kb region of chromosome Xq28, that predicts resistance uniquely to blockade of CTLA-4, but not PD-1. We validate this gene expression signature in an independent anti-CTLA-4-treated cohort and show its specificity to the CTLA-4 pathway with two independent anti-PD-1-treated cohorts. Autophagy, a process critical for optimal anti-cancer immunity, has previously been shown to be suppressed by the MAGE-TRIM28 ubiquitin ligase in vitro. We now show that the expression of the key autophagosome component LC3B and other activators of autophagy are negatively associated with MAGE-A protein levels in human melanomas, including samples from patients with resistance to CTLA-4 blockade. Our findings implicate autophagy suppression in resistance to CTLA-4 blockade in melanoma, suggesting exploitation of autophagy induction for potential therapeutic synergy with CTLA-4 inhibitors.	[Shukla, Sachet A.; Bachireddy, Pavan; Bango, Clyde; Lee, Patrick C.; Gusenleitner, Daniel; Keskin, Derin B.; Cartun, Zachary J.; Van Allen, Eliezer M.; Miao, Diana; Huang, Ying; Garraway, Levi A.; Hodi, F. Stephen; Wu, Catherine J.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Shukla, Sachet A.; Bachireddy, Pavan; Keskin, Derin B.; Babadi, Mehrtash; Mohammad, Arman; Gnirke, Andreas; Clement, Kendell; Van Allen, Eliezer M.; Miao, Diana; Garraway, Levi A.; Meissner, Alexander; Hacohen, Nir; Wu, Catherine J.] Broad Inst, Cambridge, MA 02142 USA; [Bachireddy, Pavan; Keskin, Derin B.; Van Allen, Eliezer M.; Garraway, Levi A.; Hodi, F. Stephen; Wu, Catherine J.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Schilling, Bastian; Schadendorf, Dirk] Univ Duisburg Essen, Univ Hosp, Dept Dermatol, D-45147 Essen, Germany; [Schilling, Bastian; Schadendorf, Dirk] German Canc Consortium DKTK, D-69121 Heidelberg, Germany; [Schilling, Bastian] Univ Hosp Wurzburg, Dept Dermatol Venereol & Allergol, D-97080 Wurzburg, Germany; [Galonska, Christina] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Zhan, Qian; Murphy, George F.; Lian, Christine G.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Program Dermatopathol, Boston, MA 02115 USA; [Clement, Kendell; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Snyder, Alexandra; Merghoub, Taha; Wolchok, Jedd D.] Weill Cornell Med Coll, New York, NY USA; [Snyder, Alexandra; Merghoub, Taha; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10016 USA; [Weber, Jeffrey S.] NYU, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Neuberg, Donna] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Potts, Patrick R.] St Jude Childrens Res Hosp, Dept Cell & Mol Biol, 332 N Lauderdale, Memphis, TN 38105 USA; [Langer, Rupert] Univ Bern, Dept Pathol, CH-3012 Bern, Switzerland	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); University of Wurzburg; Max Planck Society; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Cornell University; Memorial Sloan Kettering Cancer Center; New York University; NYU Langone Medical Center; Harvard University; Dana-Farber Cancer Institute; St Jude Children's Research Hospital; University of Bern	Wu, CJ (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.; Wu, CJ (corresponding author), Broad Inst, Cambridge, MA 02142 USA.; Wu, CJ (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	cwu@partners.org	Bachireddy, Pavan/ABG-8998-2020; Clement, Kendell/AAZ-6854-2021; Langer, Rupert/AAU-1174-2021; Potts, Patrick R/P-4707-2018; Merghoub, Taha/ABD-8362-2021; Schilling, Bastian/AAY-8646-2020; Schadendorf, Dirk/AAE-8206-2019	Bachireddy, Pavan/0000-0002-8698-4957; Langer, Rupert/0000-0001-9491-3609; Potts, Patrick R/0000-0002-2024-8885; Schilling, Bastian/0000-0001-8859-4103; Weber, Jeffrey/0000-0002-4962-2957; Galonska, Christina/0000-0002-6920-5608; Schadendorf, Dirk/0000-0003-3524-7858	Blavatnik Family Foundation; National Heart, Lung, and Blood Institute (NHLBI) [1RO1HL103532-01]; National Cancer Institute (NCI) [1R01CA155010-01A1]; NCI [R50 RCA211482A]; Damon Runyon Physician-Scientist Training Award; Conquer Cancer Foundation Young Investigator Award; Starr Foundation; New York Stem Cell Foundation; NIH [R01DA036898]; DoD [BC134001P1]; DanaFarber/Harvard Cancer Center [5P30 CA006516]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R50CA211482, P30CA006516, P30CA008748, R01CA155010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036898] Funding Source: NIH RePORTER	Blavatnik Family Foundation; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Damon Runyon Physician-Scientist Training Award; Conquer Cancer Foundation Young Investigator Award; Starr Foundation; New York Stem Cell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD(United States Department of Defense); DanaFarber/Harvard Cancer Center; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Patrick Ott for stimulating scientific discussions; Samuel Lee and David Benjamin for method development for copy-number analysis; and Christine Horak, Donald Jackson, and Han Chang for facilitating access to RNA sequencing data from the CheckMate 064 trial. This work has made extensive use of data generated by TCGA, a project of the National Cancer Institute and National Human Genome Research Institute. C.J.W. is a Scholar of the Leukemia and Lymphoma Society and acknowledges support from the Blavatnik Family Foundation, National Heart, Lung, and Blood Institute (NHLBI) (1RO1HL103532-01), and National Cancer Institute (NCI) (1R01CA155010-01A1). S.A.S. acknowledges support by the NCI (R50 RCA211482A). P.B. acknowledges support by the Damon Runyon Physician-Scientist Training Award and the Conquer Cancer Foundation Young Investigator Award. A.M. was supported by the Starr Foundation, the New York Stem Cell Foundation, NIH (R01DA036898), and DoD (BC134001P1). D.N. is supported by DanaFarber/Harvard Cancer Center Support Grant 5P30 CA006516. D.M. is supported by the Howard Hughes Medical Institute.	Adams O, 2016, ONCOTARGET, V7, P39241, DOI 10.18632/oncotarget.9649; Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Azimi F, 2012, J CLIN ONCOL, V30, P2678, DOI 10.1200/JCO.2011.37.8539; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barrow C, 2006, CLIN CANCER RES, V12, P764, DOI 10.1158/1078-0432.CCR-05-1544; Bredenbeck A, 2008, GENE, V415, P68, DOI 10.1016/j.gene.2008.02.019; Bronietzki AW, 2015, IMMUNOL CELL BIOL, V93, P25, DOI 10.1038/icb.2014.81; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Coulie PG, 2014, NAT REV CANCER, V14, P135, DOI 10.1038/nrc3670; DEPLAEN E, 1994, IMMUNOGENETICS, V40, P360, DOI 10.1007/BF01246677; Di Biase S, 2016, CANCER CELL, V30, P136, DOI 10.1016/j.ccell.2016.06.005; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gumireddy K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10715; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kleffel S, 2015, CELL, V162, P1242, DOI 10.1016/j.cell.2015.08.052; Lee AK, 2017, J MOL BIOL, V429, P1114, DOI 10.1016/j.jmb.2017.03.005; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Palucka K, 2014, CELL, V157, P516, DOI 10.1016/j.cell.2014.03.044; Pedicord VA, 2011, P NATL ACAD SCI USA, V108, P266, DOI 10.1073/pnas.1016791108; Pietrocola F, 2016, CANCER CELL, V30, P147, DOI 10.1016/j.ccell.2016.05.016; Pineda CT, 2015, CELL, V160, P715, DOI 10.1016/j.cell.2015.01.034; Pu Y, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad5659; Riaz N, 2016, NAT GENET, V48, P1327, DOI 10.1038/ng.3677; Roeder C, 2005, ARCH DERMATOL RES, V296, P314, DOI 10.1007/s00403-004-0527-7; Saiag P, 2016, ANN ONCOL, V27, DOI 10.1093/annonc/mdw291; Schlafli AM, 2015, EUR J HISTOCHEM, V59, P137, DOI 10.4081/ejh.2015.2481; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; van der Bruggen P, 2002, IMMUNOL REV, V188, P51, DOI 10.1034/j.1600-065X.2002.18806.x; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vansteenkiste JF, 2016, LANCET ONCOL, V17, P822, DOI 10.1016/S1470-2045(16)00099-1; Weber JS, 2016, LANCET ONCOL, V17, P943, DOI 10.1016/S1470-2045(16)30126-7; Weerasekara VK, 2014, MOL CELL BIOL, V34, P4379, DOI 10.1128/MCB.00740-14; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yuan JD, 2011, P NATL ACAD SCI USA, V108, P16723, DOI 10.1073/pnas.1110814108; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	47	76	80	4	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2018	173	3					624	+		10.1016/j.cell.2018.03.026	http://dx.doi.org/10.1016/j.cell.2018.03.026			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7GB	29656892	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000430677400013
J	Maw, AM; Soni, NJ				Maw, Anna M.; Soni, Nilam J.			Inpatient Notes: Why Should Hospitalists Use Point-of-Care Ultrasound?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							LUNG ULTRASOUND; HEART-FAILURE; ULTRASONOGRAPHY; DIAGNOSIS		[Maw, Anna M.] Univ Colorado, Denver, CO 80202 USA; [Soni, Nilam J.] Univ Texas Hlth San Antonio, San Antonio, TX USA; [Soni, Nilam J.] South Texas Vet Hlth Care Syst, San Antonio, TX USA	University of Colorado System; University of Colorado Denver; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Maw, AM (corresponding author), Univ Colorado, Dept Med, Div Hosp Med, St 12401 East 17th Ave, Aurora, CO 80045 USA.	anna.maw@ucdenver.edu	Nilam Soni, Nilam J Soni/AAU-4098-2021	Nilam Soni, Nilam J Soni/0000-0002-8460-0323	Department of Veterans Affairs	Department of Veterans Affairs(US Department of Veterans Affairs)	Dr. Soni reports grants/grants pending from the Department of Veterans Affairs and royalties for Elsevier-Saunders. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do? msNum=M18-0367.	Llamas-Alvarez AM, 2017, CHEST, V151, P374, DOI 10.1016/j.chest.2016.10.039; Mozzini C, 2018, INTERN EMERG MED, V13, P27, DOI 10.1007/s11739-017-1738-1; Oks M, 2014, CHEST, V146, P1574, DOI 10.1378/chest.14-0728; Pivetta E, 2015, CHEST, V148, P202, DOI 10.1378/chest.14-2608; Soni NJ, 2015, J HOSP MED, V10, P120, DOI 10.1002/jhm.2285	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2018	168	8					HO2	HO3		10.7326/M18-0367	http://dx.doi.org/10.7326/M18-0367			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GC8XZ	29677272				2022-12-28	WOS:000430083100001
J	Werner, RM; Konetzka, RT				Werner, Rachel M.; Konetzka, R. Tamara			Trends in Post-Acute Care Use Among Medicare Beneficiaries: 2000 to 2015	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Werner, Rachel M.] Univ Penn, Perelman Sch Med, Div Gen Internal Med, 423 Guardian Dr,Blockley Hall,Room 1314, Philadelphia, PA 19104 USA; [Konetzka, R. Tamara] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA	University of Pennsylvania; Pennsylvania Medicine; University of Chicago	Werner, RM (corresponding author), Univ Penn, Perelman Sch Med, Div Gen Internal Med, 423 Guardian Dr,Blockley Hall,Room 1314, Philadelphia, PA 19104 USA.	rwerner@upenn.edu		Konetzka, R Tamara/0000-0003-3016-1318; Werner, Rachel/0000-0003-3435-4221	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS024266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG047908] Funding Source: NIH RePORTER; AHRQ HHS [R01 HS024266] Funding Source: Medline; NIA NIH HHS [K24 AG047908] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Burke RE, 2015, JAMA INTERN MED, V175, P295, DOI 10.1001/jamainternmed.2014.6383; Centers for Medicare & Medicaid Services, MEDPAR RIF; Dummit LA, 2016, JAMA-J AM MED ASSOC, V316, P1267, DOI 10.1001/jama.2016.12717; Mechanic R, 2014, NEW ENGL J MED, V370, P692, DOI 10.1056/NEJMp1315607; MedPac, 2017, DAT BOOK HLTH CAR SP	5	64	64	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2018	319	15					1616	1617		10.1001/jama.2018.2408	http://dx.doi.org/10.1001/jama.2018.2408			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD0UT	29677292	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000430217100022
J	Burnett, DL; Langley, DB; Schofield, P; Hermes, JR; Chan, TD; Jackson, J; Bourne, K; Reed, JH; Patterson, K; Porebski, BT; Brink, R; Christ, D; Goodnow, CC				Burnett, Deborah L.; Langley, David B.; Schofield, Peter; Hermes, Jana R.; Chan, Tyani D.; Jackson, Jennifer; Bourne, Katherine; Reed, Joanne H.; Patterson, Kate; Porebski, Benjamin T.; Brink, Robert; Christ, Daniel; Goodnow, Christopher C.			Germinal center antibody mutation trajectories are determined by rapid self/foreign discrimination	SCIENCE			English	Article							REACTIVE B-CELLS; SELF-REACTIVITY; PLASMA-CELL; ANTIGEN; AUTOANTIBODIES; RECOGNITION; REPERTOIRE; REDEMPTION	Antibodies have the specificity to differentiate foreign antigens that mimic self antigens, but it remains unclear how such specificity is acquired. In a mouse model, we generated B cells displaying an antibody that cross-reacts with two related protein antigens expressed on self versus foreign cells. B cell anergy was imposed by self antigen but reversed upon challenge with high-density foreign antigen, leading to germinal center recruitment and antibody gene hypermutation. Single-cell analysis detected rapid selection for mutations that decrease self affinity and slower selection for epistatic mutations that specifically increase foreign affinity. Crystal structures revealed that these mutations exploited subtle topological differences to achieve 5000-fold preferential binding to foreign over self epitopes. Resolution of antigenic mimicry drove the optimal affinity maturation trajectory, highlighting the value of retaining self-reactive clones as substrates for protective antibody responses.	[Burnett, Deborah L.; Langley, David B.; Schofield, Peter; Hermes, Jana R.; Chan, Tyani D.; Jackson, Jennifer; Bourne, Katherine; Reed, Joanne H.; Patterson, Kate; Brink, Robert; Christ, Daniel; Goodnow, Christopher C.] Garvan Inst Med Res, 384 Victoria St, Darlinghurst, NSW 2010, Australia; [Burnett, Deborah L.; Schofield, Peter; Chan, Tyani D.; Brink, Robert; Christ, Daniel; Goodnow, Christopher C.] Univ New South Wales Sydney, St Vincents Clin Sch, Sydney, NSW, Australia; [Porebski, Benjamin T.] MRC, Lab Mol Biol, Francis Crick Ave, Cambridge CB2 OQH, England	Garvan Institute of Medical Research; University of New South Wales Sydney	Christ, D; Goodnow, CC (corresponding author), Garvan Inst Med Res, 384 Victoria St, Darlinghurst, NSW 2010, Australia.; Christ, D; Goodnow, CC (corresponding author), Univ New South Wales Sydney, St Vincents Clin Sch, Sydney, NSW, Australia.	d.christ@garvan.org.au; c.goodnow@garvan.org.au	Goodnow, Christopher C/V-8108-2018; Brink, Robert/B-7910-2010; Langley, David B/B-1861-2009; Christ, Daniel/C-1861-2018	Goodnow, Christopher C/0000-0001-5296-6155; Brink, Robert/0000-0002-9586-3655; Langley, David B/0000-0003-2752-0041; Chan, Tyani/0000-0001-9276-8479; Christ, Daniel/0000-0002-7313-3977; Patterson, Kate/0000-0003-3919-7261; Schofield, Peter/0000-0002-8046-3667; Reed, Joanne/0000-0002-7585-7848	National Health and Medical Research Council [1016953, 1113904, 1108800, 585490, 1081858]; Australian Research Council [160104915, 140103465]; Bill and Patricia Ritchie Foundation; MRC [MC_U105178804] Funding Source: UKRI	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Bill and Patricia Ritchie Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by program grants 1016953 and 1113904, project grant 1108800, and fellowships 585490 and 1081858 from the National Health and Medical Research Council; by Discovery grants 160104915 and 140103465 from the Australian Research Council; and by The Bill and Patricia Ritchie Foundation.	Acchione M, 2009, MOL IMMUNOL, V47, P457, DOI 10.1016/j.molimm.2009.08.018; Burnet F., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Chan TD, 2012, IMMUNITY, V37, P893, DOI 10.1016/j.immuni.2012.07.017; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; FULCHER DA, 1994, J EXP MED, V179, P125, DOI 10.1084/jem.179.1.125; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Gristick HB, 2016, NAT STRUCT MOL BIOL, V23, P906, DOI 10.1038/nsmb.3291; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; LEDERBERG J, 1959, SCIENCE, V129, P1649, DOI 10.1126/science.129.3364.1649; Nemazee D, 2000, J EXP MED, V191, P1813, DOI 10.1084/jem.191.11.1813; Nemazee D, 1996, IMMUNOL TODAY, V17, P25, DOI 10.1016/0167-5699(96)80565-2; PADLAN EA, 1989, P NATL ACAD SCI USA, V86, P5938, DOI 10.1073/pnas.86.15.5938; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; PERELSON AS, 1979, J THEOR BIOL, V81, P645, DOI 10.1016/0022-5193(79)90275-3; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; Pinschewer DD, 2004, J CLIN INVEST, V114, P988, DOI 10.1172/JCI200422374; Reed JH, 2016, J EXP MED, V213, P1255, DOI 10.1084/jem.20151978; Sabouri Z, 2014, P NATL ACAD SCI USA, V111, pE2567, DOI 10.1073/pnas.1406974111; Tan J, 2016, NATURE, V529, P105, DOI 10.1038/nature16450; Wakerley BR, 2013, EXPERT REV CLIN IMMU, V9, P627, DOI 10.1586/1744666X.2013.811119; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514	25	83	84	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2018	360	6385					223	226		10.1126/science.aao3859	http://dx.doi.org/10.1126/science.aao3859			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC5DK	29650674	Green Accepted			2022-12-28	WOS:000429805400051
J	This, H				This, H			Chemins et Savoirs du Sel	NATURE			English	Book Review									Coll France, Lab Interact Mol, F-75231 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; College de France	This, H (corresponding author), Coll France, Lab Interact Mol, F-75231 Paris 05, France.		This vo Kientza, Herve Jacques Marie/GWQ-7304-2022					LASZLO P, 1998, CHEMINS SAVOIRS SEL	1	0	0	0	4	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					403	404		10.1038/17062	http://dx.doi.org/10.1038/17062			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667977	Bronze			2022-12-28	WOS:000078461700037
J	Bennett, WL; Wilson, RF; Zhang, A; Tseng, E; Knapp, EA; Kharrazi, H; Stuart, EA; Shogbesan, O; Bass, EB; Cheskin, LJ				Bennett, Wendy L.; Wilson, Renee F.; Zhang, Allen; Tseng, Eva; Knapp, Emily A.; Kharrazi, Hadi; Stuart, Elizabeth A.; Shogbesan, Oluwaseun; Bass, Eric B.; Cheskin, Lawrence J.			Methods for Evaluating Natural Experiments in Obesity A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							BODY-MASS INDEX; CHILDRENS PHYSICAL-ACTIVITY; SUGAR-SWEETENED BEVERAGES; LOW-INCOME CHILDREN; CHILDHOOD OBESITY; VEGETABLE CONSUMPTION; SCHOOL NUTRITION; COMPETITIVE FOOD; DRINK CONSUMPTION; DIETARY BEHAVIORS	Background: Given the obesity pandemic, rigorous methodological approaches, including natural experiments, are needed. Purpose: To identify studies that report effects of programs, policies, or built environment changes on obesity prevention and control and to describe their methods. Data Sources: PubMed, CINAHL, PsycINFO, and EconLit (January 2000 to August 2017). Study Selection: Natural experiments and experimental studies evaluating a program, policy, or built environment change in U.S. or non-U.S. populations by using measures of obesity or obesity-related health behaviors. Data Extraction: 2 reviewers serially extracted data on study design, population characteristics, data sources and linkages, measures, and analytic methods and independently evaluated risk of bias. Data Synthesis: 294 studies (188 U.S., 106 non-U.S.) were identified, including 156 natural experiments (53%), 118 experimental studies (40%), and 20 (7%) with unclear study design. Studies used 106 (71 U.S., 35 non-U.S.) data systems; 37% of the U.S. data systems were linked to another data source. For outcomes, 112 studies reported childhood weight and 32 adult weight; 152 had physical activity and 148 had dietary measures. For analysis, natural experiments most commonly used cross-sectional comparisons of exposed and unexposed groups (n = 55 [35%]). Most natural experiments had a high risk of bias, and 63% had weak handling of withdrawals and dropouts. Limitation: Outcomes restricted to obesity measures and health behaviors; inconsistent or unclear descriptions of natural experiment designs; and imperfect methods for assessing risk of bias in natural experiments. Conclusion: Many methodologically diverse natural experiments and experimental studies were identified that reported effects of U.S. and non-U.S. programs, policies, or built environment changes on obesity prevention and control. The findings reinforce the need for methodological and analytic advances that would strengthen evaluations of obesity prevention and control initiatives.	[Bennett, Wendy L.] Johns Hopkins Univ, Sch Med, Div Gen Internal Med, 2024 East Monument St,Suite 2-616, Baltimore, MD 21205 USA; [Tseng, Eva] Johns Hopkins Univ, Div Gen Internal Med, Sch Med, 2024 East Monument St,Suite 2-601, Baltimore, MD 21205 USA; [Bass, Eric B.] Johns Hopkins Univ, Div Gen Internal Med, Sch Med, 624 North Broadway,Room 680A, Baltimore, MD 21205 USA; [Wilson, Renee F.; Zhang, Allen; Knapp, Emily A.; Kharrazi, Hadi; Stuart, Elizabeth A.; Shogbesan, Oluwaseun; Cheskin, Lawrence J.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; [Bennett, Wendy L.; Wilson, Renee F.; Zhang, Allen; Tseng, Eva; Knapp, Emily A.; Kharrazi, Hadi; Stuart, Elizabeth A.; Shogbesan, Oluwaseun; Bass, Eric B.; Cheskin, Lawrence J.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Wilson, Renee F.] Johns Hopkins Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 624 North Broadway,Room 645, Baltimore, MD 21205 USA; [Zhang, Allen; Kharrazi, Hadi; Shogbesan, Oluwaseun] Johns Hopkins Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 624 North Broadway,Room 661, Baltimore, MD 21205 USA; [Knapp, Emily A.] Johns Hopkins Univ, Dept Epidemiol, Sch Publ Hlth, 615 North Wolfe St, Baltimore, MD 21205 USA; [Cheskin, Lawrence J.] Johns Hopkins Univ, Sch Publ Hlth, 550 North Broadway,Suite 1001, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Bennett, WL (corresponding author), Johns Hopkins Univ, Sch Med, Div Gen Internal Med, 2024 East Monument St,Suite 2-616, Baltimore, MD 21205 USA.	wendy.bennett@jhmi.edu	Kharrazi, Hadi/Q-1725-2015; Cheskin, Lawrence/AAM-1094-2021	Kharrazi, Hadi/0000-0003-1481-4323; Cheskin, Lawrence/0000-0003-0262-1030; Stuart, Elizabeth/0000-0002-9042-8611; Bennett, Wendy/0000-0001-9828-0706; Knapp, Emily/0000-0003-3953-9874; Bass, Eric/0000-0001-9106-527X	National Institutes of Health, Office of Disease Prevention, and Agency for Healthcare Research and Quality [CRD42017055750]	National Institutes of Health, Office of Disease Prevention, and Agency for Healthcare Research and Quality	National Institutes of Health, Office of Disease Prevention, and Agency for Healthcare Research and Quality. (PROSPERO: CRD42017055750)	Barnidge EK, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-128; Bauhoff S, 2014, ECON HUM BIOL, V12, P45, DOI 10.1016/j.ehb.2013.06.001; Bennett WL, 2017, AHRQ PUBLICATION, V18-EHC006-EF; Bere E, 2006, HEALTH EDUC RES, V21, P268, DOI 10.1093/her/cyh063; Bere E, 2005, PREV MED, V41, P463, DOI 10.1016/j.ypmed.2004.11.024; Branas CC, 2011, AM J EPIDEMIOL, V174, P1296, DOI 10.1093/aje/kwr273; Camacho-Rivera M, 2017, J RACIAL ETHN HEALTH, V4, P346, DOI 10.1007/s40615-016-0234-z; Capogrossi K, 2017, HEALTH ECON, V26, P980, DOI 10.1002/hec.3378; Cheadle A, 2012, AM J HEALTH PROMOT, V27, pE59, DOI 10.4278/ajhp.111222-QUAN-462; Chen C, 2015, J HUM CAPITAL, V9, P364, DOI 10.1086/683055; Chen R, 2015, AM J PUBLIC HEALTH, V105, P546, DOI 10.2105/AJPH.2014.302262; Cleland V, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-14; Coffield JE, 2011, J ADOLESCENT HEALTH, V49, P363, DOI 10.1016/j.jadohealth.2011.01.010; Committee on Evaluating Progress of Obesity Prevention Effort; Food and Nutrition Board; Institute of Medicine, 2013, EV OB PREV EFF PLAN; Corriveau N, 2015, AM J PUBLIC HEALTH, V105, pE19, DOI 10.2105/AJPH.2015.302835; Cradock AL, 2011, PREV CHRONIC DIS, V8; Craig P, 2012, J EPIDEMIOL COMMUN H, V66, P1182, DOI 10.1136/jech-2011-200375; Cummins S, 2005, J EPIDEMIOL COMMUN H, V59, P1035, DOI 10.1136/jech.2004.029843; Cummins S, 2008, ENVIRON PLANN A, V40, P402, DOI 10.1068/a38371; Cummins S, 2014, HEALTH AFFAIR, V33, P283, DOI 10.1377/hlthaff.2013.0512; Datar A, 2017, J ADOLESCENT HEALTH, V60, P520, DOI 10.1016/j.jadohealth.2016.09.003; de Silva-Sanigorski A, 2011, CHILD CARE HLTH DEV, V37, P385, DOI 10.1111/j.1365-2214.2010.01205.x; Dubowitz T, 2015, HEALTH AFFAIR, V34, P1858, DOI 10.1377/hlthaff.2015.0667; Economos CD, 2017, OBESITY, V25, P1155, DOI 10.1002/oby.21893; Effective Public Health Practice Project (EPHPP), 2009, QUAL ASS TOOL QUANT; Elbel B, 2009, HEALTH AFFAIR, V28, pW1110, DOI 10.1377/hlthaff.28.6.w1110; Evans CEL, 2013, PUBLIC HEALTH NUTR, V16, P1073, DOI 10.1017/S1368980012005290; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Falbe J, 2016, AM J PUBLIC HEALTH, V106, P1865, DOI 10.2105/AJPH.2016.303362; Fitzpatrick C, 2017, INT J OBESITY, V41, P1005, DOI 10.1038/ijo.2017.39; Fleurence RL, 2014, J AM MED INFORM ASSN, V21, P578, DOI 10.1136/amiajnl-2014-002747; Folta SC, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-157; Frongillo EA, 2017, AM J PREV MED, V53, P576, DOI 10.1016/j.amepre.2017.05.006; Fulcher CL, 2014, NATL CIV REV, V103, P9; Gee KA, 2015, J ADOLESCENT HEALTH, V57, P270, DOI 10.1016/j.jadohealth.2015.05.007; Giles-Corti B, 2013, SOC SCI MED, V77, P20, DOI 10.1016/j.socscimed.2012.10.016; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Hammond RA, 2009, PREV CHRONIC DIS, V6; Hennessy E, 2014, J SCHOOL HEALTH, V84, P609, DOI 10.1111/josh.12181; Hobin E, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0550-7; Hobin E, 2014, J OBES, V2014, DOI 10.1155/2014/958645; Hoelscher D, 2016, ENVIRON BEHAV, V48, P210, DOI 10.1177/0013916515613541; Howlett E, 2016, J BUS ETHICS, V139, P215, DOI 10.1007/s10551-015-2605-5; Hu YN, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3505-z; Hughes RJ, 2012, BRIT J NUTR, V108, P733, DOI 10.1017/S0007114511005939; Hunter S, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0411-9; Institute of Education Sciences, 2015, WHAT WORKS CLEAR PRE; Jia P, 2017, INT J OBESITY, V41, P813, DOI 10.1038/ijo.2017.2; Jones Kelly K, 2017, BMC Res Notes, V10, P35, DOI 10.1186/s13104-016-2355-1; Just DR, 2014, OBESITY, V22, P24, DOI 10.1002/oby.20591; Kern E, 2014, MMWR-MORBID MORTAL W, V63, P155; Kim J, 2012, J SCHOOL HEALTH, V82, P268, DOI 10.1111/j.1746-1561.2012.00697.x; Kubik MY, 2005, ARCH PEDIAT ADOL MED, V159, P1111, DOI 10.1001/archpedi.159.12.1111; Lachapelle U, 2009, J PUBLIC HEALTH POL, V30, pS73, DOI 10.1057/jphp.2008.52; Liu J, 2017, PUBLIC HEALTH NUTR, V20, P2478, DOI [10.1017/S1368980016002329, 10.1017/s1368980016002329]; Lorentzen C, 2009, HEALTH EDUC BEHAV, V36, P348, DOI 10.1177/1090198107308372; Ludwig J, 2011, NEW ENGL J MED, V365, P1509, DOI 10.1056/NEJMsa1103216; MacDonald JM, 2010, AM J PREV MED, V39, P105, DOI 10.1016/j.amepre.2010.03.016; Madsen KA, 2011, ARCH PEDIAT ADOL MED, V165, P987, DOI 10.1001/archpediatrics.2011.127; Malakellis M, 2017, AUST NZ J PUBL HEAL, V41, P490, DOI 10.1111/1753-6405.12696; Masse LC, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-29; Medical Research Council, 2010, US NAT EXP EV POP HL; Miewald C, 2012, CAN J DIET PRACT RES, V73, P59, DOI 10.3148/73.2.2012.59; Miller HJ, 2015, HEALTH PLACE, V36, P8, DOI 10.1016/j.healthplace.2015.08.005; Nanney MS, 2016, AM J PREV MED, V51, P656, DOI 10.1016/j.amepre.2016.05.008; Naylor PJ, 2006, J SCI MED SPORT, V9, P413, DOI 10.1016/j.jsams.2006.06.013; Nguyen BT, 2015, PREV MED, V81, P82, DOI 10.1016/j.ypmed.2015.08.003; Olsho LEW, 2015, PUBLIC HEALTH NUTR, V18, P2712, DOI 10.1017/S1368980015001056; Parsons WG, 2014, J SCH NURS, V30, P324, DOI 10.1177/1059840513513155; Perry CL, 2004, HEALTH EDUC BEHAV, V31, P65, DOI 10.1177/1090198103255530; Peterson KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134470; Pope M, 2016, PEDIATR PHYS THER, V28, P207, DOI 10.1097/PEP.0000000000000243; Porta M., 2014, DICT EPIDEMIOLOGY, V6th ed; Powell LM, 2009, J ADOLESCENT HEALTH, V45, pS57, DOI 10.1016/j.jadohealth.2009.03.003; Quigg R, 2012, J URBAN HEALTH, V89, P171, DOI 10.1007/s11524-011-9622-1; Restrepo BJ, 2017, HEALTH ECON, V26, P1191, DOI 10.1002/hec.3389; Riis J, 2012, MATERN CHILD HLTH J, V16, pS111, DOI 10.1007/s10995-012-1000-4; Robles B, 2017, J ACAD NUTR DIET, V117, P58, DOI 10.1016/j.jand.2016.07.012; Rush E, 2014, BRIT J NUTR, V111, P363, DOI 10.1017/S0007114513002316; Sabia JJ, 2017, HEALTH ECON, V26, P1291, DOI 10.1002/hec.3399; Sadler RC, 2013, INT J ENV RES PUB HE, V10, P3325, DOI 10.3390/ijerph10083325; Schwartz AE, 2016, JAMA PEDIATR, V170, P220, DOI 10.1001/jamapediatrics.2015.3778; Sekhobo JP, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140152; Sisnowski J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182581; Slater S, 2014, PREV MED, V69, pS37, DOI 10.1016/j.ypmed.2014.08.032; Sturm R, 2015, SOC SCI MED, V133, P205, DOI 10.1016/j.socscimed.2015.03.004; Sturm R, 2010, HEALTH AFFAIR, V29, P1052, DOI 10.1377/hlthaff.2009.0061; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Taber DR, 2012, PEDIATRICS, V130, P437, DOI 10.1542/peds.2011-3353; Taber DR, 2012, ARCH PEDIAT ADOL MED, V166, P256, DOI 10.1001/archpediatrics.2011.200; Taber DR, 2011, AM J PUBLIC HEALTH, V101, P1769, DOI 10.2105/AJPH.2011.300221; Tester JM, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3557; Thom G, 2017, GASTROENTEROLOGY, V152, P1739, DOI 10.1053/j.gastro.2017.01.056; Toussaint LL, 2017, FAM COMMUNITY HEALTH, V40, P192, DOI [10.1097/FCH.0000000000000151, 10.1097/fch.0000000000000151]; Utter J, 2016, PREV MED, V83, P1, DOI 10.1016/j.ypmed.2015.11.022; Vadiveloo MK, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-51; von Hippel PT, 2015, PREV MED, V78, P44, DOI 10.1016/j.ypmed.2015.06.011; Webb E, 2012, J EPIDEMIOL COMMUN H, V66, P176, DOI 10.1136/jech.2011.133165; Wells L, 2005, BRIT J NUTR, V93, P537, DOI 10.1079/BJN20051393; Wong S H, 2016, Hong Kong Med J, V22 Suppl 6, P43; Woodward-Lopez G, 2010, AM J PUBLIC HEALTH, V100, P2137, DOI 10.2105/AJPH.2010.193490; World Health Organization Rotary International Centers for Disease Control and Prevention and UNICEF, 2013, GLOBAL ACTION PLAN P; Wright K, 2012, CHILD OBES, V8, P347, DOI 10.1089/chi.2012.0045; [No title captured]	104	13	13	0	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2018	168	11					791	+		10.7326/M18-0309	http://dx.doi.org/10.7326/M18-0309			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI3EK	29710087				2022-12-28	WOS:000434254100006
J	Becher, I; Andres-Pons, A; Romanov, N; Stein, F; Schramm, M; Baudin, F; Helm, D; Kurzawa, N; Mateus, A; Mackmull, MT; Typas, A; Muller, CW; Bork, P; Beck, M; Savitski, MM				Becher, Isabelle; Andres-Pons, Amparo; Romanov, Natalie; Stein, Frank; Schramm, Maike; Baudin, Florence; Helm, Dominic; Kurzawa, Nils; Mateus, Andre; Mackmull, Marie-Therese; Typas, Athanasios; Mueller, Christoph W.; Bork, Peer; Beck, Martin; Savitski, Mikhail M.			Pervasive Protein Thermal Stability Variation during the Cell Cycle	CELL			English	Article							RANGTP-DEPENDENT MAP; DISORDERED PROTEIN; PHOSPHORYLATION; MITOSIS; SPINDLE; DYNAMICS; REVEALS; COMPLEX; IDENTIFICATION; TRANSCRIPTION	Quantitative mass spectrometry has established proteome-wide regulation of protein abundance and post-translational modifications in various biological processes. Here, we used quantitative mass spectrometry to systematically analyze the thermal stability and solubility of proteins on a proteome-wide scale during the eukaryotic cell cycle. We demonstrate pervasive variation of these biophysical parameters with most changes occurring in mitosis and G1. Various cellular pathways and components vary in thermal stability, such as cell-cycle factors, polymerases, and chromatin remodelers. We demonstrate that protein thermal stability serves as a proxy for enzyme activity, DNA binding, and complex formation in situ. Strikingly, a large cohort of intrinsically disordered and mitotically phosphorylated proteins is stabilized and solubilized in mitosis, suggesting a fundamental remodeling of the biophysical environment of the mitotic cell. Our data represent a rich resource for cell, structural, and systems biologists interested in proteome regulation during biological transitions.	[Becher, Isabelle; Schramm, Maike; Kurzawa, Nils; Mateus, Andre; Typas, Athanasios; Savitski, Mikhail M.] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Andres-Pons, Amparo; Romanov, Natalie; Baudin, Florence; Mackmull, Marie-Therese; Mueller, Christoph W.; Bork, Peer; Beck, Martin] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Stein, Frank; Helm, Dominic] European Mol Biol Lab, Prote Core Facil, D-69117 Heidelberg, Germany; [Bork, Peer] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Bork, Peer] Mol Med Partnership Unit, D-69120 Heidelberg, Germany; [Bork, Peer] Univ Wurzburg, Bioctr, Dept Bioinformat, D-97074 Wurzburg, Germany; [Beck, Martin] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Wurzburg; European Molecular Biology Laboratory (EMBL)	Savitski, MM (corresponding author), European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany.; Bork, P; Beck, M (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany.; Bork, P (corresponding author), Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany.; Bork, P (corresponding author), Mol Med Partnership Unit, D-69120 Heidelberg, Germany.; Bork, P (corresponding author), Univ Wurzburg, Bioctr, Dept Bioinformat, D-97074 Wurzburg, Germany.; Beck, M (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany.	bork@embl.de; martin.beck@embl.de; mikhail.savitski@embl.de	Bork, Peer/F-1813-2013; Kurzawa, Nils/ABB-5422-2020; Beck, Martin/B-5589-2011; Müller, Christoph W/I-7420-2012	Bork, Peer/0000-0002-2627-833X; Kurzawa, Nils/0000-0002-7846-2817; Beck, Martin/0000-0002-7397-1321; Müller, Christoph W/0000-0003-2176-8337; Mateus, Andre/0000-0001-6870-0677; Becher, Isabelle/0000-0001-7170-2235; Andres-Pons, Amparo/0000-0001-5801-4024; Stein, Frank/0000-0001-9695-1692; Mackmull, Marie-Therese/0000-0003-2928-1144; Baudin, Florence/0000-0003-0816-0861; Helm, Dominic/0000-0001-9321-2069; Typas, Athanasios/0000-0002-0797-9018	EMBL; European Research Council [NPCAtlas-309271, ComplexAssembly-724349]	EMBL; European Research Council(European Research Council (ERC)European Commission)	We thank the Proteomics, Flow Cytometry, Genomics, and Advanced Light Microscopy Core Facilities at the EMBL. This work was funded by EMBL and grants from the European Research Council (NPCAtlas-309271 and ComplexAssembly-724349) (to M.B.).	Arnaoutov A, 2014, SCIENCE, V345, P1512, DOI 10.1126/science.1251550; Bah A, 2015, NATURE, V519, P106, DOI 10.1038/nature13999; Becher I, 2016, NAT CHEM BIOL, V12, P908, DOI [10.1038/NCHEMBIO.2185, 10.1038/nchembio.2185]; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011429; Boisvert FM, 2010, MOL CELL PROTEOMICS, V9, P457, DOI 10.1074/mcp.M900429-MCP200; CHOU YH, 1990, CELL, V62, P1063, DOI 10.1016/0092-8674(90)90384-Q; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Erfle H, 2007, NAT PROTOC, V2, P392, DOI 10.1038/nprot.2006.483; Foisner R, 1996, MOL BIOL CELL, V7, P273, DOI 10.1091/mbc.7.2.273; Franken H, 2015, NAT PROTOC, V10, P1567, DOI 10.1038/nprot.2015.101; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Graham AC, 2009, MOL BIOL CELL, V20, P2242, DOI 10.1091/mbc.E08-08-0825; Grob A, 2014, GENE DEV, V28, P220, DOI 10.1101/gad.234591.113; Guo X, 2016, NAT CELL BIOL, V18, P202, DOI 10.1038/ncb3289; Hashizume C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.370; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hernandez-Verdun D, 2011, NUCLEUS-PHILA, V2, P189, DOI 10.4161/nucl.2.3.16246; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hughes CS, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145625; Jensen LJ, 2006, NATURE, V443, P594, DOI 10.1038/nature05186; Jiang H, 2015, CELL, V163, P108, DOI 10.1016/j.cell.2015.08.010; Jongsma MLM, 2015, TRENDS CELL BIOL, V25, P112, DOI 10.1016/j.tcb.2014.10.005; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Kinor N, 2011, NUCLEUS-PHILA, V2, P229, DOI 10.4161/nucl.2.3.15893; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Laurell E, 2011, CELL, V144, P539, DOI 10.1016/j.cell.2011.01.012; Lee IH, 2013, CURR OPIN CELL BIOL, V25, P724, DOI 10.1016/j.ceb.2013.07.002; Lemke EA, 2016, J MOL BIOL, V428, P2011, DOI 10.1016/j.jmb.2016.01.002; Leuenberger P, 2017, SCIENCE, V355, DOI 10.1126/science.aai7825; Liang KW, 2015, MOL CELL, V60, P435, DOI 10.1016/j.molcel.2015.09.021; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mann M, 2013, MOL CELL, V49, P583, DOI 10.1016/j.molcel.2013.01.029; Milles S, 2013, EMBO REP, V14, P178, DOI 10.1038/embor.2012.204; Murakami H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000317; Oates ME, 2013, NUCLEIC ACIDS RES, V41, pD508, DOI 10.1093/nar/gks1226; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ori A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0912-5; Pelisch F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6485; Poole W, 2016, BIOINFORMATICS, V32, P430, DOI 10.1093/bioinformatics/btw438; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Romanova L, 2009, J BIOL CHEM, V284, P26685, DOI 10.1074/jbc.M109.013342; SASAKI K, 1993, CYTOMETRY, V14, P876, DOI 10.1002/cyto.990140805; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; Savitski MM, 2014, SCIENCE, V346, P55, DOI 10.1126/science.1255784; Scaglia N, 2014, CELL CYCLE, V13, P859, DOI 10.4161/cc.27767; Schwarz DS, 2016, CELL MOL LIFE SCI, V73, P79, DOI 10.1007/s00018-015-2052-6; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Tafur L, 2016, MOL CELL, V64, P1135, DOI 10.1016/j.molcel.2016.11.013; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Tiku V, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16083; Tyanova S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002842; von Appen A, 2015, NATURE, V526, P140, DOI 10.1038/nature15381; Werner T, 2014, ANAL CHEM, V86, P3594, DOI 10.1021/ac500140s; Wilkie GS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003129; Yao Q, 2011, J BIOL CHEM, V286, P27342, DOI 10.1074/jbc.M111.220848; Yokoyama H, 2013, CURR BIOL, V23, P2443, DOI 10.1016/j.cub.2013.09.062; Yokoyama H, 2009, J CELL BIOL, V187, P813, DOI 10.1083/jcb.200906020; Zeng SX, 2010, MOL CELL BIOL, V30, P935, DOI 10.1128/MCB.01379-09	65	103	107	3	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2018	173	6					1495	+		10.1016/j.cell.2018.03.053	http://dx.doi.org/10.1016/j.cell.2018.03.053			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GH9KU	29706546	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000433989100020
J	Pavlovich, SS; Lovett, SP; Koroleva, G; Guito, JC; Arnold, CE; Nagle, ER; Kulcsar, K; Lee, A; Thibaud-Nissen, F; Hume, AJ; Muhlberger, E; Uebelhoer, LS; Towner, JS; Rabadan, R; Sanchez-Lockhart, M; Kepler, TB; Palacios, G				Pavlovich, Stephanie S.; Lovett, Sean P.; Koroleva, Galina; Guito, Jonathan C.; Arnold, Catherine E.; Nagle, Elyse R.; Kulcsar, Kirsten; Lee, Albert; Thibaud-Nissen, Francoise; Hume, Adam J.; Muhlberger, Elke; Uebelhoer, Luke S.; Towner, Jonathan S.; Rabadan, Raul; Sanchez-Lockhart, Mariano; Kepler, Thomas B.; Palacios, Gustavo			The Egyptian Rousette Genome Reveals Unexpected Features of Bat Antiviral Immunity	CELL			English	Article							MARBURG VIRUS; MESSENGER-RNAS; ALIGNMENT; EVOLUTION; SEQUENCE; TOOL; RECOGNITION; EXPRESSION; RECEPTORS; GENES	Bats harbor many viruses asymptomatically, including several notorious for causing extreme virulence in humans. To identify differences between antiviral mechanisms in humans and bats, we sequenced, assembled, and analyzed the genome of Rousettus aegyptiacus, a natural reservoir of Marburg virus and the only known reservoir for any filovirus. We found an expanded and diversified KLRC/KLRD family of natural killer cell receptors, MHC class I genes, and type I interferons, which dramatically differ from their functional counterparts in other mammals. Such concerted evolution of key components of bat immunity is strongly suggestive of novel modes of antiviral defense. An evaluation of the theoretical function of these genes suggests that an inhibitory immune state may exist in bats. Based on our findings, we hypothesize that tolerance of viral infection, rather than enhanced potency of antiviral defenses, may be a key mechanism by which bats asymptomatically host viruses that are pathogenic in humans.	[Pavlovich, Stephanie S.; Hume, Adam J.; Muhlberger, Elke; Kepler, Thomas B.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Lovett, Sean P.; Koroleva, Galina; Arnold, Catherine E.; Nagle, Elyse R.; Kulcsar, Kirsten; Sanchez-Lockhart, Mariano; Palacios, Gustavo] US Army, Ctr Genome Sci, Res Inst Infect Dis USAMRIID, Frederick, MD 21702 USA; [Lee, Albert; Rabadan, Raul] Columbia Univ, Dept Syst Biol, New York, NY USA; [Lee, Albert; Rabadan, Raul] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Thibaud-Nissen, Francoise] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Guito, Jonathan C.; Uebelhoer, Luke S.; Towner, Jonathan S.] Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Atlanta, GA 30333 USA; [Sanchez-Lockhart, Mariano] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Kepler, Thomas B.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Kepler, Thomas B.] Boston Univ, Natl Emerging Infect Dis Lab, Boston, MA 02118 USA	Boston University; Columbia University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Centers for Disease Control & Prevention - USA; University of Nebraska System; University of Nebraska Medical Center; Boston University; Boston University	Kepler, TB (corresponding author), Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA.; Palacios, G (corresponding author), US Army, Ctr Genome Sci, Res Inst Infect Dis USAMRIID, Frederick, MD 21702 USA.; Kepler, TB (corresponding author), Boston Univ, Dept Math & Stat, Boston, MA 02215 USA.; Kepler, TB (corresponding author), Boston Univ, Natl Emerging Infect Dis Lab, Boston, MA 02118 USA.	tbkepler@bu.edu; gustavo.f.palacios.ctr@mail.mil	Sanchez-Lockhart, Mariano/M-6446-2019; Muhlberger, Elke/AAD-6924-2019; Sanchez-Lockhart, Mariano/H-1321-2019; Palacios, Gustavo/I-7773-2015; Hume, Adam/ABA-7439-2020; Towner, Jonathan/ABC-3780-2020; Rabadan, Raul/AAZ-7367-2020	Sanchez-Lockhart, Mariano/0000-0001-8009-7540; Sanchez-Lockhart, Mariano/0000-0001-8009-7540; Palacios, Gustavo/0000-0001-5062-1938; Hume, Adam/0000-0001-8454-3472; Rabadan, Raul/0000-0001-7946-9255; Muhlberger, Elke/0000-0003-3547-9376; Kulcsar, Kirsten/0000-0001-9385-8775; Arnold, Catherine/0000-0002-1635-4941	Defense Threat Reduction Agency, Department of Defense [HDTRA1-14-1-0016]; NIH NIAID [T32AI007309-26]; NIH NIGMS [5R01GM117591, 1R01GM109018]; NIH, National Library of Medicine; EU ANTIGONE [278976]; German Research Council [DR 772/10-2]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117591, R01GM109018] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIHLM200888] Funding Source: NIH RePORTER	Defense Threat Reduction Agency, Department of Defense(United States Department of DefenseDefense Threat Reduction Agency); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH, National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); EU ANTIGONE; German Research Council(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank John H. Connor for his generous contribution of VSV-eGFP, Kaitlin Sawatzki for her help with Figure 1 and members of the Kepler lab for their helpful discussion. We gratefully acknowledge Ayan K. Chakrabarti, who performed the RNA extraction for the interferon induction experiment. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the U.S. Army or the Centers for Disease Control and Prevention. Research was conducted under an IACUC-approved protocol in compliance with the Animal Welfare Act, PHS Policy, and other federal statutes and regulations relating to animals and experiments involving animals. The facility where this research was conducted is accredited by the Association for Assessment and Accreditation of Laboratory Animal Care, International and adheres to principles stated in the Guide for the Care and Use of Laboratory Animals, National Research Council, 2011. This work has been funded by the Defense Threat Reduction Agency, Department of Defense (HDTRA1-14-1-0016 to G.P. and J.S.T.) and NIH NIAID (training grant T32AI007309-26 to S.S.P., awarded to David H. Sherr). Part of the work was funded by NIH NIGMS (5R01GM117591 and 1R01GM109018 to R.R. and A.L.). Part of this project was also supported by the Intramural Research Program of the NIH, National Library of Medicine (F.T.-N.). The Rousettus aegyptiacus cell line RoNi/7.1 was generated by M.A. Muller and C. Drosten, Charite-Universitatsmedizin Berlin, Germany with funds from the EU-FP7 ANTIGONE (no. 278976) framework and the German Research Council (DR 772/10-2).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amman BR, 2015, J WILDLIFE DIS, V51, P113, DOI 10.7589/2014-08-198; Averdam A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000688; Bailly-Bechet M, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-13; Baker ML, 2013, ZOONOSES PUBLIC HLTH, V60, P104, DOI 10.1111/j.1863-2378.2012.01528.x; Banerjee A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01513-w; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bielawski JP, 2005, STAT BIOL HEALTH, P103, DOI 10.1007/0-387-27733-1_5; Biesold SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028131; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Connor JH, 2015, J VIROL, V89, P9865, DOI 10.1128/JVI.01142-15; De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097; De La Cruz-Rivera PC, 2018, J IMMUNOL, V200, P209, DOI 10.4049/jimmunol.1701214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fischer Steve, 2011, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0612s35; Gifford R. J., DIGS FOR EVES; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Holzer M, 2016, SCI REP-UK, V6, DOI 10.1038/srep34589; Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004; Jones MEB, 2015, VIRUSES-BASEL, V7, P3420, DOI 10.3390/v7072779; Kaiser BK, 2008, P NATL ACAD SCI USA, V105, P6696, DOI 10.1073/pnas.0802736105; Kapustin Y, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-20; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kepler TB, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-444; Kikuchi-Maki A, 2005, J IMMUNOL, V174, P3859, DOI 10.4049/jimmunol.174.7.3859; Koch J, 2013, TRENDS IMMUNOL, V34, P182, DOI 10.1016/j.it.2013.01.003; Kolde R, 2012, PHEATMAP PRETTY HEAT, V61, P617; Kulski JK, 2002, IMMUNOL REV, V190, P95, DOI 10.1034/j.1600-065X.2002.19008.x; Kwiecinski Gary G., 1999, Mammalian Species, V611, P1; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lanier LL, 2009, IMMUNOL REV, V227, P150, DOI 10.1111/j.1600-065X.2008.00720.x; Lee AK, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2124-x; Li H., 2013, ARXIV13033997, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Liu X, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1137-3; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maldonado E, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1204-5; Malireddi RKS, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00077; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Molfetta R, 2016, TRENDS IMMUNOL, V37, P790, DOI 10.1016/j.it.2016.08.015; Morgulis A, 2006, BIOINFORMATICS, V22, P134, DOI 10.1093/bioinformatics/bti774; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; National Center for Biotechnology Information, GNOM NCBI EUK GEN PR; NCBI Eukaryotic Annotation Group, 2016, NCBI ROUS AEG ANN RE; Ng JHJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21256; O'Callaghan CA, 2000, CLIN SCI, V99, P9, DOI 10.1042/CS19990334; Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975; Papenfuss AT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-261; Parham P, 2013, NAT REV IMMUNOL, V13, P133, DOI 10.1038/nri3370; Parker J, 2013, NATURE, V502, P228, DOI 10.1038/nature12511; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Petrie EJ, 2008, J EXP MED, V205, P725, DOI 10.1084/jem.20072525; Rapaport AS, 2015, IMMUNITY, V43, P1112, DOI 10.1016/j.immuni.2015.11.005; Salmela L, 2014, BIOINFORMATICS, V30, P3506, DOI 10.1093/bioinformatics/btu538; Schuh AJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14446; Secombes CJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00209; Seim I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3212; Shaw TI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048472; Smit A, REPEATMASKER OPEN 4; Smith I, 2013, CURR OPIN VIROL, V3, P84, DOI 10.1016/j.coviro.2012.11.006; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thibaud-Nissen F., 2013, EUKARYOTIC GENOME AN; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Tsagkogeorga G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00132-9; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Warren RL, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0076-3; Whitlow ZW, 2008, J VIROL, V82, P2286, DOI 10.1128/JVI.01761-07; Whitlow ZW, 2006, J VIROL, V80, P11733, DOI 10.1128/JVI.00971-06; Xue W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-604; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Ye CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep31900; Ye CX, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S6-S1; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; Zhang GJ, 2013, SCIENCE, V339, P456, DOI 10.1126/science.1230835; Zhang Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182866; Zhou P, 2016, P NATL ACAD SCI USA, V113, P2696, DOI 10.1073/pnas.1518240113	85	118	123	4	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 17	2018	173	5					1098	+		10.1016/j.cell.2018.03.070	http://dx.doi.org/10.1016/j.cell.2018.03.070			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GG1UA	29706541	Green Published, Bronze			2022-12-28	WOS:000432471700008
J	Tanaka, EM				Tanaka, Elly M.			Regenerating tissues Studies of regeneration inform us about how to position organs	SCIENCE			English	Editorial Material							MORPHOGENESIS; PLANARIANS; EVOLUTION; GENOME		[Tanaka, Elly M.] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Tanaka, EM (corresponding author), Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Vienna, Austria.	elly.tanaka@imp.ac.at		Tanaka, Elly/0000-0003-4240-2158				Atabay KD, 2018, SCIENCE, V360, P404, DOI 10.1126/science.aap8179; BRYANT SV, 1976, DEV BIOL, V50, P212, DOI 10.1016/0012-1606(76)90079-8; BUTLER ELMER GRIMSHAW, 1955, J MORPH, V96, P265, DOI 10.1002/jmor.1050960204; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Elliott SA, 2013, WIRES DEV BIOL, V2, P301, DOI 10.1002/wdev.82; GOULD RP, 1972, EXP CELL RES, V72, P325, DOI 10.1016/0014-4827(72)90593-9; Grohme MA, 2018, NATURE, V554, P56, DOI 10.1038/nature25473; Hill EM, 2018, ELIFE, V7, DOI 10.7554/eLife.33680; Nowoshilow S, 2018, NATURE, V554, P50, DOI 10.1038/nature25458; Owlarn S, 2016, REGENERATION, V3, P139, DOI 10.1002/reg2.56; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Raspopovic J, 2014, SCIENCE, V345, P566, DOI 10.1126/science.1252960; Takata N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01105-2; Tanaka EM, 2016, CELL, V165, P1598, DOI 10.1016/j.cell.2016.05.038	15	3	3	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					374	375		10.1126/science.aat4588	http://dx.doi.org/10.1126/science.aat4588			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1AR	29700249				2022-12-28	WOS:000430949600018
J	Lemoine, F; Entfellner, JBD; Wilkinson, E; Correia, D; Felipe, MD; De Oliveira, T; Gascuel, O				Lemoine, F.; Entfellner, J. -B. Domelevo; Wilkinson, E.; Correia, D.; Felipe, M. Davila; De Oliveira, T.; Gascuel, O.			Renewing Felsenstein's phylogenetic bootstrap in the era of big data	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; 1ST-ORDER CORRECT; CONFIDENCE-LIMITS; ROGUE TAXA; SUBTYPE-C; TREES; SUPPORT; APPROXIMATION; PERFORMANCE; PARTITIONS	Felsenstein's application of the bootstrap method to evolutionary trees is one of the most cited scientific papers of all time. The bootstrap method, which is based on resampling and replications, is used extensively to assess the robustness of phylogenetic inferences. However, increasing numbers of sequences are now available for a wide variety of species, and phylogenies based on hundreds or thousands of taxa are becoming routine. With phylogenies of this size Felsenstein's bootstrap tends to yield very low supports, especially on deep branches. Here we propose a new version of the phylogenetic bootstrap in which the presence of inferred branches in replications is measured using a gradual ` transfer' distance rather than the binary presence or absence index used in Felsenstein's original version. The resulting supports are higher and do not induce falsely supported branches. The application of our method to large mammal, HIV and simulated datasets reveals their phylogenetic signals, whereas Felsenstein's bootstrap fails to do so.	[Lemoine, F.; Correia, D.; Felipe, M. Davila; Gascuel, O.] Inst Pasteur, USR C3BI 3756, Unite Bioinformat Evolut, Paris, France; [Lemoine, F.; Correia, D.; Felipe, M. Davila; Gascuel, O.] CNRS, Paris, France; [Lemoine, F.] Inst Pasteur, USR C3BI 3756, Hub Bioinformat & Biostat, Paris, France; [Entfellner, J. -B. Domelevo] Univ Western Cape, Dept Comp Sci, Cape Town, South Africa; [Entfellner, J. -B. Domelevo] Univ Western Cape, South African Natl Bioinformat Inst, South African MRC Bioinformat Unit, Cape Town, South Africa; [Wilkinson, E.; De Oliveira, T.] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa; [De Oliveira, T.] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa; [Gascuel, O.] Univ Montpellier, LIRMM UMR 5506, Methodes & Algorithmes Bioinformat, Montpellier, France; [Gascuel, O.] CNRS, Montpellier, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of the Western Cape; University of the Western Cape; University of Kwazulu Natal; University of Kwazulu Natal; Centre National de la Recherche Scientifique (CNRS); Universite Paul-Valery; Universite Perpignan Via Domitia; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS)	Gascuel, O (corresponding author), Inst Pasteur, USR C3BI 3756, Unite Bioinformat Evolut, Paris, France.; Gascuel, O (corresponding author), CNRS, Paris, France.; Gascuel, O (corresponding author), Univ Montpellier, LIRMM UMR 5506, Methodes & Algorithmes Bioinformat, Montpellier, France.; Gascuel, O (corresponding author), CNRS, Montpellier, France.	olivier.gascuel@pasteur.fr			EU-H Virogenesis project [634650]; INCEPTION project [PIA/ANR-16-CONV-0005]; Institut Francais de Bioinformatique [IFB - ANR-11-INBS-0013]; Flagship grant from the South African Medical Research Council [MRC-RFA-UFSP-01-2013/UKZN HIVEPI]; H3ABioNet project (NIH) [U41HG006941, U24HG006941]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U24HG006941, U41HG006941] Funding Source: NIH RePORTER	EU-H Virogenesis project; INCEPTION project; Institut Francais de Bioinformatique; Flagship grant from the South African Medical Research Council; H3ABioNet project (NIH); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank F. Delsuc, S. Holmes, L. Chindelevitch and E. Susko for help and suggestions. This work was supported by the EU-H2020 Virogenesis project (grant number 634650, to E.W., T.D.O. and O.G.), by the INCEPTION project (PIA/ANR-16-CONV-0005, to F.L., D.C., M.D.F. and O.G.), by the Institut Francais de Bioinformatique (IFB - ANR-11-INBS-0013, to D.C.), by the Flagship grant from the South African Medical Research Council (MRC-RFA-UFSP-01-2013/UKZN HIVEPI to E.W., T.D.O. and J.-B.D.E.) and by the H3ABioNet project (NIH grant number U41HG006941 to J.-B.D.E. and U24HG006941 to E.W. and T.D.O.).	Aberer AJ, 2013, SYST BIOL, V62, P162, DOI 10.1093/sysbio/sys078; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Billera LJ, 2001, ADV APPL MATH, V27, P733, DOI 10.1006/aama.2001.0759; Brehelin L, 2008, BIOINFORMATICS, V24, P682, DOI 10.1093/bioinformatics/btn017; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Charon I, 2006, J CLASSIF, V23, P103, DOI 10.1007/s00357-006-0006-2; DAY WHE, 1981, MATH SOC SCI, V1, P269, DOI 10.1016/0165-4896(81)90042-1; Delatorre EO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041904; Di Tommaso P, 2017, NAT BIOTECHNOL, V35, P316, DOI 10.1038/nbt.3820; Efron B, 1996, P NATL ACAD SCI USA, V93, P7085, DOI 10.1073/pnas.93.14.7085; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Efron B., 1994, MONOGRAPHS STAT APPL; FELSENSTEIN J, 1993, SYST BIOL, V42, P193, DOI 10.2307/2992541; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fletcher W, 2009, MOL BIOL EVOL, V26, P1879, DOI 10.1093/molbev/msp098; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hemelaar J, 2012, TRENDS MOL MED, V18, P182, DOI 10.1016/j.molmed.2011.12.001; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Holmes S, 2003, STAT SCI, V18, P241, DOI 10.1214/ss/1063994979; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kumar S, 2012, MOL BIOL EVOL, V29, P457, DOI 10.1093/molbev/msr202; Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Lin Y, 2012, IEEE ACM T COMPUT BI, V9, P1014, DOI 10.1109/TCBB.2011.157; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Sand A, 2014, BIOINFORMATICS, V30, P2079, DOI 10.1093/bioinformatics/btu157; Sanderson MJ, 2002, ANNU REV ECOL SYST, V33, P49, DOI 10.1146/annurev.ecolsys.33.010802.150509; SANDERSON MJ, 1995, SYST BIOL, V44, P299, DOI 10.2307/2413594; SANDERSON MJ, 1989, CLADISTICS, V5, P113, DOI 10.1111/j.1096-0031.1989.tb00559.x; Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371; Semple C., 2003, PHYLOGENETICS; Siddappa NB, 2004, J CLIN MICROBIOL, V42, P2742, DOI 10.1128/JCM.42.6.2742-2751.2004; Soares MA, 2003, AIDS, V17, P11, DOI 10.1097/00002030-200301030-00004; Soltis PS, 2003, STAT SCI, V18, P256; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Susko E, 2010, MOL BIOL EVOL, V27, P1621, DOI 10.1093/molbev/msq048; Susko E, 2009, SYST BIOL, V58, P211, DOI 10.1093/sysbio/syp016; Thomson RC, 2010, SYST BIOL, V59, P42, DOI 10.1093/sysbio/syp075; Thorley JL, 1999, J THEOR BIOL, V200, P343, DOI 10.1006/jtbi.1999.0999; Truszkowski J, 2016, SYST BIOL, V65, P328, DOI 10.1093/sysbio/syv089; Van Noorden R, 2014, NATURE, V514, P550, DOI 10.1038/514550a; Wilkinson M, 1996, MOL BIOL EVOL, V13, P437, DOI 10.1093/oxfordjournals.molbev.a025604; Zharkikh A, 1995, MOL PHYLOGENET EVOL, V4, P44, DOI 10.1006/mpev.1995.1005	48	246	246	3	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					452	+		10.1038/s41586-018-0043-0	http://dx.doi.org/10.1038/s41586-018-0043-0			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8VX	29670290	Green Submitted, Green Accepted			2022-12-28	WOS:000430793000037
J	Xu, J; Bartolome, CL; Low, CS; Yi, XC; Chien, CH; Wang, P; Kong, D				Xu, Jie; Bartolome, Christopher L.; Low, Cho Shing; Yi, Xinchi; Chien, Cheng-Hao; Wang, Peng; Kong, Dong			Genetic identification of leptin neural circuits in energy and glucose homeostases	NATURE			English	Article							ARCUATE NUCLEUS; AGRP NEURONS; POMC NEURONS; INSULIN-SECRETION; MICE; OBESITY; MOUSE; SYSTEM; SUPPRESSION; METABOLISM	Leptin, a hormone produced in white adipose tissue, acts in the brain to communicate fuel status, suppress appetite following a meal, promote energy expenditure and maintain blood glucose stability(1,2). Dysregulation of leptin or its receptors (LEPR) results in severe obesity and diabetes(3-5). Although intensive studies on leptin have transformed obesity and diabetes research(2,6), clinical applications of the molecule are still limited(7), at least in part owing to the complexity and our incomplete understanding of the underlying neural circuits. The hypothalamic neurons that express agouti-related peptide (AGRP) and pro-opiomelanocortin (POMC) have been hypothesized to be the main first-order, leptin-responsive neurons. Selective deletion of LEPR in these neurons with the Cre-loxP system, however, has previously failed to recapitulate, or only marginally recapitulated, the obesity and diabetes that are seen in LEPR-deficient Lepr(db/db) mice, suggesting that AGRP or POMC neurons are not directly required for the effects of leptin in vivo(8-10). The primary neural targets of leptin are therefore still unclear. Here we conduct a systematic, unbiased survey of leptin-responsive neurons in streptozotocin-induced diabetic mice and exploit CRISPR-Cas9-mediated genetic ablation of LEPR in vivo. Unexpectedly, we find that AGRP neurons but not POMC neurons are required for the primary action of leptin to regulate both energy balance and glucose homeostasis. Leptin deficiency disinhibits AGRP neurons, and chemogenetic inhibition of these neurons reverses both diabetic hyperphagia and hyperglycaemia. In sharp contrast to previous studies, we show that CRISPR-mediated deletion of LEPR in AGRP neurons causes severe obesity and diabetes, faithfully replicating the phenotype of Lepr(db/db) mice. We also uncover divergent mechanisms of acute and chronic inhibition of AGRP neurons by leptin (presynaptic potentiation of GABA (gamma-aminobutyric acid) neurotransmission and postsynaptic activation of ATP-sensitive potassium channels, respectively). Our findings identify the underlying basis of the neurobiological effects of leptin and associated metabolic disorders.	[Xu, Jie; Bartolome, Christopher L.; Low, Cho Shing; Yi, Xinchi; Chien, Cheng-Hao; Wang, Peng; Kong, Dong] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Bartolome, Christopher L.; Kong, Dong] Tufts Univ, Sackler Sch Grad Biomed Sci, Program Neurosci, Boston, MA 02111 USA; [Low, Cho Shing; Kong, Dong] Tufts Univ, Sackler Sch Grad Biomed Sci, Program Cellular Mol & Dev Biol, Boston, MA 02111 USA	Tufts University; Tufts University; Tufts University	Kong, D (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA.; Kong, D (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Program Neurosci, Boston, MA 02111 USA.; Kong, D (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Program Cellular Mol & Dev Biol, Boston, MA 02111 USA.	dong.kong@tufts.edu	Core, Vector/CAF-4832-2022	xu, jie/0000-0001-7761-4666	NIH/NINDS [P30 NS047243]; NIH/NEI [P30 EY012196-17]; NIH/NIDDK [P30 DK046200-26, K01 DK094943, R01 DK108797]; NINDS [T32NS061764-09, R21 NS097922]; AHA-Postdoctoral Fellowship [17POST33661185]; BNORC Transgenic core; BNORC P F grant; BNORC small grant program [NIDDK P30 DK046200]; Charles Hood Foundation Award; NATIONAL EYE INSTITUTE [P30EY012196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK108797, P30DK046200, K01DK094943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243, R21NS097922, T32NS061764] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); AHA-Postdoctoral Fellowship(American Heart Association); BNORC Transgenic core; BNORC P F grant; BNORC small grant program; Charles Hood Foundation Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all members of the Kong laboratory for helpful discussions and comments on the manuscript; F. Zhang for providing pX330 plasmid and Rosa26-LSL-Cas9-GFP mice; Tufts CNR for confocal imaging (supported by NIH/NINDS P30 NS047243); Boston Children's Hospital Viral Core for AAV virus packaging (supported by NIH/NEI P30 EY012196-17); the Adipose Tissue Biology and Nutrient Metabolism Core and A. Greenberg for help with body mass and oxygen consumption measurement (supported by NIH/NIDDK P30 DK046200-26); BIDMC-FNL and G. Blackburn for equipment support; and P. Haydon and M. Rios for reading the manuscript. This research is supported by the following grants: to C.L.B., NINDS T32NS061764-09; to C.H.C., AHA-Postdoctoral Fellowship 17POST33661185; to D.K., NIH/NIDDK K01 DK094943, R01 DK108797, NINDS R21 NS097922, BNORC Transgenic core, BNORC P& F grant, BNORC small grant program (NIDDK P30 DK046200) and Charles Hood Foundation Award.	Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; de Wall EV, 2008, ENDOCRINOLOGY, V149, P1773, DOI 10.1210/en.2007-1132; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Flak JN, 2016, MOL ENDOCRINOL, V30, P3, DOI 10.1210/me.2015-1232; Friedman J, 2014, J ENDOCRINOL, V223, pT1, DOI 10.1530/JOE-14-0405; Fujikawa T, 2010, P NATL ACAD SCI USA, V107, P17391, DOI 10.1073/pnas.1008025107; Garfield AS, 2016, NAT NEUROSCI, V19, P1628, DOI 10.1038/nn.4392; Henry FE, 2015, ELIFE, V4, DOI 10.7554/eLife.09800; Kelesidis T, 2010, ANN INTERN MED, V152, P93, DOI 10.7326/0003-4819-152-2-201001190-00008; Knight ZA, 2012, CELL, V151, P1126, DOI 10.1016/j.cell.2012.10.039; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Kong D, 2016, NEURON, V91, P25, DOI 10.1016/j.neuron.2016.05.025; Kong D, 2012, CELL, V151, P645, DOI 10.1016/j.cell.2012.09.020; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Leiter E. H., 1993, ILAR News, V35, P4; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Morton GJ, 2011, PHYSIOL REV, V91, P389, DOI 10.1152/physrev.00007.2010; Opland D, 2013, MOL METAB, V2, P423, DOI 10.1016/j.molmet.2013.07.008; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Perry RJ, 2014, NAT MED, V20, P759, DOI 10.1038/nm.3579; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rudolph U, 2004, ANNU REV PHARMACOL, V44, P475, DOI 10.1146/annurev.pharmtox.44.101802.121429; Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; van den Pol AN, 2009, J NEUROSCI, V29, P4622, DOI 10.1523/JNEUROSCI.3249-08.2009; van den Top M, 2004, NAT NEUROSCI, V7, P493, DOI 10.1038/nn1226; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	40	123	129	1	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					505	+		10.1038/s41586-018-0049-7	http://dx.doi.org/10.1038/s41586-018-0049-7			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8VX	29670283	Green Accepted			2022-12-28	WOS:000430793000048
J	Demaio, A; Marshall, R				Demaio, Alessandro; Marshall, Robert			Social lobbying: a call to arms for public health	LANCET			English	Editorial Material									[Demaio, Alessandro] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Demaio, Alessandro] Univ Copenhagen, Sch Global Hlth, Dept Publ Hlth, Copenhagen, Denmark; [Demaio, Alessandro] EAT Fdn, Oslo, Norway; [Marshall, Robert] Royal Australasian Coll Phys, Sydney, NSW, Australia	University of Melbourne; University of Copenhagen	Demaio, A (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia.; Demaio, A (corresponding author), Univ Copenhagen, Sch Global Hlth, Dept Publ Hlth, Copenhagen, Denmark.; Demaio, A (corresponding author), EAT Fdn, Oslo, Norway.	sandro@sandrofoundation.org		Demaio, Alessandro/0000-0002-1767-4576				[Anonymous], 2015, LANCET, V386, P1312, DOI 10.1016/S0140-6736(15)00397-9; Bass G. D., 2007, SEEN NOT HEARD STREN; Center for Responsive Politics, 2018, LOBB DAT; Clark J, 2016, LANCET, V388, P2457, DOI 10.1016/S0140-6736(16)32184-5; Hoffer AJ, 2014, INDEP REV, V19, P58; Kelly B, 2014, J SCI MED SPORT, V17, P394, DOI 10.1016/j.jsams.2013.07.005; Kickbusch I, 2016, LANCET GLOB HEALTH, V4, pE895, DOI 10.1016/S2214-109X(16)30217-0; Mackay J, 2012, BRIT MED BULL, V102, P5, DOI 10.1093/bmb/lds007; Oliver TR, 2006, ANNU REV PUBL HEALTH, V27, P195, DOI 10.1146/annurev.publhealth.25.101802.123126; Pettijohn S.L., 2013, NONPROFIT GOVT CONTR; Salamon LM, 2012, STATE OF NONPROFIT AMERICA, SECOND EDITION, P1; Vernick JS, 1999, AM J PUBLIC HEALTH, V89, P1425, DOI 10.2105/AJPH.89.9.1425; *WHO, 2017, WHO STAT PHIL MORR F	13	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2018	391	10130					1558	1559		10.1016/S0140-6736(18)30831-6	http://dx.doi.org/10.1016/S0140-6736(18)30831-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GD5JG	29695332				2022-12-28	WOS:000430542700008
J	Rodriguez, H; Pennington, SR				Rodriguez, Henry; Pennington, Stephen R.			Revolutionizing Precision Oncology through Collaborative Proteogenomics and Data Sharing	CELL			English	Editorial Material							REPRODUCIBILITY	The integration of proteomics into precision oncology presents opportunities that may transform the molecular analysis of cancer and accelerate basic and clinical cancer research. This Commentary discusses the importance of international collaboration and data sharing inspired by the Cancer Moonshot to accelerate the progress of multi-omic precision medicine-an approach that addresses the global diversity of people and of cancers.	[Rodriguez, Henry] NCI, Off Canc Clin Prote Res, NIH, Bethesda, MD 20892 USA; [Pennington, Stephen R.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Sch Med, Belfield Dublin 4, Ireland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University College Dublin	Rodriguez, H (corresponding author), NCI, Off Canc Clin Prote Res, NIH, Bethesda, MD 20892 USA.	henry.rodriguez@nih.gov		Pennington, Stephen/0000-0001-7529-1015	Intramural NIH HHS [Z99 CA999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Blackhall F, 2006, LANCET ONCOL, V7, P499, DOI 10.1016/S1470-2045(06)70725-2; Carr SA, 2014, MOL CELL PROTEOMICS, V13, P907, DOI 10.1074/mcp.M113.036095; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Jaffe JD, 2004, PROTEOMICS, V4, P59, DOI 10.1002/pmic.200300511; Kennedy JJ, 2014, NAT METHODS, V11, P149, DOI [10.1038/NMETH.2763, 10.1038/nmeth.2763]; Kinsinger CR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.O111.015446; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Pegram M, 2000, SEMIN ONCOL, V27, P13; Regnier FE, 2010, CLIN CHEM, V56, P165, DOI 10.1373/clinchem.2009.140087; Tabb DL, 2010, J PROTEOME RES, V9, P761, DOI 10.1021/pr9006365; Whiteaker JR, 2014, NAT METHODS, V11, P703, DOI 10.1038/nmeth.3002; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438; Zhang H, 2016, CELL, V166, P755, DOI 10.1016/j.cell.2016.05.069	15	42	42	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2018	173	3					533	537		10.1016/j.cell.2018.04.008	http://dx.doi.org/10.1016/j.cell.2018.04.008			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7GB	29677503	Green Accepted, hybrid			2022-12-28	WOS:000430677400002
J	Thompson, AA; Walters, MC; Kwiatkowski, J; Rasko, JEJ; Ribeil, JA; Hongeng, S; Magrin, E; Schiller, GJ; Payen, E; Semeraro, M; Moshous, D; Lefrere, F; Puy, H; Bourget, P; Magnani, A; Caccavelli, L; Diana, JS; Suarez, F; Monpoux, F; Brousse, V; Poirot, C; Brouzes, C; Meritet, JF; Pondarre, C; Beuzard, Y; Chretien, S; Lefebvre, T; Teachey, DT; Anurathapan, U; Ho, PJ; von Kalle, C; Kletzel, M; Vichinsky, E; Soni, S; Veres, G; Negre, O; Ross, RW; Davidson, D; Petrusich, A; Sandler, L; Asmal, M; Hermine, O; De Montalembert, M; Hacein-Bey-Abina, S; Blanche, S; Leboulch, P; Cavazzana, M				Thompson, A. A.; Walters, M. C.; Kwiatkowski, J.; Rasko, J. E. J.; Ribeil, J. -A.; Hongeng, S.; Magrin, E.; Schiller, G. J.; Payen, E.; Semeraro, M.; Moshous, D.; Lefrere, F.; Puy, H.; Bourget, P.; Magnani, A.; Caccavelli, L.; Diana, J. -S.; Suarez, F.; Monpoux, F.; Brousse, V.; Poirot, C.; Brouzes, C.; Meritet, J. -F.; Pondarre, C.; Beuzard, Y.; Chretien, S.; Lefebvre, T.; Teachey, D. T.; Anurathapan, U.; Ho, P. J.; von Kalle, C.; Kletzel, M.; Vichinsky, E.; Soni, S.; Veres, G.; Negre, O.; Ross, R. W.; Davidson, D.; Petrusich, A.; Sandler, L.; Asmal, M.; Hermine, O.; De Montalembert, M.; Hacein-Bey-Abina, S.; Blanche, S.; Leboulch, P.; Cavazzana, M.			Gene Therapy in Patients with Transfusion-Dependent beta-Thalassemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; GLOBIN GENE; CONDITIONING REGIMEN; HEMOGLOBINOPATHIES; ERYTHROPOIESIS; EFFICACY; DISEASE; BURDEN; VECTOR	BACKGROUND Donor availability and transplantation-related risks limit the broad use of allogeneic hematopoietic-cell transplantation in patients with transfusion-dependent beta-thalassemia. After previously establishing that lentiviral transfer of a marked beta-globin (beta(A-T87Q)) gene could substitute for long-term red-cell transfusions in a patient with beta-thalassemia, we wanted to evaluate the safety and efficacy of such gene therapy in patients with transfusion-dependent beta-thalassemia. METHODS In two phase 1-2 studies, we obtained mobilized autologous CD34+ cells from 22 patients (12 to 35 years of age) with transfusion-dependent beta-thalassemia and transduced the cells ex vivo with LentiGlobin BB305 vector, which encodes adult hemoglobin (HbA) with a T87Q amino acid substitution (HbA(T87Q)). The cells were then reinfused after the patients had undergone myeloablative busulfan conditioning. We subsequently monitored adverse events, vector integration, and levels of replication-competent lentivirus. Efficacy assessments included levels of total hemoglobin and HbA(T87Q), transfusion requirements, and average vector copy number. RESULTS At a median of 26 months (range, 15 to 42) after infusion of the gene-modified cells, all but 1 of the 13 patients who had a non-beta(0)/beta(0) genotype had stopped receiving red-cell transfusions; the levels of HbA(T87Q) ranged from 3.4 to 10.0 g per deciliter, and the levels of total hemoglobin ranged from 8.2 to 13.7 g per deciliter. Correction of biologic markers of dyserythropoiesis was achieved in evaluated patients with hemoglobin levels near normal ranges. In 9 patients with a beta(0)/beta(0) genotype or two copies of the IVS1-110 mutation, the median annualized transfusion volume was decreased by 73%, and red-cell transfusions were discontinued in 3 patients. Treatment-related adverse events were typical of those associated with autologous stem-cell transplantation. No clonal dominance related to vector integration was observed. CONCLUSIONS Gene therapy with autologous CD34+ cells transduced with the BB305 vector reduced or eliminated the need for long-term red-cell transfusions in 22 patients with severe beta-thalassemia without serious adverse events related to the drug product. (Funded by Bluebird Bio and others; HGB-204 and HGB-205 ClinicalTrials. gov numbers, NCT01745120 and NCT02151526.)	[Thompson, A. A.; Kletzel, M.] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Feinberg Sch Med, Chicago, IL 60611 USA; [Walters, M. C.; Vichinsky, E.] Univ Calif San Francisco, Benioff Childrens Hosp, Oakland, CA 94143 USA; [Soni, S.] Lucile Salter Packard Childrens Hosp Stanford, Palo Alto, CA USA; [Schiller, G. J.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Kwiatkowski, J.; Teachey, D. T.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Kwiatkowski, J.; Teachey, D. T.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Rasko, J. E. J.] Centenary Inst, Camperdown, NSW, Australia; [Rasko, J. E. J.; Ho, P. J.] Univ Sydney, Sydney Med Sch, Camperdown, NSW, Australia; [Rasko, J. E. J.; Ho, P. J.] Royal Prince Alfred Hosp, Camperdown, NSW, Australia; [Ribeil, J. -A.; Magrin, E.; Moshous, D.; Lefrere, F.; Bourget, P.; Magnani, A.; Caccavelli, L.; Diana, J. -S.; Suarez, F.; Brousse, V.; Brouzes, C.; Hermine, O.; De Montalembert, M.; Blanche, S.; Cavazzana, M.] Hop Univ Necker Enfants Malades, AP HP, Paris, France; [Ribeil, J. -A.; Magnani, A.; Caccavelli, L.; Cavazzana, M.] Grp Hosp Univ Ouest, Paris, France; [Magrin, E.; Semeraro, M.; Moshous, D.; Cavazzana, M.] IMAGINE Inst, Paris, France; [Semeraro, M.; Poirot, C.; Hacein-Bey-Abina, S.] Univ Paris 05, Paris, France; [Puy, H.; Lefebvre, T.] Univ Paris Diderot, Paris, France; [Poirot, C.] Pierre & Marie Curie Univ, Paris, France; [Meritet, J. -F.] Hop Cochin, Paris, France; [Payen, E.; Beuzard, Y.; Chretien, S.; Leboulch, P.] Univ Paris Sud, CEA, Inst Emerging Dis & Innovat Therapies, Fontenay Aux Roses, France; [Puy, H.; Lefebvre, T.] Hop Louis Mourier, Colombes, France; [Pondarre, C.] Ctr Hosp Intercommunal Creteil, Creteil, France; [Hacein-Bey-Abina, S.] Hop Bicetre, Le Kremlin Bicetre, France; [Ribeil, J. -A.; Soni, S.; Veres, G.; Negre, O.; Ross, R. W.; Davidson, D.; Petrusich, A.; Sandler, L.; Asmal, M.] Bluebird Bio, Cambridge, MA USA; [Leboulch, P.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA; [Hongeng, S.; Anurathapan, U.; Leboulch, P.] Mahidol Univ, Ramathibodi Hosp, Bangkok, Thailand; [von Kalle, C.] German Canc Res Ctr, Natl Ctr Tumor Dis, Heidelberg, Germany	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Lucile Packard Children's Hospital (LPCH); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Sydney; Centenary Institute; University of Sydney; University of Sydney; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Mahidol University; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Thompson, AA (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, Hematol Oncol, 225 E Chicago Ave,Box 30, Chicago, IL 60611 USA.; Walters, MC (corresponding author), Univ Calif San Francisco, Benioff Childrens Hosp, Oakland, CA 94143 USA.; Cavazzana, M (corresponding author), Hop Univ Necker Enfants Malades, AP HP, Paris, France.; Cavazzana, M (corresponding author), Grp Hosp Univ Ouest, Paris, France.; Cavazzana, M (corresponding author), IMAGINE Inst, Paris, France.; Leboulch, P (corresponding author), Univ Paris Sud, CEA, Inst Emerging Dis & Innovat Therapies, Fontenay Aux Roses, France.; Leboulch, P (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA.; Leboulch, P (corresponding author), Mahidol Univ, Ramathibodi Hosp, Bangkok, Thailand.	a-thompson@northwestern.edu; mwalters@mail.cho.org; pleboulch@rics.bwh.harvard.edu; m.cavazzana@aphp.fr	NEGRE, Olivier/AAA-2027-2022; Ribeil, Jean-Antoine/AAK-7979-2020; Vichinsky, Elliott P/F-8541-2011; Chretien, Stany/M-5166-2018; Payen, Emmanuel/S-5357-2018; Moshous, Despina/B-7507-2017	Ribeil, Jean-Antoine/0000-0002-4549-4783; Vichinsky, Elliott P/0000-0002-0500-9579; Payen, Emmanuel/0000-0002-1329-2327; Moshous, Despina/0000-0001-6719-3693; rasko, John/0000-0003-2975-807X; Anurathapan, Usanarat/0000-0002-2791-7471; Teachey, David/0000-0001-7373-8987; Hongeng, Suradej/0000-0002-7376-9393; von Kalle, Christof/0000-0001-9221-3297; Cavazzana, Marina/0000-0002-0264-0891	Bluebird Bio; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000003, UL1TR001878]; Assistance Publique-Hopitaux de Paris; INSERM; Commissariat a l'Energie Atomique et aux Energies Alternatives; Agence National de la Recherche; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001878, UL1TR000003] Funding Source: NIH RePORTER	Bluebird Bio; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Assistance Publique-Hopitaux de Paris; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Commissariat a l'Energie Atomique et aux Energies Alternatives; Agence National de la Recherche(French National Research Agency (ANR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported by Bluebird Bio; by grants (UL1TR000003 and UL1TR001878) from the National Center for Advancing Translational Sciences of the National Institutes of Health; by Assistance Publique-Hopitaux de Paris and INSERM to the Biotherapy Clinical Investigation Center, Biotherapy Department, and Imagine Institute; by Commissariat a l'Energie Atomique et aux Energies Alternatives; and by a grant (to Dr. Leboulch) from the Agence National de la Recherche.	Anurathapan U, 2014, BIOL BLOOD MARROW TR, V20, P2066, DOI 10.1016/j.bbmt.2014.07.016; Arlet JB, 2014, NATURE, V514, P242, DOI 10.1038/nature13614; Ataga KI, 2016, BLOOD, V128; Bank A, 2005, ANN NY ACAD SCI, V1054, P308, DOI 10.1196/annals.1345.007; Baronciani D, 2016, BONE MARROW TRANSPL, V51, P536, DOI 10.1038/bmt.2015.293; Bonifazi F, 2017, CURR MED RES OPIN, V33, P1525, DOI 10.1080/03007995.2017.1326890; Bourget P, 2012, B CANCER, V99, P643, DOI 10.1684/bdc.2012.1589; Cao A, 2010, GENET MED, V12, P61, DOI [10.1097/GIM.0b013e3181cd68ed, 10.1038/gim.2016.173]; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chandrasekaran D, 2014, HUM GENE THER, V25, P1013, DOI 10.1089/hum.2014.031; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Engert A, 2016, HAEMATOLOGICA, V101, P115, DOI 10.3324/haematol.2015.136739; Ferrari G, 2017, HEMATOL ONCOL CLIN N, V31, P835, DOI 10.1016/j.hoc.2017.06.010; Graham EA, 1996, J PEDIATR-US, V129, P105, DOI 10.1016/S0022-3476(96)70196-8; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Hacein-Bey-Abina S, 2014, NEW ENGL J MED, V371, P1407, DOI 10.1056/NEJMoa1404588; Hayakawa J, 2009, HUM GENE THER, V20, P563, DOI 10.1089/hum.2008.186; Locatelli F, 2013, BLOOD, V122, P1072, DOI 10.1182/blood-2013-03-489112; Lucarelli G, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011825; Malik P, 2016, MOL THER, V24, P668, DOI 10.1038/mt.2016.57; Mansilla-Soto J, 2016, HUM GENE THER, V27, P295, DOI 10.1089/hum.2016.037; May C, 2000, NATURE, V406, P82, DOI 10.1038/35017565; Motta I, 2017, EXPERT OPIN INV DRUG, V26, P793, DOI 10.1080/13543784.2017.1335709; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Negre O, 2016, HUM GENE THER, V27, P148, DOI 10.1089/hum.2016.007; Negre O, 2015, CURR GENE THER, V15, P64; Olivieri Nancy F, 2011, Indian J Med Res, V134, P522; Pawliuk R, 2001, SCIENCE, V294, P2368, DOI 10.1126/science.1065806; Piel FB, 2016, HEMATOL ONCOL CLIN N, V30, P327, DOI 10.1016/j.hoc.2015.11.004; Porter JB, 2017, BRIT J HAEMATOL, V176, P288, DOI 10.1111/bjh.14373; Ribeil JA, 2017, NEW ENGL J MED, V376, P848, DOI 10.1056/NEJMoa1609677; Ricchi P, 2016, BLOOD TRANSFUS-ITALY, V14, P538, DOI 10.2450/2016.0279-15; Schambach A, 2013, HUM GENE THER, V24, P132, DOI 10.1089/hum.2012.229; Shteyer E, 2015, VOX SANG, V108, P268, DOI 10.1111/vox.12223; TAKEKOSHI KJ, 1995, P NATL ACAD SCI USA, V92, P3014, DOI 10.1073/pnas.92.7.3014; Thein Swee Lay, 2005, Hematology Am Soc Hematol Educ Program, P31; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; Tubman VN, 2015, J PEDIAT HEMATOL ONC, V37, pE162, DOI 10.1097/MPH.0000000000000307; Walters M, 2017, HAEMATOLOGICA, V102, P335; Westerman KA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-96	40	357	383	8	111	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2018	378	16					1479	1493		10.1056/NEJMoa1705342	http://dx.doi.org/10.1056/NEJMoa1705342			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD2EI	29669226	Green Published, Bronze			2022-12-28	WOS:000430312500004
J	Kirkland, KB; Craig, SR				Kirkland, Kathryn B.; Craig, Sienna R.			Exploring the Surgical Gaze Through Literature and Art	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kirkland, Kathryn B.] Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, Dept Med, Hanover, NH USA; [Kirkland, Kathryn B.] Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, Dept Med, Lebanon, NH 03756 USA; [Craig, Sienna R.] Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College; Dartmouth College	Kirkland, KB (corresponding author), Dartmouth Hitchcock Med Ctr, Palliat Care Sect, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	kathryn.kirkland@dartmouth.edu						Charon R., 2017, PRINCIPLES PRACTICE, P5; Cozzolino R., B PERLIN STATE MODER; Foucault Michel., 2003, BIRTH CLIN; Nin, 1961, SEDUCTION MINOTAUR	4	5	5	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2018	319	15					1532	1534		10.1001/jama.2018.0396	http://dx.doi.org/10.1001/jama.2018.0396			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD0UT	29677282				2022-12-28	WOS:000430217100001
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Falls in older people-can we really make a difference?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FEAR					davidoliver372@googlemail.com						Age UK, 2010, FALLS 65S COST NHS 4; Age UK, 2013, FALLS PREV RES; Burstow P., 2012, BURST P BETT CAR PRE; Campbell D., 2018, OBSERVER; Curtis EM, 2016, BONE, V87, P19, DOI 10.1016/j.bone.2016.03.006; Hopewell S, 2016, MULTIFACTORIAL MULTI; National Institute for Health and Care Excellence, 2015, QS86 NAT I HLTH CAR; National Institute for Health and Care Excellence, OSTEOPOROSIS; NICE, 2011, HIP FRACT MAN CLIN G; Royal College of Physicians, 2013, FALLS FRAG FRACT AUD; Sherrington C, 2017, BRIT J SPORT MED, V51, P1749, DOI 10.1136/bjsports-2016-096547; The Chartered Society of Physiotherapy , 2014, FALLS PREV EC MOD; WHO, 2007, WHO GLOB REP FALLP; Yardley L, 2006, HEALTH EDUC RES, V21, P508, DOI 10.1093/her/cyh077; Young WR, 2015, GAIT POSTURE, V41, P7, DOI 10.1016/j.gaitpost.2014.09.006; Zijlstra GAR, 2007, J AM GERIATR SOC, V55, P603, DOI 10.1111/j.1532-5415.2007.01148.x	16	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2018	361								k1655	10.1136/bmj.k1655	http://dx.doi.org/10.1136/bmj.k1655			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8WK	29666147	Green Published, Bronze			2022-12-28	WOS:000430794600002
J	Dickson, B				Dickson, B			Oceanography - All change in the Arctic	NATURE			English	Editorial Material									CEFAS, Environm Grp, Lowestoft NR33 OHT, Suffolk, England	Centre for Environment Fisheries & Aquaculture Science	Dickson, B (corresponding author), CEFAS, Environm Grp, Lowestoft NR33 OHT, Suffolk, England.	r.r.dickson@cefas.co.uk						Dickson B, 1999, NATURE, V397, P243, DOI 10.1038/16680; DICKSON RR, UNPUB J CHIM; *ENV WORK GROUP, 1997, JOINT US RUSS ATL AR; Hurrell JW, 1996, GEOPHYS RES LETT, V23, P665, DOI 10.1029/96GL00459; MANABE S, 1993, NATURE, V364, P215, DOI 10.1038/364215a0; MASLOWSKI W, 1998, EOS T, V79, P414; MASLOWSKI W, 1998, EOS S, V79, P398; MASLOWSKI W, 1998, EOS S, V79, P434; MASLOWSKI W, 1998, EOS S, V79, P413; McPhee MG, 1998, GEOPHYS RES LETT, V25, P1729, DOI 10.1029/98GL00933; MORISON I, 1998, 8 ARCT SYST SCI; RAHMSTORF S, IN PRESS CLIM CHANGE; Steele M, 1998, J GEOPHYS RES-OCEANS, V103, P10419, DOI 10.1029/98JC00580; STOCKTON CW, 1999, ANN M AM MET SOC; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; Walsh JE, 1996, J CLIMATE, V9, P480, DOI 10.1175/1520-0442(1996)009<0480:RDOSLP>2.0.CO;2	16	84	105	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	1999	397	6718					389	391		10.1038/17018	http://dx.doi.org/10.1038/17018			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667957				2022-12-28	WOS:000078461700025
J	Young, DP; Hall, D; Torelli, ME; Fisk, Z; Sarrao, JL; Thompson, JD; Ott, HR; Oseroff, SB; Goodrich, RG; Zysler, R				Young, DP; Hall, D; Torelli, ME; Fisk, Z; Sarrao, JL; Thompson, JD; Ott, HR; Oseroff, SB; Goodrich, RG; Zysler, R			High-temperature weak ferromagnetism in a low-density free-electron gas	NATURE			English	Article								The magnetic properties of the ground state of a low-density free-electron gas in three dimensions have been the subject of theoretical speculation and controversy for seven decades(1). Not only is this a difficult theoretical problem to solve, it is also a problem which has not hitherto been directly addressed experimentally. Here we report measurements on electron-doped calcium hexaboride (CaB6) which, we argue, show that-at a density of 7 x 10(19) electrons cm(-3)-the ground state is ferromagnetically polarized with a saturation moment of 0.07 mu(B) per electron. Surprisingly, the magnetic ordering temperature of this itinerant ferromagnet is 600 K, of the order of the Fermi temperature of the electron gas.	Florida State Univ, NHMFL, Tallahassee, FL 32306 USA; Univ Calif Los Alamos Natl Lab, Div Mat Sci & Technol, Los Alamos, NM 87454 USA; ETH Honggerberg, Festkorperphys Lab, CH-8093 Zurich, Switzerland; San Diego State Univ, Dept Phys, San Diego, CA 92182 USA; Louisiana State Univ, Dept Phys, Baton Rouge, LA 70803 USA; Ctr Atom Bariloche, RA-8400 Bariloche, Rio Negro, Argentina	State University System of Florida; Florida State University; United States Department of Energy (DOE); Los Alamos National Laboratory; Swiss Federal Institutes of Technology Domain; ETH Zurich; California State University System; San Diego State University; Louisiana State University System; Louisiana State University; Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche	Fisk, Z (corresponding author), Florida State Univ, NHMFL, Tallahassee, FL 32306 USA.	fisk@magnet.fsu.edu		Zysler, Roberto/0000-0003-0687-5898				ALDER BJ, 1982, INT J QUANTUM CHEM S, V16, P49; CEPERLEY DM, 1980, PHYS REV LETT, V45, P566, DOI 10.1103/PhysRevLett.45.566; Degiorgi L, 1997, PHYS REV LETT, V79, P5134, DOI 10.1103/PhysRevLett.79.5134; ERKELENS WAC, 1987, J MAGN MAGN MATER, V63-4, P61, DOI 10.1016/0304-8853(87)90522-1; HERRING C, 1966, MAGNETISM, V4, pCH2; LAFFERTY JM, 1951, J APPL PHYS, V22, P299, DOI 10.1063/1.1699946; LONGUETHIGGINS HC, 1954, PROC R SOC LON SER-A, V224, P336, DOI 10.1098/rspa.1954.0162; Nyhus P, 1997, PHYS REV B, V55, P12488, DOI 10.1103/PhysRevB.55.12488; ORTIZ G, CONDMAT9810126; Ott HR, 1997, Z PHYS B CON MAT, V102, P337, DOI 10.1007/s002570050297; SCHMIDT PH, 1976, APPL PHYS LETT, V29, P400, DOI 10.1063/1.89119; Sullow S, 1998, PHYS REV B, V57, P5860, DOI 10.1103/PhysRevB.57.5860	12	409	414	0	49	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					412	414		10.1038/17081	http://dx.doi.org/10.1038/17081			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667965	Green Published			2022-12-28	WOS:000078461700040
J	Gohel, MS; Heatley, F; Liu, XX; Bradbury, A; Bulbulia, R; Cullum, N; Epstein, DM; Nyamekye, I; Poskitt, KR; Renton, S; Warwick, J; Davies, AH				Gohel, Manjit S.; Heatley, Francine; Liu, Xinxue; Bradbury, Andrew; Bulbulia, Richard; Cullum, Nicky; Epstein, David M.; Nyamekye, Isaac; Poskitt, Keith R.; Renton, Sophie; Warwick, Jane; Davies, Alun H.		EVRA Trial Investigators	A Randomized Trial of Early Endovenous Ablation in Venous Ulceration	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPRESSION PLUS SURGERY; LEG ULCERS; MANAGEMENT; ESCHAR	BACKGROUND Venous disease is the most common cause of leg ulceration. Although compression therapy improves venous ulcer healing, it does not treat the underlying causes of venous hypertension. Treatment of superficial venous reflux has been shown to reduce the rate of ulcer recurrence, but the effect of early endovenous ablation of superficial venous reflux on ulcer healing remains unclear. METHODS In a trial conducted at 20 centers in the United Kingdom, we randomly assigned 450 patients with venous leg ulcers to receive compression therapy and undergo early endovenous ablation of superficial venous reflux within 2 weeks after randomization (earlyintervention group) or to receive compression therapy alone, with consideration of endovenous ablation deferred until after the ulcer was healed or until 6 months after randomization if the ulcer was unhealed (deferred-intervention group). The primary outcome was the time to ulcer healing. Secondary outcomes were the rate of ulcer healing at 24 weeks, the rate of ulcer recurrence, the length of time free from ulcers (ulcer-free time) during the first year after randomization, and patient-reported healthrelated quality of life. RESULTS Patient and clinical characteristics at baseline were similar in the two treatment groups. The time to ulcer healing was shorter in the early-intervention group than in the deferred-intervention group; more patients had healed ulcers with early intervention (hazard ratio for ulcer healing, 1.38; 95% confidence interval [CI], 1.13 to 1.68; P = 0.001). The median time to ulcer healing was 56 days (95% CI, 49 to 66) in the early-intervention group and 82 days (95% CI, 69 to 92) in the deferred-intervention group. The rate of ulcer healing at 24 weeks was 85.6% in the early-intervention group and 76.3% in the deferred-intervention group. The median ulcer-free time during the first year after trial enrollment was 306 days (interquartile range, 240 to 328) in the early-intervention group and 278 days (interquartile range, 175 to 324) in the deferredintervention group (P = 0.002). The most common procedural complications of endovenous ablation were pain and deep-vein thrombosis. CONCLUSIONS Early endovenous ablation of superficial venous reflux resulted in faster healing of venous leg ulcers and more time free from ulcers than deferred endovenous ablation.	[Gohel, Manjit S.] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England; [Gohel, Manjit S.; Heatley, Francine; Davies, Alun H.] Imperial Coll London, Dept Surg & Canc, London, England; [Liu, Xinxue; Warwick, Jane] Imperial Coll London, Imperial Clin Trials Unit, London, England; [Bradbury, Andrew] Univ Birmingham, Birmingham, W Midlands, England; [Bulbulia, Richard; Poskitt, Keith R.] Gloucestershire Hosp NHS Fdn Trust, Gloucester, England; [Bulbulia, Richard] Univ Oxford, MRC, Populat Hlth Res Unit, Nuffield Dept Populat Hlth, Oxford, England; [Bulbulia, Richard] Univ Oxford, Clin Trial Serv Unit, Nuffield Dept Populat Hlth, Oxford, England; [Bulbulia, Richard] Univ Oxford, Epidemiol Studies Unit, Nuffield Dept Populat Hlth, Oxford, England; [Cullum, Nicky] Univ Manchester, Manchester, Lancs, England; [Nyamekye, Isaac] Worcestershire Acute Hosp NHS Trust, Worcester, England; [Renton, Sophie] North West London Hosp NHS Trust, Harrow, Middx, England; [Warwick, Jane] Univ Warwick, Coventry, W Midlands, England; [Epstein, David M.] Univ Granada, Granada, Spain	University of Cambridge; Imperial College London; Imperial College London; University of Birmingham; Gloucestershire Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; University of Oxford; University of Manchester; University of Warwick; University of Granada	Davies, AH (corresponding author), Charing Cross Hosp, Imperial Coll London, Dept Surg & Canc, Sect Vasc Surg, London W6 8RF, England.	a.h.davies@imperial.ac.uk	Lane, Tristan/C-3780-2009; Epstein, David/I-2839-2019; Cullum, Nicky/AAT-5888-2020	Lane, Tristan/0000-0002-8681-7075; Epstein, David/0000-0002-2275-0916; Cullum, Nicky/0000-0003-2631-123X; Bicknell, Colin/0000-0003-0158-1831; Heatley, Francine/0000-0002-5184-0259; Liu, Xinxue/0000-0003-1107-0365; Popplewell, Matthew/0000-0002-6239-4039; Gohel, Manj/0000-0001-5685-0723; chetter, ian/0000-0002-2566-6859; Stansby, Gerard/0000-0001-5539-3049; Nandhra, Sandip/0000-0002-6036-5760	NIHR Health Technology Assessment Program [11/129/197]; National Institute for Health Research [11/129/197, NF-SI-0512-10028, 13/81/02] Funding Source: researchfish	NIHR Health Technology Assessment Program; National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by a grant from the NIHR Health Technology Assessment Program (project number 11/129/197) (to Drs. Davies, Gohel, Bradbury, Bulbulia, Cullum, Epstein, Poskitt, and Warwick). Infrastructure support was provided by the NIHR Imperial Biomedical Research Centre.	Adam DJ, 2003, EUR J VASC ENDOVASC, V25, P462, DOI 10.1053/ejvs.2002.1906; Adam DJ, 2003, EUR J VASC ENDOVASC, V25, P469, DOI 10.1053/ejvs.2002.1894; [Anonymous], 2013, VAR VEINS LEGS CG168; Ashby RL, 2014, LANCET, V383, P871, DOI 10.1016/S0140-6736(13)62368-5; Barwell JR, 2004, LANCET, V363, P1854, DOI 10.1016/S0140-6736(04)16353-8; Brittenden J, 2014, NEW ENGL J MED, V371, P1218, DOI 10.1056/NEJMoa1400781; Devlin NJ, 2018, HEALTH ECON, V27, P7, DOI 10.1002/hec.3564; Garratt A M, 1993, Qual Health Care, V2, P5, DOI 10.1136/qshc.2.1.5; Gloviczki P, 2011, J VASC SURG, V53, p2S, DOI 10.1016/j.jvs.2011.01.079; Gohel MS, 2007, BMJ-BRIT MED J, V335, P83, DOI 10.1136/bmj.39216.542442.BE; Gohel MS, 2005, BRIT J SURG, V92, P291, DOI 10.1002/bjs.4837; Grothier L., 2017, LEG ULCER MANAGEMENT; Guest JF, 2018, INT WOUND J, V15, P29, DOI 10.1111/iwj.12814; Heyer K, 2017, INT WOUND J, V14, P338, DOI 10.1111/iwj.12605; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Marston WA, 2017, J VASC SURG-VENOUS L, V5, P525, DOI 10.1016/j.jvsv.2017.02.007; Mauck KF, 2014, J VASC SURG, V60, pe1; National Institute for Health Research, EVRA STUD PROT; O'Donnell TF, 2014, J VASC SURG, V60, p3S, DOI 10.1016/j.jvs.2014.04.049; O'Meara S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000265.pub3; Padberg FT, 1996, J VASC SURG, V24, P711, DOI 10.1016/S0741-5214(96)70002-2; Passman MA, 2011, J VASC SURG, V54, p2S, DOI 10.1016/j.jvs.2011.05.117; Rasmussen Lars, 2013, J Vasc Surg Venous Lymphat Disord, V1, P349, DOI 10.1016/j.jvsv.2013.04.008; Samuel N, 2013, COCHRANE DB SYST REV, V10; Sinabulya H, 2017, EUR J VASC ENDOVASC, V53, P710, DOI 10.1016/j.ejvs.2017.02.028; Singer AJ, 2017, NEW ENGL J MED, V377, P1559, DOI 10.1056/NEJMra1615243; van Gent WB, 2006, J VASC SURG, V44, P563, DOI 10.1016/j.jvs.2006.04.053	27	125	131	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2018	378	22					2105	2114		10.1056/NEJMoa1801214	http://dx.doi.org/10.1056/NEJMoa1801214			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH5AL	29688123	Green Published, Bronze			2022-12-28	WOS:000433428000008
J	Kangovi, S; Asch, D				Kangovi, Shreya; Asch, David A.			Behavioral Phenotyping in Health Promotion Embracing or Avoiding Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kangovi, Shreya] Univ Penn, Perelman Sch Med, Div Gen Internal Med, 423 Guardian Dr,1233 Blockley Hall, Philadelphia, PA 19104 USA; [Kangovi, Shreya] Penn Med, Penn Ctr Community Hlth Workers, Philadelphia, PA USA; [Asch, David A.] Univ Penn, Ctr Hlth Care Innovat, Philadelphia, PA 19104 USA; [Asch, David A.] Corporal Michael J Crescenz VA Med Ctr, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Kangovi, S (corresponding author), Univ Penn, Perelman Sch Med, Div Gen Internal Med, 423 Guardian Dr,1233 Blockley Hall, Philadelphia, PA 19104 USA.	kangovi@upenn.edu		Asch, David/0000-0002-7970-286X	National Heart, Lung, and Blood Institute [K23-HL128837]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL128837] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Kangovi's work is supported by a grant from the National Heart, Lung, and Blood Institute (K23-HL128837).	Charlson ME, 2014, TRANSL BEHAV MED, V4, P7, DOI 10.1007/s13142-013-0241-0; Eberly M. B., 2013, NEW DEV GOAL SETTING; O'Kane MJ, 2008, BRIT MED J, V336, P1174, DOI 10.1136/bmj.39534.571644.BE; Sarkisian CA, 2007, J AM GERIATR SOC, V55, P1842, DOI 10.1111/j.1532-5415.2007.01427.x; Webb TL, 2013, SOC PERSONAL PSYCHOL, V7, P794, DOI 10.1111/spc3.12071; Young LA, 2017, JAMA INTERN MED, V177, P920, DOI 10.1001/jamainternmed.2017.1233	6	23	23	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2018	319	20					2075	2076		10.1001/jama.2018.2921	http://dx.doi.org/10.1001/jama.2018.2921			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4PT	29710244	Green Accepted			2022-12-28	WOS:000432679400015
J	Keating, NL; Pace, LE				Keating, Nancy L.; Pace, Lydia E.			Breast Cancer Screening in 2018 Time for Shared Decision Making	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Keating, Nancy L.] Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA; [Keating, Nancy L.; Pace, Lydia E.] Brigham & Womens Hosp, Div Gen Internal Med, 75 Francis St, Boston, MA 02115 USA; [Pace, Lydia E.] Brigham & Womens Hosp, Div Womens Hlth, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Keating, NL (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	keating@hcp.med.harvard.edu						Grady D, 2017, JAMA INTERN MED, V177, P763, DOI 10.1001/jamainternmed.2017.0458; Kopans DB, 2018, JAMA INTERN MED, V178, P298, DOI 10.1001/jamainternmed.2017.7081; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; National Committee for Quality Assurance, HEDIS 2014 SUMM TABL; Nelson HD, 2016, ANN INTERN MED, V164, P244, DOI 10.7326/M15-0969; Radhakrishnan A, 2017, JAMA INTERN MED, V177, P877, DOI 10.1001/jamainternmed.2017.0453; Smith RA, 2017, CA-CANCER J CLIN, V67, P100, DOI 10.3322/caac.21392; Stacey D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub5	8	55	56	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2018	319	17					1814	1815		10.1001/jama.2018.3388	http://dx.doi.org/10.1001/jama.2018.3388			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GE3UQ	29715344	Bronze			2022-12-28	WOS:000431138800019
J	Parker, L; Williams, J; Bero, L				Parker, Lisa; Williams, Jane; Bero, Lisa			Ethical drug marketing criteria for the 21st century	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONFLICTS-OF-INTEREST; PATIENT-ADVOCACY ORGANIZATIONS; WORLD-HEALTH-ORGANIZATION; PHARMACEUTICAL-INDUSTRY; PROMOTION; DOCUMENTS		[Parker, Lisa; Williams, Jane; Bero, Lisa] Univ Sydney, Charles Perkins Ctr, Fac Pharm, Sydney, NSW, Australia	University of Sydney	Bero, L (corresponding author), Univ Sydney, Charles Perkins Ctr, Fac Pharm, Sydney, NSW, Australia.	lisa.bero@sydney.edu.au		Bero, Lisa/0000-0003-1893-6651; Williams, Jane/0000-0002-0142-0299				Alam Kadir, 2009, South Med Rev, V2, P2; Alkhaled L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004880; [Anonymous], 2018, PRESCRIRE INT, V27, P79; [Anonymous], 1994, ESSENTIAL DRUGS MONI, V17, P1; Applbaum K, 2009, HASTINGS CENT REP, V39, P13; Australian Government Department of Health, AUSTR GOV THER GOODS; Barbour V, 2016, TRIALS, V17, DOI 10.1186/s13063-015-1107-1; Behrmann J., 2012, BIOETHIQUE ONLINE, P1; Berger D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3169; Brax H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175493; Carter SM, 2010, AJOB PRIMARY RES, V1, P11, DOI [10.1080/21507716.2010.482871, DOI 10.1080/21507716.2010.482871]; Chiang KP, 2012, INT J HEALTHCARE MAN, V5, P108, DOI 10.1179/2047971912Y.0000000009; Cutrona SL, 2008, AM J PUBLIC HEALTH, V98, P284, DOI 10.2105/AJPH.2007.114249; Datta A, 2017, HEALTH ECON, V26, P450, DOI 10.1002/hec.3323; Dawson A, 2007, EXCEPTIONAL STATE CO, P1; De Freitas J, 2014, J AM ACAD PSYCHIATRY, V42, P219; DeJong C, 2016, JAMA INTERN MED, V176, P1114, DOI 10.1001/jamainternmed.2016.2765; Doshi P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5164; Frosch DL, 2007, ANN FAM MED, V5, P6, DOI 10.1370/afm.611; Gostin LO, 2015, PUBLIC HEALTH, V129, P854, DOI 10.1016/j.puhe.2015.05.002; Hill KP, 2008, ANN INTERN MED, V149, P251, DOI 10.7326/0003-4819-149-4-200808190-00006; Charan J, 2011, J PHARM BIOALLIED SC, V3, P403, DOI 10.4103/0975-7406.84449; Kesselheim AS, 2013, CLIN PHARMACOL THER, V94, P336, DOI 10.1038/clpt.2013.115; Kesselheim AS, 2010, NEW ENGL J MED, V362, P1832, DOI 10.1056/NEJMsr0912039; Krumholz H, 2007, BMJ-BRIT MED J, V334, P120, DOI 10.1136/bmj.39024.487720.68; Lin DH, 2017, JAMA INTERN MED, V177, P427, DOI 10.1001/jamainternmed.2016.8471; LIU JJ, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J4619; Lundh A, 2017, COCHRANE DB SYST REV, V2; Mali SN, 2010, INDIAN J PHARMACOL, V42, P267, DOI 10.4103/0253-7613.70020; Matheson A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4578; McCoy MS, 2017, NEW ENGL J MED, V376, P880, DOI 10.1056/NEJMsr1610625; Mintzes B, 2003, CAN MED ASSOC J, V169, P405; Moynihan R, 2002, BRIT MED J, V324, P886, DOI 10.1136/bmj.324.7342.886; Moynihan RN, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001500; Naci H, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5542; Othman N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006350; Rose SL, 2017, JAMA INTERN MED, V177, P344, DOI 10.1001/jamainternmed.2016.8443; Singh J, 2014, INNOVATION MAREKTING, P701, DOI [10.1007/978-1-4614-7801-0_24, DOI 10.1007/978-1-4614-7801-0_24]; Spithoff S, 2014, CAN FAM PHYSICIAN, V60; Spithoff S, 2014, CAN FAM PHYSICIAN, V60, P694; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352; Steinman MA, 2006, ANN INTERN MED, V145, P284, DOI 10.7326/0003-4819-145-4-200608150-00008; Vakratsas D, 2014, INNOVATION MARKETING, P651, DOI [10.1007/978-1-4614-7801-0_22, DOI 10.1007/978-1-4614-7801-0_22]; Warrier R, 2010, CLIN REV OPIN, V2, P41; WHO, 1988, ETH CRIT MED DRUG PR; Wieringa J, 2014, INNOVATION MARKETING, P591, DOI [10.1007/978-1-4614-7801-0_20, DOI 10.1007/978-1-4614-7801-0_20]; World Health Organization Executive Board, 1993, WHO ETH CRIT MED DRU; World Health Organization Executive Board, 1988, RAT US DRUGS REP EX; World Health Organization Health Action International, 2010, UND RESP PHARM PROM; Zee AV, 2009, AM J PUBLIC HEALTH, V99, P221, DOI 10.2105/AJPH.2007.131714	50	12	12	2	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2018	361								k1809	10.1136/bmj.k1809	http://dx.doi.org/10.1136/bmj.k1809			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GF4XX	29712644				2022-12-28	WOS:000431968600002
J	Rimmer, A				Rimmer, Abi			Collaborative procurement: five minutes with . . . Des Breen	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2018	361								k1772	10.1136/bmj.k1772	http://dx.doi.org/10.1136/bmj.k1772			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF4WC	29695480				2022-12-28	WOS:000431963600012
J	Tsugawa, Y; Jena, AB; Orav, EJ; Blumenthal, DM; Tsai, TC; Mehtsun, WT; Jha, AK				Tsugawa, Yusuke; Jena, Anupam B.; Orav, E. John; Blumenthal, Daniel M.; Tsai, Thomas C.; Mehtsun, Winta T.; Jha, Ashish K.			Age and sex of surgeons and mortality of older surgical patients: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							US MEDICAL-SCHOOLS; OPERATIVE MORTALITY; HOSPITAL VOLUME; UNITED-STATES; EXPERIENCE; OUTCOMES; ASSOCIATION; WOMEN; SPECIALIZATION; PROGRAMS	OBJECTIVE To investigate whether patients' mortality differs according to the age and sex of surgeons. DESIGN Observational study. SETTING US acute care hospitals. PARTICIPANTS 100% of Medicare fee-for-service beneficiaries aged 65-99 years who underwent one of 20 major nonelective surgeries between 2011 and 2014. MAIN OUTCOME MEASURE Operative mortality rate of patients, defined as death during hospital admission or within 30 days of the operative procedure, after adjustment for patients' and surgeons' characteristics and indicator variables for hospitals. RESULTS 892 187 patients who were treated by 45 826 surgeons were included. Patients' mortality was lower for older surgeons than for younger surgeons: the adjusted operative mortality rates were 6.6% (95% confidence interval 6.5% to 6.7%), 6.5% (6.4% to 6.6%), 6.4% (6.3% to 6.5%), and 6.3% (6.2% to 6.5%) for surgeons aged under 40 years, 40-49 years, 50-59 years, and 60 years or over, respectively (P for trend=0.001). There was no evidence that adjusted operative mortality differed between patients treated by female versus male surgeons (adjusted mortality 6.3% for female surgeons versus 6.5% for male surgeons; adjusted odds ratio 0.97, 95% confidence interval 0.93 to 1.01). After stratification by sex of surgeon, patients' mortality declined with age of surgeon for both male and female surgeons (except for female surgeons aged 60 or older); female surgeons in their 50s had the lowest operative mortality. CONCLUSION Using national data on Medicare beneficiaries in the US, this study found that patients treated by older surgeons had lower mortality than patients treated by younger surgeons. There was no evidence that operative mortality differed between male and female surgeons.	[Tsugawa, Yusuke] Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA; [Jena, Anupam B.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA; [Jena, Anupam B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Jena, Anupam B.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Orav, E. John; Jha, Ashish K.] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA; [Orav, E. John] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Blumenthal, Daniel M.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Tsai, Thomas C.] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA; [Tsai, Thomas C.; Jha, Ashish K.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Mehtsun, Winta T.] Massachusetts Gen Hosp, Div Surg, Boston, MA 02114 USA; [Jha, Ashish K.] VA Healthcare Syst, Boston, MA 02138 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; National Bureau of Economic Research; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Tsugawa, Y (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA.	ytsugawa@mednet.ucla.edu		Tsugawa, Yusuke/0000-0002-1937-4833	National Institutes of Health (NIH early independence award) [1DP5OD017897]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017892] Funding Source: NIH RePORTER	National Institutes of Health (NIH early independence award)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	ABJ was supported by the Office of the Director, National Institutes of Health (NIH early independence award, grant 1DP5OD017897). Study sponsors were not involved in study design, data interpretation, writing, or the decision to submit the article for publication.	American College of Surgeons Board of Governors Physician Competency and Health Workgroup, 2016, Bull Am Coll Surg, V101, P42; Arrington AK, 2009, ANN SURG ONCOL, V16, P2697, DOI 10.1245/s10434-009-0641-z; Aylin P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2424; Bell RH, 2009, ANN SURG, V249, P719, DOI 10.1097/SLA.0b013e3181a38e59; Bhatt NR, 2016, BRIT J SURG, V103, P35, DOI 10.1002/bjs.9925; Bilimoria KY, 2016, NEW ENGL J MED, V374, P713, DOI 10.1056/NEJMoa1515724; Bilimoria KY, 2009, ANN SURG ONCOL, V16, P1799, DOI 10.1245/s10434-009-0467-8; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Capek L, 1997, PLAST RECONSTR SURG, V99, P289, DOI 10.1097/00006534-199702000-00001; Chai CY, 2010, WORLD J SURG, V34, P3, DOI 10.1007/s00268-009-0291-0; Condren AB, 2015, J SURG EDUC, V72, P855, DOI 10.1016/j.jsurg.2015.04.018; Dresler CM, 1996, ARCH SURG-CHICAGO, V131, P1128; Duclos A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8041; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Epstein Nancy E, 2017, Surg Neurol Int, V8, P93, DOI 10.4103/sni.sni_90_17; Finks JF, 2011, NEW ENGL J MED, V364, P2128, DOI 10.1056/NEJMsa1010705; Fitzmaurice G.M., 2012, APPL LONGITUDINAL AN; Gardiner JC, 2009, STAT MED, V28, P221, DOI 10.1002/sim.3478; Gillies MA, 2017, BRIT J SURG, V104, P936, DOI 10.1002/bjs.10507; Gilligan MA, 2007, ARCH SURG-CHICAGO, V142, P17, DOI 10.1001/archsurg.142.1.17; Gunasekara FI, 2014, INT J EPIDEMIOL, V43, P264, DOI 10.1093/ije/dyt221; Hartz AJ, 1999, MED CARE, V37, P93, DOI 10.1097/00005650-199901000-00013; Hershman DL, 2008, JNCI-J NATL CANCER I, V100, P199, DOI 10.1093/jnci/djm320; Jena AB, 2016, JAMA INTERN MED, V176, P1294, DOI 10.1001/jamainternmed.2016.3284; Jena AB, 2015, JAMA-J AM MED ASSOC, V314, P1149, DOI 10.1001/jama.2015.10680; Katlic MR, 2014, ANN SURG, V260, P199, DOI 10.1097/SLA.0000000000000667; Ly DP, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2923; Miller ME, 1996, MED CARE, V34, P455, DOI 10.1097/00005650-199605000-00007; Moja L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046175; Neumayer LA, 2005, ANN SURG, V242, P344, DOI 10.1097/01.sla.0000179644.02187.ea; Norcini JJ, 2013, MED CARE, V51, P1034, DOI 10.1097/MLR.0b013e3182a048af; O'Neill L, 2000, NEUROLOGY, V55, P773, DOI 10.1212/WNL.55.6.773; Parzen M, 2002, STAT MED, V21, P2421, DOI 10.1002/sim.1195; Patel MS, 2014, JAMA-J AM MED ASSOC, V312, P2364, DOI 10.1001/jama.2014.15273; Prystowsky JB, 2005, ARCH SURG-CHICAGO, V140, P495, DOI 10.1001/archsurg.140.5.495; Rajaram R, 2014, JAMA-J AM MED ASSOC, V312, P2374, DOI 10.1001/jama.2014.15277; Reames BN, 2014, ANN SURG, V260, P244, DOI 10.1097/SLA.0000000000000375; Research Data Assistance Center, 2016, DEATH INF RES ID MED; Sahni NR, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3571; Schneider JR, 2007, J AM COLL SURGEONS, V205, P393, DOI 10.1016/j.jamcollsurg.2007.05.013; Shoda N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000416; Silliman RA, 1999, MED CARE, V37, P1057, DOI 10.1097/00005650-199910000-00009; Spencer ES, 2016, J UROLOGY, V195, P450, DOI 10.1016/j.juro.2015.08.100; Tsugawa Y, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1797; Tsugawa Y, 2017, JAMA INTERN MED, V177, P675, DOI 10.1001/jamainternmed.2017.0059; Tsugawa Y, 2017, JAMA INTERN MED, V177, P206, DOI 10.1001/jamainternmed.2016.7875; Tsugawa Y, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j273; Waljee JF, 2006, ANN SURG, V244, P353, DOI 10.1097/01.sla.0000234803.11991.6d; Waljee Jennifer F, 2007, Adv Surg, V41, P189, DOI 10.1016/j.yasu.2007.05.012; Williams R, 2012, STATA J, V12, P308, DOI 10.1177/1536867X1201200209; Xu X., 2014, CLIN GENET, V87, P327, DOI [DOI 10.1136/BMJ.J4366, 10.1111/cge.12538, DOI 10.1111/CGE.12538]; Ying ZG, 2011, ANN SURG, V253, P637, DOI 10.1097/SLA.0b013e3182111120; Zare MM, 2007, ANN SURG, V246, P866, DOI 10.1097/SLA.0b013e3180cc2e60	53	48	48	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2018	361								k1343	10.1136/bmj.k1343	http://dx.doi.org/10.1136/bmj.k1343			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF4WC	29695473	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000431963600003
J	Mayor, S				Mayor, Susan			Sixty seconds on ... the WannaCry cyberattack	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		House of Commons Public Accounts Committee, 2018, CYB ATT NHS 32 REP S	1	1	1	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2018	361								k1750	10.1136/bmj.k1750	http://dx.doi.org/10.1136/bmj.k1750			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF4VZ	29691254				2022-12-28	WOS:000431963200008
J	Atabaki, AH; Moazeni, S; Pavanello, F; Gevorgyan, H; Notaros, J; Alloatti, L; Wade, MT; Sun, C; Kruger, SA; Meng, HY; Al Qubaisi, K; Wang, I; Zhang, BH; Khilo, A; Baiocco, CV; Popovic, MA; Stojanovic, VM; Ram, RJ				Atabaki, Amir H.; Moazeni, Sajjad; Pavanello, Fabio; Gevorgyan, Hayk; Notaros, Jelena; Alloatti, Luca; Wade, Mark T.; Sun, Chen; Kruger, Seth A.; Meng, Huaiyu; Al Qubaisi, Kenaish; Wang, Imbert; Zhang, Bohan; Khilo, Anatol; Baiocco, Christopher V.; Popovic, Milos A.; Stojanovic, Vladimir M.; Ram, Rajeev J.			Integrating photonics with silicon nanoelectronics for the next generation of systems on a chip	NATURE			English	Article							ELECTROOPTIC MODULATOR; ADVANCED CMOS; TECHNOLOGY; PLATFORM	Electronic and photonic technologies have transformed our lives-from computing and mobile devices, to information technology and the internet. Our future demands in these fields require innovation in each technology separately, but also depend on our ability to harness their complementary physics through integrated solutions(1,2). This goal is hindered by the fact that most silicon nanotechnologies-which enable our processors, computer memory, communications chips and image sensors-rely on bulk silicon substrates, a cost-effective solution with an abundant supply chain, but with substantial limitations for the integration of photonic functions. Here we introduce photonics into bulk silicon complementary metal-oxide-semiconductor (CMOS) chips using a layer of polycrystalline silicon deposited on silicon oxide (glass) islands fabricated alongside transistors. We use this single deposited layer to realize optical waveguides and resonators, high-speed optical modulators and sensitive avalanche photodetectors. We integrated this photonic platform with a 65-nanometre-transistor bulk CMOS process technology inside a 300-millimetre-diameter-wafer microelectronics foundry. We then implemented integrated high-speed optical transceivers in this platform that operate at ten gigabits per second, composed of millions of transistors, and arrayed on a single optical bus for wavelength division multiplexing, to address the demand for high-bandwidth optical interconnects in data centres and high-performance computing(3,4). By decoupling the formation of photonic devices from that of transistors, this integration approach can achieve many of the goals of multi-chip solutions(5), but with the performance, complexity and scalability of 'systems on a chip'(1,6-8). As transistors smaller than ten nanometres across become commercially available(9), and as new nanotechnologies emerge(10,11), this approach could provide a way to integrate photonics with state-of-the-art nanoelectronics.	[Atabaki, Amir H.; Alloatti, Luca; Meng, Huaiyu; Ram, Rajeev J.] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Moazeni, Sajjad; Sun, Chen; Stojanovic, Vladimir M.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Pavanello, Fabio; Notaros, Jelena; Wade, Mark T.; Popovic, Milos A.] Univ Colorado, Boulder, CO 80309 USA; [Gevorgyan, Hayk; Al Qubaisi, Kenaish; Wang, Imbert; Zhang, Bohan; Khilo, Anatol; Popovic, Milos A.] Boston Univ, Boston, MA 02215 USA; [Pavanello, Fabio; Kruger, Seth A.; Baiocco, Christopher V.] State Univ New York SUNY Polytech Inst, Coll Nanoscale Sci & Engn, Albany, NY USA; [Notaros, Jelena] Univ Ghent, IMEC, Photon Res Grp, Ghent, Belgium; [Notaros, Jelena] Ctr Nano & Biophoton, Ghent, Belgium; [Wade, Mark T.] ETH, IEF, Zurich, Switzerland; Ayar Labs Inc, Emeryville, CA USA	Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley; University of Colorado System; University of Colorado Boulder; Boston University; SUNY Polytechnic Institute; Ghent University; IMEC; Ghent University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Atabaki, AH (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	atabaki@mit.edu	Pavanello, Fabio/D-7096-2018; Popović, Miloš A./AAC-6940-2020; Alloatti, Luca/A-3817-2015	Pavanello, Fabio/0000-0002-6889-2012; Popović, Miloš A./0000-0002-8048-0678; Alloatti, Luca/0000-0002-1245-4179; AlQubaisi, Kenaish/0000-0001-7176-6618	DARPA POEM [HR0011-11-C-0100, HR00111190009]; Microsystems Technology Laboratories (MTL) at MIT; Berkeley Wireless Research Center; Center for Nanoscale Sciences and Engineering; Packard Foundation	DARPA POEM; Microsystems Technology Laboratories (MTL) at MIT; Berkeley Wireless Research Center; Center for Nanoscale Sciences and Engineering; Packard Foundation(The David & Lucile Packard Foundation)	We thank E. Timurdogan and M. Byrd for help with highspeed photonic measurements, and A. Nikiforov of the Boston University Photonics Center for assistance with sample imaging and analysis. This work was supported by DARPA POEM award HR0011-11-C-0100 and contract HR00111190009, led by J. Shah. We also acknowledge support from the Microsystems Technology Laboratories (MTL) at MIT, the Berkeley Wireless Research Center, the Center for Nanoscale Sciences and Engineering and the Packard Foundation. The views expressed are those of the authors and do not reflect the official policy or position of the DoD or the US Government.	Ackert JJ, 2013, OPT EXPRESS, V21, P19530, DOI 10.1364/OE.21.019530; Alloatti L, 2015, IET OPTOELECTRON, V9, P163, DOI 10.1049/iet-opt.2015.0003; Assefa S, 2012, IEEE PHOTON CONF, P626, DOI 10.1109/IPCon.2012.6358777; Atabaki AH, 2016, APPL PHYS LETT, V109, DOI 10.1063/1.4962641; Awny A, 2015, IEEE MICROW WIREL CO, V25, P469, DOI 10.1109/LMWC.2015.2430615; Boeuf F, 2013, IEDM, P13; Dangel R, 2008, IEEE T ADV PACKAGING, V31, P759, DOI 10.1109/TADVP.2008.2005996; del Alamo JA, 2011, NATURE, V479, P317, DOI 10.1038/nature10677; Desai SB, 2016, SCIENCE, V354, P99, DOI 10.1126/science.aah4698; Eggleton BJ, 2011, NAT PHOTONICS, V5, P141, DOI [10.1038/nphoton.2011.309, 10.1038/NPHOTON.2011.309]; Fossum ER, 1997, IEEE T ELECTRON DEV, V44, P1689, DOI 10.1109/16.628824; Ghelfi P, 2014, NATURE, V507, P341, DOI 10.1038/nature13078; Ieong Meikei, 2004, Science, V306, P2057, DOI 10.1126/science.1100731; Khilo A, 2012, OPT EXPRESS, V20, P4454, DOI 10.1364/OE.20.004454; Magarshack P, 2013, DES AUT TEST EUROPE, P952; Mehta KK, 2014, OPT LETT, V39, P1061, DOI 10.1364/OL.39.001061; Miller DAB, 2000, P IEEE, V88, P728, DOI 10.1109/5.867687; Mudumba S, 2017, J IMMUNOL METHODS, V448, P34, DOI 10.1016/j.jim.2017.05.005; Narasimha A., 2008, OPT FIB COMM C OMK7; Nishi Y., 2000, HDB SEMICONDUCTOR MA; Notaros J., 2016, P OPT FIB COMM C EXH, P1; Preston K, 2009, OPT EXPRESS, V17, P5118, DOI 10.1364/OE.17.005118; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Rumley S, 2015, J LIGHTWAVE TECHNOL, V33, P547, DOI 10.1109/JLT.2014.2363947; Selvaraja SK, 2009, OPT COMMUN, V282, P1767, DOI 10.1016/j.optcom.2009.01.021; SETO JYW, 1975, J APPL PHYS, V46, P5247, DOI 10.1063/1.321593; Settaluri KT, 2015, PROC EUR SOLID-STATE, P156, DOI 10.1109/ESSCIRC.2015.7313852; Shainline JM, 2013, OPT LETT, V38, P2657, DOI 10.1364/OL.38.002657; SOREF RA, 1987, IEEE J QUANTUM ELECT, V23, P123, DOI 10.1109/JQE.1987.1073206; Sun C, 2016, IEEE J SOLID-ST CIRC, V51, P893, DOI 10.1109/JSSC.2016.2519390; Sun C, 2015, IEEE J SOLID-ST CIRC, V50, P828, DOI 10.1109/JSSC.2014.2382101; Worhoff K, 2015, ADV OPT TECHNOL, V4, P189, DOI 10.1515/aot-2015-0016; Xu QF, 2005, NATURE, V435, P325, DOI 10.1038/nature03569; Yang S, 2017, S VLSI TECH, pT70, DOI 10.23919/VLSIT.2017.7998203; Zolfaghari A, 2001, IEEE J SOLID-ST CIRC, V36, P620, DOI 10.1109/4.913740	36	443	472	66	693	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2018	556	7701					349	+		10.1038/s41586-018-0028-z	http://dx.doi.org/10.1038/s41586-018-0028-z			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1TW	29670262	Green Submitted			2022-12-28	WOS:000430285200046
J	Kokko, H				Kokko, Hanna			When sex differences lead to extinction	NATURE			English	Editorial Material							SELECTION; RISK		[Kokko, Hanna] Univ Zurich, Dept Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland	University of Zurich	Kokko, H (corresponding author), Univ Zurich, Dept Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland.	hanna.kokko@ieu.uzh.ch		Kokko, Hanna/0000-0002-5772-4881				Doherty PF, 2003, P NATL ACAD SCI USA, V100, P5858, DOI 10.1073/pnas.0836953100; Kokko H, 2003, ANN ZOOL FENN, V40, P207; Le Galliard JF, 2005, P NATL ACAD SCI USA, V102, P18231, DOI 10.1073/pnas.0505172102; Lumley AJ, 2015, NATURE, V522, P470, DOI 10.1038/nature14419; Mank JE, 2017, NAT REV GENET, V18, P721, DOI 10.1038/nrg.2017.83; Martins MJF, 2018, NATURE, V556, P366, DOI 10.1038/s41586-018-0020-7; Morrow EH, 2004, P ROY SOC B-BIOL SCI, V271, P2395, DOI 10.1098/rspb.2004.2888; Park AW, 2014, J EVOLUTION BIOL, V27, P1650, DOI 10.1111/jeb.12419; Warren WC, 2018, NAT ECOL EVOL, V2, P669, DOI 10.1038/s41559-018-0473-y; Whitlock MC, 2000, EVOLUTION, V54, P1855, DOI 10.1111/j.0014-3820.2000.tb01232.x	10	0	0	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2018	556	7701					315	316		10.1038/d41586-018-04059-7	http://dx.doi.org/10.1038/d41586-018-04059-7			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1TW	29662133	Bronze			2022-12-28	WOS:000430285200037
J	Thielking, J; Okhapkin, MV; Glowacki, P; Meier, DM; von der Wense, L; Seiferle, B; Dullmann, CE; Thirolf, PG; Peik, E				Thielking, Johannes; Okhapkin, Maxim V.; Glowacki, Przemyslaw; Meier, David M.; von der Wense, Lars; Seiferle, Benedict; Duellmann, Christoph E.; Thirolf, Peter G.; Peik, Ekkehard			Laser spectroscopic characterization of the nuclear-clock isomer Th-229m	NATURE			English	Article							TRANSITION; EXCITATION; STATES	The isotope Th-229 is the only nucleus known to possess an excited state Th-229m in the energy range of a few electronvolts-a transition energy typical for electrons in the valence shell of atoms, but about four orders of magnitude lower than typical nuclear excitation energies. Of the many applications that have been proposed for this nuclear system, which is accessible by optical methods, the most promising is a highly precise nuclear clock that outperforms existing atomic timekeepers. Here we present the laser spectroscopic investigation of the hyperfine structure of the doubly charged Th-229m ion and the determination of the fundamental nuclear properties of the isomer, namely, its magnetic dipole and electric quadrupole moments, as well as its nuclear charge radius. Following the recent direct detection of this long-sought isomer, we provide detailed insight into its nuclear structure and present a method for its non-destructive optical detection.	[Thielking, Johannes; Okhapkin, Maxim V.; Glowacki, Przemyslaw; Meier, David M.; Peik, Ekkehard] Phys Tech Bundesanstalt, Braunschweig, Germany; [von der Wense, Lars; Seiferle, Benedict] Ludwig Maximilians Univ Munchen, Garching, Germany; [Duellmann, Christoph E.] GSI Helmholtzzentrum Schwerionenforsch GmbH, Darmstadt, Germany; [Duellmann, Christoph E.] Helmholtz Inst Mainz, Mainz, Germany; [Duellmann, Christoph E.] Johannes Gutenberg Univ Mainz, Mainz, Germany; [Glowacki, Przemyslaw] Poznan Univ Tech, Poznan, Poland	Physikalisch-Technische Bundesanstalt (PTB); University of Munich; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Johannes Gutenberg University of Mainz; Poznan University of Technology	Peik, E (corresponding author), Phys Tech Bundesanstalt, Braunschweig, Germany.	ekkehard.peik@ptb.de	Düllmann, Christoph E/L-3401-2017; Głowacki, Przemysław/F-1511-2013	Düllmann, Christoph E/0000-0002-1194-0423; Głowacki, Przemysław/0000-0003-0899-9106; Thielking, Johannes/0000-0002-4511-2407; Okhapkin, Maksim/0000-0003-0420-3115	European Union [664732]; DFG [CRC 1227, TH956-3-2]; LMU Department of Medical Physics via the Maier-Leibnitz Laboratory	European Union(European Commission); DFG(German Research Foundation (DFG)); LMU Department of Medical Physics via the Maier-Leibnitz Laboratory	We thank C. Mokry, J. Runke, K. Eberhardt and N. G. Trautmann for the production of the <SUP>233</SUP>U source and M. Ehlers, S. Hennig and K. Kossert for the PTB <SUP>229</SUP>Th source. We acknowledge discussions with C. Tamm and B. Lipphardt and thank T. Leder, M. Menzel and A. Hoppmann for technical support. We acknowledge financial support from the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement number 664732 (nuClock), from DFG through CRC 1227 (DQ-mat, project B04) and TH956-3-2 and from the LMU Department of Medical Physics via the Maier-Leibnitz Laboratory.	Barci V, 2003, PHYS REV C, V68, DOI 10.1103/PhysRevC.68.034329; Beck BR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.142501; Beck B. R., 2009, LLNLPROC415170; BEMIS CE, 1988, PHYS SCRIPTA, V38, P657, DOI 10.1088/0031-8949/38/5/004; Berengut JC, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.210801; BJORKHOLM JE, 1976, PHYS REV A, V14, P751, DOI 10.1103/PhysRevA.14.751; Blaise J., 1983, ANL8395; Blaise J., 2017, DATABASE SELECTED CO; BOHR A, 1950, PHYS REV, V77, P94, DOI 10.1103/PhysRev.77.94; Burke DG, 2008, NUCL PHYS A, V809, P129, DOI 10.1016/j.nuclphysa.2008.06.009; BUTTGENBACH S, 1984, HYPERFINE INTERACT, V20, P1, DOI 10.1007/BF02043319; Campbell CJ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.120802; Campbell CJ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.223001; CHASMAN RR, 1977, REV MOD PHYS, V49, P833, DOI 10.1103/RevModPhys.49.833; Dykhne AM, 1998, JETP LETT+, V67, P251, DOI 10.1134/1.567659; Flambaum VV, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.092502; GERSTENKORN S, 1974, J PHYS-PARIS, V35, P483, DOI 10.1051/jphys:01974003506048300; Gulda K, 2002, NUCL PHYS A, V703, P45, DOI 10.1016/S0375-9474(01)01456-7; Hayes AC, 2008, PHYS REV C, V78, DOI 10.1103/PhysRevC.78.024311; HELMER RG, 1994, PHYS REV C, V49, P1845, DOI 10.1103/PhysRevC.49.1845; Herrera-Sancho OA, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.012512; Herrera-Sancho OA, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.033402; Jeet J, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.253001; KALBER W, 1989, Z PHYS A-HADRON NUCL, V334, P103, DOI 10.1007/BF01294392; Karpeshin FF, 2007, PHYS REV C, V76, DOI 10.1103/PhysRevC.76.054313; Kazakov GA, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/8/083019; Kopfermann H., 1958, NUCL MOMENTS; KROGER LA, 1976, NUCL PHYS A, V259, P29, DOI 10.1016/0375-9474(76)90494-2; Litvinova E, 2009, PHYS REV C, V79, DOI 10.1103/PhysRevC.79.064303; Matinyan S, 1998, PHYS REP, V298, P200; McCarron DJ, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/10/105601; Minkov N, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.212501; Nilsson S.G, 1955, KONG DAN SEL MAT FYS, V29, P1; Palmer B. A., 1980, LA8251MS LOS AL SCI; Peik E, 2003, EUROPHYS LETT, V61, P181, DOI 10.1209/epl/i2003-00210-x; Peik E, 2015, CR PHYS, V16, P516, DOI 10.1016/j.crhy.2015.02.007; Rellergert WG, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.200802; Ruchowska E, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.044326; Safronova MS, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.060501; Seiferle B, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.042501; Sobelman I. I., 1979, ATOMIC SPECTRA RAD T; Tkalya EV, 2015, PHYS REV C, V92, DOI 10.1103/PhysRevC.92.054324; Tkalya EV, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.162501; Tkalya EV, 2003, PHYS-USP+, V46, P315, DOI 10.1070/PU2003v046n03ABEH001379; Vascon A, 2012, NUCL INSTRUM METH A, V696, P180, DOI 10.1016/j.nima.2012.08.072; von der Wense L, 2016, THESIS; von der Wense L, 2016, NATURE, V533, P47, DOI 10.1038/nature17669; Von der Wense L, 2015, EUR PHYS J A, V51, DOI 10.1140/epja/i2015-15029-8; Wright TG, 2010, J PHYS CHEM A, V114, P3182, DOI 10.1021/jp9091927; Yamaguchi A, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/5/053053	51	69	69	4	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2018	556	7701					321	+		10.1038/s41586-018-0011-8	http://dx.doi.org/10.1038/s41586-018-0011-8			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1TW	29670266	Green Submitted			2022-12-28	WOS:000430285200041
J	Ceperley, D				Ceperley, D			Condensed-matter physics - Return of the itinerant electron	NATURE			English	Editorial Material									Univ Illinois, Dept Phys, Champaign, IL 61821 USA; Univ Illinois, NCSA, Champaign, IL 61821 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Ceperley, D (corresponding author), Univ Illinois, Dept Phys, Champaign, IL 61821 USA.		Ceperley, David M/A-6858-2008	Ceperley, David/0000-0001-5082-6271				Bloch F, 1929, Z PHYS, V57, P545, DOI 10.1007/BF01340281; CEPERLEY DM, 1980, PHYS REV LETT, V45, P566, DOI 10.1103/PhysRevLett.45.566; CEPERLEY DM, 1982, INT J QUANTUM CHEM, V16, P49; HERRING C, 1966, MAGNETISM, V4, P71; HERRING C, 1966, MAGNETISM, V4, P9; Massidda S, 1997, Z PHYS B CON MAT, V102, P83, DOI 10.1007/s002570050267; Stoner EC, 1938, PROC R SOC LON SER-A, V165, P0372, DOI 10.1098/rspa.1938.0066; Wigner E, 1934, PHYS REV, V46, P1002, DOI 10.1103/PhysRev.46.1002; Young DP, 1999, NATURE, V397, P412, DOI 10.1038/17081	9	82	83	0	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					386	387		10.1038/17011	http://dx.doi.org/10.1038/17011			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667966				2022-12-28	WOS:000078461700023
J	Scott, IA				Scott, Ian A.			Machine Learning and Evidence-Based Medicine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CONSEQUENCES		[Scott, Ian A.] Univ Queensland, Translat Res Inst, 37 Kent St, Brisbane, Qld 4102, Australia	University of Queensland	Scott, IA (corresponding author), Univ Queensland, Translat Res Inst, 37 Kent St, Brisbane, Qld 4102, Australia.	ian.scott@health.qld.gov.au	Scott, Ian A/F-1482-2011; Scott, Ian/Z-4577-2019					Alanazi HO, 2017, J MED SYST, V41, DOI 10.1007/s10916-017-0715-6; Bae MH, 2012, CLIN CARDIOL, V35, P348, DOI 10.1002/clc.22000; Bruland P, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0259-3; Cabitza F, 2017, JAMA-J AM MED ASSOC, V318, P517, DOI 10.1001/jama.2017.7797; Deo RC, 2015, CIRCULATION, V132, P1920, DOI 10.1161/CIRCULATIONAHA.115.001593; Derman E, 2012, MODELS BEHAV BADLY W; Frizzell JD, 2017, JAMA CARDIOL, V2, P204, DOI 10.1001/jamacardio.2016.3956; Hashimoto D. A., 2018, ANN SURG; Karim ME, 2018, EPIDEMIOLOGY, V29, P191, DOI 10.1097/EDE.0000000000000787; Linden A, 2016, J EVAL CLIN PRACT, V22, P864, DOI 10.1111/jep.12592	10	13	13	2	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 3	2018	169	1					44	+		10.7326/M18-0115	http://dx.doi.org/10.7326/M18-0115			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL2FB	29710098				2022-12-28	WOS:000436931900007
J	Ghadimi, AH; Fedorov, SA; Engelsen, NJ; Bereyhi, MJ; Schilling, R; Wilson, DJ; Kippenberg, TJ				Ghadimi, A. H.; Fedorov, S. A.; Engelsen, N. J.; Bereyhi, M. J.; Schilling, R.; Wilson, D. J.; Kippenberg, T. J.			Elastic strain engineering for ultralow mechanical dissipation	SCIENCE			English	Article								Extreme stresses can be produced in nanoscale structures; this feature has been used to realize enhanced materials properties, such as the high mobility of silicon in modern transistors. We show how nanoscale stress can be used to realize exceptionally low mechanical dissipation when combined with "soft-clamping"-a form of phononic engineering. Specifically, using a nonuniform phononic crystal pattern, we colocalize the strain and flexural motion of a free-standing silicon nitride nanobeam. Ringdown measurements at room temperature reveal string-like vibrational modes with quality (Q) factors as high as 800 million and Q x frequency exceeding 10(15) hertz. These results illustrate a promising route for engineering ultracoherent nanomechanical devices.	[Ghadimi, A. H.; Fedorov, S. A.; Engelsen, N. J.; Bereyhi, M. J.; Schilling, R.; Kippenberg, T. J.] Ecole Polytech Fed Lausanne, Inst Phys, CH-1015 Lausanne, Switzerland; [Wilson, D. J.] IBM Res Zurich, CH-8803 Ruschlikon, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; International Business Machines (IBM)	Kippenberg, TJ (corresponding author), Ecole Polytech Fed Lausanne, Inst Phys, CH-1015 Lausanne, Switzerland.; Wilson, DJ (corresponding author), IBM Res Zurich, CH-8803 Ruschlikon, Switzerland.	daw@zurich.ibm.com; tobias.kippenberg@epfl.ch	Engelsen, Nils Johan/L-5865-2017; Kippenberg, T. J./B-3133-2013	Engelsen, Nils Johan/0000-0001-8044-4629; Kippenberg, T. J./0000-0002-3408-886X; Fedorov, Sergey/0000-0003-4606-0546	EU Horizon Research and Innovation Program [732894]; SNF Cavity Quantum Optomechanics project [163387]; MSCA ETN-OMT [722923]; ERC AdG QuREM [320966]; DARPA seedling grant [HR0011181003]	EU Horizon Research and Innovation Program; SNF Cavity Quantum Optomechanics project; MSCA ETN-OMT; ERC AdG QuREM; DARPA seedling grant	Supported by the EU Horizon 2020 Research and Innovation Program under grant agreement 732894 (FET Proactive HOT) and the SNF Cavity Quantum Optomechanics project (grant 163387); MSCA ETN-OMT grant 722923 (M.J.B.); ERC AdG QuREM grant 320966 (T.J.K.); and DARPA seedling grant HR0011181003. All samples were fabricated at the Center for MicroNanoTechnology (CMi) at EPFL.	Aspelmeyer M, 2014, REV MOD PHYS, V86, P1391, DOI 10.1103/RevModPhys.86.1391; Barton RA, 2011, NANO LETT, V11, P1232, DOI 10.1021/nl1042227; Braginsky V. B., 1985, SYSTEMS SMALL DISSIP; Castellanos-Gomez A, 2013, NANO LETT, V13, P5361, DOI 10.1021/nl402875m; Chakram S, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.127201; Chan J, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4747726; Chidambaram PR, 2006, IEEE T ELECTRON DEV, V53, P944, DOI 10.1109/TED.2006.872912; Cole GD, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4879755; Cole GD, 2013, NAT PHOTONICS, V7, P644, DOI [10.1038/NPHOTON.2013.174, 10.1038/nphoton.2013.174]; Feng J, 2012, NAT PHOTONICS, V6, P865, DOI [10.1038/NPHOTON.2012.285, 10.1038/nphoton.2012.285]; GABRIELA GI, 1994, J ACOUST SOC AM, V96, P207, DOI 10.1121/1.410467; Ghadimi AH, 2017, NANO LETT, V17, P3501, DOI 10.1021/acs.nanolett.7b00573; Li J, 2014, MRS BULL, V39, P108, DOI 10.1557/mrs.2014.3; Liu YC, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.013824; Minamisawa RA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2102; Moura J. P., 2017, ARXIV170708128PHYSIC; Poggio M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.017201; Poggio M, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/34/342001; Schmid S, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.165307; Southworth DR, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.225503; Suess MJ, 2013, NAT PHOTONICS, V7, P466, DOI [10.1038/nphoton.2013.67, 10.1038/NPHOTON.2013.67]; Tsaturyan Y, 2017, NAT NANOTECHNOL, V12, P776, DOI [10.1038/nnano.2017.101, 10.1038/NNANO.2017.101]; Unterreithmeier QP, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.027205; Villanueva LG, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.227201; Wilson DJ, 2015, NATURE, V524, P325, DOI 10.1038/nature14672; Wilson DJ, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.207204; Yu DP, 2014, MRS BULL, V39, P157, DOI 10.1557/mrs.2014.6; Yu PL, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.083603; Zhang R, 2015, APPL PHYS LETT, V107, DOI 10.1063/1.4932201	29	162	161	9	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2018	360	6390			SI		764	+		10.1126/science.aar6939	http://dx.doi.org/10.1126/science.aar6939			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG1US	29650701				2022-12-28	WOS:000432473500042
J	Ruan, JB; Xia, SY; Liu, X; Lieberman, J; Wu, H				Ruan, Jianbin; Xia, Shiyu; Liu, Xing; Lieberman, Judy; Wu, Hao			Cryo-EM structure of the gasdermin A3 membrane pore	NATURE			English	Article							PYROPTOTIC CELL-DEATH; PLASMA-MEMBRANE; CRYSTAL-STRUCTURE; REVEALS; GSDMD; CASPASE-11; MECHANISM; PROTEINS; CLEAVAGE; PERFORIN	Gasdermins mediate inflammatory cell death after cleavage by caspases or other, unknown enzymes. The cleaved N-terminal fragments bind to acidic membrane lipids to form pores, but the mechanism of pore formation remains unresolved. Here we present the cryo-electron microscopy structures of the 27-fold and 28-fold single-ring pores formed by the N-terminal fragment of mouse GSDMA3 (GSDMA3-NT) at 3.8 and 4.2 angstrom resolutions, and of a double-ring pore at 4.6 angstrom resolution. In the 27-fold pore, a 108-stranded anti-parallel beta-barrel is formed by two beta-hairpins from each subunit capped by a globular domain. We identify a positively charged helix that interacts with the acidic lipid cardiolipin. GSDMA3-NT undergoes radical conformational changes upon membrane insertion to form long, membrane-spanning beta-strands. We also observe an unexpected additional symmetric ring of GSDMA3-NT subunits that does not insert into the membrane in the double-ring pore, which may represent a pre-pore state of GSDMA3-NT. These structures provide a basis that explains the activities of several mutant gasdermins, including defective mutants that are associated with cancer.	[Ruan, Jianbin; Xia, Shiyu; Liu, Xing; Lieberman, Judy; Wu, Hao] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Ruan, Jianbin; Xia, Shiyu; Wu, Hao] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Liu, Xing; Lieberman, Judy] Harvard Med Sch, Dept Paediat, Boston, MA USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wu, H (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.; Wu, H (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	wu@crystal.harvard.edu	Xia, Shiyu/P-8621-2019; Lieberman, Judy/A-2717-2015	Xia, Shiyu/0000-0001-9024-0689; 	US NIH [DP1HD087988, R01Al124491, R01AI123265]; Charles A. King Trust Postdoctoral Fellowship Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD087988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123265, R01AI124491, R01AI139914] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles A. King Trust Postdoctoral Fellowship Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US NIH grant DP1HD087988 (H.W.), R01Al124491 (H.W.), R01AI123265 (J.L.) and Charles A. King Trust Postdoctoral Fellowship Program (J.R., X.L.). We thank the University of Massachusetts Cryo-EM Core Facility and NCI National Cryo-EM Facility at the Frederick National Laboratory for Cancer Research for data collection, and D. Ni and M. Liao for discussions.	Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Chen X, 2016, CELL RES, V26, P1007, DOI 10.1038/cr.2016.100; Degiacomi MT, 2013, NAT CHEM BIOL, V9, P623, DOI [10.1038/NCHEMBIO.1312, 10.1038/nchembio.1312]; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Iacovache I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12062; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Jacoboni I, 2001, PROTEIN SCI, V10, P779, DOI 10.1110/ps.37201; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; Koster S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4690; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Marshall JE, 2015, SCI REP-UK, V5, DOI 10.1038/srep13293; MURZIN AG, 1994, J MOL BIOL, V236, P1369, DOI 10.1016/0022-2836(94)90064-7; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Russo HM, 2016, J IMMUNOL, V197, P1353, DOI 10.4049/jimmunol.1600699; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; van Pee K, 2017, ELIFE, V6, DOI 10.7554/eLife.23644; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393	27	191	194	4	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2018	557	7703					62	+		10.1038/s41586-018-0058-6	http://dx.doi.org/10.1038/s41586-018-0058-6			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5BW	29695864	Green Accepted			2022-12-28	WOS:000431234500030
J	Lee, SF; Klenerman, D				Lee, Steven F.; Klenerman, David			Weighing one protein with light	SCIENCE			English	Editorial Material									[Lee, Steven F.; Klenerman, David] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Klenerman, D (corresponding author), Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England.	dk10012@cam.ac.uk	MUI, HOI LING/I-3220-2018	Klenerman, David/0000-0001-7116-6954	EPSRC [EP/M003663/1] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Ando Toshio, 2017, Biophys Rev, V9, P421, DOI 10.1007/s12551-017-0281-7; Arroyo Ortega, 2014, NANO LETT, V14, P2065, DOI [10.1126/science.aat5851, DOI 10.1126/SCIENCE.AAT5851]; Auer A, 2017, NANO LETT, V17, P6428, DOI 10.1021/acs.nanolett.7b03425; Gaiduk A, 2010, SCIENCE, V330, P353, DOI 10.1126/science.1195475; Hanay MS, 2012, NAT NANOTECHNOL, V7, P602, DOI [10.1038/nnano.2012.119, 10.1038/NNANO.2012.119]; Piliarik M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5495; Shashkova S, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170031; Vamosi G, 2016, SCI REP-UK, V6, DOI 10.1038/srep33022; Yampolsky S, 2014, NAT PHOTONICS, V8, P650, DOI [10.1038/nphoton.2014.143, 10.1038/NPHOTON.2014.143]; Yates EV, 2015, NAT CHEM, V7, P802, DOI [10.1038/NCHEM.2344, 10.1038/nchem.2344]; Young G, 2018, SCIENCE, V360, P423, DOI 10.1126/science.aar5839	11	0	0	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					378	379		10.1126/science.aat5851	http://dx.doi.org/10.1126/science.aat5851			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1AR	29700252				2022-12-28	WOS:000430949600021
J	Rosen, J				Rosen, Julia			Robotic weather balloon launchers spread in Alaska US weather service union fears that automation threatens jobs and sacrifices forecasters' local knowledge	SCIENCE			English	News Item																			0	0	0	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					366	366		10.1126/science.360.6387.366	http://dx.doi.org/10.1126/science.360.6387.366			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1AR	29700245				2022-12-28	WOS:000430949600014
J	Kim, HS; Tan, YL; Ma, WB; Merkurjev, D; Destici, E; Ma, Q; Suter, T; Ohgi, K; Friedman, M; Skowronska-Krawczyk, D; Rosenfeld, MG				Kim, Hong Sook; Tan, Yuliang; Ma, Wubin; Merkurjev, Daria; Destici, Eugin; Ma, Qi; Suter, Tom; Ohgi, Kenneth; Friedman, Meyer; Skowronska-Krawczyk, Dorota; Rosenfeld, Michael G.			Pluripotency factors functionally premark cell-type-restricted enhancers in ES cells	NATURE			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; SELF-RENEWAL; CHROMATIN; STATE; HEMATOPOIESIS; POPULATIONS; MACROPHAGES; ACTIVATION; LANDSCAPE	Enhancers for embryonic stem (ES) cell-expressed genes and lineage-determining factors are characterized by conventional marks of enhancer activation in ES cells(1-3), but it remains unclear whether enhancers destined to regulate cell-type-restricted transcription units might also have distinct signatures in ES cells. Here we show that cell-type-restricted enhancers are 'premarked' and activated as transcription units by the binding of one or two ES cell transcription factors, although they do not exhibit traditional enhancer epigenetic marks in ES cells, thus uncovering the initial temporal origins of cell-type-restricted enhancers. This premarking is required for future cell-type-restricted enhancer activity in the differentiated cells, with the strength of the ES cell signature being functionally important for the subsequent robustness of cell-type-restricted enhancer activation. We have experimentally validated this model in macrophage-restricted enhancers and neural precursor cell (NPC)-restricted enhancers using ES cell-derived macrophages or NPCs, edited to contain specific ES cell transcription factor motif deletions. DNA hydroxyl-methylation of enhancers in ES cells, determined by ES cell transcription factors, may serve as a potential molecular memory for subsequent enhancer activation in mature macrophages. These findings suggest that the massive repertoire of cell-type-restricted enhancers are essentially hierarchically and obligatorily premarked by binding of a defining ES cell transcription factor in ES cells, dictating the robustness of enhancer activation in mature cells.	[Kim, Hong Sook; Tan, Yuliang; Ma, Wubin; Merkurjev, Daria; Destici, Eugin; Ma, Qi; Suter, Tom; Ohgi, Kenneth; Friedman, Meyer; Skowronska-Krawczyk, Dorota; Rosenfeld, Michael G.] Univ Calif San Diego, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Kim, Hong Sook; Tan, Yuliang; Ma, Wubin; Merkurjev, Daria; Destici, Eugin; Ma, Qi; Suter, Tom; Ohgi, Kenneth; Friedman, Meyer; Skowronska-Krawczyk, Dorota; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Skowronska-Krawczyk, Dorota] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Kim, HS; Rosenfeld, MG (corresponding author), Univ Calif San Diego, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA.; Kim, HS; Rosenfeld, MG (corresponding author), Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA.	hsk020@ucsd.edu; mrosenfeld@ucsd.edu		Destici, Eugin/0000-0002-8472-1766; Ma, Qi/0000-0002-8705-4460	NIH [5R01NS093066, DK018477, DK039949, NS093066, GM104459]; NATIONAL CANCER INSTITUTE [R01CA097134, R01CA213371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039949, R01DK018477, R37DK039949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS093066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG057706] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Hightower for assistance with figure preparation, and H. Taylor for help with animal-based cell culture. M.G.R. is an investigator with the Howard Hughes Medical Institute. This work was supported by grants from NIH to M.G.R. (5R01NS093066, DK018477, DK039949, NS093066, and GM104459).	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Gagliardi A, 2013, EMBO J, V32, P2231, DOI 10.1038/emboj.2013.161; Han D, 2016, MOL CELL, V63, P711, DOI 10.1016/j.molcel.2016.06.028; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Huang HT, 2013, NAT CELL BIOL, V15, P1516, DOI 10.1038/ncb2870; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kumar RM, 2014, NATURE, V516, P56, DOI 10.1038/nature13920; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Lichtinger M, 2012, EMBO J, V31, P4318, DOI 10.1038/emboj.2012.275; Miguel-Escalada I, 2015, CURR OPIN GENET DEV, V33, P71, DOI 10.1016/j.gde.2015.08.009; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Thu KL, 2009, JOVE-J VIS EXP, pe935, DOI [10.3791/935, DOI 10.3791/935]; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; Wang A, 2015, CELL STEM CELL, V16, P386, DOI 10.1016/j.stem.2015.02.013; Will B, 2015, NAT MED, V21, P1172, DOI 10.1038/nm.3936; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhuang LH, 2012, J IMMUNOL METHODS, V385, P1, DOI 10.1016/j.jim.2012.06.008	27	26	26	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					510	+		10.1038/s41586-018-0048-8	http://dx.doi.org/10.1038/s41586-018-0048-8			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8VX	29670286	Green Accepted			2022-12-28	WOS:000430793000049
J	Guirguis-Blake, JM; Michael, YL; Perdue, LA; Coppola, EL; Beil, TL				Guirguis-Blake, Janelle M.; Michael, Yvonne L.; Perdue, Leslie A.; Coppola, Erin L.; Beil, Tracy L.			Interventions to Prevent Falls in Older Adults Updated Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIAL; VITAMIN-D SUPPLEMENTATION; HOME-BASED EXERCISE; ELDERLY-PEOPLE; REDUCE FALLS; MULTIFACTORIAL INTERVENTION; HIGH-RISK; EMERGENCY-DEPARTMENT; GENERAL-PRACTICE; TAI-CHI	IMPORTANCE Falls are the most common cause of injury-related morbidity and mortality among older adults. OBJECTIVE To systematically review literature on the effectiveness and harms of fall prevention interventions in community-dwelling older adults to inform the US Preventive Services Task Force. DATA SOURCES MEDLINE, PubMed, Cumulative Index for Nursing and Allied Health Literature, and Cochrane Central Register of Controlled Trials for relevant English-language literature published through August 2016, with ongoing surveillance through February 7, 2018. STUDY SELECTION Randomized clinical trials of interventions to prevent falls in community-dwelling adults 65 years and older. DATA EXTRACTION AND SYNTHESIS Independent critical appraisal and data abstraction by 2 reviewers. Random-effects meta-analyses using the method of DerSimonian and Laird. MAIN OUTCOMES AND MEASURES Number of falls (number of unexpected events in which a person comes to rest on the ground, floor, or lower level), people experiencing 1 or more falls, injurious falls, people experiencing injurious falls, fractures, people experiencing fractures, mortality, hospitalizations, institutionalizations, changes in disability, and treatment harms. RESULTS Sixty-two randomized clinical trials (N = 35 058) examining 7 fall prevention intervention types were identified. This article focused on the 3 most commonly studied intervention types: multifactorial (customized interventions based on initial comprehensive individualized falls risk assessment) (26 trials [n = 15 506]), exercise (21 trials [n = 7297]), and vitamin D supplementation (7 trials [n = 7531]). Multifactorial intervention trials were associated with a reduction in falls (incidence rate ratio [IRR], 0.79 [95% Cl, 0.68-0.91]) but were not associated with a reduction in other fall-related morbidity and mortality outcomes. Exercise trials were associated with statistically significant reductions in people experiencing a fall (relative risk, 0.89 [95% 13 Cl, 0.81-0.97]) and injurious falls (IRR, 0.81 [95% Cl, 0.73-0.90]) and with a statistically nonsignificant reduction in falls (IRR, 0.87 [95% Cl, 0.75-1.00]) but showed no association with mortality. Few exercise trials reported fall-related fractures. Seven heterogeneous trials of vitamin D formulations (with or without calcium) showed mixed results. One trial of annual high-dose cholecalciferol (500 000 IU), which has not been replicated, showed an increase in falls, people experiencing a fall, and injuries, while 1 trial of calcitriol showed a reduction in falls and people experiencing a fall; the remaining 5 trials showed no significant difference in falls, people experiencing a fall, or injuries. Harms of multifactorial and exercise trials were rarely reported but generally included minor musculoskeletal injuries. CONCLUSIONS AND RELEVANCE Multifactorial and exercise interventions were associated with fall-related benefit, but evidence was most consistent across multiple fall-related outcomes for exercise. Vitamin D supplementation interventions had mixed results, with a high dose being associated with higher rates of fall-related outcomes.	[Guirguis-Blake, Janelle M.; Perdue, Leslie A.; Coppola, Erin L.; Beil, Tracy L.] Kaiser Permanente, Res Affiliates Evidence based Practice Ctr Ctr Hl, Portland, OR USA; [Guirguis-Blake, Janelle M.] Univ Washington, Dept Family Med, Tacoma, WA USA; [Michael, Yvonne L.] Drexel Univ, Dornsife Sch Publ Hlth, Philadelphia, PA 19104 USA	Kaiser Permanente; University of Washington; University of Washington Tacoma; Drexel University	Guirguis-Blake, JM (corresponding author), Univ Washington, Dept Family Med, Kaiser Permanente Res Affiliates EPC, 521 Martin Luther King Jr Way, Tacoma, WA 98405 USA.	jguirgui@u.washington.edu	Michael, Yvonne Louise/AAB-9995-2020		Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA-290-2012-00015-I-EPC4]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services	This research was funded under contract HHSA-290-2012-00015-I-EPC4, Task Order 6, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the USPSTF.	Barnett A, 2003, AGE AGEING, V32, P407, DOI 10.1093/ageing/32.4.407; Barry E, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-14; Bergen G, 2016, MMWR-MORBID MORTAL W, V65, P993, DOI 10.15585/mmwr.mm6537a2; Bischoff-Ferrari HA, 2006, ARCH INTERN MED, V166, P424; Bolland MJ, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3005; Bolland MJ, 2014, J CLIN ENDOCR METAB, V99, P4265, DOI 10.1210/jc.2014-2562; Bolland MJ, 2014, LANCET DIABETES ENDO, V2, P573, DOI 10.1016/S2213-8587(14)70068-3; Buchner DM, 1997, J GERONTOL A-BIOL, V52, pM218, DOI 10.1093/gerona/52A.4.M218; Campbell AJ, 1997, BMJ-BRIT MED J, V315, P1065, DOI 10.1136/bmj.315.7115.1065; Chu MML, 2017, J AM GERIATR SOC, V65, P364, DOI 10.1111/jgs.14527; Ciaschini PM, 2009, AGE AGEING, V38, P724, DOI 10.1093/ageing/afp176; Close J, 1999, LANCET, V353, P93, DOI 10.1016/S0140-6736(98)06119-4; Cohen MA, 2015, HEALTH AFFAIR, V34, P971, DOI 10.1377/hlthaff.2014.1172; Conroy S, 2010, AGE AGEING, V39, P704, DOI 10.1093/ageing/afq096; Davison J, 2005, AGE AGEING, V34, P162, DOI 10.1093/ageing/afi053; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; de Vries OJ, 2010, ARCH INTERN MED, V170, P1110, DOI 10.1001/archinternmed.2010.169; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Donner A, 2003, EVAL HEALTH PROF, V26, P340, DOI 10.1177/0163278703255234; Dukas L, 2004, J AM GERIATR SOC, V52, P230, DOI 10.1111/j.1532-5415.2004.52060.x; El-Khoury F, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6234; El-Khoury F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3830; Elley CR, 2008, J AM GERIATR SOC, V56, P1383, DOI 10.1111/j.1532-5415.2008.01802.x; Fairhall N, 2014, AGE AGEING, V43, P616, DOI 10.1093/ageing/aft204; Ferrer A, 2014, CLIN INTERV AGING, V9, P383, DOI 10.2147/CIA.S57580; Fitzharris MP, 2010, AGE AGEING, V39, P728, DOI 10.1093/ageing/afq109; Freiberger E, 2012, J AM GERIATR SOC, V60, P437, DOI 10.1111/j.1532-5415.2011.03859.x; Gallagher JC, 2016, NAT REV ENDOCRINOL, V12, P680, DOI 10.1038/nrendo.2016.123; Gallagher JC, 2001, J CLIN ENDOCR METAB, V86, P3618, DOI 10.1210/jc.86.8.3618; Gates S, 2008, J REHABIL RES DEV, V45, P1105, DOI 10.1682/JRRD.2008.04.0057; Gawler S, 2016, ARCH GERONTOL GERIAT, V67, P46, DOI 10.1016/j.archger.2016.06.019; Gill TM, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i245; Gillespie L. D., 2012, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD007146; Glendenning P, 2012, J BONE MINER RES, V27, P170, DOI 10.1002/jbmr.524; Hendriks MRC, 2008, J AM GERIATR SOC, V56, P1390, DOI 10.1111/j.1532-5415.2008.01803.x; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hogan DB, 2001, CAN MED ASSOC J, V165, P537; Imhof L, 2012, J AM GERIATR SOC, V60, P2223, DOI 10.1111/jgs.12026; Kalyani RR, 2010, J AM GERIATR SOC, V58, P1299, DOI 10.1111/j.1532-5415.2010.02949.x; Kamide Naoto, 2009, Journal of Physiological Anthropology, V28, P115, DOI 10.2114/jpa2.28.115; Karinkanta S, 2015, AGE AGEING, V44, P784, DOI 10.1093/ageing/afv064; Kovacs E, 2013, EUR J PHYS REHAB MED, V49, P301; Lamb SE, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-125; Lightbody E, 2002, AGE AGEING, V31, P203, DOI 10.1093/ageing/31.3.203; Logan PA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2102; Logghe IHJ, 2009, J AM GERIATR SOC, V57, P70, DOI 10.1111/j.1532-5415.2008.02064.x; Lord SR, 2005, J AM GERIATR SOC, V53, P1296, DOI 10.1111/j.1532-5415.2005.53425.x; Lusardi MM, 2017, J GERIATR PHYS THER, V40, P1, DOI 10.1519/JPT.0000000000000099; Luukinen H, 2007, PREV MED, V44, P265, DOI 10.1016/j.ypmed.2006.09.011; Matchar DB, 2017, ARCH PHYS MED REHAB, V98, P1086, DOI 10.1016/j.apmr.2017.01.014; Michael YL., 2010, INTERVENTIONS PREVEN; Michael YL, 2010, ANN INTERN MED, V153, P815, DOI 10.7326/0003-4819-153-12-201012210-00008; Moller UO, 2014, J AGING PHYS ACTIV, V22, P457, DOI [10.1123/JAPA.2013-0101, 10.1123/japa.2013-0101]; Morgan RO, 2004, J GERONTOL A-BIOL, V59, P1062; Moyer VA, 2012, ANN INTERN MED, V157, P197, DOI 10.7326/0003-4819-157-3-201208070-00462; Murad MH, 2011, J CLIN ENDOCR METAB, V96, P2997, DOI 10.1210/jc.2011-1193; Newbury JW, 2001, MED J AUSTRALIA, V175, P104, DOI 10.5694/j.1326-5377.2001.tb143541.x; Ng TP, 2015, AM J MED, V128, P1225, DOI 10.1016/j.amjmed.2015.06.017; Palvanen M, 2014, INJURY, V45, P265, DOI 10.1016/j.injury.2013.03.010; Perula LA, 2012, ARCH PHYS MED REHAB, V93, P1677, DOI 10.1016/j.apmr.2012.03.035; Porthouse J, 2005, BMJ-BRIT MED J, V330, P1003, DOI 10.1136/bmj.330.7498.1003; Robertson MC, 2001, BRIT MED J, V322, P697, DOI 10.1136/bmj.322.7288.697; Russell MA, 2010, J AM GERIATR SOC, V58, P2265, DOI 10.1111/j.1532-5415.2010.03191.x; Salminen MJ, 2009, J AM GERIATR SOC, V57, P612, DOI 10.1111/j.1532-5415.2009.02176.x; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Schleicher RL, 2016, AM J CLIN NUTR, V104, P454, DOI 10.3945/ajcn.115.127985; Sherrington C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104412; Spice CL, 2009, AGE AGEING, V38, P33, DOI 10.1093/ageing/afn192; Stubbs B, 2015, PHYS THER, V95, P1095, DOI 10.2522/ptj.20140461; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; Tricco AC, 2017, JAMA-J AM MED ASSOC, V318, P1687, DOI 10.1001/jama.2017.15006; Trombetti A, 2011, ARCH INTERN MED, V171, P525, DOI 10.1001/archinternmed.2010.446; Uusi-Rasi K, 2015, JAMA INTERN MED, V175, P703, DOI 10.1001/jamainternmed.2015.0225; van Haastregt JCM, 2000, BMJ-BRIT MED J, V321, P994, DOI 10.1136/bmj.321.7267.994; Vind AB, 2009, J AM GERIATR SOC, V57, P971, DOI 10.1111/j.1532-5415.2009.02270.x; Voukelatos A, 2007, J AM GERIATR SOC, V55, P1185, DOI 10.1111/j.1532-5415.2007.01244.x; Voukelatos A, 2015, AGE AGEING, V44, P377, DOI 10.1093/ageing/afu186; WAGNER EH, 1994, AM J PUBLIC HEALTH, V84, P1800, DOI 10.2105/AJPH.84.11.1800	78	184	192	13	105	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2018	319	16					1705	1716		10.1001/jama.2017.21962	http://dx.doi.org/10.1001/jama.2017.21962			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GD7RF	29710140	Bronze			2022-12-28	WOS:000430709300025
J	Rubin, R				Rubin, Rita			Just 4 Weeks of Antibiotics Prevents Active TB in People With HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2018	319	16					1648	1648		10.1001/jama.2018.4736	http://dx.doi.org/10.1001/jama.2018.4736			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD7RF	29710149				2022-12-28	WOS:000430709300005
J	Dedovets, D; Monteux, C; Deville, S				Dedovets, Dmytro; Monteux, Cecile; Deville, Sylvain			Five-dimensional imaging of freezing emulsions with solute effects	SCIENCE			English	Article							RED-BLOOD-CELLS; SOLIDIFICATION; PARTICLES; INTERFACE; ALLOYS	The interaction of objects with a moving solidification front is a common feature of many industrial and natural processes such as metal processing, the growth of single crystals, the cryopreservation of cells, or the formation of sea ice. Interaction of solidification fronts with objects leads to different outcomes, from total rejection of the objects to their complete engulfment. We imaged the freezing of emulsions in five dimensions (space, time, and solute concentration) with confocal microscopy. We showed that the solute induces long-range interactions that determine the solidification microstructure. The local increase of solute concentration enhances premelting, which controls the engulfment of droplets by the front and the evolution of grain boundaries. Freezing emulsions may be a good analog of many solidification systems where objects interact with a solidification interface.	[Dedovets, Dmytro; Deville, Sylvain] St Gobain CREE, CNRS, Lab Synth & Fonctionnalisat Ceram, UMR 3080, Cavaillon, France; [Monteux, Cecile] UPMC Univ Paris 06, Sorbonne Univ, PSL Res Univ, CNRS,ESPCI Paris,Sci & Ingn Mat Molle, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Saint Gobain SA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite	Deville, S (corresponding author), St Gobain CREE, CNRS, Lab Synth & Fonctionnalisat Ceram, UMR 3080, Cavaillon, France.	sylvain.deville@saint-gobain.com	Deville, Sylvain/H-5515-2019	Deville, Sylvain/0000-0002-3363-3184; Dedovets, Dmytro/0000-0002-9040-2614	European Research Council under the European Community's Seventh Framework Programme (FP7) Grant [278004]	European Research Council under the European Community's Seventh Framework Programme (FP7) Grant	The research leading to these results has received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013) Grant Agreement no. 278004.	ANDERSON JL, 1982, J FLUID MECH, V117, P107, DOI 10.1017/S0022112082001542; ASTHANA R, 1993, J MATER SCI, V28, P5414, DOI 10.1007/BF00367810; Bunoiu OM, 2010, PROG CRYST GROWTH CH, V56, P123, DOI 10.1016/j.pcrysgrow.2010.09.001; Bystricky P., 1997, THESIS; Catalina AV, 2004, METALL MATER TRANS A, V35A, P1525, DOI 10.1007/s11661-004-0260-z; DASH JG, 1995, REP PROG PHYS, V58, P115, DOI 10.1088/0034-4885/58/1/003; Daudin R, 2015, MATER DESIGN, V87, P313, DOI 10.1016/j.matdes.2015.07.141; Deville S, 2017, ENG MATER PROCESS, P47, DOI 10.1007/978-3-319-50515-2_2; Deville S, 2018, SCRIPTA MATER, V147, P119, DOI 10.1016/j.scriptamat.2017.06.020; Dong JP, 2010, BIOPHYS J, V99, P2453, DOI 10.1016/j.bpj.2010.08.035; Farup I, 2001, ACTA MATER, V49, P1261, DOI 10.1016/S1359-6454(01)00013-1; GUPTA AK, 1992, J MATER SCI, V27, P853, DOI 10.1007/BF01197634; Hubel A, 1997, TRANSFUS MED REV, V11, P224, DOI 10.1053/tmrv.1997.0110224; ISHIGURO H, 1994, CRYOBIOLOGY, V31, P483, DOI 10.1006/cryo.1994.1059; KORBER C, 1988, Q REV BIOPHYS, V21, P229, DOI 10.1017/S0033583500004303; KOUROSH S, 1990, INT J HEAT MASS TRAN, V33, P39, DOI 10.1016/0017-9310(90)90139-L; Majumdar B, 1996, METALL MATER TRANS A, V27, P2053, DOI 10.1007/BF02651956; Neumann-Heyme H, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.060401; Park MS, 2006, J FLUID MECH, V560, P415, DOI 10.1017/S0022112006000796; Ratke L, 2005, MAT SCI ENG A-STRUCT, V413, P504, DOI 10.1016/j.msea.2005.08.195; Ratke L, 2006, SCRIPTA MATER, V54, P1217, DOI 10.1016/j.scriptamat.2005.07.044; Rempel AW, 2010, J GLACIOL, V56, P1122, DOI 10.3189/002214311796406149; Rowenhorst DJ, 2012, ANNU REV MATER RES, V42, P105, DOI 10.1146/annurev-matsci-070511-155028; Scott KL, 2005, TRANSFUS MED REV, V19, P127, DOI 10.1016/j.tmrv.2004.11.004; Tolnai D, 2012, ACTA MATER, V60, P2568, DOI 10.1016/j.actamat.2012.01.024; Uemura M, 2015, CRYOBIOLOGY, V70, P122, DOI 10.1016/j.cryobiol.2015.01.006; Weber CA, 2017, NEW J PHYS, V19, DOI 10.1088/1367-2630/aa6b84; Wettlaufer JS, 2006, ANNU REV FLUID MECH, V38, P427, DOI 10.1146/annurev.fluid.37.061903.175758; Zhang, 2006, J IRON STEEL RES INT, V13, P1	29	38	38	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2018	360	6386					303	306		10.1126/science.aar4503	http://dx.doi.org/10.1126/science.aar4503			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD3IC	29674590	Green Submitted, Green Published			2022-12-28	WOS:000430396600040
J	Iliff, AJ; Xu, XZS				Iliff, Adam J.; Xu, X. Z. Shawn			A Mechanosensitive GPCR that Detects the Bloody Force	CELL			English	Editorial Material							CHANNELS	Mechanoreceptors mediate a wide variety of physiological processes, such as hearing, touch, proprioception, and blood flow regulation. It is generally believed that mechanoreceptors are force-gated ion channels. Now, Xu et al. uncover a GPCR that is activated by shear force in endothelial cells of blood vessels.	[Iliff, Adam J.; Xu, X. Z. Shawn] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA; [Iliff, Adam J.; Xu, X. Z. Shawn] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Xu, XZS (corresponding author), Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA.; Xu, XZS (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	shawnxu@umich.edu	Iliff, Adam/ABC-7832-2021	Iliff, Adam/0000-0001-6525-6822	NRSA fellowship grant from the NIDCD; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083241] Funding Source: NIH RePORTER	NRSA fellowship grant from the NIDCD; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.J.I. is supported by an NRSA fellowship grant from the NIDCD. Research in the Xu lab is supported by grants from the NIH (X.Z.S.X.).	Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Davies PF, 2009, NAT CLIN PRACT CARD, V6, P16, DOI 10.1038/ncpcardio1397; Katta S, 2015, ANNU REV CELL DEV BI, V31, P347, DOI 10.1146/annurev-cellbio-100913-013426; Schnitzler MMY, 2008, EMBO J, V27, P3092, DOI 10.1038/emboj.2008.233; Sharif-Naeini R, 2010, J MOL CELL CARDIOL, V48, P83, DOI 10.1016/j.yjmcc.2009.03.020; Xiao R, 2010, CURR BIOL, V20, pR936, DOI 10.1016/j.cub.2010.09.053; Xu J, 2018, CELL, V173, P762, DOI 10.1016/j.cell.2018.03.076	7	3	3	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2018	173	3					540	543		10.1016/j.cell.2018.04.001	http://dx.doi.org/10.1016/j.cell.2018.04.001			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7GB	29677505	Green Accepted, Bronze			2022-12-28	WOS:000430677400004
J	Schiermeier, Q				Schiermeier, Quirin			Great Barrier Reef saw huge losses from 2016 heatwave	NATURE			English	News Item																		Hughes TP, 2018, NATURE, V556, P492, DOI 10.1038/s41586-018-0041-2; Hughes TP, 2018, SCIENCE, V359, P80, DOI 10.1126/science.aan8048; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707	3	0	0	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2018	556	7701					281	282		10.1038/d41586-018-04660-w	http://dx.doi.org/10.1038/d41586-018-04660-w			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1TW	29670275	Bronze			2022-12-28	WOS:000430285200014
J	Zhao, YT; Huang, YS				Zhao, Yun-Tao; Huang, Yen-Shu			ECG Pattern Associated with Left Anterior Descending Coronary Artery Occlusion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zhao, Yun-Tao] Aerosp Ctr Hosp, Beijing, Peoples R China; [Huang, Yen-Shu] Xiamen Chang Gung Hosp, Xiamen, Peoples R China		Zhao, YT (corresponding author), Aerosp Ctr Hosp, Beijing, Peoples R China.	raas@hsc.pku.edu.cn							0	2	2	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2018	378	16					E22	E22		10.1056/NEJMicm1714059	http://dx.doi.org/10.1056/NEJMicm1714059			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GD2EI	29669230				2022-12-28	WOS:000430312500010
J	Pickersgill, M; Chan, S; Haddow, G; Laurie, G; Sridhar, D; Sturdy, S; Cunningham-Burley, S				Pickersgill, Martyn; Chan, Sarah; Haddow, Gill; Laurie, Graeme; Sridhar, Devi; Sturdy, Steve; Cunningham-Burley, Sarah			The social sciences, humanities, and health	LANCET			English	Editorial Material									[Pickersgill, Martyn; Chan, Sarah; Haddow, Gill; Laurie, Graeme; Sridhar, Devi; Sturdy, Steve; Cunningham-Burley, Sarah] Univ Edinburgh, Old Med Sch, Ctr Biomed Self & Soc, Edinburgh EH8 9AG, Midlothian, Scotland	University of Edinburgh	Pickersgill, M (corresponding author), Univ Edinburgh, Old Med Sch, Ctr Biomed Self & Soc, Edinburgh EH8 9AG, Midlothian, Scotland.	martyn.pickersgill@ed.ac.uk		Laurie, Graeme/0000-0002-1571-8272; Pickersgill, Martyn/0000-0001-9807-9148; Haddow, Gill/0000-0001-7205-6933; Cunningham-Burley, Sarah/0000-0002-0009-7653	Wellcome Trust [209519/Z/17/Z, 201652/Z/16/Z, 100561/Z/12/Z, 104831/Z/14/Z, 103360MA, 106612/Z/14/Z, 106635/Z/14/Z, 100597/Z/12Z]; British Academy [EN160164]; Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission); British Academy; Wellcome Trust(Wellcome TrustEuropean Commission)	Our collaborative work is supported by the Wellcome Trust (grant number: 209519/Z/17/Z). Individually, we are also supported by the Wellcome Trust (grant numbers 201652/Z/16/Z for SC; 100561/Z/12/Z for GH; 104831/Z/14/Z for SC-B; 103360MA for GL; 106612/Z/14/Z for MP; 106635/Z/14/Z for DS; 100597/Z/12Z for SS) and the British Academy (EN160164 for MP). We are all employees of The University of Edinburgh in the Wellcome Trust-supported Centre for Biomedicine, Self and Society. We declare no other competing interests.	[Anonymous], 2018, GUARDIAN; Broer T, 2017, SCI CULT-UK, V26, P135, DOI 10.1080/09505431.2016.1212003; Callard F, 2015, PALGRAVE PIVOT, P1, DOI 10.1057/9781137407962; Campaign for Social Science, 2017, HLTH PEOPL SOC SCI C; Huzair F, 2017, STUD HIST PHI PART C, V64, P11, DOI 10.1016/j.shpsc.2017.05.004; Pickersgill MD, 2013, EUROPEAN LAW NEW HLT, P323; Sethi Nayha, 2013, Med Law Int, V13, P168; Sridhar D, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3339; UK Government , 2018, PRIM MIN LAUNCH MAJ; Wellcome Trust, 2010, STRAT PLAN 2010 2020	10	9	9	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2018	391	10129					1462	1463		10.1016/S0140-6736(18)30669-X	http://dx.doi.org/10.1016/S0140-6736(18)30669-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GC6TS	29676265	Green Submitted			2022-12-28	WOS:000429926000007
J	Deutscher, G				Deutscher, G			Coherence and single-particle excitations in the high-temperature superconductors	NATURE			English	Article							POINT-CONTACT SPECTROSCOPY; GAP; PSEUDOGAP; BEHAVIOR; CRYSTALS; STATE	The 'pseudogap' observed in the electron excitation spectrum of underdoped copper oxide superconductors has become the focus of considerable attention in the field of high-temperature superconductivity. In conventional superconductors, described by 'BCS' theory, an energy gap appears at the superconducting transition temperature (T-c); the pseudogap, in contrast, is observed well above T-c (ref. 1) and can be large compared to the conventional BCS gap(2-4). Here I compare gap energies, measured by different experimental techniques, for the copper oxide superconductors and show that these reveal the existence of two distinct energy scales: Delta(p) and Delta(c). The first, determined either by angle-resolved photoemission spectroscopy or by tunnelling, is the single-particle excitation energy-the energy (per particle) required to split the paired charge-carriers that are required for superconductivity. The second energy scale is determined by Andreev reflection experiments, and I associate it with the coherence energy range of the superconducting state-the macroscopic quantum condensate of the paired charges. I find that, in the overdoped regime, Delta(p) and Delta(c) converge to approximately the same value, as would be the case for a BCS superconductor where pairs form and condense simultaneously. But in the underdoped regime, where the pseudogap is observed, the two values diverge and Delta(p) is larger than Delta(c). Models that may provide a framework for understanding these results involve the existence of pairing above the condensation temperature, as might occur in a crossover from BCS to Bose-Einstein condensation behaviour(5) or from the formation of striped phases(6).	Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Sch Phys & Astron, IL-69978 Tel Aviv, Israel	Tel Aviv University	Deutscher, G (corresponding author), Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Sch Phys & Astron, IL-69978 Tel Aviv, Israel.							Achsaf N., 1996, COHERENCE HIGH TEMPE, P428; ALLOUL H, 1989, PHYS REV LETT, V63, P1700, DOI 10.1103/PhysRevLett.63.1700; [Anonymous], 1995, BOSE EINSTEIN CONDEN; BONN DA, 1994, PHYS REV B, V50, P4051, DOI 10.1103/PhysRevB.50.4051; Chen QJ, 1998, PHYS REV LETT, V81, P4708, DOI 10.1103/PhysRevLett.81.4708; CHEN XK, 1994, PHYS REV LETT, V73, P3290, DOI 10.1103/PhysRevLett.73.3290; DEUTSCHER G, 1988, PHYSICA C, V153, P15, DOI 10.1016/0921-4534(88)90485-6; Ding H, 1996, NATURE, V382, P51, DOI 10.1038/382051a0; Ekino T, 1996, PHYSICA C, V263, P249, DOI 10.1016/0921-4534(95)00714-8; Emery VJ, 1997, PHYS REV B, V56, P6120, DOI 10.1103/PhysRevB.56.6120; Harris JM, 1996, PHYS REV B, V54, P15665, DOI 10.1103/PhysRevB.54.R15665; HASS N, 1992, J SUPERCOND, V5, P191, DOI 10.1007/BF00618066; KOHEN A, 1997, THESIS TEL AVIV U; Lee PA, 1997, PHYS REV LETT, V78, P4111, DOI 10.1103/PhysRevLett.78.4111; MAGGIOAPRILE L, 1997, PHYS REV LETT, V75, P2754; Miyakawa N, 1998, PHYS REV LETT, V80, P157, DOI 10.1103/PhysRevLett.80.157; MOTT N, 1990, PHYSICA A, V168, P221, DOI 10.1016/0378-4371(90)90372-Y; Nemetschek R, 1997, PHYS REV LETT, V78, P4837, DOI 10.1103/PhysRevLett.78.4837; Panagopoulos C, 1998, PHYS REV B, V57, P13422, DOI 10.1103/PhysRevB.57.13422; PINES D, 1998, NATO ASI SER; Racah D, 1996, PHYSICA C, V263, P218, DOI 10.1016/0921-4534(96)00067-6; Renner C, 1998, PHYS REV LETT, V80, P149, DOI 10.1103/PhysRevLett.80.149; Sacuto A, 1997, EUROPHYS LETT, V39, P207, DOI 10.1209/epl/i1997-00336-3; Sinha S, 1998, PHYS REV LETT, V80, P1296, DOI 10.1103/PhysRevLett.80.1296; TANAKA Y, 1996, COHERENCE HIGH TEMPE, P393; Uemura YJ, 1997, PHYSICA C, V282, P194, DOI 10.1016/S0921-4534(97)00194-9; YAGIL Y, 1995, PHYSICA C, V250, P59, DOI 10.1016/0921-4534(95)00343-6; ZHAO G, 1996, NATURE, V385, P236	28	297	302	1	38	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					410	412		10.1038/17075	http://dx.doi.org/10.1038/17075			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667953				2022-12-28	WOS:000078461700039
J	Boerma, T; Victora, C; Abouzahr, C				Boerma, Ties; Victora, Cesar; Abouzahr, Carla			Monitoring country progress and achievements by making global predictions: is the tail wagging the dog?	LANCET			English	Editorial Material							DISEASE; HEALTH; BURDEN; MORTALITY		[Boerma, Ties] Univ Manitoba, Winnipeg, MB R3T 2N2, Canada; [Victora, Cesar] Univ Pelotas, Pelotas, Brazil	University of Manitoba	Boerma, T (corresponding author), Univ Manitoba, Winnipeg, MB R3T 2N2, Canada.	ties.boerma@umanitoba.ca	Victora, Cesar Gomes/Y-2455-2019	Victora, Cesar Gomes/0000-0002-2465-2180				AbouZahr C, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1290370; Barber RM, 2017, LANCET, V390, P231, DOI [10.1016/S0140-6736(17)30818-8, 10.1016/s0140-6736(17)30818-8]; Byass P, 2017, NATURE, V545, P421, DOI 10.1038/545421a; Kassebaum NJ, 2016, LANCET, V388, P1775, DOI 10.1016/S0140-6736(16)31470-2; Lim SS, 2016, LANCET, V388, P1813, DOI 10.1016/S0140-6736(16)31467-2; Mahy M, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1291169; Pedersen J, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001289; Pisani E, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.3402/gha.v9.32298; Rajaratnam JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000253; Stevens GA, 2016, LANCET, V388, pE19, DOI 10.1016/S0140-6736(16)30388-9; UN, 2019, IMPROVING SUSTAINABL; Unicef, 2015, LEV TRENDS CHILD MOR; Victora C, 2016, LANCET GLOB HEALTH, V4, pE775, DOI 10.1016/S2214-109X(16)30204-2; WHO, 2016, WORLD HLTH STAT 2016; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; Zhou MG, 2016, LANCET, V387, P251, DOI 10.1016/S0140-6736(15)00551-6	17	34	34	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2018	392	10147					607	609		10.1016/S0140-6736(18)30586-5	http://dx.doi.org/10.1016/S0140-6736(18)30586-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GQ8MN	29661480				2022-12-28	WOS:000442009500026
J	Mishkin, AD; Mapara, MY; Reshef, R				Mishkin, Adrienne D.; Mapara, Markus Y.; Reshef, Ran			Iatrogenic Infertility After Curative Stem Cell Transplantation in Patients With Sickle Cell Disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							FERTILITY PRESERVATION; ETHICAL CHALLENGES; ANEMIA		[Mishkin, Adrienne D.; Mapara, Markus Y.; Reshef, Ran] Columbia Univ, Med Ctr, New York, NY USA	Columbia University	Mishkin, AD (corresponding author), Columbia Univ, Med Ctr, Dept Psychiat, Div Psychosomat Med, 622 West 168th St,PH16-37, New York, NY 10032 USA.	adm2172@cumc.columbia.edu	Mishkin, Adrienne/S-8471-2019	Reshef, Ran/0000-0003-2185-9546				Berthaut I, 2017, BLOOD, V130, P2354, DOI 10.1182/blood-2017-03-771857; Centers for Disease Control and Prevention, 2016, SICKL CELL DIS DAT S; Katz P, 2011, FERTIL STERIL, V95, P915, DOI 10.1016/j.fertnstert.2010.11.026; Lavery SA, 2016, HUM REPROD, V31, P1501, DOI 10.1093/humrep/dew084; Letourneau JM, 2012, CANCER-AM CANCER SOC, V118, P4579, DOI 10.1002/cncr.26649; Livestrong, 2015, BEC PAR CANC; Loren AW, 2015, HEMATOL-AM SOC HEMAT, P138, DOI 10.1182/asheducation-2015.1.138; Lucarelli G, 2014, BONE MARROW TRANSPL, V49, P1376, DOI 10.1038/bmt.2014.167; Nickel RS, 2018, BIOL BLOOD MARROW TR, V24, P219, DOI 10.1016/j.bbmt.2017.08.034; Piel FB, 2017, NEW ENGL J MED, V377, P305, DOI 10.1056/NEJMc1706325	10	6	6	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2018	168	12					881	+		10.7326/M18-0185	http://dx.doi.org/10.7326/M18-0185			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK1TE	29710348				2022-12-28	WOS:000435903500020
J	Cassel, CK				Cassel, Christine K.			Can Retail Clinics Transform Health Care?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Cassel, Christine K.] Natl Qual Forum, Washington, DC 20005 USA		Cassel, CK (corresponding author), Natl Qual Forum, Washington, DC 20005 USA.	chriskcassel@gmail.com						Ashwood JS, 2016, HEALTH AFFAIR, V35, P449, DOI 10.1377/hlthaff.2015.0995; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P2151, DOI 10.1001/jama.2012.3966; Christianson J, 2017, RETAIL CLINICS ARE S; Merced M, 2017, NY TIMES; Shrank WH, 2014, AM J MANAG CARE, V20, P794; The Economist, 2012, ECONOMIST; Wahba P, 2017, FORTUNE	7	7	8	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2018	319	18					1855	1856		10.1001/jama.2018.2172	http://dx.doi.org/10.1001/jama.2018.2172			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GF1CB	29710326				2022-12-28	WOS:000431668600008
J	Groschner, LN; Hak, LCW; Bogacz, R; DasGupta, S; Miesenbock, G				Groschner, Lukas N.; Hak, Laura Chan Wah; Bogacz, Rafal; DasGupta, Shamik; Miesenbock, Gero			Dendritic Integration of Sensory Evidence in Perceptual Decision-Making	CELL			English	Article							DROSOPHILA MUSHROOM BODY; CA1 PYRAMIDAL NEURONS; PARIETAL CORTEX; SIGNAL PROPAGATION; LANGUAGE DISORDER; MEMORY RETRIEVAL; NEURAL BASIS; GENE; DOPAMINE; SPEECH	Perceptual decisions require the accumulation of sensory information to a response criterion. Most accounts of how the brain performs this process of temporal integration have focused on evolving patterns of spiking activity. We report that subthreshold changes in membrane voltage can represent accumulating evidence before a alpha beta core Kenyon cells (alpha beta(c), KCs) in the mushroom bodies of fruit flies integrate odor-evoked synaptic inputs to action potential threshold at timescales matching the speed of olfactory discrimination. The forkhead box P transcription factor (FoxP) neuronal integration and behavioral decision times by controlling the abundance of the voltage-gated potassium channel Shal (K(v)4) in alpha beta(c) KC dendrites alpha beta(c) KCs thus tailor, through a particular constellation of biophysical properties, the generic process of synaptic integration to the demands of sequential sampling.	[Groschner, Lukas N.; Hak, Laura Chan Wah; DasGupta, Shamik; Miesenbock, Gero] Univ Oxford, Ctr Neural Circuits & Behav, Tinsley Bldg,Mansfield Rd, Oxford OX1 3SR, England; [Bogacz, Rafal] Univ Oxford, MRC Brain Network Dynam Unit, Mansfield Rd, Oxford OX1 3TH, England; [DasGupta, Shamik] Tata Inst Fundamental Res, Mumbai 400005, Maharashtra, India	University of Oxford; University of Oxford; Tata Institute of Fundamental Research (TIFR)	DasGupta, S; Miesenbock, G (corresponding author), Univ Oxford, Ctr Neural Circuits & Behav, Tinsley Bldg,Mansfield Rd, Oxford OX1 3SR, England.; DasGupta, S (corresponding author), Tata Inst Fundamental Res, Mumbai 400005, Maharashtra, India.	shamik.dasgupta@tifr.res.in; gero.miesenboeck@cncb.ox.ac.uk	Groschner, Lukas/AHD-6319-2022	Groschner, Lukas/0000-0002-4325-0232; Miesenboeck, Gero/0000-0003-2940-3228; Chan Wah Hak, Laura/0000-0002-6858-049X; DasGupta, Shamik/0000-0001-5803-8982	Wellcome Trust [106988/Z/15/Z, 090309/Z/09/Z]; Gatsby Charitable Foundation [GAT3237]; Wellcome Trust; UK Medical Research Council [MC_UU_12024/5, LT000498/2010-L]; career development award from the Human Frontier Science Program [CDA00011/2016-C]; Marie Curie International Incoming Fellowship [PIIF-GA-2010-274258]; MRC [MC_UU_12024/5, G0700888] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA112016] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Gatsby Charitable Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); career development award from the Human Frontier Science Program; Marie Curie International Incoming Fellowship(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Ronald Davis, Barry Dickson, F. Rob Jackson, Liqun Luo, Mani Ramaswami, Susan Tsunoda, the Bloomington and Kyoto Stock Centers, and the Vienna Drosophila Resource Center for flies. Clifford B. Talbot helped with instrumentation. This work was supported by grants from the Wellcome Trust (106988/Z/15/Z and 090309/Z/09/Z) and the Gatsby Charitable Foundation (GAT3237) (to G.M.). L.N.G. and L.C.W.H. received doctoral training fellowships from the Wellcome Trust; R.B. was supported by the UK Medical Research Council (MC_UU_12024/5); S.D. was awarded a long-term fellowship (LT000498/2010-L) and career development award (CDA00011/2016-C) from the Human Frontier Science Program and a Marie Curie International Incoming Fellowship (PIIF-GA-2010-274258).	Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04580; Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04577; Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Burke CJ, 2012, NATURE, V492, P433, DOI 10.1038/nature11614; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Caron SJC, 2013, NATURE, V497, P113, DOI 10.1038/nature12063; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; DasGupta S, 2014, SCIENCE, V344, P901, DOI 10.1126/science.1252114; Diao FQ, 2010, MOL CELL NEUROSCI, V45, P75, DOI 10.1016/j.mcn.2010.06.001; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Donders F.C, 1869, ACTA PSYCHOL, V4, P117; Santos ME, 2011, MOL BIOL EVOL, V28, P237, DOI 10.1093/molbev/msq182; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Gasparini S, 2007, J PHYSIOL-LONDON, V580, P787, DOI 10.1113/jphysiol.2006.121343; Gasque G, 2005, J NEUROSCI, V25, P2348, DOI 10.1523/JNEUROSCI.4384-04.2005; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gouwens NW, 2009, J NEUROSCI, V29, P6239, DOI 10.1523/JNEUROSCI.0764-09.2009; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Gruntman E, 2013, NAT NEUROSCI, V16, P1821, DOI 10.1038/nn.3547; Hamdan FF, 2010, AM J HUM GENET, V87, P671, DOI 10.1016/j.ajhg.2010.09.017; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hige T, 2015, NEURON, V88, P985, DOI 10.1016/j.neuron.2015.11.003; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Huang YM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001703; Ito I, 2008, NAT NEUROSCI, V11, P1177, DOI 10.1038/nn.2192; Ito K, 1997, DEVELOPMENT, V124, P761; Kakihara K, 2008, MECH DEVELOP, V125, P325, DOI 10.1016/j.mod.2007.10.012; Kim J, 2005, J PHYSIOL-LONDON, V569, P41, DOI 10.1113/jphysiol.2005.095042; Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549; Kvon EZ, 2014, NATURE, V512, P91, DOI 10.1038/nature13395; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Latimer KW, 2015, SCIENCE, V349, P184, DOI 10.1126/science.aaa4056; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin AC, 2014, NAT NEUROSCI, V17, P559, DOI 10.1038/nn.3660; Liu C, 2012, NATURE, V488, P512, DOI 10.1038/nature11304; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Murthy M, 2008, NEURON, V59, P1009, DOI 10.1016/j.neuron.2008.07.040; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Norris AJ, 2010, J NEUROSCI, V30, P5092, DOI 10.1523/JNEUROSCI.5890-09.2010; Papadopoulou M, 2011, SCIENCE, V332, P721, DOI 10.1126/science.1201835; Ping Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016043; Podlaski WF, 2017, ELIFE, V6, DOI 10.7554/eLife.22152; Rajan K, 2016, NEURON, V90, P128, DOI 10.1016/j.neuron.2016.02.009; RALL W, 1985, VOLTAGE PATCH CLAMPI, P191; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Roitman JD, 2002, J NEUROSCI, V22, P9475; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Sejourne J, 2011, NAT NEUROSCI, V14, P903, DOI 10.1038/nn.2846; Shadlen MN, 2013, NEURON, V80, P791, DOI 10.1016/j.neuron.2013.10.047; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; Turner GC, 2008, J NEUROPHYSIOL, V99, P734, DOI 10.1152/jn.01283.2007; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; VARGHAKHADEM F, 1995, P NATL ACAD SCI USA, V92, P930, DOI 10.1073/pnas.92.3.930; VICKERS D, 1970, Ergonomics, V13, P37, DOI 10.1080/00140137008931117; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511	67	28	28	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 3	2018	173	4					894	+		10.1016/j.cell.2018.03.075	http://dx.doi.org/10.1016/j.cell.2018.03.075			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	GG1TU	29706545	hybrid, Green Published			2022-12-28	WOS:000432471100012
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Religion must defy the harms of futile medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2017, COMMUNICATION 1107; Burton TI, 2018, VOX             0428	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 2	2018	361								k1896	10.1136/bmj.k1896	http://dx.doi.org/10.1136/bmj.k1896			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF4YF	29720368	Bronze, Green Published			2022-12-28	WOS:000431969500009
J	Armour, A				Armour, Andrew			Entangled vibrations in mechanical oscillators	NATURE			English	Editorial Material								Two experiments have demonstrated entanglement - non-classical correlations between remote mechanical systems comprising billions of atoms. The results could advance our understanding of quantum physics.	[Armour, Andrew] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England; [Armour, Andrew] Univ Nottingham, Ctr Math & Theoret Phys Quantum Nonequilibrium Sy, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Armour, A (corresponding author), Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England.; Armour, A (corresponding author), Univ Nottingham, Ctr Math & Theoret Phys Quantum Nonequilibrium Sy, Nottingham NG7 2RD, England.	andrew.armour@nottingham.ac.uk		Armour, Andrew/0000-0002-7190-8601				ASPECT A, 1982, PHYS REV LETT, V49, P1804, DOI 10.1103/PhysRevLett.49.1804; Aspelmeyer M, 2014, REV MOD PHYS, V86, P1391, DOI 10.1103/RevModPhys.86.1391; Blencowe M, 2011, NATURE, V471, P168, DOI 10.1038/471168a; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Jost JD, 2009, NATURE, V459, P683, DOI 10.1038/nature08006; Lee KC, 2011, SCIENCE, V334, P1253, DOI 10.1126/science.1211914; Mancini S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.120401; Moser J, 2013, NAT NANOTECHNOL, V8, P493, DOI [10.1038/nnano.2013.97, 10.1038/NNANO.2013.97]; Ockeloen-Korppi CF, 2018, NATURE, V556, P478, DOI 10.1038/s41586-018-0038-x; Riedinger R, 2018, NATURE, V556, P473, DOI 10.1038/s41586-018-0036-z; Woolley MJ, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.063805	12	2	2	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					444	445		10.1038/d41586-018-04827-5	http://dx.doi.org/10.1038/d41586-018-04827-5			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD8VX	29691508				2022-12-28	WOS:000430793000034
J	Miller, TB; Chapman, SC; Aravena, M; Ashby, MLN; Hayward, CC; Vieira, JD; Weiss, A; Babul, A; Bethermin, M; Bradford, CM; Brodwin, M; Carlstrom, JE; Chen, CC; Cunningham, DJM; De Breuck, C; Gonzalez, AH; Greve, TR; Harnett, J; Hezaveh, Y; Lacaille, K; Litke, KC; Ma, J; Malkan, M; Marrone, DP; Morningstar, W; Murphy, EJ; Narayanan, D; Pass, E; Perry, R; Phadke, KA; Rennehan, D; Rotermund, KM; Simpson, J; Spilker, JS; Sreevani, J; Stark, AA; Strandet, ML; Strom, AL				Miller, T. B.; Chapman, S. C.; Aravena, M.; Ashby, M. L. N.; Hayward, C. C.; Vieira, J. D.; Weiss, A.; Babul, A.; Bethermin, M.; Bradford, C. M.; Brodwin, M.; Carlstrom, J. E.; Chen, Chian-Chou; Cunningham, D. J. M.; De Breuck, C.; Gonzalez, A. H.; Greve, T. R.; Harnett, J.; Hezaveh, Y.; Lacaille, K.; Litke, K. C.; Ma, J.; Malkan, M.; Marrone, D. P.; Morningstar, W.; Murphy, E. J.; Narayanan, D.; Pass, E.; Perry, R.; Phadke, K. A.; Rennehan, D.; Rotermund, K. M.; Simpson, J.; Spilker, J. S.; Sreevani, J.; Stark, A. A.; Strandet, M. L.; Strom, A. L.			A massive core for a cluster of galaxies at a redshift of 4.3	NATURE			English	Article							DARK-MATTER HALOS; SUBMILLIMETER GALAXIES; ELLIPTIC GALAXY; SPACE-TELESCOPE; EMISSION-LINE; PROTOCLUSTER; SEARCH; SIMULATIONS; PREDICTIONS; EVOLUTION	Massive galaxy clusters have been found that date to times as early as three billion years after the Big Bang, containing stars that formed at even earlier epochs(1-3). The high-redshift progenitors of these galaxy clusters-termed 'protoclusters'-can be identified in cosmological simulations that have the highest overdensities (greater-than-average densities) of dark matter(4-6). Protoclusters are expected to contain extremely massive galaxies that can be observed as luminous starbursts7. However, recent detections of possible protoclusters hosting such starbursts(8-11) do not support the kind of rapid cluster-core formation expected from simulations(12): the structures observed contain only a handful of starbursting galaxies spread throughout a broad region, with poor evidence for eventual collapse into a protocluster. Here we report observations of carbon monoxide and ionized carbon emission from the source SPT234956. We find that this source consists of at least 14 gas-rich galaxies, all lying at redshifts of 4.31. We demonstrate that each of these galaxies is forming stars between 50 and 1,000 times more quickly than our own Milky Way, and that all are located within a projected region that is only around 130 kiloparsecs in diameter. This galaxy surface density is more than ten times the average blank-field value (integrated over all redshifts), and more than 1,000 times the average field volume density. The velocity dispersion (approximately 410 kilometres per second) of these galaxies and the enormous gas and star-formation densities suggest that this system represents the core of a cluster of galaxies that was already at an advanced stage of formation when the Universe was only 1.4 billion years old. A comparison with other known protoclusters at high redshifts shows that SPT2349-56 could be building one of the most massive structures in the Universe today.	[Miller, T. B.; Chapman, S. C.; Lacaille, K.; Pass, E.; Perry, R.; Rotermund, K. M.] Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS, Canada; [Miller, T. B.] Yale Univ, Dept Astron, New Haven, CT 06511 USA; [Chapman, S. C.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC, Canada; [Chapman, S. C.] Natl Res Council Canada, Herzberg Astron & Astrophys, Victoria, BC, Canada; [Aravena, M.] Univ Diego Portales, Fac Ingn & Ciencias, Nucleo Astron, Santiago, Chile; [Ashby, M. L. N.; Hayward, C. C.; Stark, A. A.] Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA; [Hayward, C. C.] Flatiron Inst, Ctr Computat Astrophys, New York, NY USA; [Vieira, J. D.; Phadke, K. A.; Sreevani, J.] Univ Illinois, Dept Astron, 1002 W Green St, Urbana, IL 61801 USA; [Weiss, A.; Strandet, M. L.] Max Planck Inst Radioastron, Bonn, Germany; [Babul, A.; Rennehan, D.] Univ Victoria, Dept Phys & Astron, Victoria, BC, Canada; [Bethermin, M.] Aix Marseille Univ, Lab Astrophys Marseille, LAM, CNRS, Marseille, France; [Bradford, C. M.] CALTECH, Pasadena, CA 91125 USA; [Bradford, C. M.] Jet Prop Lab, Pasadena, CA USA; [Brodwin, M.] Univ Missouri, Dept Phys & Astron, Kansas City, MO 64110 USA; [Carlstrom, J. E.] Univ Chicago, Kavli Inst Cosmol Phys, Chicago, IL 60637 USA; [Carlstrom, J. E.] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Carlstrom, J. E.] Univ Chicago, Enrico Fermi Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA; [Carlstrom, J. E.] Univ Chicago, Dept Astron & Astrophys, 5640 S Ellis Ave, Chicago, IL 60637 USA; [Chen, Chian-Chou; De Breuck, C.] European Southern Observ, Garching, Germany; [Cunningham, D. J. M.] St Marys Univ, Dept Astron & Phys, Halifax, NS, Canada; [Gonzalez, A. H.; Ma, J.; Narayanan, D.] Univ Florida, Dept Astron, Gainesville, FL 32611 USA; [Greve, T. R.] UCL, Dept Phys & Astron, London, England; [Harnett, J.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Hezaveh, Y.; Morningstar, W.] Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94305 USA; [Lacaille, K.] McMaster Univ, Dept Phys & Astron, Hamilton, ON, Canada; [Litke, K. C.; Marrone, D. P.; Spilker, J. S.] Univ Arizona, Steward Observ, Tucson, AZ USA; [Malkan, M.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA USA; [Murphy, E. J.] Natl Radio Astron Observ, Charlottesville, VA USA; [Pass, E.] Univ Waterloo, Dept Phys & Astron, Waterloo, ON, Canada; [Simpson, J.] Univ Edinburgh, Royal Observ, Inst Astron, Edinburgh, Midlothian, Scotland; [Simpson, J.] Univ Durham, Dept Phys, Ctr Extragalact Astron, Durham, England; [Strandet, M. L.] Int Max Planck Res Sch IMPRS Astron & Astrophys, Bonn, Germany; [Strom, A. L.] Observ Carnegie Inst Sci, Pasadena, CA USA	Dalhousie University; Yale University; University of British Columbia; National Research Council Canada; University Diego Portales; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Illinois System; University of Illinois Urbana-Champaign; Max Planck Society; University of Victoria; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Missouri System; University of Missouri Kansas City; University of Chicago; University of Chicago; University of Chicago; University of Chicago; European Southern Observatory; Saint Marys University - Canada; State University System of Florida; University of Florida; University of London; University College London; University of Sydney; Stanford University; McMaster University; University of Arizona; University of California System; University of California Los Angeles; National Radio Astronomy Observatory (NRAO); University of Waterloo; University of Edinburgh; Durham University; University of Bonn; Carnegie Institution for Science	Miller, TB (corresponding author), Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS, Canada.; Miller, TB (corresponding author), Yale Univ, Dept Astron, New Haven, CT 06511 USA.	tim.miller@yale.edu	Babul, Arif/E-2730-2010; Murphy, Eric/AAE-8450-2021; CHEN, Chian-Chou (TC) 陳建州/ABB-2819-2020	Babul, Arif/0000-0003-1746-9529; CHEN, Chian-Chou (TC) 陳建州/0000-0002-3805-0789; Lacaille, Kevin/0000-0001-9870-5663; Jarugula, Sreevani/0000-0002-5386-7076; Phadke, Kedar/0000-0001-7946-557X; Aravena, Manuel/0000-0002-6290-3198; Stark, Antony/0000-0002-2718-9996; Pass, Emily/0000-0002-1533-9029; Weiss, Axel/0000-0003-4678-3939; Strom, Allison/0000-0001-6369-1636; Greve, Thomas R./0000-0002-2554-1837; Rennehan, Douglas/0000-0002-1619-8555	NSF [PLR-1248097, PHY-1125897]; Kavli Foundation; Gordon and Betty Moore Foundation [GBMF 947]; Atacama Pathfinder Experiment (APEX) [E-299.A-5045A-2017, M-091.F-0031-2013]; Australian Government; US NSF [AST-1312950]; National Sciences and Engineering Research Council (NSERC); Canada Foundation for Innovation (CFI); Killam trust; Fondo Nacional de Desarrollo Cientifica y Tecnologico (FONDECYT, Chile) [114009]; Simons Foundation; A.P. Sloan Foundation Fellowship; Directorate For Geosciences [1248097] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Kavli Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Atacama Pathfinder Experiment (APEX); Australian Government(Australian GovernmentCGIAR); US NSF(National Science Foundation (NSF)); National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Killam trust; Fondo Nacional de Desarrollo Cientifica y Tecnologico (FONDECYT, Chile); Simons Foundation; A.P. Sloan Foundation Fellowship; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This paper makes use of the following ALMA data (http://www.almaobservatory.org/en/home/): ADS/JAO.ALMA#2016.1.00236.T and ADS/JAO.ALMA#2015.1.01543.T. ALMA is a partnership of the European Southern Observatory (ESO, representing its member states), the National Science Foundation (NSF, USA) and the National Institute of Natural Sciences (NINS, Japan), together with the National Research Council (NRC, Canada) and the National Security Council (NSC) and the Academia Sinica Institute of Astronomy and Astrophysics (ASIAA, Taiwan), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO, Associated Universities Inc. (AUI)/National Radio Astronomy Observatory (NRAO) and the National Astronomical Observatory of Japan (NAOJ). This work is also based in part on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. The SPT is supported by the NSF through grant PLR-1248097, with partial support through grant PHY-1125897, the Kavli Foundation and the Gordon and Betty Moore Foundation grant GBMF 947. This publication is based on data acquired with the Atacama Pathfinder Experiment (APEX) under programmes E-299.A-5045A-2017 and ID M-091.F-0031-2013. APEX is a collaboration between the Max-Planck-Institut fur Radioastronomie, the ESO, and the Onsala Space Observatory. Supporting observations were obtained at the Gemini Observatory, which is operated by the Association of Universities for Research in Astronomy, Inc., under a cooperative agreement with the NSF on behalf of the Gemini partnership: the NSF (USA), the NRC (Canada), Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT, Chile), Ministerio de Ciencia, Tecnologa e Innovacion Productiva (Argentina), and Ministerio da Ciencia, Tecnologia e Inovacao (Brazil). The Australia Telescope Compact Array (ATCA) is part of the Australia Telescope National Facility which is funded by the Australian Government for operation as a National Facility managed by the Commonwealth Scientific and Industrial Research Organisation (CSIRO). D.P.M., J.S.S., J.D.V., K.C.L. and J.S. acknowledge support from the US NSF under grant AST-1312950. S.C.C., T.B.M. and A.B. acknowledge support from the National Sciences and Engineering Research Council (NSERC). S.C.C. and T.B.M. acknowledge the Canada Foundation for Innovation (CFI) and the Killam trust. M.A. acknowledges partial support from the Fondo Nacional de Desarrollo Cientifica y Tecnologico (FONDECYT, Chile) through grant 114009. The Flatiron Institute is supported by the Simons Foundation. J.D.V. acknowledges support from an A.P. Sloan Foundation Fellowship.	Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321569; Andreon S, 2014, ASTRON ASTROPHYS, V565, DOI 10.1051/0004-6361/201323077; Aravena M, 2016, ASTROPHYS J, V833, DOI 10.3847/1538-4357/833/1/71; Ashby MLN, 2013, ASTROPHYS J SUPPL S, V209, DOI 10.1088/0067-0049/209/2/22; Barger AJ, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/9; BEERS TC, 1990, ASTRON J, V100, P32, DOI 10.1086/115487; Behroozi PS, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/57; Behroozi PS, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/2/109; Bethermin M, 2010, ASTRON ASTROPHYS, V516, DOI 10.1051/0004-6361/200913910; Blain AW, 2004, ASTROPHYS J, V611, P725, DOI 10.1086/422353; Bocquet S, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/2/214; Bothwell MS, 2013, MON NOT R ASTRON SOC, V429, P3047, DOI 10.1093/mnras/sts562; Bower RG, 2006, MON NOT R ASTRON SOC, V370, P645, DOI 10.1111/j.1365-2966.2006.10519.x; Brodwin M, 2016, ASTROPHYS J, V817, DOI 10.3847/0004-637X/817/2/122; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Burgarella D, 2005, MON NOT R ASTRON SOC, V360, P1413, DOI 10.1111/j.1365-2966.2005.09131.x; Carlstrom JE, 2011, PUBL ASTRON SOC PAC, V123, P568, DOI 10.1086/659879; Casey CM, 2015, ASTROPHYS J LETT, V808, DOI 10.1088/2041-8205/808/2/L33; Casey CM, 2016, ASTROPHYS J, V824, DOI 10.3847/0004-637X/824/1/36; Cautun M, 2014, MON NOT R ASTRON SOC, V441, P2923, DOI 10.1093/mnras/stu768; Chabrier G, 2003, ASTROPHYS J, V586, pL133, DOI 10.1086/374879; Chapman SC, 2015, MON NOT R ASTRON SOC, V453, P951, DOI 10.1093/mnras/stv1618; Chapman SC, 2009, ASTROPHYS J, V691, P560, DOI 10.1088/0004-637X/691/1/560; Chapman SC, 2005, ASTROPHYS J, V622, P772, DOI 10.1086/428082; Chapman SC, 2001, ASTROPHYS J, V548, pL17, DOI 10.1086/318919; Chiang YK, 2017, ASTROPHYS J LETT, V844, DOI 10.3847/2041-8213/aa7e7b; Chiang YK, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/2/127; Cole S, 2008, MON NOT R ASTRON SOC, V383, P546, DOI [10.1111/j.1365-2966.2007.12516.x, 10.1111/j.1365-2966.2007.125l6.x]; Daddi E, 2009, ASTROPHYS J LETT, V695, pL176, DOI 10.1088/0004-637X/695/2/L176; Daddi E, 2009, ASTROPHYS J, V694, P1517, DOI 10.1088/0004-637X/694/2/1517; Dannerbauer H, 2014, ASTRON ASTROPHYS, V570, DOI 10.1051/0004-6361/201423771; Evrard AE, 2008, ASTROPHYS J, V672, P122, DOI 10.1086/521616; Fu H, 2013, NATURE, V498, P338, DOI 10.1038/nature12184; Geach JE, 2005, MON NOT R ASTRON SOC, V363, P1398, DOI 10.1111/j.1365-2966.2005.09538.x; Gobat R, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/1/9; Gobat R, 2011, ASTRON ASTROPHYS, V526, DOI 10.1051/0004-6361/201016084; Granato GL, 2015, MON NOT R ASTRON SOC, V450, P1320, DOI 10.1093/mnras/stv676; Hayashino T, 2004, ASTRON J, V128, P2073, DOI 10.1086/424935; Hayward CC, 2013, MON NOT R ASTRON SOC, V434, P2572, DOI 10.1093/mnras/stt1202; Hayward CC, 2013, MON NOT R ASTRON SOC, V428, P2529, DOI 10.1093/mnras/sts222; Hayward CC, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/159; Hopkins PF, 2008, ASTROPHYS J SUPPL S, V175, P356, DOI 10.1086/524362; Hung CL, 2016, ASTROPHYS J, V826, DOI 10.3847/0004-637X/826/2/130; Ivison RJ, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/137; Kuiper E, 2011, MON NOT R ASTRON SOC, V415, P2245, DOI 10.1111/j.1365-2966.2011.18852.x; Kurk JD, 2000, ASTRON ASTROPHYS, V358, pL1; Lewis A. J. R., 2017, ULTRARED GALAXIES SI; Ma JZ, 2015, ASTROPHYS J, V812, DOI 10.1088/0004-637X/812/1/88; Mandelker N., 2017, COLD FILAMENTARY ACC; Mantz AB, 2018, ASTRON ASTROPHYS, V620, DOI 10.1051/0004-6361/201630096; McMullin JP, 2007, ASTR SOC P, V376, P127; Miley G, 2008, ASTRON ASTROPHYS REV, V15, P67, DOI 10.1007/S00159-007-0008-Z; Miller TB, 2015, MON NOT R ASTRON SOC, V452, P878, DOI 10.1093/mnras/stv1267; Mocanu LM, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/61; Noirot G, 2016, ASTROPHYS J, V830, DOI 10.3847/0004-637X/830/2/90; Noll S, 2009, ASTRON ASTROPHYS, V507, P1793, DOI 10.1051/0004-6361/200912497; Ono Y, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/1/5; Onorbe J, 2014, MON NOT R ASTRON SOC, V437, P1894, DOI 10.1093/mnras/stt2020; Oteo I., 2017, EXTREME PROTO CLUSTE; Overzier RA, 2009, MON NOT R ASTRON SOC, V394, P577, DOI 10.1111/j.1365-2966.2008.14264.x; Prada F, 2012, MON NOT R ASTRON SOC, V423, P3018, DOI 10.1111/j.1365-2966.2012.21007.x; Renzini A, 2006, ANNU REV ASTRON ASTR, V44, P141, DOI 10.1146/annurev.astro.44.051905.092450; Rosati P, 2009, ASTRON ASTROPHYS, V508, P583, DOI 10.1051/0004-6361/200913099; Safarzadeh M, 2016, ASTROPHYS J, V818, DOI 10.3847/0004-637X/818/1/62; Sargent MT, 2012, ASTROPHYS J LETT, V747, DOI 10.1088/2041-8205/747/2/L31; Sault RJ, 1995, ASTR SOC P, V77, P433; Simpson JM, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/2/125; Siringo G, 2009, ASTRON ASTROPHYS, V497, P945, DOI 10.1051/0004-6361/200811454; Solomon PM, 1997, ASTROPHYS J, V478, P144, DOI 10.1086/303765; Spilker JS, 2016, ASTROPHYS J, V826, DOI 10.3847/0004-637X/826/2/112; Springel V, 2005, NATURE, V435, P629, DOI 10.1038/nature03597; Stanford SA, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/164; Steidel CC, 1998, ASTROPHYS J, V492, P428, DOI 10.1086/305073; Strandet ML, 2016, ASTROPHYS J, V822, DOI 10.3847/0004-637X/822/2/80; Tamura Y, 2009, NATURE, V459, P61, DOI 10.1038/nature07947; Trainor RF, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/39; Umehata H, 2015, ASTROPHYS J LETT, V815, DOI 10.1088/2041-8205/815/1/L8; Vieira JD, 2013, NATURE, V495, P344, DOI 10.1038/nature12001; Vieira JD, 2010, ASTROPHYS J, V719, P763, DOI 10.1088/0004-637X/719/1/763; Walter F, 2012, NATURE, V486, P233, DOI 10.1038/nature11073; Wang T, 2016, ASTROPHYS J, V828, DOI 10.3847/0004-637X/828/1/56; Weiss A, 2008, ASTRON ASTROPHYS, V490, P77, DOI 10.1051/0004-6361:200809909; Weiss A, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/88; Williams J. P., 2011, ASCL1107014; Wilson WE, 2011, MON NOT R ASTRON SOC, V416, P832, DOI 10.1111/j.1365-2966.2011.19054.x	87	96	96	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					469	+		10.1038/s41586-018-0025-2	http://dx.doi.org/10.1038/s41586-018-0025-2			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8VX	29695849	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000430793000040
J	Riedinger, R; Wallucks, A; Marinkovic, I; Loschnauer, C; Aspelmeyer, M; Hong, S; Groblacher, S				Riedinger, Ralf; Wallucks, Andreas; Marinkovic, Igor; Loeschnauer, Clemens; Aspelmeyer, Markus; Hong, Sungkun; Groblacher, Simon			Remote quantum entanglement between two micromechanical oscillators	NATURE			English	Article							GROUND-STATE; MECHANICAL RESONATOR; ATOMIC ENSEMBLES; MOTION; MICROWAVE; PHOTONS; CONVERSION; DISTANCE; CRYSTAL; PHONONS	Entanglement, an essential feature of quantum theory that allows for inseparable quantum correlations to be shared between distant parties, is a crucial resource for quantum networks(1). Of particular importance is the ability to distribute entanglement between remote objects that can also serve as quantum memories. This has been previously realized using systems such as warm(2,3) and cold atomic vapours(4,5), individual atoms(6) and ions(7,8), and defects in solid-state systems(9-11). Practical communication applications require a combination of several advantageous features, such as a particular operating wavelength, high bandwidth and long memory lifetimes. Here we introduce a purely micromachined solid-state platform in the form of chip-based optomechanical resonators made of nanostructured silicon beams. We create and demonstrate entanglement between two micromechanical oscillators across two chips that are separated by 20 centimetres. The entangled quantum state is distributed by an optical field at a designed wavelength near 1,550 nanometres. Therefore, our system can be directly incorporated in a realistic fibre-optic quantum network operating in the conventional optical telecommunication band. Our results are an important step towards the development of large-area quantum networks based on silicon photonics.	[Riedinger, Ralf; Loeschnauer, Clemens; Aspelmeyer, Markus; Hong, Sungkun] Univ Vienna, Vienna Ctr Quantum Sci & Technol, Fac Phys, Vienna, Austria; [Wallucks, Andreas; Marinkovic, Igor; Groblacher, Simon] Delft Univ Technol, Kavli Inst Nanosci, Delft, Netherlands	University of Vienna; Delft University of Technology	Hong, S (corresponding author), Univ Vienna, Vienna Ctr Quantum Sci & Technol, Fac Phys, Vienna, Austria.; Groblacher, S (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, Delft, Netherlands.	sungkun.hong@univie.ac.at; s.groeblacher@tudelft.nl	Hong, Sungkun/D-3282-2014; Aspelmeyer, Markus/C-4098-2017; Riedinger, Ralf/AAJ-5952-2020; Groeblacher, Simon/O-2455-2014	Hong, Sungkun/0000-0003-0985-6641; Aspelmeyer, Markus/0000-0003-4499-7335; Riedinger, Ralf/0000-0002-0187-2332; Groeblacher, Simon/0000-0003-3932-7820; Marinkovic, Igor/0000-0002-9027-3517	European Commission [722923]; Foundation for Fundamental Research on Matter (FOM) Projectruimte grants [15PR3210, 16PR1054]; Vienna Science and Technology Fund WWTF [ICT12-049]; European Research Council (ERC CoG QLev4G); European Research Council (ERC StG Strong-Q); Austrian Science Fund (FWF) [F40, P28172]; Netherlands Organisation for Scientific Research (NWO/OCW), Frontiers of Nanoscience programme; Vidi grant [680-47-541/994]; FWF [W1210]; DOC fellowship of the Austrian Academy of Sciences at the University of Vienna	European Commission(European CommissionEuropean Commission Joint Research Centre); Foundation for Fundamental Research on Matter (FOM) Projectruimte grants; Vienna Science and Technology Fund WWTF; European Research Council (ERC CoG QLev4G)(European Research Council (ERC)); European Research Council (ERC StG Strong-Q)(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Netherlands Organisation for Scientific Research (NWO/OCW), Frontiers of Nanoscience programme; Vidi grant; FWF(Austrian Science Fund (FWF)); DOC fellowship of the Austrian Academy of Sciences at the University of Vienna	We thank V. Anant, K. Hammerer, J. Hofer, S. Hofer, R. Norte, K. Phelan and J. Slater for discussions and help. We also acknowledge assistance from the Kavli Nanolab Delft, in particular from M. Zuiddam and C. de Boer. This project was supported by the European Commission under the Marie Curie Horizon 2020 initial training programme OMT (grant 722923), Foundation for Fundamental Research on Matter (FOM) Projectruimte grants (15PR3210, 16PR1054), the Vienna Science and Technology Fund WWTF (ICT12-049), the European Research Council (ERC CoG QLev4G, ERC StG Strong-Q), the Austrian Science Fund (FWF) under projects F40 (SFB FOQUS) and P28172, and by the Netherlands Organisation for Scientific Research (NWO/OCW), as part of the Frontiers of Nanoscience programme, as well as through a Vidi grant (680-47-541/994). R. R. is supported by the FWF under project W1210 (CoQuS) and is a recipient of a DOC fellowship of the Austrian Academy of Sciences at the University of Vienna.	Asano T, 2017, OPT EXPRESS, V25, P1769, DOI 10.1364/OE.25.001769; Bochmann J, 2013, NAT PHYS, V9, P712, DOI [10.1038/NPHYS2748, 10.1038/nphys2748]; Borkje K, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.123601; Chan J., 2012, THESIS CALIFORNIA I; Chan J, 2011, NATURE, V478, P89, DOI 10.1038/nature10461; Chu YW, 2017, SCIENCE, V358, P199, DOI 10.1126/science.aao1511; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Hensen B, 2015, NATURE, V526, P682, DOI 10.1038/nature15759; Higginbotham A. P., 2017, PREPRINT; Hong S, 2017, SCIENCE, V358, P203, DOI 10.1126/science.aan7939; Jensen K, 2011, NAT PHYS, V7, P13, DOI 10.1038/NPHYS1819; Jost JD, 2009, NATURE, V459, P683, DOI 10.1038/nature08006; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Lee KC, 2011, SCIENCE, V334, P1253, DOI 10.1126/science.1211914; Maring N, 2017, NATURE, V551, P485, DOI 10.1038/nature24468; Matsukevich DN, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.030405; Meenehan SM, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041002; Moehring DL, 2007, NATURE, V449, P68, DOI 10.1038/nature06118; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; Palomaki TA, 2013, SCIENCE, V342, P710, DOI 10.1126/science.1244563; Patel RN, 2017, PHYS REV APPL, V8, DOI 10.1103/PhysRevApplied.8.041001; Razavi M, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.032301; Reed AP, 2017, NAT PHYS, V13, P1163, DOI 10.1038/NPHYS4251; Reim KF, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.053603; Riedinger R, 2016, NATURE, V530, P313, DOI 10.1038/nature16536; Ritter S, 2012, NATURE, V484, P195, DOI 10.1038/nature11023; Rueda A, 2016, OPTICA, V3, P597, DOI 10.1364/OPTICA.3.000597; Saglamyurek E, 2015, NAT PHOTONICS, V9, P83, DOI [10.1038/nphoton.2014.311, 10.1038/NPHOTON.2014.311]; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261; Usmani I, 2012, NAT PHOTONICS, V6, P234, DOI 10.1038/nphoton.2012.34; Wieczorek W, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.223601; Wollman EE, 2015, SCIENCE, V349, P952, DOI 10.1126/science.aac5138	33	310	312	9	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					473	477		10.1038/s41586-018-0036-z	http://dx.doi.org/10.1038/s41586-018-0036-z			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8VX	29695844	Green Submitted			2022-12-28	WOS:000430793000041
J	Wise, J				Wise, Jacqui			European countries are urged to carry out catch-up campaigns as measles outbreaks continue	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		European Centre for Disease Prevention and Control, 2018, EUR IMM WEEK 2018; European Centre for Disease Prevention and Control, 2018, MONTHL MEASL RUB MON	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2018	361								k1771	10.1136/bmj.k1771	http://dx.doi.org/10.1136/bmj.k1771			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF4VW	29685945				2022-12-28	WOS:000431962900004
J	Dyer, C				Dyer, Clare			Junior doctors lose legal test case over right to have breaks every four hours	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BMA, MON BREACH HIGH COUR; Dyer C, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k852	2	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2018	361								k1762	10.1136/bmj.k1762	http://dx.doi.org/10.1136/bmj.k1762			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8WT	29678930				2022-12-28	WOS:000430795700005
J	Grandgeorge, P; Krins, N; Hourlier-Fargette, A; Laberty-Robert, C; Neukirch, S; Antkowiak, A				Grandgeorge, Paul; Krins, Natacha; Hourlier-Fargette, Aurelie; Laberty-Robert, Christel; Neukirch, Sebastien; Antkowiak, Arnaud			Capillarity-induced folds fuel extreme shape changes in thin wicked membranes	SCIENCE			English	Article							MECHANICAL-PROPERTIES; MICROVILLI; GROWTH	Soft deformable materials are needed for applications such as stretchable electronics, smart textiles, or soft biomedical devices. However, the design of a durable, cost-effective, or biologically compatible version of such a material remains challenging. Living animal cells routinely cope with extreme deformations by unfolding preformed membrane reservoirs available in the form of microvilli or membrane folds. We synthetically mimicked this behavior by creating nanofibrous liquid-infused tissues that spontaneously form similar reservoirs through capillarity-induced folding. By understanding the physics of membrane buckling within the liquid film, we developed proof-of-concept conformable chemical surface treatments and stretchable basic electronic circuits.	[Grandgeorge, Paul; Hourlier-Fargette, Aurelie; Neukirch, Sebastien; Antkowiak, Arnaud] Sorbonne Univ, CNRS, Inst Jean le Rond dAlembert, F-75005 Paris, France; [Krins, Natacha; Laberty-Robert, Christel] Sorbonne Univ, CNRS, Lab Chim Mat Condensee Paris, F-75005 Paris, France; [Hourlier-Fargette, Aurelie] PSL Res Univ, Ecole Normale Super, CNRS, Dept Phys, F-75005 Paris, France; [Antkowiak, Arnaud] Surface Verre & Interfaces, CNRS, St Gobain, F-93303 Aubervilliers, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; Chimie ParisTech; College de France; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS)	Antkowiak, A (corresponding author), Sorbonne Univ, CNRS, Inst Jean le Rond dAlembert, F-75005 Paris, France.; Antkowiak, A (corresponding author), Surface Verre & Interfaces, CNRS, St Gobain, F-93303 Aubervilliers, France.	arnaud.antkowiak@upmc.fr	Laberty, Christel/G-8847-2011	Hourlier-Fargette, Aurelie/0000-0002-0148-4145; Grandgeorge, Paul/0000-0002-1140-7557; Laberty-Robert, christel/0000-0003-3230-3164	ANR grant [ANR-14-CE07-0023-01]; CNRS PEPS-PTI grant; CNRS PICS grant	ANR grant(French National Research Agency (ANR)); CNRS PEPS-PTI grant; CNRS PICS grant	Supported by ANR grant ANR-14-CE07-0023-01 and by CNRS PEPS-PTI and PICS grants.	Audoly B., 2010, ELASTICITY GEOMETRY; Cerda E, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.074302; DAI JW, 1995, BIOPHYS J, V68, P988, DOI 10.1016/S0006-3495(95)80274-2; Davidovitch B, 2011, P NATL ACAD SCI USA, V108, P18227, DOI 10.1073/pnas.1108553108; Elettro H, 2016, P NATL ACAD SCI USA, V113, P6143, DOI 10.1073/pnas.1602451113; ERICKSON CA, 1976, EXP CELL RES, V99, P375, DOI 10.1016/0014-4827(76)90595-4; Groulx N, 2006, J MEMBRANE BIOL, V214, P43, DOI 10.1007/s00232-006-0080-8; Guillou L, 2016, MOL BIOL CELL, V27, P3574, DOI 10.1091/mbc.E16-06-0414; Hu JL, 2012, SMART MATER STRUCT, V21, DOI 10.1088/0964-1726/21/5/053001; Lam J, 2009, BIOPHYS J, V96, P248, DOI 10.1529/biophysj.108.139154; Lazarus A, 2015, ADV ENG MATER, V17, P815, DOI 10.1002/adem.201400433; Liu W, 2017, ADV MATER, V29, DOI 10.1002/adma.201603436; Majstoravich S, 2004, BLOOD, V104, P1396, DOI 10.1182/blood-2004-02-0437; Nichol JA, 1996, J PHYSIOL-LONDON, V493, P187, DOI 10.1113/jphysiol.1996.sp021374; Raucher D, 1999, BIOPHYS J, V77, P1992, DOI 10.1016/S0006-3495(99)77040-2; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Roman B, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/49/493101; Roman B, 1999, EUROPHYS LETT, V46, P602, DOI 10.1209/epl/i1999-00306-3; Salbreux G, 2012, TRENDS CELL BIOL, V22, P536, DOI 10.1016/j.tcb.2012.07.001; Shepherd RF, 2011, P NATL ACAD SCI USA, V108, P20400, DOI 10.1073/pnas.1116564108; Tallinen T, 2016, NAT PHYS, V12, P588, DOI [10.1038/nphys3632, 10.1038/NPHYS3632]; Vandeparre H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.224301	22	39	39	6	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2018	360	6386					296	299		10.1126/science.aaq0677	http://dx.doi.org/10.1126/science.aaq0677			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD3IC	29674588				2022-12-28	WOS:000430396600038
J	Koch, M				Koch, Marta			Artificial Intelligence Is Becoming Natural	CELL			English	Editorial Material																		Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Grace K., 2017, ARXIV170508807V2; Kermany DS, 2018, CELL, V172, P1122, DOI 10.1016/j.cell.2018.02.010; Madani A, 2018, NPJ DIGIT MED, V1, DOI [10.1038/s41746-017-0013-1, 10.1038/s41746-018-0065-x]; Poplin R, 2018, NAT BIOMED ENG, V2, P158, DOI 10.1038/s41551-018-0195-0; Tison GH, 2018, JAMA CARDIOL, V3, P409, DOI 10.1001/jamacardio.2018.0136	6	14	15	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2018	173	3					531	532		10.1016/j.cell.2018.04.007	http://dx.doi.org/10.1016/j.cell.2018.04.007			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7GB	29677502	Bronze			2022-12-28	WOS:000430677400001
J	Sullivan, DP; Lundberg, E				Sullivan, Devin P.; Lundberg, Emma			Seeing More: A Future of Augmented Microscopy	CELL			English	Editorial Material								Microscope images are information rich. In this issue of Cell, Christiansen et al. show that label-free images of cells can be used to predict fluorescent labels representing cell type, state, and organelle distribution using a deep-learning framework. This paves the way for computationally multiplexed assays derived from inexpensive label-free microscopy.	[Sullivan, Devin P.; Lundberg, Emma] KTH Royal Inst Technol, Sch Engn Sci Chem Biotechnol & Hlth, Sci Life Lab, S-17121 Stockholm, Sweden	Royal Institute of Technology	Lundberg, E (corresponding author), KTH Royal Inst Technol, Sch Engn Sci Chem Biotechnol & Hlth, Sci Life Lab, S-17121 Stockholm, Sweden.	emma.lundberg@scilifelab.se	Lundberg, Emma S K/F-3891-2010	Kaller Lundberg, Emma/0000-0001-7034-0850; Sullivan, Devin/0000-0001-6176-108X				Abrahamsson S, 2015, OPT EXPRESS, V23, P7734, DOI 10.1364/OE.23.007734; Chen LC, 2018, IEEE T PATTERN ANAL, V40, P834, DOI 10.1109/TPAMI.2017.2699184; Christiansen EM, 2018, CELL, V173, P792, DOI 10.1016/j.cell.2018.03.040; Dixon AR, 2015, EXPERT REV MOL DIAGN, V15, P1171, DOI 10.1586/14737159.2015.1069182; Roberts B, 2017, MOL BIOL CELL, V28, P2854, DOI 10.1091/mbc.E17-03-0209; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321	9	10	10	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2018	173	3					546	548		10.1016/j.cell.2018.04.003	http://dx.doi.org/10.1016/j.cell.2018.04.003			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7GB	29677507	Bronze			2022-12-28	WOS:000430677400006
J	Slawther, E				Slawther, Eliza			NHS AT 70 Medical leaders have their say on NHS's greatest achievements	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2018	361								k1698	10.1136/bmj.k1698	http://dx.doi.org/10.1136/bmj.k1698			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8WK	29666063				2022-12-28	WOS:000430794600008
J	[Anonymous]				[Anonymous]			WHO Issues New Guidelines for LTBI	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2018	319	15					1539	1539		10.1001/jama.2018.3344	http://dx.doi.org/10.1001/jama.2018.3344			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD0UT	29677310				2022-12-28	WOS:000430217100004
J	Villareal, TA; Pilskaln, C; Brzezinski, M; Lipschultz, F; Dennett, M; Gardner, GB				Villareal, TA; Pilskaln, C; Brzezinski, M; Lipschultz, F; Dennett, M; Gardner, GB			Upward transport of oceanic nitrate by migrating diatom mats	NATURE			English	Article							NORTH PACIFIC-OCEAN; NITROGEN-FIXATION; SARGASSO-SEA; WATERS; LAYER	The oligotrophic gyres of the open sea are home to a nora that includes the largest known phytoplankton. These rare species migrate as solitary cells or aggregations (mats) between deep nutrient pools (below 80-100 m) and the surface. This migration contributes to new production because of the concomitant upward transport of nitrate(1-3). But just how significant this contribution is remains uncertain because of the difficulty of making quantitative measurements of these rare cells(4). Here we report remote video observations of a previously undersampled class of diatom (Rhizosolenia) mats throughout the upper 150 m of the central North Pacific Ocean. These mats are virtually invisible to divers, and their presence increases the calculated phytoplankton-mediated nitrate transport into the surface ocean by up to a factor of eight. Cruise averages indicate that Rhizosolenia mats transport 18-97 mu mol N m(-2) d(-1); however, this value reached 171 mu mol N m(-2) d(-1) at individual stations, a value equivalent to 59% of the export production(5). Although considerable temporal and spatial variability occurs, this means of upward nutrient transport appears to be an important source of new nitrogen to the surface ocean, and may contribute to other regional elemental cycles as well(6).	Univ Texas, Inst Marine Sci, Port Aransas, TX 78373 USA; Univ Maine, Sch Marine Sci, Orono, ME 04469 USA; Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Bermuda Biol Stn Res Inc, Ferry Reach, Bermuda; Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; Univ Massachusetts, Environm Coastal & Ocean Sci Program, Boston, MA 02125 USA	University of Texas System; University of Maine System; University of Maine Orono; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Woods Hole Oceanographic Institution; University of Massachusetts System; University of Massachusetts Boston	Villareal, TA (corresponding author), Univ Texas, Inst Marine Sci, 750 Channel View Dr, Port Aransas, TX 78373 USA.	tracy@utmsi.utexas.edu	Villareal, Tracy A/I-9462-2012	Villareal, Tracy A/0000-0002-5717-8163; Lipschultz, Fred/0000-0003-1634-6754				ALLDREDGE AL, 1982, MAR BIOL, V66, P83, DOI 10.1007/BF00397258; BANSE K, 1987, J PLANKTON RES, V9, P1031, DOI 10.1093/plankt/9.5.1031; Brzezinski MA, 1998, MAR ECOL PROG SER, V167, P89, DOI 10.3354/meps167089; CARPENTER E J, 1977, Limnology and Oceanography, V22, P739; DAVIS CS, 1992, ERGEB LIMNOL, V32, P67; EMERSON S, 1995, J MAR RES, V53, P499, DOI 10.1357/0022240953213179; EPPLEY RW, 1979, NATURE, V282, P677, DOI 10.1038/282677a0; Goldman J. C, 1988, THEORY BIOL PHYSICAL, P273, DOI [10.1007/978-94-009-3023-0_15, DOI 10.1007/978-94-009-3023-0_15]; Hall MM, 1997, DEEP-SEA RES PT I, V44, P1127, DOI 10.1016/S0967-0637(97)00015-0; HAYWARD TL, 1994, DEEP-SEA RES PT I, V41, P559, DOI 10.1016/0967-0637(94)90095-7; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Karl DM, 1998, LIMNOL OCEANOGR, V43, P1270, DOI 10.4319/lo.1998.43.6.1270; Karl DM, 1996, DEEP-SEA RES PT II, V43, P129, DOI 10.1016/0967-0645(96)00005-7; KARL DM, 1995, NATURE, V378, P21; MARTINEZ L, 1983, SCIENCE, V221, P152, DOI 10.1126/science.221.4606.152; McGillicuddy DJ, 1997, DEEP-SEA RES PT I, V44, P1427, DOI 10.1016/S0967-0637(97)00024-1; Parsons T.R., 1984, MANUAL BIOL CHEM MET; PILSKALN CH, IN PRESS DEEP SEA RE; Richardson TL, 1998, J PLANKTON RES, V20, P219, DOI 10.1093/plankt/20.2.219; SHIPE RF, UNPUB SILICA PRODUCT; Villareal T.A., 1989, BIOL OCEANOGR, V6, P327, DOI [10.1080/01965581.1988.10749535, DOI 10.1080/01965581.1988.10749535]; VILLAREAL TA, 1993, NATURE, V363, P709, DOI 10.1038/363709a0; Villareal TA, 1996, J PLANKTON RES, V18, P1103, DOI 10.1093/plankt/18.7.1103; VILLAREAL TA, 1995, J PHYCOL, V31, P689, DOI 10.1111/j.0022-3646.1995.00689.x; YODER JA, 1994, NATURE, V371, P689, DOI 10.1038/371689a0	25	114	123	3	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	1999	397	6718					423	425		10.1038/17103	http://dx.doi.org/10.1038/17103			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667969				2022-12-28	WOS:000078461700044
J	Grigoli, F; Cesca, S; Rinaldi, AP; Manconi, A; Lopez-Comino, JA; Clinton, JF; Westaway, R; Cauzzi, C; Dahm, T; Wiemer, S				Grigoli, F.; Cesca, S.; Rinaldi, A. P.; Manconi, A.; Lopez-Comino, J. A.; Clinton, J. F.; Westaway, R.; Cauzzi, C.; Dahm, T.; Wiemer, S.			The November 2017 M-w 5.5 Pohang earthquake: A possible case of induced seismicity in South Korea	SCIENCE			English	Article							RUPTURE; DISPLACEMENT; MAGNITUDE; INJECTION; GYEONGJU; FAULTS; AREA	The moment magnitude (M-w) 5.5 earthquake that struck South Korea in November 2017 was one of the largest and most damaging events in that country over the past century. Its proximity to an enhanced geothermal system site, where high-pressure hydraulic injection had been performed during the previous 2 years, raises the possibility that this earthquake was anthropogenic. We have combined seismological and geodetic analyses to characterize the mainshock and its largest aftershocks, constrain the geometry of this seismic sequence, and shed light on its causal factors. According to our analysis, it seems plausible that the occurrence of this earthquake was influenced by the aforementioned industrial activities. Finally, we found that the earthquake transferred static stress to larger nearby faults, potentially increasing the seismic hazard in the area.	[Grigoli, F.; Rinaldi, A. P.; Clinton, J. F.; Cauzzi, C.; Wiemer, S.] ETH, Swiss Seismol Serv, Zurich, Switzerland; [Cesca, S.; Lopez-Comino, J. A.; Dahm, T.] German Res Ctr Geosci GFZ, Sect Phys Earthquakes & Volcanoes 2 1, Potsdam, Germany; [Manconi, A.] ETH, Dept Earth Sci, Engn Geol Grp, Zurich, Switzerland; [Westaway, R.] Univ Glasgow, Sch Engn, Glasgow, Lanark, Scotland; [Dahm, T.] Univ Potsdam, Inst Earth & Environm Sci, Potsdam, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Glasgow; University of Potsdam	Grigoli, F (corresponding author), ETH, Swiss Seismol Serv, Zurich, Switzerland.	francesco.grigoli@sed.ethz.ch	Cesca, Simone/AAZ-2572-2020; Manconi, Andrea/B-8367-2009; Rinaldi, Antonio Pio/N-3284-2013; Grigoli, Francesco/ABA-8647-2020; Comino, Jose Angel Lopez/H-6392-2015; Cauzzi, Carlo/H-5641-2011; Cesca, Simone/K-4081-2017	Cesca, Simone/0000-0001-9419-3904; Manconi, Andrea/0000-0003-2930-4422; Rinaldi, Antonio Pio/0000-0001-7052-8618; Grigoli, Francesco/0000-0002-2858-9756; Cauzzi, Carlo/0000-0003-2033-4537; Cesca, Simone/0000-0001-9419-3904; Dahm, Torsten/0000-0001-6432-7422; Clinton, John/0000-0001-8626-2703; Westaway, Rob/0000-0001-5683-4192; Wiemer, Stefan/0000-0002-4919-3283	EU [691728, 640896]; Swiss National Science Foundation, Ambizione Energy grant [PZENP2-160555]	EU(European Commission); Swiss National Science Foundation, Ambizione Energy grant	This work was funded by the EU projects DESTRESS (EU H2020 research and innovation program, grant agreement 691728) and SHEER (EU H2020 research and innovation program, grant agreement 640896). A.P.R. is currently funded by a Swiss National Science Foundation, Ambizione Energy grant (PZENP2-160555).	Atkinson GM, 2016, SEISMOL RES LETT, V87, P631, DOI 10.1785/0220150263; Davis S. D., 1993, Seismological Research Letters, V64, P207; Ellsworth WL, 2013, SCIENCE, V341, P142, DOI 10.1126/science.1225942; FROHLICH C, 1992, TECTONICS, V11, P279, DOI 10.1029/91TC02888; Grigoli F, 2017, REV GEOPHYS, V55, P310, DOI 10.1002/2016RG000542; Han M, 2017, TECTONOPHYSICS, V694, P414, DOI 10.1016/j.tecto.2016.11.026; Hayes GP, 2010, NAT GEOSCI, V3, P800, DOI [10.1038/ngeo977, 10.1038/NGEO977]; Keranen KM, 2014, SCIENCE, V345, P448, DOI 10.1126/science.1255802; Kim KH, 2018, B SEISMOL SOC AM, V108, P517, DOI 10.1785/0120170104; Kim Y, 2017, B SEISMOL SOC AM, V107, P2525, DOI 10.1785/0120170004; Lee K, 2006, B SEISMOL SOC AM, V96, P846, DOI 10.1785/0120050050; MASSONNET D, 1993, NATURE, V364, P138, DOI 10.1038/364138a0; McGarr A, 2014, J GEOPHYS RES-SOL EA, V119, P1008, DOI 10.1002/2013JB010597; Mignan A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13585-9; OKADA Y, 1985, B SEISMOL SOC AM, V75, P1135; Park S, 2017, PROCEDIA ENGINEER, V191, P829, DOI 10.1016/j.proeng.2017.05.250; WELLS DL, 1994, B SEISMOL SOC AM, V84, P974; Westaway R, 2002, PURE APPL GEOPHYS, V159, P7, DOI 10.1007/PL00001268; Westaway R., 2016, ENV HLTH ISSUES UNCO, P175	19	247	251	9	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2018	360	6392					1003	1006		10.1126/science.aat2010	http://dx.doi.org/10.1126/science.aat2010			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6SL	29700226	Green Submitted, Green Accepted			2022-12-28	WOS:000433574200038
J	Forde, PM; Chaft, JE; Smith, KN; Anagnostou, V; Cottrell, TR; Hellmann, MD; Zahurak, M; Yang, SC; Jones, DR; Broderick, S; Battafarano, RJ; Velez, MJ; Rekhtman, N; Olah, Z; Naidoo, J; Marrone, KA; Verde, F; Guo, H; Zhang, J; Caushi, JX; Chan, HY; Sidhom, JW; Scharpf, RB; White, J; Gabrielson, E; Wang, H; Rosner, GL; Rusch, V; Wolchok, JD; Merghoub, T; Taube, JM; Velculescu, VE; Topalian, SL; Brahmer, JR; Pardoll, DM				Forde, P. M.; Chaft, J. E.; Smith, K. N.; Anagnostou, V.; Cottrell, T. R.; Hellmann, M. D.; Zahurak, M.; Yang, S. C.; Jones, D. R.; Broderick, S.; Battafarano, R. J.; Velez, M. J.; Rekhtman, N.; Olah, Z.; Naidoo, J.; Marrone, K. A.; Verde, F.; Guo, H.; Zhang, J.; Caushi, J. X.; Chan, H. Y.; Sidhom, J. -W.; Scharpf, R. B.; White, J.; Gabrielson, E.; Wang, H.; Rosner, G. L.; Rusch, V.; Wolchok, J. D.; Merghoub, T.; Taube, J. M.; Velculescu, V. E.; Topalian, S. L.; Brahmer, J. R.; Pardoll, D. M.			Neoadjuvant PD-1 Blockade in Resectable Lung Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNE CHECKPOINT BLOCKADE; MISMATCH-REPAIR DEFICIENCY; RESPONSE CRITERIA; SOLID TUMORS; OPEN-LABEL; CHEMOTHERAPY; PEMBROLIZUMAB; TRIAL; IMMUNOTHERAPY; MULTICENTER	BACKGROUND Antibodies that block programmed death 1 (PD-1) protein improve survival in patients with advanced non-small-cell lung cancer (NSCLC) but have not been tested in resectable NSCLC, a condition in which little progress has been made during the past decade. METHODS In this pilot study, we administered two preoperative doses of PD-1 inhibitor nivolumab in adults with untreated, surgically resectable early (stage I, II, or IIIA) NSCLC. Nivolumab (at a dose of 3 mg per kilogram of body weight) was administered intravenously every 2 weeks, with surgery planned approximately 4 weeks after the first dose. The primary end points of the study were safety and feasibility. We also evaluated the tumor pathological response, expression of programmed death ligand 1 (PD-L1), mutational burden, and mutation-associated, neoantigen-specific T-cell responses. RESULTS Neoadjuvant nivolumab had an acceptable side-effect profile and was not associated with delays in surgery. Of the 21 tumors that were removed, 20 were completely resected. A major pathological response occurred in (of 20 resected tumors (45%). Responses occurred in both PD-L1-positive and PD-L1-negative tumors. There was a significant correlation between the pathological response and the pretreatment tumor mutational burden. The number of T-cell clones that were found in both the tumor and peripheral blood increased systemically after PD-1 blockade in eight of nine patients who were evaluated. Mutation-associated, neoantigen-specific T-cell clones from a primary tumor with a complete response on pathological assessment rapidly expanded in peripheral blood at 2 to 4 weeks after treatment; some of these clones were not detected before the administration of nivolumab. CONCLUSIONS Neoadjuvant nivolumab was associated with few side effects, did not delay surgery, and induced a major pathological response in 45% of resected tumors. The tumor mutational burden was predictive of the pathological response to PD-1 blockade. Treatment induced expansion of mutation-associated, neoantigen-specific T-cell clones in peripheral blood.	[Forde, P. M.; Smith, K. N.; Anagnostou, V.; Cottrell, T. R.; Zahurak, M.; Yang, S. C.; Broderick, S.; Battafarano, R. J.; Naidoo, J.; Marrone, K. A.; Verde, F.; Guo, H.; Zhang, J.; Caushi, J. X.; Chan, H. Y.; Sidhom, J. -W.; Scharpf, R. B.; White, J.; Gabrielson, E.; Wang, H.; Rosner, G. L.; Taube, J. M.; Velculescu, V. E.; Topalian, S. L.; Brahmer, J. R.; Pardoll, D. M.] Johns Hopkins Univ, Sch Med, Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD USA; [Forde, P. M.; Smith, K. N.; Anagnostou, V.; Cottrell, T. R.; Zahurak, M.; Yang, S. C.; Broderick, S.; Battafarano, R. J.; Naidoo, J.; Marrone, K. A.; Verde, F.; Guo, H.; Zhang, J.; Caushi, J. X.; Chan, H. Y.; Sidhom, J. -W.; Scharpf, R. B.; White, J.; Gabrielson, E.; Wang, H.; Rosner, G. L.; Taube, J. M.; Velculescu, V. E.; Topalian, S. L.; Brahmer, J. R.; Pardoll, D. M.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Chaft, J. E.; Hellmann, M. D.; Jones, D. R.; Velez, M. J.; Rekhtman, N.; Olah, Z.; Rusch, V.; Wolchok, J. D.; Merghoub, T.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Chaft, J. E.; Hellmann, M. D.; Jones, D. R.; Velez, M. J.; Rekhtman, N.; Olah, Z.; Rusch, V.; Wolchok, J. D.; Merghoub, T.] Weill Cornell Med, New York, NY USA; [Wolchok, J. D.; Merghoub, T.] Ludwig Collaborat, New York, NY USA; [Wolchok, J. D.; Merghoub, T.] Parker Inst Canc Immunotherapy, San Francisco, CA USA; [Wolchok, J. D.; Merghoub, T.] Swim Amer Lab, Charlotte, NC USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Memorial Sloan Kettering Cancer Center; Cornell University	Pardoll, DM (corresponding author), Sidney Kimmel Comprehens Canc Ctr, Rm 444,Bunting Blaustein CRB 1,1650 Orleans St, Baltimore, MD 21287 USA.	dpardol1@jhmi.edu	Rosner, Gary/ABG-8161-2021; Merghoub, Taha/ABD-8362-2021; Velculescu, Victor/ABF-4846-2020; Forde, Patrick/AAX-2936-2021	Velculescu, Victor/0000-0003-1195-438X; Sidhom, John-William/0000-0002-5575-0285; Naidoo, Jarushka/0000-0002-3470-8686; Jones, David/0000-0002-3318-0146	Cancer Immunology Translational Cancer Research Grant from Cancer Research Institute-Stand Up 2 Cancer [SU2C-AACR-DT1012]; Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy; Bristol-Myers Squibb; International Immuno-Oncology Network; LUNGevity Foundation; International Association for the Study of Lung Cancer; Prevent Cancer Foundation; Lung Cancer Foundation of America; MacMillan Foundation; Eastern Cooperative Oncology Group-American College of Radiology Imaging Network; National Institutes of Health [CA121113, CA006973, CA180950, T32 CA193145, R01 CA142779]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Commonwealth Foundation; Memorial Sloan Kettering Cancer Center [P30 CA008748]; Johns Hopkins University Cancer Center [P30 CA006973]; NATIONAL CANCER INSTITUTE [R01CA121113, P30CA008748, P30CA006973, R01CA142779, T32CA193145, U10CA180950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	Cancer Immunology Translational Cancer Research Grant from Cancer Research Institute-Stand Up 2 Cancer; Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy; Bristol-Myers Squibb(Bristol-Myers Squibb); International Immuno-Oncology Network; LUNGevity Foundation; International Association for the Study of Lung Cancer; Prevent Cancer Foundation; Lung Cancer Foundation of America; MacMillan Foundation; Eastern Cooperative Oncology Group-American College of Radiology Imaging Network; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Commonwealth Foundation; Memorial Sloan Kettering Cancer Center; Johns Hopkins University Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by a Cancer Immunology Translational Cancer Research Grant (SU2C-AACR-DT1012) from Cancer Research Institute-Stand Up 2 Cancer, Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Bristol-Myers Squibb, International Immuno-Oncology Network, LUNGevity Foundation, International Association for the Study of Lung Cancer, Prevent Cancer Foundation, Lung Cancer Foundation of America, MacMillan Foundation, Eastern Cooperative Oncology Group-American College of Radiology Imaging Network, grants (CA121113, CA006973, CA180950, T32 CA193145, and R01 CA142779) from the National Institutes of Health, Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, Commonwealth Foundation, a grant (P30 CA008748) from Memorial Sloan Kettering Cancer Center, and a grant (P30 CA006973) from Johns Hopkins University Cancer Center. Stand Up 2 Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research.	Anagnostou V, 2017, CANCER DISCOV, V7, P264, DOI 10.1158/2159-8290.CD-16-0828; Antonia SJ, 2017, NEW ENGL J MED, V377, P1919, DOI 10.1056/NEJMoa1709937; Chaft JE, 2013, J THORAC ONCOL, V8, P1084, DOI 10.1097/JTO.0b013e31829923ec; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Gettinger SN, 2015, J CLIN ONCOL, V33, P2004, DOI 10.1200/JCO.2014.58.3708; Giraldo NA, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.AM2017-662; Goldberg MV, 2007, BLOOD, V110, P186, DOI 10.1182/blood-2006-12-062422; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hellmann MD, 2014, LANCET ONCOL, V15, pE42, DOI 10.1016/S1470-2045(13)70334-6; Hodi FS, 2016, J CLIN ONCOL, V34, P1510, DOI 10.1200/JCO.2015.64.0391; Jones S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7161; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Liu J, 2016, CANCER DISCOV, V6, P1382, DOI 10.1158/2159-8290.CD-16-0577; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Nghiem PT, 2016, NEW ENGL J MED, V374, P2542, DOI 10.1056/NEJMoa1603702; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Pataer A, 2012, J THORAC ONCOL, V7, P825, DOI 10.1097/JTO.0b013e318247504a; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Ribas A, 2009, CLIN CANCER RES, V15, P7116, DOI 10.1158/1078-0432.CCR-09-2376; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Srivastava SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052250; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Wakelee HA, 2017, LANCET ONCOL, V18, P1610, DOI 10.1016/S1470-2045(17)30691-5	31	940	1009	9	186	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2018	378	21					1976	1986		10.1056/NEJMoa1716078	http://dx.doi.org/10.1056/NEJMoa1716078			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG6KK	29658848	Green Accepted, Bronze			2022-12-28	WOS:000432804900005
J	MacLean, CH; Kerr, EA; Qaseem, A				MacLean, Catherine H.; Kerr, Eve A.; Qaseem, Amir			Time Out - Charting a Path for Improving Performance Measurement	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[MacLean, Catherine H.] Hosp Special Surg, Ctr Adv Value Musculoskeletal Care, 535 E 70th St, New York, NY 10021 USA; [Kerr, Eve A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Kerr, Eve A.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Kerr, Eve A.] Univ Michigan, Vet Affairs Ann Arbor Ctr Clin Management & Res, Ann Arbor, MI 48109 USA; [Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA USA; [MacLean, Catherine H.; Kerr, Eve A.] ACP Performance Measurement Comm, Philadelphia, PA 19106 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; American College of Physicians	MacLean, CH (corresponding author), Hosp Special Surg, Ctr Adv Value Musculoskeletal Care, 535 E 70th St, New York, NY 10021 USA.; MacLean, CH (corresponding author), ACP Performance Measurement Comm, Philadelphia, PA 19106 USA.		Callahan, Charles D/L-1641-2013					Berwick DM, 2016, JAMA-J AM MED ASSOC, V315, P1329, DOI 10.1001/jama.2016.1509; Casalino LP, 2016, HEALTH AFFAIR, V35, P401, DOI 10.1377/hlthaff.2015.1258; Hemingway H, 2001, NEW ENGL J MED, V344, P645, DOI 10.1056/NEJM200103013440906; Higashi T, 2005, ANN INTERN MED, V143, P274, DOI 10.7326/0003-4819-143-4-200508160-00008; Qaseem A, 2010, ANN INTERN MED, V152, P366, DOI 10.7326/0003-4819-152-6-201003160-00006	5	83	84	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2018	378	19					1757	1761		10.1056/NEJMp1802595	http://dx.doi.org/10.1056/NEJMp1802595			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GF2MO	29668361				2022-12-28	WOS:000431774400001
J	Haslag-Minoff, J; Regunath, H				Haslag-Minoff, Jen; Regunath, Hariharan			Relapsing Polychondritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Haslag-Minoff, Jen] Univ Hosp, Columbia, MO USA; [Regunath, Hariharan] Univ Missouri, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Haslag-Minoff, J (corresponding author), Univ Hosp, Columbia, MO USA.	haslagminoffj@health.missouri.edu	Amedee, Ronald/A-5480-2011						0	5	6	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2018	378	18					1715	1715		10.1056/NEJMicm1713302	http://dx.doi.org/10.1056/NEJMicm1713302			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GE4WO	29719184				2022-12-28	WOS:000431218600010
J	Agniel, D; Kohane, IS; Weber, GM				Agniel, Denis; Kohane, Isaac S.; Weber, Griffin M.			Biases in electronic health record data due to processes within the healthcare system: retrospective observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DIURNAL-VARIATION; DISEASE; TIME	OBJECTIVE To evaluate on a large scale, across 272 common types of laboratory tests, the impact of healthcare processes on the predictive value of electronic health record (EHR) data. DESIG Retrospective observational study. SETTING Two large hospitals in Boston, Massachusetts, with inpatient, emergency, and ambulatory care. PARTICIPANTS All 669 452 patients treated at the two hospitals over one year between 2005 and 2006. MAIN OUTCOME MEASURES The relative predictive accuracy of each laboratory test for three year survival, using the time of the day, day of the week, and ordering frequency of the test, compared to the value of the test result. RESULTS The presence of a laboratory test order, regardless of any other information about the test result, has a significant association (P < 0.001) with the odds of survival in 233 of 272 (86%) tests. Data about the timing of when laboratory tests were ordered were more accurate than the test results in predicting survival in 118 of 174 tests (68%). CONCLUSIONS Healthcare processes must be addressed and accounted for in analysis of observational health data. Without careful consideration to context, EHR data are unsuitable for many research questions. However, if explicitly modeled, the same processes that make EHR data complex can be leveraged to gain insight into patients' state of health.	[Agniel, Denis; Kohane, Isaac S.; Weber, Griffin M.] Harvard Med Sch, Dept Biomed Informat, 10 Shattuck St, Boston, MA 02115 USA; [Kohane, Isaac S.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Weber, Griffin M.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center	Weber, GM (corresponding author), Harvard Med Sch, Dept Biomed Informat, 10 Shattuck St, Boston, MA 02115 USA.; Weber, GM (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.	weber@hms.harvard.edu		Weber, Griffin/0000-0002-2597-881X	Informatics for Integrating Biology and the Bedside, a National Institutes of Health (NIH) [U54LM008748]; NIH Big Data to Knowledge (BD2K) awards through the National Cancer Institute (NCI) [U01CA198934]; NIH Big Data to Knowledge (BD2K) awards through the National Human Genome Research Institute (NHGRI) [U54HG007963]; NATIONAL CANCER INSTITUTE [U01CA198934] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007963] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER	Informatics for Integrating Biology and the Bedside, a National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Big Data to Knowledge (BD2K) awards through the National Cancer Institute (NCI); NIH Big Data to Knowledge (BD2K) awards through the National Human Genome Research Institute (NHGRI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was supported by Informatics for Integrating Biology and the Bedside, a National Institutes of Health (NIH) funded National Center for Biomedical Computing (U54LM008748). Additional funding was provided by NIH Big Data to Knowledge (BD2K) awards U01CA198934 through the National Cancer Institute (NCI) and U54HG007963 through the National Human Genome Research Institute (NHGRI). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096443; Albers DJ, 2012, CHAOS, V22, DOI 10.1063/1.3675621; Albers DJ, 2010, PHYS LETT A, V374, P1159, DOI 10.1016/j.physleta.2009.12.067; [Anonymous], 2011, PREC MED BUILD KNOWL, DOI [10.17226/13284, DOI 10.17226/13284]; Centers for Medicare & Medicaid Services (CMS), EHR INC PROGR; Chen YF, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0260-2; Coleman JJ, 2015, J AM MED INFORM ASSN, V22, P206, DOI 10.1136/amiajnl-2014-002822; Collins SA, 2013, AM J CRIT CARE, V22, P306, DOI 10.4037/ajcc2013426; Copeland LA, 2013, CLIN MED RES, V11, P120, DOI 10.3121/cmr.2013.1175; Dahlem D, 2015, SCI REP-UK, V5, DOI 10.1038/srep11865; Foy R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010276; Friedman CP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001456; Hagar Y, 2014, STAT ANAL DATA MIN, V7, P385, DOI 10.1002/sam.11236; Healey F, 2008, QUAL SAF HEALTH CARE, V17, P424, DOI 10.1136/qshc.2007.024695; Homer JB, 2006, AM J PUBLIC HEALTH, V96, P452, DOI 10.2105/AJPH.2005.062059; Hripcsak G, 2015, J AM MED INFORM ASSN, V22, P794, DOI 10.1093/jamia/ocu051; Hripcsak G, 2013, J AM MED INFORM ASSN, V20, pE311, DOI 10.1136/amiajnl-2013-001922; Hripcsak G, 2013, J AM MED INFORM ASSN, V20, P117, DOI 10.1136/amiajnl-2012-001145; Jones AR, 1996, AM J CLIN PATHOL, V106, P723; Jones Richard G, 2014, Clin Biochem Rev, V35, P177; Kelly C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013059; Kitagawa Y, 2015, ASIAN J ANDROL, V17, P475, DOI 10.4103/1008-682X.143756; Klann JG, 2014, J AM MED INFORM ASSN, V21, P650, DOI 10.1136/amiajnl-2014-002707; Kohane IS, 2011, NAT REV GENET, V12, P417, DOI 10.1038/nrg2999; Lasko TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066341; Levine Matthew E, 2016, AMIA Annu Symp Proc, V2016, P779; Levinson W, 2015, BMJ QUAL SAF, V24, P167, DOI 10.1136/bmjqs-2014-003821; Lin JH, 2008, J BIOMED INFORM, V41, P1, DOI 10.1016/j.jbi.2007.06.001; Lowe Henry J, 2009, AMIA Annu Symp Proc, V2009, P391; Madigan D, 2013, AM J EPIDEMIOL, V178, P645, DOI 10.1093/aje/kwt010; Mandl KD, 2014, J AM MED INFORM ASSN, V21, P615, DOI 10.1136/amiajnl-2014-002727; McLintock K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005178; McMurry AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055811; Murphy SN, 2010, J AM MED INFORM ASSN, V17, P124, DOI 10.1136/jamia.2009.000893; Nalichowski Ruth, 2006, AMIA Annu Symp Proc, P1044; National Research Council, 2007, LEARN HEALTHC SYST W; Pivovarov R, 2014, J BIOMED INFORM, V51, P24, DOI 10.1016/j.jbi.2014.03.016; Sennels HP, 2011, SCAND J CLIN LAB INV, V71, P532, DOI 10.3109/00365513.2011.602422; Weber GM, 2014, JAMA-J AM MED ASSOC, V311, P2479, DOI 10.1001/jama.2014.4228; Weber GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064933; Weber GM, 2009, J AM MED INFORM ASSN, V16, P624, DOI 10.1197/jamia.M3191; Weiskopf NG, 2013, J AM MED INFORM ASSN, V20, P144, DOI 10.1136/amiajnl-2011-000681	42	133	133	3	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2018	361								k1479	10.1136/bmj.k1479	http://dx.doi.org/10.1136/bmj.k1479			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GF4XX	29712648	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000431968600001
J	Kuehn, B				Kuehn, Bridget			ER Opioid Overdoses Increasing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2018	319	16					1650	1650		10.1001/jama.2018.4026	http://dx.doi.org/10.1001/jama.2018.4026			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD7RF	29710171				2022-12-28	WOS:000430709300013
J	Kuehn, B				Kuehn, Bridget			Dentists at Risk of Lung Disease?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2018	319	16					1650	1650		10.1001/jama.2018.4585	http://dx.doi.org/10.1001/jama.2018.4585			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD7RF	29710172				2022-12-28	WOS:000430709300012
J	Rubin, R				Rubin, Rita			VA Using Telemedicine to Provide Therapy to Rural Veterans With PTSD	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2018	319	16					1648	1648		10.1001/jama.2018.4737	http://dx.doi.org/10.1001/jama.2018.4737			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD7RF	29710150				2022-12-28	WOS:000430709300006
J	LLorca, J				LLorca, Javier			On the quest for the strongest materials	SCIENCE			English	Editorial Material							MULTIWALLED CARBON NANOTUBES; STRENGTH		[LLorca, Javier] IMDEA Mat Inst, C Eric Kandel 2, Madrid 28906, Spain; [LLorca, Javier] Univ Politecn Madrid, Dept Mat Sci, ETS Ingenieros Caminos, Madrid 28040, Spain	IMDEA Materials Institute; Universidad Politecnica de Madrid	LLorca, J (corresponding author), IMDEA Mat Inst, C Eric Kandel 2, Madrid 28906, Spain.; LLorca, J (corresponding author), Univ Politecn Madrid, Dept Mat Sci, ETS Ingenieros Caminos, Madrid 28040, Spain.	javier.llorca@imdea.org	LLorca, Javier/C-1140-2013	LLorca, Javier/0000-0002-3122-7879				Banerjee A, 2018, SCIENCE, V360, P300, DOI 10.1126/science.aar4165; Beese AM, 2014, ACS NANO, V8, P11454, DOI 10.1021/nn5045504; BRENNER SS, 1958, SCIENCE, V128, P569, DOI 10.1126/science.128.3324.569; Cepeda-Jimenez CM, 2017, ACTA MATER, V123, P206, DOI 10.1016/j.actamat.2016.10.052; Field JE, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/12/126505; Gilman J.J., 2008, ELECT BASIS STRENGTH; Gonzalez C, 2017, PROG MATER SCI, V89, P194, DOI 10.1016/j.pmatsci.2017.04.005; Lee GH, 2013, SCIENCE, V340, P1073, DOI 10.1126/science.1235126; Li J, 2014, MRS BULL, V39, P108, DOI 10.1557/mrs.2014.3; Miyoshi K., 2001, SOLID LUBRICATION FU, V1st ed., P416; Peng B, 2008, NAT NANOTECHNOL, V3, P626, DOI 10.1038/nnano.2008.211; Sun Y, 2007, J APPL PHYS, V101, DOI 10.1063/1.2730561; Yildiz B, 2014, MRS BULL, V39, P147, DOI 10.1557/mrs.2014.8; Yu MF, 2000, SCIENCE, V287, P637, DOI 10.1126/science.287.5453.637; Zhu T, 2010, PROG MATER SCI, V55, P710, DOI 10.1016/j.pmatsci.2010.04.001	15	7	7	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2018	360	6386					264	265		10.1126/science.aat5211	http://dx.doi.org/10.1126/science.aat5211			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD3IC	29674578	Green Submitted			2022-12-28	WOS:000430396600023
J	Rocha, AG; Franco, A; Krezel, AM; Rumsey, JM; Alberti, JM; Knight, WC; Biris, N; Zacharioudakis, E; Janetka, JW; Baloh, RH; Kitsis, RN; Mochly-Rosen, D; Townsend, RR; Gavathiotis, E; Dorn, GW				Rocha, Agostinho G.; Franco, Antonietta; Krezel, Andrzej M.; Rumsey, Jeanne M.; Alberti, Justin M.; Knight, William C.; Biris, Nikolaos; Zacharioudakis, Emmanouil; Janetka, James W.; Baloh, Robert H.; Kitsis, Richard N.; Mochly-Rosen, Daria; Townsend, R. Reid; Gavathiotis, Evripidis; Dorn, Gerald W., II			MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A	SCIENCE			English	Article							MUTATIONS; TRANSPORT; DYNAMICS; FEATURES; FUSION; HEALTH	Mitofusins (MFNs) promote fusion-mediated mitochondrial content exchange and subcellular trafficking. Mutations in Mfn2 cause neurodegenerative Charcot-Marie-Tooth disease type 2A (CMT2A). We showed that MFN2 activity can be determined by Met(376) and His(380) interactions with Asp(725) and Leu(727) and controlled by PINK1 kinase-mediated phosphorylation of adjacent MFN2 Ser(378). Small-molecule mimics of the peptide-peptide interface of MFN2 disrupted this interaction, allosterically activating MFN2 and promoting mitochondrial fusion. These first-in-class mitofusin agonists overcame dominant mitochondrial defects provoked in cultured neurons by CMT2A mutants MFN2 Arg(94)-> Gln(94) and MFN2 Thr(105)-> Met(105), as demonstrated by amelioration of mitochondrial dysmotility, fragmentation, depolarization, and clumping. A mitofusin agonist normalized axonal mitochondrial trafficking within sciatic nerves of MFN2 Thr(105)-> Met(105) mice, promising a therapeutic approach for CMT2A and other untreatable diseases of impaired neuronal mitochondrial dynamism and/or trafficking.	[Rocha, Agostinho G.; Franco, Antonietta; Rumsey, Jeanne M.; Alberti, Justin M.; Knight, William C.; Townsend, R. Reid; Dorn, Gerald W., II] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Krezel, Andrzej M.; Janetka, James W.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Biris, Nikolaos; Zacharioudakis, Emmanouil; Gavathiotis, Evripidis] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Wilf Family Cardiovasc Res Inst, Dept Biochem, Bronx, NY 10467 USA; [Biris, Nikolaos; Zacharioudakis, Emmanouil; Kitsis, Richard N.; Gavathiotis, Evripidis] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Wilf Family Cardiovasc Res Inst, Dept Med, Bronx, NY 10467 USA; [Baloh, Robert H.] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA; [Kitsis, Richard N.] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Wilf Family Cardiovasc Res Inst, Dept Cell Biol, Bronx, NY 10467 USA; [Kitsis, Richard N.] Albert Einstein Coll Med, Einstein Mt Sinai Diabet Res Ctr, Bronx, NY 10467 USA; [Mochly-Rosen, Daria] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Washington University (WUSTL); Washington University (WUSTL); Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Cedars Sinai Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Stanford University	Dorn, GW (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.	gdorn@wustl.edu	Franco, Antonietta/AAP-5515-2021; Janetka, James/A-8216-2011	Janetka, James/0000-0002-9888-5411; G Rocha, PhD, Agostinho/0000-0001-7134-7376; Gavathiotis, Evripidis/0000-0001-6319-8331; Biris, Nikolaos/0000-0003-4055-5521; Mochly-Rosen, Daria/0000-0002-6691-8733; Franco, Antonietta/0000-0002-5487-1800; Knight, William/0000-0002-1481-676X; Baloh, Robert/0000-0002-0100-8376	NIH [R35HL135736, R01HL128071, R01CA178394, P30CA013330]; McDonnell Center for Cellular and Molecular Neurobiology postdoctoral fellowship; National Center for Advancing Translational Sciences [UL1TR000448, NIGMSP41, GM103422, NCIP30 CA091842]; NATIONAL CANCER INSTITUTE [R01CA178394, P30CA013330, P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, UL1TR002345] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL135736, R01HL128071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Center for Cellular and Molecular Neurobiology postdoctoral fellowship; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R35HL135736 (G.W.D.), R01HL128071 (R.N.K. and G.W.D.), and R01CA178394 and P30CA013330 (E.G.); a McDonnell Center for Cellular and Molecular Neurobiology postdoctoral fellowship (A.F.); and the Washington University Proteomics Shared Resource, supported by National Center for Advancing Translational Sciences grants UL1TR000448, NIGMSP41, GM103422, and NCIP30 CA091842. G.W.D. is the Philip and Sima K. Needleman-endowed professor.	Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Bombelli F, 2014, JAMA NEUROL, V71, P1036, DOI 10.1001/jamaneurol.2014.629; Casasnovas C, 2010, J MED GENET, V47, P249, DOI 10.1136/jmg.2009.072488; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Chung KW, 2006, BRAIN, V129, P2103, DOI 10.1093/brain/awl174; Franco A, 2016, NATURE, V540, P74, DOI 10.1038/nature20156; Gong GH, 2015, SCIENCE, V350, DOI 10.1126/science.aad2459; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306; Lawson VH, 2005, NEUROLOGY, V65, P197, DOI 10.1212/01.wnl.0000168898.76071.70; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Misko AL, 2012, J NEUROSCI, V32, P4145, DOI 10.1523/JNEUROSCI.6338-11.2012; Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126; Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013	16	119	129	4	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2018	360	6386					336	341		10.1126/science.aao1785	http://dx.doi.org/10.1126/science.aao1785			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD3IC	29674596	Green Accepted			2022-12-28	WOS:000430396600049
J	Frum, T; Ralston, A				Frum, Tristan; Ralston, Amy			AttrActin' Attention to Early Mouse Development	CELL			English	Editorial Material							EMBRYO	A new study by Zenker et al. uses time-lapse imaging to discover how dynamic actin movements contribute to epithelialization of living mouse embryos. Together with work from other labs, this study presents exciting new ways to think about the emergence of cell fates during mammalian development.	[Frum, Tristan; Ralston, Amy] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University	Ralston, A (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	aralston@msu.edu		Ralston, Amy/0000-0003-3755-8262; FRUM, Tristan/0000-0003-3452-8762	NIH [R01 GM104009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104009] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in A.R. lab is supported by NIH R01 GM104009.	Anani S, 2014, DEVELOPMENT, V141, P2813, DOI 10.1242/dev.107276; Eckert JJ, 2015, ADV EXP MED BIOL, V843, P1, DOI 10.1007/978-1-4939-2480-6_1; Galea GL, 2017, P NATL ACAD SCI USA, V114, pE5177, DOI 10.1073/pnas.1700934114; Jacinto A, 2000, CURR BIOL, V10, P1420, DOI 10.1016/S0960-9822(00)00796-X; Korotkevich E, 2017, DEV CELL, V40, P235, DOI 10.1016/j.devcel.2017.01.006; Maitre JL, 2016, NATURE, V536, P344, DOI 10.1038/nature18958; Nowotschin Sonja, 2014, Methods Mol Biol, V1092, P405, DOI 10.1007/978-1-60327-292-6_24; Samarage CR, 2015, DEV CELL, V34, P435, DOI 10.1016/j.devcel.2015.07.004; Zenker J, 2018, CELL, V173, P776, DOI 10.1016/j.cell.2018.02.035	9	0	0	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2018	173	3					543	545		10.1016/j.cell.2018.03.078	http://dx.doi.org/10.1016/j.cell.2018.03.078			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7GB	29677506	Bronze			2022-12-28	WOS:000430677400005
J	Kiel, DP				Kiel, Douglas P.			Review: In community-dwelling older adults, calcium and vitamin D, alone or combined, do not reduce fractures	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							D SUPPLEMENTATION; OSTEOPOROSIS		[Kiel, Douglas P.] Harvard Med Sch, Inst Aging Res, Hebrew Senior Life, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Hebrew SeniorLife	Kiel, DP (corresponding author), Harvard Med Sch, Inst Aging Res, Hebrew Senior Life, Boston, MA 02115 USA.							Abrahamsen B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5463; Avenell A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub4; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; Duque G, 2016, J AM MED DIR ASSOC, V17, P852, DOI 10.1016/j.jamda.2016.05.011; Kahwati LC, 2017, AHRQ PUBLICATION; Prentice RL, 2013, OSTEOPOROSIS INT, V24, P567, DOI 10.1007/s00198-012-2224-2; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Weaver CM, 2016, OSTEOPOROSIS INT, V27, P367, DOI 10.1007/s00198-015-3386-5	8	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2018	168	8					JC44	JC44		10.7326/ACPJC-2018-168-8-044	http://dx.doi.org/10.7326/ACPJC-2018-168-8-044			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GC8XZ	29677251				2022-12-28	WOS:000430083100009
J	Kaltenboeck, A; Bach, PB				Kaltenboeck, Anna; Bach, Peter B.			Value-Based Pricing for Drugs Theme and Variations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kaltenboeck, Anna; Bach, Peter B.] Mem Sloan Kettering Canc Ctr, Ctr Hlth Policy & Outcomes, 1275 York Ave, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Kaltenboeck, A (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Hlth Policy & Outcomes, 1275 York Ave, New York, NY 10065 USA.	kaltenba@mskcc.org			Laura and John Arnold Foundation; Kaiser Permanente	Laura and John Arnold Foundation; Kaiser Permanente	Support for the activities of the Drug Pricing Lab is provided by grants from the Laura and John Arnold Foundation and Kaiser Permanente.	Bach PB, 2015, JAMA-J AM MED ASSOC, V314, P2503, DOI 10.1001/jama.2015.16843; Bach PB, 2014, JAMA-J AM MED ASSOC, V312, P1629, DOI 10.1001/jama.2014.13235; Choudhry NK, 2010, HEALTH AFFAIR, V29, P1995, DOI 10.1377/hlthaff.2010.0336; Gottlieb S., 2018, AM HLTH INS PLANS AH; Mailankody S, ANN INTERN MED, DOI 10.73261M18-0539; Silverman E., STATNEWS	6	46	46	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2018	319	21					2165	2166		10.1001/jama.2018.4871	http://dx.doi.org/10.1001/jama.2018.4871			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI1MA	29710320				2022-12-28	WOS:000434133400009
J	Kerlikowske, K; Scott, CG; Mahmoudzadeh, AP; Ma, L; Winham, S; Jensen, MR; Wu, FF; Malkov, S; Pankratz, VS; Cummings, SR; Shepherd, JA; Brandt, KR; Miglioretti, DL; Vachon, CM				Kerlikowske, Karla; Scott, Christopher G.; Mahmoudzadeh, Amir P.; Ma, Lin; Winham, Stacey; Jensen, Matthew R.; Wu, Fang Fang; Malkov, Serghei; Pankratz, V. Shane; Cummings, Steven R.; Shepherd, John A.; Brandt, Kathleen R.; Miglioretti, Diana L.; Vachon, Celine M.			Automated and Clinical Breast Imaging Reporting and Data System Density Measures Predict Risk for Screen-Detected and Interval Cancers A Case-Control Study	ANNALS OF INTERNAL MEDICINE			English	Article							MAMMOGRAPHIC DENSITY; BI-RADS; SURVEILLANCE CONSORTIUM; DIGITAL MAMMOGRAPHY; COHORT; WOMEN; PERFORMANCE; TOMOSYNTHESIS; EPIDEMIOLOGY; RADIOLOGISTS	Background: In 30 states, women who have had screening mammography are informed of their breast density on the basis of Breast Imaging Reporting and Data System (BI-RADS) density categories estimated subjectively by radiologists. Variation in these clinical categories across and within radiologists has led to discussion about whether automated BI-RADS density should be reported instead. Objective: To determine whether breast cancer risk and detection are similar for automated and clinical BI-RADS density measures. Design: Case-control. Setting: San Francisco Mammography Registry and Mayo Clinic. Participants: 1609 women with screen-detected cancer, 351 women with interval invasive cancer, and 4409 matched control participants. Measurements: Automated and clinical BI-RADS density assessed on digital mammography at 2 time points from September 2006 to October 2014, interval and screen-detected breast cancer risk, and mammography sensitivity. Results: Of women whose breast density was categorized by automated BI-RADS more than 6 months to 5 years before diagnosis, those with extremely dense breasts had a 5.65-fold higher interval cancer risk (95% CI, 3.33 to 9.60) and a 1.43-fold higher screen-detected risk (CI, 1.14 to 1.79) than those with scattered fibroglandular densities. Associations of interval and screen-detected cancer with clinical BI-RADS density were similar to those with automated BI-RADS density, regardless of whether density was measured more than 6 months to less than 2 years or 2 to 5 years before diagnosis. Automated and clinical BI-RADS density measures had similar discriminatory accuracy, which was higher for interval than screen-detected cancer (c-statistics: 0.70 vs. 0.62 [P < 0.001] and 0.72 vs. 0.62 [P < 0.001], respectively). Mammography sensitivity was similar for automated and clinical BI-RADS categories: fatty, 93% versus 92%; scattered fibroglandular densities, 90% versus 90%; heterogeneously dense, 82% versus 78%; and extremely dense, 63% versus 64%, respectively. Limitation: Neither automated nor clinical BI-RADS density was assessed on tomosynthesis, an emerging breast screening method. Conclusion: Automated and clinical BI-RADS density similarly predict interval and screen-detected cancer risk, suggesting that either measure may be used to inform women of their breast density.	[Kerlikowske, Karla; Mahmoudzadeh, Amir P.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Scott, Christopher G.; Winham, Stacey; Jensen, Matthew R.; Wu, Fang Fang; Brandt, Kathleen R.; Vachon, Celine M.] Mayo Clin, Coll Med, Rochester, MN USA; [Ma, Lin] Kaiser Permanente Div Res, 2000 Broadway, Oakland, CA 94612 USA; [Malkov, Serghei] Appl Mat Inc, 3100 Bowers Ave, Santa Clara, CA 95054 USA; [Pankratz, V. Shane] Univ New Mexico, Albuquerque, NM 87131 USA; [Cummings, Steven R.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; [Shepherd, John A.] Univ Hawaii, Canc Ctr, 701 Ilalo St,Suite 431, Honolulu, HI 96813 USA; [Miglioretti, Diana L.] Univ Calif Davis, Davis, CA 95616 USA; [Miglioretti, Diana L.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA; [Kerlikowske, Karla] San Francisco VA Med Ctr, Gen Internal Med Sect, 111A1,4150 Clement St, San Francisco, CA 94121 USA; [Scott, Christopher G.; Winham, Stacey; Jensen, Matthew R.; Wu, Fang Fang; Brandt, Kathleen R.; Vachon, Celine M.] 200 First St Southwest, Rochester, MN 55905 USA; [Mahmoudzadeh, Amir P.] 1 Irving St,Suite AC109, San Francisco, CA 94143 USA; [Pankratz, V. Shane] MSC 04-2785,1 Univ New Mexico, Albuquerque, NM 87131 USA; [Cummings, Steven R.] Mission Hall,Box 0560,550 16th St,2nd Floor, San Francisco, CA 94143 USA; [Miglioretti, Diana L.] One Shields Ave,Med Sci 1C,Room 144, Davis, CA 95616 USA	University of California System; University of California San Francisco; Mayo Clinic; Kaiser Permanente; Applied Materials Inc; University of New Mexico; California Pacific Medical Center; California Pacific Medical Center Research Institute; Cancer Research Center of Hawaii; University of Hawaii System; University of California System; University of California Davis; Kaiser Permanente; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Kerlikowske, K (corresponding author), San Francisco VA Med Ctr, Gen Internal Med Sect, 111A1,4150 Clement St, San Francisco, CA 94121 USA.	Karla.Kerlikowske@ucsf.edu; scott.christopher@mayo.edu	Shepherd, John/S-3146-2018	Shepherd, John/0000-0003-2280-2541; Ma, Lin/0000-0002-7009-8213	National Institutes of Health, National Cancer Institute. [R01 CA177150, P01 2CA154292, R01 CA207085]; NATIONAL CANCER INSTITUTE [R01CA177150, P01CA154292, P30CA093373] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	In part by grants R01 CA177150, P01 2CA154292, and R01 CA207085 from the National Institutes of Health, National Cancer Institute.	Alonzo-Proulx O, 2015, RADIOLOGY, V275, P366, DOI 10.1148/radiol.15141686; American College of Radiology, 2013, AM COLL RAD BREAST I, V5; BallardBarbash R, 1997, AM J ROENTGENOL, V169, P1001, DOI 10.2214/ajr.169.4.9308451; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Boyd Norman F, 2014, Breast Cancer Res, V16, P417, DOI 10.1186/s13058-014-0417-7; Brandt KR, 2016, RADIOLOGY, V279, P710, DOI 10.1148/radiol.2015151261; Conant EF, 2016, BREAST CANCER RES TR, V156, P109, DOI 10.1007/s10549-016-3695-1; Cuzick J, 2004, JNCI-J NATL CANCER I, V96, P621, DOI 10.1093/jnci/djh106; DenseBreast-info, 2018, DENS BREAST TISS DEN; Destounis S, 2017, AM J ROENTGENOL, V208, P222, DOI 10.2214/AJR.16.16489; Ekpo EU, 2016, AM J ROENTGENOL, V206, P1119, DOI 10.2214/AJR.15.15049; Engmann NJ, 2017, JAMA ONCOL, V3, P1228, DOI 10.1001/jamaoncol.2016.6326; Garcia E, 2017, EUR J RADIOL, V93, P121, DOI 10.1016/j.ejrad.2017.05.033; Gard CC, 2015, BREAST J, V21, P481, DOI 10.1111/tbj.12443; Henderson LM, 2015, CANCER CAUSE CONTROL, V26, P1495, DOI 10.1007/s10552-015-0631-3; Houssami N, 2017, NPJ BREAST CANCER, V3, DOI 10.1038/s41523-017-0014-x; Jeffers AM, 2017, RADIOLOGY, V282, P348, DOI 10.1148/radiol.2016152062; Kerlikowske K, 2015, ANN INTERN MED, V162, P673, DOI 10.7326/M14-1465; Kerlikowske K, 2010, J CLIN ONCOL, V28, P3830, DOI 10.1200/JCO.2009.26.4770; Krishnan K, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0722-4; Lehman CD, 2017, RADIOLOGY, V283, P49, DOI 10.1148/radiol.2016161174; Machida Y, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2519-4; McCarthy AM, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw104; Melnikow J, 2016, ANN INTERN MED, V164, P268, DOI 10.7326/M15-1789; Spayne MC, 2012, BREAST J, V18, P326, DOI 10.1111/j.1524-4741.2012.01250.x; Sprague BL, 2016, ANN INTERN MED, V165, P457, DOI 10.7326/M15-2934; Sprague BL, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju255; St Sauver JL, 2012, INT J EPIDEMIOL, V41, P1614, DOI 10.1093/ije/dys195; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; Tice JA, 2015, J CLIN ONCOL, V33, P3137, DOI 10.1200/JCO.2015.60.8869; Trentham-Dietz A, 2016, ANN INTERN MED, V165, P700, DOI 10.7326/M16-0476; Volpara Solutions, 2017, VOLP DENS US MAN VER; Wanders JOP, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0859-9; Wanders JOP, 2017, BREAST CANCER RES TR, V162, P95, DOI 10.1007/s10549-016-4090-7	34	45	46	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2018	168	11					757	+		10.7326/M17-3008	http://dx.doi.org/10.7326/M17-3008			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3EK	29710124	Green Accepted			2022-12-28	WOS:000434254100002
J	Zuccotti, G; Samal, L; Maloney, FL; Ai, A; Wright, A				Zuccotti, Gianna; Samal, Lipika; Maloney, Francine L.; Ai, Angela; Wright, Adam			The Need for Closed-Loop Systems for Management of Abnormal Test Results	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							FOLLOW-UP; COMMUNICATION; DELAYS		[Zuccotti, Gianna; Samal, Lipika; Wright, Adam] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA; [Zuccotti, Gianna; Samal, Lipika; Wright, Adam] Partners HealthCare, Boston, MA USA; [Maloney, Francine L.] Brigham & Womens Hosp, Ariadne Labs, Boston, MA USA; [Maloney, Francine L.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Ai, Angela] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA; [Zuccotti, Gianna] Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA; [Samal, Lipika; Ai, Angela; Wright, Adam] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 1620 Tremont St, Boston, MA 02120 USA; [Maloney, Francine L.] Ariadne Labs, 401 Pk Dr,Third Floor East, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Partners Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Zuccotti, G (corresponding author), Partners eCare, Partners Healthcare Syst, 399 Revolution Dr,Suite 1065, Somerville, MA 02145 USA.	gzuccotti@partners.org			Partners-Siemens Research Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK097187] Funding Source: NIH RePORTER	Partners-Siemens Research Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By the Partners-Siemens Research Council.	Callen JL, 2012, J GEN INTERN MED, V27, P1334, DOI 10.1007/s11606-011-1949-5; Giardina TD, 2013, HEALTH AFFAIR, V32, P1368, DOI 10.1377/hlthaff.2013.0130; Lin JJ, 2006, AM J MED QUAL, V21, P178, DOI 10.1177/1062860605285049; Murphy DR, 2015, J CLIN ONCOL, V33, P3560, DOI 10.1200/JCO.2015.61.1301; O'Connor SD, 2016, J AM MED INFORM ASSN, V23, P333, DOI 10.1093/jamia/ocv105; Pillemer F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154743; Poon EG, 2004, ARCH INTERN MED, V164, P2223, DOI 10.1001/archinte.164.20.2223; Singh H, 2007, J AM MED INFORM ASSN, V14, P459, DOI 10.1197/jamia.M2280; Singh H, 2009, ARCH INTERN MED, V169, P1578, DOI 10.1001/archinternmed.2009.263; Wahls TL, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-32	10	5	5	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2018	168	11					820	+		10.7326/M17-2425	http://dx.doi.org/10.7326/M17-2425			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI3EK	29710065				2022-12-28	WOS:000434254100011
J	Balestrieri, C; Alfarano, G; Milan, M; Tosi, V; Prosperini, E; Nicoli, P; Palamidessi, A; Scita, G; Diaferia, GR; Natoli, G				Balestrieri, Chiara; Alfarano, Gabriele; Milan, Marta; Tosi, Valentina; Prosperini, Elena; Nicoli, Paola; Palamidessi, Andrea; Scita, Giorgio; Diaferia, Giuseppe R.; Natoli, Gioacchino			Co-optation of Tandem DNA Repeats for the Maintenance of Mesenchymal Identity	CELL			English	Article							TRANSCRIPTION FACTOR-BINDING; EPIDERMAL PROGENITOR CELLS; GENE-EXPRESSION; CANCER-CELLS; STEM-CELLS; PCR PRIMER; RNA-SEQ; EMT; EVOLUTION; ZEB1	Tandem repeats (TRs) are generated by DNA replication errors and retain a high level of instability, which in principle would make them unsuitable for integration into gene regulatory networks. However, the appearance of DNA sequence motifs recognized by transcription factors may turn TRs into functional cis-regulatory elements, thus favoring their stabilization in genomes. Here, we show that, in human cells, the transcriptional repressor ZEB1, which promotes the maintenance of mesenchymal features largely by suppressing epithelial genes and microRNAs, occupies TRs harboring dozens of copies of its DNA-binding motif within genomic loci relevant for maintenance of epithelial identity. The deletion of one such TR caused quasi-mesenchymal cancer cells to reacquire epithelial features, partially recapitulating the effects of ZEB1 gene deletion. These data demonstrate that the high density of identical motifs in TRs can make them suitable platforms for recruitment of transcriptional repressors, thus promoting their exaptation into pre-existing cis-regulatory networks.	[Balestrieri, Chiara; Alfarano, Gabriele; Milan, Marta; Tosi, Valentina; Nicoli, Paola; Diaferia, Giuseppe R.] European Inst Oncol IEO, Dept Expt Oncol, Via Adamello 16, I-20139 Milan, Italy; [Prosperini, Elena; Natoli, Gioacchino] Humanitas Clin & Res Ctr, Via Manzoni 56, I-20089 Milan, Italy; [Palamidessi, Andrea; Scita, Giorgio] FIRC Inst Mol Oncol, IFOM, Via Adamello 16, I-20139 Milan, Italy; [Scita, Giorgio] Univ Milan, Dept Oncol & Hematooncol, I-20122 Milan, Italy; [Balestrieri, Chiara; Alfarano, Gabriele; Milan, Marta; Diaferia, Giuseppe R.; Natoli, Gioacchino] Humanitas Univ, Via Rita Levi Montalcini 4, I-20090 Milan, Italy	IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; University of Milan; Humanitas University	Diaferia, GR (corresponding author), European Inst Oncol IEO, Dept Expt Oncol, Via Adamello 16, I-20139 Milan, Italy.; Natoli, G (corresponding author), Humanitas Clin & Res Ctr, Via Manzoni 56, I-20089 Milan, Italy.; Diaferia, GR; Natoli, G (corresponding author), Humanitas Univ, Via Rita Levi Montalcini 4, I-20090 Milan, Italy.	giuseppe.diaferia@humanitasresearch.it; gioacchino.natoli@hunimed.eu	Diaferia, Giuseppe/AAN-5910-2020; PROSPERINI, ELENA/AAB-1952-2021; Alfarano, Gabriele/AAA-9595-2021; Nicoli, Paola/AAR-1878-2020; Palamidessi, Andrea/F-1203-2018; Natoli, gioacchino/J-2100-2018; Natoli, gioacchino/ABB-8679-2020	Diaferia, Giuseppe/0000-0003-4022-8483; Alfarano, Gabriele/0000-0002-5441-6904; Milan, Marta/0000-0003-1231-0586; Natoli, Gioacchino/0000-0003-0711-2411; palamidessi, andrea/0000-0002-7134-7023; Balestrieri, Chiara/0000-0001-7362-3530	Italian Association for Research on Cancer (AIRC IG grant) [20251, 11672]; Umberto Veronesi Foundation (FUV)	Italian Association for Research on Cancer (AIRC IG grant); Umberto Veronesi Foundation (FUV)(Fondazione Umberto Veronesi)	This project was supported by the Italian Association for Research on Cancer (AIRC IG grant 20251 and 11672 to G.N.). G.R.D. and M.M. received fellowships from the Umberto Veronesi Foundation (FUV). We thank B. Amati and S. Monticelli for critical comments on the manuscript; L. Rotta, T. Capra, and S. Bianchi (IEO and IIT Center for Genomic Sciences) for processing of NGS libraries; and I. Costa and F. Casagrande (Cogentech) for help in confocal and time-lapse experiments.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barozzi I, 2014, MOL CELL, V54, P844, DOI 10.1016/j.molcel.2014.04.006; Bennett ST, 1996, ANNU REV GENET, V30, P343, DOI 10.1146/annurev.genet.30.1.343; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Bracken CP, 2014, EMBO J, V33, P2040, DOI 10.15252/embj.201488641; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chuong EB, 2017, NAT REV GENET, V18, P71, DOI 10.1038/nrg.2016.139; Chuong EB, 2016, SCIENCE, V351, P1083, DOI 10.1126/science.aad5497; Curina A, 2017, GENE DEV, V31, P399, DOI 10.1101/gad.293134.116; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Diaferia GR, 2016, EMBO J, V35, P595, DOI 10.15252/embj.201592404; Diaferia GR, 2013, DEVELOPMENT, V140, P3360, DOI 10.1242/dev.098533; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Furusawa T, 1999, MOL CELL BIOL, V19, P8581; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Gertz J, 2013, MOL CELL, V52, P25, DOI 10.1016/j.molcel.2013.08.037; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Gymrek M, 2016, NAT GENET, V48, P22, DOI 10.1038/ng.3461; Hasuwa H, 2013, SCIENCE, V341, P71, DOI 10.1126/science.1237999; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Jacques PE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003504; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee B, 2014, DEV CELL, V29, P47, DOI 10.1016/j.devcel.2014.03.005; Legendre M, 2007, GENOME RES, V17, P1787, DOI 10.1101/gr.6554007; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liu T, 2014, METHODS MOL BIOL, V1150, P81, DOI 10.1007/978-1-4939-0512-6_4; Loo JM, 2015, CELL, V160, P393, DOI 10.1016/j.cell.2014.12.018; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martin P, 2005, P NATL ACAD SCI USA, V102, P3800, DOI 10.1073/pnas.0406805102; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mistry DS, 2014, STEM CELLS, V32, P3209, DOI 10.1002/stem.1809; Montagner S, 2016, CELL REP, V15, P1566, DOI 10.1016/j.celrep.2016.04.044; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pattyn F, 2003, NUCLEIC ACIDS RES, V31, P122, DOI 10.1093/nar/gkg011; Pham H, 2016, METHODS MOL BIOL, V1358, P43, DOI 10.1007/978-1-4939-3067-8_3; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073; Reynolds N, 2013, DEVELOPMENT, V140, P505, DOI 10.1242/dev.083105; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; S muc T., 2011, PLOS ONE, V6; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Sanchez-Tillo E, 2012, CELL MOL LIFE SCI, V69, P3429, DOI 10.1007/s00018-012-1122-2; Saunders LR, 2014, DEVELOPMENT, V141, P1503, DOI 10.1242/dev.101436; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Singh S, 2016, ELIFE, V5, DOI [10.7554/elife.12717, 10.7554/eLife.12717]; Sipos B, 2003, VIRCHOWS ARCH, V442, P444, DOI 10.1007/s00428-003-0784-4; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; STERN A, 1986, CELL, V47, P61, DOI 10.1016/0092-8674(86)90366-1; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trumbach D, 2015, CELL TISSUE RES, V359, P161, DOI 10.1007/s00441-014-1911-z; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Villar D, 2015, CELL, V160, P554, DOI 10.1016/j.cell.2015.01.006; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; WEISER JN, 1989, CELL, V59, P657, DOI 10.1016/0092-8674(89)90011-1; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yogev S, 2014, ANNU REV CELL DEV BI, V30, P417, DOI 10.1146/annurev-cellbio-100913-012953; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	75	19	19	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 17	2018	173	5					1150	+		10.1016/j.cell.2018.03.081	http://dx.doi.org/10.1016/j.cell.2018.03.081			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GG1UA	29706544	Green Submitted, Bronze			2022-12-28	WOS:000432471700012
J	Manrai, AK; Patel, CJ; Ioannidis, JPA				Manrai, Arjun K.; Patel, Chirag J.; Ioannidis, John P. A.			In the Era of Precision Medicine and Big Data, Who Is Normal?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Manrai, Arjun K.; Patel, Chirag J.] Harvard Med Sch, Dept Biomed Informat, Boston, MA USA; [Ioannidis, John P. A.] Stanford Univ, Stanford Prevent Res Ctr, Med Sch Off Bldg,1265 Welch Rd, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Metares Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA	Harvard University; Harvard Medical School; Stanford University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Univ, Stanford Prevent Res Ctr, Med Sch Off Bldg,1265 Welch Rd, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011	Manrai, Arjun/0000-0001-9657-9800; Ioannidis, John P./0000-0003-3118-6859	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL138259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES023504] Funding Source: NIH RePORTER; NHLBI NIH HHS [K01 HL138259] Funding Source: Medline; NIEHS NIH HHS [R00 ES023504] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Centers for Disease Control and Prevention, NAT CTR HLTH STAT NA; *CLIN LAB STAND I, DEF EST VER REF INT; Ioannidis JPA, 2013, JAMA-J AM MED ASSOC, V309, P1410, DOI 10.1001/jama.2013.3150; Lacy ME, 2017, JAMA-J AM MED ASSOC, V317, P507, DOI 10.1001/jama.2016.21035; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Rotimi CN, 2010, NEW ENGL J MED, V363, P1551, DOI 10.1056/NEJMra0911564; Toward NRC, 2011, PRECISION MED BUILDI	7	53	58	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2018	319	19					1981	1982		10.1001/jama.2018.2009	http://dx.doi.org/10.1001/jama.2018.2009			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF8QV	29710130	Green Accepted			2022-12-28	WOS:000432238300012
J	Taylor, DR; Park, YS; Smith, CA; Karpinski, J; Coke, W; Tekian, A				Taylor, David R.; Park, Yoon Soo; Smith, Christopher A.; Karpinski, Jolanta; Coke, William; Tekian, Ara			Creating Entrustable Professional Activities to Assess Internal Medicine Residents in Training A Mixed-Methods Approach	ANNALS OF INTERNAL MEDICINE			English	Article							ACCREDITATION SYSTEM; REPORTING MILESTONES; COMPETENCE; EDUCATION; 21ST-CENTURY; VIEWPOINT; PROGRAMS	Background: Competency-based medical education has not advanced residency training as much as many observers expected. Some medical educators now advocate reorienting competency-based approaches to focus on a resident's ability to do authentic clinical work. Objective: To develop descriptions of clinical work for which internal medicine residents must gain proficiency to deliver meaningful patient care (for example, "Admit and manage a medical inpatient with a new acute problem"). Design: A modified Delphi process involving clinical experts followed by a conference of educational experts. Setting: The Royal College of Physicians and Surgeons of Canada. Participants: In phase 1 of the project, members of the Specialty Committee for Internal Medicine participated in a modified Delphi process to identify activities in internal medicine that represent the scope of the specialty. In phase 2 of the project, 5 experts who were scholars and leaders in competency-based medical education reviewed the results. Measurements: Phase 1 identified important activities, revised descriptions to improve accuracy and avoid overlap, and as-signed activities to stages of training. Phase 2 compared proposed activity descriptions with published guidelines for their development and application in medical education. Results: The project identified 29 activities that qualify as entrustable professional activities. The project also produced a detailed description of each activity and guidelines for using them to assess residents. Limitation: These activities reflect the practice patterns of the developers and may not fully represent internal medicine practice in Canada. Conclusion: Identification of these activities is expected to facilitate modification of training and assessment programs for medical residents so that programs focus less on isolated skills and more on integrated tasks.	[Taylor, David R.; Smith, Christopher A.] Queens Univ, Sch Med, Dept Med, 94 Stuart St, Kingston, ON K7L 3N6, Canada; [Park, Yoon Soo; Tekian, Ara] Univ Illinois, Coll Med, Dept Med Educ, 808 South Wood St, Chicago, IL 60612 USA; [Karpinski, Jolanta] Univ Ottawa, Ottawa, ON, Canada; [Karpinski, Jolanta; Coke, William] Royal Coll Phys & Surg Canada, 774 Echo Dr, Ottawa, ON K1S 5N8, Canada	Queens University - Canada; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Ottawa	Taylor, DR (corresponding author), Queens Univ, Dept Med, 94 Stuart St, Kingston, ON K7L 3N6, Canada.	taylord@queensu.ca	Park, Yoon Soo/AFK-2778-2022; Park, Yoon Soo/AAG-1098-2022	Park, Yoon Soo/0000-0001-8583-4335; Park, Yoon Soo/0000-0001-8583-4335; Taylor, David/0000-0001-9762-7878	Southeastern Ontario Academic Medical Organization Endowed Scholarship and Education Fund; Queen's University Department of Medicine Innovation Fund	Southeastern Ontario Academic Medical Organization Endowed Scholarship and Education Fund; Queen's University Department of Medicine Innovation Fund	This research was supported by grants from the Southeastern Ontario Academic Medical Organization Endowed Scholarship and Education Fund and the Queen's University Department of Medicine Innovation Fund.	Aggarwal R, 2006, NEW ENGL J MED, V355, P2695, DOI 10.1056/NEJMe068179; Caverzagie KJ, 2015, ACAD MED, V90, P479, DOI 10.1097/ACM.0000000000000564; Caverzagie KJ, 2013, ANN INTERN MED, V158, P557, DOI 10.7326/0003-4819-158-7-201304020-00593; Choe JH, 2016, ACAD MED, V91, P943, DOI 10.1097/ACM.0000000000001161; Frank JR, 2010, MED TEACH, V32, P631, DOI 10.3109/0142159X.2010.500898; Glass JM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2909; Hauer KE, 2016, ANN INTERN MED, V165, P356, DOI 10.7326/M15-2411; Hauer Karen E, 2013, J Grad Med Educ, V5, P54, DOI 10.4300/JGME-D-12-00060.1; Holmboe ES, 2016, JAMA INTERN MED, V176, P1601, DOI 10.1001/jamainternmed.2016.5556; Holmboe ES, 2010, MED TEACH, V32, P676, DOI 10.3109/0142159X.2010.500704; Huddle TS, 2007, ACAD MED, V82, P536, DOI 10.1097/ACM.0b013e3180555935; Keeney S., 2011, DELPHI TECHNIQUE NUR; Kennedy TJT, 2007, J GEN INTERN MED, V22, P1080, DOI 10.1007/s11606-007-0179-3; Kothari NK, 2014, ANN INTERN MED, V161, P760, DOI 10.7326/L14-5023; Leung WC, 2002, BRIT MED J, V325, P693, DOI 10.1136/bmj.325.7366.693; Li Su-Ting T, 2017, J Grad Med Educ, V9, P54, DOI 10.4300/JGME-D-16-00694.1; Malone K, 2012, ADV HEALTH SCI EDUC, V17, P241, DOI 10.1007/s10459-010-9247-2; Neufeld VR, 1998, ACAD MED, V73, P1133, DOI 10.1097/00001888-199811000-00010; Norman G, 2006, ADV HEALTH SCI EDUC, V11, P217, DOI 10.1007/s10459-006-0006-3; Park YS, 2016, TEACH LEARN MED, V28, P135, DOI 10.1080/10401334.2016.1146607; Royal College of Physicians and Surgeons of Canada, 2014, COMP BY DES; SABATINO F, 1991, HOSPITALS, V65, P50; Shute VJ, 2008, REV EDUC RES, V78, P153, DOI 10.3102/0034654307313795; Stillman MD, 2014, ANN INTERN MED, V160, P800, DOI 10.7326/M13-2358; Talbot M, 2004, MED EDUC, V38, P587, DOI 10.1046/j.1365-2923.2004.01794.x; Taylor DR, 2017, ACAD MED, V92, pS110, DOI 10.1097/ACM.0000000000001908; ten Cate O, 2007, ACAD MED, V82, P542, DOI 10.1097/ACM.0b013e31805559c7; ten Cate O, 2017, CLIN TEACH, V14, P385, DOI 10.1111/tct.12710; ten Cate O, 2015, MED TEACH, V37, P983, DOI 10.3109/0142159X.2015.1060308; The Accreditation Council for Graduate Medical Education and the American Board of Internal Medicine, 2015, INT MED MIL PROJ; Waggoner J, 2016, ACAD MED, V91, P663, DOI 10.1097/ACM.0000000000001092; Witteles RM, 2016, JAMA INTERN MED, V176, P1599, DOI 10.1001/jamainternmed.2016.5552; World Health Organization, 1991, CHANG MED ED AG ACT	34	14	16	2	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2018	168	10					724	+		10.7326/M17-1680	http://dx.doi.org/10.7326/M17-1680			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3DE	29710333				2022-12-28	WOS:000434250700017
J	Ghani, AC				Ghani, Azra C.			Can improving access to care help to eliminate malaria?	LANCET			English	Editorial Material							PLASMODIUM-FALCIPARUM MALARIA; RESISTANCE; AFRICA		[Ghani, Azra C.] Imperial Coll London, MRC, Ctr Global Infect Dis Anal, Dept Infect Dis Epidemiol, London W2 1PG, England	Imperial College London	Ghani, AC (corresponding author), Imperial Coll London, MRC, Ctr Global Infect Dis Anal, Dept Infect Dis Epidemiol, London W2 1PG, England.	a.ghani@imperial.ac.uk		Ghani, Azra/0000-0002-0007-4910	Bill & Melinda Gates Foundation; Medicines for Malaria Venture; Integrated Vector Control Consortium National Institutes for Health; Wellcome Trust; Global Fund; MRC [MR/R015600/1] Funding Source: UKRI	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Medicines for Malaria Venture; Integrated Vector Control Consortium National Institutes for Health; Wellcome Trust(Wellcome TrustEuropean Commission); Global Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	I have received grants from the Bill & Melinda Gates Foundation (includes epidemiological analysis and mathematical modelling of the full range of malaria interventions [existing and novel] including early diagnosis and treatment and mass drug adminstration), Medicines for Malaria Venture (focused on exploring use-case scenarios for different drug profiles, which includes early diagnosis and treatment and mass drug adminstration), Integrated Vector Control Consortium National Institutes for Health, and The Wellcome Trust, and consulting fees from The Global Fund; I am a Trustee for Malaria No More; and I have received non-financial support from WHO and Gavi for attendance at advisory meetings.	[Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Bennett A, 2017, LANCET GLOB HEALTH, V5, pE418, DOI 10.1016/s2214-109x(17)30076-1; Bousema T, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001993; Brady OJ, 2017, LANCET GLOB HEALTH, V5, pE680, DOI [10.1016/S2214-109X(17)30220-6, 10.1016/s2214-109x(17)30220-6]; Duru V, 2016, AM J TROP MED HYG, V95, P1228, DOI 10.4269/ajtmh.16-0234; Hemingway J, 2016, LANCET, V387, P1785, DOI 10.1016/S0140-6736(15)00417-1; Landier J, 2018, LANCET, V391, P1916, DOI [10.1016/S0140-6736(18)30792-X, 10.1016/s0140-6736(18)30792-x]; Mogeni P, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0887-4; Perry HB, 2014, ANNU REV PUBL HEALTH, V35, P399, DOI 10.1146/annurev-publhealth-032013-182354; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Rao VB, 2013, TRENDS PARASITOL, V29, P164, DOI 10.1016/j.pt.2013.01.005; WHO, 2015, GLOB TECHN STRAT MAL; World Health Organization, 2015, STRAT MAL EL GREAT M; World Health Organization, 2017, DEPRESSION	15	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2018	391	10133					1870	1871		10.1016/S0140-6736(18)30910-3	http://dx.doi.org/10.1016/S0140-6736(18)30910-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GF3NC	29703426	hybrid, Green Published			2022-12-28	WOS:000431861800006
J	Sun, C; Benlekbir, S; Venkatakrishnan, P; Wang, YH; Hong, SJ; Hosler, J; Tajkhorshid, E; Rubinstein, JL; Gennis, RB				Sun, Chang; Benlekbir, Samir; Venkatakrishnan, Padmaja; Wang, Yuhang; Hong, Sangjin; Hosler, Jonathan; Tajkhorshid, Emad; Rubinstein, John L.; Gennis, Robert B.			Structure of the alternative complex III in a supercomplex with cytochrome oxidase	NATURE			English	Article							ELECTRON-TRANSFER CHAIN; CRYO-EM; RHODOTHERMUS-MARINUS; BC(1) COMPLEX; SPHAEROIDES; VALIDATION; PREDICTION; MECHANISM; FEATURES; SULFUR	Alternative complex III (ACIII) is a key component of the respiratory and/or photosynthetic electron transport chains of many bacteria(1-3). Like complex III (also known as the bc(1) complex), ACIII catalyses the oxidation of membrane-bound quinol and the reduction of cytochrome c or an equivalent electron carrier. However, the two complexes have no structural similarity(4-7). Although ACIII has eluded structural characterization, several of its subunits are known to be homologous to members of the complex iron- sulfur molybdoenzyme (CISM) superfamily(8), including the proton pump polysulfide reductase(9,10). We isolated the ACIII from Flavobacterium johnsoniae with native lipids using styrene maleic acid copolymer(11-14), both as an independent enzyme and as a functional 1:1 supercomplex with an aa(3)-type cytochrome c oxidase (cyt aa(3)). We determined the structure of ACIII to 3.4 angstrom resolution by cryo-electron microscopy and constructed an atomic model for its six subunits. The structure, which contains a [3Fe-4S] cluster, a [4Fe-4S] cluster and six haem c units, shows that ACIII uses known elements from other electron transport complexes arranged in a previously unknown manner. Modelling of the cyt aa3 component of the supercomplex revealed that it is structurally modified to facilitate association with ACIII, illustrating the importance of the supercomplex in this electron transport chain. The structure also resolves two of the subunits of ACIII that are anchored to the lipid bilayer with N-terminal triacylated cysteine residues, an important post-translational modification found in numerous prokaryotic membrane proteins that has not previously been observed structurally in a lipid bilayer.	[Sun, Chang; Venkatakrishnan, Padmaja; Wang, Yuhang; Hong, Sangjin; Tajkhorshid, Emad; Gennis, Robert B.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Sun, Chang; Wang, Yuhang; Tajkhorshid, Emad] Univ Illinois, Beckman Inst Adv Sci & Technol, Ctr Macromol Modeling & Bioinformat, NIH, Urbana, IL 61801 USA; [Benlekbir, Samir; Rubinstein, John L.] Hosp Sick Children, Res Inst, Mol Med Program, Toronto, ON, Canada; [Wang, Yuhang; Tajkhorshid, Emad] Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA; [Hosler, Jonathan] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; [Rubinstein, John L.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Rubinstein, John L.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Venkatakrishnan, Padmaja] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA	University of Illinois System; University of Illinois Urbana-Champaign; National Institutes of Health (NIH) - USA; University of Illinois System; University of Illinois Urbana-Champaign; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Illinois System; University of Illinois Urbana-Champaign; University of Mississippi; University of Mississippi Medical Center; University of Toronto; University of Toronto; University of California System; University of California Davis	Tajkhorshid, E; Gennis, RB (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.; Tajkhorshid, E (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Ctr Macromol Modeling & Bioinformat, NIH, Urbana, IL 61801 USA.; Rubinstein, JL (corresponding author), Hosp Sick Children, Res Inst, Mol Med Program, Toronto, ON, Canada.; Tajkhorshid, E (corresponding author), Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA.; Rubinstein, JL (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.; Rubinstein, JL (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.	emad@life.illinois.edu; john.rubinstein@utoronto.ca; r-gennis@illinois.edu	Wang, Yuhang/AAH-4816-2019; Tajkhorshid, Emad/AAN-8323-2021; Sun, Chang/AAJ-5983-2020	Wang, Yuhang/0000-0003-3715-8349; Sun, Chang/0000-0001-6070-5545	National Institutes of Health [R01-HL016101, P41-GM104601, U54-GM087519, R01-GM123455]; Canadian Institutes of Health Research [MOP-81294]; Canada Research Chairs program; Simons Foundation [349247]; National Institute of General Medical Sciences [P41-GM103310, S10-OD019994]; National Science Foundation [OCI-0725070, ACI-1238993, ACI-1548562]; State of Illinois; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM104601, R01GM123455, U54GM087519, P41GM103310] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD019994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs); Simons Foundation; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); State of Illinois; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by funds from the National Institutes of Health (R01-HL016101 to R.B.G.; P41-GM104601, U54-GM087519 and R01-GM123455 to E.T.) and Canadian Institutes of Health Research (MOP-81294 to J.L.R.); J.L.R. was supported by the Canada Research Chairs program. Some of this work was performed at the Simons Electron Microscopy Center and National Resource for Automated Molecular Microscopy, supported by grants from the Simons Foundation (349247), and the National Institute of General Medical Sciences (P41-GM103310, S10-OD019994). Molecular dynamics simulations were performed at Blue Waters (ACI-1713784 to E.T.) and XSEDE (TG-MCA06N060 to E.T.). Blue Waters is supported by the National Science Foundation (OCI-0725070 and ACI-1238993) and the State of Illinois. XSEDE is supported by the National Science Foundation (ACI-1548562). We thank M. McBride for providing us with the Flavobacterium johnsoniae UW101 strain, B. Carragher and C. Potter for facilitating access to the Titan Krios, Z. Zhang for collecting data, and M. Mazhab-Jafari for advice on building atomic models.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen M.P., 1991, COMPUTER SIMULATION; Autenrieth F, 2004, J COMPUT CHEM, V25, P1613, DOI 10.1002/jcc.20079; Autenrieth F, 2004, J PHYS CHEM B, V108, P20376, DOI 10.1021/jp047994q; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Bell AJ, 2015, J BIOL CHEM, V290, P18429, DOI 10.1074/jbc.M115.663872; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; BOWYER JR, 1979, FEBS LETT, V101, P207, DOI 10.1016/0014-5793(79)81327-7; Carrell CJ, 2007, BIOCHEMISTRY-US, V46, P1900, DOI 10.1021/bi0619674; Carvalho ATP, 2015, J CHEM INF MODEL, V55, P1508, DOI 10.1021/acs.jcim.5b00390; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Dietrich V, 2002, EUR J BIOCHEM, V269, P1086, DOI 10.1046/j.0014-2956.2001.02662.x; Dorr JM, 2016, EUR BIOPHYS J BIOPHY, V45, P3, DOI 10.1007/s00249-015-1093-y; Dorr JM, 2014, P NATL ACAD SCI USA, V111, P18607, DOI 10.1073/pnas.1416205112; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Dutton P L, 1978, Methods Enzymol, V54, P411; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FLETCHER R, 1964, COMPUT J, V7, P149, DOI 10.1093/comjnl/7.2.149; FULTZ ML, 1982, ANAL CHIM ACTA, V140, P1, DOI 10.1016/S0003-2670(01)95447-9; Gao XL, 2010, BIOCHEMISTRY-US, V49, P6670, DOI 10.1021/bi100858k; Gao XL, 2009, FEBS LETT, V583, P3275, DOI 10.1016/j.febslet.2009.09.022; Graf S, 2016, SCI REP-UK, V6, DOI 10.1038/srep34098; Hedderich R, 1998, FEMS MICROBIOL REV, V22, P353, DOI 10.1111/j.1574-6976.1998.tb00376.x; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jormakka M, 2008, NAT STRUCT MOL BIOL, V15, P730, DOI 10.1038/nsmb.1434; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kao WC, 2016, BBA-BIOENERGETICS, V1857, P1705, DOI 10.1016/j.bbabio.2016.07.009; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Madden TL, 1996, METHOD ENZYMOL, V266, P131; Majumder ELW, 2013, BBA-BIOENERGETICS, V1827, P1383, DOI 10.1016/j.bbabio.2013.01.008; Marr CR, 2014, J STRUCT BIOL, V185, P42, DOI 10.1016/j.jsb.2013.11.002; McBride MJ, 1996, APPL ENVIRON MICROB, V62, P3017, DOI 10.1128/AEM.62.8.3017-3022.1996; MINGHETTI KC, 1992, BIOCHEMISTRY-US, V31, P6917, DOI 10.1021/bi00145a008; Ouyang HL, 2012, BIOCHEMISTRY-US, V51, P7290, DOI 10.1021/bi3006847; Parmar M, 2018, BBA-BIOMEMBRANES, V1860, P378, DOI 10.1016/j.bbamem.2017.10.005; Pereira MM, 2007, FEBS LETT, V581, P4831, DOI 10.1016/j.febslet.2007.09.008; Pereira MM, 1999, BIOCHEMISTRY-US, V38, P1268, DOI 10.1021/bi9818063; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Postis V, 2015, BBA-BIOMEMBRANES, V1848, P496, DOI 10.1016/j.bbamem.2014.10.018; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Ragan C, 1987, MITOCHONDRIA PRACTIC; Refojo PN, 2013, BBA-BIOENERGETICS, V1827, P1378, DOI 10.1016/j.bbabio.2013.01.001; Refojo PN, 2012, BBA-BIOENERGETICS, V1817, P1852, DOI 10.1016/j.bbabio.2012.05.003; Refojo PN, 2010, BBA-BIOENERGETICS, V1797, P1869, DOI 10.1016/j.bbabio.2010.04.012; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singharoy A., 2016, ELIFE, V5, P61; Sousa J. S., NAT COMMUN IN PRESS; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Sun W, 2006, SPRINGER SER OPTIM A, V1, P1, DOI 10.1007/b106451; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; Tivol WF, 2008, MICROSC MICROANAL, V14, P375, DOI 10.1017/S1431927608080781; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Yanyushin MF, 2005, BIOCHEMISTRY-US, V44, P10037, DOI 10.1021/bi047267l; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	66	141	143	6	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2018	557	7703					123	+		10.1038/s41586-018-0061-y	http://dx.doi.org/10.1038/s41586-018-0061-y			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5BW	29695868	Green Accepted			2022-12-28	WOS:000431234500042
J	Grossman, DC; Curry, SJ; Owens, DK; Barry, M; Caughey, AB; Davidson, KW; Doubeni, CA; Epling, JW; Kemper, AR; Krist, AH; Kubik, M; Landefeld, S; Mangione, CM; Pignone, M; Silverstein, M; Simon, MA; Tseng, CW				Grossman, David C.; Curry, Susan J.; Owens, Douglas K.; Barry, Michael; Caughey, Aaron B.; Davidson, Karina W.; Doubeni, Chyke A.; Epling, John W., Jr.; Kemper, Alex R.; Krist, Alex H.; Kubik, Martha; Landefeld, Seth; Mangione, Carol M.; Pignone, Michael; Silverstein, Michael; Simon, Melissa A.; Tseng, Chien-Wen		US Preventive Services Task Force	Interventions to Prevent Falls in Community-Dwelling Older Adults US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							VITAMIN-D; WOMEN; INJURIES; FRACTURES	IMPORTANCE Falls are the leading cause of injury-related morbidity and mortality among older adults in the United States. In 2014.28.7% of community-dwelling adults 65 years or older reported falling, resulting in 29 million falls (37.5% of which needed medical treatment or restricted activity for a day or longer) and an estimated 33 000 deaths in 2015. OBJECTIVE To update the 2012 US Preventive Services Task Force (USPSTF) recommendation on the prevention of falls in community-dwelling older adults. EVIDENCE REVIEW The USPSTF reviewed the evidence on the effectiveness and harms of primary care-relevant interventions to prevent falls and fall-related morbidity and mortality in community-dwelling older adults 65 years or older who are not known to have osteoporosis or vitamin D deficiency. FINDINGS The USPSTF found adequate evidence that exercise interventions have a moderate benefit in preventing falls in older adults at increased risk for falls and that multifactorial interventions have a small benefit. The USPSTF found adequate evidence that vitamin D supplementation has no benefit in preventing falls in older adults. The USPSTF found adequate evidence to bound the harms of exercise and multifactorial interventions as no greater than small. The USPSTF found adequate evidence that the overall harms of vitamin D supplementation are small to moderate. CONCLUSIONS AND RECOMMENDATION The USPSTF recommends exercise interventions to prevent falls in community-dwelling adults 65 years or older who are at increased risk for falls. (B recommendation) The USPSTF recommends that clinicians selectively offer multifactorial interventions to prevent falls in community-dwelling adults 65 years or older who are at increased risk for falls. Existing evidence indicates that the overall net benefit of routinely offering multifactorial interventions to prevent falls is small. When determining whether this service is appropriate for an individual, patients and clinicians should consider the balance of benefits and harms based on the circumstances of prior falls, presence of comorbid medical conditions, and the patient's values and preferences. (C recommendation) The USPSTF recommends against vitamin D supplementation to prevent falls in community-dwelling adults 65 years or older. (D recommendation) These recommendations apply to community-dwelling adults who are not known to have osteoporosis or vitamin D deficiency.	[Grossman, David C.] Kaiser Permanente, Washington Hlth Res Inst, Seattle, WA 98109 USA; [Curry, Susan J.] Univ Iowa, Iowa City, IA USA; [Owens, Douglas K.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Owens, Douglas K.] Stanford Univ, Stanford, CA 94305 USA; [Barry, Michael] Harvard Med Sch, Boston, MA USA; [Caughey, Aaron B.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Davidson, Karina W.] Columbia Univ, New York, NY USA; [Doubeni, Chyke A.] Univ Penn, Philadelphia, PA 19104 USA; [Epling, John W., Jr.] Virginia Tech, Carilion Sch Med, Roanoke, VA USA; [Kemper, Alex R.] Nationwide Childrens Hosp, Columbus, OH USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Kubik, Martha] Temple Univ, Philadelphia, PA 19122 USA; [Landefeld, Seth] Univ Alabama Birmingham, Birmingham, AL USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Pignone, Michael] Univ Texas Austin, Austin, TX 78712 USA; [Silverstein, Michael] Boston Univ, Boston, MA 02215 USA; [Simon, Melissa A.] Northwestern Univ, Evanston, IL USA; [Tseng, Chien-Wen] Univ Hawaii, Honolulu, HI 96822 USA; [Tseng, Chien-Wen] Pacific Hlth Res & Educ Inst, Honolulu, HI USA	Kaiser Permanente; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Harvard University; Harvard Medical School; Oregon Health & Science University; Columbia University; University of Pennsylvania; Virginia Polytechnic Institute & State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Virginia Commonwealth University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; University of Texas System; University of Texas Austin; Boston University; Northwestern University; University of Hawaii System; Pacific Health Research & Education Institute	Grossman, DC (corresponding author), Kaiser Permanente, Washington Hlth Res Inst, Seattle, WA 98109 USA.	chair@uspstf.net	Davidson, Karina/GWC-0996-2022; Epling, John W/J-1097-2019; Davidson, Karina/AAG-2388-2019	Davidson, Karina/0000-0002-9162-477X; Epling, John W/0000-0001-9445-8669; Davidson, Karina/0000-0002-9162-477X; Kemper, Alex/0000-0001-5491-3997	Agency for Healthcare Research and Quality (AHRQ)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	ALEXANDER BH, 1992, AM J PUBLIC HEALTH, V82, P1020, DOI 10.2105/AJPH.82.7.1020; American Academy of Family Physicians, 2012, CLIN PREV SERV REC F; Arnold Catherine M, 2007, BMC Geriatr, V7, P17; Barry E, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-14; Bergen G, 2016, MMWR-MORBID MORTAL W, V65, P993, DOI 10.15585/mmwr.mm6537a2; Bischoff-Ferrari HA, 2006, ARCH INTERN MED, V166, P424; Calonge N, 2011, ANN INTERN MED, V154, P356, DOI 10.7326/0003-4819-154-5-201103010-00307; Centers for Disease Control and Prevention, 2016, WEB BAS INJ STAT QUE; El-Khoury F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3830; Fuller GF, 2000, AM FAM PHYSICIAN, V61, P2159; Gallagher JC, 2001, J CLIN ENDOCR METAB, V86, P3618, DOI 10.1210/jc.86.8.3618; Gill TM, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i245; Guirguis-Blake JM, 2018, JAMA-J AM MED ASSOC, V319, P1705, DOI 10.1001/jama.2017.21962; Guirguis-Blake JM, 2018, AHRQ PUBLICATION 17; Institute of Medicine, 2011, DIETARY REFERENCE IN; Kahwati LC, 2018, AHRQ PUBLICATION; Kahwati LC, 2018, JAMA-J AM MED ASSOC, V319, P1600, DOI 10.1001/jama.2017.21640; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Kochanek Kenneth D, 2016, Natl Vital Stat Rep, V65, P1; National Center for Injury Prevention and Control, 2015, PREV FALLS GUID IMPL; National Institute on Aging, 2017, PREV FALLS FRACT; Parkkari J, 1999, CALCIFIED TISSUE INT, V65, P183; Pike JW, 2016, ENDOCRINOLOGY, V157, P48, DOI 10.1210/en.2015-2009; Pojednic RM, 2015, CALCIFIED TISSUE INT, V96, P256, DOI 10.1007/s00223-014-9932-x; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Thomas JI, 2005, ARCH PHYS MED REHAB, V86, P1636, DOI 10.1016/j.apmr.2005.03.004; US Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; US Preventive Services Task Force, JAMA-J AM MED ASSOC, DOI [10.1001/jaina.2018.3185, DOI 10.1001/JAINA.2018.3185]; Uusi-Rasi K, 2015, JAMA INTERN MED, V175, P703, DOI 10.1001/jamainternmed.2015.0225; Zijlstra GAR, 2009, J AM GERIATR SOC, V57, P2020, DOI 10.1111/j.1532-5415.2009.02489.x	31	168	176	6	68	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2018	319	16					1696	1704		10.1001/jama.2018.3097	http://dx.doi.org/10.1001/jama.2018.3097			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GD7RF	29710141	Bronze			2022-12-28	WOS:000430709300024
J	Slomski, A				Slomski, Anita			Vegetarian and Mediterranean Diets Effective for Weight Loss	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2018	319	16					1649	1649		10.1001/jama.2018.4738	http://dx.doi.org/10.1001/jama.2018.4738			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD7RF	29710160				2022-12-28	WOS:000430709300008
J	Iacobucci, G				Iacobucci, Gareth			WHO recommends additional tests for Sanofi's dengue vaccine after safety concerns	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Blamont M, 2018, REUTERS; DYER O, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J5759	2	9	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2018	361								k1765	10.1136/bmj.k1765	http://dx.doi.org/10.1136/bmj.k1765			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8WT	29678901				2022-12-28	WOS:000430795700006
J	Khullar, D; Rajkumar, R				Khullar, Dhruv; Rajkumar, Rahul			Innovations to cut US healthcare prices	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							UNITED-STATES; COUNTRIES; COMPETITION; INCREASES; PAYMENT; TRENDS; REFORM; COST		[Khullar, Dhruv] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY 10065 USA; [Khullar, Dhruv] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Rajkumar, Rahul] Blue Cross Blue Shield North Carolina, Durham, NC USA	Cornell University; Cornell University	Khullar, D (corresponding author), Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY 10065 USA.; Khullar, D (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.	Khd9010@med.cornell.edu						Anderson GF, 2003, HEALTH AFFAIR, V22, P89, DOI 10.1377/hlthaff.22.3.89; Baicker K, 2013, NEW ENGL J MED, V369, P789, DOI 10.1056/NEJMp1306268; Berenson RA, 2016, NEW ENGL J MED, V374, P1306, DOI 10.1056/NEJMp1600999; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Brot-Goldberg ZC, 2015, 21632 NBER; Carroll C, 2017, 23926 NBER; Centers for Medicare and Medicaid Services, 2013, MED DMEPOS COMP BIDD; Clemens J, 2014, AM ECON REV, V104, P1320, DOI 10.1257/aer.104.4.1320; Cooper Z, 2015, 21815 NBER; Cutler DM, 2013, JAMA-J AM MED ASSOC, V310, P1964, DOI 10.1001/jama.2013.281675; Dieleman JL, 2017, JAMA-J AM MED ASSOC, V318, P1668, DOI 10.1001/jama.2017.15927; Elshaug AG, 2017, LANCET, V390, P191, DOI 10.1016/S0140-6736(16)32586-7; Frakt AB, 2018, JAMA-J AM MED ASSOC, V319, P441, DOI 10.1001/jama.2017.20047; Glied SA, 2017, HEALTH AFFAIR, V36, P1572, DOI 10.1377/hlthaff.2017.0555; Huber M, 2003, HEALTH CARE FINANC R, V25, P1; Murray R, 2015, HOSP RATE SETTING RE; National Academy of Social Insurance, 2015, ADDR PRIC POW HLTH C; Navathe AS, 2017, JAMA INTERN MED, V177, P214, DOI 10.1001/jamainternmed.2016.8263; Papanicolas I, 2018, JAMA-J AM MED ASSOC, V319, P1024, DOI 10.1001/jama.2018.1150; Rajkumar R, 2014, NEW ENGL J MED, V370, P493, DOI 10.1056/NEJMp1314868; Robinson JC, 2015, JAMA INTERN MED, V175, P1783, DOI 10.1001/jamainternmed.2015.4588; Robinson JC, 2013, HEALTH AFFAIR, V32, P1392, DOI 10.1377/hlthaff.2013.0188; Squires D, ISSUE BRIEF; Yurukoglu A, 2016, 17987 NBER; Zhang YT, 2012, NEW ENGL J MED, V367, P1724, DOI 10.1056/NEJMsa1203980	25	1	1	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2018	361								k1591	10.1136/bmj.k1591	http://dx.doi.org/10.1136/bmj.k1591			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GD8WT	29678814				2022-12-28	WOS:000430795700001
J	Reich, PB; Hobbie, SE; Lee, TD; Pastore, MA				Reich, Peter B.; Hobbie, Sarah E.; Lee, Tali D.; Pastore, Melissa A.			Unexpected reversal of C-3 versus C-4 grass response to elevated CO2 during a 20-year field experiment	SCIENCE			English	Article							ATMOSPHERIC CO2; GLOBAL DISTRIBUTION; SEMIARID GRASSLAND; PHOTOSYNTHESIS; TEMPERATURE; CLIMATE; PRECIPITATION; IMPACTS; CARBON; ECOSYSTEMS	Theory predicts and evidence shows that plant species that use the C-4 photosynthetic pathway (C-4 species) are less responsive to elevated carbon dioxide (eCO(2)) than species that use only the C-3 pathway (C-3 species). We document a reversal from this expected C-3-C-4 contrast. Over the first 12 years of a 20-year free-air CO2 enrichment experiment with 88 C-3 or C-4 grassland plots, we found that biomass was markedly enhanced at eCO2 relative to ambient CO2 in C-3 but not C-4 plots, as expected. During the subsequent 8 years, the pattern reversed: Biomass was markedly enhanced at eCO(2) relative to ambient CO2 in C-4 but not C-3 plots. Soil net nitrogen mineralization rates, an index of soil nitrogen supply, exhibited a similar shift: eCO(2) first enhanced but later depressed rates in C-3 plots, with the opposite true in C-4 plots, partially explaining the reversal of the eCO(2) biomass response. These findings challenge the current C-3-C-4 eCO(2) paradigm and show that even the best-supported short-term drivers of plant response to global change might not predict long-term results.	[Reich, Peter B.] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Reich, Peter B.] Western Sydney Univ, Hawkesbury Inst Environm, Penrith, NSW 2753, Australia; [Hobbie, Sarah E.; Pastore, Melissa A.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Lee, Tali D.] Univ Wisconsin, Dept Biol, Eau Claire, WI 54701 USA	University of Minnesota System; University of Minnesota Twin Cities; Western Sydney University; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System	Reich, PB (corresponding author), Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA.; Reich, PB (corresponding author), Western Sydney Univ, Hawkesbury Inst Environm, Penrith, NSW 2753, Australia.	preich@umn.edu	Pastore, Melissa/AAO-6820-2020	Pastore, Melissa/0000-0002-7465-1418; Hobbie, Sarah/0000-0001-5159-031X; Lee, Tali/0000-0002-3933-6607	NSF [DEB-0620652, DEB-1234162, DEB-1242531, DEB-1120064]; U.S. Department of Energy Programs for Ecosystem Research [DE-FG02-96ER62291]; Direct For Biological Sciences [1242531] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); U.S. Department of Energy Programs for Ecosystem Research; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Supported by NSF Long-Term Ecological Research grants DEB-0620652 and DEB-1234162, Long-Term Research in Environmental Biology grant DEB-1242531, and Ecosystem Sciences grant DEB-1120064 and by U.S. Department of Energy Programs for Ecosystem Research grant DE-FG02-96ER62291.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Ali AA, 2013, FUNCT ECOL, V27, P1011, DOI 10.1111/1365-2435.12102; Andresen LC, 2016, ADV ECOL RES, V55, P437, DOI 10.1016/bs.aecr.2016.07.001; Baudena M, 2015, BIOGEOSCIENCES, V12, P1833, DOI 10.5194/bg-12-1833-2015; Bremond L, 2012, GLOBAL CHANGE BIOL, V18, P2324, DOI 10.1111/j.1365-2486.2012.02690.x; Collatz GJ, 1998, OECOLOGIA, V114, P441, DOI 10.1007/s004420050468; Cotton JM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501346; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; EHLERINGER J, 1977, PLANT PHYSIOL, V59, P86, DOI 10.1104/pp.59.1.86; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Griffith DM, 2017, J BIOGEOGR, V44, P2564, DOI 10.1111/jbi.13061; Harper AB, 2016, GEOSCI MODEL DEV, V9, P2415, DOI 10.5194/gmd-9-2415-2016; Koven C.D., 2013, TECHNICAL DESCRIPTIO, DOI DOI 10.1073/pnas.1407302112; Langley JA, 2010, NATURE, V466, P96, DOI 10.1038/nature09176; Lee TD, 2011, GLOBAL CHANGE BIOL, V17, P2893, DOI 10.1111/j.1365-2486.2011.02435.x; Luo YQ, 2008, GLOBAL CHANGE BIOL, V14, P1986, DOI 10.1111/j.1365-2486.2008.01629.x; Morgan JA, 2011, NATURE, V476, P202, DOI 10.1038/nature10274; Mueller KE, 2016, ECOL LETT, V19, P956, DOI 10.1111/ele.12634; Polley HW, 2014, J EXP BOT, V65, P3415, DOI 10.1093/jxb/eru009; Reich PB, 2004, P NATL ACAD SCI USA, V101, P10101, DOI 10.1073/pnas.0306602101; Reich PB, 2001, NEW PHYTOL, V150, P435, DOI 10.1046/j.1469-8137.2001.00114.x; Reich PB, 2013, NAT CLIM CHANGE, V3, P278, DOI [10.1038/nclimate1694, 10.1038/NCLIMATE1694]; Sage RF, 2007, PLANT CELL ENVIRON, V30, P1086, DOI 10.1111/j.1365-3040.2007.01682.x; Still CJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001807; Taylor SH, 2014, GLOBAL CHANGE BIOL, V20, P1992, DOI 10.1111/gcb.12498; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; Wang D, 2012, OECOLOGIA, V169, P1, DOI 10.1007/s00442-011-2172-0; Whitley R, 2017, BIOGEOSCIENCES, V14, P4711, DOI 10.5194/bg-14-4711-2017; Xu ZZ, 2014, PLANTA, V239, P421, DOI 10.1007/s00425-013-1987-9	29	143	150	19	305	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2018	360	6386					317	+		10.1126/science.aas9313	http://dx.doi.org/10.1126/science.aas9313			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD3IC	29674593				2022-12-28	WOS:000430396600044
J	Schinder, AF; Lanuza, GM				Schinder, Alejandro F.; Lanuza, Guillermo M.			Whispering neurons fuel cortical highways	SCIENCE			English	Editorial Material							CEREBRAL-CORTEX; SUBPLATE; MIGRATION; DIVERSITY		[Schinder, Alejandro F.] Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest Bioquim Buenos Aires, Fdn Inst Leloir, Lab Plasticidad Neuronal, Ave Patricias Argentinas 435,C1405BWE, Buenos Aires, DF, Argentina; [Lanuza, Guillermo M.] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, Fdn Inst Leloir, Lab Genet Desarrollo Neural, Ave Patricias Argentinas 435,C1405BWE, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Schinder, AF (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest Bioquim Buenos Aires, Fdn Inst Leloir, Lab Plasticidad Neuronal, Ave Patricias Argentinas 435,C1405BWE, Buenos Aires, DF, Argentina.	aschinder@leloir.org.ar	Lanuza, Guillermo/AAT-6286-2020	Lanuza, Guillermo/0000-0003-3311-2263				ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.neuro.17.1.185; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Cooper JA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00386; Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Harris KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005587; Kanold PO, 2010, ANNU REV NEUROSCI, V33, P23, DOI 10.1146/annurev-neuro-060909-153244; Kanold PO, 2003, SCIENCE, V301, P521, DOI 10.1126/science.1084152; Komuro H, 1998, J NEUROBIOL, V37, P110, DOI 10.1002/(SICI)1097-4695(199810)37:1<110::AID-NEU9>3.3.CO;2-Q; Lodato S, 2015, ANNU REV CELL DEV BI, V31, P699, DOI 10.1146/annurev-cellbio-100814-125353; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Ohtaka-Maruyama C, 2018, SCIENCE, V360, P313, DOI 10.1126/science.aar2866; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Tabata H, 2003, J NEUROSCI, V23, P9996	14	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2018	360	6386					265	266		10.1126/science.aat4587	http://dx.doi.org/10.1126/science.aat4587			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD3IC	29674579				2022-12-28	WOS:000430396600024
J	Rimmer, A				Rimmer, Abi			BMJ Careers launches recruitment tool to help NHS trusts fill vacancies	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Moberly T, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3414; Rimmer A, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3634	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2018	361								k1755	10.1136/bmj.k1755	http://dx.doi.org/10.1136/bmj.k1755			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8WQ	29674507				2022-12-28	WOS:000430795300012
J	Damji, O; Lang, E				Damji, Omar; Lang, Eddy			In perfusion imaging-selected acute ischemic stroke, thrombectomy at 6 to 16 hours improved functional outcomes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Damji, Omar; Lang, Eddy] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada	University of Calgary	Damji, O (corresponding author), Univ Calgary, Cumming Sch Med, Calgary, AB, Canada.							Nogueira RG, 2018, NEW ENGL J MED, V378, P11, DOI 10.1056/NEJMoa1706442; Phan K, 2017, WORLD NEUROSURG, V108, P850, DOI 10.1016/j.wneu.2017.08.040; Powers WJ, 2015, STROKE, V46, P3020, DOI 10.1161/STR.0000000000000074; Sevick LK, 2017, STROKE, V48, P2519, DOI 10.1161/STROKEAHA.117.017199	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2018	168	8					JC42	JC42		10.7326/ACPJC-2018-168-8-042	http://dx.doi.org/10.7326/ACPJC-2018-168-8-042			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GC8XZ	29677249				2022-12-28	WOS:000430083100007
J	Abbott, A				Abbott, A			Rubbia proposes a speedier voyage to Mars and back	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					374	374		10.1038/16966	http://dx.doi.org/10.1038/16966			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667959	Bronze			2022-12-28	WOS:000078461700005
J	Plass, M; Solana, J; Wolf, FA; Ayoub, S; Misios, A; Glazar, P; Obermayer, B; Theis, FJ; Kocks, C; Rajewsky, N				Plass, Mireya; Solana, Jordi; Wolf, F. Alexander; Ayoub, Salah; Misios, Aristotelis; Glazar, Petar; Obermayer, Benedikt; Theis, Fabian J.; Kocks, Christine; Rajewsky, Nikolaus			Cell type atlas and lineage tree of a whole complex animal by single-cell transcriptomics	SCIENCE			English	Article							STEM-CELLS; GENE-EXPRESSION; RNA-SEQ; REGENERATION; PLURIPOTENCY; PLANARIANS; SYSTEM	Flatworms of the species Schmidtea mediterranea are immortal-adult animals contain a large pool of pluripotent stem cells that continuously differentiate into all adult cell types. Therefore, single-cell transcriptome profiling of adult animals should reveal mature and progenitor cells. By combining perturbation experiments, gene expression analysis, a computational method that predicts future cell states from transcriptional changes, and a lineage reconstruction method, we placed all major cell types onto a single lineage tree that connects all cells to a single stem cell compartment. We characterized gene expression changes during differentiation and discovered cell types important for regeneration. Our results demonstrate the importance of single-cell transcriptome analysis for mapping and reconstructing fundamental processes of developmental and regenerative biology at high resolution.	[Plass, Mireya; Solana, Jordi; Ayoub, Salah; Misios, Aristotelis; Glazar, Petar; Obermayer, Benedikt; Kocks, Christine; Rajewsky, Nikolaus] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, Lab Syst Biol Gene Regulatory Elements, Berlin, Germany; [Wolf, F. Alexander; Theis, Fabian J.] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Computat Biol, Neuherberg, Germany; [Theis, Fabian J.] Tech Univ Munich, Dept Math, Munich, Germany; [Solana, Jordi] Oxford Brookes Univ, Dept Biol & Med Sci, Oxford, England; [Obermayer, Benedikt] Berlin Inst Hlth, Core Unit Bioinformat, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Oxford Brookes University; Berlin Institute of Health	Rajewsky, N (corresponding author), Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, Lab Syst Biol Gene Regulatory Elements, Berlin, Germany.	rajewsky@mdc-berlin.de	Theis, Fabian J/ABD-5212-2021; Plass, Mireya/B-4240-2010; plass, mireya/AAB-7483-2019	Theis, Fabian J/0000-0002-2419-1943; Plass, Mireya/0000-0002-9891-2723; plass, mireya/0000-0002-9891-2723; Ayoub, Salah/0000-0001-5043-8922; Rajewsky, Nikolaus/0000-0002-4785-4332; Solana, Jordi/0000-0002-6770-3929; Wolf, F. Alexander/0000-0002-8760-7838; Obermayer, Benedikt/0000-0002-9116-630X	German Center for Cardiovascular Research [DZHK BER 1.2 VD]; DFG [RA 838/5-1]; BMBF [01ZX1711A]; Helmholtz Association [ZT-I-0007]; Helmholtz Postdoc Program, Initiative and Networking Fund of the Helmholtz Association	German Center for Cardiovascular Research; DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Helmholtz Association(Helmholtz Association); Helmholtz Postdoc Program, Initiative and Networking Fund of the Helmholtz Association	Work on this project was funded by the German Center for Cardiovascular Research (DZHK BER 1.2 VD), the DFG (grant RA 838/5-1), the BMBF (grant 01ZX1711A), and the Helmholtz Association (Incubator grant sparse2big, grant ZT-I-0007). F.A.W. acknowledges the support of the Helmholtz Postdoc Program, Initiative and Networking Fund of the Helmholtz Association.	Agata K, 2007, DEV GROWTH DIFFER, V49, P73, DOI 10.1111/j.1440-169x.2007.00919.x; Alemany A, 2018, NATURE, V556, P108, DOI 10.1038/nature25969; Alles J, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0383-5; BAGUNA J, 1981, HYDROBIOLOGIA, V84, P181, DOI 10.1007/BF00026179; Cao JY, 2017, SCIENCE, V357, P661, DOI 10.1126/science.aam8940; Cebria F, 2007, DEVELOPMENT, V134, P833, DOI 10.1242/dev.02794; Cowles MW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004746; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Fan J, 2016, NAT METHODS, V13, P241, DOI [10.1038/NMETH.3734, 10.1038/nmeth.3734]; Frieda KL, 2017, NATURE, V541, P107, DOI 10.1038/nature20777; Gonzalez-Estevez C, 2007, P NATL ACAD SCI USA, V104, P13373, DOI 10.1073/pnas.0703588104; Grun D, 2016, CELL STEM CELL, V19, P266, DOI 10.1016/j.stem.2016.05.010; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Guillaumet-Adkins A, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1171-9; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Hayashi T, 2006, DEV GROWTH DIFFER, V48, P371, DOI 10.1111/j.1440-169x.2006.00876.x; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Karaiskos N, 2017, SCIENCE, V358, P194, DOI 10.1126/science.aan3235; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; La Manno G., 2017, BIORXIV 206052; Labbe RM, 2012, STEM CELLS, V30, P1734, DOI 10.1002/stem.1144; Lapan SW, 2012, CELL REP, V2, P294, DOI 10.1016/j.celrep.2012.06.018; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Molinaro AM, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0937-9; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Onal P, 2012, EMBO J, V31, P2755, DOI 10.1038/emboj.2012.110; Oviedo NJ, 2003, DEV DYNAM, V226, P326, DOI 10.1002/dvdy.10228; PEDERSEN KJ, 1961, Z ZELLFORSCH MIK ANA, V53, P569, DOI 10.1007/BF00339508; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Regev A, 2017, ELIFE, V6, DOI 10.7554/eLife.27041; Rink JC, 2011, DEVELOPMENT, V138, P3769, DOI 10.1242/dev.066852; Roberts-Galbraith RH, 2016, ELIFE, V5, DOI 10.7554/eLife.17002; Scimone ML, 2017, NATURE, V551, P623, DOI 10.1038/nature24660; Setty M, 2016, NAT BIOTECHNOL, V34, P637, DOI 10.1038/nbt.3569; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013; Solana J, 2016, ELIFE, V5, DOI 10.7554/eLife.16797; Solana J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r19; Spanjaard B, 2018, NAT BIOTECHNOL, V36, P469, DOI 10.1038/nbt.4124; Stubenhaus BM, 2016, ELIFE, V5, DOI 10.7554/eLife.14175; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; van Wolfswinkel JC, 2014, CELL STEM CELL, V15, P326, DOI 10.1016/j.stem.2014.06.007; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983; Wang C, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.29; Wang IE, 2016, ELIFE, V5, DOI 10.7554/eLife.16996; Wenemoser D, 2010, DEV BIOL, V344, P979, DOI 10.1016/j.ydbio.2010.06.017; Wolf F. A., 2017, BIORXIV 208819; Wurtzel O, 2017, DEV CELL, V40, P491, DOI 10.1016/j.devcel.2017.02.008; Wurtzel O, 2015, DEV CELL, V35, P632, DOI 10.1016/j.devcel.2015.11.004	54	218	220	3	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391							eaaq1723	10.1126/science.aaq1723	http://dx.doi.org/10.1126/science.aaq1723			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG9RW	29674432	Green Submitted			2022-12-28	WOS:000433039800039
J	Pandya, A				Pandya, Ankur			Adding Cost-effectiveness to Define Low-Value Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISEASE		[Pandya, Ankur] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Pandya, A (corresponding author), Harvard TH Chan Sch Publ Hlth, 718 Huntington Ave, Boston, MA 02115 USA.	anpandya@hsph.harvard.edu						[Anonymous], 5 THINGS PHYS PAT SH; Bach PB, 2014, JAMA-J AM MED ASSOC, V312, P4629; Guadagnolo BA, 2006, J CLIN ONCOL, V24, P4116, DOI 10.1200/JCO.2006.07.0409; Kazi DS, 2016, JAMA-J AM MED ASSOC, V316, P743, DOI 10.1001/jama.2016.11004; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Overkill Gawande A., 2015, NEW YORKER; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; Schwartz AL, 2014, JAMA INTERN MED, V174, P1067, DOI 10.1001/jamainternmed.2014.1541; Tufts Medical Center, COST EFF AN REG; van Hees F, 2014, ANN INTERN MED, V160, P750, DOI 10.7326/M13-2263	10	39	39	2	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2018	319	19					1977	1978		10.1001/jama.2018.2856	http://dx.doi.org/10.1001/jama.2018.2856			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF8QV	29710341				2022-12-28	WOS:000432238300010
J	Martijn, J; Vosseberg, J; Guy, L; Offre, P; Ettema, TJG				Martijn, Joran; Vosseberg, Julian; Guy, Lionel; Offre, Pierre; Ettema, Thijs J. G.			Deep mitochondrial origin outside the sampled alphaproteobacteria	NATURE			English	Article							SINGLE-CELL; EVOLUTION; SEQUENCE; TREE; PHYLOGENY; INSIGHTS; TOOL	Mitochondria are ATP-generating organelles, the endosymbiotic origin of which was a key event in the evolution of eukaryotic cells(1). Despite strong phylogenetic evidence that mitochondria had an alphaproteobacterial ancestry(2), efforts to pinpoint their closest relatives among sampled alphaproteobacteria have generated conflicting results, complicating detailed inferences about the identity and nature of the mitochondrial ancestor. While most studies support the idea that mitochondria evolved from an ancestor related to Rickettsiales(3-9), an order that includes several host-associated pathogenic and endosymbiotic lineages(10,11), others have suggested that mitochondria evolved from a free-living group(12-14). Here we re-evaluate the phylogenetic placement of mitochondria. We used genome-resolved binning of oceanic metagenome datasets and increased the genomic sampling of Alphaproteobacteria with twelve divergent clades, and one clade representing a sister group to all Alphaproteobacteria. Subsequent phylogenomic analyses that specifically address long branch attraction and compositional bias artefacts suggest that mitochondria did not evolve from Rickettsiales or any other currently recognized alphaproteobacterial lineage. Rather, our analyses indicate that mitochondria evolved from a proteobacterial lineage that branched off before the divergence of all sampled alphaproteobacteria. In light of this new result, previous hypotheses on the nature of the mitochondrial ancestor(6,15,16) should be re-evaluated.	[Martijn, Joran; Vosseberg, Julian; Ettema, Thijs J. G.] Uppsala Univ, Sci Life Lab, Dept Cell & Mol Biol, Uppsala, Sweden; [Guy, Lionel] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Offre, Pierre] Max Planck Inst Marine Microbiol, Bremen, Germany; [Offre, Pierre] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Microbiol & Biogeochem, Den Burg, Netherlands; [Offre, Pierre] Univ Utrecht, Den Burg, Netherlands; [Vosseberg, Julian] Univ Utrecht, Dept Biol, Utrecht, Netherlands	Uppsala University; Uppsala University; Max Planck Society; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; Utrecht University	Ettema, TJG (corresponding author), Uppsala Univ, Sci Life Lab, Dept Cell & Mol Biol, Uppsala, Sweden.	thijs.ettema@icm.uu.se	Offre, Pierre/S-3382-2019; Guy, Lionel/B-4501-2008	Guy, Lionel/0000-0001-8354-2398; Martijn, Joran/0000-0001-7651-5252; Vosseberg, Julian/0000-0002-3105-9414	European Research Council (ERC) [310039-PUZZLE_CELL]; Swedish Foundation for Strategic Research [SSF-FFL5]; Swedish Research Council (VR) [2015-04959]	European Research Council (ERC)(European Research Council (ERC)); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council (VR)(Swedish Research Council)	We thank the Tara Oceans consortium for generating metagenomic datasets and for making these publically available. We thank G. Herndl and C. Schleper for sharing metagenomic datasets before publication, and to M. Wu for sharing the genome of 'Candidatus Magnetococcus yuandaducum' before publication; K. Zaremba-Niedzwiedzka, C. Stairs, L. Eme, T. Williams, N. Lartillot, J. Alneberg, B. Quang Minh and H.C. Wang for useful advice, discussions and technical support; the Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) at Uppsala University and the Swedish National Infrastructure for Computing (SNIC) at the PDC Center for High-Performance Computing for providing computational resources. This work is supported by grants of the European Research Council (ERC Starting grant 310039-PUZZLE_CELL), the Swedish Foundation for Strategic Research (SSF-FFL5) and the Swedish Research Council (VR grant 2015-04959) awarded to T.J.G.E.	Alneberg J, 2014, NAT METHODS, V11, P1144, DOI [10.1038/NMETH.3103, 10.1038/nmeth.3103]; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Andrews S., 2010, FASTQC QUALITY CONTR; Ball SG, 2016, SCIENCE, V351, P659, DOI 10.1126/science.aad8864; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bork P, 2015, SCIENCE, V348, P873, DOI 10.1126/science.aac5605; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Brindefalk B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024457; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Darby AC, 2007, TRENDS GENET, V23, P511, DOI 10.1016/j.tig.2007.08.002; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Ferla MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083383; Fitzpatrick DA, 2006, MOL BIOL EVOL, V23, P74, DOI 10.1093/molbev/msj009; Foster PG, 2004, SYST BIOL, V53, P485, DOI 10.1080/10635150490445779; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248; Hugenholtz P, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018085; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/nmeth.4285, 10.1038/NMETH.4285]; Kannan S, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0237-5; Karst S. M., 2016, PREPRINT; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Landry Z, 2017, MBIO, V8, DOI 10.1128/mBio.00413-17; Lang BF, 2012, ADV BOT RES, V63, P1, DOI 10.1016/B978-0-12-394279-1.00001-6; Lartillot N, 2013, SYST BIOL, V62, P611, DOI 10.1093/sysbio/syt022; Martijn J, 2015, ISME J, V9, P2373, DOI 10.1038/ismej.2015.46; NOMURA M, 1977, ANNU REV GENET, V11, P297, DOI 10.1146/annurev.ge.11.120177.001501; Nurk S, 2017, GENOME RES, V27, P824, DOI 10.1101/gr.213959.116; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Pittis AA, 2016, NATURE, V531, P101, DOI 10.1038/nature16941; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quang LS, 2008, BIOINFORMATICS, V24, P2317, DOI 10.1093/bioinformatics/btn445; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Raymann K, 2015, P NATL ACAD SCI USA, V112, P6670, DOI 10.1073/pnas.1420858112; Renvoise A, 2011, TRENDS MOL MED, V17, P573, DOI 10.1016/j.molmed.2011.05.009; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Rodriguez-Ezpeleta N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030520; Sassera D, 2011, MOL BIOL EVOL, V28, P3285, DOI 10.1093/molbev/msr159; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shi XF, 2005, MOL BIOL EVOL, V22, P2285, DOI 10.1093/molbev/msi226; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STUART A, 1955, BIOMETRIKA, V42, P412, DOI 10.2307/2333387; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Susko E, 2007, MOL BIOL EVOL, V24, P2139, DOI 10.1093/molbev/msm144; Thrash JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00013; Viklund J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078858; Viklund J, 2012, MOL BIOL EVOL, V29, P599, DOI 10.1093/molbev/msr203; Wang HC, 2018, SYST BIOL, V67, P216, DOI 10.1093/sysbio/syx068; WANG Z, 2015, SCI REP UK, V5; Wang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110685; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09	60	158	160	6	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2018	557	7703					101	+		10.1038/s41586-018-0059-5	http://dx.doi.org/10.1038/s41586-018-0059-5			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5BW	29695865				2022-12-28	WOS:000431234500038
J	Wade, L				Wade, Lizzie			Peace dividend Colombian scientists race to study once-forbidden territory before it is lost to development-or new conflict	SCIENCE			English	Editorial Material															Pulitzer Center on Crisis Reporting	Pulitzer Center on Crisis Reporting	Reporting for this story was supported by the Pulitzer Center on Crisis Reporting.		0	3	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					368	373		10.1126/science.360.6387.368	http://dx.doi.org/10.1126/science.360.6387.368			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1AR	29700247				2022-12-28	WOS:000430949600016
J	Jamtveit, B; Ben-Zion, Y; Renard, F; Austrheim, H				Jamtveit, Bjorn; Ben-Zion, Yehuda; Renard, Francois; Austrheim, Hakon			Earthquake-induced transformation of the lower crust	NATURE			English	Article							CONTINENTAL-CRUST; NORWAY; PSEUDOTACHYLYTE; CONSTRAINTS; MAGNITUDE; FLUID; FAULT; INTERMEDIATE; LITHOSPHERE; EVOLUTION	The structural and metamorphic evolution of the lower crust has direct effects on the lithospheric response to plate tectonic processes involved in orogeny, including subsidence of sedimentary basins, stability of deep mountain roots and extension of high-topography regions. Recent research shows that before orogeny most of the lower crust is dry, impermeable and mechanically strong(1). During an orogenic event, the evolution of the lower crust is controlled by infiltration of fluids along localized shear or fracture zones. In the Bergen Arcs of Western Norway, shear zones initiate as faults generated by lower-crustal earthquakes. Seismic slip in the dry lower crust requires stresses at a level that can only be sustained over short timescales or local weakening mechanisms. However, normal earthquake activity in the seismogenic zone produces stress pulses that drive aftershocks in the lower crust(2). Here we show that the volume of lower crust affected by such aftershocks is substantial and that fluid-driven associated metamorphic and structural transformations of the lower crust follow these earthquakes. This provides a 'top-down' effect on crustal geodynamics and connects processes operating at very different timescales.	[Jamtveit, Bjorn; Renard, Francois; Austrheim, Hakon] Univ Oslo, Dept Geosci, Njord Ctr, PGP, Oslo, Norway; [Ben-Zion, Yehuda] Univ Southern Calif, Dept Earth Sci, Los Angeles, CA USA; [Renard, Francois] Univ Grenoble Alpes, Univ Savoie Mont Blanc, CNRS, IRD,IFSTTAR,ISTerre, Grenoble, France	University of Oslo; University of Southern California; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Gustave-Eiffel; Universite de Savoie	Jamtveit, B (corresponding author), Univ Oslo, Dept Geosci, Njord Ctr, PGP, Oslo, Norway.	bjorn.jamtveit@geo.uio.no	Renard, Francois/A-7862-2008; Austrheim, Håkon/AAT-7057-2021	Renard, Francois/0000-0002-5125-5930; 	European Union's Horizon Research and Innovation Programme under ERC Advanced Grant [669972]; Norwegian Research Council [250661]; National Science Foundation [EAR-1722561]	European Union's Horizon Research and Innovation Programme under ERC Advanced Grant; Norwegian Research Council(Research Council of NorwayEuropean Commission); National Science Foundation(National Science Foundation (NSF))	This project has been supported by the European Union's Horizon 2020 Research and Innovation Programme under ERC Advanced Grant Agreement number 669972, 'Disequilibrium Metamorphism' ('DIME'; to B.J.), and by the Norwegian Research Council grant number 250661 ('HADES'; to F.R.). Y.B.-Z. acknowledges support from the National Science Foundation (grant EAR-1722561). The paper benefited from discussions with and comments by I. Zaliapin, J. Jackson, A. Putnis, S. Schmalholz, S. Xu, P. Meakin and J. Platt.	Andersen TB, 2008, GEOLOGY, V36, P995, DOI 10.1130/G25230A.1; AUSTRHEIM H, 1994, SCIENCE, V265, P82, DOI 10.1126/science.265.5168.82; Austrheim H, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602067; Austrheim H, 2013, TECTONOPHYSICS, V609, P620, DOI 10.1016/j.tecto.2013.08.030; Azuma S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04403; BATH M, 1965, TECTONOPHYSICS, V2, P483, DOI 10.1016/0040-1951(65)90003-X; Ben-Zion Y, 2002, GEOPHYS J INT, V148, pF1, DOI 10.1046/j.1365-246X.2002.01637.x; Ben-Zion Y, 2006, GEOPHYS J INT, V165, P197, DOI 10.1111/j.1365-246X.2006.02878.x; Ben-Zion Y, 2008, REV GEOPHYS, V46, DOI 10.1029/2008RG000260; Ben-Zion Y, 2009, GEOPHYS J INT, V178, P1351, DOI 10.1111/j.1365-246X.2009.04285.x; Bhowany K, 2018, J METAMORPH GEOL, V36, P315, DOI 10.1111/jmg.12294; Bingen B, 2001, GEOL SOC AM BULL, V113, P640, DOI 10.1130/0016-7606(2001)113<0640:ZUPGIT>2.0.CO;2; CHEN WP, 1983, J GEOPHYS RES, V88, P4183, DOI 10.1029/JB088iB05p04183; Copley A, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008137; Craig TJ, 2012, EARTH PLANET SC LETT, V353, P231, DOI 10.1016/j.epsl.2012.07.010; Edwards B, 2010, GEOPHYS J INT, V183, P407, DOI 10.1111/j.1365-246X.2010.04743.x; Ellis S, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002744; Hawemann F., 2017, SOLID EARTH DI UNPUB, V123, DOI [10.5194/se-2017-123, DOI 10.5194/SE-2017-123]; Hillers G, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003859; Jackson J. A., 2002, GSA TODAY, V12, P4, DOI [DOI 10.1130/1052-5173(2002)0122.0.CO;2, DOI 10.1130/1052-5173(2002)012<0004:S0TCLT>2.0.C0;2]; Jamtveit B, 2016, EARTH-SCI REV, V154, P1, DOI 10.1016/j.earscirev.2015.12.002; Jiang JL, 2017, J GEOPHYS RES-SOL EA, V122, P6491, DOI 10.1002/2017JB014030; John T, 2006, GEOLOGY, V34, P557, DOI 10.1130/G22411.1; KOHLSTEDT DL, 1995, J GEOPHYS RES-SOL EA, V100, P17587, DOI 10.1029/95JB01460; McNamara DE, 2017, TECTONOPHYSICS, V714, P21, DOI 10.1016/j.tecto.2016.08.004; Mitchell TM, 2016, GEOLOGY, V44, P1059, DOI 10.1130/G38373.1; Moecher DP, 2009, GEOLOGY, V37, P999, DOI 10.1130/G30166A.1; MUNZ IA, 1995, GEOCHIM COSMOCHIM AC, V59, P239, DOI 10.1016/0016-7037(94)00322-D; Putnis A, 2017, J PETROL, V58, P1871, DOI 10.1093/petrology/egx076; RUDNICK RL, 1995, REV GEOPHYS, V33, P267, DOI 10.1029/95RG01302; Rybacki E, 2004, TECTONOPHYSICS, V382, P173, DOI 10.1016/j.tecto.2004.01.006; Tullis J., 1992, INT GEOPHYS, V51, P89, DOI DOI 10.1016/S0074-6142(08)62816-8; WELLS DL, 1994, B SEISMOL SOC AM, V84, P974; Yardley BWD, 2009, J GEOL SOC LONDON, V166, P585, DOI 10.1144/0016-76492008-101; Zaliapin I, 2016, GEOPHYS J INT, V207, P608, DOI 10.1093/gji/ggw300; Zaliapin I, 2013, J GEOPHYS RES-SOL EA, V118, P2847, DOI 10.1002/jgrb.50179	36	77	79	3	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					487	+		10.1038/s41586-018-0045-y	http://dx.doi.org/10.1038/s41586-018-0045-y			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8VX	29695846	Green Accepted, Green Submitted			2022-12-28	WOS:000430793000044
J	Tollefson, J				Tollefson, Jeff			CARBON'S FUTURE IN BLACK AND WHITE THERE ARE REASONS TO BE OPTIMISTIC THAT THE WORLD WILL BREAK ITS ADDICTION TO FOSSIL FUELS. BUT TIME IS RUNNING OUT	NATURE			English	News Item																			0	36	37	5	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					422	425		10.1038/d41586-018-04931-6	http://dx.doi.org/10.1038/d41586-018-04931-6			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8VX	29695857	Bronze			2022-12-28	WOS:000430793000020
J	Wise, J				Wise, Jacqui			MPs call for urgent ban on surgical mesh	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NHS Digital, 2018, RETR REV SURG UR PRO; WISE J, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J5523; Wise J, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1701	3	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2018	361								k1758	10.1136/bmj.k1758	http://dx.doi.org/10.1136/bmj.k1758			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8WT	29678808				2022-12-28	WOS:000430795700004
J	Banerjee, G; Stone, SP; Werring, DJ				Banerjee, Gargi; Stone, Sheldon P.; Werring, David J.			EASILY MISSED? Posterior circulation ischaemic stroke	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSIS; THROMBOLYSIS; DISSECTION; HEADACHE; MIGRAINE; ONSET		[Banerjee, Gargi; Werring, David J.] UCL Inst Neurol, Dept Brain Repair & Rehabil, Stroke Res Ctr, London WC1B 5EH, England; [Banerjee, Gargi; Werring, David J.] Natl Hosp Neurol & Neurosurg, London WC1B 5EH, England; [Stone, Sheldon P.] UCL, Med Sch, Dept Med, Royal Free Campus, London, England; [Stone, Sheldon P.] Univ Coll Hosp, London, England	University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London	Werring, DJ (corresponding author), UCL Inst Neurol, Dept Brain Repair & Rehabil, Stroke Res Ctr, London WC1B 5EH, England.; Werring, DJ (corresponding author), Natl Hosp Neurol & Neurosurg, London WC1B 5EH, England.	d.werring@ucl.ac.uk	Werring, David/Q-8435-2019; Banerjee, Gargi/AAU-3081-2020	Werring, David/0000-0003-2074-1861; Banerjee, Gargi/0000-0003-0190-7782	Rosetrees Trust; Stroke Association; British Heart Foundation; Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme	Rosetrees Trust(Rosetrees Trust); Stroke Association; British Heart Foundation(British Heart Foundation); Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR))	GB receives funding from the Rosetrees Trust. DJW receives research support from the Stroke Association, the British Heart Foundation, and the Rosetrees Trust. This work was undertaken at UCL University College Hospital, which receives a proportion of funding from the Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme.	Caplan LR, 2004, ANN NEUROL, V56, P389, DOI 10.1002/ana.20204; Chang FC, 2015, CEREBROVASC DIS, V40, P144, DOI 10.1159/000437172; DRACHMAN DA, 1972, NEUROLOGY, V22, P323, DOI 10.1212/WNL.22.4.323; Edlow BL, 2017, NEUROLOGY, V89, P256, DOI 10.1212/WNL.0000000000004120; Edlow JA, 2008, LANCET NEUROL, V7, P951, DOI 10.1016/S1474-4422(08)70216-3; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Forster A, 2011, CEREBROVASC DIS, V32, P349, DOI 10.1159/000330346; Hu XM, 2017, NEUROL SCI, V38, P33, DOI 10.1007/s10072-016-2746-z; Inoa V, 2014, CEREBROVASC DIS, V37, P251, DOI 10.1159/000358869; Kattah JC, 2009, STROKE, V40, P3504, DOI 10.1161/STROKEAHA.109.551234; Markus HS, 2013, LANCET NEUROL, V12, P989, DOI 10.1016/S1474-4422(13)70211-4; Mattle HP, 2011, LANCET NEUROL, V10, P1002, DOI 10.1016/S1474-4422(11)70229-0; Merwick A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3175; Mitsias PD, 2006, CEPHALALGIA, V26, P150, DOI 10.1111/j.1468-2982.2005.01012.x; Rist PM, 2011, CEPHALALGIA, V31, P886, DOI 10.1177/0333102411401634; Sand KM, 2017, ACTA NEUROL SCAND, V135, P546, DOI 10.1111/ane.12627; Sarikaya H, 2011, STROKE, V42, P2498, DOI 10.1161/STROKEAHA.110.607614; Sarraj A, 2015, INT J STROKE, V10, P672, DOI 10.1111/j.1747-4949.2012.00952.x; Schievink WI, 2001, NEW ENGL J MED, V344, P898, DOI 10.1056/NEJM200103223441206; Schulz UG, 2017, J NEUROL NEUROSUR PS, V88, P45, DOI 10.1136/jnnp-2015-311299; Searls DE, 2012, ARCH NEUROL-CHICAGO, V69, P346, DOI 10.1001/archneurol.2011.2083; Sommer P, 2017, J NEUROL, V264, P131, DOI 10.1007/s00415-016-8330-x; Spector JT, 2010, AM J MED, V123, P612, DOI 10.1016/j.amjmed.2009.12.021; Tarnutzer AA, 2017, NEUROLOGY, V88, P1468, DOI 10.1212/WNL.0000000000003814; Tentschert S, 2005, STROKE, V36, pE1, DOI 10.1161/01.STR.0000151360.03567.2b; Tong X, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003848; van Os HJA, 2016, NEUROLOGY, V87, P1124, DOI 10.1212/WNL.0000000000003092; Vongvaivanich K, 2015, CEPHALALGIA, V35, P894, DOI 10.1177/0333102414560635	28	15	17	3	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2018	361								k1185	10.1136/bmj.k1185	http://dx.doi.org/10.1136/bmj.k1185			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8WQ	29674391	Green Published, Green Submitted			2022-12-28	WOS:000430795300003
J	Ilardo, MA; Moltke, I; Korneliussen, TS; Cheng, J; Stern, AJ; Racimo, F; Damgaard, PD; Sikora, M; Seguin-Orlando, A; Rasmussen, S; van den Munckhof, ICL; ter Horst, R; Joosten, LAB; Netea, MG; Salingkat, S; Nielsen, R; Willerslev, E				Ilardo, Melissa A.; Moltke, Ida; Korneliussen, Thorfinn S.; Cheng, Jade; Stern, Aaron J.; Racimo, Fernando; Damgaard, Peter de Barros; Sikora, Martin; Seguin-Orlando, Andaine; Rasmussen, Simon; van den Munckhof, Inge C. L.; ter Horst, Rob; Joosten, Leo A. B.; Netea, Mihai G.; Salingkat, Suhartini; Nielsen, Rasmus; Willerslev, Eske			Physiological and Genetic Adaptations to Diving in Sea Nomads	CELL			English	Article							HIGH-ALTITUDE ADAPTATION; HYPOXIA-INDUCIBLE FACTORS; GENOME SEQUENCE; SPLENIC CONTRACTION; UNDERWATER VISION; THYROID-HORMONE; TIBETAN; IDENTIFICATION; POPULATION; EXPRESSION	Understanding the physiology and genetics of human hypoxia tolerance has important medical implications, but this phenomenon has thus far only been investigated in high-altitude human populations. Another system, yet to be explored, is humans who engage in breath-hold diving. The indigenous Bajau people ("Sea Nomads'') of Southeast Asia live a subsistence lifestyle based on breath-hold diving and are renowned for their extraordinary breath-holding abilities. However, it is unknown whether this has a genetic basis. Using a comparative genomic study, we show that natural selection on genetic variants in the PDE10A gene have increased spleen size in the Bajau, providing them with a larger reservoir of oxygenated red blood cells. We also find evidence of strong selection specific to the Bajau on BDKRB2, a gene affecting the human diving reflex. Thus, the Bajau, and possibly other diving populations, provide a new opportunity to study human adaptation to hypoxia tolerance.	[Ilardo, Melissa A.; Korneliussen, Thorfinn S.; Racimo, Fernando; Damgaard, Peter de Barros; Sikora, Martin; Seguin-Orlando, Andaine; Nielsen, Rasmus; Willerslev, Eske] Univ Copenhagen, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Moltke, Ida] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Korneliussen, Thorfinn S.; Willerslev, Eske] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Cheng, Jade; Stern, Aaron J.; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Stern, Aaron J.] Univ Calif Berkeley, Dept Computat Biol, Berkeley, CA 94720 USA; [Seguin-Orlando, Andaine] Univ Copenhagen, Danish Natl High Throughput DNA Sequencing Ctr, DK-1353 Copenhagen, Denmark; [Rasmussen, Simon] Tech Univ Denmark, Bioinformat, DK-2800 Lyngby, Denmark; [van den Munckhof, Inge C. L.; ter Horst, Rob; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 Nijmegen, Netherlands; [van den Munckhof, Inge C. L.; ter Horst, Rob; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis RCI, NL-6525 Nijmegen, Netherlands; [Netea, Mihai G.] Univ Bonn, Life & Med Sci Inst LIMES, Dept Genom & Immunoregulat, D-53115 Bonn, Germany; [Salingkat, Suhartini] Tompotika Univ, Tompotika Luwuk Banggai, Luwuk 94711, Indonesia; [Willerslev, Eske] Wellcome Trust Res Labs, Sanger Inst, Hinxton CB10 1SA, England	University of Copenhagen; University of Copenhagen; University of Cambridge; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Copenhagen; Technical University of Denmark; Radboud University Nijmegen; Radboud University Nijmegen; University of Bonn; Wellcome Trust Sanger Institute	Nielsen, R; Willerslev, E (corresponding author), Univ Copenhagen, Ctr GeoGenet, DK-1350 Copenhagen, Denmark.; Willerslev, E (corresponding author), Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England.; Nielsen, R (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.; Willerslev, E (corresponding author), Wellcome Trust Res Labs, Sanger Inst, Hinxton CB10 1SA, England.	rasmus_nielsen@berkeley.edu; ewillerslev@snm.ku.dk	Rasmussen, Simon/G-6258-2016; Joosten, Leo AB/H-3138-2015; Rasmussen, Simon/AAA-2308-2020; Sikora, Martin/C-8609-2015; Moltke, Ida/C-6158-2011; Korneliussen, Thorfinn Sand/F-6421-2014; Horst, Rob Ter/G-3536-2016; Netea, Mihai/N-5155-2014; Korneliussen, Thorfinn Sand/ABB-7656-2021; Nielsen, Rasmus/D-4405-2009; Willerslev, Eske/A-9619-2011; Willerslev, Eske/AAA-5686-2019	Rasmussen, Simon/0000-0001-6323-9041; Joosten, Leo AB/0000-0001-6166-9830; Rasmussen, Simon/0000-0001-6323-9041; Sikora, Martin/0000-0003-2818-8319; Moltke, Ida/0000-0001-7052-8554; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Horst, Rob Ter/0000-0003-0576-5873; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Nielsen, Rasmus/0000-0003-0513-6591; Willerslev, Eske/0000-0002-7081-6748; Racimo, Fernando/0000-0002-5025-2607	Lundbeck Foundation; Danish National Research Foundation [DNRF94]; Danish National Science Foundation [FNU 109931]; European Research Council (ERC) [ERC 310372]; IN-CONTROL CVON grant from the Netherlands Heart Foundation [CVON2012-03]; Spinoza grant of the Netherlands Organization for Scientific Research; KU	Lundbeck Foundation(Lundbeckfonden); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish National Science Foundation(Danmarks Grundforskningsfond); European Research Council (ERC)(European Research Council (ERC)); IN-CONTROL CVON grant from the Netherlands Heart Foundation; Spinoza grant of the Netherlands Organization for Scientific Research; KU	We thank Richard Dougherty for medical imaging consultation, Yani Mile and Mardiyanto Saahi for assistance in Indonesia, and the residents of Jaya Bakti and Koyoan for their participation and support, especially Kepala Desa Hasan and Pai Bayubu. We would also like to acknowledge GenomeDK HPC Hub at Aarhus University and its staff, the staff of the Danish National High-throughput DNA Sequencing Centre, the laboratory technicians of the Centre for GeoGenetics, and Kurt Kjaer for assistance with graphic design. The authors would like to thank the Rivas lab for making the Global Biobank Engine resource available. We gratefully acknowledge Marinette van der Graaf for the assistance with the MRIs and Vincenzo Positano of the CNR Institute of Clinical Physiology, Pisa, Italy, for providing us with the HIPPO FAT. This project was supported by the Lundbeck Foundation, the Danish National Research Foundation (DNRF94), the Danish National Science Foundation (FNU 109931), and KU2016. The 500FG study from the HFGP is supported by an European Research Council (ERC) Consolidator grant (ERC 310372) to M.G.N. The 300-OB study was supported by an IN-CONTROL CVON grant (CVON2012-03) from the Netherlands Heart Foundation to M.G.N. and L.A.B.J. M.G.N. was supported by a Spinoza grant of the Netherlands Organization for Scientific Research. E.W. thanks St. Johns College, Cambridge, for providing a stimulating environment for scientific discussion.	Aguirre-Gamboa R, 2016, CELL REP, V17, P2474, DOI 10.1016/j.celrep.2016.10.053; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Angelin-Duclos C, 2005, DEVELOPMENT, V132, P925, DOI 10.1242/dev.01648; [Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; Baranova TI, 2017, AM J PHYSIOL-HEART C, V312, pH622, DOI 10.1152/ajpheart.00080.2016; Beall CM, 2006, INTEGR COMP BIOL, V46, P18, DOI 10.1093/icb/icj004; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Cheng J. Y., 2016, BIORXIV, DOI [10.1101/071233, DOI 10.1101/071233]; Clifton J, 2012, SOC NATUR RESOUR, V25, P716, DOI 10.1080/08941920.2011.618487; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Drew K, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167490; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; ELSNER R, 1966, SCIENCE, V153, P941, DOI 10.1126/science.153.3739.941; Excoffier L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003905; EXTON JH, 1981, MOL CELL ENDOCRINOL, V23, P233, DOI 10.1016/0303-7207(81)90123-4; Ferrigno M, 1997, J APPL PHYSIOL, V83, P1282, DOI 10.1152/jappl.1997.83.4.1282; Flamant F, 2002, MOL ENDOCRINOL, V16, P24, DOI 10.1210/me.16.1.24; Foster GE, 2005, SCAND J MED SCI SPOR, V15, P3, DOI 10.1111/j.1600-0838.2005.00440.x; Fujishige K, 1999, J BIOL CHEM, V274, P18438, DOI 10.1074/jbc.274.26.18438; Fumagalli M, 2015, SCIENCE, V349, P1343, DOI 10.1126/science.aab2319; Gislen A, 2003, CURR BIOL, V13, P833, DOI 10.1016/S0960-9822(03)00290-2; Gislen A, 2006, VISION RES, V46, P3443, DOI 10.1016/j.visres.2006.05.004; Grocott M, 2007, CRIT CARE, V11, DOI 10.1186/cc5921; Gunther T, 2013, GENETICS, V195, P205, DOI 10.1534/genetics.113.152462; HOCHACHKA PW, 1986, FASEB J, V45, P2948; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/nmeth.1937, 10.1038/NMETH.1937]; Holewijn S, 2010, J INTERN MED, V268, P567, DOI 10.1111/j.1365-2796.2010.02277.x; HURFORD WE, 1990, J APPL PHYSIOL, V69, P932, DOI 10.1152/jappl.1990.69.3.932; Hurford WE, 1996, J APPL PHYSIOL, V80, P298, DOI 10.1152/jappl.1996.80.1.298; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; KOOYMAN GL, 1972, COMP BIOCHEM PHYSIOL, V43, P31, DOI 10.1016/0300-9629(72)90465-3; Korneliussen TS, 2015, BIOINFORMATICS, V31, P4009, DOI 10.1093/bioinformatics/btv509; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LIN YC, 1983, J APPL PHYSIOL, V54, P172, DOI 10.1152/jappl.1983.54.1.172; LIN YC, 1972, AM J PHYSIOL, V222, P260, DOI 10.1152/ajplegacy.1972.222.2.260; Lipson M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5689; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Martin SH, 2015, MOL BIOL EVOL, V32, P244, DOI 10.1093/molbev/msu269; McKenna H, 2016, TRENDS ANAESTH CRIT, V11, P6, DOI 10.1016/j.tacc.2016.11.003; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mottishaw PD, 1999, AM ZOOL, V39, P434; Netea MG, 2016, NAT MED, V22, P831, DOI 10.1038/nm.4140; Ngamphiw C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021451; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Racimo F, 2017, MOL BIOL EVOL, V34, P296, DOI 10.1093/molbev/msw216; Ranciaro A, 2014, AM J HUM GENET, V94, P496, DOI 10.1016/j.ajhg.2014.02.009; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Sankararaman S, 2016, CURR BIOL, V26, P1241, DOI 10.1016/j.cub.2016.03.037; Sather C, 1997, BAJAU LAUT ADAPTATIO; Schagatay E, 2014, HUM EVOL, V29, P125; Schagatay E, 2011, DIVING HYPERB MED, V41, P27; Schubert Mikkel, 2016, BMC Res Notes, V9, P88, DOI 10.1186/s13104-016-1900-2; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Skotte L, 2012, GENET EPIDEMIOL, V36, P430, DOI 10.1002/gepi.21636; Sopher D., 1965, SEA NOMADS STUDY MAR; STERBA JA, 1988, UNDERSEA BIOMED RES, V15, P361; Stewart IB, 2002, SPORTS MED, V32, P361, DOI 10.2165/00007256-200232060-00002; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Team RC., 2022, LANG ENV STAT COMP; ter Horst R, 2016, CELL, V167, P1111, DOI 10.1016/j.cell.2016.10.018; Thornton SJ, 2004, UNDERSEA HYPERBAR M, V31, P81; Wang V, 2005, CANCER RES, V65, P3299, DOI 10.1158/0008-5472.CAN-04-4130; WATANABE K, 1995, ENDOCR J, V42, P661, DOI 10.1507/endocrj.42.661; Wuren T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088252; Xiang K, 2013, MOL BIOL EVOL, V30, P1889, DOI 10.1093/molbev/mst090; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yang J, 2017, P NATL ACAD SCI USA, V114, P4189, DOI 10.1073/pnas.1617042114; Yetter EM, 2003, AM J ROENTGENOL, V181, P1615, DOI 10.2214/ajr.181.6.1811615; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; ZAPOL WM, 1979, J APPL PHYSIOL, V47, P968, DOI 10.1152/jappl.1979.47.5.968; Zhong H, 1999, CANCER RES, V59, P5830	85	84	85	8	104	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2018	173	3					569	+		10.1016/j.cell.2018.03.054	http://dx.doi.org/10.1016/j.cell.2018.03.054			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7GB	29677510	Green Published, Bronze			2022-12-28	WOS:000430677400009
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Let's start talking to colleagues	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Tang D., 2017, FINANCIAL TIMES	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2018	361								k1602	10.1136/bmj.k1602	http://dx.doi.org/10.1136/bmj.k1602			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8WF	29661753	Bronze, Green Published			2022-12-28	WOS:000430794000001
J	Graham, KL; Auerbach, AD; Schnipper, JL; Flanders, SA; Kim, CS; Robinson, EJ; Ruhnke, GW; Thomas, LR; Kripalani, S; Vasilevskis, EE; Fletcher, GS; Sehgal, NJ; Lindenauer, PK; Williams, MV; Metlay, JP; Davis, RB; Yang, J; Marcantonio, ER; Herzig, SJ				Graham, Kelly L.; Auerbach, Andrew D.; Schnipper, Jeffrey L.; Flanders, Scott A.; Kim, Christopher S.; Robinson, Edmondo J.; Ruhnke, Gregory W.; Thomas, Larissa R.; Kripalani, Sunil; Vasilevskis, Eduard E.; Fletcher, Grant S.; Sehgal, Neil J.; Lindenauer, Peter K.; Williams, Mark V.; Metlay, Joshua P.; Davis, Roger B.; Yang, Julius; Marcantonio, Edward R.; Herzig, Shoshana J.			Preventability of Early Versus Late Hospital Readmissions in a National Cohort of General Medicine Patients	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; HEART-FAILURE; RETROSPECTIVE COHORT; 30-DAY READMISSIONS; AFTER-DISCHARGE; CARE; EVENTS; RATES; PNEUMONIA; ASSOCIATION	Background: Many experts believe that hospitals with more frequent readmissions provide lower-quality care, but little is known about how the preventability of readmissions might change over the postdischarge time frame. Objective: To determine whether readmissions within 7 days of discharge differ from those between 8 and 30 days after discharge with respect to preventability. Design: Prospective cohort study. Setting: 10 academic medical centers in the United States. Patients: 822 adults readmitted to a general medicine service. Measurements: For each readmission, 2 site-specific physician adjudicators used a structured survey instrument to determine whether it was preventable and measured other characteristics. Results: Overall, 36.2% of early readmissions versus 23.0% of late readmissions were preventable (median risk difference, 13.0 percentage points [interquartile range, 5.5 to 26.4 percentage points]). Hospitals were identified as better locations for preventing early readmissions (47.2% vs. 25.5%; median risk difference, 22.8 percentage points [interquartile range, 17.9 to 31.8 percentage points]), whereas outpatient clinics (15.2% vs. 6.6%; median risk difference, 10.0 percentage points [interquartile range, 4.6 to 12.2 percentage points]) and home (19.4% vs. 14.0%; median risk difference, 5.6 percentage points [interquartile range, -6.1 to 17.1 percentage points]) were better for preventing late readmissions. Limitation: Physician adjudicators were not blinded to readmission timing, community hospitals were not included in the study, and readmissions to nonstudy hospitals were not included in the results. Conclusion: Early readmissions were more likely to be preventable and amenable to hospital-based interventions. Late readmissions were less likely to be preventable and were more amenable to ambulatory and home-based interventions.	[Graham, Kelly L.; Davis, Roger B.; Yang, Julius; Marcantonio, Edward R.; Herzig, Shoshana J.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Graham, Kelly L.; Schnipper, Jeffrey L.; Davis, Roger B.; Yang, Julius; Marcantonio, Edward R.; Herzig, Shoshana J.] Harvard Med Sch, Boston, MA 02215 USA; [Auerbach, Andrew D.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Schnipper, Jeffrey L.] Brigham & Womens Hosp, Boston, MA USA; [Flanders, Scott A.] Univ Michigan, Med Sch, Ann Arbor, MI 48109 USA; [Kim, Christopher S.] Univ Washington, Seattle, WA 98195 USA; [Robinson, Edmondo J.] Value Inst, Christiana Care Hlth Syst, Wilmington, DE USA; [Ruhnke, Gregory W.] Univ Chicago, Chicago, IL 60637 USA; [Thomas, Larissa R.] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, San Francisco, CA 94143 USA; [Kripalani, Sunil] Vanderbilt Univ, Med Ctr, Ctr Clin Qual & Implementat Res, Nashville, TN USA; [Vasilevskis, Eduard E.] Univ Med Ctr, Ctr Qual Aging Vanderbilt, Nashville, TN USA; [Vasilevskis, Eduard E.] VA Tennessee Valley Healthcare Syst, Geriatr Res Educ & Clin Ctr, Nashville, TN USA; [Fletcher, Grant S.] Univ Washington, Harborview Med Ctr, 325 9Th Ave, Seattle, WA 98104 USA; [Sehgal, Neil J.] Univ Maryland, Sch Publ Hlth, College Pk, MD 20742 USA; [Lindenauer, Peter K.] Univ Massachusetts, Med Sch Baystate, Inst Healthcare Delivery & Populat Sci, Springfield, MA USA; [Williams, Mark V.] Univ Kentucky, Ctr Hlth Serv Res, Lexington, KY USA; [Metlay, Joshua P.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; Christiana Care Health System; University of Chicago; University of California System; University of California San Francisco; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Harborview Medical Center; University of Washington; University of Washington Seattle; University System of Maryland; University of Maryland College Park; University of Massachusetts System; University of Kentucky; Harvard University; Massachusetts General Hospital	Graham, KL (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, 330 Brookline Ave,E Shapiro 607D, Boston, MA 02215 USA.	kgraham@bidmc.harvard.edu; sherzig@bidmc.harvard.edu	Marcantonio, Edward R/U-3929-2017; Vasilevskis, Eduard/AAA-3065-2019	Marcantonio, Edward R/0000-0002-2911-4250; Vasilevskis, Eduard/0000-0001-8165-5321; Robinson, Edmondo/0000-0001-9625-6235; Williams, Mark V/0000-0001-6107-0457; Auerbach, Andrew/0000-0001-8440-0527	Association of American Medical Colleges; The Harvard Clinical and Translational Science Center [UL1 TR001102]; Eleanor and Miles Shore 50th Anniversary Fellowship Program for Scholars in Medicine at Beth Israel Deaconess Medical Center; Harvard Medical School; National Institute on Aging [R01AG030618, K24AG035075, K23AG040157]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS022241] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445, UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030618, K23AG042459, K23AG040157, K24AG035075] Funding Source: NIH RePORTER	Association of American Medical Colleges; The Harvard Clinical and Translational Science Center; Eleanor and Miles Shore 50th Anniversary Fellowship Program for Scholars in Medicine at Beth Israel Deaconess Medical Center; Harvard Medical School; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By an unrestricted research grant from the Association of American Medical Colleges. This work was done with support from Harvard Catalyst, The Harvard Clinical and Translational Science Center, through award UL1 TR001102 from the National Institutes of Health and financial contributions from Harvard University and its affiliated academic health care centers. Dr. Graham is funded by the Eleanor and Miles Shore 50th Anniversary Fellowship Program for Scholars in Medicine at Beth Israel Deaconess Medical Center and Harvard Medical School. Dr. Herzig is funded by grant K23AG042459 from the National Institute on Aging. Dr. Marcantonio was supported in part by grants R01AG030618 and K24AG035075 from the National Institute on Aging. Dr. Vasilevskis was supported by National Institute on Aging award K23AG040157, the Veterans Affairs Clinical Research Center of Excellence, and the Geriatric Research Education and Clinical Center.	Auerbach AD, 2016, JAMA INTERN MED, V176, P484, DOI 10.1001/jamainternmed.2015.7863; Burke RE, 2013, J HOSP MED, V8, P102, DOI 10.1002/jhm.1990; Calvillo-King L, 2013, J GEN INTERN MED, V28, P269, DOI 10.1007/s11606-012-2235-x; Centers for Medicare and Medicaid Services (CMS) HHS, 2011, Fed Regist, V76, P51476; Chin DL, 2016, HEALTH AFFAIR, V35, P1867, DOI 10.1377/hlthaff.2016.0205; Fontanarosa PB, 2013, JAMA-J AM MED ASSOC, V309, P398, DOI 10.1001/jama.2013.42; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Gerhardt Geoffrey, 2013, Medicare Medicaid Res Rev, V3, DOI 10.5600/mmrr.003.02.b01; Goodwin AJ, 2015, CRIT CARE MED, V43, P738, DOI 10.1097/CCM.0000000000000859; Gorodeski EZ, 2010, NEW ENGL J MED, V363, P297, DOI 10.1056/NEJMc1001882; Graham KL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178718; Graham KL, 2015, ANN INTERN MED, V162, P741, DOI 10.7326/M14-2159; Herrin J, 2015, HEALTH SERV RES, V50, P20, DOI 10.1111/1475-6773.12177; Herzig SJ, 2016, J GEN INTERN MED, V31, P1287, DOI 10.1007/s11606-016-3764-5; Joynt KE, 2013, NEW ENGL J MED, V368, P1175, DOI 10.1056/NEJMp1300122; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Joynt KE, 2012, NEW ENGL J MED, V366, P1366, DOI 10.1056/NEJMp1201598; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Kahlon S, 2015, CAN MED ASSOC J, V187, P799, DOI 10.1503/cmaj.150100; Kind AJH, 2014, ANN INTERN MED, V161, P765, DOI 10.7326/M13-2946; Kripalani S, 2012, ANN INTERN MED, V157, P1, DOI 10.7326/0003-4819-157-1-201207030-00003; Krumholz HM, 2013, JAMA-J AM MED ASSOC, V309, P587, DOI 10.1001/jama.2013.333; Lavenberg JG, 2014, J HOSP MED, V9, P598, DOI 10.1002/jhm.2226; Lindenauer PK, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f521; Localio AR, 1996, ANN INTERN MED, V125, P457, DOI 10.7326/0003-4819-125-6-199609150-00005; Odonkor CA, 2015, AM J PHYS MED REHAB, V94, P555, DOI 10.1097/PHM.0000000000000213; ONEIL AC, 1993, ANN INTERN MED, V119, P370, DOI 10.7326/0003-4819-119-5-199309010-00004; Parina RP, 2015, J AM COLL SURGEONS, V220, P169, DOI 10.1016/j.jamcollsurg.2014.10.020; Schnipper JL, 2006, ARCH INTERN MED, V166, P565, DOI 10.1001/archinte.166.5.565; Stefan MS, 2013, J GEN INTERN MED, V28, P377, DOI 10.1007/s11606-012-2229-8; Tsai TC, 2013, NEW ENGL J MED, V369, P1134, DOI 10.1056/NEJMsa1303118; van Walraven C, 2011, CAN MED ASSOC J, V183, pE391, DOI 10.1503/cmaj.101860; Wijlaars LPMM, 2015, ARCH DIS CHILD, V100, P845, DOI 10.1136/archdischild-2014-307771	33	60	60	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2018	168	11					766	+		10.7326/M17-1724	http://dx.doi.org/10.7326/M17-1724			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3EK	29710243	Green Accepted			2022-12-28	WOS:000434254100003
J	Wyant, GA; Abu-Remaileh, M; Frenkel, EM; Laqtom, NN; Dharamdasani, V; Lewis, CA; Chan, SH; Heinze, I; Ori, A; Sabatini, DM				Wyant, Gregory A.; Abu-Remaileh, Monther; Frenkel, Evgeni M.; Laqtom, Nouf N.; Dharamdasani, Vimisha; Lewis, Caroline A.; Chan, Sze Ham; Heinze, Ivonne; Ori, Alessandro; Sabatini, David M.			NUFIP1 is a ribosome receptor for starvation-induced ribophagy	SCIENCE			English	Article							HEREDITARY SPASTIC PARAPLEGIA; AUTOPHAGY RECEPTOR; SELECTIVE AUTOPHAGY; RAG GTPASES; LYSOSOMES; PROTEINS; CELLS; YEAST; MTORC1; DEGRADATION	The lysosome degrades and recycles macromolecules, signals to the master growth regulator mTORC1 [mechanistic target of rapamycin (mTOR) complex 1], and is associated with human disease. We performed quantitative proteomic analyses of rapidly isolated lysosomes and found that nutrient levels and mTOR dynamically modulate the lysosomal proteome. Upon mTORC1 inhibition, NUFIP1 (nuclear fragile Xmental retardation-interacting protein 1) redistributes from the nucleus to autophagosomes and lysosomes. Upon these conditions, NUFIP1 interacts with ribosomes and delivers them to autophagosomes by directly binding to microtubule-associated proteins 1A/1B light chain 3B (LC3B). The starvation-induced degradation of ribosomes via autophagy (ribophagy) depends on the capacity of NUFIP1 to bind LC3B and promotes cell survival. We propose that NUFIP1 is a receptor for the selective autophagy of ribosomes.	[Wyant, Gregory A.; Abu-Remaileh, Monther; Frenkel, Evgeni M.; Laqtom, Nouf N.; Dharamdasani, Vimisha; Lewis, Caroline A.; Chan, Sze Ham; Sabatini, David M.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Wyant, Gregory A.; Abu-Remaileh, Monther; Frenkel, Evgeni M.; Laqtom, Nouf N.; Dharamdasani, Vimisha; Lewis, Caroline A.; Chan, Sze Ham; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Wyant, Gregory A.; Abu-Remaileh, Monther; Frenkel, Evgeni M.; Laqtom, Nouf N.; Dharamdasani, Vimisha; Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Wyant, Gregory A.; Abu-Remaileh, Monther; Frenkel, Evgeni M.; Laqtom, Nouf N.; Dharamdasani, Vimisha; Sabatini, David M.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Wyant, Gregory A.; Abu-Remaileh, Monther; Frenkel, Evgeni M.; Laqtom, Nouf N.; Dharamdasani, Vimisha; Sabatini, David M.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Heinze, Ivonne; Ori, Alessandro] Leibniz Inst Aging, Fritz Lipmann Inst, D-07745 Jena, Germany	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Sabatini, DM (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.; Sabatini, DM (corresponding author), MIT, Dept Biol, Cambridge, MA 02142 USA.; Sabatini, DM (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA.; Sabatini, DM (corresponding author), MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA.; Sabatini, DM (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.; Ori, A (corresponding author), Leibniz Inst Aging, Fritz Lipmann Inst, D-07745 Jena, Germany.	alessandro.ori@leibniz-fli.de; sabatini@wi.mit.edu	Laqtom, Nouf/ABF-1890-2021; Ori, Alessandro/B-7067-2011; Ori, Alessandro/M-8586-2019	Ori, Alessandro/0000-0002-3046-0871; Ori, Alessandro/0000-0002-3046-0871; Abu-Remaileh, Monther/0000-0003-3772-0477; Chan, Sze Ham/0000-0002-3235-0852; /0000-0002-1446-7256	NIH [R01 CA103866, R01 CA129105, R37 AI47389]; U.S. Department of Defense [W81XWH-15-1-0230, W81XWH-15-1-0337]; Lustgarten Foundation; EMBO Long-Term Fellowship; Saudi Aramco Ibn Khaldun Fellowship for Saudi Women; MIT School of Science Fellowship in Cancer Research; FLI proteomics core facility; Federal Government of Germany; State of Thuringia; NATIONAL CANCER INSTITUTE [R01CA129105, R01CA103866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); Lustgarten Foundation; EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Saudi Aramco Ibn Khaldun Fellowship for Saudi Women; MIT School of Science Fellowship in Cancer Research; FLI proteomics core facility; Federal Government of Germany; State of Thuringia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grants R01 CA103866, R01 CA129105, and R37 AI47389, U.S. Department of Defense grant W81XWH-15-1-0230, and the Lustgarten Foundation (D.M.S.); U.S. Department of Defense grant W81XWH-15-1-0337 (E.M.F.); an EMBO Long-Term Fellowship (M.A.-R.); a Saudi Aramco Ibn Khaldun Fellowship for Saudi Women (N.N.L.); an MIT School of Science Fellowship in Cancer Research (G.A.W.); and the FLI proteomics core facility (A.O. and I.H.). The FLI is a member of the Leibniz Association and is financially supported by the Federal Government of Germany and the State of Thuringia. D.M.S. is an investigator of the Howard Hughes Medical Institute.	Abu-Remaileh M, 2017, SCIENCE, V358, P807, DOI 10.1126/science.aan6298; An H, 2018, NAT CELL BIOL, V20, P135, DOI 10.1038/s41556-017-0007-x; Ballabio A, 2009, BBA-MOL CELL RES, V1793, P684, DOI 10.1016/j.bbamcr.2008.12.001; Bardoni B, 2003, EXP CELL RES, V289, P95, DOI 10.1016/S0014-4827(03)00222-2; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; DARNELL JE, 1968, BACTERIOL REV, V32, P262, DOI 10.1128/MMBR.32.3.262-290.1968; Deosaran E, 2013, J CELL SCI, V126, P939, DOI 10.1242/jcs.114819; Groth-Pedersen L, 2013, CANCER LETT, V332, P265, DOI 10.1016/j.canlet.2010.05.021; Guo JY, 2016, GENE DEV, V30, P1704, DOI 10.1101/gad.283416.116; Hirst J, 2013, MOL BIOL CELL, V24, P2558, DOI 10.1091/mbc.E13-03-0170; Huang HH, 2015, EMBO J, V34, P154, DOI 10.15252/embj.201489083; Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498; Klinge S, 2012, TRENDS BIOCHEM SCI, V37, P189, DOI 10.1016/j.tibs.2012.02.007; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Kristensen AR, 2008, MOL CELL PROTEOMICS, V7, P2419, DOI 10.1074/mcp.M800184-MCP200; LINDLEY ER, 1993, BIOCHEM J, V290, P457, DOI 10.1042/bj2900457; Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148; Martina JA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004754; Mathis AD, 2017, MOL CELL PROTEOMICS, V16, P243, DOI 10.1074/mcp.M116.063255; McKeegan KS, 2007, MOL CELL BIOL, V27, P6782, DOI 10.1128/MCB.01097-07; Murmu RP, 2011, MOL CELL NEUROSCI, V47, P191, DOI 10.1016/j.mcn.2011.04.004; Petit CS, 2013, J CELL BIOL, V202, P1107, DOI 10.1083/jcb.201307084; Platt FM, 2012, J CELL BIOL, V199, P723, DOI 10.1083/jcb.201208152; Quinternet M, 2016, STRUCTURE, V24, P1693, DOI 10.1016/j.str.2016.07.016; Quinternet M, 2015, J MOL BIOL, V427, P2816, DOI 10.1016/j.jmb.2015.07.012; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Rothe B, 2014, NUCLEIC ACIDS RES, V42, P10731, DOI 10.1093/nar/gku612; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Sung MK, 2016, ELIFE, V5, DOI 10.7554/eLife.19105; Sung MK, 2016, MOL BIOL CELL, V27, P2642, DOI 10.1091/mbc.E16-05-0290; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Tumbarello DA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005174; Verlhac P, 2015, CELL HOST MICROBE, V17, P515, DOI 10.1016/j.chom.2015.02.008; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WARNER JR, 1977, J MOL BIOL, V115, P315, DOI 10.1016/0022-2836(77)90157-7; Wei YJ, 2017, CELL, V168, P224, DOI 10.1016/j.cell.2016.11.042; Weinberg DE, 2016, CELL REP, V14, P1787, DOI 10.1016/j.celrep.2016.01.043; Wong YC, 2014, P NATL ACAD SCI USA, V111, pE4439, DOI 10.1073/pnas.1405752111; Wyant GA, 2017, CELL, V171, P642, DOI 10.1016/j.cell.2017.09.046	44	182	186	7	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2018	360	6390			SI		751	+		10.1126/science.aar2663	http://dx.doi.org/10.1126/science.aar2663			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG1US	29700228	Green Accepted, Green Published			2022-12-28	WOS:000432473500040
J	Liu, ZM; Wang, J; Cheng, H; Ke, X; Sun, L; Zhang, QC; Wang, HW				Liu, Zhongmin; Wang, Jia; Cheng, Hang; Ke, Xin; Sun, Lei; Zhang, Qiangfeng Cliff; Wang, Hong-Wei			Cryo-EM Structure of Human Dicer and Its Complexes with a Pre-miRNA Substrate	CELL			English	Article							BEAM-INDUCED MOTION; DUF283 DOMAIN; STRUCTURE PREDICTION; RIBONUCLEASE-III; RNA-INTERFERENCE; TRBP COMPLEX; IN-VIVO; RIG-I; MICRORNA; BIOGENESIS	Human Dicer (hDicer) is a multi-domain protein belonging to the RNase III family. It plays pivotal roles in small RNA biogenesis during the RNA interference (RNAi) pathway by processing a diverse range of double-stranded RNA (dsRNA) precursors to generate similar to 22 nt microRNA (miRNA) or small interfering RNA (siRNA) products for sequence-directed gene silencing. In this work, we solved the cryoelectron microscopy (cryo-EM) structure of hDicer in complex with its cofactor protein TRBP and revealed the precise spatial arrangement of hDicer's multiple domains. We further solved structures of the hDicer-TRBP complex bound with pre-let-7 RNA in two distinct conformations. In combination with biochemical analysis, these structures reveal a property of the hDicer-TRBP complex to promote the stability of pre-miRNA's stem duplex in a predicing state. These results provide insights into the mechanism of RNA processing by hDicer and illustrate the regulatory role of hDicer's N-terminal helicase domain.	[Liu, Zhongmin; Wang, Jia; Cheng, Hang; Ke, Xin; Sun, Lei; Zhang, Qiangfeng Cliff; Wang, Hong-Wei] Tsinghua Univ, Sch Life Sci, Beijing Adv Innovat Ctr Struct Biol, Minist Educ,Key Lab Prot Sci,Tsinghua Peking Join, Beijing 100084, Peoples R China; [Cheng, Hang] Tsinghua Univ, Sch Life Sci, Joint Grad Program Peking Tsinghua NIBS, Beijing 100084, Peoples R China	Tsinghua University; National Institute of Biological Sciences, Beijing; Tsinghua University	Wang, HW (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing Adv Innovat Ctr Struct Biol, Minist Educ,Key Lab Prot Sci,Tsinghua Peking Join, Beijing 100084, Peoples R China.	hongweiwang@tsinghua.edu.cn	Sun, Lei/ABF-1422-2021; Liu, Zhongmin/M-8381-2019	Sun, Lei/0000-0003-1400-2157; Wang, Jia/0000-0002-5978-4191; Ke, Xin/0000-0002-5860-5366; Liu, Zhongmin/0000-0002-3280-3890	National Science Foundation of China [31530018, 31671355]; National Key R&D Program of China [2016YFA0501100]; Beijing Municipal Science & Technology Commission [Z161100000116034]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	The plasmids of hDicer and TRBP were gifts from J. Doudna. We are thankful to J.L. Lei, Y.J. Xu, X.M. Li, and T. Yang at the Tsinghua University Branch of the China National Center for Protein Sciences (Beijing) for providing the cryo-EM and high-performance computational facility support. We also thank the "Explorer 100" High Performance Computation Facility of Tsinghua National Laboratory for Informational Science and Technology. We acknowledge the helpful advice of E. Ma, S. Sun, M.S. Ma, L. Wang, and K. Ye in the setup of protein expression and purification as well as RNA biochemistry assays. We thank J. Wang, C.Y. Yan, D.S. Liu, and Y. Wu for their guidance in model building and R.M. Glaeser and N. Yan for their careful reading of this work. This work is supported by funds from the National Science Foundation of China (Grant 31530018 to H.-W.W. and Grant 31671355 to Q.C.Z.), the National Key R&D Program of China (Grant 2016YFA0501100 to H.-W.W.), and the Beijing Municipal Science & Technology Commission (Grant Z161100000116034 to H.-W.W.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Betancur JG, 2012, RNA, V18, P24, DOI 10.1261/rna.029785.111; Blaszczyk J, 2004, STRUCTURE, V12, P457, DOI 10.1016/j.str.2004.02.004; Castilla-Liorente V, 2013, BIOCHEM SOC T, V41, P861, DOI 10.1042/BST20130058; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Court DL, 2013, ANNU REV GENET, V47, P405, DOI 10.1146/annurev-genet-110711-155618; Daniels SM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-38; Das AK, 2007, ACS CHEM BIOL, V2, P217, DOI 10.1021/cb700064h; Dlakic M, 2006, BIOINFORMATICS, V22, P2711, DOI 10.1093/bioinformatics/btl468; Du Z, 2008, P NATL ACAD SCI USA, V105, P2391, DOI 10.1073/pnas.0711506105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flynn RA, 2016, NAT PROTOC, V11, P273, DOI 10.1038/nprot.2016.011; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Gu S, 2012, CELL, V151, P900, DOI 10.1016/j.cell.2012.09.042; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Heale BSE, 2009, EMBO J, V28, P3145, DOI 10.1038/emboj.2009.244; Heo I, 2012, CELL, V151, P521, DOI 10.1016/j.cell.2012.09.022; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim Y, 2014, CELL REP, V9, P1061, DOI 10.1016/j.celrep.2014.09.039; Kim YK, 2016, P NATL ACAD SCI USA, V113, pE1881, DOI 10.1073/pnas.1602532113; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kurzynska-Kokorniak A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23989; Kwon SC, 2016, CELL, V164, P81, DOI 10.1016/j.cell.2015.12.019; Lau PW, 2012, NAT STRUCT MOL BIOL, V19, P436, DOI 10.1038/nsmb.2268; Lau PW, 2009, STRUCTURE, V17, P1326, DOI 10.1016/j.str.2009.08.013; Lee HY, 2012, RNA, V18, P2012, DOI 10.1261/rna.035501.112; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Li XM, 2015, J STRUCT BIOL, V192, P174, DOI 10.1016/j.jsb.2015.09.003; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Nicholson AW, 2014, WIRES RNA, V5, P31, DOI 10.1002/wrna.1195; Noland CL, 2011, MOL CELL, V43, P110, DOI 10.1016/j.molcel.2011.05.028; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Purzycka KJ, 2015, METHOD ENZYMOL, V553, P3, DOI 10.1016/bs.mie.2014.10.050; Qin HN, 2010, RNA, V16, P474, DOI 10.1261/rna.1965310; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spitale RC, 2015, NATURE, V519, P486, DOI 10.1038/nature14263; Starega-Roslan J, 2011, CELL MOL LIFE SCI, V68, P2859, DOI 10.1007/s00018-011-0726-2; Takeshita D, 2007, J MOL BIOL, V374, P106, DOI 10.1016/j.jmb.2007.08.069; Taylor DW, 2013, NAT STRUCT MOL BIOL, V20, P662, DOI 10.1038/nsmb.2564; Tian Y, 2014, MOL CELL, V53, P606, DOI 10.1016/j.molcel.2014.01.003; Tsutsumi A, 2011, NAT STRUCT MOL BIOL, V18, P1153, DOI 10.1038/nsmb.2125; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Wilson RC, 2015, MOL CELL, V57, P397, DOI 10.1016/j.molcel.2014.11.030; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	68	60	62	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 17	2018	173	5					1191	+		10.1016/j.cell.2018.03.080	http://dx.doi.org/10.1016/j.cell.2018.03.080			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GG1UA	29706542	Bronze			2022-12-28	WOS:000432471700015
J	Durand, CM; Bowring, MG; Thomas, AG; Kucirka, LM; Massie, AB; Cameron, A; Desai, NM; Sulkowski, M; Segev, DL				Durand, Christine M.; Bowring, Mary G.; Thomas, Alvin G.; Kucirka, Lauren M.; Massie, Allan B.; Cameron, Andrew; Desai, Niraj M.; Sulkowski, Mark; Segev, Dorry L.			The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							HEPATITIS-C; KIDNEY; RISK; VIRUS; RECIPIENTS; INCREASES; INFECTION; SURVIVAL; OUTCOMES; DISCARD	Background: The epidemic of drug overdose deaths in the United States has led to an increase in organ donors. Objective: To characterize donors who died of overdose and to analyze outcomes among transplant recipients. Design: Prospective observational cohort study. Setting: Scientific Registry of Transplant Recipients, 1 January 2000 to 1 September 2017. Participants: 138 565 deceased donors; 337 934 transplant recipients at 297 transplant centers. Measurements: The primary exposure was donor mechanism of death (overdose-death donor [ODD], trauma-death donor [TDD], or medical-death donor [MDD]). Patient and graft survival and organ discard (organ recovered but not transplanted) were compared using propensity score-weighted standardized risk differences (sRDs). Results: A total of 7313 ODDs and 19 897 ODD transplants (10 347 kidneys, 5707 livers, 2471 hearts, and 1372 lungs) were identified. Overdose-death donors accounted for 1.1% of donors in 2000 and 13.4% in 2017. They were more likely to be white (85.1%), aged 21 to 40 years (66.3%), infected with hepatitis C virus (HCV) (18.3%), and increased-infectious risk donors (IRDs) (56.4%). Standardized 5-year patient survival was similar for ODD organ recipients compared with TDD organ recipients (sRDs ranged from 3.1% lower to 3.9% higher survival) and MDD organ recipients (sRDs ranged from 2.1% to 5.2% higher survival). Standardized 5-year graft survival was similar between ODD and TDD grafts (minimal difference for kidneys and lungs, marginally lower [sRD, -3.2%] for livers, and marginally higher [sRD, 1.9%] for hearts). Kidney discard was higher for ODDs than TDDs (sRD, 5.2%) or MDDs (sRD, 1.5%); standardization for HCV and IRD status attenuated this difference. Limitation: Inability to distinguish between opioid and nonopioid overdoses. Conclusion: In the United States, transplantation with ODD organs has increased dramatically, with noninferior outcomes in transplant recipients. Concerns about IRD behaviors and hepatitis C among donors lead to excess discard that should be minimized given the current organ shortage.	[Durand, Christine M.] Johns Hopkins Univ, Sch Med, Dept Med, 725 North Wolfe St,Suite 211, Baltimore, MD 21205 USA; [Bowring, Mary G.; Thomas, Alvin G.; Massie, Allan B.; Segev, Dorry L.] Johns Hopkins Univ, Dept Surg, 2000 East Monument St, Baltimore, MD 21205 USA; [Kucirka, Lauren M.] Johns Hopkins Univ, Sch Med, Dept Surg, 2215 East Pratt St, Baltimore, MD 21231 USA; [Cameron, Andrew; Desai, Niraj M.] Johns Hopkins Univ, Dept Med, 720 Rutland Ave,Ross 765,Ross 771, Baltimore, MD 21205 USA; [Sulkowski, Mark] Johns Hopkins Univ, Sch Med, 1830 East Monument St,Room 445, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Durand, CM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, 725 North Wolfe St,Suite 211, Baltimore, MD 21205 USA.	cdurand2@jhmi.edu; mbowrin1@jhmi.edu	Thomas, Alvin/R-9391-2016	Thomas, Alvin/0000-0003-4911-8192	National Institutes of Health; Division of Intramural Research, National Cancer Institute [K23CA177321-01A1]; National Institute of Diabetes and Digestive and Kidney Diseases [F30DK095545, K23DK101677, R01DK111966, K24DK101828, R01AI120938]; National Institute of Allergy and Infectious Diseases [K24DA034621]; NATIONAL CANCER INSTITUTE [K23CA177321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI120938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK095545, R01DK111966, K24DK101828, K01DK101677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016065, K24DA034621] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, National Cancer Institute; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Dr. Durand is supported by the Division of Intramural Research, National Cancer Institute (grant K23CA177321-01A1). Drs. Kucirka, Massie, Cameron, and Segev are supported by the National Institute of Diabetes and Digestive and Kidney Diseases (grants F30DK095545 [Dr. Kucirka], K23DK101677 [Dr. Massie], R01DK111966 [Dr. Cameron], and K24DK101828 and R01AI120938 [Dr. Segev]). Dr. Sulkowski is supported by the National Institute of Allergy and Infectious Diseases (grant K24DA034621).	[Anonymous], 1994, MMWR Recomm Rep, V43, P1; [Anonymous], 2017, ORG PROC TRANSPL NET; Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Ballarin R, 2011, TRANSPLANTATION, V91, P1265, DOI 10.1097/TP.0b013e318219eb8f; Bowring MG, 2017, AM J TRANSPLANT, V17, P519, DOI 10.1111/ajt.13976; Bowring MG, 2018, AM J TRANSPLANT, V18, P617, DOI 10.1111/ajt.14577; Brown RS, 2016, LIVER TRANSPLANT, V22, P24, DOI 10.1002/lt.24366; Centers for Disease Control and Prevention National Center for Health Statistics, 2017, UND CAUS DEATH 1999; Cohen JB, 2017, CLIN KIDNEY J, V10, P564, DOI 10.1093/ckj/sfx048; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; Danovitch GM, 2005, AM J TRANSPLANT, V5, P904, DOI 10.1111/j.1600-6135.2005.00835.x; Dumortier J, 2016, LIVER TRANSPLANT, V22, P1367, DOI 10.1002/lt.24505; Durand CM, 2018, ANN INTERN MED, V168, P533, DOI 10.7326/M17-2871; Friedewald JJ, 2012, AM J TRANSPLANT, V12, P1971, DOI 10.1111/j.1600-6143.2012.04149.x; Gill JS, 2007, KIDNEY INT, V71, P442, DOI 10.1038/sj.ki.5002072; Gok MA, 2004, CLIN TRANSPLANT, V18, P541, DOI 10.1111/j.1399-0012.2004.00207.x; Goldberg DS, 2016, AM J TRANSPLANT, V16, P2836, DOI 10.1111/ajt.13971; Goldberg DS, 2017, NEW ENGL J MED, V376, P2394, DOI 10.1056/NEJMc1705221; Gordon EJ, 2014, TRANSPL INFECT DIS, V16, P251, DOI 10.1111/tid.12199; Goss M, 2017, LIVER TRANSPLANT, V23, P698, DOI 10.1002/lt.24761; Kucirka LM, 2011, AM J TRANSPLANT, V11, P1176, DOI 10.1111/j.1600-6143.2010.03329.x; Kucirka LM, 2011, AM J TRANSPLANT, V11, P1188, DOI 10.1111/j.1600-6143.2011.03460.x; Kucirka LM, 2010, AM J TRANSPLANT, V10, P1238, DOI 10.1111/j.1600-6143.2010.03091.x; Marrero WJ, 2017, TRANSPLANTATION, V101, P1690, DOI 10.1097/TP.0000000000001238; Massie AB, 2010, AM J TRANSPLANT, V10, P2472, DOI 10.1111/j.1600-6143.2010.03294.x; Metzger RA, 2003, AM J TRANSPLANT, V3, P114, DOI 10.1034/j.1600-6143.3.s4.11.x; Montenovo MI, 2015, ANN TRANSPL, V20, P44, DOI 10.12659/AOT.892530; Rao PS, 2009, TRANSPLANTATION, V88, P231, DOI 10.1097/TP.0b013e3181ac620b; Reese PP, 2015, NEW ENGL J MED, V373, P303, DOI 10.1056/NEJMp1505074; Reese PP, 2010, CLIN J AM SOC NEPHRO, V5, P917, DOI 10.2215/CJN.08251109; Ros RL, 2012, CLIN TRANSPLANT, V26, P247, DOI 10.1111/j.1399-0012.2011.01469.x; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Rudd RA, 2014, MMWR-MORBID MORTAL W, V63, P849; Saxena V, 2017, HEPATOLOGY, V66, P1090, DOI 10.1002/hep.29258; Scientific Registry of Transplant Recipients, 2018, SRTR RISK ADJ MOD DO; Seem DL, 2013, PUBLIC HEALTH REP, V128, P247, DOI 10.1177/003335491312800403; Sutter ME, 2010, WEST J EMERG MED, V11, P506; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Weiner SG, 2017, TRANSPLANTATION, V101, P678, DOI 10.1097/TP.0000000000001671; Weinkauf JG, 2013, TRANSPL P, V45, P2375, DOI 10.1016/j.transproceed.2012.11.004	42	132	132	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2018	168	10					702	+		10.7326/M17-2451	http://dx.doi.org/10.7326/M17-2451			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3DE	29710288	Green Accepted			2022-12-28	WOS:000434250700014
J	Myrow, PM; Lamb, MP; Ewing, RC				Myrow, P. M.; Lamb, M. P.; Ewing, R. C.			Rapid sea level rise in the aftermath of a Neoproterozoic snowball Earth	SCIENCE			English	Article							SOUTH-AUSTRALIA; CAP CARBONATE; LOW-LATITUDE; GLACIATION; SHEET; WAVES; SHELF; FLOW	Earth's most severe climate changes occurred during global-scale "snowball Earth" glaciations, which profoundly altered the planet's atmosphere, oceans, and biosphere. Extreme rates of glacioeustatic sea level rise are predicted by the snowball Earth hypothesis, but supporting geologic evidence has been lacking. We use paleohydraulic analysis of wave ripples and tidal laminae in the Elatina Formation, Australia-deposited after the Marinoan glaciation similar to 635 million years ago-to show that water depths of 9 to 16 meters remained nearly constant for similar to 100 years throughout 27 meters of sediment accumulation. This accumulation rate was too great to have been accommodated by subsidence and instead indicates an extraordinarily rapid rate of sea level rise (0.2 to 0.27 meters per year). Our results substantiate a fundamental prediction of snowball Earth models of rapid deglaciation during the early transition to a supergreenhouse climate.	[Myrow, P. M.] Colorado Coll, Dept Geol, Colorado Springs, CO 80903 USA; [Lamb, M. P.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91124 USA; [Ewing, R. C.] Texas A&M Univ, Dept Geol & Geophys, College Stn, TX 77843 USA	Colorado College; California Institute of Technology; Texas A&M University System; Texas A&M University College Station	Myrow, PM (corresponding author), Colorado Coll, Dept Geol, Colorado Springs, CO 80903 USA.	pmyrow@coloradocollege.edu		Ewing, Ryan/0000-0001-6337-610X	U.S. National Science Foundation [EAR-1225879, EAR-PF-0846233]	U.S. National Science Foundation(National Science Foundation (NSF))	This study was supported by the U.S. National Science Foundation through award EAR-1225879 to P.M.M. and award EAR-PF-0846233 to R.C.E.	Allen PA, 2005, NATURE, V433, P123, DOI 10.1038/nature03176; Carminati E, 2002, ENG GEOL, V66, P241, DOI 10.1016/S0013-7952(02)00031-5; Clifton H. E., 1984, WAVE DOMINATED COAST, P165; Creveling JR, 2014, EARTH PLANET SC LETT, V399, P74, DOI 10.1016/j.epsl.2014.04.029; Cronin TM, 2012, QUATERNARY SCI REV, V56, P11, DOI 10.1016/j.quascirev.2012.08.021; Evans DAD, 2011, GEOL SOC MEM, V36, P93, DOI 10.1144/M36.7; Ewing RC, 2014, EARTH PLANET SC LETT, V406, P110, DOI 10.1016/j.epsl.2014.09.017; Grotzinger JP, 2015, SCIENCE, V350, DOI 10.1126/science.aac7575; Hanebuth T, 2000, SCIENCE, V288, P1033, DOI 10.1126/science.288.5468.1033; Hoffman PF, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600983; Hoffman PF, 2011, SEDIMENTOLOGY, V58, P57, DOI 10.1111/j.1365-3091.2010.01206.x; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; Kilner B, 2005, GEOLOGY, V33, P413, DOI 10.1130/G21227.1; Kirschvink J. L., 1992, PROTEROZOIC BIOSPHER, P51; Lamb MP, 2005, J SEDIMENT RES, V75, P386, DOI 10.2110/jsr.2005.030; Myrow PM, 2002, J SEDIMENT RES, V72, P641, DOI 10.1306/022102720641; Partin CA, 2016, GEOLOGY, V44, P1019, DOI 10.1130/G38350.1; Preiss W., 1987, GEOLOGICAL SURVEY S, V53, P29; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Rose CV, 2013, GEOSCI CAN, V40, P256, DOI 10.12789/geocanj.2013.40.019; SCHMIDT PW, 1995, EARTH PLANET SC LETT, V134, P107, DOI 10.1016/0012-821X(95)00106-M; Trindade RIF, 2003, TERRA NOVA, V15, P441, DOI 10.1046/j.1365-3121.2003.00510.x; WIBERG PL, 1994, J GEOPHYS RES-OCEANS, V99, P775, DOI 10.1029/93JC02726; WILLIAMS GE, 1989, J GEOL SOC LONDON, V146, P97, DOI 10.1144/gsjgs.146.1.0097; Williams GE, 1998, AUST J EARTH SCI, V45, P733, DOI 10.1080/08120099808728429; WILLIAMS GE, 1981, NATURE, V291, P624, DOI 10.1038/291624a0; Yang J, 2017, GEOLOGY, V45, P615, DOI 10.1130/G38920.1; You ZJ, 2006, SEDIMENTOLOGY, V53, P1181, DOI 10.1111/j.1365-3091.2006.00810.x	28	27	28	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2018	360	6389					649	651		10.1126/science.aap8612	http://dx.doi.org/10.1126/science.aap8612			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2SV	29674430	Bronze			2022-12-28	WOS:000431790900044
J	Barker, M; Dombrowski, SU; Colbourn, T; Fall, CHD; Kriznik, NM; Lawrence, WT; Norris, SA; Ngaiza, G; Patel, D; Skordis-Worrall, J; Sniehotta, FF; Steegers-Theunissen, R; Vogel, C; Woods-Townsend, K; Stephenson, J				Barker, Mary; Dombrowski, Stephan U.; Colbourn, Tim; Fall, Caroline H. D.; Kriznik, Natasha M.; Lawrence, Wendy T.; Norris, Shane A.; Ngaiza, Gloria; Patel, Dilisha; Skordis-Worrall, Jolene; Sniehotta, Falko F.; Steegers-Theunissen, Regine; Vogel, Christina; Woods-Townsend, Kathryn; Stephenson, Judith			Intervention strategies to improve nutrition and health behaviours before conception	LANCET			English	Article							OBESITY-RELATED BEHAVIORS; LOW-BIRTH-WEIGHT; LIFE-STYLE; PHYSICAL-ACTIVITY; ADOLESCENT GIRLS; POSTPARTUM WOMEN; MATERNAL NUTRITION; CONTROLLED-TRIAL; CHILD NUTRITION; SOUTH-AFRICA	The nutritional status of both women and men before conception has profound implications for the growth, development, and long-term health of their offspring. Evidence of the effectiveness of preconception interventions for improving outcomes for mothers and babies is scarce. However, given the large potential health return, and relatively low costs and risk of harm, research into potential interventions is warranted. We identified three promising strategies for intervention that are likely to be scalable and have positive effects on a range of health outcomes: supplementation and fortification; cash transfers and incentives; and behaviour change interventions. On the basis of these strategies, we suggest a model specifying pathways to effect. Pathways are incorporated into a life-course framework using individual motivation and receptiveness at different preconception action phases, to guide design and targeting of preconception interventions. Interventions for individuals not planning immediate pregnancy take advantage of settings and implementation platforms outside the maternal and child health arena, since this group is unlikely to be engaged with maternal health services. Interventions to improve women's nutritional status and health behaviours at all preconception action phases should consider social and environmental determinants, to avoid exacerbating health and gender inequalities, and be underpinned by a social movement that touches the whole population. We propose a dual strategy that targets specific groups actively planning a pregnancy, while improving the health of the population more broadly. Modern marketing techniques could be used to promote a social movement based on an emotional and symbolic connection between improved preconception maternal health and nutrition, and offspring health. We suggest that speedy and scalable benefits to public health might be achieved through strategic engagement with the private sector. Political theory supports the development of an advocacy coalition of groups interested in preconception health, to harness the political will and leadership necessary to turn high-level policy into effective coordinated action.	[Barker, Mary; Fall, Caroline H. D.; Lawrence, Wendy T.; Vogel, Christina] Univ Southampton, Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Barker, Mary; Lawrence, Wendy T.; Vogel, Christina; Woods-Townsend, Kathryn] Southampton Gen Hosp, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Dombrowski, Stephan U.] Univ Stirling, Div Psychol, Fac Nat Sci, Stirling, Scotland; [Colbourn, Tim; Ngaiza, Gloria; Skordis-Worrall, Jolene] UCL, UCL Inst Global Hlth, London, England; [Patel, Dilisha; Stephenson, Judith] UCL, UCL EGA Inst Womens Hlth, Fac Populat Hlth Sci, London, England; [Kriznik, Natasha M.] Univ Cambridge, Healthcare Improvement Studies Inst, Cambridge, England; [Norris, Shane A.] Univ Witwatersrand, Sch Clin Med, Dept Paediat, MRC Dev Pathways Hlth Res Unit,Fac Hlth Sci, Johannesburg, South Africa; [Sniehotta, Falko F.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Sniehotta, Falko F.] Fuse, Newcastle Upon Tyne, Tyne & Wear, England; [Steegers-Theunissen, Regine] Univ Med Ctr, Erasmus MC, Dept Obstet & Gynaecol, Rotterdam, Netherlands; [Steegers-Theunissen, Regine] Univ Med Ctr, Erasmus MC, Dept Pediat, Div Neonatol, Rotterdam, Netherlands; [Woods-Townsend, Kathryn] Univ Southampton, Southampton Educ Sch, Fac Social & Human Sci, Southampton, Hants, England	University of Southampton; University of Southampton; University of Stirling; University of London; University College London; University of London; University College London; University of Cambridge; University of Witwatersrand; Newcastle University - UK; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Southampton	Stephenson, J (corresponding author), UCL, Inst Womens Hlth, Fac Populat Hlth Sci, Med Sch Bldg,74 Huntley St, London WC1E 6AU, England.	judith.stephenson@ucl.ac.uk	Colbourn, Tim/AAE-6645-2019; Sniehotta, Falko F/C-5481-2008; Sniehotta, Falko/ABF-7131-2021; Norris, Shane/C-4664-2014	Colbourn, Tim/0000-0002-6917-6552; Sniehotta, Falko F/0000-0003-1738-4269; Sniehotta, Falko/0000-0003-1738-4269; Norris, Shane/0000-0001-7124-3788; Lawrence, Wendy/0000-0003-1264-0438; Barker, Mary/0000-0003-2976-0217; Fall, Caroline/0000-0003-4402-5552; Kriznik, Natasha/0000-0002-4291-0614; Woods-Townsend, Kathryn/0000-0003-3376-6988; Skordis, Jolene/0000-0002-8633-0208; Vogel, Christina/0000-0002-3897-3786	Rank Prize Funds, on Preconception Nutrition and Lifelong Health in Grasmere, UK; MRC [MC_PC_MR/R018545/1, MR/N011848/1, MC_UP_A620_1017, MC_UU_12011/4, MC_UU_12011/3] Funding Source: UKRI	Rank Prize Funds, on Preconception Nutrition and Lifelong Health in Grasmere, UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The idea for this Series was conceived by JS and developed during a 4-day symposium, led by MB and JS and funded by The Rank Prize Funds, on Preconception Nutrition and Lifelong Health in Grasmere, UK, February, 2016. We thank a number of individuals who have contributed their thoughts and time to this paper: Nicola Heslehurst (Newcastle University, Newcastle, UK) for her contribution to an early draft of the paper; Zulfi Bhutta (Aga Khan University, Karachi, Pakistan) for his perspectives on interventions in LMICs; Chandni Jacob and Mark Hanson (University of Southampton, Southampton, UK) for their contribution to the review; Jayne Hutchinson and Janet Cade (University of Leeds, Leeds, UK) for advice on fortification; Matthijs van Dijk (Erasmus MC, Rotterdam, Netherlands) for data from Smarter Pregnancy; Julius Cheah and the Jom Mama project partners comprised of the Ministry of Health of Malaysia (Putrajaya, Malaysia), University of Southampton (Southampton, UK), University of Witwatersrand (Johannesburg, South Africa), Steno Diabetes Center (Gentofte, Denmark), and Novo Nordisk (Gentofte, Denmark); Mike Kelly (University of Cambridge, Cambridge, UK) for discussions on the value of social practices; and Andy Last (MullenLowe salt, London, UK) for his insights into how a social movement might be created around preconception health.	Acosta AM, 2011, EXAMINING POLITICAL; Adams J, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1001990, 10.1371/journal.pmed.1002045]; Bachrach CA, 2013, POPUL DEV REV, V39, P459, DOI 10.1111/j.1728-4457.2013.00612.x; Baird J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005290; Barker M, 2006, J NUTR, V136, P3062, DOI 10.1093/jn/136.12.3062; Bates B, 2014, NATL DIET NUTR SURVE; Bhutta ZA, 2017, ANN NY ACAD SCI, V1393, P61, DOI 10.1111/nyas.13352; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; BIRDWELL AE, 1968, J BUS, V41, P76, DOI 10.1086/295047; Black C, 2014, PUBLIC HEALTH NUTR, V17, P700, DOI 10.1017/S1368980012004089; Black RE, 2013, LANCET, V382, P372, DOI 10.1016/S0140-6736(13)60988-5; Blakemore SJ, 2014, ANNU REV PSYCHOL, V65, P187, DOI 10.1146/annurev-psych-010213-115202; Brady JP, 2012, ARCH DIS CHILD, V97, P529, DOI 10.1136/archdischild-2011-301299; CAAN B, 1987, AM J CLIN NUTR, V45, P29, DOI 10.1093/ajcn/45.1.29; Ceschia A, 2016, LANCET, V388, P2064, DOI 10.1016/S0140-6736(16)31534-3; Chorghade GP, 2006, PUBLIC HEALTH NUTR, V9, P9, DOI 10.1079/PHN2005762; Compernolle S, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0147-3; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; Crider KS, 2011, NUTRIENTS, V3, P370, DOI 10.3390/nu3030370; De-Regil LM, 2016, J NUTR, V146, p1461S, DOI 10.3945/jn.115.223487; Dennison L, 2014, J MED INTERNET RES, V16, P130, DOI 10.2196/jmir.3199; Dodd JM, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0161-y; Draper CE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-S2-S5; Elsinga J, 2008, WOMEN HEALTH ISS, V18, pS117, DOI 10.1016/j.whi.2008.09.003; Fenn B, 2015, RES FOOD ASSISTANCE; Fenn B, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002305; Flynn AC, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0450-2; Food Fortification Initiative, 2017, SAY HELL FORT FUT 20; Gaglio B, 2013, AM J PUBLIC HEALTH, V103, pE38, DOI 10.2105/AJPH.2013.301299; Gardner B, 2011, OBES REV, V12, pE602, DOI 10.1111/j.1467-789X.2011.00884.x; Gaziano TA, 2015, LANCET GLOB HEALTH, V3, pE556, DOI 10.1016/S2214-109X(15)00143-6; Godfrey KM, 2010, TRENDS ENDOCRIN MET, V21, P199, DOI 10.1016/j.tem.2009.12.008; Grace M, 2012, HEALTH EDUC, V112, P543, DOI 10.1108/09654281211275890; Hammiche F, 2011, HUM REPROD, V26, P2432, DOI 10.1093/humrep/der225; Hawkes C., 2017, GLOBAL NUTR REPORT 2; Hawkes C, 2008, DEV POLICY REV, V26, P657, DOI 10.1111/j.1467-7679.2008.00428.x; Heckhausen H., 1991, MOTIVATION ACTION; Heckhausen J, 2006, DEV REGULATION ADULT; Herman DR, 2006, J AM DIET ASSOC, V106, P740, DOI 10.1016/j.jada.2006.02.004; Huseinovic E, 2016, AM J CLIN NUTR, V104, P362, DOI 10.3945/ajcn.116.135673; Hussein N, 2016, EUR J GEN PRACT, V22, P42, DOI 10.3109/13814788.2015.1099039; Kelly MP, 2016, PUBLIC HEALTH, V136, P109, DOI 10.1016/j.puhe.2016.03.030; King JC, 2016, J NUTR, V146, p1437S, DOI 10.3945/jn.115.223479; Kirkpatrick S, 2017, FASEB J, V31; Kwasnicka D, 2016, HEALTH PSYCHOL REV, V10, P277, DOI 10.1080/17437199.2016.1151372; Lassi ZS, 2012, INT J WOMENS HEALTH, V4, P185, DOI 10.2147/IJWH.S18611; Last A., 2016, BUSINESS MISSION BUI; Lawrence W, 2016, J HEALTH PSYCHOL, V21, P138, DOI 10.1177/1359105314523304; Lee SH, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010401; Lim S, 2015, OBES REV, V16, P972, DOI 10.1111/obr.12312; Lorenc T, 2013, J EPIDEMIOL COMMUN H, V67, P190, DOI 10.1136/jech-2012-201257; Lumley J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-299; Manley J, 2012, EFFECTIVE ARE CASH T; Mastroiacovo P, 2011, BIOFACTORS, V37, P272, DOI 10.1002/biof.172; MCDONALD EC, 1981, AM J CLIN NUTR, V34, P2133, DOI 10.1093/ajcn/34.10.2133; Michie S, 2013, HEALTH PSYCHOL REV, V7, P1, DOI 10.1080/17437199.2011.649445; Miller W B, 1994, Genet Soc Gen Psychol Monogr, V120, P223; Monteiro CA, 2010, B WORLD HEALTH ORGAN, V88, P305, DOI 10.2471/BLT.09.069195; Morrison J, 2018, PUBLIC HEALTH NUTR, V21, P377, DOI 10.1017/S1368980017002646; Muktabhant B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007145.pub3; Nair N, 2017, LANCET GLOB HEALTH, V5, pE1004, DOI 10.1016/S2214-109X(17)30339-X; Nair N, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1655-z; Nettle D, 2011, PHILOS T R SOC B, V366, P357, DOI 10.1098/rstb.2010.0073; Neville CE, 2014, BIRTH-ISS PERINAT C, V41, P223, DOI 10.1111/birt.12111; Norris SA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3827-x; Patel V, 2017, LANCET, V389, P176, DOI 10.1016/S0140-6736(16)31589-6; Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1; Peacock AS, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/423717; Pechey R, 2015, AM J PREV MED, V49, P868, DOI 10.1016/j.amepre.2015.04.020; Pena-Rosas JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub4; Phelan S, 2017, JAMA-J AM MED ASSOC, V317, P2381, DOI 10.1001/jama.2017.7119; Poston L, 2016, LANCET DIABETES ENDO, V4, P1025, DOI 10.1016/S2213-8587(16)30217-0; Potdar RD, 2014, AM J CLIN NUTR, V100, P1257, DOI 10.3945/ajcn.114.084921; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Ramakrishnan U, 2012, PAEDIATR PERINAT EP, V26, P285, DOI 10.1111/j.1365-3016.2012.01281.x; Rawlings LB, 2005, WORLD BANK RES OBSER, V20, P29, DOI 10.1093/wbro/lki001; Ritchie LD, 2010, J NUTR EDUC BEHAV, V42, pS2, DOI 10.1016/j.jneb.2010.02.014; Ruel MT, 2013, LANCET, V382, P536, DOI 10.1016/S0140-6736(13)60843-0; Sahariah SA, 2016, J NUTR, V146, p1453S, DOI 10.3945/jn.115.223461; Santos I, 2017, OBES REV, V18, P32, DOI 10.1111/obr.12466; Saville NM, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1102-x; Scientific Advisory Committee on Nutrition (SACN), 2017, FOL AC UPD SACN REC; Shove E., 2012, DYNAMICS SOCIAL PRAC, DOI DOI 10.4135/9781446250655; Steegers EAP, 2016, PAEDIATR PERINAT EP, V30, P201, DOI 10.1111/ppe.12275; Swinburn B, 2015, LANCET, V385, P2534, DOI 10.1016/S0140-6736(14)61747-5; Tanentsapf I, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-81; Tuomainen H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002977; Twigt JM, 2012, HUM REPROD, V27, P2526, DOI 10.1093/humrep/des157; UN Department of Economic and Social Affairs, 2016, SUST DEV GOAL 2, V2; Unilever, 2015, KNORRS GREEN FOOD ST; United Nations Secretary-General, 2015, GLOB STRAT WOM CHILD; US Centers for Disease Control and Prevention, 2014, MY REPR LIF PLAN; van der Pligt P, 2013, OBES REV, V14, P792, DOI 10.1111/obr.12053; van Dijk MR, 2017, REPROD BIOMED ONLINE, V35, P453, DOI 10.1016/j.rbmo.2017.06.014; Van Dijk Matthijs R, 2016, JMIR Mhealth Uhealth, V4, pe53, DOI 10.2196/mhealth.5197; Vansteenkiste M, 2004, J PERS SOC PSYCHOL, V87, P246, DOI 10.1037/0022-3514.87.2.246; Viner RM, 2015, J EPIDEMIOL COMMUN H, V69, P719, DOI 10.1136/jech-2014-205300; Vogel C, 2016, AM J PREV MED, V51, pE27, DOI 10.1016/j.amepre.2016.02.030; Weible CM, 2007, PUBLIC ADM PUBLIC PO, V125, P123; Whitworth M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007536.pub2; WHO, 2014, GUID FORT FOOD GRAD, P1; WHO, 2017, GLOB ACC ACT HLTH AD; WHO/UNICEF, 2014, GLOB NUTR TARG 2025, DOI [10.1057/9781137477699_6, DOI 10.1057/9781137477699_6]; Woods-Townsend K, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0890-z; World Health Organisation, 2013, M DEV GLOB CONS PREC	105	173	174	8	90	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2018	391	10132					1853	1864		10.1016/S0140-6736(18)30313-1	http://dx.doi.org/10.1016/S0140-6736(18)30313-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GE7NY	29673875	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000431421300030
J	Gogalniceanu, P; Lancaster, RT; Patel, VI				Gogalniceanu, Peter; Lancaster, Robert T.; Patel, Virendra I.			Clinical Assessment of Peripheral Arterial Disease of the Lower Limbs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LOWER-EXTREMITY; PRACTICE GUIDELINES; VASCULAR-SURGERY; TASK-FORCE; MANAGEMENT; SOCIETY		[Gogalniceanu, Peter] Royal Free Hosp, London, England; [Lancaster, Robert T.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Patel, Virendra I.] New York Presbyterian Columbia Univ, Med Ctr, New York, NY USA	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Harvard University; Massachusetts General Hospital	Gogalniceanu, P (corresponding author), Royal Free Hosp, London, England.							Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; BREWSTER D C, 1991, Cardiology Clinics, V9, P497; Conte MS, 2015, J VASC SURG, V61, p2S, DOI 10.1016/j.jvs.2014.12.009; Creager MA, 2012, NEW ENGL J MED, V366, P2198, DOI 10.1056/NEJMcp1006054; Gogalniceanu P, 2015, PHYS EXAMINATION SUR, P223; Grenon SM, 2009, NEW ENGL J MED, V361, DOI 10.1056/NEJMvcm0807012; Hirsch AT, 2006, CIRCULATION, V113, P1474, DOI 10.1161/CIRCULATIONAHA.106.173994; Khan NA, 2006, JAMA-J AM MED ASSOC, V295, P536, DOI 10.1001/jama.295.5.536; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Wennberg PW, 2013, CIRCULATION, V128, P2241, DOI 10.1161/CIRCULATIONAHA.113.000502	11	8	8	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2018	378	18								10.1056/NEJMvcm1406358	http://dx.doi.org/10.1056/NEJMvcm1406358			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GE4WO	29719182				2022-12-28	WOS:000431218600009
J	Nigwekar, SU; Thadhani, R; Brandenburg, VM				Nigwekar, Sagar U.; Thadhani, Ravi; Brandenburg, Vincent M.			Calciphylaxis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CALCIFIC UREMIC ARTERIOLOPATHY; MATRIX GLA-PROTEIN; GENERALIZED ARTERIAL CALCIFICATION; VITAMIN-K SUPPLEMENTATION; SODIUM THIOSULFATE; VASCULAR CALCIFICATION; RISK-FACTORS; RENAL-DISEASE; DEPENDENT CARBOXYLATION; DIALYSIS PATIENTS		[Nigwekar, Sagar U.; Thadhani, Ravi] Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA; [Thadhani, Ravi] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Thadhani, Ravi] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Brandenburg, Vincent M.] RWTH Aachen Univ Hosp, Dept Cardiol, Pauwelsstr 30, D-52057 Aachen, Germany; [Brandenburg, Vincent M.] Rhein Maas Klinikum, Dept Cardiol, Wurselen, Germany	Harvard University; Massachusetts General Hospital; Cedars Sinai Medical Center; Cedars Sinai Medical Center; RWTH Aachen University; RWTH Aachen University Hospital	Brandenburg, VM (corresponding author), RWTH Aachen Univ Hosp, Dept Cardiol, Pauwelsstr 30, D-52057 Aachen, Germany.	vincent.brandenburg@post.rwth-aachen.de			Sanofi Aventis; Hope Pharmaceuticals; Allena Pharmaceuticals; Epizon; Fresenius Medical Care; Amgen; Sanifit; Bayer; Pharmacosmos; Pfizer	Sanofi Aventis(Sanofi-Aventis); Hope Pharmaceuticals; Allena Pharmaceuticals; Epizon; Fresenius Medical Care; Amgen(Amgen); Sanifit; Bayer(Bayer AG); Pharmacosmos; Pfizer(Pfizer)	Dr. Nigwekar reports receiving grant support from Sanofi Aventis, Hope Pharmaceuticals, and Allena Pharmaceuticals, and consulting fees from Epizon; Dr. Thadhani, receiving consulting fees from Fresenius Medical Care; and Dr. Brandenburg, receiving grant support paid to the European Calciphylaxis Network (EuCalNet) from Amgen, grant support from Sanifit, Bayer, and Pharmacosmos, and lecture fees from Pfizer. No other potential conflict of interest relevant to this article was reported.	Albright RA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10006; Amuluru L, 2009, J AM ACAD DERMATOL, V61, P73, DOI 10.1016/j.jaad.2009.01.042; An J, 2015, NEPHROLOGY, V20, P444, DOI 10.1111/nep.12433; [Anonymous], 2007, NEW ENGL J MED, V356, P1049; Araki N, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0421-3; Araya CE, 2006, CLIN J AM SOC NEPHRO, V1, P1161, DOI 10.2215/CJN.01520506; Baldwin C, 2011, AM J KIDNEY DIS, V58, P988, DOI 10.1053/j.ajkd.2011.06.022; Brandenburg VM, 2017, CIRCULATION, V135, P2081, DOI 10.1161/CIRCULATIONAHA.116.027011; Brandenburg VM, 2017, NEPHROL DIAL TRANSPL, V32, P126, DOI 10.1093/ndt/gfv438; Brandenburg VM, 2016, NEPHROL DIAL TRANSPL, V31, P1211, DOI 10.1093/ndt/gfw025; Cassius C, 2018, BRIT J DERMATOL, V178, P292, DOI 10.1111/bjd.15655; Chen NX, 2014, BIOCHEM BIOPH RES CO, V449, P151, DOI 10.1016/j.bbrc.2014.05.005; Chen TY, 2017, AM J DERMATOPATH, V39, P795, DOI 10.1097/DAD.0000000000000824; Chertow GM, 2012, NEW ENGL J MED, V367, P2482, DOI 10.1056/NEJMoa1205624; Coates T, 1998, AM J KIDNEY DIS, V32, P384, DOI 10.1053/ajkd.1998.v32.pm9740153; Dauden E, 2008, DERMATOL CLIN, V26, P557, DOI 10.1016/j.det.2008.05.006; Dobry AS, 2018, JAMA DERMATOL, V154, P182, DOI 10.1001/jamadermatol.2017.4920; Fine A, 2002, KIDNEY INT, V61, P2210, DOI 10.1046/j.1523-1755.2002.00375.x; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Ghosh T, 2017, INT J DERMATOL, V56, P856, DOI 10.1111/ijd.13622; Griethe W, 2003, J NEPHROL, V16, P728; Hayashi M, 2013, CLIN EXP NEPHROL, V17, P498, DOI 10.1007/s10157-013-0782-z; Hayashi M, 2012, NEPHROL DIAL TRANSPL, V27, P1580, DOI 10.1093/ndt/gfr658; Honda Y, 2015, EUR J DERMATOL, V25, P497, DOI 10.1684/ejd.2015.2627; James LR, 1999, AM J KIDNEY DIS, V34, P932, DOI 10.1016/S0272-6386(99)70053-3; Kalajian AH, 2009, ARCH DERMATOL, V145, P451, DOI 10.1001/archdermatol.2008.602; King BJ, 2017, INT J DERMATOL, V56, P1065, DOI 10.1111/ijd.13685; Knapen MHJ, 2015, THROMB HAEMOSTASIS, V113, P1135, DOI 10.1160/TH14-08-0675; Kramann R, 2013, NEPHROL DIAL TRANSPL, V28, P856, DOI 10.1093/ndt/gfs466; Lomashvili KA, 2014, KIDNEY INT, V85, P1351, DOI 10.1038/ki.2013.521; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Mawad HW, 1999, CLIN NEPHROL, V52, P160; McCarthy JT, 2016, MAYO CLIN PROC, V91, P1384, DOI 10.1016/j.mayocp.2016.06.025; Mikhaylova L, 2007, CALCIFIED TISSUE INT, V81, P372, DOI 10.1007/s00223-007-9073-6; Mochel MC, 2013, AM J DERMATOPATH, V35, P582, DOI 10.1097/DAD.0b013e31827c7f5d; Moe SM, 2003, PEDIATR NEPHROL, V18, P969, DOI 10.1007/s00467-003-1276-0; Mutch DM, 2009, INT J OBESITY, V33, P354, DOI 10.1038/ijo.2009.3; Nigwekar SU, 2008, CLIN J AM SOC NEPHRO, V3, P1139, DOI 10.2215/CJN.00530108; Nigwekar SU, 2017, AM J NEPHROL, V46, P429, DOI 10.1159/000484418; Nigwekar SU, 2017, CURR OPIN NEPHROL HY, V26, P276, DOI 10.1097/MNH.0000000000000328; Nigwekar SU, 2017, J AM SOC NEPHROL, V28, P1717, DOI 10.1681/ASN.2016060651; Nigwekar SU, 2016, J AM SOC NEPHROL, V27, P3421, DOI 10.1681/ASN.2015091065; Nigwekar SU, 2016, SEMIN DIALYSIS, V29, P312, DOI 10.1111/sdi.12502; Nigwekar SU, 2014, J GEN INTERN MED, V29, pS924, DOI 10.1007/s11606-014-2910-1; Nigwekar SU, 2013, CLIN J AM SOC NEPHRO, V8, P1162, DOI 10.2215/CJN.09880912; Nigwekar SU, 2013, AM J NEPHROL, V37, P325, DOI 10.1159/000348806; Nordheim E, 2016, TRANSPLANT DIRECT, V2, DOI 10.1097/TXD.0000000000000627; Paul S, 2017, JAMA DERMATOL, V153, P101, DOI 10.1001/jamadermatol.2015.4591; Pillai ICL, 2017, CELL STEM CELL, V20, P218, DOI 10.1016/j.stem.2016.10.005; Polizzotto MN, 2006, J PAIN SYMPTOM MANAG, V32, P186, DOI 10.1016/j.jpainsymman.2006.03.009; Ramjan KA, 2009, NAT CLIN PRACT ENDOC, V5, P167, DOI 10.1038/ncpendmet1067; Riemer CA, 2017, BRIT J DERMATOL, V177, P1510, DOI 10.1111/bjd.15702; Rothe H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172407; Santos PW, 2017, INT UROL NEPHROL, V49, P2247, DOI 10.1007/s11255-017-1721-9; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schurgers LJ, 2013, TRENDS MOL MED, V19, P217, DOI 10.1016/j.molmed.2012.12.008; Scialla JJ, 2013, KIDNEY INT, V83, P1159, DOI 10.1038/ki.2013.3; SELYE H, 1961, SCIENCE, V134, P1876, DOI 10.1126/science.134.3493.1876; Shea MK, 2009, AM J CLIN NUTR, V89, P1799, DOI 10.3945/ajcn.2008.27338; Shmidt E, 2012, J AM ACAD DERMATOL, V67, P1296, DOI 10.1016/j.jaad.2012.05.037; Shroff R, 2013, J AM SOC NEPHROL, V24, P179, DOI 10.1681/ASN.2011121191; Singh RP, 2011, CLIN J AM SOC NEPHRO, V6, P1155, DOI 10.2215/CJN.09671010; Smith ER, 2013, NEPHROLOGY, V18, P215, DOI 10.1111/nep.12021; Sowers KM, 2010, OXID MED CELL LONGEV, V3, P109, DOI 10.4161/oxim.3.2.11354; Spanakis EK, 2014, OSTEOPOROSIS INT, V25, P1411, DOI 10.1007/s00198-013-2580-6; Sprague SM, 2014, CLIN J AM SOC NEPHRO, V9, P166, DOI 10.2215/CJN.00320113; St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI [10.1056/NEJMoa0912923, 10.1056/NEJMc1102515]; Strazzula L, 2013, JAMA DERMATOL, V149, P946, DOI 10.1001/jamadermatol.2013.4565; Torregrosa JV, 2015, CLIN NEPHROL, V83, P231, DOI 10.5414/CN107923; Vanparys J, 2013, ACTA CLIN BELG, V68, P128, DOI 10.2143/ACB.3191; Weenig RH, 2007, J AM ACAD DERMATOL, V56, P569, DOI 10.1016/j.jaad.2006.08.065; Wilmer WA, 2001, AM J KIDNEY DIS, V37, P797, DOI 10.1016/S0272-6386(01)80129-3; Yamada S, 2017, BONE, V100, P87, DOI 10.1016/j.bone.2016.11.012; Zhang YC, 2016, INT J NEPHROL RENOV, V9, P235, DOI 10.2147/IJNRD.S115701; Zitt E, 2013, NEPHROL DIAL TRANSPL, V28, P1232, DOI 10.1093/ndt/gfs548	75	193	206	3	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2018	378	18					1704	1714		10.1056/NEJMra1505292	http://dx.doi.org/10.1056/NEJMra1505292			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GE4WO	29719190				2022-12-28	WOS:000431218600008
J	Bambouskova, M; Gorvel, L; Lampropoulou, V; Sergushichev, A; Loginicheva, E; Johnson, K; Korenfeld, D; Mathyer, ME; Kim, H; Huang, LH; Duncan, D; Bregman, H; Keskin, A; Santeford, A; Apte, RS; Sehgal, R; Johnson, B; Amarasinghe, GK; Soares, MP; Satoh, T; Akira, S; Hai, T; Strong, CD; Auclair, K; Roddy, TP; Biller, SA; Jovanovic, M; Klechevsky, E; Stewart, KM; Randolph, GJ; Artyomov, MN				Bambouskova, Monika; Gorvel, Laurent; Lampropoulou, Vicky; Sergushichev, Alexey; Loginicheva, Ekaterina; Johnson, Kendall; Korenfeld, Daniel; Mathyer, Mary Elizabeth; Kim, Hyeryun; Huang, Li-Hao; Duncan, Dustin; Bregman, Howard; Keskin, Abdurrahman; Santeford, Andrea; Apte, Rajendra S.; Sehgal, Raghav; Johnson, Britney; Amarasinghe, Gaya K.; Soares, Miguel P.; Satoh, Takashi; Akira, Shizuo; Hai, Tsonwin; Strong, Cristina de Guzman; Auclair, Karine; Roddy, Thomas P.; Biller, Scott A.; Jovanovic, Marko; Klechevsky, Eynav; Stewart, Kelly M.; Randolph, Gwendalyn J.; Artyomov, Maxim N.			Electrophilic properties of itaconate and derivatives regulate the I kappa B zeta-ATF3 inflammatory axis	NATURE			English	Article							KAPPA-B-ZETA; SUCCINATE-DEHYDROGENASE; OXIDATIVE STRESS; KEY REGULATOR; PSORIASIS; OXYGENASE-1; EXPRESSION; APOPTOSIS; CELLS; HEME	Metabolic regulation has been recognized as a powerful principle guiding immune responses. Inflammatory macrophages undergo extensive metabolic rewiring(1) marked by the production of substantial amounts of itaconate, which has recently been described as an immunoregulatory metabolite(2). Itaconate and its membrane-permeable derivative dimethyl itaconate (DI) selectively inhibit a subset of cytokines(2), including IL-6 and IL-12 but not TNF. The major effects of itaconate on cellular metabolism during macrophage activation have been attributed to the inhibition of succinate dehydrogenase(2,3), yet this inhibition alone is not sufficient to account for the pronounced immunoregulatory effects observed in the case of DI. Furthermore, the regulatory pathway responsible for such selective effects of itaconate and DI on the inflammatory program has not been defined. Here we show that itaconate and DI induce electrophilic stress, react with glutathione and subsequently induce both Nrf2 (also known as NFE2L2)-dependent and -independent responses. We find that electrophilic stress can selectively regulate secondary, but not primary, transcriptional responses to toll-like receptor stimulation via inhibition of I kappa B zeta protein induction. The regulation of I kappa B zeta is independent of Nrf2, and we identify ATF3 as its key mediator. The inhibitory effect is conserved across species and cell types, and the in vivo administration of DI can ameliorate IL-17-I kappa B zeta driven skin pathology in a mouse model of psoriasis, highlighting the therapeutic potential of this regulatory pathway. Our results demonstrate that targeting the DI-I kappa B zeta regulatory axis could be an important new strategy for the treatment of IL-17-I kappa B zeta-mediated autoimmune diseases.	[Bambouskova, Monika; Gorvel, Laurent; Lampropoulou, Vicky; Loginicheva, Ekaterina; Korenfeld, Daniel; Huang, Li-Hao; Johnson, Britney; Amarasinghe, Gaya K.; Klechevsky, Eynav; Randolph, Gwendalyn J.; Artyomov, Maxim N.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Sergushichev, Alexey] ITMO Univ, Comp Technol Dept, St Petersburg, Russia; [Johnson, Kendall; Kim, Hyeryun; Bregman, Howard; Roddy, Thomas P.; Biller, Scott A.; Stewart, Kelly M.] Agios Pharmaceut, Cambridge, MA USA; [Mathyer, Mary Elizabeth; Strong, Cristina de Guzman] Washington Univ, Sch Med, Dept Med, Div Dermatol,Ctr Pharmacogen,Ctr Study Itch, St Louis, MO 63110 USA; [Duncan, Dustin; Auclair, Karine] McGill Univ, Dept Chem, Montreal, PQ, Canada; [Keskin, Abdurrahman; Jovanovic, Marko] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Santeford, Andrea; Apte, Rajendra S.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Sehgal, Raghav] Elucidata Corp, Cambridge, MA USA; [Soares, Miguel P.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Satoh, Takashi; Akira, Shizuo] Osaka Univ, Immunol Frontier Res Ctr, Host Def, Suita, Osaka, Japan; [Hai, Tsonwin] Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA	Washington University (WUSTL); ITMO University; Agios Pharmaceuticals; Washington University (WUSTL); McGill University; Columbia University; Washington University (WUSTL); Instituto Gulbenkian de Ciencia; Osaka University; University System of Ohio; Ohio State University	Artyomov, MN (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	martyomov@wustl.edu	GORVEL, Laurent/AAB-1749-2020; Hai, Tsonwin/E-3185-2011; de Guzman Strong, Cristina/AAA-7270-2019; Sergushichev, Alexey A/J-8756-2015	GORVEL, Laurent/0000-0001-7526-261X; Hai, Tsonwin/0000-0003-4510-0315; de Guzman Strong, Cristina/0000-0001-8540-9611; Sergushichev, Alexey A/0000-0003-1159-7220; Soares, Miguel/0000-0002-9314-4833; Duncan, Dustin/0000-0003-1240-8495; Klechevsky, Eynav/0000-0001-6121-1571	MES of Russia [2.3300.2017/4.6];  [R01-A1125618]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125618, T32AI007163] Funding Source: NIH RePORTER	MES of Russia; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank H. Virgin for providing p62-deficient mice; I. Schukina, J. Middleton and L. Arthur for technical support; and R. Dolle for assistance. This work was supported by R01-A1125618 to M.N.A. and MES of Russia (project 2.3300.2017/4.6) to A.Se.	Cheng Z, 2018, CELL, V172, P910, DOI 10.1016/j.cell.2018.01.035; Cordes T, 2016, J BIOL CHEM, V291, P14274, DOI 10.1074/jbc.M115.685792; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dhamija S, 2016, J BIOL CHEM, V291, P24801, DOI 10.1074/jbc.A110.146365; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Harder BJ, 2016, METAB ENG, V38, P29, DOI 10.1016/j.ymben.2016.05.008; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Hildebrand DG, 2013, J IMMUNOL, V190, P4812, DOI 10.4049/jimmunol.1300089; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Johansen C, 2015, P NATL ACAD SCI USA, V112, pE5825, DOI 10.1073/pnas.1509971112; Keshishian H, 2015, MOL CELL PROTEOMICS, V14, P2375, DOI 10.1074/mcp.M114.046813; Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Labzin LI, 2015, J IMMUNOL, V195, P4446, DOI 10.4049/jimmunol.1500204; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; McGuire VA, 2016, SCI REP-UK, V6, DOI 10.1038/srep31159; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Muromoto R, 2016, INT IMMUNOL, V28, P443, DOI 10.1093/intimm/dxw011; Okada K, 2009, HEPATOL RES, V39, P490, DOI 10.1111/j.1872-034X.2008.00478.x; Okuma A, 2013, IMMUNITY, V38, P450, DOI 10.1016/j.immuni.2012.11.016; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Parada E, 2013, ANTIOXID REDOX SIGN, V19, P1135, DOI 10.1089/ars.2012.4671; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Sahil, 2017, ELUCIDATAINC ELMAVEN; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sergushichev A., 2016, PREPRINT; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Strong CD, 2010, HUM MOL GENET, V19, P1453, DOI 10.1093/hmg/ddq019; Sullivan LB, 2013, MOL CELL, V51, P236, DOI 10.1016/j.molcel.2013.05.003; Tsoi LC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8001; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Vincent EE, 2015, MOL CELL, V60, P195, DOI 10.1016/j.molcel.2015.08.013; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Zheng L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7001	39	286	295	7	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					501	+		10.1038/s41586-018-0052-z	http://dx.doi.org/10.1038/s41586-018-0052-z			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8VX	29670287	Green Accepted			2022-12-28	WOS:000430793000047
J	Ziperstein, JC; Churchill, TW; Hedgire, SS; Dec, GW; Stone, JR				Ziperstein, Joshua C.; Churchill, Timothy W.; Hedgire, Sandeep S.; Dec, G. William; Stone, James R.			Case 13-2018: A 53-Year-Old Man with Cardiomyopathy and Recurrent Ventricular Tachycardia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GIANT-CELL MYOCARDITIS; EUROPEAN CARDIOVASCULAR PATHOLOGY; CARDIAC SARCOIDOSIS; CONSENSUS STATEMENT; MAGNETIC-RESONANCE; VIRAL MYOCARDITIS; DIAGNOSIS; HYPERSENSITIVITY; ASSOCIATION; SOCIETY		[Ziperstein, Joshua C.; Churchill, Timothy W.; Dec, G. William] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Hedgire, Sandeep S.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Stone, James R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Ziperstein, Joshua C.; Churchill, Timothy W.; Dec, G. William] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Hedgire, Sandeep S.] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Stone, James R.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Ziperstein, JC (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Ziperstein, JC (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.				GlaxoSmith-Kline; USP Labs; Alnylam Pharmaceuticals	GlaxoSmith-Kline(GlaxoSmithKline); USP Labs; Alnylam Pharmaceuticals	Dr. Stone reports receiving consulting fees from GlaxoSmith-Kline, fees for expert testimony from USP Labs, and lecture fees from Alnylam Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2016, NEW ENGL J MED, V375, P262; [Anonymous], 2011, NEW ENGL J MED, V365, P2413; Bernstein M, 1929, ARCH INTERN MED, V44, P721, DOI 10.1001/archinte.1929.00140050098009; Blauwet LA, 2013, HEART FAIL REV, V18, P733, DOI 10.1007/s10741-012-9358-3; Blauwet LA, 2010, PROG CARDIOVASC DIS, V52, P274, DOI 10.1016/j.pcad.2009.11.006; Cheng R, 2014, J CARD FAIL, V20, P400, DOI 10.1016/j.cardfail.2014.03.005; Cooper LT, 1997, NEW ENGL J MED, V336, P1860, DOI 10.1056/NEJM199706263362603; Daniels PR, 2000, CARDIOVASC PATHOL, V9, P287, DOI 10.1016/S1054-8807(00)00049-1; Elamm CA, 2017, J CARD FAIL, V23, P566, DOI 10.1016/j.cardfail.2017.04.015; Friedrich MG, 2009, J AM COLL CARDIOL, V53, P1475, DOI 10.1016/j.jacc.2009.02.007; Friedrich MG, 1998, CIRCULATION, V97, P1802, DOI 10.1161/01.CIR.97.18.1802; Frustaci A, 2002, CIRCULATION, V105, P2611, DOI 10.1161/01.CIR.0000017880.86166.87; Jakovljevic DG, 2017, J AM COLL CARDIOL, V69, P1924, DOI 10.1016/j.jacc.2017.02.018; Kadkhodayan Ana, 2016, JACC Cardiovasc Imaging, V9, P603, DOI 10.1016/j.jcmg.2016.01.010; Kandolin R, 2013, CIRC-HEART FAIL, V6, P15, DOI 10.1161/CIRCHEARTFAILURE.112.969261; Leone O, 2012, CARDIOVASC PATHOL, V21, P245, DOI 10.1016/j.carpath.2011.10.001; Litovsky SH, 1996, MODERN PATHOL, V9, P1126; Magnani JW, 2006, CIRCULATION, V113, P876, DOI 10.1161/CIRCULATIONAHA.105.584532; MORGERA T, 1992, AM HEART J, V124, P455, DOI 10.1016/0002-8703(92)90613-Z; Nunes MCP, 2017, HEART, V103, P651, DOI 10.1136/heartjnl-2016-309870; Okura Y, 2003, J AM COLL CARDIOL, V41, P322, DOI 10.1016/S0735-1097(02)02715-8; Petrovic M, 2018, CARDIOVASC PATHOL, V33, P1, DOI 10.1016/j.carpath.2017.11.001; Pollack A, 2015, NAT REV CARDIOL, V12, P670, DOI 10.1038/nrcardio.2015.108; Sabatine MS, 2007, NEW ENGL J MED, V357, P2167, DOI 10.1056/NEJMcpc079030; Saltykow S, 1905, VIRCHOWS ARCH A, V182, P1, DOI 10.1007/BF01995636; Stone JR, 2012, CARDIOVASC PATHOL, V21, P2, DOI 10.1016/j.carpath.2011.01.001; TESLUK H, 1956, AM J CLIN PATHOL, V26, P1326; Trachtenberg BH, 2017, CIRC RES, V121, P803, DOI 10.1161/CIRCRESAHA.117.310221	28	1	1	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2018	378	17					1622	1633		10.1056/NEJMcpc1800333	http://dx.doi.org/10.1056/NEJMcpc1800333			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8XP	29694808				2022-12-28	WOS:000430797900011
J	Hofweber, M; Hutten, S; Bourgeois, B; Spreitzer, E; Niedner-Boblenz, A; Schifferer, M; Ruepp, MD; Simons, M; Niessing, D; Madl, T; Dormann, D				Hofweber, Mario; Hutten, Saskia; Bourgeois, Benjamin; Spreitzer, Emil; Niedner-Boblenz, Annika; Schifferer, Martina; Ruepp, Marc-David; Simons, Mikael; Niessing, Dierk; Madl, Tobias; Dormann, Dorothee			Phase Separation of FUS Is Suppressed by Its Nuclear Import Receptor and Arginine Methylation	CELL			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; STRESS GRANULE DYNAMICS; PRION-LIKE DOMAINS; SARCOMA FUS; FTLD-FUS; NEURODEGENERATIVE DISEASE; DISTINGUISH FTLD; PROTEIN IMPORT; RNA GRANULES	Cytoplasmic FUS aggregates are a pathological hallmark in a subset of patients with frontotemporal dementia (FTD) or amyotrophic lateral sclerosis (ALS). A key step that is disrupted in these patients is nuclear import of FUS mediated by the import receptor Transportin/ Karyopherin-beta 2. In ALS-FUS patients, this is caused by mutations in the nuclear localization signal (NLS) of FUS that weaken Transportin binding. In FTD-FUS patients, Transportin is aggregated, and post-translational arginine methylation, which regulates the FUS-Transportin interaction, is lost. Here, we show that Transportin and arginine methylation have a crucial function beyond nuclear import-namely to suppress RGG/RG-driven phase separation and stress granule association of FUS. ALS-associated FUS-NLS mutations weaken the chaperone activity of Transportin and loss of FUS arginine methylation, as seen in FTD-FUS, promote phase separation, and stress granule partitioning of FUS. Our findings reveal two regulatory mechanisms of liquid-phase homeostasis that are disrupted in FUS-associated neurodegeneration.	[Hofweber, Mario; Hutten, Saskia; Niedner-Boblenz, Annika; Niessing, Dierk; Dormann, Dorothee] Ludwig Maximilians Univ Munchen, Biomed Ctr BMC, D-82152 Planegg Martinsried, Germany; [Hofweber, Mario; Dormann, Dorothee] Ludwig Maximilians Univ Munchen, Grad Sch Syst Neurosci GSN, D-82152 Planegg Martinsried, Germany; [Bourgeois, Benjamin; Spreitzer, Emil; Madl, Tobias] Med Univ Graz, Inst Mol Biol & Biochem, Ctr Mol Med, A-8010 Graz, Austria; [Niedner-Boblenz, Annika; Niessing, Dierk] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Biol Struct, D-85763 Neuherberg, Germany; [Schifferer, Martina; Simons, Mikael] Tech Univ Munich, Inst Neuronal Cell Biol, D-80805 Munich, Germany; [Schifferer, Martina; Simons, Mikael] German Ctr Neurodegenerat Dis DZNE, D-81377 Munich, Germany; [Schifferer, Martina; Simons, Mikael; Dormann, Dorothee] Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany; [Ruepp, Marc-David] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; [Niessing, Dierk] Ulm Univ, Inst Pharmaceut Biotechnol, D-89081 Ulm, Germany	University of Munich; University of Munich; Medical University of Graz; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Bern; Ulm University	Dormann, D (corresponding author), Ludwig Maximilians Univ Munchen, Biomed Ctr BMC, D-82152 Planegg Martinsried, Germany.; Dormann, D (corresponding author), Ludwig Maximilians Univ Munchen, Grad Sch Syst Neurosci GSN, D-82152 Planegg Martinsried, Germany.; Dormann, D (corresponding author), Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany.	dorothee.dormann@med.uni-muenchen.de	Niessing, Dierk/M-4619-2014; Madl, Tobias/B-1682-2012; Bourgeois, Benjamin/U-2482-2019; Ruepp, Marc-David/H-9916-2018	Niessing, Dierk/0000-0002-5589-369X; Madl, Tobias/0000-0002-9725-5231; Ruepp, Marc-David/0000-0003-3264-9800; Simons, Mikael/0000-0001-5329-192X	Deutsche Forschungsgemeinschaft (DFG) within the Emmy Noether grant [DO 1804/1-1]; Munich Cluster for Systems Neurology (Synergy) [EXC 1010]; Investment Fund and Junior Research Fund of the LMU Munich; Integrative Metabolism Research Center Graz of the Austrian infrastructure program [2016/2017]; BioTechMed-Graz; Bavarian Ministry of Sciences, Research; President's International Fellowship Initiative of CAS [2015VBB045]; National Natural Science Foundation of China [31450110423]; Austrian Science Fund [FWF: P28854, W1226-B18]; DFG [MA5703/1-1, FOR2333]; NOMIS Foundation; Arts (Bavarian Molecular Biosystems Research Network); Omics Center Graz	Deutsche Forschungsgemeinschaft (DFG) within the Emmy Noether grant(German Research Foundation (DFG)); Munich Cluster for Systems Neurology (Synergy); Investment Fund and Junior Research Fund of the LMU Munich; Integrative Metabolism Research Center Graz of the Austrian infrastructure program; BioTechMed-Graz; Bavarian Ministry of Sciences, Research; President's International Fellowship Initiative of CAS; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Austrian Science Fund(Austrian Science Fund (FWF)); DFG(German Research Foundation (DFG)); NOMIS Foundation; Arts (Bavarian Molecular Biosystems Research Network); Omics Center Graz	We thank Michael Kiebler for infrastructure (including SD confocal microscope; DFG INST 86/1581-1 FUGG). We thank Frauke van Bebber, Hilary Wunderlich, Jim Shorter, Yuh Min Chook, and Michael Rosen for critical comments on the manuscript. We are grateful to the Biomedical Center core facilities Bioimaging and Bioinformatics, as well as Bastian Popper, Shovamayee Maharana, Claudia Abou-Ajram, Melanie Fritz, and Daniela Rieger for technical assistance. We thank Michael Kiebler, Angelika Noegel, Elisabeth Kremmer, the Helmholtz Center Munich Monoclonal Antibody Core Facility, Ralph Kehlenbach, Elmar Wahle, Arie Geerlof, Ina Poser, Tony Hyman, Dirk Gorlich, Matthias Geyer, Simon Alberti, and Jie Wang for generous gifts of reagents. This work was supported by the Deutsche Forschungsgemeinschaft (DFG) within the Emmy Noether grant DO 1804/1-1 and the Munich Cluster for Systems Neurology (Synergy, EXC 1010), as well as the Investment Fund and Junior Research Fund of the LMU Munich (to D. D.). T. M. is supported by the Integrative Metabolism Research Center Graz of the Austrian infrastructure program 2016/2017, BioTechMed-Graz, Omics Center Graz, the Bavarian Ministry of Sciences, Research, and the Arts (Bavarian Molecular Biosystems Research Network), the President's International Fellowship Initiative of CAS (2015VBB045), the National Natural Science Foundation of China (31450110423), the Austrian Science Fund (FWF: P28854, W1226-B18) as well as the DFG (MA5703/1-1). The research of M.-D. R. was supported by the NOMIS Foundation and the research of A. N.-B. and D. N. was supported by the DFG (FOR2333).	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Alberti S, 2016, BIOESSAYS, V38, P959, DOI 10.1002/bies.201600042; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bentmann E, 2012, J BIOL CHEM, V287, P23079, DOI 10.1074/jbc.M111.328757; Boeynaems S, 2017, MOL CELL, V65, P1044, DOI 10.1016/j.molcel.2017.02.013; Brelstaff J, 2011, ACTA NEUROPATHOL, V122, P591, DOI 10.1007/s00401-011-0863-6; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; Chang WL, 2009, NUCLEIC ACIDS RES, V37, P6600, DOI 10.1093/nar/gkp717; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Chio A, 2009, NEUROBIOL AGING, V30, P1272, DOI 10.1016/j.neurobiolaging.2009.05.001; Devoy A, 2017, BRAIN, V140, P2797, DOI 10.1093/brain/awx248; Dormann D, 2012, EMBO J, V31, P4258, DOI 10.1038/emboj.2012.261; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Edbauer D, 2016, CURR OPIN NEUROBIOL, V36, P99, DOI 10.1016/j.conb.2015.10.009; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Fuhrmann J, 2015, CHEM REV, V115, P5413, DOI 10.1021/acs.chemrev.5b00003; Fujimura K, 2010, BBA-MOL CELL RES, V1803, P865, DOI 10.1016/j.bbamcr.2010.03.020; Gobl C, 2016, ANGEW CHEM INT EDIT, V55, P14847, DOI 10.1002/anie.201607261; Guo L, 2018, CELL, V173, P677, DOI 10.1016/j.cell.2018.03.002; Hutten S, 2008, MOL BIOL CELL, V19, P2300, DOI 10.1091/mbc.E07-12-1279; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kosugi S, 2008, CHEM BIOL, V15, P940, DOI 10.1016/j.chembiol.2008.07.019; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee KH, 2016, CELL, V167, P774, DOI 10.1016/j.cell.2016.10.002; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Lin Y, 2017, J BIOL CHEM, V292, P19110, DOI 10.1074/jbc.M117.800466; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Livernois AM, 2009, ANAL BIOCHEM, V392, P70, DOI 10.1016/j.ab.2009.05.023; Love DC, 1998, P NATL ACAD SCI USA, V95, P10608, DOI 10.1073/pnas.95.18.10608; Mackenzie IR, 2017, NEURON, V95, P808, DOI 10.1016/j.neuron.2017.07.025; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Milles S, 2013, EMBO REP, V14, P178, DOI 10.1038/embor.2012.204; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Mori K, 2013, ACTA NEUROPATHOL, V125, P413, DOI 10.1007/s00401-013-1088-7; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2012, ACTA NEUROPATHOL, V124, P705, DOI 10.1007/s00401-012-1020-6; Neumann M, 2011, BRAIN, V134, P2595, DOI 10.1093/brain/awr201; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Noegel AA, 2004, MOL BIOL CELL, V15, P934, DOI 10.1091/mbc.E03-05-0269; Nott TJ, 2016, NAT CHEM, V8, P570, DOI [10.1038/NCHEM.2519, 10.1038/nchem.2519]; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; Orozco D, 2012, EMBO REP, V13, P759, DOI 10.1038/embor.2012.90; Ozdilek BA, 2017, NUCLEIC ACIDS RES, V45, P7984, DOI 10.1093/nar/gkx460; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Ryan VH, 2018, MOL CELL, V69, P465, DOI 10.1016/j.molcel.2017.12.022; Saha S, 2016, CELL, V166, P1572, DOI 10.1016/j.cell.2016.08.006; Scaramuzzino C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061576; Scekic-Zahirovic J, 2017, ACTA NEUROPATHOL, V133, P887, DOI 10.1007/s00401-017-1687-9; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Snowden JS, 2011, ACTA NEUROPATHOL, V122, P99, DOI 10.1007/s00401-011-0816-0; Suarez-Calvet M, 2016, ACTA NEUROPATHOL, V131, P587, DOI 10.1007/s00401-016-1544-2; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Thandapani P, 2013, MOL CELL, V50, P613, DOI 10.1016/j.molcel.2013.05.021; van den Bogaart G, 2009, NAT CELL BIOL, V11, P350, DOI 10.1038/ncb1844; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Weinmann L, 2009, CELL, V136, P496, DOI 10.1016/j.cell.2008.12.023; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; YONEDA Y, 1987, EXP CELL RES, V173, P586, DOI 10.1016/0014-4827(87)90297-7; Yoshizawa T, 2018, CELL, V173, P693, DOI 10.1016/j.cell.2018.03.003; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang ZC, 2012, P NATL ACAD SCI USA, V109, P12017, DOI 10.1073/pnas.1207247109	69	313	319	13	92	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2018	173	3					706	+		10.1016/j.cell.2018.03.004	http://dx.doi.org/10.1016/j.cell.2018.03.004			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7GB	29677514	Bronze, Green Submitted			2022-12-28	WOS:000430677400019
J	Stafford, N				Stafford, Ned			Medical school holds joint funeral for 74 children whose preserved bodies were found on site	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2018, RATSEL VERGESSENEN K; Winter F, 2018, ANN ANAT, V215, P40, DOI 10.1016/j.aanat.2017.09.005	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2018	361								k1744	10.1136/bmj.k1744	http://dx.doi.org/10.1136/bmj.k1744			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8WQ	29674525				2022-12-28	WOS:000430795300010
J	Jones, D				Jones, D			Daedalus - Powerful lighting	NATURE			English	Editorial Material																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					395	395		10.1038/17032	http://dx.doi.org/10.1038/17032			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667964				2022-12-28	WOS:000078461700029
J	Cho, JH; Collins, JJ; Wong, WW				Cho, Jang Hwan; Collins, James J.; Wong, Wilson W.			Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses	CELL			English	Article							B-CELL; OVARIAN-CANCER; FUSION PROTEINS; TARGET-CELLS; HALF-LIFE; IN-VITRO; CAR; INTRAPERITONEAL; STIMULATION; RECOGNITION	T cells expressing chimeric antigen receptors (CARs) are promising cancer therapeutic agents, with the prospect of becoming the ultimate smart cancer therapeutics. To expand the capability of CAR T cells, here, we present a split, universal, and programmable (SUPRA) CAR system that simultaneously encompasses multiple critical "upgrades," such as the ability to switch targets without re-engineering the T cells, finely tune T cell activation strength, and sense and logically respond to multiple antigens. These features are useful to combat relapse, mitigate over-activation, and enhance specificity. We test our SUPRA system against two different tumor models to demonstrate its broad utility and humanize its components to minimize potential immunogenicity concerns. Furthermore, we extend the orthogonal SUPRA CAR system to regulate different T cell subsets independently, demonstrating a dually inducible CAR system. Together, these SUPRA CARs illustrate that multiple advanced logic and control features can be implemented into a single, integrated system.	[Cho, Jang Hwan; Wong, Wilson W.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Cho, Jang Hwan; Wong, Wilson W.] Boston Univ, Biol Design Ctr, Boston, MA 02215 USA; [Collins, James J.] MIT, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Collins, James J.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Collins, James J.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Collins, James J.] Harvard MIT Program Hlth Sci & Technol, Cambridge, MA 02139 USA; [Collins, James J.] Broad Inst MIT & Harvard, 415 Main St, Cambridge, MA 02142 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, 3 Blackfan Circle, Boston, MA 02115 USA	Boston University; Boston University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Wong, WW (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.; Wong, WW (corresponding author), Boston Univ, Biol Design Ctr, Boston, MA 02215 USA.	wilwong@bu.edu			Kwanjeong Educational Foundation; Paul G. Allen Frontiers Group; Wyss Institute; Boston University; NIH Director's New Innovator Award [1DP2CA186574]; NSF Expedition in Computing [1522074]; NSF CAREER [162457]; NSF BBSRC [1614642]; NATIONAL CANCER INSTITUTE [DP2CA186574] Funding Source: NIH RePORTER	Kwanjeong Educational Foundation; Paul G. Allen Frontiers Group; Wyss Institute; Boston University; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Expedition in Computing; NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	J.H.C. acknowledges funding from the Kwanjeong Educational Foundation. J.J.C. acknowledges funding from the Paul G. Allen Frontiers Group and the Wyss Institute. W.W.W. acknowledges funding from the Boston University Ignition Award, the NIH Director's New Innovator Award (1DP2CA186574), NSF Expedition in Computing (1522074), NSF CAREER (162457), and NSF BBSRC (1614642). We thank Teresa Wiese for cloning zipCAR constructs used for Jurkat T cell experiments, Devin R. Burrill for initial guidance on protein purifications, and Jeong Min Park for protein purifications during her summer research at the Wong lab. We also thank Wong lab members for suggestions on the manuscript; Dr. Jennifer Cappione, Dr. Anna Belkina, Mr. Brian Tilton, and Dr. Patrick Autissier from the BU Flow Cytometry Core for flow cytometry assistance; Dr. Thomas Balon from the BU animal facility and In Vivo Imaging Core for IVIS imaging assistance; and Mr. Matthew Au from BU Analytical Instrumentation Core for helping with Luminex analysis.	Bonifant CL, 2016, MOL THER-ONCOLYTICS, V3, DOI 10.1038/mto.2016.11; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brudno JN, 2016, BLOOD, V127, P3321, DOI 10.1182/blood-2016-04-703751; Cartellieri M, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.61; Carter P, 2001, NAT REV CANCER, V1, P118, DOI 10.1038/35101072; Caruso HG, 2015, CANCER RES, V75, P3505, DOI 10.1158/0008-5472.CAN-15-0139; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chmielewski M, 2004, J IMMUNOL, V173, P7647, DOI 10.4049/jimmunol.173.12.7647; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Fu XP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011867; Geller MA, 2013, CYTOTHERAPY, V15, P1297, DOI 10.1016/j.jcyt.2013.05.022; Glienke W, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00021; Golubovskaya V, 2016, CANCERS, V8, DOI 10.3390/cancers8030036; Gould LH, 2005, J VIROL, V79, P14606, DOI 10.1128/JVI.79.23.14606-14613.2005; Grada Z, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.32; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Haso W, 2013, BLOOD, V121, P1165, DOI 10.1182/blood-2012-06-438002; Hegde M, 2013, MOL THER, V21, P2087, DOI 10.1038/mt.2013.185; Hombach A, 2006, J IMMUNOL, V177, P5668, DOI 10.4049/jimmunol.177.8.5668; Hudecek M, 2015, CANCER IMMUNOL RES, V3, P125, DOI 10.1158/2326-6066.CIR-14-0127; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kawalekar OU, 2016, IMMUNITY, V44, P380, DOI 10.1016/j.immuni.2016.01.021; Kimchi-Sarfaty C, 2013, TRENDS PHARMACOL SCI, V34, P534, DOI 10.1016/j.tips.2013.08.005; Klingemann H, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28147; Kloss CC, 2013, NAT BIOTECHNOL, V31, P71, DOI 10.1038/nbt.2459; Kontermann RE, 2011, CURR OPIN BIOTECH, V22, P868, DOI 10.1016/j.copbio.2011.06.012; Kudo K, 2014, CANCER RES, V74, P93, DOI 10.1158/0008-5472.CAN-13-1365; Lee MJ, 2002, GENE THER, V9, P859, DOI 10.1038/sj.gt.3301704; Lengyel E, 2014, ONCOGENE, V33, P3619, DOI 10.1038/onc.2013.321; Liu XJ, 2015, CANCER RES, V75, P3596, DOI 10.1158/0008-5472.CAN-15-0159; LUCAS PJ, 1995, J IMMUNOL, V154, P5757; Luckheeram RV, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/925135; Ma JSY, 2016, P NATL ACAD SCI USA, V113, pE450, DOI 10.1073/pnas.1524193113; MacDonald KG, 2016, J CLIN INVEST, V126, P1413, DOI 10.1172/JCI82771; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Maude SL, 2014, CANCER J, V20, P119, DOI 10.1097/PPO.0000000000000035; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Perna F, 2016, TRANSL CANCER RES, V5, pS221, DOI 10.21037/tcr.2016.08.15; Reinke AW, 2010, J AM CHEM SOC, V132, P6025, DOI 10.1021/ja907617a; Rodgers DT, 2016, P NATL ACAD SCI USA, V113, pE459, DOI 10.1073/pnas.1524155113; Roybal KT, 2016, CELL, V164, P770, DOI 10.1016/j.cell.2016.01.011; Ruella M, 2016, J CLIN INVEST, V126, P3814, DOI 10.1172/JCI87366; Sadelain M, 2017, NATURE, V545, P423, DOI 10.1038/nature22395; Scholler J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003761; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Skapenko A, 2001, J IMMUNOL, V166, P4283, DOI 10.4049/jimmunol.166.7.4283; Strohl WR, 2015, BIODRUGS, V29, P215, DOI 10.1007/s40259-015-0133-6; Szlachcic A, 2011, BIOTECHNOL ADV, V29, P436, DOI 10.1016/j.biotechadv.2011.03.005; Tamada K, 2012, CLIN CANCER RES, V18, P6436, DOI 10.1158/1078-0432.CCR-12-1449; Thompson KE, 2012, ACS SYNTH BIOL, V1, P118, DOI 10.1021/sb200015u; Turtle CJ, 2016, J CLIN INVEST, V126, P2123, DOI 10.1172/JCI85309; Urbanska K, 2012, CANCER RES, V72, P1844, DOI 10.1158/0008-5472.CAN-11-3890; VANDENBERGHE P, 1993, IMMUNOLOGY, V78, P210; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wu CY, 2015, SCIENCE, V350, DOI 10.1126/science.aab4077; Yoon J, 2017, BLOOD, V129, P238, DOI 10.1182/blood-2016-07-727834; Zah E, 2016, CANCER IMMUNOL RES, V4, P498, DOI 10.1158/2326-6066.CIR-15-0231; Zhao ZG, 2015, CANCER CELL, V28, P415, DOI 10.1016/j.ccell.2015.09.004; Zhu YW, 2007, BLOOD, V109, P4882, DOI 10.1182/blood-2006-10-043463; Zhu YW, 2011, IMMUNITY, V34, P466, DOI 10.1016/j.immuni.2011.04.008	65	310	336	9	118	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2018	173	6					1426	+		10.1016/j.cell.2018.03.038	http://dx.doi.org/10.1016/j.cell.2018.03.038			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GH9KU	29706540	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000433989100015
J	Summerskill, W; Wang, HH; Horton, R				Summerskill, William; Wang, Helena Hui; Horton, Richard			Healthy cities: key to a healthy future in China	LANCET			English	Editorial Material									[Wang, Helena Hui] The Lancet, Beijing, Peoples R China; [Summerskill, William; Horton, Richard] The Lancet, London EC2Y 5AS, England		Summerskill, W (corresponding author), The Lancet, London EC2Y 5AS, England.	bill.summerskill@lancet.com						[Anonymous], 2014, LANCET, V384, P1902, DOI 10.1016/S0140-6736(14)62263-7; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Woetzel J., 2009, PREPARING CHINAS URB; Yang J, 2018, LANCET, V391, P2140, DOI 10.1016/S0140-6736(18)30486-0; Zhao Q, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1012	6	10	10	3	38	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2018	391	10135					2086	2087		10.1016/S0140-6736(18)30608-1	http://dx.doi.org/10.1016/S0140-6736(18)30608-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GH2UJ	29678343				2022-12-28	WOS:000433257200008
J	Mompean, M; Li, WB; Li, JX; Laage, S; Siemer, AB; Bozkurt, G; Wu, H; McDermott, AE				Mompean, Miguel; Li, Wenbo; Li, Jixi; Laage, Segolene; Siemer, Ansgar B.; Bozkurt, Gunes; Wu, Hao; McDermott, Ann E.			The Structure of the Necrosome RIPK1-RIPK3 Core, a Human Hetero-Amyloid Signaling Complex	CELL			English	Article							ATOMIC-RESOLUTION STRUCTURE; CELL-DEATH; NECROPTOSIS; REVEALS; TNF; INFLAMMATION; ACTIVATION; FIBRILS; DOMAIN; RIP1	The RIPK1-RIPK3 necrosome is an amyloid signaling complex that initiates TNF- induced necroptosis, serving in human immune defense, cancer, and neurodegenerative diseases. RIPK1 and RIPK3 associate through their RIP homotypic interaction motifs with consensus sequences IQIG (RIPK1) and VQVG (RIPK3). Using solid- state nuclear magnetic resonance, we determined the high- resolution structure of the RIPK1- RIPK3 core. RIPK1 and RIPK3 alternately stack (RIPK1, RIPK3, RIPK1, RIPK3, etc.) to form heterotypic beta sheets. Two such beta sheets bind together along a compact hydrophobic interface featuring an unusual ladder of alternating Ser (from RIPK1) and Cys (from RIPK3). The crystal structure of a four-residue RIPK3 consensus sequence is consistent with the architecture determined by NMR. The RIPK1- RIPK3 core is the first detailed structure of a hetero-amyloid and provides a potential explanation for the specificity of heteroover homo-amyloid formation and a structural basis for understanding the mechanisms of signal transduction.	[Mompean, Miguel; Li, Wenbo; Laage, Segolene; Siemer, Ansgar B.; McDermott, Ann E.] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Li, Jixi] Fudan Univ, Huashan Hosp, Dept Neurol, State Key Lab Genet Engn, Shanghai 200438, Peoples R China; [Li, Jixi] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, Shanghai 200438, Peoples R China; [Li, Jixi; Bozkurt, Gunes; Wu, Hao] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02215 USA; [Bozkurt, Gunes; Wu, Hao] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Mompean, Miguel] Univ Castilla La Mancha, IRICA, E-13071 Ciudad Real, Spain; [Li, Wenbo] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Laage, Segolene] Adocia, Lyon, France; [Siemer, Ansgar B.] USC, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA USA	Columbia University; Fudan University; Fudan University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Universidad de Castilla-La Mancha; Johns Hopkins University; University of Southern California; University of Southern California Keck Hospital	McDermott, AE (corresponding author), Columbia Univ, Dept Chem, New York, NY 10027 USA.; Wu, H (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02215 USA.; Wu, H (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	wu@crystal.harvard.edu; aem5@columbia.edu	Bozkurt, Gunes/I-6453-2019; Mompeán, Miguel/A-4909-2016	Bozkurt, Gunes/0000-0002-6025-3582; Mompeán, Miguel/0000-0002-5608-3648	NIH [R01 AI045937]; National Science Foundation [MCB 0749381, MCB 1412253]; National Key Research and Development Program of China [2016YFA0500600]; National Natural Science Foundation of China [31670878]; Spanish MINECO [CTQ2017-84825-R]; New York State Office of Science, Technology and Academic Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD087988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045937, R37AI050872] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1412253] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Spanish MINECO(Spanish Government); New York State Office of Science, Technology and Academic Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the NIH (R01 AI045937) (to H.W. and A.E.M.), the National Science Foundation (MCB 0749381 and MCB 1412253) (to A.E.M.), the National Key Research and Development Program of China (2016YFA0500600), and National Natural Science Foundation of China (31670878) (to J.L.). M.M. acknowledges the Spanish MINECO (CTQ2017-84825-R). A.E.M. is a member of the New York Structural Biology Center NYSBC). The NYSBC is a STAR center supported by the New York State Office of Science, Technology and Academic Research.	Adamo C, 1999, J CHEM PHYS, V110, P6158, DOI 10.1063/1.478522; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Castellani F, 2002, NATURE, V420, P98, DOI 10.1038/nature01070; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Colvin MT, 2016, J AM CHEM SOC, V138, P9663, DOI 10.1021/jacs.6b05129; Daskalov A, 2016, P NATL ACAD SCI USA, V113, P2720, DOI 10.1073/pnas.1522361113; Daskalov A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004158; De Paepe G, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3036928; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Guo HY, 2015, CELL HOST MICROBE, V17, P243, DOI 10.1016/j.chom.2015.01.003; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Ito Y, 2016, SCIENCE, V353, P603, DOI 10.1126/science.aaf6803; Jaroniec CP, 2002, J AM CHEM SOC, V124, P10728, DOI 10.1021/ja026385y; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Lewandowski JR, 2007, J AM CHEM SOC, V129, P728, DOI 10.1021/ja0650394; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Mompean M, 2016, J PHYS CHEM LETT, V7, P1859, DOI 10.1021/acs.jpclett.6b00699; Moquin D, 2010, TRENDS BIOCHEM SCI, V35, P434, DOI 10.1016/j.tibs.2010.03.001; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearson JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.258; Plumley JA, 2010, J AM CHEM SOC, V132, P1758, DOI 10.1021/ja909690a; Raveendra BL, 2013, NAT STRUCT MOL BIOL, V20, P495, DOI 10.1038/nsmb.2503; Rebsamen M, 2009, EMBO REP, V10, P916, DOI 10.1038/embor.2009.109; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schrodinger, 2015, PYMOL MOL GRAPH SYST; Schutz AK, 2015, ANGEW CHEM INT EDIT, V54, P331, DOI 10.1002/anie.201408598; Seifert L, 2016, NATURE, V532, P245, DOI 10.1038/nature17403; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tayeb-Fligelman E, 2017, SCIENCE, V355, P831, DOI 10.1126/science.aaf4901; Tuttle MD, 2016, NAT STRUCT MOL BIOL, V23, P409, DOI 10.1038/nsmb.3194; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Walczak H, 2011, IMMUNOL REV, V244, P9, DOI 10.1111/j.1600-065X.2011.01066.x; Walti MA, 2016, P NATL ACAD SCI USA, V113, pE4976, DOI 10.1073/pnas.1600749113; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu XN, 2014, CELL DEATH DIFFER, V21, P1709, DOI 10.1038/cdd.2014.77; Yanai T, 2004, CHEM PHYS LETT, V393, P51, DOI 10.1016/j.cplett.2004.06.011; Zhao Y, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2370993	49	139	142	4	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 17	2018	173	5					1244	+		10.1016/j.cell.2018.03.032	http://dx.doi.org/10.1016/j.cell.2018.03.032			20	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GG1UA	29681455	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000432471700019
J	Spencer, DT; Drake, T; Briles, TC; Stone, J; Sinclair, LC; Fredrick, C; Li, Q; Westly, D; Ilic, BR; Bluestone, A; Volet, N; Komljenovic, T; Chang, L; Lee, SH; Oh, DY; Suh, MG; Yang, KY; Pfeiffer, MHP; Kippenberg, TJ; Norberg, E; Theogarajan, L; Vahala, K; Newbury, NR; Srinivasan, K; Bowers, JE; Diddams, SA; Papp, SB				Spencer, Daryl T.; Drake, Tara; Briles, Travis C.; Stone, Jordan; Sinclair, Laura C.; Fredrick, Connor; Li, Qing; Westly, Daron; Ilic, B. Robert; Bluestone, Aaron; Volet, Nicolas; Komljenovic, Tin; Chang, Lin; Lee, Seung Hoon; Oh, Dong Yoon; Suh, Myoung-Gyun; Yang, Ki Youl; Pfeiffer, Martin H. P.; Kippenberg, Tobias J.; Norberg, Erik; Theogarajan, Luke; Vahala, Kerry; Newbury, Nathan R.; Srinivasan, Kartik; Bowers, John E.; Diddams, Scott A.; Papp, Scott B.			An optical-frequency synthesizer using integrated photonics	NATURE			English	Article							NOBEL LECTURE; MICRORESONATOR; COMBS; GENERATION; CIRCUITS; CAVITY; LASER	Optical-frequency synthesizers, which generate frequency-stable light from a single microwave-frequency reference, are revolutionizing ultrafast science and metrology, but their size, power requirement and cost need to be reduced if they are to be more widely used. Integrated-photonics microchips can be used in high-coherence applications, such as data transmission(1), highly optimized physical sensors(2) and harnessing quantum states(3), to lower cost and increase efficiency and portability. Here we describe a method for synthesizing the absolute frequency of a lightwave signal, using integrated photonics to create a phase-coherent microwave-to-optical link. We use a heterogeneously integrated III-V/silicon tunable laser, which is guided by nonlinear frequency combs fabricated on separate silicon chips and pumped by off-chip lasers. The laser frequency output of our optical-frequency synthesizer can be programmed by a microwave clock across 4 terahertz near 1,550 nanometres (the telecommunications C-band) with 1 hertz resolution. Our measurements verify that the output of the synthesizer is exceptionally stable across this region (synthesis error of 7.7 x 10(-15) or below). Any application of an optical-frequency source could benefit from the high-precision optical synthesis presented here. Leveraging high-volume semiconductor processing built around advanced materials could allow such low-cost, lowpower and compact integrated-photonics devices to be widely used.	[Spencer, Daryl T.; Drake, Tara; Briles, Travis C.; Stone, Jordan; Sinclair, Laura C.; Fredrick, Connor; Newbury, Nathan R.; Diddams, Scott A.; Papp, Scott B.] Natl Inst Stand & Technol, Time & Frequency Div, Boulder, CO 80305 USA; [Briles, Travis C.; Stone, Jordan; Fredrick, Connor; Diddams, Scott A.; Papp, Scott B.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Li, Qing; Westly, Daron; Ilic, B. Robert; Srinivasan, Kartik] Natl Inst Stand & Technol, Ctr Nanoscale Sci & Technol, Gaithersburg, MD 20899 USA; [Bluestone, Aaron; Volet, Nicolas; Komljenovic, Tin; Chang, Lin; Theogarajan, Luke; Bowers, John E.] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; [Lee, Seung Hoon; Oh, Dong Yoon; Suh, Myoung-Gyun; Yang, Ki Youl; Vahala, Kerry] CALTECH, Pasadena, CA 91125 USA; [Pfeiffer, Martin H. P.; Kippenberg, Tobias J.] Ecole Polytech Fed Lausanne, Lausanne, Switzerland; [Norberg, Erik] Aurrion Inc, Goleta, CA USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA; University of California System; University of California Santa Barbara; California Institute of Technology; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Spencer, DT; Papp, SB (corresponding author), Natl Inst Stand & Technol, Time & Frequency Div, Boulder, CO 80305 USA.; Papp, SB (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.	daryl.spencer@nist.gov; scott.papp@nist.gov	Diddams, Scott A/L-2819-2013; Suh, Myoung-Gyun/AGM-6714-2022; Kippenberg, T. J./B-3133-2013; Theogarajan, Luke/AAS-5260-2021; Bowers, John E/B-3486-2012; Yang, Kiyoul/AAI-4141-2020	Diddams, Scott A/0000-0002-2144-0764; Suh, Myoung-Gyun/0000-0002-9527-0585; Kippenberg, T. J./0000-0002-3408-886X; Bowers, John E/0000-0003-4270-8296; Yang, Kiyoul/0000-0002-0587-3201; DRAKE, TARA/0000-0001-9716-1078; Newbury, Nathan/0000-0002-4932-2153; Volet, Nicolas/0000-0002-6619-2901	Swiss National Science Foundation (SNSF); Defense Advanced Research Projects Agency DODOS program; NIST	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Defense Advanced Research Projects Agency DODOS program; NIST(National Institute of Standards & Technology (NIST) - USA)	We thank Srico, Inc. for use of the waveguide PPLN device, Aurrion Inc. for use of the III-v/Si tunable laser, and D. Hickstein, T. Dunker, A. Wallin, D. Carlson and Z. Newman for comments on the experiment. N.V. acknowledges support from the Swiss National Science Foundation (SNSF). This research is supported by the Defense Advanced Research Projects Agency DODOS program and NIST. We thank R. Lutwak and the DODOS program management team for discussions throughout the experiment.	Arafin S, 2017, IEEE PHOTONICS J, V9, DOI 10.1109/JPHOT.2017.2696858; Arafin S, 2017, OPT EXPRESS, V25, P681, DOI 10.1364/OE.25.000681; Bluestone A, 2017, OPT EXPRESS, V25, P29086, DOI 10.1364/OE.25.029086; Brasch V, 2016, SCIENCE, V351, P357, DOI 10.1126/science.aad4811; Brasch V, 2017, LIGHT-SCI APPL, V6, DOI 10.1038/lsa.2016.202; Briles T. C., 2017, PREPRINT; Chang L, 2016, OPTICA, V3, P531, DOI 10.1364/OPTICA.3.000531; Cole DC, 2017, NAT PHOTONICS, V11, P671, DOI 10.1038/s41566-017-0009-z; Del'Haye P, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.053903; Del'Haye P, 2007, NATURE, V450, P1214, DOI 10.1038/nature06401; Del'Haye P, 2016, NAT PHOTONICS, V10, P516, DOI [10.1038/NPHOTON.2016.105, 10.1038/nphoton.2016.105]; Del'Haye P, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.263901; Ferdous F, 2011, NAT PHOTONICS, V5, P770, DOI 10.1038/nphoton.2011.255; Giorgetta FR, 2010, NAT PHOTONICS, V4, P853, DOI 10.1038/nphoton.2010.228; Greenhall CA, 2003, PROC PRECISION TIME, P267; Grudinin IS, 2009, OPT LETT, V34, P878, DOI 10.1364/OL.34.000878; Hansch TW, 2006, REV MOD PHYS, V78, P1297, DOI 10.1103/RevModPhys.78.1297; Hall JL, 2006, REV MOD PHYS, V78, P1279, DOI 10.1103/RevModPhys.78.1279; Herr T, 2014, NAT PHOTONICS, V8, P145, DOI [10.1038/NPHOTON.2013.343, 10.1038/nphoton.2013.343]; Jost JD, 2015, OPTICA, V2, P706, DOI 10.1364/OPTICA.2.000706; Jost JD, 2002, OPT EXPRESS, V10, P515, DOI 10.1364/OE.10.000515; Kippenberg TJ, 2011, SCIENCE, V332, P555, DOI 10.1126/science.1193968; Komljenovic T, 2016, J LIGHTWAVE TECHNOL, V34, P20, DOI 10.1109/JLT.2015.2465382; Komljenovic T, 2015, IEEE J SEL TOP QUANT, V21, DOI 10.1109/JSTQE.2015.2422752; Leo F, 2010, NAT PHOTONICS, V4, P471, DOI [10.1038/nphoton.2010.120, 10.1038/NPHOTON.2010.120]; Li J, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.233901; Li Q, 2017, OPTICA, V4, P193, DOI 10.1364/OPTICA.4.000193; Moss DJ, 2013, NAT PHOTONICS, V7, P597, DOI [10.1038/NPHOTON.2013.183, 10.1038/nphoton.2013.183]; O'Brien JL, 2009, NAT PHOTONICS, V3, P687, DOI 10.1038/nphoton.2009.229; Okawachi Y, 2014, OPT LETT, V39, P3535, DOI 10.1364/OL.39.003535; Papp SB, 2014, OPTICA, V1, P10, DOI 10.1364/OPTICA.1.000010; Papp SB, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.053833; Pfeiffer MHP, 2017, OPTICA, V4, P684, DOI 10.1364/OPTICA.4.000684; Purdy TP, 2017, SCIENCE, V356, P1265, DOI 10.1126/science.aag1407; Rumley S, 2015, J LIGHTWAVE TECHNOL, V33, P547, DOI 10.1109/JLT.2014.2363947; Savchenkov AA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.093902; Sinclair LC, 2014, OPT EXPRESS, V22, P6996, DOI 10.1364/OE.22.006996; Srinivasan S, 2015, IEEE PHOTONICS J, V7, DOI 10.1109/JPHOT.2015.2428255; Stone J., 2017, PREPRINT; Volet N, 2017, LASER PHOTONICS REV, V11, DOI 10.1002/lpor.201600165; Yang K. Y., 2018, NAT PHOTONICS; Ycas G, 2012, OPT LETT, V37, P2199, DOI 10.1364/OL.37.002199; Yi X, 2015, OPTICA, V2, P1078, DOI 10.1364/OPTICA.2.001078	43	387	398	38	362	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2018	557	7703					81	+		10.1038/s41586-018-0065-7	http://dx.doi.org/10.1038/s41586-018-0065-7			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5BW	29695870	Green Accepted, Green Submitted			2022-12-28	WOS:000431234500034
J	Oliver, D				Oliver, David			David Oliver: Learning from deaths in hospital	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Hogan H, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3239; Kirkup B., 2015, REPORT MORECAMBE BAY; Matthews-King Alex, 2018, INDEPENDENT; National Quality Board, 2017, NAT GUID LEARN DEATH; NHS England, 2015, IND REV DEATHS PEOPL; NHS Improvement, 2017, TEMPL LEARN DEATHS P; NHS Improvement, 2017, LEARN DEATHS ON YEAR; Ramesh R., 2015, GUARDIAN; Royal College of Pathologists, MED EX	9	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 2	2018	361								k969	10.1136/bmj.k969	http://dx.doi.org/10.1136/bmj.k969			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF4YF	29720367	Green Published, Bronze			2022-12-28	WOS:000431969500021
J	Feld, L; Cifu, AS				Feld, Lauren; Cifu, Adam S.			Management of Dyspepsia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; HELICOBACTER-PYLORI TEST; PRIMARY-CARE PATIENTS; ENDOSCOPY		[Feld, Lauren; Cifu, Adam S.] Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA	University of Chicago	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu	Sood, Ruchit/H-7048-2013	Sood, Ruchit/0000-0003-1011-8910				Chiba N, 2002, BRIT MED J, V324, P1012, DOI 10.1136/bmj.324.7344.1012; Delaney BC, 2008, BMJ-BRIT MED J, V336, P651, DOI 10.1136/bmj.39479.640486.AE; Duggan AE, 2009, ALIMENT PHARM THER, V29, P55, DOI 10.1111/j.1365-2036.2008.03852.x; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Lassen AT, 2004, GUT, V53, P1758, DOI 10.1136/gut.2004.043570; Moayyedi PM, 2017, AM J GASTROENTEROL, V112, P988, DOI 10.1038/ajg.2017.154; Vakil N, 2006, GASTROENTEROLOGY, V131, P390, DOI 10.1053/j.gastro.2006.04.029; Vakil N, 2009, CLIN GASTROENTEROL H, V7, P756, DOI 10.1016/j.cgh.2009.03.031; van Zanten SJOV, 2005, AM J GASTROENTEROL, V100, P1477, DOI 10.1111/j.1572-0241.2005.40280.x	9	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2018	319	17					1816	1817		10.1001/jama.2018.3435	http://dx.doi.org/10.1001/jama.2018.3435			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GE3UQ	29715342				2022-12-28	WOS:000431138800020
J	Bardill, J; Bader, AC; Garrison, NA; Bolnick, DA; Raff, JA; Walker, A; Malhi, RS				Bardill, Jessica; Bader, Alyssa C.; Garrison, Nanibaa' A.; Bolnick, Deborah A.; Raff, Jennifer A.; Walker, Alexa; Malhi, Ripan S.		Summer Internship INdigenous Peopl	Advancing the ethics of paleogenomics	SCIENCE			English	Editorial Material												jessica.bardill@concordia.ca; malhi@illinois.edu		Nakatsuka, Nathan/0000-0002-5091-4914	NIH [R25HG007158]; NSF [BCS 1518026]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG008818, R25HG007158] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank J. Cybulski, B. Petzelt, J. Mitchell, Lax Kw'alaams Metlakatla community members, A. Jensen, D. O'Rourke, M. G. Hayes, the community members and Senior Advisory Council of Utqiagvik, and the Ukpeagvik Inupiat Corporation (UIC) for collaboration. We also thank the anonymous reviewers, D. Lippert, G. Nicholas, and members of the Bolnick Lab for feedback. Funded by NIH R25HG007158 and NSF BCS 1518026.	[Anonymous], 2014, TRIC POL STAT ETH CO; [Anonymous], 2016, NATURE, V533, P7; Burhansstipanov L, 2001, GENETICS, V158, P941; Callaway E, 2015, NATURE, V522, P404, DOI 10.1038/nature.2015.17797; Claw K. G., 2017, HUMAN BIOL; Garrison N. A., 2011, CASES TRIBES ARE REL; Kennett DJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14115; Martindale A, 2014, RETHINKING COLONIAL, P397; McInnes RR, 2011, AM J HUM GENET, V88, P254, DOI 10.1016/j.ajhg.2011.02.014; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1978, BELM REP ETH PRINC G; Rasmussen M, 2015, NATURE, V523, P455, DOI 10.1038/nature14625; Turner T., 2005, BIOL ANTHR ETHICS	12	53	56	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					384	385		10.1126/science.aaq1131	http://dx.doi.org/10.1126/science.aaq1131			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1AR	29700256	Green Accepted			2022-12-28	WOS:000430949600025
J	Fadel, M; Zibold, T; Decamps, B; Treutlein, P				Fadel, Matteo; Zibold, Tilman; Decamps, Boris; Treutlein, Philipp			Spatial entanglement patterns and Einstein-Podolsky-Rosen steering in Bose-Einstein condensates	SCIENCE			English	Article							QUANTUM METROLOGY; ATOM-CHIP; GENERATION; SYSTEMS	Many-particle entanglement is a fundamental concept of quantum physics that still presents conceptual challenges. Although nonclassical states of atomic ensembles were used to enhance measurement precision in quantum metrology, the notion of entanglement in these systems was debated because the correlations among the indistinguishable atoms were witnessed by collective measurements only. Here, we use high-resolution imaging to directly measure the spin correlations between spatially separated parts of a spin-squeezed Bose-Einstein condensate. We observe entanglement that is strong enough for Einstein-Podolsky-Rosen steering: We can predict measurement outcomes for noncommuting observables in one spatial region on the basis of corresponding measurements in another region with an inferred uncertainty product below the Heisenberg uncertainty bound. This method could be exploited for entanglement-enhanced imaging of electromagnetic field distributions and quantum information tasks.	[Treutlein, Philipp] Univ Basel, Dept Phys, Klingelbergstr 82, CH-4056 Basel, Switzerland; Univ Basel, Swiss Nanosci Inst, Klingelbergstr 82, CH-4056 Basel, Switzerland	University of Basel; University of Basel	Treutlein, P (corresponding author), Univ Basel, Dept Phys, Klingelbergstr 82, CH-4056 Basel, Switzerland.	philipp.treutlein@unibas.ch	Treutlein, Philipp/H-6158-2012	Treutlein, Philipp/0000-0001-9025-9574; Zibold, Tilman/0000-0003-0266-6650	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was financially supported by the Swiss National Science Foundation.	Amico L, 2008, REV MOD PHYS, V80, P517, DOI 10.1103/RevModPhys.80.517; Bohi P, 2009, NAT PHYS, V5, P592, DOI 10.1038/NPHYS1329; Brunner N, 2014, REV MOD PHYS, V86, DOI 10.1103/RevModPhys.86.419; Cavalcanti D, 2017, REP PROG PHYS, V80, DOI 10.1088/1361-6633/80/2/024001; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Fukuhara T, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.035302; Giovannetti V, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.022320; Giovannetti V, 2011, NAT PHOTONICS, V5, P222, DOI [10.1038/NPHOTON.2011.35, 10.1038/nphoton.2011.35]; Gross C, 2010, NATURE, V464, P1165, DOI 10.1038/nature08919; Guhne O, 2009, PHYS REP, V474, P1, DOI 10.1016/j.physrep.2009.02.004; Handchen V, 2012, NAT PHOTONICS, V6, P596, DOI [10.1038/nphoton.2012.202, 10.1038/NPHOTON.2012.202]; Hagley E, 1997, PHYS REV LETT, V79, P1, DOI 10.1103/PhysRevLett.79.1; He QY, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.060402; Hu JZ, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.063816; Islam R, 2015, NATURE, V528, P77, DOI 10.1038/nature15750; Julsgaard B, 2001, NATURE, V413, P400, DOI 10.1038/35096524; Ketterle W, 1999, P INT SCH PHYS, V140, P67; Killoran N, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.150501; Kunkel P, 2018, SCIENCE, V360, P413, DOI 10.1126/science.aao2254; Lange K, 2018, SCIENCE, V360, P416, DOI 10.1126/science.aao2035; Leroux ID, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.250801; Louchet-Chauvet A, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/6/065032; Matsukevich DN, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.030405; Midgley SLW, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.022101; Muessel W, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.103004; Ockeloen CF, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.143001; Peise J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9984; Pezze L., 2016, ARXIV160901609QUANTP; Quintino MT, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.032107; Reid MD, 2009, REV MOD PHYS, V81, P1727, DOI 10.1103/RevModPhys.81.1727; Riedel MF, 2010, NATURE, V464, P1170, DOI 10.1038/nature08988; Schmied R, 2016, SCIENCE, V352, P441, DOI 10.1126/science.aad8665; Schrodinger E, 1935, P CAMB PHILOS SOC, V31, P555, DOI 10.1017/S0305004100013554; Simon J, 2007, NAT PHYS, V3, P765, DOI 10.1038/nphys726; Wagner K, 2014, J PHYS B-AT MOL OPT, V47, DOI 10.1088/0953-4075/47/22/225502; WINELAND DJ, 1994, PHYS REV A, V50, P67, DOI 10.1103/PhysRevA.50.67; Wiseman HM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.140402; Wollmann S, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.160403	39	104	105	3	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					409	412		10.1126/science.aao1850	http://dx.doi.org/10.1126/science.aao1850			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1AR	29700261	Green Submitted			2022-12-28	WOS:000430949600035
J	Ciottone, GR				Ciottone, Gregory R.			Toxidrome Recognition in Chemical-Weapons Attacks	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SUBWAY SARIN ATTACK; MASS CASUALTY TRIAGE; WARFARE AGENTS; PREHOSPITAL MANAGEMENT; DISASTER MANAGEMENT; MEDICAL RESPONSE; SULFUR MUSTARD; EXPOSURE; GAS; HEALTH		[Ciottone, Gregory R.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Ciottone, GR (corresponding author), Beth Israel Deaconess Med Ctr, Dept Emergency Med, Rosenberg Bldg,1 Deaconess Rd, Boston, MA 02215 USA.	gciotton@bidmc.harvard.edu	Ciottone, Gregory/AAM-9446-2021	Ciottone, Gregory/0000-0002-3313-1379				[Anonymous], 2009, BEST PRACT PROT EMS; [Anonymous], 2017, EMERGENCY PREPAREDNE; [Anonymous], 2005, CONVENTION PROHIBITI; Baker David, 2004, Prehosp Disaster Med, V19, P174; Bentley MA, 2016, PREHOSP DISASTER MED, V31, pS96, DOI 10.1017/S1049023X16001102; Berger Tamar, 2016, Disaster Mil Med, V2, P7, DOI 10.1186/s40696-016-0017-4; Borron SW, 2015, EMERG MED CLIN N AM, V33, P213, DOI 10.1016/j.emc.2014.09.013; Brennan RJ, 1999, ANN EMERG MED, V34, P191, DOI 10.1016/S0196-0644(99)70229-5; Cagliuso N, 2015, CIOTTONES DISASTER M, P416; Carota A, 2016, FRONT NEUROL NEUROSC, V38, P214, DOI 10.1159/000442658; Cevik Y, 2009, SOUTH MED J, V102, P1209, DOI 10.1097/SMJ.0b013e3181bfdc67; Chaboo CS, 2016, ZOOKEYS, P9, DOI 10.3897/zookeys.558.5957; Chauhan S, 2008, ENVIRON TOXICOL PHAR, V26, P113, DOI 10.1016/j.etap.2008.03.003; Cieslak T., 2014, USAMRIIDS MED MANAGE, P23; Cone DC, 2008, PREHOSP EMERG CARE, V12, P236, DOI 10.1080/10903120801907620; Cone DC, 2005, EUR J EMERG MED, V12, P287, DOI 10.1097/00063110-200512000-00009; Culley Joan M, 2014, Am J Disaster Med, V9, P137, DOI 10.5055/ajdm.2014.0150; Dolgin E, 2013, NAT MED, V19, P1194, DOI 10.1038/nm1013-1194; Eisenkraft A, 2014, AM J EMERG MED, V32, P186, DOI 10.1016/j.ajem.2013.11.005; Eyre AJ, 2015, CIOTTONES DISASTER M, P294; Fitzgerald GJ, 2008, AM J PUBLIC HEALTH, V98, P611, DOI 10.2105/AJPH.2007.11930; Ganesan K, 2010, J PHARM BIOALLIED SC, V2, P166, DOI 10.4103/0975-7406.68498; Ghabili K, 2010, J APPL TOXICOL, V30, P627, DOI 10.1002/jat.1581; Haines D D, 2014, Forensic Sci Rev, V26, P97; Joosen MJA, 2017, CHEM-BIOL INTERACT, V267, P48, DOI 10.1016/j.cbi.2016.02.001; Kales SN, 2004, NEW ENGL J MED, V350, P800, DOI 10.1056/NEJMra030370; Keim ME, 2015, CIOTTONES DISASTER M, P664; Kenar L, 2004, EMERG MED J, V21, P84, DOI 10.1136/emj.2003.005488; Khoshnevis MA, 2015, TRAUMA MON, V20, DOI 10.5812/traumamon.16211; Kirk MA, 2007, EMERG MED CLIN N AM, V25, P527, DOI 10.1016/j.emc.2007.02.005; Krivoy A, 2005, PREHOSPITAL DISASTER, V20, P155, DOI 10.1017/S1049023X00002375; LEADBEATER L, 1985, FUND APPL TOXICOL, V5, pS225, DOI 10.1016/0272-0590(85)90132-0; Lim Sung-Chul, 1996, Korean Journal of Internal Medicine (English Edition), V11, P87; Lioy PJ, 2016, ANN NY ACAD SCI, V1378, P108, DOI 10.1111/nyas.13173; Madsen J.M., 2020, UPTODATE; Madsen James M, 2010, Am J Disaster Med, V5, P333; Melnikova N, 2018, DISASTER MED PUBLIC, V12, P211, DOI 10.1017/dmp.2017.50; MUNRO NB, 1994, ENVIRON HEALTH PERSP, V102, P18, DOI 10.1289/ehp.9410218; Nozaki H, 1995, INTENS CARE MED, V21, P1032, DOI 10.1007/BF01700667; Okumura S, 2005, CRIT CARE, V9, P397, DOI 10.1186/cc3062; Okumura T, 2005, Toxicol Appl Pharmacol, V207, P471, DOI 10.1016/j.taap.2005.02.032; Okumura T, 1998, ACAD EMERG MED, V5, P625, DOI 10.1111/j.1553-2712.1998.tb02472.x; Okumura T, 1998, ACAD EMERG MED, V5, P618, DOI 10.1111/j.1553-2712.1998.tb02471.x; OPCW Technical Secretariat, 2017, REP OPCW FACT FIND M; Pacsial-Ong Eden Joy, 2013, Front Biosci (Schol Ed), V5, P516; Phelps S, 2007, PREHOSPITAL DISASTER, V22, P293, DOI 10.1017/S1049023X00004891; Pitschmann V, 2014, TOXINS, V6, P1761, DOI 10.3390/toxins6061761; Ramesh AC, 2010, J PHARM BIOALLIED SC, V2, P239, DOI 10.4103/0975-7406.68506; Reilly MJ, 2007, PREHOSP DISASTER MED, V22, P297, DOI 10.1017/S1049023X00004908; Rodgers GC, 2010, CLIN PHARMACOL THER, V88, P318, DOI 10.1038/clpt.2010.152; Rosman Y, 2014, ANN INTERN MED, V160, P644, DOI 10.7326/M13-2799; Sandler T, 2014, J PEACE RES, V51, P257, DOI 10.1177/0022343313491277; Schmaltz F, 2006, J HIST NEUROSCI, V15, P186, DOI 10.1080/09647040600658229; Schumacher J, 2015, PREHOSP DISASTER MED, V30, P254, DOI 10.1017/S1049023X15004690; Subbarao I, 2005, PREHOSP DISASTER MED, V20, P301, DOI 10.1017/S1049023X00002752; Tewari-Singh N, 2014, FREE RADICAL BIO MED, V72, P285, DOI 10.1016/j.freeradbiomed.2014.04.022; Thierren T, 2018, BBC NEWS; Tokuda Y, 2006, RESUSCITATION, V68, P193, DOI 10.1016/j.resuscitation.2005.05.023; Tomassoni AJ, 2015, EMERG MED CLIN N AM, V33, P13, DOI 10.1016/j.emc.2014.09.004; Turris SA, 2012, PREHOSP DISASTER MED, V27, P531, DOI 10.1017/S1049023X12001446; UN, 2013, MISS INV ALL US CHEM; Vale A., 2016, MEDICINE, V44, P106, DOI DOI 10.1016/J.MPMED.2007.07.012; Watermeyer MJ, 2018, DISASTER MED PUBLIC, V12, P249, DOI 10.1017/dmp.2017.49; Wattana M, 2009, PREHOSP DISASTER MED, V24, P19, DOI 10.1017/S1049023X0000649X; Zarocostas J, 2017, LANCET, V389, P1501, DOI 10.1016/S0140-6736(17)30997-2	65	33	34	1	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2018	378	17					1611	1620		10.1056/NEJMra1705224	http://dx.doi.org/10.1056/NEJMra1705224			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GD8XP	29694809				2022-12-28	WOS:000430797900008
J	Hawkes, N				Hawkes, Nigel			NHS hospital drug costs are set to surpass spending in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ewbank L, 2018, RISING COST MED NHS; NHS Digital, 2017, PRESCR COSTS HOSP CO	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2018	361								k1766	10.1136/bmj.k1766	http://dx.doi.org/10.1136/bmj.k1766			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF4WE	29699976				2022-12-28	WOS:000431963800005
J	Schneider, H; Faschingbauer, F; Schuepbach-Mallepell, S; Korber, I; Wohlfart, S; Dick, A; Wahlbuhl, M; Kowalczyk-Quintas, C; Vigolo, M; Kirby, N; Tannert, C; Rompel, O; Rascher, W; Beckmann, MW; Schneider, P				Schneider, Holm; Faschingbauer, Florian; Schuepbach-Mallepell, Sonia; Koerber, Iris; Wohlfart, Sigrun; Dick, Angela; Wahlbuhl, Mandy; Kowalczyk-Quintas, Christine; Vigolo, Michele; Kirby, Neil; Tannert, Corinna; Rompel, Oliver; Rascher, Wolfgang; Beckmann, Matthias W.; Schneider, Pascal			Prenatal Correction of X-Linked Hypohidrotic Ectodermal Dysplasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEONATAL FC-RECEPTOR; RECOMBINANT ECTODYSPLASIN; DIAGNOSIS; MUTATION; DISEASE; AGE	Genetic deficiency of ectodysplasin A (EDA) causes X-linked hypohidrotic ectodermal dysplasia (XLHED), in which the development of sweat glands is irreversibly impaired, an condition that can lead to life-threatening hyperthermia. We observed normal development of mouse fetuses with Eda mutations after they had been exposed in utero to a recombinant protein that includes the receptor-binding domain of EDA. We administered this protein intraamniotically to two affected human twins at gestational weeks 26 and 31 and to a single affected human fetus at gestational week 26; the infants, born in week 33 (twins) and week 39 (singleton), were able to sweat normally, and XLHED-related illness had not developed by 14 to 22 months of age. (Funded by Edimer Pharmaceuticals and others.)	[Schneider, Holm; Koerber, Iris; Wohlfart, Sigrun; Dick, Angela; Wahlbuhl, Mandy; Rascher, Wolfgang] Univ Erlangen Nurnberg, Dept Pediat, Loschgestr 15, D-91054 Erlangen, Germany; [Faschingbauer, Florian; Beckmann, Matthias W.] Univ Erlangen Nurnberg, Dept Obstet & Gynecol, Erlangen, Germany; [Rompel, Oliver] Univ Erlangen Nurnberg, Dept Radiol, Erlangen, Germany; [Tannert, Corinna] Radiol Nienburg, Nienburg Weser, Germany; [Schuepbach-Mallepell, Sonia; Kowalczyk-Quintas, Christine; Vigolo, Michele; Schneider, Pascal] Univ Lausanne, Dept Biochem, Epalinges, Switzerland; [Kirby, Neil] Edimer Pharmaceut, Andover, MA USA	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Lausanne	Schneider, H (corresponding author), Univ Erlangen Nurnberg, Dept Pediat, Loschgestr 15, D-91054 Erlangen, Germany.	holm.schneider@uk-erlangen.de		Vigolo, Michele/0000-0002-4765-6598; Schneider, Pascal/0000-0003-0677-9409; Dick, Angela/0000-0003-4085-2964; Maier-Wohlfart, Sigrun/0000-0002-7073-9674	Edimer Pharmaceuticals	Edimer Pharmaceuticals	Funded by Edimer Pharmaceuticals and others.	Akolekar R, 2015, ULTRASOUND OBST GYN, V45, P16, DOI 10.1002/uog.14636; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Biggs LC, 2014, SEMIN CELL DEV BIOL, V25, P11, DOI 10.1016/j.semcdb.2014.01.007; Bluschke G, 2010, EARLY HUM DEV, V86, P397, DOI 10.1016/j.earlhumdev.2010.04.008; Burger K, 2014, AM J MED GENET A, V164, P2424, DOI 10.1002/ajmg.a.36541; Casal ML, 2007, AM J HUM GENET, V81, P1050, DOI 10.1086/521988; CLARKE A, 1987, ARCH DIS CHILD, V62, P989, DOI 10.1136/adc.62.10.989; Ersch J, 1999, OBSTET GYNECOL, V94, P753, DOI 10.1016/S0029-7844(99)00379-8; Gaide O, 2003, NAT MED, V9, P614, DOI 10.1038/nm861; Hermes K, 2014, J INVEST DERMATOL, V134, P2985, DOI 10.1038/jid.2014.264; Kaercher T, 2015, CURR EYE RES, V40, P884, DOI 10.3109/02713683.2014.967869; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kowalczyk C, 2011, J BIOL CHEM, V286, P30769, DOI 10.1074/jbc.M111.267997; Kuo TT, 2011, MABS-AUSTIN, V3, P422, DOI 10.4161/mabs.3.5.16983; Martin J. A., 2018, NATL VITAL STAT REPO, V67; Mauldin EA, 2009, AM J MED GENET A, V149A, P2045, DOI 10.1002/ajmg.a.32916; Melamed N, 2009, J MATERN-FETAL NEO M, V22, P1051, DOI 10.3109/14767050903019650; Niemann S, 2004, AM J HUM GENET, V74, P558, DOI 10.1086/382196; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; SALISBURY DM, 1981, LANCET, V1, P153; Swee LK, 2009, J BIOL CHEM, V284, P27567, DOI 10.1074/jbc.M109.042259; Ulm MR, 1998, ULTRASOUND OBST GYN, V12, P240, DOI 10.1046/j.1469-0705.1998.12040240.x; Wunsche S, 2015, ULTRASCHALL MED, V36, P381, DOI 10.1055/s-0034-1384933	23	81	84	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2018	378	17					1604	1610		10.1056/NEJMoa1714322	http://dx.doi.org/10.1056/NEJMoa1714322			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8XP	29694819	Green Accepted, Bronze			2022-12-28	WOS:000430797900007
J	Rankin, LC; Artis, D				Rankin, Lucille C.; Artis, David			Beyond Host Defense: Emerging Functions of the Immune System in Regulating Complex Tissue Physiology	CELL			English	Review							INNATE LYMPHOID-CELLS; ARYL-HYDROCARBON RECEPTOR; CENTRAL-NERVOUS-SYSTEM; ALTERNATIVELY ACTIVATED MACROPHAGES; VASOACTIVE-INTESTINAL-PEPTIDE; T-CELLS; ADIPOSE-TISSUE; BEIGE FAT; ORCHESTRATE DEVELOPMENT; ADAPTIVE THERMOGENESIS	The essential roles played by the immune system in the discrimination between self-versus non/altered-self and its integral role in promoting host defense against invading microbes and tumors have been extensively studied for many years. In these contexts, significant advances have been made in defining the molecular and cellular networks that orchestrate cell-cell communication to mediate host defense and pathogen expulsion. Notably, recent studies indicate that in addition to these classical immune functions, cells of the innate and adaptive immune system also sense complex tissue- and environment-derived signals, including those from the nervous system and the diet. In turn these responses regulate physiologic processes in multiple tissues throughout the body, including nervous system function, metabolic state, thermogenesis, and tissue repair. In this review we propose an integrated view of how the mammalian immune system senses and interacts with other complex organ systems to maintain tissue and whole-body homeostasis.	[Rankin, Lucille C.; Artis, David] Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Weill Cornell Med, New York, NY 10021 USA; [Rankin, Lucille C.; Artis, David] Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med, New York, NY 10021 USA	Cornell University; Cornell University	Artis, D (corresponding author), Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Weill Cornell Med, New York, NY 10021 USA.; Artis, D (corresponding author), Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med, New York, NY 10021 USA.	dartis@med.cornell.edu		Rankin, Lucille/0000-0002-3699-1569; Artis, David/0000-0002-1753-4100	U.S. NIH [AI074878, AI083480, AI095466, AI095608, AI102942, AI097333]; Burroughs Wellcome Fund; Crohn's & Colitis Foundation of America and cure for IBD [AI106697]; Australian NHMRC Early Career Fellowship [App 1107400]	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Crohn's & Colitis Foundation of America and cure for IBD; Australian NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	Research in the Artis lab is funded by the U.S. NIH (AI074878, AI083480, AI095466, AI095608, AI102942, and AI097333), the Burroughs Wellcome Fund, the Crohn's & Colitis Foundation of America and cure for IBD (AI106697). Lucille Rankin is funded by the Australian NHMRC Early Career Fellowship (App 1107400). We thank members of the Artis lab and the Jill Roberts Institute of IBD for critically reading the manuscript.	Aballay A, 2009, CELL CYCLE, V8, P966, DOI 10.4161/cc.8.7.8074; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Arreola R, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/354957; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Cervantes-Barragan L, 2017, SCIENCE, V357, P806, DOI 10.1126/science.aah5825; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Cohen P, 2015, DIABETES, V64, P2346, DOI 10.2337/db15-0318; Delgado M, 2001, J IMMUNOL, V166, P2907, DOI 10.4049/jimmunol.166.5.2907; Eberl G, 2016, NAT REV IMMUNOL, V16, P524, DOI 10.1038/nri.2016.75; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Fabbiano S, 2016, CELL METAB, V24, P434, DOI 10.1016/j.cmet.2016.07.023; Filiano AJ, 2016, NATURE, V535, P425, DOI 10.1038/nature18626; Fischer K, 2017, NAT MED, V23, P623, DOI 10.1038/nm.4316; Fonseca-Pereira D, 2014, NATURE, V514, P98, DOI 10.1038/nature13498; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Gadani SP, 2017, J EXP MED, V214, P285, DOI 10.1084/jem.20161982; Garre JM, 2017, NAT MED, V23, P714, DOI 10.1038/nm.4340; Gonzalez-Rey E, 2007, TRENDS MOL MED, V13, P241, DOI 10.1016/j.molmed.2007.04.003; Haghikia A, 2015, IMMUNITY, V43, P817, DOI 10.1016/j.immuni.2015.09.007; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Herz J, 2016, IMMUNITY, V44, P718, DOI 10.1016/j.immuni.2016.03.010; Hibberd MC, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal4069; Hulsmans M, 2017, CELL, V169, P510, DOI 10.1016/j.cell.2017.03.050; Ibiza S, 2016, NATURE, V535, P440, DOI 10.1038/nature18644; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kim S, 2017, NATURE, V549, P528, DOI 10.1038/nature23910; Kipnis J, 2016, SCIENCE, V353, P766, DOI 10.1126/science.aag2638; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Kolmus K, 2015, BRAIN BEHAV IMMUN, V45, P297, DOI 10.1016/j.bbi.2014.10.007; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Macpherson AJ, 2017, NAT REV IMMUNOL, V17, P508, DOI 10.1038/nri.2017.58; Margolis KG, 2016, TRENDS NEUROSCI, V39, P614, DOI 10.1016/j.tins.2016.06.007; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Mielke LA, 2013, J EXP MED, V210, P1117, DOI 10.1084/jem.20121588; Minutti CM, 2017, IMMUNITY, V47, P710, DOI 10.1016/j.immuni.2017.09.013; Monticelli LA, 2015, P NATL ACAD SCI USA, V112, P10762, DOI 10.1073/pnas.1509070112; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Moriyama S, 2018, SCIENCE, V359, P1056, DOI 10.1126/science.aan4829; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nowak EC, 2012, J EXP MED, V209, P2127, DOI 10.1084/jem.20120408; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; O'Sullivan TE, 2016, IMMUNITY, V45, P428, DOI 10.1016/j.immuni.2016.06.016; Odegaard JI, 2016, CELL, V166, P841, DOI 10.1016/j.cell.2016.06.040; Oetjen LK, 2017, CELL, V171, P217, DOI 10.1016/j.cell.2017.08.006; Padro CJ, 2014, SEMIN IMMUNOL, V26, P357, DOI 10.1016/j.smim.2014.01.003; Pirzgalska RM, 2017, NAT MED, V23, P1309, DOI 10.1038/nm.4422; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Rankin LC, 2016, NAT IMMUNOL, V17, P179, DOI 10.1038/ni.3332; Rao S, 2017, CELL, V168, P503, DOI 10.1016/j.cell.2017.01.006; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Sallam T., 2018, CELL, V172; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Sanders VM, 2012, BRAIN BEHAV IMMUN, V26, P195, DOI 10.1016/j.bbi.2011.08.001; Schieber AMP, 2015, SCIENCE, V350, P558, DOI 10.1126/science.aac6468; Shibata N, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02171; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Song C, 2015, J EXP MED, V212, P1869, DOI 10.1084/jem.20151403; Sonnenburg ED, 2014, CELL METAB, V20, P779, DOI 10.1016/j.cmet.2014.07.003; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Talbot S, 2015, NEURON, V87, P341, DOI 10.1016/j.neuron.2015.06.007; Thorburn AN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8320; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Tidball JG, 2017, NAT REV IMMUNOL, V17, P165, DOI 10.1038/nri.2016.150; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Veiga-Fernandes H, 2017, TRENDS IMMUNOL, V38, P777, DOI 10.1016/j.it.2017.02.007; Veiga-Fernandes H, 2017, NAT IMMUNOL, V18, P116, DOI 10.1038/ni.3634; Veiga-Fernandes H, 2016, CELL, V165, P801, DOI 10.1016/j.cell.2016.04.041; Veldhoen M, 2015, NAT IMMUNOL, V16, P215, DOI 10.1038/ni.3100; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026; Whitham M, 2016, NAT REV DRUG DISCOV, V15, P719, DOI 10.1038/nrd.2016.153; Wolf Y, 2017, NAT IMMUNOL, V18, P665, DOI 10.1038/ni.3746; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Yissachar N, 2017, CELL, V168, P1135, DOI 10.1016/j.cell.2017.02.009; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111; Zaiss DMW, 2015, IMMUNITY, V42, P216, DOI 10.1016/j.immuni.2015.01.020	103	106	110	7	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2018	173	3					554	567		10.1016/j.cell.2018.03.013	http://dx.doi.org/10.1016/j.cell.2018.03.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7GB	29677509	Bronze			2022-12-28	WOS:000430677400008
J	Yoshizawa, T; Ali, R; Jiou, J; Fung, HYJ; Burke, KA; Kim, SJ; Lin, Y; Peeples, WB; Saltzberg, D; Soniat, M; Baumhardt, JM; Oldenbourg, R; Sali, A; Fawzi, NL; Rosen, MK; Chook, YM				Yoshizawa, Takuya; Ali, Rustam; Jiou, Jenny; Fung, Ho Yee Joyce; Burke, Kathleen A.; Kim, Seung Joong; Lin, Yuan; Peeples, William B.; Saltzberg, Daniel; Soniat, Michael; Baumhardt, Jordan M.; Oldenbourg, Rudolf; Sali, Andrej; Fawzi, Nicolas L.; Rosen, Michael K.; Chook, Yuh Min			Nuclear Import Receptor Inhibits Phase Separation of FUS through Binding to Multiple Sites	CELL			English	Article							PRION-LIKE DOMAINS; STRUCTURAL BASIS; STRESS GRANULES; LIQUID DROPLETS; PROTEIN; INTEGRATION; RECOGNITION; SCATTERING; MODEL; TRANSITION	Liquid-liquid phase separation (LLPS) is believed to underlie formation of biomolecular condensates, cellular compartments that concentrate macromolecules without surrounding membranes. Physical mechanisms that control condensate formation/dissolution are poorly understood. The RNA-binding protein fused in sarcoma (FUS) undergoes LLPS in vitro and associates with condensates in cells. We show that the importin karyopherin-beta 2/transportin-1 inhibits LLPS of FUS. This activity depends on tight binding of karyopherin-beta 2 to the C-terminal proline-tyrosine nuclear localization signal (PY-NLS) of FUS. Nuclear magnetic resonance (NMR) analyses reveal weak interactions of karyopherin-beta 2 with sequence elements and structural domains distributed throughout the entirety of FUS. Biochemical analyses demonstrate that most of these same regions also contribute to LLPS of FUS. The data lead to a model where high-affinity binding of karyopherin-beta 2 to the FUS PY-NLS tethers the proteins together, allowing multiple, distributed weak intermolecular contacts to disrupt FUS self-association, blocking LLPS. Karyopherin-beta 2 may act analogously to control condensates in diverse cellular contexts.	[Yoshizawa, Takuya; Jiou, Jenny; Fung, Ho Yee Joyce; Soniat, Michael; Baumhardt, Jordan M.; Chook, Yuh Min] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Ali, Rustam; Lin, Yuan; Peeples, William B.; Rosen, Michael K.] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Ali, Rustam; Lin, Yuan; Peeples, William B.; Rosen, Michael K.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Burke, Kathleen A.; Fawzi, Nicolas L.] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Kim, Seung Joong; Saltzberg, Daniel; Sali, Andrej] Univ Calif San Francisco, Calif Inst Quantitat Biosci, Dept Pharmaceut Chem, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Lin, Yuan; Peeples, William B.; Rosen, Michael K.; Chook, Yuh Min] Marine Biol Lab, Howard Hughes Med Inst, Summer Inst, Woods Hole, MA 02543 USA; [Oldenbourg, Rudolf] Marine Biol Labs, 7 MBL St, Woods Hole, MA 02543 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Brown University; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Marine Biological Laboratory - Woods Hole; Marine Biological Laboratory - Woods Hole	Chook, YM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.; Rosen, MK (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.; Rosen, MK (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.; Rosen, MK; Chook, YM (corresponding author), Marine Biol Lab, Howard Hughes Med Inst, Summer Inst, Woods Hole, MA 02543 USA.	michael.rosen@utsouthwestern.edu; yuhmin.chook@utsouthwestern.edu	Ali, Rustam/AAA-1726-2019; Chook, Yuh Min/AAA-9549-2019; Kim, Seung Joong/S-6970-2018	Ali, Rustam/0000-0001-7717-930X; Jiou, Jenny/0000-0002-2124-5272; Soniat, Michael/0000-0003-3670-4344; Fung, Ho Yee Joyce/0000-0002-0502-1957	U. S. Department of Energy (DOE), Office of Biological and Environmental Research (BER) [DE-AC02-06CH11357]; Division of Biology and Medicine, Brown University; NIH [1S10RR26461-1, 1S10OD018027-01]; DOE by Stanford University; DOE BER; NIH; NCRR; Biomedical Technology Program [P41RR001209]; NIGMS, NIH [P41GM103393]; NIGMS of NIH [R01GM069909, U01GM98256-01, R01GM56322, R01GM118530, R01GM083960, P41GM109824, R01GM112108, R01GM114274, T32GM008203, T32GM008297]; Howard Hughes Medical Institute HCIA grant; Welch Foundation grants [I-1532, I-1544]; Leukemia and Lymphoma Society Scholar Award; University of Texas Southwestern Endowed Scholars Program; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026461, P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM098256, T32GM008297, R01GM112108, R01GM114274, P41GM109824, P41GM103393, R01GM056322, R01GM083960, T32GM008203, R01GM069909, R01GM118530] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021596, S10OD018027] Funding Source: NIH RePORTER	U. S. Department of Energy (DOE), Office of Biological and Environmental Research (BER)(United States Department of Energy (DOE)); Division of Biology and Medicine, Brown University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE by Stanford University; DOE BER(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biomedical Technology Program; NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS of NIH; Howard Hughes Medical Institute HCIA grant; Welch Foundation grants(The Welch Foundation); Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); University of Texas Southwestern Endowed Scholars Program; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Dormann and J. Shorter for critical reading of the manuscript. We thank A. Patel and A. A. Hyman for their gift of FUS-GFP, T. Cagatay and A. Gonzalez for help subcloning, J. Hu and D. Corey for their help with temperature-dependent turbidity analysis, N. Conrad and K. Lynch for advice on FUSRNA analysis, T. Matsui and T. M. Weiss at SSRL, SLAC National Accelerator Laboratory, for assistance with collecting SAXS data, and B. Raveh for discussions on SAXS analysis. We thank D. Tomchick for advice on X-ray structure determination, and the Structural Biology Laboratory and Macromolecular Biophysics Resource at UTSW for their assistance with crystallographic and biophysical data collection. Crystallographic results are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the U. S. Department of Energy (DOE), Office of Biological and Environmental Research (BER) under contract DE-AC02-06CH11357. NMR data were obtained in part at the Brown University Structural Biology Core Facility supported by the Division of Biology and Medicine, Brown University. NMR spectroscopy at UTSW is supported by NIH instrumentation grants 1S10RR26461-1 and 1S10OD018027-01. SAXS experiments were performed at the SSRL, SLAC National Accelerator Laboratory operated for DOE by Stanford University. The SSRL SMBP is supported by the DOE BER, by the NIH, NCRR, Biomedical Technology Program (P41RR001209), and by NIGMS, NIH (P41GM103393). This work was funded by NIGMS of NIH under R01GM069909 (Y. M. C.), U01GM98256-01 (Y. M. C. and A. S.), R01GM56322 (M. K. R.), R01GM118530 (N. L. F.), R01GM083960, P41GM109824, and R01GM112108 (A. S), R01GM114274 (R. O.), T32GM008203 (J. J.), T32GM008297 (J. M. B.), the Howard Hughes Medical Institute HCIA grant (M. K. R.), the Welch Foundation grants I-1532 (Y. M. C.) and I-1544 (M. K. R.), Leukemia and Lymphoma Society Scholar Award (Y. M. C.), and the University of Texas Southwestern Endowed Scholars Program (Y. M. C.). Work in M. K. R.' s lab was supported by the Howard Hughes Medical Institute. R. A. was an American Heart Association Postdoctoral Fellow and H. Y. J. F was a Howard Hughes Medical Institute International Student Research fellow.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 2015, PYMOL MOL GRAPH SYST; Brangwynne CP, 2015, NAT PHYS, V11, P899, DOI [10.1038/NPHYS3532, 10.1038/nphys3532]; Brautigam CA, 2016, NAT PROTOC, V11, P882, DOI 10.1038/nprot.2016.044; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Cansizoglu AE, 2007, STRUCTURE, V15, P1431, DOI 10.1016/j.str.2007.09.009; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Chook YM, 2002, BIOCHEMISTRY-US, V41, P6955, DOI 10.1021/bi012122p; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Connolly BD, 2012, BIOPHYS J, V103, P69, DOI 10.1016/j.bpj.2012.04.047; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Dormann D, 2011, TRENDS NEUROSCI, V34, P339, DOI 10.1016/j.tins.2011.05.002; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Ederle H, 2017, FEBS LETT, V591, P1489, DOI 10.1002/1873-3468.12646; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Fung HYJ, 2015, ELIFE, V4, DOI 10.7554/eLife.10034; Fung HYJ, 2014, SEMIN CANCER BIOL, V27, P52, DOI 10.1016/j.semcancer.2014.03.002; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Guo L, 2018, CELL, V173, P677, DOI 10.1016/j.cell.2018.03.002; Harrison AF, 2017, BIOCHEM J, V474, P1417, DOI 10.1042/BCJ20160499; Hofweber M, 2018, CELL, V173, P706, DOI 10.1016/j.cell.2018.03.004; Hough LE, 2015, ELIFE, V4, DOI 10.7554/eLife.10027; Iko Y, 2004, J BIOL CHEM, V279, P44834, DOI 10.1074/jbc.M408552200; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Jayalakshmi V, 2002, J MAGN RESON, V155, P106, DOI 10.1006/jmre.2001.2499; Ju SL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001052; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kikhney AG, 2015, FEBS LETT, V589, P2570, DOI 10.1016/j.febslet.2015.08.027; Kim SJ, 2014, MOL CELL PROTEOMICS, V13, P2911, DOI 10.1074/mcp.M114.040915; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kobayashi J, 2013, J MOL BIOL, V425, P1852, DOI 10.1016/j.jmb.2013.02.035; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Lin Y, 2017, J BIOL CHEM, V292, P19110, DOI 10.1074/jbc.M117.800466; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Liu XH, 2013, BBA-MOL BASIS DIS, V1832, P375, DOI 10.1016/j.bbadis.2012.11.012; Loughlin FE, 2009, P NATL ACAD SCI USA, V106, P5581, DOI 10.1073/pnas.0802466106; Milles S, 2015, CELL, V163, P734, DOI 10.1016/j.cell.2015.09.047; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Monahan Z, 2017, EMBO J, V36, P2951, DOI 10.15252/embj.201696394; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; OLDENBOURG R, 1991, BIOPHYS J, V60, P629, DOI 10.1016/S0006-3495(91)82092-6; OLDENBOURG R, 1995, J MICROSC-OXFORD, V180, P140, DOI 10.1111/j.1365-2818.1995.tb03669.x; Ozdilek BA, 2017, NUCLEIC ACIDS RES, V45, P7984, DOI 10.1093/nar/gkx460; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Port SA, 2015, CELL REP, V13, P690, DOI 10.1016/j.celrep.2015.09.042; Ryu HH, 2014, NEUROBIOL AGING, V35, P2822, DOI 10.1016/j.neurobiolaging.2014.07.026; Scheuermann TH, 2015, METHODS, V76, P87, DOI 10.1016/j.ymeth.2014.11.024; Schwartz JC, 2015, ANNU REV BIOCHEM, V84, P355, DOI 10.1146/annurev-biochem-060614-034325; Schwartz JC, 2013, CELL REP, V5, P918, DOI 10.1016/j.celrep.2013.11.017; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Takahama K, 2013, J AM CHEM SOC, V135, P18016, DOI 10.1021/ja4086929; Ueda T, 2014, Q REV BIOPHYS, V47, P143, DOI 10.1017/S0033583514000043; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Xiang SH, 2015, CELL, V163, P829, DOI 10.1016/j.cell.2015.10.040; Zhao HY, 2015, METHODS, V76, P137, DOI 10.1016/j.ymeth.2014.11.012	69	175	179	1	97	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2018	173	3					693	+		10.1016/j.cell.2018.03.003	http://dx.doi.org/10.1016/j.cell.2018.03.003			35	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7GB	29677513	Bronze, Green Accepted			2022-12-28	WOS:000430677400018
J	Zhou, JD; Lin, JH; Huang, XW; Zhou, Y; Chen, Y; Xia, J; Wang, H; Xie, Y; Yu, HM; Lei, JC; Wu, D; Liu, FC; Fu, QD; Zeng, QS; Hsu, CH; Yang, CL; Lu, L; Yu, T; Shen, ZX; Lin, H; Yakobson, BI; Liu, Q; Suenaga, K; Liu, GT; Liu, Z				Zhou, Jiadong; Lin, Junhao; Huang, Xiangwei; Zhou, Yao; Chen, Yu; Xia, Juan; Wang, Hong; Xie, Yu; Yu, Huimei; Lei, Jincheng; Wu, Di; Liu, Fucai; Fu, Qundong; Zeng, Qingsheng; Hsu, Chuang-Han; Yang, Changli; Lu, Li; Yu, Ting; Shen, Zexiang; Lin, Hsin; Yakobson, Boris I.; Liu, Qian; Suenaga, Kazu; Liu, Guangtong; Liu, Zheng			A library of atomically thin metal chalcogenides	NATURE			English	Article							LARGE-AREA SYNTHESIS; TRANSITION; MONOLAYER; GROWTH; LAYERS; PHASE; WSE2; MOO3	Investigations of two-dimensional transition-metal chalcogenides (TMCs) have recently revealed interesting physical phenomena, including the quantum spin Hall effect(1,2), valley polarization(3,4) and two-dimensional superconductivity(5), suggesting potential applications for functional devices(6-10). However, of the numerous compounds available, only a handful, such as Mo- and W-based TMCs, have been synthesized, typically via sulfurization(11-15), selenization(16,17) and tellurization(18) of metals and metal compounds. Many TMCs are difficult to produce because of the high melting points of their metal and metal oxide precursors. Molten-salt-assisted methods have been used to produce ceramic powders at relatively low temperature(19) and this approach(20) was recently employed to facilitate the growth of monolayer WS2 and WSe2. Here we demonstrate that molten-salt-assisted chemical vapour deposition can be broadly applied for the synthesis of a wide variety of two-dimensional (atomically thin) TMCs. We synthesized 47 compounds, including 32 binary compounds (based on the transition metals Ti, Zr, Hf, V, Nb, Ta, Mo, W, Re, Pt, Pd and Fe), 13 alloys (including 11 ternary, one quaternary and one quinary), and two heterostructured compounds. We elaborate how the salt decreases the melting point of the reactants and facilitates the formation of intermediate products, increasing the overall reaction rate. Most of the synthesized materials in our library are useful, as supported by evidence of superconductivity in our monolayer NbSe2 and MoTe2 samples(21,22) and of high mobilities in MoS2 and ReS2. Although the quality of some of the materials still requires development, our work opens up opportunities for studying the properties and potential application of a wide variety of two-dimensional TMCs.	[Zhou, Jiadong; Wang, Hong; Liu, Fucai; Fu, Qundong; Zeng, Qingsheng; Liu, Zheng] Nanyang Technol Univ, Sch Mat Sci & Engn, Ctr Programmable Mat, Singapore, Singapore; [Lin, Junhao; Suenaga, Kazu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Huang, Xiangwei; Yang, Changli; Lu, Li; Liu, Guangtong] Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Inst Phys, Beijing, Peoples R China; [Zhou, Yao; Liu, Qian] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai, Peoples R China; [Chen, Yu; Xia, Juan; Yu, Ting; Shen, Zexiang] Nanyang Technol Univ, Sch Phys & Math Sci, Div Phys & Appl Phys, Singapore, Singapore; [Xie, Yu; Lei, Jincheng; Yakobson, Boris I.] Rice Univ, Dept Mat Sci & NanoEngn, Houston, TX USA; [Xie, Yu; Lei, Jincheng; Yakobson, Boris I.] Rice Univ, Dept Chem, Houston, TX USA; [Yu, Huimei] East China Univ Sci & Technol, Sch Mat Sci & Engn, Shanghai, Peoples R China; [Wu, Di; Hsu, Chuang-Han; Lin, Hsin] Natl Univ Singapore, Ctr Adv Mat 2D, Singapore, Singapore; [Wu, Di; Hsu, Chuang-Han; Lin, Hsin] Natl Univ Singapore, Graphene Res Ctr, Singapore, Singapore; [Wu, Di; Hsu, Chuang-Han; Lin, Hsin] Natl Univ Singapore, Dept Phys, Singapore, Singapore; [Yang, Changli; Lu, Li] Collaborat Innovat Ctr Quantum Matter, Beijing, Peoples R China; [Lin, Hsin] Acad Sinica, Inst Phys, Taipei, Taiwan; [Liu, Zheng] Nanyang Technol Univ, Sch Elect & Elect Engn, Ctr Micro Nanoelect NOVITAS, Singapore, Singapore; [Liu, Zheng] CINTRA CNRS NTU THALES, UMI 3288, Res Techno Plaza, Singapore, Singapore; [Liu, Zheng] Nanyang Environm & Water Res Inst, Environm Chem & Mat Ctr, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Advanced Industrial Science & Technology (AIST); Chinese Academy of Sciences; Institute of Physics, CAS; Chinese Academy of Sciences; Shanghai Institute of Ceramics, CAS; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Rice University; Rice University; East China University of Science & Technology; National University of Singapore; National University of Singapore; National University of Singapore; Academia Sinica - Taiwan; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Liu, Z (corresponding author), Nanyang Technol Univ, Sch Mat Sci & Engn, Ctr Programmable Mat, Singapore, Singapore.; Lin, JH (corresponding author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan.; Liu, GT (corresponding author), Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Inst Phys, Beijing, Peoples R China.; Liu, Z (corresponding author), Nanyang Technol Univ, Sch Elect & Elect Engn, Ctr Micro Nanoelect NOVITAS, Singapore, Singapore.; Liu, Z (corresponding author), CINTRA CNRS NTU THALES, UMI 3288, Res Techno Plaza, Singapore, Singapore.; Liu, Z (corresponding author), Nanyang Environm & Water Res Inst, Environm Chem & Mat Ctr, Singapore, Singapore.	lin.junhao.stem@gmail.com; gtliu@iphy.ac.cn; z.liu@ntu.edu.sg	Huang, Xiangwei/H-4776-2015; Yakobson, Boris/ABA-3897-2020; FU, QUNDONG/Y-1667-2019; zhou, jiadong/AAG-1070-2021; Lin, Hsin/F-9568-2012; 曾, 庆圣/GSE-1731-2022; Wang, Hong/P-4316-2019; Suenaga, Kazu/E-2339-2014; Shen, Ze Xiang/B-6988-2011; Hsu, Chuang-Han/N-4505-2019; Lin, Junhao/D-7980-2015; Wang, Hong/G-3206-2019; Liu, Zheng/C-1813-2014; Xie, Yu/E-5875-2011; Lei, Jincheng/GPT-0715-2022	Yakobson, Boris/0000-0001-8369-3567; Lin, Hsin/0000-0002-4688-2315; Wang, Hong/0000-0002-7190-1469; Suenaga, Kazu/0000-0002-6107-1123; Shen, Ze Xiang/0000-0001-7432-7936; Hsu, Chuang-Han/0000-0002-2394-8537; Lin, Junhao/0000-0002-2195-2823; Wang, Hong/0000-0002-7190-1469; Liu, Zheng/0000-0002-8825-7198; Xie, Yu/0000-0002-7782-5428; Liu, Fucai/0000-0003-1275-0573; Chen, Yu/0000-0002-7258-2607; Huang, Xiangwei/0000-0003-3803-1390	Singapore National Research Foundation under NRF [NRF-NRFF2013-08, NRF-NRFF2013-03]; CoE Industry Collaboration Grant WINTECH-NTU; A*Star QTE programme; MOE [RG100/15]; JST-ACCEL; JSPS KAKENHI [JP16H06333, P16382]; National Key Research and Development Program of China [2016YFB0700204]; National Natural Science Foundation of China [51502327, 11174340, 912212012, 11527806, 91421303]; Ministry of Science and Technology of China [2014CB920904, 2015CB921101, 2016YFA0300600]; Chinese Academy of Sciences [XDB07010100]; US Department of Energy [DE-SC0012547]; R. Welch Foundation [C-1590];  [MOE2016-T2-2-153];  [MOE2016-T2-1-131];  [MOE2015-T2-2-007];  [RG164/15];  [RG4/17]	Singapore National Research Foundation under NRF(National Research Foundation, Singapore); CoE Industry Collaboration Grant WINTECH-NTU; A*Star QTE programme(Agency for Science Technology & Research (A*STAR)); MOE(Ministry of Higher Education & Scientific Research (MHESR)); JST-ACCEL(Japan Science & Technology Agency (JST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); US Department of Energy(United States Department of Energy (DOE)); R. Welch Foundation(The Welch Foundation); ; ; ; ; 	This work was supported by the Singapore National Research Foundation under NRF award number NRF-NRFF2013-08, Tier 2 MOE2016-T2-2-153, MOE2016-T2-1-131, MOE2015-T2-2-007, Tier 1 RG164/15, Tier 1 RG4/17, CoE Industry Collaboration Grant WINTECH-NTU and the A*Star QTE programme. T.Y. acknowledges MOE Tier 1 RG100/15. J.L. and K.S. acknowledge the financial support of JST-ACCEL and JSPS KAKENHI (JP16H06333 and P16382). The work in SICCAS was supported by the National Key Research and Development Program of China (2016YFB0700204) and the National Natural Science Foundation of China (51502327). The work at IOP was supported by the Ministry of Science and Technology of China (grant numbers 2014CB920904, 2015CB921101 and 2016YFA0300600), the National Natural Science Foundation of China (grant numbers 11174340, 912212012, 11527806 and 91421303) and the Chinese Academy of Sciences (grant numbers XDB07010100). H.L. acknowledges the Singapore National Research Foundation for support under NRF award number NRF-NRFF2013-03. The work at Rice was supported by the US Department of Energy (DE-SC0012547) and by the R. Welch Foundation (C-1590).	Alov NV, 2015, PHYS STATUS SOLIDI C, V12, P263, DOI 10.1002/pssc.201400108; Azizi A, 2016, NANO LETT, V16, P6982, DOI 10.1021/acs.nanolett.6b03075; Chen YF, 2013, ACS NANO, V7, P4610, DOI 10.1021/nn401420h; Dumcenco D, 2015, ACS NANO, V9, P4611, DOI 10.1021/acsnano.5b01281; Elias AL, 2013, ACS NANO, V7, P5235, DOI 10.1021/nn400971k; Fei LF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12206; Gong YJ, 2016, ADV FUNCT MATER, V26, P2009, DOI 10.1002/adfm.201504633; Gong YJ, 2014, NANO LETT, V14, P442, DOI 10.1021/nl4032296; Huang JK, 2014, ACS NANO, V8, P923, DOI 10.1021/nn405719x; Kimura T., 2011, ADV CERAMICS SYNTHES; Lee YH, 2012, ADV MATER, V24, P2320, DOI 10.1002/adma.201104798; Li B, 2016, ANGEW CHEM INT EDIT, V55, P10656, DOI 10.1002/anie.201604445; Li SS, 2015, APPL MATER TODAY, V1, P60, DOI 10.1016/j.apmt.2015.09.001; Lin YC, 2012, NANOSCALE, V4, P6637, DOI 10.1039/c2nr31833d; Lin Z, 2014, APL MATER, V2, DOI 10.1063/1.4895469; Lopez-Sanchez O, 2013, NAT NANOTECHNOL, V8, P497, DOI [10.1038/NNANO.2013.100, 10.1038/nnano.2013.100]; Lu X, 2014, NANO LETT, V14, P2419, DOI 10.1021/nl5000906; MCGUIRE GE, 1973, INORG CHEM, V12, P2450, DOI 10.1021/ic50128a045; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Park JC, 2015, ACS NANO, V9, P6548, DOI 10.1021/acsnano.5b02511; Qian XF, 2014, SCIENCE, V346, P1344, DOI 10.1126/science.1256815; Radisavljevic B, 2013, NAT MATER, V12, P815, DOI [10.1038/NMAT3687, 10.1038/nmat3687]; Roy K, 2013, NAT NANOTECHNOL, V8, P826, DOI [10.1038/nnano.2013.206, 10.1038/NNANO.2013.206]; Saito Y, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2016.94; van der Zande AM, 2013, NAT MATER, V12, P554, DOI [10.1038/NMAT3633, 10.1038/nmat3633]; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; WU HM, 1987, SYNTHETIC MET, V20, P169, DOI 10.1016/0379-6779(87)90556-X; Xi XX, 2016, NAT PHYS, V12, P139, DOI [10.1038/NPHYS3538, 10.1038/nphys3538]; Xi XX, 2015, NAT NANOTECHNOL, V10, P765, DOI [10.1038/nnano.2015.143, 10.1038/NNANO.2015.143]; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Zeng HL, 2012, NAT NANOTECHNOL, V7, P490, DOI [10.1038/nnano.2012.95, 10.1038/NNANO.2012.95]; Zhan YJ, 2012, SMALL, V8, P966, DOI 10.1002/smll.201102654; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	33	905	938	226	2353	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2018	556	7701					355	+		10.1038/s41586-018-0008-3	http://dx.doi.org/10.1038/s41586-018-0008-3			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1TW	29670263	Green Accepted			2022-12-28	WOS:000430285200047
J	Waljee, JF; Chopra, V; Saint, S				Waljee, Jennifer F.; Chopra, Vineet; Saint, Sanjay			Mentoring Millennials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACADEMIC MEDICINE; FACULTY		[Waljee, Jennifer F.] Michigan Med, Dept Surg, Sect Plast Surg, Ann Arbor, MI USA; [Chopra, Vineet] Michigan Med, Dept Internal Med, Ann Arbor, MI USA; [Saint, Sanjay] Michigan Med, VA Ann Arbor Healthcare, Dept Internal Med, Ann Arbor, MI USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Waljee, JF (corresponding author), Michigan Med, Sect Plast Surg, Taubman Ctr 2130, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	filip@medurnich.edu	Saint, Sanjay/AAF-5126-2019	Chopra, Vineet/0000-0001-8670-9376				Borges NJ, 2010, MED EDUC, V44, P570, DOI 10.1111/j.1365-2923.2010.03633.x; Chopra V, HARVARD ROSINESS REV; Chopra V, 2018, JAMA INTERN MED, V178, P175, DOI 10.1001/jamainternmed.2017.6537; Desy JR, 2017, MAYO CLIN PROC, V92, P243, DOI 10.1016/j.mayocp.2016.10.026; Pfau B., HARVARD BUSINESS REV; Pololi LH, 2012, ACAD MED, V87, P859, DOI 10.1097/ACM.0b013e3182582b18; Williams VN, 2017, AM J MED SCI, V353, P109, DOI 10.1016/j.amjms.2016.12.004	7	57	58	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2018	319	15					1547	1548		10.1001/jama.2018.3804	http://dx.doi.org/10.1001/jama.2018.3804			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD0UT	29677306				2022-12-28	WOS:000430217100013
J	Connor, J; Hall, W				Connor, Jason; Hall, Wayne			Thresholds for safer alcohol use might need lowering	LANCET			English	Editorial Material							CONSUMPTION; COUNTRIES; MORTALITY; DISEASE; COHORT; HEART		[Connor, Jason; Hall, Wayne] Univ Queensland, Ctr Youth Substance Abuse Res, St Lucia, Qld, Australia; [Connor, Jason] Univ Queensland, Fac Med, Herston, Qld, Australia; [Hall, Wayne] Kings Coll London, Natl Addict Ctr, London, England	University of Queensland; University of Queensland; University of London; King's College London	Hall, W (corresponding author), Univ Queensland, Ctr Youth Substance Abuse Res, St Lucia, Qld, Australia.; Hall, W (corresponding author), Kings Coll London, Natl Addict Ctr, London, England.	w.hall@uq.edu.au	Hall, Wayne D/A-3283-2008; Connor, Jason/F-7040-2010	Hall, Wayne D/0000-0003-1984-0096; Connor, Jason/0000-0002-7020-1196				Connor JP, 2016, LANCET, V387, P988, DOI 10.1016/S0140-6736(15)00122-1; Danesh J, 2007, EUR J EPIDEMIOL, V22, P129, DOI 10.1007/s10654-006-9096-8; Department of Health, 2016, UK CHIEF MED OFF LOW; Leong DP, 2014, CIRCULATION, V130, P390, DOI 10.1161/CIRCULATIONAHA.113.007627; NMHRC, 2009, AUSTR GUID RED HLTH; Rehm J, 2017, ADDICTION, V112, P968, DOI 10.1111/add.13757; Smyth A, 2015, LANCET, V386, P1945, DOI 10.1016/S0140-6736(15)00235-4; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; US Department of Health and Human Services US Department of Agriculture, APP 9 ALC 2015 2020; Wood AM, 2018, LANCET, V391, P1513, DOI 10.1016/S0140-6736(18)30134-X; Zhao J, 2017, J STUD ALCOHOL DRUGS, V78, P375, DOI 10.15288/jsad.2017.78.375	11	9	9	0	32	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2018	391	10129					1460	1461		10.1016/S0140-6736(18)30545-2	http://dx.doi.org/10.1016/S0140-6736(18)30545-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GC6TS	29676264	Green Published, hybrid			2022-12-28	WOS:000429926000006
J	McCall, C				McCall, Chris			Charles Perkins Centre	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2018	391	10129					1470	1470		10.1016/S0140-6736(18)30893-6	http://dx.doi.org/10.1016/S0140-6736(18)30893-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GC6TS	29676269				2022-12-28	WOS:000429926000012
J	Parker, RH; Yu, CH; Zhong, WC; Estey, B; Muller, H				Parker, Richard H.; Yu, Chenghui; Zhong, Weicheng; Estey, Brian; Muller, Holger			Measurement of the fine-structure constant as a test of the Standard Model	SCIENCE			English	Article							QUANTIZED HALL RESISTANCE; CALCULABLE CAPACITOR; INTERFEROMETRY; ELECTRON; MASS; OHM	Measurements of the fine-structure constant a require methods from across subfields and are thus powerful tests of the consistency of theory and experiment in physics. Using the recoil frequency of cesium-133 atoms in a matter-wave interferometer, we recorded the most accurate measurement of the fine-structure constant to date: alpha = 1/137.035999046(27) at 2.0 x 10(-10) accuracy. Using multiphoton interactions (Bragg diffraction and Bloch oscillations), we demonstrate the largest phase (12 million radians) of any Ramsey-Borde interferometer and control systematic effects at a level of 0.12 part per billion. Comparison with Penning trap measurements of the electron gyromagnetic anomaly g(e) - 2 via the Standard Model of particle physics is now limited by the uncertainty in g(e) - 2; a 2.5 sigma tension rejects dark photons as the reason for the unexplained part of the muon's magnetic moment at a 99% confidence level. Implications for dark-sector candidates and electron substructure may be a sign of physics beyond the Standard Model that warrants further investigation.	[Parker, Richard H.; Yu, Chenghui; Zhong, Weicheng; Estey, Brian; Muller, Holger] Univ Calif Berkeley, Dept Phys, 366 Le Conte Hall MC 7300, Berkeley, CA 94720 USA; [Muller, Holger] Lawrence Berkeley Natl Lab, One Cyclotron Rd, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Muller, H (corresponding author), Univ Calif Berkeley, Dept Phys, 366 Le Conte Hall MC 7300, Berkeley, CA 94720 USA.; Muller, H (corresponding author), Lawrence Berkeley Natl Lab, One Cyclotron Rd, Berkeley, CA 94720 USA.	hm@berkeley.edu		Parker, Richard/0000-0003-3880-4357; Zhong, Weicheng/0000-0002-7142-0075	Alfred P. Sloan Foundation [BR-5044]; David and Lucile Packard Foundation [2009-34712]; Jet Propulsion Laboratory [1458850, 1483242, 1531033, 1553641]; National Institute of Standards and Technology [60NANB9D9169]; NSF (CAREER) [PHY-1056620]; NSF (MRI) [PHY-0923445]; University of California Office of the President [040219]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Jet Propulsion Laboratory(National Aeronautics & Space Administration (NASA)); National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); NSF (CAREER)(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF (MRI)(National Science Foundation (NSF)NSF - Office of the Director (OD)); University of California Office of the President(University of California System)	This work was supported by the Alfred P. Sloan Foundation (grant BR-5044), the David and Lucile Packard Foundation (grant 2009-34712), Jet Propulsion Laboratory (grants 1458850, 1483242, 1531033, and 1553641), National Institute of Standards and Technology (award 60NANB9D9169), NSF (CAREER award PHY-1056620 and MRI award PHY-0923445), and the University of California Office of the President (award 040219).	Aoyama T, 2017, PHYS REV D, V96, DOI 10.1103/PhysRevD.96.019901; Aoyama T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.111807; Asenbaum P, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.183602; Audi G, 2012, CHINESE PHYS C, V36, P1157, DOI 10.1088/1674-1137/36/12/001; Bade S., 2017, ARXIV171204023PHYSIC; Bouchendira R, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.080801; Cronin AD, 2009, REV MOD PHYS, V81, P1051, DOI 10.1103/RevModPhys.81.1051; Estey B, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.083002; Foster GT, 2002, OPT LETT, V27, P951, DOI 10.1364/OL.27.000951; Gabrielse G, 2014, SPRINGER TRAC MOD PH, V256, P1, DOI 10.1007/978-3-642-45201-7_1; Hanneke D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.120801; Jeffery A, 1998, METROLOGIA, V35, P83, DOI 10.1088/0026-1394/35/2/3; Jeffery AM, 1997, IEEE T INSTRUM MEAS, V46, P264, DOI 10.1109/19.571828; Kovachy T, 2015, NATURE, V528, P530, DOI 10.1038/nature16155; Lan SY, 2013, SCIENCE, V339, P554, DOI 10.1126/science.1230767; Laporta S, 2017, PHYS LETT B, V772, P232, DOI 10.1016/j.physletb.2017.06.056; Lees JP, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.131804; Mohr PJ, 2016, REV MOD PHYS, V88, DOI 10.1103/RevModPhys.88.035009; Muller H, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.180405; Parker RH, 2016, PHYS REV A, V94, DOI 10.1103/PhysRevA.94.053618; Rosi G, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.013001; Smiciklas M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.123001; Sorrentino F, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.023607; Sturm S, 2014, NATURE, V506, P467, DOI 10.1038/nature13026; Terranova F, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.052118; Tino G. M, 2014, P INT SCH PHYS ENR F; Wicht A, 2002, PHYS SCRIPTA, VT102, P82, DOI 10.1238/Physica.Topical.102a00082	28	394	399	9	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2018	360	6385					191	+		10.1126/science.aap7706	http://dx.doi.org/10.1126/science.aap7706			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC5DK	29650669	Green Submitted			2022-12-28	WOS:000429805400043
J	Wilen, CB; Lee, S; Hsieh, LL; Orchard, RC; Desai, C; Hykes, BL; McAllaster, MR; Balce, DR; Feehley, T; Brestoff, JR; Hickey, CA; Yokoyama, CC; Wang, YT; MacDuff, DA; Kreamalmayer, D; Howitt, MR; Neil, JA; Cadwell, K; Allen, PM; Handley, SA; Campagne, MV; Baldridge, MT; Virgin, HW				Wilen, Craig B.; Lee, Sanghyun; Hsieh, Leon L.; Orchard, Robert C.; Desai, Chandni; Hykes, Barry L., Jr.; McAllaster, Michael R.; Balce, Dale R.; Feehley, Taylor; Brestoff, Jonathan R.; Hickey, Christina A.; Yokoyama, Christine C.; Wang, Ya-Ting; MacDuff, Donna A.; Kreamalmayer, Darren; Howitt, Michael R.; Neil, Jessica A.; Cadwell, Ken; Allen, Paul M.; Handley, Scott A.; Campagne, Menno van Lookeren; Baldridge, Megan T.; Virgin, Herbert W.			Tropism for tuft cells determines immune promotion of norovirus pathogenesis	SCIENCE			English	Article							INTESTINAL EPITHELIUM; RECEPTOR; VIRUS; INFECTION; PERSISTENCE; REVEALS; REPLICATION; SUFFICIENT; PROTEIN; MICE	Complex interactions between host immunity and the microbiome regulate norovirus infection. However, the mechanism of host immune promotion of enteric virus infection remains obscure. The cellular tropism of noroviruses is also unknown. Recently, we identified CD300lf as a murine norovirus (MNoV) receptor. In this study, we have shown that tuft cells, a rare type of intestinal epithelial cell, express CD300lf and are the target cell for MNoV in the mouse intestine. We found that type 2 cytokines, which induce tuft cell proliferation, promote MNoV infection in vivo. These cytokines can replace the effect of commensal microbiota in promoting virus infection. Our work thus provides insight into how the immune system and microbes can coordinately promote enteric viral infection.	[Wilen, Craig B.; Lee, Sanghyun; Hsieh, Leon L.; Orchard, Robert C.; Desai, Chandni; Hykes, Barry L., Jr.; McAllaster, Michael R.; Balce, Dale R.; Feehley, Taylor; Brestoff, Jonathan R.; Hickey, Christina A.; Yokoyama, Christine C.; Wang, Ya-Ting; Kreamalmayer, Darren; Allen, Paul M.; Handley, Scott A.; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [MacDuff, Donna A.] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Howitt, Michael R.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Neil, Jessica A.; Cadwell, Ken] NYU, Skirball Inst, Kimmel Ctr Biol & Med, Sch Med, New York, NY 10016 USA; [Neil, Jessica A.; Cadwell, Ken] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Campagne, Menno van Lookeren] Genentech Inc, Dept Immunol, 1 DNA Way, San Francisco, CA 94080 USA; [Baldridge, Megan T.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Harvard University; Harvard T.H. Chan School of Public Health; New York University; New York University; Roche Holding; Genentech; Washington University (WUSTL)	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	virgin@wustl.edu	Neil, Jessica/GLS-0700-2022; Desai, Chandni/AAA-5477-2020; Brestoff, Jonathan R./I-7000-2019; MacDuff, Donna/AAD-2786-2019; Baldridge, Megan/T-7274-2019	Desai, Chandni/0000-0002-3708-3634; Brestoff, Jonathan R./0000-0002-7018-7400; MacDuff, Donna/0000-0002-6183-6827; Baldridge, Megan/0000-0002-7030-6131; Wilen, Craig/0000-0003-2495-9403; Virgin, Herbert/0000-0001-8580-7628; Hsieh, Leon/0000-0002-6920-7718; , Jessica/0000-0003-2824-3701; Cadwell, Ken/0000-0002-5860-0661	NIH [K08 AI128043, K22 AI127846, K99 DK116666, T32 AI007163, R01 AI127552, U19 AI109725, DK093668, DK103788, HL123340, R01 AI121244]; National Research Foundation of Korea - Ministry of Education [NRF-2016R1A6A3A03012352]; Digestive Diseases Research Core Centers grant [P30 DK052574]; Vilcek Fellowship; Sir Keith Murdoch Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109725, R01AI121244, K22AI127846, T32AI007090, R01AI127552, K08AI128043, T32AI007163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093668, K01DK113041, K99DK116666, R01DK103788, P30DK052574, P30DK034854] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea - Ministry of Education; Digestive Diseases Research Core Centers grant; Vilcek Fellowship; Sir Keith Murdoch Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants K08 AI128043 (C.B.W.); K22 AI127846 (M.T.B.); K99 DK116666 (R.C.O.); T32 AI007163 (C.C.Y.); R01 AI127552 and U19 AI109725 (H.W.V.); and DK093668, DK103788, HL123340, and R01 AI121244 (J.A.N. and K.C.). In addition, S.L. was supported by the Basic Sciences Research Program through the National Research Foundation of Korea, funded by the Ministry of Education (grant NRF-2016R1A6A3A03012352). M.T.B. was supported by Digestive Diseases Research Core Centers grant P30 DK052574. J.A.N. was supported by a Vilcek Fellowship and a Sir Keith Murdoch Fellowship.	Ayukekbong J, 2011, J MED VIROL, V83, P2135, DOI 10.1002/jmv.22243; Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025; Basic M, 2014, INFLAMM BOWEL DIS, V20, P431, DOI 10.1097/01.MIB.0000441346.86827.ed; Bjerknes M, 2012, DEV BIOL, V362, P194, DOI 10.1016/j.ydbio.2011.12.009; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Chung DH, 2003, J IMMUNOL, V171, P6541, DOI 10.4049/jimmunol.171.12.6541; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Gerbe F, 2012, CELL MOL LIFE SCI, V69, P2907, DOI 10.1007/s00018-012-0984-7; Gerbe F, 2009, GASTROENTEROLOGY, V137, P2179, DOI 10.1053/j.gastro.2009.06.072; Grau KR, 2017, NAT MICROBIOL, V2, P1586, DOI 10.1038/s41564-017-0057-7; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Haga K, 2016, P NATL ACAD SCI USA, V113, pE6248, DOI 10.1073/pnas.1605575113; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Lee S, 2017, CELL HOST MICROBE, V22, P449, DOI 10.1016/j.chom.2017.08.021; Mohrs M, 1999, J IMMUNOL, V162, P7302; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Nice TJ, 2013, J VIROL, V87, P327, DOI 10.1128/JVI.01864-12; Orchard RC, 2016, SCIENCE, V353, P933, DOI 10.1126/science.aaf1220; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Phillips G, 2010, EPIDEMIOL INFECT, V138, P1454, DOI 10.1017/S0950268810000439; Strong DW, 2012, J VIROL, V86, P2950, DOI 10.1128/JVI.07038-11; Sukhrie FHA, 2010, J CLIN MICROBIOL, V48, P4303, DOI 10.1128/JCM.01308-10; Tomov VT, 2017, IMMUNITY, V47, P723, DOI 10.1016/j.immuni.2017.09.017; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Xi H, 2010, J EXP MED, V207, P7, DOI 10.1084/jem.20091508; Yan KS, 2017, NATURE, V545, P238, DOI 10.1038/nature22313	31	113	118	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2018	360	6385					204	208		10.1126/science.aar3799	http://dx.doi.org/10.1126/science.aar3799			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC5DK	29650672	Green Accepted			2022-12-28	WOS:000429805400046
J	Stocker, T				Stocker, T			Obituary - Hans Oeschger (1927-98) - Pioneer in environmental physics	NATURE			English	Biographical-Item									Univ Bern, Inst Phys, CH-3012 Bern, Switzerland	University of Bern	Stocker, T (corresponding author), Univ Bern, Inst Phys, Sidlerstr 5, CH-3012 Bern, Switzerland.		Stocker, Thomas/B-1273-2013						0	0	0	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					396	396		10.1038/17034	http://dx.doi.org/10.1038/17034			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667985	Bronze			2022-12-28	WOS:000078461700030
J	Kim, KH; Ree, JH; Kim, Y; Kim, S; Kang, SY; Seo, W				Kim, Kwang-Hee; Ree, Jin-Han; Kim, YoungHee; Kim, Sungshil; Kang, Su Young; Seo, Wooseok			Assessing whether the 2017 M-w 5.4 Pohang earthquake in South Korea was an induced event	SCIENCE			English	Article							BACK-ARC BASIN; EAST SEA SEA; INDUCED SEISMICITY; PENINSULA; SEDIMENTARY; EVOLUTION; SEQUENCE; SYSTEM; JAPAN; FAULT	The moment magnitude (M-w) 5.4 Pohang earthquake, the most damaging event in South Korea since instrumental seismic observation began in 1905, occurred beneath the Pohang geothermal power plant in 2017. Geological and geophysical data suggest that the Pohang earthquake was induced by fluid from an enhanced geothermal system (EGS) site, which was injected directly into a near-critically stressed subsurface fault zone. The magnitude of the mainshock makes it the largest known induced earthquake at an EGS site.	[Kim, Kwang-Hee; Kang, Su Young; Seo, Wooseok] Pusan Natl Univ, Dept Geol Sci, Busan 46241, South Korea; [Ree, Jin-Han; Kim, Sungshil] Korea Univ, Dept Earth & Environm Sci, Seoul 02841, South Korea; [Kim, YoungHee] Seoul Natl Univ, Sch Earth & Environm Sci, Seoul 08826, South Korea	Pusan National University; Korea University; Seoul National University (SNU)	Kim, KH (corresponding author), Pusan Natl Univ, Dept Geol Sci, Busan 46241, South Korea.; Ree, JH (corresponding author), Korea Univ, Dept Earth & Environm Sci, Seoul 02841, South Korea.	kwanghee@pusan.ac.kr; reejh@korea.ac.kr	Ree, JIn-Han/AAT-6183-2021; Kim, YoungHee/G-7576-2019	Kim, YoungHee/0000-0002-1111-632X; Seo, Wooseok/0000-0002-6676-5669; Ree, Jin-Han/0000-0002-9919-1067	Nuclear Safety Research Program through the Korea Foundation of Nuclear Safety (KoFONS) - Nuclear Safety and Security Commission (NSSC) of the Republic of Korea [1705010]	Nuclear Safety Research Program through the Korea Foundation of Nuclear Safety (KoFONS) - Nuclear Safety and Security Commission (NSSC) of the Republic of Korea	This work was supported by the Nuclear Safety Research Program through the Korea Foundation of Nuclear Safety (KoFONS) using financial resources granted by the Nuclear Safety and Security Commission (NSSC) of the Republic of Korea (no. 1705010).	Caine JS, 1996, GEOLOGY, V24, P1025, DOI 10.1130/0091-7613(1996)024<1025:FZAAPS>2.3.CO;2; Choi H, 2012, TECTONOPHYSICS, V572, P123, DOI 10.1016/j.tecto.2011.12.023; Chough SK, 2000, EARTH-SCI REV, V52, P175, DOI 10.1016/S0012-8252(00)00029-5; Ellsworth WL, 2013, SCIENCE, V341, P142, DOI 10.1126/science.1225942; Frohlich C, 2016, SEISMOL RES LETT, V87, P1022, DOI 10.1785/0220160016; Grunthal G, 2014, GEOTHERMICS, V52, P22, DOI 10.1016/j.geothermics.2013.09.009; Haring MO, 2008, GEOTHERMICS, V37, P469, DOI 10.1016/j.geothermics.2008.06.002; Kim KH, 2016, GEOSCI J, V20, P753, DOI 10.1007/s12303-016-0034-9; Kim M., 2017, MICROSEISMIC MONITOR; Lee T. J., 2005, MULLI TAMSA, V8, P145; Lee TJ, 2015, P WORLD GEOTH C MELB; Majer EL, 2007, GEOTHERMICS, V36, P185, DOI 10.1016/j.geothermics.2007.03.003; McGarr A, 2014, J GEOPHYS RES-SOL EA, V119, P1008, DOI 10.1002/2013JB010597; MCGARR A, 1976, J GEOPHYS RES, V81, P1487, DOI 10.1029/JB081i008p01487; Park JC, 2007, GEOPHYS J INT, V169, P1103, DOI 10.1111/j.1365-246X.2007.03321.x; Ree JH, 2003, ISL ARC, V12, P1, DOI 10.1046/j.1440-1738.2003.00372.x; SENO T, 1993, J GEOPHYS RES-SOL EA, V98, P17941, DOI 10.1029/93JB00782; Sohn YK, 2004, SEDIMENTOLOGY, V51, P1387, DOI 10.1111/j.1365-3091.2004.00679.x; Sohn YK, 2001, SEDIMENT GEOL, V143, P265, DOI 10.1016/S0037-0738(01)00100-2; Trugman DT, 2014, GEOPHYS RES LETT, V41, P8767, DOI 10.1002/2014GL061959; van der Elst NJ, 2016, J GEOPHYS RES-SOL EA, V121, P4575, DOI 10.1002/2016JB012818; Waldhauser F, 2000, B SEISMOL SOC AM, V90, P1353, DOI 10.1785/0120000006; Yoon SH, 2014, MAR GEOL, V352, P70, DOI 10.1016/j.margeo.2014.03.004; Yoon W.-S, 2015, P WORLD GEOTH C MELB; Zang AN, 2014, GEOTHERMICS, V52, P6, DOI 10.1016/j.geothermics.2014.06.005; Zoback MD, 2012, P NATL ACAD SCI USA, V109, P10164, DOI 10.1073/pnas.1202473109	26	220	228	12	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2018	360	6392					1007	1009		10.1126/science.aat6081	http://dx.doi.org/10.1126/science.aat6081			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6SL	29700224				2022-12-28	WOS:000433574200039
J	Srivastava, AP; Luo, M; Zhou, WC; Symersky, J; Bai, DY; Chambers, MG; Faraldo-Gomez, JD; Liao, MF; Mueller, DM				Srivastava, Anurag P.; Luo, Min; Zhou, Wenchang; Symersky, Jindrich; Bai, Dongyang; Chambers, Melissa G.; Faraldo-Gomez, Jose D.; Liao, Maofu; Mueller, David M.			High-resolution cryo-EM analysis of the yeast ATP synthase in a lipid membrane	SCIENCE			English	Article							PROTON TRANSLOCATION; STRUCTURAL BASIS; BINDING-SITE; FORCE-FIELD; MECHANISM; SUBUNIT; MODEL; VALIDATION; RING; ARRANGEMENT	Mitochondrial adenosine triphosphate (ATP) synthase comprises a membrane embedded F-o motor that rotates to drive ATP synthesis in the F-1 subunit. We used single-particle cryo-electron microscopy (cryo-EM) to obtain structures of the full complex in a lipid bilayer in the absence or presence of the inhibitor oligomycin at 3.6-and 3.8-angstrom resolution, respectively. To limit conformational heterogeneity, we locked the rotor in a single conformation by fusing the F6 subunit of the stator with the delta subunit of the rotor. Assembly of the enzyme with the F6-delta fusion caused a twisting of the rotor and a 9 degrees rotation of the F-o c(10)-ring in the direction of ATP synthesis, relative to the structure of isolated F-o. Our cryo-EM structures show how F-1 and F-o are coupled, give insight into the proton translocation pathway, and show how oligomycin blocks ATP synthesis.	[Srivastava, Anurag P.; Symersky, Jindrich; Bai, Dongyang; Mueller, David M.] Rosalind Franklin Univ, Dept Biol Chem & Mol Biol, Chicago Med Sch, 3333 Green Bay Rd, N Chicago, IL 60064 USA; [Luo, Min; Chambers, Melissa G.; Liao, Maofu] Harvard Med Sch, Dept Cell Biol, 250 Longwood Ave,SGM 509, Boston, MA 02115 USA; [Zhou, Wenchang; Faraldo-Gomez, Jose D.] NHLBI, Theoret Mol Biophys Lab, NIH, 50 South Dr, Bethesda, MD 20892 USA	Chicago Medical School; Rosalind Franklin University Medical & Science; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Mueller, DM (corresponding author), Rosalind Franklin Univ, Dept Biol Chem & Mol Biol, Chicago Med Sch, 3333 Green Bay Rd, N Chicago, IL 60064 USA.; Liao, MF (corresponding author), Harvard Med Sch, Dept Cell Biol, 250 Longwood Ave,SGM 509, Boston, MA 02115 USA.	maofu_liao@hms.harvard.edu; david.mueller@rosalindfranklin.edu	Liao, Maofu/AAD-7333-2021; Luo, Min/H-1573-2015; Srivastava, Anurag/I-6118-2018	Liao, Maofu/0000-0002-3481-450X; Luo, Min/0000-0002-3493-2282; Chambers, Melissa/0000-0001-5111-7194; Srivastava, Anurag/0000-0003-3493-1375; Zhou, Wenchang/0000-0003-0397-1032; , David/0000-0002-1180-0287	NIH [R01GM066223]; Division of Intramural Research of the National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066223] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research of the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by a grant from NIH, R01GM066223, to D.M.M. W.Z. and J.D.F.-G. are funded by the Division of Intramural Research of the National Heart, Lung, and Blood Institute.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allegretti M, 2015, NATURE, V521, P237, DOI 10.1038/nature14185; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; AssadiPorter FM, 1995, BIOCHEMISTRY-US, V34, P16186, DOI 10.1021/bi00049a034; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Baker LA, 2012, P NATL ACAD SCI USA, V109, P11675, DOI 10.1073/pnas.1204935109; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Daum B, 2010, PLANT CELL, V22, P1299, DOI 10.1105/tpc.109.071431; Dautant A, 2010, J BIOL CHEM, V285, P29502, DOI 10.1074/jbc.M110.124529; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Denisov IG, 2007, J BIOL CHEM, V282, P7066, DOI 10.1074/jbc.M609589200; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Guo H, 2017, SCIENCE, V358, P936, DOI 10.1126/science.aao4815; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Huang L, 2013, J CHEM THEORY COMPUT, V9, P3543, DOI 10.1021/ct4003477; JOHN UP, 1986, FEBS LETT, V207, P79, DOI 10.1016/0014-5793(86)80016-3; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Klusch N, 2017, ELIFE, V6, DOI 10.7554/eLife.33274; KOEPPE RE, 1976, BIOCHEMISTRY-US, V15, P3450, DOI 10.1021/bi00661a009; Leone V, 2016, J GEN PHYSIOL, V148, P441, DOI 10.1085/jgp.201611679; Li XM, 2015, J STRUCT BIOL, V192, P174, DOI 10.1016/j.jsb.2015.09.003; Mi W, 2017, NATURE, V549, P233, DOI 10.1038/nature23649; Mitome N, 2010, BIOCHEM J, V430, P171, DOI 10.1042/BJ20100621; Morrill JA, 1999, J GEN PHYSIOL, V114, P71, DOI 10.1085/jgp.114.1.71; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pagadala V, 2011, J BIOENERG BIOMEMBR, V43, P333, DOI 10.1007/s10863-011-9364-5; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Penefsky H S, 1979, Methods Enzymol, V56, P527; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Puri N, 2005, J BIOL CHEM, V280, P22418, DOI 10.1074/jbc.M411113200; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; ROOT MJ, 1994, SCIENCE, V265, P1852, DOI 10.1126/science.7522344; Ru H, 2015, CELL, V163, P1138, DOI 10.1016/j.cell.2015.10.055; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; SIKORSKI RS, 1989, GENETICS, V122, P19; Staritzbichler R, 2011, J CHEM THEORY COMPUT, V7, P1167, DOI 10.1021/ct100576m; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Symersky J, 2012, P NATL ACAD SCI USA, V109, P13961, DOI 10.1073/pnas.1207912109; Symersky J, 2012, NAT STRUCT MOL BIOL, V19, P485, DOI 10.1038/nsmb.2284; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; Vik SB, 2000, BBA-BIOENERGETICS, V1458, P457, DOI 10.1016/S0005-2728(00)00094-3; VIK SB, 1994, J BIOL CHEM, V269, P30364; Vinothkumar KR, 2016, P NATL ACAD SCI USA, V113, P12709, DOI 10.1073/pnas.1615902113; Xu T, 2015, MICROB CELL, V2, P105, DOI 10.15698/mic2015.04.197; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou W, 2017, J PHYS CHEM B, V121, P3297, DOI 10.1021/acs.jpcb.6b08051	58	115	118	3	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2018	360	6389							eaas9699	10.1126/science.aas9699	http://dx.doi.org/10.1126/science.aas9699			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2SV	29650704	Green Accepted			2022-12-28	WOS:000431790900035
J	Busch, AB; Bates, DW; Rauch, SL				Busch, Alisa B.; Bates, David W.; Rauch, Scott L.			Improving Adoption of EHRs in Psychiatric Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Busch, Alisa B.; Rauch, Scott L.] McLean Hosp, 115 Mill St, Belmont, MA 02178 USA; [Busch, Alisa B.; Rauch, Scott L.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Busch, Alisa B.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA; [Bates, David W.] Brigham & Womens Hosp, Div Gen Internal Med, 75 Francis St, Boston, MA 02115 USA; [Bates, David W.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy, Boston, MA USA	Harvard University; McLean Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Busch, AB (corresponding author), McLean Hosp, 115 Mill St, Belmont, MA 02178 USA.; Busch, AB (corresponding author), Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA.; Busch, AB (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA.		Busch, Alisa/AAA-4885-2021; Bates, David/AAE-7283-2019; Busch, Alisa/ABE-1524-2021		NATIONAL INSTITUTE ON DRUG ABUSE [P30DA035772] Funding Source: NIH RePORTER; NIDA NIH HHS [P30 DA035772] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		[Anonymous], 2017, WAY FORW FED ACT SYS; Bishop TF, 2014, JAMA PSYCHIAT, V71, P176, DOI 10.1001/jamapsychiatry.2013.2862; Henry J, 2016, ONC DATA BRIEF; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Yang N., 2017, TABLE ELECT HLTH REC	5	19	19	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2018	378	18					1665	1667		10.1056/NEJMp1800465	http://dx.doi.org/10.1056/NEJMp1800465			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GE4WO	29719176	Green Accepted			2022-12-28	WOS:000431218600003
J	Huttner, A; Kowalczyk, A; Turjeman, A; Babich, T; Brossier, C; Eliakim-Raz, N; Kosiek, K; de Tejada, BM; Roux, X; Shiber, S; Theuretzbacher, U; von Dach, E; Yahav, D; Leibovici, L; Godycki-Cwirko, M; Mouton, JW; Harbarth, S				Huttner, Angela; Kowalczyk, Anna; Turjeman, Adi; Babich, Tanya; Brossier, Caroline; Eliakim-Raz, Noa; Kosiek, Katarzyna; de Tejada, Begona Martinez; Roux, Xavier; Shiber, Shachaf; Theuretzbacher, Ursula; von Dach, Elodie; Yahav, Dafna; Leibovici, Leonard; Godycki-Cwirko, Maciek; Mouton, Johan W.; Harbarth, Stephan			Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COTRIMOXAZOLE; METAANALYSIS; TROMETAMOL; AGENTS	IMPORTANCE The use of nitrofurantoin and fosfomycin has increased since guidelines began recommending them as first-line therapy for lower urinary tract infection (UTI). OBJECTIVE To compare the clinical and microbiologic efficacy of nitrofurantoin and fosfomycin in women with uncomplicated cystitis. DESIGN, SETTING, AND PARTICIPANTS Multinational, open-label, analyst-blinded, randomized clinical trial including 513 nonpregnant women aged 18 years and older with symptoms of lower UTI (dysuria, urgency, frequency, or suprapubic tenderness), a positive urine dipstick result (with detection of nitrites or leukocyte esterase), and no known colonization or previous infection with uropathogens resistant to the study antibiotics. Recruitment took place from October 2013 through April 2017 at hospital units and outpatient clinics in Geneva, Switzerland; Lodz, Poland; and Petah-Tiqva, Israel. INTERVENTIONS Participants were randomized in a 1:1 ratio to oral nitrofurantoin, 100 mg 3 times a day for 5 days (n = 255), or a single 3-g dose of oral fosfomycin (n = 258). They returned 14 and 28 days after therapy completion for clinical evaluation and urine culture collection. MAIN OUTCOMES AND MEASURES The primary outcome was clinical response in the 28 days following therapy completion, defined as clinical resolution (complete resolution of symptoms and signs of UTI without prior failure), failure (need for additional or change in antibiotic treatment due to UTI or discontinuation due to lack of efficacy), or indeterminate (persistence of symptoms without objective evidence of infection). Secondary outcomes included bacteriologic response and incidence of adverse events. RESULTS Among 513 patients who were randomized (median age, 44 years [interquartile range, 31-64]), 475 (93%) completed the trial and 377 (73%) had a confirmed positive baseline culture. Clinical resolution through day 28 was achieved in 171 of 244 patients (70%) receiving nitrofurantoin vs 139 of 241 patients (58%) receiving fosfomycin (difference, 12% [95% CI, 4%-21%]; P = .004). Microbiologic resolution occurred in 129 of 175 (74%) vs 103 of 163 (63%), respectively (difference, 11% [95% CI, 1%-20%]; P = .04). Adverse events were few and primarily gastrointestinal; the most common were nausea and diarrhea (7/248 [3%] and 3/248 [1%] in the nitrofurantoin group vs 5/247 [2%] and 5/247 [1%] in the fosfomycin group, respectively). CONCLUSIONS AND RELEVANCE Among women with uncomplicated UTI, 5-day nitrofurantoin, compared with single-dose fosfomycin, resulted in a significantly greater likelihood of clinical and microbiologic resolution at 28 days after therapy completion.	[Huttner, Angela; Brossier, Caroline; Harbarth, Stephan] Geneva Univ Hosp & Fac Med, Infect Control Program, Geneva, Switzerland; [Huttner, Angela; von Dach, Elodie; Harbarth, Stephan] Geneva Univ Hosp & Fac Med, Div Infect Dis, Geneva, Switzerland; [Kowalczyk, Anna; Godycki-Cwirko, Maciek] Med Univ Lodz, Ctr Family & Community Med, Lodz, Poland; [Turjeman, Adi; Babich, Tanya; Eliakim-Raz, Noa; Yahav, Dafna; Leibovici, Leonard] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Eliakim-Raz, Noa; Leibovici, Leonard] Rabin Med Ctr, Dept Internal Med E, Beilinson Campus, Peta- Tiqva, Israel; [Kosiek, Katarzyna; Godycki-Cwirko, Maciek] Med Univ Lodz, Div Publ Hlth, Fac Hlth Sci, Lodz, Poland; [de Tejada, Begona Martinez] Geneva Univ Hosp & Fac Med, Obstet Div, Dept Obstet & Gynecol, Geneva, Switzerland; [Roux, Xavier] Geneva Univ Hosp & Fac Med, Dept Internal Med, Geneva, Switzerland; [Shiber, Shachaf] Rabin Med Ctr, Dept Emergency Med, Beilinson Campus, Peta- Tiqva, Israel; [Theuretzbacher, Ursula] Ctr Antiinfect Agents, Vienna, Austria; [von Dach, Elodie] Geneva Univ Hosp & Fac Med, Clin Trials Unit, Geneva, Switzerland; [Yahav, Dafna] Beilinson Med Ctr, Infect Dis Unit, Rabin Med Ctr, Petah Tiqwa, Israel; [Mouton, Johan W.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands	University of Geneva; University of Geneva; Medical University Lodz; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Medical University Lodz; University of Geneva; University of Geneva; Rabin Medical Center; University of Geneva; Rabin Medical Center; Erasmus University Rotterdam; Erasmus MC	Harbarth, S (corresponding author), Geneva Univ Hosp & Fac Med, Div Infect Dis, Infect Control Program, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland.	stephan.harbarth@hcuge.ch	roux, xavier/Y-9661-2019; Yahav, Dafna/AAX-9961-2020; Roux, Xavier/AAQ-6414-2021; Huttner, Angela/AAM-1197-2020	Yahav, Dafna/0000-0003-3181-9791; Huttner, Angela/0000-0002-8380-368X; Godycki-Cwirko, Maciej/0000-0002-9204-5518; Kowalczyk, Anna/0000-0002-7524-2085; Roux, Xavier/0000-0003-4356-1898	European Commission under the Life Science Health Priority of the 7th Framework Program [278348]; Polish Ministry of Science and Higher Education [2979/7.PR/2014/2]	European Commission under the Life Science Health Priority of the 7th Framework Program; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The study was funded by the European Commission under the Life Science Health Priority of the 7th Framework Program (Assessment of Clinical Efficacy by a Pharmacokinetic/Pharmacodynamic Approach to Optimize Effectiveness and Reduce Resistance for Off-Patent Antibiotics project, grant agreement 278348). The Lodz site received additional funding from the Polish Ministry of Science and Higher Education (2014-2017, contract 2979/7.PR/2014/2).	Abbott IJ, 2018, J ANTIMICROB CHEMOTH, V73, P709, DOI 10.1093/jac/dkx441; [Anonymous], 1997, MED LETT DRUGS THER, V39, P66; BORSA F, 1988, ANTIMICROB AGENTS CH, V32, P938, DOI 10.1128/AAC.32.6.938; Ernst Erika J, 2005, Health Qual Life Outcomes, V3, P45, DOI 10.1186/1477-7525-3-45; European Centre for Disease Prevention and Control, TREND ANT CONS COUNT; Garcia LS, 2010, CLIN MICROBIOLOGY PR; Giesen LGM, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-78; Gupta K, 2005, J ANTIMICROB CHEMOTH, V56, P243, DOI 10.1093/jac/dki169; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Huttner A, 2017, 27 EUR C CLIN MICR I; Huttner A, 2015, J ANTIMICROB CHEMOTH, V70, P2456, DOI 10.1093/jac/dkv147; Iravani A, 1999, J ANTIMICROB CHEMOTH, V43, P67, DOI 10.1093/jac/43.suppl_1.67; KAHAN FM, 1974, ANN NY ACAD SCI, V235, P364, DOI 10.1111/j.1749-6632.1974.tb43277.x; Maraki S, 2009, ANTIMICROB AGENTS CH, V53, P4508, DOI 10.1128/AAC.00721-09; Mazzei T, 2006, INT J ANTIMICROB AG, V28, pS35, DOI 10.1016/j.ijantimicag.2006.05.019; Mezzatesta ML, 2017, INT J ANTIMICROB AG, V49, P763, DOI 10.1016/j.ijantimicag.2017.01.020; Michalopoulos AS, 2011, INT J INFECT DIS, V15, pE732, DOI 10.1016/j.ijid.2011.07.007; Muller AE, 2017, CLIN MICROBIOL INFEC, V23, P355, DOI 10.1016/j.cmi.2016.08.003; Neuner EA, 2012, ANTIMICROB AGENTS CH, V56, P5744, DOI 10.1128/AAC.00402-12; Nicolle LE, 2008, UROL CLIN N AM, V35, P1, DOI 10.1016/j.ucl.2007.09.004; Oteo J, 2010, J ANTIMICROB CHEMOTH, V65, P2459, DOI 10.1093/jac/dkq346; Patel J.B., 2015, PERFORMANCE STANDARD; Slekovec C, 2014, J ANTIMICROB CHEMOTH, V69, P282, DOI 10.1093/jac/dkt328; Spellberg B, 2012, CLIN INFECT DIS, V55, P1031, DOI 10.1093/cid/cis688; SPENCER RC, 1994, J ANTIMICROB CHEMOTH, V33, P121, DOI 10.1093/jac/33.suppl_A.121; Stein GE, 1999, CLIN THER, V21, P1864, DOI 10.1016/S0149-2918(00)86734-X; Stewardson AJ, 2018, CLIN MICROBIOL INFEC; Trestioreanu AZ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007182.pub2; VANPIENBROEK E, 1993, PHARM WORLD SCI, V15, P257; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wijma RA, 2018, CLIN MICROBIOL INFEC, V24, P528, DOI 10.1016/j.cmi.2017.08.023	32	96	102	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2018	319	17					1781	1789		10.1001/jama.2018.3627	http://dx.doi.org/10.1001/jama.2018.3627			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GE3UQ	29710295	Bronze, Green Published			2022-12-28	WOS:000431138800016
J	Abbott, A				Abbott, Alison			THE BRAIN INFLAMED	NATURE			English	News Item							MICROGLIA; PATHOLOGY; TREM2											Bu XL, 2015, EUR J NEUROL, V22, P1519, DOI 10.1111/ene.12477; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Salter M. W., 2017, NAT MED, V9, P1018; Tomasoni R, 2017, ELIFE, V6, DOI 10.7554/eLife.21735; Venegas C, 2017, NATURE, V552, P355, DOI 10.1038/nature25158; Wallin K, 2012, J ALZHEIMERS DIS, V31, P669, DOI 10.3233/JAD-2012-111736; Wendeln AC, 2018, NATURE, V556, P332, DOI 10.1038/s41586-018-0023-4; Yeh FL, 2017, TRENDS MOL MED, V23, P512, DOI 10.1016/j.molmed.2017.03.008	13	31	32	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					426	428		10.1038/d41586-018-04930-7	http://dx.doi.org/10.1038/d41586-018-04930-7			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8VX	29691517				2022-12-28	WOS:000430793000021
J	England, BR; Thiele, GM; Anderson, DR; Mikuls, TR				England, Bryant R.; Thiele, Geoffrey M.; Anderson, Daniel R.; Mikuls, Ted R.			Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications	BMJ-BRITISH MEDICAL JOURNAL			English	Review							NECROSIS-FACTOR-ALPHA; HIGH-DENSITY-LIPOPROTEIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ACUTE MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR STRUCTURE; CONGESTIVE-HEART-FAILURE; CAUSE-SPECIFIC MORTALITY; BODY-MASS INDEX; DISEASE-ACTIVITY; ENDOTHELIAL DYSFUNCTION	Rheumatoid arthritis is a systemic autoimmune disease characterized by excess morbidity and mortality from cardiovascular disease. Mechanisms linking rheumatoid arthritis and cardiovascular disease include shared inflammatory mediators, post-translational modifications of peptides/proteins and subsequent immune responses, alterations in the composition and function of lipoproteins, increased oxidative stress, and endothelial dysfunction. Despite a growing understanding of these mechanisms and their complex interplay with conventional cardiovascular risk factors, optimal approaches of risk stratification, prevention, and treatment in the context of rheumatoid arthritis remain unknown. A multifaceted approach to reduce the burden posed by cardiovascular disease requires optimal management of traditional risk factors in addition to those intrinsic to rheumatoid arthritis such as increased disease activity. Treatments for rheumatoid arthritis seem to exert differential effects on cardiovascular risk as well as the mechanisms linking these conditions. More research is needed to establish whether preferential rheumatoid arthritis therapies exist in terms of prevention of cardiovascular disease. Ultimately, understanding the unique mechanisms for cardiovascular disease in rheumatoid arthritis will aid in risk stratification and the identification of novel targets for meaningful reduction of cardiovascular risk in this patient population.	[England, Bryant R.; Thiele, Geoffrey M.; Mikuls, Ted R.] Veterans Affairs VA Nebraska Western Iowa Hlth Ca, Omaha, NE 68105 USA; [England, Bryant R.; Thiele, Geoffrey M.; Mikuls, Ted R.] Univ Nebraska Med Ctr, Dept Internal Med, Div Rheumatol & Immunol, Omaha, NE 68198 USA; [Anderson, Daniel R.] Univ Nebraska Med Ctr, Dept Internal Med, Div Cardiol, Omaha, NE USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Mikuls, TR (corresponding author), Veterans Affairs VA Nebraska Western Iowa Hlth Ca, Omaha, NE 68105 USA.; Mikuls, TR (corresponding author), Univ Nebraska Med Ctr, Dept Internal Med, Div Rheumatol & Immunol, Omaha, NE 68198 USA.	tmikuls@unmc.edu	England, Bryant/AAH-6545-2020	England, Bryant/0000-0002-9649-3588	University of Nebraska Medical Center (UNMC) internal medicine scientist development award; UNMC Mentored Scholars Program; UNMC College of Medicine Physician-Scientist Training Program; National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases [P50AR060772]; National Institute of Alcohol Abuse and Alcoholism [R25AA020818]; National Institute of General Medical Sciences [U54GM115458]; Veterans Affairs Office of Research and Development [CX000896]; Bristol Myers Squibb; Ironwood Pharmaceuticals; Harry R and Sarah H Caspersen Coronary Artery Disease Research Fund; Division of Cardiovascular Medicine, Department of Internal Medicine, UNMC; Rheumatology Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR060772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM115458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R25AA020818] Funding Source: NIH RePORTER	University of Nebraska Medical Center (UNMC) internal medicine scientist development award; UNMC Mentored Scholars Program; UNMC College of Medicine Physician-Scientist Training Program; National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs Office of Research and Development; Bristol Myers Squibb(Bristol-Myers Squibb); Ironwood Pharmaceuticals; Harry R and Sarah H Caspersen Coronary Artery Disease Research Fund; Division of Cardiovascular Medicine, Department of Internal Medicine, UNMC; Rheumatology Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	BRE is supported by a University of Nebraska Medical Center (UNMC) internal medicine scientist development award, the UNMC Mentored Scholars Program, and the UNMC College of Medicine Physician-Scientist Training Program. TRM is supported by grants from the National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (P50AR060772), National Institute of Alcohol Abuse and Alcoholism (R25AA020818), National Institute of General Medical Sciences (U54GM115458), Veterans Affairs Office of Research and Development (Merit Award, CX000896), Bristol Myers Squibb, and Ironwood Pharmaceuticals. DRA is supported by the Harry R and Sarah H Caspersen Coronary Artery Disease Research Fund and the Division of Cardiovascular Medicine, Department of Internal Medicine, UNMC. GMT is supported by grants from the Rheumatology Research Foundation and a Bristol Myers Squibb investigator initiated grant.	Agca R, 2017, ANN RHEUM DIS, V76, P17, DOI 10.1136/annrheumdis-2016-209775; Ahmed A, 2016, ARTHRITIS RHEUMATOL, V68, P1361, DOI 10.1002/art.39574; Ajeganova S, 2012, J RHEUMATOL, V39, P1146, DOI 10.3899/jrheum.111334; An J, 2016, J RHEUMATOL, V43, P1989, DOI 10.3899/jrheum.160110; Anderson DEJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115163; Angel K, 2010, HYPERTENSION, V55, P333, DOI 10.1161/HYPERTENSIONAHA.109.143982; Arts EEA, 2015, ANN RHEUM DIS, V74, P668, DOI 10.1136/annrheumdis-2013-204024; Arts EEA, 2015, ANN RHEUM DIS, V74, P998, DOI 10.1136/annrheumdis-2013-204531; Avina-Zubieta JA, 2013, RHEUMATOLOGY, V52, P68, DOI 10.1093/rheumatology/kes353; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Avina-Zubieta JA, 2012, ANN RHEUM DIS, V71, P1524, DOI 10.1136/annrheumdis-2011-200726; Baker JF, 2015, ARTHRITIS RHEUMATOL, V67, P1711, DOI 10.1002/art.39136; Barber CEH, 2016, J RHEUMATOL, V43, P1965, DOI 10.3899/jrheum.160241; Bartels CM, 2011, ARTHRITIS RHEUM-US, V63, P1221, DOI 10.1002/art.30239; Bernatsky S, 2005, RHEUMATOLOGY, V44, P677, DOI 10.1093/rheumatology/keh610; Cambridge G, 2013, ATHEROSCLEROSIS, V228, P243, DOI 10.1016/j.atherosclerosis.2013.02.009; Cannon CP, 2006, LANCET, V368, P1771, DOI 10.1016/S0140-6736(06)69666-9; Charles-Schoeman C, 2017, ARTHRITIS RHEUMATOL, V69, P46, DOI 10.1002/art.39833; Charles-Schoeman C, 2016, SEMIN ARTHRITIS RHEU, V46, P71, DOI 10.1016/j.semarthrit.2016.03.004; Charles-Schoeman C, 2016, ARTHRITIS RHEUMATOL, V68, P577, DOI 10.1002/art.39502; Charles-Schoeman C, 2013, ARTHRITIS RHEUM-US, V65, P2765, DOI 10.1002/art.38118; Charles-Schoeman C, 2012, ANN RHEUM DIS, V71, P1157, DOI 10.1136/annrheumdis-2011-200493; Charles-Schoeman C, 2009, ARTHRITIS RHEUM-US, V60, P2870, DOI 10.1002/art.24802; Choi HK, 2014, NAT REV RHEUMATOL, V10, P403, DOI 10.1038/nrrheum.2014.36; Chung CP, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4314; Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; Crowson CS, 2017, RHEUMATOLOGY, V56, P1102, DOI 10.1093/rheumatology/kex038; Crowson CS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174656; Crowson CS, 2012, AM J CARDIOL, V110, P420, DOI 10.1016/j.amjcard.2012.03.044; Curtis JR, 2012, ARTHRIT CARE RES, V64, P1282, DOI 10.1002/acr.21693; Daien CI, 2013, ANN RHEUM DIS, V72, P881, DOI 10.1136/annrheumdis-2012-201489; Daien CI, 2012, ANN RHEUM DIS, V71, P862, DOI 10.1136/annrheumdis-2011-201148; Davis JM, 2007, ARTHRITIS RHEUM-US, V56, P820, DOI 10.1002/art.22418; Davis LA, 2013, J RHEUMATOL, V40, P809, DOI 10.3899/jrheum.121012; de Groot L, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3538; de Jong Z, 2003, ARTHRITIS RHEUM, V48, P2415, DOI 10.1002/art.11216; De Vera MA, 2012, ARTHRIT CARE RES, V64, P809, DOI 10.1002/acr.21643; De Vera MA, 2011, ANN RHEUM DIS, V70, P1020, DOI 10.1136/ard.2010.142455; del Rincon I, 2015, ANN RHEUM DIS, V74, P1118, DOI 10.1136/annrheumdis-2013-205058; del Rincon I, 2014, ARTHRITIS RHEUMATOL, V66, P264, DOI 10.1002/art.38210; El-Barbary AM, 2011, J RHEUMATOL, V38, P229, DOI 10.3899/jrheum.100582; Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932; England BR, 2018, ARTHRIT CARE RES, V70, P11, DOI 10.1002/acr.23258; England BR, 2016, ARTHRIT CARE RES, V68, P36, DOI 10.1002/acr.22642; Escalante A, 2005, ARCH INTERN MED, V165, P1624, DOI 10.1001/archinte.165.14.1624; Everett BM, 2013, AM HEART J, V166, P199, DOI 10.1016/j.ahj.2013.03.018; Ferraz-Amaro I, 2013, J RHEUMATOL, V40, P1040, DOI 10.3899/jrheum.121507; Fine NM, 2014, ANN RHEUM DIS, V73, P1833, DOI 10.1136/annrheumdis-2013-203314; Fisher MC, 2012, J RHEUMATOL, V39, P904, DOI 10.3899/jrheum.110852; Gabay C, 2016, ANN RHEUM DIS, V75, P1806, DOI 10.1136/annrheumdis-2015-207872; Galarraga B, 2010, J RHEUMATOL, V37, P521, DOI 10.3899/jrheum.090417; Genovese MC, 2008, ARTHRITIS RHEUM-US, V58, P2968, DOI 10.1002/art.23940; George MD, 2017, ARTHRIT CARE RES, V69, P1789, DOI 10.1002/acr.23229; Geraldino-Pardilla L, 2017, ARTHRIT CARE RES, V69, P1276, DOI 10.1002/acr.23106; Geraldino-Pardilla L, 2017, RHEUMATOLOGY, V56, P534, DOI 10.1093/rheumatology/kew436; Giles JT, 2015, ARTHRITIS RHEUMATOL, V67, P626, DOI 10.1002/art.38986; Giles JT, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3752; Giles JT, 2011, ARTHRITIS RHEUM-US, V63, P3216, DOI 10.1002/art.30542; Giles JT, 2010, ARTHRITIS RHEUM-US, V62, P940, DOI 10.1002/art.27349; Giles JT, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2641; Gonzalez A, 2008, ANN RHEUM DIS, V67, P64, DOI 10.1136/ard.2006.059980; Gonzalez-Gay MA, 2007, ARTHRIT RHEUM-ARTHR, V57, P125, DOI 10.1002/art.22482; Gyberg V, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0296-y; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Harrison D, 2003, AM J CARDIOL, V91, p7A; Haruna Y, 2007, ARTHRITIS RHEUM-US, V56, P1827, DOI 10.1002/art.22632; Haruna Y, 2006, ARTHRITIS RHEUM-US, V54, P1847, DOI 10.1002/art.21891; Hashizume M, 2012, EUR J PHARMACOL, V689, P249, DOI 10.1016/j.ejphar.2012.05.035; Hashizume M, 2012, CYTOKINE, V58, P424, DOI 10.1016/j.cyto.2012.02.010; Hot A, 2012, ANN RHEUM DIS, V71, P768, DOI 10.1136/annrheumdis-2011-200468; Hsue PY, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001267; Ikdahl E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153440; Ikonomidis I, 2009, HEART, V95, P1502, DOI 10.1136/hrt.2009.168971; Jafri K, 2017, ARTHRIT CARE RES, V69, P51, DOI 10.1002/acr.23094; Lopez-Longo FJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P419, DOI 10.1002/art.24390; Jones G, 2010, ANN RHEUM DIS, V69, P88, DOI 10.1136/ard.2008.105197; Kang Y, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4384; Karpouzas GA, 2014, ANN RHEUM DIS, V73, P1797, DOI 10.1136/annrheumdis-2013-203617; Kavanaugh A, 2013, ANN RHEUM DIS, V72, P674, DOI 10.1136/annrheumdis-2013-204345; Kawai VK, 2015, ARTHRITIS RHEUMATOL, V67, P381, DOI 10.1002/art.38944; Kerr G, 2014, ARTHRIT CARE RES, V66, P1619, DOI 10.1002/acr.22341; Khoja SS, 2016, ARTHRIT CARE RES, V68, P424, DOI 10.1002/acr.22711; Kim JY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164564; Kim SC, 2017, ARTHRITIS RHEUMATOL, V69, P1154, DOI 10.1002/art.40084; Kirkham BW, 2014, ANN RHEUM DIS, V73, P161, DOI 10.1136/annrheumdis-2012-202089; Klarenbeek NB, 2010, ANN RHEUM DIS, V69, P1342, DOI 10.1136/ard.2009.124180; Kremer JM, 2011, ARTHRITIS RHEUM-US, V63, P609, DOI 10.1002/art.30158; Kume K, 2011, J RHEUMATOL, V38, P2169, DOI 10.3899/jrheum.110340; Liang KP, 2010, ANN RHEUM DIS, V69, P1665, DOI 10.1136/ard.2009.124362; Liao KP, 2015, ARTHRITIS RHEUMATOL, V67, P2004, DOI 10.1002/art.39165; Liao KP, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001588; Lindhardsen J, 2014, ANN RHEUM DIS, V73, P1515, DOI 10.1136/annrheumdis-2012-203137; Ljung L, 2016, ANN RHEUM DIS, V75, P2087, DOI 10.1136/annrheumdis-2015-208995; Logstrup BB, 2014, AM J CARDIOVASC DIS, V4, P79; Low ASL, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2016-209784; Mackey RH, 2015, ARTHRITIS RHEUMATOL, V67, P2311, DOI 10.1002/art.39198; Majka DS, 2017, ARTHRIT CARE RES, V69, P166, DOI 10.1002/acr.22930; Mann DL, 2004, CIRCULATION, V109, P1594, DOI 10.1161/01.CIR.0000124490.27666.B2; Mantel A, 2015, ARTHRITIS RHEUMATOL, V67, P2845, DOI 10.1002/art.39267; Marasovic-Krstulovic D, 2011, RHEUMATOLOGY, V50, P1505, DOI 10.1093/rheumatology/ker121; Quinonez-Flores CM, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6097417; McInnes IB, 2014, ANN RHEUM DIS, V73, P124, DOI 10.1136/annrheumdis-2012-202442; Menghini R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099053; Metsios GS, 2014, ANN RHEUM DIS, V73, P748, DOI 10.1136/annrheumdis-2013-203291; Midtbo H, 2017, ANN RHEUM DIS, V76, P371, DOI 10.1136/annrheumdis-2016-209223; Midtbo H, 2015, RHEUMATOLOGY, V54, P511, DOI 10.1093/rheumatology/keu368; Montes A, 2015, ARTHRITIS RHEUMATOL, V67, P2861, DOI 10.1002/art.39302; Morris SJ, 2011, ARTHRIT CARE RES, V63, P530, DOI 10.1002/acr.20393; Myasoedova E, 2016, ANN RHEUM DIS, V75, P560, DOI 10.1136/annrheumdis-2014-206411; Myasoedova E, 2011, J RHEUMATOL, V38, P1601, DOI 10.3899/jrheum.100979; Myasoedova E, 2011, ANN RHEUM DIS, V70, P482, DOI 10.1136/ard.2010.135871; Navarro-Millan I, 2016, ANN RHEUM DIS, V75, P341, DOI 10.1136/annrheumdis-2013-204987; Navarro-Millan I, 2013, ARTHRITIS RHEUM-US, V65, P1430, DOI 10.1002/art.37916; Nissen SE, 2016, NEW ENGL J MED, V375, P2519, DOI 10.1056/NEJMoa1611593; O'Neill F, 2017, HEART, V103, P766, DOI 10.1136/heartjnl-2015-308953; Park YJ, 2014, ARTHRITIS RHEUMATOL, V66, P1450, DOI 10.1002/art.38352; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Popa C, 2009, ANN RHEUM DIS, V68, P868, DOI 10.1136/ard.2008.092171; Provan SA, 2011, ANN RHEUM DIS, V70, P812, DOI 10.1136/ard.2010.141523; Rao VU, 2015, ARTHRITIS RHEUMATOL, V67, P372, DOI 10.1002/art.38920; Raterman HG, 2013, ANN RHEUM DIS, V72, P560, DOI 10.1136/annrheumdis-2011-201228; Reiss AB, 2008, ARTHRITIS RHEUM-US, V58, P3675, DOI 10.1002/art.24040; Rho YH, 2010, ARTHRITIS RHEUM-US, V62, P1259, DOI 10.1002/art.27376; Rho YH, 2009, ARTHRIT RHEUM-ARTHR, V61, P1580, DOI 10.1002/art.25009; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Rodriguez-Carrio J, 2016, ARTHRITIS RHEUMATOL, V68, P1367, DOI 10.1002/art.39609; Rodriguez-Carrio J, 2015, ANN RHEUM DIS, V74, P921, DOI 10.1136/annrheumdis-2013-204250; Rollefstad S, 2015, ARTHRITIS RHEUMATOL, V67, P1718, DOI 10.1002/art.39114; Ronda N, 2015, ARTHRITIS RHEUMATOL, V67, P1155, DOI 10.1002/art.39039; Ronda N, 2014, ANN RHEUM DIS, V73, P609, DOI 10.1136/annrheumdis-2012-202914; Roubille C, 2015, ANN RHEUM DIS, V74, P480, DOI 10.1136/annrheumdis-2014-206624; Ruiz-Limon P, 2017, TRANSL RES, V183, P87, DOI 10.1016/j.trsl.2016.12.003; Sakuta T, 2010, ARTHRITIS RHEUM-US, V62, P1319, DOI 10.1002/art.27384; Sandoo A, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4396; Sandoo A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3847; Semb AG, 2012, ARTHRITIS RHEUM-US, V64, P2836, DOI 10.1002/art.34524; Setoguchi S, 2008, AM HEART J, V156, P336, DOI 10.1016/j.ahj.2008.02.025; Sharma TS, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002867; Shi J, 2011, P NATL ACAD SCI USA, V108, P17372, DOI 10.1073/pnas.1114465108; Shi Q, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4062; Sidibe A, 2012, ARTHRITIS RHEUM-US, V64, P77, DOI 10.1002/art.33336; Sodergren A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3116; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Sokolove J, 2016, RHEUMATOLOGY, V55, P1969, DOI 10.1093/rheumatology/kew285; Solomon DH, 2015, ARTHRITIS RHEUMATOL, V67, P1995, DOI 10.1002/art.39195; Solomon DH, 2015, ARTHRITIS RHEUMATOL, V67, P1449, DOI 10.1002/art.39098; Solomon DH, 2013, ANN RHEUM DIS, V72, P1813, DOI 10.1136/annrheumdis-2012-202136; Solomon DH, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.02.016; Solomon DH, 2010, ANN RHEUM DIS, V69, P1920, DOI 10.1136/ard.2009.122226; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; Spinelli FR, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/537539; Spinelli FR, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1563-8; Stavropoulos-Kalinoglou A, 2013, ANN RHEUM DIS, V72, P1819, DOI 10.1136/annrheumdis-2012-202075; Strang AC, 2013, ATHEROSCLEROSIS, V229, P174, DOI 10.1016/j.atherosclerosis.2013.04.031; Sugiyama D, 2010, ANN RHEUM DIS, V69, P70, DOI 10.1136/ard.2008.096487; Svensson AL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009134; Thiele GM, 2015, ARTHRITIS RHEUMATOL, V67, P645, DOI 10.1002/art.38969; Thiele GM, 1998, ALCOHOL CLIN EXP RES, V22, P1731, DOI 10.1111/j.1530-0277.1998.tb03973.x; Thornton CC, 2016, ANN RHEUM DIS, V75, P439, DOI 10.1136/annrheumdis-2014-206305; Toms TE, 2011, ANGIOLOGY, V62, P167, DOI 10.1177/0003319710373749; Toms Tracey E, 2010, Ann Rheum Dis, V69, P683, DOI 10.1136/ard.2009.115717; Totoson P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146744; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Tuma DJ, 2001, CHEM RES TOXICOL, V14, P822, DOI 10.1021/tx000222a; Turiel M, 2009, RHEUMATOLOGY, V48, P834, DOI 10.1093/rheumatology/kep082; Veetil BMA, 2013, J RHEUMATOL, V40, P1082, DOI 10.3899/jrheum.121302; Verbrugge FH, 2015, KIDNEY INT, V88, P474, DOI 10.1038/ki.2015.166; Vivekanandan-Giri A, 2013, ANN RHEUM DIS, V72, P1725, DOI 10.1136/annrheumdis-2012-202033; Voloshyna I, 2013, EXP BIOL MED, V238, P1192, DOI 10.1177/1535370213503262; Wasko MC, 2014, JCR-J CLIN RHEUMATOL, V20, P1, DOI 10.1097/RHU.0000000000000053; Wasko MCM, 2007, JAMA-J AM MED ASSOC, V298, P187, DOI 10.1001/jama.298.2.187; Watanabe J, 2012, ARTHRITIS RHEUM-US, V64, P1828, DOI 10.1002/art.34363; Wen W, 2016, AUTOIMMUNITY, V49, P115, DOI 10.3109/08916934.2015.1118761; Winchester R, 2016, ARTHRITIS RHEUMATOL, V68, P92, DOI 10.1002/art.39419; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Zhang J, 2016, ANN RHEUM DIS, V75, P1813, DOI 10.1136/annrheumdis-2015-207870; Zhang J, 2014, ANN RHEUM DIS, V73, P1301, DOI 10.1136/annrheumdis-2013-204715; Zimmermann MC, 2017, REDOX BIOL, V13, P588, DOI 10.1016/j.redox.2017.07.018	178	178	184	22	91	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2018	361								k1036	10.1136/bmj.k1036	http://dx.doi.org/10.1136/bmj.k1036			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF4VW	29685876	Green Published			2022-12-28	WOS:000431962900001
J	Hirsch, C				Hirsch, Calvin			Review: In adults with normal cognition or MCI, drugs do not prevent or delay cognitive decline	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Hirsch, Calvin] Univ Calif, Davis Med Ctr, Sacramento, CA 95819 USA		Hirsch, C (corresponding author), Univ Calif, Davis Med Ctr, Sacramento, CA 95819 USA.							Edmonds EC, 2017, ALZHEIMERS DEMENT NY, V4, P11; Meng XF, 2014, J ALZHEIMERS DIS, V42, P1295, DOI 10.3233/JAD-140954; Petersen RC, 2018, NEUROLOGY, V90, P126, DOI 10.1212/WNL.0000000000004826	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2018	168	8					JC39	JC39		10.7326/ACPJC-2018-168-8-039	http://dx.doi.org/10.7326/ACPJC-2018-168-8-039			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GC8XZ	29677246				2022-12-28	WOS:000430083100005
J	Zheng, SL; Roddick, AJ; Aghar-Jaffar, R; Shun-Shin, MJ; Francis, D; Oliver, N; Meeran, K				Zheng, Sean L.; Roddick, Alistair J.; Aghar-Jaffar, Rochan; Shun-Shin, Matthew J.; Francis, Darrel; Oliver, Nick; Meeran, Karim			Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CARDIOVASCULAR OUTCOMES; LOWERING DRUGS; CLINICAL-OUTCOMES; HEART-FAILURE; CVD-REAL; INCONSISTENCY; STATEMENT; THERAPY; MODELS; TRIALS	IMPORTANCE The comparative clinical efficacy of sodium-glucose cotransporter 2 (SGLT-2) inhibitors, glucagon-like peptide 1 (GLP-1) agonists, and dipeptidyl peptidase 4 (DPP-4) inhibitors for treatment of type 2 diabetes is unknown. OBJECTIVE To compare the efficacies of SGLT-2 inhibitors, GLP-1 agonists, and DPP-4 inhibitors on mortality and cardiovascular end points using network meta-analysis. DATA SOURCES MEDLINE, Embase, Cochrane Library Central Register of Controlled Trials, and published meta-analyses from inception through October 11, 2017. STUDY SELECTION Randomized clinical trials enrolling participants with type 2 diabetes and a follow-up of at least 12 weeks were included, for which SGLT-2 inhibitors, GLP-1 agonists, and DPP-4 inhibitors were compared with either each other or placebo or no treatment. DATA EXTRACTION AND SYNTHESIS Data were screened by 1 investigator and extracted in duplicate by 2 investigators. A Bayesian hierarchical network meta-analysis was performed. MAIN OUTCOMES AND MEASURES The primary outcome: all-cause mortality; secondary outcomes: cardiovascular (CV) mortality, heart failure (HF) events, myocardial infarction (MI), unstable angina, and stroke; safety end points: adverse events and hypoglycemia. RESULTS This network meta-analysis of 236 trials randomizing 176 310 participants found SGLT-2 inhibitors (absolute risk difference [RD], -1.0%; hazard ratio [HR], 0.80 [95% credible interval {CrI}, 0.71 to 0.89]) and GLP-1 agonists (absolute RD, -0.6%; HR, 0.88 [95% CrI, 0.81 to 0.94]) were associated with significantly lower all-cause mortality than the control groups. SGLT-2 inhibitors (absolute RD, -0.9%; HR, 0.78 [95% CrI, 0.68 to 0.90]) and GLP-1 agonists (absolute RD, -0.5%; HR, 0.86 [95% CrI, 0.77 to 0.96]) were associated with lower mortality than were DPP-4 inhibitors. DPP-4 inhibitors were not significantly associated with lower all-cause mortality (absolute RD, 0.1%; HR, 1.02 [95% CrI, 0.94 to 1.11]) than were the control groups. SGLT-2 inhibitors (absolute RD, -0.8%; HR, 0.79 [95% CrI, 0.69 to 0.91]) and GLP-1 agonists (absolute RD, -0.5%; HR, 0.85 [95% CrI, 0.77 to 0.94]) were significantly associated with lower CV mortality than were the control groups. SGLT-2 inhibitors were significantly associated with lower rates of HF events (absolute RD, -1.1%; HR, 0.62 [95% CrI, 0.54 to 0.72]) and MI (absolute RD, -0.6%; HR, 0.86 [95% CrI, 0.77 to 0.97]) than were the control groups. GLP-1 agonists were associated with a higher risk of adverse events leading to trial withdrawal than were SGLT-2 inhibitors (absolute RD, 5.8%; HR, 1.80 [95% CrI, 1.44 to 2.25]) and DPP-4 inhibitors (absolute RD, 3.1%; HR, 1.93 [95% CrI, 1.59 to 2.35]). CONCLUSIONS AND RELEVANCE In this network meta-analysis, the use of SGLT-2 inhibitors or GLP-1 agonists was associated with lower mortality than DPP-4 inhibitors or placebo or no treatment. Use of DPP-4 inhibitors was not associated with lower mortality than placebo or no treatment.	[Zheng, Sean L.; Aghar-Jaffar, Rochan; Oliver, Nick; Meeran, Karim] Imperial Coll Healthcare NHS Fdn Trust, Dept Endocrinol, London, England; [Zheng, Sean L.] Royal Brompton & Harefield NHS Fdn Trust, Dept Cardiol, London, England; [Zheng, Sean L.; Aghar-Jaffar, Rochan; Shun-Shin, Matthew J.; Francis, Darrel; Oliver, Nick; Meeran, Karim] Imperial Coll London, London, England; [Roddick, Alistair J.] Kings Coll London, Fac Life Sci & Med, London, England; [Aghar-Jaffar, Rochan; Oliver, Nick; Meeran, Karim] Imperial Coll London, Div Diabet Endocrinol & Metab, London, England	Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; University of London; King's College London; Imperial College London	Zheng, SL (corresponding author), Royal Brompton Hosp, Dept Cardiol, Sydney St, London SW3 6NP, England.	sean.zheng@nhs.net	Kabak, Serdar/I-8113-2018; Zheng, Sean L./J-5998-2019; Oliver, Nick/G-9109-2016	Zheng, Sean L./0000-0002-5762-6392; Roddick, Alistair/0000-0002-4184-2541; Oliver, Nick/0000-0003-3525-3633; Shun-Shin, Matthew/0000-0002-1179-0867	British Heart Foundation [FS/14/27/30752]; British Heart Foundation [FS/10/38/28268] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	Dr Shun-Shin is supported by grant FS/14/27/30752 from the British Heart Foundation.	Amiel SA, 2017, DIABETOLOGIA, V60, P3, DOI 10.1007/s00125-016-4146-6; [Anonymous], 2017, TRIAL INVESTIGATING; [Anonymous], 2017, STUDY EVALUATE EFFEC; Armstrong C, 2017, AM FAM PHYSICIAN, V95, P40; Birkeland KI, 2017, LANCET DIABETES ENDO, V5, P709, DOI 10.1016/S2213-8587(17)30258-9; Butler J, 2017, EUR J HEART FAIL, V19, P1390, DOI 10.1002/ejhf.933; Davies M, 2017, JAMA-J AM MED ASSOC, V318, P1460, DOI 10.1001/jama.2017.14752; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Emdin CA, 2015, JAMA-J AM MED ASSOC, V313, P603, DOI 10.1001/jama.2014.18574; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Higgins JPT, 2012, RES SYNTH METHODS, V3, P98, DOI 10.1002/jrsm.1044; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holman RR, 2017, NEW ENGL J MED, V377, P1228, DOI 10.1056/NEJMoa1612917; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Kosiborod M, 2017, CIRCULATION, V136, P249, DOI 10.1161/CIRCULATIONAHA.117.029190; Liu JL, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2499; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; National Institute for Health and Care Excellence, TYP 2 DIAB AD MAN; Nauck MA, 2017, CIRCULATION, V136, P849, DOI 10.1161/CIRCULATIONAHA.117.028136; Nauck MA, 2016, LANCET DIABETES ENDO, V4, P525, DOI 10.1016/S2213-8587(15)00482-9; Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925; Palmer SC, 2016, JAMA-J AM MED ASSOC, V316, P313, DOI 10.1001/jama.2016.9400; Pfeffer MA, 2015, NEW ENGL J MED, V373, P2247, DOI 10.1056/NEJMoa1509225; Rawshani A, 2017, NEW ENGL J MED, V376, P1407, DOI 10.1056/NEJMoa1608664; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Shyangdan DS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006423.pub2; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; van Valkenhoef G, 2016, RES SYNTH METHODS, V7, P80, DOI 10.1002/jrsm.1167; Vasilakou D, 2013, ANN INTERN MED, V159, P262, DOI 10.7326/0003-4819-159-4-201308200-00007; Waldrop G, 2016, J AM COLL CARDIOL, V67, P1488, DOI 10.1016/j.jacc.2015.12.058; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Zheng SL, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2016-000449; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	35	223	228	2	69	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2018	319	15					1580	1591		10.1001/jama.2018.3024	http://dx.doi.org/10.1001/jama.2018.3024			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD0UT	29677303	Green Published, Bronze			2022-12-28	WOS:000430217100018
J	O'Mahony, S				O'Mahony, Seamus			Do doctors die better than philosophers?	LANCET			English	Editorial Material									[O'Mahony, Seamus] Cork Univ Hosp, Cork T12 DC4A, Ireland		O'Mahony, S (corresponding author), Cork Univ Hosp, Cork T12 DC4A, Ireland.	seamus.omahony@hse.ie						Bakewell Sarah, 2010, LIVE LIFE MONTAIGNE, P123; Critchley S., 2015, BOOK DEAD PHILOS; Montaigne M., 2004, COMPLETE ESSAYS; O'Mahony S, 2016, THE WAY WE DIE NOW; Tolstoy L., 1960, DEATH IVAN ILYICH	5	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2018	391	10129					1474	1475		10.1016/S0140-6736(18)30835-3	http://dx.doi.org/10.1016/S0140-6736(18)30835-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GC6TS	29676272				2022-12-28	WOS:000429926000015
J	Bel'kov, VV; Hirschinger, J; Novak, V; Niedernostheide, FJ; Ganichev, SD; Prettl, W				Bel'kov, VV; Hirschinger, J; Novak, V; Niedernostheide, FJ; Ganichev, SD; Prettl, W			Pattern formation in semiconductors	NATURE			English	Letter							GAAS		Univ Regensburg, Inst Expt & Angew Phys, D-93040 Regensburg, Germany; AV CR, Inst Elect Engn, Prague 18202 8, Czech Republic	University of Regensburg; Czech Academy of Sciences	Bel'kov, VV (corresponding author), Univ Regensburg, Inst Expt & Angew Phys, D-93040 Regensburg, Germany.		Novak, Vit/G-6844-2014; Bel'kov, Vasily V/E-4363-2014	Novak, Vit/0000-0003-2461-1685; 				Eberle W, 1996, APPL PHYS LETT, V68, P3329, DOI 10.1063/1.116047; JEFFRIES CD, 1975, SCIENCE, V189, P955, DOI 10.1126/science.189.4207.955; KOZHEVNIKOV M, 1995, PHYS REV B, V52, P4855, DOI 10.1103/PhysRevB.52.4855; LANDSBERG PT, 1976, J PHYS C SOLID STATE, V9, P1243, DOI 10.1088/0022-3719/9/7/015; LEVINSON IB, 1965, FIZ TVERD TELA+, V7, P1098; RIDLEY BK, 1963, P PHYS SOC LOND, V82, P954, DOI 10.1088/0370-1328/82/6/315; Scholl E., 1987, NONEQUILIBRIUM PHASE	7	13	13	0	7	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					398	398		10.1038/17040	http://dx.doi.org/10.1038/17040			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667986	Green Published, Bronze			2022-12-28	WOS:000078461700032
J	Pockley, P				Pockley, P			Treaty nations 'are exploiting Antarctica'	NATURE			English	News Item																		Pockley P, 1997, NATURE, V390, P109, DOI 10.1038/36418	1	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					375	375		10.1038/16973	http://dx.doi.org/10.1038/16973			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667988	Bronze			2022-12-28	WOS:000078461700008
J	Voelker, R				Voelker, Rebecca			Blood Glucose Readings Made Possible Via Smartphone	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2018	319	17					1758	1758		10.1001/jama.2018.4928	http://dx.doi.org/10.1001/jama.2018.4928			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GE3UQ	29715340				2022-12-28	WOS:000431138800006
J	Yang, ZL; Han, S; Keller, M; Kaiser, A; Bender, BJ; Bosse, M; Burkert, K; Kogler, LM; Wifling, D; Bernhardt, G; Plank, N; Littmann, T; Schmidt, P; Yi, CY; Li, BB; Ye, S; Zhang, RG; Xu, B; Larhammar, D; Stevens, RC; Huster, D; Meiler, J; Zhao, Q; Beck-Sickinger, AG; Buschauer, A; Wu, BL				Yang, Zhenlin; Han, Shuo; Keller, Max; Kaiser, Anette; Bender, Brian J.; Bosse, Mathias; Burkert, Kerstin; Koegler, Lisa M.; Wifling, David; Bernhardt, Guenther; Plank, Nicole; Littmann, Timo; Schmidt, Peter; Yi, Cuiying; Li, Beibei; Ye, Sheng; Zhang, Rongguang; Xu, Bo; Larhammar, Dan; Stevens, Raymond C.; Huster, Daniel; Meiler, Jens; Zhao, Qiang; Beck-Sickinger, Annette G.; Buschauer, Armin; Wu, Beili			Structural basis of ligand binding modes at the neuropeptide Y Y-1 receptor	NATURE			English	Article							PROTEIN-COUPLED RECEPTORS; PANCREATIC-POLYPEPTIDE; NEUROTENSIN RECEPTOR; PEPTIDE YY; ANTAGONISTS; MUTAGENESIS; AFFINITY; TOOL; ACTIVATION; REFINEMENT	Neuropeptide Y (NPY) receptors belong to the G-protein-coupled receptor superfamily and have important roles in food intake, anxiety and cancer biology(1,2). The NPY-Y receptor system has emerged as one of the most complex networks with three peptide ligands (NPY, peptide YY and pancreatic polypeptide) binding to four receptors in most mammals, namely the Y-1, Y-2, Y-4 and Y-5 receptors, with different affinity and selectivity(3). NPY is the most powerful stimulant of food intake and this effect is primarily mediated by the Y-1 receptor (Y1R)(4). A number of peptides and small-molecule compounds have been characterized as Y1R antagonists and have shown clinical potential in the treatment of obesity(4), tumour(1) and bone loss(5). However, their clinical usage has been hampered by low potency and selectivity, poor brain penetration ability or lack of oral bioavailability(6). Here we report crystal structures of the human Y1R bound to the two selective antagonists UR-MK299 and BMS-193885 at 2.7 and 3.0 angstrom resolution, respectively. The structures combined with mutagenesis studies reveal the binding modes of Y1R to several structurally diverse antagonists and the determinants of ligand selectivity. The Y1R structure and molecular docking of the endogenous agonist NPY, together with nuclear magnetic resonance, photo-crosslinking and functional studies, provide insights into the binding behaviour of the agonist and for the first time, to our knowledge, determine the interaction of its N terminus with the receptor. These insights into Y1R can enable structure-based drug discovery that targets NPY receptors.	[Yang, Zhenlin; Han, Shuo; Yi, Cuiying; Li, Beibei; Zhao, Qiang; Wu, Beili] Chinese Acad Sci, Shanghai Inst Mat Medica, Key Lab Receptor Res, Shanghai, Peoples R China; [Yang, Zhenlin; Zhao, Qiang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China; [Han, Shuo; Ye, Sheng; Zhang, Rongguang] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China; [Keller, Max; Wifling, David; Bernhardt, Guenther; Plank, Nicole; Littmann, Timo; Buschauer, Armin] Univ Regensburg, Inst Pharm, Pharmaceut Med Chem 2, Regensburg, Germany; [Burkert, Kerstin; Koegler, Lisa M.; Beck-Sickinger, Annette G.] Univ Leipzig, Inst Biochem, Fac Life Sci, Leipzig, Germany; [Bender, Brian J.; Meiler, Jens] Vanderbilt Univ, Dept Pharmacol, Struct Biol Ctr, Nashville, TN USA; [Bosse, Mathias; Schmidt, Peter; Huster, Daniel] Univ Leipzig, Inst Med Phys & Biophys, Leipzig, Germany; [Li, Beibei; Zhao, Qiang; Wu, Beili] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Rongguang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Natl Ctr Prot Sci Shanghai, Shanghai, Peoples R China; [Xu, Bo; Larhammar, Dan] Uppsala Univ, Sci Life Lab, Dept Neurosci, Uppsala, Sweden; [Stevens, Raymond C.] ShanghaiTech Univ, Human Inst, Shanghai, Peoples R China; [Stevens, Raymond C.; Wu, Beili] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Meiler, Jens] Vanderbilt Univ, Struct Biol Ctr, Dept Chem, 221 Kirkland Hall, Nashville, TN 37235 USA; [Meiler, Jens] Vanderbilt Univ, Dept Bioinformat, Struct Biol Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA; [Zhao, Qiang; Wu, Beili] Chinese Acad Sci, Ctr Excellence Biomacromol, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Regensburg; Leipzig University; Vanderbilt University; Leipzig University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Uppsala University; ShanghaiTech University; ShanghaiTech University; Vanderbilt University; Vanderbilt University; Chinese Academy of Sciences	Wu, BL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Medica, Key Lab Receptor Res, Shanghai, Peoples R China.; Keller, M (corresponding author), Univ Regensburg, Inst Pharm, Pharmaceut Med Chem 2, Regensburg, Germany.; Beck-Sickinger, AG (corresponding author), Univ Leipzig, Inst Biochem, Fac Life Sci, Leipzig, Germany.; Wu, BL (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Wu, BL (corresponding author), Chinese Acad Sci, Ctr Excellence Biomacromol, Beijing, Peoples R China.	max.keller@chemie.uni-regensburg.de; abeck-sickinger@uni-leipzig.de; beiliwu@simm.ac.cn	Stevens, Raymond/K-7272-2015; Wifling, David/AAB-8213-2020	Stevens, Raymond/0000-0002-4522-8725; Wifling, David/0000-0002-1370-2138; Kaiser, Anette/0000-0002-5477-201X; Yang, zhenlin/0000-0001-9735-4742	CAS Strategic Priority Research Programs [XDB08020000, XDB08030102]; Key Research Program of Frontier Sciences, CAS [QYZDB-SSW-SMC024, QYZDB-SSW-SMC054]; National Science Foundation of China [31570739, 81525024, 3170040264, 31470792]; Program of Shanghai Academic/Technology Research Leader [18XD1404800]; European Community; Free State of Saxony [SAB 100148835, 100881433]; Deutsche Forschungsgemeinschaft (DFG) [Be1264-16, SFB 1052/A3, KE 1857/1-1, GRK 1910]; NIH [R01 GM080403, R01 DK097376, R01 HL122010]; NSF [CHE 1305874]; Japan Synchrotron Radiation Research Institute [2015B2026, 2015B2027, 2016A2517, 2016A2518, 2016B2517, 2016B2518]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, R01DK097376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007628, R01GM080403] Funding Source: NIH RePORTER	CAS Strategic Priority Research Programs; Key Research Program of Frontier Sciences, CAS; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Academic/Technology Research Leader; European Community(European Commission); Free State of Saxony; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Japan Synchrotron Radiation Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to T. Zellmann for his contribution to the modelling in the early state of the project and for the technical support of R. Reppich-Sacher (mass spectrometry) and K. Lobner (cell culture). We thank H.A. Scheidt for support with solid-state NMR measurements and M. Beer-Kron, D. Fritsch, S. Bollwein and B. Wenzl for expert help in performing radioligand-binding experiments. The synchrotron radiation experiments were performed at the BL41XU of SPring-8 with approval of the Japan Synchrotron Radiation Research Institute (proposal no. 2015B2026, 2015B2027, 2016A2517, 2016A2518, 2016B2517 and 2016B2518). We thank the beamline staff members K. Hasegawa, H. Okumura, N. Mizuno, T. Kawamura and H. Murakami of the BL41XU for help with X-ray data collection. This work was supported by CAS Strategic Priority Research Programs XDB08020000 (B.W.) and XDB08030102 (R.Z.), the Key Research Program of Frontier Sciences, CAS, Grant no. QYZDB-SSW-SMC024 (B.W.) and QYZDB-SSW-SMC054 (Q.Z.), the National Science Foundation of China grants 31570739 (B.W.), 81525024 (Q.Z.), 3170040264 (Z.Y.) and 31470792 (S.Y.), Program of Shanghai Academic/Technology Research Leader no. 18XD1404800 (Z.Y., Q.Z.), the European Community, the Free State of Saxony (SAB 100148835 to D.H. and 100881433 to A.G.B.-S.) and the Deutsche Forschungsgemeinschaft (DFG) (Be1264-16, SFB 1052/A3, research grant KE 1857/1-1 and Graduate Training Program GRK 1910). Work in the Meiler laboratory is supported by the NIH (R01 GM080403, R01 DK097376, R01 HL122010) and NSF (CHE 1305874).	Antal-Zimanyi I, 2008, EUR J PHARMACOL, V590, P224, DOI 10.1016/j.ejphar.2008.06.032; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bender BJ, 2016, BIOCHEMISTRY-US, V55, P4748, DOI 10.1021/acs.biochem.6b00444; Bosse M, 2011, BIOCHEMISTRY-US, V50, P9817, DOI 10.1021/bi201320e; Burkert K, 2017, CHEMMEDCHEM, V12, P75, DOI 10.1002/cmdc.201600433; Casiraghi M, 2016, J AM CHEM SOC, V138, P11170, DOI 10.1021/jacs.6b04432; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Els S, 2010, METHOD ENZYMOL, V485, P103, DOI [10.1016/S0076-6879(10)85006-2, 10.1016/B978-0-12-381296-4.00006-3]; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gerald C, 1996, NATURE, V382, P168, DOI 10.1038/382168a0; Hoffmann S, 1996, REGUL PEPTIDES, V65, P61, DOI 10.1016/0167-0115(96)00073-0; Hohwy M, 1999, J CHEM PHYS, V110, P7983, DOI 10.1063/1.478702; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaiser A, 2015, ANGEW CHEM INT EDIT, V54, P7446, DOI 10.1002/anie.201411688; Keller M, 2016, J MED CHEM, V59, P1925, DOI 10.1021/acs.jmedchem.5b01495; Keller M, 2015, J MED CHEM, V58, P8834, DOI 10.1021/acs.jmedchem.5b00925; Keller M, 2008, J MED CHEM, V51, P8168, DOI 10.1021/jm801018u; Kostenis E, 2001, TRENDS PHARMACOL SCI, V22, P560, DOI 10.1016/S0165-6147(00)01810-1; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; LEIBOWITZ SF, 1988, BRAIN RES BULL, V21, P905, DOI 10.1016/0361-9230(88)90025-1; Lindner D, 2009, CELL SIGNAL, V21, P61, DOI 10.1016/j.cellsig.2008.09.007; MacNeil DJ, 2007, CURR TOP MED CHEM, V7, P1721, DOI 10.2174/156802607782341028; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merten N, 2007, J BIOL CHEM, V282, P7543, DOI 10.1074/jbc.M608902200; Michel MC, 1998, PHARMACOL REV, V50, P143; Morales-Medina JC, 2010, BRAIN RES, V1314, P194, DOI 10.1016/j.brainres.2009.09.077; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pedragosa-Badia X, 2014, J BIOL CHEM, V289, P5846, DOI 10.1074/jbc.M113.502021; Pedragosa-Badia Xavier, 2013, Front Endocrinol (Lausanne), V4, P5, DOI 10.3389/fendo.2013.00005; Poindexter GS, 2002, BIOORG MED CHEM LETT, V12, P379, DOI 10.1016/S0960-894X(01)00761-2; Poindexter GS, 2004, BIOORGAN MED CHEM, V12, P507, DOI 10.1016/j.bmc.2003.10.016; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Raveh B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018934; Reubi JC, 2001, CANCER RES, V61, P4636; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Roth CB, 2008, J MOL BIOL, V376, P1305, DOI 10.1016/j.jmb.2007.12.028; Sautel M, 1996, MOL PHARMACOL, V50, P285; Schmidt P, 2010, BIOPHYS CHEM, V150, P29, DOI 10.1016/j.bpc.2010.02.019; Schwarz D, 2007, NAT PROTOC, V2, P2945, DOI 10.1038/nprot.2007.426; Shihoya W, 2016, NATURE, V537, P363, DOI 10.1038/nature19319; Sjodin P, 2006, BIOCHEM J, V393, P161, DOI 10.1042/BJ20050708; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Sousa DM, 2009, CURR DRUG TARGETS, V10, P9, DOI 10.2174/138945009787122888; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Wilkins MR, 1997, ELECTROPHORESIS, V18, P403, DOI 10.1002/elps.1150180314; Xu B, 2013, BIOCHEMISTRY-US, V52, P7987, DOI 10.1021/bi400830c; Yin J, 2016, NAT STRUCT MOL BIOL, V23, P293, DOI 10.1038/nsmb.3183; Yin J, 2015, NATURE, V519, P247, DOI 10.1038/nature14035; Yulyaningsih E, 2011, BRIT J PHARMACOL, V163, P1170, DOI 10.1111/j.1476-5381.2011.01363.x; Zhang L, 2011, PHARMACOL THERAPEUT, V131, P91, DOI 10.1016/j.pharmthera.2011.03.011	53	75	76	5	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					520	+		10.1038/s41586-018-0046-x	http://dx.doi.org/10.1038/s41586-018-0046-x			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8VX	29670288	Green Accepted			2022-12-28	WOS:000430793000051
J	Oldfield, BJ				Oldfield, Benjamin J.			When You Got the Yams-Kendrick Lamar and the Language of Power in Clinical Encounters	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Oldfield, Benjamin J.] Yale Sch Med, Dept Med, Natl Clinician Scholars Program, New Haven, CT 06520 USA; [Oldfield, Benjamin J.] Yale Sch Med, Dept Pediat, Natl Clinician Scholars Program, New Haven, CT 06520 USA; [Oldfield, Benjamin J.] Fair Haven Community Hlth Care, New Haven, CT USA	Yale University; Yale University	Oldfield, BJ (corresponding author), Yale Sch Med, Dept Med, POB 208088, New Haven, CT 06520 USA.; Oldfield, BJ (corresponding author), Yale Sch Med, Dept Pediat, POB 208088, New Haven, CT 06520 USA.	benjamin.oldfiel@yale.edu		Oldfield, Benjamin/0000-0003-1708-803X				Achebe C., 1959, THINGS FAIL APART; Bourdieu P., 1984, DISTINCTION; Chang Jeff, 2005, CANT STOP WONT STOP; Coscarelli J., 2015, K LAMAR GRAMMYS BLAC; Coulehan J, 2016, JAMA-J AM MED ASSOC, V316, P1340, DOI 10.1001/jama.2016.9536; Kubrin CE, 2014, RACE JUSTICE, V4, P185, DOI 10.1177/2153368714525411; Lowe Z., Z LOWE K LAMAR; Marchalink D., READING NOVELS MED S; Samuels D., THE RAP ON RAP	9	2	2	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2018	319	16					1642	1643		10.1001/jama.2018.3768	http://dx.doi.org/10.1001/jama.2018.3768			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD7RF	29710142				2022-12-28	WOS:000430709300001
J	Banerjee, A; Bernoulli, D; Zhang, HT; Yuen, MF; Liu, JB; Dong, JC; Ding, F; Lu, J; Dao, M; Zhang, WJ; Lu, Y; Suresh, S				Banerjee, Amit; Bernoulli, Daniel; Zhang, Hongti; Yuen, Muk-Fung; Liu, Jiabin; Dong, Jichen; Ding, Feng; Lu, Jian; Dao, Ming; Zhang, Wenjun; Lu, Yang; Suresh, Subra			Ultralarge elastic deformation of nanoscale diamond	SCIENCE			English	Article							STRENGTH; DELIVERY; STRAIN	Diamonds have substantial hardness and durability, but attempting to deform diamonds usually results in brittle fracture. We demonstrate ultralarge, fully reversible elastic deformation of nanoscale (similar to 300 nanometers) single-crystalline and polycrystalline diamond needles. For single-crystalline diamond, the maximum tensile strains (up to 9%) approached the theoretical elastic limit, and the corresponding maximum tensile stress reached similar to 89 to 98 gigapascals. After combining systematic computational simulations and characterization of pre- and postdeformation structural features, we ascribe the concurrent high strength and large elastic strain to the paucity of defects in the small-volume diamond nanoneedles and to the relatively smooth surfaces compared with those of microscale and larger specimens. The discovery offers the potential for new applications through optimized design of diamond nanostructure, geometry, elastic strains, and physical properties.	[Banerjee, Amit; Zhang, Hongti; Liu, Jiabin; Lu, Jian; Lu, Yang] City Univ Hong Kong, Dept Mech & Biomed Engn, Kowloon, Hong Kong, Peoples R China; [Banerjee, Amit; Yuen, Muk-Fung; Zhang, Wenjun; Lu, Yang] City Univ Hong Kong, Ctr Super Diamond & Adv Films COSDAF, Kowloon, Hong Kong, Peoples R China; [Bernoulli, Daniel; Dao, Ming] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Zhang, Hongti; Lu, Jian; Lu, Yang] City Univ Hong Kong, Ctr Adv Struct Mat, Shenzhen Res Inst, Shenzhen 518057, Peoples R China; [Yuen, Muk-Fung; Zhang, Wenjun] City Univ Hong Kong, Dept Mat Sci & Engn, Kowloon, Hong Kong, Peoples R China; [Dong, Jichen; Ding, Feng] Inst Basic Sci IBS, Ctr Multidimens Carbon Mat, Ulsan 44919, South Korea; [Ding, Feng] Ulsan Natl Inst Sci & Technol UNIST, Dept Mat Sci & Engn, Ulsan 44919, South Korea; [Suresh, Subra] Nanyang Technol Univ, Singapore 639798, Singapore	City University of Hong Kong; City University of Hong Kong; Massachusetts Institute of Technology (MIT); City University of Hong Kong; City University of Hong Kong; Institute for Basic Science - Korea (IBS); Ulsan National Institute of Science & Technology (UNIST); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Lu, Y (corresponding author), City Univ Hong Kong, Dept Mech & Biomed Engn, Kowloon, Hong Kong, Peoples R China.; Zhang, WJ; Lu, Y (corresponding author), City Univ Hong Kong, Ctr Super Diamond & Adv Films COSDAF, Kowloon, Hong Kong, Peoples R China.; Dao, M (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.; Lu, Y (corresponding author), City Univ Hong Kong, Ctr Adv Struct Mat, Shenzhen Res Inst, Shenzhen 518057, Peoples R China.; Zhang, WJ (corresponding author), City Univ Hong Kong, Dept Mat Sci & Engn, Kowloon, Hong Kong, Peoples R China.; Suresh, S (corresponding author), Nanyang Technol Univ, Singapore 639798, Singapore.	mingdao@mit.edu; apwjzh@cityu.edu.hk; yanglu@cityu.edu.hk; ssuresh@ntu.edu.sg	Dao, Ming/B-1602-2008; Lu, Yang/D-4972-2011; Suresh, Subra/B-8289-2008; DING, FENG/D-5938-2011; Lu, Jian/C-6044-2013; Liu, Jiabin/GRO-6169-2022; Zhang, Hongti/M-1065-2019; Zhang, WJ/C-6995-2012	Dao, Ming/0000-0001-5372-385X; Lu, Yang/0000-0002-9280-2718; Suresh, Subra/0000-0002-6223-6831; DING, FENG/0000-0001-9153-9279; Lu, Jian/0000-0001-5362-0316; Zhang, WJ/0000-0002-4497-0688; Banerjee, Amit/0000-0001-7775-9400; jiabin, liu/0000-0002-6974-9680; Zhang, Hongti/0000-0002-4051-2655	Research Grants Council of the Hong Kong Special Administrative Region, China [CityU11216515, CityU11207416]; National Natural Science Foundation of China [51301147, 51372213, 51672230]; Singapore-MIT Alliance for Research and Technology (SMART); Shenzhen Science, Technology and Innovation Commission [JSGG20141020103826038]; Advanced Postdoc Mobility fellowship from the Swiss National Science Foundation [P300P2_167604]; IBS of South Korea [IBS-R019-D1]; CityU International Transition Team-Graduate Teaching Assistants scheme (ITT-GTA) postdoctoral fellowship; Nanyang Technological University, Singapore	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Singapore-MIT Alliance for Research and Technology (SMART)(Singapore-MIT Alliance for Research & Technology Centre (SMART)); Shenzhen Science, Technology and Innovation Commission; Advanced Postdoc Mobility fellowship from the Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); IBS of South Korea; CityU International Transition Team-Graduate Teaching Assistants scheme (ITT-GTA) postdoctoral fellowship; Nanyang Technological University, Singapore(Nanyang Technological University)	The work was supported by the Research Grants Council of the Hong Kong Special Administrative Region, China, under the projects CityU11216515 and CityU11207416 and by the National Natural Science Foundation of China under the project 51301147. W.Z. acknowledges the National Natural Science Foundation of China (grants 51372213 and 51672230). M.D. and D.B. acknowledge support by the Singapore-MIT Alliance for Research and Technology (SMART). J.Lu acknowledges support by the Shenzhen Science, Technology and Innovation Commission under grant JSGG20141020103826038. D.B. acknowledges support by the Advanced Postdoc Mobility fellowship from the Swiss National Science Foundation under grant P300P2_167604. J.D. and F.D. acknowledge the support of the IBS of South Korea (grant IBS-R019-D1). A.B. acknowledges a CityU International Transition Team-Graduate Teaching Assistants scheme (ITT-GTA) postdoctoral fellowship. S.S. thanks Nanyang Technological University, Singapore, for support through the Distinguished University Professorship.	Aharonovich I, 2011, NAT PHOTONICS, V5, P397, DOI [10.1038/NPHOTON.2011.54, 10.1038/nphoton.2011.54]; Chen XF, 2017, CHEM SOC REV, V46, P734, DOI 10.1039/c6cs00109b; Dhomkar S, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600911; FENG Z, 1992, J PHYS D APPL PHYS, V25, P1418, DOI 10.1088/0022-3727/25/10/006; Field E.J., 1992, PROPERTIES NATURAL S; Field JE, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/12/126505; Hemley RJ, 1997, SCIENCE, V276, P1242, DOI 10.1126/science.276.5316.1242; Huang Q, 2014, NATURE, V510, P250, DOI 10.1038/nature13381; Khanaliloo B, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041051; Li J, 2014, MRS BULL, V39, P108, DOI 10.1557/mrs.2014.3; Mochalin VN, 2012, NAT NANOTECHNOL, V7, P11, DOI [10.1038/nnano.2011.209, 10.1038/NNANO.2011.209]; Ovartchaiyapong P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5429; Pereira VM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.046801; ROBINSON AL, 1986, SCIENCE, V234, P1074, DOI 10.1126/science.234.4780.1074; SEAL M, 1958, NATURE, V182, P1264, DOI 10.1038/1821264a0; Tanigaki K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3343; Telling RH, 2000, PHYS REV LETT, V84, P5160, DOI 10.1103/PhysRevLett.84.5160; Wang Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5466; Watanabe H, 2009, SCIENCE, V324, P1425, DOI 10.1126/science.1172419; Wheeler JM, 2016, NANO LETT, V16, P812, DOI 10.1021/acs.nanolett.5b04989; Yu DP, 2014, MRS BULL, V39, P157, DOI 10.1557/mrs.2014.6; Zhu T, 2010, PROG MATER SCI, V55, P710, DOI 10.1016/j.pmatsci.2010.04.001; Zhu W, 1998, SCIENCE, V282, P1471, DOI 10.1126/science.282.5393.1471; Zhu XY, 2016, ADV HEALTHC MATER, V5, P1157, DOI 10.1002/adhm.201500990	24	154	159	26	357	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2018	360	6386					300	302		10.1126/science.aar4165	http://dx.doi.org/10.1126/science.aar4165			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD3IC	29674589				2022-12-28	WOS:000430396600039
J	Arshad, J; Sayegh, R				Arshad, Jawad; Sayegh, Rony			Scleral Discoloration from Minocycline Treatment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Arshad, Jawad; Sayegh, Rony] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University	Sayegh, R (corresponding author), Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA.	rrs109@case.edu	Sayegh, Rony/G-8777-2013	Sayegh, Rony/0000-0002-0119-4201					0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2018	378	16					1537	1537		10.1056/NEJMicm1702031	http://dx.doi.org/10.1056/NEJMicm1702031			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GD2EI	29669233				2022-12-28	WOS:000430312500009
J	Friedrich, MJ				Friedrich, M. J.			Urgency to End Newborn Deaths	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2018	319	15					1539	1539		10.1001/jama.2018.4127	http://dx.doi.org/10.1001/jama.2018.4127			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD0UT	29677312				2022-12-28	WOS:000430217100006
J	Goodwins, R				Goodwins, R			We were burning: Japanese entrepreneurs and the forging of the electronic age	NATURE			English	Book Review									IT Week, London E1 9UW, England		Goodwins, R (corresponding author), IT Week, 1 St Kathrines Way, London E1 9UW, England.							JOHNSTONE B, 1998, WE WERE BURNING JAPA	1	1	1	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					401	402		10.1038/17052	http://dx.doi.org/10.1038/17052			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667968	Bronze			2022-12-28	WOS:000078461700035
J	Briggs, JA; Weinreb, C; Wagner, DE; Megason, S; Peshkin, L; Kirschner, MW; Klein, AM				Briggs, James A.; Weinreb, Caleb; Wagner, Daniel E.; Megason, Sean; Peshkin, Leonid; Kirschner, Marc W.; Klein, Allon M.			The dynamics of gene expression in vertebrate embryogenesis at single-cell resolution	SCIENCE			English	Article							MAJOR DEVELOPMENTAL TRANSITION; EARLY XENOPUS-EMBRYOS; STEM-CELLS; LINEAGE COMMITMENT; DIFFERENTIATION; ORIGIN; LAEVIS; FATE; PLURIPOTENCY; ENDODERM		[Briggs, James A.; Weinreb, Caleb; Wagner, Daniel E.; Megason, Sean; Peshkin, Leonid; Kirschner, Marc W.; Klein, Allon M.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kirschner, MW; Klein, AM (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.	marc@hms.harvard.edu; allon_klein@hms.harvard.edu		Wagner, Daniel/0000-0002-2983-635X; Klein, Allon/0000-0001-8913-7879; Peshkin, Leonid/0000-0002-6420-848X	Edward J. Mallinckrodt Foundation Grant; Burroughs Wellcome Fund CASI Award; NIH [5R33CA212697-02, 2R01HD073104-06];  [R21 HD087723]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD087723, R01HD073104] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R33CA212697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080177] Funding Source: NIH RePORTER	Edward J. Mallinckrodt Foundation Grant; Burroughs Wellcome Fund CASI Award(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.M.K was supported by an Edward J. Mallinckrodt Foundation Grant, a Burroughs Wellcome Fund CASI Award, and NIH award 5R33CA212697-02. J.A.B., L.P. and M.W.K were supported by NIH award 2R01HD073104-06. M.W.K was also supported by R21 HD087723.	Achim K, 2015, NAT BIOTECHNOL, V33, P503, DOI 10.1038/nbt.3209; Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Arendt D, 2016, NAT REV GENET, V17, P744, DOI 10.1038/nrg.2016.127; Briggs JA, 2017, ELIFE, V6, DOI 10.7554/eLife.26945; Buitrago-Delgado E, 2015, SCIENCE, V348, P1332, DOI 10.1126/science.aaa3655; Cao JY, 2017, SCIENCE, V357, P661, DOI 10.1126/science.aam8940; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Davis RL, 2000, DEVELOPMENT, V127, P255; FORMAN D, 1980, NATURE, V286, P492, DOI 10.1038/286492a0; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; HEASMAN J, 1984, CELL, V37, P185, DOI 10.1016/0092-8674(84)90314-3; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hontelez S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10148; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Karaiskos N, 2017, SCIENCE, V358, P194, DOI 10.1126/science.aan3235; Karimi K, 2018, NUCLEIC ACIDS RES, V46, pD861, DOI 10.1093/nar/gkx936; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Liu F, 2008, CURR BIOL, V18, P1234, DOI 10.1016/j.cub.2008.07.048; Lubeck E, 2014, NAT METHODS, V11, P360, DOI 10.1038/nmeth.2892; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; Nagasawa T, 2016, ZOOL SCI, V33, P272, DOI 10.2108/zs150183; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schiebinger G., 2017, BIORXIV BETA, DOI [10.1101/191056, DOI 10.1101/191056]; Segerdell E, 2013, J BIOMED SEMANT, V4, DOI 10.1186/2041-1480-4-31; Segerdell E, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-92; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Wagner D. E., 2018, SCIENCE, V360; Walmsley M, 2002, DEVELOPMENT, V129, P5683, DOI 10.1242/dev.00169; Wardle FC, 2004, DEVELOPMENT, V131, P4687, DOI 10.1242/dev.01340; Weber H, 2000, DEVELOPMENT, V127, P4345; Weinreb C, 2018, P NATL ACAD SCI USA, V115, pE2467, DOI 10.1073/pnas.1714723115; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; YASUTOMI M, 1972, J ULTRA MOL STRUCT R, V38, P421, DOI 10.1016/0022-5320(72)90080-9	45	266	269	16	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2018	360	6392					980	+	eaar5780	10.1126/science.aar5780	http://dx.doi.org/10.1126/science.aar5780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6SL	29700227	Green Accepted			2022-12-28	WOS:000433574200033
J	Ding, YL; Sun, TJ; Ao, K; Peng, YJ; Zhang, YX; Li, X; Zhang, YL				Ding, Yuli; Sun, Tongjun; Ao, Kevin; Peng, Yujun; Zhang, Yaxi; Li, Xin; Zhang, Yuelin			Opposite Roles of Salicylic Acid Receptors NPR1 and NPR3/NPR4 in Transcriptional Regulation of Plant Immunity	CELL			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; DEFENSE RESPONSES; ARABIDOPSIS; PROTEIN; GENE; ACTIVATION; INDUCTION; REDUNDANT; FAMILY; INDUCERS	Salicylic acid (SA) is a plant defense hormone required for immunity. Arabidopsis NPR1 and NPR3/NPR4 were previously shown to bind SA and all three proteins were proposed as SA receptors. NPR1 functions as a transcriptional co-activator, whereas NPR3/NPR4 were suggested to function as E3 ligases that promote NPR1 degradation. Here we report that NPR3/NPR4 function as transcriptional co-repressors and SA inhibits their activities to promote the expression of downstream immune regulators. npr4-4D, a gain-of-function npr4 allele that renders NPR4 unable to bind SA, constitutively represses SA-induced immune responses. In contrast, the equivalent mutation in NPR1 abolishes its ability to bind SA and promote SA-induced defense gene expression. Further analysis revealed that NPR3/NPR4 and NPR1 function independently to regulate SA-induced immune responses. Our study indicates that both NPR1 and NPR3/NPR4 are bonafide SA receptors, but play opposite roles in transcriptional regulation of SA-induced defense gene expression.	[Ding, Yuli; Sun, Tongjun; Ao, Kevin; Peng, Yujun; Li, Xin; Zhang, Yuelin] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; [Ao, Kevin; Li, Xin] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Zhang, Yaxi] Natl Inst Biol Sci, Beijing 102206, Peoples R China	University of British Columbia; University of British Columbia; National Institute of Biological Sciences, Beijing	Zhang, YL (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada.	yuelin.zhang@ubc.ca	Sun, Tongjun/AGV-6839-2022; Peng, Yujun/GSJ-1069-2022; Ding, Yuli/AAT-3959-2020	Ding, Yuli/0000-0002-7299-5356; Ao, Kevin/0000-0001-9465-9524; sun, tongjun/0000-0002-0263-3448	Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Dewar Cooper Memorial Fund from UBC	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Dewar Cooper Memorial Fund from UBC	We thank Yuanai Yang (National Institute of Biological Sciences, Beijing) for assistance with the snc2 npr1-1 suppressor screen, Angela Chang (University of British Columbia [UBC]) for assistance with RNA-seq sample preparation, Weijie Huang (UBC), Chunwu Yang (UBC) and Hainan Tian (UBC) for technical assistance, Pingtao Ding (UBC) for the purified anti-TGA2 antibodies, Harry Brumer (UBC) and Louise Creagh (UBC) for suggestions on the analysis of the Kds of NPR1 and NPR4, and Wei Cheng (Sichuan University) for the pLou3 vector. We are grateful for the financial support to Y.Z. and X.L. from the Natural Sciences and Engineering Research Council of Canada, Canada Foundation for Innovation and Dewar Cooper Memorial Fund from UBC.	Bi DL, 2010, PLANT PHYSIOL, V153, P1771, DOI 10.1104/pp.110.158501; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Cecchini NM, 2015, MOL PLANT MICROBE IN, V28, P455, DOI 10.1094/MPMI-06-14-0187-R; DELANEY TP, 1995, P NATL ACAD SCI USA, V92, P6602, DOI 10.1073/pnas.92.14.6602; Despres C, 2000, PLANT CELL, V12, P279, DOI 10.1105/tpc.12.2.279; Fan WH, 2002, PLANT CELL, V14, P1377, DOI 10.1105/tpc.001628; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Gao MH, 2009, CELL HOST MICROBE, V6, P34, DOI 10.1016/j.chom.2009.05.019; Gorlach J, 1996, PLANT CELL, V8, P629, DOI 10.1105/tpc.8.4.629; Grant JJ, 2003, MOL PLANT MICROBE IN, V16, P669, DOI 10.1094/MPMI.2003.16.8.669; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Klessig DF, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00206; KOHALMI SE, 1997, DIFFERENTIALLY EXPRE, P63; Kong Q, 2016, PLANT PHYSIOL, V171, P1344, DOI 10.1104/pp.15.01954; Kuai XHZ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00235; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Manohar M, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00777; Metraux J. P., 1991, Advances in molecular genetics of plant-microbe interactions. Vol. 1. Proceedings of the 5th international symposium on the molecular genetics of plant-microbe interactions, Interlaken, Switzerland, September 9-14, 1990., P432; Ohta M, 2001, PLANT CELL, V13, P1959, DOI 10.1105/tpc.13.8.1959; Rochon A, 2006, PLANT CELL, V18, P3670, DOI 10.1105/tpc.106.046953; Tiwari Shiv, 2006, V323, P237; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang L, 2011, PLANT J, V67, P1029, DOI 10.1111/j.1365-313X.2011.04655.x; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Wu Y, 2012, CELL REPORTS, V1, P639, DOI 10.1016/j.celrep.2012.05.008; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang YX, 2010, PLANT CELL, V22, P3153, DOI 10.1105/tpc.110.074120; Zhang YX, 2010, P NATL ACAD SCI USA, V107, P18220, DOI 10.1073/pnas.1005225107; Zhang YL, 2003, PLANT CELL, V15, P2647, DOI 10.1105/tpc.014894; Zhang YL, 1999, P NATL ACAD SCI USA, V96, P6523, DOI 10.1073/pnas.96.11.6523; Zhang YL, 2006, PLANT J, V48, P647, DOI 10.1111/j.1365-313X.2006.02903.x; Zhou JM, 2000, MOL PLANT MICROBE IN, V13, P191, DOI 10.1094/MPMI.2000.13.2.191	41	283	297	41	236	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2018	173	6					1454	+		10.1016/j.cell.2018.03.044	http://dx.doi.org/10.1016/j.cell.2018.03.044			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GH9KU	29656896	Bronze			2022-12-28	WOS:000433989100017
J	Maharana, S; Wang, J; Papadopoulos, DK; Richter, D; Pozniakovsky, A; Poser, I; Bickle, M; Rizk, S; Guillen-Boixet, J; Franzmann, TM; Jahnel, M; Marrone, L; Chang, YT; Sterneckert, J; Tomancak, P; Hyman, AA; Alberti, S				Maharana, Shovamayee; Wang, Jie; Papadopoulos, Dimitrios K.; Richter, Doris; Pozniakovsky, Andrey; Poser, Ina; Bickle, Marc; Rizk, Sandra; Guillen-Boixet, Jordina; Franzmann, Titus M.; Jahnel, Marcus; Marrone, Lara; Chang, Young-Tae; Sterneckert, Jared; Tomancak, Pavel; Hyman, Anthony A.; Alberti, Simon			RNA buffers the phase separation behavior of prion-like RNA binding proteins	SCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FUS MUTATIONS; TOXIC GAIN; TDP-43; ALS; TRANSITION; DEGENERATION; MECHANISM; DOMAINS; DISEASE	Prion-like RNA binding proteins (RBPs) such as TDP43 and FUS are largely soluble in the nucleus but form solid pathological aggregates when mislocalized to the cytoplasm. What keeps these proteins soluble in the nucleus and promotes aggregation in the cytoplasm is still unknown. We report here that RNAcritically regulates the phase behavior of prion-like RBPs. Low RNA/protein ratios promote phase separation into liquid droplets, whereas high ratios prevent droplet formation in vitro. Reduction of nuclear RNA levels or genetic ablation of RNA binding causes excessive phase separation and the formation of cytotoxic solid-like assemblies in cells. We propose that the nucleus is a buffered system in which high RNA concentrations keep RBPs soluble. Changes in RNA levels or RNA binding abilities of RBPs cause aberrant phase transitions.	[Maharana, Shovamayee; Wang, Jie; Papadopoulos, Dimitrios K.; Richter, Doris; Pozniakovsky, Andrey; Poser, Ina; Bickle, Marc; Rizk, Sandra; Guillen-Boixet, Jordina; Franzmann, Titus M.; Jahnel, Marcus; Tomancak, Pavel; Hyman, Anthony A.; Alberti, Simon] Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany; [Papadopoulos, Dimitrios K.] Univ Edinburgh, MRC Human Genet Unit, Inst Genet & Mol Med, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland; [Rizk, Sandra] Tech Univ Dresden, Cube Ctr Mol Bioengn B, Arnoldstr 18, D-01307 Dresden, Germany; [Jahnel, Marcus] Tech Univ Dresden, Ctr Biotechnol, Tatzberg 47-49, D-01307 Dresden, Germany; [Marrone, Lara; Sterneckert, Jared] Tech Univ Dresden, CMCB, DFG Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany; [Chang, Young-Tae] Inst for Basic Sci Korea, Ctr Self Assembly & Complex, Pohang 37673, South Korea; [Chang, Young-Tae] Pohang Univ Sci & Technol POSTECH, Dept Chem, Pohang 37673, South Korea	Max Planck Society; University of Edinburgh; Technische Universitat Dresden; Technische Universitat Dresden; German Research Foundation (DFG); Technische Universitat Dresden; Institute for Basic Science - Korea (IBS); Pohang University of Science & Technology (POSTECH)	Hyman, AA; Alberti, S (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	hyman@mpi-cbg.de; alberti@mpi-cbg.de	Franzmann, Titus M/D-1962-2011; Chang, Young-Tae/B-2780-2010; Hyman, Tony/F-1923-2011; Papadopoulos, Dimitrios/AAU-4751-2021; Tomancak, Pavel/C-2109-2009; Guillen-Boixet, Jordina/AAE-1920-2021; Alberti, Simon/ABB-8277-2021; Alberti, Simon/B-2822-2017; Wang, Jie/H-3367-2014	Chang, Young-Tae/0000-0002-1927-3688; Papadopoulos, Dimitrios/0000-0003-0914-3051; Tomancak, Pavel/0000-0002-2222-9370; Guillen-Boixet, Jordina/0000-0003-4777-8031; Alberti, Simon/0000-0003-4017-6505; Bickle, Marc/0000-0002-8918-1869; Maharana, Shovamayee/0000-0003-3909-9151; Sterneckert, Jared/0000-0002-7688-3124; Rizk, Sandra/0000-0002-5022-2539; Wang, Jie/0000-0002-4673-9025; Jahnel, Marcus/0000-0002-8355-277X; Poser, Ina/0000-0002-9108-1592; Franzmann, Titus/0000-0002-4281-7209	Max Planck Society; ERC [725836, 643417]; BMBF [01ED1601A, 031A359A]; JPND (CureALS); Humboldt Foundation [3.5-INI/1155756 STP]; Hans und Ilse Breuer Stiftung; EMBO fellowship [ALTF 406-2017]	Max Planck Society(Max Planck SocietyFoundation CELLEX); ERC(European Research Council (ERC)European Commission); BMBF(Federal Ministry of Education & Research (BMBF)); JPND (CureALS); Humboldt Foundation(Alexander von Humboldt Foundation); Hans und Ilse Breuer Stiftung; EMBO fellowship(European Molecular Biology Organization (EMBO))	We acknowledge funding from the Max Planck Society, the ERC (nos. 725836 and 643417), the BMBF (01ED1601A and 031A359A), and the JPND (CureALS). S.M. was supported by a fellowship of the Humboldt Foundation (3.5-INI/1155756 STP), L.M. by the Hans und Ilse Breuer Stiftung, and J.G.-B. by an EMBO fellowship (ALTF 406-2017).	Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Berry J, 2015, P NATL ACAD SCI USA, V112, pE5237, DOI 10.1073/pnas.1509317112; Deng H, 2014, NAT REV NEUROL, V10, P337, DOI 10.1038/nrneurol.2014.78; Diaper DC, 2013, HUM MOL GENET, V22, P1539, DOI 10.1093/hmg/ddt005; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Fox AH, 2018, TRENDS BIOCHEM SCI, V43, P124, DOI 10.1016/j.tibs.2017.12.001; Huang YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073890; Ishiguro T, 2017, NEURON, V94, P108, DOI 10.1016/j.neuron.2017.02.046; Kitamura A, 2016, SCI REP-UK, V6, DOI 10.1038/srep19230; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Li Q, 2006, CHEM BIOL, V13, P615, DOI 10.1016/j.chembiol.2006.04.007; March ZM, 2016, BRAIN RES, V1647, P9, DOI 10.1016/j.brainres.2016.02.037; Mateju D, 2017, EMBO J, V36, P1669, DOI 10.15252/embj.201695957; Modigliani SD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5335; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Sabatelli M, 2013, HUM MOL GENET, V22, P4748, DOI 10.1093/hmg/ddt328; Saha S, 2016, CELL, V166, P1572, DOI 10.1016/j.cell.2016.08.006; Scekic-Zahirovic J, 2016, EMBO J, V35, P1077, DOI 10.15252/embj.201592559; Shang YL, 2016, BRAIN RES, V1647, P65, DOI 10.1016/j.brainres.2016.03.036; Sharma A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10465; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017	31	487	486	15	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391					918	921		10.1126/science.aar7366	http://dx.doi.org/10.1126/science.aar7366			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG9RW	29650702	Green Accepted, Bronze			2022-12-28	WOS:000433039800051
J	Darnall, B				Darnall, Beth			To treat pain, study people in all their complexity	NATURE			English	Editorial Material									[Darnall, Beth] Stanford Univ Calif, Dept Anesthesiol Perioperat & Pain Med, Stanford, CA 94305 USA		Darnall, B (corresponding author), Stanford Univ Calif, Dept Anesthesiol Perioperat & Pain Med, Stanford, CA 94305 USA.			Darnall, Beth D./0000-0003-3590-511X					0	14	15	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2018	557	7703					7	7		10.1038/d41586-018-04994-5	http://dx.doi.org/10.1038/d41586-018-04994-5			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE5BW	29717254	Bronze			2022-12-28	WOS:000431234500004
J	Voelker, R				Voelker, Rebecca			Progress in Lead Test Investigation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2018	319	17					1758	1758		10.1001/jama.2018.4938	http://dx.doi.org/10.1001/jama.2018.4938			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GE3UQ	29715341				2022-12-28	WOS:000431138800007
J	Hughes, TP; Kerry, JT; Baird, AH; Connolly, SR; Dietzel, A; Eakin, CM; Heron, SF; Hoey, AS; Hoogenboom, MO; Liu, G; McWilliam, MJ; Pears, RJ; Pratchett, MS; Skirving, WJ; Stella, JS; Torda, G				Hughes, Terry P.; Kerry, James T.; Baird, Andrew H.; Connolly, Sean R.; Dietzel, Andreas; Eakin, C. Mark; Heron, Scott F.; Hoey, Andrew S.; Hoogenboom, Mia O.; Liu, Gang; McWilliam, Michael J.; Pears, Rachel J.; Pratchett, Morgan S.; Skirving, William J.; Stella, Jessica S.; Torda, Gergely			Global warming transforms coral reef assemblages	NATURE			English	Article							CLIMATE-CHANGE; RECOVERY; IMPACTS	Global warming is rapidly emerging as a universal threat to ecological integrity and function, highlighting the urgent need for a better understanding of the impact of heat exposure on the resilience of ecosystems and the people who depend on them(1). Here we show that in the aftermath of the record-breaking marine heatwave on the Great Barrier Reef in 2016(2), corals began to die immediately on reefs where the accumulated heat exposure exceeded a critical threshold of degree heating weeks, which was 3-4 degrees C-weeks. After eight months, an exposure of 6 degrees C-weeks or more drove an unprecedented, regional-scale shift in the composition of coral assemblages, reflecting markedly divergent responses to heat stress by different taxa. Fast-growing staghorn and tabular corals suffered a catastrophic die-off, transforming the three-dimensionality and ecological functioning of 29% of the 3,863 reefs comprising the world's largest coral reef system. Our study bridges the gap between the theory and practice of assessing the risk of ecosystem collapse, under the emerging framework for the International Union for Conservation of Nature (IUCN) Red List of Ecosystems(3), by rigorously defining both the initial and collapsed states, identifying the major driver of change, and establishing quantitative collapse thresholds. The increasing prevalence of post-bleaching mass mortality of corals represents a radical shift in the disturbance regimes of tropical reefs, both adding to and far exceeding the influence of recurrent cyclones and other local pulse events, presenting a fundamental challenge to the long-term future of these iconic ecosystems.	[Hughes, Terry P.; Kerry, James T.; Baird, Andrew H.; Connolly, Sean R.; Dietzel, Andreas; Hoey, Andrew S.; Hoogenboom, Mia O.; McWilliam, Michael J.; Pratchett, Morgan S.; Torda, Gergely] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld, Australia; [Connolly, Sean R.; Hoogenboom, Mia O.] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; [Eakin, C. Mark; Heron, Scott F.; Liu, Gang; Skirving, William J.] NOAA, Coral Reef Watch, College Pk, MD USA; [Heron, Scott F.; Liu, Gang; Skirving, William J.] Global Sci & Technol Inc, Greenbelt, MD USA; [Heron, Scott F.] James Cook Univ, Marine Geophys Lab, Phys Dept, Townsville, Qld, Australia; [Pears, Rachel J.; Stella, Jessica S.] Great Barrier Reef Marine Pk Author, Townsville, Qld, Australia; [Torda, Gergely] Australian Inst Marine Sci, Townsville, Qld, Australia	James Cook University; James Cook University; National Oceanic Atmospheric Admin (NOAA) - USA; National Aeronautics & Space Administration (NASA); James Cook University; Australian Institute of Marine Science	Hughes, TP (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld, Australia.	terry.hughes@jcu.edu.au	McWilliam, Mike/AAB-1179-2019; Pratchett, Morgan/AAW-5179-2020; Heron, Scott F/E-7928-2011; Hoogenboom, Mia O/D-3664-2012; Torda, Gergely/ABE-6400-2020; Liu, Gang/E-7921-2011; Baird, Andrew Hamilton/C-8449-2009; Torda, Gergely/ABE-6388-2020; Hoey, Andrew S/B-5457-2015; Eakin, C. Mark/F-5585-2010; Skirving, William/E-7927-2011; Hughes, Terry/L-4721-2013	Pratchett, Morgan/0000-0002-1862-8459; Hoogenboom, Mia O/0000-0003-3709-6344; Torda, Gergely/0000-0002-4585-3045; Baird, Andrew Hamilton/0000-0001-8504-4077; Eakin, C. Mark/0000-0002-5987-0858; Pears, Rachel/0000-0001-8092-0365; McWilliam, Mike/0000-0001-5748-0859; Skirving, William/0000-0003-0167-6427; Hughes, Terry/0000-0002-5257-5063; Heron, Scott/0000-0001-5262-6978; Hoey, Andrew/0000-0002-4261-5594	Australian Research Council Centre of Excellence Program; Australian Research Council Laureate Fellowship; Great Barrier Reef Marine Park Authority; US National Oceanic and Atmospheric Administration	Australian Research Council Centre of Excellence Program(Australian Research Council); Australian Research Council Laureate Fellowship(Australian Research Council); Great Barrier Reef Marine Park Authority; US National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	We acknowledge support from the Australian Research Council's Centre of Excellence Program and a Laureate Fellowship to T.P.H., from the Great Barrier Reef Marine Park Authority, and from the US National Oceanic and Atmospheric Administration. The scientific results and conclusions, as well as any views or opinions expressed herein, are those of the authors and do not necessarily reflect the views of NOAA or the US Department of Commerce. We thank T. Simpson, who provided 225 aerial scores of bleaching from the Torres Strait; M. Jacobson for assistance with statistical programming; members of the Australian National Coral Bleaching Taskforce, marine park managers and rangers, and 30 student volunteers, who participated in extensive field studies on the Great Barrier Reef throughout 2016.	Australian Bureau of Meteorology, 2016, 2016 MAR HEATW GREAT; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Beeden R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121272; Bland LM, 2018, FRONT ECOL ENVIRON, V16, P29, DOI 10.1002/fee.1747; Donner SD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175490; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Great Barrier Reef Marine Park Authority, 2017, FIN REP 2016 COR BLE; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; Heron S. F., SCI REP, V6, P38402; Hock K, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003355; Hughes T., 2017, CONVERSATION; Hughes TP, 2018, ECOLOGY, V99, P501, DOI 10.1002/ecy.2092; Hughes TP, 2018, SCIENCE, V359, P80, DOI 10.1126/science.aan8048; Hughes TP, 2017, NATURE, V546, P82, DOI 10.1038/nature22901; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kayanne H, 2002, MAR ECOL PROG SER, V239, P93, DOI 10.3354/meps239093; Kayanne H, 2017, CORAL REEFS, V36, P63, DOI 10.1007/s00338-016-1524-y; Liu G, 2014, REMOTE SENS-BASEL, V6, P11579, DOI 10.3390/rs61111579; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Madin JS, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.17; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Muller EM, 2008, CORAL REEFS, V27, P191, DOI 10.1007/s00338-007-0310-2; Swain TD, 2016, GLOBAL CHANGE BIOL, V22, P2475, DOI 10.1111/gcb.13276; Webster NS, 2011, ISME J, V5, P759, DOI 10.1038/ismej.2010.152	29	764	776	91	983	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					492	+		10.1038/s41586-018-0041-2	http://dx.doi.org/10.1038/s41586-018-0041-2			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8VX	29670282				2022-12-28	WOS:000430793000045
J	O'Sullivan, DM; Linnane, B				O'Sullivan, Donnchadh Martin; Linnane, Barry			Recurrent haemoptysis in a child with advanced cystic fibrosis lung disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[O'Sullivan, Donnchadh Martin; Linnane, Barry] Univ Hosp Limerick, Dept Paediat, Limerick, Ireland; [Linnane, Barry] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland; [Linnane, Barry] Univ Limerick, Ctr Intervent Infect Inflammat & Immun, Limerick, Ireland; [Linnane, Barry] Natl Childrens Res Ctr, Dublin, Ireland	University of Limerick; University of Limerick; University of Limerick; National Children's Research Centre (NCRC); Trinity College Dublin	O'Sullivan, DM (corresponding author), Univ Hosp Limerick, Dept Paediat, Limerick, Ireland.	dosullivan373@gmail.com						Barben Juerg U, 2003, J Cyst Fibros, V2, P105, DOI 10.1016/S1569-1993(03)00066-3; Flume PA, 2010, AM J RESP CRIT CARE, V182, P298, DOI 10.1164/rccm.201002-0157CI; Oh THT, 2013, AM J RESP CRIT CARE, V188, P517, DOI 10.1164/rccm.201210-1823CR; Panda A, 2017, DIAGN INTERV RADIOL, V23, P307, DOI 10.5152/dir.2017.16454	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2018	361								k1142	10.1136/bmj.k1142	http://dx.doi.org/10.1136/bmj.k1142			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF4WE	29700166				2022-12-28	WOS:000431963800001
J	Ng, DHC; Embleton, ND; McGuire, W				Ng, Derek H. C.; Embleton, Nicholas D.; McGuire, William			Hydrolyzed Formula Compared With Standard Formula for Preterm Infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								CLINICAL QUESTION For preterm infants, is hydrolyzed formula associated with lower rates of feeding intolerance, lower rates of necrotizing enterocolitis, and faster rates of growth compared with standard cow's milk formula?& para;& para;BOTTOM LINE Compared with standard formula, feeding preterm infants hydrolyzed formula is not associated with a lower rate of feeding intolerance, a lower rate of necrotizing enterocolitis, or with faster growth.	[Ng, Derek H. C.; McGuire, William] Univ York, Ctr Reviews & Disseminat, York, N Yorkshire, England; [Embleton, Nicholas D.] Newcastle Hosp NHS Fdn Trust, Neonatal Serv, Newcastle, England; [Embleton, Nicholas D.] Univ Newcastle, Newcastle, England	University of York - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK	McGuire, W (corresponding author), Univ York, Ctr Reviews & Disseminat, Heslington YO41 4AD, England.	william.mcguire@york.ac.uk	; Embleton, Nicholas/D-4905-2011	McGuire, William/0000-0001-8572-3467; Embleton, Nicholas/0000-0003-3750-5566				Agostoni C, 2010, J PEDIATR GASTR NUTR, V50, P85, DOI 10.1097/MPG.0b013e3181adaee0; Morgan JA, 2011, CURR OPIN INFECT DIS, V24, P183, DOI 10.1097/QCO.0b013e328345d5b5; Ng DHC, 2017, COCHRANE DB SYST REV, V10; Zuppa AA, 2005, ACTA PAEDIATR, V94, P84, DOI 10.1080/08035320510043600	4	6	6	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2018	319	16					1717	+		10.1001/jama.2018.3623	http://dx.doi.org/10.1001/jama.2018.3623			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD7RF	29710147				2022-12-28	WOS:000430709300026
J	Chhabra, A				Chhabra, Arnav			Academia's forgotten footnote	SCIENCE			English	Editorial Material								In my third year of grad school, everything seemed to fall apart. I was dealing with my grandmother's death, and then my girlfriend and I broke up. I spent the following year in a painful feedback loop of depression and despair. Every day, I would trudge into lab and try to get excited about my projects. But when I encountered minor hurdles such as a failed replication or contaminated samples, I would become discouraged and give up. Even when my experiments went smoothly, I felt guilty about the time I had wasted being unproductive. I knew I was struggling, but I didn't ask for help. I thought I could deal with my state of mind just as I had dealt with every other problem in my life: Bottle up my emotions, attack the problem with logic, and iterate until I arrived at a solution.	[Chhabra, Arnav] Harvard MIT Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University	Chhabra, A (corresponding author), Harvard MIT Hlth Sci & Technol, Cambridge, MA 02139 USA.								0	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2018	360	6386					350	350		10.1126/science.360.6386.350	http://dx.doi.org/10.1126/science.360.6386.350			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD3IC	29674597				2022-12-28	WOS:000430396600050
J	Hovenden, M; Newton, P				Hovenden, Mark; Newton, Paul			Plant responses to CO2 are a question of time	SCIENCE			English	Editorial Material							ELEVATED CO2; C-4		[Hovenden, Mark] Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia; [Newton, Paul] AgRes Grasslands, Land & Environm Management, Palmerston North, New Zealand	University of Tasmania; AgResearch - New Zealand	Hovenden, M (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia.	mark.hovenden@utas.edu.au	Hovenden, Mark/A-1323-2008	Hovenden, Mark/0000-0001-7208-9700				HATCH MD, 1966, BIOCHEM J, V101, P103, DOI 10.1042/bj1010103; Holm L. G., 1977, WORLDS WORST WEEDS D; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; McMurtrie RE, 2008, FUNCT PLANT BIOL, V35, P521, DOI 10.1071/FP08128; Reich PB, 2018, SCIENCE, V360, P317, DOI 10.1126/science.aas9313; Sage R. F., 2017, J EXP BOT, V68, pe11; Sage RF, 2003, PHOTOSYNTH RES, V77, P209, DOI 10.1023/A:1025882003661; Sage RF, 2015, J PLANT PHYSIOL, V172, P104, DOI 10.1016/j.jplph.2014.07.024; Wedin D. A., 2004, WARM SEAS C4 GRASSES, V45, P15	9	13	14	5	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2018	360	6386					263	264		10.1126/science.aat2481	http://dx.doi.org/10.1126/science.aat2481			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD3IC	29674577				2022-12-28	WOS:000430396600022
J	Guo, L; Kim, HJ; Wang, HJ; Monaghan, J; Freyermuth, F; Sung, JC; O'Donovan, K; Fare, CM; Diaz, Z; Singh, N; Zhang, ZC; Coughlin, M; Sweeny, EA; DeSantis, ME; Jackrel, ME; Rodell, CB; Burdick, JA; King, OD; Gitler, AD; Lagier-Tourenne, C; Pandey, UB; Chook, YM; Taylor, JP; Shorter, J				Guo, Lin; Kim, Hong Joo; Wang, Hejia; Monaghan, John; Freyermuth, Fernande; Sung, Julie C.; O'Donovan, Kevin; Fare, Charlotte M.; Diaz, Zamia; Singh, Nikita; Zhang, Zi Chao; Coughlin, Maura; Sweeny, Elizabeth A.; DeSantis, Morgan E.; Jackrel, Meredith E.; Rodell, Christopher B.; Burdick, Jason A.; King, Oliver D.; Gitler, Aaron D.; Lagier-Tourenne, Clotilde; Pandey, Udai Bhan; Chook, Yuh Min; Taylor, J. Paul; Shorter, James			Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains	CELL			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NUCLEOCYTOPLASMIC TRANSPORT; ALZHEIMERS-DISEASE; LINKED MUTATIONS; LIQUID DROPLETS; FUS; ALS; SEPARATION; AGGREGATION; TDP-43	RNA-binding proteins (RBPs) with prion-like domains (PrLDs) phase transition to functional liquids, which can mature into aberrant hydrogels composed of pathological fibrils thatunderpin fatal neurodegenerative disorders. Several nuclear RBPs with PrLDs, including TDP-43, FUS, hnRNPA1, and hnRNPA2, mislocalize to cytoplasmic inclusions in neurodegenerative disorders, and mutations in their PrLDs can accelerate fibrillization and cause disease. Here, we establish that nuclear-import receptors (NIRs) specifically chaperone and potently disaggregate wild-type and disease-linked RBPs bearing a NLS. Karyopherin-b2 (also called Transportin-1) engages PY-NLSs to inhibit and reverse FUS, TAF15, EWSR1, hnRNPA1, and hnRNPA2 fibrillization, whereas Importin-a plus Karyopherin-b1 prevent and reverse TDP-43 fibrillization. Remarkably, Karyopherin-b2 dissolves phase-separated liquids and aberrant fibrillar hydrogels formed by FUS and hnRNPA1. In vivo, Karyopherin-b2 prevents RBPs with PY-NLSs accumulating in stress granules, restores nuclear RBPlocalization and function, and rescues degeneration caused by disease-linked FUS and hnRNPA2. Thus, NIRs therapeutically restore RBP homeostasis and mitigate neurodegeneration.	[Guo, Lin; Wang, Hejia; Sung, Julie C.; Fare, Charlotte M.; Diaz, Zamia; Singh, Nikita; Sweeny, Elizabeth A.; DeSantis, Morgan E.; Jackrel, Meredith E.; Shorter, James] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kim, Hong Joo; O'Donovan, Kevin; Coughlin, Maura; Taylor, J. Paul] St Jude Childrens Res Hosp, Dept Cell & Mol Biol, Memphis, TN 38120 USA; [Monaghan, John; Pandey, Udai Bhan] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat Child Neurol & Neurobiol, Pittsburgh, PA 15224 USA; [Freyermuth, Fernande; Lagier-Tourenne, Clotilde] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Freyermuth, Fernande; Lagier-Tourenne, Clotilde] Broad Inst Harvard Univ & MIT, Cambridge, MA 02142 USA; [Zhang, Zi Chao; Chook, Yuh Min] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Zhang, Zi Chao] Southeast Univ, Inst Life Sci, Nanjing 210096, Jiangsu, Peoples R China; [Rodell, Christopher B.; Burdick, Jason A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [King, Oliver D.] Univ Massachusetts, Med Sch, Dept Neurol, Worcester, MA 01655 USA; [Gitler, Aaron D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Taylor, J. Paul] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Monaghan, John] Trinity Coll Dublin, Sch Med, Dublin, Ireland	University of Pennsylvania; Pennsylvania Medicine; St Jude Children's Research Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Southeast University - China; University of Pennsylvania; University of Massachusetts System; University of Massachusetts Worcester; Stanford University; Howard Hughes Medical Institute; Trinity College Dublin	Shorter, J (corresponding author), Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA.; Taylor, JP (corresponding author), St Jude Childrens Res Hosp, Dept Cell & Mol Biol, Memphis, TN 38120 USA.; Taylor, JP (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	jpaul.taylor@stjude.org; jshorter@pennmedicine.upenn.edu	lagier-Tourenne, Clotilde/ABE-6303-2020; Chook, Yuh Min/AAA-9549-2019; Shorter, James/ABE-7307-2020	lagier-Tourenne, Clotilde/0000-0002-3058-8322; Shorter, James/0000-0001-5269-8533; Kim, Hong Joo/0000-0002-9157-1612; Wang, Hejia/0000-0003-1836-7567; Sweeny, Elizabeth/0000-0001-7818-9112; Gitler, Aaron/0000-0001-8603-1526; Jackrel, Meredith/0000-0003-4406-9504	EMF/AFAR fellowship; AARF fellowship; ALSA Milton Safenowitz fellowship; MGH ECOR Tosteson fellowship; AHA fellowships; NIH [T32GM008275, T32GM071339, F31NS079009, R01NS081303, R21NS100055, R21NS094921, R35NS097263, R01NS087227, R01GM069909, R35NS097974, R21NS090205, R01GM099836]; Target ALS; Welch Foundation; UTSW Endowed Scholars Program; HHMI; ALS FindingACure; ALSAC; ALSA; MDA; Packard Center for ALS Research; NATIONAL CANCER INSTITUTE [T32CA079443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071339, R01GM069909, R01GM099836, T32GM008275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087227, R35NS097974, R35NS097263, F31NS079009, R21NS090205, R21NS100055, R01NS081303, R21NS094921] Funding Source: NIH RePORTER	EMF/AFAR fellowship; AARF fellowship; ALSA Milton Safenowitz fellowship; MGH ECOR Tosteson fellowship; AHA fellowships(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Target ALS; Welch Foundation(The Welch Foundation); UTSW Endowed Scholars Program; HHMI(Howard Hughes Medical Institute); ALS FindingACure; ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); ALSA; MDA(Muscular Dystrophy Association); Packard Center for ALS Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dorothee Dormann, Mike Rosen, Richard Wheeler, Nancy Bonini, and Ben Black for suggestions and support, and we thank Philip Van Damme, Gideon Dreyfuss, Greg Petsko, and Steve McKnight for reagents. Our work was supported by an EMF/AFAR fellowship (L.G.), an AARF fellowship (L.G.), an ALSA Milton Safenowitz fellowship (F.F.), a MGH ECOR Tosteson fellowship (F.F.), AHA fellowships (E.A.S., M.E.J., and C.B.R), NIH grants T32GM008275 (E.A.S.), T32GM071339 (M.E.D.S.), F31NS079009 (M.E.D.S.), R01NS081303 (U.B.P.), R21NS100055 (U.B.P.), R21NS094921 (U.B.P.), R35NS097263 (A.D.G.), R01NS087227 (C.L.-T.), R01GM069909 (Y.M.C.), R35NS097974 (J.P.T.), R21NS090205 (J.S.), R01GM099836 (J.S.), Target ALS (L.G., M.E.J., C.L.-T., J.P.T., and J.S), the Welch Foundation (Y.M.C.), UTSW Endowed Scholars Program (Y.M.C.), HHMI (J.P.T.), ALS FindingACure (C.L.-T.), ALSAC (J.P.T.), ALSA (J.S.), MDA (J.S.), and the Packard Center for ALS Research (J.P.T. and J.S.).	Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Chou CC, 2018, NAT NEUROSCI, V21, P228, DOI 10.1038/s41593-017-0047-3; Couthouis J, 2012, HUM MOL GENET, V21, P2899, DOI 10.1093/hmg/dds116; Couthouis J, 2011, P NATL ACAD SCI USA, V108, P20881, DOI 10.1073/pnas.1109434108; Daigle JG, 2013, HUM MOL GENET, V22, P1193, DOI 10.1093/hmg/dds526; Franzmann TM, 2018, SCIENCE, V359, P47, DOI 10.1126/science.aao5654; Harrison AF, 2017, BIOCHEM J, V474, P1417, DOI 10.1042/BCJ20160499; Hofweber M, 2018, CELL, V173, P706, DOI 10.1016/j.cell.2018.03.004; Jackrel ME, 2014, CELL, V156, P170, DOI 10.1016/j.cell.2013.11.047; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Jaru-Ampornpan P, 2010, NAT STRUCT MOL BIOL, V17, P696, DOI 10.1038/nsmb.1836; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Ju SL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001052; Kim HJ, 2017, NEURON, V96, P285, DOI 10.1016/j.neuron.2017.07.029; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kim YH, 2015, NAT PROTOC, V10, P985, DOI 10.1038/nprot.2015.065; Lanson NA, 2011, HUM MOL GENET, V20, P2510, DOI 10.1093/hmg/ddr150; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; March ZM, 2016, BRAIN RES, V1647, P9, DOI 10.1016/j.brainres.2016.02.037; Milles S, 2013, EMBO REP, V14, P178, DOI 10.1038/embor.2012.204; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Monahan Z, 2017, EMBO J, V36, P2951, DOI 10.15252/embj.201696394; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rodell CB, 2013, BIOMACROMOLECULES, V14, P4125, DOI 10.1021/bm401280z; Schmidt HB, 2016, TRENDS BIOCHEM SCI, V41, P46, DOI 10.1016/j.tibs.2015.11.001; Shorter J, 2016, MOL BIOL CELL, V27, P1556, DOI 10.1091/mbc.E15-10-0693; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang WY, 2013, NAT NEUROSCI, V16, P1383, DOI 10.1038/nn.3514; Xiang SH, 2015, CELL, V163, P829, DOI 10.1016/j.cell.2015.10.040; Yoshizawa T, 2018, CELL, V173, P693, DOI 10.1016/j.cell.2018.03.003; Zhang ZC, 2012, P NATL ACAD SCI USA, V109, P12017, DOI 10.1073/pnas.1207247109; Zhang ZC, 2011, MOL BIOL CELL, V22, P4657, DOI 10.1091/mbc.E11-03-0222	38	243	247	6	90	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2018	173	3					677	+		10.1016/j.cell.2018.03.002	http://dx.doi.org/10.1016/j.cell.2018.03.002			36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7GB	29677512	Green Accepted, Bronze			2022-12-28	WOS:000430677400017
J	Kahwati, LC; Weber, RP; Pan, HL; Gourlay, M; LeBlanc, E; Coker-Schwimmer, M; Viswanathan, M				Kahwati, Leila C.; Weber, Rachel Palmieri; Pan, Huiling; Gourlay, Margaret; LeBlanc, Erin; Coker-Schwimmer, Manny; Viswanathan, Meera			Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							NON-VERTEBRAL FRACTURES; POSTMENOPAUSAL WOMEN; CLINICAL-TRIAL; DOUBLE-BLIND; BONE LOSS; RISK; CANCER; METAANALYSIS; SECONDARY; MEN	IMPORTANCE Osteoporotic fractures result in significant morbidity and mortality. OBJECTIVE To update the evidence for benefits and harms of vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults to inform the US Preventive Services Task Force. DATA SOURCES PubMed, EMBASE, Cochrane Library, and trial registries through March 21, 2017; references; and experts. Surveillance continued through February 28, 2018. STUDY SELECTION English-language randomized clinical trials (RCTs) or observational studies of supplementation with vitamin D, calcium, or both among adult populations; studies of populations that were institutionalized or had known vitamin D deficiency, osteoporosis, or prior fracture were excluded. DATA EXTRACTION AND SYNTHESIS Dual, independent review of titles/abstracts and full-text articles and study quality rating using predefined criteria. Random-effects meta-analysis used when at least 3 similar studies were available. MAIN OUTCOMES AND MEASURES Incident fracture, mortality, kidney stones, cardiovascular events, and cancer. RESULTS Eleven RCTs (N = 51 419) in adults 50 years and older conducted over 2 to 7 years were included. Compared with placebo, supplementation with vitamin D decreased total fracture incidence (1 RCT [n = 2686]; absolute risk difference [ARD], -2.26%[95% CI, -4.53% to 0.00%]) but had no significant association with hip fracture (3 RCTs [n = 5496]; pooled ARD, -0.01% [95% CI, -0.80% to 0.78%]). Supplementation using vitamin D with calcium had no effect on total fracture incidence (1 RCT [n = 36 282]; ARD, -0.35%[95% CI, -1.02% to 0.31%]) or hip fracture incidence (2 RCTs [n = 36 727]; ARD from the larger trial, -0.14%[95% CI, -0.34% to 0.07%]). The evidence for calcium alone was limited, with only 2 studies (n = 339 total) and very imprecise results. Supplementation with vitamin D alone or with calcium had no significant effect on all-cause mortality or incident cardiovascular disease; ARDs ranged from -1.93% to 1.79%, with CIs consistent with no significant differences. Supplementation using vitamin D with calcium was associated with an increased incidence of kidney stones (3 RCTs [n = 39 213]; pooled ARD, 0.33%[95% CI, 0.06% to 0.60%]), but supplementation with calcium alone was not associated with an increased risk (3 RCTs [n = 1259]; pooled ARD, 0.00% [95% CI, -0.87% to 0.87%]). Supplementation with vitamin D and calcium was not associated with an increase in cancer incidence (3 RCTs [n = 39 213]; pooled ARD, -1.48%[95% CI, -3.32% to 0.35%]). CONCLUSIONS AND RELEVANCE Vitamin D supplementation alone or with calcium was not associated with reduced fracture incidence among community-dwelling adults without known vitamin D deficiency, osteoporosis, or prior fracture. Vitamin D with calcium was associated with an increase in the incidence of kidney stones.	[Kahwati, Leila C.; Weber, Rachel Palmieri; Pan, Huiling; Gourlay, Margaret; Coker-Schwimmer, Manny; Viswanathan, Meera] Univ N Carolina, RTI Int, Evidence Based Practice Ctr, Chapel Hill, NC USA; [Kahwati, Leila C.; Pan, Huiling; Viswanathan, Meera] RTI Int, 3040 E Cornwallis Rd, Res Triangle Pk, NC 27709 USA; [Weber, Rachel Palmieri; Coker-Schwimmer, Manny] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA; [Gourlay, Margaret] Univ N Carolina, Sch Med, Dept Family Med, Chapel Hill, NC USA; [LeBlanc, Erin] Kaiser Permanente, Ctr Hlth Res Northwest, Portland, OR USA	Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Kaiser Permanente	Kahwati, LC (corresponding author), RTI Int, 3040 E Cornwallis Rd, Res Triangle Pk, NC 27709 USA.	lkahwati@rti.org		Weber, Rachel/0000-0001-7119-7734; Kahwati, Leila/0000-0001-6963-2848	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA-290-2015-00011-I]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services	This research was funded under contract HHSA-290-2015-00011-I, Task Order 5, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the USPSTF.	[Anonymous], 2014, AHRQ PUBLICATION; Avenell A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub4; Blondon M, 2015, THROMB HAEMOSTASIS, V113, P999, DOI 10.1160/TH14-05-0478; Bolland MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115934; Bolland Mark J, 2011, BMJ, V342, pd2040, DOI 10.1136/bmj.d2040; Bolland MJ, 2011, AM J CLIN NUTR, V94, P1144, DOI 10.3945/ajcn.111.015032; Brunner RL, 2011, NUTR CANCER, V63, P827, DOI 10.1080/01635581.2011.594208; Chung M, 2016, ANN INTERN MED, V165, P856, DOI 10.7326/M16-1165; Chung M, 2011, ANN INTERN MED, V155, P827, DOI 10.7326/0003-4819-155-12-201112200-00005; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Donneyong MM, 2015, CIRC-HEART FAIL, V8, P49, DOI 10.1161/CIRCHEARTFAILURE.114.001738; Ensrud KE, 2013, J GERONTOL A-BIOL, V68, P1236, DOI 10.1093/gerona/glt092; Finkelstein JS, 2006, NEW ENGL J MED, V354, P750, DOI 10.1056/NEJMe068007; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Higgins JP, 2011, COCHRANE HDB SYSTEMA; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Jackson RD, 2003, ANN EPIDEMIOL, V13, pS98, DOI 10.1016/S1047-2797(03)00046-2; Khaw KT, 2017, LANCET DIABETES ENDO, V5, P438, DOI 10.1016/S2213-8587(17)30103-1; Komulainen M, 1999, J CLIN ENDOCR METAB, V84, P546, DOI 10.1210/jc.84.2.546; Komulainen MH, 1998, MATURITAS, V31, P45, DOI 10.1016/S0378-5122(98)00085-1; Lappe J, 2017, JAMA-J AM MED ASSOC, V317, P1234, DOI 10.1001/jama.2017.2115; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Li M, 2011, CHINESE MED J-PEKING, V124, P3049, DOI 10.3760/cma.j.issn.0366-6999.2011.19.017; Lips P, 1996, ANN INTERN MED, V124, P400, DOI 10.7326/0003-4819-124-4-199602150-00003; Moyer Virginia A, 2013, Ann Intern Med, V158, P691, DOI 10.7326/0003-4819-158-9-201305070-00603; Office of the Surgeon General, 2003, SURG GEN WORKSH OST; Prentice RL, 2013, OSTEOPOROSIS INT, V24, P567, DOI 10.1007/s00198-012-2224-2; Recker RR, 1996, J BONE MINER RES, V11, P1961; Reid IR, 2008, ARCH INTERN MED, V168, P2276, DOI 10.1001/archinte.168.20.2276; Reid IR, 2015, J CELL BIOCHEM, V116, P494, DOI 10.1002/jcb.25028; Riggs BL, 1998, J BONE MINER RES, V13, P168, DOI 10.1359/jbmr.1998.13.2.168; Scragg R, 2017, JAMA CARDIOL, V2, P608, DOI 10.1001/jamacardio.2017.0175; Tang JY, 2011, J CLIN ONCOL, V29, P3078, DOI 10.1200/JCO.2011.34.5967; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; Wallace RB, 2011, AM J CLIN NUTR, V94, P270, DOI 10.3945/ajcn.110.003350; West SL., 2010, AHRQ PUBLICATION	39	103	108	3	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2018	319	15					1600	1612		10.1001/jama.2017.21640	http://dx.doi.org/10.1001/jama.2017.21640			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD0UT	29677308	Bronze			2022-12-28	WOS:000430217100020
J	Stanbrook, MB				Stanbrook, Matthew B.			In COPD, new use of long-acting bronchodilators was linked to CV events at <= 30 days, but not > 30 days	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Stanbrook, Matthew B.] Univ Toronto, Toronto Western Hosp, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Stanbrook, MB (corresponding author), Univ Toronto, Toronto Western Hosp, Toronto, ON, Canada.							GOLD, GLOB STRAT DIAGN MAN; Lahousse L, 2016, LANCET RESP MED, V4, P149, DOI 10.1016/S2213-2600(15)00518-4	2	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2018	168	8					JC47	JC47		10.7326/ACPJC-2018-168-8-047	http://dx.doi.org/10.7326/ACPJC-2018-168-8-047			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GC8XZ	29677254				2022-12-28	WOS:000430083100012
J	Richardson, J				Richardson, Jennifer			Divided views rule implementation of integrated care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jrichardson@bmj.com						[Anonymous], 2018, NHS ENGLAND ANNOUNCE; King's Fund, INT CAR WHAT DOES FU; National Audit Office, 2018, PFI PF2	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 13	2018	361								k1620	10.1136/bmj.k1620	http://dx.doi.org/10.1136/bmj.k1620			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD1WT	29654056				2022-12-28	WOS:000430292700001
J	Jayaraman, KS				Jayaraman, KS			Asian scientists call on Unesco to protect indigenous knowledge	NATURE			English	News Item																		1998, NATURE, V396, P299	1	1	1	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					376	376		10.1038/16981	http://dx.doi.org/10.1038/16981			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667983	Bronze			2022-12-28	WOS:000078461700011
J	Phillips, KA				Phillips, Kathryn A.			Evolving Payer Coverage Policies on Genomic Sequencing Tests Beginning of the End or End of the Beginning?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Phillips, Kathryn A.] Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA; [Phillips, Kathryn A.] Ctr Translat & Policy Res Personalized Med, San Francisco, CA USA; [Phillips, Kathryn A.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy, San Francisco, CA 94143 USA; [Phillips, Kathryn A.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Phillips, KA (corresponding author), Univ Calif San Francisco, 3333 Calif St,Room 420,Box 0613, San Francisco, CA 94143 USA.	kathryn.phillips@ucsf.edu			National Human Genome Research Institute [R01 HG007063, U01 HG009599]; Helen Diller Family Comprehensive Cancer Center of the National Institutes of Health [P30 CA082103-18]; NATIONAL CANCER INSTITUTE [P30CA082103] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007063, U01HG009599] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Helen Diller Family Comprehensive Cancer Center of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was funded by grants R01 HG007063 and U01 HG009599 from the National Human Genome Research Institute and by the Helen Diller Family Comprehensive Cancer Center support grant of the National Institutes of Health under award P30 CA082103-18.	Levinson DR., LOCAL COVERAGE DETER; Phillips KA, 2017, NAT BIOTECHNOL, V35, P614, DOI 10.1038/nbt.3912; Phillips KA, 2014, HEALTH AFFAIR, V33, P1246, DOI 10.1377/hlthaff.2014.0020; Subbiah V, 2016, JAMA ONCOL, V2, P719, DOI 10.1001/jamaoncol.2016.0078; Tan O, 2018, CLIN GENET, V93, P533, DOI 10.1111/cge.13199; Trosman JR, 2017, J NATL COMPR CANC NE, V15, P219, DOI 10.6004/jnccn.2017.0022; US Centers for Medicare & Medicaid Services, DEC MEM NEXT GEN SEQ; West H, 2016, JAMA ONCOL, V2, P717, DOI 10.1001/jamaoncol.2016.0075	8	15	15	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2018	319	23					2379	2380		10.1001/jama.2018.4863	http://dx.doi.org/10.1001/jama.2018.4863			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ7JX	29710095	Green Accepted			2022-12-28	WOS:000435564100014
J	Dai, LY; Zhao, TY; Bisteau, X; Sun, WD; Prabhu, N; Lim, YT; Sobota, RM; Kaldis, P; Nordlund, P				Dai, Lingyun; Zhao, Tianyun; Bisteau, Xavier; Sun, Wendi; Prabhu, Nayana; Lim, Yan Ting; Sobota, Radoslaw M.; Kaldis, Philipp; Nordlund, Par			Modulation of Protein-Interaction States through the Cell Cycle	CELL			English	Article							DRUG TARGET ENGAGEMENT; DNA-REPLICATION; DEPENDENT KINASES; CDK INHIBITORS; CONDENSIN-I; COMPLEX; PHASE; SYNCHRONIZATION; CYTOSCAPE; THYMIDINE	Global profiling of protein expression through the cell cycle has revealed subsets of periodically expressed proteins. However, expression levels alone only give a partial view of the biochemical processes determining cellular events. Using a proteome-wide implementation of the cellular thermal shift assay (CETSA) to study specific cell-cycle phases, we uncover changes of interaction states for more than 750 proteins during the cell cycle. Notably, many protein complexes are modulated in specific cell-cycle phases, reflecting their roles in processes such as DNA replication, chromatin remodeling, transcription, translation, and disintegration of the nuclear envelope. Surprisingly, only small differences in the interaction states were seen between the G1 and the G2 phase, suggesting similar hardwiring of biochemical processes in these two phases. The present work reveals novel molecular details of the cell cycle and establishes proteome-wide CETSA as a new strategy to study modulation of protein-interaction states in intact cells.	[Dai, Lingyun; Zhao, Tianyun; Sun, Wendi; Prabhu, Nayana; Lim, Yan Ting; Nordlund, Par] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Bisteau, Xavier; Sobota, Radoslaw M.; Kaldis, Philipp; Nordlund, Par] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Nordlund, Par] Karolinska Inst, Dept Oncol & Pathol, S-17177 Stockholm, Sweden; [Sobota, Radoslaw M.] ASTAR, Inst Med Biol, Singapore 138648, Singapore; [Kaldis, Philipp] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Karolinska Institutet; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore	Nordlund, P (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.; Nordlund, P (corresponding author), ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore.; Nordlund, P (corresponding author), Karolinska Inst, Dept Oncol & Pathol, S-17177 Stockholm, Sweden.	par.nordlund@ki.se	Bisteau, Xavier/Q-7239-2018; Dai, Lingyun/HIR-6574-2022; Bisteau, Xavier/AAH-6744-2021; Kaldis, Philipp/G-2714-2010	Bisteau, Xavier/0000-0002-8896-5098; Dai, Lingyun/0000-0001-9386-5967; Kaldis, Philipp/0000-0002-7247-7591; Sobota, Radoslaw/0000-0002-2455-2526; Prabhu, Nayana/0000-0002-2350-6552	Nanyang Technological University; Swedish Research Council; Swedish Cancer Society; Knut and Alice Wallenberg Foundation; Singapore Ministry of Health's National Medical Research Council [MOHIAFCAT2/004/2015]; A*STAR [BMRC YIG2015, BMRC YIG2016, NMRC-CBRG14nov086]; Biomedical Research Council A*STAR	Nanyang Technological University(Nanyang Technological University); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore); A*STAR(Agency for Science Technology & Research (A*STAR)); Biomedical Research Council A*STAR(Agency for Science Technology & Research (A*STAR))	We thank Dr. Chris Tan for discussions. P.N. acknowledges a structural genomics startup grant from Nanyang Technological University and grants from the Swedish Research Council, the Swedish Cancer Society, and the Knut and Alice Wallenberg Foundation. This research is also partly supported by the Singapore Ministry of Health's National Medical Research Council (MOHIAFCAT2/004/2015) (to P.N. and R.M.S.), A*STAR grants (BMRC YIG2015 to R.M.S.; BMRC YIG2016 to X.B.), grant (NMRC-CBRG14nov086) (to P.K.), and the Biomedical Research Council A*STAR (to P.K.).	Abe T, 2011, J BIOL CHEM, V286, P30504, DOI 10.1074/jbc.M111.264721; Banfalvi G, 2008, NAT PROTOC, V3, P663, DOI 10.1038/nprot.2008.34; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bellaoui M, 2003, EMBO J, V22, P4304, DOI 10.1093/emboj/cdg406; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bisteau X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003546; BOSTOCK CJ, 1971, EXP CELL RES, V68, P163, DOI 10.1016/0014-4827(71)90599-4; Burke JR, 2012, GENE DEV, V26, P1156, DOI 10.1101/gad.189837.112; Canavan R, 2007, NUCLEIC ACIDS RES, V35, P6268, DOI 10.1093/nar/gkm691; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Coulonval K, 2011, MOL BIOL CELL, V22, P3971, DOI 10.1091/mbc.E11-02-0136; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; des Georges A, 2015, NATURE, V525, P491, DOI 10.1038/nature14891; Dyson NJ, 2016, GENE DEV, V30, P1492, DOI 10.1101/gad.282145.116; Gopinathan L, 2011, RESULTS PROBL CELL D, V53, P365, DOI 10.1007/978-3-642-19065-0_16; Han JM, 2003, BIOCHEM BIOPH RES CO, V303, P985, DOI 10.1016/S0006-291X(03)00485-6; Harper Jane V., 2004, V296, P157; Hills SA, 2014, CURR BIOL, V24, pR435, DOI 10.1016/j.cub.2014.04.012; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Hydbring P, 2016, NAT REV MOL CELL BIO, V17, P280, DOI 10.1038/nrm.2016.27; Jeffrey PD, 2000, GENE DEV, V14, P3115, DOI 10.1101/gad.851100; Keilhauer EC, 2015, MOL CELL PROTEOMICS, V14, P120, DOI 10.1074/mcp.M114.041012; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Liu Y, 2017, P NATL ACAD SCI USA, V114, P3473, DOI 10.1073/pnas.1617636114; Ly T, 2017, ELIFE, V6, DOI 10.7554/eLife.27574; Ly T, 2015, ELIFE, V4, DOI 10.7554/eLife.04534; Ly T, 2014, ELIFE, V3, DOI 10.7554/eLife.01630; Molina DM, 2016, ANNU REV PHARMACOL, V56, P141, DOI 10.1146/annurev-pharmtox-010715-103715; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Muchardt C, 1996, EMBO J, V15, P3394, DOI 10.1002/j.1460-2075.1996.tb00705.x; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Savitski MM, 2014, SCIENCE, V346, P55, DOI 10.1126/science.1255784; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tan CSH, 2018, SCIENCE, V359, P1170, DOI 10.1126/science.aan0346; Toledo CM, 2014, DEV CELL, V28, P282, DOI 10.1016/j.devcel.2013.12.014; VOGEL W, 1978, HUM GENET, V45, P193, DOI 10.1007/BF00286962; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; XEROS N, 1962, NATURE, V194, P682, DOI 10.1038/194682a0; Zhai YL, 2017, MOL CELL, V67, P168, DOI 10.1016/j.molcel.2017.06.016; Zhang T, 2016, CHROMOSOME RES, V24, P243, DOI 10.1007/s10577-016-9519-7; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105	54	81	83	7	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2018	173	6					1481	+		10.1016/j.cell.2018.03.065	http://dx.doi.org/10.1016/j.cell.2018.03.065			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GH9KU	29706543	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000433989100019
J	Cembrowski, MS; Phillips, MG; DiLisio, SF; Shields, BC; Winnubst, J; Chandrashekar, J; Bas, E; Spruston, N				Cembrowski, Mark S.; Phillips, Matthew G.; DiLisio, Salvatore F.; Shields, Brenda C.; Winnubst, Johan; Chandrashekar, Jayaram; Bas, Erhan; Spruston, Nelson			Dissociable Structural and Functional Hippocampal Outputs via Distinct Subiculum Cell Classes	CELL			English	Article							CA1 PYRAMIDAL NEURONS; PATTERN COMPLETION; ENTORHINAL CORTEX; TRANSVERSE AXIS; RAT HIPPOCAMPUS; LEPTIN ACTION; AREA CA1; RNA-SEQ; MEMORY; CIRCUITS	The mammalian hippocampus, comprised of serially connected subfields, participates in diverse behavioral and cognitive functions. It has been postulated that parallel circuitry embedded within hippocampal subfields may underlie such functional diversity. We sought to identify, delineate, and manipulate this putatively parallel architecture in the dorsal subiculum, the primary output subfield of the dorsal hippocampus. Populationand single-cellRNA-seq revealed that the subiculum can be divided into two spatially adjacent subregions associated with prominent differences in pyramidal cell gene expression. Pyramidal cells occupying these two regions differed in their long-range inputs, local wiring, projection targets, and electrophysiological properties. Leveraging gene-expression differences across these regions, we use genetically restricted neuronal silencing to show that these regions differentially contribute to spatial working memory. This work provides a coherent molecular-, cellular-, circuit-, and behavioral-level demonstration that the hippocampus embeds structurally and functionally dissociable streams within its serial architecture.	[Cembrowski, Mark S.; Phillips, Matthew G.; DiLisio, Salvatore F.; Shields, Brenda C.; Winnubst, Johan; Chandrashekar, Jayaram; Bas, Erhan; Spruston, Nelson] Howard Hughes Med Inst, Janelia Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA; [Phillips, Matthew G.] UCL Sainsbury Wellcome Ctr Neural Circuits & Beha, London W1T 4JG, England; [Shields, Brenda C.] Duke Univ, Pratt Sch Engn, 311 Res Dr,Bryan Res Bldg,Box 3209, Durham, NC 27710 USA	Howard Hughes Medical Institute; University of London; University College London; Duke University	Cembrowski, MS; Spruston, N (corresponding author), Howard Hughes Med Inst, Janelia Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	cembrowskim@janelia.hhmi.org; sprustonn@janelia.hhmi.org	Cembrowski, Mark/V-7083-2019; Core, Vector/CAF-4832-2022	Chandrashekar, jayaram/0000-0001-6412-0114	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The authors would like to thank members of the Spruston laboratory and Brett Mensh for helpful discussions; Monique Copeland for histological processing; Lihua Wang, Erina Hara, and Andrew Lemire for help with RNA-seq data generation; Vilas Menon for help with RNA-seq data analysis; Jesse Jackson for help in extracellular recordings; the MouseLight project team for whole-brain axon imaging and reconstruction; and Deanna Otstot, Sarah Erwin, and Anne Kuszpit for injections and animal care. We are also grateful to the Allen Institute for Brain Science for providing the public Allen Mouse Brain Atlas (http://mouse.brain-map.org/) and the creators of TuxedoSuite and Seurat for providing essential and publicly available RNA-seq analysis and visualization software. Funding was provided by the Howard Hughes Medical Institute.	Aggleton JP, 2015, PROG BRAIN RES, V219, P65, DOI 10.1016/bs.pbr.2015.03.003; Alexander AS, 2015, NAT NEUROSCI, V18, P1143, DOI 10.1038/nn.4058; Amaral D G, 1991, Hippocampus, V1, P415, DOI 10.1002/hipo.450010410; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Behr J, 2009, PROG NEUROBIOL, V89, P334, DOI 10.1016/j.pneurobio.2009.09.002; Berns DS, 2018, NATURE, V554, P328, DOI 10.1038/nature25463; Bloss EB, 2016, NEURON, V89, P1016, DOI 10.1016/j.neuron.2016.01.029; Bohm C, 2015, J NEUROSCI, V35, P13608, DOI 10.1523/JNEUROSCI.5034-14.2015; Cembrowski MS, 2018, TRENDS NEUROSCI, V41, P337, DOI 10.1016/j.tins.2018.02.010; Cembrowski MS, 2016, ELIFE, V5, DOI 10.7554/eLife.14997; Cembrowski MS, 2016, NEURON, V89, P351, DOI 10.1016/j.neuron.2015.12.013; Danielson NB, 2016, NEURON, V91, P652, DOI 10.1016/j.neuron.2016.06.020; Deguchi Y, 2011, NAT NEUROSCI, V14, P495, DOI 10.1038/nn.2768; Ding SL, 2013, J COMP NEUROL, V521, P4145, DOI 10.1002/cne.23416; Economon MN, 2016, ELIFE, V5, DOI 10.7554/eLife.10566; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; Goff LA, 2013, CUMMERBUND ANAL EXPL; Gomez JL, 2017, SCIENCE, V357, P503, DOI 10.1126/science.aan2475; Graves AR, 2012, NEURON, V76, P776, DOI 10.1016/j.neuron.2012.09.036; Hempel CM, 2007, NAT PROTOC, V2, P2924, DOI 10.1038/nprot.2007.416; Igarashi KM, 2014, FEBS LETT, V588, P2470, DOI 10.1016/j.febslet.2014.06.004; Jackson J, 2014, NAT NEUROSCI, V17, P1362, DOI 10.1038/nn.3803; Jarsky T, 2008, J COMP NEUROL, V506, P535, DOI 10.1002/cne.21564; Kaifosh P, 2016, NEURON, V90, P622, DOI 10.1016/j.neuron.2016.03.019; Kim SM, 2012, J NEUROSCI, V32, P11539, DOI 10.1523/JNEUROSCI.5942-11.2012; Kim Y, 2012, HIPPOCAMPUS, V22, P693, DOI 10.1002/hipo.20931; Knierim JJ, 2006, HIPPOCAMPUS, V16, P755, DOI 10.1002/hipo.20203; Knierim JJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0369; LASHLEY KS, 1950, SYM SOC EXP BIOL, V4, P454; Lee H, 2015, NEURON, V87, P1093, DOI 10.1016/j.neuron.2015.07.012; Lee SH, 2014, NEURON, V82, P1129, DOI 10.1016/j.neuron.2014.03.034; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leinninger GM, 2011, CELL METAB, V14, P313, DOI 10.1016/j.cmet.2011.06.016; Li YD, 2017, NAT NEUROSCI, V20, P559, DOI 10.1038/nn.4517; Lopez AJ, 2016, J NEUROSCI, V36, P3588, DOI 10.1523/JNEUROSCI.3682-15.2016; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Masurkar AV, 2017, CELL REP, V18, P148, DOI 10.1016/j.celrep.2016.12.012; de la Prida LM, 2006, BEHAV BRAIN RES, V174, P198, DOI 10.1016/j.bbr.2006.05.033; Milstein AD, 2015, NEURON, V87, P1274, DOI 10.1016/j.neuron.2015.08.025; MORRIS RGM, 1990, EUR J NEUROSCI, V2, P1016, DOI 10.1111/j.1460-9568.1990.tb00014.x; Murphy S. D., 2014, KEYST S BIG DAT BIOL; Naber PA, 2000, ANN NY ACAD SCI, V911, P392; Naber PA, 1998, J COMP NEUROL, V393, P284; Nadel L, 2011, NEUROPSYCHOPHARMACOL, V36, P251, DOI 10.1038/npp.2010.169; Neunuebel JP, 2014, NEURON, V81, P416, DOI 10.1016/j.neuron.2013.11.017; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Roth BL, 2016, NEURON, V89, P683, DOI 10.1016/j.neuron.2016.01.040; Roy DS, 2017, CELL, V170, P1000, DOI 10.1016/j.cell.2017.07.013; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Soumillon M., 2014, BIORXIV, DOI [10.1101/003236, DOI 10.1101/003236]; Staff NP, 2000, J NEUROPHYSIOL, V84, P2398, DOI 10.1152/jn.2000.84.5.2398; STEWARD O, 1976, J COMP NEUROL, V167, P285, DOI 10.1002/cne.901670303; Team RC., 2022, LANG ENV STAT COMP; Tervo DGR, 2016, NEURON, V92, P372, DOI 10.1016/j.neuron.2016.09.021; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Witter MP, 2006, BEHAV BRAIN RES, V174, P251, DOI 10.1016/j.bbr.2006.06.022; WOUTERLOOD FG, 1990, J COMP NEUROL, V296, P179, DOI 10.1002/cne.902960202; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48; Zingg B, 2017, NEURON, V93, P33, DOI 10.1016/j.neuron.2016.11.045	66	76	76	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 17	2018	173	5					1280	+		10.1016/j.cell.2018.03.031	http://dx.doi.org/10.1016/j.cell.2018.03.031			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GG1UA	29681453	Bronze			2022-12-28	WOS:000432471700022
J	Durrmeyer, X; Breinig, S; Claris, O; Tourneux, P; Alexandre, C; Saliba, E; Beuchee, A; Jung, C; Levy, C; Marchand-Martin, L; Marcoux, MO; Dechartres, A; Danan, C				Durrmeyer, Xavier; Breinig, Sophie; Claris, Olivier; Tourneux, Pierre; Alexandre, Ceneric; Saliba, Elie; Beuchee, Alain; Jung, Camille; Levy, Corinne; Marchand-Martin, Laetitia; Marcoux, Marie-Odile; Dechartres, Agnes; Danan, Claude		PRETTINEO Res Grp	Effect of Atropine With Propofol vs Atropine With Atracurium and Sufentanil on Oxygen Desaturation in Neonates Requiring Nonemergency Intubation A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENDOTRACHEAL INTUBATION; NASOTRACHEAL INTUBATION; SUXAMETHONIUM REGIMEN; INDUCTION-AGENTS; PROCEDURAL PAIN; PREMEDICATION; PRETERM; FENTANYL; INFANTS; FACILITATION	IMPORTANCE Propofol or a combination of a synthetic opioid and muscle relaxant are both recommended for premedication before neonatal intubation but have yet to be compared. OBJECTIVE To compare prolonged desaturation during neonatal nasotracheal intubation after premedication with atropine-propofol vs atropine-atracurium-sufentanil treatment. DESIGN, SETTING, AND PARTICIPANTS Multicenter, double-blind, randomized clinical trial (2012-2016) in 6 NICUs in France that included 173 neonates requiring nonemergency intubation. The study was interrupted due to expired study kits and lack of funding. INTERVENTIONS Eighty-nine participants were randomly assigned to the atropine-propofol group and 82 to the atropine-atracurium-sufentanil group before nasotracheal intubation. MAIN OUTCOMES AND MEASURES The primary outcome was prolonged desaturation (SpO(2) (<)80% lasting > 60 seconds), using intention-to-treat analysis using mixed models. Secondary outcomes assessed the characteristics of the procedure and its tolerance. RESULTS Of 173 neonates randomized (mean gestational age, 30.6 weeks; mean birth weight, 1502 g; 71 girls), 171 (99%) completed the trial. Of 89 infants, 53 (59.6%) in the atropine-propofol group vs 54 of 82 (65.9%) in the atropine-atracurium-sufentanil group achieved the primary outcome (adjusted RD, -6.4; 95% CI, -21.0 to 8.1; P = .38). The atropine-propofol group had a longer mean procedure duration than did the atropine-atracurium-sufentanil group (adjusted RD, 1.7 minutes; 95% CI, 0.1-3.3 minutes; P = .04); a less frequent excellent quality of sedation rate, 51.7%(45 of 87) vs 92.6%(75 of 81; P < .001); a shorter median time to respiratory recovery, 14 minutes (IQR, 8-34 minutes) vs 33 minutes (IQR, 15-56 minutes; P = .002), and shorter median time to limb movement recovery, 18 minutes (IQR, 10-43 minutes) vs 36 minutes (IQR, 19-65 minutes; P = .003). In the 60 minutes after inclusion, SpO(2) was preserved significantly better in the atropine-propofol group (time x treatment interaction P = .02). Of the atropine-propofol group 20.6% had head ultrasound scans that showed worsening intracranial hemorrhaging (any or increased intraventricular hemorrhage) in the 7 days after randomization vs 17.6% in the atropine-atracurium-sufentanil group (adjusted RD, 1.2; 95% CI, -13.1 to 15.5, P = .87). Severe adverse events occurred in 11% of the atropine-propofol group and in 20% of the atropine-atracurium-sufentanil group. CONCLUSIONS AND RELEVANCE Among neonates undergoing nonemergency nasotracheal intubation, the frequency of prolonged desaturation did not differ significantly between atropine used with propofol or atropine used with atracurium and sufentanil. However, the study may have been underpowered to detect a clinically important difference, and further research may be warranted.	[Durrmeyer, Xavier; Danan, Claude] CHI Creteil, Neonatal Intens Care Unit, 40 Ave Verdun, F-94000 Creteil, France; [Durrmeyer, Xavier; Marchand-Martin, Laetitia] Paris Descartes Univ, INSERM, U1153, Obstet Perinatal & Pediat Epidemiol Team,Epidemio, Paris, France; [Breinig, Sophie; Marcoux, Marie-Odile] CHU Toulouse, Pediat & Neonatal Intens Care Unit, Toulouse, France; [Claris, Olivier] Hosp Civils Lyon, Neonatal Intens Care Unit, Lyon, France; [Tourneux, Pierre] CHU Amiens, Neonatal Intens Care Unit, Amiens, France; [Alexandre, Ceneric] CHU Caen, Neonatal Intens Care Unit, Caen, France; [Saliba, Elie] CHU Tours, Neonatal Intens Care Unit, Tours, France; [Beuchee, Alain] CHU Rennes, Neonatal Intens Care Unit, Rennes, France; [Jung, Camille; Danan, Claude] CHI Creteil, Clin Res Ctr, Creteil, France; [Levy, Corinne] ACTIV, St Maur, France; [Levy, Corinne] Univ Paris Est, IMRB GRC GEMINI, Creteil, France; [Dechartres, Agnes] Paris Descartes Univ, Hotel Dieu Hosp, AP HP, INSERM,U1153,METHODS Team,Epidemiol & Stat,Sorbon, Paris, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; CHU Lyon; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU Tours; CHU Rennes; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Durrmeyer, X (corresponding author), CHI Creteil, Neonatal Intens Care Unit, 40 Ave Verdun, F-94000 Creteil, France.	xavier.durrmeyer@chicreteil.fr	Tourneux, Pierre/AAX-3748-2021; Durrmeyer, Xavier/AAB-7519-2020; Breinig, Sophie/AAC-3934-2019; Beuchée, Alain/AAB-7024-2021; LEVY, Corinne/AAM-3541-2021	Durrmeyer, Xavier/0000-0002-6303-7252; Breinig, Sophie/0000-0001-9034-3135; Beuchée, Alain/0000-0003-0064-7085; LEVY, Corinne/0000-0002-1927-6360; Marchand-Martin, Laetitia/0000-0002-8036-8387; JUNG, Camille/0000-0001-8486-8939	French Health Ministry (Programme Hospitalier de Recherche Clinique, PHRC) [Prettineo 00-96];  [AOM09 096]	French Health Ministry (Programme Hospitalier de Recherche Clinique, PHRC); 	This study was supported by grants AOM09 096 in 2009 and grant Prettineo 00-96 from the French Health Ministry (Programme Hospitalier de Recherche Clinique, PHRC). Masimo Inc provided some equipment for monitoring pulse oximetry.	ANAND KJS, 1987, LANCET, V1, P62; Barrington KJ, 2011, PAED CHILD HEALT-CAN, V16, P159, DOI 10.1093/pch/16.3.159; Barrington KJ, 1998, AM J PERINAT, V15, P213, DOI 10.1055/s-2007-993928; Choong K, 2010, ARCH DIS CHILD-FETAL, V95, pF80, DOI 10.1136/adc.2009.167338; Dempsey EM, 2006, ARCH DIS CHILD-FETAL, V91, pF279, DOI 10.1136/adc.2005.087213; Durrmeyer X, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-120; Durrmeyer X, 2013, PEDIATR CRIT CARE ME, V14, pE169, DOI 10.1097/PCC.0b013e3182720616; Fahnenstich H, 2000, CRIT CARE MED, V28, P836, DOI 10.1097/00003246-200003000-00037; Fleck T, 2015, PEDIATR CARDIOL, V36, P543, DOI 10.1007/s00246-014-1047-7; Ghanta S, 2007, PEDIATRICS, V119, pE1248, DOI 10.1542/peds.2006-2708; Hatch LD, 2016, J PEDIATR-US, V168, P62, DOI 10.1016/j.jpeds.2015.09.077; Haubner LY, 2013, RESUSCITATION, V84, P1359, DOI 10.1016/j.resuscitation.2013.03.014; Jones P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057478; Keels E, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-4271; Kumar P, 2010, PEDIATRICS, V125, P608, DOI 10.1542/peds.2009-2863; Lemyre B, 2009, ARCH DIS CHILD-FETAL, V94, pF439, DOI 10.1136/adc.2008.146068; MCMILLAN DD, 1986, PEDIATRICS, V77, P39; MEAKIN G, 1988, BRIT J ANAESTH, V60, P171, DOI 10.1093/bja/60.2.171; Meyer S, 2007, PEDIATRICS, V120, P932, DOI 10.1542/peds.2007-2083; Muniraman HK, 2015, AM J PERINAT, V32, P821, DOI 10.1055/s-0034-1543987; NIGHTINGALE DA, 1986, BRIT J ANAESTH, V58, pS32, DOI 10.1093/bja/58.suppl_1.32S; Norman E, 2011, J PEDIAT, V159, P893; O'Donnell CPF, 2006, PEDIATRICS, V117, pE16, DOI 10.1542/peds.2005-0901; Oei J, 2002, J PAEDIATR CHILD H, V38, P146, DOI 10.1046/j.1440-1754.2002.00726.x; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Papoff P, 2008, PEDIATRICS, V121, P448, DOI 10.1542/peds.2007-3132; Parker MM, 2017, PEDIATR CRIT CARE ME, V18, P310, DOI 10.1097/PCC.0000000000001074; Penido MG, 2011, J PERINATOL, V31, P356, DOI 10.1038/jp.2010.135; Roberts KD, 2006, PEDIATRICS, V118, P1583, DOI 10.1542/peds.2006-0590; SHAH PS, 2011, COCHRANE DB SYST REV, V3; Simons SHP, 2013, ACTA PAEDIATR, V102, pE487, DOI 10.1111/apa.12367; Skellern CY, 2001, J PAEDIATR CHILD H, V37, P125, DOI 10.1046/j.1440-1754.2001.00604.x; Smits A, 2016, J PEDIATR-US, V179, P54, DOI 10.1016/j.jpeds.2016.07.049; Spence K, 2000, COCHRANE DB SYST REV, V1999; Tourneux P, 2008, PEDIATR RES, V64, P171, DOI 10.1203/PDR.0b013e318179951d; van den Anker JN, 2007, PEDIATRICS, V120, P691, DOI 10.1542/peds.2007-1741; Vanderhaegen J, 2010, NEONATOLOGY, V98, P57, DOI 10.1159/000271224; Vinall J, 2014, PEDIATR RES, V75, P584, DOI 10.1038/pr.2014.16; Welzing L, 2010, PEDIATR ANESTH, V20, P605, DOI 10.1111/j.1460-9592.2010.03330.x	39	20	20	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2018	319	17					1790	1801		10.1001/jama.2018.3708	http://dx.doi.org/10.1001/jama.2018.3708			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GE3UQ	29715354	Green Published, Bronze			2022-12-28	WOS:000431138800017
J	Swanson, SM; Strate, LL				Swanson, Sophia M.; Strate, Lisa L.			Acute Colonic Diverticulitis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RANDOMIZED-CLINICAL-TRIAL; COMPLICATED DIVERTICULITIS; DISEASE; RISK; RECURRENCE; HOSPITALIZATION; DIAGNOSIS; SURGERY; TRENDS		[Swanson, Sophia M.; Strate, Lisa L.] Univ Washington, Sch Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Swanson, SM (corresponding author), Univ Washington, Sch Med, Seattle, WA 98195 USA.				NIDDK NIH HHS [R01 DK101495] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101495] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andeweg CS, 2011, ANN SURG, V253, P940, DOI 10.1097/SLA.0b013e3182113614; Bharucha AE, 2015, AM J GASTROENTEROL, V110, P1588, DOI 10.1038/ajg.2015.302; Biondo S, 2014, ANN SURG, V259, P38, DOI 10.1097/SLA.0b013e3182965a11; Biondo S, 2012, AM J SURG, V204, P172, DOI 10.1016/j.amjsurg.2011.09.027; Chabok A, 2012, BRIT J SURG, V99, P532, DOI 10.1002/bjs.8688; Cohen E, 2013, CLIN GASTROENTEROL H, V11, P1614, DOI 10.1016/j.cgh.2013.03.007; Daniels L, 2017, BRIT J SURG, V104, P52, DOI 10.1002/bjs.10309; Dharmarajan S, 2011, DIS COLON RECTUM, V54, P663, DOI 10.1007/DCR.0b013e31820ef759; Feingold D, 2014, DIS COLON RECTUM, V57, P284, DOI 10.1097/DCR.0000000000000075; Gaertner WB, 2013, DIS COLON RECTUM, V56, P622, DOI 10.1097/DCR.0b013e31828545e3; Gilbert DN, 2017, SANFORD GUIDE ANTIMI; Gregersen R, 2016, INT J SURG, V35, P201, DOI 10.1016/j.ijsu.2016.10.006; Hall JF, 2011, DIS COLON RECTUM, V54, P283, DOI 10.1007/DCR.0b013e3182028576; Hjern F, 2011, BRIT J SURG, V98, P997, DOI 10.1002/bjs.7477; Humes DJ, 2012, GUT, V61, P95, DOI 10.1136/gut.2011.238808; Humes DJ, 2011, GUT, V60, P219, DOI 10.1136/gut.2010.217281; Kaiser AM, 2005, AM J GASTROENTEROL, V100, P910, DOI 10.1111/j.1572-0241.2005.41154.x; Kiewiet JJS, 2014, DIGEST LIVER DIS, V46, P119, DOI 10.1016/j.dld.2013.09.017; Lameris W, 2010, DIS COLON RECTUM, V53, P896, DOI 10.1007/DCR.0b013e3181d98d86; Laurell H, 2007, COLORECTAL DIS, V9, P496, DOI 10.1111/j.1463-1318.2006.01162.x; Lidor AO, 2011, SURGERY, V150, P146, DOI 10.1016/j.surg.2011.05.006; Lidor AO, 2010, J GASTROINTEST SURG, V14, P1867, DOI 10.1007/s11605-010-1344-2; Liu PH, 2017, AM J GASTROENTEROL, V112, P1868, DOI 10.1038/ajg.2017.398; Maguire LH, 2013, CLIN GASTROENTEROL H, V11, P1631, DOI 10.1016/j.cgh.2013.07.035; Mizuki A, 2005, ALIMENT PHARM THER, V21, P889, DOI 10.1111/j.1365-2036.2005.02422.x; Nizri E, 2014, TECH COLOPROCTOL, V18, P145, DOI 10.1007/s10151-013-1044-5; Oberkofler CE, 2012, ANN SURG, V256, P819, DOI 10.1097/SLA.0b013e31827324ba; Oor JE, 2014, J GASTROINTEST SURG, V18, P2038, DOI 10.1007/s11605-014-2593-2; Peery AF, 2017, CLIN GASTROENTEROL H; Peery AF, 2013, CLIN GASTROENTEROL H, V11, P1622, DOI 10.1016/j.cgh.2013.06.033; Peery AF, 2012, GASTROENTEROLOGY, V142, P266, DOI 10.1053/j.gastro.2011.10.035; Penna M, 2018, ANN SURG, V267, P252, DOI 10.1097/SLA.0000000000002236; Regenbogen SE, 2014, JAMA SURG, V149, P292, DOI 10.1001/jamasurg.2013.5477; Ritz JP, 2011, SURGERY, V149, P606, DOI 10.1016/j.surg.2010.10.005; Schug-Pass C, 2010, INT J COLORECTAL DIS, V25, P751, DOI 10.1007/s00384-010-0899-4; Shahedi K, 2013, CLIN GASTROENTEROL H, V11, P1609, DOI 10.1016/j.cgh.2013.06.020; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; Stam MAW, 2017, COLORECTAL DIS, V19, P372, DOI 10.1111/codi.13505; Stollman N, 2015, GASTROENTEROLOGY, V149, P1944, DOI 10.1053/j.gastro.2015.10.003; Strate LL, 2008, JAMA-J AM MED ASSOC, V300, P907, DOI 10.1001/jama.300.8.907; Strate LL, 2015, GASTROENTEROLOGY, V149, P1950, DOI 10.1053/j.gastro.2015.10.001; Strate LL, 2013, GASTROENTEROLOGY, V144, P736, DOI 10.1053/j.gastro.2012.12.030; Strate LL, 2011, GASTROENTEROLOGY, V140, P1427, DOI 10.1053/j.gastro.2011.02.004; Strate LL, 2009, AM J GASTROENTEROL, V104, P1221, DOI 10.1038/ajg.2009.121; Strate LL, 2009, GASTROENTEROLOGY, V136, P115, DOI 10.1053/j.gastro.2008.09.025; Strate LL, 2017, GASTROENTEROLOGY, V152; Tonnesen H, 1999, BRIT J SURG, V86, P1067, DOI 10.1046/j.1365-2168.1999.01171.x; Tursi A, 2015, J CLIN GASTROENTEROL, V49, P218, DOI 10.1097/MCG.0000000000000094; Wasvary H, 1999, AM SURGEON, V65, P632; Wheat CL, 2016, CLIN GASTROENTEROL H, V14, P96, DOI 10.1016/j.cgh.2015.03.030	50	39	41	3	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2018	168	9					ITC65	ITC79		10.7326/AITC201805010	http://dx.doi.org/10.7326/AITC201805010			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3BZ	29710265	Green Accepted			2022-12-28	WOS:000434247300002
J	Kunkel, P; Prufer, M; Strobel, H; Linnemann, D; Frolian, A; Gasenzer, T; Garttner, M; Oberthaler, MK				Kunkel, Philipp; Pruefer, Maximilian; Strobel, Helmut; Linnemann, Daniel; Froelian, Anika; Gasenzer, Thomas; Gaerttner, Martin; Oberthaler, Markus K.			Spatially distributed multipartite entanglement enables EPR steering of atomic clouds	SCIENCE			English	Article							PODOLSKY-ROSEN PARADOX; CONTINUOUS-VARIABLES; OPTICAL LATTICES; QUANTUM; SYSTEMS	A key resource for distributed quantum-enhanced protocols is entanglement between spatially separated modes. However, the robust generation and detection of entanglement between spatially separated regions of an ultracold atomic system remain a challenge. We used spin mixing in a tightly confined Bose-Einstein condensate to generate an entangled state of indistinguishable particles in a single spatial mode. We show experimentally that this entanglement can be spatially distributed by self-similar expansion of the atomic cloud. We used spatially resolved spin read-out to reveal a particularly strong form of quantum correlations known as Einstein-Podolsky-Rosen (EPR) steering between distinct parts of the expanded cloud. Based on the strength of EPR steering, we constructed a witness, which confirmed genuine 5-partite entanglement.	[Kunkel, Philipp; Pruefer, Maximilian; Strobel, Helmut; Linnemann, Daniel; Froelian, Anika; Gasenzer, Thomas; Gaerttner, Martin; Oberthaler, Markus K.] Heidelberg Univ, Kirchhoff Inst Phys, Neuenheimer Feld 227, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Kunkel, P (corresponding author), Heidelberg Univ, Kirchhoff Inst Phys, Neuenheimer Feld 227, D-69120 Heidelberg, Germany.	steering@matterwave.de	Prüfer, Maximilian/ABF-9613-2021	Prüfer, Maximilian/0000-0001-5768-3517; Gasenzer, Thomas/0000-0002-9363-7822; Kunkel, Philipp/0000-0002-8145-9184; Garttner, Martin/0000-0003-1914-7099	Heidelberg Graduate School of Fundamental Physics; Heidelberg Center for Quantum Dynamics; European Commission, within the Horizon program, through the FET-Proactive grant AQuS [640800]; European Research Commission Advanced Grant EntangleGen [694561]; DFG (German Research Foundation) Collaborative Research Center [SFB1225]	Heidelberg Graduate School of Fundamental Physics; Heidelberg Center for Quantum Dynamics; European Commission, within the Horizon program, through the FET-Proactive grant AQuS; European Research Commission Advanced Grant EntangleGen; DFG (German Research Foundation) Collaborative Research Center(German Research Foundation (DFG))	This work was supported by the Heidelberg Graduate School of Fundamental Physics; the Heidelberg Center for Quantum Dynamics; the European Commission, within the Horizon-2020 program, through the FET-Proactive grant AQuS (project no. 640800) and the European Research Commission Advanced Grant EntangleGen (project ID 694561); and the DFG (German Research Foundation) Collaborative Research Center SFB1225 (ISOQUANT).	Armstrong S, 2015, NAT PHYS, V11, P167, DOI [10.1038/NPHYS3202, 10.1038/nphys3202]; ASPECT A, 1981, PHYS REV LETT, V47, P460, DOI 10.1103/PhysRevLett.47.460; Bar-Gill N, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.120404; Bloch I, 2008, NATURE, V453, P1016, DOI 10.1038/nature07126; Braunstein SL, 2005, REV MOD PHYS, V77, P513, DOI 10.1103/RevModPhys.77.513; Cavalcanti D, 2017, REP PROG PHYS, V80, DOI 10.1088/1361-6633/80/2/024001; Cerf N. J., 2007, QUANTUM INFORM CONTI; Dai HN, 2016, NAT PHYS, V12, P783, DOI [10.1038/nphys3705, 10.1038/NPHYS3705]; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Fadel M, 2018, SCIENCE, V360, P409, DOI 10.1126/science.aao1850; FREEDMAN SJ, 1972, PHYS REV LETT, V28, P938, DOI 10.1103/PhysRevLett.28.938; Giovannetti V, 2004, SCIENCE, V306, P1330, DOI 10.1126/science.1104149; Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145; Hamley CD, 2012, NAT PHYS, V8, P305, DOI [10.1038/nphys2245, 10.1038/NPHYS2245]; He QY, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.120405; Hyllus P, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.012337; Julsgaard B, 2001, NATURE, V413, P400, DOI 10.1038/35096524; Killoran N, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.150501; Kurkjian H, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.043605; Labuhn H, 2016, NATURE, V534, P667, DOI 10.1038/nature18274; Lange K, 2018, SCIENCE, V360, P416, DOI 10.1126/science.aao2035; Menicucci NC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.110501; OU ZY, 1992, PHYS REV LETT, V68, P3663, DOI 10.1103/PhysRevLett.68.3663; Peise J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9984; Pezze L., 2016, ARXIV160901609QUANTP; Reid MD, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.062108; Reid MD, 2009, REV MOD PHYS, V81, P1727, DOI 10.1103/RevModPhys.81.1727; REID MD, 1989, PHYS REV A, V40, P913, DOI 10.1103/PhysRevA.40.913; Rigol M, 2008, NATURE, V452, P854, DOI 10.1038/nature06838; Schrodinger E, 1935, P CAMB PHILOS SOC, V31, P555, DOI 10.1017/S0305004100013554; Stamper-Kurn DM, 2013, REV MOD PHYS, V85, P1191, DOI 10.1103/RevModPhys.85.1191; Teh RY, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.062337; Wiseman HM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.140402; Zeiher J, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031015	34	96	97	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					413	415		10.1126/science.aao2254	http://dx.doi.org/10.1126/science.aao2254			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1AR	29700262	Green Submitted			2022-12-28	WOS:000430949600036
J	Walter, P; Anderson, D				Walter, Peter; Anderson, David			Gunter Blobel (1936-2018)	SCIENCE			English	Biographical-Item									[Walter, Peter] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Anderson, David] CALTECH, Pasadena, CA 91125 USA	University of California System; University of California San Francisco; California Institute of Technology	Walter, P (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	peter@walterlab.ucsf.edu; wuwei@caltech.edu							0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					383	383		10.1126/science.aat7913	http://dx.doi.org/10.1126/science.aat7913			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1AR	29700255				2022-12-28	WOS:000430949600024
J	Mi, MY; Block, PC; Broderick, JP				Mi, Michael Y.; Block, Peter C.; Broderick, Joseph P.			PFO Closure for Cryptogenic Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PATENT FORAMEN OVALE; MEDICAL THERAPY; EMBOLIC STROKE		[Block, Peter C.] Emory Univ, Sch Med, Dept Med, Emory Univ Hosp, Atlanta, GA 30322 USA; [Broderick, Joseph P.] Univ Cincinnati, Gardner Neurosci Inst, Dept Neurol & Rehabil Med, Cincinnati, OH USA	Emory University; University System of Ohio; University of Cincinnati	Block, PC (corresponding author), Emory Univ, Sch Med, Dept Med, Emory Univ Hosp, Atlanta, GA 30322 USA.		Mi, Michael/GZG-4113-2022	Mi, Michael/0000-0001-8031-8948				Carroll JD, 2013, NEW ENGL J MED, V368, P1092, DOI 10.1056/NEJMoa1301440; Hart RG, 2017, STROKE, V48, P867, DOI 10.1161/STROKEAHA.116.016414; Lip GYH, 2011, J AM COLL CARDIOL, V57, P173, DOI 10.1016/j.jacc.2010.09.024; Mas JL, 2017, NEW ENGL J MED, V377, P1011, DOI 10.1056/NEJMoa1705915; Meier B, 2013, NEW ENGL J MED, V368, P1083, DOI 10.1056/NEJMoa1211716; Melkumova Emiliya, 2017, Interv Cardiol Clin, V6, P487, DOI 10.1016/j.iccl.2017.05.005; Ntaios G, 2017, CIRCULATION, V136, P2403, DOI 10.1161/CIRCULATIONAHA.117.030509; Petty GW, 2006, MAYO CLIN PROC, V81, P602, DOI 10.4065/81.5.602; Saver JL, 2017, NEW ENGL J MED, V377, P1022, DOI 10.1056/NEJMoa1610057; Sondergaard L, 2017, NEW ENGL J MED, V377, P1033, DOI 10.1056/NEJMoa1707404	10	4	4	2	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2018	378	17					1639	1642		10.1056/NEJMclde1715853	http://dx.doi.org/10.1056/NEJMclde1715853			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GD8XP	29694824				2022-12-28	WOS:000430797900014
J	Ockeloen-Korppi, CF; Damskagg, E; Pirkkalainen, JM; Asjad, M; Clerk, AA; Massel, F; Woolley, MJ; Sillanpaa, MA				Ockeloen-Korppi, C. F.; Damskagg, E.; Pirkkalainen, J. -M.; Asjad, M.; Clerk, A. A.; Massel, F.; Woolley, M. J.; Sillanpaa, M. A.			Stabilized entanglement of massive mechanical oscillators	NATURE			English	Article							MOTION; STATE	Quantum entanglement is a phenomenon whereby systems cannot be described independently of each other, even though they may be separated by an arbitrarily large distance(1). Entanglement has a solid theoretical and experimental foundation and is the key resource behind many emerging quantum technologies, including quantum computation, cryptography and metrology. Entanglement has been demonstrated for microscopic-scale systems, such as those involving photons(2-5), ions(6) and electron spins(7), and more recently in microwave and electromechanical devices(8-10). For macroscopic-scale objects(8-14), however, it is very vulnerable to environmental disturbances, and the creation and verification of entanglement of the centre-of-mass motion of macroscopic-scale objects remains an outstanding goal. Here we report such an experimental demonstration, with the moving bodies being two massive micromechanical oscillators, each composed of about 10(12) atoms, coupled to a microwave-frequency electromagnetic cavity that is used to create and stabilize the entanglement of their centre-of-mass motion(15-17). We infer the existence of entanglement in the steady state by combining measurements of correlated mechanical fluctuations with an analysis of the microwaves emitted from the cavity. Our work qualitatively extends the range of entangled physical systems and has implications for quantum information processing, precision measurements and tests of the limits of quantum mechanics.	[Ockeloen-Korppi, C. F.; Damskagg, E.; Pirkkalainen, J. -M.; Sillanpaa, M. A.] Aalto Univ, Dept Appl Phys, Aalto, Finland; [Asjad, M.; Massel, F.] Univ Jyvaskyla, Dept Phys, Jyvaskyla, Finland; [Asjad, M.; Massel, F.] Univ Jyvaskyla, Nanosci Ctr, Jyvaskyla, Finland; [Clerk, A. A.] Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA; [Woolley, M. J.] UNSW Canberra, Sch Engn & Informat Technol, Canberra, ACT, Australia	Aalto University; University of Jyvaskyla; University of Jyvaskyla; University of Chicago; University of New South Wales Sydney	Sillanpaa, MA (corresponding author), Aalto Univ, Dept Appl Phys, Aalto, Finland.	mika.sillanpaa@aalto.fi	Massel, Francesco P/F-3372-2012; Sillanpaa, Mika/A-3554-2013; Pirkkalainen, Juha-Matti/J-1792-2012; Asjad, Muhammad/E-8393-2012	Massel, Francesco P/0000-0002-6132-109X; Pirkkalainen, Juha-Matti/0000-0002-8631-7767; Asjad, Muhammad/0000-0001-6895-3332; Damskagg, Erno/0000-0002-5422-7660; Ockeloen-Korppi, Caspar/0000-0003-1967-3021	Academy of Finland [250280, 308290, 307757]; European Research Council [615755-CAVITYQPD]; European Union [732894]	Academy of Finland(Academy of Finland); European Research Council(European Research Council (ERC)European Commission); European Union(European Commission)	We thank S. Paraoanu and I. Petersen for discussions. This work was supported by the Academy of Finland (contracts 250280, 308290 and 307757) and by the European Research Council (615755-CAVITYQPD). We acknowledge funding from the European Union's Horizon 2020 research and innovation programme under grant agreement number 732894 (FETPRO HOT). For this work, we used the facilities of the Micronova Nanofabrication Center and the Low Temperature Laboratory.	ASPECT A, 1982, PHYS REV LETT, V49, P1804, DOI 10.1103/PhysRevLett.49.1804; Banaszek K, 1998, PHYS REV A, V58, P4345, DOI 10.1103/PhysRevA.58.4345; Bowen WP, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.253601; DiCarlo L, 2010, NATURE, V467, P574, DOI 10.1038/nature09416; Duan LM, 2000, PHYS REV LETT, V84, P2722, DOI 10.1103/PhysRevLett.84.2722; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; HEIDMANN A, 1987, PHYS REV LETT, V59, P2555, DOI 10.1103/PhysRevLett.59.2555; Hensen B, 2015, NATURE, V526, P682, DOI 10.1038/nature15759; Jost JD, 2009, NATURE, V459, P683, DOI 10.1038/nature08006; Julsgaard B, 2001, NATURE, V413, P400, DOI 10.1038/35096524; Klimov PV, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501015; Lecocq F, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041037; Lee KC, 2011, SCIENCE, V334, P1253, DOI 10.1126/science.1211914; LEGGETT AJ, 1980, SUP PROG THEOR PHYS, P80, DOI 10.1143/PTPS.69.80; Li J, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/10/103037; Mahboob I, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.167203; Mancini S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.120401; Ockeloen-Korppi CF, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.140401; OU ZY, 1992, PHYS REV LETT, V68, P3663, DOI 10.1103/PhysRevLett.68.3663; Palomaki TA, 2013, SCIENCE, V342, P710, DOI 10.1126/science.1244563; Pinard M, 2005, EUROPHYS LETT, V72, P747, DOI 10.1209/epl/i2005-10317-6; Pirkkalainen JM, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.243601; Pontin A, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.103601; Steffen M, 2006, SCIENCE, V313, P1423, DOI 10.1126/science.1130886; Tan HT, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.033829; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261; Wang YD, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.253601; Weedbrook C, 2012, REV MOD PHYS, V84, P621, DOI 10.1103/RevModPhys.84.621; Wollman EE, 2015, SCIENCE, V349, P952, DOI 10.1126/science.aac5138; Woolley MJ, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.063805; Woolley MJ, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.063846	31	288	291	6	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					478	482		10.1038/s41586-018-0038-x	http://dx.doi.org/10.1038/s41586-018-0038-x			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8VX	29695847	Green Submitted			2022-12-28	WOS:000430793000042
J	Bester, AC; Lee, JD; Chavez, A; Lee, YR; Nachmani, D; Vora, S; Victor, J; Sauvageau, M; Monteleone, E; Rinn, JL; Provero, P; Church, GM; Clohessy, JG; Pandolfi, PP				Bester, Assaf C.; Lee, Jonathan D.; Chavez, Alejandro; Lee, Yu-Ru; Nachmani, Daphna; Vora, Suhani; Victor, Joshua; Sauvageau, Martin; Monteleone, Emanuele; Rinn, John L.; Provero, Paolo; Church, George M.; Clohessy, John G.; Pandolfi, Pier Paolo			An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance	CELL			English	Article							TYROSINE KINASE AXL; LONG NONCODING RNAS; TRANSCRIPTIONAL ACTIVATION; CYTARABINE RESPONSE; EXPRESSION; SENSITIVITY; GENES; ENCYCLOPEDIA; METABOLISM; KNOWLEDGE	Resistance to chemotherapy plays a significant role in cancer mortality. To identify genetic units affecting sensitivity to cytarabine, the mainstay of treatment for acute myeloid leukemia (AML), we developed a comprehensive and integrated genome-wide platform based on a dual protein-coding and non-coding integrated CRISPRa screening (DICaS). Putative resistance genes were initially identified using pharmacogenetic data from 760 human pan-cancer cell lines. Subsequently, genome scale functional characterization of both coding and long non-coding RNA (lncRNA) genes by CRISPR activation was performed. For lncRNA functional assessment, we developed a CRISPR activation of lncRNA (CaLR) strategy, targeting 14,701 lncRNA genes. Computational and functional analysis identified novel cell-cycle, survival/apoptosis, and cancer signaling genes. Furthermore, transcriptional activation of the GAS6-AS2 lncRNA, identified in our analysis, leads to hyperactivation of the GAS6/TAM pathway, a resistance mechanism in multiple cancers including AML. Thus, DICaS represents a novel and powerful approach to identify integrated coding and non-coding pathways of therapeutic relevance.	[Bester, Assaf C.; Lee, Jonathan D.; Lee, Yu-Ru; Nachmani, Daphna; Victor, Joshua; Clohessy, John G.; Pandolfi, Pier Paolo] Harvard Med Sch, Canc Res Inst, Dept Med & Pathol, Beth Israel Deaconess Canc Ctr, Boston, MA 02115 USA; [Bester, Assaf C.; Lee, Jonathan D.; Lee, Yu-Ru; Nachmani, Daphna; Victor, Joshua; Clohessy, John G.; Pandolfi, Pier Paolo] Harvard Med Sch, Ludwig Ctr Harvard, Boston, MA 02115 USA; [Chavez, Alejandro; Vora, Suhani; Church, George M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Chavez, Alejandro] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, 630 W 168th St, New York, NY 10032 USA; [Chavez, Alejandro] Columbia Univ Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, 630 W 168th St, New York, NY 10032 USA; [Monteleone, Emanuele; Provero, Paolo] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Monteleone, Emanuele; Provero, Paolo] Univ Turin, GenoBiToUS, Genom & Bioinformat Serv, Turin, Italy; [Provero, Paolo] Ist Sci San Raffaele, Ctr Translat Genom & Bioinformat, IRCCS, Milan, Italy; [Sauvageau, Martin; Rinn, John L.] Harvard Univ, Broad Inst MIT & Harvard, Dept Stem Cell & Regenerat Biol, Cambridge, MA USA; [Clohessy, John G.] Harvard Med Sch, Preclin Murine Pharmacogenet Facil, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Clohessy, John G.] Harvard Med Sch, Mouse Hosp, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Sauvageau, Martin] IRCM, Funct Genom & Noncoding RNAs Res Unit, Montreal, PQ, Canada; [Sauvageau, Martin] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ, Canada	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Columbia University; Columbia University; University of Turin; University of Turin; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal	Pandolfi, PP (corresponding author), Harvard Med Sch, Canc Res Inst, Dept Med & Pathol, Beth Israel Deaconess Canc Ctr, Boston, MA 02115 USA.; Pandolfi, PP (corresponding author), Harvard Med Sch, Ludwig Ctr Harvard, Boston, MA 02115 USA.	ppandolf@bidmc.harvard.edu	Monteleone, Emanuele/AAC-4847-2022; Lee, Yu-Ru/AAH-6409-2021; Bester, Assaf/ABG-1707-2021; Provero, Paolo/AAC-1930-2019	Monteleone, Emanuele/0000-0001-7440-900X; Pandolfi, Pier Paolo/0000-0002-5352-5295; Sauvageau, Martin/0000-0001-9487-5016; Lee, Yu-Ru/0000-0001-6592-6806; Lee, Jonathan/0000-0002-1229-0098; Clohessy, John/0000-0001-5186-9775; Victor, Joshua/0000-0002-6304-898X; church, george/0000-0001-6232-9969	EMBO Long-Term Fellowship [ALTF 318-2013]; Fulbright awards; NCI [5T32CA009216-34]; Burroughs Wellcome Fund Career Award for Medical Scientists; NIH [RM1 HG008525, P50 HG005550]; NIH NCI R35 grant [CA197529]; Ludwig Center at Harvard; Common Fund of the Office of the Director of the NIH; NATIONAL CANCER INSTITUTE [R35CA197529, T32CA009216] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RM1HG008525, P50HG005550] Funding Source: NIH RePORTER	EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Fulbright awards; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NCI R35 grant; Ludwig Center at Harvard; Common Fund of the Office of the Director of the NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors would like to thank Rory Kirchner of the Harvard Chan Bioinformatics Core, Harvard T.H. Chan School of Public Health, Boston, MA for assistance with computational analysis. The authors would like to thank Davide Cora and Claudio Isella of the Department of Oncology, and Genomics, Genomics and Bioinformatics Service, University of Turin, Italy for assistance with computational analysis. We thank the P.P.P. laboratory members for critical discussions. This work was supported by EMBO Long-Term Fellowship (ALTF 318-2013) and Fulbright awards to A.C.B. A.C. was funded by NCI (5T32CA009216-34) and a Burroughs Wellcome Fund Career Award for Medical Scientists. G.M.C was supported by NIH (RM1 HG008525 and P50 HG005550). P.P.P. is supported by an NIH NCI R35 grant (CA197529) and through support from the Ludwig Center at Harvard. The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the NIH. The data used for the analyses described in this manuscript were obtained from the GTEx Portal. The results published here are fully or partially based on data generated by the Cancer Target Discovery and Development (CTD<SUP>2</SUP>) Network established by the NCI Office of Cancer Genomics.	Abraham A, 2015, PHARMACOGENOMICS, V16, P877, DOI [10.2217/PGS.15.44, 10.2217/pgs.15.44]; Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/NMETH.3871, 10.1038/nmeth.3871]; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/NMETH.3312, 10.1038/nmeth.3312]; Cheng JL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-113; Cheng ZX, 2013, CLIN CANCER RES, V19, P1748, DOI 10.1158/1078-0432.CCR-12-3066; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Di Ruscio A, 2013, NATURE, V503, P371, DOI 10.1038/nature12598; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Garzon R, 2014, P NATL ACAD SCI USA, V111, P18679, DOI 10.1073/pnas.1422050112; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Herold N, 2017, NAT MED, V23, P256, DOI 10.1038/nm.4265; Hon CC, 2017, NATURE, V543, P199, DOI 10.1038/nature21374; Hong CC, 2008, CANCER LETT, V268, P314, DOI 10.1016/j.canlet.2008.04.017; Hu XW, 2014, CANCER CELL, V26, P344, DOI 10.1016/j.ccr.2014.07.009; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Joung J, 2017, NATURE, V548, P343, DOI 10.1038/nature23451; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Kaimal V, 2010, NUCLEIC ACIDS RES, V38, pW96, DOI 10.1093/nar/gkq418; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kassambara A, 2017, SURVMINER DRAWING SU; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lamba JK, 2009, PHARMACOGENOMICS, V10, P1657, DOI [10.2217/pgs.09.118, 10.2217/PGS.09.118]; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2015, CANCER RES, V75, P3728, DOI 10.1158/0008-5472.CAN-15-0273; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aah7111; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mudduluru G, 2008, BIOSCIENCE REP, V28, P161, DOI 10.1042/BSR20080046; Perron U, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1535-x; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Ramos NR, 2015, J CLIN MED, V4, P665, DOI 10.3390/jcm4040665; Rees MG, 2016, NAT CHEM BIOL, V12, P109, DOI [10.1038/NCHEMBIO.1986, 10.1038/nchembio.1986]; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Saland E, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.19; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider C, 2017, NAT MED, V23, P250, DOI 10.1038/nm.4255; Schoumacher M, 2017, CURR ONCOL REP, V19, DOI 10.1007/s11912-017-0579-4; Sergushichev A., 2016, BIORXIV, DOI [10.1101/060012, DOI 10.1101/060012]; Shechner DM, 2015, NAT METHODS, V12, P664, DOI [10.1038/NMETH.3433, 10.1038/nmeth.3433]; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stavropoulou V, 2016, CANCER CELL, V30, P43, DOI 10.1016/j.ccell.2016.05.011; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu GL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.113; Xu L, 2017, P NATL ACAD SCI USA, V114, P3981, DOI 10.1073/pnas.1609758114; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111	62	174	180	10	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2018	173	3					649	+		10.1016/j.cell.2018.03.052	http://dx.doi.org/10.1016/j.cell.2018.03.052			36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7GB	29677511	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000430677400015
J	Slawther, E				Slawther, Eliza			NHS's first humanist chaplain: five minutes with ... Lindsay van Dijk	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2018	361								k1686	10.1136/bmj.k1686	http://dx.doi.org/10.1136/bmj.k1686			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8WP	29669723				2022-12-28	WOS:000430795200008
J	Wood, AM; Kaptoge, S; Butterworth, AS; Willeit, P; Warnakula, S; Bolton, T; Paige, E; Paul, DS; Sweeting, M; Burgess, S; Bell, S; Astle, W; Stevens, D; Koulman, A; Selmer, RM; Verschuren, WMM; Sato, S; Njolstad, I; Woodward, M; Salomaa, V; Nordestgaard, BG; Yeap, BB; Fletcher, A; Melander, O; Kuller, LH; Balkau, B; Marmot, M; Koenig, W; Casiglia, E; Cooper, C; Arndt, V; Franco, OH; Wennberg, P; Gallacher, J; de la Camara, AG; Volzke, H; Dahm, CC; Dale, CE; Bergmann, MM; Crespo, CJ; van der Schouw, YT; Kaaks, R; Simons, LA; Lagiou, P; Schoufour, JD; Boer, JMA; Key, TJ; Rodriguez, B; Moreno-Iribas, C; Davidson, KW; Taylor, JO; Sacerdote, C; Wallace, RB; Quiros, JR; Tumino, R; Blazer, DG; Linneberg, A; Daimon, M; Panico, S; Howard, B; Skeie, G; Strandberg, T; Weiderpass, E; Nietert, PJ; Psaty, BM; Kromhout, D; Salamanca-Fernandez, E; Kiechl, S; Krumholz, HM; Grioni, S; Palli, D; Huerta, JM; Price, J; Sundstrom, J; Arriola, L; Arima, H; Travis, RC; Panagiotakos, DB; Karakatsani, A; Trichopoulou, A; Kuhn, T; Grobbee, DE; Barrett-Connor, E; van Schoor, N; Boeing, H; Overvad, K; Kauhanen, J; Wareham, N; Langenberg, C; Forouhi, N; Wennberg, M; Despres, JP; Cushman, M; Cooper, JA; Rodriguez, CJ; Sakurai, M; Shaw, JE; Knuiman, M; Voortman, T; Meisinger, C; Tjonneland, A; Brenner, H; Palmieri, L; Dallongeville, J; Brunner, EJ; Assmann, G; Trevisan, M; Gillum, RF; Ford, I; Sattar, N; Lazo, M; Thompson, SG; Ferrari, P; Leon, DA; Smith, GD; Peto, R; Jackson, R; Banks, E; Di Angelantonio, E; Danesh, J				Wood, Angela M.; Kaptoge, Stephen; Butterworth, Adam S.; Willeit, Peter; Warnakula, Samantha; Bolton, Thomas; Paige, Ellie; Paul, Dirk S.; Sweeting, Michael; Burgess, Stephen; Bell, Steven; Astle, William; Stevens, David; Koulman, Albert; Selmer, Randi M.; Verschuren, W. M. Monique; Sato, Shinichi; Njolstad, Inger; Woodward, Mark; Salomaa, Veikko; Nordestgaard, Borge G.; Yeap, Bu B.; Fletcher, Astrid; Melander, Olle; Kuller, Lewis H.; Balkau, Beverley; Marmot, Michael; Koenig, Wolfgang; Casiglia, Edoardo; Cooper, Cyrus; Arndt, Volker; Franco, Oscar H.; Wennberg, Patrik; Gallacher, John; de la Camara, Agustin Gomez; Volzke, Henry; Dahm, Christina C.; Dale, Caroline E.; Bergmann, Manuela M.; Crespo, Carlos J.; van der Schouw, Yvonne T.; Kaaks, Rudolf; Simons, Leon A.; Lagiou, Pagona; Schoufour, Josje D.; Boer, Jolanda M. A.; Key, Timothy J.; Rodriguez, Beatriz; Moreno-Iribas, Conchi; Davidson, Karina W.; Taylor, James O.; Sacerdote, Carlotta; Wallace, Robert B.; Quiros, J. Ramon; Tumino, Rosario; Blazer, Dan G., II; Linneberg, Allan; Daimon, Makoto; Panico, Salvatore; Howard, Barbara; Skeie, Guri; Strandberg, Timo; Weiderpass, Elisabete; Nietert, Paul J.; Psaty, Bruce M.; Kromhout, Daan; Salamanca-Fernandez, Elena; Kiechl, Stefan; Krumholz, Harlan M.; Grioni, Sara; Palli, Domenico; Huerta, Jose M.; Price, Jackie; Sundstrom, Johan; Arriola, Larraitz; Arima, Hisatomi; Travis, Ruth C.; Panagiotakos, Demosthenes B.; Karakatsani, Anna; Trichopoulou, Antonia; Kuhn, Tilman; Grobbee, Diederick E.; Barrett-Connor, Elizabeth; van Schoor, Natasja; Boeing, Heiner; Overvad, Kim; Kauhanen, Jussi; Wareham, Nick; Langenberg, Claudia; Forouhi, Nita; Wennberg, Maria; Despres, Jean-Pierre; Cushman, Mary; Cooper, Jackie A.; Rodriguez, Carlos J.; Sakurai, Masaru; Shaw, Jonathan E.; Knuiman, Matthew; Voortman, Trudy; Meisinger, Christa; Tjonneland, Anne; Brenner, Hermann; Palmieri, Luigi; Dallongeville, Jean; Brunner, Eric J.; Assmann, Gerd; Trevisan, Maurizio; Gillum, Richard F.; Ford, Ian; Sattar, Naveed; Lazo, Mariana; Thompson, Simon G.; Ferrari, Pietro; Leon, David A.; Smith, George Davey; Peto, Richard; Jackson, Rod; Banks, Emily; Di Angelantonio, Emanuele; Danesh, John		Emerging Risk Factors Collabora	Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies	LANCET			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; ASSOCIATION; MORTALITY; STROKE; METAANALYSIS; CANCER; CHOLESTEROL; PATTERN	Background Low-risk limits recommended for alcohol consumption vary substantially across different national guidelines. To define thresholds associated with lowest risk for all-cause mortality and cardiovascular disease, we studied individual-participant data from 599 912 current drinkers without previous cardiovascular disease. Methods We did a combined analysis of individual-participant data from three large-scale data sources in 19 high-income countries (the Emerging Risk Factors Collaboration, EPIC-CVD, and the UK Biobank). We characterised dose-response associations and calculated hazard ratios (HRs) per 100 g per week of alcohol (12.5 units per week) across 83 prospective studies, adjusting at least for study or centre, age, sex, smoking, and diabetes. To be eligible for the analysis, participants had to have information recorded about their alcohol consumption amount and status (ie, non-drinker vs current drinker), plus age, sex, history of diabetes and smoking status, at least 1 year of follow-up after baseline, and no baseline history of cardiovascular disease. The main analyses focused on current drinkers, whose baseline alcohol consumption was categorised into eight predefined groups according to the amount in grams consumed per week. We assessed alcohol consumption in relation to all-cause mortality, total cardiovascular disease, and several cardiovascular disease subtypes. We corrected HRs for estimated long-term variability in alcohol consumption using 152 640 serial alcohol assessments obtained some years apart (median interval 5.6 years [5th-95th percentile 1.04-13.5]) from 71 011 participants from 37 studies. Findings In the 599 912 current drinkers included in the analysis, we recorded 40 310 deaths and 39 018 incident cardiovascular disease events during 5.4 million person-years of follow-up. For all-cause mortality, we recorded a positive and curvilinear association with the level of alcohol consumption, with the minimum mortality risk around or below 100 g per week. Alcohol consumption was roughly linearly associated with a higher risk of stroke (HR per 100 g per week higher consumption 1.14, 95% CI, 1.10-1.17), coronary disease excluding myocardial infarction (1.06, 1.00-1.11), heart failure (1.09, 1.03-1.15), fatal hypertensive disease (1.24, 1.15-1.33); and fatal aortic aneurysm (1.15, 1.03-1.28). By contrast, increased alcohol consumption was loglinearly associated with a lower risk of myocardial infarction (HR 0.94, 0.91-0.97). In comparison to those who reported drinking >0-<= 100 g per week, those who reported drinking >100-<= 200 g per week, >200-<= 350 g per week, or >350 g per week had lower life expectancy at age 40 years of approximately 6 months, 1-2 years, or 4-5 years, respectively. Interpretation In current drinkers of alcohol in high-income countries, the threshold for lowest risk of all-cause mortality was about 100 g/week. For cardiovascular disease subtypes other than myocardial infarction, there were no clear risk thresholds below which lower alcohol consumption stopped being associated with lower disease risk. These data support limits for alcohol consumption that are lower than those recommended in most current guidelines. Copyright (C) The Author(s). Published by Elsevier Ltd.	[Wood, Angela M.; Kaptoge, Stephen; Butterworth, Adam S.; Willeit, Peter; Warnakula, Samantha; Bolton, Thomas; Paul, Dirk S.; Sweeting, Michael; Burgess, Stephen; Bell, Steven; Astle, William; Stevens, David; Thompson, Simon G.; Di Angelantonio, Emanuele; Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Willeit, Peter; Kiechl, Stefan] Med Univ Innsbruck, Innsbruck, Austria; [Paige, Ellie; Banks, Emily] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Burgess, Stephen] Univ Cambridge, Cambridge Inst Publ Hlth, MRC Biostat Unit, Cambridge, England; [Koulman, Albert] Univ Cambridge, NIHR BRC Nutr Biomarker Lab, Cambridge, England; [Selmer, Randi M.] Norwegian Inst Publ Hlth, Oslo, Norway; [Verschuren, W. M. Monique; Boer, Jolanda M. A.] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands; [Verschuren, W. M. Monique; van der Schouw, Yvonne T.; Grobbee, Diederick E.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Sato, Shinichi] Chiba Prefectural Inst Publ Hlth, Chiba, Japan; [Njolstad, Inger] Univ Tromso, Dept Community Med, Tromso, Norway; [Woodward, Mark; Key, Timothy J.; Travis, Ruth C.] Univ Oxford, Nuffield Dept Populat Hlth, Med Sci Div, Oxford, England; [Woodward, Mark] Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia; [Woodward, Mark] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Lazo, Mariana] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Salomaa, Veikko] THL Natl Inst Hlth & Welf, Helsinki, Finland; [Nordestgaard, Borge G.] Copenhagen Univ Hosp, Copenhagen, Denmark; [Nordestgaard, Borge G.; Linneberg, Allan] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Yeap, Bu B.] Univ Western Australia, Sch Med, Perth, WA, Australia; [Yeap, Bu B.] Fiona Stanley Hosp, Perth, WA, Australia; [Yeap, Bu B.] Harry Perkins Inst Med Res, Perth, WA, Australia; [Fletcher, Astrid; Leon, David A.] London Sch Hyg & Trop Med, London, England; [Melander, Olle] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Kuller, Lewis H.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Balkau, Beverley] INSERM, UMRS 1018, CESP, Villejuif, France; [Marmot, Michael; Cooper, Jackie A.; Brunner, Eric J.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Koenig, Wolfgang] Tech Univ Munich, Deutsch Herzzentrum Munchen 92, DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Ulm, Germany; [Casiglia, Edoardo] Univ Padua, Dept Med, Padua, Italy; [Cooper, Cyrus] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Arndt, Volker; Kaaks, Rudolf; Kuhn, Tilman; Brenner, Hermann] German Canc Res Ctr, Heidelberg, Germany; [Franco, Oscar H.; Schoufour, Josje D.; Voortman, Trudy] Erasmus Univ, Med Ctr, Rotterdam, Netherlands; [Wennberg, Patrik; Wennberg, Maria] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Gallacher, John] Cardiff Univ, Dept Primary Care & Publ Hlth, Cardiff, S Glam, Wales; [de la Camara, Agustin Gomez] CIBERESP, Octubre Res Inst 12, Madrid, Spain; [Volzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Dahm, Christina C.; Overvad, Kim] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark; [Dale, Caroline E.] UCL, UCL Inst Hlth Informat, Farr Inst Hlth Informat Res, London, England; [Bergmann, Manuela M.; Boeing, Heiner] German Inst Human Nutr, Potsdam, Germany; [Crespo, Carlos J.] Portland State Univ, Sch Community Hlth, Portland, OR 97207 USA; [Simons, Leon A.] Univ New South Wales, St Vincents Clin Sch, Sydney, NSW, Australia; [Lagiou, Pagona; Karakatsani, Anna; Trichopoulou, Antonia] Hellen Hlth Fdn, Athens, Greece; [Lagiou, Pagona; Karakatsani, Anna; Trichopoulou, Antonia] Univ Athens, Athens, Greece; [Lagiou, Pagona] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Rodriguez, Beatriz] Univ Hawaii, Off Publ Hlth Studies, Honolulu, HI 96822 USA; [Moreno-Iribas, Conchi] Navarra Inst Hlth Res, IdiSNA, Inst Salud Publ Navarra, Pamplona, Spain; [Moreno-Iribas, Conchi] Red Invest Serv Salud Enfermedades Cronicas REDIS, Pamplona, Spain; [Davidson, Karina W.] Columbia Univ Irving, Med Ctr, New York, NY USA; [Taylor, James O.] East Boston Neighborhood Hlth Ctr, Boston, MA USA; [Sacerdote, Carlotta] Citta Salute Sci Torino Hosp, Turin, Italy; [Wallace, Robert B.] Univ Iowa, Coll Publ Hlth, Iowa City, IA USA; [Quiros, J. Ramon] Consejeria Sanidad Principado Asturias, Oviedo, Asturias, Spain; [Tumino, Rosario] ASP, Civic M Arezzo Hosp, Ragusa, Italy; [Blazer, Dan G., II] Duke Univ, Duke Div Sch, Durham, NC USA; [Daimon, Makoto] Hirosaki Univ, Dept Endocrinol & Metab, Hirosaki, Aomori, Japan; [Panico, Salvatore] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Howard, Barbara] Tuskegee Univ, Dept Biol, Tuskegee, AL 36088 USA; [Skeie, Guri; Weiderpass, Elisabete] UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway; [Strandberg, Timo] Univ Helsinki, Helsinki, Finland; [Strandberg, Timo] Helsinki Univ Hosp, Helsinki, Finland; [Strandberg, Timo] Univ Oulu, Ctr Life Course Hlth Res, Oulu, Finland; [Weiderpass, Elisabete] Canc Registry Norway, Inst Population Based Canc Res, Oslo, Norway; [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Weiderpass, Elisabete] Univ Helsinki, Epidemiol Grp, Folkhalsan Res Ctr, Fac Med, Helsinki, Finland; [Nietert, Paul J.] Univ South Carolina, Med, Charleston, SC USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA; [Kromhout, Daan] Wageningen Univ, Dept Agrotechnol & Food Sci, Wageningen, Netherlands; [Kromhout, Daan] Univ Groningen, Univ Med Ctr Groningen, Fac Med Sci, Groningen, Netherlands; [Salamanca-Fernandez, Elena] Univ Granada, Hospit Univ Granada, Inst Invest Biosanitaria ibs GRANADA, Escuela Andaluza Salud Publ, Granada, Spain; [Salamanca-Fernandez, Elena; Huerta, Jose M.; Arriola, Larraitz] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Kromhout, Daan] Yale Univ, Sch Med, New Haven, CT USA; [Grioni, Sara] Fdn IRCCS Ist Nazl Tumori, Epidemiol & Prevent Unit, Milan, Italy; [Palli, Domenico] Canc Res & Prevent Inst ISPO, Florence, Italy; [Huerta, Jose M.] IMIB Arrixaca, Murcia Reg Hlth Council, Murcia, Spain; [Price, Jackie] Univ Edinburgh, Usher Inst, Edinburgh, Midlothian, Scotland; [Sundstrom, Johan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Arriola, Larraitz] Basque Govt, Inst Biodonostia, San Sebastian, Spain; [Arima, Hisatomi] Univ Sydney, Sydney, NSW, Australia; [Arima, Hisatomi] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Arima, Hisatomi] Kyushu Univ, Dept Prevent Med & Publ Hlth, Fukuoka, Japan; [Panagiotakos, Demosthenes B.] Harokopio Univ, Sch Hlth Sci & Educ, Athens, Greece; [Barrett-Connor, Elizabeth] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA; [van Schoor, Natasja] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Overvad, Kim] Aalborg Univ Hosp, Aalborg, Denmark; [Kauhanen, Jussi] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Wareham, Nick; Langenberg, Claudia; Forouhi, Nita] Univ Cambridge, Med Res Council Epidemiol Unit, Cambridge, England; [Despres, Jean-Pierre] Laval Univ, Dept Kinesiol, Quebec City, PQ, Canada; [Cushman, Mary] Univ Vermont, Dept Med, Burlington, VT USA; [Rodriguez, Carlos J.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; [Rodriguez, Carlos J.] Wake Forest Baptist Med Ctr, Winston Salem, NC USA; [Sakurai, Masaru] Kanazawa Med Univ, Dept Social & Environm Med, Kanazawa, Ishikawa, Japan; [Shaw, Jonathan E.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Knuiman, Matthew] Populat Med Res Inst, Busselton, WA, Australia; [Knuiman, Matthew] Univ Western Australia, Sch Populat & Global Hlth, Perth, WA, Australia; [Meisinger, Christa] Helmholtz Zentrum Munchen German Res Ctr Environm, Munich, Germany; [Tjonneland, Anne] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Brenner, Hermann] Heidelberg Univ, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Palmieri, Luigi] Ist Supe Sanita, Rome, Italy; [Dallongeville, Jean] Inst Pasteur, Lille, France; [Assmann, Gerd] Assmann Stiftung Pravent, Munster, Germany; [Trevisan, Maurizio] CUNY City Coll, New York, NY USA; [Gillum, Richard F.] Howard Univ Hosp, Washington, DC USA; [Ford, Ian; Sattar, Naveed] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Ferrari, Pietro] Int Agcy Res Canc, Lyon, France; [Smith, George Davey] Univ Bristol, MRC Integrat Epidemiol Unit IEU, Bristol, Avon, England; [Jackson, Rod] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand	University of Cambridge; Medical University of Innsbruck; Australian National University; MRC Biostatistics Unit; University of Cambridge; University of Cambridge; Norwegian Institute of Public Health (NIPH); Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; UiT The Arctic University of Tromso; University of Oxford; George Institute for Global Health; University of Sydney; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Finland National Institute for Health & Welfare; University of Copenhagen; University of Copenhagen; University of Western Australia; Harry Perkins Institute of Medical Research; University of London; London School of Hygiene & Tropical Medicine; Lund University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; German Centre for Cardiovascular Research; German Heart Centre Munich; Munich Heart Alliance; Technical University of Munich; Ulm University; University of Padua; University of Southampton; Helmholtz Association; German Cancer Research Center (DKFZ); Erasmus University Rotterdam; Erasmus MC; Umea University; Cardiff University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Greifswald Medical School; Aarhus University; University of London; University College London; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Portland State University; University of New South Wales Sydney; National & Kapodistrian University of Athens; Harvard University; Harvard T.H. Chan School of Public Health; University of Hawaii System; Public Health Institute of Navarra; NewYork-Presbyterian Hospital; A.O.U. Citta della Salute e della Scienza di Torino; University of Iowa; Civile M.P. Arezzo Hospital; Duke University; Hirosaki University; University of Naples Federico II; Tuskegee University; UiT The Arctic University of Tromso; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Oulu; University of Oslo; Karolinska Institutet; Folkhalsan Research Center; University of Helsinki; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kaiser Permanente; Wageningen University & Research; University of Groningen; Escuela Andaluza de Salud Publica; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Yale University; Fondazione IRCCS Istituto Nazionale Tumori Milan; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Hospital Clinico Universitario Virgen de la Arrixaca; Murcia Regional Health Council; University of Edinburgh; Uppsala University; Basque Government; Instituto de Investigacion Sanitaria Biodonostia; University of Sydney; University of Sydney; Kyushu University; Harokopio University Athens; University of California System; University of California San Diego; Vrije Universiteit Amsterdam; Aalborg University; Aalborg University Hospital; University of Eastern Finland; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; Laval University; University of Vermont; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Kanazawa Medical University; Baker Heart and Diabetes Institute; University of Western Australia; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Danish Cancer Society; Ruprecht Karls University Heidelberg; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; City University of New York (CUNY) System; City College of New York (CUNY); Howard University; University of Glasgow; World Health Organization; International Agency for Research on Cancer (IARC); University of Bristol; University of Auckland	Wood, AM; Danesh, J (corresponding author), Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Emerging Risk Factors Collaborat & EPIC CVD Coord, Cambridge CB1 8RN, England.	amw79@medschl.cam.ac.uk; jd292@medschl.cam.ac.uk	Weiderpass, Elisabete/M-4029-2016; Brunner, Eric/H-2114-2011; Huerta, José María/N-8654-2015; Brenner, Hermann/ABE-6383-2020; /AAM-5330-2020; Meisinger, Christine/B-5358-2014; Paul, Dirk S./H-3469-2019; Sakurai, Masaru/AAC-6551-2021; Langenberg, Claudia/ABG-9067-2021; Panagiotakos, Demosthenes/C-9776-2013; Franco, Óscar H/ABE-2305-2020; Brenner, Hermann/B-4627-2017; wei, yuki/AAF-9999-2021; , Harlan/AAI-2875-2020; Grioni, Sara/K-5320-2016; Panagiotakos, Demosthenes/K-8294-2019; Koulman, Albert/B-2967-2009; Arndt, Volker/B-4999-2014; Woodward, Mark/L-6817-2017; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Arndt, Volker/AAI-7282-2020; Karakatsani, Anna/J-1862-2019; Sundstrom, Johan/R-2139-2019; Salamanca-Fernandez, Elena/R-5943-2016; DiAngelantonio, Emanuele/ABE-6852-2020; van der Schouw, Yvonne T./F-8327-2014; Marmot, M G/Y-3920-2019; Dahm, Christina C/G-9787-2014; Nordestgaard, Borge Gronne/ABF-1310-2020; Davidson, Karina/AAG-2388-2019; Njolstad, Inger/X-3784-2019; de la Camara, Agustin Gomez/S-7123-2018; Leon, David A/G-2195-2010; Ford, Ian/ABE-6145-2020; Weiderpass, Elisabete/AAP-2747-2021; Davidson, Karina/GWC-0996-2022; Davey Smith, George/A-7407-2013; Sweeting, Michael John/U-3917-2019; Kauhanen, Jussi/ABC-4064-2021; Panagiotakos, Demosthenes/M-9167-2019; Wood, Angela/GZA-5762-2022; Daimon, Makoto/AAY-1289-2020; Voortman, Trudy/C-2963-2015; Sundström, Johan/A-6286-2009; Willeit, Peter/HCI-7091-2022; PALMIERI, LUIGI/O-1845-2017	Weiderpass, Elisabete/0000-0003-2237-0128; Brunner, Eric/0000-0002-0595-4474; Huerta, José María/0000-0002-9637-3869; Brenner, Hermann/0000-0002-6129-1572; Paul, Dirk S./0000-0002-8230-0116; Sakurai, Masaru/0000-0002-4929-3225; Langenberg, Claudia/0000-0002-5017-7344; Panagiotakos, Demosthenes/0000-0001-8583-153X; Franco, Óscar H/0000-0002-4606-4929; Brenner, Hermann/0000-0002-6129-1572; Grioni, Sara/0000-0002-5891-8426; Koulman, Albert/0000-0001-9998-051X; Arndt, Volker/0000-0001-9320-8684; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Arndt, Volker/0000-0001-9320-8684; Karakatsani, Anna/0000-0002-3275-2026; Sundstrom, Johan/0000-0003-2247-8454; Salamanca-Fernandez, Elena/0000-0002-1795-2206; van der Schouw, Yvonne T./0000-0002-4605-435X; Marmot, M G/0000-0002-2431-6419; Dahm, Christina C/0000-0003-0481-2893; Davidson, Karina/0000-0002-9162-477X; Leon, David A/0000-0001-9747-1762; Weiderpass, Elisabete/0000-0003-2237-0128; Davidson, Karina/0000-0002-9162-477X; Davey Smith, George/0000-0002-1407-8314; Sweeting, Michael John/0000-0003-0980-8965; Panagiotakos, Demosthenes/0000-0001-8583-153X; Wood, Angela/0000-0002-7937-304X; Daimon, Makoto/0000-0002-3775-1719; Voortman, Trudy/0000-0003-2830-6813; Sundström, Johan/0000-0003-2247-8454; Willeit, Peter/0000-0002-1866-7159; PALMIERI, LUIGI/0000-0002-4298-2642; Melander, Olle/0000-0002-2581-484X; Woodward, Mark/0000-0001-9800-5296; Overvad, Kim/0000-0001-6429-7921; Di Angelantonio, Emanuele/0000-0001-8776-6719; Cooper, Cyrus/0000-0003-3510-0709; Rasul, holem/0000-0003-0579-9029; Stevens, David/0000-0001-8874-7122; Bell, Steven/0000-0001-6774-3149; Gomez de la Camara, Agustin/0000-0001-6827-6319; Nordestgaard, Borge/0000-0002-1954-7220; Tjonneland, Anne/0000-0003-4385-2097; Banks, Emily/0000-0002-4617-1302; Paige, Ellie/0000-0003-0855-9872; Linneberg, Allan/0000-0002-0994-0184; Nietert, Paul/0000-0002-3933-4986; Burgess, Stephen/0000-0001-5365-8760; tumino, rosario/0000-0003-2666-414X; Sacerdote, Carlotta/0000-0002-8008-5096; Gallacher, John/0000-0002-2394-5299; Dale, Caroline/0000-0002-3889-8974; van Schoor, Natasja/0000-0002-0870-0795; Astle, William John/0000-0001-8866-6672; strandberg, timo/0000-0001-6299-925X; Knuiman, Matthew/0000-0001-8874-2305; Koenig, Wolfgang/0000-0002-2064-9603; Forouhi, Nita/0000-0002-5041-248X	UK Medical Research Council; British Heart Foundation; National Institute for Health Research; European Union Framework 7; European Research Council; UK Medical Research Council [G0800270, MR/L003120/1]; British Heart Foundation [SP/09/002, RG/08/014, RG13/13/30194]; National Institute for Health Research (National Institute for Health Research Cambridge Biomedical Research Centre); European Commission Framework 7 (the EPIC-CVD award) [HEALTH-F2-2012-279233]; European Research Council [268834]; EU FP6 programme [LSHM_CT_2006_037197]; EPIC centres; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA025286] Funding Source: NIH RePORTER; MRC [G0700463, MC_UU_12012/5, MC_UU_00002/7, MC_UU_12015/1, G0701619, G0800270, MC_U147585827, G0400491, MR/N003284/1, MR/R024227/1, MC_UU_12015/5, MR/K014811/1, MC_UU_00011/1, MR/K013351/1, MC_U147585819, MR/L003120/1] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR)); European Union Framework 7; European Research Council(European Research Council (ERC)European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); National Institute for Health Research (National Institute for Health Research Cambridge Biomedical Research Centre); European Commission Framework 7 (the EPIC-CVD award); European Research Council(European Research Council (ERC)European Commission); EU FP6 programme(European Commission); EPIC centres; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	UK Medical Research Council, British Heart Foundation, National Institute for Health Research, European Union Framework 7, and European Research Council.r The study's coordinating centre (Emerging Risk Factors Collaboration and EPIC-CVD Coordinating Centres, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK) has been underpinned by grants from the UK Medical Research Council (G0800270 and MR/L003120/1), British Heart Foundation (SP/09/002, RG/08/014 and RG13/13/30194), National Institute for Health Research (through the National Institute for Health Research Cambridge Biomedical Research Centre), European Commission Framework 7 (through the EPIC-CVD award; HEALTH-F2-2012-279233), and the European Research Council (through an Advanced Investigator Award to JD; 268834). JD holds a BHF Professorship and NIHR Senior Investigator Award. A study website Funding for the EPIC-InterAct project was provided by the EU FP6 programme (grant number LSHM_CT_2006_037197). A study website includes a list that investigators have provided of funding agencies that have supported individual EPIC centres. A study website includes a list that investigators have provided of funding agencies that have supported individual cohorts of the ERFC contributing to the present consortium. This research has been conducted using the UK Biobank resource (application 21886). We thank Nicola Kerrison and Stephen Sharp (both from the University of Cambridge MRC Epidemiology Unit, Cambridge, UK) for the former's data management in the EPIC-InterAct subcohort and the latter's statistical input into development of the EPIC-CVD's analytical guidelines.	Ahmed I, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7762; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bell S, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j909; Bergmann MM, 2013, INT J EPIDEMIOL, V42, P1772, DOI 10.1093/ije/dyt154; Boffetta P, 1990, Epidemiology, V1, P342, DOI 10.1097/00001648-199009000-00003; Brien SE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d636; Centers for Disease Control and Prevention National Center for Health Statistics, UND CAUS DEATH 1999; Chen L, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050052; Cho Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep18422; Conen D, 2015, EUR HEART J, V36, P897, DOI 10.1093/eurheartj/ehv021; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Danesh J, 2007, EUR J EPIDEMIOL, V22, P129, DOI 10.1007/s10654-006-9096-8; Del Boca FK, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1359-6357.2003.00586.x; Department of Health, 2016, ALC GUID REV REP GUI; Di Angelantonio E, 2015, JAMA-J AM MED ASSOC, V314, P52, DOI 10.1001/jama.2015.7008; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Emberson JR, 2006, VASC HEALTH RISK MAN, V2, P239, DOI 10.2147/vhrm.2006.2.3.239; Fat LN, 2014, J EPIDEMIOL COMMUN H, V68, P71, DOI 10.1136/jech-2013-202576; Ferrari P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005245; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164; HPS3 TIMI55-REVEAl Collaborative, 2017, NEW ENGL J MED, V377, P1217, DOI 10.1056/NEJMoa1706444; Hvidtfeldt UA, 2010, CIRCULATION, V121, P1589, DOI 10.1161/CIRCULATIONAHA.109.887513; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC MONOGR EVAL CAR, V100, P1; Jackson R, 2005, LANCET, V366, P1911, DOI 10.1016/S0140-6736(05)67770-7; Kalinowski A, 2016, ADDICTION, V111, P1293, DOI 10.1111/add.13341; Kiechl S, 2014, CIRCULATION, V130, P383, DOI 10.1161/CIRCULATIONAHA.114.011036; Knott CS, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.h384, 10.1136/BMJ.h384]; Lazo M, 2016, CLIN CHEM, V62, P1202, DOI 10.1373/clinchem.2016.255778; Leong DP, 2014, CIRCULATION, V130, P390, DOI 10.1161/CIRCULATIONAHA.113.007627; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mukamal KJ, 2016, ALCOHOL CLIN EXP RES, V40, P2283, DOI 10.1111/acer.13231; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; Patra J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-258; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Roerecke M, 2012, ADDICTION, V107, P1246, DOI 10.1111/j.1360-0443.2012.03780.x; Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Smyth A, 2015, LANCET, V386, P1945, DOI 10.1016/S0140-6736(15)00235-4; STAMPFER MJ, 1988, NEW ENGL J MED, V319, P267, DOI 10.1056/NEJM198808043190503; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Taylor AE, 2015, SCI REP-UK, V5, DOI 10.1038/srep14005; Thompson S, 2010, INT J EPIDEMIOL, V39, P1345, DOI 10.1093/ije/dyq063; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401; UN Population Division, 2005, WORLD POP PROSP; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wood AM, 2009, STAT MED, V28, P1067, DOI 10.1002/sim.3530; Wood A, 2006, INT J EPIDEMIOL, V35, P1570, DOI 10.1093/ije/dyl233; Woodward M, 2007, EUR HEART J, V28, P2653, DOI 10.1093/eurheartj/ehm427; World Health Organization, 2007, WHO STAT INF SYST WH; Wu ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078485; Xi B, 2017, J AM COLL CARDIOL, V70, P913, DOI 10.1016/j.jacc.2017.06.054; Yun KE, 2017, INT J EPIDEMIOL, V46, P950, DOI 10.1093/ije/dyw237; Zanoni P, 2016, SCIENCE, V351, P1166, DOI 10.1126/science.aad3517	57	588	623	16	137	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2018	391	10129					1513	1523		10.1016/S0140-6736(18)30134-X	http://dx.doi.org/10.1016/S0140-6736(18)30134-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GC6TS	29676281	hybrid, Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000429926000027
J	Yang, MM; Kim, DJ; Alexe, M				Yang, Ming-Min; Kim, Dong Jik; Alexe, Marin			Flexo-photovoltaic effect	SCIENCE			English	Article							SOLAR-CELLS; POLARIZATION; EFFICIENCY; CRYSTALS; LIMIT	It is highly desirable to discover photovoltaic mechanisms that enable enhanced efficiency of solar cells. Here we report that the bulk photovoltaic effect, which is free from the thermodynamic Shockley-Queisser limit but usually manifested only in noncentrosymmetric (piezoelectric or ferroelectric) materials, can be realized in any semiconductor, including silicon, by mediation of flexoelectric effect. We used either an atomic force microscope or a micrometer-scale indentation system to introduce strain gradients, thus creating very large photovoltaic currents from centrosymmetric single crystals of strontium titanate, titanium dioxide, and silicon. This strain gradient-induced bulk photovoltaic effect, which we call the flexo-photovoltaic effect, functions in the absence of a p-n junction. This finding may extend present solar cell technologies by boosting the solar energy conversion efficiency from a wide pool of established semiconductors.	[Yang, Ming-Min; Kim, Dong Jik; Alexe, Marin] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England	University of Warwick	Alexe, M (corresponding author), Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England.	m.alexe@warwick.ac.uk	Alexe, Marin/K-3882-2016; Kim, Dong Jik/C-4602-2011	Alexe, Marin/0000-0002-0386-3026; Kim, Dong Jik/0000-0003-1900-4629	University of Warwick; Royal Society; EPSRC (UK) [EP/M022706/1, EP/P031544/1, EP/P025803/1]; EPSRC [EP/P025803/1, EP/M022706/1] Funding Source: UKRI	University of Warwick; Royal Society(Royal Society of London); EPSRC (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	M.-M.Y. acknowledges the University of Warwick for a Chancellor's International Scholarship. M.A. acknowledges the Wolfson Research Merit and Theo Murphy Blue Skies awards from The Royal Society. This work was partly supported by the EPSRC (UK) through grants EP/M022706/1, EP/P031544/1, and EP/P025803/1.	BENNETT MS, 1983, J APPL PHYS, V54, P7159, DOI 10.1063/1.331987; Bhaskar UK, 2016, NAT NANOTECHNOL, V11, P263, DOI [10.1038/NNANO.2015.260, 10.1038/nnano.2015.260]; Bhatnagar A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3835; Breneman KD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005201; Chu MW, 2004, NAT MATER, V3, P87, DOI 10.1038/nmat1057; CHYNOWETH AG, 1956, PHYS REV, V102, P705, DOI 10.1103/PhysRev.102.705; Dumitrica T, 2002, CHEM PHYS LETT, V360, P182, DOI 10.1016/S0009-2614(02)00820-5; Fahrenbruch A., 2012, FUNDAMENTALS SOLAR C; Feng J, 2012, NAT PHOTONICS, V6, P865, DOI [10.1038/NPHOTON.2012.285, 10.1038/nphoton.2012.285]; Fischer-Cripps A.C., 2000, INTRO CONTACT MECH; Fousek J, 1999, MATER LETT, V39, P287, DOI 10.1016/S0167-577X(99)00020-8; Fridkin V.M., 2012, PHOTOFERROELECTRICS, V9; Fridkin VM, 2001, CRYSTALLOGR REP+, V46, P654, DOI 10.1134/1.1387133; Fu XW, 2014, ACS NANO, V8, P3412, DOI 10.1021/nn4062353; Green MA, 2017, NAT MATER, V16, P23, DOI [10.1038/nmat4676, 10.1038/NMAT4676]; Greil J, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4871458; Guennou M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.054115; Kalinin SV, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.033403; Lee D, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.057602; Liu YC, 2016, APL MATER, V4, DOI 10.1063/1.4971798; Lu H, 2012, SCIENCE, V336, P59, DOI 10.1126/science.1218693; Ocenasek J, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.035417; Polman A, 2016, SCIENCE, V352, DOI 10.1126/science.aad4424; Reyes-Martinez MA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7948; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Siemens W., 1885, LOND EDINB DUBLIN PH, V19, P315; Sonntag MD, 2014, J PHYS CHEM LETT, V5, P3125, DOI 10.1021/jz5015746; Spanier JE, 2016, NAT PHOTONICS, V10, P611, DOI 10.1038/nphoton.2016.143; Sturman B. I., 1992, PHOTOVOLTAIC PHOTORE; TAGANTSEV AK, 1986, PHYS REV B, V34, P5883, DOI 10.1103/PhysRevB.34.5883; Tang QX, 2011, SMALL, V7, P189, DOI 10.1002/smll.201001217; Yang MM, 2017, SCI REP-UK, V7, DOI 10.1038/srep43070; Zubko P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.167601; Zubko P, 2013, ANNU REV MATER RES, V43, P387, DOI 10.1146/annurev-matsci-071312-121634	34	177	180	39	367	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391					904	907		10.1126/science.aan3256	http://dx.doi.org/10.1126/science.aan3256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG9RW	29674433	Green Submitted, Bronze			2022-12-28	WOS:000433039800047
J	Butkus, R; Serchen, J; Moyer, DV; Bornstein, SS; Hingle, ST				Butkus, Renee; Serchen, Joshua; Moyer, Darilyn V.; Bornstein, Sue S.; Hingle, Susan Thompson		Hlth Public Policy Comm American C	Achieving Gender Equity in Physician Compensation and Career Advancement: A Position Paper of the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							ACADEMIC MEDICINE; SEXUAL-HARASSMENT; FEMALE PHYSICIANS; PAY GAP; WOMEN; RACE; DISCRIMINATION; FAMILY; RATES; COMMUNICATION	Women comprise more than one third of the active physician workforce, an estimated 46% of all physicians-in-training, and more than half of all medical students in the United States. Although progress has been made toward gender diversity in the physician workforce, disparities in compensation exist and inequities have contributed to a disproportionately low number of female physicians achieving academic advancement and serving in leadership positions. Women in medicine face other challenges, including a lack of mentors, discrimination, gender bias, cultural environment of the workplace, imposter syndrome, and the need for better work-life integration. In this position paper, the American College of Physicians summarizes the unique challenges female physicians face over the course of their careers and provides recommendations to improve gender equity and ensure that the full potential of female physicians is realized.	[Butkus, Renee; Serchen, Joshua] Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA; [Moyer, Darilyn V.] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA; [Bornstein, Sue S.] Texas Med Home Initiat, 3111 Beverly Dr, Dallas, TX 75205 USA; [Hingle, Susan Thompson] Southern Illinois Univ, Sch Med, 801 North Rutledge St,POB 19628, Springfield, IL 62794 USA	American College of Physicians; American College of Physicians; Southern Illinois University System; Southern Illinois University	Butkus, R (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.	rbutkus@acponline.org						Abbuhl S, 2010, J GEN INTERN MED, V25, P57, DOI 10.1007/s11606-009-1092-8; Adamczyk A, 2016, TIME; Adesoye T, 2017, JAMA INTERN MED, V177, P1033, DOI 10.1001/jamainternmed.2017.1394; AMA Insurance, 2014, 2014 WORK LIF PROF T; Anderson J, 2018, PAY EQUITY DISCRIMIN; [Anonymous], 2016, 2016 PHYS SPEC DAT R; Association of American Medical Colleges, 2016, DIV PHYS WORKF FACTS; Association of American Medical Colleges, 2016, SURV RES FELL STIP B; Association of American Medical Colleges, 2017, TAK BREAK YOUR MED E; Association of American Medical Colleges, 2017, MATR STUD QUEST 2017; Babcock L., 2003, HARVARD BUSINESS REV; Baker LC, 1996, NEW ENGL J MED, V334, P960, DOI 10.1056/NEJM199604113341506; Berg S., 2017, AMA WIRE        0927; Berkowitz CD, 2010, ACAD PEDIATR, V10, P360, DOI 10.1016/j.acap.2010.06.013; Bylund CL, 2002, PATIENT EDUC COUNS, V48, P207, DOI 10.1016/S0738-3991(02)00173-8; Cajigal S, 2015, MEDSCAPE; Child Care Aware of America, 2017, PAR HIGH COST CHILD; Chopra V, 2017, JAMA-J AM MED ASSOC, V318, P1007, DOI 10.1001/jama.2017.8324; Coleman VH, 2005, J CONTIN EDUC HEALTH, V25, P268, DOI 10.1002/chp.40; Coombs AAT, 2005, J NATL MED ASSOC, V97, P467; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; Davids JS, 2017, J AM COLL SURGEONS, V225, P411, DOI 10.1016/j.jamcollsurg.2017.05.018; de la Cruz MSD, 2013, J AM BOARD FAM MED, V26, P720, DOI 10.3122/jabfm.2013.06.120260; Desai T, 2016, POSTGRAD MED J, V92, P571, DOI 10.1136/postgradmedj-2016-134094; Devine PG, 2012, J EXP SOC PSYCHOL, V48, P1267, DOI 10.1016/j.jesp.2012.06.003; Fang M, 2013, PREGNANCY WOMEN PHYS; Files JA, 2017, J WOMENS HEALTH, V26, P413, DOI 10.1089/jwh.2016.6044; FITZGERALD LF, 1995, J SOC ISSUES, V51, P117, DOI 10.1111/j.1540-4560.1995.tb01312.x; Frank E, 1996, ARCH FAM MED, V5, P215, DOI 10.1001/archfami.5.4.215; Freund KM, 2016, ACAD MED, V91, P1068, DOI 10.1097/ACM.0000000000001250; Girod S, 2016, ACAD MED, V91, P1143, DOI 10.1097/ACM.0000000000001099; Grischkan J, 2017, JAMA INTERN MED, V177, P1532, DOI 10.1001/jamainternmed.2017.4023; Grisham S., 2017, PHYS COMPENSATION RE; Grisham S, 2017, MEDSC PHYS COMP REP; Grisso JA, 2017, J WOMENS HEALTH, V26, P571, DOI 10.1089/jwh.2016.6025; Hauser C., 2016, NY TIMES; Hayat MJ, 2017, JAMA INTERN MED, V177, P1057, DOI 10.1001/jamainternmed.2017.2130; Hill C, 2017, SIMPLE TRUTH GENDER; Holmes MA, 2011, EOS T AGU, V92, P421; Humphrey HJ., 2010, TEACHING MED, V5, P1; Hurt J, 2017, MED EC; Jackson M, 2017, IS BREASTFEEDING WOR; Jagsi R, 2007, NEW ENGL J MED, V357, P1889, DOI 10.1056/NEJMp078163; Jagsi R, 2006, NEW ENGL J MED, V355, P281, DOI 10.1056/NEJMsa053910; Jagsi R, 2016, JAMA-J AM MED ASSOC, V315, P2120, DOI 10.1001/jama.2016.2188; Jagsi R, 2012, JAMA-J AM MED ASSOC, V307, P2410, DOI 10.1001/jama.2012.6183; Jagsi R, 2009, ANN INTERN MED, V151, P804, DOI 10.7326/0003-4819-151-11-200912010-00009; Jena AB, 2016, JAMA INTERN MED, V176, P1294, DOI 10.1001/jamainternmed.2016.3284; Jolly S, 2014, ANN INTERN MED, V160, P344, DOI 10.7326/M13-0974; Kim M, 2015, IND RELAT, V54, P648, DOI 10.1111/irel.12109; KREUTER MW, 1995, J GEN INTERN MED, V10, P119, DOI 10.1007/BF02599664; Lautenberger D, 2017, ANAL BRIEF UNDERREPR; Lautenberger DM, 2014, STATE WOMEN ACAD MED; LEVINSON W, 1991, WESTERN J MED, V154, P423; Linzer M, 2014, J GEN INTERN MED, V29, P18, DOI 10.1007/s11606-013-2597-8; Lo Sasso AT, 2011, HEALTH AFFAIR, V30, P193, DOI 10.1377/hlthaff.2010.0597; Lurie N, 1997, J GEN INTERN MED, V12, P34; LURIE N, 1993, NEW ENGL J MED, V329, P478, DOI 10.1056/NEJM199308123290707; Ly DP, 2018, ANN INTERN MED, V168, P375, DOI 10.7326/M17-1758; Ly DP, 2017, JAMA INTERN MED, V177, P1524, DOI 10.1001/jamainternmed.2017.3437; Ly DP, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2923; Mast MS, 2011, PATIENT EDUC COUNS, V83, P174, DOI 10.1016/j.pec.2010.06.030; Mitchell JP, 2003, J EXP PSYCHOL GEN, V132, P455, DOI 10.1037/0096-3445.132.3.455; National Committee on Pay Equity, 2016, WAG GAP TIM REAL DOL; Nora LM, 2002, ACAD MED, V77, P1226, DOI 10.1097/00001888-200212000-00018; Paquette D., 2016, WASHINGTON POST; Peckham C., 2017, MEDSCAPE; Prazeres F, 2017, JAMA INTERN MED, V177, P1056, DOI 10.1001/jamainternmed.2017.2127; Rabin RC., 2017, NY TIMES; Reisman AB, 2002, TEACH LEARN MED, V14, P236, DOI 10.1207/S15328015TLM1404_6; Rochon PA, 2016, ACAD MED, V91, P1053, DOI 10.1097/ACM.0000000000001281; Roter DL, 2002, JAMA-J AM MED ASSOC, V288, P756, DOI 10.1001/jama.288.6.756; Rudman LA, 2001, J PERS SOC PSYCHOL, V81, P856, DOI 10.1037/0022-3514.81.5.856; Saadi A, 2016, AM MUSLIM DOCTOR REF; Sambunjak D, 2006, JAMA-J AM MED ASSOC, V296, P1103, DOI 10.1001/jama.296.9.1103; Schieder J, 2016, THE GENDER PAY GAP, P11; Schor NF, 2018, ACAD MED, V93, P237, DOI 10.1097/ACM.0000000000001863; SHAPIRO J, 1991, FAM PRACT, V8, P10, DOI 10.1093/fampra/8.1.10; Snyder Rebecca A, 2013, J Grad Med Educ, V5, P365, DOI 10.4300/JGME-D-12-00294.1; Snyder RA, 2008, J AM COLL SURGEONS, V207, P942, DOI 10.1016/j.jamcollsurg.2008.08.017; Sobecks NW, 1999, ANN INTERN MED, V130, P312, DOI 10.7326/0003-4819-130-4-199902160-00017; Sowa A, 2017, NPR; Swindler S, THE OREGONIAN; The University of Arizona College of Medicine, 2002, GRACE PROJ GEN RESP; Travis EL, 2013, ACAD MED, V88, P1414, DOI 10.1097/ACM.0b013e3182a35456; Tsugawa Y, 2017, JAMA INTERN MED, V177, P206, DOI 10.1001/jamainternmed.2016.7875; Villwock J, 2016, INT J MED EDUC, V7, P364, DOI 10.5116/ijme.5801.eac4; Wallace Byron C, 2016, JERK JUDGEMENTAL PAT; Weaver AC, 2015, J HOSP MED, V10, P486, DOI 10.1002/jhm.2400; Weeks WB, 2006, J GEN INTERN MED, V21, P1167, DOI 10.1111/j.1525-1497.2006.00592.x; Weeks WB, 2009, HEALTH AFFAIR, V28, P557, DOI 10.1377/hlthaff.28.2.557; Welder A, 2016, MATERNITY LEAVE COST; White K, 2008, NATL WOMENS HLTH NET; Wible P, 2016, WASHINGTON POST; Willett Lisa L, 2015, Am J Med, V128, P659, DOI 10.1016/j.amjmed.2015.02.002	95	172	173	8	68	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2018	168	10					721	+		10.7326/M17-3438	http://dx.doi.org/10.7326/M17-3438			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GI3DE	29710100				2022-12-28	WOS:000434250700016
J	Baker, DW; Yendro, S				Baker, David W.; Yendro, Susan			Setting Achievable Benchmarks for Value-Based Payments No Perfect Solution	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Baker, David W.; Yendro, Susan] Joint Commiss, Oak Brook, IL USA		Baker, DW (corresponding author), Joint Commiss, One Renaissance Blvd, Oakbrook Terrance, IL 60181 USA.	dbaker@jointcommission.org						Clark SL, 2014, OBSTET GYNECOL, V123, P29, DOI 10.1097/AOG.0000000000000059; DuPree ES, 2016, HIGH RELIABILITY PAT, P66; Persell SD, 2011, MED CARE, V49, P117, DOI 10.1097/MLR.0b013e318202913d	3	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2018	319	18					1857	1858		10.1001/jama.2018.2360	http://dx.doi.org/10.1001/jama.2018.2360			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF1CB	29710252				2022-12-28	WOS:000431668600009
J	Deming, D				Deming, Drake			Helium discovered in the tail of an exoplanet	NATURE			English	Editorial Material									[Deming, Drake] Univ Maryland, Dept Astron, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Deming, D (corresponding author), Univ Maryland, Dept Astron, College Pk, MD 20742 USA.	ddeming@astro.umd.edu						ALPHER RA, 1948, PHYS REV, V73, P803, DOI 10.1103/PhysRev.73.803; Ben-Jaffel L, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201221014; Hu RY, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/1/8; Liske J, 2012, PROC SPIE, V8444, DOI 10.1117/12.926087; Moutou C, 2003, ASTRON ASTROPHYS, V405, P341, DOI 10.1051/0004-6361:20030656; Seager S, 2000, ASTROPHYS J, V537, P916, DOI 10.1086/309088; Vidal-Madjar A, 2003, NATURE, V422, P143, DOI 10.1038/nature01448	8	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2018	557	7703					35	36		10.1038/d41586-018-04969-6	http://dx.doi.org/10.1038/d41586-018-04969-6			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE5BW	29717248	Bronze			2022-12-28	WOS:000431234500022
J	Vallance, AE; Fearnhead, NS; Kuryba, A; Hill, J; Maxwell-Armstrong, C; Braun, M; van der Meulen, J; Walker, K				Vallance, Abigail E.; Fearnhead, Nicola S.; Kuryba, Angela; Hill, James; Maxwell-Armstrong, Charles; Braun, Michael; van der Meulen, Jan; Walker, Kate			Effect of public reporting of surgeons' outcomes on patient selection, "gaming," and mortality in colorectal cancer surgery in England: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ARTERY-BYPASS-SURGERY; REPORT CARDS; RISK; MORBIDITY; IMPACT; PERFORMANCE; SCORE	OBJECTIVE To determine the effect of surgeon specific outcome reporting in colorectal cancer surgery on risk averse clinical practice, "gaming" of clinical data, and 90 day postoperative mortality. DESIGN National cohort study. SETTING English National Health Service hospital trusts. POPULATION 111 431 patients diagnosed as having colorectal cancer from 1 April 2011 to 31 March 2015 included in the National Bowel Cancer Audit. INTERVENTION Public reporting of surgeon specific 90 day mortality in elective colorectal cancer surgery in England introduced in June 2013. MAIN OUTCOME MEASURES Proportion of patients with colorectal cancer who had an elective major resection, predicted 90 day mortality based on characteristics of patients and tumours, and observed 90 day mortality adjusted for differences in characteristics of patients and tumours, comparing patients who had surgery between April 2011 and June 2013 and between July 2013 and March 2015. RESULTS The proportion of patients with colorectal cancer undergoing major resection did not change after the introduction of surgeon specific public outcome reporting (39 792/62 854 (63.3%) before versus 30 706/48 577 (63.2%) after; P=0.8). The proportion of these major resections categorised as elective or scheduled also did not change (33 638/39 792 (84.5%) before versus 25 905/30 706 (84.4%) after; P=0.5). The predicted 90 day mortality remained the same (2.7% v 2.7%; P=0.3), but the observed 90 day mortality fell (952/33 638 (2.8%) v 552/25 905 (2.1%)). Change point analysis showed that this reduction was over and above the existing downward trend in mortality before the introduction of public outcome reporting (P=0.03). CONCLUSIONS This study did not find evidence that the introduction of public reporting of surgeon specific 90 day postoperative mortality in elective colorectal cancer surgery has led to risk averse clinical practice behaviour or "gaming" of data. However, its introduction coincided with a significant reduction in 90 day mortality.	[Vallance, Abigail E.; Kuryba, Angela; van der Meulen, Jan; Walker, Kate] Royal Coll Surgeons England, Clin Effectiveness Unit, London WC2A 3PE, England; [Fearnhead, Nicola S.] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Hills Rd, Cambridge CB2 0QQ, England; [Hill, James] Manchester Royal Infirm, Manchester M13 9WL, Lancs, England; [Hill, James] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester M13 9NT, Lancs, England; [Maxwell-Armstrong, Charles] Nottingham Univ Hosp NHS Trust, Natl Inst Hlth Res, Nottingham Digest Dis Biomed Res Unit, Nottingham NG7 2UH, England; [Maxwell-Armstrong, Charles] Univ Nottingham, Nottingham NG7 2UH, England; [Braun, Michael] Christie NHS Fdn Trust, Manchester M20 4BX, Lancs, England; [van der Meulen, Jan; Walker, Kate] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England	Royal College of Surgeons of England; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Manchester; University of Manchester; Nottingham University Hospital NHS Trust; University of Nottingham; University of Nottingham; Christie NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine	van der Meulen, J (corresponding author), Royal Coll Surgeons England, Clin Effectiveness Unit, London WC2A 3PE, England.; van der Meulen, J (corresponding author), London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England.	jan.vandermeulen@lshtm.ac.uk		van der Meulen, Jan/0000-0002-9451-2335; Walker, Kate/0000-0001-5392-6323	NHS England; Welsh Government	NHS England; Welsh Government	The National Bowel Cancer Audit is commissioned by the Healthcare Quality Improvement Partnership (HQIP) as part of the National Clinical Audit and Patient Outcomes Programme, and funded by NHS England and the Welsh Government (www.hqip.org.uk/national-programmes). Neither HQIP nor the funders had any involvement in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. The researchers had full independence from the Healthcare Quality Improvement Partnership.	Aggarwal A, 2017, MED CARE RES REV, V74, P379, DOI 10.1177/1077558716654631; Alderson D, 2014, BRIT J SURG, V101, P1335, DOI 10.1002/bjs.9641; Armitage JN, 2010, BRIT J SURG, V97, P772, DOI 10.1002/bjs.6930; Braunholtz DA, 2001, J CLIN EPIDEMIOL, V54, P217, DOI 10.1016/S0895-4356(00)00305-X; Bridgewater B, 2007, HEART, V93, P744, DOI 10.1136/hrt.2006.106393; Chen J., 2011, PARAMETRIC STAT CHAN; Choices NHS, 2017, CONS SPEC COL CANC S; Digital NHS, NAT BOW CANC AUD; Dranove D, 2003, J POLIT ECON, V111, P555, DOI 10.1086/374180; England NHS, 2012, EV COUNTS PLANN PAT; Ergina PL, 2009, LANCET, V374, P1097, DOI 10.1016/S0140-6736(09)61086-2; GREEN J, 1995, NEW ENGL J MED, V332, P1229, DOI 10.1056/NEJM199505043321812; HANNAN EL, 1994, JAMA-J AM MED ASSOC, V271, P761, DOI 10.1001/jama.271.10.761; Khajuria A, 2014, INT J SURG, V12, P369, DOI 10.1016/j.ijsu.2014.02.001; Khan OA, 2007, ANN ROY COLL SURG, V89, P796, DOI 10.1308/003588407X232080; Li ZM, 2010, ANN THORAC SURG, V89, P1131, DOI 10.1016/j.athoracsur.2009.12.073; Ljungqvist O, 2017, JAMA SURG, V152, P292, DOI 10.1001/jamasurg.2016.4952; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; Moonesinghe SR, 2013, POSTGRAD MED J, V89, P677, DOI 10.1136/postgradmedj-2013-132442; Moran J, 2016, BRIT J ANAESTH, V116, P177, DOI 10.1093/bja/aev454; National Bowel Cancer Audit, 2016, REP 2016; National Bowel Cancer Audit, REPORTS; National Confidential Enquiry into Patient Outcome and Death, 2004, NCEPOD CLASS INT; NHS Classifications Service, 2007, OPCS CLASS INT PROC; NHS Digital, 2017, NAT BOW CANC AUD NBO; Office for National Statistics, 2014, DEATHS REG ENGL WAL; Penna M, 2016, COLORECTAL DIS, V18, P1031, DOI 10.1111/codi.13433; Radford PD, 2015, INT J SURG, V13, P211, DOI 10.1016/j.ijsu.2014.11.049; RELMAN AS, 1988, NEW ENGL J MED, V319, P1220, DOI 10.1056/NEJM198811033191810; Resnic FS, 2009, J AM COLL CARDIOL, V53, P825, DOI 10.1016/j.jacc.2008.11.034; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; Tarantino I, 2015, ANN SURG, V262, P112, DOI 10.1097/SLA.0000000000000860; van der Geest LGM, 2015, CLIN EXP METASTAS, V32, P457, DOI 10.1007/s10585-015-9719-0; Walker K, 2015, BRIT J SURG, V102, P269, DOI 10.1002/bjs.9696; Wallace D, 2014, BRIT J CANCER, V111, P577, DOI 10.1038/bjc.2014.300; West MA, 2014, BRIT J SURG, V101, P1166, DOI 10.1002/bjs.9551; West MA, 2014, BRIT J ANAESTH, V112, P665, DOI 10.1093/bja/aet408	37	23	23	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 2	2018	361								k1581	10.1136/bmj.k1581	http://dx.doi.org/10.1136/bmj.k1581			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF4YF	29720371				2022-12-28	WOS:000431969500002
J	Farahany, NA; Greely, HT; Hyman, S; Koch, C; Grady, C; Pasca, SP; Sestan, N; Arlotta, P; Bernat, JL; Ting, J; Lunshof, JE; Iyer, EPR; Hyun, I; Capestany, BH; Church, GM; Huang, H; Song, HJ				Farahany, Nita A.; Greely, Henry T.; Hyman, Steven; Koch, Christof; Grady, Christine; Pasca, Sergiu P.; Sestan, Nenad; Arlotta, Paola; Bernat, James L.; Ting, Jonathan; Lunshof, Jeantine E.; Iyer, Eswar P. R.; Hyun, Insoo; Capestany, Beatrice H.; Church, George M.; Huang, Hao; Song, Hongjun			The ethics of experimenting with human brain tissue	NATURE			English	Editorial Material							ORGANOIDS; DYNAMICS		[Farahany, Nita A.] Duke Univ, Law & Philosophy, Durham, NC 27708 USA; [Farahany, Nita A.] Duke Univ, Duke Initiat Sci & Soc, Durham, NC 27708 USA; [Greely, Henry T.] Stanford Univ, Ctr Law & Biosci, Stanford, CA 94305 USA; [Greely, Henry T.] Stanford Univ, Stanford Program Neurosci & Soc, Stanford, CA 94305 USA	Duke University; Duke University; Stanford University; Stanford University	Farahany, NA (corresponding author), Duke Univ, Law & Philosophy, Durham, NC 27708 USA.; Farahany, NA (corresponding author), Duke Univ, Duke Initiat Sci & Soc, Durham, NC 27708 USA.	farahany@duke.edu	Pasca, Sergiu/AAY-3949-2021; Farahany, Nita/AGH-5500-2022	Pasca, Sergiu/0000-0002-3216-3248; Farahany, Nita/0000-0003-4808-6256; Ting, Jonathan/0000-0001-8266-0392	NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH106434] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 CL999999] Funding Source: Medline; NIMH NIH HHS [U19 MH106434] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arlotta P, 2018, NAT METHODS, V15, P27, DOI 10.1038/nmeth.4557; Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330; Bourret R, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0345-9; Eisenstein M, 2018, NAT METHODS, V15, P19, DOI 10.1038/nmeth.4538; Greely HT, 2016, NEURON, V92, P637, DOI 10.1016/j.neuron.2016.10.048; Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110; Koch C, 2016, NAT REV NEUROSCI, V17, P307, DOI 10.1038/nrn.2016.22; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Mansour AA, 2018, NAT BIOTECHNOL, V36, P432, DOI 10.1038/nbt.4127; Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034; Pasca SP, 2018, NATURE, V553, P437, DOI 10.1038/nature25032; Presidential Commission for the Study of Bioethical Issues, 2015, GRAY MATT TOP INT NE; Presidential Commission for the Study of Bioethical Issues, 2014, GRAY MATT INT APPR N; Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047; Quadrato G, 2016, NAT MED, V22, P1220, DOI 10.1038/nm.4214; Sloan SA, 2017, NEURON, V95, P779, DOI 10.1016/j.neuron.2017.07.035; Ye F, 2017, NEURON, V96, P1041, DOI 10.1016/j.neuron.2017.10.010	19	80	81	4	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					429	432		10.1038/d41586-018-04813-x	http://dx.doi.org/10.1038/d41586-018-04813-x			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD8VX	29691509	Green Accepted, Bronze			2022-12-28	WOS:000430793000022
J	Keenan, JD; Bailey, RL; West, SK; Arzika, AM; Hart, J; Weaver, J; Kalua, K; Mrango, Z; Ray, KJ; Cook, C; Lebas, E; O'Brien, KS; Emerson, PM; Porco, TC; Lietman, TM				Keenan, J. D.; Bailey, R. L.; West, S. K.; Arzika, A. M.; Hart, J.; Weaver, J.; Kalua, K.; Mrango, Z.; Ray, K. J.; Cook, C.; Lebas, E.; O'Brien, K. S.; Emerson, P. M.; Porco, T. C.; Lietman, T. M.		MORDOR Study Grp	Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MASS AZITHROMYCIN; TRACHOMA CONTROL; RISK; IMPACT; CARRIAGE; CHILDREN	BACKGROUND We hypothesized that mass distribution of a broad-spectrum antibiotic agent to preschool children would reduce mortality in areas of sub-Saharan Africa that are currently far from meeting the Sustainable Development Goals of the United Nations. METHODS In this cluster-randomized trial, we assigned communities in Malawi, Niger, and Tanzania to four twice-yearly mass distributions of either oral azithromycin (approximately 20 mg per kilogram of body weight) or placebo. Children 1 to 59 months of age were identified in twice-yearly censuses and were offered participation in the trial. Vital status was determined at subsequent censuses. The primary outcome was aggregate all-cause mortality; country-specific rates were assessed in prespecified subgroup analyses. RESULTS A total of 1533 communities underwent randomization, 190,238 children were identified in the census at baseline, and 323,302 person-years were monitored. The mean (+/- SD) azithromycin and placebo coverage over the four twice-yearly distributions was 90.4 +/- 10.4%. The overall annual mortality rate was 14.6 deaths per 1000 person-years in communities that received azithromycin (9.1 in Malawi, 22.5 in Niger, and 5.4 in Tanzania) and 16.5 deaths per 1000 person-years in communities that received placebo (9.6 in Malawi, 27.5 in Niger, and 5.5 in Tanzania). Mortality was 13.5% lower overall (95% confidence interval [CI], 6.7 to 19.8) in communities that received azithromycin than in communities that received placebo (P<0.001); the rate was 5.7% lower in Malawi (95% CI, -9.7 to 18.9), 18.1% lower in Niger (95% CI, 10.0 to 25.5), and 3.4% lower in Tanzania (95% CI, -21.2 to 23.0). Children in the age group of 1 to 5 months had the greatest effect from azithromycin (24.9% lower mortality than that with placebo; 95% CI, 10.6 to 37.0). Serious adverse events occurring within a week after administration of the trial drug or placebo were uncommon, and the rate did not differ significantly between the groups. Evaluation of selection for antibiotic resistance is ongoing. CONCLUSIONS Among postneonatal, preschool children in sub-Saharan Africa, childhood mortality was lower in communities randomly assigned to mass distribution of azithromycin than in those assigned to placebo, with the largest effect seen in Niger. Any implementation of a policy of mass distribution would need to strongly consider the potential effect of such a strategy on antibiotic resistance. (Funded by the Bill and Melinda Gates Foundation; MORDOR ClinicalTrials.gov number, NCT02047981.)	[Keenan, J. D.; Ray, K. J.; Cook, C.; Lebas, E.; O'Brien, K. S.; Porco, T. C.; Lietman, T. M.] Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA; [Keenan, J. D.; Porco, T. C.; Lietman, T. M.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Porco, T. C.; Lietman, T. M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Porco, T. C.; Lietman, T. M.] Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA; [Bailey, R. L.; Hart, J.] London Sch Hyg & Trop Med, London, England; [West, S. K.; Weaver, J.] Johns Hopkins Univ, Sch Med, Dana Ctr, Baltimore, MD USA; [Arzika, A. M.] Carter Ctr, Niamey, Niger; [Kalua, K.] Univ Malawi, Blantyre Inst Community Outreach, Blantyre, Malawi; [Kalua, K.] Univ Malawi, Coll Med, Blantyre, Malawi; [Mrango, Z.] Natl Inst Med Res, Dar Es Salaam, Tanzania; [Emerson, P. M.] Int Trachoma Initiat, Decatur, GA USA; [Emerson, P. M.] Emory Univ, Atlanta, GA 30322 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; University of Malawi; University of Malawi; National Institute of Medical Research; Emory University	Lietman, TM (corresponding author), Univ Calif San Francisco, 513 Parnassus Ave,Med Sci Bldg,Rm S309, San Francisco, CA 94143 USA.	tom.lietman@ucsf.edu	Keenan, Jeremy David/AAO-5882-2020; Kalua, Khumbo k/D-8449-2019	Keenan, Jeremy David/0000-0002-7118-1457; Kalua, Khumbo k/0000-0001-9284-9009; Wittberg, Dionna M./0000-0002-9887-5993; Solomon, Anthony/0000-0001-7101-6649; Mabey, David/0000-0002-0031-8276; Hart, John/0000-0002-9637-7974	Bill and Melinda Gates Foundation; MORDOR	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); MORDOR	Funded by the Bill and Melinda Gates Foundation; MORDOR ClinicalTrials.gov number, NCT02047981.	Centers for Disease Control and Prevention, 2017, PERT WHOOP COUGH; Chidambaram JD, 2006, JAMA-J AM MED ASSOC, V295, P1142, DOI 10.1001/jama.295.10.1142; Coles CL, 2012, PEDIATR INFECT DIS J, V31, P341, DOI 10.1097/INF.0b013e31824155c9; Coles CL, 2011, AM J TROP MED HYG, V85, P691, DOI 10.4269/ajtmh.2011.11-0046; Eberly MD, 2015, PEDIATRICS, V135, P483, DOI 10.1542/peds.2014-2026; Emerson PM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005402; Espadas D, 2016, ARCH DIS CHILD, V101, P1079, DOI 10.1136/archdischild-2016-310956; Fry AM, 2002, CLIN INFECT DIS, V35, P395, DOI 10.1086/341414; Gaynor BD, 2014, AM J TROP MED HYG, V90, P846, DOI 10.4269/ajtmh.13-0379; Ho DKH, 2015, J TROP MED-US, V2015, DOI 10.1155/2015/917370; House JI, 2009, LANCET, V373, P1111, DOI 10.1016/S0140-6736(09)60323-8; Kalter HD, 2015, J GLOB HEALTH, V5, P196, DOI 10.7189/jogh.05.010415; Keenan JD, 2013, JAMA INTERN MED, V173, P821, DOI 10.1001/jamainternmed.2013.3041; Keenan JD, 2011, CLIN INFECT DIS, V52, P883, DOI 10.1093/cid/cir069; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Leach AJ, 1997, CLIN INFECT DIS, V24, P356, DOI 10.1093/clinids/24.3.356; Lund Marie, 2014, BMJ, V348, pg1908, DOI 10.1136/bmj.g1908; Matheson AI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096658; Peters B, 2014, EXPERT REV GASTROENT, V8, P533, DOI 10.1586/17474124.2014.903799; Porco TC, 2009, JAMA-J AM MED ASSOC, V302, P962, DOI 10.1001/jama.2009.1266; Schachter J, 1999, LANCET, V354, P630, DOI 10.1016/S0140-6736(98)12387-5; Schachterle SE, 2014, EMERG INFECT DIS, V20, P941, DOI 10.3201/eid2006.131302; See CW, 2015, AM J TROP MED HYG, V93, P1106, DOI 10.4269/ajtmh.15-0106; Seidman JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01420; Seidman JC, 2014, INT J EPIDEMIOL, V43, P1105, DOI 10.1093/ije/dyu062; Skalet AH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000377; Svanstrom H, 2013, NEW ENGL J MED, V368, P1704, DOI 10.1056/NEJMoa1300799; Taylor HR, 2014, LANCET, V384, P2142, DOI 10.1016/S0140-6736(13)62182-0; Whitty CJM, 1999, PEDIATR INFECT DIS J, V18, P955, DOI 10.1097/00006454-199911000-00003; WHO, INT STAND VERB AUT Q; WHO, 2006, TRACH CONTR GUID PRO; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421	32	185	185	2	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2018	378	17					1583	1592		10.1056/NEJMoa1715474	http://dx.doi.org/10.1056/NEJMoa1715474			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8XP	29694816	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000430797900005
J	Wendlandt, AE; Vangal, P; Jacobsen, EN				Wendlandt, Alison E.; Vangal, Prithvi; Jacobsen, Eric N.			Quaternary stereocentres via an enantioconvergent catalytic S(N)1 reaction	NATURE			English	Article							ENANTIOSELECTIVE CONSTRUCTION; CENTERS	The unimolecular nucleophilic substitution (S(N)1) mechanism features prominently in every introductory organic chemistry course. In principle, stepwise displacement of a leaving group by a nucleophile via a carbocationic intermediate enables the construction of highly congested carbon centres. However, the intrinsic instability and high reactivity of the carbocationic intermediates make it very difficult to control product distributions and stereoselectivity in reactions that proceed via S(N)1 pathways. Here we report asymmetric catalysis of an S(N)1-type reaction mechanism that results in the enantioselective construction of quaternary stereocentres from racemic precursors. The transformation relies on the synergistic action of a chiral hydrogen-bond-donor catalyst with a strong Lewis-acid promoter to mediate the formation of tertiary carbocationic intermediates at low temperature and to achieve high levels of control over reaction enantioselectivity and product distribution. This work provides a foundation for the enantioconvergent synthesis of other fully substituted carbon stereocentres.	[Wendlandt, Alison E.; Vangal, Prithvi; Jacobsen, Eric N.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University	Jacobsen, EN (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	jacobsen@chemistry.harvard.edu			NIH [GM043214]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043214, R37GM043214] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support for this work was provided by the NIH through GM043214 and a postdoctoral fellowship to A.E.W. We thank S. McCann and C. Fry for assistance with NMR experiments, E.E. Kwan for discussions regarding the KIE studies, and S.-L. Zheng for X-ray structure determination.	Banik SM, 2017, SCIENCE, V358, P761, DOI 10.1126/science.aao5894; Behenna DC, 2004, J AM CHEM SOC, V126, P15044, DOI 10.1021/ja044812x; Bhat V, 2017, CHEM REV, V117, P4528, DOI 10.1021/acs.chemrev.6b00731; Blackmond DG, 2005, ANGEW CHEM INT EDIT, V44, P4302, DOI 10.1002/anie.200462544; Brak K, 2013, ANGEW CHEM INT EDIT, V52, P534, DOI 10.1002/anie.201205449; Braun M, 2004, ANGEW CHEM INT EDIT, V43, P514, DOI 10.1002/anie.200352128; BROWN HC, 1957, J AM CHEM SOC, V79, P1913, DOI 10.1021/ja01565a039; Das JP, 2011, CHEM COMMUN, V47, P4593, DOI 10.1039/c0cc05222a; Feng JJ, 2017, CHEM REV, V117, P12564, DOI 10.1021/acs.chemrev.7b00385; HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016; Jung B, 2012, J AM CHEM SOC, V134, P1490, DOI 10.1021/ja211269w; Kennedy CR, 2016, ANGEW CHEM INT EDIT, V55, P12596, DOI 10.1002/anie.201600547; Krautwald S, 2013, SCIENCE, V340, P1065, DOI 10.1126/science.1237068; Liu YY, 2015, ACCOUNTS CHEM RES, V48, P740, DOI 10.1021/ar5004658; MCKINNEY JD, 1983, J MOL STRUC-THEOCHEM, V14, P427, DOI 10.1016/0166-1280(83)80220-6; Mei TS, 2014, NATURE, V508, P340, DOI 10.1038/nature13231; Murphy JJ, 2016, NATURE, V532, P218, DOI 10.1038/nature17438; Neel AJ, 2017, NATURE, V543, P637, DOI 10.1038/nature21701; Quasdorf KW, 2014, NATURE, V516, P181, DOI 10.1038/nature14007; Reisman SE, 2008, J AM CHEM SOC, V130, P7198, DOI 10.1021/ja801514m; SINGLETON DA, 1995, J AM CHEM SOC, V117, P9357, DOI 10.1021/ja00141a030; Wilson RM, 2005, J AM CHEM SOC, V127, P11616, DOI 10.1021/ja054008q; Xu H, 2010, SCIENCE, V327, P986, DOI 10.1126/science.1182826; Zhang P, 2011, J AM CHEM SOC, V133, P9716, DOI 10.1021/ja2039248; Zhao WX, 2015, ANGEW CHEM INT EDIT, V54, P1910, DOI 10.1002/anie.201405252	25	112	114	7	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					447	451		10.1038/s41586-018-0042-1	http://dx.doi.org/10.1038/s41586-018-0042-1			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8VX	29695848	Green Accepted			2022-12-28	WOS:000430793000036
J	Wood, E				Wood, Evan			Strategies for Reducing Opioid-Overdose Deaths - Lessons from Canada	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MORTALITY		[Wood, Evan] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Wood, Evan] British Columbia Ctr Substance Use, Vancouver, BC, Canada	University of British Columbia	Wood, E (corresponding author), Univ British Columbia, Dept Med, Vancouver, BC, Canada.; Wood, E (corresponding author), British Columbia Ctr Substance Use, Vancouver, BC, Canada.							Hickman M, 2011, J PUBLIC HEALTH-UK, V33, P332, DOI 10.1093/pubmed/fdr055; Marshall BDL, 2011, LANCET, V377, P1429, DOI 10.1016/S0140-6736(10)62353-7; National Center on Addiction and Substance Abuse at Columbia University, 2012, ADD MED CLOS GAP SCI; Oviedo-Joekes E, 2009, NEW ENGL J MED, V361, P777, DOI 10.1056/NEJMoa0810635	4	39	39	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2018	378	17					1565	1567		10.1056/NEJMp1800216	http://dx.doi.org/10.1056/NEJMp1800216			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GD8XP	29694813	Bronze			2022-12-28	WOS:000430797900001
J	Slomski, A				Slomski, Anita			Virtual CBT Improves Social Functioning in Psychosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2018	319	16					1649	1649		10.1001/jama.2018.4740	http://dx.doi.org/10.1001/jama.2018.4740			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD7RF	29710162				2022-12-28	WOS:000430709300010
J	Wise, J				Wise, Jacqui			Women see no benefit from colorectal cancer screening, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Bibbins-Domingo K, 2018, ANN INTERN MED, V168, P824, DOI 10.7326/M18-0963; Holme O, 2018, ANN INTERN MED, V168, P775, DOI 10.7326/M17-1441	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2018	361								k1747	10.1136/bmj.k1747	http://dx.doi.org/10.1136/bmj.k1747			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF4VZ	29691231				2022-12-28	WOS:000431963200006
J	Zarocostas, J				Zarocostas, John			Winnie Mpanju-Shumbusho: leader in the fight against malaria	LANCET			English	Biographical-Item																		MPANJUSHUMBUSHO W, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2018	391	10130					1566	1566		10.1016/S0140-6736(18)30894-8	http://dx.doi.org/10.1016/S0140-6736(18)30894-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD5JG	29695335				2022-12-28	WOS:000430542700011
J	Syed, NM; Oczkowski, W				Syed, Nabeel M.; Oczkowski, Wieslaw			Review: In cryptogenic stroke with PFO, adding PFO closure to medical therapy reduces recurrence	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PATENT FORAMEN OVALE		[Syed, Nabeel M.; Oczkowski, Wieslaw] McMaster Univ, Hamilton, ON, Canada	McMaster University	Syed, NM (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Hart RG, 2014, LANCET NEUROL, V13, P429, DOI 10.1016/S1474-4422(13)70310-7; Kitsios GD, 2012, STROKE, V43, P422, DOI 10.1161/STROKEAHA.111.631648; Patti G, 2015, AM J CARDIOL, V115, P837, DOI 10.1016/j.amjcard.2014.12.051; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2018	168	8					JC43	JC43		10.7326/ACPJC-2018-168-8-043	http://dx.doi.org/10.7326/ACPJC-2018-168-8-043			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GC8XZ	29677250				2022-12-28	WOS:000430083100008
J	Torjesen, I				Torjesen, Ingrid			Epidemic of flesh eating tropical ulcers hits Australia	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		O'Brien DP, 2018, MED J AUSTRALIA, V208, P287, DOI 10.5694/mja17.00879	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2018	361								k1706	10.1136/bmj.k1706	http://dx.doi.org/10.1136/bmj.k1706			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8WK	29666069				2022-12-28	WOS:000430794600012
J	Makri, A				Makri, Anita			Ireland to vote on a referendum to repeal the Eighth	LANCET			English	Editorial Material																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2018	391	10129					1466	1467		10.1016/S0140-6736(18)30891-2	http://dx.doi.org/10.1016/S0140-6736(18)30891-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GC6TS	29676267				2022-12-28	WOS:000429926000010
J	Gesmundo, NJ; Sauvagnat, B; Curran, PJ; Richards, MP; Andrews, CL; Dandliker, PJ; Cernak, T				Gesmundo, Nathan J.; Sauvagnat, Berengere; Curran, Patrick J.; Richards, Matthew P.; Andrews, Christine L.; Dandliker, Peter J.; Cernak, Tim			Nanoscale synthesis and affinity ranking	NATURE			English	Article							CHEMICAL SPACE; C-N; INHIBITORS; DISCOVERY; LIBRARIES; PLATFORM; AGONISTS; DESIGN	Most drugs are developed through iterative rounds of chemical synthesis and biochemical testing to optimize the affinity of a particular compound for a protein target of therapeutic interest. This process is challenging because candidate molecules must be selected from a chemical space of more than 10(60) drug-like possibilities(1), and a single reaction used to synthesize each molecule has more than 10(7) plausible permutations of catalysts, ligands, additives and other parameters(2). The merger of a method for high-throughput chemical synthesis with a biochemical assay would facilitate the exploration of this enormous search space and streamline the hunt for new drugs and chemical probes. Miniaturized high-throughput chemical synthesis(3-7) has enabled rapid evaluation of reaction space, but so far the merger of such syntheses with bioassays has been achieved with only low-density reaction arrays, which analyse only a handful of analogues prepared under a single reaction condition(8-13). High-density chemical synthesis approaches that have been coupled to bioassays, including on-bead(14), on-surface(15), on-DNA(16) and mass-encoding technologies(17), greatly reduce material requirements, but they require the covalent linkage of substrates to a potentially reactive support, must be performed under high dilution and must operate in a mixture format. These reaction attributes limit the application of transition-metal catalysts, which are easily poisoned by the many functional groups present in a complex mixture, and of transformations for which the kinetics require a high concentration of reactant. Here we couple high-throughput nanomole-scale synthesis with a label-free affinity-selection mass spectrometry bioassay. Each reaction is performed at a 0.1-molar concentration in a discrete well to enable transition-metal catalysis while consuming less than 0.05 milligrams of substrate per reaction. The affinity-selection mass spectrometry bioassay is then used to rank the affinity of the reaction products to target proteins, removing the need for time-intensive reaction purification. This method enables the primary synthesis and testing steps that are critical to the invention of protein inhibitors to be performed rapidly and with minimal consumption of starting materials.	[Gesmundo, Nathan J.; Cernak, Tim] Merck & Co Inc, Dept Discovery Chem, Boston, MA 02115 USA; [Sauvagnat, Berengere; Curran, Patrick J.; Richards, Matthew P.; Andrews, Christine L.; Dandliker, Peter J.] Merck & Co Inc, Dept Pharmacol, Boston, MA USA; [Gesmundo, Nathan J.] AbbVie, Res & Dev, N Chicago, IL USA; [Cernak, Tim] Univ Michigan, Dept Chem, Program Chem Biol, Dept Med Chem, Ann Arbor, MI 48109 USA	Merck & Company; Merck & Company; AbbVie; University of Michigan System; University of Michigan	Cernak, T (corresponding author), Merck & Co Inc, Dept Discovery Chem, Boston, MA 02115 USA.; Cernak, T (corresponding author), Univ Michigan, Dept Chem, Program Chem Biol, Dept Med Chem, Ann Arbor, MI 48109 USA.	tcernak@umich.edu			MRL Postdoctoral Research Fellowship	MRL Postdoctoral Research Fellowship	We are grateful to L. Nogle, D. Smith and M. Pietrafitta (MSD) for assistance with compound purification, S. Bano and X. Bu (MSD) for measuring residual palladium concentrations, A. M. Norris (MSD) for assistance with graphics and Z. Gu (DFKZ German Cancer Research Center) for suggestions for data visualization. N.J.G. was supported by an MRL Postdoctoral Research Fellowship.	Ahneman DT, 2018, SCIENCE, V360, P186, DOI 10.1126/science.aar5169; Anderson DR, 2007, J MED CHEM, V50, P2647, DOI 10.1021/jm0611004; Andrews C. L., 2012, PROTEIN PEPTIDE MASS, P253; Annis DA, 2004, J AM CHEM SOC, V126, P15495, DOI 10.1021/ja048365x; Annis DA, 2004, INT J MASS SPECTROM, V238, P77, DOI 10.1016/j.ijms.2003.11.022; Aronov AM, 2007, J MED CHEM, V50, P1280, DOI 10.1021/jm061381f; Baranczak A, 2017, ACS MED CHEM LETT, V8, P461, DOI 10.1021/acsmedchemlett.7b00054; Brow DG, 2016, J MED CHEM, V59, P4443, DOI 10.1021/acs.jmedchem.5b01409; Bruno NC, 2013, CHEM SCI, V4, P916, DOI 10.1039/c2sc20903a; Collins KD, 2014, NAT CHEM, V6, P859, DOI [10.1038/NCHEM.2062, 10.1038/nchem.2062]; Cuozzo JW, 2017, CHEMBIOCHEM, V18, P864, DOI 10.1002/cbic.201600573; Desai B, 2013, J MED CHEM, V56, P3033, DOI 10.1021/jm400099d; Goodnow RA, 2017, NAT REV DRUG DISCOV, V16, P131, DOI 10.1038/nrd.2016.213; Guetzoyan L, 2013, CHEM SCI, V4, P764, DOI 10.1039/c2sc21850j; Huang XH, 2013, BIOORG MED CHEM LETT, V23, P2590, DOI 10.1016/j.bmcl.2013.02.108; Karageorgis G, 2015, ANGEW CHEM INT EDIT, V54, P13538, DOI 10.1002/anie.201506944; Kutchukian PS, 2016, CHEM SCI, V7, P2604, DOI 10.1039/c5sc04751j; Murray JB, 2014, J MED CHEM, V57, P2845, DOI 10.1021/jm401848a; Murray PM, 2013, ORG PROCESS RES DEV, V17, P40, DOI 10.1021/op300275p; O'Connell TN, 2014, ANAL CHEM, V86, P7413, DOI 10.1021/ac500938y; Price AK, 2016, ANAL CHEM, V88, P2904, DOI 10.1021/acs.analchem.5b04811; Reymond JL, 2015, ACCOUNTS CHEM RES, V48, P722, DOI 10.1021/ar500432k; Santanilla AB, 2015, ORG LETT, V17, P3370, DOI 10.1021/acs.orglett.5b01648; Santanilla AB, 2015, SCIENCE, V347, P49, DOI 10.1126/science.1259203; Schneider N, 2016, J MED CHEM, V59, P4385, DOI 10.1021/acs.jmedchem.6b00153; Shevlin M, 2017, ACS MED CHEM LETT, V8, P601, DOI 10.1021/acsmedchemlett.7b00165; Troshin K, 2017, SCIENCE, V357, P175, DOI 10.1126/science.aan1568; Vastl J, 2017, ACS COMB SCI, V19, P255, DOI 10.1021/acscombsci.6b00181; Werner M, 2014, ANGEW CHEM INT EDIT, V53, P1704, DOI 10.1002/anie.201309301	30	89	90	7	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2018	557	7704					228	+		10.1038/s41586-018-0056-8	http://dx.doi.org/10.1038/s41586-018-0056-8			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2MV	29686415				2022-12-28	WOS:000431775100047
J	Dieleman, JL; Haakenstad, A; Micah, A; Moses, M; Abbafati, C; Acharya, P; Adhikari, TB; Adou, AK; Kiadaliri, AA; Alam, K; Alizadeh-Navaei, R; Alkerwi, A; Ammar, W; Antonio, CAT; Aremu, O; Asgedom, SW; Atey, TM; Avila-Burgos, L; Awasthi, A; Ayer, R; Badali, H; Banach, M; Banstola, A; Barac, A; Belachew, AB; Birungi, C; Bragazzi, NL; Breitborde, NJK; Cahuana-Hurtado, L; Car, J; Catala-Lopez, F; Chapin, A; Dandona, L; Dandona, R; Daryani, A; Dharmaratne, SD; Dubey, M; Edessa, D; Eldrenkamp, E; Eshrati, B; Faro, A; Feigl, AB; Fenny, AP; Fischer, F; Foigt, N; Foreman, KJ; Fullman, N; Ghimire, M; Goli, S; Hailu, AD; Hamidi, S; Harb, HL; Hay, SI; Hendrie, D; Ikilezi, G; Javanbakht, M; John, D; Jonas, JB; Kaldjian, A; Kasaeian, A; Kates, J; Khalil, IA; Khang, YH; Khubchandani, J; Kim, YJ; Kinge, JM; Kosen, S; Krohn, KJ; Kumar, GA; Lam, H; Listl, S; Abd El Razek, HM; Abd El Razek, MM; Majeed, A; Malekzadeh, R; Malta, DC; Mensah, GA; Meretoja, A; Miller, TR; Mirrakhimov, EM; Mlashu, FW; Mohammed, E; Mohammed, S; Naghavi, M; Nangia, V; Ngalesoni, FN; Nguyen, CT; Nguyen, TH; Niriayo, Y; Noroozi, M; Owolabi, MO; Pereira, DM; Qorbani, M; Rafay, A; Rafiei, A; Rahimi-Movaghar, V; Rai, RK; Ram, U; Ranabhat, CL; Ray, SE; Reiner, RC; Sadat, N; Sajadi, HS; Santos, JV; Sarker, AR; Sartorius, B; Satpathy, M; Savic, M; Schneider, M; Sepanlou, SG; Shaikh, MA; Sharif, M; She, J; Sheikh, A; Sisay, M; Soneji, S; Soofi, M; Tadesse, AH; Tao, TC; Templin, T; Tesema, AG; Thapa, S; Thomson, AJ; Tobe-Gai, R; Topor-Madry, R; Tran, BX; Tran, KB; Tran, TT; Undurraga, EA; Vasankari, T; Violante, FS; Wijeratne, T; Xu, GL; Yonemoto, N; Younis, MZ; Yu, CH; Zaki, ME; Zhou, L; Zlavog, B; Murray, CJL				Dieleman, Joseph L.; Haakenstad, Annie; Micah, Angela; Moses, Mark; Abbafati, Cristiana; Acharya, Pawan; Adhikari, Tara Ballav; Adou, Arsene Kouablan; Kiadaliri, Aliasghar Ahmad; Alam, Khurshid; Alizadeh-Navaei, Reza; Alkerwi, Ala'a; Ammar, Walid; Antonio, Carl Abelardo T.; Aremu, Olatunde; Asgedom, Solomon Weldegebreal; Atey, Tesfay Mehari; Avila-Burgos, Leticia; Awasthi, Ashish; Ayer, Rakesh; Badali, Hamid; Banach, Maciej; Banstola, Amrit; Barac, Aleksandra; Belachew, Abate Bekele; Birungi, Charles; Bragazzi, Nicola L.; Breitborde, Nicholas J. K.; Cahuana-Hurtado, Lucero; Car, Josip; Catala-Lopez, Ferran; Chapin, Abigail; Dandona, Lalit; Dandona, Rakhi; Daryani, Ahmad; Dharmaratne, Samath D.; Dubey, Manisha; Edessa, Dumessa; Eldrenkamp, Erika; Eshrati, Babak; Faro, Andre; Feigl, Andrea B.; Fenny, Ama P.; Fischer, Florian; Foigt, Nataliya; Foreman, Kyle J.; Fullman, Nancy; Ghimire, Mamata; Goli, Srinivas; Hailu, Alemayehu Desalegne; Hamidi, Samer; Harb, Hilda L.; Hay, Simon I.; Hendrie, Delia; Ikilezi, Gloria; Javanbakht, Mehdi; John, Denny; Jonas, Jost B.; Kaldjian, Alexander; Kasaeian, Amir; Kates, Jennifer; Khalil, Ibrahim A.; Khang, Young-Ho; Khubchandani, Jagdish; Kim, Yun Jin; Kinge, Jonas M.; Kosen, Soewarta; Krohn, Kristopher J.; Kumar, G. Anil; Lam, Hilton; Listl, Stefan; Abd El Razek, Hassan Magdy; Abd El Razek, Mohammed Magdy; Majeed, Azeem; Malekzadeh, Reza; Malta, Deborah Carvalho; Mensah, George A.; Meretoja, Atte; Miller, Ted R.; Mirrakhimov, Erkin M.; Mlashu, Fitsum Weldegebreal; Mohammed, Ebrahim; Mohammed, Shafiu; Naghavi, Mohsen; Nangia, Vinay; Ngalesoni, Frida Namnyak; Cuong Tat Nguyen; Trang Huyen Nguyen; Niriayo, Yirga; Noroozi, Mehdi; Owolabi, Mayowa O.; Pereira, David M.; Qorbani, Mostafa; Rafay, Anwar; Rafiei, Alireza; Rahimi-Movaghar, Vafa; Rai, Rajesh Kumar; Ram, Usha; Ranabhat, Chhabi Lal; Ray, Sarah E.; Reiner, Robert C.; Sadat, Nafis; Sajadi, Haniye Sadat; Santos, Joao Vasco; Sarker, Abdur Razzaque; Sartorius, Benn; Satpathy, Maheswar; Savic, Miloje; Schneider, Matthew; Sepanlou, Sadaf G.; Shaikh, Masood Ali; Sharif, Mehdi; She, Jun; Sheikh, Aziz; Sisay, Mekonnen; Soneji, Samir; Soofi, Moslem; Tadesse, Andualem Henok; Tao, Tianchan; Templin, Tara; Tesema, Azeb Gebresilassie; Thapa, Subash; Thomson, Alan J.; Tobe-Gai, Ruoyan; Topor-Madry, Roman; Bach Xuan Tran; Khanh Bao Tran; Tung Thanh Tran; Undurraga, Eduardo A.; Vasankari, Tommi; Violante, Francesco S.; Wijeratne, Tissa; Xu, Gelin; Yonemoto, Naohiro; Younis, Mustafa Z.; Yu, Chuanhua; Zaki, Maysaa El Sayed; Zhou, Lei; Zlavog, Bianca; Murray, Christopher J. L.		Global Burden Dis Hlth Financing	Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995-2015	LANCET			English	Article							SYSTEMATIC ANALYSIS; GLOBAL BURDEN; DISEASE; GOVERNMENT; CARE	Background Comparable estimates of health spending are crucial for the assessment of health systems and to optimally deploy health resources. The methods used to track health spending continue to evolve, but little is known about the distribution of spending across diseases. We developed improved estimates of health spending by source, including development assistance for health, and, for the first time, estimated HIV/AIDS spending on prevention and treatment and by source of funding, for 188 countries. Methods We collected published data on domestic health spending, from 1995 to 2015, from a diverse set of international agencies. We tracked development assistance for health from 1990 to 2017. We also extracted 5385 datapoints about HIV/AIDS spending, between 2000 and 2015, from online databases, country reports, and proposals submitted to multilateral organisations. We used spatiotemporal Gaussian process regression to generate complete and comparable estimates for health and HIV/AIDS spending. We report most estimates in 2017 purchasing-power parity-adjusted dollars and adjust all estimates for the effect of inflation. Findings Between 1995 and 2015, global health spending per capita grew at an annualised rate of 3.1% (95% uncertainty interval [UI] 3.1 to 3.2), with growth being largest in upper-middle-income countries (5.4% per capita [UI 5.3-5.5]) and lower-middle-income countries (4.2% per capita [4.2-4.3]). In 2015, $9.7 trillion (9.7 trillion to 9.8 trillion) was spent on health worldwide. High-income countries spent $6.5 trillion (6.4 trillion to 6.5 trillion) or 66.3% (66.0 to 66.5) of the total in 2015, whereas low-income countries spent $70.3 billion (69.3 billion to 71.3 billion) or 0.7% (0.7 to 0.7). Between 1990 and 2017, development assistance for health increased by 394.7% ($29.9 billion), with an estimated $37.4 billion of development assistance being disbursed for health in 2017, of which $9.1 billion (24.2%) targeted HIV/AIDS. Between 2000 and 2015, $562.6 billion (531.1 billion to 621.9 billion) was spent on HIV/AIDS worldwide. Governments financed 57.6% (52.0 to 60.8) of that total. Global HIV/AIDS spending peaked at 49.7 billion (46.2-54.7) in 2013, decreasing to $48.9 billion (45.2 billion to 54.2 billion) in 2015. That year, low-income and lower-middle-income countries represented 74.6% of all HIV/AIDS disability-adjusted life-years, but just 36.6% (34.4 to 38.7) of total HIV/AIDS spending. In 2015, $9.3 billion (8.5 billion to 10.4 billion) or 19.0% (17.6 to 20.6) of HIV/AIDS financing was spent on prevention, and $27.3 billion (24.5 billion to 31.1 billion) or 55.8% (53.3 to 57.9) was dedicated to care and treatment. Interpretation From 1995 to 2015, total health spending increased worldwide, with the fastest per capita growth in middle-income countries. While these national disparities are relatively well known, low-income countries spent less per person on health and HIV/AIDS than did high-income and middle-income countries. Furthermore, declines in development assistance for health continue, including for HIV/AIDS. Additional cuts to development assistance could hasten this decline, and risk slowing progress towards global and national goals. Copyright (c) 2018 The Author(s). Published by Elsevier Ltd.	[Dieleman, Joseph L.; Haakenstad, Annie; Micah, Angela; Moses, Mark; Chapin, Abigail; Dandona, Lalit; Dandona, Rakhi; Eldrenkamp, Erika; Foreman, Kyle J.; Fullman, Nancy; Hay, Simon I.; Ikilezi, Gloria; Kaldjian, Alexander; Khalil, Ibrahim A.; Krohn, Kristopher J.; Naghavi, Mohsen; Ray, Sarah E.; Reiner, Robert C.; Sadat, Nafis; Schneider, Matthew; Tao, Tianchan; Zlavog, Bianca; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Abbafati, Cristiana] Univ Roma La Sapienza, Rome, Italy; [Acharya, Pawan] Nepal Dev Soc, Chitwan, Nepal; [Adhikari, Tara Ballav] Univ Southern Denmark, Unit Hlth Promot Res, Fac Hlth Sci, Esbjerg, Denmark; [Adou, Arsene Kouablan] Assoc Ivoirienne Bien Etre Familial, Abidjan, Cote Ivoire; [Kiadaliri, Aliasghar Ahmad] Lund Univ, Dept Clin Sci, Dept Orthopaed, Clin Epidemiol Unit, Lund, Sweden; [Alam, Khurshid] Univ Western Australia, Sch Populat & Global Hlth, Perth, WA, Australia; [Alizadeh-Navaei, Reza] Univ Med Sci, Gastrointestinal Canc Res Ctr, Sari, Iran; [Badali, Hamid] Univ Med Sci, Invas Fungi Res Ctr, Sari, Iran; [Daryani, Ahmad; Sharif, Mehdi] Univ Med Sci, Toxoplasmosis Res Ctr, Sari, Iran; [Belachew, Abate Bekele; Rafiei, Alireza] Univ Med Sci, Mol & Cell Biol Res Ctr, Sari, Iran; [Rafiei, Alireza] Univ Med Sci, Sch Med, Sari, Iran; [Alkerwi, Ala'a] Luxembourg Inst Hlth, Strassen, Luxembourg; [Ammar, Walid; Harb, Hilda L.] Minist Publ Hlth, Beirut, Lebanon; [Antonio, Carl Abelardo T.] Univ Philippines Manila, Dept Hlth Policy & Adm, Coll Publ Hlth, Manila, Philippines; [Aremu, Olatunde] Univ Dept Publ Hlth & Therapies, Birmingham, W Midlands, England; [Belachew, Abate Bekele] Mekelle Univ, Sch Publ Hlth, Mekelle, Ethiopia; [Asgedom, Solomon Weldegebreal; Atey, Tesfay Mehari; Mohammed, Ebrahim; Niriayo, Yirga; Tesema, Azeb Gebresilassie] Mekelle Univ, Mekelle, Ethiopia; [Avila-Burgos, Leticia; Cahuana-Hurtado, Lucero] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Awasthi, Ashish] Indian Inst Publ Hlth, Gandhinagar, India; [Ayer, Rakesh] Univ Tokyo, Tokyo, Japan; [Banach, Maciej] Med Univ Lodz, Dept Hypertens, Lodz, Poland; [Banstola, Amrit] Publ Hlth Perspect Nepal, Pokhara, Nepal; [Barac, Aleksandra] Univ Belgrade, Fac Med, Belgrade, Serbia; [Birungi, Charles] UCL, London, England; [Bragazzi, Nicola L.] Univ Genoa, Genoa, Italy; [Breitborde, Nicholas J. K.] Ohio State Univ, Columbus, OH USA; [Car, Josip] Nanyang Technol Univ, LKCMed, Singapore, Singapore; [Majeed, Azeem] Imperial Coll London, Dept Primary Care & Publ Hlth, London, England; [Car, Josip; Foreman, Kyle J.] Imperial Coll London, London, England; [Catala-Lopez, Ferran] Univ Valencia, INCLIVA Hlth Res Inst, Dept Med, Valencia, Spain; [Catala-Lopez, Ferran] Univ Valencia, CIBERSAM, Valencia, Spain; [Catala-Lopez, Ferran] Ottawa Hosp, Clin Epidemiol Program, Res Inst, Ottawa, ON, Canada; [Dandona, Lalit; Dandona, Rakhi; Kumar, G. Anil] Publ Hlth Fdn India, Gurugram, India; [Dharmaratne, Samath D.] Univ Peradeniya, Dept Community Med, Fac Med, Peradeniya, Sri Lanka; [Dubey, Manisha; Ram, Usha] Int Inst Populat Sci, Bombay, Maharashtra, India; [Edessa, Dumessa; Mlashu, Fitsum Weldegebreal; Sisay, Mekonnen] Haramaya Univ, Harar, Ethiopia; [Rai, Rajesh Kumar] Minist Hlth & Med Educ, Tehran, Iran; [Eshrati, Babak] Arak Univ Med Sci, Arak, Iran; [Faro, Andre] Univ Fed Sergipe, Aracaju, Brazil; [Feigl, Andrea B.] Harvard Univ, Dept Global Hlth & Populat, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Fenny, Ama P.] Univ Ghana, Legon, Ghana; [Fischer, Florian] Univ Bielefeld, Sch Publ Hlth, Bielefeld, Germany; [Foigt, Nataliya] Acad Med Sci, Inst Gerontol, Kiev, Ukraine; [Ghimire, Mamata] Univ Tsukuba, Tsukuba, Ibaraki, Japan; [Goli, Srinivas] Jawaharlal Nehru Univ, New Delhi, India; [Hailu, Alemayehu Desalegne] Univ Addis Ababa, Addis Ababa, Ethiopia; [Hailu, Alemayehu Desalegne] Univ Bergen, Bergen, Norway; [Hamidi, Samer] Hamdan Bin Mohammed Smart Univ, Dubai, U Arab Emirates; [Hay, Simon I.] Univ Oxford, Oxford Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England; [Hendrie, Delia; Miller, Ted R.] Curtin Univ, Sch Publ Hlth, Perth, WA, Australia; [Javanbakht, Mehdi] Univ Aberdeen, Aberdeen, Scotland; [John, Denny] Campbell Collaborat, New Delhi, India; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany; [Kasaeian, Amir] Univ Tehran Med Sci, Hematol Oncol & Stem Cell Transplantat Res Ctr, Tehran, Iran; [Kasaeian, Amir] Univ Tehran Med Sci, Hematol Malignancies Res Ctr, Tehran, Iran; [Malekzadeh, Reza; Sepanlou, Sadaf G.] Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran; [Rahimi-Movaghar, Vafa] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran; [Sajadi, Haniye Sadat] Univ Tehran Med Sci, Natl Inst Hlth Res, Tehran, Iran; [Kates, Jennifer] Kaiser Family Fdn, Washington, DC USA; [Khang, Young-Ho] Seoul Natl Univ, Dept Hlth Policy & Management, Coll Med, Seoul, South Korea; [Khang, Young-Ho] Seoul Natl Univ, Inst Hlth Policy & Management, Med Ctr, Seoul, South Korea; [Khubchandani, Jagdish] Ball State Univ, Dept Nutr & Hlth Sci, Muncie, IN USA; [Kim, Yun Jin] Xiamen Univ, Sch Med, Malaysia Campus, Xiamen, Malaysia; [Kinge, Jonas M.; Savic, Miloje] Norwegian Inst Publ Hlth, Oslo, Norway; [Kosen, Soewarta] Natl Inst Hlth Res & Dev, Ctr Community Empowerment Hlth Policy & Humanitie, Jakarta, Indonesia; [Lam, Hilton] NIH, Inst Hlth Policy & Dev Studies, Manila, Philippines; [Listl, Stefan] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands; [Mohammed, Shafiu] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany; [Listl, Stefan] Heidelberg Univ, Heidelberg, Germany; [Abd El Razek, Hassan Magdy; Zaki, Maysaa El Sayed] Mansoura Univ, Fac Med, Mansoura, Egypt; [Abd El Razek, Mohammed Magdy] Aswan Univ Hosp, Aswan Fac Med, Aswan, Egypt; [Malta, Deborah Carvalho] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Mensah, George A.] NHLBI, NIH, Ctr Translat Res & Implementat Sci, Bldg 10, Bethesda, MD 20892 USA; [Meretoja, Atte] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Wijeratne, Tissa] Univ Melbourne, Melbourne, Vic, Australia; [Meretoja, Atte] Helsinki Univ Hosp, Dept Neurol, Helsinki, Finland; [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA; [Mirrakhimov, Erkin M.] Kyrgyz State Med Acad, Bishkek, Kyrgyzstan; [Mirrakhimov, Erkin M.] Natl Ctr Cardiol & Internal Dis, Bishkek, Kyrgyzstan; [Mohammed, Shafiu] Ahmadu Bello Univ, Hlth Syst & Policy Res Unit, Zaria, Nigeria; [Nangia, Vinay] Suraj Eye Inst, Nagpur, Maharashtra, India; [Ngalesoni, Frida Namnyak] Minist Hlth & Social Welf, Dar Es Salaam, Tanzania; [Cuong Tat Nguyen; Trang Huyen Nguyen; Tung Thanh Tran] Duy Tan Univ, Inst Global Hlth Innovat, Da Nang, Vietnam; [Noroozi, Mehdi] Univ Social Welf & Rehabil Sci, Substance Abuse & Dependence Res Ctr, Tehran, Iran; [Owolabi, Mayowa O.] Univ Ibadan, Dept Med, Ibadan, Nigeria; [Owolabi, Mayowa O.] Blossom Specialist Med Ctr, Ibadan, Nigeria; [Pereira, David M.] Univ Porto, Lab Farmacognosia, Dept Quim, Fac Farm,REQUIMTE LAQV, Porto, Portugal; [Santos, Joao Vasco] Univ Porto, Fac Med, Porto, Portugal; [Qorbani, Mostafa] Alborz Univ Med Sci, Noncommun Dis Res Ctr, Karaj, Iran; [Rafay, Anwar] Contech Int Hlth Consultants, Lahore, Pakistan; [Rafay, Anwar] Contech Sch Publ Hlt, Lahore, Pakistan; [Rai, Rajesh Kumar] Soc Hlth & Demog Surveillance, Suri, India; [Ranabhat, Chhabi Lal] Yonsei Univ, Wonju Coll Med, Dept Prevent Med, Wonju, South Korea; [Ranabhat, Chhabi Lal] Hlth Sci Fdn & Study Ctr, Kathmandu, Nepal; [Santos, Joao Vasco] Ctr Hlth Technol & Serv Res CINTESIS, Dept Community Med Informat & Hlth Decis Sci, Porto, Portugal; [Sarker, Abdur Razzaque] Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh; [Sartorius, Benn] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Publ Hlth Med, Durban, South Africa; [Sartorius, Benn] South African Med Res Council, UKZN Gastrointestinal Canc Res Ctr, Durban, South Africa; [Satpathy, Maheswar] Utkal Univ, Ctr Adv Study Psychol, Bhubaneswar, India; [She, Jun] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai, Peoples R China; [Sheikh, Aziz] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Sheikh, Aziz] Harvard Med Sch, Boston, MA USA; [Soneji, Samir] Dartmouth Coll, Hanover, NH USA; [Soofi, Moslem] Kermanshah Univ Med Sci, Kermanshah, Iran; [Tadesse, Andualem Henok] Mizan Tepi Univ, Mizan Teferi, Ethiopia; [Templin, Tara] Stanford Univ, Palo Alto, CA 94304 USA; [Thapa, Subash] Katholieke Univ Leuven, Leuven, Belgium; [Thomson, Alan J.] Adapt Knowledge Management, Victoria, BC, Canada; [Tobe-Gai, Ruoyan] Natl Ctr Child Hlth & Dev, Tokyo, Japan; [Topor-Madry, Roman] Jagellonian Univ, Inst Publ Hlth, Fac Hlth Sci, Med Coll, Krakow, Poland; [Topor-Madry, Roman] Wroclaw Med Univ, Fac Hlth Sci, Wroclaw, Poland; [Bach Xuan Tran] Johns Hopkins Univ, Baltimore, MD USA; [Bach Xuan Tran] Hanoi Med Univ, Hanoi, Vietnam; [Bach Xuan Tran] Univ Auckland, Auckland Canc Soc Res Ctr, Auckland, New Zealand; [Undurraga, Eduardo A.] Pontificia Univ Catolica Chile, Sch Govt, Santiago, Chile; [Vasankari, Tommi] UKK Inst Hlth Promot Res, Tampere, Finland; [Violante, Francesco S.] Univ Bologna, Bologna, Italy; [Wijeratne, Tissa] Western Hlth, Footscray, Vic, Australia; [Xu, Gelin] Nanjing Univ, Jinling Hosp, Dept Neurol, Sch Med, Nanjing, Jiangsu, Peoples R China; [Yonemoto, Naohiro] Kyoto Univ, Sch Publ Hlth, Dept Biostat, Kyoto, Japan; [Younis, Mustafa Z.] Jackson State Univ, Jackson, MS USA; [Yu, Chuanhua] Wuhan Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan, Hubei, Peoples R China; [Yu, Chuanhua] Wuhan Univ, Global Hlth Inst, Wuhan, Hubei, Peoples R China; [Zhou, Lei] Jinan Cent Hosp, Jinan, Shandong, Peoples R China	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Sapienza University Rome; University of Southern Denmark; Lund University; University of Western Australia; Luxembourg Institute of Health; University of the Philippines System; University of the Philippines Manila; Mekelle University; Mekelle University; Instituto Nacional de Salud Publica; University of Tokyo; Medical University Lodz; University of Belgrade; University of London; University College London; University of Genoa; University System of Ohio; Ohio State University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Imperial College London; Imperial College London; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Valencia; University of Ottawa; Ottawa Hospital Research Institute; Public Health Foundation of India; University of Peradeniya; International Institute for Population Sciences; Haramaya University; Ministry of Health & Medical Education (MOHME); Universidade Federal de Sergipe; Harvard University; Harvard T.H. Chan School of Public Health; University of Ghana; University of Bielefeld; National Academy of Medical Sciences of Ukraine; D. F. Chebotarev Institute of Gerontology of the National Academy of Medical Sciences of Ukraine; University of Tsukuba; Jawaharlal Nehru University, New Delhi; Addis Ababa University; University of Bergen; University of Oxford; Curtin University; University of Aberdeen; Ruprecht Karls University Heidelberg; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Seoul National University (SNU); Seoul National University (SNU); Ball State University; Xiamen University Malaysia Campus; Norwegian Institute of Public Health (NIPH); National Institute of Health Research & Development - Indonesia; Radboud University Nijmegen; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Aswan University; Universidade Federal de Minas Gerais; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Melbourne; University of Melbourne; University of Helsinki; Helsinki University Central Hospital; Pacific Institute for Research & Evaluation (PIRE); Kyrgyz State Medical Academy; Ministry of Health - Kyrgyzstan; Ahmadu Bello University; Suraj Eye Institute; Duy Tan University; University of Ibadan; Universidade do Porto; Universidade do Porto; Yonsei University; International Centre for Diarrhoeal Disease Research (ICDDR); University of Kwazulu Natal; South African Medical Research Council; Utkal University; Fudan University; University of Edinburgh; Harvard University; Harvard Medical School; Dartmouth College; Kermanshah University of Medical Sciences; Stanford University; KU Leuven; National Center for Child Health & Development - Japan; Jagiellonian University; Collegium Medicum Jagiellonian University; Wroclaw Medical University; Johns Hopkins University; Hanoi Medical University; University of Auckland; Pontificia Universidad Catolica de Chile; UKK Institute; University of Bologna; Nanjing University; Kyoto University; Jackson State University; Wuhan University; Wuhan University; Shandong First Medical University & Shandong Academy of Medical Sciences	Dieleman, JL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.	dieleman@uw.edu	Meretoja, Atte/H-6531-2019; Pereira, David/M-9286-2013; Violante, Francesco S/A-6934-2009; Edessa, Dumessa/K-2892-2019; Aremu, Olatunde/AAD-1995-2019; Kasaeian, Amir/C-8290-2017; Santos, João V/F-4602-2018; Zaki, Maysaa El Sayed/C-1522-2013; Malta, Deborah Carvalho/L-2491-2019; Alizadeh-Navaei, Reza/B-2207-2017; Qorbani, Mostafa/M-8171-2017; Bragazzi, Nicola Luigi/G-1672-2011; Daryani, Ahmad/E-2186-2017; abbafati, cristiana/AAD-7511-2022; Listl, Stefan/S-7600-2017; Banach, Maciej/A-1271-2009; Yimer, Ebrahim M./N-4597-2018; Satpathy, Maheswar/J-3135-2017; Kim, Yun Jin/AAE-8281-2019; Belachew, Abate Bekele/I-1758-2019; rahim, fakher/AAC-3905-2019; Banstola, Amrit/T-4242-2019; Mirrakhimov, Erkin/E-6900-2017; Badali, Hamid/J-8036-2016; Antonio, Carl Abelardo/AAP-4280-2020; Rahimi-Movaghar, Vafa/L-6339-2019; Sisay, Mekonnen/AAD-3257-2020; Foigt, Nataliya/AAU-5229-2020; Catalá-López, Ferrán/N-6018-2018; Hay, Simon Iain/F-8967-2015; Zaki, Maysaa El Sayed/H-3049-2019; KUMAR, ANIL/ACD-8340-2022; Avila-Burgos, Leticia/AAR-1815-2021; John, Denny/J-7815-2017; Søgaard, Ole S/P-6058-2016; Khubchandani, Jagdish/D-1831-2014; Boothapati, Anil Kumar/HHS-1813-2022; Faro, Andre/J-1696-2014; Hailu, Alemayehu/AAZ-5206-2020; Ram, Usha/AAS-4140-2020; Goli, Srinivas/J-7238-2012; Rubino, Salvatore/AAC-5848-2022; Tran, Khanh/A-2437-2019; FRACP, Tissa Wijeratne MD PhD/I-2086-2019; Barac, Aleksandra/W-9785-2019; Adhikari, Tara Ballav/J-7071-2019; Meressa, Beyene/W-6568-2019; Santos, João/HHZ-5595-2022; Sepanlou, Sadaf G/H-9343-2016; Undurraga, Eduardo/I-3739-2014; Awasthi, Ashish/Y-5915-2019; Fenny, Ama/I-1828-2019; Edessa, Dumessa/K-3885-2019; Naohiro, Yonemoto/Y-3761-2019; Mohammed, Shafiu/P-2016-2014; Car, Josip/H-6755-2015; Rafiei, Alireza/A-2314-2009; Topor-Madry, Roman/ABF-5449-2020; Soofi, Moslem/E-7665-2019; Rahimi-Movaghar, Vafa/T-7816-2017	Meretoja, Atte/0000-0001-6433-1931; Pereira, David/0000-0003-0384-7592; Violante, Francesco S/0000-0003-4084-2782; Aremu, Olatunde/0000-0002-5832-2403; Kasaeian, Amir/0000-0003-2018-9368; Santos, João V/0000-0003-4696-1002; Zaki, Maysaa El Sayed/0000-0001-5431-0248; Malta, Deborah Carvalho/0000-0002-8214-5734; Alizadeh-Navaei, Reza/0000-0003-0580-000X; Bragazzi, Nicola Luigi/0000-0001-8409-868X; Daryani, Ahmad/0000-0001-8571-5803; Listl, Stefan/0000-0002-8176-3397; Banach, Maciej/0000-0001-6690-6874; Yimer, Ebrahim M./0000-0003-3140-4967; Satpathy, Maheswar/0000-0003-3521-4781; Kim, Yun Jin/0000-0001-8853-6587; Belachew, Abate Bekele/0000-0003-2583-9913; rahim, fakher/0000-0002-2857-4562; Banstola, Amrit/0000-0003-3185-9638; Mirrakhimov, Erkin/0000-0003-2982-6108; Badali, Hamid/0000-0002-6010-8414; Antonio, Carl Abelardo/0000-0001-7476-0553; Sisay, Mekonnen/0000-0001-6611-1174; Foigt, Nataliya/0000-0002-3613-5965; Catalá-López, Ferrán/0000-0002-3833-9312; Hay, Simon Iain/0000-0002-0611-7272; Zaki, Maysaa El Sayed/0000-0001-5431-0248; John, Denny/0000-0002-4486-632X; Khubchandani, Jagdish/0000-0002-9058-4278; Faro, Andre/0000-0002-7348-6297; Hailu, Alemayehu/0000-0003-4872-8036; Ram, Usha/0000-0001-6722-7347; Goli, Srinivas/0000-0002-8481-484X; Tran, Khanh/0000-0002-8730-3340; FRACP, Tissa Wijeratne MD PhD/0000-0002-1701-7111; Adhikari, Tara Ballav/0000-0002-7654-5483; Meressa, Beyene/0000-0002-1864-0765; Sepanlou, Sadaf G/0000-0002-3669-5129; Undurraga, Eduardo/0000-0002-4425-1253; Awasthi, Ashish/0000-0002-9308-9782; Fenny, Ama/0000-0001-9367-1265; Edessa, Dumessa/0000-0001-6558-5829; Mohammed, Shafiu/0000-0001-5715-966X; Car, Josip/0000-0001-8969-371X; Rafiei, Alireza/0000-0002-1766-6605; Magdy Abd El Razek, Hassan/0000-0002-8857-0408; Ray, Sarah/0000-0002-5775-8344; Barac, Aleksandra/0000-0002-0132-2277; Owolabi, Mayowa/0000-0003-1146-3070; Cahuana-Hurtado, Lucero/0000-0002-9438-1443; , bennsartorius/0000-0001-6761-2325; Miller, Ted/0000-0002-0958-2639; Soofi, Moslem/0000-0003-4922-8412; Hendrie, Delia/0000-0001-5022-5281; Dandona, Rakhi/0000-0003-0926-788X; Hamidi, Samer/0000-0002-6766-3728; Kiadaliri, Ali/0000-0002-4254-9099; Sheikh, Aziz/0000-0001-7022-3056; Rai, Rajesh Kumar/0000-0002-5249-9937; Rahimi-Movaghar, Vafa/0000-0001-7347-8767; Alam, Khurshid/0000-0002-7402-7519	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The Bill & Melinda Gates Foundation.	AIDSinfo, 2017, 2017 GLOB AIDS MON G; Amico P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012997; Aran-Matero D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022373; Bui AL, 2017, JAMA PEDIATR, V171, P181, DOI 10.1001/jamapediatrics.2016.4086; Di Giorgio L, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0653-z; Dieleman JL, 2017, JAMA; Dieleman J, 2017, LANCET, V389, P1981, DOI 10.1016/S0140-6736(17)30874-7; Dieleman JL, 2016, JAMA-J AM MED ASSOC, V316, P2627, DOI 10.1001/jama.2016.16885; Dieleman JL, 2014, HEALTH ECON, V23, P129, DOI 10.1002/hec.3016; Durairaj V, 2010, WORLD HLTH REP; Elovainio R, 2017, HEALTH ECON POLICY L, V12, P139, DOI [10.1017/S1744133116000426, 10.1017/s1744133116000426]; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; James SL, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-12; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Kinge JM, 2017, HEALTH POLICY, V121, P691, DOI 10.1016/j.healthpol.2017.03.020; Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4; Micah AE, 2017, HEALTH AFFAIR, V36, P2133, DOI 10.1377/hlthaff.2017.1055; Organisation for Economic Co-operation and Development, HLTH SPEND CONT OUTP; Organisation for Economic Co-operation and Development WHO, 2013, GUID IMPL SHE 2011 F; Shretta R, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1890-0; The World Bank, WORLD BANK COUNTR LE; UNAIDS, NASA COUNTR REP; UNAIDS, 2011, UNAIDS TERM GUID; UNAIDS, 2009, NAT AIDS SPEND ASS N; UNAIDS, 2015, UND FAST TRACK ACC A; United Nations, SUST DEV GOALS; United Nations General Assembly, 2000, UN MILL DECL; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Wang HD, 2017, LANCET, V390, P1084, DOI 10.1016/S0140-6736(17)31833-0; WHO, 2011, SYST HLTH ACC 2011; WHO, GLOB HLTH EXP DAT; World Bank Group, 2016, 2014 2015 W AFR EB C	32	95	95	5	33	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2018	391	10132					1799	1829		10.1016/S0140-6736(18)30698-6	http://dx.doi.org/10.1016/S0140-6736(18)30698-6			31	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GE7NY	29678342	Green Published, hybrid			2022-12-28	WOS:000431421300027
J	McBride, JA; Lepak, AJ; Dhaliwal, G; Saint, S; Safdar, N				McBride, Joseph A.; Lepak, Alexander J.; Dhaliwal, Gurpreet; Saint, Sanjay; Safdar, Nasia			The Wrong Frame of Mind	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							URINARY-TRACT-INFECTION; TUBERCULOSIS		[McBride, Joseph A.; Lepak, Alexander J.; Safdar, Nasia] Univ Wisconsin, Madison Sch Med, William S Middleton Mem Vet Hosp, Madison, WI 53706 USA; [McBride, Joseph A.; Lepak, Alexander J.; Safdar, Nasia] Univ Wisconsin, Madison Sch Med, Dept Med, Madison, WI 53706 USA; [McBride, Joseph A.] Univ Wisconsin, Madison Sch Med, Dept Pediat, Madison, WI 53706 USA; [Saint, Sanjay] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Saint, Sanjay] Dept Vet Affairs VA Hlth Serv Res & Dev Ctr Excel, Ann Arbor, MI USA; [Dhaliwal, Gurpreet] Univ Calif San Francisco, Med Serv, San Francisco VA Med Ctr, San Francisco, CA 94143 USA; [Dhaliwal, Gurpreet] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	McBride, JA (corresponding author), Univ Wisconsin, Madison Sch Med, William S Middleton Mem Vet Hosp, Madison, WI 53706 USA.; McBride, JA (corresponding author), Univ Wisconsin, Madison Sch Med, Dept Med, Madison, WI 53706 USA.; McBride, JA (corresponding author), Univ Wisconsin, Madison Sch Med, Dept Pediat, Madison, WI 53706 USA.	jmcbride@medicine.wisc.edu	Saint, Sanjay/AAF-5126-2019		ISMIE Mutual Insurance Company; Physicians' Reciprocal Insurers; Doximity; Jvion	ISMIE Mutual Insurance Company; Physicians' Reciprocal Insurers; Doximity; Jvion	Dr. Dhaliwal reports receiving lecture fees from ISMIE Mutual Insurance Company and Physicians' Reciprocal Insurers; and Dr. Saint, receiving advisory board fees from Doximity and Jvion. No other potential conflict of interest relevant to this article was reported.	Bent S, 2002, JAMA-J AM MED ASSOC, V287, P2701, DOI 10.1001/jama.287.20.2701; Centers for Disease Control and Prevention (CDC), 2016, REP TUB US; Daher ED, 2013, AM J TROP MED HYG, V88, P54, DOI 10.4269/ajtmh.2013.12-0413; Figueiredo AA, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.TNMI7-0015-2016; Figueiredo AA, 2008, INT J UROL, V15, P827, DOI 10.1111/j.1442-2042.2008.02099.x; Geiss HK, 2005, INFECTION, V33, P393, DOI 10.1007/s15010-005-5075-3; Ghaleb K, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.034; Michel P, 2002, INTENS CARE MED, V28, P1827, DOI 10.1007/S00134-002-1526-9; Nahid P, 2016, CLIN INFECT DIS, V63, pe147, DOI 10.1093/cid/ciw376; Saint S, 1999, AM J MED, V106, P636, DOI 10.1016/S0002-9343(99)00122-9; SIMON HB, 1977, AM J MED, V63, P410, DOI 10.1016/0002-9343(77)90279-0; WHO, 2017, GLOB TUB REP	12	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2018	378	18					1716	1721		10.1056/NEJMcps1710814	http://dx.doi.org/10.1056/NEJMcps1710814			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GE4WO	29719187				2022-12-28	WOS:000431218600012
J	Senat, MV; Affres, H; Letourneau, A; Coustols-Valat, M; Cazaubiel, M; Legardeur, H; Jacquier, JF; Bourcigaux, N; Simon, E; Rod, A; Heron, I; Castera, V; Sentilhes, L; Bretelle, F; Rolland, C; Morin, M; Deruelle, P; De Carne, C; Maillot, F; Beucher, G; Verspyck, E; Desbriere, R; Laboureau, S; Mitanchez, D; Bouyer, J				Senat, Marie-Victoire; Affres, Helene; Letourneau, Alexandra; Coustols-Valat, Magali; Cazaubiel, Marie; Legardeur, Helene; Jacquier, Julie Fort; Bourcigaux, Nathalie; Simon, Emmanuel; Rod, Anne; Heron, Isabelle; Castera, Virginie; Sentilhes, Loic; Bretelle, Florence; Rolland, Catherine; Morin, Mathieu; Deruelle, Philippe; De Carne, Celine; Maillot, Francois; Beucher, Gael; Verspyck, Eric; Desbriere, Raoul; Laboureau, Sandrine; Mitanchez, Delphine; Bouyer, Jean		Grp Rec Obstetrique Gynecologie	Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREGNANCY OUTCOMES; MELLITUS; METAANALYSIS; MANAGEMENT; NONINFERIORITY; GLIBENCLAMIDE; HYPERGLYCEMIA; EQUIVALENCE; ASSOCIATION; SAFETY	IMPORTANCE Randomized trials have not focused on neonatal complications of glyburide for women with gestational diabetes. OBJECTIVE To compare oral glyburide vs subcutaneous insulin in prevention of perinatal complications in newborns of women with gestational diabetes. DESIGN, SETTINGS, AND PARTICIPANTS The Insulin Daonil trial (INDAO), a multicenter noninferiority randomized trial conducted between May 2012 and November 2016 (end of participant follow-up) in 13 tertiary care university hospitals in France including 914 women with singleton pregnancies and gestational diabetes diagnosed between 24 and 34 weeks of gestation. INTERVENTIONS Women who required pharmacologic treatment after 10 days of dietary intervention were randomly assigned to receive glyburide (n=460) or insulin (n=454). The starting dosage for glyburide was 2.5 mg orally once per day and could be increased if necessary 4 days later by 2.5 mg and thereafter by 5 mg every 4 days in 2 morning and evening doses, up to a maximum of 20 mg/d. The starting dosage for insulin was 4 IU to 20 IU given subcutaneously 1 to 4 times per day as necessary and increased according to self-measured blood glucose concentrations. MAIN OUTCOMES AND MEASURES The primary outcomewas a composite criterion including macrosomia, neonatal hypoglycemia, and hyperbilirubinemia. The noninferiority margin was set at 7% based on a 1-sided 97.5% confidence interval. RESULTS Among the 914 patients who were randomized (mean age, 32.8 [SD, 5.2] years), 98% completed the trial. In a per-protocol analysis, 367 and 442 women and their neonates were analyzed in the glyburide and insulin groups, respectively. The frequency of the primary outcome was 27.6% in the glyburide group and 23.4% in the insulin group, a difference of 4.2%(1-sided 97.5% CI, -infinity to 10.5%; P=.19). CONCLUSION AND RELEVANCE This study of women with gestational diabetes failed to show that use of glyburide compared with subcutaneous insulin does not result in a greater frequency of perinatal complications. These findings do not justify the use of glyburide as a first-line treatment.	[Senat, Marie-Victoire] Bicetre Hosp, AP HP, Dept Gynecol Obstet, Le Kremlin Bicetre, France; [Senat, Marie-Victoire] Univ Paris Sud, Univ Med Paris Saclay, Le Kremlin Bicetre, France; [Senat, Marie-Victoire; Bouyer, Jean] Univ Paris Sud, Univ Paris Saclay, Univ Versailles St Quentin en Yvelines, Ctr Res Epidemiol & Populat Hlth,INSERM, Villejuif, France; [Affres, Helene] Bicetre Hosp, AP HP, Dept Reprod Endocrinol, Le Kremlin Bicetre, France; [Letourneau, Alexandra] Beclere Hosp, AP HP, Dept Gynecol Obstet, Clamart, France; [Coustols-Valat, Magali] Toulouse Univ Hosp, Dept Endocrinol Obstet, Toulouse, France; [Cazaubiel, Marie] Lille Univ Hosp, Dept Endocrinol, Hosp EA Environm Perinatal & Sante 4489, Lille, France; [Legardeur, Helene] Hop Louis Mourier, AP HP, Dept Gynecol & Obstet, Colombes, France; [Jacquier, Julie Fort] Poissy St Germain Hosp, Dept Gynecol Obstet, Poissy, France; [Bourcigaux, Nathalie] St Antoine Hosp Paris, AP HP, Dept Endocrinol, Paris, France; [Simon, Emmanuel] Univ Hosp Ctr Tours, Dept Obstet Gynecol & Fetal Med, Tours, France; [Rod, Anne] Caen Univ Hosp, Dept Endocrinol, Caen, France; [Heron, Isabelle] Rouen Univ Hosp Charles Nicolle, Dept Endocrinol, Rouen, France; [Castera, Virginie] St Joseph Hosp, Dept Endocrinol, Marseille, France; [Sentilhes, Loic] Angers Univ Hosp, Dept Obstet & Gynecol, Angers, France; [Sentilhes, Loic] Bordeaux Univ Hosp, Dept Obstet & Gynecol, Bordeaux, France; [Bretelle, Florence] Aix Marseille Univ, Pole Femme Enfant, AP HP, Dept Gynecol & Obstet, Marseille, France; [Rolland, Catherine] Beclere Hosp, AP HP, Dept Hepatoenterol Gastroenteritis, Clamart, France; [Morin, Mathieu] Toulouse Univ Hosp, Dept Gynecol Obstet, Toulouse, France; [Deruelle, Philippe] Univ Lille, Dept Gynecol Obstet, EA Environm Perinatal & Sante 4489, Lille, France; [De Carne, Celine] Trousseau Hosp, AP HP, Dept Gynecol Obstet, Paris, France; [Maillot, Francois] Francois Rabelais Univ, Univ Hosp Ctr Tours, Dept Internal Med, Tours, France; [Beucher, Gael] Caen Univ Hosp, Dept Gynecol Obstet, Caen, France; [Verspyck, Eric] Rouen Univ Hosp Charles Nicolle, Dept Gynecol & Obstet, Rouen, France; [Desbriere, Raoul] St Joseph Hosp, Dept Gynecol Obstet, Marseille, France; [Laboureau, Sandrine] Angers Univ Hosp, Dept Endocrinol, Angers, France; [Mitanchez, Delphine] Univ Paris 06, Univ Pierre & Marie Curie, Armand Trousseau Hosp, AP HP,Sorbonne Univ,Dept Neonatol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; CHU de Toulouse; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Tours; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Rouen; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; CHU de Toulouse; Universite de Lille - ISITE; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Tours; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Rouen; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite	Senat, MV (corresponding author), Hop Bicetre, Serv Gynecol Obstet, 78 Ave Gen Leclerc, F-94270 Le Kremlin Bicetre, France.	marie-victoire.senat@aphp.fr	bouyer, jean/G-2717-2013	bouyer, jean/0000-0003-4861-0783; Maillot, Francois/0000-0002-1979-5769; Simon, Emmanuel/0000-0001-6442-1013	French Ministry of Health; Departement de la Recherche Clinique et du Developpement de l'Assistance Publique-Hopitaux de Paris	French Ministry of Health; Departement de la Recherche Clinique et du Developpement de l'Assistance Publique-Hopitaux de Paris	This study was funded by a research grant from the French Ministry of Health (PHRC 2011) and was sponsored by the Departement de la Recherche Clinique et du Developpement de l'Assistance Publique-Hopitaux de Paris.	Anjalakshi C, 2007, DIABETES RES CLIN PR, V76, P474, DOI 10.1016/j.diabres.2006.09.031; [Anonymous], 2018, Obstet Gynecol, V131, pe49, DOI 10.1097/AOG.0000000000002501; Balsells M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h102; Bertini AM, 2005, J PERINAT MED, V33, P519, DOI 10.1515/JPM.2005.092; Buschur E, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-014-0570-5; Castillo WC, 2015, JAMA PEDIATR, V169, P452, DOI 10.1001/jamapediatrics.2015.74; Castillo WC, 2014, OBSTET GYNECOL, V123, P1177, DOI 10.1097/AOG.0000000000000285; Cheng YW, 2012, J MATERN-FETAL NEO M, V25, P379, DOI 10.3109/14767058.2011.580402; Cornblath M, 2000, PEDIATRICS, V105, P1141, DOI 10.1542/peds.105.5.1141; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Farrar D, 2016, INT J WOMENS HEALTH, V8, P519, DOI 10.2147/IJWH.S102117; Goetzl Laura, 2002, J Perinatol, V22, P403, DOI 10.1038/sj.jp.7210759; Jiang YF, 2015, J CLIN ENDOCR METAB, V100, P2071, DOI 10.1210/jc.2014-4403; Kaji AH, 2015, JAMA-J AM MED ASSOC, V313, P2371, DOI 10.1001/jama.2015.6645; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Langer O, 2000, NEW ENGL J MED, V343, P1134, DOI 10.1056/NEJM200010193431601; Lesaffre E, 2008, BULL HOSP JT DIS, V66, P150; Mamelle N., 1996, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V25, P61; McKinlay CJD, 2015, NEW ENGL J MED, V373, P1507, DOI 10.1056/NEJMoa1504909; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Moretti ME, 2008, ANN PHARMACOTHER, V42, P483, DOI 10.1345/aph.1K577; Ogunyemi Dotun, 2007, Endocr Pract, V13, P427; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Poolsup N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109985; Schumi J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-106; Silva JC, 2007, ARQ BRAS ENDOCRINOL, V51, P541, DOI 10.1590/S0004-27302007000400007; Simmons D, 2010, DIABETES CARE, V33, P34, DOI 10.2337/dc09-1376; Song R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182488; Stata Corp, 2015, STAT STAT SOFTW REL; Zeng YC, 2014, ADV MED SCI-POLAND, V59, P95, DOI 10.1016/j.advms.2014.03.001	30	55	60	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2018	319	17					1773	1780		10.1001/jama.2018.4072	http://dx.doi.org/10.1001/jama.2018.4072			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GE3UQ	29715355	Green Published, Bronze			2022-12-28	WOS:000431138800015
J	Curry, A				Curry, Andrew			Siberian sculpture is among the oldest monumental art The 11,600-year-old Shigir Idol offers an enigmatic glimpse of hunter-gatherers' world view	SCIENCE			English	News Item																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					364	364		10.1126/science.360.6387.364	http://dx.doi.org/10.1126/science.360.6387.364			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1AR	29700243				2022-12-28	WOS:000430949600012
J	Campbell, BCV; Mitchell, PJ; Churilov, L; Yassi, N; Kleinig, TJ; Dowling, RJ; Yan, B; Bush, SJ; Dewey, HM; Thijs, V; Scroop, R; Simpson, M; Brooks, M; Asadi, H; Wu, TY; Shah, DG; Wijeratne, T; Ang, T; Miteff, F; Levi, CR; Rodrigues, E; Zhao, H; Salvaris, P; Garcia-Esperon, C; Bailey, P; Rice, H; de Villiers, L; Brown, H; Redmond, K; Leggett, D; Fink, JN; Collecutt, W; Wong, AA; Muller, C; Coulthard, A; Mitchell, K; Clouston, J; Mahady, K; Field, D; Ma, H; Phan, TG; Chong, W; Chandra, RV; Slater, LA; Krause, M; Harrington, TJ; Faulder, KC; Steinfort, BS; Bladin, CF; Sharma, G; Desmond, PM; Parsons, MW; Donnan, GA; Davis, SM				Campbell, B. C. V.; Mitchell, P. J.; Churilov, L.; Yassi, N.; Kleinig, T. J.; Dowling, R. J.; Yan, B.; Bush, S. J.; Dewey, H. M.; Thijs, V.; Scroop, R.; Simpson, M.; Brooks, M.; Asadi, H.; Wu, T. Y.; Shah, D. G.; Wijeratne, T.; Ang, T.; Miteff, F.; Levi, C. R.; Rodrigues, E.; Zhao, H.; Salvaris, P.; Garcia-Esperon, C.; Bailey, P.; Rice, H.; de Villiers, L.; Brown, H.; Redmond, K.; Leggett, D.; Fink, J. N.; Collecutt, W.; Wong, A. A.; Muller, C.; Coulthard, A.; Mitchell, K.; Clouston, J.; Mahady, K.; Field, D.; Ma, H.; Phan, T. G.; Chong, W.; Chandra, R. V.; Slater, L. -A.; Krause, M.; Harrington, T. J.; Faulder, K. C.; Steinfort, B. S.; Bladin, C. F.; Sharma, G.; Desmond, P. M.; Parsons, M. W.; Donnan, G. A.; Davis, S. M.		EXTEND-IA TNK Investigators	Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; BLINDED END-POINT; ENDOVASCULAR THROMBECTOMY; RANDOMIZED-TRIAL; ASSUMPTION-FREE; OPEN-LABEL; THROMBOLYSIS; METAANALYSIS; MANAGEMENT; OUTCOMES	BACKGROUND Intravenous infusion of alteplase is used for thrombolysis before endovascular thrombectomy for ischemic stroke. Tenecteplase, which is more fibrin-specific and has longer activity than alteplase, is given as a bolus and may increase the incidence of vascular reperfusion. METHODS We randomly assigned patients with ischemic stroke who had occlusion of the internal carotid, basilar, or middle cerebral artery and who were eligible to undergo thrombectomy to receive tenecteplase (at a dose of 0.25 mg per kilogram of body weight; maximum dose, 25 mg) or alteplase (at a dose of 0.9 mg per kilogram; maximum dose, 90 mg) within 4.5 hours after symptom onset. The primary outcome was reperfusion of greater than 50% of the involved ischemic territory or an absence of retrievable thrombus at the time of the initial angiographic assessment. Noninferiority of tenecteplase was tested, followed by superiority. Secondary outcomes included the modified Rankin scale score (on a scale from 0 [no neurologic deficit] to 6 [death]) at 90 days. Safety outcomes were death and symptomatic intracerebral hemorrhage. RESULTS Of 202 patients enrolled, 101 were assigned to receive tenecteplase and 101 to receive alteplase. The primary outcome occurred in 22% of the patients treated with tenecteplase versus 10% of those treated with alteplase (incidence difference, 12 percentage points; 95% confidence interval [CI], 2 to 21; incidence ratio, 2.2; 95% CI, 1.1 to 4.4; P=0.002 for noninferiority; P=0.03 for superiority). Tenecteplase resulted in a better 90-day functional outcome than alteplase (median modified Rankin scale score, 2 vs. 3; common odds ratio, 1.7; 95% CI, 1.0 to 2.8; P=0.04). Symptomatic intracerebral hemorrhage occurred in 1% of the patients in each group. CONCLUSIONS Tenecteplase before thrombectomy was associated with a higher incidence of reperfusion and better functional outcome than alteplase among patients with ischemic stroke treated within 4.5 hours after symptom onset. (Funded by the National Health and Medical Research Council of Australia and others; EXTEND-IA TNK ClinicalTrials.gov number, NCT02388061.)	[Campbell, B. C. V.; Yassi, N.; Yan, B.; Wu, T. Y.; Shah, D. G.; Rodrigues, E.; Zhao, H.; Salvaris, P.; Sharma, G.; Parsons, M. W.; Davis, S. M.] Univ Melbourne, Dept Med, Melbourne Brain Ctr, Parkville, Vic, Australia; [Campbell, B. C. V.; Yassi, N.; Yan, B.; Wu, T. Y.; Shah, D. G.; Rodrigues, E.; Zhao, H.; Salvaris, P.; Sharma, G.; Parsons, M. W.; Davis, S. M.] Univ Melbourne, Dept Neurol, Melbourne Brain Ctr, Parkville, Vic, Australia; [Mitchell, P. J.; Dowling, R. J.; Bush, S. J.; Desmond, P. M.] Univ Melbourne, Dept Radiol, Parkville, Vic, Australia; [Churilov, L.; Yassi, N.; Thijs, V.; Asadi, H.; Ma, H.; Bladin, C. F.; Donnan, G. A.] Univ Melbourne, Royal Melbourne Hosp, Parkville, Vic, Australia; [Churilov, L.; Yassi, N.; Thijs, V.; Asadi, H.; Ma, H.; Bladin, C. F.; Donnan, G. A.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Kleinig, T. J.] Lyell McEwin Hosp, Dept Neurol, Adelaide, SA, Australia; [Scroop, R.] Lyell McEwin Hosp, Dept Radiol, Adelaide, SA, Australia; [Field, D.] Lyell McEwin Hosp, Royal Adelaide Hosp, Adelaide, SA, Australia; [Field, D.] Lyell McEwin Hosp, Dept Neurol, Adelaide, SA, Australia; [Dewey, H. M.; Bladin, C. F.] Monash Univ, Dept Neurosci, Eastern Hlth & Eastern Hlth Clin Sch, Monash Med Ctr, Clayton, Vic, Australia; [Ma, H.; Phan, T. G.] Monash Univ, Dept Neurol, Monash Med Ctr, Clayton, Vic, Australia; [Chong, W.; Chandra, R. V.; Slater, L. -A.] Monash Univ, Dept Radiol, Monash Med Ctr, Clayton, Vic, Australia; [Thijs, V.; Simpson, M.] Austin Hlth, Dept Neurol, Austin Hosp, Heidelberg, Vic, Australia; [Brooks, M.; Asadi, H.] Austin Hlth, Austin Hosp, Dept Radiol, Heidelberg, Vic, Australia; [Asadi, H.] Deakin Univ, Sch Med, Fac Hlth, Melbourne, Vic, Australia; [Wijeratne, T.] Univ Melbourne, Melbourne Med Sch, Dept Med, St Albans, Vic, Australia; [Wijeratne, T.] Univ Melbourne, Melbourne Med Sch, Dept Neurol, St Albans, Vic, Australia; [Wijeratne, T.] Western Hlth, Sunshine Hosp, St Albans, Vic, Australia; [Shah, D. G.; Brown, H.] Princess Alexandra Hosp, Dept Neurol, Brisbane, Qld, Australia; [Redmond, K.; Leggett, D.] Princess Alexandra Hosp, Dept Radiol, Brisbane, Qld, Australia; [Wong, A. A.; Muller, C.] Royal Brisbane & Womens Hosp, Dept Neurol, Brisbane, Qld, Australia; [Coulthard, A.; Mitchell, K.; Clouston, J.; Mahady, K.] Royal Brisbane & Womens Hosp, Dept Radiol, Brisbane, Qld, Australia; Univ Queensland, Brisbane, Qld, Australia; [Bailey, P.] Gold Coast Univ Hosp, Dept Neurol, Southport, Qld, Australia; [Rice, H.; de Villiers, L.] Gold Coast Univ Hosp, Dept Radiol, Southport, Qld, Australia; [Ang, T.; Miteff, F.; Levi, C. R.; Garcia-Esperon, C.; Parsons, M. W.] Univ Newcastle, John Hunter Hosp, Dept Neurol, Prior Res Ctr Brain & Mental Hlth Res, Newcastle, NSW, Australia; [Krause, M.] Univ Sydney, Dept Neurol, Royal North Shore Hosp, Sydney, NSW, Australia; [Krause, M.] Univ Sydney, Kolling Inst, Sydney, NSW, Australia; [Harrington, T. J.; Faulder, K. C.; Steinfort, B. S.] Royal North Shore Hosp, Dept Radiol, St Leonards, NSW, Australia; [Harrington, T. J.; Faulder, K. C.; Steinfort, B. S.] Westmead Hosp, Dept Radiol, Sydney, NSW, Australia; [Wu, T. Y.; Fink, J. N.] Christchurch Hosp, Dept Neurol, Christchurch, New Zealand; [Collecutt, W.] Christchurch Hosp, Dept Radiol, Christchurch, New Zealand	University of Melbourne; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Lyell McEwin Hospital; Lyell McEwin Hospital; Lyell McEwin Hospital; Royal Adelaide Hospital; Lyell McEwin Hospital; Monash University; Monash University; Monash University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Deakin University; University of Melbourne; University of Melbourne; Royal Brisbane & Women's Hospital; Royal Brisbane & Women's Hospital; University of Queensland; Gold Coast University Hospital; Gold Coast University Hospital; John Hunter Hospital; University of Newcastle; Royal North Shore Hospital; University of Sydney; University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; University of Sydney; Christchurch Hospital New Zealand; Christchurch Hospital New Zealand	Campbell, BCV (corresponding author), Royal Melbourne Hosp, Dept Neurol, 300 Grattan St, Parkville, Vic 3050, Australia.	bruce.campbell@mh.org.au	Salvaris, Patrick/GPK-7084-2022; Wong, Andrew/C-1569-2011; Thijs, Vincent/C-3647-2009; Zhao, Henry/AAL-9919-2020; Garcia-Esperon, Carlos/AAY-6810-2020; Coulthard, Alan/C-3649-2011; Chandra, Ronil/GPK-0357-2022; Wu, Teddy/AAD-7864-2020; Campbell, Bruce/J-1220-2019; FRACP, Tissa Wijeratne MD PhD/I-2086-2019; Davis, Stephen/L-5260-2013; Desmond, Patricia/D-1966-2014	Wong, Andrew/0000-0002-7272-8944; Thijs, Vincent/0000-0002-6614-8417; Zhao, Henry/0000-0002-4320-4287; Coulthard, Alan/0000-0003-1110-9207; Wu, Teddy/0000-0003-1845-1769; Campbell, Bruce/0000-0003-3632-9433; FRACP, Tissa Wijeratne MD PhD/0000-0002-1701-7111; Slater, Lee-Anne/0000-0002-1140-8664; Steinfort, Brendan/0000-0002-6627-7972; Davis, Stephen/0000-0003-0962-2300; Muller, Claire/0000-0002-9250-936X; Dowling, Richard/0000-0002-4082-8676; Levi, Christopher/0000-0002-9474-796X; Yassi, Nawaf/0000-0002-0685-0060; MA, HENRY/0000-0002-0510-8059; Desmond, Patricia/0000-0002-4803-6323; Chandra, Ronil/0000-0001-7555-2297; kleinig, Timothy/0000-0003-4430-3276	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funded by the National Health and Medical Research Council of Australia and others; EXTEND-IA TNK ClinicalTrials.gov number, NCT02388061.	Bivard A, 2017, NEUROLOGY, V89, P62, DOI 10.1212/WNL.0000000000004062; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Campbell BCV, 2016, EUR STROKE J S1, P635; Campbell BCV, 2018, INT J STROKE, V13, P328, DOI 10.1177/1747493017733935; Chia NH, 2016, STROKE, V47, P1377, DOI 10.1161/STROKEAHA.116.013165; Churilov L, 2014, INT J STROKE, V9, P999, DOI 10.1111/ijs.12364; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Haley EC, 2010, STROKE, V41, P707, DOI 10.1161/STROKEAHA.109.572040; Hansson L, 1992, Blood Press, V1, P113, DOI 10.3109/08037059209077502; Howard G, 2012, STROKE, V43, P664, DOI 10.1161/STROKEAHA.111.632935; Huang XY, 2015, LANCET NEUROL, V14, P368, DOI 10.1016/S1474-4422(15)70017-7; Logallo N, 2017, LANCET NEUROL, V16, P781, DOI 10.1016/S1474-4422(17)30253-3; Malhotra K, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00651; Mehta CR, 2011, STAT MED, V30, P3267, DOI 10.1002/sim.4102; Parsons M, 2012, NEW ENGL J MED, V366, P1099, DOI 10.1056/NEJMoa1109842; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; Saver JL, 2016, JAMA-J AM MED ASSOC, V316, P1279, DOI 10.1001/jama.2016.13647; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Tanswell P, 2002, CLIN PHARMACOKINET, V41, P1229, DOI 10.2165/00003088-200241150-00001; Van de Werf F, 1999, LANCET, V354, P716, DOI 10.1016/S0140-6736(99)07403-6; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wintermark M, 2013, STROKE, V44, P2628, DOI 10.1161/STROKEAHA.113.002015; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	25	322	336	4	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2018	378	17					1573	1582		10.1056/NEJMoa1716405	http://dx.doi.org/10.1056/NEJMoa1716405			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8XP	29694815	Bronze, Green Published			2022-12-28	WOS:000430797900004
J	Morack, T; Gilmour, R				Morack, Tobias; Gilmour, Ryan			Facial recognition for molecules	NATURE			English	Editorial Material							STEREOCENTERS	A catalyst has been developed that recognizes the topology of just one face of a planar reaction intermediate. Remarkably, this enables one mirror-image isomer of the reaction product to be made selectively.	[Morack, Tobias; Gilmour, Ryan] Univ Munster, Organ Chem Inst, D-48149 Munster, Germany	University of Munster	Gilmour, R (corresponding author), Univ Munster, Organ Chem Inst, D-48149 Munster, Germany.	ryan.gilmour@uni-muenster.de		Morack, Tobias/0000-0003-2045-730X				Brak K, 2013, ANGEW CHEM INT EDIT, V52, P534, DOI 10.1002/anie.201205449; Feng JJ, 2017, CHEM REV, V117, P12564, DOI 10.1021/acs.chemrev.7b00385; Quasdorf KW, 2014, NATURE, V516, P181, DOI 10.1038/nature14007; Wendlandt AE, 2018, NATURE, V556, P447, DOI 10.1038/s41586-018-0042-1	4	0	0	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2018	556	7702					438	439		10.1038/d41586-018-04684-2	http://dx.doi.org/10.1038/d41586-018-04684-2			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD8VX	29691506	Bronze			2022-12-28	WOS:000430793000029
J	Gordon, LB; Shappell, H; Massaro, J; D'Agostino, RB; Brazier, J; Campbell, SE; Kleinman, ME; Kieran, MW				Gordon, Leslie B.; Shappell, Heather; Massaro, Joe; D'Agostino, Ralph B., Sr.; Brazier, Joan; Campbell, Susan E.; Kleinman, Monica E.; Kieran, Mark W.			Association of Lonafarnib Treatment vs No Treatment With Mortality Rate in Patients With Hutchinson-Gilford Progeria Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FARNESYLATION INHIBITORS; CLINICAL-TRIAL; PHENOTYPE; SURVIVAL; CHILDREN; PROTEIN; LAMIN	IMPORTANCE Hutchinson-Gilford progeria syndrome (HGPS) is an extremely rare fatal premature aging disease. There is no approved treatment.& para;& para;OBJECTIVE To evaluate the association of monotherapy using the protein farnesyltransferase inhibitor lonafarnib with mortality rate in children with HGPS.& para;& para;DESIGN, SETTING, AND PARTICIPANTS Cohort study comparing contemporaneous (birth date >= 1991) untreated patients with HGPS matched with treated patients by age, sex, and continent of residency using conditional Cox proportional hazards regression. Treatment cohorts included patients from 2 single-group, single-site clinical trials (ProLon1 [n = 27; completed] and ProLon2 [n = 36; ongoing]). Untreated patients originated from a separate natural history study (n = 103). The cutoff date for patient follow-up was January 1, 2018.& para;& para;EXPOSURE Treated patients received oral lonafarnib (150 mg/m(2)) twice daily. Untreated patients received no clinical trial medications.& para;& para;MAIN OUTCOMES AND MEASURES The primary outcome was mortality. The primary analysis compared treated patients from the first lonafarnib trial with matched untreated patients. A secondary analysis compared the combined cohorts from both lonafarnib trials with matched untreated patients.& para;& para;RESULTS Among untreated and treated patients (n = 258) from 6 continents, 123 (477%) were female; 141 (54.7%) had a known genotype, of which 125 (88.7%) were classic (c.1824C>T in LMNA). When identified (n = 73), the primary cause of death was heart failure (79.4%). The median treatment duration was 2.2 years. Median age at start of follow-up was 8.4 (interquartile range [IQR], 4.8-9.5) years in the first trial cohort and 6.5 (IQR, 3.7-9.0) years in the combined cohort. There was 1 death (3.7%) among 27 patients in the first trial group and there were 9 deaths (33.3%) among 27 patients in the matched untreated group. Treatment was associated with a lower mortality rate (hazard ratio, 0.12; 95% CI, 0.01-0.93; P = .04). In the combined cohort, there were 4 deaths (6.3%) among 63 patients in the treated group and 17 deaths (27.0%) among 63 patients in the matched untreated group (hazard ratio. 0.23; 95% CI, 0.06-0.90; P = .04).& para;& para;CONCLUSIONS AND RELEVANCE Among patients with HGPS, lonafarnib monotherapy, compared with no treatment, was associated with a lower mortality rate after 2.2 years of follow-up. Study interpretation is limited by its observational design.	[Gordon, Leslie B.] Hasbro Childrens Hosp, Div Genet, Dept Pediat, Providence, RI 02903 USA; [Gordon, Leslie B.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Gordon, Leslie B.; Kleinman, Monica E.] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA; [Gordon, Leslie B.; Kleinman, Monica E.; Kieran, Mark W.] Harvard Med Sch, Boston, MA USA; [Shappell, Heather; Massaro, Joe; D'Agostino, Ralph B., Sr.] Boston Univ, Harvard Clin Res Inst, Dept Math & Stat, Boston, MA 02215 USA; [Brazier, Joan; Campbell, Susan E.] Brown Univ, Ctr Gerontol & Hlth Care Res, Providence, RI 02912 USA; [Kieran, Mark W.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Kieran, Mark W.] Harvard Med Sch, Dana Farber Canc Inst, Div Pediat Oncol, Boston, MA USA	Hasbro Children's Hospital; Brown University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Boston University; Harvard University; Harvard Medical School; Brown University; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Gordon, LB (corresponding author), Hasbro Childrens Hosp, Dept Pediat, 593 Eddy St, Providence, RI 02903 USA.	leslie_gordon@brown.edu	Gordon, Leslie B./AAJ-5793-2021; Kleinman, Monica/AAO-5641-2020		Progeria Research Foundation [PRF-2012-NH, PRF-2002-CB, PRF-2002-MRD]	Progeria Research Foundation	This study was funded by grants PRF-2012-NH, PRF-2002-CB, and PRF-2002-MRD from The Progeria Research Foundation. Schering Plough/Merck provided the medication used in the 2 treatment trials.	Casasola A, 2016, NUCLEUS-PHILA, V7, P84, DOI 10.1080/19491034.2016.1150397; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Gordon L.B, PRF BY THE NUMBERS; Gordon L.B., 2003, GENEREVIEWS; Gordon LB, 2005, J PEDIATR-US, V146, P336, DOI 10.1016/j.jpeds.2004.10.064; Gordon LB, 2016, CIRCULATION, V134, P114, DOI 10.1161/CIRCULATIONAHA.116.022188; Gordon LB, 2014, CIRCULATION, V130, P27, DOI 10.1161/CIRCULATIONAHA.113.008285; Gordon LB, 2012, P NATL ACAD SCI USA, V109, P16666, DOI 10.1073/pnas.1202529109; Gruenbaum Y, 2015, ANNU REV BIOCHEM, V84, P131, DOI 10.1146/annurev-biochem-060614-034115; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Hisama FM, 2011, AM J MED GENET A, V155A, P3002, DOI 10.1002/ajmg.a.34336; Li Y, 2014, STAT BIOSCI, V6, P105, DOI 10.1007/s12561-013-9085-x; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Moscicki RA, 2017, NEW ENGL J MED, V376, P1698, DOI 10.1056/NEJMc1702644; Rubin DB, 2004, MULTIPLE IMPUTATION, V81; Shalev SA, 2007, AM J MED GENET A, V143A, P1821, DOI 10.1002/ajmg.a.31803; Strandgren C, 2017, BIOCHEM SOC T, V45, P1279, DOI 10.1042/BST20170141; Ullrich NJ, 2013, NEUROLOGY, V81, P427, DOI 10.1212/WNL.0b013e31829d85c0	19	95	98	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2018	319	16					1687	1695		10.1001/jama.2018.3264	http://dx.doi.org/10.1001/jama.2018.3264			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD7RF	29710166	Green Published, Bronze			2022-12-28	WOS:000430709300023
J	Slomski, A				Slomski, Anita			Better Communication Can Improve HPV Vaccine Rates	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2018	319	16					1649	1649		10.1001/jama.2018.4013	http://dx.doi.org/10.1001/jama.2018.4013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD7RF	29710159				2022-12-28	WOS:000430709300007
J	Slomski, A				Slomski, Anita			Prazosin May Not Reduce Nightmares in Veterans With PTSD	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2018	319	16					1649	1649		10.1001/jama.2018.4741	http://dx.doi.org/10.1001/jama.2018.4741			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD7RF	29710163				2022-12-28	WOS:000430709300011
J	Lyons, B; Gibson, M; Dolezal, L				Lyons, Barry; Gibson, Matthew; Dolezal, Luna			Stories of shame	LANCET			English	Editorial Material									[Lyons, Barry] Univ Dublin, Sch Med, Trinity Coll Dublin, Dublin 2, Ireland; [Lyons, Barry] Our Ladys Childrens Hosp, Dept Anaesthesia & Crit Care Med, Dublin 12, Ireland; [Gibson, Matthew] Univ Birmingham, Dept Social Work & Social Care, Birmingham, W Midlands, England; [Dolezal, Luna] Univ Exeter, Med Humanities & Philosophy, Exeter, Devon, England	Trinity College Dublin; National Children's Research Centre (NCRC); University of Birmingham; University of Exeter	Lyons, B (corresponding author), Univ Dublin, Sch Med, Trinity Coll Dublin, Dublin 2, Ireland.; Lyons, B (corresponding author), Our Ladys Childrens Hosp, Dept Anaesthesia & Crit Care Med, Dublin 12, Ireland.	balyons@tcd.ie		Lyons, Barry/0000-0002-8806-1195				Dolezal L, 2017, MED HUMANIT, V43, P257, DOI 10.1136/medhum-2017-011186; Gawande Atul, 2003, COMPLICATIONS SURG N; Gibson M, 2014, J SOC WORK PRACT, V28, P417, DOI 10.1080/02650533.2014.913237; Kay A., 2017, THIS IS GOING HURT S; Marsh H., 2014, DO HARM STORIES LIFE; Ofri D., 2013, WHAT DOCTORS FEEL EM; Weston G., 2009, DIRECT RED SURG VIEW	7	9	9	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2018	391	10130					1568	1569		10.1016/S0140-6736(18)30897-3	http://dx.doi.org/10.1016/S0140-6736(18)30897-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GD5JG	29695336				2022-12-28	WOS:000430542700012
J	Xu, J; Mathur, J; Vessieres, E; Hammack, S; Nonomura, K; Favre, J; Grimaud, L; Petrus, M; Francisco, A; Li, JY; Lee, V; Xiang, FL; Mainquist, JK; Cahalan, SM; Orth, AP; Walker, JR; Ma, S; Lukacs, V; Bordone, L; Bandell, M; Laffitte, B; Xu, Y; Chien, S; Henrion, D; Patapoutian, A				Xu, Jie; Mathur, Jayanti; Vessieres, Emilie; Hammack, Scott; Nonomura, Keiko; Favre, Julie; Grimaud, Linda; Petrus, Matt; Francisco, Allain; Li, Jingyuan; Lee, Van; Xiang, Fu-li; Mainquist, James K.; Cahalan, Stuart M.; Orth, Anthony P.; Walker, John R.; Ma, Shang; Lukacs, Viktor; Bordone, Laura; Bandell, Michael; Laffitte, Bryan; Xu, Yan; Chien, Shu; Henrion, Daniel; Patapoutian, Ardem			GPR68 Senses Flow and Is Essential for Vascular Physiology	CELL			English	Article							COMBINED TRANSMEMBRANE TOPOLOGY; MESENTERIC RESISTANCE ARTERIES; SIGNAL PEPTIDE PREDICTION; SHEAR-STRESS; ENDOTHELIAL-CELLS; MECHANOSENSORY TRANSDUCTION; MECHANOTRANSDUCTION CHANNEL; CAENORHABDITIS-ELEGANS; MOLECULAR-MECHANISMS; LIVING CELLS	Mechanotransduction plays a crucial role in vascular biology. One example of this is the local regulation of vascular resistance via flow-mediated dilation (FMD). Impairment of this process is a hallmark of endothelial dysfunction and a precursor to a wide array of vascular diseases, such as hypertension and atherosclerosis. Yet the molecules responsible for sensing flow (shear stress) within endothelial cells remain largely unknown. We designed a 384-well screening system that applies shear stress on cultured cells. We identified a mechanosensitive cell line that exhibits shear stress-activated calcium transients, screened a focused RNAi library, and identified GPR68 as necessary and sufficient for shear stress responses. GPR68 is expressed in endothelial cells of small-diameter (resistance) arteries. Importantly, Gpr68-deficient mice display markedly impaired acute FMD and chronic flowmediated outward remodeling in mesenteric arterioles. Therefore, GPR68 is an essential flow sensor in arteriolar endothelium and is a critical signaling component in cardiovascular pathophysiology.	[Xu, Jie; Mathur, Jayanti; Hammack, Scott; Petrus, Matt; Li, Jingyuan; Lee, Van; Xiang, Fu-li; Mainquist, James K.; Orth, Anthony P.; Walker, John R.; Bordone, Laura; Bandell, Michael; Laffitte, Bryan] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Vessieres, Emilie; Favre, Julie; Grimaud, Linda; Henrion, Daniel] Angers Univ, INSERM, U1083, MITOVASC Inst,CARFI Facil,CNRS,UMR 6015, Angers, France; [Nonomura, Keiko; Francisco, Allain; Cahalan, Stuart M.; Ma, Shang; Lukacs, Viktor; Patapoutian, Ardem] Scripps Res Inst, Howard Hughes Med Inst, Doris Neurosci Ctr, La Jolla, CA 92037 USA; [Xu, Yan] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA; [Chien, Shu] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Chien, Shu] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Chien, Shu] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA; [Nonomura, Keiko] Natl Inst Basic Biol, Div Embryol, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan; [Cahalan, Stuart M.] Vertex Pharmaceut, 11010 Torreyana Rd, San Diego, CA 92121 USA	Novartis; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Howard Hughes Medical Institute; Scripps Research Institute; Indiana University System; Indiana University Bloomington; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Vertex Pharmaceuticals	Patapoutian, A (corresponding author), Scripps Res Inst, Howard Hughes Med Inst, Doris Neurosci Ctr, La Jolla, CA 92037 USA.	ardem@scripps.edu	Henrion, Daniel/N-7023-2015; Henrion, Daniel/AAK-1995-2021; Henrion, Daniel/J-8141-2015	Henrion, Daniel/0000-0003-1094-0285; Henrion, Daniel/0000-0003-1094-0285; Henrion, Daniel/0000-0003-1094-0285; Lukacs, Viktor/0000-0003-3652-5469	NIH [DE022358]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022358] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Alec Wilson, Ton Trinh, and Hai Nguyen for engineering support; Sungjoon Kim for supplying human cancer cells; Craig Mickanin for picking the siRNA library; Yufeng Zhai and Yingyao Zhou for help with siRNA screen data analysis; Zhaozhu Qiu, Buu Tu, Loren Miraglia, Sanjeev Ranade, Angelica Romero, Glenn Federe, James Watson, Teri Johnson, Rita Moran and Kathryn Spencer for assistance; and members of Patapoutian group for constructive discussions. This work was partly supported by a grant from the NIH (NIH R01 #DE022358 to A.P.). A.P. is an investigator of the Howard Hughes Medical Institute.	Aoki H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079985; Burns ME, 2010, PHYSIOLOGY, V25, P72, DOI 10.1152/physiol.00001.2010; Chen PW, 2017, P NATL ACAD SCI USA, V114, P580, DOI 10.1073/pnas.1614035114; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Chuang HH, 1997, CELL, V89, P1121, DOI 10.1016/S0092-8674(00)80299-8; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Dumont O, 2008, CARDIOVASC RES, V77, P600, DOI 10.1093/cvr/cvm055; Ernstrom GG, 2002, ANNU REV GENET, V36, P411, DOI 10.1146/annurev.genet.36.061802.101708; Freidja ML, 2012, DIABETES, V61, P1562, DOI 10.2337/db11-0750; Grgic I, 2009, BRIT J PHARMACOL, V157, P509, DOI 10.1111/j.1476-5381.2009.00132.x; Henrion D, 1997, J CLIN INVEST, V100, P2909, DOI 10.1172/JCI119840; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Huang XP, 2015, NATURE, V527, P477, DOI 10.1038/nature15699; Ishida T, 1997, ANN NY ACAD SCI, V811, P12, DOI 10.1111/j.1749-6632.1997.tb51984.x; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Joyner MJ, 2015, PHYSIOL REV, V95, P549, DOI 10.1152/physrev.00035.2013; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kang LJ, 2010, NEURON, V67, P381, DOI 10.1016/j.neuron.2010.06.032; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Levy BI, 2008, CIRCULATION, V118, P968, DOI 10.1161/CIRCULATIONAHA.107.763730; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005705; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Lindauer U, 2003, J CEREBR BLOOD F MET, V23, P1227, DOI 10.1097/01.WCB.0000088764.02615.B7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loufrani L, 2001, CIRCULATION, V103, P864, DOI 10.1161/01.CIR.103.6.864; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Lukacs V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9329; Lynch FM, 2012, J HYPERTENS, V30, P384, DOI 10.1097/HJH.0b013e32834e38a0; Melchior B, 2012, AM J PHYSIOL-CELL PH, V303, pC467, DOI 10.1152/ajpcell.00117.2012; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Navone SE, 2013, NAT PROTOC, V8, P1680, DOI 10.1038/nprot.2013.107; Niebauer J, 1996, J AM COLL CARDIOL, V28, P1652, DOI 10.1016/S0735-1097(96)00393-2; Nonomura K, 2017, NATURE, V541, P176, DOI 10.1038/nature20793; Parry DA, 2016, AM J HUM GENET, V99, P984, DOI 10.1016/j.ajhg.2016.08.020; Pathan AR, 2011, HYPERTENSION, V58, P539, DOI 10.1161/HYPERTENSIONAHA.111.179390; Ramkhelawon B, 2013, FASEB J, V27, P3008, DOI 10.1096/fj.12-222299; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; Retailleau K, 2015, CELL REP, V13, P1161, DOI 10.1016/j.celrep.2015.09.072; Rode B, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00429-3; Schwaderer AL, 2004, PEDIATR REV, V25, P350, DOI 10.1542/pir.25-10-350; Silvestre JS, 2013, PHYSIOL REV, V93, P1743, DOI 10.1152/physrev.00006.2013; Storch U, 2012, AM J PHYSIOL-HEART C, V302, pH1241, DOI 10.1152/ajpheart.00818.2011; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; Tuttle JL, 2002, MICROCIRCULATION, V9, P343, DOI 10.1038/sj.mn.7800151; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598; Wang SP, 2016, J CLIN INVEST, V126, P4527, DOI 10.1172/JCI87343; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251; Yan L, 2014, ONCOGENE, V33, P157, DOI 10.1038/onc.2012.566; Yan ZQ, 2013, NATURE, V493, P221, DOI 10.1038/nature11685; Zhang YL, 2009, AM J PHYSIOL-CELL PH, V296, pC1391, DOI 10.1152/ajpcell.00549.2008	57	123	128	3	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2018	173	3					762	+		10.1016/j.cell.2018.03.076	http://dx.doi.org/10.1016/j.cell.2018.03.076			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7GB	29677517	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000430677400023
J	Hunter, BR				Hunter, Benton R.			Review: Adjunctive corticosteroids reduce mortality and clinical failure in adult inpatients with CAP	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Hunter, Benton R.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Hunter, BR (corresponding author), Indiana Univ Sch Med, Indianapolis, IN 46202 USA.							Goldberg H, 2015, JAMA-J AM MED ASSOC, V313, P1915, DOI 10.1001/jama.2015.4468; Sadeghirad B, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3887; Walters JA, 2014, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD001288	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2018	168	8					JC40	JC41		10.7326/ACPJC-2018-168-8-040	http://dx.doi.org/10.7326/ACPJC-2018-168-8-040			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GC8XZ	29677247				2022-12-28	WOS:000430083100006
J	Wagner, DE; Weinreb, C; Collins, ZM; Briggs, JA; Megason, SG; Klein, AM				Wagner, Daniel E.; Weinreb, Caleb; Collins, Zach M.; Briggs, James A.; Megason, Sean G.; Klein, Allon M.			Single-cell mapping of gene expression landscapes and lineage in the zebrafish embryo	SCIENCE			English	Article							NEURAL CREST; FATE MAP; CHORDIN; TAILBUD; SPECIFICATION; GASTRULATION; PROGRESSION; INHIBITION; PLASTICITY; ORIGIN	High-throughput mapping of cellular differentiation hierarchies from single-cell data promises to empower systematic interrogations of vertebrate development and disease. Here we applied single-cell RNA sequencing to >92,000 cells from zebrafish embryos during the first day of development. Using a graph-based approach, we mapped a cell-state landscape that describes axis patterning, germ layer formation, and organogenesis. We tested how clonally related cells traverse this landscape by developing a transposon-based barcoding approach (TracerSeq) for reconstructing single-cell lineage histories. Clonally related cells were often restricted by the state landscape, including a case in which two independent lineages converge on similar fates. Cell fates remained restricted to this landscape in embryos lacking the chordin gene. We provide web-based resources for further analysis of the single-cell data.	[Wagner, Daniel E.; Weinreb, Caleb; Collins, Zach M.; Briggs, James A.; Megason, Sean G.; Klein, Allon M.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Megason, SG; Klein, AM (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.	sean_megason@hms.harvard.edu; allon_klein@hms.harvard.edu		Klein, Allon/0000-0001-8913-7879; Wagner, Daniel/0000-0002-2983-635X; Collins, Zach/0000-0002-8943-7967	Howard Hughes Medical Institute-Life Sciences Research Foundation postdoctoral fellowship; NIH [1K99GM121852, R01GM107733, R01DC015478]; Edward J. Mallinckrodt Foundation Grant; Burroughs Wellcome Fund CASI Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080177, R01GM107733, K99GM121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC015478] Funding Source: NIH RePORTER	Howard Hughes Medical Institute-Life Sciences Research Foundation postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward J. Mallinckrodt Foundation Grant; Burroughs Wellcome Fund CASI Award(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	D.E.W. acknowledges support from a Howard Hughes Medical Institute-Life Sciences Research Foundation postdoctoral fellowship and NIH grant 1K99GM121852. A.M.K. was supported by an Edward J. Mallinckrodt Foundation Grant and a Burroughs Wellcome Fund CASI Award. S.G.M. was supported by NIH grants R01GM107733 and R01DC015478.	Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Davis RL, 2000, DEVELOPMENT, V127, P255; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Gouti M, 2017, DEV CELL, V41, P243, DOI 10.1016/j.devcel.2017.04.002; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/nmeth.2772, 10.1038/NMETH.2772]; Junker J.P., 2017, BIORXIV056499; Kanki JP, 1997, DEVELOPMENT, V124, P881; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Le Douarin NM, 2004, DEVELOPMENT, V131, P4637, DOI 10.1242/dev.01350; Le Douarin NM, 2003, CURR OPIN GENET DEV, V13, P529, DOI 10.1016/j.gde.2003.08.002; Le Lievre C S, 1975, J Embryol Exp Morphol, V34, P125; Leung AYH, 2005, DEV BIOL, V277, P235, DOI 10.1016/j.ydbio.2004.09.032; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mazutis L, 2013, NAT PROTOC, V8, P870, DOI 10.1038/nprot.2013.046; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Melby AE, 1996, DEVELOPMENT, V122, P2225; Miller-Bertoglio VE, 1997, DEV BIOL, V192, P537, DOI 10.1006/dbio.1997.8788; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Row RH, 2016, DEVELOPMENT, V143, P244, DOI 10.1242/dev.129015; Row RH, 2009, DEV BIOL, V329, P55, DOI 10.1016/j.ydbio.2009.02.016; SASAI Y, 1995, NATURE, V378, P419, DOI 10.1038/378419d0; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013; Thisse B., 2001, EXPRESSION ZEBRAFISH; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Tzouanacou E, 2009, DEV CELL, V17, P365, DOI 10.1016/j.devcel.2009.08.002; Warga RM, 2009, DEV CELL, V16, P744, DOI 10.1016/j.devcel.2009.04.007; Warga RM, 1999, DEVELOPMENT, V126, P827; Whitlock KE, 2000, DEVELOPMENT, V127, P3645; WOO K, 1995, DEVELOPMENT, V121, P2595; Zilionis R, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.154	40	365	372	21	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2018	360	6392					981	+		10.1126/science.aar4362	http://dx.doi.org/10.1126/science.aar4362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH6SL	29700229	Green Accepted			2022-12-28	WOS:000433574200034
J	Cheung, P; Vallania, F; Warsinske, HC; Donato, M; Schaffert, S; Chang, SE; Dvorak, M; Dekker, CL; Davis, MM; Utz, PJ; Khatri, P; Kuo, AJ				Cheung, Peggie; Vallania, Francesco; Warsinske, Hayley C.; Donato, Michele; Schaffert, Steven; Chang, Sarah E.; Dvorak, Mai; Dekker, Cornelia L.; Davis, Mark M.; Utz, Paul J.; Khatri, Purvesh; Kuo, Alex J.			Single-Cell Chromatin Modification Profiling Reveals Increased Epigenetic Variations with Aging	CELL			English	Article							TRANSCRIPTIONAL SIGNATURES; HISTONE VARIANTS; GENE-EXPRESSION; IMMUNE-SYSTEM; METHYLATION; HEMATOPOIESIS; LYMPHOCYTES; MUTATION; PROTEIN; YOUNG	Post-translational modifications of histone proteins and exchanges of histone variants of chromatin are central to the regulation of nearly all DNA-templated biological processes. However, the degree and variability of chromatin modifications in specific human immune cells remain largely unknown. Here, we employ a highly multiplexed mass cytometry analysis to profile the global levels of a broad array of chromatin modifications in primary human immune cells at the single-cell level. Our data reveal markedly different cell-type- and hematopoietic-lineage-specific chromatin modification patterns. Differential analysis between younger and older adults shows that aging is associated with increased heterogeneity between individuals and elevated cell-to-cell variability in chromatin modifications. Analysis of a twin cohort unveils heritability of chromatin modifications and demonstrates that aging-related chromatin alterations are predominantly driven by non-heritable influences. Together, we present a powerful platform for chromatin and immunology research. Our discoveries highlight the profound impacts of aging on chromatin modifications.	[Cheung, Peggie; Vallania, Francesco; Warsinske, Hayley C.; Donato, Michele; Schaffert, Steven; Chang, Sarah E.; Dvorak, Mai; Davis, Mark M.; Utz, Paul J.; Khatri, Purvesh; Kuo, Alex J.] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Cheung, Peggie; Chang, Sarah E.; Dvorak, Mai; Utz, Paul J.; Kuo, Alex J.] Stanford Univ, Sch Med, Dept Med, Div Immunol & Rheumatol, Stanford, CA 94305 USA; [Vallania, Francesco; Warsinske, Hayley C.; Donato, Michele; Schaffert, Steven; Khatri, Purvesh] Stanford Univ, Sch Med, Dept Med, Div Biomed Informat Res, Stanford, CA 94305 USA; [Dekker, Cornelia L.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94304 USA; [Davis, Mark M.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94304 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Utz, PJ; Khatri, P; Kuo, AJ (corresponding author), Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.; Utz, PJ; Kuo, AJ (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Immunol & Rheumatol, Stanford, CA 94305 USA.; Khatri, P (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Biomed Informat Res, Stanford, CA 94305 USA.	pjutz@stanford.edu; pkhatri@stanford.edu; alex0229@stanford.edu	Kuo, Alex/AAL-2845-2020	Schaffert, Steven/0000-0001-8842-0218; Davis, Mark/0000-0001-6868-657X; Khatri, Purvesh/0000-0002-4143-4708	NIH [S10RR025518-01, S10RR027431-01, S10OD016318-01, 5U19AI109662-05, 5R01AI125197-02, 5U19AI057229-15, U19AI090019, 2T32AR050942-06A1]; Autoimmunity Center of Excellence [5U19AI110491-04, 5UM1A110498-04]; NIAID/NIH; Bill AMP; Melinda Gates Foundation; Donald E. and Delia B. Baxter Foundation; Henry Gustav Floren Trust; NIH Clinical and Translational Science Award [UL1 RR025744]; Novo Nordisk Senior Postdoctoral Fellowship; NIH K12 Award [5K12HL120001-02]; NIH T32 training grant [5T32AI07290-31, 5T32AI007290-29];  [U19AI057229]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025518, UL1RR025744, S10RR027431] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL120001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109662, U19AI090019, T32AI007290, U19AI057229, U19AI110491, R01AI125197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR050942] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016318] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autoimmunity Center of Excellence; NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill AMP; Melinda Gates Foundation(CGIAR); Donald E. and Delia B. Baxter Foundation; Henry Gustav Floren Trust; NIH Clinical and Translational Science Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Senior Postdoctoral Fellowship; NIH K12 Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH T32 training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Drs. Catherine Blish, Anne Brunet, Or Gozani, and Robin Yeo (alphabetically listed) for insightful discussions. We thank the Stanford Blood Center and LPCH Vaccine Program staff for recruiting subjects and collecting blood samples. We thank Dr. Holden Maecker and Stanford Human Immune Monitoring Center (HIMC) for coordinating the selection of twin samples from Cooperative Center for Human Immunology (funded by U19AI057229) (to M.M.D.). We thank the Stanford Shared FACS Facility (SSFF), where cell sorting, flow cytometry, and CyTOF were performed. The instruments at SSFF were made possible in part by NIH funding (S10RR025518-01, S10RR027431-01, and S10OD016318-01). This work was supported in part by grants from Autoimmunity Center of Excellence (5U19AI110491-04 and 5UM1A110498-04), a research consortium supported by the NIAID/NIH (to P.J.U.), the Bill & Melinda Gates Foundation (to P.K.), the Donald E. and Delia B. Baxter Foundation (to P.J.U.), Elizabeth F. Adler (to P.J.U.), the Henry Gustav Floren Trust (to P.J.U.), NIH (5U19AI109662-05) (to P.K.), NIH Clinical and Translational Science Award (UL1 RR025744) for the Stanford Center for Clinical and Translational Education and Research (Spectrum), NIH (5R01AI125197-02) (to P.J.U. and P.K.), NIH (5U19AI057229-15) (to P.K.), and NIH (U19AI090019) (to M.M.D.) (listed alphabetically). P.C. was supported by NIH T32 training grant 2T32AR050942-06A1 and Novo Nordisk Senior Postdoctoral Fellowship. F.V. was supported by NIH K12 Award 5K12HL120001-02. H.C.W. was supported by NIH T32 training grant 5T32AI07290-31. A.J.K. was supported by NIH T32 training grant 5T32AI007290-29 and Novo Nordisk Senior Postdoctoral Fellowship. ClinicalTrial.gov numbers for the studies that contributed twin participant samples are NCT01987349, NCT03022396, and NCT03022422.	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Andres-Terre M, 2015, IMMUNITY, V43, P1199, DOI 10.1016/j.immuni.2015.11.003; Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Benaglia T, 2009, J STAT SOFTW, V32, P1; Benayoun BA, 2015, NAT REV MOL CELL BIO, V16, P593, DOI 10.1038/nrm4048; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Booth LN, 2016, MOL CELL, V62, P728, DOI 10.1016/j.molcel.2016.05.013; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Cover TM, 2012, ELEMENTS INFORM THEO, DOI DOI 10.1002/047174882X; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dorshkind K, 2009, NAT REV IMMUNOL, V9, P57, DOI 10.1038/nri2471; DuPage M, 2015, IMMUNITY, V42, P227, DOI 10.1016/j.immuni.2015.01.007; Enge M, 2017, CELL, V171, P321, DOI 10.1016/j.cell.2017.09.004; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kaczorowski KJ, 2017, P NATL ACAD SCI USA, V114, pE6097, DOI 10.1073/pnas.1705065114; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; LANIER LL, 1986, J IMMUNOL, V136, P4480; Li QT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6780; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Martinez-Jimenez CP, 2017, SCIENCE, V355, P1433, DOI 10.1126/science.aah4115; Maze I, 2014, NAT REV GENET, V15, P259, DOI 10.1038/nrg3673; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; McRae AF, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r73; Moskowitz DM, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag0192; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rijsdijk Fruhling V, 2002, Brief Bioinform, V3, P119, DOI 10.1093/bib/3.2.119; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rotem A, 2015, NAT BIOTECHNOL, V33, P1165, DOI 10.1038/nbt.3383; Schwartzman O, 2015, NAT REV GENET, V16, P716, DOI 10.1038/nrg3980; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002; Talbert PB, 2017, NAT REV MOL CELL BIO, V18, P115, DOI 10.1038/nrm.2016.148; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Ucar D, 2017, J EXP MED, V214, P3123, DOI 10.1084/jem.20170416; van Dongen J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11115; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wertheimer AM, 2014, J IMMUNOL, V192, P2143, DOI 10.4049/jimmunol.1301721; Wu CF, 2014, CELL STEM CELL, V14, P486, DOI 10.1016/j.stem.2014.01.020; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhu B, 2011, CELL RES, V21, P435, DOI 10.1038/cr.2011.26	61	155	156	3	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 31	2018	173	6					1385	+		10.1016/j.cell.2018.03.079	http://dx.doi.org/10.1016/j.cell.2018.03.079			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GH9KU	29706550	Green Accepted, Bronze			2022-12-28	WOS:000433989100012
J	Langdon, EM; Qiu, YP; Niaki, AG; McLaughlin, GA; Weidmann, CA; Gerbich, TM; Smith, JA; Crutchley, JM; Termini, CM; Weeks, KM; Myong, S; Gladfelter, AS				Langdon, Erin M.; Qiu, Yupeng; Niaki, Amirhossein Ghanbari; McLaughlin, Grace A.; Weidmann, Chase A.; Gerbich, Therese M.; Smith, Jean A.; Crutchley, John M.; Termini, Christina M.; Weeks, Kevin M.; Myong, Sua; Gladfelter, Amy S.			mRNA structure determines specificity of a polyQ-driven phase separation	SCIENCE			English	Article							PROTEIN; WHI3; YEAST; AGGREGATION; TRANSITIONS; DROPLETS; CELLS	RNA promotes liquid-liquid phase separation (LLPS) to build membraneless compartments in cells. How distinct molecular compositions are established and maintained in these liquid compartments is unknown. Here, we report that secondary structure allows messenger RNAs (mRNAs) to self-associate and determines whether an mRNA is recruited to or excluded from liquid compartments. The polyQ-protein Whi3 induces conformational changes in RNA structure and generates distinct molecular fluctuations depending on the RNA sequence. These data support a model in which structure-based, RNA-RNA interactions promote assembly of distinct droplets and protein-driven, conformational dynamics of the RNA maintain this identity. Thus, the shape of RNA can promote the formation and coexistence of the diverse array of RNA-rich liquid compartments found in a single cell.	[Langdon, Erin M.; McLaughlin, Grace A.; Gerbich, Therese M.; Smith, Jean A.; Crutchley, John M.; Gladfelter, Amy S.] Univ North Carolina Chapel Hill, Dept Biol, Chapel Hill, NC 27599 USA; [Qiu, Yupeng; Niaki, Amirhossein Ghanbari; Myong, Sua] Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21218 USA; [Weidmann, Chase A.; Weeks, Kevin M.] Univ North Carolina Chapel Hill, Dept Chem, Chapel Hill, NC 27599 USA; [Termini, Christina M.] Univ Calif Los Angeles, Div Hematol Oncol, Dept Med, Los Angeles, CA 90095 USA; [Gladfelter, Amy S.] Marine Biol Lab, Woods Hole, MA 02543 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of California System; University of California Los Angeles; Marine Biological Laboratory - Woods Hole	Gladfelter, AS (corresponding author), Univ North Carolina Chapel Hill, Dept Biol, Chapel Hill, NC 27599 USA.; Gladfelter, AS (corresponding author), Marine Biol Lab, Woods Hole, MA 02543 USA.	amyglad@unc.edu	Termini, Christina/AAC-7667-2019	Termini, Christina/0000-0002-1831-1347; Weidmann, Chase/0000-0002-2941-0500; Smith, Jean/0000-0002-8981-9930; Gerbich, Therese/0000-0003-4232-9536	NIH [GM R01-GM081506, 1DP2 GM105453, R01 GM115631]; HHMI Faculty Scholars program [R35 GM122532]; ACS [130845-RSG-17-114-01-RMC]; NATIONAL CANCER INSTITUTE [T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081506, DP2GM105453, R35GM122532, R01GM115631] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI Faculty Scholars program; ACS(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH GM R01-GM081506, the HHMI Faculty Scholars program, R35 GM122532, ACS 130845-RSG-17-114-01-RMC, NIH 1DP2 GM105453, and NIH R01 GM115631.	Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Caudron F, 2013, CELL, V155, P1244, DOI 10.1016/j.cell.2013.10.046; Colomina N, 2009, CELL CYCLE, V8, P1912, DOI 10.4161/cc.8.12.8740; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Holmes KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084060; Jain A, 2017, NATURE, V546, P243, DOI 10.1038/nature22386; Kim Y, 2016, MOL CELL, V63, P865, DOI 10.1016/j.molcel.2016.07.010; Lee CH, 2015, J CELL BIOL, V208, P533, DOI 10.1083/jcb.201407105; Lee C, 2013, DEV CELL, V25, P572, DOI 10.1016/j.devcel.2013.05.007; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Nash RS, 2001, GENETICS, V157, P1469; Schlissel G, 2017, SCIENCE, V355, P1184, DOI 10.1126/science.aaj2103; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Smola MJ, 2015, NAT PROTOC, V10, P1643, DOI 10.1038/nprot.2015.103; Trcek T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8962; Van Treeck B., 2018, P NATL ACAD SCI USA, V115, P2734; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017; Zhang XM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002183	18	266	267	8	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2018	360	6391					922	927		10.1126/science.aar7432	http://dx.doi.org/10.1126/science.aar7432			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG9RW	29650703	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000433039800052
J	Schumer, M; Xu, CL; Powell, DL; Durvasula, A; Skov, L; Holland, C; Blazier, JC; Sankararaman, S; Andolfatto, P; Rosenthal, GG; Przeworski, M				Schumer, Molly; Xu, Chenling; Powell, Daniel L.; Durvasula, Arun; Skov, Laurits; Holland, Chris; Blazier, John C.; Sankararaman, Sriram; Andolfatto, Peter; Rosenthal, Gil G.; Przeworski, Molly			Natural selection interacts with recombination to shape the evolution of hybrid genomes	SCIENCE			English	Article							GENE FLOW; DELETERIOUS MUTATIONS; SPECIATION; NEANDERTHAL; INCOMPATIBILITY; HYBRIDIZATION; STERILITY; BARRIER; MICE	To investigate the consequences of hybridization between species, we studied three replicate hybrid populations that formed naturally between two swordtail fish species, estimating their fine-scale genetic map and inferring ancestry along the genomes of 690 individuals. In all three populations, ancestry from the "minor" parental species is more common in regions of high recombination and where there is linkage to fewer putative targets of selection. The same patterns are apparent in a reanalysis of human and archaic admixture. These results support models in which ancestry from the minor parental species is more likely to persist when rapidly uncoupled from alleles that are deleterious in hybrids. Our analyses further indicate that selection on swordtail hybrids stems predominantly from deleterious combinations of epistatically interacting alleles.	[Schumer, Molly] Howard Hughes Med Inst, Boston, MA 02115 USA; [Schumer, Molly] Harvard Univ, Harvard Soc Fellows, Cambridge, MA 02138 USA; [Schumer, Molly; Przeworski, Molly] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Schumer, Molly; Powell, Daniel L.; Holland, Chris; Rosenthal, Gil G.] Ctr Invest Cient Huastecas Aguaza, Calnali, Hidalgo, Mexico; [Xu, Chenling] Univ Calif Berkeley, Ctr Computat Biol, Berkeley, CA 94720 USA; [Powell, Daniel L.; Holland, Chris; Blazier, John C.; Rosenthal, Gil G.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Durvasula, Arun; Sankararaman, Sriram] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Skov, Laurits] Aarhus Univ, Bioinformat Res Ctr, Aarhus, Denmark; [Blazier, John C.] Texas A&M Inst Genome Sci & Soc, College Stn, TX USA; [Sankararaman, Sriram] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA; [Andolfatto, Peter] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Andolfatto, Peter] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Przeworski, Molly] Columbia Univ, Dept Syst Biol, New York, NY USA	Howard Hughes Medical Institute; Harvard University; Columbia University; University of California System; University of California Berkeley; Texas A&M University System; Texas A&M University College Station; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Aarhus University; Texas A&M University System; Texas A&M University College Station; University of California System; University of California Los Angeles; Princeton University; Princeton University; Columbia University	Schumer, M (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.; Schumer, M (corresponding author), Harvard Univ, Harvard Soc Fellows, Cambridge, MA 02138 USA.; Schumer, M; Przeworski, M (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.; Schumer, M (corresponding author), Ctr Invest Cient Huastecas Aguaza, Calnali, Hidalgo, Mexico.; Przeworski, M (corresponding author), Columbia Univ, Dept Syst Biol, New York, NY USA.	schumer@fas.harvard.edu; mp3284@columbia.edu	Blazier, John/AAL-1717-2021; Rosenthal, Gil/E-6924-2015	Schumer, Molly/0000-0002-2075-5668; Powell, Daniel/0000-0001-9204-645X; Xu, Chenling/0000-0001-9610-7627; Andolfatto, Peter/0000-0003-3393-4574; Rosenthal, Gil/0000-0003-0342-9024; Blazier, John/0000-0001-9712-0153	NSF [DEB-1405232]; Cancer Prevention Research Institute of Texas; HHMI Hanna H. Gray fellowship; Milton grant;  [R01 GM83098]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM111744, R01GM083098, R35GM125055] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Cancer Prevention Research Institute of Texas; HHMI Hanna H. Gray fellowship; Milton grant; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by grant R01 GM83098 to M.P.; NSF grant DEB-1405232, an HHMI Hanna H. Gray fellowship, and a Milton grant to M.S.; and a grant from the Cancer Prevention Research Institute of Texas to G.G.R.	Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Arnegard ME, 2014, NATURE, V511, P307, DOI 10.1038/nature13301; Baker Z, 2017, ELIFE, V6, DOI 10.7554/eLife.24133; Bierne N, 2002, GENET RES, V80, P197, DOI 10.1017/S001667230200592X; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Brandvain Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004410; Carneiro M, 2009, GENETICS, V181, P593, DOI 10.1534/genetics.108.096826; Coyne J.A., 2004, SPECIATION; Cui RF, 2013, EVOLUTION, V67, P2166, DOI 10.1111/evo.12099; Davies B, 2016, NATURE, V530, P171, DOI 10.1038/nature16931; Do R, 2015, NAT GENET, V47, P126, DOI 10.1038/ng.3186; Geraldes A, 2011, MOL ECOL, V20, P4722, DOI 10.1111/j.1365-294X.2011.05285.x; Harris K, 2016, GENETICS, V203, P881, DOI 10.1534/genetics.116.186890; Jacobsen F, 2011, MOL ECOL, V20, P2236, DOI 10.1111/j.1365-294X.2011.05120.x; Juric I, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006340; Lee HY, 2008, CELL, V135, P1065, DOI 10.1016/j.cell.2008.10.047; Masly JP, 2007, PLOS BIOL, V5, P1890, DOI 10.1371/journal.pbio.0050243; Nachman MW, 2012, PHILOS T R SOC B, V367, P409, DOI 10.1098/rstb.2011.0249; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Orr HA, 2001, EVOLUTION, V55, P1085; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Rieseberg LH, 1999, GENETICS, V152, P713; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Schumer M, 2016, MOL ECOL, V25, P2661, DOI 10.1111/mec.13602; Schumer M, 2016, MOL ECOL, V25, P2577, DOI 10.1111/mec.13641; Schumer M, 2014, ELIFE, V3, DOI 10.7554/eLife.02535; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x	28	162	162	6	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2018	360	6389					656	659		10.1126/science.aar3684	http://dx.doi.org/10.1126/science.aar3684			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2SV	29674434	Green Submitted, Green Accepted			2022-12-28	WOS:000431790900046
J	Baneyx, F				Baneyx, Francois			A perfect marriage of materials	NATURE			English	Editorial Material							POLYMERS		[Baneyx, Francois] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Baneyx, F (corresponding author), Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.	baneyx@uw.edu						Bale JB, 2016, SCIENCE, V353, P389, DOI 10.1126/science.aaf8818; Hsia Y, 2016, NATURE, V535, P136, DOI 10.1038/nature18010; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; Mann S, 2009, NAT MATER, V8, P781, DOI [10.1038/NMAT2496, 10.1038/nmat2496]; Rother M, 2016, CHEM SOC REV, V45, P6213, DOI 10.1039/c6cs00177g; Roy N, 2015, CHEM SOC REV, V44, P3786, DOI 10.1039/c5cs00194c; Zhang L, 2018, NATURE, V557, P86, DOI 10.1038/s41586-018-0057-7	7	0	0	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2018	557	7703					38	39		10.1038/d41586-018-04956-x	http://dx.doi.org/10.1038/d41586-018-04956-x			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE5BW	29717250	Bronze			2022-12-28	WOS:000431234500024
J	Tang, LSY; Covert, E; Wilson, E; Kottilil, S				Tang, Lydia S. Y.; Covert, Emily; Wilson, Eleanor; Kottilil, Shyam			Chronic Hepatitis B Infection A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							TENOFOVIR DISOPROXIL FUMARATE; ALANINE AMINOTRANSFERASE LEVELS; CLINICAL-PRACTICE GUIDELINES; RANDOMIZED CONTROLLED-TRIAL; LONG-TERM THERAPY; E-ANTIGEN; ADEFOVIR DIPIVOXIL; VIRUS-INFECTION; DOUBLE-BLIND; HEPATOCELLULAR-CARCINOMA	IMPORTANCE More than 240 million individuals worldwide are infected with chronic hepatitis B virus (HBV). Among individuals with chronic HBV infection who are untreated, 15% to 40% progress to cirrhosis, which may lead to liver failure and liver cancer. OBSERVATIONS Pegylated interferon and nucleos(t)ide analogues (lamivudine, adefovir, entecavir, tenofovir disoproxil, and tenofovir alafenamide) suppress HBV DNA replication and improve liver inflammation and fibrosis. Long-term viral suppression is associated with regression of liver fibrosis and reduced risk of hepatocellular carcinoma in cohort studies. The cure (defined as hepatitis B surface antigen loss with undetectable HBV DNA) rates after treatment remain low (3%-7% with pegylated interferon and 1%-12% with nucleos[t] ide analogue therapy). Pegylated interferon therapy can be completed in 48 weeks and is not associated with the development of resistance; however, its use is limited by poor tolerability and adverse effects such as bone marrow suppression and exacerbation of existing neuropsychiatric symptoms such as depression. Newer agents (entecavir, tenofovir disoproxil, and tenofovir alafenamide) may be associated with a significantly reduced risk of drug resistance compared with older agents (lamivudine and adefovir) and should be considered as the first-line treatment. CONCLUSIONS AND RELEVANCE Antiviral treatment with either pegylated interferon or a nucleos(t) ide analogue (lamivudine, adefovir, entecavir, tenofovir disoproxil, or tenofovir alafenamide) should be offered to patients with chronic HBV infection and liver inflammation in an effort to reduce progression of liver disease. Nucleos(t)ide analogues should be considered as first-line therapy. Because cure rates are low, most patients will require therapy indefinitely.	[Tang, Lydia S. Y.; Covert, Emily; Wilson, Eleanor; Kottilil, Shyam] Univ Maryland, Sch Med, Div Clin Care & Res, Inst Human Virol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Kottilil, S (corresponding author), Univ Maryland, Inst Human Virol, 725 W Lombard St,Room S222, Baltimore, MD 21201 USA.	skottilil@ihv.umaryland.edu	Kottilil, Shyam/ABF-7605-2021	Wilson, Eleanor/0000-0002-4855-514X	Gilead Sciences	Gilead Sciences(Gilead Sciences)	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Tang, Wilson, and Kottilil reported receiving grant funding from Gilead Sciences. No other disclosures were reported.	Ahn SH, 2005, J HEPATOL, V42, P188, DOI 10.1016/j.jhep.2004.10.026; An C, 2015, CLIN MOL HEPATOL, V21, P279, DOI 10.3350/cmh.2015.21.3.279; Asselah T, 2007, CLIN LIVER DIS, V11, pviii; Asselah Tarik, 2007, Clin Liver Dis, V11, P839, DOI 10.1016/j.cld.2007.08.010; Belperio PS, 2017, HEPATOLOGY, V66, P27, DOI 10.1002/hep.29135; Bersoff-Matcha SJ, 2017, ANN INTERN MED, V166, P792, DOI 10.7326/M17-0377; Bourliere M, 2017, LANCET GASTROENTEROL, V2, P177, DOI 10.1016/S2468-1253(16)30189-3; Buster EHCJ, 2008, GASTROENTEROLOGY, V135, P459, DOI 10.1053/j.gastro.2008.05.031; Buti M, 2016, LANCET GASTROENTEROL, V1, P90, DOI [10.1016/S2468-1253(16)30020-6, 10.1016/S2468-1253(16)30107-8]; Buti M, 2015, DIGEST DIS SCI, V60, P1457, DOI 10.1007/s10620-014-3486-7; Centers for Disease Control and Prevention, CHRON HEP B; Chan HLY, 2016, LANCET GASTROENTEROL, V1, P185, DOI 10.1016/S2468-1253(16)30024-3; Chan HLY, 2007, ANTIVIR THER, V12, P345; Chang TT, 2010, HEPATOLOGY, V51, P422, DOI 10.1002/hep.23327; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Chayanupatkul M, 2017, J HEPATOL, V66, P355, DOI 10.1016/j.jhep.2016.09.013; Chen CJ, 2011, J GASTROEN HEPATOL, V26, P628, DOI 10.1111/j.1440-1746.2011.06695.x; Chen Xue-Fu, 2012, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V26, P117; Chu CM, 2010, ANTIVIR THER, V15, P133, DOI 10.3851/IMP1497; Chu CJ, 2003, GASTROENTEROLOGY, V125, P444, DOI 10.1016/S0016-5085(03)00895-3; CHU CM, 1993, CLIN INFECT DIS, V16, P709, DOI 10.1093/clind/16.5.709; Chu CM, 2004, AM J MED, V116, P829, DOI 10.1016/j.amjmed.2003.12.040; Dienstag JL, 1999, NEW ENGL J MED, V341, P1256, DOI 10.1056/NEJM199910213411702; European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021; Fattovich G, 2003, SEMIN LIVER DIS, V23, P47, DOI 10.1055/s-2003-37590; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fung S, 2017, J HEPATOL, V66, P11, DOI 10.1016/j.jhep.2016.08.008; Garg H, 2011, HEPATOLOGY, V53, P774, DOI 10.1002/hep.24109; Gilead Sciences, VIREAD TEN DIS FUM P; Gilead Sciences, VEMLIDY TEN AL PACK; Gilead Sciences, HEPSERA AD DIP PACK; Gish RG, 2007, GASTROENTEROLOGY, V133, P1437, DOI 10.1053/j.gastro.2007.08.025; Hadziyannis SJ, 2003, NEW ENGL J MED, V348, P800, DOI 10.1056/NEJMoa021812; Hadziyannis SJ, 2005, NEW ENGL J MED, V352, P2673, DOI 10.1056/NEJMoa042957; Hadziyannis SJ, 2006, GASTROENTEROLOGY, V131, P1743, DOI 10.1053/j.gastro.2006.09.020; Healthcare V, EP TABL OR SOL PACK; Hsu YS, 2002, HEPATOLOGY, V35, P1522, DOI 10.1053/jhep.2002.33638; Huang H, 2014, JAMA-J AM MED ASSOC, V312, P2521, DOI 10.1001/jama.2014.15704; Huang YH, 2013, J CLIN ONCOL, V31, P2765, DOI 10.1200/JCO.2012.48.5938; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; Kamarulzaman A, 2016, LANCET, V388, P1115, DOI 10.1016/S0140-6736(16)30769-3; Kim GA, 2014, GUT, V63, P1325, DOI 10.1136/gutjnl-2013-305517; Kim WR, 2016, J HEPATOL, V64, P773, DOI 10.1016/j.jhep.2015.11.012; Koike K, 2018, HEPATOL RES, V48, P59, DOI 10.1111/hepr.12902; Kozielewicz D, 2014, EXPERT OPIN DRUG SAF, V13, P1009, DOI 10.1517/14740338.2014.921156; Kumar M, 2009, GASTROENTEROLOGY, V136, P1272, DOI 10.1053/j.gastro.2009.01.011; Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201; Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Li Y, 2016, ALIMENT PHARM THER, V43, P458, DOI 10.1111/apt.13488; Li YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111707; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; LIAW YF, 1987, HEPATOLOGY, V7, P20, DOI 10.1002/hep.1840070106; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Liaw YF, 2011, HEPATOLOGY, V54, P91, DOI 10.1002/hep.24361; Lim YS, 2016, GUT, V65, P1042, DOI 10.1136/gutjnl-2014-308435; Lim YS, 2016, GUT, V65, P852, DOI 10.1136/gutjnl-2014-308353; Lin MT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166157; Lin SM, 2007, J HEPATOL, V46, P45, DOI 10.1016/j.jhep.2006.08.021; Lok AS, 2017, HEPATOLOGY, V66, P1296, DOI 10.1002/hep.29323; Lok AS, 2012, GASTROENTEROLOGY, V143, P619, DOI 10.1053/j.gastro.2012.05.037; Marcellin P, 2004, NEW ENGL J MED, V351, P1206, DOI 10.1056/NEJMoa040431; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; Marcellin P, 2009, GASTROENTEROLOGY, V136, P2169; Marcellin P, 2008, NEW ENGL J MED, V359, P2442, DOI 10.1056/NEJMoa0802878; Marcellin P, 2008, HEPATOLOGY, V48, P750, DOI 10.1002/hep.22414; Marcellin P, 2016, GASTROENTEROLOGY, V150, P134, DOI 10.1053/j.gastro.2015.09.043; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Omata M, 2017, HEPATOL INT, V11, P317, DOI 10.1007/s12072-017-9799-9; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Pan CQ, 2016, NEW ENGL J MED, V374, P2324, DOI 10.1056/NEJMoa1508660; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; PICCININO F, 1986, J HEPATOL, V2, P165, DOI 10.1016/S0168-8278(86)80075-7; Poh ZX, 2015, EUR J GASTROEN HEPAT, V27, P638, DOI 10.1097/MEG.0000000000000341; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Rijckborst Vincent, 2010, Curr Hepat Rep, V9, P231, DOI 10.1007/s11901-010-0055-1; Roberts H, 2016, HEPATOLOGY, V63, P388, DOI 10.1002/hep.28109; Salkic NN, 2014, AM J GASTROENTEROL, V109, P796, DOI 10.1038/ajg.2014.21; Sarin SK, 2016, HEPATOL INT, V10, P1, DOI 10.1007/s12072-015-9675-4; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Seeff LB, 2010, CLIN GASTROENTEROL H, V8, P877, DOI 10.1016/j.cgh.2010.03.025; Seto WK, 2015, GUT, V64, P667, DOI 10.1136/gutjnl-2014-307237; Sherman M, 2006, GASTROENTEROLOGY, V130, P2039, DOI 10.1053/j.gastro.2006.04.007; Simonetti J, 2010, HEPATOLOGY, V51, P1531, DOI 10.1002/hep.23464; Sriprayoon T, 2017, HEPATOL RES, V47, pE161, DOI 10.1111/hepr.12743; Tassopoulos NC, 1999, HEPATOLOGY, V29, P889, DOI 10.1002/hep.510290321; Tenney DJ, 2009, HEPATOLOGY, V49, P1503, DOI 10.1002/hep.22841; ter Borg F, 2000, J CLIN PATHOL, V53, P541, DOI 10.1136/jcp.53.7.541; Terrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156; Tseng KC, 2014, ANTIVIR THER, V19, P755, DOI 10.3851/IMP2754; US Food and Drug Administration, PEGASYS PEG ALF 2A P; van Zonneveld M, 2004, HEPATOLOGY, V39, P804, DOI 10.1002/hep.20128; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; Wong GLH, 2013, ALIMENT PHARM THER, V37, P517, DOI 10.1111/apt.12207; Wong RJ, 2017, J VIRAL HEPATITIS, V24, P1089, DOI 10.1111/jvh.12736; Xu WM, 2009, J VIRAL HEPATITIS, V16, P94, DOI 10.1111/j.1365-2893.2008.01056.x; Yang JD, 2011, CLIN GASTROENTEROL H, V9, P64, DOI 10.1016/j.cgh.2010.08.019; Yip TCF, 2018, J HEPATOL, V68, P63, DOI 10.1016/j.jhep.2017.09.018; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0	99	341	364	27	172	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2018	319	17					1802	1813		10.1001/jama.2018.3795	http://dx.doi.org/10.1001/jama.2018.3795			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GE3UQ	29715359				2022-12-28	WOS:000431138800018
J	Dyer, C				Dyer, Clare			Alfie Evans case: Proposed law aims to prevent conflicts between parents and doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Dyer C, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k849; Halliday J, 2018, GUARDIAN; Mayor S, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3673; Shepherd A, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1801	4	5	5	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2018	361								k1895	10.1136/bmj.k1895	http://dx.doi.org/10.1136/bmj.k1895			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF4XX	29712665				2022-12-28	WOS:000431968600016
J	Levitt, L				Levitt, Larry			Single-Payer Health Care: Opportunities and Vulnerabilities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Levitt, Larry] Kaiser Family Fdn, San Francisco, CA 94107 USA		Levitt, L (corresponding author), Kaiser Family Fdn, San Francisco, CA 94107 USA.	llevitt@kff.org							0	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2018	319	16					1646	1647		10.1001/jama.2018.3997	http://dx.doi.org/10.1001/jama.2018.3997			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD7RF	29710152	Bronze			2022-12-28	WOS:000430709300003
J	Ohtaka-Maruyama, C; Okamoto, M; Endo, K; Oshima, M; Kaneko, N; Yura, K; Okado, H; Miyata, T; Maeda, N				Ohtaka-Maruyama, Chiaki; Okamoto, Mayumi; Endo, Kentaro; Oshima, Minori; Kaneko, Noe; Yura, Kei; Okado, Haruo; Miyata, Takaki; Maeda, Nobuaki			Synaptic transmission from subplate neurons controls radial migration of neocortical neurons	SCIENCE			English	Article							BIPOLAR TRANSITION; CORTEX; MULTIPOLAR	The neocortex exhibits a six-layered structure that is formed by radial migration of excitatory neurons, for which the multipolar-to-bipolar transition of immature migrating multipolar neurons is required. Here, we report that subplate neurons, one of the first neuron types born in the neocortex, manage the multipolar-to-bipolar transition of migrating neurons. By histochemical, imaging, and microarray analyses on the mouse embryonic cortex, we found that subplate neurons extend neurites toward the ventricular side of the subplate and form transient glutamatergic synapses on the multipolar neurons just below the subplate. NMDAR (N-methyl-D-aspartate receptor)-mediated synaptic transmission from subplate neurons to multipolar neurons induces the multipolar-to-bipolar transition, leading to a change inmigration mode from slow multipolar migration to faster radial glial-guided locomotion. Our data suggested that transient synapses formed on early immature neurons regulate radial migration.	[Ohtaka-Maruyama, Chiaki; Oshima, Minori; Kaneko, Noe; Maeda, Nobuaki] Tokyo Metropolitan Inst Med Sci, Neural Network Project, Tokyo 1568506, Japan; [Endo, Kentaro] Tokyo Metropolitan Inst Med Sci, Ctr Basic Technol Res, Tokyo 1568506, Japan; [Okado, Haruo] Tokyo Metropolitan Inst Med Sci, Neural Dev Project, Tokyo 1568506, Japan; [Okamoto, Mayumi; Miyata, Takaki] Nagoya Univ, Grad Sch Med, Anat & Cell Biol, Nagoya, Aichi 4668550, Japan; [Oshima, Minori; Kaneko, Noe] Ochanomizu Univ, Dept Biol, Tokyo 1128610, Japan; [Yura, Kei] Ochanomizu Univ, Grad Sch Humanities & Sci, Tokyo 1128610, Japan; [Yura, Kei] Waseda Univ, Sch Adv Sci & Engn, Tokyo 1690072, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Nagoya University; Ochanomizu University; Ochanomizu University; Waseda University	Ohtaka-Maruyama, C; Maeda, N (corresponding author), Tokyo Metropolitan Inst Med Sci, Neural Network Project, Tokyo 1568506, Japan.	maruyama-ck@igakuken.or.jp; maeda-nb@igakuken.or.jp	MIYATA, TAKAKI/I-7066-2014; Yura, Kei/S-1030-2018	Yura, Kei/0000-0003-0197-5478; Ohtaka-Maruyama, Chiaki/0000-0002-0632-7341; Maeda, Nobuaki/0000-0002-9938-9225	Japan Society for the Promotion of Science [17K07428, 16K07077, 16H02457]; Ministry of Education, Culture, Sports, Science and Technology KAKENHI [22111006]; Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS) from the Japan Agency for Medical Research and Development (AMED)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (KAKENHI) (17K07428 to C.O.-M., 16K07077 to N.M., and 16H02457 to T.M.), Ministry of Education, Culture, Sports, Science and Technology KAKENHI (22111006 to T.M.), and the Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS) from the Japan Agency for Medical Research and Development (AMED) to K.Y.	ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.neuro.17.1.185; Bando Y, 2016, CEREB CORTEX, V26, P106, DOI 10.1093/cercor/bhu180; Behar TN, 1999, J NEUROSCI, V19, P4449; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Hirai K, 1999, DEV BRAIN RES, V114, P63, DOI 10.1016/S0165-3806(99)00019-X; Hoerder-Suabedissen A, 2013, CEREB CORTEX, V23, P1473, DOI 10.1093/cercor/bhs137; Hoerder-Suabedissen A, 2013, P NATL ACAD SCI USA, V110, P3555, DOI 10.1073/pnas.1218510110; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Jiang HY, 2015, BRAIN RES, V1610, P20, DOI 10.1016/j.brainres.2015.03.031; La Fata G, 2014, NAT NEUROSCI, V17, P1693, DOI 10.1038/nn.3870; LOTURCO JJ, 1991, J NEUROSCI, V11, P792; Ohtaka-Maruyama C, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00447; Ohtaka-Maruyama C, 2013, CELL REP, V3, P458, DOI 10.1016/j.celrep.2013.01.012; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Rash BG, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501733; Sakamoto M, 2014, J NEUROSCI, V34, P5788, DOI 10.1523/JNEUROSCI.0674-14.2014; Sekine K, 2014, NEUROSCI RES, V86, P50, DOI 10.1016/j.neures.2014.06.004	19	68	69	4	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2018	360	6386					313	316		10.1126/science.aar2866	http://dx.doi.org/10.1126/science.aar2866			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD3IC	29674592				2022-12-28	WOS:000430396600043
J	Hawkes, N				Hawkes, Nigel			Treatment for those with multiple serious illnesses is "ineffective," warns major review	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		MacMahon SC., 2018, MULTIMORBIDITY PRIOR	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2018	361								k1736	10.1136/bmj.k1736	http://dx.doi.org/10.1136/bmj.k1736			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD8WQ	29674315				2022-12-28	WOS:000430795300008
J	Bindman, A				Bindman, Andrew			Redesigning Medicaid Managed Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Bindman, Andrew] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, Med & Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bindman, A (corresponding author), Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, Med & Epidemiol & Biostat, San Francisco, CA 94143 USA.	andrew.bindman@ucsf.edu							0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2018	319	15					1537	+		10.1001/jama.2018.3411	http://dx.doi.org/10.1001/jama.2018.3411			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD0UT	29677290	Bronze			2022-12-28	WOS:000430217100003
J	Bischoff-Ferran, HA; Bhasin, S; Manson, JE				Bischoff-Ferran, Heike A.; Bhasin, Shalender; Manson, JoAnn E.			Preventing Fractures and Falls A Limited Role for Calcium and Vitamin D Supplements?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CLINICAL-TRIAL; OLDER-ADULTS; DOUBLE-BLIND; WOMEN; OSTEOPOROSIS; COMMUNITY; RISK		[Bischoff-Ferran, Heike A.] Univ Zurich, Dept Geriatr & Aging Res, Univ Hosp Zurich, Zurich, Switzerland; [Bischoff-Ferran, Heike A.] Univ Zurich, Waid City Hosp, Zurich, Switzerland; [Bhasin, Shalender; Manson, JoAnn E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA USA; [Bhasin, Shalender] Res Program Mens Hlth Aging & Metab, Boston, MA USA; [Bhasin, Shalender] Boston Claude D Pepper Older Amer Independence Ct, Boston, MA USA; [Manson, JoAnn E.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	University of Zurich; University Zurich Hospital; University of Zurich; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Manson, JE (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.	jmanson@rics.bwh.harvard.edu		Bischoff-Ferrari, Heike/0000-0002-4554-658X	National Institute on Aging; National Institute of Nursing Research; AbbVie; MIB LLC; AliveGen; Abbott; Transition Therapeutics; Novartis; National Institutes of Health (NIH); NIH	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); AbbVie(AbbVie); MIB LLC; AliveGen; Abbott(Abbott Laboratories); Transition Therapeutics; Novartis(Novartis); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Bhasin reported receiving grant funding from the National Institute on Aging, the National Institute of Nursing Research, AbbVie, MIB LLC, AliveGen, Abbott, and Transition Therapeutics; receiving personal fees from Novartis; holding equity interest in FPT LLC; and serving as chair of the American Board of Internal Medicine examination writing committee for endocrinology. Dr Manson reported receiving grant funding from the National Institutes of Health (NIH) and serving as a principal investigator of the VITamin D and OmegA-3 TriaL (VITAL), which is funded by the NIH. No other disclosures were reported.	Bhasin S, 2017, J GERONTOL A-BIOL, DOI [10.1093/gerona/gIx190, DOI 10.1093/GERONA/GIX190]; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; Grossman DC, 2018, JAMA-J AM MED ASSOC, V319, P1696, DOI 10.1001/jama.2018.3097; Grossman DC, 2018, JAMA-J AM MED ASSOC, V319, P1592, DOI 10.1001/jama.2018.3185; Guirguis-Blake JM, 2018, JAMA-J AM MED ASSOC, V319, P1705, DOI 10.1001/jama.2017.21962; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Kahwati LC, 2018, JAMA-J AM MED ASSOC, V319, P1600, DOI 10.1001/jama.2017.21640; Khaw KT, 2017, LANCET DIABETES ENDO, V5, P438, DOI 10.1016/S2213-8587(17)30103-1; Lappe J, 2017, JAMA-J AM MED ASSOC, V317, P1234, DOI 10.1001/jama.2017.2115; Melton LJ, 1999, OSTEOPOROSIS INT, V9, P29, DOI 10.1007/s001980050113; Moyer VA, 2012, ANN INTERN MED, V157, P197, DOI 10.7326/0003-4819-157-3-201208070-00462; Pahor M, 2014, JAMA-J AM MED ASSOC, V311, P2387, DOI 10.1001/jama.2014.5616; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Weaver CM, 2016, OSTEOPOROSIS INT, V27, P367, DOI 10.1007/s00198-015-3386-5	18	26	28	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2018	319	15					1552	1553		10.1001/jama.2018.4023	http://dx.doi.org/10.1001/jama.2018.4023			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD0UT	29677284	Green Accepted			2022-12-28	WOS:000430217100015
J	Lennerz, C; O'Connor, M; Horlbeck, L; Michel, J; Weigand, S; Grebmer, C; Blazek, P; Brkic, A; Semmler, V; Haller, B; Reents, T; Hessling, G; Deisenhofer, I; Whittaker, P; Lienkamp, M; Kolb, C				Lennerz, C.; O'Connor, M.; Horlbeck, L.; Michel, J.; Weigand, S.; Grebmer, C.; Blazek, P.; Brkic, A.; Semmler, V.; Haller, B.; Reents, T.; Hessling, G.; Deisenhofer, I.; Whittaker, P.; Lienkamp, M.; Kolb, C.			Do Electric Cars Interfere With Pacemakers and Defibrillators?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2018	169	5					I26	I26		10.7326/P18-0005	http://dx.doi.org/10.7326/P18-0005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS2MV	29710315				2022-12-28	WOS:000443385100004
J	Gandhi, L; Rodriguez-Abreu, D; Gadgeel, S; Esteban, E; Felip, E; De Angelis, F; Domine, M; Clingan, P; Hochmair, MJ; Powell, SF; Cheng, SYS; Bischoff, HG; Peled, N; Grossi, F; Jennens, RR; Reck, M; Hui, R; Garon, EB; Boyer, M; Rubio-Viqueira, B; Novello, S; Kurata, T; Gray, JE; Vida, J; Wei, Z; Yang, J; Raftopoulos, H; Pietanza, MC; Garassino, MC				Gandhi, L.; Rodriguez-Abreu, D.; Gadgeel, S.; Esteban, E.; Felip, E.; De Angelis, F.; Domine, M.; Clingan, P.; Hochmair, M. J.; Powell, S. F.; Cheng, S. Y. -S.; Bischoff, H. G.; Peled, N.; Grossi, F.; Jennens, R. R.; Reck, M.; Hui, R.; Garon, E. B.; Boyer, M.; Rubio-Viqueira, B.; Novello, S.; Kurata, T.; Gray, J. E.; Vida, J.; Wei, Z.; Yang, J.; Raftopoulos, H.; Pietanza, M. C.; Garassino, M. C.		KEYNOTE-189 Investigators	Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PEMETREXED PLUS; OPEN-LABEL; INDUCTION TREATMENT; PHASE-III; DOCETAXEL; CISPLATIN; NIVOLUMAB; 1ST-LINE; THERAPY	BACKGROUND First-line therapy for advanced non-small-cell lung cancer (NSCLC) that lacks targetable mutations is platinum-based chemotherapy. Among patients with a tumor proportion score for programmed death ligand 1 (PD-L1) of 50% or greater, pembrolizumab has replaced cytotoxic chemotherapy as the first-line treatment of choice. The addition of pembrolizumab to chemotherapy resulted in significantly higher rates of response and longer progression-free survival than chemotherapy alone in a phase 2 trial. METHODS In this double-blind, phase 3 trial, we randomly assigned (in a 2: 1 ratio) 616 patients with metastatic nonsquamous NSCLC without sensitizing EGFR or ALK mutations who had received no previous treatment for metastatic disease to receive pemetrexed and a platinum-based drug plus either 200 mg of pembrolizumab or placebo every 3 weeks for 4 cycles, followed by pembrolizumab or placebo for up to a total of 35 cycles plus pemetrexed maintenance therapy. Crossover to pembrolizumab monotherapy was permitted among the patients in the placebo-combination group who had verified disease progression. The primary end points were overall survival and progression-free survival, as assessed by blinded, independent central radiologic review. RESULTS After a median follow-up of 10.5 months, the estimated rate of overall survival at 12 months was 69.2% (95% confidence interval [CI], 64.1 to 73.8) in the pembrolizumab-combination group versus 49.4% (95% CI, 42.1 to 56.2) in the placebocombination group (hazard ratio for death, 0.49; 95% CI, 0.38 to 0.64; P< 0.001). Improvement in overall survival was seen across all PD-L1 categories that were evaluated. Median progression-free survival was 8.8 months (95% CI, 7.6 to 9.2) in the pembrolizumab-combination group and 4.9 months (95% CI, 4.7 to 5.5) in the placebo-combination group (hazard ratio for disease progression or death, 0.52; 95% CI, 0.43 to 0.64; P< 0.001). Adverse events of grade 3 or higher occurred in 67.2% of the patients in the pembrolizumab-combination group and in 65.8% of those in the placebo-combination group. CONCLUSIONS In patients with previously untreated metastatic nonsquamous NSCLC without EGFR or ALK mutations, the addition of pembrolizumab to standard chemotherapy of pemetrexed and a platinum-based drug resulted in significantly longer overall survival and progression-free survival than chemotherapy alone.	[Gandhi, L.] NYU, Perlmutter Canc Ctr, New York, NY USA; [Rodriguez-Abreu, D.] Univ Las Palmas Gran Canaria, Univ Insular Maternoinfantil Gran Canaria, Complejo Hosp, Las Palmas Gran Canaria, Spain; [Esteban, E.] Hosp Univ Cent Asturias, Oviedo, Spain; [Felip, E.] Vall dHebron Univ, Vall dHebron Inst Oncol, Barcelona, Spain; [Domine, M.] Fdn Jimenez Diaz, Madrid, Spain; [Rubio-Viqueira, B.] Hosp Univ Quiron Madrid, Madrid, Spain; [Gadgeel, S.] Karmanos Canc Inst, Detroit, MI USA; [De Angelis, F.] Monteregie Ctr, Integrated Hlth & Social Serv Ctr, Greenfield Pk, PQ, Canada; [Cheng, S. Y. -S.] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Clingan, P.] Southern Med Day Care Ctr, Wollongong, NSW, Australia; [Jennens, R. R.] Epworth Healthcare, Richmond, Vic, Australia; [Hui, R.] Westmead Hosp, Sydney, NSW, Australia; [Hui, R.] Univ Sydney, Sydney, NSW, Australia; [Boyer, M.] Chris OBrien Lifehouse, Camperdown, NSW, Australia; [Hochmair, M. J.] Otto Wagner Hosp, Vienna, Austria; [Powell, S. F.] Sanford Hlth, Sioux Falls, SD USA; [Bischoff, H. G.] Thoraxklin, Heidelberg, Germany; [Reck, M.] German Ctr Lung Res, Airway Res Ctr North, Lungen Clin, Grosshansdorf, Germany; [Peled, N.] Tel Aviv Univ, Davidoff Canc Ctr, Petah Tiqwa, Israel; [Grossi, F.] Osped Policlin San Martino, Genoa, Italy; [Novello, S.] Univ San Luigi, Univ Turin, Azienda Osped, Orbassano, Italy; [Garassino, M. C.] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Garon, E. B.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Kurata, T.] Kansai Med Univ Hosp, Osaka, Japan; [Gray, J. E.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Vida, J.; Wei, Z.; Yang, J.; Raftopoulos, H.; Pietanza, M. C.] Merck, Kenilworth, NJ USA	New York University; Universidad de Las Palmas de Gran Canaria; Central University Hospital Asturias; Vall d'Hebron Institut d'Oncologia (VHIO); Barbara Ann Karmanos Cancer Institute; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Sydney; University of Sydney; University of Sydney; Sanford Health; Ruprecht Karls University Heidelberg; Tel Aviv University; University of Turin; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Kansai Medical University; H Lee Moffitt Cancer Center & Research Institute; Merck & Company	Gandhi, L (corresponding author), New York Univ Langone Hlth, Laura & Isaac Perlmutter Canc Ctr, 160 E 34th St, New York, NY 10016 USA.	leena.gandhi@nyumc.org	Grossi, Francesco/AAL-5024-2021; Esteban, Emilio/AAB-2188-2019; Reck, Martin/ABF-5721-2020; Powell, Steven/ABD-1472-2021; novello, silvia/K-6335-2016; Hui, Rina/L-6114-2019; Miquel, Josep Maria/AAG-3508-2019; Blackhall, Fiona/N-2186-2015	Grossi, Francesco/0000-0001-8412-3136; Esteban, Emilio/0000-0002-2980-5254; Reck, Martin/0000-0002-5348-4462; Rybkin, Igor/0000-0002-8434-1093; Rodriguez-Abreu, Delvys/0000-0003-0506-1366; Bray, Victoria/0000-0002-6357-3899; Peled, Nir/0000-0003-3714-4377; Gandhi, Leena/0000-0002-2398-9179; Myllarniemi, L Marjukka/0000-0001-9343-0867; Blackhall, Fiona/0000-0001-8716-3395; Kollmeier, Jens/0000-0002-8048-3895; FELIP, ENRIQUETA/0000-0002-7620-0098; Zer, Alona/0000-0001-6597-5261; Castonguay, Vincent/0000-0001-8053-4026; Bambury, Richard/0000-0002-2189-6972	Merck; Genentech/Roche; Pfizer; Ignyta; Syndax; AbbVie; AstraZeneca; Bristol-Myers Squibb; Merck Sharp Dohme; Roche/Genentech; Boehringer Ingelheim; Ariad/Takeda; Eli Lilly; Roche; Novartis; Regeneron; Incyte; Vyriad; Genentech; Foundation Medicine; Guardant360; NovellusDx; Takeda; Pierre Fabre; Amgen; Hoffmann-La Roche; Celgene; Mirati; Dynavax; Peregrine Pharmaceuticals; Array	Merck(Merck & Company); Genentech/Roche(Roche HoldingGenentech); Pfizer(Pfizer); Ignyta; Syndax; AbbVie(AbbVie); AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Merck Sharp Dohme(Merck & Company); Roche/Genentech(Roche HoldingGenentech); Boehringer Ingelheim(Boehringer Ingelheim); Ariad/Takeda; Eli Lilly(Eli Lilly); Roche(Roche Holding); Novartis(Novartis); Regeneron(Regeneron); Incyte; Vyriad; Genentech(Roche HoldingGenentech); Foundation Medicine; Guardant360; NovellusDx; Takeda(Takeda Pharmaceutical Company Ltd); Pierre Fabre; Amgen(Amgen); Hoffmann-La Roche(Hoffmann-La Roche); Celgene(Bristol-Myers SquibbCelgene Corporation); Mirati; Dynavax; Peregrine Pharmaceuticals; Array	Supported by Merck.; Dr. Gandhi reports receiving grant support and advisory board fees from Merck, advisory board fees from Genentech/Roche, Pfizer, Ignyta, Syndax, AbbVie, and AstraZeneca, and grant support from Bristol-Myers Squibb; Dr. Rodriguez-Abreu, receiving lecture fees, advisory board fees, and travel support from Merck Sharp & Dohme, Bristol-Myers Squibb, Roche/Genentech, and Boehringer Ingelheim; Dr. Gadgeel, receiving advisory fees from AbbVie, AstraZeneca, Genentech/Roche, and Ariad/Takeda; Dr. Felip, receiving consulting fees from Boehringer Ingelheim, Eli Lilly, Pfizer, Roche, Merck Sharp & Dohme, and AbbVie and lecture fees from AstraZeneca, Bristol-Myers Squibb, and Novartis; Dr. Clingan, receiving funding for study patient visits from Merck Sharp & Dohme, AbbVie, Regeneron, and Bristol- Myers Squibb; Dr. Powell, receiving grant support, paid to his institution, from Merck Sharp & Dohme, Bristol-Myers Squibb, Incyte, Pfizer, Vyriad, and Genentech; Dr. Peled, receiving grant support, advisory fees, and honoraria from AstraZeneca, Bristol-Myers Squibb, Merck Sharp & Dohme, and Roche and advisory fees and honoraria from Boehringer Ingelheim, Eli Lilly, Foundation Medicine, Guardant360, Novartis, NovellusDx, Pfizer, and Takeda; Dr. Grossi, receiving lecture fees and advisory board fees from Merck, Pierre Fabre, Pfizer, Novartis, and Boehringer Ingelheim, grant support, lecture fees, and advisory board fees from Bristol-Myers Squibb, and lecture fees from AstraZeneca, Amgen, and Roche; Dr. Reck, receiving lecture fees and consulting fees from Hoffmann-La Roche, Eli Lilly, AstraZeneca, Celgene, Bristol-Myers Squibb, Merck, Boehringer Ingelheim, Pfizer, Novartis, and Merck Sharp & Dohme; Dr. Hui, receiving advisory board fees and lecture fees from Merck Sharp & Dohme, AstraZeneca, and Novartis, advisory board fees from Roche, and lecture fees from Bristol-Myers Squibb and Boehringer Ingelheim; Dr. Garon, receiving grant support, paid to his institution, from AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Genentech, Boehringer Ingelheim, Pfizer, Novartis, Mirati, Dynavax, and Merck; Dr. Boyer, receiving grant support and travel support from AstraZeneca, Bristol-Myers Squibb, and Pfizer and grant support from Genentech/Roche, Amgen, Novartis, and Peregrine Pharmaceuticals; Dr. Rubio-Viqueira, receiving advisory board fees and lecture fees from Eli Lilly and lecture fees from Roche and Pfizer; Dr. Novello, receiving lecture fees from Boehringer Ingelheim, AstraZeneca, Pfizer, Merck Sharp & Dohme, Bristol-Myers Squibb, Roche, and Eli Lilly; Dr. Kurata, receiving honoraria from Merck Sharp & Dohme, Eli Lilly, Chugai, Ono, Bristol-Myers Squibb, AstraZeneca, and Boehringer Ingelheim; Dr. Gray, receiving grant support from Merck, Bristol-Myers Squibb, and Array, grant support and honoraria from AstraZeneca, Genentech, and Boehringer Ingelheim, and honoraria from Celgene and Eli Lilly; Drs. Vida, Wei, Yang, and Pietanza, being employed by Merck; Dr. Rafto-poulos, being employed by Bayer and being employed by Merck during the conduct of the study; and Dr. Garassino, receiving consulting fees and lecture fees from AstraZeneca, Roche, and Boehringer Ingelheim. No other potential conflict of interest relevant to this article was reported.	Ahn MJ, 2015, ANN ONCOL, V26, P140; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Bracci L, 2014, CELL DEATH DIFFER, V21, P15, DOI 10.1038/cdd.2013.67; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brahmer JR, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.9000; Carbone DP, 2017, NEW ENGL J MED, V376, P2415, DOI 10.1056/NEJMoa1613493; Ciuleanu T, 2009, LANCET, V374, P1432, DOI 10.1016/S0140-6736(09)61497-5; Cutica I, 2014, EUR J INTERN MED, V25, P685, DOI 10.1016/j.ejim.2014.07.002; Davies J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175679; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Hartmann JT, 2003, EXPERT OPIN PHARMACO, V4, P889, DOI 10.1517/14656566.4.6.889; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Langer CJ, 2016, LANCET ONCOL, V17, P1497, DOI 10.1016/S1470-2045(16)30498-3; Lazzari C, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00004; Lesterhuis WJ, 2011, J CLIN INVEST, V121, P3100, DOI 10.1172/JCI43656; Li GZ, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1328339; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Paz-Ares L, 2012, LANCET ONCOL, V13, P247, DOI 10.1016/S1470-2045(12)70063-3; Paz-Ares LG, 2013, J CLIN ONCOL, V31, P2895, DOI 10.1200/JCO.2012.47.1102; Perol M, 2017, J CLIN ONCOL S, V35; Peters S, 2017, J CLIN ONCOL, V35, P2781, DOI 10.1200/JCO.2016.71.9476; Reck M, 2017, ANN ONCOL, V28, P31; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Roach C, 2016, APPL IMMUNOHISTO M M, V24, P392, DOI 10.1097/PAI.0000000000000408; Roselli M, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.27025; Scagliotti GV, 2014, LUNG CANCER, V85, P408, DOI 10.1016/j.lungcan.2014.07.005; Tomasini P, 2016, THER ADV MED ONCOL, V8, P198, DOI 10.1177/1758834016644155; Zattera Tito, 2017, J Nephropathol, V6, P43, DOI 10.15171/jnp.2017.07; Zinner RG, 2015, J THORAC ONCOL, V10, P134, DOI 10.1097/JTO.0000000000000366	31	3244	3348	31	402	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2018	378	22					2078	2092		10.1056/NEJMoa1801005	http://dx.doi.org/10.1056/NEJMoa1801005			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH5AL	29658856	Green Published, Bronze			2022-12-28	WOS:000433428000006
J	Nguyen, THD; Tam, J; Wu, RA; Greber, BJ; Toso, D; Nogales, E; Collins, K				Thi Hoang Duong Nguyen; Tam, Jane; Wu, Robert A.; Greber, Basil J.; Toso, Daniel; Nogales, Eva; Collins, Kathleen			Cryo-EM structure of substrate-bound human telomerase holoenzyme	NATURE			English	Article							CAJAL BODY LOCALIZATION; CATALYTIC SUBUNIT TERT; N-TERMINAL DOMAIN; TETRAHYMENA TELOMERASE; REVERSE-TRANSCRIPTASE; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; YEAST TELOMERASE; IMMORTAL CELLS; HIGH-LEVEL	The enzyme telomerase adds telomeric repeats to chromosome ends to balance the loss of telomeres during genome replication. Telomerase regulation has been implicated in cancer, other human diseases, and ageing, but progress towards clinical manipulation of telomerase has been hampered by the lack of structural data. Here we present the cryo-electron microscopy structure of the substrate-bound human telomerase holoenzyme at subnanometre resolution, showing two flexibly RNA-tethered lobes: the catalytic core with telomerase reverse transcriptase (TERT) and conserved motifs of telomerase RNA (hTR), and an H/ACA ribonucleoprotein (RNP). In the catalytic core, RNA encircles TERT, adopting a well-ordered tertiary structure with surprisingly limited protein-RNA interactions. The H/ACA RNP lobe comprises two sets of heterotetrameric H/ACA proteins and one Cajal body protein, TCAB1, representing a pioneering structure of a large eukaryotic family of ribosome and spliceosome biogenesis factors. Our findings provide a structural framework for understanding human telomerase disease mutations and represent an important step towards telomerase-related clinical therapeutics.	[Thi Hoang Duong Nguyen; Tam, Jane; Wu, Robert A.; Nogales, Eva; Collins, Kathleen] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Thi Hoang Duong Nguyen; Greber, Basil J.; Toso, Daniel; Nogales, Eva; Collins, Kathleen] Univ Calif Berkeley, Calif Inst Quantitat Biol, Berkeley, CA 94720 USA; [Thi Hoang Duong Nguyen; Greber, Basil J.; Nogales, Eva] Lawrence Berkeley Natl Lab, Mol Biophys & Integrat Bioimaging Div, Berkeley, CA 94720 USA; [Thi Hoang Duong Nguyen] Univ Calif Berkeley, Miller Inst Basic Res Sci, Berkeley, CA 94720 USA; [Nogales, Eva] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Wu, Robert A.] Harvard Med Sch, Boston, MA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Harvard University; Harvard Medical School	Nogales, E; Collins, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Nogales, E; Collins, K (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biol, Berkeley, CA 94720 USA.; Nogales, E (corresponding author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrat Bioimaging Div, Berkeley, CA 94720 USA.; Nogales, E (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	enogales@lbl.gov; kcollins@berkeley.edu		Nguyen, Thi Hoang Duong/0000-0002-2180-3430; Greber, Basil/0000-0001-9379-7159; Wu, R. Alex/0000-0003-4190-4615	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; N.I.H. [GM054198]; Swiss National Science Foundation [P300PA_160983, P300PA_174355]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232, R01GM054198] Funding Source: NIH RePORTER	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Grob, J. Fang, A. Chintangal, P. Tobias and H. Upton for technical support; X. Zhang and J. Vogan for establishing the suspension cell transfection protocol used in early stages of this work and sharing cell lines for in vivo studies and CAB-box mutant hTR; L. Kohlstaedt and QB3 mass spectrometry facility for analysis of purified telomerase; Y. Wang, J. Jiang and J. Feigon for sharing the coordinates of the Tetrahymena catalytic core and the modelled human t/PK; E. Rodina for sharing the Hansenula polymorpha TEN coordinates before publication; and H. Upton and A. Deshpande for comments on the manuscript. We thank the National Energy Research Scientific Computing Center supported by the Office of Science of the US Department of Energy for providing computing resources under contract number DE-AC02-05CH11231. This work was funded by N.I.H. grant GM054198 to K.C. T.H.D.N. is a Fellow of the University of California, Berkeley Miller Institute for Basic Research in Science. B.J.G. was supported by fellowships from the Swiss National Science Foundation (projects P300PA_160983, P300PA_174355). E.N. is a Howard Hughes Medical Investigator.	Alves D, 2008, NAT CHEM BIOL, V4, P287, DOI 10.1038/nchembio.82; Arnoult N, 2015, NAT STRUCT MOL BIOL, V22, P859, DOI 10.1038/nsmb.3092; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Bajon E, 2015, CELL REP, V12, P441, DOI 10.1016/j.celrep.2015.06.045; Biyani N, 2017, J STRUCT BIOL, V198, P124, DOI 10.1016/j.jsb.2017.03.007; Blackburn EH, 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A003558; Bley CJ, 2011, P NATL ACAD SCI USA, V108, P20333, DOI 10.1073/pnas.1100270108; Cash DD, 2017, NUCLEIC ACIDS RES, V45, P482, DOI 10.1093/nar/gkw1153; Chan H, 2017, ANNU REV BIOPHYS, V46, P199, DOI 10.1146/annurev-biophys-062215-011140; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; Chen JL, 2002, NUCLEIC ACIDS RES, V30, P592, DOI 10.1093/nar/30.2.592; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Cristofari G, 2007, MOL CELL, V27, P882, DOI 10.1016/j.molcel.2007.07.020; Dodonova SO, 2015, SCIENCE, V349, P195, DOI 10.1126/science.aab1121; Doksani Y, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016576; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Egan ED, 2012, MOL CELL BIOL, V32, P2428, DOI 10.1128/MCB.00286-12; Egan ED, 2010, MOL CELL BIOL, V30, P2775, DOI 10.1128/MCB.00151-10; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fu D, 2003, MOL CELL, V11, P1361, DOI 10.1016/S1097-2765(03)00196-5; Fu D, 2007, MOL CELL, V28, P773, DOI 10.1016/j.molcel.2007.09.023; Gillis AJ, 2008, NATURE, V455, P633, DOI 10.1038/nature07283; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Hamma T, 2010, J BIOL CHEM, V285, P805, DOI 10.1074/jbc.R109.076893; Holohan B, 2014, J CELL BIOL, V205, P289, DOI 10.1083/jcb.201401012; Huang J, 2014, NAT STRUCT MOL BIOL, V21, P507, DOI 10.1038/nsmb.2819; Jacobs SA, 2006, NAT STRUCT MOL BIOL, V13, P218, DOI 10.1038/nsmb1054; Jansson LI, 2015, NAT STRUCT MOL BIOL, V22, P883, DOI 10.1038/nsmb.3101; Jiang JS, 2015, SCIENCE, V350, DOI 10.1126/science.aab4070; Jiang JS, 2013, NATURE, V496, P187, DOI 10.1038/nature12062; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim NK, 2008, J MOL BIOL, V384, P1249, DOI 10.1016/j.jmb.2008.10.005; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kittur N, 2006, RNA, V12, P2057, DOI 10.1261/rna.249306; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3; Li L, 2006, NATURE, V443, P302, DOI 10.1038/nature05151; MacNeil DE, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090064; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mitchell JR, 2000, MOL CELL, V6, P361, DOI 10.1016/S1097-2765(00)00036-8; Mitchell M, 2010, NAT STRUCT MOL BIOL, V17, P513, DOI 10.1038/nsmb.1777; Petrova OA, 2018, NUCLEIC ACIDS RES, V46, P1525, DOI 10.1093/nar/gkx1275; Podlevsky JD, 2016, RNA BIOL, V13, P720, DOI 10.1080/15476286.2016.1205768; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Robart AR, 2011, MOL CELL, V42, P308, DOI 10.1016/j.molcel.2011.03.012; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sarek G, 2015, NAT STRUCT MOL BIOL, V22, P867, DOI 10.1038/nsmb.3093; Sauerwald A, 2013, NAT STRUCT MOL BIOL, V20, P454, DOI 10.1038/nsmb.2530; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schirmer Eric C, 2003, Discov Med, V3, P38; Sexton AN, 2014, GENE DEV, V28, P1885, DOI 10.1101/gad.246819.114; Shay JW, 2016, CANCER DISCOV, V6, P584, DOI 10.1158/2159-8290.CD-16-0062; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Theimer CA, 2007, MOL CELL, V27, P869, DOI 10.1016/j.molcel.2007.07.017; Nguyen THD, 2015, NATURE, V523, P47, DOI 10.1038/nature14548; Tivol WF, 2008, MICROSC MICROANAL, V14, P375, DOI 10.1017/S1431927608080781; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Vogan JM, 2016, ELIFE, V5, DOI 10.7554/eLife.18221; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wang YQ, 2016, P NATL ACAD SCI USA, V113, pE5125, DOI 10.1073/pnas.1607411113; Wegman-Ostrosky T, 2017, BRIT J HAEMATOL, V177, P526, DOI 10.1111/bjh.14535; Wenz C, 2001, EMBO J, V20, P3526, DOI 10.1093/emboj/20.13.3526; Wu RA, 2017, ANNU REV BIOCHEM, V86, P439, DOI 10.1146/annurev-biochem-061516-045019; Wu RA, 2015, ELIFE, V4, DOI 10.7554/eLife.08363; Wu RA, 2014, EMBO J, V33, P921, DOI 10.1002/embj.201387205; Yu YT, 2014, RNA BIOL, V11, P1483, DOI 10.4161/15476286.2014.972855; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang Q, 2011, P NATL ACAD SCI USA, V108, P20325, DOI 10.1073/pnas.1100279108; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	76	117	118	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2018	557	7704					190	+		10.1038/s41586-018-0062-x	http://dx.doi.org/10.1038/s41586-018-0062-x			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2MV	29695869	Green Accepted, Green Submitted			2022-12-28	WOS:000431775100040
J	Fleming, TP; Watkins, AJ; Velazquez, MA; Mathers, JC; Prentice, AM; Stephenson, J; Barker, M; Saffery, R; Yajnik, CS; Eckert, JJ; Hanson, MA; Forrester, T; Gluckman, PD; Godfrey, KM				Fleming, Tom P.; Watkins, Adam J.; Velazquez, Miguel A.; Mathers, John C.; Prentice, Andrew M.; Stephenson, Judith; Barker, Mary; Saffery, Richard; Yajnik, Chittaranjan S.; Eckert, Judith J.; Hanson, Mark A.; Forrester, Terrence; Gluckman, Peter D.; Godfrey, Keith M.			Origins of lifetime health around the time of conception: causes and consequences	LANCET			English	Article							DIET-INDUCED OBESITY; BODY-MASS INDEX; IN-VITRO FERTILIZATION; HIGH-FAT DIET; DNA METHYLATION; GENE-EXPRESSION; EMBRYO CULTURE; FETAL-GROWTH; MATERNAL UNDERNUTRITION; INSULIN-RESISTANCE	Parental environmental factors, including diet, body composition, metabolism, and stress, affect the health and chronic disease risk of people throughout their lives, as captured in the Developmental Origins of Health and Disease concept. Research across the epidemiological, clinical, and basic science fields has identified the period around conception as being crucial for the processes mediating parental influences on the health of the next generation. During this time, from the maturation of gametes through to early embryonic development, parental lifestyle can adversely influence long-term risks of offspring cardiovascular, metabolic, immune, and neurological morbidities, often termed developmental programming. We review periconceptional induction of disease risk from four broad exposures: maternal overnutrition and obesity; maternal undernutrition; related paternal factors; and the use of assisted reproductive treatment. Studies in both humans and animal models have demonstrated the underlying biological mechanisms, including epigenetic, cellular, physiological, and metabolic processes. We also present a meta-analysis of mouse paternal and maternal protein undernutrition that suggests distinct parental periconceptional contributions to postnatal outcomes. We propose that the evidence for periconceptional effects on lifetime health is now so compelling that it calls for new guidance on parental preparation for pregnancy, beginning before conception, to protect the health of offspring.	[Fleming, Tom P.] Univ Southampton, Biol Sci, Southampton, Hants, England; [Barker, Mary; Godfrey, Keith M.] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Eckert, Judith J.; Hanson, Mark A.; Godfrey, Keith M.] Univ Southampton, Inst Dev Sci, Southampton, Hants, England; [Watkins, Adam J.] Univ Nottingham, Sch Med, Div Child Hlth Obstet & Gynaecol, Nottingham, England; [Velazquez, Miguel A.] Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Mathers, John C.] Newcastle Univ, Human Nutr Res Ctr, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Mathers, John C.] Newcastle Univ, Inst Ageing, Newcastle Upon Tyne, Tyne & Wear, England; [Prentice, Andrew M.] London Sch Hyg & Trop Med, MRC Unit Gambia, London, England; [Prentice, Andrew M.] London Sch Hyg & Trop Med, MRC Int Nutr Grp, London, England; [Stephenson, Judith] UCL, UCL EGA Inst Womens Hlth, Fac Populat Hlth Sci, London, England; [Barker, Mary; Hanson, Mark A.; Godfrey, Keith M.] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Barker, Mary; Hanson, Mark A.; Godfrey, Keith M.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Saffery, Richard] Univ Melbourne, Murdoch Childrens Res Inst, Canc & Dis Epigenet, Melbourne, Vic, Australia; [Saffery, Richard] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Yajnik, Chittaranjan S.] KEM Hosp Res Ctr, Pune, Maharashtra, India; [Forrester, Terrence] Univ West Indies, Solut Developing Countries, Monaco, Jamaica; [Gluckman, Peter D.] Univ Auckland, Liggins Inst, Auckland, New Zealand; [Gluckman, Peter D.] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore	University of Southampton; University of Southampton; University of Southampton; University of Nottingham; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; University West Indies Mona Jamaica; University of Auckland; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS)	Godfrey, KM (corresponding author), Univ Southampton, Tremona Rd, Southampton SO16 6YD, Hants, England.; Godfrey, KM (corresponding author), Univ Hosp Southampton, MRC Lifecourse Epidemiol Unit, Tremona Rd, Southampton SO16 6YD, Hants, England.	kmg@mrc.soton.ac.uk	Hanson, Mark/AAE-8236-2019; Prentice, Andrew/AAG-1961-2019; Watkins, Adam J/J-4839-2013; Watkins, Adam/AAH-9401-2021; Saffery, Richard/GLS-1976-2022	Hanson, Mark/0000-0002-6907-613X; Watkins, Adam J/0000-0002-0842-1251; Watkins, Adam/0000-0002-0842-1251; Saffery, Richard/0000-0002-9510-4181; Barker, Mary/0000-0003-2976-0217; Velazquez, Miguel/0000-0001-7074-5399; Godfrey, Keith/0000-0002-4643-0618	Rank Prize Funds, on Developmental Programming for Human Disease: Preconception Nutrition and Lifelong Health in Grasmere, UK; BBSRC [BB/1001840/1, BB/F007450/1]; European Union [278418, 317146, 289346, 613977]; Rosetrees Trust; UK Medical Research Council [MC_UU_12011/4]; National Institute for Health Research [NF-SI-0515-10042]; NIHR Southampton Biomedical Research Centre; Aston Research Centre for Healthy Ageing fellowship from Aston University; UK Medical Research Council (MRC) [MC-A760-5QX00]; UK Department for International Development (DFID) under the MRC/DFID Concordat agreement; British Heart Foundation; National Health and Medical Research Fellowship; Victorian Government operational infrastructure support scheme (Australia); MRC through the Centre for Ageing Vitality [MR/L016354/1]; BBSRC through the Centre for Ageing Vitality [MR/L016354/1]; BBSRC [BB/R003556/1] Funding Source: UKRI; MRC [MR/L016354/1, MC_EX_MR/M01424X/1, MC_UU_12011/3, MC_UU_00026/3, MC_UU_12011/4, MR/N011848/1, MC_UP_A620_1017, MC_U123292700] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F007450/1] Funding Source: researchfish; British Heart Foundation [PG/14/33/30827, RG/15/17/31749] Funding Source: researchfish; Medical Research Council [MC_UU_12011/4] Funding Source: researchfish; Rosetrees Trust [M518] Funding Source: researchfish	Rank Prize Funds, on Developmental Programming for Human Disease: Preconception Nutrition and Lifelong Health in Grasmere, UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); Rosetrees Trust(Rosetrees Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); NIHR Southampton Biomedical Research Centre; Aston Research Centre for Healthy Ageing fellowship from Aston University; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID Concordat agreement(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); National Health and Medical Research Fellowship; Victorian Government operational infrastructure support scheme (Australia); MRC through the Centre for Ageing Vitality(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC through the Centre for Ageing Vitality(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust)	The idea for this Series was conceived by JS and developed during a 4-day symposium, led by MB and JS and funded by The Rank Prize Funds, on Developmental Programming for Human Disease: Preconception Nutrition and Lifelong Health in Grasmere, UK, in February, 2016. We are grateful for research funding from BBSRC (BB/1001840/1; BB/F007450/1), European Union FP7 (Epihealth, 278418; EpiHealthNet, 317146), and Rosetrees Trust to TPF. KMG is supported by the UK Medical Research Council (MC_UU_12011/4), the National Institute for Health Research (as an NIHR Senior Investigator (NF-SI-0515-10042), and through the NIHR Southampton Biomedical Research Centre and by the European Union's Erasmus+ Capacity-Building ENeA<SUP>SEA</SUP> Project and Seventh Framework Programme (FP7/2007-2013), projects EarlyNutrition and ODIN under grant agreement numbers 289346 and 613977. AJW is supported by an Aston Research Centre for Healthy Ageing fellowship from Aston University. AMP is supported by the UK Medical Research Council (MRC; grant no MC-A760-5QX00) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement. MAH is supported by the British Heart Foundation. RS is funded by a National Health and Medical Research Fellowship and the Victorian Government operational infrastructure support scheme (Australia). JCM is supported by the MRC and BBSRC through the Centre for Ageing & Vitality (MR/L016354/1).	Agbaje IM, 2007, HUM REPROD, V22, P1871, DOI 10.1093/humrep/dem077; Bakos HW, 2011, INT J ANDROL, V34, P402, DOI 10.1111/j.1365-2605.2010.01092.x; Bakos HW, 2011, FERTIL STERIL, V95, P1700, DOI 10.1016/j.fertnstert.2010.11.044; Barker D, 2013, NATURE, V504, P209, DOI 10.1038/504209a; Barker DJP, 2013, CLIN OBSTET GYNECOL, V56, P511, DOI 10.1097/GRF.0b013e31829cb9ca; Basson M Albert, 2012, Cold Spring Harb Perspect Biol, V4, DOI 10.1101/cshperspect.a008151; Bedzhov I, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0538; Bellver J, 2013, FERTIL STERIL, V100, P1050, DOI 10.1016/j.fertnstert.2013.06.001; Bromfield JJ, 2014, P NATL ACAD SCI USA, V111, P2200, DOI 10.1073/pnas.1305609111; Burrage DM, 2009, J PHYSIOL-LONDON, V587, P611, DOI 10.1113/jphysiol.2008.165944; Cardozo ER, 2016, HUM REPROD, V31, P385, DOI 10.1093/humrep/dev298; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Ceelen M, 2008, J CLIN ENDOCR METAB, V93, P1682, DOI 10.1210/jc.2007-2432; Chen Q, 2016, SCIENCE, V351, P397, DOI 10.1126/science.aad7977; Chen SL, 2010, FERTIL STERIL, V94, P2356, DOI 10.1016/j.fertnstert.2010.01.120; Cleal JK, 2007, PEDIATR RES, V62, P422, DOI 10.1203/PDR.0b013e31813cbe60; Costello PM, 2008, J PHYSIOL-LONDON, V586, P2371, DOI 10.1113/jphysiol.2008.150987; Cropley JE, 2016, MOL METAB, V5, P699, DOI 10.1016/j.molmet.2016.06.008; Denisenko O, 2016, BBA-GENE REGUL MECH, V1859, P906, DOI 10.1016/j.bbagrm.2016.04.001; Dominguez-Salas P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4746; Eckert JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052791; Fleming TP, 2015, REPROD FERT DEVELOP, V27, P684, DOI 10.1071/RD14455; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Gardebjer EM, 2015, FASEB J, V29, P2690, DOI 10.1096/fj.14-268979; Gardner DK, 2015, REPROD FERT DEVELOP, V27, P638, DOI 10.1071/RD14421; Gaskins AJ, 2012, HUM REPROD, V27, P2899, DOI 10.1093/humrep/des298; Gkourogianni A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094001; Godfrey KM, 2017, LANCET DIABETES ENDO, V5, P53, DOI 10.1016/S2213-8587(16)30107-3; Hammoud AO, 2009, FERTIL STERIL, V91, P1630, DOI 10.1016/j.fertnstert.2007.10.038; Hammoud SS, 2011, HUM REPROD, V26, P2558, DOI 10.1093/humrep/der192; Hansen PJ, 2016, CELL TISSUE RES, V363, P237, DOI 10.1007/s00441-015-2287-4; Hanson M, 2015, ANN REP CHIEF MED OF; Hanson MA, 2014, PHYSIOL REV, V94, P1027, DOI 10.1152/physrev.00029.2013; Holland ML, 2016, SCIENCE, V353, P495, DOI 10.1126/science.aaf7040; Horii T, 2011, J REPROD DEVELOP, V57, P579, DOI 10.1262/jrd.10-194A; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Jodar M, 2012, HUM REPROD, V27, P1431, DOI 10.1093/humrep/des021; Jungheim ES, 2010, ENDOCRINOLOGY, V151, P4039, DOI 10.1210/en.2010-0098; Khosla S, 2001, BIOL REPROD, V64, P918, DOI 10.1095/biolreprod64.3.918; Kleijkers SHM, 2016, HUM REPROD, V31, P2219, DOI 10.1093/humrep/dew156; Kleijkers SHM, 2014, HUM REPROD, V29, P661, DOI 10.1093/humrep/deu025; Kort HI, 2006, J ANDROL, V27, P450, DOI 10.2164/jandrol.05124; Kuhnen P, 2016, CELL METAB, V24, P502, DOI 10.1016/j.cmet.2016.08.001; Kwong WY, 2000, DEVELOPMENT, V127, P4195; Lambrot R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3889; Lazaraviciute G, 2014, HUM REPROD UPDATE, V20, P840, DOI 10.1093/humupd/dmu033; Leary C, 2015, HUM REPROD, V30, P122, DOI 10.1093/humrep/deu276; Li L, 2013, MOL ASPECTS MED, V34, P919, DOI 10.1016/j.mam.2013.01.003; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Luzzo KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049217; McKay JA, 2016, MOL NUTR FOOD RES, V60, P2031, DOI 10.1002/mnfr.201600079; McPherson NO, 2016, SCI REP-UK, V6, DOI 10.1038/srep27010; Messerschmidt DM, 2014, GENE DEV, V28, P812, DOI 10.1101/gad.234294.113; Mitchell M, 2011, FERTIL STERIL, V95, P1349, DOI 10.1016/j.fertnstert.2010.09.038; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Nicholas LM, 2016, INT J OBESITY, V40, P229, DOI 10.1038/ijo.2015.178; Nicholas LM, 2013, FASEB J, V27, P3786, DOI 10.1096/fj.13-227918; Ostermeier GC, 2002, LANCET, V360, P772, DOI 10.1016/S0140-6736(02)09899-9; Palmer NO, 2012, AM J PHYSIOL-ENDOC M, V302, pE768, DOI 10.1152/ajpendo.00401.2011; Pentinat T, 2010, ENDOCRINOLOGY, V151, P5617, DOI 10.1210/en.2010-0684; Prasad S, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0253-4; Qin JB, 2017, ARCH GYNECOL OBSTET, V295, P285, DOI 10.1007/s00404-016-4250-3; Rayco-Solon P, 2005, AM J CLIN NUTR, V81, P134; Rexhaj E, 2015, AM J PHYSIOL-HEART C, V309, pH1151, DOI 10.1152/ajpheart.00621.2014; Rivera RM, 2008, HUM MOL GENET, V17, P1, DOI 10.1093/hmg/ddm280; Robker RL, 2009, J CLIN ENDOCR METAB, V94, P1533, DOI 10.1210/jc.2008-2648; Ruebel ML, 2017, J CLIN ENDOCR METAB, V102, P2029, DOI 10.1210/jc.2016-3524; Rumbold AR, 2017, HUM REPROD, V32, P1489, DOI 10.1093/humrep/dex085; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Scherrer U, 2012, CIRCULATION, V125, P1890, DOI 10.1161/CIRCULATIONAHA.111.071183; Seli E, 2004, FERTIL STERIL, V82, P378, DOI 10.1016/j.fertnstert.2003.12.039; Sharkey DJ, 2007, MOL HUM REPROD, V13, P491, DOI 10.1093/molehr/gam028; Sharma U, 2016, SCIENCE, V351, P391, DOI 10.1126/science.aad6780; Silver MJ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0660-y; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Sinclair KD, 2014, REPROD FERT DEVELOP, V26, P99, DOI 10.1071/RD13290; Sjoblom C, 2005, ENDOCRINOLOGY, V146, P2142, DOI 10.1210/en.2004-1260; Steegers-Theunissen RPM, 2013, HUM REPROD UPDATE, V19, P640, DOI 10.1093/humupd/dmt041; Sun CS, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0053-1; Sun CS, 2014, DEVELOPMENT, V141, P1140, DOI 10.1242/dev.103952; Sunde A, 2016, HUM REPROD, V31, P2174, DOI 10.1093/humrep/dew157; Tobi EW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6592; Torrens C, 2009, EXP PHYSIOL, V94, P1024, DOI 10.1113/expphysiol.2009.047340; Tunc O, 2011, ANDROLOGIA, V43, P121, DOI 10.1111/j.1439-0272.2009.01032.x; Turan N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001033; Valenzuela-Alcaraz B, 2013, CIRCULATION, V128, P1442, DOI 10.1161/CIRCULATIONAHA.113.002428; van der Heijden GW, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-34; Velazquez MA, 2016, HUM REPROD, V31, P1970, DOI 10.1093/humrep/dew177; Wang PX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049720; Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252; Watkins AJ, 2008, J PHYSIOL-LONDON, V586, P2231, DOI 10.1113/jphysiol.2007.149229; Watkins AJ, 2008, BIOL REPROD, V78, P299, DOI 10.1095/biolreprod.107.064220; Watkins AJ, 2007, P NATL ACAD SCI USA, V104, P5449, DOI 10.1073/pnas.0610317104; Watkins AJ, 2017, BBA-MOL BASIS DIS, V1863, P1371, DOI 10.1016/j.bbadis.2017.02.009; Watkins AJ, 2015, REPRODUCTION, V149, P563, DOI 10.1530/REP-14-0667; Watkins AJ, 2014, AM J PHYSIOL-HEART C, V306, DOI 10.1152/ajpheart.00981.2013; Williams CL, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-49; Wyman A, 2008, ENDOCRINOLOGY, V149, P466, DOI 10.1210/en.2007-1273; Yang X, 2012, FERTIL STERIL, V97, P1438, DOI 10.1016/j.fertnstert.2012.02.034; Zeybel M, 2012, NAT MED, V18, P1369, DOI 10.1038/nm.2893	100	465	469	11	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2018	391	10132					1842	1852		10.1016/S0140-6736(18)30312-X	http://dx.doi.org/10.1016/S0140-6736(18)30312-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GE7NY	29673874	Green Submitted, Green Accepted			2022-12-28	WOS:000431421300029
J	Gilbert, T; Neuburger, J; Kraindler, J; Keeble, E; Smith, P; Ariti, C; Arora, S; Street, A; Parker, S; Roberts, HC; Bardsley, M; Conroy, S				Gilbert, Thomas; Neuburger, Jenny; Kraindler, Joshua; Keeble, Eilis; Smith, Paul; Ariti, Cono; Arora, Sandeepa; Street, Andrew; Parker, Stuart; Roberts, Helen C.; Bardsley, Martin; Conroy, Simon			Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study	LANCET			English	Article							COMPREHENSIVE GERIATRIC ASSESSMENT; ADVERSE OUTCOMES; ELDERLY-PEOPLE; MORTALITY; ACCURACY; ADULTS	Background Older people are increasing users of health care globally. We aimed to establish whether older people with characteristics of frailty and who are at risk of adverse health-care outcomes could be identified using routinely collected data. Methods A three-step approach was used to develop and validate a Hospital Frailty Risk Score from International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) diagnostic codes. First, we carried out a cluster analysis to identify a group of older people (>= 75 years) admitted to hospital who had high resource use and diagnoses associated with frailty. Second, we created a Hospital Frailty Risk Score based on ICD-10 codes that characterised this group. Third, in separate cohorts, we tested how well the score predicted adverse outcomes and whether it identified similar groups as other frailty tools. Findings In the development cohort (n=22 139), older people with frailty diagnoses formed a distinct group and had higher non-elective hospital use (33.6 bed-days over 2 years compared with 23.0 bed-days for the group with the next highest number of bed-days). In the national validation cohort (n=1013 590), compared with the 429 762 (42.4%) patients with the lowest risk scores, the 202 718 (20.0%) patients with the highest Hospital Frailty Risk Scores had increased odds of 30-day mortality (odds ratio 1.71, 95% CI 1.68-1.75), long hospital stay (6.03, 5.92-6.10), and 30-day readmission (1.48, 1.46-1.50). The c statistics (ie, model discrimination) between individuals for these three outcomes were 0.60, 0.68, and 0.56, respectively. The Hospital Frailty Risk Score showed fair overlap with dichotomised Fried and Rockwood scales (kappa scores 0.22, 95% CI 0.15-0.30 and 0.30, 0.22-0.38, respectively) and moderate agreement with the Rockwood Frailty Index (Pearson's correlation coefficient 0.41, 95% CI 0.38-0.47). Interpretation The Hospital Frailty Risk Score provides hospitals and health systems with a low-cost, systematic way to screen for frailty and identify a group of patients who are at greater risk of adverse outcomes and for whom a frailty-attuned approach might be useful. Copyright (c) 2018 The Author(s). Published by Elsevier Ltd.	[Gilbert, Thomas] Lyon Teaching Hosp, Dept Geriatr Med, Lyon, France; [Neuburger, Jenny; Kraindler, Joshua; Keeble, Eilis; Arora, Sandeepa] Nuffield Trust, London, England; [Smith, Paul] Manchester Univ NHS Fdn Trust, Dept Business Intelligence, Manchester, Lancs, England; [Ariti, Cono] Cardiff Univ, Dept Publ Hlth, Cardiff, S Glam, Wales; [Street, Andrew] London Sch Econ, Dept Hlth Policy, London, England; [Parker, Stuart] Newcastle Univ, Inst Ageing, Newcastle Upon Tyne, Tyne & Wear, England; [Roberts, Helen C.] Univ Southampton, Acad Geriatr Med, Southampton, Hants, England; [Bardsley, Martin] Hlth Fdn, Data Analyt Team, London, England; [Conroy, Simon] Univ Leicester, Dept Hlth Sci, Coll Life Sci, Leicester, Leics, England	CHU Lyon; Cardiff University; University of London; London School Economics & Political Science; Newcastle University - UK; University of Southampton; University of Leicester	Conroy, S (corresponding author), Univ Leicester, Dept Hlth Sci, Coll Life Sci, Ctr Med, Leicester LE1 7RH, Leics, England.	spc3@le.ac.uk	Gilbert, Thomas/Q-5451-2018	Gilbert, Thomas/0000-0001-8270-7605; Kraindler, Joshua/0000-0003-2103-6726; Conroy, Simon/0000-0002-4306-6064; Street, Andrew David/0000-0002-2540-0364; Parker, Stuart/0000-0002-8675-6276	National Institute for Health Research	National Institute for Health Research(National Institute for Health Research (NIHR))	National Institute for Health Research.	Aguayo GA, 2017, AM J EPIDEMIOL, V186, P420, DOI 10.1093/aje/kwx061; Bakker FC, 2011, BMJ QUAL SAF, V20, P680, DOI 10.1136/bmjqs.2010.047183; Burns EM, 2012, J PUBLIC HEALTH-UK, V34, P138, DOI 10.1093/pubmed/fdr054; Buurman BM, 2011, EUR J EMERG MED, V18, P215, DOI 10.1097/MEJ.0b013e328344597e; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clegg A, 2016, AGE AGEING, V45, P353, DOI 10.1093/ageing/afw039; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; de Vos AJBM, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-7; Department of Health, 2008, END LIF CAR STRAT PR; Elliott A, 2017, AGE AGEING, V46, P840, DOI 10.1093/ageing/afx089; Evans SJ, 2014, AGE AGEING, V43, P127, DOI 10.1093/ageing/aft156; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Hubbard RE, 2017, AGE AGEING, V46, P801, DOI 10.1093/ageing/afx081; Mamede S, 2014, MED EDUC, V48, P34, DOI 10.1111/medu.12264; McCusker J, 1999, J AM GERIATR SOC, V47, P1229, DOI 10.1111/j.1532-5415.1999.tb05204.x; Mohammed MA, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b780; National Institute for Health and Care Excellence, 2010, DEL PREV DIAGN MAN; NHS Benchmarking Network, 2016, OLD PEOPL AC SETT; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; Parker SG, 2018, AGE AGEING, V47, P149, DOI 10.1093/ageing/afx166; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rechel B, 2013, LANCET, V381, P1312, DOI 10.1016/S0140-6736(12)62087-X; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Romero-Ortuno R, 2016, EUR J INTERN MED, V35, P24, DOI 10.1016/j.ejim.2016.08.033; Ruiz MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123987; Soong J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008457; Spillman BC, 2000, NEW ENGL J MED, V342, P1409, DOI 10.1056/NEJM200005113421906; Theou O, 2013, J AM GERIATR SOC, V61, P1537, DOI 10.1111/jgs.12420; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; World Health Organization, 2018, WORLD REP AG HLTH; World Health Organization, INT STAT CLASS DIS R, V10th	33	461	463	5	38	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2018	391	10132					1775	1782		10.1016/S0140-6736(18)30668-8	http://dx.doi.org/10.1016/S0140-6736(18)30668-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GE7NY	29706364	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000431421300025
J	Hicks, J; Vasko, P; Goicoechea, JM; Aldridge, S				Hicks, Jamie; Vasko, Petra; Goicoechea, Jose M.; Aldridge, Simon			Synthesis, structure and reaction chemistry of a nucleophilic aluminyl anion	NATURE			English	Article							OXIDATIVE ADDITION; MG-MG; ALUMINUM(I); GALLIUM; BONDS; AL	The reactivity of aluminium compounds is dominated by their electron deficiency and consequent electrophilicity; these compounds are archetypal Lewis acids (electron-pair acceptors). The main industrial roles of aluminium, and classical methods of synthesizing aluminium-element bonds (for example, hydroalumination and metathesis), draw on the electron deficiency of species of the type AlR3 and AlCl3 (1,2). Whereas aluminates, [AlR4](-), are well known, the idea of reversing polarity and using an aluminium reagent as the nucleophilic partner in bondforming substitution reactions is unprecedented, owing to the fact that low-valent aluminium anions analogous to nitrogen-, carbon- and boron-centred reagents of the types [NX2](-), [CX3](-) and [BX2](-) are unknown(3-5). Aluminium compounds in the + 1 oxidation state are known, but are thermodynamically unstable with respect to disproportionation. Compounds of this type are typically oligomeric(6-8), although monomeric systems that possess a metal-centred lone pair, such as Al(Nacnac) Dipp (where (Nacnac)(Dipp) = (NDippCR)(2)CH and R = Bu-t, Me; Dipp = 2,6-(Pr2C6H3)-Pr-i), have also been reported(9,10). Coordination of these species, and also of (eta(5)-C5Me5)Al, to a range of Lewis acids has been observed(11-13), but their primary mode of reactivity involves facile oxidative addition to generate Al(iii) species(6-8,14-16). Here we report the synthesis, structure and reaction chemistry of an anionic aluminium(i) nucleophile, the dimethylxanthenestabilized potassium aluminyl [K{Al(NON)}](2) (NON = 4,5-bis(2,6-diisopropylanilido)-2,7-di-tert-butyl-9,9-dimethylxanthene). This species displays unprecedented reactivity in the formation of aluminium-element covalent bonds and in the C-H oxidative addition of benzene, suggesting that it could find further use in both metal-carbon and metal-metal bond-forming reactions.	[Hicks, Jamie; Vasko, Petra; Goicoechea, Jose M.; Aldridge, Simon] Univ Oxford, Dept Chem, Inorgan Chem Lab, Oxford, England; [Vasko, Petra] Univ Jyvaskyla, NanoSci Ctr, Dept Chem, Jyvaskyla, Finland	University of Oxford; University of Jyvaskyla	Goicoechea, JM; Aldridge, S (corresponding author), Univ Oxford, Dept Chem, Inorgan Chem Lab, Oxford, England.	jose.goicoechea@chem.ox.ac.uk; simon.aldridge@chem.ox.ac.uk	Goicoechea, Jose M/E-5711-2011; Hicks, Jamie/W-7860-2019; Vasko, Petra/ABH-4221-2020	Goicoechea, Jose M/0000-0002-7311-1663; Hicks, Jamie/0000-0001-9450-2594; Vasko, Petra/0000-0003-4202-6869; Aldridge, Simon/0000-0001-9998-9434	SCG-Oxford Centre of Excellence; Magnus Ehrnrooth Foundation; Emil Aaltonen Foundation; EPSRC [EP/M027732/1] Funding Source: UKRI	SCG-Oxford Centre of Excellence; Magnus Ehrnrooth Foundation; Emil Aaltonen Foundation; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the SCG-Oxford Centre of Excellence. P.V. thanks the Magnus Ehrnrooth and Emil Aaltonen Foundations for postdoctoral funding. We thank the University of Oxford Advanced Research Computing facility, and N. Rees and H. Tuononen for assistance with NMR and quantum chemical studies, respectively.	Adamo C, 1999, J CHEM PHYS, V110, P6158, DOI 10.1063/1.478522; Aldridge S., 2011, GROUP 13 METALS ALUM; [Anonymous], 2011, CRYSALISPRO 1 171 35; Asay M, 2011, CHEM REV, V111, P354, DOI 10.1021/cr100216y; Bakewell C, 2018, CHEM SCI, V9, P2348, DOI 10.1039/c7sc05059c; Bonyhady SJ, 2010, CHEM-EUR J, V16, P938, DOI 10.1002/chem.200902425; Chu T, 2015, ORGANOMETALLICS, V34, P5363, DOI 10.1021/acs.organomet.5b00793; Chu T, 2014, J AM CHEM SOC, V136, P9195, DOI 10.1021/ja5038337; Cordero B, 2008, DALTON T, P2832, DOI 10.1039/b801115j; COSIER J, 1986, J APPL CRYSTALLOGR, V19, P105, DOI 10.1107/S0021889886089835; Crimmin MR, 2015, CHEM COMMUN, V51, P15994, DOI 10.1039/c5cc07140b; Cruz CA, 2007, ORGANOMETALLICS, V26, P692, DOI 10.1021/om060914f; Cui CM, 2000, ANGEW CHEM INT EDIT, V39, P4274, DOI 10.1002/1521-3773(20001201)39:23<4274::AID-ANIE4274>3.0.CO;2-K; Dennington R., 2009, GAUSSVIEW V 5 0; Dohmeier C, 1996, ANGEW CHEM INT EDIT, V35, P129, DOI 10.1002/anie.199601291; Frisch M. J., 2009, GAUSSIAN 09 REV D 01; Glendening E. D., 2011, NBO V 5 9; Gonzalez-Gallardo S, 2012, CHEM REV, V112, P3136, DOI 10.1021/cr2001146; Green SP, 2007, SCIENCE, V318, P1754, DOI 10.1126/science.1150856; Grimme S, 2011, J COMPUT CHEM, V32, P1456, DOI 10.1002/jcc.21759; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Helmboldt O., 2007, ALUMINUM COMPOUNDS I, DOI [10.1002/14356007.a01527.pub2, DOI 10.1002/14356007.A01527.PUB2]; Hubschle CB, 2011, J APPL CRYSTALLOGR, V44, P1281, DOI 10.1107/S0021889811043202; Jones C., 2011, GROUP 13 METALS ALUM, P285, DOI 10.1002/9780470976548.ch5; Lappert M.F., 2009, METAL AMIDE CHEM; Li XF, 2007, ORGANOMETALLICS, V26, P1039, DOI 10.1021/om061107j; Linti G, 2000, COORDIN CHEM REV, V206, P285, DOI 10.1016/S0010-8545(00)00339-8; Martinez-Martinez AJ, 2014, SCIENCE, V346, P834, DOI 10.1126/science.1259662; Nagendran S, 2008, ORGANOMETALLICS, V27, P457, DOI 10.1021/om7007869; Ohsato T, 2016, ANGEW CHEM INT EDIT, V55, P11426, DOI 10.1002/anie.201605005; Perdew JP, 1996, J CHEM PHYS, V105, P9982, DOI 10.1063/1.472933; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Rappoport Z., 2004, CHEM ORGANOLITHIUM C; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; Segawa Y, 2006, SCIENCE, V314, P113, DOI 10.1126/science.1131914; Sheldrick G.M., 2014, SHELX 2014; Sundermann A, 1998, EUR J INORG CHEM, P305, DOI 10.1002/(SICI)1099-0682(199803)1998:3<305::AID-EJIC305>3.0.CO;2-0; Tuononen HM, 2007, INORG CHEM, V46, P10693, DOI 10.1021/ic701350e; Twamley B, 2000, ANGEW CHEM INT EDIT, V39, P3500, DOI 10.1002/1521-3773(20001002)39:19<3500::AID-ANIE3500>3.0.CO;2-3; Uhl W, 2004, ADV ORGANOMET CHEM, V51, P53, DOI 10.1016/S0065-3055(03)51002-4; Westrum L. J., 2015, HDB GRIGNARD REAGENT; Zakharkin L. I., 1962, RUSS CHEM B, V11, P1076	42	163	162	11	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2018	557	7703					92	+		10.1038/s41586-018-0037-y	http://dx.doi.org/10.1038/s41586-018-0037-y			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5BW	29662211	Green Submitted, Green Accepted			2022-12-28	WOS:000431234500036
J	Lipson, DA; Barnhart, F; Brealey, N; Brooks, J; Criner, GJ; Day, NC; Dransfield, MT; Halpin, DMG; Han, MK; Jones, CE; Kilbride, S; Lange, P; Lomas, DA; Martinez, FJ; Singh, D; Tabberer, M; Wise, RA; Pascoe, SJ				Lipson, David A.; Barnhart, Frank; Brealey, Noushin; Brooks, Jean; Criner, Gerard J.; Day, Nicola C.; Dransfield, Mark T.; Halpin, David M. G.; Han, MeiLan K.; Jones, C. Elaine; Kilbride, Sally; Lange, Peter; Lomas, David A.; Martinez, Fernando J.; Singh, Dave; Tabberer, Maggie; Wise, Robert A.; Pascoe, Steven J.		IMPACT Investigators	Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; RANDOMIZED CONTROLLED-TRIAL; FLUTICASONE PROPIONATE/SALMETEROL; DOUBLE-BLIND; PARALLEL-GROUP; TIOTROPIUM; SALMETEROL; IMPACT	BACKGROUND The benefits of triple therapy for chronic obstructive pulmonary disease (COPD) with an inhaled glucocorticoid, a long-acting muscarinic antagonist (LAMA), and a longacting beta(2) - agonist (LABA), as compared with dual therapy (either inhaled glucocorticoid-LABA or LAMA-LABA), are uncertain. METHODS In this randomized trial involving 10,355 patients with COPD, we compared 52 weeks of a once-daily combination of fluticasone furoate (an inhaled glucocorticoid) at a dose of 100 mu g, umeclidinium (a LAMA) at a dose of 62.5 mu g, and vilanterol (a LABA) at a dose of 25 mu g (triple therapy) with fluticasone furoatevilanterol (at doses of 100 mu g and 25 mu g, respectively) and umeclidinium-vilanterol (at doses of 62.5 mu g and 25 mu g, respectively). Each regimen was administered in a single Ellipta inhaler. The primary outcome was the annual rate of moderate or severe COPD exacerbations during treatment. RESULTS The rate of moderate or severe exacerbations in the triple-therapy group was 0.91 per year, as compared with 1.07 per year in the fluticasone furoate-vilanterol group (rate ratio with triple therapy, 0.85; 95% confidence interval [ CI], 0.80 to 0.90; 15% difference; P< 0.001) and 1.21 per year in the umeclidinium-vilanterol group (rate ratio with triple therapy, 0.75; 95% CI, 0.70 to 0.81; 25% difference; P< 0.001). The annual rate of severe exacerbations resulting in hospitalization in the triple-therapy group was 0.13, as compared with 0.19 in the umeclidinium-vilanterol group (rate ratio, 0.66; 95% CI, 0.56 to 0.78; 34% difference; P< 0.001). There was a higher incidence of pneumonia in the inhaled-glucocorticoid groups than in the umeclidinium-vilanterol group, and the risk of clinician-diagnosed pneumonia was significantly higher with triple therapy than with umeclidinium-vilanterol, as assessed in a time-to-first-event analysis (hazard ratio, 1.53; 95% CI, 1.22 to 1.92; P< 0.001). CONCLUSIONS Triple therapy with fluticasone furoate, umeclidinium, and vilanterol resulted in a lower rate of moderate or severe COPD exacerbations than fluticasone furoatevilanterol or umeclidinium-vilanterol in this population. Triple therapy also resulted in a lower rate of hospitalization due to COPD than umeclidinium-vilanterol.	[Lipson, David A.; Brooks, Jean; Pascoe, Steven J.] GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426 USA; [Lipson, David A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Criner, Gerard J.] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Barnhart, Frank; Jones, C. Elaine] GlaxoSmithKline, Res Triangle Pk, NC USA; [Brealey, Noushin; Day, Nicola C.; Kilbride, Sally; Tabberer, Maggie] GlaxoSmithKline, Stockley Pk West, Uxbridge, Middx, England; [Halpin, David M. G.] Royal Devon & Exeter Hosp, Dept Resp Med, Exeter, Devon, England; [Lomas, David A.] UCL, UCL Resp, London, England; [Singh, Dave] Univ Manchester, Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Ctr Resp Med & Allergy,Inst Inflammat & Repair, Manchester, Lancs, England; [Dransfield, Mark T.] Univ Alabama, Lung Hlth Ctr, Div Pulm Allergy & Crit Care Med, Birmingham, W Midlands, England; [Han, MeiLan K.] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Lange, Peter] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Lange, Peter] Herlev Gentofte Hosp, Pulm Sect, Med Dept, Herlev, Denmark; [Martinez, Fernando J.] New York Presbyterian Hosp, Weill Cornell Med Ctr, New York, NY USA; [Wise, Robert A.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA	GlaxoSmithKline; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; GlaxoSmithKline; GlaxoSmithKline; University of Exeter; University of London; University College London; University of Manchester; Aston University; University of Michigan System; University of Michigan; University of Copenhagen; Cornell University; NewYork-Presbyterian Hospital; Johns Hopkins University	Lipson, DA (corresponding author), GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426 USA.	david.a.lipson@gsk.com	Singh, Dave/AAH-4342-2020	Singh, Dave/0000-0001-8918-7075; Wise, Robert/0000-0002-8353-2349; Lipson, David/0000-0001-6732-4593	GlaxoSmithKline; AstraZeneca; Boehringer Ingelheim; Genentech; PneumRx/BTG; Boston Scientific; Novartis; Chiesi; Pfizer; Sandoz; Sunovion Pharmaceuticals; ProterixBio; Pearl Therapeutics; UpToDate; Apellis Pharmaceuticals; Cipla; Peptinnovate; Sky Pharma; Glenmark Pharmaceuticals; Menarini; Merck; Mundipharma; Pulmatrix; Teva Pharmaceuticals; Theravance Biopharma; Verona Pharma; MRC [MR/N024842/1] Funding Source: UKRI	GlaxoSmithKline(GlaxoSmithKline); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Genentech(Roche HoldingGenentech); PneumRx/BTG; Boston Scientific(Boston Scientific); Novartis(Novartis); Chiesi(Chiesi Pharmaceuticals Inc); Pfizer(Pfizer); Sandoz(Novartis); Sunovion Pharmaceuticals; ProterixBio; Pearl Therapeutics; UpToDate; Apellis Pharmaceuticals; Cipla; Peptinnovate; Sky Pharma; Glenmark Pharmaceuticals; Menarini(Menarini Group); Merck(Merck & Company); Mundipharma; Pulmatrix; Teva Pharmaceuticals(Teva Pharmaceutical Industries); Theravance Biopharma; Verona Pharma; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by GlaxoSmithKline. The Ellipta brand of inhalers is owned by or licensed to the GlaxoSmithKline group of companies.; Dr. Lipson, Dr. Brealey, Ms. Brooks, Dr. Day, Dr. Jones, Ms. Kilbride, and Dr. Pascoe report being employed by and being a shareholder in GlaxoSmithKline; Dr. Barnhart, being employed by and holding stock options in GlaxoSmithKline; Dr. Dransfield, receiving consulting fees from AstraZeneca, Boehringer Ingelheim, Genentech, PneumRx/BTG, Boston Scientific, Novartis, and GlaxoSmithKline; Dr. Halpin, receiving honoraria from AstraZeneca, Boehringer Ingelheim, Chiesi, Novartis, Pfizer, Sandoz, and GlaxoSmithKline; Dr. Han, receiving consulting fees from AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline and research support from Novartis and Sunovion Pharmaceuticals; Dr. Lange, receiving advisory board fees from GlaxoSmithKline; Dr. Lomas, receiving fees for serving as chair of the GlaxoSmithKline Respiratory Therapy Area Board and advisory board fees from GlaxoSmithKline; Dr. Martinez, receiving advisory board fees and fees for serving on a steering committee from AstraZeneca and GlaxoSmithKline, fees for serving on a steering committee from Boehringer Ingelheim, consulting fees from ProterixBio, fees for serving on a data and safety monitoring board from Genentech, advisory board fees and fees for a global disease state presentation from Novartis, advisory board fees from Pearl Therapeutics, and fees for continuing medical education from UpToDate; Dr. Singh, receiving consulting fees from Apellis Pharmaceuticals, Cipla, Genentech, Peptinnovate, and Sky Pharma and grant support and consulting fees from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Glenmark Pharmaceuticals, Menarini, Merck, Mundipharma, Novartis, Pfizer, Pulmatrix, Teva Pharmaceuticals, Theravance Biopharma, and Verona Pharma; Ms. Tabberer, being employed by and holding stock in GlaxoSmithKline; and Dr. Wise, receiving grant support and fees for serving on an advisory committee from GlaxoSmithKline. No other potential conflict of interest relevant to this article was reported.	Aaron SD, 2007, ANN INTERN MED, V146, P545, DOI 10.7326/0003-4819-146-8-200704170-00152; Cazzola M, 2007, PULM PHARMACOL THER, V20, P556, DOI 10.1016/j.pupt.2006.06.001; Chatterjee A, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-15; Hanania NA, 2012, RESP MED, V106, P91, DOI 10.1016/j.rmed.2011.09.002; Jung KS, 2012, RESP MED, V106, P382, DOI 10.1016/j.rmed.2011.09.004; Lipson DA, 2017, AM J RESP CRIT CARE, V196, P438, DOI 10.1164/rccm.201703-0449OC; Pascoe SJ, 2016, EUR RESPIR J, V48, P320, DOI 10.1183/13993003.02165-2015; Rotenstein LS, 2017, NEW ENGL J MED, V377, P1309, DOI 10.1056/NEJMp1707537; Short PM, 2012, CHEST, V141, P81, DOI 10.1378/chest.11-0038; Siler TM, 2015, RESP MED, V109, P1155, DOI 10.1016/j.rmed.2015.06.006; Simeone JC, 2017, INT J CHRONIC OBSTR, V12, P73, DOI 10.2147/COPD.S122013; Singh D, 2016, LANCET, V388, P963, DOI 10.1016/S0140-6736(16)31354-X; Vestbo J, 2017, LANCET, V389, P1919, DOI 10.1016/S0140-6736(17)30188-5; Vestbo J, 2016, LANCET, V387, P1817, DOI 10.1016/S0140-6736(16)30069-1; Vogelmeier CF, 2017, AM J RESP CRIT CARE, V195, P557, DOI 10.1164/rccm.201701-0218PP; Wedzicha JA, 2016, NEW ENGL J MED, V374, P2222, DOI 10.1056/NEJMoa1516385; Welte T, 2009, AM J RESP CRIT CARE, V180, P741, DOI 10.1164/rccm.200904-0492OC; Wurst KE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105296	18	560	603	0	61	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2018	378	18					1671	1680		10.1056/NEJMoa1713901	http://dx.doi.org/10.1056/NEJMoa1713901			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GE4WO	29668352	Green Published, Bronze			2022-12-28	WOS:000431218600005
J	Rush, R				Rush, Raphael			Questionable Admissions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rush, Raphael] Toronto Grace Hlth Sci Ctr, Toronto, ON, Canada; [Rush, Raphael] Sinai Hlth Syst, Toronto, ON, Canada	University of Toronto; Sinai Health System Toronto	Rush, R (corresponding author), Toronto Grace Hlth Sci Ctr, Toronto, ON, Canada.; Rush, R (corresponding author), Sinai Hlth Syst, Toronto, ON, Canada.							BRAVEMAN P, 1995, PEDIATRICS, V96, P716; Buie V.C., 2010, VITAL HLTH STAT, V13, P168; Hacking Ian, 1999, SOCIAL CONSTRUCTION, P22; Kahneman D., 2011, THINKING FAST SLOW; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377	5	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2018	378	18					1668	1669		10.1056/NEJMp1801629	http://dx.doi.org/10.1056/NEJMp1801629			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GE4WO	29719178				2022-12-28	WOS:000431218600004
J	Wang, WS; Mauleon, R; Hu, ZQ; Chebotarov, D; Tai, SS; Wu, ZC; Li, M; Zheng, TQ; Fuentes, RR; Zhang, F; Mansueto, L; Copetti, D; Sanciangco, M; Palis, KC; Xu, JL; Sun, C; Fu, BY; Zhang, HL; Gao, YM; Zhao, XQ; Shen, F; Cui, X; Yu, H; Li, ZC; Chen, ML; Detras, J; Zhou, YL; Zhang, XY; Zhao, Y; Kudrna, D; Wang, CC; Li, R; Jia, B; Lu, JY; He, XC; Dong, ZT; Xu, JB; Li, YH; Wang, M; Shi, JX; Li, J; Zhang, DB; Lee, S; Hu, WS; Poliakov, A; Dubchak, I; Ulat, VJ; Borja, FN; Mendoza, JR; Ali, J; Li, J; Gao, Q; Niu, YC; Yue, Z; Naredo, MEB; Talag, J; Wang, XQ; Li, JJ; Fang, XD; Yin, Y; Glaszmann, JC; Zhang, JW; Li, JY; Hamilton, RS; Wing, RA; Ruan, J; Zhang, GY; Wei, CC; Alexandrov, N; McNally, KL; Li, ZK; Leung, H				Wang, Wensheng; Mauleon, Ramil; Hu, Zhiqiang; Chebotarov, Dmytro; Tai, Shuaishuai; Wu, Zhichao; Li, Min; Zheng, Tianqing; Fuentes, Roven Rommel; Zhang, Fan; Mansueto, Locedie; Copetti, Dario; Sanciangco, Millicent; Palis, Kevin Christian; Xu, Jianlong; Sun, Chen; Fu, Binying; Zhang, Hongliang; Gao, Yongming; Zhao, Xiuqin; Shen, Fei; Cui, Xiao; Yu, Hong; Li, Zichao; Chen, Miaolin; Detras, Jeffrey; Zhou, Yongli; Zhang, Xinyuan; Zhao, Yue; Kudrna, Dave; Wang, Chunchao; Li, Rui; Jia, Ben; Lu, Jinyuan; He, Xianchang; Dong, Zhaotong; Xu, Jiabao; Li, Yanhong; Wang, Miao; Shi, Jianxin; Li, Jing; Zhang, Dabing; Lee, Seunghee; Hu, Wushu; Poliakov, Alexander; Dubchak, Inna; Ulat, Victor Jun; Borja, Frances Nikki; Mendoza, John Robert; Ali, Jauhar; Li, Jing; Gao, Qiang; Niu, Yongchao; Yue, Zhen; Naredo, Ma. Elizabeth B.; Talag, Jayson; Wang, Xueqiang; Li, Jinjie; Fang, Xiaodong; Yin, Ye; Glaszmann, Jean-Christophe; Zhang, Jianwei; Li, Jiayang; Hamilton, Ruaraidh Sackville; Wing, Rod A.; Ruan, Jue; Zhang, Gengyun; Wei, Chaochun; Alexandrov, Nickolai; McNally, Kenneth L.; Li, Zhikang; Leung, Hei			Genomic variation in 3,010 diverse accessions of Asian cultivated rice	NATURE			English	Article							GRAIN WIDTH; WEB SERVER; MAJOR QTL; GENE; DOMESTICATION; ENCODES; DIVERSIFICATION; IDENTIFICATION; ASSOCIATION; TRANSITION	Here we analyse genetic variation, population structure and diversity among 3,010 diverse Asian cultivated rice (Oryza sativa L.) genomes from the 3,000 Rice Genomes Project. Our results are consistent with the five major groups previously recognized, but also suggest several unreported subpopulations that correlate with geographic location. We identified 29 million single nucleotide polymorphisms, 2.4 million small indels and over 90,000 structural variations that contribute to within-and between-population variation. Using pan-genome analyses, we identified more than 10,000 novel full-length protein-coding genes and a high number of presence-absence variations. The complex patterns of introgression observed in domestication genes are consistent with multiple independent rice domestication events. The public availability of data from the 3,000 Rice Genomes Project provides a resource for rice genomics research and breeding.	[Wang, Wensheng; Hu, Zhiqiang; Wu, Zhichao; Zheng, Tianqing; Zhang, Fan; Xu, Jianlong; Fu, Binying; Gao, Yongming; Zhao, Xiuqin; Zhou, Yongli; Wang, Chunchao; Li, Jiayang; Li, Zhikang] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China; [Mauleon, Ramil; Chebotarov, Dmytro; Fuentes, Roven Rommel; Mansueto, Locedie; Copetti, Dario; Sanciangco, Millicent; Palis, Kevin Christian; Detras, Jeffrey; Li, Jing; Ulat, Victor Jun; Borja, Frances Nikki; Ali, Jauhar; Naredo, Ma. Elizabeth B.; Hamilton, Ruaraidh Sackville; Wing, Rod A.; Alexandrov, Nickolai; McNally, Kenneth L.; Leung, Hei] Int Rice Res Inst, Manila, Philippines; [Hu, Zhiqiang; Sun, Chen; Cui, Xiao; Chen, Miaolin; Zhao, Yue; Li, Rui; Jia, Ben; Lu, Jinyuan; He, Xianchang; Dong, Zhaotong; Shi, Jianxin; Li, Jing; Zhang, Dabing; Wei, Chaochun] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai, Peoples R China; [Tai, Shuaishuai; Xu, Jiabao; Li, Yanhong; Wang, Miao; Hu, Wushu; Gao, Qiang; Niu, Yongchao; Yue, Zhen; Fang, Xiaodong; Yin, Ye; Zhang, Gengyun] BGI Shenzhen, BGI Genom, Shenzhen, Peoples R China; [Wu, Zhichao; Xu, Jianlong; Zhang, Xinyuan; Ruan, Jue] Chinese Acad Agr Sci, Agr Genom Inst, Shenzhen, Peoples R China; [Li, Min; Zhang, Gengyun; Li, Zhikang] Chinese Acad Agr Sci, Shenzhen Inst Innovat Breeding, Shenzhen, Peoples R China; [Li, Min] Anhui Agr Univ, Hefei, Anhui, Peoples R China; [Copetti, Dario; Kudrna, Dave; Lee, Seunghee; Talag, Jayson; Zhang, Jianwei; Wing, Rod A.] Univ Arizona, Arizona Genom Inst, Sch Plant Sci, Tucson, AZ 85721 USA; [Zhang, Hongliang; Shen, Fei; Li, Zichao; Wang, Xueqiang; Li, Jinjie] China Agr Univ, Beijing, Peoples R China; [Yu, Hong; Li, Jiayang] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China; [Poliakov, Alexander; Dubchak, Inna] DOE Joint Genome Inst, Walnut Creek, CA USA; [Dubchak, Inna] Lawrence Berkeley Natl Lab, Berkeley, CA USA; [Mendoza, John Robert] Adv Sci & Technol Inst, Dept Sci & Technol, Quezon City, Philippines; [Glaszmann, Jean-Christophe] CIRAD, UMR AGAP, Montpellier, France; [Glaszmann, Jean-Christophe] Univ Montpellier, UMR AGAP, Montpellier, France; [Wei, Chaochun] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; CGIAR; International Rice Research Institute (IRRI); Shanghai Jiao Tong University; Beijing Genomics Institute (BGI); Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; Chinese Academy of Agricultural Sciences; Anhui Agricultural University; University of Arizona; China Agricultural University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; United States Department of Energy (DOE); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Department of Science & Technology (DOST), Philippines; CIRAD; Universite de Montpellier; Universite de Montpellier; Chinese Academy of Sciences	Li, ZK (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China.; Wing, RA; Alexandrov, N; McNally, KL (corresponding author), Int Rice Res Inst, Manila, Philippines.; Wei, CC (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai, Peoples R China.; Zhang, GY (corresponding author), BGI Shenzhen, BGI Genom, Shenzhen, Peoples R China.; Ruan, J (corresponding author), Chinese Acad Agr Sci, Agr Genom Inst, Shenzhen, Peoples R China.; Zhang, GY; Li, ZK (corresponding author), Chinese Acad Agr Sci, Shenzhen Inst Innovat Breeding, Shenzhen, Peoples R China.; Wing, RA (corresponding author), Univ Arizona, Arizona Genom Inst, Sch Plant Sci, Tucson, AZ 85721 USA.; Wei, CC (corresponding author), Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China.	rwing@ag.arizona.edu; ruanjue@caas.cn; zhanggengyun@genomics.cn; ccwei@sjtu.edu.cn; nalexandrov@inariag.com; k.mcnally@irri.org; lizhikang@caas.cn	Fang, Xiaodong/K-6743-2018; Zhang, Dabing/AAR-6473-2020; Ali, Jauhar Ali or A. Jauhar/E-4432-2012; Wing, Rod A/Z-2885-2019; Shi, Jianxin/AAE-7123-2020; Chebotarov, Dmytro/AAN-5689-2020; Mauleon, Ramil/AAW-1697-2020; Li, Jiayang/AAG-4377-2020; Zhao, Yue/AAL-4665-2021; wei, chaochun/AAW-2846-2020; Hu, Zhiqiang/P-5083-2019; McNally, Kenneth L./L-3970-2019; Xu, Jianlong/AAI-8310-2020; Li, Zichao/AAS-8954-2021; Shen, Fei/ABG-5833-2021; Sun, Chen/AAC-6231-2021; Yu, Hong/H-2770-2012	Fang, Xiaodong/0000-0001-7061-3337; Ali, Jauhar Ali or A. Jauhar/0000-0002-3177-2607; Wing, Rod A/0000-0001-6633-6226; Chebotarov, Dmytro/0000-0003-1351-9453; Mauleon, Ramil/0000-0001-8512-144X; Zhao, Yue/0000-0001-5257-5103; Hu, Zhiqiang/0000-0001-8854-3410; McNally, Kenneth L./0000-0002-9613-5537; Sun, Chen/0000-0003-0657-207X; Yu, Hong/0000-0002-1748-8693; Wu, Zhichao/0000-0002-3006-043X; Zhang, Jianwei/0000-0001-8030-5346; Tai, Shuaishuai/0000-0001-8204-6982; Copetti, Dario/0000-0002-2680-2568; Ruan, Jue/0000-0003-3713-3192; Wei, Chaochun/0000-0002-1031-034X; Detras, Jeffrey/0000-0002-6680-578X; Li, Zichao/0000-0002-3186-1132; Wang, Xueqiang/0000-0001-5593-5223	863 Program from the Chinese Ministry of Science Technology [2014AA10A601]; National Key R&D Program Chinese Ministry of Science Technology [2016YFD0100904]; Bill & Melinda Gates Foundation Project [OPP1130530]; Agricultural Science and Technology Innovation Program Cooperation and Innovation Mission [CAAS-ZDXT201800]; CAAS Innovative Team Award; International S&T Cooperation Program of China [2012DFB32280]; Shenzhen Peacock Plan, National Key Technology Support Program [2015BAD01B02]; Fundamental Research Funds for Central Non-Profit of CAAS [Y2017CG21]; National Natural Science Foundation of China [31501291, 61472246, 61272250]; CGIAR Research Program CRP 3.3 (Global Rice Science Partnership)	863 Program from the Chinese Ministry of Science Technology; National Key R&D Program Chinese Ministry of Science Technology; Bill & Melinda Gates Foundation Project(CGIAR); Agricultural Science and Technology Innovation Program Cooperation and Innovation Mission; CAAS Innovative Team Award; International S&T Cooperation Program of China; Shenzhen Peacock Plan, National Key Technology Support Program; Fundamental Research Funds for Central Non-Profit of CAAS; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CGIAR Research Program CRP 3.3 (Global Rice Science Partnership)(CGIAR)	This work was supported by the 863 Program (2014AA10A601) and National Key R&D Program (2016YFD0100904) from the Chinese Ministry of Science & Technology, Bill & Melinda Gates Foundation Project (OPP1130530), the Agricultural Science and Technology Innovation Program Cooperation and Innovation Mission (CAAS-ZDXT201800), CAAS Innovative Team Award, International S&T Cooperation Program of China (2012DFB32280), Shenzhen Peacock Plan, National Key Technology Support Program (2015BAD01B02), Fundamental Research Funds for Central Non-Profit of CAAS (Y2017CG21) and National Natural Science Foundation of China (31501291, 61472246 and 61272250). IRRI was supported by the CGIAR Research Program CRP 3.3 (Global Rice Science Partnership). We thank the High-Performance Computing Centers at Shanghai Jiao Tong University, Agricultural Genomics Institute of CAAS and State Key Laboratory of Agricultural Genomics, BGI-Shenzhen (2011DQ782025). We thank M. Roa of the Philippine Genome Center Core Facilities for Bioinformatics, Department of Science and Technology-Advanced Science and Technology Institute of the Philippines, CyVerse, and XSEDE for computing and bioinformatics support; Z. Chong from University of Alabama for help in running novoBreak; the AXA Chair Research Fund and the Bud Antle Endowed Chair for the sequence analysis of IR 8 and N 22 genomes; and Amazon Public Data for free hosting of the 3K-RG analyses results.	Agrama H. A., 2010, Natural Science, V2, P247, DOI 10.4236/ns.2010.24036; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Alexandrov N, 2015, NUCLEIC ACIDS RES, V43, pD1023, DOI 10.1093/nar/gku1039; Allender C., 2010, EXP AGR, V47, P574; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chandler Jr R. F., 1969, PHYSL ASPECTS CROP Y; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; CHANG TT, 1976, EUPHYTICA, V25, P425, DOI 10.1007/BF00041576; Chen SH, 2008, PLANT CELL, V20, P1850, DOI 10.1105/tpc.108.058917; Chin CS, 2016, NAT METHODS, V13, P1050, DOI [10.1038/NMETH.4035, 10.1038/nmeth.4035]; Chong ZC, 2017, NAT METHODS, V14, P65, DOI [10.1038/NMETH.4084, 10.1038/nmeth.4084]; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Fuller DQ, 2010, WORLD ARCHAEOL, V42, P13, DOI 10.1080/00438240903429680; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; GLASZMANN JC, 1987, THEOR APPL GENET, V74, P21, DOI 10.1007/BF00290078; Golicz AA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13390; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Han B, 2003, CURR OPIN PLANT BIOL, V6, P134, DOI 10.1016/S1369-5266(03)00004-9; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Hu ZQ, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.79; Hu ZQ, 2017, BIOINFORMATICS, V33, P2408, DOI 10.1093/bioinformatics/btx170; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Hutter S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-409; I. P. Consortium, 2015, NUCL ACIDS RES, V44, pD1172; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li LF, 2017, NAT GENET, V49, P811, DOI 10.1038/ng.3825; Liu L, 2007, HOLOCENE, V17, P1059, DOI 10.1177/0959683607085121; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; McCouch SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10532; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ohyanagi H, 2006, NUCLEIC ACIDS RES, V34, pD741, DOI 10.1093/nar/gkj094; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rellosa MC, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-7; Saitoh K, 2004, GENETICS, V168, P997, DOI 10.1534/genetics.103.018390; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Seck PA, 2012, FOOD SECUR, V4, P7, DOI 10.1007/s12571-012-0168-1; Shen RX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01400-y; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Smith CD, 2007, GENE, V389, P1, DOI 10.1016/j.gene.2006.09.011; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Stein JC, 2018, NAT GENET, V50, P285, DOI 10.1038/s41588-018-0040-0; Sun C, 2017, NUCLEIC ACIDS RES, V45, P597, DOI 10.1093/nar/gkw958; Sun XL, 2004, PLANT J, V37, P517, DOI 10.1046/j.1365-313X.2003.01976.x; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Taoka K, 2011, NATURE, V476, P332, DOI 10.1038/nature10272; Ting Y., 1949, SUN YAT SEN U, V7, P11; Vernikos G, 2015, CURR OPIN MICROBIOL, V23, P148, DOI 10.1016/j.mib.2014.11.016; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wang HR, 2017, GENOME RES, V27, P1029, DOI 10.1101/gr.204800.116; Wang YX, 2015, NAT GENET, V47, P944, DOI 10.1038/ng.3346; WANG ZY, 1995, PLANT J, V7, P613, DOI 10.1046/j.1365-313X.1995.7040613.x; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Wilson BA, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0146; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yamamoto E, 2012, RICE, V5, DOI 10.1186/1939-8433-5-26; Yonemaru J, 2010, RICE, V3, P194, DOI 10.1007/s12284-010-9041-z; Zhang JW, 2016, BIOINFORMATICS, V32, P3058, DOI 10.1093/bioinformatics/btw370; Zhang JW, 2016, P NATL ACAD SCI USA, V113, pE5163, DOI 10.1073/pnas.1611012113; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]; Zhu BF, 2011, PLANT PHYSIOL, V155, P1301, DOI 10.1104/pp.110.168500	79	624	669	46	370	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2018	557	7703					43	+		10.1038/s41586-018-0063-9	http://dx.doi.org/10.1038/s41586-018-0063-9			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5BW	29695866	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000431234500027
J	Fortescue, EB				Fortescue, Elizabeth B.			Oblivion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DEATHS; STATES					elizabeth.fortescue@gmail.com						Gonzales K, 2014, MMWR-MORBID MORTAL W, V63, P213; Kanny D, 2015, MMWR-MORBID MORTAL W, V63, P1238; Stahre M, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130293	3	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2018	319	17					1767	1768		10.1001/jama.2018.4147	http://dx.doi.org/10.1001/jama.2018.4147			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GE3UQ	29715358				2022-12-28	WOS:000431138800012
J	Watson, R				Watson, Rory			European Commission moves to boost vaccination cover across the continent	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		European Commission, VACC	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2018	361								k1889	10.1136/bmj.k1889	http://dx.doi.org/10.1136/bmj.k1889			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF4XX	29712647				2022-12-28	WOS:000431968600015
J	Ilton, M; Bhamla, MS; Ma, XT; Cox, SM; Fitchett, LL; Kim, Y; Koh, JS; Krishnamurthy, D; Kuo, CY; Temel, FZ; Crosby, AJ; Prakash, M; Sutton, GP; Wood, RJ; Azizi, E; Bergbreiter, S; Patek, SN				Ilton, Mark; Bhamla, M. Saad; Ma, Xiaotian; Cox, Suzanne M.; Fitchett, Leah L.; Kim, Yongjin; Koh, Je-sung; Krishnamurthy, Deepak; Kuo, Chi-Yun; Temel, Fatma Zeynep; Crosby, Alfred J.; Prakash, Manu; Sutton, Gregory P.; Wood, Robert J.; Azizi, Emanuel; Bergbreiter, Sarah; Patek, S. N.			The principles of cascading power limits in small, fast biological and engineered systems	SCIENCE			English	Article							MECHANICAL-PROPERTIES; JUMPING MECHANISMS; PLANTARIS TENDON; ENERGY-STORAGE; PHYSICAL WORLD; MUSCLE; BIOMECHANICS; ROBOT; DEFORMATION; PERFORMANCE	Mechanical power limitations emerge from the physical trade-off between force and velocity. Many biological systems incorporate power-enhancing mechanisms enabling extraordinary accelerations at small sizes. We establish how power enhancement emerges through the dynamic coupling of motors, springs, and latches and reveal how each displays its own force-velocity behavior. We mathematically demonstrate a tunable performance space for spring-actuated movement that is applicable to biological and synthetic systems. Incorporating nonideal spring behavior and parameterizing latch dynamics allows the identification of critical transitions in mass and trade-offs in spring scaling, both of which offer explanations for long-observed scaling patterns in biological systems. This analysis defines the cascading challenges of power enhancement, explores their emergent effects in biological and engineered systems, and charts a pathway for higher-level analysis and synthesis of power-amplified systems.	[Ilton, Mark; Kim, Yongjin; Crosby, Alfred J.] Univ Massachusetts Amherst, Dept Polymer Sci & Engn, Amherst, MA 01003 USA; [Bhamla, M. Saad; Krishnamurthy, Deepak; Prakash, Manu] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Ma, Xiaotian; Bergbreiter, Sarah] Univ Maryland Coll Pk, Dept Mech Engn, College Pk, MD 20742 USA; [Ma, Xiaotian; Bergbreiter, Sarah] Univ Maryland Coll Pk, Syst Res Inst, College Pk, MD 20742 USA; [Cox, Suzanne M.; Fitchett, Leah L.; Kuo, Chi-Yun; Patek, S. N.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Koh, Je-sung; Temel, Fatma Zeynep; Wood, Robert J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Koh, Je-sung; Temel, Fatma Zeynep; Wood, Robert J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Sutton, Gregory P.] Univ Bristol, Sch Biol Sci, Bristol BS8 1TH, Avon, England; [Azizi, Emanuel] Univ Calif Irvine, Ecol & Evolutionary Biol, Irvine, CA USA; [Bhamla, M. Saad] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Koh, Je-sung] Ajou Univ, Dept Mech Engn, Suwon 16499, South Korea; [Kuo, Chi-Yun] Ludwig Maximilian Univ Munich, Div Evolutionary Biol, Grosshaderner Str 2, D-82152 Planegg Martinsried, Germany	University of Massachusetts System; University of Massachusetts Amherst; Stanford University; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Duke University; Harvard University; Harvard University; University of Bristol; University of California System; University of California Irvine; University System of Georgia; Georgia Institute of Technology; Ajou University; University of Munich	Patek, SN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	snp2@duke.edu	Krishnamurthy, Deepak/ABC-4087-2020; Kuo, Chi-Yun/AAL-2829-2020; Kuo, Chi-Yun/AAI-9708-2020; Bhamla, Saad/K-8398-2019; Kim, Yongjin/R-5216-2019	Krishnamurthy, Deepak/0000-0002-4504-1530; Kuo, Chi-Yun/0000-0002-8533-9358; Kuo, Chi-Yun/0000-0002-8533-9358; Bhamla, Saad/0000-0002-9788-9920; Ilton, Mark/0000-0002-2439-3940; Prakash, Manu/0000-0002-8046-8388; Patek, S. N./0000-0001-9738-882X; Kim, Yongjin/0000-0001-8935-9527; Fitchett, Leah/0000-0002-8310-9305; ma, xiaotian/0000-0003-0804-7084; Koh, Je-sung/0000-0002-7739-0882; Crosby, Alfred/0000-0001-8850-8869; Temel, Zeynep/0000-0002-1241-3959				Aerts P, 1998, PHILOS T R SOC B, V353, P1607, DOI 10.1098/rstb.1998.0313; Aguilar J, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.174301; Alexander R. M., 1988, ELASTIC MECHANISMS I; ALEXANDER RM, 1977, NATURE, V265, P114, DOI 10.1038/265114a0; Anderson CV, 2016, SCI REP-UK, V6, DOI 10.1038/srep18625; Anderson CV, 2012, J MORPHOL, V273, P1214, DOI 10.1002/jmor.20053; Anderson PSL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3088; Anderson PSL, 2016, EVOL DEV, V18, P171, DOI 10.1111/ede.12190; Apperson SJ, 2009, J PROPUL POWER, V25, P1086, DOI 10.2514/1.43206; Astley HC, 2014, J EXP BIOL, V217, P4372, DOI 10.1242/jeb.110296; Astley HC, 2012, BIOL LETTERS, V8, P386, DOI 10.1098/rsbl.2011.0982; Barth O, 2000, MECHATRONICS, V10, P545, DOI 10.1016/S0957-4158(99)00062-8; Bartlett NW, 2015, SCIENCE, V349, P161, DOI 10.1126/science.aab0129; BENNETCLARK HC, 1967, J EXP BIOL, V47, P59; BENNETCLARK HC, 1975, J EXP BIOL, V63, P53; Bergbreiter S., 2007, THESIS; Blanco MM, 2014, EVOLUTION, V68, P1399, DOI 10.1111/evo.12365; Bogoslovov RB, 2007, J APPL PHYS, V102, DOI 10.1063/1.2784018; Bonsignori G, 2013, J EXP BIOL, V216, P1270, DOI 10.1242/jeb.076083; Burdick J, 2003, INT J ROBOT RES, V22, P653, DOI 10.1177/02783649030227013; Burrows M, 2012, J EXP BIOL, V215, P3612, DOI 10.1242/jeb.074682; Burrows M, 2003, NATURE, V424, P509, DOI 10.1038/424509a; Burrows M, 2010, J EXP BIOL, V213, P2386, DOI 10.1242/jeb.042192; Burrows M, 2006, J EXP BIOL, V209, P4607, DOI 10.1242/jeb.02539; Burrows M, 2012, CURR BIOL, V22, pR990, DOI 10.1016/j.cub.2012.10.045; Burrows M, 2012, J EXP BIOL, V215, P3501, DOI 10.1242/jeb.071993; Burrows M, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-41; Chen CC, 2003, BIOMATERIALS, V24, P1167, DOI 10.1016/S0142-9612(02)00466-0; Churaman WA, 2012, J MICROELECTROMECH S, V21, P198, DOI 10.1109/JMEMS.2011.2174414; Claverie T, 2013, EVOLUTION, V67, P3191, DOI 10.1111/evo.12185; Claverie T, 2011, EVOLUTION, V65, P443, DOI 10.1111/j.1558-5646.2010.01133.x; Cofer D, 2010, J EXP BIOL, V213, P1060, DOI 10.1242/jeb.034678; de Groot JH, 2004, P ROY SOC B-BIOL SCI, V271, P761, DOI 10.1098/rspb.2003.2637; Debray A, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/2/026002; Edwards J, 2005, NATURE, V435, P164, DOI 10.1038/435164a; Ferris DP, 1998, P ROY SOC B-BIOL SCI, V265, P989, DOI 10.1098/rspb.1998.0388; FISCHELL RE, 1965, J SPACECRAFT ROCKETS, V2, P376, DOI 10.2514/3.28187; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Forterre Y, 2013, J EXP BOT, V64, P4745, DOI 10.1093/jxb/ert230; Fukamachi N, 2015, IEEE ASME INT C ADV, P1102, DOI 10.1109/AIM.2015.7222687; Galantis A, 2003, P ROY SOC B-BIOL SCI, V270, P1493, DOI 10.1098/rspb.2003.2403; German J., 2000, SANDIA LAB NEWS, V52; Gerratt AP, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/1/014010; Gosline J, 2002, PHILOS T R SOC B, V357, P121, DOI 10.1098/rstb.2001.1022; Gronenberg W, 1996, ZOOL-ANAL COMPLEX SY, V99, P153; Gronenberg W, 1996, J COMP PHYSIOL A, V178, P727, DOI 10.1007/BF00225821; GRONENBERG W, 1993, SCIENCE, V262, P561, DOI 10.1126/science.262.5133.561; Haldane DW, 2016, SCI ROBOT, V1, DOI 10.1126/scirobotics.aag2048; HEITLER WJ, 1974, J COMP PHYSIOL, V89, P93, DOI 10.1007/BF00696166; Hillier K. W., 1949, P PHYS SOC         B, V62, P111, DOI [DOI 10.1088/0370-1301/62/2/304, 10.1088/0370-1301/62/2/304]; Hopkinson B, 1914, PHILOS T R SOC LOND, V213, P437, DOI 10.1098/rsta.1914.0010; Hudspeth M, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4789780; James RS, 2008, PHYSIOL BIOCHEM ZOOL, V81, P176, DOI 10.1086/525290; Johnson AM, 2013, IEEE INT CONF ROBOT, P2568, DOI 10.1109/ICRA.2013.6630928; Justusson B, 2013, INT J IMPACT ENG, V58, P55, DOI 10.1016/j.ijimpeng.2013.01.012; Kagaya K, 2016, J EXP BIOL, V219, P319, DOI 10.1242/jeb.130518; Kaneko M., 2004, AUTOMATION CONGRESS, P117; KER RF, 1988, J ZOOL, V216, P309, DOI 10.1111/j.1469-7998.1988.tb02432.x; KER RF, 1981, J EXP BIOL, V93, P283; Kim SW, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/3/036004; Klocke D, 2011, ACTA BIOMATER, V7, P2935, DOI 10.1016/j.actbio.2011.04.004; Koch AW, 1998, J CELL SCI, V111, P1545; Koh JS, 2015, SCIENCE, V349, P517, DOI 10.1126/science.aab1637; Koh JS, 2013, IEEE INT CONF ROBOT, P26, DOI 10.1109/ICRA.2013.6630552; Koh JS, 2013, IEEE INT C INT ROBOT, P3796, DOI 10.1109/IROS.2013.6696899; Kovac M, 2008, IEEE INT CONF ROBOT, P373, DOI 10.1109/ROBOT.2008.4543236; Lambrecht BGA, 2005, IEEE INT CONF ROBOT, P1240; Lawrence CC, 2015, INT J NONLIN MECH, V68, P59, DOI 10.1016/j.ijnonlinmec.2014.08.009; Leal L. G., 2007, ADVANCED TRANSPORT P, V7; Li F, 2012, MECHATRONICS, V22, P167, DOI 10.1016/j.mechatronics.2012.01.001; Lindsay W., 2001, IEEE 14 INT C MICROE, P606; Liu FJ, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0083; Mahadevan L, 2000, SCIENCE, V288, P95, DOI 10.1126/science.288.5463.95; McHenry MJ, 2016, J EXP BIOL, V219, P3399, DOI 10.1242/jeb.140590; Moon F. C., 2007, THE MACHINES OF LEON; Mott PH, 2011, J POLYM SCI POL PHYS, V49, P1195, DOI 10.1002/polb.22292; Muller UK, 2004, SCIENCE, V304, P217; Mulliken AD, 2006, INT J SOLIDS STRUCT, V43, P1331, DOI 10.1016/j.ijsolstr.2005.04.016; Munoz MM, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2325; Namiki A, 2003, IROS 2003: PROCEEDINGS OF THE 2003 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P2666; Niemczura J. G., 2010, TECH REP; Niiyama R, 2007, IEEE INT CONF ROBOT, P2546, DOI 10.1109/ROBOT.2007.363848; Noblin X, 2012, SCIENCE, V335, P1322, DOI 10.1126/science.1215985; Noblin X, 2009, J EXP BIOL, V212, P2835, DOI 10.1242/jeb.029975; Nuchter T, 2006, CURR BIOL, V16, pR316, DOI 10.1016/j.cub.2006.03.089; Patek SN, 2007, J EXP BIOL, V210, P3677, DOI 10.1242/jeb.006486; Patek SN, 2006, P NATL ACAD SCI USA, V103, P12787, DOI 10.1073/pnas.0604290103; Patek SN, 2015, AM SCI, V103, P28; Patek SN, 2013, J EXP BIOL, V216, P1317, DOI 10.1242/jeb.078998; Patek SN, 2011, J EXP BIOL, V214, P1973, DOI 10.1242/jeb.038596; Peplowski MM, 1997, J EXP BIOL, V200, P2861; Pringle A, 2005, MYCOLOGIA, V97, P866, DOI 10.3852/mycologia.97.4.866; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Raabe D, 2005, ACTA MATER, V53, P4281, DOI 10.1016/j.actamat.2005.05.027; RITZMANN R, 1973, SCIENCE, V181, P459, DOI 10.1126/science.181.4098.459; Roberts TJ, 2011, J EXP BIOL, V214, P353, DOI 10.1242/jeb.038588; Roberts TJ, 2003, J EXP BIOL, V206, P2567, DOI 10.1242/jeb.00452; Rodgers M. S., 1999, P SOC PHOTO-OPT INS, P212; Roland CM, 2006, RUBBER CHEM TECHNOL, V79, P429, DOI 10.5254/1.3547945; Rollinson D, 2013, PROCEEDINGS OF THE ASME 2013 DYNAMIC SYSTEMS AND CONTROL CONFERENCE (DSCC2013), VOL. 1, DOI 10.1115/DSCC2013-3875; Rome LC, 1998, NEWS PHYSIOL SCI, V13, P261, DOI 10.1152/physiologyonline.1998.13.6.261; Rosario MV, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1561; Rosario MV, 2015, J MORPHOL, V276, P1123, DOI 10.1002/jmor.20398; Sakes A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158277; Siviour C. R., 2016, J DYNAM BEHAV MAT, V2, P15, DOI [10.1007/s40870-016-0052-8, DOI 10.1007/S40870-016-0052-8]; Skotheim JM, 2005, SCIENCE, V308, P1308, DOI 10.1126/science.1107976; Spagnolie S., 2014, COMPLEX FLUIDS IN BI; STAAB GH, 1991, EXP MECH, V31, P232, DOI 10.1007/BF02326065; Stoeter SA, 2002, 2002 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-3, PROCEEDINGS, P721, DOI 10.1109/IRDS.2002.1041476; Sutton GP, 2011, J EXP BIOL, V214, P836, DOI 10.1242/jeb.052399; Tsukagoshi H, 2005, IEEE INT CONF ROBOT, P1276; Tunnicliffe LB, 2015, POLYM TEST, V47, P36, DOI 10.1016/j.polymertesting.2015.07.012; Vermorel R, 2007, P ROY SOC A-MATH PHY, V463, P641, DOI 10.1098/rspa.2006.1781; Versluis M, 2000, SCIENCE, V289, P2114, DOI 10.1126/science.289.5487.2114; Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006; Vincent JFV, 2002, COMPOS PART A-APPL S, V33, P1311, DOI 10.1016/S1359-835X(02)00167-7; Vincent O, 2011, P ROY SOC B-BIOL SCI, V278, P2909, DOI 10.1098/rspb.2010.2292; Vogel S, 2005, J BIOSCIENCES, V30, P303, DOI 10.1007/BF02703667; Vogel S, 2005, J BIOSCIENCES, V30, P167, DOI 10.1007/BF02703696; Vogel S., 2009, GLIMPSES OF CREATURE; Weiss P., 2001, SCI NEWS, V159, P88, DOI [10.2307/3981566, DOI 10.2307/3981566]; Wetzel B, 2006, ENG FRACT MECH, V73, P2375, DOI 10.1016/j.engfracmech.2006.05.018; Whitaker DL, 2007, FUNCT ECOL, V21, P219, DOI 10.1111/j.1365-2435.2007.01249.x; Yi J, 2006, POLYMER, V47, P319, DOI 10.1016/j.polymer.2005.10.107; Zaitsev V, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/6/066012; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359; Zhao JG, 2013, IEEE T ROBOT, V29, P602, DOI 10.1109/TRO.2013.2249371; Zhao J, 2011, IEEE INT C SEMANT CO, P141, DOI 10.1109/ICSC.2011.42	128	92	93	9	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387							eaao1082	10.1126/science.aao1082	http://dx.doi.org/10.1126/science.aao1082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1AR	29700237	Green Submitted, Green Accepted			2022-12-28	WOS:000430949600032
J	Matsushita, M; Pearce, EJ				Matsushita, Mai; Pearce, Edward J.			Disrupting metabolism to treat autoimmunity Dimethyl fumarate, a treatment for multiple sclerosis, inhibits Warburg metabolism	SCIENCE			English	Editorial Material							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CELLS; IDENTIFICATION; SUCCINATION; GAPDH; NRF2		[Matsushita, Mai; Pearce, Edward J.] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Pearce, Edward J.] Univ Freiburg, Fac Biol, Freiburg, Germany	Max Planck Society; University of Freiburg	Pearce, EJ (corresponding author), Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany.; Pearce, EJ (corresponding author), Univ Freiburg, Fac Biol, Freiburg, Germany.	pearceed@ie-freiburg.mpg.de		Matsushita, Mai/0000-0001-5693-461X				Baker KF, 2018, ANN RHEUM DIS, V77, P175, DOI 10.1136/annrheumdis-2017-211555; Biatnik M, 2008, ANN NY ACAD SCI, V1126, P272, DOI 10.1196/annals.1433.047; Blewett MM, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7694; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Kornberg MD, 2018, SCIENCE, V360, P449, DOI 10.1126/science.aan4665; Liberti MV, 2017, CELL METAB, V26, P648, DOI 10.1016/j.cmet.2017.08.017; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Mills EA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00005; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Piroli GG, 2014, BIOCHEM J, V462, P231, DOI 10.1042/BJ20131581; Puleston DJ, 2017, CELL METAB, V26, P131, DOI 10.1016/j.cmet.2017.06.019; SAKAI K, 1991, BIOCHIM BIOPHYS ACTA, V1077, P192, DOI 10.1016/0167-4838(91)90058-8; Schulze-Topphoff U, 2016, P NATL ACAD SCI USA, V113, P4777, DOI 10.1073/pnas.1603907113; Yun J, 2015, SCIENCE, V350, P1391, DOI 10.1126/science.aaa5004	14	7	7	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					377	378		10.1126/science.aat4984	http://dx.doi.org/10.1126/science.aat4984			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1AR	29700251				2022-12-28	WOS:000430949600020
J	Horton, R				Horton, Richard			Offline: The legacy and lessons of May '68	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2018	391	10130					1560	1560		10.1016/S0140-6736(18)30934-6	http://dx.doi.org/10.1016/S0140-6736(18)30934-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GD5JG	29695333	Bronze			2022-12-28	WOS:000430542700009
J	Filbin, MG; Tirosh, I; Hovestadt, V; Shaw, ML; Escalante, LE; Mathewson, ND; Neftel, C; Frank, N; Pelton, K; Hebert, C; Haberler, C; Yizhak, K; Gojo, J; Egervari, K; Mount, C; van Galen, P; Bonal, DM; Nguyen, QD; Beck, A; Sinai, C; Czech, T; Dorfer, C; Goumnerova, L; Lavarino, C; Carcaboso, AM; Mora, J; Mylvaganam, R; Luo, CC; Peyrl, A; Popovic, M; Azizi, A; Batchelor, TT; Frosch, MP; Martinez-Lage, M; Kieran, MW; Bandopadhayay, P; Beroukhim, R; Fritsch, G; Getz, G; Rozenblatt-Rosen, O; Wucherpfennig, KW; Louis, DN; Monje, M; Slavc, I; Ligon, KL; Golub, TR; Regev, A; Bernstein, BE; Suva, ML				Filbin, Mariella G.; Tirosh, Itay; Hovestadt, Volker; Shaw, McKenzie L.; Escalante, Leah E.; Mathewson, Nathan D.; Neftel, Cyril; Frank, Nelli; Pelton, Kristine; Hebert, ChristineM.; Haberler, Christine; Yizhak, Keren; Gojo, Johannes; Egervari, Kristof; Mount, Christopher; van Galen, Peter; Bonal, Dennis M.; Quang-De Nguyen; Beck, Alexander; Sinai, Claire; Czech, Thomas; Dorfer, Christian; Goumnerova, Liliana; Lavarino, Cinzia; Carcaboso, Angel M.; Mora, Jaume; Mylvaganam, Ravindra; Luo, Christina C.; Peyrl, Andreas; Popovic, Mara; Azizi, Amedeo; Batchelor, Tracy T.; Frosch, Matthew P.; Martinez-Lage, Maria; Kieran, Mark W.; Bandopadhayay, Pratiti; Beroukhim, Rameen; Fritsch, Gerhard; Getz, Gad; Rozenblatt-Rosen, Orit; Wucherpfennig, Kai W.; Louis, David N.; Monje, Michelle; Slavc, Irene; Ligon, Keith L.; Golub, Todd R.; Regev, Aviv; Bernstein, Bradley E.; Suva, Mario L.			Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq	SCIENCE			English	Article							STEM-CELLS; GLIOBLASTOMA; HETEROGENEITY; MUTATION; MOUSE	Gliomas with histone H3 lysine27-to-methionine mutations (H3K27M-glioma) arise primarily in the midline of the central nervous system of young children, suggesting a cooperation between genetics and cellular context in tumorigenesis. Although the genetics of H3K27M-glioma are well characterized, their cellular architecture remains uncharted. We performed single-cell RNA sequencing in 3321 cells from six primary H3K27M-glioma and matched models. We found that H3K27M-glioma primarily contain cells that resemble oligodendrocyte precursor cells (OPC-like), whereas more differentiated malignant cells are a minority. OPC-like cells exhibit greater proliferation and tumor-propagating potential than their more differentiated counterparts and are at least in part sustained by PDGFRA signaling. Our study characterizes oncogenic and developmental programs in H3K27M-glioma at single-cell resolution and across genetic subclones, suggesting potential therapeutic targets in this disease.	[Filbin, Mariella G.; Hovestadt, Volker; Shaw, McKenzie L.; Escalante, Leah E.; Neftel, Cyril; Hebert, ChristineM.; Egervari, Kristof; van Galen, Peter; Beck, Alexander; Mylvaganam, Ravindra; Luo, Christina C.; Frosch, Matthew P.; Martinez-Lage, Maria; Getz, Gad; Louis, David N.; Bernstein, Bradley E.; Suva, Mario L.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Filbin, Mariella G.; Hovestadt, Volker; Shaw, McKenzie L.; Escalante, Leah E.; Neftel, Cyril; Hebert, ChristineM.; Egervari, Kristof; van Galen, Peter; Beck, Alexander; Mylvaganam, Ravindra; Luo, Christina C.; Frosch, Matthew P.; Martinez-Lage, Maria; Louis, David N.; Bernstein, Bradley E.; Suva, Mario L.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Filbin, Mariella G.; Hovestadt, Volker; Shaw, McKenzie L.; Escalante, Leah E.; Mathewson, Nathan D.; Neftel, Cyril; Hebert, ChristineM.; Egervari, Kristof; van Galen, Peter; Beck, Alexander; Mylvaganam, Ravindra; Luo, Christina C.; Frosch, Matthew P.; Martinez-Lage, Maria; Beroukhim, Rameen; Getz, Gad; Wucherpfennig, Kai W.; Louis, David N.; Bernstein, Bradley E.; Suva, Mario L.] Harvard Med Sch, Boston, MA 02114 USA; [Filbin, Mariella G.; Sinai, Claire; Goumnerova, Liliana; Kieran, Mark W.; Bandopadhayay, Pratiti; Ligon, Keith L.; Golub, Todd R.] Dana Farber Boston Childrens Canc & Blood Disorde, Dept Pediat Oncol, Boston, MA 02215 USA; [Filbin, Mariella G.; Tirosh, Itay; Hovestadt, Volker; Shaw, McKenzie L.; Escalante, Leah E.; Neftel, Cyril; Hebert, ChristineM.; van Galen, Peter; Rozenblatt-Rosen, Orit; Regev, Aviv; Bernstein, Bradley E.; Suva, Mario L.] Broad Inst Harvard & Massachussetts Inst Technol, Klarman Cell Observ, Cambridge, MA 02142 USA; [Filbin, Mariella G.; Tirosh, Itay; Hovestadt, Volker; Shaw, McKenzie L.; Escalante, Leah E.; Neftel, Cyril; Hebert, ChristineM.; Yizhak, Keren; van Galen, Peter; Bandopadhayay, Pratiti; Getz, Gad; Rozenblatt-Rosen, Orit; Ligon, Keith L.; Golub, Todd R.; Regev, Aviv; Bernstein, Bradley E.; Suva, Mario L.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Filbin, Mariella G.; Gojo, Johannes; Peyrl, Andreas; Slavc, Irene] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Tirosh, Itay] Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel; [Mathewson, Nathan D.; Wucherpfennig, Kai W.] Dana Farber Canc Inst, Dept Neurol, Dept Microbiol & Immunobiol, Dept Canc Immunol & Virol, Boston, MA 02215 USA; [Neftel, Cyril] CHU Vaudois, Fac Biol & Med, Inst Pathol, CH-1011 Lausanne, Switzerland; [Frank, Nelli; Fritsch, Gerhard] Med Univ Vienna, St Anna Kinderspital, CCRI, Vienna, Austria; [Pelton, Kristine; Sinai, Claire; Ligon, Keith L.] Boston Childrens Hosp, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Oncol Pathol, Boston, MA 02215 USA; [Haberler, Christine] Med Univ Vienna, Inst Neurol, Vienna, Austria; [Mount, Christopher; Monje, Michelle] Stanford Univ, Dept Neurol, Sch Med, Stanford, CA 94305 USA; [Mount, Christopher; Monje, Michelle] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Mount, Christopher; Monje, Michelle] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Bonal, Dennis M.; Quang-De Nguyen] Dana Farber Canc Inst, Lurie Family Imaging Ctr, Ctr Biomed Imaging Oncol, Boston, MA 02215 USA; [Czech, Thomas; Dorfer, Christian] Med Univ Vienna, Dept Neurosurg, Vienna, Austria; [Lavarino, Cinzia; Carcaboso, Angel M.; Mora, Jaume] Hosp St Joan Deu, Dev Tumor Biol Lab, Barcelona 08950, Spain; [Popovic, Mara] Univ Ljubljana, Inst Pathol, Fac Med, Ljubljana, Slovenia; [Batchelor, Tracy T.] Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Div Hematol Oncol,Dept Neurol, Boston, MA USA; [Batchelor, Tracy T.] Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Div Hematol Oncol,Dept Radiat Oncol, Boston, MA USA; [Beroukhim, Rameen] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Beroukhim, Rameen] Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Koch Inst Integrat Canc Res, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Medical University of Vienna; Weizmann Institute of Science; Harvard University; Dana-Farber Cancer Institute; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Medical University of Vienna; Saint Anna Children's Hospital; Harvard University; Boston Children's Hospital; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Medical University of Vienna; Stanford University; Stanford University; Stanford University; Harvard University; Dana-Farber Cancer Institute; Medical University of Vienna; University of Barcelona; University of Ljubljana; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Bernstein, BE; Suva, ML (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.; Bernstein, BE; Suva, ML (corresponding author), Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA.; Bernstein, BE; Suva, ML (corresponding author), Harvard Med Sch, Boston, MA 02114 USA.; Regev, A; Bernstein, BE; Suva, ML (corresponding author), Broad Inst Harvard & Massachussetts Inst Technol, Klarman Cell Observ, Cambridge, MA 02142 USA.; Regev, A; Bernstein, BE; Suva, ML (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.; Regev, A (corresponding author), MIT, Howard Hughes Med Inst, Koch Inst Integrat Canc Res, Dept Biol, Cambridge, MA 02139 USA.	aregev@broadinstitute.org; bernstein.bradley@mgh.harvard.edu; suva.mario@mgh.harvard.edu	Hovestadt, Volker/ABG-2076-2021; Rozenblatt-Rosen, Orit/HDN-4182-2022; Dorfer, Christian/AAP-1990-2020; Suva, Mario/AAY-7798-2020; Frosch, Matthew P/ABD-7456-2021; Martinez-Lage, Maria/S-6665-2019	Hovestadt, Volker/0000-0002-3480-6649; Suva, Mario/0000-0001-9898-5351; Frosch, Matthew P/0000-0002-3940-9861; Filbin, Mariella/0000-0002-2613-8126; Dorfer, Christian/0000-0002-1843-7732; van Galen, Peter/0000-0002-0735-1570; Mount, Christopher/0000-0003-1635-2492; Gojo, Johannes/0000-0002-8113-3416; Mathewson, Nathan/0000-0002-8895-2609; Azizi, Amedeo/0000-0002-1347-6644; Carcaboso, Angel/0000-0002-8485-426X; Martinez-Lage, Maria/0000-0002-5859-7562; czech, thomas/0000-0001-8112-2795	Alex Lemonade Stand; Wang Family Fund; Smith Family Foundation; Broad Institute Broadnext10; V Foundation for Cancer Research; Howard Goodman Fellowship at Massachussetts General Hospital (MGH); Merkin Institute Fellowship at the Broad Institute of MIT and Harvard; Rachel Molly Markoff Foundation; NIH-National Cancer Institute (NCI) brain cancer SPORE [P50CA165962]; MGH department of Pathology; Cure Starts Now Foundation; Hope for Caroline Foundation; Julian Boivin Courage for Cures Foundation; Abbie's Army; Michael Mosier Defeat DIPG Foundation; Reflections of Grace Foundation; Cure Starts Now Australia; Brooke Healey Foundation; Soar With Grace Foundation; Jeffrey Thomas Hayden Foundation; Cure Brain Cancer Foundation; Jones Family Foundation; Musella Foundation; Pray, Hope Believe Foundation; Smiles for Sophie Foundation; Benny's World; Love Chloe Foundation; Aiden's Avengers; A Cure from Caleb Society; Operation Grace White Foundation; Ryan's Hope; Wayland Villars DIPG Foundation; American Childhood Cancer Organization; Juliana Rose Donnelly Trust; Sheila Jones Friends; Ellie Kavalieros DIPG Research Fund; Voices Against Brain Cancer; DIPG Collaborative; Zach Carson Foundation; Micky Czech Foundation; Guglietti Family Trust; Prayers From Maria Foundation; Ryan Harvey Foundation; Markoff Art in Giving; Brock Fleming Foundation; Burroughs Wellcome Fund; K12 Paul Calabresi Career Award for Clinical Oncology-Training Program in Nervous System Tumors [K12CA090354]; Zuckerman STEM Leadership Program; Benoziyo Endowment Fund for the Advancement of Science; European Molecular Biology Organization long-term fellowship; Human Frontier Science Program fellowship; Placide Nicod Foundation; NCI [P01 CA142536, R01CA219943, R01CA188228, R33CA202820]; Fondation Nuovo-Soldati; St. Baldrick's Foundation; Pediatric Brain Tumor Foundation; Gray Matters Brain Cancer Foundation Olivia Caldwell Foundation; Howard Hughes Medical Institute; Klarman Cell Observatory; STARR cancer consortium; Koch Institute Support (core) grant from NCI [P30-CA14051]; Ludwig Center; Broad Institute; NIH Common Fund; National Cancer Institute [DP1CA216873]; American Cancer Society; Ludwig Center at Harvard Medical School; Bernard and Mildred Kayden MGH Research Institute Chair; California Institute of Regenerative Medicine (CIRM) [RB4-06093, RN3-06510]; Lyla Nsouli Foundation; Virginia and D. K. Ludwig Fund for Cancer Research; Alicia Pueyo Foundation;  [1S10RR023440-01A1]; NATIONAL CANCER INSTITUTE [R01CA188228, K12CA090354, DP1CA216873, R33CA202820, P50CA165962, P30CA014051, R01CA219943, U24CA180922, P01CA142536, R01CA215489] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023440] Funding Source: NIH RePORTER	Alex Lemonade Stand; Wang Family Fund; Smith Family Foundation; Broad Institute Broadnext10; V Foundation for Cancer Research; Howard Goodman Fellowship at Massachussetts General Hospital (MGH); Merkin Institute Fellowship at the Broad Institute of MIT and Harvard; Rachel Molly Markoff Foundation; NIH-National Cancer Institute (NCI) brain cancer SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MGH department of Pathology; Cure Starts Now Foundation; Hope for Caroline Foundation; Julian Boivin Courage for Cures Foundation; Abbie's Army; Michael Mosier Defeat DIPG Foundation; Reflections of Grace Foundation; Cure Starts Now Australia; Brooke Healey Foundation; Soar With Grace Foundation; Jeffrey Thomas Hayden Foundation; Cure Brain Cancer Foundation; Jones Family Foundation; Musella Foundation; Pray, Hope Believe Foundation; Smiles for Sophie Foundation; Benny's World; Love Chloe Foundation; Aiden's Avengers; A Cure from Caleb Society; Operation Grace White Foundation; Ryan's Hope; Wayland Villars DIPG Foundation; American Childhood Cancer Organization; Juliana Rose Donnelly Trust; Sheila Jones Friends; Ellie Kavalieros DIPG Research Fund; Voices Against Brain Cancer; DIPG Collaborative; Zach Carson Foundation; Micky Czech Foundation; Guglietti Family Trust; Prayers From Maria Foundation; Ryan Harvey Foundation; Markoff Art in Giving; Brock Fleming Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); K12 Paul Calabresi Career Award for Clinical Oncology-Training Program in Nervous System Tumors; Zuckerman STEM Leadership Program; Benoziyo Endowment Fund for the Advancement of Science; European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); Human Frontier Science Program fellowship(Human Frontier Science Program); Placide Nicod Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fondation Nuovo-Soldati; St. Baldrick's Foundation; Pediatric Brain Tumor Foundation; Gray Matters Brain Cancer Foundation Olivia Caldwell Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Klarman Cell Observatory; STARR cancer consortium; Koch Institute Support (core) grant from NCI; Ludwig Center; Broad Institute; NIH Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Ludwig Center at Harvard Medical School; Bernard and Mildred Kayden MGH Research Institute Chair; California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Lyla Nsouli Foundation; Virginia and D. K. Ludwig Fund for Cancer Research; Alicia Pueyo Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the Alex Lemonade Stand (M.M. and M.L.Su.), the Wang Family Fund (M.L.Su., A.R., B.E.B., and M.M.), the Smith Family Foundation (M.L.Su.), the Broad Institute Broadnext10 (M.L.Su. and O.R.-R.), the V Foundation for Cancer Research (M.L.Su.), the Howard Goodman Fellowship at Massachussetts General Hospital (MGH) (M.L.Su.), the Merkin Institute Fellowship at the Broad Institute of MIT and Harvard (M.L.Su.), the Rachel Molly Markoff Foundation (M.L.Su. and B.E.B.), NIH-National Cancer Institute (NCI) brain cancer SPORE P50CA165962 (M.G.F., T.T.B., and M.L.Su.), start-up funds from the MGH department of Pathology, The Cure Starts Now Foundation, Hope for Caroline Foundation, Julian Boivin Courage for Cures Foundation, Abbie's Army, Michael Mosier Defeat DIPG Foundation, Reflections of Grace Foundation, The Cure Starts Now Australia, Brooke Healey Foundation, Soar With Grace Foundation, Jeffrey Thomas Hayden Foundation, Cure Brain Cancer Foundation, The Jones Family Foundation, Musella Foundation, Pray, Hope Believe Foundation, Smiles for Sophie Foundation, Benny's World, Love Chloe Foundation, Aiden's Avengers, A Cure from Caleb Society, The Operation Grace White Foundation, Ryan's Hope, Wayland Villars DIPG Foundation, Reflections of Grace Foundation, The Cure Starts Now Australia, Brooke Healey Foundation, Soar With Grace Foundation, Jeffrey Thomas Hayden Foundation, Cure Brain Cancer Foundation, The Jones Family Foundation, Musella Foundation, Pray, Hope Believe Foundation, Smiles for Sophie Foundation, Benny's World, Love Chloe Foundation, Aiden's Avengers, A Cure from Caleb Society, The Operation Grace White Foundation, Ryan's Hope, Wayland Villars DIPG Foundation, American Childhood Cancer Organization, Juliana Rose Donnelly Trust, Sheila Jones & Friends, The Ellie Kavalieros DIPG Research Fund, Voices Against Brain Cancer, The DIPG Collaborative, Zach Carson Foundation, the Micky Czech Foundation, The Guglietti Family Trust, Prayers From Maria Foundation, Ryan Harvey Foundation, Markoff Art in Giving, and the Brock Fleming Foundation. M.G.F. holds a Career Award for Medical Scientist from Burroughs Wellcome Fund and K12 Paul Calabresi Career Award for Clinical Oncology-Training Program in Nervous System Tumors (K12CA090354). I.T. was supported by the Zuckerman STEM Leadership Program and the Benoziyo Endowment Fund for the Advancement of Science. V.H. was supported by a European Molecular Biology Organization long-term fellowship and a Human Frontier Science Program fellowship. C.N. is supported by the Placide Nicod Foundation. K.L.L., L.G., and M.W.K. received support from NCI grant P01 CA142536. K.E. is supported by the Fondation Nuovo-Soldati. P.B. and R.B were supported by the St. Baldrick's Foundation, the Pediatric Brain Tumor Foundation, Gray Matters Brain Cancer Foundation Olivia Caldwell Foundation, and NCI (grants R01CA219943 and R01CA188228). A.R. was supported by funds from the Howard Hughes Medical Institute, the Klarman Cell Observatory, STARR cancer consortium, NCI grant 1U24CA180922, NCI grant R33CA202820, by the Koch Institute Support (core) grant P30-CA14051 from NCI, the Ludwig Center, and the Broad Institute. B.E.B. was supported by the NIH Common Fund and National Cancer Institute (grant DP1CA216873), the American Cancer Society, the Ludwig Center at Harvard Medical School, and the Bernard and Mildred Kayden MGH Research Institute Chair. Flow cytometry and sorting services were supported by shared instrumentation grant 1S10RR023440-01A1. M.M.; was supported by the California Institute of Regenerative Medicine (CIRM) grants RB4-06093 and RN3-06510, Lyla Nsouli Foundation, and the Virginia and D. K. Ludwig Fund for Cancer Research. C.L., A.M.C., and J.M. are supported by The Alicia Pueyo Foundation.	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Darmanis S, 2017, CELL REP, V21, P1399, DOI 10.1016/j.celrep.2017.10.030; Funato K, 2014, SCIENCE, V346, P1529, DOI 10.1126/science.1253799; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; La Manno G, 2016, CELL, V167, P566, DOI 10.1016/j.cell.2016.09.027; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Liau BB, 2017, CELL STEM CELL, V20, P233, DOI 10.1016/j.stem.2016.11.003; Marques S, 2016, SCIENCE, V352, P1326, DOI 10.1126/science.aaf6463; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Sturm D, 2014, NAT REV CANCER, V14, P92, DOI 10.1038/nrc3655; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Tirosh I, 2016, NATURE, V539, P309, DOI 10.1038/nature20123; Venteicher AS, 2017, SCIENCE, V355, DOI 10.1126/science.aai8478	14	261	271	6	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2018	360	6386					331	335		10.1126/science.aao4750	http://dx.doi.org/10.1126/science.aao4750			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD3IC	29674595	Green Accepted, Green Published			2022-12-28	WOS:000430396600048
J	Gibney, E				Gibney, Elizabeth			LAST SECONDS OF STARDOM	NATURE			English	News Item							SUPERNOVA											BURBIDGE EM, 1957, REV MOD PHYS, V29, P547, DOI 10.1103/RevModPhys.29.547; COLGATE SA, 1966, ASTROPHYS J, V143, P626, DOI 10.1086/148549; Lentz EJ, 2015, ASTROPHYS J LETT, V807, DOI 10.1088/2041-8205/807/2/L31; Melson T, 2015, ASTROPHYS J LETT, V801, DOI 10.1088/2041-8205/801/2/L24	4	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2018	556	7701					287	289		10.1038/d41586-018-04601-7	http://dx.doi.org/10.1038/d41586-018-04601-7			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1TW	29670276	Bronze			2022-12-28	WOS:000430285200020
J	Grossman, DC; Curry, SJ; Owens, DK; Barry, MJ; Caughey, AB; Davidson, KW; Doubeni, CA; Epling, JW; Kemper, AR; Krist, AH; Kubik, M; Landefeld, S; Mangione, CM; Silverstein, M; Simon, MA; Tseng, CW				Grossman, David C.; Curry, Susan J.; Owens, Douglas K.; Barry, Michael J.; Caughey, Aaron B.; Davidson, Karina W.; Doubeni, Chyke A.; Epling, John W., Jr.; Kemper, Alex R.; Krist, Alex H.; Kubik, Martha; Landefeld, Seth; Mangione, Carol M.; Silverstein, Michael; Simon, Melissa A.; Tseng, Chien-Wen		US Preventive Services Task Force	Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIAL; NON-VERTEBRAL FRACTURES; HIP FRACTURE; D DEFICIENCY; OLDER WOMEN; POSTMENOPAUSAL WOMEN; CLINICAL-TRIAL; UNITED-STATES; ELDERLY-WOMEN; DOUBLE-BLIND	IMPORTANCE Because of the aging population, osteoporotic fractures are an increasingly important cause of morbidity and mortality in the United States. Approximately 2 million osteoporotic fractures occurred in the United States in 2005, and annual incidence is projected to increase to more than 3 million fractures by 2025. Within 1 year of experiencing a hip fracture, many patients are unable to walk independently, more than half require assistance with activities of daily living, and 20% to 30% of patients will die. OBJECTIVE To update the 2013 US Preventive Services Task Force (USPSTF) recommendation on vitamin D supplementation, with or without calcium, to prevent fractures. EVIDENCE REVIEW The USPSTF reviewed the evidence on vitamin D, calcium, and combined supplementation for the primary prevention of fractures in community-dwelling adults (defined as not living in a nursing home or other institutional care setting). The review excluded studies conducted in populations with a known disorder related to bone metabolism (eg, osteoporosis or vitamin D deficiency), taking medications known to be associated with osteoporosis (eg, long-term steroids), or with a previous fracture. FINDINGS The USPSTF found inadequate evidence to estimate the benefits of vitamin D, calcium, or combined supplementation to prevent fractures in community-dwelling men and premenopausal women. The USPSTF found adequate evidence that daily supplementation with 400 IU or less of vitamin D and 1000 mg or less of calcium has no benefit for the primary prevention of fractures in community-dwelling, postmenopausal women. The USPSTF found inadequate evidence to estimate the benefits of doses greater than 400 IU of vitamin D or greater than 1000 mg of calcium to prevent fractures in community-dwelling postmenopausal women. The USPSTF found adequate evidence that supplementation with vitamin D and calcium increases the incidence of kidney stones. CONCLUSIONS AND RECOMMENDATION The USPSTF concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in community-dwelling, asymptomatic men and premenopausal women. (I statement) The USPSTF concludes that the current evidence is insufficient to assess the balance of the benefits and harms of daily supplementation with doses greater than 400 IU of vitamin D and greater than 1000 mg of calcium for the primary prevention of fractures in community-dwelling, postmenopausal women. (I statement) The USPSTF recommends against daily supplementation with 400 IU or less of vitamin D and 1000 mg or less of calcium for the primary prevention of fractures in community-dwelling, postmenopausal women. (D recommendation) These recommendations do not apply to persons with a history of osteoporotic fractures, increased risk for falls, or a diagnosis of osteoporosis or vitamin D deficiency.	[Grossman, David C.] Kaiser Permanente, Washington Hlth Res Inst, Seattle, WA 98101 USA; [Curry, Susan J.] Univ Iowa, Iowa City, IA USA; [Owens, Douglas K.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Owens, Douglas K.] Stanford Univ, Stanford, CA USA; [Barry, Michael J.] Harvard Med Sch, Boston, MA USA; [Caughey, Aaron B.] Oregon Hlth & Sci Univ, Portland, OR USA; [Davidson, Karina W.] Columbia Univ, New York, NY USA; [Doubeni, Chyke A.] Univ Penn, Philadelphia, PA 19104 USA; [Epling, John W., Jr.] Virginia Tech Caril Sch Med, Roanoke, VA USA; [Kemper, Alex R.] Nationwide Childrens Hosp, Columbus, OH USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA USA; [Kubik, Martha] Temple Univ, Philadelphia, PA 19122 USA; [Landefeld, Seth] Univ Alabama Birmingham, Birmingham, AL USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Silverstein, Michael] Boston Univ, Boston, MA 02215 USA; [Simon, Melissa A.] Northwestern Univ, Evanston, IL USA; [Tseng, Chien-Wen] Univ Hawaii, Honolulu, HI 96822 USA; [Tseng, Chien-Wen] Pacific Hlth Res & Educ Inst, Honolulu, HI 96822 USA	Kaiser Permanente; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Harvard University; Harvard Medical School; Oregon Health & Science University; Columbia University; University of Pennsylvania; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Virginia Commonwealth University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; Boston University; Northwestern University; University of Hawaii System; Pacific Health Research & Education Institute	Grossman, DC (corresponding author), Kaiser Permanente, Washington Hlth Res Inst, Seattle, WA 98101 USA.	chair@uspstf.net	Davidson, Karina/AAG-2388-2019; Davidson, Karina/GWC-0996-2022; Epling, John W/J-1097-2019	Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X; Epling, John W/0000-0001-9445-8669; Kemper, Alex/0000-0001-5491-3997	Agency for Healthcare Research and Quality (AHRQ)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	Amer Geriatrics Soc Workgrp Vitami, 2014, J AM GERIATR SOC, V62, P147, DOI 10.1111/jgs.12631; Bouvard B, 2012, ANN ONCOL, V23, P1151, DOI 10.1093/annonc/mdr356; Brauer CA, 2009, JAMA-J AM MED ASSOC, V302, P1573, DOI 10.1001/jama.2009.1462; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Calonge N, 2011, ANN INTERN MED, V154, P356, DOI 10.7326/0003-4819-154-5-201103010-00307; Cawthon PM, 2011, CLIN ORTHOP RELAT R, V469, P1900, DOI 10.1007/s11999-011-1780-7; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; Ensrud KE, 2013, J GERONTOL A-BIOL, V68, P1236, DOI 10.1093/gerona/glt092; FAO/WHO/UNU, 2004, FAO FOOD NUTR TECH R, V1, P103; Goss PE, 2014, LANCET ONCOL, V15, P474, DOI 10.1016/S1470-2045(14)70035-X; Grossman DC, 2018, JAMA-J AM MED ASSOC, V319, P1696, DOI 10.1001/jama.2018.3097; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; HCUPnet, HEALTHC COST UT PROJ; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Holroyd C, 2008, BEST PRACT RES CL EN, V22, P671, DOI 10.1016/j.beem.2008.06.001; Institute of Medicine, 2011, DIETARY REFERENCE IN; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Kahwati LC, 2018, AHRQ PUBLICATION; Kahwati LC, 2018, JAMA-J AM MED ASSOC, V319, P1600, DOI 10.1001/jama.2017.21640; Khaw KT, 2017, LANCET DIABETES ENDO, V5, P438, DOI 10.1016/S2213-8587(17)30103-1; Komulainen MH, 1998, MATURITAS, V31, P45, DOI 10.1016/S0378-5122(98)00085-1; Lappe J, 2017, JAMA-J AM MED ASSOC, V317, P1234, DOI 10.1001/jama.2017.2115; LeFevre ML, 2015, ANN INTERN MED, V162, P133, DOI 10.7326/M14-2450; Lips P, 1996, ANN INTERN MED, V124, P400, DOI 10.7326/0003-4819-124-4-199602150-00003; MAGAZINER J, 1990, J GERONTOL, V45, pM101, DOI 10.1093/geronj/45.3.M101; Michael YL, 2018, AHRQ PUBLICATION, V17-05232-EF-1; Moyer Virginia A, 2013, Ann Intern Med, V158, P691, DOI 10.7326/0003-4819-158-9-201305070-00603; Office of the Surgeon General (US), 2004, BON HLTH OST REP SUR; Olszynski WP, 2004, CLIN THER, V26, P15, DOI 10.1016/S0149-2918(04)90002-1; Parkkari J, 1999, CALCIFIED TISSUE INT, V65, P183; Recker RR, 1996, J BONE MINER RES, V11, P1961; Reid IR, 2008, ARCH INTERN MED, V168, P2276, DOI 10.1001/archinte.168.20.2276; Riggs BL, 1998, J BONE MINER RES, V13, P168, DOI 10.1359/jbmr.1998.13.2.168; Robbins J, 2007, JAMA-J AM MED ASSOC, V298, P2389, DOI 10.1001/jama.298.20.2389; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Scragg R, 2017, JAMA CARDIOL, V2, P608, DOI 10.1001/jamacardio.2017.0175; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; US Department of Agriculture Agricultural Research Service Beltsville Human Nutrition Research Center Food Surveys Research Group and US 1002 Department of Health and Human Services Centers for Disease Control and Prevention National Center for Health Statistics, 2013, WHAT WE EAT AM NHANE; Vondracek SF, 2009, PHARMACOTHERAPY, V29, P305, DOI 10.1592/phco.29.3.305	41	93	97	1	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2018	319	15					1592	1599		10.1001/jama.2018.3185	http://dx.doi.org/10.1001/jama.2018.3185			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD0UT	29677309	Bronze			2022-12-28	WOS:000430217100019
J	Melnik, OE				Melnik, OE			Volcanology - Fragmenting magma	NATURE			English	Editorial Material							ERUPTIONS		Moscow State Univ, Inst Mech, Moscow 117192, Russia	Lomonosov Moscow State University	Melnik, OE (corresponding author), Moscow State Univ, Inst Mech, 1 Mitchurinski Prospect, Moscow 117192, Russia.		Melnik, Oleg E/E-4224-2010; Melnik, Oleg/O-3733-2019	Melnik, Oleg E/0000-0002-4655-5269; Melnik, Oleg/0000-0002-4655-5269				Alidibirov M, 1996, NATURE, V380, P146, DOI 10.1038/380146a0; ALIDIBIROV MA, 1994, B VOLCANOL, V56, P459, DOI 10.1007/s004450050055; BARMIN AA, 1993, IZV ROS AKAD NAUK ME, V2, P49; DOBRAN F, 1992, J VOLCANOL GEOTH RES, V49, P285, DOI 10.1016/0377-0273(92)90019-A; Papale P, 1999, NATURE, V397, P425, DOI 10.1038/17109; SLEZIN YB, 1991, VULKANOL SEISMOL+, V1, P35; WILSON L, 1980, J VOLCANOL GEOTH RES, V8, P297, DOI 10.1016/0377-0273(80)90110-9; WILSON L, 1980, GEOPHYS J ROY ASTR S, V63, P117, DOI 10.1111/j.1365-246X.1980.tb02613.x	8	9	9	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					394	395		10.1038/17029	http://dx.doi.org/10.1038/17029			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667970				2022-12-28	WOS:000078461700028
J	Schiermeier, Q				Schiermeier, Q			German science council clashes with anti-nuclear government	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					375	375		10.1038/16976	http://dx.doi.org/10.1038/16976			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667971	Bronze			2022-12-28	WOS:000078461700009
J	Singer, W				Singer, W			Neurobiology - Striving for coherence	NATURE			English	Editorial Material									Max Planck Inst Brain Res, D-60528 Frankfurt, Germany	Max Planck Society	Singer, W (corresponding author), Max Planck Inst Brain Res, Deutschordenstr 46, D-60528 Frankfurt, Germany.		Singer, Wolf/D-6874-2012					Alais D, 1998, NAT NEUROSCI, V1, P160, DOI 10.1038/414; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Hebb Donald O., 1949, ORG BEHAV; Leonards U, 1996, VISION RES, V36, P2689, DOI 10.1016/0042-6989(96)86829-5; Miltner WHR, 1999, NATURE, V397, P434, DOI 10.1038/17126; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; ROELFSEMA PR, 1997, NATURE, V385, P57; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Usher M, 1998, NATURE, V394, P179, DOI 10.1038/28166; VONDERMALSBURG C, 1985, BER BUNSEN PHYS CHEM, V89, P703, DOI 10.1002/bbpc.19850890625	12	127	128	0	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	1999	397	6718					391	+		10.1038/17021	http://dx.doi.org/10.1038/17021			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164KA	29667958				2022-12-28	WOS:000078461700026
